Citrus Sinensis ID: 047739
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1099 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGS2 | 1136 | Probable LRR receptor-lik | yes | no | 0.995 | 0.963 | 0.681 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.916 | 0.914 | 0.340 | 1e-147 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.936 | 0.863 | 0.325 | 1e-147 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.890 | 0.888 | 0.331 | 1e-143 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.952 | 0.836 | 0.316 | 1e-142 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.907 | 0.887 | 0.321 | 1e-141 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.896 | 0.788 | 0.333 | 1e-140 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.932 | 0.873 | 0.316 | 1e-138 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.907 | 0.873 | 0.329 | 1e-136 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.882 | 0.863 | 0.322 | 1e-134 |
| >sp|C0LGS2|Y4361_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g36180 OS=Arabidopsis thaliana GN=At4g36180 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1467 bits (3799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 776/1139 (68%), Positives = 910/1139 (79%), Gaps = 45/1139 (3%)
Query: 1 MALSAFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRG 60
M +S F F+++ AP S A + EI+ALT+FKLNLHDPLGAL WD STPAAPCDWRG
Sbjct: 3 MDISLFFIFLVIYAPLVSYADESQAEIDALTAFKLNLHDPLGALTSWDPSTPAAPCDWRG 62
Query: 61 VACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVF 120
V CTN+RVTE+RLPRLQLSGRISD +S LRMLRKLSLRSNSFNGTIP +LA CT L +VF
Sbjct: 63 VGCTNHRVTEIRLPRLQLSGRISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVF 122
Query: 121 LQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSI 180
LQYNSLSG LP + NL++LE+ NVA NRLSGEI LP +L++ D+SSN FSG IP+ +
Sbjct: 123 LQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLPSSLQFLDISSNTFSGQIPSGL 182
Query: 181 SNLSQLQLINFSFNKFSREVPATF----------------EGTLPSAIANCSSLVHLSAQ 224
+NL+QLQL+N S+N+ + E+PA+ +GTLPSAI+NCSSLVHLSA
Sbjct: 183 ANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSAS 242
Query: 225 GNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNV 284
N +GGVIP A GALPKL+V+SL+ NN SG VP S+FCN S + +VQLGFNAF+++
Sbjct: 243 ENEIGGVIPAAYGALPKLEVLSLSNNNFSGTVPFSLFCNTS-----LTIVQLGFNAFSDI 297
Query: 285 AGPET-GSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWR 343
PET +C + LQVLDLQ+N+I G FPLWLT +L LDVSGN SG+IP IG L R
Sbjct: 298 VRPETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKR 357
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
LEELK+ANNS G +PVEIKQC SL +LD EGN G+IPEFLG ++ LK L+L N FS
Sbjct: 358 LEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFS 417
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
G +P+S NL LE LNL N+L+GS P E++ + +LS LDLS N+FSG VP SI NLS
Sbjct: 418 GYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLSN 477
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
L NLSGN FSG IPAS+GNL KLT LDLSKQN SGE+P+EL+GLPN+QVIALQ N S
Sbjct: 478 LSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFS 537
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583
G VPEGFSSL+SLRY+NLS N F G+IP TF FLR +V LS S NHISGSIPPE+GNCS
Sbjct: 538 GVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSA 597
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
LEVLELRSN L GHIP D+S L L VLDL NNL+GEIP EIS+ SSL SL ++ NHLS
Sbjct: 598 LEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLS 657
Query: 644 GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG-LMNFNVSSNNLQA---------- 692
G IP S + LSNL +DLS NNL+GEIPA+L+ I L+ FNVSSNNL+
Sbjct: 658 GVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPASLGSRI 717
Query: 693 -----FANNQDLCGKPLGRKCEN--ADDRDRRKKLILLIVIAASGACLLALCCCFYIFSL 745
F+ N +LCGKPL R+CE+ A+ + +++K+IL+IV+AA GA LL+L CCFY+++L
Sbjct: 718 NNTSEFSGNTELCGKPLNRRCESSTAEGKKKKRKMILMIVMAAIGAFLLSLFCCFYVYTL 777
Query: 746 LRWRRRLK-ESAAAEKKRSPARASSG---ASGGRRSSTDNGGPKLVMFNNKITLAETVEA 801
L+WR++LK +S EKKRSP R S+G S RSST+NG PKLVMFNNKITLAET+EA
Sbjct: 778 LKWRKKLKQQSTTGEKKRSPGRTSAGSRVRSSTSRSSTENGEPKLVMFNNKITLAETIEA 837
Query: 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNL 860
TRQFDEENVLSRTRYGL+FKA YNDGMVLSIRRLP+GS L+ENLF+KEAE LGKV+HRN+
Sbjct: 838 TRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLNENLFKKEAEVLGKVKHRNI 897
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
TVLRGYYAG PDLRLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGL FL
Sbjct: 898 TVLRGYYAGPPDLRLLVYDYMPNGNLSTLLQEASHQDGHVLNWPMRHLIALGIARGLGFL 957
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H SNMVHGDIKPQNVLFDADFEAH+SDFGLDRLTI +P+ ++ + +GTLGYVSPEA L
Sbjct: 958 HQSNMVHGDIKPQNVLFDADFEAHISDFGLDRLTIRSPSRSAVTANTIGTLGYVSPEATL 1017
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+GE T+ESD+YSFGIVLLE+LTGKRPVMFTQDEDIVKWVKKQLQ+GQ+TELLEPGLLELD
Sbjct: 1018 SGEITRESDIYSFGIVLLEILTGKRPVMFTQDEDIVKWVKKQLQRGQVTELLEPGLLELD 1077
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
PESSEWEEFLLG+KV LLCTA DP+DRPTMSD+VFMLEGCRVGPD+PSSADPT+QPSPA
Sbjct: 1078 PESSEWEEFLLGIKVGLLCTATDPLDRPTMSDVVFMLEGCRVGPDVPSSADPTSQPSPA 1136
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 524 bits (1349), Expect = e-147, Method: Compositional matrix adjust.
Identities = 388/1141 (34%), Positives = 560/1141 (49%), Gaps = 134/1141 (11%)
Query: 5 AFLFFVLLCAPFSSCAVDR-SPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVAC 63
FL V+LC+ FS V + E L FK L+D G L W+ + PC+W G+AC
Sbjct: 6 CFLAIVILCS-FSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQ-LDSNPCNWTGIAC 63
Query: 64 TNNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
T+ R VT + L + LSG +S + L LRKL++ +N +G IP L+ C L + L
Sbjct: 64 THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLC 123
Query: 123 YNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPTSI 180
N G +P + + L+ L + N L G I + +L+ + SN +G IP S+
Sbjct: 124 TNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSM 183
Query: 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240
+ L QL++I N FS G +PS I+ C SL L N L G +P + L
Sbjct: 184 AKLRQLRIIRAGRNGFS--------GVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQ 235
Query: 241 KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLD 300
L + L QN LSG +P P G+ S L+VL
Sbjct: 236 NLTDLILWQNRLSGEIP-----------------------------PSVGNISR-LEVLA 265
Query: 301 LQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPV 360
L +N G+ P + + + + RL + N ++G+IP +IG L E+ + N G +P
Sbjct: 266 LHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPK 325
Query: 361 EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420
E +L LL L N G IP LG++ L+ L L+ N +G+IP + LP L +L
Sbjct: 326 EFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQ 385
Query: 421 LRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480
L N L G +P + +N S LD+S N SG +PA L++ +L N SG IP
Sbjct: 386 LFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPR 445
Query: 481 SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLN 540
L LT L L +G LPIEL L NL + L +N LSGN+ L +L L
Sbjct: 446 DLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLR 505
Query: 541 LSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPT 600
L+ N F G+IP L +V + S N ++G IP ELG+C ++ L+L N +G+I
Sbjct: 506 LANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQ 565
Query: 601 DISHLSHLNVLDLSINNLTGEIPD------------------------EISKCSSLR-SL 635
++ L +L +L LS N LTGEIP E+ K +SL+ SL
Sbjct: 566 ELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISL 625
Query: 636 LVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA--- 692
++ N+LSG IPDSL L L +L L+ N LSGEIPA++ ++ L+ N+S+NNL
Sbjct: 626 NISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP 685
Query: 693 ------------FANNQDLCG------KPLGRKCENA-----DDRDRRKKLILLIVIAAS 729
FA N LC +PL ++ + R+K L + ++ S
Sbjct: 686 DTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGS 745
Query: 730 GACLLALCCCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMF 789
+ L C+ I +RR A E + P S F
Sbjct: 746 VFLITFLGLCWTI------KRREPAFVALEDQTKPDVMDS-----------------YYF 782
Query: 790 NNK-ITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRL---PDGSLDENLF 845
K T V+ATR F E+ VL R G V+KA + G V+++++L +G+ +N F
Sbjct: 783 PKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSF 842
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPM 905
R E LGK+RHRN+ L G + + LL+Y+YM G+LG LQ + +L+W
Sbjct: 843 RAEISTLGKIRHRNIVKLYG-FCYHQNSNLLLYEYMSKGSLGEQLQRG--EKNCLLDWNA 899
Query: 906 RHLIALGVARGLAFLHTS---NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
R+ IALG A GL +LH +VH DIK N+L D F+AH+ DFGL +L I S
Sbjct: 900 RYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL-IDLSYSKS 958
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM-FTQDEDIVKWVKK 1021
S A G+ GY++PE A T + T++ D+YSFG+VLLEL+TGK PV Q D+V WV++
Sbjct: 959 MSAVA-GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRR 1017
Query: 1022 QLQKGQIT-ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
++ T E+ + L D + E L +K+AL CT+ P RPTM ++V M+
Sbjct: 1018 SIRNMIPTIEMFDARLDTNDKRTV--HEMSLVLKIALFCTSNSPASRPTMREVVAMITEA 1075
Query: 1081 R 1081
R
Sbjct: 1076 R 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1345), Expect = e-147, Method: Compositional matrix adjust.
Identities = 390/1199 (32%), Positives = 580/1199 (48%), Gaps = 170/1199 (14%)
Query: 21 VDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSG 80
VD S E +L SFK +L +P L+ W+ S+ A+ CDW GV C RV L LP L L G
Sbjct: 21 VDLSSETTSLISFKRSLENP-SLLSSWNVSSSASHCDWVGVTCLLGRVNSLSLPSLSLRG 79
Query: 81 RISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNL 140
+I +S+L+ LR+L L N F+G IP + L+ + L NSL+G LP + L L
Sbjct: 80 QIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQL 139
Query: 141 EILNVAANRLSGEIAN----DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKF 196
L+++ N SG + LP L D+S+N SG IP I LS L + N F
Sbjct: 140 LYLDLSDNHFSGSLPPSFFISLPA-LSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSF 198
Query: 197 SREVPAT----------------FEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240
S ++P+ F G LP I+ L L N L IP + G L
Sbjct: 199 SGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELH 258
Query: 241 KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV-LQVL 299
L +++L L G++P + G S++ + L FN+ ++GP S + L
Sbjct: 259 NLSILNLVSAELIGLIPPEL-----GNCKSLKSLMLSFNS---LSGPLPLELSEIPLLTF 310
Query: 300 DLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVP 359
++NQ+ G+ P W+ + L L ++ N SG+IP +I L+ L +A+N G++P
Sbjct: 311 SAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIP 370
Query: 360 VEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP----- 414
E+ SL +DL GN SG I E L L L N +GSIP LP
Sbjct: 371 RELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALD 430
Query: 415 ------------------GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA 456
L +N L G LP E+ +L L LS+N+ +GE+P
Sbjct: 431 LDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPR 490
Query: 457 SIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQ--- 513
IG L+ L V NL+ N F G+IP LG+ LTTLDL N G++P ++ L LQ
Sbjct: 491 EIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLV 550
Query: 514 ---------------------------------VIALQENKLSGNVPEGFSSLMSLRYLN 540
+ L N+LSG +PE + L ++
Sbjct: 551 LSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEIS 610
Query: 541 LSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHI-- 598
LS N G+IPA+ S L ++ +L SGN ++GSIP E+GN L+ L L +N L GHI
Sbjct: 611 LSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPE 670
Query: 599 ----------------------PTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL 636
P + +L L +DLS NNL+GE+ E+S L L
Sbjct: 671 SFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLY 730
Query: 637 VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA---- 692
+ N +G IP L L+ L LD+S N LSGEIP + + L N++ NNL+
Sbjct: 731 IEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPS 790
Query: 693 -----------FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFY 741
+ N++LCG+ +G C+ + R I +++ + +
Sbjct: 791 DGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGLMLG------FTIIVFVF 844
Query: 742 IFSLLRW--RRRLKESAAAEKKRSPARASSGA-------SGGRRSSTDNGGPKLVMFNN- 791
+FSL RW +R+K+ E+ +R SG R S + + MF
Sbjct: 845 VFSLRRWAMTKRVKQRDDPERMEE-SRLKGFVDQNLYFLSGSR--SREPLSINIAMFEQP 901
Query: 792 --KITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENL-FRKE 848
K+ L + VEAT F ++N++ +G V+KAC +++++L + N F E
Sbjct: 902 LLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAE 961
Query: 849 AEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDG--HVLNWPMR 906
E LGKV+H NL L GY + + + +LLVY+YM NG+L L+ +Q G VL+W R
Sbjct: 962 METLGKVKHPNLVSLLGYCSFSEE-KLLVYEYMVNGSLDHWLR---NQTGMLEVLDWSKR 1017
Query: 907 HLIALGVARGLAFLHTS---NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
IA+G ARGLAFLH +++H DIK N+L D DFE ++DFGL RL + E+
Sbjct: 1018 LKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI--SACESHV 1075
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM--FTQDE--DIVKWV 1019
ST GT GY+ PE + T + DVYSFG++LLEL+TGK P F + E ++V W
Sbjct: 1076 STVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWA 1135
Query: 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+++ +G+ ++++P L+ + ++S+ L +++A+LC A P RP M D++ L+
Sbjct: 1136 IQKINQGKAVDVIDPLLVSVALKNSQ----LRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-143, Method: Compositional matrix adjust.
Identities = 372/1122 (33%), Positives = 543/1122 (48%), Gaps = 143/1122 (12%)
Query: 26 EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNN----RVTELRLPRLQLSGR 81
E + L K D L W+S+ + PC W GV C+N V L L + LSG+
Sbjct: 30 EGQYLLEIKSKFVDAKQNLRNWNSND-SVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGK 88
Query: 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLE 141
+S + L L++L L N +G IP + C+ L + L N G +P IG L +LE
Sbjct: 89 LSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLE 148
Query: 142 ILNVAANRLSG----EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFS 197
L + NR+SG EI N L +L SN SG +P SI NL +L N S
Sbjct: 149 NLIIYNNRISGSLPVEIGNLL--SLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMIS 206
Query: 198 REVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVP 257
G+LPS I C SLV L N L G +P IG L KL V L +N SG +P
Sbjct: 207 --------GSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIP 258
Query: 258 ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA 317
E +C+S L+ L L +NQ+ G P L
Sbjct: 259 R-----------------------------EISNCTS-LETLALYKNQLVGPIPKELGDL 288
Query: 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377
+L L + N ++G IP +IG L E+ + N+ G +P+E+ L LL L N+
Sbjct: 289 QSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQ 348
Query: 378 FSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGM 437
+G IP L ++ L L L+ N +G IP F+ L GL L L NSLSG++P ++
Sbjct: 349 LTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWY 408
Query: 438 NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN 497
++L LD+S+N SG +P+ + S +++ NL N SG IP + L L L++ N
Sbjct: 409 SDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNN 468
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557
G P L N+ I L +N+ G++P + +L+ L L+ NGF G++P L
Sbjct: 469 LVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGML 528
Query: 558 RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617
+ L+ S N ++G +P E+ NC L+ L++ N+ +G +P+++ L L +L LS NN
Sbjct: 529 SQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNN 588
Query: 618 LTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAV-LDLSANNLSGEIP----- 671
L+G IP + S L L + N +G IP L L+ L + L+LS N L+GEIP
Sbjct: 589 LSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSN 648
Query: 672 ----------------------ANLSSIFGLMNFNVSSNNL------------QAFANNQ 697
ANLSS+ G +N S N+L +F N+
Sbjct: 649 LVMLEFLLLNNNNLSGEIPSSFANLSSLLG---YNFSYNSLTGPIPLLRNISMSSFIGNE 705
Query: 698 DLCGKPLGR----------KCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLR 747
LCG PL + + R K+I + G L+ + Y+
Sbjct: 706 GLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLM---- 761
Query: 748 WRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDE 807
RR ++ A++ + P+ S D P F T + V AT FDE
Sbjct: 762 -RRPVRTVASSAQDGQPSEM----------SLDIYFPPKEGF----TFQDLVAATDNFDE 806
Query: 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLP---DGSLDENL---FRKEAEFLGKVRHRNLT 861
V+ R G V+KA G L++++L +G + N+ FR E LG +RHRN+
Sbjct: 807 SFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIV 866
Query: 862 VLRGY--YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
L G+ + G+ LL+Y+YMP G+LG +L + S L+W R IALG A+GLA+
Sbjct: 867 KLHGFCNHQGS---NLLLYEYMPKGSLGEILHDPSCN----LDWSKRFKIALGAAQGLAY 919
Query: 920 LHTS---NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
LH + H DIK N+L D FEAH+ DFGL ++ I P S S A G+ GY++P
Sbjct: 920 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV-IDMPHSKSMSAIA-GSYGYIAP 977
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVM-FTQDEDIVKWVKKQLQKGQITELLEPG 1035
E A T + T++SD+YS+G+VLLELLTGK PV Q D+V WV+ +++ ++ +
Sbjct: 978 EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDA 1037
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
L L+ E L +K+ALLCT+ P+ RP+M +V ML
Sbjct: 1038 RLTLEDERI-VSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 389/1231 (31%), Positives = 585/1231 (47%), Gaps = 184/1231 (14%)
Query: 7 LFFVLLCAPFSSCAVDRSPEIEAL----TSFKLNLHDPLGALNGWDSSTPAAPCDWRGVA 62
LFF+ + S + +++ L SF N + L W+S +P+ C+W GV
Sbjct: 10 LFFLCFSSGLGSGQPGQRDDLQTLLELKNSFITNPKEE-DVLRDWNSGSPSY-CNWTGVT 67
Query: 63 CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPAT------------- 109
C + L L L L+G IS + L + L SN G IP T
Sbjct: 68 CGGREIIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHL 127
Query: 110 ------------LAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAND 157
L L+++ L N L+G +P GNL NL++L +A+ RL+G I +
Sbjct: 128 FSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSR 187
Query: 158 LPR--NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA------------- 202
R L+ L N GPIP I N + L L +FN+ + +PA
Sbjct: 188 FGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNL 247
Query: 203 ---TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPAS 259
+F G +PS + + S+ +L+ GN L G+IP + L LQ + L+ NNL+GV+
Sbjct: 248 GDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEE 307
Query: 260 MF------------CNVSGYPP--------SIRVVQLGFNAFTNVAGPETGSCSSVLQVL 299
+ +SG P S++ + L + E +C S L++L
Sbjct: 308 FWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQS-LKLL 366
Query: 300 DLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG------------------------KIP 335
DL N + G P L + LT L ++ NS+ G K+P
Sbjct: 367 DLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVP 426
Query: 336 AQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395
+IG L +LE + + N F G +PVEI C+ L +D GNR SGEIP +G ++ L L
Sbjct: 427 KEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRL 486
Query: 396 ------------------------TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431
LA N SGSIP+SF L LE + +NSL G+LP
Sbjct: 487 HLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLP 546
Query: 432 EEVLGMNNLS-----------------------TLDLSENKFSGEVPASIGNLSQLMVFN 468
+ ++ + NL+ + D++EN F G++P +G + L
Sbjct: 547 DSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLR 606
Query: 469 LSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPE 528
L N F+GRIP + G + +L+ LD+S+ + SG +P+EL L I L N LSG +P
Sbjct: 607 LGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPT 666
Query: 529 GFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLE 588
L L L LS N FVG +P L +++ L GN ++GSIP E+GN L L
Sbjct: 667 WLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALN 726
Query: 589 LRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL-VNSNHLSGGIP 647
L N L+G +P+ I LS L L LS N LTGEIP EI + L+S L ++ N+ +G IP
Sbjct: 727 LEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIP 786
Query: 648 DSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ-------------AFA 694
+++ L L LDLS N L GE+P + + L N+S NNL+ AF
Sbjct: 787 STISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFV 846
Query: 695 NNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKE 754
N LCG PL C A +++R +VI ++ + L A+ + L K+
Sbjct: 847 GNAGLCGSPLSH-CNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILF-----FKQ 900
Query: 755 SAAAEKKRSPARASSGASGGRRSST--DNGGPKLVMFNNKITLAETVEATRQFDEENVLS 812
+ KK ++ ++ + NGG K + I + +EAT +EE ++
Sbjct: 901 NHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAK-----SDIKWDDIMEATHYLNEEFMIG 955
Query: 813 RTRYGLVFKACYNDGMVLSIRRL--PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
G V+KA +G ++++++ D + F +E + LG +RHR+L L GY +
Sbjct: 956 SGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSK 1015
Query: 871 PD-LRLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHTSN---M 925
D L LL+Y+YM NG++ L + + VL W R IALG+A+G+ +LH +
Sbjct: 1016 ADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPI 1075
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
VH DIK NVL D++ EAHL DFGL + LT ++T G+ GY++PE A + +
Sbjct: 1076 VHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKA 1135
Query: 985 TKESDVYSFGIVLLELLTGKRPV--MFTQDEDIVKWVKKQLQKGQITE----LLEPGLLE 1038
T++SDVYS GIVL+E++TGK P MF ++ D+V+WV+ L +E L++ L
Sbjct: 1136 TEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKS 1195
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPT 1069
L P E E +++AL CT P +RP+
Sbjct: 1196 LLP--CEEEAAYQVLEIALQCTKSYPQERPS 1224
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1293), Expect = e-141, Method: Compositional matrix adjust.
Identities = 367/1141 (32%), Positives = 551/1141 (48%), Gaps = 144/1141 (12%)
Query: 37 LHDPLGALNGWDSSTPAAPCDWRGVACTNNR---------VTELRLPRLQLSGRISDHLS 87
D L L+ W+ PC+W GV C++ VT L L + LSG +S +
Sbjct: 48 FQDSLNRLHNWNG-IDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIG 106
Query: 88 NLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAA 147
L L L+L N+ G IP + C+ L +FL N G++P I LS L N+
Sbjct: 107 GLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICN 166
Query: 148 NRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE 205
N+LSG + ++ NL+ +N +GP+P S+ NL++L N FS
Sbjct: 167 NKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFS-------- 218
Query: 206 GTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265
G +P+ I C +L L N + G +P IG L KLQ V L QN SG +P
Sbjct: 219 GNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPK------- 271
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDV 325
+ G+ +S L+ L L N + G P + +L +L +
Sbjct: 272 ----------------------DIGNLTS-LETLALYGNSLVGPIPSEIGNMKSLKKLYL 308
Query: 326 SGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF 385
N ++G IP ++G L ++ E+ + N G +PVE+ + S L LL L N+ +G IP
Sbjct: 309 YQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNE 368
Query: 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDL 445
L +R L L L+ N +G IP F+NL + L L HNSLSG +P+ + + L +D
Sbjct: 369 LSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDF 428
Query: 446 SENKFSGEVPASIGNLSQLMVFNLS------------------------GNAFSGRIPAS 481
SEN+ SG++P I S L++ NL GN +G+ P
Sbjct: 429 SENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTE 488
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
L L+ L+ ++L + FSG LP E+ LQ + L N+ S N+P S L +L N+
Sbjct: 489 LCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNV 548
Query: 542 SFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
S N G IP+ + + + L S N GS+PPELG+ LE+L L N +G+IP
Sbjct: 549 SSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFT 608
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLR-SLLVNSNHLSGGIPDSLAKLSNLAVLD 660
I +L+HL L + N +G IP ++ SSL+ ++ ++ N SG IP + L L L
Sbjct: 609 IGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLS 668
Query: 661 LSANNLSGEIPANLSSIFGLMNFNVSSNNL-------QAFAN--------NQDLCGKPLG 705
L+ N+LSGEIP ++ L+ N S NNL Q F N N+ LCG L
Sbjct: 669 LNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL- 727
Query: 706 RKCENADD-----------RDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKE 754
R C+ + RR ++I+++ G LL + + R ++
Sbjct: 728 RSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL-----RNPVEP 782
Query: 755 SAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRT 814
+A + P S + + T+ + +EAT+ F + ++ R
Sbjct: 783 TAPYVHDKEPFFQESDI--------------YFVPKERFTVKDILEATKGFHDSYIVGRG 828
Query: 815 RYGLVFKACYNDGMVLSIRRLP--------DGSLDENLFRKEAEFLGKVRHRNLTVLRGY 866
G V+KA G +++++L + + +N FR E LGK+RHRN+ L +
Sbjct: 829 ACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSF 888
Query: 867 -YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-- 923
Y + LL+Y+YM G+LG LL H ++WP R IALG A GLA+LH
Sbjct: 889 CYHQGSNSNLLLYEYMSRGSLGELLHGG---KSHSMDWPTRFAIALGAAEGLAYLHHDCK 945
Query: 924 -NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
++H DIK N+L D +FEAH+ DFGL ++ I P S S A G+ GY++PE A T
Sbjct: 946 PRIIHRDIKSNNILIDENFEAHVGDFGLAKV-IDMPLSKSVSAVA-GSYGYIAPEYAYTM 1003
Query: 983 ETTKESDVYSFGIVLLELLTGKRPVM-FTQDEDIVKWVKKQLQKGQIT-ELLEPGLLELD 1040
+ T++ D+YSFG+VLLELLTGK PV Q D+ W + ++ +T E+L+P L +++
Sbjct: 1004 KVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVE 1063
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML--EGCRVGPDIPSSADPTTQPSP 1098
+ + K+A+LCT P DRPTM ++V ML G R G I S+ + P P
Sbjct: 1064 -DDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIESGERAGKVIVSTTC-SDLPPP 1121
Query: 1099 A 1099
A
Sbjct: 1122 A 1122
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 357/1070 (33%), Positives = 540/1070 (50%), Gaps = 85/1070 (7%)
Query: 71 LRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNL 130
L L +L+G I L L ++ L L+ N G IPA L C+ L N L+G +
Sbjct: 172 LALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTI 231
Query: 131 PANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPTSISNLSQLQL 188
PA +G L NLEILN+A N L+GEI + L L+Y L +N G IP S+++L LQ
Sbjct: 232 PAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQT 291
Query: 189 INFSFNKFSREVPATF----------------EGTLPSAI-ANCSSLVHLSAQGNALGGV 231
++ S N + E+P F G+LP +I +N ++L L G L G
Sbjct: 292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351
Query: 232 IPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGS 291
IP + L+ + L+ N+L+G +P ++F V + + L N P +
Sbjct: 352 IPVELSKCQSLKQLDLSNNSLAGSIPEALFELVE-----LTDLYLHNNTLEGTLSPSISN 406
Query: 292 CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351
++ LQ L L N + G P ++ L L + N SG+IP +IG L+ + M
Sbjct: 407 LTN-LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFG 465
Query: 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR 411
N F G +P I + L+LL L N G +P LG+ L L LA N SGSIP+SF
Sbjct: 466 NHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFG 525
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG------------------- 452
L GLE L L +NSL G+LP+ ++ + NL+ ++LS N+ +G
Sbjct: 526 FLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNN 585
Query: 453 ----EVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAG 508
E+P +GN L L N +G+IP +LG + +L+ LD+S +G +P++L
Sbjct: 586 GFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVL 645
Query: 509 LPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGN 568
L I L N LSG +P L L L LS N FV +P ++VLS GN
Sbjct: 646 CKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGN 705
Query: 569 HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISK 628
++GSIP E+GN L VL L N +G +P + LS L L LS N+LTGEIP EI +
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 629 CSSLRSLL-VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSS 687
L+S L ++ N+ +G IP ++ LS L LDLS N L+GE+P ++ + L NVS
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 688 NNL-------------QAFANNQDLCGKPLGRKCENADDRDRRKKL-ILLIVIAASGACL 733
NNL +F N LCG PL R C ++++ L +VI ++ + L
Sbjct: 826 NNLGGKLKKQFSRWPADSFLGNTGLCGSPLSR-CNRVRSNNKQQGLSARSVVIISAISAL 884
Query: 734 LALCCCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKI 793
A+ + +L +R + +SS + + NG K + I
Sbjct: 885 TAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASK-----SDI 939
Query: 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRL--PDGSLDENLFRKEAEF 851
+ +EAT EE ++ G V+KA +G ++++++ D + F +E +
Sbjct: 940 RWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKT 999
Query: 852 LGKVRHRNLTVLRGYYAGAPD-LRLLVYDYMPNGNLGTLLQEAS---HQDGHVLNWPMRH 907
LG++RHR+L L GY + + L LL+Y+YM NG++ L E + +L+W R
Sbjct: 1000 LGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059
Query: 908 LIALGVARGLAFLHTSN---MVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEAST 963
IA+G+A+G+ +LH +VH DIK NVL D++ EAHL DFGL + LT +
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV--MFTQDEDIVKWVKK 1021
+T + GY++PE A + + T++SDVYS GIVL+E++TGK P +F + D+V+WV+
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 1022 QLQKG--QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT 1069
L+ +L++P L L P E + +++AL CT P +RP+
Sbjct: 1180 HLEVAGSARDKLIDPKLKPLLP--FEEDAACQVLEIALQCTKTSPQERPS 1227
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-138, Method: Compositional matrix adjust.
Identities = 379/1196 (31%), Positives = 589/1196 (49%), Gaps = 171/1196 (14%)
Query: 5 AFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNL-HDPLGALNGWDSSTPAAPCDWRGVAC 63
F FF + A S PEIEAL SFK + +DPLG L+ W C+W G+ C
Sbjct: 14 TFFFFGIALAKQS-----FEPEIEALKSFKNGISNDPLGVLSDWTIIGSLRHCNWTGITC 68
Query: 64 -TNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
+ V + L QL G +S ++NL L+ L L SNSF G IPA + + T L + L
Sbjct: 69 DSTGHVVSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILY 128
Query: 123 YNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR---------------------- 160
N SG++P+ I L N+ L++ N LSG++ ++ +
Sbjct: 129 LNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECL 188
Query: 161 ----NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATF------------ 204
+L+ F + N +G IP SI L+ L ++ S N+ + ++P F
Sbjct: 189 GDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLT 248
Query: 205 ----EGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260
EG +P+ I NCSSLV L N L G IP +G L +LQ + + +N L+ +P+S+
Sbjct: 249 ENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSL 308
Query: 261 FCNVSGYPPSIRVVQLGFNAFT--NVAGP---ETGSCSSVLQVLDLQQNQIRGAFPLWLT 315
F R+ QL + ++ GP E G S L+VL L N G FP +T
Sbjct: 309 F----------RLTQLTHLGLSENHLVGPISEEIGFLES-LEVLTLHSNNFTGEFPQSIT 357
Query: 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375
LT L V N+ISG++PA +G L L L +N G +P I C+ L LLDL
Sbjct: 358 NLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSH 417
Query: 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL 435
N+ +GEIP G + L +++ N F+G IP N LE L++ N+L+G+L +
Sbjct: 418 NQMTGEIPRGFGRMN-LTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIG 476
Query: 436 GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSK 495
+ L L +S N +G +P IGNL L + L N F+GRIP + NL L L +
Sbjct: 477 KLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYS 536
Query: 496 QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFS 555
+ G +P E+ + L V+ L NK SG +P FS L SL YL+L N F G IPA+
Sbjct: 537 NDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLK 596
Query: 556 FLRSV--------------------------VVLSFSGNHISGSIPPELGNCSDLEVLEL 589
L + + L+FS N ++G+IP ELG ++ ++L
Sbjct: 597 SLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDL 656
Query: 590 RSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISK-CSSLRSLLVNSNHLSGGIPD 648
+N +G IP + ++ LD S NNL+G IPDE+ + + SL ++ N SG IP
Sbjct: 657 SNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQ 716
Query: 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ-------AFAN------ 695
S +++L LDLS+NNL+GEIP +L+++ L + ++SNNL+ F N
Sbjct: 717 SFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDL 776
Query: 696 --NQDLCG--KPLGRKC---ENADDRDRRKKLILLIV-----IAASGACLLALCCCFYIF 743
N DLCG KPL + C + + +R ++IL+I+ + +L L CC
Sbjct: 777 MGNTDLCGSKKPL-KPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKE 835
Query: 744 SLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATR 803
+ ES+ + + KL F K E +AT
Sbjct: 836 KKI---ENSSESSLPDL--------------------DSALKLKRFEPK----ELEQATD 868
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIR--RLPDGSLD-ENLFRKEAEFLGKVRHRNL 860
F+ N++ + V+K DG V++++ L + S + + F EA+ L +++HRNL
Sbjct: 869 SFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNL 928
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
+ G+ + + LV +M NGNL + ++ G +L + + + +A G+ +L
Sbjct: 929 VKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLE---KIDLCVHIASGIDYL 985
Query: 921 HTSN---MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV--GTLGYVS 975
H+ +VH D+KP N+L D+D AH+SDFG R+ ++T++T+ GT+GY++
Sbjct: 986 HSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLA 1045
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMF----TQDEDIVKWVKKQL---QKGQI 1028
PE A + T ++DV+SFGI+++EL+T +RP +QD + + V+K + +KG +
Sbjct: 1046 PEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMV 1105
Query: 1029 TEL---LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
L L ++ L E + E+FL K+ L CT+ P DRP M++I+ L R
Sbjct: 1106 RVLDMELGDSIVSLKQEEA-IEDFL---KLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1254), Expect = e-136, Method: Compositional matrix adjust.
Identities = 356/1079 (32%), Positives = 562/1079 (52%), Gaps = 82/1079 (7%)
Query: 47 WDSSTPAAPCD-WRGVACTNNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNG 104
W+S PC+ W + C++ +T++ + + L + +L R L+KL++ + G
Sbjct: 61 WNS-IDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTG 119
Query: 105 TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NL 162
T+P +L C L+ + L N L G++P ++ L NLE L + +N+L+G+I D+ + L
Sbjct: 120 TLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKL 179
Query: 163 KYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLS 222
K L N +G IPT + LS L++I NK G +PS I +CS+L L
Sbjct: 180 KSLILFDNLLTGSIPTELGKLSGLEVIRIGGNK-------EISGQIPSEIGDCSNLTVLG 232
Query: 223 AQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFT 282
++ G +P ++G L KL+ +S+ +SG +P+ + G + + L N+ +
Sbjct: 233 LAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDL-----GNCSELVDLFLYENSLS 287
Query: 283 NVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLW 342
E G + + Q+ L QN + G P + S L +D+S N +SG IP+ IG L
Sbjct: 288 GSIPREIGQLTKLEQLF-LWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLS 346
Query: 343 RLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLF 402
LEE +++N F G++P I CSSL L L+ N+ SG IP LG + L +N
Sbjct: 347 FLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL 406
Query: 403 SGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLS 462
GSIP + L+ L+L NSL+G++P + + NL+ L L N SG +P IGN S
Sbjct: 407 EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCS 466
Query: 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKL 522
L+ L N +G IP+ +G+L K+ LD S G++P E+ LQ+I L N L
Sbjct: 467 SLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSL 526
Query: 523 SGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582
G++P SSL L+ L++S N F G+IPA+ L S+ L S N SGSIP LG CS
Sbjct: 527 EGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCS 586
Query: 583 DLEVLELRSNSLTGHIPTDISHLSHLNV-LDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
L++L+L SN L+G IP+++ + +L + L+LS N LTG+IP +I+ + L L ++ N
Sbjct: 587 GLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNM 646
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLC- 700
L G + LA + NL L++S N+ SG +P N +F ++ N + ++ QD C
Sbjct: 647 LEGDLA-PLANIENLVSLNISYNSFSGYLPDN--KLFRQLSPQDLEGNKKLCSSTQDSCF 703
Query: 701 -----GKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKES 755
G LG ++ D RK + L ++ L+ L +++R RR +
Sbjct: 704 LTYRKGNGLG---DDGDASRTRKLRLTLALLITLTVVLMILGA----VAVIRARRNIDNE 756
Query: 756 AAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEA-TRQFDEENVLSRT 814
+E G F L +V+ R E NV+ +
Sbjct: 757 RDSEL---------------------GETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKG 795
Query: 815 RYGLVFKACYNDGMVLSIRRL----PDGSLDENL------FRKEAEFLGKVRHRNLTVLR 864
G+V++A ++G V+++++L +G DE F E + LG +RH+N+
Sbjct: 796 CSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFL 855
Query: 865 GYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN 924
G + RLL+YDYMPNG+LG+LL E + G L+W +R+ I LG A+GLA+LH
Sbjct: 856 GCCWNR-NTRLLMYDYMPNGSLGSLLHE---RRGSSLDWDLRYRILLGAAQGLAYLHHDC 911
Query: 925 M---VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
+ VH DIK N+L DFE +++DFGL +L + S T G+ GY++PE +
Sbjct: 912 LPPIVHRDIKANNILIGLDFEPYIADFGLAKL-VDEGDIGRCSNTVAGSYGYIAPEYGYS 970
Query: 982 GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI--VKWVKKQLQKGQITELLEPGLLEL 1039
+ T++SDVYS+G+V+LE+LTGK+P+ T E I V WV++ +G + E+L+ L
Sbjct: 971 MKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQ--NRGSL-EVLDSTLRS- 1026
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
+E +E + + ALLC P +RPTM D+ ML+ + + + D + SP
Sbjct: 1027 -RTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSP 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-134, Method: Compositional matrix adjust.
Identities = 362/1123 (32%), Positives = 561/1123 (49%), Gaps = 153/1123 (13%)
Query: 47 WD-SSTPAAPCDWRGVACTNNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNG 104
W +++ A PC+W G+ C +++ V L R ++SG++ + L+ L+ L L +N+F+G
Sbjct: 54 WKINASEATPCNWFGITCDDSKNVASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSG 113
Query: 105 TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NL 162
TIP+TL CT L + L N S +P + +L LE+L + N L+GE+ L R L
Sbjct: 114 TIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKL 173
Query: 163 KYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPAT----------------FEG 206
+ L N +GPIP SI + +L ++ N+FS +P + G
Sbjct: 174 QVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVG 233
Query: 207 TLPSAIA------------------------NCSSLVHLSAQGNALGGVIPPAIGALPKL 242
+LP ++ NC +L+ L N G +PPA+G L
Sbjct: 234 SLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPALGNCSSL 293
Query: 243 QVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV------- 295
+ + NLSG +P+S+ G ++ ++ L N + E G+CSS+
Sbjct: 294 DALVIVSGNLSGTIPSSL-----GMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLND 348
Query: 296 ----------------LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIG 339
L+ L+L +N+ G P+ + ++ +LT+L V N+++G++P ++
Sbjct: 349 NQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMT 408
Query: 340 GLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA 399
+ +L+ + NNSF GA+P + SSL +D GN+ +GEIP L R L+ L L +
Sbjct: 409 EMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGS 468
Query: 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIG 459
NL G+IPAS + + LR N+LSG LP E ++LS LD + N F G +P S+G
Sbjct: 469 NLLHGTIPASIGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGSLG 527
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQE 519
+ L NLS N F+G+IP LGNL L ++LS+ G LP +L+ +L+ +
Sbjct: 528 SCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGF 587
Query: 520 NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579
N L+G+VP FS+ L L LS N F G IP L+ + L + N G IP +G
Sbjct: 588 NSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIG 647
Query: 580 NCSDLEV-LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
DL L+L N LTG IP + L L L++S NNLTG + + +SL + V+
Sbjct: 648 LIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVS 706
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMN------FNVSSNNLQA 692
+N +G IPD NL G++ + SS G N F+ S+N+ A
Sbjct: 707 NNQFTGPIPD----------------NLEGQLLSEPSSFSGNPNLCIPHSFSASNNSRSA 750
Query: 693 FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRL 752
+D + R +++IA + L+ + +F LR R+
Sbjct: 751 LKYCKD-----------QSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGR 799
Query: 753 KESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLS 812
E A T GP L++ NK+ + AT +E+ +
Sbjct: 800 PEKDAY------------------VFTQEEGPSLLL--NKV-----LAATDNLNEKYTIG 834
Query: 813 RTRYGLVFKACYNDGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAG 869
R +G+V++A G V +++RL S ++++ R E + +GKVRHRNL L G++
Sbjct: 835 RGAHGIVYRASLGSGKVYAVKRLVFASHIRANQSMMR-EIDTIGKVRHRNLIKLEGFWLR 893
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---NMV 926
D L++Y YMP G+L +L S ++ +VL+W R+ +ALGVA GLA+LH +V
Sbjct: 894 KDD-GLMLYRYMPKGSLYDVLHGVSPKE-NVLDWSARYNVALGVAHGLAYLHYDCHPPIV 951
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
H DIKP+N+L D+D E H+ DFGL RL + +T T GT GY++PE A +
Sbjct: 952 HRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTATVT---GTTGYIAPENAFKTVRGR 1008
Query: 987 ESDVYSFGIVLLELLTGKRPV--MFTQDEDIVKWVKKQLQ------KGQITELLEPGLLE 1038
ESDVYS+G+VLLEL+T KR V F + DIV WV+ L + +T +++P L++
Sbjct: 1009 ESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVD 1068
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
+SS E+ + ++AL CT DP RPTM D V +LE +
Sbjct: 1069 ELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLEDVK 1111
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1099 | ||||||
| 359476840 | 1130 | PREDICTED: probable LRR receptor-like se | 0.995 | 0.968 | 0.732 | 0.0 | |
| 255581412 | 1143 | Leucine-rich repeat receptor protein kin | 0.989 | 0.951 | 0.737 | 0.0 | |
| 224094931 | 1126 | predicted protein [Populus trichocarpa] | 0.982 | 0.959 | 0.745 | 0.0 | |
| 449434496 | 1131 | PREDICTED: probable LRR receptor-like se | 0.993 | 0.965 | 0.721 | 0.0 | |
| 449531097 | 1131 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.964 | 0.723 | 0.0 | |
| 357483697 | 1131 | Receptor-like protein kinase [Medicago t | 0.987 | 0.959 | 0.701 | 0.0 | |
| 351723079 | 1129 | receptor-like protein kinase precursor [ | 0.981 | 0.955 | 0.686 | 0.0 | |
| 356502132 | 1130 | PREDICTED: probable LRR receptor-like se | 0.995 | 0.968 | 0.691 | 0.0 | |
| 225458087 | 1127 | PREDICTED: probable LRR receptor-like se | 0.993 | 0.968 | 0.684 | 0.0 | |
| 297798294 | 1132 | hypothetical protein ARALYDRAFT_491015 [ | 0.993 | 0.964 | 0.683 | 0.0 |
| >gi|359476840|ref|XP_003631896.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1627 bits (4213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 830/1133 (73%), Positives = 948/1133 (83%), Gaps = 39/1133 (3%)
Query: 1 MALSAFLFFVLLCAPFSSCA---VDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCD 57
+ L+ F +L PF SCA + EIEALT+FKLNLHDPLG LNGWDSSTP+APCD
Sbjct: 3 VTLTPLFFLMLSFTPFLSCAQRSAETLAEIEALTAFKLNLHDPLGVLNGWDSSTPSAPCD 62
Query: 58 WRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLR 117
WRGV C++ RV++LRLPRLQL GR++DHL +L LRKLSLRSN+FNGTIP++L++CTLLR
Sbjct: 63 WRGVGCSSGRVSDLRLPRLQLGGRLTDHLGDLTQLRKLSLRSNAFNGTIPSSLSKCTLLR 122
Query: 118 AVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIP 177
AVFLQYNS SGNLP IGNL+NL++ NVA N LSGE+ DLP L+Y DLSSN FSG IP
Sbjct: 123 AVFLQYNSFSGNLPPEIGNLTNLQVFNVAQNLLSGEVPGDLPLTLRYLDLSSNLFSGQIP 182
Query: 178 TSISNLSQLQLINFSFNKFSREVPATF----------------EGTLPSAIANCSSLVHL 221
S S S LQLIN S+N FS E+P TF +GTLPSAIANCS+L+HL
Sbjct: 183 ASFSAASDLQLINLSYNDFSGEIPVTFGALQQLQYLWLDYNFLDGTLPSAIANCSALIHL 242
Query: 222 SAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281
S +GNAL GV+P AI +LPKLQV+SL+ NNLSG VP+SMFCNVS S+R+VQLGFNAF
Sbjct: 243 SVEGNALRGVVPVAIASLPKLQVISLSHNNLSGAVPSSMFCNVS----SLRIVQLGFNAF 298
Query: 282 TNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGL 341
T++ P T +CSSVLQVLD+QQN + G FPLWLT ++LT LDVSGNS +G +P QIG L
Sbjct: 299 TDIVAPGTATCSSVLQVLDVQQNLMHGVFPLWLTFVTSLTMLDVSGNSFAGALPVQIGNL 358
Query: 342 WRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANL 401
RL+ELKMANNS G +P E+++CS L +LDLEGN+FSG +P FLGD+ LK+L+L NL
Sbjct: 359 LRLQELKMANNSLDGEIPEELRKCSYLRVLDLEGNQFSGAVPAFLGDLTSLKTLSLGENL 418
Query: 402 FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNL 461
FSG IP F L LE LNLRHN+LSG++PEE+L ++NL+TLDLS NK SGE+PA+IGNL
Sbjct: 419 FSGLIPPIFGKLSQLETLNLRHNNLSGTIPEELLRLSNLTTLDLSWNKLSGEIPANIGNL 478
Query: 462 SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
S+L+V N+SGNA+SG+IPA++GNL KLTTLDLSKQ SGE+P EL+GLPNLQ+IALQEN
Sbjct: 479 SKLLVLNISGNAYSGKIPATVGNLFKLTTLDLSKQKLSGEVPDELSGLPNLQLIALQENM 538
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNC 581
LSG+VPEGFSSL+SLRYLNLS N F G IPATF FL+SVVVLS S N I G IP E+GNC
Sbjct: 539 LSGDVPEGFSSLVSLRYLNLSSNSFSGHIPATFGFLQSVVVLSLSENLIGGLIPSEIGNC 598
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
S+L VLEL SNSL+G IP D+S LSHLN L+L NNLTGEIP+EISKCS+L SLL+++NH
Sbjct: 599 SELRVLELGSNSLSGDIPADLSRLSHLNELNLGRNNLTGEIPEEISKCSALTSLLLDTNH 658
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA--------- 692
LSG IP+SL+ LSNL LDLS NNL+GEIPANL+ I GL+NFNVS N+L+
Sbjct: 659 LSGHIPNSLSNLSNLTTLDLSTNNLTGEIPANLTLISGLVNFNVSRNDLEGEIPGLLGSR 718
Query: 693 ------FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLL 746
FA N++LCGKPL RKC+ + RRK+LILL +AASGACL+ALCCCFYIFSLL
Sbjct: 719 FNNPSVFAMNENLCGKPLDRKCKEINTGGRRKRLILLFAVAASGACLMALCCCFYIFSLL 778
Query: 747 RWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFD 806
RWR+RLKE AA EKKRSPARASSGASG R STDNGGPKLVMFNN ITLAET EATRQFD
Sbjct: 779 RWRKRLKEGAAGEKKRSPARASSGASG-GRGSTDNGGPKLVMFNNNITLAETSEATRQFD 837
Query: 807 EENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY 866
EENVLSRTRYGLVFKACYNDGMVLSIRRLPDG LDEN FRKEAE LGKV+HRNLTVLRGY
Sbjct: 838 EENVLSRTRYGLVFKACYNDGMVLSIRRLPDGLLDENTFRKEAEALGKVKHRNLTVLRGY 897
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
YAGA D+RLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGLAFLHT++MV
Sbjct: 898 YAGASDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHTASMV 957
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
HGD+KPQNVLFDADFEAHLSDFGLDRLTI PAEASTS+T+VGTLGYVSPEA LTGETTK
Sbjct: 958 HGDVKPQNVLFDADFEAHLSDFGLDRLTIAAPAEASTSSTSVGTLGYVSPEAVLTGETTK 1017
Query: 987 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK+QLQ+GQ++ELLEPGLLELDPESSEW
Sbjct: 1018 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKRQLQRGQVSELLEPGLLELDPESSEW 1077
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
EEFLLGVKV LLCTAPDP+DRPTM+D VFMLEGCRVGPDIPSSADPT+QPSPA
Sbjct: 1078 EEFLLGVKVGLLCTAPDPLDRPTMADTVFMLEGCRVGPDIPSSADPTSQPSPA 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581412|ref|XP_002531514.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223528867|gb|EEF30868.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1606 bits (4159), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 832/1128 (73%), Positives = 946/1128 (83%), Gaps = 40/1128 (3%)
Query: 9 FVLLCAPFSSCAVDRSPE----IEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACT 64
++LC SS RSPE IE+L SFKLNL DPLGALNGWDSSTP+APCDWRGV CT
Sbjct: 13 LLILC---SSAQTQRSPENLAEIESLMSFKLNLDDPLGALNGWDSSTPSAPCDWRGVFCT 69
Query: 65 NNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYN 124
NRVTELRLP LQL GR+SDHLSNL+ML KLSLRSNSFNGTIP++L++CTLLRA+FLQYN
Sbjct: 70 KNRVTELRLPNLQLGGRLSDHLSNLQMLSKLSLRSNSFNGTIPSSLSKCTLLRALFLQYN 129
Query: 125 SLSGNLPANIGNLSNLEILNVAANRLSGEIA-NDLPRNLKYFDLSSNGFSGPIPTSISNL 183
SLSGNLP ++ NL+ L++LNVA N LSG+I+ N+LP NL Y DLSSN F +P SISN+
Sbjct: 130 SLSGNLPPDMSNLTQLQVLNVAQNHLSGQISSNNLPPNLVYMDLSSNSFISALPESISNM 189
Query: 184 SQLQLINFSFNKFSREVPATFE----------------GTLPSAIANCSSLVHLSAQGNA 227
SQLQLIN S+N+FS +PA+F GTLPSAI NCSSLVHLSA GNA
Sbjct: 190 SQLQLINLSYNQFSGPIPASFGHLQYLQFLWLDYNHLVGTLPSAIVNCSSLVHLSANGNA 249
Query: 228 LGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGP 287
LGGVIP AIGALP LQV+SL++NNLSG VP S+FCNVS YPPS+R+VQLGFN F+ + GP
Sbjct: 250 LGGVIPAAIGALPHLQVLSLSENNLSGSVPLSIFCNVSVYPPSLRIVQLGFNGFSEIVGP 309
Query: 288 ETG-SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346
E+G C SVLQVLDL +NQI G FP+WLT+ ++LT LD SGN SG+IPA+IG + RLE+
Sbjct: 310 ESGGDCFSVLQVLDLSKNQIHGGFPVWLTKVASLTMLDFSGNLFSGEIPAEIGDMSRLEQ 369
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI 406
L MANNSF GA+PVE+KQCSSL +LDLE NRFSGEIP FL DIR LK L+L N F GS+
Sbjct: 370 LWMANNSFSGALPVEMKQCSSLRVLDLERNRFSGEIPAFLSDIRALKELSLGGNQFFGSV 429
Query: 407 PASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV 466
PA+FR+ LE L+L N L+GSLPEE++ M+NL+TLD+S NKFSGE+PA+IGNLS++M
Sbjct: 430 PATFRSFTQLETLSLHDNGLNGSLPEELITMSNLTTLDVSGNKFSGEIPANIGNLSRIMS 489
Query: 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
NLS N FSG+IP+SLGNLL+LTTLDLSKQN SG++P EL+GLPNLQVIALQEN+LSG++
Sbjct: 490 LNLSRNVFSGKIPSSLGNLLRLTTLDLSKQNLSGQVPSELSGLPNLQVIALQENRLSGDI 549
Query: 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEV 586
EGFSSLM LRYLNLS NG GQIP T+ FLRS+VVLS S NHISG IPPELGNCSDLE+
Sbjct: 550 REGFSSLMGLRYLNLSSNGLSGQIPPTYGFLRSLVVLSLSNNHISGVIPPELGNCSDLEI 609
Query: 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGI 646
EL+SN +TGHIP D+SHLSHL VL+L NNL+G+IP+EIS+CSSL SLL+++NHLSG I
Sbjct: 610 FELQSNYVTGHIPADLSHLSHLKVLNLGKNNLSGDIPEEISQCSSLTSLLLDTNHLSGSI 669
Query: 647 PDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ--------------- 691
PDSL+ LSNL+ LDLS NNLSGEIPANL+ I L NVS NNL+
Sbjct: 670 PDSLSNLSNLSSLDLSTNNLSGEIPANLTRIASLAYLNVSGNNLEGEIPFLLGSRFNDPS 729
Query: 692 AFANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRR 751
AFA N +LCGKPL RKC + +RDRRK+LILLIVIAASGACLL LCCCFY+FSLLRWR+R
Sbjct: 730 AFAGNAELCGKPLNRKCVDLAERDRRKRLILLIVIAASGACLLTLCCCFYVFSLLRWRKR 789
Query: 752 LKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVL 811
LK+ AAA +K+ +S A+ G R STDNGGPKL+MFNNKITLAET+EATRQFDEENVL
Sbjct: 790 LKQRAAAGEKKRSPARASSAASGGRGSTDNGGPKLIMFNNKITLAETIEATRQFDEENVL 849
Query: 812 SRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
SRTRYGLVFKACYNDGMVLSIRRLPDGS+DEN+FRKEAEFL KV+HRNLTVLRGYYAG P
Sbjct: 850 SRTRYGLVFKACYNDGMVLSIRRLPDGSMDENMFRKEAEFLSKVKHRNLTVLRGYYAGPP 909
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
D+RLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGLAFLHTSNMVHGDIK
Sbjct: 910 DMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHTSNMVHGDIK 969
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
PQNVLFDADFEAHLSDFGL+ LT ++S+T VGTLGYVSPE LTGE TKESDVY
Sbjct: 970 PQNVLFDADFEAHLSDFGLEHLTTAATTAEASSSTTVGTLGYVSPEVILTGEVTKESDVY 1029
Query: 992 SFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051
SFGIVLLELLTGKRPVMFT+DEDIVKWVKKQLQ+GQITELLEPGLLELDPESSEWEEFLL
Sbjct: 1030 SFGIVLLELLTGKRPVMFTEDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLL 1089
Query: 1052 GVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
GVKV LLCTAPDP+DRPTMSDIVFMLEGCRV DIPSSADPT+QPSPA
Sbjct: 1090 GVKVGLLCTAPDPLDRPTMSDIVFMLEGCRVATDIPSSADPTSQPSPA 1137
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094931|ref|XP_002310296.1| predicted protein [Populus trichocarpa] gi|222853199|gb|EEE90746.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1585 bits (4104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 830/1113 (74%), Positives = 929/1113 (83%), Gaps = 33/1113 (2%)
Query: 18 SCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQ 77
+C ++P+ +ALTS K NLHDPLGAL GWD +TP APCDWRGV CTNNRVTELRLPRLQ
Sbjct: 16 ACKSQQNPQTQALTSIKQNLHDPLGALTGWDPTTPLAPCDWRGVFCTNNRVTELRLPRLQ 75
Query: 78 LSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNL 137
L G++SD ++L LRK+SLRSN NGT+P +LA+CTLLRA+FLQYNS SGNLP I NL
Sbjct: 76 LRGQLSDQFASLTSLRKISLRSNFLNGTLPHSLAKCTLLRALFLQYNSFSGNLPPEISNL 135
Query: 138 SNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFS 197
+NL++LN+A NR SGEI LP +LKY DLSSN FSG IP+S+S+L+QLQLIN S+N+FS
Sbjct: 136 TNLQVLNIAQNRFSGEIPRSLPVSLKYLDLSSNTFSGSIPSSVSDLAQLQLINLSYNQFS 195
Query: 198 REVPATF----------------EGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
+PA+F EGTLPSAIANCSSLVH SA GN LGG+IP AIG LPK
Sbjct: 196 GSIPASFGQLQSLEYLWLDYNILEGTLPSAIANCSSLVHFSANGNRLGGLIPAAIGELPK 255
Query: 242 LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301
LQVVSL++N G VP SMFCNVS YPPS+R+VQLGFN F+ V GPE+G C SVLQVLDL
Sbjct: 256 LQVVSLSENKFVGAVPTSMFCNVSVYPPSLRIVQLGFNGFSGVVGPESGGCFSVLQVLDL 315
Query: 302 QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE 361
Q+N IRG FPLWLTR TLT LDVS N SG +PA+IG L RLEELKM N F VPVE
Sbjct: 316 QENHIRGVFPLWLTRVVTLTMLDVSRNLFSGVVPAEIGNLSRLEELKMGGNGFREVVPVE 375
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
I+QC SL +LDL GN +GEIPE LGD+RGLK L+L N FSGS+P SFRNL GLE LNL
Sbjct: 376 IQQCRSLQVLDLHGNDLAGEIPEVLGDLRGLKVLSLGENQFSGSVPGSFRNLTGLETLNL 435
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAS 481
N L+GSLP+EV+G++NL+TLDLS N FSGE+PA+IGNL+++M+ NLSGN FSGRIP+S
Sbjct: 436 GGNGLNGSLPDEVMGLSNLTTLDLSGNGFSGEIPATIGNLNRVMLLNLSGNGFSGRIPSS 495
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
GNLL+L++LDLS+Q+ SGELP ELAGLPNLQVIALQEN LSG+V EGFSSL+ LRYLNL
Sbjct: 496 FGNLLRLSSLDLSRQSLSGELPSELAGLPNLQVIALQENMLSGDVHEGFSSLLGLRYLNL 555
Query: 542 SFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
S NGF GQIP TF FL+S+VVLS S NHISG IPPELGNCSDLE LEL SNSLTG+IP D
Sbjct: 556 SSNGFSGQIPLTFGFLKSLVVLSLSKNHISGLIPPELGNCSDLETLELESNSLTGNIPGD 615
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
+S L HL VLDL NNL+GEIP+EI KCSSL SL ++SNHLSG IPDSL+ LSNL LDL
Sbjct: 616 LSRLLHLKVLDLGRNNLSGEIPNEIFKCSSLSSLSLDSNHLSGSIPDSLSNLSNLTSLDL 675
Query: 662 SANNLSGEIPANLSSIFGLMNFNVSSNNLQ---------------AFANNQDLCGKPLGR 706
S NNLSG+IP NL+ I GL+ NVS NNL+ AFA+N LCGKPL R
Sbjct: 676 STNNLSGQIPVNLAQISGLVYLNVSRNNLEGGIPTLLGSRFNNPSAFADNPRLCGKPLPR 735
Query: 707 KCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAAAEKKRSPAR 766
C + + +RRK+LILLIV+ SGAC+LALCCCFY +SLLRWR+RLK+ AA EKKRSPAR
Sbjct: 736 NCVDVEASNRRKRLILLIVVVVSGACMLALCCCFYTYSLLRWRKRLKQGAAGEKKRSPAR 795
Query: 767 ASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYND 826
SS G R STDNGGPKLVMFNNKITLAET EATRQFDEENVLSRTRYGLVFKACY+D
Sbjct: 796 PSS-NGSGGRGSTDNGGPKLVMFNNKITLAETTEATRQFDEENVLSRTRYGLVFKACYSD 854
Query: 827 GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886
GMVLSIRRLPDGSLDEN+FRKEAEFL KV+HRNLTVLRGYYAGAPD+RLLVYDYMPNGNL
Sbjct: 855 GMVLSIRRLPDGSLDENMFRKEAEFLSKVKHRNLTVLRGYYAGAPDMRLLVYDYMPNGNL 914
Query: 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946
TLLQEASHQDGHVLNWPMRHLIALG+ARGLAFLHTSN+VHGD+KPQ+VLFDADFEAHLS
Sbjct: 915 ATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHTSNIVHGDVKPQSVLFDADFEAHLS 974
Query: 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
DFGLDRLTI TPAE STS T VGTLGYVSPEA LTGE +KE+DVYSFGIVLLELLTGKRP
Sbjct: 975 DFGLDRLTIATPAEPSTSAT-VGTLGYVSPEAVLTGEVSKEADVYSFGIVLLELLTGKRP 1033
Query: 1007 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID 1066
VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKV LLCTAPDP+D
Sbjct: 1034 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD 1093
Query: 1067 RPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
RPTM DIVFMLEGCRVGPDIPSSADPT+QPSPA
Sbjct: 1094 RPTMPDIVFMLEGCRVGPDIPSSADPTSQPSPA 1126
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434496|ref|XP_004135032.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1560 bits (4040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 815/1129 (72%), Positives = 930/1129 (82%), Gaps = 37/1129 (3%)
Query: 6 FLFFVLLCAPFSSCAVDRSP----EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGV 61
FFV LC S + D EI+AL SFKLNLHDPLGAL WDSSTP APCDWRGV
Sbjct: 5 LFFFVFLCGGLFSSSADTGAQTQLEIQALMSFKLNLHDPLGALTAWDSSTPLAPCDWRGV 64
Query: 62 ACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFL 121
CTNNRVTELRLPRLQLSGR++D L+NLRMLRK S+RSN FNGTIP++L++C LLR++FL
Sbjct: 65 VCTNNRVTELRLPRLQLSGRLTDQLANLRMLRKFSIRSNFFNGTIPSSLSKCALLRSLFL 124
Query: 122 QYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSIS 181
QYN SG LPA GNL+NL +LNVA NRLSG I++DLP +LKY DLSSN FSG IP S+
Sbjct: 125 QYNLFSGGLPAEFGNLTNLHVLNVAENRLSGVISSDLPSSLKYLDLSSNAFSGQIPRSVV 184
Query: 182 NLSQLQLINFSFNKFSREVPATF----------------EGTLPSAIANCSSLVHLSAQG 225
N++QLQ++N SFN+F E+PA+F EGTLPSA+ANCSSLVHLS +G
Sbjct: 185 NMTQLQVVNLSFNRFGGEIPASFGELQELQHLWLDHNVLEGTLPSALANCSSLVHLSVEG 244
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVA 285
NAL GVIP AIGAL LQV+SL+QN LSG VP SMFCNVS + PS+R+VQLGFNAFT++
Sbjct: 245 NALQGVIPAAIGALTNLQVISLSQNGLSGSVPYSMFCNVSSHAPSLRIVQLGFNAFTDIV 304
Query: 286 GPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLE 345
P+T +C S LQVLD+Q NQIRG FPLWLT STL+ LD S N SG+IP+ IG L L+
Sbjct: 305 KPQTATCFSALQVLDIQHNQIRGEFPLWLTGVSTLSVLDFSVNHFSGQIPSGIGNLSGLQ 364
Query: 346 ELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGS 405
EL+M+NNSF G +P+EIK C+S+S++D EGNR +GEIP FLG +RGLK L+L N FSG+
Sbjct: 365 ELRMSNNSFHGEIPLEIKNCASISVIDFEGNRLTGEIPSFLGYMRGLKRLSLGGNRFSGT 424
Query: 406 IPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLM 465
+PAS NL LE LNL N L+G+ P E++G+ NL+ ++L NK SGEVP IGNLS+L
Sbjct: 425 VPASLGNLLELEILNLEDNGLNGTFPLELMGLGNLTVMELGGNKLSGEVPTGIGNLSRLE 484
Query: 466 VFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN 525
+ NLS N+ SG IP+SLGNL KLTTLDLSKQN SGELP EL+GLPNLQVIALQENKLSGN
Sbjct: 485 ILNLSANSLSGMIPSSLGNLFKLTTLDLSKQNLSGELPFELSGLPNLQVIALQENKLSGN 544
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585
VPEGFSSL+ LRYLNLS N F GQIP+ + FLRS+V LS S NHISG +P +LGNCSDLE
Sbjct: 545 VPEGFSSLVGLRYLNLSSNRFSGQIPSNYGFLRSLVSLSLSDNHISGLVPSDLGNCSDLE 604
Query: 586 VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645
LE+RSN+L+GHIP D+S LS+L LDL NNLTGEIP+EIS CS+L SL +NSNHLSG
Sbjct: 605 TLEVRSNALSGHIPADLSRLSNLQELDLGRNNLTGEIPEEISSCSALESLRLNSNHLSGP 664
Query: 646 IPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA------------- 692
IP SL++LSNL LDLS+NNLSG IPANLSSI GL + NVSSNNL+
Sbjct: 665 IPGSLSELSNLTTLDLSSNNLSGVIPANLSSITGLTSLNVSSNNLEGKIPSLLGSRFNSS 724
Query: 693 --FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRR 750
FANN DLCGKPL R C++ D +D+ K+LIL I +AASGA LL LCCCFYIFSLLRWR+
Sbjct: 725 SVFANNSDLCGKPLARHCKDTDKKDKMKRLILFIAVAASGAVLLTLCCCFYIFSLLRWRK 784
Query: 751 RLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENV 810
RLKE A+ EKK SPAR SS A G R S++NGGPKLVMFNNKITLAET+EATRQFDEENV
Sbjct: 785 RLKERASGEKKTSPARVSS-AGSGGRGSSENGGPKLVMFNNKITLAETIEATRQFDEENV 843
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
LSRTRYGLVFKACYNDGMVLSIRRL +GSLDEN+FRKEAE LGK+RHRNLTVLRGYYAG
Sbjct: 844 LSRTRYGLVFKACYNDGMVLSIRRLSNGSLDENMFRKEAEALGKIRHRNLTVLRGYYAGP 903
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
PD+RLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGLAFLH+S+++HGD+
Sbjct: 904 PDMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSSSIIHGDV 963
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
KPQ+VLFDADFEAHLSDFGLDRLTI AEASTST VGTLGY++PEA LTGE TKESDV
Sbjct: 964 KPQSVLFDADFEAHLSDFGLDRLTIAASAEASTSTL-VGTLGYIAPEAVLTGEATKESDV 1022
Query: 991 YSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFL 1050
YSFGIVLLE+LTGK+PVMFT+DEDIVKWVKKQLQ+GQITELLEPGLLELDPESSEWEEFL
Sbjct: 1023 YSFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFL 1082
Query: 1051 LGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
LGVKV LLCTAPDP DRPTMSDIVFMLEGCRVGPDIPSSADPT+QPSPA
Sbjct: 1083 LGVKVGLLCTAPDPRDRPTMSDIVFMLEGCRVGPDIPSSADPTSQPSPA 1131
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531097|ref|XP_004172524.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1560 bits (4038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 816/1128 (72%), Positives = 931/1128 (82%), Gaps = 37/1128 (3%)
Query: 7 LFFVLLCAPFSSCAVDRSP----EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVA 62
+FFV LC S + D EI+AL SFKLNLHDPLGAL WDSSTP APCDWRGV
Sbjct: 6 VFFVFLCGGLFSSSADTGAQTQLEIQALMSFKLNLHDPLGALTAWDSSTPLAPCDWRGVV 65
Query: 63 CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
CTNNRVTELRLPRLQLSGR++D L+NLRMLRK S+RSN FNGTIP++L++C LLR++FLQ
Sbjct: 66 CTNNRVTELRLPRLQLSGRLTDQLANLRMLRKFSIRSNFFNGTIPSSLSKCALLRSLFLQ 125
Query: 123 YNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISN 182
YN SG LPA GNL+NL +LNVA NRLSG I++DLP +LKY DLSSN FSG IP S+ N
Sbjct: 126 YNLFSGGLPAEFGNLTNLHVLNVAENRLSGVISSDLPSSLKYLDLSSNAFSGQIPRSVVN 185
Query: 183 LSQLQLINFSFNKFSREVPATF----------------EGTLPSAIANCSSLVHLSAQGN 226
++QLQ++N SFN+F E+PA+F EGTLPSA+ANCSSLVHLS +GN
Sbjct: 186 MTQLQVVNLSFNRFGGEIPASFGELQELQHLWLDHNVLEGTLPSALANCSSLVHLSVEGN 245
Query: 227 ALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAG 286
AL GVIP AIGAL LQV+SL+QN LSG VP SMFCNVS + PS+R+VQLGFNAFT++
Sbjct: 246 ALQGVIPAAIGALTNLQVISLSQNGLSGSVPYSMFCNVSSHAPSLRIVQLGFNAFTDIVK 305
Query: 287 PETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346
P+T +C S LQVLD+Q NQIRG FPLWLT STL+ LD S N SG+IP+ IG L L+E
Sbjct: 306 PQTATCFSALQVLDIQHNQIRGEFPLWLTGVSTLSVLDFSVNHFSGQIPSGIGNLSGLQE 365
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI 406
L+M+NNSF G +P+EIK C+S+S++D EGNR +GEIP FLG +RGLK L+L N FSG++
Sbjct: 366 LRMSNNSFQGEIPLEIKNCASISVIDFEGNRLTGEIPSFLGYMRGLKRLSLGGNRFSGTV 425
Query: 407 PASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV 466
PAS NL LE LNL N L+G+ P E++G+ NL+ ++L NK SGEVP IGNLS+L +
Sbjct: 426 PASLGNLLELEILNLEDNGLNGTFPLELMGLGNLTVMELGGNKLSGEVPTGIGNLSRLEI 485
Query: 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
NLS N+ SG IP+SLGNL KLTTLDLSKQN SGELP EL+GLPNLQVIALQENKLSGNV
Sbjct: 486 LNLSANSLSGMIPSSLGNLFKLTTLDLSKQNLSGELPFELSGLPNLQVIALQENKLSGNV 545
Query: 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEV 586
PEGFSSL+ LRYLNLS N F GQIP+ + FLRS+V LS S NHISG +P +LGNCSDLE
Sbjct: 546 PEGFSSLVGLRYLNLSSNRFSGQIPSNYGFLRSLVSLSLSDNHISGLVPSDLGNCSDLET 605
Query: 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGI 646
LE+RSN+L+GHIP D+S LS+L LDL NNLTGEIP+EIS CS+L SL +NSNHLSG I
Sbjct: 606 LEVRSNALSGHIPADLSRLSNLQELDLGRNNLTGEIPEEISSCSALESLRLNSNHLSGPI 665
Query: 647 PDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA-------------- 692
P SL++LSNL LDLS+NNLSG IPANLSSI GL + NVSSNNL+
Sbjct: 666 PGSLSELSNLTTLDLSSNNLSGVIPANLSSITGLTSLNVSSNNLEGKIPSLLGSRFNSSS 725
Query: 693 -FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRR 751
FANN DLCGKPL R C++ D +D+ K+LIL I +AASGA LL LCCCFYIFSLLRWR+R
Sbjct: 726 VFANNSDLCGKPLARHCKDTDKKDKMKRLILFIAVAASGAVLLTLCCCFYIFSLLRWRKR 785
Query: 752 LKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVL 811
LKE A+ EKK SPAR SS A G R S++NGGPKLVMFNNKITLAET+EATRQFDEENVL
Sbjct: 786 LKERASGEKKTSPARVSS-AGSGGRGSSENGGPKLVMFNNKITLAETIEATRQFDEENVL 844
Query: 812 SRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
SRTRYGLVFKACYNDGMVLSIRRL +GSLDEN+FRKEAE LGKVRHRNLTVLRGYYAG P
Sbjct: 845 SRTRYGLVFKACYNDGMVLSIRRLSNGSLDENMFRKEAEALGKVRHRNLTVLRGYYAGPP 904
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
D+RLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGLAFLH+S+++HGD+K
Sbjct: 905 DMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSSSIIHGDVK 964
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
PQ+VLFDADFEAHLSDFGLDRLTI AEASTST VGTLGY++PEA LTGE TKESDVY
Sbjct: 965 PQSVLFDADFEAHLSDFGLDRLTIAASAEASTSTL-VGTLGYIAPEAVLTGEATKESDVY 1023
Query: 992 SFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051
SFGIVLLE+LTGK+PVMFT+DEDIVKWVKKQLQ+GQITELLEPGLLELDPESSEWEEFLL
Sbjct: 1024 SFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLL 1083
Query: 1052 GVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
GVKV LLCTAPDP DRPTMSDIVFMLEGCRVGPDIPSSADPT+QPSPA
Sbjct: 1084 GVKVGLLCTAPDPRDRPTMSDIVFMLEGCRVGPDIPSSADPTSQPSPA 1131
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357483697|ref|XP_003612135.1| Receptor-like protein kinase [Medicago truncatula] gi|355513470|gb|AES95093.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1531 bits (3964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 786/1121 (70%), Positives = 920/1121 (82%), Gaps = 36/1121 (3%)
Query: 13 CAPFSSCAVDRS-PEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTEL 71
CAPF S AV + EI+ LTSFKLNLHDPLGAL+GWD S+P APCDWRGVAC N+RVTEL
Sbjct: 13 CAPFLSYAVTVTVTEIQILTSFKLNLHDPLGALDGWDPSSPEAPCDWRGVACNNHRVTEL 72
Query: 72 RLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLP 131
RLPRLQL+G++S+HL LRMLRKLSLRSN FNGTIP TL++C LLR +FLQ N SG++P
Sbjct: 73 RLPRLQLAGKLSEHLGELRMLRKLSLRSNFFNGTIPRTLSKCKLLRFLFLQDNQFSGDIP 132
Query: 132 ANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINF 191
IGNL+ L ILNVA N L+G + + LP LKY D+SSN FSG IP ++ NLS LQL+N
Sbjct: 133 PEIGNLTGLMILNVAQNHLTGTVPSSLPVGLKYLDVSSNAFSGEIPVTVGNLSLLQLVNL 192
Query: 192 SFNKFSREVPATFE----------------GTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
S+N+FS E+PA F GTLPSA+ANCSSLVHLSA+GN+L GVIP A
Sbjct: 193 SYNQFSGEIPARFGELQKLQFLWLDHNFLGGTLPSALANCSSLVHLSAEGNSLSGVIPSA 252
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295
I ALP LQV+SL+ NNL+G +PAS+FCNVS + PS+R+VQLGFN FT+ G ET +C SV
Sbjct: 253 ISALPMLQVMSLSHNNLTGSIPASVFCNVSVHAPSLRIVQLGFNGFTDFVGVETNTCFSV 312
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
LQVLD+Q N IRG FPLWLT +TL+ LD+S N++SG+IP QIG L L ELK+ANNSF
Sbjct: 313 LQVLDIQHNSIRGTFPLWLTNVTTLSVLDLSSNALSGEIPRQIGNLAGLMELKVANNSFN 372
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
G +PVE+ +C SLS++D EGN+F+GE+P F G+++GLK L+L N F GS+PASF NL
Sbjct: 373 GVIPVELMKCKSLSVVDFEGNKFAGEVPTFFGNVKGLKVLSLGGNQFIGSVPASFGNLSL 432
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
LE L+LR N L+G++PE ++ ++NL+TLDLS+NKF+GE+ SIGNL++L V NLSGN FS
Sbjct: 433 LETLSLRSNRLNGTMPEMIMSLSNLTTLDLSDNKFNGEIYDSIGNLNRLTVLNLSGNDFS 492
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
G+I +SLGNL +LTTLDLSKQN SGELP EL+GLPNLQVIALQEN+LSG VPEGFSSLMS
Sbjct: 493 GKISSSLGNLFRLTTLDLSKQNLSGELPFELSGLPNLQVIALQENRLSGVVPEGFSSLMS 552
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L+ +NLS N F GQIP + FLRS+VVLS S N I+G+IP E+GN S +EVLEL SNSL+
Sbjct: 553 LQSVNLSSNAFSGQIPENYGFLRSLVVLSLSHNRITGTIPSEIGNSSAIEVLELGSNSLS 612
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
G IPTD+S L+HL VLDL N LTG++P +ISKC SL +LLV+ NHL G +P SL+ LS
Sbjct: 613 GQIPTDLSRLTHLKVLDLGGNKLTGDMPGDISKCLSLTTLLVDHNHLGGVVPGSLSNLSK 672
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA---------------FANNQDLC 700
LA+LDLSANNLSGEIP+N S + L+ FNVS NNL+ FA+NQ LC
Sbjct: 673 LAMLDLSANNLSGEIPSNFSMMPDLVYFNVSGNNLEGKIPQTMGSRFNNPSLFADNQGLC 732
Query: 701 GKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAAAEK 760
GKPL KCE D+RD +K+LI+L++I A GA LL L CCFYI L RWR++LKE + EK
Sbjct: 733 GKPLESKCEGTDNRD-KKRLIVLVIIIAIGAFLLVLFCCFYIIGLWRWRKKLKEKVSGEK 791
Query: 761 KRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVF 820
K+SPARASS + G R S++NGGPKLVMFN K+TLAET+EATRQFDEENVLSRTRYGLVF
Sbjct: 792 KKSPARASS-GASGGRGSSENGGPKLVMFNTKVTLAETIEATRQFDEENVLSRTRYGLVF 850
Query: 821 KACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880
KACYNDGMVLSIRRLPDGSLDEN+FRKEAE LGK++HRNLTVLRGYYAG PD+RLL YDY
Sbjct: 851 KACYNDGMVLSIRRLPDGSLDENMFRKEAESLGKIKHRNLTVLRGYYAGPPDMRLLAYDY 910
Query: 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940
MPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGLAF+H S MVHGD+KPQNVLFDAD
Sbjct: 911 MPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFIHQSTMVHGDVKPQNVLFDAD 970
Query: 941 FEAHLSDFGLDRLTIPTPA--EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLL 998
FEAHLSDFGL+RLT+P A EA++++T+VGTLGYVSPEA LT E TKESDVYSFGIVLL
Sbjct: 971 FEAHLSDFGLERLTVPASASGEAASTSTSVGTLGYVSPEAILTSEITKESDVYSFGIVLL 1030
Query: 999 ELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALL 1058
ELLTGKRPVMFTQDEDIVKWVKKQLQ+GQITELLEPGLLELDPESSEWEEFLLGVKV LL
Sbjct: 1031 ELLTGKRPVMFTQDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLLGVKVGLL 1090
Query: 1059 CTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
CTAPDP+DRPTMSDIVFMLEGCRVGPDIPSSADPT+Q SPA
Sbjct: 1091 CTAPDPLDRPTMSDIVFMLEGCRVGPDIPSSADPTSQHSPA 1131
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723079|ref|NP_001238034.1| receptor-like protein kinase precursor [Glycine max] gi|212717139|gb|ACJ37411.1| receptor-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1527 bits (3953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 787/1147 (68%), Positives = 923/1147 (80%), Gaps = 68/1147 (5%)
Query: 3 LSAFLFFVLLCAPFSSCAVDRSP----EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDW 58
+ A L ++LCAPF +CA DRS EI+ALTSFKLNLHDP+ AL+G S
Sbjct: 1 MPALLLLMVLCAPFLTCA-DRSAVTIAEIQALTSFKLNLHDPVRALDGLGSVVADG---- 55
Query: 59 RGVACTNNRVTELRLPRLQLSGRIS---------------DHLSNLRMLRKLSLRSNSFN 103
LRL R ++ R S + +S LRMLRK+SLRSNSFN
Sbjct: 56 -----------TLRLARSRMHQRPSHGAASASSSTQWQTHERISELRMLRKISLRSNSFN 104
Query: 104 GTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLK 163
GTIP++L++CTLLR++FLQ NS GNLPA I NL+ L ILNVA N +SG + +LP +LK
Sbjct: 105 GTIPSSLSKCTLLRSLFLQDNSFYGNLPAEIANLTGLMILNVAQNHISGSVPGELPLSLK 164
Query: 164 YFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE----------------GT 207
DLSSN FSG IP+SI+NLSQLQLIN S+N+FS E+PA+ GT
Sbjct: 165 TLDLSSNAFSGEIPSSIANLSQLQLINLSYNQFSGEIPASLGELQQLQYLWLDRNLLGGT 224
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
LPSA+ANCS+L+HLS +GNAL GV+P AI ALP+LQV+SL+QNNL+G +P S+FCN S +
Sbjct: 225 LPSALANCSALLHLSVEGNALTGVVPSAISALPRLQVMSLSQNNLTGSIPGSVFCNRSVH 284
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327
PS+R+V LGFN FT+ GPET +C SVLQVLD+Q N+IRG FPLWLT +TLT LDVS
Sbjct: 285 APSLRIVNLGFNGFTDFVGPETSTCFSVLQVLDIQHNRIRGTFPLWLTNVTTLTVLDVSR 344
Query: 328 NSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLG 387
N++SG++P ++G L +LEELKMANNSF G +PVE+K+C SLS++D EGN F GE+P F G
Sbjct: 345 NALSGEVPPEVGNLIKLEELKMANNSFTGTIPVELKKCGSLSVVDFEGNDFGGEVPSFFG 404
Query: 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447
D+ GL L+L N FSGS+P SF NL LE L+LR N L+GS+PE ++G+NNL+TLDLS
Sbjct: 405 DMIGLNVLSLGGNHFSGSVPVSFGNLSFLETLSLRGNRLNGSMPEMIMGLNNLTTLDLSG 464
Query: 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA 507
NKF+G+V A+IGNL++LMV NLSGN FSG+IP+SLGNL +LTTLDLSK N SGELP+EL+
Sbjct: 465 NKFTGQVYANIGNLNRLMVLNLSGNGFSGKIPSSLGNLFRLTTLDLSKMNLSGELPLELS 524
Query: 508 GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG 567
GLP+LQ++ALQENKLSG+VPEGFSSLMSL+Y+NLS N F G IP + FLRS++VLS S
Sbjct: 525 GLPSLQIVALQENKLSGDVPEGFSSLMSLQYVNLSSNSFSGHIPENYGFLRSLLVLSLSD 584
Query: 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS 627
NHI+G+IP E+GNCS +E+LEL SNSL GHIP DIS L+ L VLDLS NNLTG++P+EIS
Sbjct: 585 NHITGTIPSEIGNCSGIEILELGSNSLAGHIPADISRLTLLKVLDLSGNNLTGDVPEEIS 644
Query: 628 KCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSS 687
KCSSL +L V+ NHLSG IP SL+ LSNL +LDLSANNLSG IP+NLS I GL+ NVS
Sbjct: 645 KCSSLTTLFVDHNHLSGAIPGSLSDLSNLTMLDLSANNLSGVIPSNLSMISGLVYLNVSG 704
Query: 688 NNLQA---------------FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGAC 732
NNL FANNQ LCGKPL +KCE+ + ++ RK+LI+L+V+ A GA
Sbjct: 705 NNLDGEIPPTLGSRFSNPSVFANNQGLCGKPLDKKCEDINGKN-RKRLIVLVVVIACGAF 763
Query: 733 LLALCCCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNK 792
L L CCFY+FSLLRWR+RLK+ + EKK+SPARASSG SG R SST++GGPKLVMFN K
Sbjct: 764 ALVLFCCFYVFSLLRWRKRLKQGVSGEKKKSPARASSGTSGARSSSTESGGPKLVMFNTK 823
Query: 793 ITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFL 852
ITLAET+EATRQFDEENVLSRTR+GLVFKACYNDGMVLSIRRL DGSLDEN+FRKEAE L
Sbjct: 824 ITLAETIEATRQFDEENVLSRTRHGLVFKACYNDGMVLSIRRLQDGSLDENMFRKEAESL 883
Query: 853 GKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG 912
GKV+HRNLTVLRGYYAG PD+RLLV+DYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG
Sbjct: 884 GKVKHRNLTVLRGYYAGPPDMRLLVHDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALG 943
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ARGLAFLH S+MVHGD+KPQNVLFDADFEAHLSDFGLD+LT+ TP EASTST+ VGTLG
Sbjct: 944 IARGLAFLHQSSMVHGDVKPQNVLFDADFEAHLSDFGLDKLTVATPGEASTSTS-VGTLG 1002
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
YVSPEA LTGE TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ+GQITELL
Sbjct: 1003 YVSPEAVLTGEATKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQRGQITELL 1062
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADP 1092
EPGLLELDPESSEWEEFLLGVKV LLCTAPDP+DRPTMSDIVFMLEGCRVGPDIPSSADP
Sbjct: 1063 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPTMSDIVFMLEGCRVGPDIPSSADP 1122
Query: 1093 TTQPSPA 1099
T+QPSPA
Sbjct: 1123 TSQPSPA 1129
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502132|ref|XP_003519875.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1521 bits (3938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 784/1133 (69%), Positives = 917/1133 (80%), Gaps = 39/1133 (3%)
Query: 3 LSAFLFFVLLCAPFSSCAVDRS-PEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGV 61
+S L VLLCA SCA S EI+ALTS KLNLHDPLGALNGWD STP APCDWRGV
Sbjct: 1 MSILLMLVLLCARCLSCAQCGSVTEIQALTSLKLNLHDPLGALNGWDPSTPLAPCDWRGV 60
Query: 62 ACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFL 121
+C N+RVTELRLPRLQLSG++ D +S+LRMLR+LSLRSNSFNGTIP +LA+CTLLRA+FL
Sbjct: 61 SCKNDRVTELRLPRLQLSGQLGDRISDLRMLRRLSLRSNSFNGTIPHSLAKCTLLRALFL 120
Query: 122 QYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSIS 181
QYNSLSG LP I NL+ L+ILNVA N LSGEI +LP LK+ D+S+N FSG IP++++
Sbjct: 121 QYNSLSGQLPPAIANLAGLQILNVAGNNLSGEIPAELPLRLKFIDISANAFSGDIPSTVA 180
Query: 182 NLSQLQLINFSFNKFSREVPA----------------TFEGTLPSAIANCSSLVHLSAQG 225
LS+L LIN S+NKFS ++PA GTLPS++ANCSSLVHLS +G
Sbjct: 181 ALSELHLINLSYNKFSGQIPARIGELQNLQYLWLDHNVLGGTLPSSLANCSSLVHLSVEG 240
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVA 285
NA+ GV+P AI ALP LQV+SLAQNN +G VPAS+FCNVS PS+R+V LGFN FT+ A
Sbjct: 241 NAIAGVLPAAIAALPNLQVLSLAQNNFTGAVPASVFCNVSLKTPSLRIVHLGFNGFTDFA 300
Query: 286 GPETGS-CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL 344
P+ + C SVLQV +Q+N++RG FPLWLT +TL+ LDVSGN++SG+IP +IG L L
Sbjct: 301 WPQPATTCFSVLQVFIIQRNRVRGKFPLWLTNVTTLSVLDVSGNALSGEIPPEIGRLENL 360
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG 404
EELK+ANNSF G +P EI +C SL ++D EGN+FSGE+P F G++ LK L+L N FSG
Sbjct: 361 EELKIANNSFSGVIPPEIVKCWSLRVVDFEGNKFSGEVPSFFGNLTELKVLSLGVNHFSG 420
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
S+P F L LE L+LR N L+G++PEEVLG+ NL+ LDLS NKFSG V +GNLS+L
Sbjct: 421 SVPVCFGELASLETLSLRGNRLNGTMPEEVLGLKNLTILDLSGNKFSGHVSGKVGNLSKL 480
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
MV NLSGN F G +P++LGNL +LTTLDLSKQN SGELP E++GLP+LQVIALQENKLSG
Sbjct: 481 MVLNLSGNGFHGEVPSTLGNLFRLTTLDLSKQNLSGELPFEISGLPSLQVIALQENKLSG 540
Query: 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDL 584
+PEGFSSL SL+++NLS N F G IP + FLRS+V LS S N I+G+IPPE+GNCSD+
Sbjct: 541 VIPEGFSSLTSLKHVNLSSNEFSGHIPKNYGFLRSLVALSLSNNRITGTIPPEIGNCSDI 600
Query: 585 EVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG 644
E+LEL SN L G IP D+S L+HL VLDL +NLTG +P++ISKCS L LL + N LSG
Sbjct: 601 EILELGSNYLEGLIPKDLSSLAHLKVLDLGNSNLTGALPEDISKCSWLTVLLADHNQLSG 660
Query: 645 GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA------------ 692
IP+SLA+LS+L +LDLSANNLSG+IP+NL++I GL+ FNVS NNL+
Sbjct: 661 AIPESLAELSHLTMLDLSANNLSGKIPSNLNTIPGLVYFNVSGNNLEGEIPPMLGSKFNN 720
Query: 693 ---FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWR 749
FANNQ+LCGKPL RKCE D ++R + I+LI+I A G CLLALCCCFYIFSLLRWR
Sbjct: 721 PSVFANNQNLCGKPLDRKCEETDSKERNRL-IVLIIIIAVGGCLLALCCCFYIFSLLRWR 779
Query: 750 RRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEEN 809
RR+K + + EKK+SP +S + RSSTD GPKLVMFN KITLAET+EATRQFDEEN
Sbjct: 780 RRIKAAVSGEKKKSPRTSSGTSQ--SRSSTDTNGPKLVMFNTKITLAETIEATRQFDEEN 837
Query: 810 VLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG 869
VLSRTR+GLVFKACYNDGMVLSIR+L DGSLDEN+FRKEAE LGK+RHRNLTVLRGYYAG
Sbjct: 838 VLSRTRHGLVFKACYNDGMVLSIRKLQDGSLDENMFRKEAESLGKIRHRNLTVLRGYYAG 897
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
PD+RLLV+DYMPNGNL TLLQEASH DGHVLNWPMRHLIALG+ARG+AFLH S+++HGD
Sbjct: 898 PPDVRLLVHDYMPNGNLATLLQEASHLDGHVLNWPMRHLIALGIARGVAFLHQSSLIHGD 957
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIP--TPAEASTSTTA-VGTLGYVSPEAALTGETTK 986
IKPQNVLFDADFEAHLSDFGLD+LT+ EASTS+TA VGTLGYVSPEA LTGE TK
Sbjct: 958 IKPQNVLFDADFEAHLSDFGLDKLTVTNNNAVEASTSSTATVGTLGYVSPEATLTGEATK 1017
Query: 987 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
E DVYSFGIVLLELLTGKRP+MFTQDEDIVKWVKKQLQKGQITELLEPGL ELDPESSEW
Sbjct: 1018 ECDVYSFGIVLLELLTGKRPMMFTQDEDIVKWVKKQLQKGQITELLEPGLFELDPESSEW 1077
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
EEFLLGVKV LLCTAPDP+DRPTMSDIVFMLEGCRVGPDI SSADPT+QPSP
Sbjct: 1078 EEFLLGVKVGLLCTAPDPLDRPTMSDIVFMLEGCRVGPDIASSADPTSQPSPV 1130
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458087|ref|XP_002280668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 776/1134 (68%), Positives = 908/1134 (80%), Gaps = 42/1134 (3%)
Query: 1 MALSAFLFF-VLLCAPFSSCA---VDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPC 56
M + FL+ +LL AP +CA D EI+ALT+FKLNLHDPLGAL+GW+SSTP+APC
Sbjct: 1 MLTAIFLYLSLLLFAPTLTCAQRSADALSEIKALTAFKLNLHDPLGALDGWNSSTPSAPC 60
Query: 57 DWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLL 116
DWRG+ C N RV ELRLPRLQL GR++D LSNLR LRKLSL SN+FNG++P +L+QC+LL
Sbjct: 61 DWRGILCYNGRVWELRLPRLQLGGRLTDQLSNLRQLRKLSLHSNAFNGSVPLSLSQCSLL 120
Query: 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPI 176
RAV+L YNS SG LP + NL+NL++LNVA N LSG I +LPRNL+Y DLSSN FSG I
Sbjct: 121 RAVYLHYNSFSGGLPPALTNLTNLQVLNVAHNFLSGGIPGNLPRNLRYLDLSSNAFSGNI 180
Query: 177 PTSISNLSQLQLINFSFNKFSREVPAT----------------FEGTLPSAIANCSSLVH 220
P + S S LQLIN SFN+FS VPA+ GT+PSAI+NCSSL+H
Sbjct: 181 PANFSVASSLQLINLSFNQFSGGVPASIGELQQLQYLWLDSNQLYGTIPSAISNCSSLLH 240
Query: 221 LSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNA 280
LSA+ NAL G+IP +GA+PKL+V+SL++N LSG VPASMFCNVS PP++ +VQLGFNA
Sbjct: 241 LSAEDNALKGLIPATLGAIPKLRVLSLSRNELSGSVPASMFCNVSANPPTLVIVQLGFNA 300
Query: 281 FTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGG 340
FT + P+ + SVL+VLDLQ+N I G FP WLT STL LD+SGN SG +P +IG
Sbjct: 301 FTGIFKPQNATFFSVLEVLDLQENHIHGVFPSWLTEVSTLRILDLSGNFFSGVLPIEIGN 360
Query: 341 LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN 400
L RLEEL++ANNS G VP EI++CS L +LDLEGNRFSG++P FLG + LK+L+L N
Sbjct: 361 LLRLEELRVANNSLQGEVPREIQKCSLLQVLDLEGNRFSGQLPPFLGALTSLKTLSLGRN 420
Query: 401 LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGN 460
FSGSIPASFRNL LE LNL N+L G + EE+L ++NLS L+LS NKF GEV ++IG+
Sbjct: 421 HFSGSIPASFRNLSQLEVLNLSENNLIGDVLEELLLLSNLSILNLSFNKFYGEVWSNIGD 480
Query: 461 LSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQEN 520
LS L N+SG FSGR+P S+G+L+KL TLDLSKQN SGELP+E+ GLPNLQV+ALQEN
Sbjct: 481 LSSLQELNMSGCGFSGRLPKSIGSLMKLATLDLSKQNMSGELPLEIFGLPNLQVVALQEN 540
Query: 521 KLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN 580
SG+VPEGFSSL+S+RYLNLS N F G++PATF FL+S+VVLS S NH+S IP ELGN
Sbjct: 541 LFSGDVPEGFSSLLSMRYLNLSSNAFSGEVPATFGFLQSLVVLSLSQNHVSSVIPSELGN 600
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
CSDLE LELRSN L+G IP ++S LSHL LDL NNLTGEIP++ISKCSS+ SLL+++N
Sbjct: 601 CSDLEALELRSNRLSGEIPGELSRLSHLKELDLGQNNLTGEIPEDISKCSSMTSLLLDAN 660
Query: 641 HLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA-------- 692
HLSG IPDSL+KLSNL +L+LS+N SG IP N S I L N+S NNL+
Sbjct: 661 HLSGPIPDSLSKLSNLTMLNLSSNRFSGVIPVNFSGISTLKYLNLSQNNLEGEIPKMLGS 720
Query: 693 -------FANNQDLCGKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSL 745
FA N LCGKPL +CE R RR KLILL+ +A GA LLALCCC YIFSL
Sbjct: 721 QFTDPSVFAMNPKLCGKPLKEECEGVTKRKRR-KLILLVCVAVGGATLLALCCCGYIFSL 779
Query: 746 LRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQF 805
LRWR++L+E AA EKKRSPA +S G R S +NGGPKLVMFNNKIT AET+EATRQF
Sbjct: 780 LRWRKKLREGAAGEKKRSPAPSSGGER--GRGSGENGGPKLVMFNNKITYAETLEATRQF 837
Query: 806 DEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRG 865
DEENVLSR RYGLVFKA + DGMVLSIRRLPDGS++EN FRKEAE LGKV+HRNLTVLRG
Sbjct: 838 DEENVLSRGRYGLVFKASFQDGMVLSIRRLPDGSIEENTFRKEAESLGKVKHRNLTVLRG 897
Query: 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
YYAG PD+RLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGL+FLH+ +M
Sbjct: 898 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLSFLHSVSM 957
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT 985
VHGD+KPQNVLFDADFEAHLSDFGLDRLTIPTPAE S+STT +G+LGYVSPEAALTG
Sbjct: 958 VHGDVKPQNVLFDADFEAHLSDFGLDRLTIPTPAEPSSSTTPIGSLGYVSPEAALTG--- 1014
Query: 986 KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045
E+DVYSFGIVLLE+LTG++PVMFTQDEDIVKWVKKQLQ+GQI+ELLEPGLLE+DPESSE
Sbjct: 1015 -EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEIDPESSE 1073
Query: 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
WEEFLLGVKV LLCTAPDP+DRP+MSDIVFMLEGCRVGPDIPSSADPT+ PSP
Sbjct: 1074 WEEFLLGVKVGLLCTAPDPLDRPSMSDIVFMLEGCRVGPDIPSSADPTSLPSPV 1127
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798294|ref|XP_002867031.1| hypothetical protein ARALYDRAFT_491015 [Arabidopsis lyrata subsp. lyrata] gi|297312867|gb|EFH43290.1| hypothetical protein ARALYDRAFT_491015 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1472 bits (3812), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 778/1139 (68%), Positives = 912/1139 (80%), Gaps = 47/1139 (4%)
Query: 1 MALSAFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRG 60
M +S F+++ AP S A + EI+ALT+FKLNLHDPLGAL WD STPAAPCDWRG
Sbjct: 1 MDISLLFIFLVIYAPLFSYADESQAEIDALTAFKLNLHDPLGALTSWDPSTPAAPCDWRG 60
Query: 61 VACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVF 120
V CTN+RVTE+RLPRLQLSGRISD +S LRMLRKLSLRSNS NGTIPA+LA CT L +VF
Sbjct: 61 VGCTNHRVTEIRLPRLQLSGRISDRISGLRMLRKLSLRSNSLNGTIPASLAYCTRLFSVF 120
Query: 121 LQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSI 180
LQYNSLSG LP + NL++LE+ NVA NRLSGEI+ LP +LK+ D+SSN FSG IP+ +
Sbjct: 121 LQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEISVGLPSSLKFLDISSNTFSGQIPSGL 180
Query: 181 SNLSQLQLINFSFNKFSREVPATF----------------EGTLPSAIANCSSLVHLSAQ 224
+NL+QLQL+N S+N+ + E+PA+ +GTLPSAI+NCSSLVHLSA
Sbjct: 181 ANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSAS 240
Query: 225 GNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNV 284
N +GGVIP A GALPKL+V+SL+ NN SG VP S+FCN S +R+VQLGFNAF+++
Sbjct: 241 ENEIGGVIPAAYGALPKLEVISLSNNNFSGTVPFSVFCNTS-----LRIVQLGFNAFSDI 295
Query: 285 AGPET-GSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWR 343
PET +C + LQVLDL++N I G FPLWLT +LT LDVSGN SG+IP IG L R
Sbjct: 296 VRPETTANCRTGLQVLDLRENPISGRFPLWLTNILSLTNLDVSGNLFSGEIPPDIGNLKR 355
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
LEELK+ANNS G +PVEIKQC SL +LDLEGNR G++PEFLG + LK L+L N FS
Sbjct: 356 LEELKLANNSLTGEIPVEIKQCGSLGVLDLEGNRLKGQVPEFLGYMNALKVLSLGRNSFS 415
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
G +P+S NL L+ LNL N+L+GS P E+L + +LS LDLS N+FSGEVP SI NLS
Sbjct: 416 GYVPSSMVNLQQLDRLNLGENNLNGSFPVELLALTSLSELDLSGNRFSGEVPVSISNLSN 475
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
L NLSGN FSG IPAS+GNL KLT LDLSKQN SGE+P+EL+GLPNLQVIALQ N S
Sbjct: 476 LSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNLQVIALQGNNFS 535
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583
G VPEGFSSL+SLRY+NLS N F GQIP TF FLR +V LS S NHISGSIPPE+GNCS
Sbjct: 536 GVVPEGFSSLVSLRYVNLSSNSFSGQIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSA 595
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
LEVLELRSN LTGHIP D+S L L VLDL NNL+GEIP E+S+ SSL SL ++ NHLS
Sbjct: 596 LEVLELRSNRLTGHIPADLSRLPRLKVLDLGRNNLSGEIPPEVSQSSSLNSLSLDHNHLS 655
Query: 644 GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG-LMNFNVSSNNLQA---------- 692
G IP S LSNL +DLS NNL+GEIPA+L+ I L+ FNVSSNNL+
Sbjct: 656 GVIPGS--GLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPASLGSKI 713
Query: 693 -----FANNQDLCGKPLGRKCEN--ADDRDRRKKLILLIVIAASGACLLALCCCFYIFSL 745
F+ N +LCGKPL RKCE+ A+++ +++K+IL+IV+AA GA LL+L CCFY+++L
Sbjct: 714 NNPSEFSGNTELCGKPLNRKCESSTAEEKKKKRKMILMIVMAAIGAFLLSLFCCFYVYTL 773
Query: 746 LRWRRRLKE-SAAAEKKRSPARASSGASGGRRSST---DNGGPKLVMFNNKITLAETVEA 801
L+WR++LK+ S EKKRSP R S+G+ +S +NG PKLVMFNNKITLAET+EA
Sbjct: 774 LKWRKKLKQQSTTGEKKRSPGRTSAGSRVRSSTSRSSTENGEPKLVMFNNKITLAETIEA 833
Query: 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNL 860
TRQFDEENVLSRTRYGL+FKA YNDGMVLSIRRLP+GSL +ENLF+KEAE LGKV+HRN+
Sbjct: 834 TRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLNENLFKKEAEVLGKVKHRNI 893
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
TVLRGYYAG PDLRLLVYDYMPNGNL TLLQEASHQDGHVLNWPMRHLIALG+ARGL FL
Sbjct: 894 TVLRGYYAGPPDLRLLVYDYMPNGNLSTLLQEASHQDGHVLNWPMRHLIALGIARGLGFL 953
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT+ +P+ ++ + +GTLGYVSPEA L
Sbjct: 954 HQSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTVRSPSRSAVTANTIGTLGYVSPEATL 1013
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+GE T+ESD+YSFGIVLLE+LTGKRPVMFTQDEDIVKWVKKQLQ+GQ+TELLEPGLLELD
Sbjct: 1014 SGEITRESDIYSFGIVLLEILTGKRPVMFTQDEDIVKWVKKQLQRGQVTELLEPGLLELD 1073
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
PESSEWEEFLLG+KV LLCTA DP+DRPTMSD+VFMLEGCRVGPD+PSSADPT+QPSPA
Sbjct: 1074 PESSEWEEFLLGIKVGLLCTATDPLDRPTMSDVVFMLEGCRVGPDVPSSADPTSQPSPA 1132
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1099 | ||||||
| TAIR|locus:2005629 | 1140 | AT1G75640 [Arabidopsis thalian | 0.930 | 0.897 | 0.525 | 1.5e-282 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.919 | 0.889 | 0.473 | 1.1e-236 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.608 | 0.607 | 0.334 | 4.1e-134 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.627 | 0.626 | 0.321 | 1.1e-133 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.640 | 0.617 | 0.325 | 1.8e-133 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.606 | 0.593 | 0.323 | 1.8e-133 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.595 | 0.582 | 0.318 | 3.7e-133 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.610 | 0.615 | 0.324 | 1.5e-125 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.612 | 0.606 | 0.327 | 1e-124 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.838 | 0.735 | 0.323 | 3.1e-122 |
| TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2715 (960.8 bits), Expect = 1.5e-282, P = 1.5e-282
Identities = 553/1053 (52%), Positives = 711/1053 (67%)
Query: 67 RVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSL 126
++ +L L ++G + LS LR L L NSF+G P + L+ + +NSL
Sbjct: 93 QLRKLSLHTNDINGAVPSSLSRCVFLRALYLHYNSFSGDFPPEILNLRNLQVLNAAHNSL 152
Query: 127 SGNLPANIGNLSNLEILNVAANRLSGEI-AN-DLPRNLKYFDLSSNGFSGPIPTSISNLS 184
+GNL +++ +L +++++N +SG+I AN +L+ +LS N FSG IP ++ L
Sbjct: 153 TGNL-SDVTVSKSLRYVDLSSNAISGKIPANFSADSSLQLINLSFNHFSGEIPATLGQLQ 211
Query: 185 QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQV 244
L+ + N+ +GT+PSA+ANCSSL+H S GN L G+IP +G + LQV
Sbjct: 212 DLEYLWLDSNQL--------QGTIPSALANCSSLIHFSVTGNHLTGLIPVTLGTIRSLQV 263
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV-LQVLDLQQ 303
+SL++N+ +G VP S+ C SGY S+R++QLG N FT +A P +C + L++LD+ +
Sbjct: 264 ISLSENSFTGTVPVSLLCGYSGYNSSMRIIQLGVNNFTGIAKPSNAACVNPNLEILDIHE 323
Query: 304 NQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIK 363
N+I G FP WLT ++L LD+SGN SG + A++G L L+EL++ANNS G +P I+
Sbjct: 324 NRINGDFPAWLTDLTSLVVLDISGNGFSGGVTAKVGNLMALQELRVANNSLVGEIPTSIR 383
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH 423
C SL ++D EGN+FSG+IP FL +R L +++L N FSG IP+ +L GLE LNL
Sbjct: 384 NCKSLRVVDFEGNKFSGQIPGFLSQLRSLTTISLGRNGFSGRIPSDLLSLYGLETLNLNE 443
Query: 424 NSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAXXX 483
N L+G++P E+ + NL+ L+LS N+FSGEVP+++G+L L V N+SG +GRIP
Sbjct: 444 NHLTGAIPSEITKLANLTILNLSFNRFSGEVPSNVGDLKSLSVLNISGCGLTGRIPVSIS 503
Query: 484 XXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
Q SG+LP+EL GLP+LQV+AL N L G VPEGFSSL+SL+YLNLS
Sbjct: 504 GLMKLQVLDISKQRISGQLPVELFGLPDLQVVALGNNLLGGVVPEGFSSLVSLKYLNLSS 563
Query: 544 NGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDIS 603
N F G IP N ISG+IPPE+GNCS LEVLEL SNSL GHIP +S
Sbjct: 564 NLFSGHIPKNYGFLKSLQVLSLSHNRISGTIPPEIGNCSSLEVLELGSNSLKGHIPVYVS 623
Query: 604 HLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSA 663
LS L LDLS N+LTG IPD+ISK SSL SLL+NSN LSG IP+SL++L+NL LDLS+
Sbjct: 624 KLSLLKKLDLSHNSLTGSIPDQISKDSSLESLLLNSNSLSGRIPESLSRLTNLTALDLSS 683
Query: 664 NNLSGEIPANLSSIFGLMNFNVSSNNLQA---------------FANNQDLCGKPLGRKC 708
N L+ IP++LS + L FN+S N+L+ F N LCGKPLG +C
Sbjct: 684 NRLNSTIPSSLSRLRFLNYFNLSRNSLEGEIPEALAARFTNPTVFVKNPGLCGKPLGIEC 743
Query: 709 ENADDRDRRKKLILLIVIXXXXXXXXXXXXXFYIFSLLRWRRRLKESAAAEKKRSPXXXX 768
N R RR+KLILL+ + Y+FSL +WR +L+ + +KK +P
Sbjct: 744 PNVRRR-RRRKLILLVTLAVAGALLLLLCCCGYVFSLWKWRNKLRLGLSRDKKGTPSRTS 802
Query: 769 XXXXXXXXXXTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGM 828
+NGGPKLVMFNNKITLAET+EATRQFDEENVLSR RYGLVFKA + DGM
Sbjct: 803 RASSGGTRGEDNNGGPKLVMFNNKITLAETLEATRQFDEENVLSRGRYGLVFKATFRDGM 862
Query: 829 VLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLG 887
VLS+RRL DG S+ + FR +AE LG+V+H+N+TVLRGYY G PDLRLLVYDYMPNGNL
Sbjct: 863 VLSVRRLMDGASITDATFRNQAEALGRVKHKNITVLRGYYCGPPDLRLLVYDYMPNGNLA 922
Query: 888 TLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947
TLLQEASHQDGHVLNWPMRHLIALG+ARGL+FLH+ +++HGD+KPQNVLFDADFEAHLS+
Sbjct: 923 TLLQEASHQDGHVLNWPMRHLIALGIARGLSFLHSLSIIHGDLKPQNVLFDADFEAHLSE 982
Query: 948 FGLDRLXXXXXXXXXXXXXX-VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
FGLDRL VG+LGY++PEA LTGET+KESDVYSFGIVLLE+LTGK+
Sbjct: 983 FGLDRLTALTPAEEPSTSSTPVGSLGYIAPEAGLTGETSKESDVYSFGIVLLEILTGKKA 1042
Query: 1007 VMFTQDEDIVKWVKKQLQKGQITXXXXXXXXXXXXXXXXWEEFLLGVKVALLCTAPDPID 1066
VMFT+DEDIVKWVK+QLQKGQI WEEFLLG+KV LLCT D +D
Sbjct: 1043 VMFTEDEDIVKWVKRQLQKGQIVELLEPGLLELDPESSEWEEFLLGIKVGLLCTGGDVVD 1102
Query: 1067 RPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
RP+M+D+VFMLEGCRVGP I SADPT+ SPA
Sbjct: 1103 RPSMADVVFMLEGCRVGPAISLSADPTSPTSPA 1135
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2282 (808.4 bits), Expect = 1.1e-236, P = 1.1e-236
Identities = 497/1049 (47%), Positives = 645/1049 (61%)
Query: 63 CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
CT R+ + L LSG++ + NL L ++ N +G IP L L+ + +
Sbjct: 115 CT--RLLSVFLQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLPSS--LQFLDIS 170
Query: 123 YNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSI 180
N+ SG +P+ + NL+ L++LN++ N+L+GEI L ++L+Y L N G +P++I
Sbjct: 171 SNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAI 230
Query: 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240
SN S L ++ S N+ +PA + G LP L LS N G +P ++
Sbjct: 231 SNCSSLVHLSASENEIGGVIPAAY-GALPK-------LEVLSLSNNNFSGTVPFSLFCNT 282
Query: 241 KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV-- 298
L +V L N S +V N ++V+ L N ++G +++L +
Sbjct: 283 SLTIVQLGFNAFSDIVRPETTANCR---TGLQVLDLQEN---RISGRFPLWLTNILSLKN 336
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
LD+ N G P + L L ++ NS++G+IP +I L+ L NS G +
Sbjct: 337 LDVSGNLFSGEIPPDIGNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQI 396
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
P + +L +L L N FSG +P + +++ L+ L L N +GS P L L
Sbjct: 397 PEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSE 456
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
L+L N SG++P + ++NLS L+LS N FSGE+PAS+GNL +L +LS SG +
Sbjct: 457 LDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEV 516
Query: 479 PAXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRY 538
P NFSG +P + L +L+ + L N SG +P+ F L L
Sbjct: 517 PVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVS 576
Query: 539 LNLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHI 598
L+LS N G IP N + G IP +L L+VL+L N+L+G I
Sbjct: 577 LSLSDNHISGSIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEI 636
Query: 599 PTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLS-NLA 657
P +IS S LN L L N+L+G IP S S+L + ++ N+L+G IP SLA +S NL
Sbjct: 637 PPEISQSSSLNSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLV 696
Query: 658 VLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLGRKCEN--ADDRD 715
++S+NNL GEIPA+L S NN F+ N +LCGKPL R+CE+ A+ +
Sbjct: 697 YFNVSSNNLKGEIPASLGSRI---------NNTSEFSGNTELCGKPLNRRCESSTAEGKK 747
Query: 716 RRKKLILLIVIXXXXXXXXXXXXXFYIFSLLRWRRRLKE-SAAAEKKRSPXXXXXXX--- 771
+++K+IL+IV+ FY+++LL+WR++LK+ S EKKRSP
Sbjct: 748 KKRKMILMIVMAAIGAFLLSLFCCFYVYTLLKWRKKLKQQSTTGEKKRSPGRTSAGSRVR 807
Query: 772 XXXXXXXTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLS 831
T+NG PKLVMFNNKITLAET+EATRQFDEENVLSRTRYGL+FKA YNDGMVLS
Sbjct: 808 SSTSRSSTENGEPKLVMFNNKITLAETIEATRQFDEENVLSRTRYGLLFKANYNDGMVLS 867
Query: 832 IRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLL 890
IRRLP+GSL +ENLF+KEAE LGKV+HRN+TVLRGYYAG PDLRLLVYDYMPNGNL TLL
Sbjct: 868 IRRLPNGSLLNENLFKKEAEVLGKVKHRNITVLRGYYAGPPDLRLLVYDYMPNGNLSTLL 927
Query: 891 QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950
QEASHQDGHVLNWPMRHLIALG+ARGL FLH SNMVHGDIKPQNVLFDADFEAH+SDFGL
Sbjct: 928 QEASHQDGHVLNWPMRHLIALGIARGLGFLHQSNMVHGDIKPQNVLFDADFEAHISDFGL 987
Query: 951 DRLXXXXXXXXXXXXXXVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT 1010
DRL +GTLGYVSPEA L+GE T+ESD+YSFGIVLLE+LTGKRPVMFT
Sbjct: 988 DRLTIRSPSRSAVTANTIGTLGYVSPEATLSGEITRESDIYSFGIVLLEILTGKRPVMFT 1047
Query: 1011 QDEDIVKWVKKQLQKGQITXXXXXXXXXXXXXXXXWEEFLLGVKVALLCTAPDPIDRPTM 1070
QDEDIVKWVKKQLQ+GQ+T WEEFLLG+KV LLCTA DP+DRPTM
Sbjct: 1048 QDEDIVKWVKKQLQRGQVTELLEPGLLELDPESSEWEEFLLGIKVGLLCTATDPLDRPTM 1107
Query: 1071 SDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
SD+VFMLEGCRVGPD+PSSADPT+QPSPA
Sbjct: 1108 SDVVFMLEGCRVGPDVPSSADPTSQPSPA 1136
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 4.1e-134, Sum P(2) = 4.1e-134
Identities = 231/690 (33%), Positives = 327/690 (47%)
Query: 6 FLFFVLLCAPFSSCAV-DRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACT 64
FL V+LC+ FS V + E L FK L+D G L W+ + PC+W G+ACT
Sbjct: 7 FLAIVILCS-FSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQ-LDSNPCNWTGIACT 64
Query: 65 NNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQY 123
+ R VT + L + LSG +S + L LRKL++ +N +G IP L+ C L + L
Sbjct: 65 HLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCT 124
Query: 124 NSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPTSIS 181
N G +P + + L+ L + N L G I + +L+ + SN +G IP S++
Sbjct: 125 NRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMA 184
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
L QL++I N FS G +PS I+ C SL L N L G +P + L
Sbjct: 185 KLRQLRIIRAGRNGFS--------GVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQN 236
Query: 242 LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301
L + L QN LSG +P S+ N+S + V+ L N FT E G + + + L L
Sbjct: 237 LTDLILWQNRLSGEIPPSVG-NIS----RLEVLALHENYFTGSIPREIGKLTKMKR-LYL 290
Query: 302 QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE 361
NQ+ G P + +D S N ++G IP + G + L+ L + N G +P E
Sbjct: 291 YTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRE 350
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
+ + + L LDL NR +G IP+ L + L L L N G IP L++
Sbjct: 351 LGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDM 410
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAX 481
NSLSG +P L L L NK SG +P + L L N +G +P
Sbjct: 411 SANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIE 470
Query: 482 XXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
SG + +L L NL+ + L N +G +P +L + N+
Sbjct: 471 LFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNI 530
Query: 542 SFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
S N G IP GN SG I ELG LE+L L N LTG IP
Sbjct: 531 SSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHS 590
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLR-SLLVNSNHLSGGIPDSLAKLSNLAVLD 660
L+ L L L N L+ IP E+ K +SL+ SL ++ N+LSG IPDSL L L +L
Sbjct: 591 FGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILY 650
Query: 661 LSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
L+ N LSGEIPA++ ++ L+ N+S+NNL
Sbjct: 651 LNDNKLSGEIPASIGNLMSLLICNISNNNL 680
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.1e-133, Sum P(2) = 1.1e-133
Identities = 233/725 (32%), Positives = 341/725 (47%)
Query: 1 MALSAFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRG 60
M L+ F +LL S + E + L K D L W+S+ + PC W G
Sbjct: 6 MKLAVFFISLLLILLISE-TTGLNLEGQYLLEIKSKFVDAKQNLRNWNSND-SVPCGWTG 63
Query: 61 VACTNN----RVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLL 116
V C+N V L L + LSG++S + L L++L L N +G IP + C+ L
Sbjct: 64 VMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSL 123
Query: 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLS--SNGFSG 174
+ L N G +P IG L +LE L + NR+SG + ++ L L SN SG
Sbjct: 124 EILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISG 183
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
+P SI NL +L N S G+LPS I C SLV L N L G +P
Sbjct: 184 QLPRSIGNLKRLTSFRAGQNMIS--------GSLPSEIGGCESLVMLGLAQNQLSGELPK 235
Query: 235 AIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSS 294
IG L KL V L +N SG +P + N + S+ + L N E G S
Sbjct: 236 EIGMLKKLSQVILWENEFSGFIPREI-SNCT----SLETLALYKNQLVGPIPKELGDLQS 290
Query: 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
L+ L L +N + G P + S +D S N+++G+IP ++G + LE L + N
Sbjct: 291 -LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQL 349
Query: 355 GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414
G +PVE+ +LS LDL N +G IP +RGL L L N SG+IP
Sbjct: 350 TGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYS 409
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474
L L++ N LSG +P + +N+ L+L N SG +P I L+ L+ N
Sbjct: 410 DLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNL 469
Query: 475 SGRIPAXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
GR P+ F G +P E+ LQ + L +N +G +P L
Sbjct: 470 VGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLS 529
Query: 535 SLRYLNLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSL 594
L LN+S N G++P+ N+ SG++P E+G+ LE+L+L +N+L
Sbjct: 530 QLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNL 589
Query: 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLR-SLLVNSNHLSGGIPDSLAKL 653
+G IP + +LS L L + N G IP E+ + L+ +L ++ N L+G IP L+ L
Sbjct: 590 SGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNL 649
Query: 654 SNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL------------QAFANNQDLCG 701
L L L+ NNLSGEIP++ +++ L+ +N S N+L +F N+ LCG
Sbjct: 650 VMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCG 709
Query: 702 KPLGR 706
PL +
Sbjct: 710 PPLNQ 714
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 1.8e-133, Sum P(2) = 1.8e-133
Identities = 240/738 (32%), Positives = 376/738 (50%)
Query: 3 LSAFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGA---LNGWDSSTPAAPCD-W 58
L +F F + C FS +++PE L S+ L+ P + L W+S PC+ W
Sbjct: 17 LFSFFFIFIFC--FSLSDAEQNPEASILYSW-LHSSSPTPSSLSLFNWNS-IDNTPCNNW 72
Query: 59 RGVACTNNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLR 117
+ C++ +T++ + + L + +L R L+KL++ + GT+P +L C L+
Sbjct: 73 TFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLK 132
Query: 118 AVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGP 175
+ L N L G++P ++ L NLE L + +N+L+G+I D+ + LK L N +G
Sbjct: 133 VLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGS 192
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
IPT + LS L++I NK E+ G +PS I +CS+L L ++ G +P +
Sbjct: 193 IPTELGKLSGLEVIRIGGNK---EI----SGQIPSEIGDCSNLTVLGLAETSVSGNLPSS 245
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295
+G L KL+ +S+ +SG +P+ + G + + L N+ + E G +
Sbjct: 246 LGKLKKLETLSIYTTMISGEIPSDL-----GNCSELVDLFLYENSLSGSIPREIGQLTK- 299
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
L+ L L QN + G P + S L +D+S N +SG IP+ IG L LEE +++N F
Sbjct: 300 LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
G++P I CSSL L L+ N+ SG IP LG + L +N GSIP +
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L+ L+L NSL+G++P + + NL+ L L N SG +P IGN S L+ L N +
Sbjct: 420 LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479
Query: 476 GRIPAXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
G IP+ G++P E+ LQ+I L N L G++P SSL
Sbjct: 480 GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSG 539
Query: 536 LRYLNLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L+ L++S N F G+IPA+ N SGSIP LG CS L++L+L SN L+
Sbjct: 540 LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599
Query: 596 GHIPTDISHLSHLNV-LDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLS 654
G IP+++ + +L + L+LS N LTG+IP +I+ + L L ++ N L G + LA +
Sbjct: 600 GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIE 658
Query: 655 NLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLC------GKPLGRKC 708
NL L++S N+ SG +P N +F ++ N + ++ QD C G LG
Sbjct: 659 NLVSLNISYNSFSGYLPDN--KLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDG 716
Query: 709 ENADDRDRRKKLILLIVI 726
+ + R R L LLI +
Sbjct: 717 DASRTRKLRLTLALLITL 734
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 1.8e-133, Sum P(2) = 1.8e-133
Identities = 224/692 (32%), Positives = 335/692 (48%)
Query: 7 LFFVL-LCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALNGWD-SSTPAAPCDWRGVACT 64
LFF L L S + S + L+ K P + W +++ A PC+W G+ C
Sbjct: 13 LFFCLFLSTHIISVSCLNSDGLTLLSLLKHLDRVPPQVTSTWKINASEATPCNWFGITCD 72
Query: 65 NNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQY 123
+++ V L R ++SG++ + L+ L+ L L +N+F+GTIP+TL CT L + L
Sbjct: 73 DSKNVASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSE 132
Query: 124 NSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPTSIS 181
N S +P + +L LE+L + N L+GE+ L R L+ L N +GPIP SI
Sbjct: 133 NGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIG 192
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
+ +L ++ N+FS G +P +I N SSL L N L G +P ++ L
Sbjct: 193 DAKELVELSMYANQFS--------GNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLGN 244
Query: 242 LQVVSLAQNNLSGVVP-ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLD 300
L + + N+L G V S C ++ + L +N F P G+CSS L L
Sbjct: 245 LTTLFVGNNSLQGPVRFGSPNCK------NLLTLDLSYNEFEGGVPPALGNCSS-LDALV 297
Query: 301 LQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPV 360
+ + G P L LT L++S N +SG IPA++G L LK+ +N G +P
Sbjct: 298 IVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPS 357
Query: 361 EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420
+ + L L+L NRFSGEIP + + L L + N +G +P + L+
Sbjct: 358 ALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIAT 417
Query: 421 LRHNSLSGSLPEEVLGMNN-LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP 479
L +NS G++P LG+N+ L +D NK +GE+P ++ + +L + NL N G IP
Sbjct: 418 LFNNSFYGAIPPG-LGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIP 476
Query: 480 AXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYL 539
A N SG LP E + +L + N G +P S +L +
Sbjct: 477 ASIGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSI 535
Query: 540 NLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHIP 599
NLS N F GQIP N + GS+P +L NC LE ++ NSL G +P
Sbjct: 536 NLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVP 595
Query: 600 TDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAV- 658
++ S+ L L LS N +G IP + + L +L + N G IP S+ + +L
Sbjct: 596 SNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYD 655
Query: 659 LDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
LDLS N L+GEIPA L + L N+S+NNL
Sbjct: 656 LDLSGNGLTGEIPAKLGDLIKLTRLNISNNNL 687
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
Identities = 222/698 (31%), Positives = 325/698 (46%)
Query: 39 DPLGALNGWDSSTPAAPCDWRGVACTNNR---------VTELRLPRLQLSGRISDHLSNL 89
D L L+ W+ PC+W GV C++ VT L L + LSG +S + L
Sbjct: 50 DSLNRLHNWNG-IDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGL 108
Query: 90 RMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANR 149
L L+L N+ G IP + C+ L +FL N G++P I LS L N+ N+
Sbjct: 109 VNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNK 168
Query: 150 LSGEIANDLPR--NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
LSG + ++ NL+ +N +GP+P S+ NL++L N FS G
Sbjct: 169 LSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFS--------GN 220
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
+P+ I C +L L N + G +P IG L KLQ V L QN SG +P + G
Sbjct: 221 IPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDI-----GN 275
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327
S+ + L N+ E G+ S L+ L L QNQ+ G P L + S + +D S
Sbjct: 276 LTSLETLALYGNSLVGPIPSEIGNMKS-LKKLYLYQNQLNGTIPKELGKLSKVMEIDFSE 334
Query: 328 NSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLG 387
N +SG+IP ++ + L L + N G +P E+ + +L+ LDL N +G IP
Sbjct: 335 NLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQ 394
Query: 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447
++ ++ L L N SG IP L ++ N LSG +P + +NL L+L
Sbjct: 395 NLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGS 454
Query: 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAXXXXXXXXXXXXXXXQNFSGELPIELA 507
N+ G +P + L+ + GN +G+ P FSG LP E+
Sbjct: 455 NRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIG 514
Query: 508 GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATXXXXXXXXXXXXXG 567
LQ + L N+ S N+P S L +L N+S N G IP+
Sbjct: 515 TCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSR 574
Query: 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS 627
N GS+PPELG+ LE+L L N +G+IP I +L+HL L + N +G IP ++
Sbjct: 575 NSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLG 634
Query: 628 KCSSLR-SLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVS 686
SSL+ ++ ++ N SG IP + L L L L+ N+LSGEIP ++ L+ N S
Sbjct: 635 LLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFS 694
Query: 687 SNNL-------QAFAN--------NQDLCGKPLGRKCE 709
NNL Q F N N+ LCG L R C+
Sbjct: 695 YNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL-RSCD 731
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 1.5e-125, Sum P(2) = 1.5e-125
Identities = 227/700 (32%), Positives = 347/700 (49%)
Query: 6 FLFFVLLCAPFSS--C-AVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVA 62
FLF + + F S C ++D AL S+K L+ AL+ W +S + PC W G+
Sbjct: 10 FLFLLFHSSLFFSIPCFSIDEQGL--ALLSWKSQLNISGDALSSWKASE-SNPCQWVGIK 66
Query: 63 CTNN-RVTELRLPRLQLSGRI-SDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVF 120
C +V+E++L + G + + +L ++ L LSL S + G+IP L + L +
Sbjct: 67 CNERGQVSEIQLQVMDFQGPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLD 126
Query: 121 LQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPT 178
L NSLSG +P +I L L+IL++ N L G I ++L NL L N +G IP
Sbjct: 127 LADNSLSGEIPVDIFKLKKLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPR 186
Query: 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA 238
+I L L++ NK R G LP I NC SLV L +L G +P +IG
Sbjct: 187 TIGELKNLEIFRAGGNKNLR-------GELPWEIGNCESLVTLGLAETSLSGRLPASIGN 239
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
L K+Q ++L + LSG +P + G ++ + L N+ + G LQ
Sbjct: 240 LKKVQTIALYTSLLSGPIPDEI-----GNCTELQNLYLYQNSISGSIPVSMGRLKK-LQS 293
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
L L QN + G P L L +D+S N ++G IP G L L+EL+++ N G +
Sbjct: 294 LLLWQNNLVGKIPTELGTCPELFLVDLSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTI 353
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
P E+ C+ L+ L+++ N+ SGEIP +G + L N +G IP S L+
Sbjct: 354 PEELANCTKLTHLEIDNNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQA 413
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
++L +N+LSGS+P + + NL+ L L N SG +P IGN + L L+GN +G I
Sbjct: 414 IDLSYNNLSGSIPNGIFEIRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNI 473
Query: 479 PAXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRY 538
PA G +P E++G +L+ + L N L+G +P SL++
Sbjct: 474 PAEIGNLKNLNFIDISENRLIGNIPPEISGCTSLEFVDLHSNGLTGGLPGTLPK--SLQF 531
Query: 539 LNLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHI 598
++LS N G +P N SG IP E+ +C L++L L N TG I
Sbjct: 532 IDLSDNSLTGSLPTGIGSLTELTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEI 591
Query: 599 PTDISHLSHLNV-LDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLA 657
P ++ + L + L+LS N+ TGEIP S ++L +L V+ N L+G + + LA L NL
Sbjct: 592 PNELGRIPSLAISLNLSCNHFTGEIPSRFSSLTNLGTLDVSHNKLAGNL-NVLADLQNLV 650
Query: 658 VLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQ 697
L++S N SGE+P L F + +V +N F + +
Sbjct: 651 SLNISFNEFSGELPNTL--FFRKLPLSVLESNKGLFISTR 688
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 1.0e-124, Sum P(2) = 1.0e-124
Identities = 233/712 (32%), Positives = 341/712 (47%)
Query: 1 MALSAFLFFVLLCAPFSS-CAVDRSPEIEALTSFKLNLHD-PLGALNGWDSSTPAAPCDW 58
+A++ FL F LC+ S A + + AL S + P W++S + PC W
Sbjct: 3 VAVNTFLLF--LCSTSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASD-STPCSW 59
Query: 59 RGVACTNNR-VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLR 117
GV C + V L L +SG +S+L+ L+K+ L N F G+IP+ L C+LL
Sbjct: 60 LGVECDRRQFVDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLE 119
Query: 118 AVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGP 175
+ L NS +GN+P +G L NL L++ N L G L +L+ + NG +G
Sbjct: 120 HIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGS 179
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
IP++I N+S+L + N+FS G +PS++ N ++L L N L G +P
Sbjct: 180 IPSNIGNMSELTTLWLDDNQFS--------GPVPSSLGNITTLQELYLNDNNLVGTLPVT 231
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMF-CN----VS--------GYPPSI-RVVQLG-FNA 280
+ L L + + N+L G +P C +S G PP + L F A
Sbjct: 232 LNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGA 291
Query: 281 FT-NVAGPETGSCSSVLQVLD---LQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPA 336
F+ ++GP SC L LD L N G P L + ++ L + N + G+IP
Sbjct: 292 FSCALSGP-IPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPG 350
Query: 337 QIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT 396
++G L +L+ L + N+ G VP+ I + SL L L N SGE+P + +++ L SL
Sbjct: 351 ELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLA 410
Query: 397 LAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA 456
L N F+G IP LE L+L N +G +P + L L L N G VP+
Sbjct: 411 LYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPS 470
Query: 457 SIGNLSQLMVFNLSGNAFSGRIPAXXXXXXXXXXXXXXXQNFSGELPIELAGLPNLQVIA 516
+G S L L N G +P NF+G +P L L N+ I
Sbjct: 471 DLGGCSTLERLILEENNLRGGLP-DFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIY 529
Query: 517 LQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATXXXXXXXXXXXXXGNHISGSIPP 576
L N+LSG++P SL+ L +LNLS N G +P+ N ++GSIP
Sbjct: 530 LSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPS 589
Query: 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL 636
LG+ ++L L L NS +G IPT + + L L L N L G+IP + +LRSL
Sbjct: 590 TLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALRSLN 648
Query: 637 VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSN 688
++SN L+G +P L KL L LD+S NNLSG + LS+I L N+S N
Sbjct: 649 LSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTLRV-LSTIQSLTFINISHN 699
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1202 (428.2 bits), Expect = 3.1e-122, P = 3.1e-122
Identities = 316/976 (32%), Positives = 482/976 (49%)
Query: 77 QLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGN 136
+L+G + L+ L+ L+ L+L NSF+G IP+ L ++ + L N L G +P +
Sbjct: 227 RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTE 286
Query: 137 LSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSF 193
L+NL+ L++++N L+G I + R L++ L+ N SG +P +I SN + L+ + S
Sbjct: 287 LANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSE 346
Query: 194 NKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLS 253
+ S E+PA I+NC SL L N L G IP ++ L +L + L N+L
Sbjct: 347 TQLSGEIPAE--------ISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLE 398
Query: 254 GVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLW 313
G + +S+ N++ +++ L N E G L+++ L +N+ G P+
Sbjct: 399 GTLSSSI-SNLT----NLQEFTLYHNNLEGKVPKEIGFLGK-LEIMYLYENRFSGEMPVE 452
Query: 314 LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373
+ + L +D GN +SG+IP+ IG L L L + N G +P + C ++++DL
Sbjct: 453 IGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDL 512
Query: 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEE 433
N+ SG IP G + L+ + N G++P S NL L +N N +GS+
Sbjct: 513 ADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSI-SP 571
Query: 434 VLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAXXXXXXXXXXXXX 493
+ G ++ + D++EN F G++P +G + L L N F+GRIP
Sbjct: 572 LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDI 631
Query: 494 XXQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPAT 553
+ SG +P+EL L I L N LSG +P L L L LS N FVG +P
Sbjct: 632 SRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE 691
Query: 554 XXXXXXXXXXXXXGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613
GN ++GSIP E+GN L L L N L+G +P+ I LS L L L
Sbjct: 692 IFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRL 751
Query: 614 SINNLTGEIPDEISKCSSLRSLL-VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPA 672
S N LTGEIP EI + L+S L ++ N+ +G IP +++ L L LDLS N L GE+P
Sbjct: 752 SRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPG 811
Query: 673 NLSSIFGLMNFNVSSNNLQ-------------AFANNQDLCGKPLGRKCENADDRDRRKK 719
+ + L N+S NNL+ AF N LCG PL C A +++R
Sbjct: 812 QIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSH-CNRAGSKNQRSL 870
Query: 720 LILLIVIXXXXXXXXXXXXXFYIFSLLRWRRRLKESAAAEKK-RSPXXXXXXXXXXXXXX 778
+VI + L K++ KK R
Sbjct: 871 SPKTVVIISAISSLAAIALMVLVIILF-----FKQNHDLFKKVRGGNSAFSSNSSSSQAP 925
Query: 779 T-DNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRL-- 835
NGG K + I + +EAT +EE ++ G V+KA +G ++++++
Sbjct: 926 LFSNGGAK-----SDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILW 980
Query: 836 PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD-LRLLVYDYMPNGNLGTLLQEAS 894
D + F +E + LG +RHR+L L GY + D L LL+Y+YM NG++ L
Sbjct: 981 KDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANE 1040
Query: 895 H-QDGHVLNWPMRHLIALGVARGLAFLH---TSNMVHGDIKPQNVLFDADFEAHLSDFGL 950
+ + VL W R IALG+A+G+ +LH +VH DIK NVL D++ EAHL DFGL
Sbjct: 1041 NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGL 1100
Query: 951 DR-LXXXXXXXXXXXXXXVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV-- 1007
+ L G+ GY++PE A + + T++SDVYS GIVL+E++TGK P
Sbjct: 1101 AKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA 1160
Query: 1008 MFTQDEDIVKWVKKQL 1023
MF ++ D+V+WV+ L
Sbjct: 1161 MFDEETDMVRWVETVL 1176
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGS2 | Y4361_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6812 | 0.9954 | 0.9630 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036820001 | SubName- Full=Chromosome chr4 scaffold_83, whole genome shotgun sequence; (1130 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1099 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-135 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 433 bits (1115), Expect = e-135
Identities = 336/1109 (30%), Positives = 509/1109 (45%), Gaps = 201/1109 (18%)
Query: 1 MALSAFLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRG 60
+ F L FS + E+E L SFK +++DPL L+ W+SS A C W+G
Sbjct: 11 YLIFMLFFLFL---NFSMLHAE---ELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQG 62
Query: 61 VACTN-NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAV 119
+ C N +RV + L +SG+IS + L ++ ++L +N
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ------------------ 104
Query: 120 FLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPT- 178
LSG +P +I S+ +L+Y +LS+N F+G IP
Sbjct: 105 ------LSGPIPDDIFTTSS---------------------SLRYLNLSNNNFTGSIPRG 137
Query: 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA 238
SI NL L L N N S G +P+ I + SSL L GN L G IP ++
Sbjct: 138 SIPNLETLDLSN---NMLS--------GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
L L+ ++LA N L G +P + G S++ + LG+N
Sbjct: 187 LTSLEFLTLASNQLVGQIPREL-----GQMKSLKWIYLGYN------------------- 222
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
+ G P + ++L LD+ N+++G IP+ +G L L+ L + N G +
Sbjct: 223 ------NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
P I L LDL N SGEIPE + ++ L+ L L +N F+G IP + +LP L+
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASI---GNLSQLMVFNLSGNAFS 475
L L N SG +P+ + NNL+ LDLS N +GE+P + GNL +L++F+ N+
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLE 393
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
G IP SLG L + L +FSGELP E LP + + + N L G + + S
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L+ L+L+ N F G +P +F GS LE L+L N +
Sbjct: 454 LQMLSLARNKFFGGLPDSF-----------------GS--------KRLENLDLSRNQFS 488
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
G +P + LS L L LS N L+GEIPDE+S C L SL ++ N LSG IP S +++
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSN---------------NLQAFANNQDLC 700
L+ LDLS N LSGEIP NL ++ L+ N+S N N A A N DLC
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608
Query: 701 G--KPLG-RKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAA 757
G G C + RK I + L L + F +R R L+
Sbjct: 609 GGDTTSGLPPC-----KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL--- 660
Query: 758 AEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEAT-RQFDEENVLSRTRY 816
+R ++G +L F++K++ + T+ EENV+SR +
Sbjct: 661 -----------------KRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKK 703
Query: 817 GLVFKA-CYNDGMVLSIRRLPD-GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874
G +K +GM ++ + D S+ + +GK++H N+ L G +
Sbjct: 704 GASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIG-LCRSEKGA 758
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH---TSNMVHGDIK 931
L+++Y+ NL +L+ L+W R IA+G+A+ L FLH + +V G++
Sbjct: 759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
P+ ++ D E HL RL++P T T + YV+PE T + T++SD+Y
Sbjct: 811 PEKIIIDGKDEPHL------RLSLPGL--LCTDTKCFISSAYVAPETRETKDITEKSDIY 862
Query: 992 SFGIVLLELLTGKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
FG++L+ELLTGK P F IV+W + + ++P + S E
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG--DVSVNQNEI 920
Query: 1050 LLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + +AL CTA DP RP +D++ LE
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 3e-35
Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 27/261 (10%)
Query: 816 YGLVFKACY-NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
+G V+ A G +++I+ + + ++ +E + L K++H N+ L +
Sbjct: 12 FGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK 71
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKP 932
L LV +Y G+L LL++ L+ + L +LH+ +VH D+KP
Sbjct: 72 L-YLVMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKP 125
Query: 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYS 992
+N+L D D L+DFGL R P TT VGT Y++PE L K D++S
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPG----EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 993 FGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
G++L ELLTGK P F D+ +++ + K++ K + + S E ++ +
Sbjct: 182 LGVILYELLTGKPP--FPGDDQLLE-LFKKIGKPKPPFPPPEWDI-----SPEAKDLIRK 233
Query: 1053 VKVALLCTAPDPIDRPTMSDI 1073
DP R T +
Sbjct: 234 ------LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 811 LSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYY 867
L +G V+ A G ++I+ + L +E E L K+ H N+ L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
L LV +Y G+L LL+E + L+ I L + GL +LH++ ++H
Sbjct: 61 EDENHL-YLVMEYCEGGSLKDLLKE----NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 928 GDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL-TGETT 985
D+KP+N+L D+D + L+DFGL +L S T VGT Y++PE L G +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDK---SLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 986 KESDVYSFGIVLLEL 1000
++SD++S G++L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 45/277 (16%)
Query: 816 YGLVFKACYNDGMVLS-----IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-Y 867
+G V+K + ++ L +G+ +E F +EA + K+ H N+ L G
Sbjct: 12 FGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCT 71
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
G P +V +YMP G+L L + G L +AL +A+G+ +L + N VH
Sbjct: 72 QGEP--LYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG---YVSPEAALTGET 984
D+ +N L + +SDFGL R G +++PE+ G+
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYED----DYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 985 TKESDVYSFGIVLLELLT-GKRP-VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042
T +SDV+SFG++L E+ T G++P + +E V + L+ G L PE
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLELLEDG---YRLPR------PE 227
Query: 1043 --SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
E E + L C A DP DRPT S++V L
Sbjct: 228 NCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 2e-33
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 46/283 (16%)
Query: 815 RYGLVFKACYNDG-----MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYY 867
+G V+K V ++ L + + +E F KEA + K+ H N+ L G
Sbjct: 7 AFGEVYKGKLKGKDGKTTEVA-VKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC 65
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQE----ASHQDGHVLNWPMRHLIALGVARGLAFLHTS 923
L LV +YM G+L L++ + L+ A+ +A+G+ +L +
Sbjct: 66 TEEEPL-YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
VH D+ +N L D +SDFGL R + + + +++PE+ G
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL-PIRWMAPESLKDGI 183
Query: 984 TTKESDVYSFGIVLLELLT-GKRP---VMFTQDEDIVKWVKK--QLQKGQITELLEPGLL 1037
T +SDV+SFG++L E+ T G P + +E+++++++K +L K
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYLRKGYRLPK------------ 228
Query: 1038 ELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE E E + L C DP DRPT S++V LE
Sbjct: 229 ---PEYCPDELYELM------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 816 YGLVFKACYNDG------MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYY 867
+G V+K V ++ L + + ++ + F +EA + K+ H N+ L G
Sbjct: 12 FGEVYKGKLKGKGGKKKVEVA-VKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVC 70
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
L +V +YM G+L + L++ + L+ AL +ARG+ +L + N +H
Sbjct: 71 TEEEPL-YIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE 987
D+ +N L + +SDFGL R + + +++PE+ G+ T +
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 988 SDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044
SDV+SFG++L E+ T G++P M ++ V + L+ G L P +
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLEYLKNG---YRLPQ------PPNC 228
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
E + L C A DP DRPT S++V +L
Sbjct: 229 P-PEL---YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 45/277 (16%)
Query: 816 YGLVFKACYNDGMVLS-----IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYA 868
+G V+K ++ L + + ++ + F +EA + K+ H N+ L G
Sbjct: 12 FGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGV-C 70
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
+ ++V +YMP G+L L++ L+ AL +ARG+ +L + N +H
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKNFIHR 127
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SPEAALTGE 983
D+ +N L + +SDFGL R V G + +PE+ G+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSR------DLYDDDYYKV-KGGKLPIRWMAPESLKEGK 180
Query: 984 TTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
T +SDV+SFG++L E+ T G+ P M + V + L+KG L
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE------VLEYLKKG---YRLPK------ 225
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
P + E K+ L C A DP DRPT S++V +L
Sbjct: 226 PPNCP-PEL---YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 37/270 (13%)
Query: 816 YGLVFKACY-NDGMVLSIRRLP---DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
+G V+KA + G +++++ L + S + R+E L ++ H N+ L +
Sbjct: 12 FGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE-DK 70
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL--IALGVARGLAFLHTSNMVHGD 929
D LV +Y G+L L + G + IAL + RGL +LH++ ++H D
Sbjct: 71 DHLYLVMEYCEGGDLFDYL----SRGGPL---SEDEAKKIALQILRGLEYLHSNGIIHRD 123
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKES 988
+KP+N+L D + ++DFGL + + +S+ TT VGT Y++PE L G +
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLL---KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 989 DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL----ELDPESS 1044
DV+S G++L ELLTGK P F+ + + QLQ I +L P L + S
Sbjct: 181 DVWSLGVILYELLTGKPP--FSGENIL-----DQLQL--IRRILGPPLEFDEPKWSSGSE 231
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
E ++ + C DP RPT +I+
Sbjct: 232 EAKDLIKK------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 74/280 (26%), Positives = 116/280 (41%), Gaps = 18/280 (6%)
Query: 805 FDEENVLSRTRYGLVFKACYNDGMVLSI--RRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
+ L +G V+ A + L + ++L S + F +E + L + H V
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 863 LRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
+ Y + L LV +Y+ G+L LL+ L+ I + L +LH
Sbjct: 62 -KLYDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLH 118
Query: 922 TSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRL---TIPTPAEASTSTTAVGTLGYVSPE 977
+ ++H DIKP+N+L D D L DFGL +L T + + +T+VGT GY++PE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 978 ---AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
+ SD++S GI L ELLTG P ++ K I EL P
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-----IILELPTP 233
Query: 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
L S+ + A DP +R + S +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 34/260 (13%)
Query: 816 YGLVFKACY-NDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-- 870
+G V+KA + G ++I+ + S + E + E + L K +H N+ YY G+
Sbjct: 13 FGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV---KYY-GSYL 67
Query: 871 PDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
L +V ++ G+L LL+ L + + +GL +LH++ ++H D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRD 123
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESD 989
IK N+L +D E L DFGL T A + VGT +++PE ++D
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDYKAD 179
Query: 990 VYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
++S GI +EL GK P + +K + K G PGL + S E+++F
Sbjct: 180 IWSLGITAIELAEGKPPYS---ELPPMKALFKIATNGP------PGLRNPEKWSDEFKDF 230
Query: 1050 LLGVKVALLCTAPDPIDRPT 1069
L C +P RPT
Sbjct: 231 L------KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 65/263 (24%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAG-- 869
+G V+ A D G +++++ + E +E L ++H N ++R Y +
Sbjct: 13 FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN--IVRYYGSERD 70
Query: 870 -APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
+ + +Y+ G+L +LL++ L P+ + GLA+LH++ +VH
Sbjct: 71 EEKNTLNIFLEYVSGGSLSSLLKKFGK-----LPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKES 988
DIK N+L D+D L+DFG + + + + GT +++PE E + +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184
Query: 989 DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SSEW 1046
D++S G ++E+ TGK P +++ + + + K G+ E+ PE S E
Sbjct: 185 DIWSLGCTVIEMATGKPP--WSELGNPMAALYKIGSSGEPPEI---------PEHLSEEA 233
Query: 1047 EEFLLGVKVALLCTAPDPIDRPT 1069
++FL C DP RPT
Sbjct: 234 KDFL------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 815 RYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYA----GA 870
++G V++ +N+ ++++ L G++D F EA+ + K+RH L L YA
Sbjct: 18 QFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAVCTLEE 74
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
P +V + M G+L LQ G L P +A VA G+A+L N +H D+
Sbjct: 75 P--IYIVTELMKYGSLLEYLQ---GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDL 129
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+NVL + ++DFGL R+ EA + + +PEAAL + +SDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
+SFGI+L E++T G+ P + ++ + ++ G P E +
Sbjct: 188 WSFGILLTEIVTYGRMPY-------------PGMTNAEVLQQVDQGYRMPCPPGCPKELY 234
Query: 1050 LLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ L C DP DRPT + + LE
Sbjct: 235 ----DIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 36/269 (13%)
Query: 810 VLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRK----EAEFLGKVRHRNLTVLR 864
VL + G+V+K + G + +++++ + FRK E + L +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 865 GYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-S 923
G + ++ + V +YM G+L LL++ + P+ IA + +GL +LHT
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEPVLAYIARQILKGLDYLHTKR 119
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
+++H DIKP N+L ++ E ++DFG+ ++ T + + T VGT+ Y+SPE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---TFVGTVTYMSPERIQGES 176
Query: 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV-KKQLQKGQITELLEPGLLELDPE 1042
+ +D++S G+ LLE GK P F + + + G L E
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPP--------PSLPAE 226
Query: 1043 --SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
S E+ +F+ C DP RP+
Sbjct: 227 EFSPEFRDFI------SACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 79/266 (29%), Positives = 127/266 (47%), Gaps = 29/266 (10%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G V+ +N ++I+ L G++ F +EA+ + K+RH L L + P
Sbjct: 19 FGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP--IY 76
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V ++M G+L L+E DG L P +A +A G+A++ N +H D++ N+
Sbjct: 77 IVTEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L + ++DFGL RL E + A + + +PEAAL G T +SDV+SFGI
Sbjct: 134 LVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 996 VLLELLTGKR---PVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
+L EL+T R P M ++ V +Q+++G + PES
Sbjct: 192 LLTELVTKGRVPYPGMVNRE------VLEQVERGYRMPCPQGC-----PESLH------- 233
Query: 1053 VKVALLCTAPDPIDRPTMSDIVFMLE 1078
++ LC DP +RPT I LE
Sbjct: 234 -ELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA 910
L ++ H + L +YA + +L LV +Y P G L + L + + A
Sbjct: 47 LSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYA 99
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970
+ L +LH+ +++ D+KP+N+L DAD L+DFGL + +E S + T GT
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGT 156
Query: 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT- 1029
Y++PE L K D +S G++L E+LTGK P F ED + +K + K +
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP--FY-AEDRKEIYEK-ILKDPLRF 212
Query: 1030 ---------ELLEPGLLELDPE 1042
+L+ GLL+ DP
Sbjct: 213 PEFLSPEARDLIS-GLLQKDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-23
Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 816 YGLVFKA-CY-----NDGMVLSIRRLPDGSLDE--NLFRKEAEFLGKVRHRNLTVLRGYY 867
+G VF CY ND +++++ L + + ++ F +EAE L +H N+ G
Sbjct: 18 FGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGV- 76
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARG 916
D ++V++YM +G+L L+ SH L IA+ +A G
Sbjct: 77 CTEGDPPIMVFEYMEHGDLNKFLR--SHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+ +L + + VH D+ +N L D + DFG+ R + T + + ++ P
Sbjct: 135 MVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYYRVGGHTMLPIRWMPP 193
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E+ + + T ESDV+SFG+VL E+ T GK+P W L ++ E + G
Sbjct: 194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WY--GLSNEEVIECITQG 240
Query: 1036 LLELDPES--SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P + SE + +LG C DP R + DI L+
Sbjct: 241 RLLQRPRTCPSEVYDIMLG------CWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYA-- 868
L ++G V+ +N ++++ L G++ F +EA+ + K+RH L L YA
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70
Query: 869 --GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
P +V +YM G+L L+ +G L P +A +A G+A+L + N +
Sbjct: 71 SEEEP--IYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT---LGYVSPEAALTGE 983
H D+ +N+L + ++DFGL RL E T G + + +PEAA G
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI-----EDDEYTAREGAKFPIKWTAPEAANYGR 180
Query: 984 TTKESDVYSFGIVLLELLT-GKRP 1006
T +SDV+SFGI+L E++T G+ P
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 8/212 (3%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
L ++G V+ +N ++++ L G++ F +EA+ + K+RH L L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
P +V +YM G+L L++ +G L P +A VA G+A++ N +H D+
Sbjct: 74 P--IYIVTEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+ N+L ++DFGL RL E + A + + +PEAAL G T +SDV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
+SFGI+L EL+T G+ P + ++++ V++
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 76/257 (29%), Positives = 114/257 (44%), Gaps = 33/257 (12%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G V Y G ++++ L D S F EA + +RH NL L G L
Sbjct: 19 FGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL-Y 76
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +YM G+L L+ + V+ + AL V G+ +L N VH D+ +NV
Sbjct: 77 IVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL--GYVSPEAALTGETTKESDVYSF 993
L D A +SDFGL A+ ++ G L + +PEA + + +SDV+SF
Sbjct: 134 LVSEDLVAKVSDFGL--------AKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 994 GIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
GI+L E+ + G+ P +D+V V+K + +E PE E +
Sbjct: 186 GILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-------MEA------PEGCPPEVY--- 229
Query: 1053 VKVALLCTAPDPIDRPT 1069
KV C DP RPT
Sbjct: 230 -KVMKDCWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 61/190 (32%), Positives = 97/190 (51%), Gaps = 7/190 (3%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G V+ +N ++I+ L G++ F +EA+ + K+RH L L + P
Sbjct: 19 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IY 76
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +YM G+L L+ + G L P +A +A G+A++ N VH D++ N+
Sbjct: 77 IVTEYMSKGSLLDFLK---GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 133
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L + ++DFGL RL E + A + + +PEAAL G T +SDV+SFGI
Sbjct: 134 LVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 996 VLLELLTGKR 1005
+L EL T R
Sbjct: 192 LLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 30/282 (10%)
Query: 809 NVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLT 861
L +G V Y N G ++++ L +++ F +E E L + H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 862 VLRG--YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+G G LRL + +Y+P+G+L LQ Q +N L + + +G+ +
Sbjct: 70 KYKGVCEKPGGRSLRL-IMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDY 124
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG-----YV 974
L + +H D+ +N+L +++ +SDFGL ++ +P + V G +
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYY----VKEPGESPIFWY 179
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRP--VMFTQDEDIVKWVKKQLQKGQITELL 1032
+PE T + + SDV+SFG+ L EL T P + ++ + Q+ ++ ELL
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ G P S E + L LC +P DRP+ +D++
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 843 NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLN 902
E L ++ H L L + ++ L+V D + G+L L + +
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVK 103
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ L +LH+ ++H DIKP N+L D H++DF + T TP +
Sbjct: 104 -----FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI--ATKVTPDTLT 156
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQ 1022
TST GT GY++PE + D +S G+ E L GKRP + KQ
Sbjct: 157 TST--SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ 214
Query: 1023 LQK------GQITELLE--PGLLELDPE 1042
TE ++ LLE DP+
Sbjct: 215 ETADVLYPATWSTEAIDAINKLLERDPQ 242
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 72/279 (25%), Positives = 133/279 (47%), Gaps = 29/279 (10%)
Query: 807 EENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDE--NLFRKEAEFLGKVRHRNL 860
++ V+ +G VF+ + ++I+ L G ++ F EA +G+ H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
L G +++ +YM NG L L++ DG ++ + ++ G+A G+ +L
Sbjct: 69 IRLEGVVTKFKPA-MIITEYMENGALDKYLRD---HDGEFSSYQLVGMLR-GIAAGMKYL 123
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
N VH D+ +N+L +++ E +SDFGL R+ P T++ + + +PEA
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 981 TGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ T SDV+SFGIV+ E+++ G+RP + +++K + + L P +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR------LPAP----M 233
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
D S+ ++ + L C D RP DIV +L+
Sbjct: 234 DCPSAVYQ-------LMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 42/238 (17%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGH-----V 900
E + L K+ H N+ + L +V +Y G+L +++ + +
Sbjct: 47 LNEVKILKKLNHPNIIKYYESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105
Query: 901 LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
L+W + L +A L +LH+ ++H DIKPQN+ ++ L DFG+ ++ T
Sbjct: 106 LDW----FVQLCLA--LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159
Query: 961 ASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQD--EDIVK 1017
A T VGT Y+SPE + +SD++S G VL EL T K P F + ++
Sbjct: 160 AKTV---VGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHP--FEGENLLELA- 212
Query: 1018 WVKKQLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++ KGQ + P SSE + DP +RP+++ I
Sbjct: 213 ---LKILKGQYPPI---------PSQYSSELRNLVSS------LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 76/271 (28%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
L ++G V+ YN ++I+ L GS+ F EA + +++H L L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
P ++ +YM NG+L L+ +G L +A +A G+AF+ N +H D+
Sbjct: 74 P--IYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+ N+L ++DFGL RL E + A + + +PEA G T +SDV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 991 YSFGIVLLELLTGKR---PVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWE 1047
+SFGI+L E++T R P M T E I + LE G P++ E
Sbjct: 187 WSFGILLTEIVTYGRIPYPGM-TNPEVI--------------QNLERGYRMPRPDNCPEE 231
Query: 1048 EFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ ++ LC P +RPT + +LE
Sbjct: 232 LY----ELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPM 905
E + L + + + V++ YY+ L LV +Y+P G+L +LL+ D V
Sbjct: 42 TERDILSQAQ--SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----A 95
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-------ADFEAHLSDFGLDRLTIPTP 958
R IA V L +LH++ ++H D+KP N+L D DF LS GL R I
Sbjct: 96 RIYIAEIVL-ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDF--GLSKVGLVRRQINLN 152
Query: 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP-VMFTQDEDIVK 1017
+ VGT Y++PE L +K D +S G +L E L G P T +E
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212
Query: 1018 WVKKQLQKGQITEL------LEPGLLELDPE 1042
+ +++ + E+ L LL DPE
Sbjct: 213 ILNGKIEWPEDVEVSDEAIDLISKLLVPDPE 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 53/180 (29%), Positives = 98/180 (54%), Gaps = 10/180 (5%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
F EA +G+ H N+ L G + + ++V +YM NG+L L++ DG +
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPV-MIVTEYMENGSLDAFLRK---HDGQ---FT 104
Query: 905 MRHLIAL--GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ L+ + G+A G+ +L VH D+ +N+L +++ +SDFGL R+ P A
Sbjct: 105 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
T+ + + +PEA + T SDV+S+GIV+ E+++ G+RP ++D++K +++
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-18
Identities = 56/165 (33%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGI 646
L L + L G IP DIS L HL ++LS N++ G IP + +SL L ++ N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 647 PDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLGR 706
P+SL +L++L +L+L+ N+LSG +PA L G + S N F +N LCG P R
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG---GRLLHRASFN----FTDNAGLCGIPGLR 535
Query: 707 KCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRR 751
C L + I + +A I ++ W+RR
Sbjct: 536 ACG--------PHLSVGAKIGIAFGVSVAF-LFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
V +Y PNG L +++ D + A + L +LH+ ++H D+KP+N+
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLALEYLHSKGIIHRDLKPENI 133
Query: 936 LFDADFEAHLSDFG----LDRLTIP-----------TPAEASTSTTA--VGTLGYVSPEA 978
L D D ++DFG LD + P + E + A VGT YVSPE
Sbjct: 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRP 1006
K SD+++ G ++ ++LTGK P
Sbjct: 194 LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 48/287 (16%)
Query: 808 ENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLT 861
E V+ +G V + + ++I+ L GS D+ F EA +G+ H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL-----GVARG 916
L G + + +++ +YM NG+L L+ DG + L G+A G
Sbjct: 69 RLEGVVTKSRPV-MIITEYMENGSLDKFLR---ENDGKF------TVGQLVGMLRGIASG 118
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG--TLGYV 974
+ +L N VH D+ +N+L +++ +SDFGL R + A T TT G + +
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA---TYTTKGGKIPIRWT 175
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLT-GKRPV--MFTQDEDIVKWVKKQLQKGQITEL 1031
+PEA + T SDV+SFGIV+ E+++ G+RP M QD V K ++ G L
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAVEDGY--RL 227
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P +D S+ ++ + L C D +RPT S IV L+
Sbjct: 228 PPP----MDCPSALYQ-------LMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 21/211 (9%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLP-DGSLDENLFRKEAEFLGKVRHRNLTV 862
+F E L +G V++ + + + ++I+ L D L + F+KE + L ++RH++L
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 863 LRGYYA----GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG--VARG 916
L +A G P ++ + M G+L L+ +G VL P+ LI + VA G
Sbjct: 67 L---FAVCSVGEP--VYIITELMEKGSLLAFLRSP---EGQVL--PVASLIDMACQVAEG 116
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+A+L N +H D+ +N+L D ++DFGL RL I S+ + +P
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKI--PYKWTAP 173
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRP 1006
EAA G + +SDV+SFGI+L E+ T G+ P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
E L ++G V+ A YN ++++ + GS+ F EA + ++H L L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
P ++ ++M G+L L+ +G P + +A G+AF+ N +H
Sbjct: 71 TKEP--IYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE 987
D++ N+L A ++DFGL R + E + A + + +PEA G T +
Sbjct: 126 RDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 988 SDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
SDV+SFGI+L+E++T G+ P + ++++ LE G PE+
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-------------ALERGYRMPRPENCPE 230
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E + + + C P +RPT I +L+
Sbjct: 231 ELY----NIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 40/283 (14%)
Query: 811 LSRTRYGLVFKA-CYN-----DGMVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVL 863
L +G VF A CYN D M+++++ L D +L F++EAE L ++H ++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQ------------EASHQDGHVLNWPMRHLIAL 911
G G D ++V++YM +G+L L+ + G + M H IA
Sbjct: 73 YGV-CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130
Query: 912 GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
+A G+ +L + + VH D+ +N L A+ + DFG+ R T T + +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PI 189
Query: 972 GYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030
++ PE+ + + T ESDV+SFG++L E+ T GK+P W QL ++ E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------WF--QLSNTEVIE 236
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ G + P E + + L C +P R + +I
Sbjct: 237 CITQGRVLERPRVCPKEVY----DIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 26/285 (9%)
Query: 811 LSRTRYGLVFKACY-----NDGMVLSIRRLPDGSLDE-NLFRKEAEFLGKVRHRNLTVLR 864
L + +G V Y N G V+++++L + + F +E E L ++H N+ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 865 G--YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
G Y AG +LRL V +Y+P G+L LQ+ + L+ L A + +G+ +L +
Sbjct: 72 GVCYSAGRRNLRL-VMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYLGS 126
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT-AVGTLGYVSPEAALT 981
VH D+ +N+L +++ + DFGL ++ +P E + + +PE+
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKV-LPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 982 GETTKESDVYSFGIVLLELLT-----GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ + SDV+SFG+VL EL T P F + + + Q+ + ELL+
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR--MMGNDKQGQMIVYHLIELLKNNG 243
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
P E + + C DP RP+ S++ +E R
Sbjct: 244 RLPAPPGCPAEIYAI----MKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 815 RYGLVFKACYND-GMVLSIRRLPDGSLDENLFRK---EAEFLGKVRHRNLTVLRGYYAGA 870
+G V+ A D G +++++ + D ++ E + L ++H NL YY G
Sbjct: 12 TFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KYY-GV 67
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
R VY +M + GTL + H G +L+ + + L + GLA+LH+ +VH DI
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 931 KPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE-- 987
KP N+ D + L DFG +L T + GT Y++PE +TG K
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE-VITGGKGKGHG 184
Query: 988 --SDVYSFGIVLLELLTGKRPVMFTQDEDIVKW-VKKQLQKGQITELLEPGLLELDPESS 1044
+D++S G V+LE+ TGKRP +E + + + G +P + + S
Sbjct: 185 RAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGAGH-----KPPIPDSLQLSP 235
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
E ++FL C DP RPT S++
Sbjct: 236 EGKDFL------DRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 34/270 (12%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIR--RLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYA 868
+ + +G V+K ++++ R + F +EAE L + H N+ L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV--ARGLAFLHTSNMV 926
+ +V + +P G+L T L++ ++ ++ L+ + + A G+ +L + N +
Sbjct: 63 QKQPI-YIVMELVPGGSLLTFLRKKKNR------LTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
H D+ +N L + +SDFG+ R S + + + +PEA G T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTS 174
Query: 987 ESDVYSFGIVLLELLT---GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
ESDV+S+GI+L E + P M Q Q E +E G P+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQ---------------QTRERIESGYRMPAPQL 219
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
E + ++ L C A DP +RP+ S+I
Sbjct: 220 CPEEIY----RLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 69/253 (27%), Positives = 113/253 (44%), Gaps = 61/253 (24%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEF----------LGKVRHRNLTVLR 864
YG V+KA G +++++++ + ++ F L K+RH N+ L+
Sbjct: 12 YGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 865 ---------GYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGV 913
Y +V++YM + +L LL + + + + M+ L+
Sbjct: 65 EIVTSKGKGSIY--------MVFEYMDH-DLTGLLDSPEVKFTESQIKCY-MKQLL---- 110
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
GL +LH++ ++H DIK N+L + D L+DFGL R T ++ T V TL Y
Sbjct: 111 -EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYTNRVITLWY 167
Query: 974 VSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----G 1026
PE L G T E D++S G +L EL GK P+ E +QL+K G
Sbjct: 168 RPPE-LLLGATRYGPEVDMWSVGCILAELFLGK-PIFQGSTE------LEQLEKIFELCG 219
Query: 1027 QITELLEPGLLEL 1039
T+ PG+ +L
Sbjct: 220 SPTDENWPGVSKL 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 45/289 (15%)
Query: 811 LSRTRYGLVFKA-CYN-----DGMVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVL 863
L +G VF A CYN D ++++++ L D S + F +EAE L ++H ++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVL----NWP-------MRHLIALG 912
G L ++V++YM +G+L L+ +H VL N P M H IA
Sbjct: 73 YGVCVEGDPL-IMVFEYMKHGDLNKFLR--AHGPDAVLMAEGNRPAELTQSQMLH-IAQQ 128
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+A G+ +L + + VH D+ +N L + + DFG+ R T T + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIR 187
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
++ PE+ + + T ESDV+S G+VL E+ T GK+P W QL ++ E
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------WY--QLSNNEVIEC 234
Query: 1032 LEPGLLELDPESSEWE--EFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ G + P + E + +LG C +P R + +I +L+
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLG------CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 24/216 (11%)
Query: 811 LSRTRYGLVFKA-CYN-----DGMVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVL 863
L +G VF A C+N D M+++++ L + S F++EAE L ++H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH-QDGHVLN-----------WPMRHLIAL 911
G L+V++YM +G+L L+ SH D +L IA
Sbjct: 73 YGVCTEG-RPLLMVFEYMRHGDLNRFLR--SHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 912 GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
+A G+ +L + + VH D+ +N L + DFG+ R T T + +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 188
Query: 972 GYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP 1006
++ PE+ L + T ESD++SFG+VL E+ T GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 41/284 (14%)
Query: 816 YGLVFKACYN--DGMVLSIRRLPDGSLDENLFRK----EAEFLGKVRHRNLTVLRGYYAG 869
YG+V K C + G +++I++ + S D+ + +K E L ++RH NL L +
Sbjct: 14 YGMVMK-CKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
L LV++++ + T+L + + L+ + RG+ F H+ N++H D
Sbjct: 72 KKRL-YLVFEFVDH----TVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT--KE 987
IKP+N+L L DFG R T+ P E T V T Y +PE L G+T +
Sbjct: 126 IKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDY--VATRWYRAPE-LLVGDTKYGRA 181
Query: 988 SDVYSFGIVLLELLTGKRPVMFTQDED------IVKWVKKQLQKGQITELLE-------- 1033
D+++ G ++ E+LTG+ P +F D D I+K + + + Q E+ +
Sbjct: 182 VDIWAVGCLVTEMLTGE-P-LFPGDSDIDQLYHIIKCLGNLIPRHQ--EIFQKNPLFAGM 237
Query: 1034 --PGLLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIV 1074
P + E++P + + L + +A C DP DRP+ S ++
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 7/212 (3%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
L ++G V+ YN+ ++++ L G++ F +EA + ++H L L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
+ ++ +YM G+L L+ +G + P + +A G+A++ N +H D+
Sbjct: 74 EPI-YIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+ NVL ++DFGL R+ E + A + + +PEA G T +SDV
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
+SFGI+L E++T GK P + D++ +++
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 34/283 (12%)
Query: 810 VLSRTRYGLVFKA------CYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNL 860
L R +G VF A ++ ++ L DENL FR+E + K+ H+N+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNV 70
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHV----LNWPMRHLIALGVARG 916
L G A + ++ +Y G+L L+ +D + L+ + + +A G
Sbjct: 71 VRLLGLCREA-EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+ L + VH D+ +N L + E +S L + +E A+ L +++P
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWLAP 187
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
EA + + +SDV+SFG+++ E+ T G+ P DE+++ +LQ G+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----NRLQAGK-------- 235
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
LEL K+ C A +P DRP+ S++V L
Sbjct: 236 -LELPVPEGCPSRLY---KLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 62/281 (22%)
Query: 809 NVLSRTRYGLVFKAC-YNDGMVLSIRR-----LPDGSLDENLFRKEAEFLGKVRHRNLTV 862
+++ R +G+V+K G ++I++ + + +L +E + L ++H N+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS--IMQEIDLLKNLKHPNIVK 63
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA---RGLAF 919
G + L ++ +Y NG+L ++ + G L+A+ V +GLA+
Sbjct: 64 YIGSIETSDSL-YIILEYAENGSLRQII----KKFGP-FP---ESLVAVYVYQVLQGLAY 114
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTSTTAVGTLGYVSPEA 978
LH ++H DIK N+L D L+DFG+ +L + + VGT +++PE
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN----DVSKDDASVVGTPYWMAPEV 170
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITE 1030
+ SD++S G ++ELLTG P +F +I +
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-----------------RIVQ 213
Query: 1031 LLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
P L PE S E ++FL + C DP RPT
Sbjct: 214 DDHPPL----PEGISPELKDFL------MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 817 GLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
G V+KA G ++I+++ ++ L E + +H N+ Y +L
Sbjct: 33 GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDEL-W 91
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +YM G+L ++ + + +N P + V +GL +LH+ N++H DIK N+
Sbjct: 92 VVMEYMDGGSLTDIITQNFVR----MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147
Query: 936 LFDADFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994
L D L+DFG +LT E S + VGT +++PE + + D++S G
Sbjct: 148 LLSKDGSVKLADFGFAAQLT----KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 995 IVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK 1054
I+ +E+ G+ P + E ++ + IT P L + S E+++FL
Sbjct: 204 IMCIEMAEGEPPYL---REPPLRALF------LITTKGIPPLKNPEKWSPEFKDFL---- 250
Query: 1055 VALLCTAPDPIDRPTMSDIV---FMLEGC 1080
C DP RP+ +++ F+ + C
Sbjct: 251 --NKCLVKDPEKRPSAEELLQHPFLKKAC 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 47/146 (32%), Positives = 69/146 (47%), Gaps = 13/146 (8%)
Query: 862 VLRGYYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
V + YY+ + D LV +Y+ G+ +L++ +W + IA V G+ L
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDW-AKQYIA-EVVLGVEDL 113
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H ++H DIKP+N+L D L+DFGL R + VGT Y++PE L
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLAPETIL 166
Query: 981 TGETTKESDVYSFGIVLLELLTGKRP 1006
K SD +S G V+ E L G P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 59/262 (22%), Positives = 112/262 (42%), Gaps = 25/262 (9%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
L ++G+V + + ++I+ + +G++ E+ F +EA+ + K+ H NL L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
+ + V +YM NG L L+E L + V + +L ++ +H D+
Sbjct: 72 RPIFI-VTEYMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+N L D +SDFGL R + + ++S + + PE + +SDV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
+SFG+++ E+ + GK P ++ ++ E + G P+ + E +
Sbjct: 185 WSFGVLMWEVFSEGKMPY-------------ERFSNSEVVESVSAGYRLYRPKLAPTEVY 231
Query: 1050 LLGVKVALLCTAPDPIDRPTMS 1071
+ C P DRP
Sbjct: 232 ----TIMYSCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
+G V+KA + + + + ++ +E L F E + L + +H N+ L Y L
Sbjct: 18 FGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
+L+ ++ G L +++ E L P + + L FLH+ ++H D+K
Sbjct: 78 WILI-EFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE------ 987
N+L D + L+DFG+ T + T +GT +++PE ET K+
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRD---TFIGTPYWMAPEVVAC-ETFKDNPYDYK 188
Query: 988 SDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWE 1047
+D++S GI L+EL + P E V ++ K + L +P SS +
Sbjct: 189 ADIWSLGITLIELAQMEPP----HHELNPMRVLLKILKSEPPTLDQPSKW-----SSSFN 239
Query: 1048 EFLLGVKVALLCTAPDPIDRPTMSDI 1073
+FL C DP DRPT +++
Sbjct: 240 DFLKS------CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 47/290 (16%)
Query: 816 YGLVFKA------CYNDGMVLSIRRLPDG-SLD-ENLFRKEAEFLGKVRHRNLTVLRGYY 867
+G VF+A Y +++++ L + S D + F++EA + + H N+ L G
Sbjct: 18 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC 77
Query: 868 A-GAPDLRLLVYDYMPNGNLGTLLQ--------EASHQDGHV---------LNWPMRHLI 909
A G P L+++YM G+L L+ SH L+ + I
Sbjct: 78 AVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCI 135
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
A VA G+A+L VH D+ +N L + ++DFGL R ++ A+
Sbjct: 136 AKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI- 194
Query: 970 TLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQI 1028
+ ++ PE+ T ESDV+++G+VL E+ + G +P E+++ +V+ G +
Sbjct: 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR----DGNV 250
Query: 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P++ E + L LC + P DRP+ + I +L+
Sbjct: 251 LSC---------PDNCPLELYNLMR----LCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 66/276 (23%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 808 ENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY 866
++ L +YG V++ + + ++++ L + +++ F KEA + +++H NL L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
P ++ ++M GNL L+E + Q+ +N + +A ++ + +L N +
Sbjct: 71 CTREPPF-YIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT---LGYVSPEAALTGE 983
H D+ +N L + ++DFGL RL T T G + + +PE+ +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 984 TTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042
+ +SDV++FG++L E+ T G P + Q+ ELLE G PE
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLSQVYELLEKGYRMERPE 228
Query: 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + ++ C +P DRP+ ++I E
Sbjct: 229 GCPPKVY----ELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 15/169 (8%)
Query: 909 IALGVARGLAFLH-TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
IA+ V GL +L+ ++H DIKP N+L ++ + L DFG+ I S + T
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-----NSIADTF 162
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027
VGT Y+SPE G+ T +SDV+S GI ++EL GK P F+ +D Q
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD-----DGQDDPMG 217
Query: 1028 ITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
I +LL+ + E P SS++ E L C DP +RPT +
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPEDL--RDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 51/186 (27%), Positives = 99/186 (53%), Gaps = 20/186 (10%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
F EA +G+ H N+ L G + + +++ ++M NG L + L++ DG +
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSRPV-MIITEFMENGALDSFLRQ---NDGQ---FT 104
Query: 905 MRHLIAL--GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ L+ + G+A G+ +L N VH D+ +N+L +++ +SDFGL R + +
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL----EDDT 160
Query: 963 TSTTAVGTLG------YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDI 1015
+ T +LG + +PEA + T SDV+S+GIV+ E+++ G+RP ++D+
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
Query: 1016 VKWVKK 1021
+ +++
Sbjct: 221 INAIEQ 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 72/268 (26%), Positives = 114/268 (42%), Gaps = 40/268 (14%)
Query: 825 NDGMVLS---IRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDY 880
N GM+ + I P+ L + + R E E + + G + + + +Y
Sbjct: 24 NTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82
Query: 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940
G+L ++ ++ + G + + IA V +GL++LH+ ++H DIKP N+L
Sbjct: 83 CEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKGLSYLHSRKIIHRDIKPSNILLTRK 141
Query: 941 FEAHLSDFGLDRLTIPTPAEASTS--TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLL 998
+ L DFG+ E S T GT Y++PE + SDV+S G+ LL
Sbjct: 142 GQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 999 ELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE------PGLLELDPESS-EW-EEFL 1050
E+ + P F + + G I ELL L+ +P + +W EEF
Sbjct: 195 EVAQNRFP--FPPE--------GEPPLGPI-ELLSYIVNMPNPELKDEPGNGIKWSEEFK 243
Query: 1051 LGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+K C DP RPT D MLE
Sbjct: 244 DFIKQ---CLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNL 860
F+ N + + +G+VFK D V +++++ + EA L K+
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY- 60
Query: 861 TVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
++R Y + +L +V +Y NG+L LL+ Q G L + + GLA
Sbjct: 61 -IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM---QRGRPLPEDQVWRFFIQILLGLAH 116
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
LH+ ++H DIK N+ DA + D G+ +L A+ T VGT Y+SPE
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN---TIVGTPYYLSPELC 173
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRP 1006
++SDV++ G+VL E TGK P
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 51/189 (26%), Positives = 97/189 (51%), Gaps = 14/189 (7%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT-LLQEASHQD------ 897
FR+EAE + ++H N+ L G +L ++Y+ +G+L L++ + H D
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 898 ----GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953
L+ IA+ +A G+ +L + + VH D+ +N L +SDFGL R
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012
I + + ++ + ++ PEA L G+ T ESD++SFG+VL E+ + G +P +
Sbjct: 174 -IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232
Query: 1013 EDIVKWVKK 1021
+++++ ++
Sbjct: 233 QEVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 815 RYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDL 873
++GLV+ + + ++I+ + +G++ E F +EA+ + K+ H L L G +P
Sbjct: 16 QFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-- 73
Query: 874 RLLVYDYMPNGNLGTLL--QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
LV+++M +G L L Q +L + L V G+A+L +SN++H D+
Sbjct: 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLG------MCLDVCEGMAYLESSNVIHRDLA 127
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
+N L + +SDFG+ R + +ST T + + SPE + + +SDV+
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDVW 185
Query: 992 SFGIVLLELLT-GKRP 1006
SFG+++ E+ + GK P
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 36/83 (43%), Positives = 54/83 (65%)
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
G IP L L+++NL NS+ G++P + + +L LDLS N F+G +P S+G L+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 464 LMVFNLSGNAFSGRIPASLGNLL 486
L + NL+GN+ SGR+PA+LG L
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 56/179 (31%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 834 RLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEA 893
RLP S RKEA L K++H N+ + + L +V +Y G+L +Q+
Sbjct: 34 RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL-YIVMEYCDGGDL---MQKI 89
Query: 894 SHQDGH------VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947
Q G +L W ++ + LGV +H ++H DIK +N+ + + L D
Sbjct: 90 KLQRGKLFPEDTILQWFVQ--MCLGVQH----IHEKRVLHRDIKSKNIFLTQNGKVKLGD 143
Query: 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
FG RL + +P + + T VGT YV PE +SD++S G +L EL T K P
Sbjct: 144 FGSARL-LTSP--GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-15
Identities = 34/95 (35%), Positives = 57/95 (60%)
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
++ L L + L G +P ++ + +L +++LS N G +P S+G+++ L V +LS N+F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLP 510
G IP SLG L L L+L+ + SG +P L G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENLFRK---EAEFLGKVRHRNLTVLRGYYAGAP 871
YG+V K G +++I++ + DE++ + E + L ++RH N+ L+ +
Sbjct: 14 YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-- 71
Query: 872 DLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
RL LV++Y+ TLL+ G + +R I + + +A+ H+ N++H DI
Sbjct: 72 KGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHNIIHRDI 126
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT--KES 988
KP+N+L L DFG R + AS T V T Y +PE L G+T K
Sbjct: 127 KPENILVSESGVLKLCDFGFAR-ALRARP-ASPLTDYVATRWYRAPE-LLVGDTNYGKPV 183
Query: 989 DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT------------------- 1029
DV++ G ++ ELL G P +F D DI + Q G +
Sbjct: 184 DVWAIGCIMAELLDG-EP-LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241
Query: 1030 ELLEPGLLELDPE---SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
E +P LE SS +FL C DP +R T
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKA------CLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
FD L YG V+KA + G V++I+ +P + + KE L + +
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI-IKEISILKQCDSPYIVK 62
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
G Y DL +V +Y G++ +++ + L I +GL +LH+
Sbjct: 63 YYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEYLHS 117
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+ +H DIK N+L + + +A L+DFG+ T A+ + T +GT +++PE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQEI 174
Query: 983 ETTKESDVYSFGIVLLELLTGKRP 1006
++D++S GI +E+ GK P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH-QDGHVLNW 903
F +EA + ++ H + L G G P +LV + P G L L++ +
Sbjct: 43 FLREASVMAQLDHPCIVRLIGVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKEL 100
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
A VA G+A+L + + VH D+ +NVL +A +SDFG+ R
Sbjct: 101 ------AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022
+T L + +PE G+ + +SDV+S+G+ L E + G +P +
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY-------------GE 201
Query: 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
++ ++ +LE G PE E + + L C P DRPT S++
Sbjct: 202 MKGAEVIAMLESGERLPRPEECPQEIY----SIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 37/200 (18%)
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHL--IALGVARGLAFLHTS-NMVHGDIKPQNV 935
+YM G+L +L+E + P R L IA+ V +GL +LH ++H D+KP N+
Sbjct: 79 EYMDGGSLDKILKEVQGR------IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNI 132
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L ++ + L DFG+ + S + T VGT Y++PE + + +SD++S G+
Sbjct: 133 LVNSRGQIKLCDFGVSGQLV-----NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187
Query: 996 VLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL------EPGLLELDPESSEWEEF 1049
L+EL TG+ P D I ELL P L S ++++F
Sbjct: 188 SLIELATGRFPYPPENDPPD-----------GIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 1050 LLGVKVALLCTAPDPIDRPT 1069
+ LC DP +RP+
Sbjct: 237 V------NLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 835 LPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE 892
L L + + F KEA + + H NL L G P ++V + P G+L L++
Sbjct: 31 LKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP--LMMVTELAPLGSLLDRLRK 88
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952
GH L A+ +A G+ +L + +H D+ +N+L +D + + DFGL R
Sbjct: 89 --DALGHFL-ISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR 145
Query: 953 LTIPTPAEASTSTTAVGT-LGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFT 1010
+P + + + +PE+ T + SDV+ FG+ L E+ T G+ P
Sbjct: 146 -ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070
I+K + K+ E LE PE+ + + V L C A +P DRPT
Sbjct: 205 SGSQILKKIDKEG------ERLE------RPEACPQDIY----NVMLQCWAHNPADRPTF 248
Query: 1071 SDIVFML 1077
+ + L
Sbjct: 249 AALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 830 LSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTL 889
++I+ + +GS+ E+ F +EA+ + K+ H L L G + +V +YM NG L
Sbjct: 31 VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI-YIVTEYMSNGCLLNY 89
Query: 890 LQEASHQDGHVLNWPMRHLIAL--GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947
L+E + + L+ + V G+A+L + +H D+ +N L D +SD
Sbjct: 90 LREHGKR------FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSD 143
Query: 948 FGLDRLTIPTPAEASTSTTAVGT---LGYVSPEAALTGETTKESDVYSFGIVLLELLT-G 1003
FGL R + T++VG+ + + PE L + + +SDV++FG+++ E+ + G
Sbjct: 144 FGLSRYVLD-----DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 1004 KRPVMFTQDEDIVKWVKKQLQ 1024
K P + + V+ V + L+
Sbjct: 199 KMPYERFNNSETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDE-----NLFRKEAEFLGKVRHRNLTVLRGYYAG 869
YG+V+KA G +++I+++ E L +E + L ++ H N+ L +
Sbjct: 12 YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL--REIKLLKELNHPNIIKLLDVF-R 68
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
LV+++M L + + + ++ + + +GLAF H+ ++H D
Sbjct: 69 HKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYL-YQLLQGLAFCHSHGILHRD 123
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKES 988
+KP+N+L + + L+DFGL R T V T Y +PE L +
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 989 DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK 1020
D++S G + ELL+ RP +F +I + K
Sbjct: 181 DIWSVGCIFAELLSR-RP-LFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 837 DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ 896
+ E++F E E L + H + L + + +L+ +Y G L T+L++
Sbjct: 33 ETGQQEHIFS-EKEILEECNHPFIVKLYRTFKDKKYIYMLM-EYCLGGELWTILRDR--- 87
Query: 897 DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956
G + R IA V +LH +++ D+KP+N+L D++ L DFG +
Sbjct: 88 -GLFDEYTARFYIA-CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK---- 141
Query: 957 TPAEASTST-TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
++ T T GT YV+PE L D +S GI+L ELLTG+ P F +D++
Sbjct: 142 -KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP--FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 69/283 (24%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 811 LSRTRYGLVFKACYND------GMVLSIRRL-PDGSLDENL-FRKEAEFLGKVRHRNLTV 862
L + +G+V++ ++I+ + + S+ E + F EA + + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 863 LRGYYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGH--VLNWPMR---HLIALGVARG 916
L G + G P L +V + M G+L + L+ + + L P +A +A G
Sbjct: 74 LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+A+L VH D+ +N + D + DFG+ R T + + +++P
Sbjct: 132 MAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAP 190
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E+ G T +SDV+SFG+VL E+ T ++P +E+++K+V G
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG------------G 238
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L+L PE + LL ++ +C +P RPT +IV L+
Sbjct: 239 HLDL-PE--NCPDKLL--ELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
F EA + ++RH NL L G +V +YM G+L L+ VL
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGD 102
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
+L V + +L +N VH D+ +NVL D A +SDFGL T +ST
Sbjct: 103 CLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL------TKEASSTQ 156
Query: 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
T + + +PEA + + +SDV+SFGI+L E+ + G+ P +D+V V+K
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 811 LSRTRYGLVFKACYNDGMVLS---IRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRG 865
+ +G V + GM + ++ L + ++ LF +E + ++ H N+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL---IALGVARGLAFLHT 922
+ LLV ++ P G+L L+ G V + + +A VA GL +LH
Sbjct: 63 QCIESIPY-LLVLEFCPLGDLKNYLRS---NRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA--- 979
++ +H D+ +N AD + D+GL P + AV L +++PE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177
Query: 980 ----LTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
L + TK+S+++S G+ + EL T +P DE ++K V ++ Q +L +P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE----QDIKLPKP 233
Query: 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
L+L S W E V C DP RPT ++ +L
Sbjct: 234 Q-LDL-KYSDRWYE------VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 815 RYGLVFKACYND-GMVLSIRRLPDGSLDE----NLFRKEAEFLGKVRHRNLTVLRGYYAG 869
+G+VFKA + G ++++++ L+ R E + L +H + L +
Sbjct: 12 AHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVF-- 68
Query: 870 APDLR--LLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
P +LV +YMP+ L +L++ + V ++ MR L+ +G+A++H + +
Sbjct: 69 -PHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSY-MRMLL-----KGVAYMHANGI 120
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG--E 983
+H D+KP N+L AD ++DFGL RL + V T Y +PE L G +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH--QVATRWYRAPE-LLYGARK 177
Query: 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
D+++ G + ELL G P +F + DI
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SP-LFPGENDI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 22/197 (11%)
Query: 816 YGLVFKACYN--DGMVLSIRRLPDGSLDENLFRK----EAEFLGKVRHRNLTVLRGYYAG 869
YG+VFK C N G +++I++ + S D+ + +K E L +++H NL L +
Sbjct: 14 YGVVFK-CRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71
Query: 870 APDLRLLVYDYMPNGNLGTLLQE-ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
L L V++Y + T+L E + G + + I + + F H N +H
Sbjct: 72 KRKLHL-VFEYCDH----TVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHNCIHR 124
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKES 988
D+KP+N+L + L DFG R+ + T V T Y +PE L G+T
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAPE-LLVGDTQYGP 180
Query: 989 --DVYSFGIVLLELLTG 1003
DV++ G V ELLTG
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 817 GLVFKA-CYNDGMVLSIRRLP----DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG-- 869
+V+ A C + ++I+R+ S+DE RKE + + + H N+ YY
Sbjct: 15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDE--LRKEVQAMSQCNHPNVV---KYYTSFV 69
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
D LV Y+ G+L +++ + + G L+ + + V +GL +LH++ +H D
Sbjct: 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 930 IKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEA--ALTGETTK 986
IK N+L D ++DFG+ L T VGT +++PE + G K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 987 ESDVYSFGIVLLELLTGKRP 1006
+D++SFGI +EL TG P
Sbjct: 188 -ADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 77/278 (27%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 809 NVLSRTRYGLVFKACY--NDGM-----VLSIRRLPD-GSLDENLFRKEAEFLGKVRHRNL 860
V+ + +G V+ +DG V S+ R+ D +++ F KE + H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNV 58
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG--VARGLA 918
L G + L+V YM +G+L ++ +H N ++ LI G VA+G+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH------NPTVKDLIGFGLQVAKGME 112
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG-TLGYVSPE 977
+L + VH D+ +N + D F ++DFGL R + + T + +++ E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 978 AALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ T + T +SDV+SFG++L EL+T G P DI + L +G+ LL+P
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQGR--RLLQP-- 224
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
E P+ +V L C P P RPT S++V
Sbjct: 225 -EYCPDPL--------YEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 24/288 (8%)
Query: 803 RQFDEENVLSRTRYGLVFKACY---NDGM-----VLSIRRLPDGSLDENLFRKEAEFLGK 854
R + VL +G V CY NDG V +++R G + + ++KE L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKT 62
Query: 855 VRHRNLTVLRGYYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV 913
+ H N+ +G + L+ +Y+P G+L L + H LN L A +
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQI 116
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE-ASTSTTAVGTLG 972
G+A+LH+ + +H D+ +NVL D D + DFGL + +P E +
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVF 175
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF--TQDEDIVKWVKKQLQKGQITE 1030
+ + E + + SDV+SFG+ L ELLT + E+++ + Q+ ++ E
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
LLE G+ P++ E ++L C + RPT ++ +L+
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPM 905
R E E L + H N+ G+ L + + +Y+P G++G+ L+ + ++
Sbjct: 56 RSEIETLKDLDHLNIVQYLGFETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLV---- 110
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965
R V GLA+LH+ ++H D+K N+L DAD +SDFG+ + +
Sbjct: 111 RFFTE-QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-M 168
Query: 966 TAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK-- 1020
+ G++ +++PE + G + K D++S G V+LE+ G+RP ++ +E I K
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRP--WSDEEAIAAMFKLG 225
Query: 1021 KQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ I + L S +FL C +P +RPT ++
Sbjct: 226 NKRSAPPIPPDVSMNL------SPVALDFLNA------CFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 845 FRKEAEFLGKVRHRNLTVLRG--YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLN 902
F +E + K+ H+NL L G + G +V + M GNL L+ +++
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGL----YIVMELMSKGNLVNFLRTRGRA---LVS 98
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+L VA G+ +L + +VH D+ +N+L D A +SDFGL R+
Sbjct: 99 VIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVD 155
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
S V + +PEA + + +SDV+S+G++L E+ + G+ P + +K VK+
Sbjct: 156 NSKLPV---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKE 208
Query: 1022 QLQKG 1026
++KG
Sbjct: 209 CVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-14
Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 11/137 (8%)
Query: 26 EIEALTSFKLNLHDPLGALNGWDSSTPAAPCD--WRGVACTNNR------VTELRLPRLQ 77
E+ AL + K +L PL GW+ P P W G C + + L L
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429
Query: 78 LSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNL 137
L G I + +S LR L+ ++L NS G IP +L T L + L YNS +G++P ++G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 138 SNLEILNVAANRLSGEI 154
++L ILN+ N LSG +
Sbjct: 490 TSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 58/236 (24%), Positives = 107/236 (45%), Gaps = 35/236 (14%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDG----HV 900
EA + V H ++ L G + L+ MP G L ++ H+D ++
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQ--VQLITQLMPLGCLLDYVRN--HKDNIGSQYL 111
Query: 901 LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
LNW + +A+G+++L +VH D+ +NVL ++DFGL +L + +
Sbjct: 112 LNW------CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEK 164
Query: 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDI-VKW 1018
+ + +++ E+ L T +SDV+S+G+ + EL+T G +P E I
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY-----EGIPAVE 219
Query: 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ L+KG+ L +P + +D +++ VK C D RPT +++
Sbjct: 220 IPDLLEKGE--RLPQPPICTIDV-------YMVLVK----CWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 9e-14
Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 40/252 (15%)
Query: 816 YGLVFKACY-NDGMVLSIRRL--------PDGSLDENLFRKEAEFLGKVRHRNLTVLRGY 866
Y +V+KA G +++I+++ DG ++ R E + L +++H N+ L
Sbjct: 13 YAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALR-EIKLLQELKHPNIIGLLDV 70
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSN 924
+ ++ L V+++M +L ++++ S + ++ M + RGL +LH++
Sbjct: 71 FGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIKSY-MLMTL-----RGLEYLHSNW 122
Query: 925 MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
++H D+KP N+L +D L+DFGL R + +P T V T Y +PE L G
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQ--VVTRWYRAPE-LLFGAR 178
Query: 985 TKES--DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQITELLEPGLL 1037
D++S G + ELL P D DI QL K G TE PG+
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV-P-FLPGDSDI-----DQLGKIFEALGTPTEENWPGVT 231
Query: 1038 ELDPESSEWEEF 1049
L P+ E++ F
Sbjct: 232 SL-PDYVEFKPF 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 96/301 (31%), Positives = 145/301 (48%), Gaps = 23/301 (7%)
Query: 314 LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373
L S ++ LD S N ++ + L ++ +N E+ + ++L+ LDL
Sbjct: 74 LLSPSGISSLDGSENLLNLLPLPSL----DLNLNRLRSNIS------ELLELTNLTSLDL 123
Query: 374 EGNRFSGEIPEFLGD-IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPE 432
+ N + +IP +G LK L L+ N S+P+ RNLP L+NL+L N LS LP+
Sbjct: 124 DNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPK 180
Query: 433 EVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLD 492
+ ++NL+ LDLS NK S ++P I LS L +LS N+ + +SL NL L+ L+
Sbjct: 181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238
Query: 493 LSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA 552
LS N +LP + L NL+ + L N++S SL +LR L+LS N +P
Sbjct: 239 LSN-NKLEDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPL 295
Query: 553 TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLD 612
L + +L N + EL S L + SN T P +S L LN L
Sbjct: 296 IALLLLLLELLL---NLLLTLKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLW 351
Query: 613 L 613
Sbjct: 352 T 352
|
Length = 394 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 1e-13
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 39/210 (18%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENL------FRKEAEFLGKVRHRN----LTVLR 864
YG+V A G ++I+++ + + ++L R E + L +RH N L +LR
Sbjct: 13 YGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILR 69
Query: 865 GYYAGAPDLRL------LVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMRHLIALGVAR 915
P +V + M +L +++ S Q D H+ + + ++ R
Sbjct: 70 ------PPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHI-QYFLYQIL-----R 114
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL +LH++N++H D+KP N+L +++ + + DFGL R P E T V T Y +
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 976 PEAALTGET-TKESDVYSFGIVLLELLTGK 1004
PE L+ TK D++S G + ELLT K
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 55/297 (18%)
Query: 799 VEATRQFDEEN---VLSRTRYGLVFKACYNDGMV-LSIRRLPD-GSLDENLFRKEAEFLG 853
+E ++DE VL + YG+V+ A V ++I+ +P+ S +E
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 854 KVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNW-PMR-HLIAL 911
++HRN+ G + ++ + + +P G+L LL+ W P++ + +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFM-EQVPGGSLSALLRS---------KWGPLKDNEQTI 110
Query: 912 G-----VARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLD-RLTIPTPAEASTS 964
+ GL +LH + +VH DIK NVL + +SDFG RL P +
Sbjct: 111 IFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC----T 166
Query: 965 TTAVGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQ 1022
T GTL Y++PE G +D++S G ++E+ TGK P + +
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-------------E 213
Query: 1023 LQKGQITELLEPGLLELDPE-----SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
L + Q + + G+ ++ PE S+E + F+L C PDP R + D++
Sbjct: 214 LGEPQ-AAMFKVGMFKIHPEIPESLSAEAKNFILR------CFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (177), Expect = 2e-13
Identities = 68/242 (28%), Positives = 112/242 (46%), Gaps = 35/242 (14%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENLFR---KEAEFLGKVRHRNLTVLRGYYAGAP 871
YG+V+KA G +++++++ + +E + +E L +++H N+ L
Sbjct: 12 YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-E 70
Query: 872 DLRLLVYDYMPNGNLGTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
LV++Y +L L + +++ M L+ RGLA+ H+ ++H D+
Sbjct: 71 RKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL-----RGLAYCHSHRILHRDL 124
Query: 931 KPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALTGET--TKE 987
KPQN+L + D L+DFGL R IP T T V TL Y +PE L G +
Sbjct: 125 KPQNILINRDGVLKLADFGLARAFGIPLR----TYTHEVVTLWYRAPE-ILLGSKHYSTA 179
Query: 988 SDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWE 1047
D++S G + E++TGK +F D +I QL K I ++L G P W
Sbjct: 180 VDIWSVGCIFAEMITGK--PLFPGDSEI-----DQLFK--IFQIL--GT----PTEESWP 224
Query: 1048 EF 1049
Sbjct: 225 GV 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/240 (25%), Positives = 120/240 (50%), Gaps = 26/240 (10%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGM----VLSIRRLPDGSLDENL--FRKEAEFLGKVR 856
+F EE L +G ++K Y GM +++I+ L D + + F++EA + ++
Sbjct: 8 RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE---------ASHQDGHVLNWPMRH 907
H N+ L G + +L ++Y+ G+L L +S +DG V + + H
Sbjct: 66 HPNIVCLLGVVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS-SLDH 123
Query: 908 ----LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
IA+ +A G+ +L + VH D+ +N+L +SD GL R I +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR-EIYSADYYRV 182
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022
++ + ++ PEA + G+ + +SD++SFG+VL E+ + G +P ++++++ V+K+
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACY--NDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHR 858
++++ V+ R +G+V C D ++ I+++P + + + E + L + H
Sbjct: 1 KYEKIRVVGRGAFGIVH-LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 859 NLTVLRGYYAG-APDLRL-LVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMRHLIALGV 913
N+ YY D L +V +Y P G L +Q+ + + +L++ ++ L+AL
Sbjct: 60 NII---EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL-- 114
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+HT ++H D+K QN+L D + DFG+ ++ + S + T VGT
Sbjct: 115 ----HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPC 166
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005
Y+SPE ++SD+++ G VL EL + KR
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-13
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
FR+E ++ H N+ L P L V++Y+P L +L DG +
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLA----ADGALPAGE 80
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAH--LSDFGLDRLTIPTPAEA 961
L+ L V LA H +VH D+KPQN++ H + DFG+ L
Sbjct: 81 TGRLM-LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 962 STSTTA----VGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV 1016
+ T +GT Y +PE L GE T SD+Y++G++ LE LTG+R V Q +
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQ-LRGEPVTPNSDLYAWGLIFLECLTGQRVV---QGASVA 195
Query: 1017 KWVKKQL 1023
+ + +QL
Sbjct: 196 EILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 54/208 (25%), Positives = 80/208 (38%), Gaps = 25/208 (12%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH 907
E + L KV V Y D LV M NG G L +
Sbjct: 43 EKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLM-NG--GDLKYHIYNVGEPGFPEARAI 98
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
A + GL LH +V+ D+KP+NVL D +SD G L +
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLG---LAVELK-GGKKIKGR 154
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027
GT GY++PE D ++ G L E++ G+ P F Q ++ V+ K++L++
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVE--KEELKRRT 210
Query: 1028 ITELLE-------------PGLLELDPE 1042
+ +E LL+ DPE
Sbjct: 211 LEMAVEYPDKFSPEAKDLCEALLQKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 866 YYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN 924
YY+ +L+ DY+ +G+L LL+ ++G L+ I + L LH N
Sbjct: 75 YYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGK-LSEAEVKKIIRQLVEALNDLHKHN 129
Query: 925 MVHGDIKPQNVLFD-ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
++H DIK +NVL+D A +L D+GL + I TP + GTL Y SPE + G
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTP------SCYDGTLDYFSPE-KIKGH 181
Query: 984 TTKES-DVYSFGIVLLELLTGKRPVMFTQDEDI-VKWVKKQLQK 1025
S D ++ G++ ELLTGK P +DE++ ++ + K+ QK
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK 225
|
Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-13
Identities = 39/97 (40%), Positives = 52/97 (53%)
Query: 340 GLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA 399
G W ++ L + N G +P +I + L ++L GN G IP LG I L+ L L+
Sbjct: 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG 436
N F+GSIP S L L LNL NSLSG +P + G
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-13
Identities = 85/262 (32%), Positives = 133/262 (50%), Gaps = 18/262 (6%)
Query: 419 LNLRHNSLSGSL-PEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477
L L +S + L P + + +L L S S + ++ NL L +L+ N
Sbjct: 50 LALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSN 108
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN----VPEGFSSL 533
I L L LT+LDL N + ++ L L L+E LS N +P +L
Sbjct: 109 ISE-LLELTNLTSLDLDNNNIT-----DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNL 162
Query: 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
+L+ L+LSFN + +P S L ++ L SGN IS +PPE+ S LE L+L +NS
Sbjct: 163 PNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKL 653
+ + + +S+L +L+ L+LS N L ++P+ I S+L +L +++N +S SL L
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSL 276
Query: 654 SNLAVLDLSANNLSGEIPANLS 675
+NL LDLS N+LS +P
Sbjct: 277 TNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 55/285 (19%)
Query: 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLP-DGSLDE-NLFRKEAEFLGKVRHRNL 860
F + + +G V+KA V++I+ + + + DE ++E +FL + R +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 861 TVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
T G + +L ++ +Y G+ LL+ + ++ I V GL +
Sbjct: 62 TKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPGKLDETYI------AFILREVLLGLEY 113
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTST---TAVGTLGYVS 975
LH +H DIK N+L + + L+DFG+ +LT ST + T VGT +++
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-------STMSKRNTFVGTPFWMA 166
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQ 1027
PE +++D++S GI +EL G+ P V+F I K
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----IPK---------- 212
Query: 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
P LE + S +++F+ LC DP +RP+ +
Sbjct: 213 ----NNPPSLEGNKFSKPFKDFV------SLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 46/140 (32%), Positives = 70/140 (50%), Gaps = 24/140 (17%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL FLH +++ D+K NVL D D ++DFG+ + + +AS T GT Y++
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS---TFCGTPDYIA 164
Query: 976 PEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDEDIV------------KWVKKQ 1022
PE L G+ ES D +SFG++L E+L G+ P +DED + +W+ K
Sbjct: 165 PE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP-FHGEDEDELFDSILNDRPHFPRWISK- 221
Query: 1023 LQKGQITELLEPGLLELDPE 1042
+ + L L E DP
Sbjct: 222 ----EAKDCLS-KLFERDPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+EA L ++H N+ +L L V++YM L Q G + + +R
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTF-VFEYMHT----DLAQYMIQHPGGLHPYNVR 106
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTST 965
L + RGLA++H +++H D+KPQN+L E L+DFGL R +IP+ T +
Sbjct: 107 -LFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS----QTYS 161
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024
+ V TL Y P+ L + + D++ G + +E+L G+ P F D+ +QL+
Sbjct: 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ-PA-FPGVSDVF----EQLE 215
Query: 1025 K-----GQITELLEPGLLELDPESSEW 1046
K G TE PG+ +L EW
Sbjct: 216 KIWTVLGVPTEDTWPGVSKLPNYKPEW 242
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 1/91 (1%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL ++H++N++H D+KP N+L + + + + DFGL R+ P T V T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 975 SPEAALTGET-TKESDVYSFGIVLLELLTGK 1004
+PE L + TK D++S G +L E+L+ +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 53/212 (25%), Positives = 107/212 (50%), Gaps = 8/212 (3%)
Query: 811 LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
L ++G+V + + ++I+ + +G++ E F +EA+ + K+ H L L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
L +V ++M NG L L++ + G L+ M + V G+ +L ++ +H D+
Sbjct: 72 KPL-YIVTEFMENGCLLNYLRQ---RQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
+N L + +SDFG+ R + E ++S+ A + + PE + + +SDV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
+SFG+++ E+ T GK P + ++V+ + +
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 33/231 (14%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY-DYMPNGNLGTLLQEASHQDGHVLNWPM 905
+E L K++H N +++ + L ++ + +P G+L LL++ V+
Sbjct: 51 QEIALLSKLQHPN--IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965
R ++ GL +LH N VH DIK N+L D + L+DFG+ + + E S +
Sbjct: 109 RQILL-----GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV----EFSFAK 159
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024
+ G+ +++PE G +D++S G +LE+ TGK P ++Q E +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQLEGV--------- 208
Query: 1025 KGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ ++ L P+ S E ++F+ L C DP RPT +++
Sbjct: 209 -AAVFKIGRSKELPPIPDHLSDEAKDFI------LKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-13
Identities = 36/88 (40%), Positives = 48/88 (54%)
Query: 440 LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499
+ L L G +P I L L NLSGN+ G IP SLG++ L LDLS +F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 500 GELPIELAGLPNLQVIALQENKLSGNVP 527
G +P L L +L+++ L N LSG VP
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 65/280 (23%), Positives = 120/280 (42%), Gaps = 39/280 (13%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRL----PDGSLDENLFRKEAEFLGKVRH- 857
+ ++ R YG V++ G V++++ + PD + + ++E L ++R
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD--IQREVALLSQLRQS 59
Query: 858 --RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
N+T G Y P L ++ +Y G++ TL++ + ++ +I V
Sbjct: 60 QPPNITKYYGSYLKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYI------SVIIREVLV 112
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L ++H ++H DIK N+L L DFG+ L +S +T VGT +++
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---SSKRSTFVGTPYWMA 169
Query: 976 PEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
PE G+ TK +D++S GI + E+ TG P D D + + +
Sbjct: 170 PEVITEGKYYDTK-ADIWSLGITIYEMATGNPPY---SDVD-------AFRAMMLIPKSK 218
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
P LE + S EF+ C +P +R + ++
Sbjct: 219 PPRLEDNGYSKLLREFVAA------CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 805 FDEENVLSRTRYGLVFKACYNDG-MVLSIRRLPDGSLDENLFRKEAEFLGKVR----HRN 859
FD V+ R +G V + V +++ L S E + R ++ F + R H N
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL---SKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 860 LT-VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
+++ +YA D L +V +YMP G+L L+ + W + + +A L
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWARFYTAEVVLA--L 155
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST-STTAVGTLGYVSP 976
+H+ +H D+KP N+L D L+DFG + A TAVGT Y+SP
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGTPDYISP 212
Query: 977 EAALT----GETTKESDVYSFGIVLLELLTGKRP 1006
E + G +E D +S G+ L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 37/240 (15%)
Query: 816 YGLVFKAC-YNDGMVLSIRRLPDGSLDE----NLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG VFKA +++++R+ DE + R E L +++H+N+ L
Sbjct: 13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL------- 64
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQD--------GHVLNWPMRHLIALGVARGLAFLHT 922
YD + + TL+ E QD ++ + + +GLAF H+
Sbjct: 65 -------YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALT 981
N++H D+KPQN+L + + E L+DFGL R IP + V TL Y P+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----RCYSAEVVTLWYRPPDVLFG 173
Query: 982 GETTKES-DVYSFGIVLLELLTGKRPVMFTQD-EDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ S D++S G + EL RP+ D +D +K + + L G TE PG+ +L
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEESWPGVSKL 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 48/239 (20%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR----LLVYDYMPNGNLGTLLQEASHQDGHVLN 902
KE FL ++RH N +G Y LR LV +Y G+ +L+ V
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCY-----LREHTAWLVMEYCL-GSASDILE--------VHK 109
Query: 903 WPMRHL----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
P++ + I G +GLA+LH+ +H DIK N+L L+DFG +
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-------SA 162
Query: 959 AEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
+ S + + VGT +++PE L G+ + DV+S GI +E L ++P +F +
Sbjct: 163 SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS 221
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ I + P L S++W ++ C P DRP+ +++
Sbjct: 222 ALY--------HIAQNDSPTL-----SSNDWSDYF--RNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 30/247 (12%)
Query: 810 VLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAE--------FLGKVRHRNL 860
V+ + +G V A + DG +++ L ++ L +KE + L V+H L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI---LKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
L Y D V DY+ G L LQ P A +A L +L
Sbjct: 59 VGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERS-----FPEPRARFYAAEIASALGYL 112
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H+ N+++ D+KP+N+L D+ L+DFGL + I + T++T GT Y++PE
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI---EHSKTTSTFCGTPEYLAPEVLR 169
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQD--EDIVKWVKKQLQ-KGQIT----ELLE 1033
+ D + G VL E+L G P +++D E + K L+ K I+ LLE
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228
Query: 1034 PGLLELD 1040
GLL+ D
Sbjct: 229 -GLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 48/239 (20%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR----LLVYDYMPNGNLGTLLQEASHQDGHVLN 902
KE +FL +++H N +G Y LR LV +Y G+ LL+ V
Sbjct: 74 KEVKFLQRIKHPNSIEYKGCY-----LREHTAWLVMEYCL-GSASDLLE--------VHK 119
Query: 903 WPMRHL----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
P++ + I G +GLA+LH+ NM+H DIK N+L + L+DFG +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-------SA 172
Query: 959 AEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
+ AS + + VGT +++PE L G+ + DV+S GI +E L ++P +F +
Sbjct: 173 SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMS 231
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ I + P L +S+EW ++ + C P DRPT +++
Sbjct: 232 ALY--------HIAQNESPTL-----QSNEWSDYFRNFVDS--CLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
IA+ V +GL +L + ++H D+KP N+L + + L DFG+ + S + T V
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKTYV 154
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
GT Y++PE + SDV+S GI +EL G+ P
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 35/89 (39%), Positives = 52/89 (58%)
Query: 491 LDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI 550
L L Q G +P +++ L +LQ I L N + GN+P S+ SL L+LS+N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 551 PATFSFLRSVVVLSFSGNHISGSIPPELG 579
P + L S+ +L+ +GN +SG +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 26/231 (11%)
Query: 793 ITLAETVEATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEF 851
I L+ + F+ V+ YG V+K + G + +I+ + +E + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 852 LGKV-RHRNLTVLRGYY-----AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPM 905
L K HRN+ G + G D LV ++ G++ L++ G+ L
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDW 122
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG----LDRLTIPTPAEA 961
I + RGLA LH ++H DIK QNVL + E L DFG LDR
Sbjct: 123 IAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-------TV 175
Query: 962 STSTTAVGTLGYVSPEAALTGETTK-----ESDVYSFGIVLLELLTGKRPV 1007
T +GT +++PE E SD++S GI +E+ G P+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 13/131 (9%)
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLF 937
++M G+L +L++A ++L I++ V RGL +L ++H D+KP N+L
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHKIMHRDVKPSNILV 133
Query: 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIV 996
++ E L DFG+ I S + + VGT Y+SPE L G T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLS 187
Query: 997 LLELLTGKRPV 1007
L+E+ G+ P+
Sbjct: 188 LVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E E L V H N+ + ++++L+ ++M G+L + H+ +
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL---------EGTHIADEQFL 170
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+A + G+A+LH ++VH DIKP N+L ++ ++DFG+ R+ T ++S
Sbjct: 171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-- 228
Query: 967 AVGTLGYVSPEAALTGETTKE-----SDVYSFGIVLLELLTGKRP 1006
VGT+ Y+SPE T D++S G+ +LE G+ P
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
V +Y+ G+L +Q H + P A + GL FLH+ +V+ D+K N
Sbjct: 72 FFVMEYLNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994
+L D D ++DFG+ + + +A T T GT Y++PE L + D +SFG
Sbjct: 127 ILLDTDGHIKIADFGMCKENM--LGDAKTCTFC-GTPDYIAPEILLGQKYNTSVDWWSFG 183
Query: 995 IVLLELLTGKRPVMFTQDEDIVKWVK 1020
++L E+L G+ P +E++ + ++
Sbjct: 184 VLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 57/170 (33%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
R E + L VR R ++ +YA D +L L+ DY+ G L T L +Q H
Sbjct: 52 RTERQVLEAVR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL----YQREHFTESE 106
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
+R IA + L LH +++ DIK +N+L D++ L+DFGL + + E + S
Sbjct: 107 VRVYIA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 965 TTAVGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQD 1012
GT+ Y++PE G K D +S G++ ELLTG P FT D
Sbjct: 166 F--CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 810 VLSRTRYGLVFKACYN--DGMVLSIRRLP------DGSLDENLFRKEAEFLGKVRHRNLT 861
+L R +G V+ CY+ G L+++++P + S + N E + L +RH +
Sbjct: 9 LLGRGAFGEVY-LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 862 VLRGYYAGAPDLRLLVY-DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
G + +L ++ +YMP G++ L+ +V R ++ +G+++L
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-----QGVSYL 122
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV-GTLGYVSPEAA 979
H++ +VH DIK N+L D+ L DFG + I T + T +V GT ++SPE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSPE-V 180
Query: 980 LTGET-TKESDVYSFGIVLLELLTGKRP 1006
++GE +++DV+S ++E+LT K P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 68/236 (28%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
KE FL K+RH N RG Y LV +Y G+ LL+ V P++
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCL-GSASDLLE--------VHKKPLQ 113
Query: 907 HL----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ + G +GLA+LH+ NM+H D+K N+L L DFG +I PA
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPA--- 168
Query: 963 TSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019
VGT +++PE L G+ + DV+S GI +E L ++P +F + +
Sbjct: 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY- 224
Query: 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075
I + P L +S W E+ + C P DRPT S+++
Sbjct: 225 -------HIAQNESPAL-----QSGHWSEYFRNFVDS--CLQKIPQDRPT-SEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/243 (25%), Positives = 113/243 (46%), Gaps = 26/243 (10%)
Query: 801 ATRQFDEENVLSRTRYGLVFK------ACYNDGMVLSIRRLPD---GSLDENLFRKEAEF 851
+T +F EE L R+G V+K A ++I+ L D G L E F+ EA
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMM 61
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT-LLQEASHQD----------GHV 900
+++H N+ L G L + ++ Y + +L L+ + H D
Sbjct: 62 RSRLQHPNIVCLLGVVTKEQPLSM-IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 901 LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
L I +A G+ FL + ++VH D+ +NVL +SD GL R +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EVYAADY 179
Query: 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWV 1019
++ + ++SPEA + G+ + +SD++S+G+VL E+ + G +P ++D+++ +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239
Query: 1020 KKQ 1022
+ +
Sbjct: 240 RNR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +Y+ G+L ++ E +G + + + L FLH++ ++H DIK N+
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFLHSNQVIHRDIKSDNI 146
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D L+DFG P E S +T VGT +++PE + D++S GI
Sbjct: 147 LLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 996 VLLELLTGKRPVM 1008
+ +E++ G+ P +
Sbjct: 204 MAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 46/130 (35%), Positives = 73/130 (56%), Gaps = 9/130 (6%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGY 973
+G+AF H + ++H D+KPQN+L + E L+DFGL R IP +T + V TL Y
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTLWY 166
Query: 974 VSPEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+P+ L T S D++S G ++ E++TG+ T +ED + + + + G TE
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM--GTPTEST 224
Query: 1033 EPGLLELDPE 1042
PG+ +L PE
Sbjct: 225 WPGISQL-PE 233
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 67/259 (25%), Positives = 103/259 (39%), Gaps = 38/259 (14%)
Query: 833 RRLPDGSL----DENLFR----------KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878
RR D SL + NL R E L ++H N+ YY D L+
Sbjct: 20 RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII---AYYNHFMDDNTLLI 76
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938
+ M N GTL + Q G + M + ++++H + ++H DIK N+
Sbjct: 77 E-MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135
Query: 939 ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLL 998
L DFG+ ++ +E S + T VGT Y+SPE + +SD+++ G VL
Sbjct: 136 KAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLY 192
Query: 999 ELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALL 1058
ELLT KR F + + V K +Q + SSE +
Sbjct: 193 ELLTLKR--TFDAT-NPLNLVVKIVQGNYT--------PVVSVYSSELIS------LVHS 235
Query: 1059 CTAPDPIDRPTMSDIVFML 1077
DP RPT +++
Sbjct: 236 LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 28/229 (12%)
Query: 842 ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLG---TLLQEASHQDG 898
E++ E + L KV R + L Y D LV M G+L + EA ++G
Sbjct: 44 ESMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG 102
Query: 899 HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
+ + A + GL LH +V+ D+KP+N+L D +SD GL + +P
Sbjct: 103 RAVFY------AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL-AVHVP-- 153
Query: 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKW 1018
E T VGT+GY++PE T D ++ G +L E++ G+ P F Q
Sbjct: 154 -EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR------ 204
Query: 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDR 1067
KK++++ ++ L++ E + S L + LLC DP +R
Sbjct: 205 -KKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM---LLCK--DPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-12
Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 11/130 (8%)
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV-HGDIKPQNVLF 937
++M G+L +L+EA +L +++ V RGLA+L + + H D+KP N+L
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVL 997
++ E L DFG+ I S + + VGT Y+SPE + +SD++S G+ L
Sbjct: 138 NSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 998 LELLTGKRPV 1007
+EL G+ P+
Sbjct: 193 VELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 40/285 (14%)
Query: 802 TRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFR----KEAEFLGKVR 856
F E + + ++ +V+KA C DG V++++++ + + R KE + L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 857 HRNLTVLRGYYAGAPDLRLL--VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV- 913
H N V++ Y A + L V + G+L +++ Q + P R + V
Sbjct: 61 HPN--VIK-YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQ 114
Query: 914 -ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA----V 968
L +H+ ++H DIKP NV A L D GL R S+ TTA V
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAAHSLV 167
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028
GT Y+SPE +SD++S G +L E+ + P F D+ + + K+++K
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEKCDY 225
Query: 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
L P D S E + L+ C PDP RP +S +
Sbjct: 226 PPL--PA----DHYSEELRD-LVSR-----CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-12
Identities = 32/92 (34%), Positives = 47/92 (51%)
Query: 323 LDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEI 382
L + + G IP I L L+ + ++ NS G +P + +SL +LDL N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 383 PEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414
PE LG + L+ L L N SG +PA+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
L LH N+++ D+KP+N+L D L DFGL +L + + + T GT Y++P
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM---KDDDKTNTFCGTPEYLAP 162
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ---------KGQ 1027
E L TK D ++ G++L E+LTG P DE++ + +K LQ
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY---DENVNEMYRKILQEPLRFPDGFDRD 219
Query: 1028 ITELLEPGLLELDPE 1042
+LL GLL DP
Sbjct: 220 AKDLLI-GLLSRDPT 233
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 27/202 (13%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDG--HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
LV MP G L ++E + G +LNW ++ +A+G+++L +VH D+ +
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEEVRLVHRDLAAR 138
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSF 993
NVL + ++DFGL RL E V + +++ E+ L T +SDV+S+
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILHRRFTHQSDVWSY 197
Query: 994 GIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
G+ + EL+T G +P + +I +LLE G P + +++
Sbjct: 198 GVTVWELMTFGAKPY-------------DGIPAREIPDLLEKGERLPQPPICTIDVYMIM 244
Query: 1053 VKVALLCTAPDPIDRPTMSDIV 1074
VK C D RP ++V
Sbjct: 245 VK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 6e-12
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL--TIPTPAEASTSTTAVGTLG 972
+ L ++H+ N++H D+KP N+L ++D L+DFGL R + E T V T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 973 YVSPEAALTGET--TKESDVYSFGIVLLELLTGK 1004
Y +PE L G T TK D++S G +L E+L GK
Sbjct: 178 YRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 25/183 (13%)
Query: 830 LSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL--- 886
++I ++ +E+ RKE L ++H N+ + + +L +V DY G+L
Sbjct: 33 INISKMSPKEREES--RKEVAVLSNMKHPNIVQYQESFEENGNL-YIVMDYCEGGDLYKK 89
Query: 887 -----GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941
G L E +L+W ++ +AL +H ++H DIK QN+ D
Sbjct: 90 INAQRGVLFPE-----DQILDWFVQICLAL------KHVHDRKILHRDIKSQNIFLTKDG 138
Query: 942 EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELL 1001
L DFG+ R+ T + T +GT Y+SPE +SD+++ G VL E+
Sbjct: 139 TIKLGDFGIARVLNST---VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 1002 TGK 1004
T K
Sbjct: 196 TLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-12
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 2/92 (2%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
R L ++HT+N+ H D+KP+N+L +AD + + DFGL R+ A T V T Y
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 975 SPE--AALTGETTKESDVYSFGIVLLELLTGK 1004
+PE + + T D++S G + E+LTGK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGT-LLQEASHQDGHVLNW 903
R E + L +R V +YA D +L L+ DY+ G L T L Q ++ V
Sbjct: 52 RTERQVLEHIRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEV--- 107
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
+ + + L LH +++ DIK +N+L D++ L+DFGL + E +
Sbjct: 108 ---QIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 964 STTAVGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
S GT+ Y++P+ G+ K D +S G+++ ELLTG P FT D +
Sbjct: 165 SF--CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--FTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-12
Identities = 35/93 (37%), Positives = 54/93 (58%)
Query: 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
+ L L +RG P +++ L +++SGNSI G IP +G + LE L ++ NSF
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 355 GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLG 387
G++P + Q +SL +L+L GN SG +P LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
KE +FL +++H N +G Y LV +Y G+ LL+ V P++
Sbjct: 70 KEVKFLQQLKHPNTIEYKGCYL-KEHTAWLVMEYCL-GSASDLLE--------VHKKPLQ 119
Query: 907 HL----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ I G +GLA+LH+ NM+H DIK N+L + L+DFG + +++S
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-------SASKSS 172
Query: 963 TSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019
+ + VGT +++PE L G+ + DV+S GI +E L ++P +F + +
Sbjct: 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY- 230
Query: 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
I + P L +S+EW + G C P +RP ++++
Sbjct: 231 -------HIAQNDSPTL-----QSNEWTDSFRG--FVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 811 LSRTRYGLVFKACYN-DGMVLSIR--RLPDGSLDENLFR---KEAEFLGKVRHRNLTVLR 864
L + YG V+K + G+ ++++ RL LDE+ F E + L H+ ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL---ELDESKFNQIIMELDIL----HKAVSPYI 61
Query: 865 GYYAGAPDLRLLVY---DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
+ GA + VY +YM G+L L +G + + I V +GL FL
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG--IPEDVLRRITYAVVKGLKFLK 119
Query: 922 TS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE--- 977
N++H D+KP NVL + + + L DFG + AS + T +G Y++PE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFG-----VSGNLVASLAKTNIGCQSYMAPERIK 174
Query: 978 ---AALTGETTKESDVYSFGIVLLELLTGKRP 1006
T +SDV+S G+ +LE+ G+ P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-12
Identities = 45/132 (34%), Positives = 65/132 (49%), Gaps = 9/132 (6%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
LV DYM G L LQ ++G + IA V L LH ++V+ D+KP+N+
Sbjct: 73 LVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVL-ALEHLHKYDIVYRDLKPENI 127
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFG 994
L DA L DFGL + + T+ T GT Y++PE L + TK D +S G
Sbjct: 128 LLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 995 IVLLELLTGKRP 1006
+++ E+ G P
Sbjct: 185 VLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 14/193 (7%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E L ++H N+ L L L V++Y+ + +L L + G+ +N
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTL-VFEYL-DKDLKQYLDDC----GNSINMHNV 106
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTST 965
L + RGL + H ++H D+KPQN+L + E L+DFGL R +IPT T +
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT----KTYS 162
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024
V TL Y P+ L + + + + D++ G + E+ TG+ + E+ + ++ + L
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL- 221
Query: 1025 KGQITELLEPGLL 1037
G TE PG+L
Sbjct: 222 -GTPTEETWPGIL 233
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 52/232 (22%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKE--------------- 848
++ + + +G V K +RR DG + L KE
Sbjct: 1 DYEVLETIGKGSFGTVRK----------VRRKSDGKI---LVWKEIDYGNMTEKEKQQLV 47
Query: 849 AEF--LGKVRHRNLTVLRGYYAGAPD----LRLLVYDYMPNGNLGTLLQEASHQDGHVLN 902
+E L +++H N+ YY D +V +Y G+L L+Q+ + ++
Sbjct: 48 SEVNILRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE 104
Query: 903 ---WPMRHLIALGVARGLAFLH-----TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954
W R L L +A L H + ++H D+KP N+ DA+ L DFGL ++
Sbjct: 105 EFIW--RILTQLLLA--LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI- 159
Query: 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
++S + T VGT Y+SPE ++SD++S G ++ EL P
Sbjct: 160 --LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTV 862
F+ ++ YG V+K + G + +I+ + +E ++E L K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 863 LRGYY-----AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
G + G D LV ++ G++ L++ G+ L I + RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGL 124
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG----LDRLTIPTPAEASTSTTAVGTLGY 973
+ LH ++H DIK QNVL + E L DFG LDR T +GT +
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-------TVGRRNTFIGTPYW 177
Query: 974 VSPEAALTGETTK-----ESDVYSFGIVLLELLTGKRPV 1007
++PE E +SD++S GI +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/250 (25%), Positives = 116/250 (46%), Gaps = 29/250 (11%)
Query: 830 LSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLG 887
++++ L G+ D+ F KEA + H N+ L G + + ++ + M G+L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQYIIMELMEGGDLL 87
Query: 888 TLLQEASHQDGHVLNWPMRHL--IALGVARGLAFLHTSNMVHGDIKPQNVL-----FDAD 940
+ L++A + ++ L I L VA+G +L + +H D+ +N L +DAD
Sbjct: 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDAD 147
Query: 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
+ DFGL R I + + +++PE+ L G+ T +SDV+SFG+++ E+
Sbjct: 148 RVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI 206
Query: 1001 LT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLC 1059
LT G++P ++++++ V G L+ + L+ C
Sbjct: 207 LTLGQQPYPALNNQEVLQHVT------------AGGRLQKPENCPDKIYQLM-----TNC 249
Query: 1060 TAPDPIDRPT 1069
A DP +RPT
Sbjct: 250 WAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 20/245 (8%)
Query: 804 QFDEENVLSRTRYGLVFKA---CYNDGMVLSIRRL-PDGSLDENLFR---KEAEFLGKVR 856
+++ E + R YG V+KA DG +I++ D + + +E L +++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 857 HRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
H N+ L + D + L++DY + +L +++ + M + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAH----LSDFGLDRLTIPTPAEASTSTTAVGTL 971
G+ +LH++ ++H D+KP N+L + + D GL RL + V T+
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 972 GYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV---KKQLQKGQ 1027
Y +PE L TK D+++ G + ELLT P+ ++ I K + QL++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSNPFQRDQLER-- 236
Query: 1028 ITELL 1032
I E+L
Sbjct: 237 IFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 39/194 (20%)
Query: 909 IALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
IA+ + + L +LH+ +++H D+KP NVL + + + L DFG+ + + A+ T
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TID 163
Query: 968 VGTLGYVSPEAALTGETTKE-----SDVYSFGIVLLELLTGKRP-----VMFTQDEDIVK 1017
G Y++PE + E ++ SDV+S GI ++EL TG+ P F Q + +V+
Sbjct: 164 AGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI---V 1074
QL + S E+++F V C + +RP ++
Sbjct: 223 EPSPQLPA--------------EKFSPEFQDF---VNK---CLKKNYKERPNYPELLQHP 262
Query: 1075 FMLEGCRVGPDIPS 1088
F D+ S
Sbjct: 263 FFELHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 45/288 (15%)
Query: 809 NVLSRTRYGLVFKACYNDGMVLS-----IRRLPDGS--LDENLFRKEAEFLGKVRHRNLT 861
++L +G +F D ++ + D + + L +E+ L + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLA 918
+ + ++Y YM GNL LQ+ + L+ +A+ +A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG------ 972
+LH ++H DI +N + D + + ++D L R P LG
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC---------LGDNENRP 182
Query: 973 --YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
+++ E+ + E + SDV+SFG++L EL+T G+ P + ++ ++K + Q
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ-- 240
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
P + E F V C A DP +RP+ S +V L
Sbjct: 241 -----------PINCPDELF----AVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 34/214 (15%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E + + +++H N+ L Y D LV D M +L ++ L
Sbjct: 69 RELKIMNEIKHENIMGLVDVYV-EGDFINLVMDIM-ASDLKKVVDRKIR-----LTESQV 121
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS-- 964
I L + GL LH +H D+ P N+ ++ ++DFGL R P + S
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 965 ---------TTAVGTLGYVSPEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDED 1014
T+ V TL Y +PE + E + D++S G + ELLTGK +F + +
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK--PLFPGENE 239
Query: 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEE 1048
I QL G+I ELL P W +
Sbjct: 240 I-----DQL--GRIFELLG------TPNEDNWPQ 260
|
Length = 335 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 836 PDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEAS 894
PD + + N F KE + L +++ N+ L G L ++ +YM NG+L L
Sbjct: 56 PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGDLNQFLSSHH 114
Query: 895 HQDGH--------------VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940
D +++ +AL +A G+ +L + N VH D+ +N L +
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN 174
Query: 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
++DFG+ R + AV + +++ E L G+ T SDV++FG+ L E+
Sbjct: 175 LTIKIADFGMSR-NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 1001 LTGKRPVMFTQ--DEDIVK 1017
L + + + DE +++
Sbjct: 234 LMLCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-11
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH----LIALGVARGLAFLHTSNMVHGDIK 931
LV DY N G L QE + N R L+ + V + +H+ +M+H DIK
Sbjct: 116 LVLDY---ANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK 170
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
N+L ++ L DFG ++ T ++ T GT YV+PE +K++D++
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 992 SFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051
S G++L ELLT KRP E++ + + K L G+ +P + PE E
Sbjct: 230 SLGVLLYELLTLKRPF---DGENMEEVMHKTL-AGR----YDPLPPSISPEMQE------ 275
Query: 1052 GVKVALLCTAPDPIDRPTMSDIVFM 1076
+ ALL + DP RP+ S ++ M
Sbjct: 276 -IVTALLSS--DPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEA----EFLGKVRHR 858
F L + YG V+K D +++ + GS+ + R++A L V H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHP 59
Query: 859 NLTVLRGYYAGAPDLRLL--VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
N+ Y D L V +Y P G+L + + + ++ I + + RG
Sbjct: 60 NII---SYKEAFLDGNKLCIVMEYAPFGDLSKAISK-RKKKRKLIPEQEIWRIFIQLLRG 115
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
L LH ++H D+K N+L A+ + D G+ ++ + + + T +GT Y++P
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGTPHYMAP 170
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
E + +SD++S G +L E+ T P +D+ + ++Q+G+
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL----RYKVQRGK--------- 217
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
P + + L P RP I
Sbjct: 218 --YPPIPPIYSQDL--QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 811 LSRTRYGLVFKACYN--DGMVLSIRRLPDGSLDE------NLFRKEAEFLGKVRHRNLTV 862
L + +G V+ CY+ G L+++++P N E + L ++H +
Sbjct: 10 LGQGAFGRVY-LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER--I 66
Query: 863 LRGYYAGAPDLRLLVY-DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
++ Y D L ++ +YMP G++ L+ V R ++ G+ +LH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL-----EGVEYLH 121
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLD-RL-TIPTPAEASTSTTAVGTLGYVSPEAA 979
++ +VH DIK N+L D+ L DFG RL TI + S T GT ++SPE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPYWMSPE-V 178
Query: 980 LTGET-TKESDVYSFGIVLLELLTGKRP 1006
++GE +++DV+S G ++E+LT K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 47/182 (25%), Positives = 91/182 (50%), Gaps = 9/182 (4%)
Query: 825 NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYM 881
N G ++++ L S ++ +KE E L + H N+ +G + L+ +++
Sbjct: 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941
P+G+L L ++ +N + A+ + +G+ +L + VH D+ +NVL +++
Sbjct: 91 PSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 942 EAHLSDFGLDRLTIPTPAEASTSTTAVGT-LGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
+ + DFGL + I T E T + + + + +PE + + SDV+SFG+ L EL
Sbjct: 147 QVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
Query: 1001 LT 1002
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPM 905
RKE + ++ H ++ + G L V ++M G++ LL + V+
Sbjct: 51 RKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYT 109
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE-AHLSDFGLD-RLTIPTPAEAST 963
L+ RGL++LH + ++H D+K N+L D+ + ++DFG RL
Sbjct: 110 EQLL-----RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 964 STTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
+GT+ +++PE L GE + DV+S G V++E+ T K P
Sbjct: 165 QGQLLGTIAFMAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 816 YGLVFKA------CYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGY 866
+G V KA N+ ++++ L D + +++L E E + + +H+N+ L G
Sbjct: 25 FGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLL-------QEASHQDGHVLNWPM--RHLI--ALGVAR 915
L ++V +Y +GNL L + AS D + + L+ A VAR
Sbjct: 85 CTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR 143
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ FL + +H D+ +NVL D ++DFGL R I +T + +++
Sbjct: 144 GMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGRLPVKWMA 202
Query: 976 PEAALTGETTKESDVYSFGIVLLELLT 1002
PEA T +SDV+SFG++L E+ T
Sbjct: 203 PEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 809 NVLSRTRYGLVFKACY------NDGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNL 860
L +G V++ Y + ++++ LP+ DE+ F EA + K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 861 TVLRGY-YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGL 917
L G + P R ++ + M G+L + L+E + + M+ L+ A VA+G
Sbjct: 72 VRLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 918 AFLHTSNMVHGDIKPQNVLFD---ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
+L ++ +H DI +N L A ++DFG+ R I + A+ + ++
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPIKWM 188
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLT 1002
PEA L G T ++DV+SFG++L E+ +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 41/100 (41%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA-VGTLGY 973
GL ++H++N++H D+KP N+L +AD E + DFGL R P E + T V T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 974 VSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012
+PE L+ TK DV+S G +L ELL G++PV +D
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 49/184 (26%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 843 NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLL--QEASHQDGHV 900
N F KE + + ++++ N+ L G + D ++ +YM NG+L L +E H
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 901 LNWPMRHL-----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955
N P + +A+ +A G+ +L + N VH D+ +N L + ++DFG+ R +
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NL 179
Query: 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL--LTGKRPVMFTQDE 1013
+ AV + +++ E+ L G+ T SDV++FG+ L E+ L ++P DE
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 1014 DIVK 1017
+++
Sbjct: 240 QVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 45/233 (19%)
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHV-----LNWPMR 906
+G + H + L G G L+L V P LG+LL + LNW ++
Sbjct: 63 MGSLDHAYIVRLLGICPG-ASLQL-VTQLSP---LGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP-----AEA 961
+A+G+ +L MVH ++ +N+L +D ++DFG+ L P +E
Sbjct: 118 ------IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVK 1020
T + +++ E+ L G T +SDV+S+G+ + E+++ G P
Sbjct: 172 KTP------IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY------------- 212
Query: 1021 KQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++ ++ +LLE G P+ + +++ VK C D RPT ++
Sbjct: 213 AGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK----CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 8/126 (6%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYV 974
GLAF H+ ++H D+KPQN+L + + L+DFGL R +P T T V TL Y
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----RTYTHEVVTLWYR 167
Query: 975 SPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
+PE L + D++S G + E++T R +F D +I + + G E++
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLFRIFRTLGTPDEVVW 225
Query: 1034 PGLLEL 1039
PG+ L
Sbjct: 226 PGVTSL 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
A +A GL FLH+ +++ D+K NV+ DA+ ++DFG+ + I T+ T G
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI---FGGKTTRTFCG 163
Query: 970 TLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
T Y++PE K D ++FG++L E+L G+ P F +DED
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP--FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 804 QFDEENVLSRTRYGLVFKA---CYNDGMVLSIRRL--PDGSLDENLFRKEAEFLGKVRHR 858
Q+++ + YG+V+KA N+ + L RL D + R E L +++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHG 61
Query: 859 NLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL---GVA 914
N ++R + RL LV++Y+ L H D LI +
Sbjct: 62 N--IVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEA-HLSDFGLDR-LTIPTPAEASTSTTAVGTLG 972
RG+A+ H+ ++H D+KPQN+L D A L+DFGL R IP T T V TL
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV----RTFTHEVVTLW 168
Query: 973 YVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
Y +PE L + D++S G + E++ ++P +F D +I
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP-LFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 19/132 (14%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RG+ FLH+ +VH D+KPQN+L +D + ++DFGL R + T+ V TL Y
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEMALTSVVVTLWYR 173
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
+PE L D++S G + EL +RP+ E QL K I +++
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSE------ADQLDK--IFDVI-- 222
Query: 1035 GLLELDPESSEW 1046
GL P EW
Sbjct: 223 GL----PSEEEW 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-11
Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 7/213 (3%)
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLR 537
+P+SL LL L L S + S + L L L + L N+L N+ E L +L
Sbjct: 62 LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLT 119
Query: 538 YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH 597
L+L N P ++ L S N I S+P L N +L+ L+L N L+
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 598 IPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLA 657
+P +S+LS+LN LDLS N ++ ++P EI S+L L +++N + + SL+ L NL+
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 658 VLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
L+LS NN ++P ++ ++ L ++S+N +
Sbjct: 236 GLELS-NNKLEDLPESIGNLSNLETLDLSNNQI 267
|
Length = 394 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 810 VLSRTRYGLVFKACYN--DGMVLSIRRL------PDGSLDENLFRKEAEFLGKVRHRNLT 861
+L + +G V+ CY+ G L+++++ P+ S + N E + L + H +
Sbjct: 9 LLGQGAFGRVY-LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 862 VLRGYYAGAPDLRLLVY-DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
G + L ++ ++MP G++ L+ +V R ++ G+++L
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSYL 122
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H++ +VH DIK N+L D+ L DFG + + + GT ++SPE +
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VI 181
Query: 981 TGET-TKESDVYSFGIVLLELLTGKRP 1006
+GE +++D++S G ++E+LT K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 42/120 (35%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL +LH++ ++H DIKP N+L +++ + DFGL R+ P E+ T V T Y
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE--EPDESKHMTQEVVTQYYR 171
Query: 975 SPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+PE L G T D++S G + ELL + ++F I +QL IT+LL
Sbjct: 172 APE-ILMGSRHYTSAVDIWSVGCIFAELLGRR--ILFQAQSPI-----QQLD--LITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 851 FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA 910
L ++H L L Y + V DY+ G L LQ P A
Sbjct: 49 LLKNLKHPFLVGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRE-----RCFLEPRARFYA 102
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970
VA + +LH+ N+++ D+KP+N+L D+ L+DFGL + + T++T GT
Sbjct: 103 AEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV---EPEETTSTFCGT 159
Query: 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012
Y++PE + D + G VL E+L G P +++D
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 26/226 (11%)
Query: 808 ENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLT 861
E +L R+G + + C + ++I L G D+ F EA LG+ H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L G + ++V +YM NG L + L++ H+ V M L G+A G+ +L
Sbjct: 70 RLEGVITRGNTM-MIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLP--GLASGMKYLS 124
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG------YVS 975
VH + VL ++D +S F + S T+ + +
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 976 PEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVK 1020
PEA + SDV+SFGIV+ E+++ G+RP +D++K V+
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 62/240 (25%), Positives = 118/240 (49%), Gaps = 22/240 (9%)
Query: 843 NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLL-----QEASHQ- 896
N F KE + + +++ N+ L + L ++ +YM NG+L L QEA+ +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-CMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 897 DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956
D +++ +A +A G+ +L + N VH D+ +N L ++ ++DFG+ R +
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLY 181
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ--DED 1014
+ AV + ++S E+ L G+ T SDV++FG+ L E+LT + ++Q DE
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 1015 IVKWVKKQLQ-KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+++ + + +G+ L +P L P+S K+ L C + +RP+ +I
Sbjct: 242 VIENTGEFFRDQGRQVYLPKPALC---PDSL--------YKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 62/172 (36%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
FR+E + L R +T L +YA + L LV DY G+L TLL S + +
Sbjct: 48 FREERDVLVNGDRRWITNL--HYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPED 102
Query: 904 PMRHLIALGVARGLAF--LHTSNMVHGDIKPQNVLFDADFEAHLSDFG--LDRLTIPTPA 959
R +A V LA +H VH DIKP NVL D + L+DFG L L T
Sbjct: 103 MARFYLAEMV---LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 960 EASTSTTAVGTLGYVSPE--AAL---TGETTKESDVYSFGIVLLELLTGKRP 1006
S AVGT Y+SPE A+ G E D +S G+ + E+L G+ P
Sbjct: 160 ----SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +Y+ G+L ++ E +G + + + L FLH++ ++H DIK N+
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALDFLHSNQVIHRDIKSDNI 146
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D L+DFG P E S +T VGT +++PE + D++S GI
Sbjct: 147 LLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 996 VLLELLTGKRPVM 1008
+ +E++ G+ P +
Sbjct: 204 MAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E L ++H N+ L L L V++Y+ L++ G++++
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTL-VFEYLDKD-----LKQYMDDCGNIMSMHNV 106
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTST 965
+ + RGLA+ H ++H D+KPQN+L + E L+DFGL R ++PT T +
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT----KTYS 162
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPV 1007
V TL Y P+ L + E + + D++ G + E+ +G RP+
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 25/182 (13%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYA---GAPDLR------LLVYDYMPNGNLGTL---LQEAS 894
+E + L ++ HRN+ L+ A D + LV++YM + +G L L S
Sbjct: 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114
Query: 895 HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954
H+ ++ M+ L+ GL + H N +H DIK N+L + + L+DFGL RL
Sbjct: 115 ED--HIKSF-MKQLL-----EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDE 1013
E+ T V TL Y PE L E + DV+S G +L EL T K+P +F ++
Sbjct: 167 N--SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP-IFQANQ 222
Query: 1014 DI 1015
++
Sbjct: 223 EL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 851 FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ-EASHQDGHVLNWPMRHLI 909
L V+H L L Y + V D++ G L LQ E S + P
Sbjct: 49 LLKNVKHPFLVGLH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE------PRARFY 101
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
A +A L +LH+ N+V+ D+KP+N+L D+ L+DFGL + I A++ T+TT G
Sbjct: 102 AAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI---AQSDTTTTFCG 158
Query: 970 TLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
T Y++PE D + G VL E+L G P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL ++H++ ++H D+KP N+ + D E + DFGL R T T V T Y
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT------DDEMTGYVATRWYR 182
Query: 975 SPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
+PE L + D++S G ++ ELLTGK +F + I QL+ +I L
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK--TLFPGSDHI-----DQLK--RIMNL 231
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
D V +Y+ G+L +Q+ P A +A GL FLH+ +++ D+K
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
NV+ D++ ++DFG+ + + + T+ T GT Y++PE K D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENM---WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 992 SFGIVLLELLTGKRPVMFTQDED 1014
+FG++L E+L G+ P +DED
Sbjct: 186 AFGVLLYEMLAGQAPFE-GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR----LLVYDYMPNGNLGTLLQEASHQDGHVLN 902
+E L ++H N+ L + A L + + ++ +L +++ D HV
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-- 122
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ + RGL ++H+++++H D+KP N+ + D E + DFGL R T
Sbjct: 123 ----QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DD 172
Query: 963 TSTTAVGTLGYVSPEAALTGETTKES-DVYSFGIVLLELLTGK 1004
T V T Y +PE L ++ D++S G ++ ELLTG+
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 49/261 (18%)
Query: 838 GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQD 897
++ F +EA+ ++H NL G LLV ++ P G+L L+ +
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAE 93
Query: 898 GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL------- 950
+ +A +A GL LH +N +H D+ +N L AD + D+GL
Sbjct: 94 LMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153
Query: 951 ------DRLTIPTPAEASTSTTAVGTLGYVSPEAA-------LTGETTKESDVYSFGIVL 997
D+L +P L +++PE L + TKES+V+S G+ +
Sbjct: 154 DYYVTPDQLWVP--------------LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199
Query: 998 LELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVA 1056
EL G +P DE ++ + ++ Q +L +P L+L P S W E V
Sbjct: 200 WELFELGSQPYRHLSDEQVLTYTVREQQ----LKLPKP-RLKL-PLSDRWYE------VM 247
Query: 1057 LLCTAPDPIDRPTMSDIVFML 1077
C P RP+ ++ +L
Sbjct: 248 QFCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRR---------LPDGSLDENLFRKEAEFLG 853
+F++ N + YG+V++A G ++++++ +P SL +E L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL------REITLLL 61
Query: 854 KVRHRNLTVLRGYYAG-APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG 912
+RH N+ L+ G D LV +Y +L +LL + + L
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP----FSESQVKCLMLQ 116
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ RGL +LH + ++H D+K N+L ++DFGL R T PA+ T V TL
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPK--VVTLW 173
Query: 973 YVSPEAALTGET-TKESDVYSFGIVLLELLTGK 1004
Y +PE L T T D+++ G +L ELL K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 816 YGLVFKACYN-DGMVLSIRRLPDGSLDENLFR---KEAEFLGKVRHRNLTVLRGYYAGAP 871
YG+V+KA G +++++++ + DE + +E L ++ H N ++R
Sbjct: 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPN--IVRLLDVVHS 69
Query: 872 DLRL-LVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
+ +L LV++++ + +L + + D ++ + L+ +G+A+ H+ ++H
Sbjct: 70 ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL-----QGIAYCHSHRVLHR 123
Query: 929 DIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE 987
D+KPQN+L D + L+DFGL R +P T T V TL Y +PE L
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGSRQYST 179
Query: 988 S-DVYSFGIVLLELLTGKRPVMFTQDEDI 1015
D++S G + E++ +RP +F D +I
Sbjct: 180 PVDIWSIGCIFAEMVN-RRP-LFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
+H LT L + D V +Y+ G+L +Q + D P A V
Sbjct: 54 KHPFLTALHCCFQ-TKDRLFFVMEYVNGGDLMFQIQRSRKFDE-----PRSRFYAAEVTL 107
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L FLH +++ D+K N+L DA+ L+DFG+ + I T+TT GT Y++
Sbjct: 108 ALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI---LNGVTTTTFCGTPDYIA 164
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
PE E D ++ G+++ E++ G+ P ++D+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL FLH+ +VH D+KPQN+L + + L+DFGL R+ + + ++ V TL Y
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV-TLWYR 176
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
+PE L D++S G + E+ +R +F D+ Q G+I +++
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVD-------QLGKILDVI-- 225
Query: 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDR--PTMSDI 1073
GL P +W + + A + PI++ + ++
Sbjct: 226 GL----PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 262
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH 907
E+ L RH LT L+ Y D V +Y+ N G L S + V +
Sbjct: 45 ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYV---NGGELFFHLSRE--RVFSEDRTR 98
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
+ L +LH+ +V+ D+K +N++ D D ++DFGL + I +A+T T
Sbjct: 99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI---TDAATMKTF 155
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
GT Y++PE + + D + G+V+ E++ G+ P + QD +
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 55/193 (28%), Positives = 77/193 (39%), Gaps = 36/193 (18%)
Query: 844 LFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLN 902
R E + L + +++ YY+ + L LV +YMP G+L LL +D
Sbjct: 47 HVRAERDIL--ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEE 101
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL------------ 950
R IA V L +H +H DIKP N+L DAD L+DFGL
Sbjct: 102 T-ARFYIAELVL-ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 951 ---DRLTIPTPAEASTST-----------TAVGTLGYVSPEAALTGET-TKESDVYSFGI 995
D + + VGT Y++PE L G E D +S G+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGV 218
Query: 996 VLLELLTGKRPVM 1008
+L E+L G P
Sbjct: 219 ILYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 20/206 (9%)
Query: 810 VLSRTRYGLVF---KACYND-GMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTV 862
VL + +G VF K D G + +++ L +L D + E + L +V H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP--FI 60
Query: 863 LRGYYAGAPDLRL-LVYDYMPNGNLGTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFL 920
++ +YA + +L L+ D++ G+L T L +E + V + +A L L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------LALALDHL 114
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H+ +++ D+KP+N+L D + L+DFGL + +I +A + GT+ Y++PE
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEVVN 171
Query: 981 TGETTKESDVYSFGIVLLELLTGKRP 1006
T+ +D +SFG+++ E+LTG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VA+G++FL + N +H D+ +N+L + DFGL R I + A +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPV-MFTQDEDIVKWVKKQLQKGQITE 1030
+++PE+ T ESDV+S+GI+L E+ + G P D K +K+
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE--------- 332
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
G L PE + E + + C DP+ RPT IV ++E
Sbjct: 333 ----GYRMLSPECAPSEMY----DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 816 YGLVFKACYND-GMVLSIRRL-PDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYY----- 867
YG V+KA + G +++I+ + +E + ++E L K H N+ G +
Sbjct: 19 YGKVYKARHKKTGQLVAIKIMDIIEDEEEEI-KEEYNILRKYSNHPNIATFYGAFIKKNP 77
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR-HLIAL---GVARGLAFLHTS 923
G D LV + G++ L++ ++ IA RGLA+LH +
Sbjct: 78 PGNDDQLWLVMELCGGGSVTDLVKGL-----RKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-----TAVGTLGYVSPEA 978
++H DIK QN+L + E L DFG+ ST T +GT +++PE
Sbjct: 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGRRNTFIGTPYWMAPEV 184
Query: 979 ALTGET-----TKESDVYSFGIVLLELLTGKRP 1006
E SDV+S GI +EL GK P
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/242 (24%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 846 RKEAEFLGKVR-------HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ--EASHQ 896
R+ EFL + H + +L G P L ++ + M G+L + L+ +
Sbjct: 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPEME 108
Query: 897 DGHVLNWP-MRHLIALG--VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953
+ V P ++ +I + +A G+A+L+ + VH D+ +N + DF + DFG+ R
Sbjct: 109 NNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR- 167
Query: 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012
I + + ++SPE+ G T SDV+SFG+VL E+ T ++P +
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 1013 EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
E ++++V +E GLL+ P++ + L ++ +C +P RP+ +
Sbjct: 228 EQVLRFV------------MEGGLLD-KPDNC--PDMLF--ELMRMCWQYNPKMRPSFLE 270
Query: 1073 IV 1074
I+
Sbjct: 271 II 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 37/272 (13%)
Query: 810 VLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGY 866
+L + +G VFK D ++++ + L + L F EA L + H N+ L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSN 924
+ +V + +P G+ + L++ + + L+ AL A G+A+L + N
Sbjct: 61 CTQRQPI-YIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAYLESKN 113
Query: 925 MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
+H D+ +N L + +SDFG+ R S+S + + +PEA G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 985 TKESDVYSFGIVLLELLT---GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
+ ESDV+S+GI+L E + P M Q Q E +E G P
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQ---------------QAREQVEKGYRMSCP 216
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + + KV C P +RP S++
Sbjct: 217 QKCPDDVY----KVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 836 PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY-DYMPNGNLGTLLQEAS 894
P+ S + + E + L ++H + G + L ++ +YMP G++ L+
Sbjct: 42 PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG 101
Query: 895 HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954
V R ++ G+++LH++ +VH DIK N+L D+ L DFG +
Sbjct: 102 ALTESVTRKYTRQIL-----EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
Query: 955 IPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
+ + GT ++SPE ++GE +++DV+S G ++E+LT K P
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 76/303 (25%), Positives = 121/303 (39%), Gaps = 82/303 (27%)
Query: 816 YGLVFKACYND-GMVLSIRRL--PDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871
+G V+ A + G +++I+++ S +E + +E + L K+ H N+ L+
Sbjct: 12 FGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK------- 64
Query: 872 DLRL------LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
++ V++YM GNL Q + G + + I + +GLA +H
Sbjct: 65 EVFRENDELYFVFEYM-EGNL---YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT 985
H D+KP+N+L ++DFGL R P T V T Y +PE L +T
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILL--RST 174
Query: 986 KES---DVYSFGIVLLELLTGKRPVMF--TQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
S D+++ G ++ EL T RP +F + + D QL K I +L G
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RP-LFPGSSEID-------QLYK--ICSVL--G----T 217
Query: 1041 PESSEWEEFLLGVKVA-----------------LLCTAP-------------DPIDRPTM 1070
P +W E G K+A L+ A DP RPT
Sbjct: 218 PTKQDWPE---GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274
Query: 1071 SDI 1073
S
Sbjct: 275 SQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL ++H++N++H D+KP N+L +A+ + + DFGL R T + T V T Y
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTRWYR 175
Query: 975 SPEAALT-GETTKESDVYSFGIVLLELLTGK 1004
+PE L E T DV+S G + ELL K
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 55/170 (32%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
FR+E + L ++ +T L +YA + L LV DY G+L TLL + + L
Sbjct: 48 FREERDVLVNGDNQWITTL--HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----LPE 101
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
M + + +H + VH DIKP N+L D + L+DFG + E T
Sbjct: 102 DMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG----SCLKLMEDGT 157
Query: 964 --STTAVGTLGYVSPEAALTGETTK-----ESDVYSFGIVLLELLTGKRP 1006
S+ AVGT Y+SPE E K E D +S G+ + E+L G+ P
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +Y+ G+L ++ E +G + + + L FLH++ ++H DIK N+
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D L+DFG P E S +T VGT +++PE + D++S GI
Sbjct: 148 LLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 996 VLLELLTGKRPVM 1008
+ +E++ G+ P +
Sbjct: 205 MAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 41/250 (16%)
Query: 837 DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ 896
S+ E F +EA + + H ++ L G P +V + P G L + LQ +
Sbjct: 47 SPSVREK-FLQEAYIMRQFDHPHIVKLIGVITENP--VWIVMELAPLGELRSYLQVNKYS 103
Query: 897 DGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954
+ LI + ++ LA+L + VH DI +NVL + L DFGL R
Sbjct: 104 ------LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
Query: 955 IPTPAEASTSTTAVGTL--GYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQ 1011
+ S + G L +++PE+ T SDV+ FG+ + E+L G +P +
Sbjct: 158 ----EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
Query: 1012 DEDIVKWVKKQLQKGQ---ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP 1068
+ D++ +++ G+ + P L L + C A DP RP
Sbjct: 214 NNDVI----GRIENGERLPMPPNCPPTLYSLMTK----------------CWAYDPSKRP 253
Query: 1069 TMSDIVFMLE 1078
+++ L
Sbjct: 254 RFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/242 (23%), Positives = 103/242 (42%), Gaps = 27/242 (11%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLR-----LLVYDYMPNGNLGTLLQEASHQDGH 899
F EA + H N+ L G A L+ +++ +M +G+L + L S G
Sbjct: 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGL 106
Query: 900 VLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957
P++ L+ + +A G+ +L N +H D+ +N + D ++DFGL + I +
Sbjct: 107 PEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYS 165
Query: 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIV 1016
A + +++ E+ T +SDV++FG+ + E+ T G+ P
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--------- 216
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076
++ +I + L G PE E + L C DP DRPT + + +
Sbjct: 217 ----PGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREV 268
Query: 1077 LE 1078
LE
Sbjct: 269 LE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-10
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
L + G G IP IS L LQ IN S N + G +P ++ + +SL L
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGN--------SIRGNIPPSLGSITSLEVLDLSY 475
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260
N+ G IP ++G L L++++L N+LSG VPA++
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 92/326 (28%), Positives = 123/326 (37%), Gaps = 60/326 (18%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
L LDL NR I E L ++ L SL L N + P L+ L+L N
Sbjct: 93 LPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK 151
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
+ SLP + + NL LDLS N S ++P + NLS L +LSGN S +P + L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG 545
L LDLS N EL L+ L NL + L NKL ++PE +L +L L+LS
Sbjct: 209 SALEELDLSN-NSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS--- 263
Query: 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHL 605
N+ SI + L
Sbjct: 264 ----------------------NNQISSISS-------------------------LGSL 276
Query: 606 SHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANN 665
++L LDLS N+L+ +P L LL L + L N +L N
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILS----N 332
Query: 666 LSGEIPANLSSIFGLMNFNVSSNNLQ 691
P LS + L N N L
Sbjct: 333 GETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 49/156 (31%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 851 FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA 910
L V+H L L + A L V DY+ G L LQ P A
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKL-YFVLDYINGGELFYHLQRE-----RCFLEPRARFYA 102
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970
+A L +LH+ N+V+ D+KP+N+L D+ L+DFGL + I T++T GT
Sbjct: 103 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---EHNGTTSTFCGT 159
Query: 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
Y++PE + D + G VL E+L G P
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 47/170 (27%), Positives = 88/170 (51%), Gaps = 21/170 (12%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLL-QEASHQDGHVLNWP 904
+E L +++H N+ G A L + + +Y+P G++ LL + ++ V N+
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNF- 111
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
+R ++ +GL +LH ++H DIK N+L D +SDFG I EA++
Sbjct: 112 VRQIL-----KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG-----ISKKLEANSL 161
Query: 965 TTAV--------GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
+T G++ +++PE T+++D++S G +++E+LTGK P
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 838 GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLL--QEASH 895
S ++N F ++ + ++H N+ G A LLV++Y G+L + L ++
Sbjct: 35 SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY-LLVFEYCELGDLKSYLSQEQWHR 93
Query: 896 QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955
++ +L + +A +A G+ +H N +H D+ +N +D + D+G+
Sbjct: 94 RNSQLL---LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG---- 146
Query: 956 PTPAEASTSTT---AVGTLGYVSPE-------AALTGETTKESDVYSFGIVLLELL-TGK 1004
P+ + T L +++PE +T E TK S+V++ G+ L EL
Sbjct: 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
Query: 1005 RPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDP 1064
+P D +++ V K Q +L +P LEL P S W E L C P
Sbjct: 207 QPYSHLSDREVLNHVIKDQQ----VKLFKPQ-LEL-PYSERWYEVL------QFCWLS-P 253
Query: 1065 IDRPTMSDI 1073
R T ++
Sbjct: 254 EKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 22/138 (15%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL FLH+ +++ D+K NV+ D D ++DFG+ + + AS T GT Y++
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS---TFCGTPDYIA 164
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV------------KWVKKQL 1023
PE + T D +SFG++L E+L G+ P DED + +W+ K+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSP-FHGDDEDELFESIRVDTPHYPRWITKES 223
Query: 1024 QKGQITELLEPGLLELDP 1041
+ ++LE L E DP
Sbjct: 224 K-----DILEK-LFERDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 40/280 (14%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFR----KEAEFLGKVRHRN 859
F E + R ++ V++A C DG+ ++++++ L + R KE + L ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 860 LTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLN---WPMRHLIALGVAR 915
V++ Y + D L +V + G+L +++ Q + W ++ + L A
Sbjct: 64 --VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA- 118
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA----VGTL 971
L +H+ ++H DIKP NV A L D GL R S+ TTA VGT
Sbjct: 119 -LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAAHSLVGTP 170
Query: 972 GYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
Y+SPE +SD++S G +L E+ + P F D+ + + K++++ L
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPL 228
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071
P EE ++ +C PDP RP ++
Sbjct: 229 ---------PSDHYSEELR---QLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 33/85 (38%), Positives = 45/85 (52%)
Query: 515 IALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI 574
+ L L G +P S L L+ +NLS N G IP + + S+ VL S N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 575 PPELGNCSDLEVLELRSNSLTGHIP 599
P LG + L +L L NSL+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA-VGTLGY 973
RGL ++H++N++H D+KP N+L + D E + DFG+ R +P E T V T Y
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 974 VSPEAALT-GETTKESDVYSFGIVLLELLTGKRPV 1007
+PE L+ E T D++S G + E+L G+R +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E L ++H N+ L L L V++Y+ + L++ G++++
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTL-VFEYLDSD-----LKQYLDNCGNLMSMHNV 105
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTST 965
+ + RGL++ H ++H D+KPQN+L + E L+DFGL R ++PT T +
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT----KTYS 161
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMF 1009
V TL Y P+ L + E + D++ G +L E+ TG RP MF
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP-MF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E+ L RH LT L+ YA RL V +Y N G L S + V
Sbjct: 45 ESRVLQNTRHPFLTALK--YAFQTHDRLCFVMEY---ANGGELFFHLSRE--RVFTEERA 97
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+ L +LH+ ++V+ DIK +N++ D D ++DFGL + I ++ +T T
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKT 154
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
GT Y++PE + + D + G+V+ E++ G+ P + QD +
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+E + L +RH N+ L + + V + + +L LL + +
Sbjct: 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFI------ 110
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+ RGL ++H++ +VH D+KP N+L + + + + DFGL R+ P T
Sbjct: 111 QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTG 164
Query: 967 AVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGK 1004
V T Y +PE LT + E D++S G + E+L GK
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDG------ 898
+KE L K++H N+ + + + RL +V +Y G+L ++ + Q G
Sbjct: 47 KKEVILLAKMKHPNIVTF--FASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED 101
Query: 899 HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPT 957
+L+W ++ ++ GL +H ++H DIK QN+ + A L DFG+ R +
Sbjct: 102 QILSWFVQ------ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
Query: 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
A T VGT Y+SPE ++D++S G VL EL T K P
Sbjct: 156 MELAYT---CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+EA+ L +++H N+ R + G L +V + G+L L+E Q G +L P
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE---QKGKLL--PEN 102
Query: 907 HLIA--LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
++ + +A L +LH +++H D+K QNV + D G+ R+ + +
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMA 159
Query: 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK 1004
+T +GT Y+SPE +SDV++ G + E+ T K
Sbjct: 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL LH +V+ D+KP+N+L D +SD GL + IP E T VGT+GY++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL-AVEIP---EGETIRGRVGTVGYMA 169
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKW 1018
PE T D + G ++ E++ GK P F Q ++ VK
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP--FRQRKEKVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 808 ENVLSRTRYGLVFKA-CYNDGMVL--SIRRLPD-GSLDENL-FRKEAEFLGKV-RHRNLT 861
++V+ +G V KA DG+ + +I+R+ + S D++ F E E L K+ H N+
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 862 VL------RGYYAGAPDLRLLVYDYMPNGNLGTLLQEA-----------SHQDGHVLNWP 904
L RGY L +Y P+GNL L+++ ++ L+
Sbjct: 72 NLLGACEHRGYL-------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR----LTIPTPAE 960
A VARG+ +L +H D+ +N+L ++ A ++DFGL R T
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT 1002
A+ +L Y T SDV+S+G++L E+++
Sbjct: 185 LPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 48/193 (24%), Positives = 90/193 (46%), Gaps = 17/193 (8%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
+G V+KA + L+ ++ + +E L + E E L H + L G + L
Sbjct: 25 FGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
+++ ++ P G + ++ E L P +I + L +LH+ ++H D+K
Sbjct: 85 WIMI-EFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKES----- 988
NVL D + L+DFG+ + T + +GT +++PE + ET K++
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKT---LQRRDSFIGTPYWMAPEVVMC-ETMKDTPYDYK 195
Query: 989 -DVYSFGIVLLEL 1000
D++S GI L+E+
Sbjct: 196 ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACY---NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL 860
++ + YG V+KA + + + + +L G D + ++E L + RH N+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNI 62
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
G Y L +V +Y G+L Q+ L+ + +GLA+L
Sbjct: 63 VAYFGSYLRRDKL-WIVMEYCGGGSL----QDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTSTTAVGTLGYVSPEAA 979
H + +H DIK N+L D + L+DFG+ +LT A + + +GT +++PE A
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPYWMAPEVA 173
Query: 980 ---LTGETTKESDVYSFGIVLLELLTGKRPVMF 1009
G + D+++ GI +EL + P MF
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP-MF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 7e-10
Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L + G D +V +Y+ G+L ++ E + + + + L FLH
Sbjct: 82 LDSFLVG--DELFVVMEYLAGGSLTDVVTETCMDEAQIA------AVCRECLQALEFLHA 133
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+ ++H DIK NVL D L+DFG P E S +T VGT +++PE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRK 190
Query: 983 ETTKESDVYSFGIVLLELLTGKRPVM 1008
+ D++S GI+ +E++ G+ P +
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQD-GHVLNW 903
F KE + L ++ N+ L G P L ++ +YM NG+L LQ+ + G N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 904 PMRHL-----IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
+A +A G+ +L + N VH D+ +N L ++ ++DFG+ R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR------ 178
Query: 959 AEASTST------TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT 1002
+S A + +++ E+ L G+ T +SDV++FG+ L E+LT
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-10
Identities = 64/252 (25%), Positives = 97/252 (38%), Gaps = 67/252 (26%)
Query: 859 NLTVLRGYYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
N V+R YY+ D V DY+P G++ +LL + + + +
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAV 114
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL--------------------------- 950
+H +H DIKP N+L D D L+DFGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 951 ------------DRLTIPTPAEAST------STTAVGTLGYVSPEAALTGETTKESDVYS 992
DRL P A+ + + VGT Y++PE L T+ D +S
Sbjct: 175 NEWGDPANCRCGDRLK-PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 993 FGIVLLELLTGKRPVMFTQD-EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051
G++L E+L G+ P + E +K + Q T L P +L PE+S+ L
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ------TSLHIPPQAKLSPEASD-----L 282
Query: 1052 GVKVALLCTAPD 1063
+K LC P+
Sbjct: 283 IIK---LCRGPE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 19/134 (14%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGY 973
RGLA+ H ++H D+KPQN+L E L+DFGL R ++P+ T + V TL Y
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS----KTYSNEVVTLWY 169
Query: 974 VSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----G 1026
P+ L G T + D++ G + E+ TG RP +F V+ QL K G
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATG-RP-LFPG----STDVEDQLHKIFRVLG 222
Query: 1027 QITELLEPGLLELD 1040
TE PG+
Sbjct: 223 TPTEETWPGVSSNP 236
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL LH N V+ D+KP+N+L D +SD GL + IP E + VGT+GY++
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL-AVKIP---EGESIRGRVGTVGYMA 169
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
PE T D + G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 38/130 (29%), Positives = 70/130 (53%), Gaps = 11/130 (8%)
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-MVHGDIKPQNVLF 937
++M G+L +L++A +L +++ V +GL +L + ++H D+KP N+L
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137
Query: 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVL 997
++ E L DFG+ I S + + VGT Y+SPE + +SD++S G+ L
Sbjct: 138 NSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 998 LELLTGKRPV 1007
+E+ G+ P+
Sbjct: 193 VEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ GL FLH +++ D+K NVL D++ ++DFG+ + I T++T GT
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI---LGGVTTSTFCGTPD 161
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
Y++PE D ++ G++L E+L G+ P F DED
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP--FEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 32/123 (26%)
Query: 219 VHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGF 278
+ L QG L G IP I L LQ ++L+ N++ G +P S+
Sbjct: 423 LGLDNQG--LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL------------------ 462
Query: 279 NAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQI 338
GS +S L+VLDL N G+ P L + ++L L+++GNS+SG++PA +
Sbjct: 463 -----------GSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
Query: 339 GGL 341
GG
Sbjct: 511 GGR 513
|
Length = 623 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 35/205 (17%)
Query: 816 YGLVFKACY----NDGMVLSIRRLPDGSLDENLFRKEA----EFLGKVRHRNLTVLRGYY 867
YG V C G ++I++L LF K A L ++H N+ L +
Sbjct: 28 YGTV---CSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83
Query: 868 AGAPDLRL-------LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
PDL L LV +M +LG L++ + + + + +GL ++
Sbjct: 84 T--PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRI------QFLVYQMLKGLKYI 134
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H + ++H D+KP N+ + D E + DFGL R T S T V T Y +PE L
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT------DSEMTGYVVTRWYRAPEVIL 188
Query: 981 TG-ETTKESDVYSFGIVLLELLTGK 1004
T+ D++S G ++ E+LTGK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL-DRLTIPTPAEASTSTTA 967
+ L V + L+FLH ++H DIK ++L +D LSDFG +++ P S
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---- 175
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027
VGT +++PE E D++S GI+++E++ G+ P +E ++ +K+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF---NEPPLQAMKR------ 226
Query: 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
I + L P L L S FL DP R T ++++
Sbjct: 227 IRDNLPPKLKNLHKVSPRLRSFL------DRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR-----LLVYDYMPNGNLGTLLQEASHQDGHVL 901
+E L ++H N+ L + A LV YM T LQ+ GH L
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-----TDLQKIM---GHPL 114
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ + + GL ++H++ ++H D+KP N+ + D E + DFGL R A+A
Sbjct: 115 SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADA 169
Query: 962 STSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGK 1004
T V T Y +PE L + D++S G ++ E+LTGK
Sbjct: 170 EM-TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 47/145 (32%), Positives = 69/145 (47%), Gaps = 18/145 (12%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
LV +Y P G+L +LL ++D + +L L +A + +H VH DIKP+NV
Sbjct: 78 LVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLA--IHSVHQMGYVHRDIKPENV 133
Query: 936 LFDADFEAHLSDFG-LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK-------E 987
L D L+DFG RLT + S VGT Y++PE LT E
Sbjct: 134 LIDRTGHIKLADFGSAARLTA---NKMVNSKLPVGTPDYIAPE-VLTTMNGDGKGTYGVE 189
Query: 988 SDVYSFGIVLLELLTGKRPVMFTQD 1012
D +S G++ E++ G+ P F +
Sbjct: 190 CDWWSLGVIAYEMIYGRSP--FHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 54/173 (31%), Positives = 77/173 (44%), Gaps = 24/173 (13%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
FR+E L + +T L +YA + L LV DY G+L TLL + + L
Sbjct: 48 FREERNVLVNGDCQWITTL--HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR----LPE 101
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG-----LDRLTIPTP 958
M + + +H + VH DIKP NVL D + L+DFG T+
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--- 158
Query: 959 AEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRP 1006
S+ AVGT Y+SPE G+ E D +S G+ + E+L G+ P
Sbjct: 159 ----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 825 NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYM 881
N + ++++ L D + D++L E E + + +H+N+ L G L +LV +Y
Sbjct: 42 NKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYA 100
Query: 882 PNGNLGTLLQEASHQDGHVLNW-----PMRHLI-------ALGVARGLAFLHTSNMVHGD 929
GNL L+ A G ++ P L A VARG+ +L + +H D
Sbjct: 101 SKGNLREYLR-ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESD 989
+ +NVL D ++DFGL R + +T + +++PEA T +SD
Sbjct: 160 LAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 990 VYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
V+SFG++L E+ T G P E++ K +K+
Sbjct: 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 54/200 (27%), Positives = 75/200 (37%), Gaps = 67/200 (33%)
Query: 876 LVYDYMPNGNLGTLL-------QEASHQDGHVLNWPMRHLIALGVARGLA--FLHTSNMV 926
L+ +Y+P G++ TLL +E + R IA + LA +H +
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEET-----------RFYIAETI---LAIDSIHKLGYI 123
Query: 927 HGDIKPQNVLFDADFEAHLSDFGL-----------------------DRLTIPTPAEAST 963
H DIKP N+L DA LSDFGL I P +
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 964 STT------------AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011
VGT Y++PE L KE D +S G+++ E+L G P F
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP--FCS 241
Query: 1012 DE------DIVKWVKKQLQK 1025
D I+ W K+ LQ
Sbjct: 242 DNPQETYRKIINW-KETLQF 260
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VARG+ FL + +H D+ +N+L + + DFGL R P + +A L
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSARLPLK 241
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQ-DEDIVKWVKKQLQKGQITE 1030
+++PE+ T +SDV+SFG++L E+ + G P Q +E+ + +K
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--------- 292
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
G PE++ E + ++ L C DP +RPT S +V +L
Sbjct: 293 ----GTRMRAPENATPEIY----RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGH--VLN 902
F EA + + H +L L G +P ++L V MP+G L + E G +LN
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCL-SPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLN 113
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
W ++ +A+G+ +L +VH D+ +NVL + ++DFGL RL E +
Sbjct: 114 WCVQ------IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
+ + +++ E + T +SDV+S+G+ + EL+T G +P D + +
Sbjct: 168 ADGGKM-PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGIPTREIPD 222
Query: 1022 QLQKGQITELLEPGLLELD 1040
L+KG+ L +P + +D
Sbjct: 223 LLEKGE--RLPQPPICTID 239
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 909 IALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTSTT 966
+ + + + L +L ++H D+KP N+L DA L DFG+ RL ++ T
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV-----DSKAKTR 173
Query: 967 AVGTLGYVSPEAALTGETTK-----ESDVYSFGIVLLELLTGKRP 1006
+ G Y++PE + +DV+S GI L+EL TG+ P
Sbjct: 174 SAGCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 54/184 (29%), Positives = 88/184 (47%), Gaps = 14/184 (7%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGT-LLQEASHQDGHVLNW 903
R E L VR V +YA + +L L+ DY+ G + T L Q + + V +
Sbjct: 52 RTERNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
++AL LH +V+ DIK +N+L D++ L+DFGL + + E +
Sbjct: 111 SGEIILAL------EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 964 STTAVGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
S GT+ Y++PE + G+ K D +S GI++ ELLTG P + + V +
Sbjct: 165 SF--CGTIEYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 1022 QLQK 1025
++ K
Sbjct: 222 RILK 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
D V +Y+ G+L +Q+ P A ++ GL FLH +++ D+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLK 128
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
NV+ D++ ++DFG+ + + + T+ T GT Y++PE K D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHM---VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 992 SFGIVLLELLTGKRPVMFTQDED 1014
++G++L E+L G+ P +DED
Sbjct: 186 AYGVLLYEMLAGQPP-FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 826 DGMVLSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882
+ + ++++ L D + +++L E E + + +H+N+ L G L ++V +Y
Sbjct: 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYAS 104
Query: 883 NGNLGTLLQ-------EASHQDGHVLNWPM--RHLIALG--VARGLAFLHTSNMVHGDIK 931
GNL L+ E S+ V + M + L++ VARG+ +L + +H D+
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
+NVL + ++DFGL R + +T + +++PEA T +SDV+
Sbjct: 165 ARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 992 SFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
SFG+++ E+ T G P E++ K +K+
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDG----HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
L+ MP G L ++E H+D ++LNW ++ +A+G+ +L +VH D+
Sbjct: 85 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQ------IAKGMNYLEERRLVHRDLA 136
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVY 991
+NVL ++DFGL +L E V + +++ E+ L T +SDV+
Sbjct: 137 ARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVW 195
Query: 992 SFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFL 1050
S+G+ + EL+T G +P + +I+ +LE G P + ++
Sbjct: 196 SYGVTVWELMTFGSKPY-------------DGIPASEISSILEKGERLPQPPICTIDVYM 242
Query: 1051 LGVKVALLCTAPDPIDRPTMSDIV 1074
+ VK C D RP +++
Sbjct: 243 IMVK----CWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +YMP G+L L+ + + ++AL +H+ ++H D+KP N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMGLIHRDVKPDNM 173
Query: 936 LFDADFEAHLSDFG----LDRLTIPTPAEASTSTTAVGTLGYVSPEAALT----GETTKE 987
L D L+DFG +D + TAVGT Y+SPE + G +E
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 988 SDVYSFGIVLLELLTGKRP 1006
D +S G+ L E+L G P
Sbjct: 228 CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
+ L V R L++LH ++H DIK ++L +D LSDFG E + V
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLV 179
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
GT +++PE E D++S GI+++E++ G+ P
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
RGL FLH + +VH D+KP+N+L + + L+DFGL R+ A T V TL Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA----LTPVVVTLWYR 174
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
+PE L D++S G + E+ +R +F + +
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 862 VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
V++ +YA D L +V +YMP G+L L+ + W V L +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE----KWA--RFYTAEVVLALDAI 158
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-TAVGTLGYVSPEAA 979
H+ +H D+KP N+L D L+DFG + E TAVGT Y+SPE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 980 LT----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
+ G +E D +S G+ L E+L G P F D + + K K +T
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ-------EASHQDGHV--LNWPMR 906
+H+N+ L G L ++V +Y GNL L+ E + V +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 907 HLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
L+ A VARG+ +L + +H D+ +NVL D ++DFGL R I +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-DIHHIDYYKKT 199
Query: 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
T + +++PEA T +SDV+SFG++L E+ T G P E++ K +K+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
RGL ++H++N++H D+KP NV + D + DFGL R+ P + + + T Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 974 VSPEAALT-GETTKESDVYSFGIVLLELLTGK 1004
SP L+ TK D+++ G + E+LTGK
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL L +V+ D+KP+N+L D +SD GL + IP E T VGT+GY++
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL-AVQIP---EGETVRGRVGTVGYMA 169
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKW 1018
PE + T D + G ++ E++ G+ P F + ++ VK
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKERVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 4e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH 907
E L +RH L L G + +L L++ +Y+P G L + L+++ P+
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVM-EYVPGGELFSHLRKSGR-----FPEPVAR 104
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
A V L +LH+ ++V+ D+KP+N+L D+D ++DFG + + T T
Sbjct: 105 FYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYTL- 158
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
GT Y++PE L+ K D ++ GI++ E+L G P
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 810 VLSRTRYGLVFKACYNDGM---------VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL 860
VL + YG VF+ G VL + D + E L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 861 TVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVL-NWPMRHLIALGVARGLA 918
L YA +L L+ +Y+ G L L+ ++G + + +L + +A L
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLA--LE 114
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
LH +++ D+KP+N+L DA L+DFGL + +I E + + T GT+ Y++PE
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI---HEGTVTHTFCGTIEYMAPEI 171
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012
+ K D +S G ++ ++LTG P FT +
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP--FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 54/248 (21%), Positives = 109/248 (43%), Gaps = 27/248 (10%)
Query: 839 SLDENLFRKEAEFLGKVRHRNLT-----VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEA 893
S D F +EA + + H N+ LR G + +++ +M +G+L T L
Sbjct: 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-M 100
Query: 894 SHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951
S P++ L+ + +A G+ +L + N +H D+ +N + + + ++DFGL
Sbjct: 101 SRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
Query: 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFT 1010
+ I + + + +++ E+ T SDV++FG+ + E++T G+ P
Sbjct: 161 K-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070
++ +I ++ K + Q + LE + E + C +P+P RP+
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLE-----------DVYELMCQ------CWSPEPKCRPSF 262
Query: 1071 SDIVFMLE 1078
+ LE
Sbjct: 263 QHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-09
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 150 LSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
L G I ND+ R+L+ +LS N G IP S+ +++ L++++ S+N F+ G+
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN--------GS 481
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240
+P ++ +SL L+ GN+L G +P A+G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR-----LLVYDYMPNGNLGTLLQEASHQDGHVL 901
+E L ++H N+ L + A + LV + M +L +++ D HV
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHV- 120
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ + RGL ++H++ ++H D+KP NV + D E + DFGL R
Sbjct: 121 -----QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA------D 169
Query: 962 STSTTAVGTLGYVSPEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDEDI 1015
T V T Y +PE L ++ D++S G ++ ELL GK +F ++ I
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK--ALFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL-----IALGVARGLAFLHTSNMVHGD 929
L+V + M +G+L + L+ + + P L +A +A G+A+L+ VH D
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRD 144
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESD 989
+ +N + DF + DFG+ R I + + +++PE+ G T SD
Sbjct: 145 LAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSD 203
Query: 990 VYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEE 1048
++SFG+VL E+ + ++P +E ++K+V ++ G L+ P++
Sbjct: 204 MWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------MDGGYLD-QPDNCPERV 250
Query: 1049 FLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L +C +P RPT +IV +L+
Sbjct: 251 TDL----MRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 21/144 (14%)
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEAST 963
M+ L+ GL ++H + ++H D+K N+L D L+DFGL R ++ ++ +
Sbjct: 125 MKMLLN-----GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 964 STTAVGTLGYVSPEAALTGETT--KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
T V TL Y PE L GE D++ G ++ E+ T + P+M E +
Sbjct: 180 YTNRVVTLWYRPPE-LLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTE------QH 231
Query: 1022 QLQ-----KGQITELLEPGLLELD 1040
QL G IT + PG+ +L+
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLE 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 17/193 (8%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
+G V+KA + VL+ ++ D +E L + E + L H N+ L + +L
Sbjct: 18 FGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
+L+ ++ G + ++ E L P ++ L +LH + ++H D+K
Sbjct: 78 WILI-EFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAG 132
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE------ 987
N+LF D + L+DFG+ T + +GT +++PE + ET+K+
Sbjct: 133 NILFTLDGDIKLADFGVSAKNTRT---IQRRDSFIGTPYWMAPEVVMC-ETSKDRPYDYK 188
Query: 988 SDVYSFGIVLLEL 1000
+DV+S GI L+E+
Sbjct: 189 ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VA+G+AFL + N +H D+ +NVL + DFGL R I + A +
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARLPVK 208
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVM-FTQDEDIVKWVKKQLQKGQITE 1030
+++PE+ T ESDV+S+GI+L E+ + G P D K +K+ + Q
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ--- 265
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE + E + + C DP+ RPT IV ++
Sbjct: 266 ----------PEHAPAEIYDIMKT----CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 809 NVLSRTRYGLVFKACYNDGMVLSIRRL----PDGSLDENLFRK---EAEFLGKVRHRNLT 861
VL + YG V+ N G +++++++ + E + K E + L ++H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
G + + + +++P G++ ++L V + ++ G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFM-EFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---TAVGTLGYVSPEA 978
+ +VH DIK NV+ + L DFG R + S + GT +++PE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRP 1006
++SD++S G + E+ TGK P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 905 MRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ LI + VARG+ FL + +H D+ +N+L + + DFGL R P +
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYV 230
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQ-DEDIVKWVK 1020
A L +++PE+ T +SDV+SFG++L E+ + G P Q DE+ + +K
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 1021 KQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ + PE + E + + L C +P DRPT S++V
Sbjct: 291 EGTRMRA-------------PEYATPEIY----SIMLDCWHNNPEDRPTFSELV 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 43/253 (16%)
Query: 848 EAEFLGKVRHRNLTVLRG--YYAGAPDLRLLVYDYMPNGNLGTLLQEAS----------- 894
E L +V H ++ L G G LL+ +Y G+L + L+E+
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPL---LLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109
Query: 895 --------HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946
+ D L A ++RG+ +L +VH D+ +NVL + +S
Sbjct: 110 NRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKR 1005
DFGL R + S + + +++ E+ T +SDV+SFG++L E++T G
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 1006 PVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPI 1065
P E + LL+ G PE+ E + + L C +P
Sbjct: 229 PYPGIAPERLFN-------------LLKTGYRMERPENCSEEMY----NLMLTCWKQEPD 271
Query: 1066 DRPTMSDIVFMLE 1078
RPT +DI LE
Sbjct: 272 KRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDG---SLDE-NLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG VF A D G +++++R+ L+E E + L + L L YA
Sbjct: 14 YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL--LYAFQ 71
Query: 871 PDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
D L L +Y+P G+ TLL + M + + LH +H D
Sbjct: 72 DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-----AVDALHELGYIHRD 126
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESD 989
+KP+N L DA L+DFGL + + + + + VG+ Y++PE D
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIV------TYANSVVGSPDYMAPEVLRGKGYDFTVD 180
Query: 990 VYSFGIVLLELLTGKRPVMFTQD------EDIVKWVKKQLQK 1025
+S G +L E L G P F+ E++ W K+ LQ+
Sbjct: 181 YWSLGCMLYEFLCGFPP--FSGSTPNETWENLKYW-KETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 19/181 (10%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL--VYDYMPNGNL 886
V++I + ++++ E L +V H + L + D R L + +Y+P G L
Sbjct: 33 VMAIPEVIRLKQEQHV-HNEKRVLKEVSHPFIIRL---FWTEHDQRFLYMLMEYVPGGEL 88
Query: 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946
+ L+ + + A + L +LH+ +V+ D+KP+N+L D + L+
Sbjct: 89 FSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLT 143
Query: 947 DFGLDRLTIPTPAEASTST-TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005
DFG + + T T GT Y++PE + K D ++ GI++ E+L G
Sbjct: 144 DFGFAK-------KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 1006 P 1006
P
Sbjct: 197 P 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 68/286 (23%)
Query: 859 NLTVLRGYYA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
N V++ YY+ D V DY+P G++ +LL + + + L +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL-----AI 114
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL--------------------------- 950
+H +H DIKP N+L D D L+DFGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 951 ------------DRL-TIPTPA----EASTSTTAVGTLGYVSPEAALTGETTKESDVYSF 993
DRL T+ A + + + VGT Y++PE L T+ D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 994 GIVLLELLTGKRPVMF-TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
G++L E+L G+ P + T E +K + + L P ++L PE+ + L+
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWE------NTLHIPPQVKLSPEAVD----LIT 284
Query: 1053 VKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
L C+A + + R DI + ++ S+D TQP+P
Sbjct: 285 ---KLCCSAEERLGRNGADDI----KAHPFFSEVDFSSDIRTQPAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 68/240 (28%), Positives = 98/240 (40%), Gaps = 53/240 (22%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
LV DY P G L LLQ Q G L+ + A V L +LH +V+ D+KP+N+
Sbjct: 78 LVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134
Query: 936 LFDADFEAHLSDFGLDRLTIPTP-------------------------AEAST-STTAVG 969
L LSDF L + + P E S S + VG
Sbjct: 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVG 194
Query: 970 TLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMF---TQDEDIVKWVKKQL-- 1023
T Y++PE ++G+ D ++ GI+L E+L G P F +DE +KK++
Sbjct: 195 TEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTP--FKGSNRDETFSNILKKEVTF 251
Query: 1024 -QKGQITELLEP---GLLELDPES--------SEWEE--FLLGVKVALL-CTAPDPIDRP 1068
++ LL DP +E ++ F GV AL+ T P I RP
Sbjct: 252 PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 22/188 (11%)
Query: 891 QEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
+EA +D + + LI + VA+G+ FL + +H D+ +N+L + + DF
Sbjct: 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDF 223
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPV 1007
GL R P + L +++PE T +SDV+SFG++L E+ + G P
Sbjct: 224 GLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 1008 MFTQ-DEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID 1066
+ DE+ ++L++G T + P D + E + +L C +P
Sbjct: 283 PGVKIDEEFC----RRLKEG--TRMRAP-----DYTTPEMYQTMLD------CWHGEPSQ 325
Query: 1067 RPTMSDIV 1074
RPT S++V
Sbjct: 326 RPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH--LIALGVARGLAFLHTSNMVHGDIKP 932
LV +Y+ G+L +Q P H A + L FLH +++ D+K
Sbjct: 72 FLVIEYVNGGDLMFHMQRQR-------KLPEEHARFYAAEICIALNFLHERGIIYRDLKL 124
Query: 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKES-DVY 991
NVL DAD L+D+G+ + + T++T GT Y++PE L GE S D +
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGL---GPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWW 180
Query: 992 SFGIVLLELLTGKRPV-MFTQDEDI 1015
+ G+++ E++ G+ P + T + D+
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 844 LFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNW 903
L E + +H+N+ + Y +L +L+ +++ G L ++ + LN
Sbjct: 64 LLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTR------LNE 116
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL-DRLTIPTPAEAS 962
+ V + L +LH+ ++H DIK ++L D LSDFG +++ P S
Sbjct: 117 EQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176
Query: 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
VGT +++PE E D++S GI+++E++ G+ P
Sbjct: 177 L----VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 38/237 (16%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
F +EA L + H N+ L G + +V + + G+ T L+ +G L
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCTQKQPI-YIVMELVQGGDFLTFLR----TEGPRLK-- 92
Query: 905 MRHLIAL--GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
++ LI + A G+ +L + + +H D+ +N L +SDFG+ R E
Sbjct: 93 VKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR------EEED 146
Query: 963 TSTTAVGTL-----GYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIV 1016
+ G + + +PEA G + ESDV+SFGI+L E + G P
Sbjct: 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY--------- 197
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
L Q E +E G+ PE + ++ C DP RP+ S +
Sbjct: 198 ----ANLSNQQTREAIEQGVRLPCPELCPDAVY----RLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VA+G+ FL + N +H D+ +NVL A + DFGL R I + A +
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARLPVK 279
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPV-MFTQDEDIVKWVKKQLQKGQITE 1030
+++PE+ T +SDV+S+GI+L E+ + GK P + K VK+ Q +
Sbjct: 280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--- 336
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P+ + E + + +C +P +RPT S I +++
Sbjct: 337 ----------PDFAPPEIY----SIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 14/137 (10%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL LH +++ D+KP+NVL D D +SD G L + S + GT G+++
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLG---LAVELKDGQSKTKGYAGTPGFMA 165
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT------ 1029
PE E D ++ G+ L E++ + P ++ K +K+++ +T
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFS 225
Query: 1030 ----ELLEPGLLELDPE 1042
E LL DPE
Sbjct: 226 PASKSFCE-ALLAKDPE 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 44/142 (30%), Positives = 59/142 (41%), Gaps = 11/142 (7%)
Query: 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
Y PD + D M G+L L Q G MR A + GL +H +
Sbjct: 64 YAFHTPDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMR-FYATEIILGLEHMHNRFV 118
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT 985
V+ D+KP N+L D +SD GL +VGT GY++PE G
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 986 KES-DVYSFGIVLLELLTGKRP 1006
S D +S G +L +LL G P
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E+ L RH LT L+ Y+ RL V +Y NG G L S + V +
Sbjct: 45 ESRVLQNTRHPFLTALK--YSFQTHDRLCFVMEYA-NG--GELFFHLSRE--RVFSEDRA 97
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+ L +LH+ ++V+ D+K +N++ D D ++DFGL + I ++ +T T
Sbjct: 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKT 154
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED------IVKWVK 1020
GT Y++PE + + D + G+V+ E++ G+ P + QD + +++ ++
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILMEEIR 213
Query: 1021 KQLQKGQITELLEPGLLELDP 1041
+ L GLL+ DP
Sbjct: 214 FPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 15/139 (10%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEA-HLSDFGLDR-LTIPTPAEASTSTTAVGTLG 972
+G+A H ++H D+KPQN+L D ++D GL R +IP + T + TL
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS----YTHEIVTLW 176
Query: 973 YVSPEAALTGETTKES--DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030
Y +PE L G T + D++S G + E+ + +F D ++ + + G TE
Sbjct: 177 YRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRKQ--PLFPGDSELQQLLHIFKLLGTPTE 233
Query: 1031 LLEPGLLELDPESSEWEEF 1049
+ PG+ +L +W EF
Sbjct: 234 QVWPGVSKL----RDWHEF 248
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 830 LSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886
++++ L D + D++L E E + + +H+N+ L G L ++V +Y GNL
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNL 105
Query: 887 GTLLQ-----------EASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
L+ + + L++ A VARG+ +L + +H D+ +NV
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D ++DFGL R TS + + +++PEA T +SDV+SFGI
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGI 224
Query: 996 VLLELLT-GKRPVMFTQDEDIVKWVKK 1021
++ E+ T G P E++ K +++
Sbjct: 225 LMWEIFTLGGSPYPGIPVEELFKLLRE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 15/172 (8%)
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
PD V +++ G+L +Q++ D A + L FLH +++ D+
Sbjct: 68 PDRLFFVMEFVNGGDLMFHIQKSRRFDE-----ARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDV 990
K NVL D + L+DFG+ + I T++T GT Y++PE D
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGI---FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 991 YSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042
++ G++L E+L G P ++D+ + + E++ P L D
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------EVVYPTWLSQDAV 224
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 87/376 (23%), Positives = 145/376 (38%), Gaps = 30/376 (7%)
Query: 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLE 141
+L ++ + R S++ +P++L++ L + S S + N+ NL L
Sbjct: 38 PDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLP 96
Query: 142 ILNVAANRLSGEIANDLPR-NLKYFDLSSNGFSGPIPTSISNL-SQLQLINFSFNKFSRE 199
L++ NRL I+ L NL DL +N + IP I L S L+ ++ S NK
Sbjct: 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-- 153
Query: 200 VPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPAS 259
+LPS + N +L +L N L +P + L L + L+ N +S +P
Sbjct: 154 -------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204
Query: 260 MFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST 319
+ ++ + L N+ + + S L L+L N++ P + S
Sbjct: 205 I-----ELLSALEELDLSNNSIIEL--LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256
Query: 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS 379
L LD+S N IS + +G L L EL ++ NS A+P+ L LL
Sbjct: 257 LETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT-- 312
Query: 380 GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNN 439
L L + + +N S P + L L NL N + N
Sbjct: 313 -LKALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWTLDN-ALDESNLNRYIVKN 369
Query: 440 LSTLDLSENKFSGEVP 455
+ + + V
Sbjct: 370 PNAIGSLLDLVKKHVN 385
|
Length = 394 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 811 LSRTRYGLVFKACYNDGM---VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
+ R YG V+KA DG +++++ + + R E L +++H N+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67
Query: 868 AGAPDLRL-LVYDYMPNGNLGTLLQ--EASHQDGHVLNWPMRHLIAL--GVARGLAFLHT 922
D ++ L++DY + +L +++ AS + + P + +L + G+ +LH
Sbjct: 68 LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 923 SNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+ ++H D+KP N+L + ++D G RL + V T Y +PE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 979 ALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
L TK D+++ G + ELLT + P+ + EDI
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 810 VLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFL----------GKVRHR 858
VL R +G V A Y G + +I+ L G + + R E E L RH
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDI---IARDEVESLMCEKRIFETANSERHP 62
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
L L + D V +Y G+L + V + P A V GL
Sbjct: 63 FLVNLFACFQ-TEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQ 115
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+LH + +V+ D+K N+L D + ++DFGL + + ++T GT +++PE
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM---GFGDRTSTFCGTPEFLAPEV 172
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
T+ D + G+++ E+L G+ P +E++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYV 974
G+ F H+ ++H D+KPQN+L D L+DFGL R IP T V TL Y
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV----YTHEVVTLWYR 168
Query: 975 SPEAALTGETTKES---DVYSFGIVLLELLTGKRPVMFTQDEDI 1015
+PE L + S D++S G + E+ T K+P +F D +I
Sbjct: 169 APEVLLGS--PRYSTPVDIWSIGTIFAEMAT-KKP-LFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
+LV + G L LQ ++ HV + L+ V+ G+ +L +N VH D+ +N
Sbjct: 71 MLVMELAELGPLNKFLQ----KNKHVTEKNITELVH-QVSMGMKYLEETNFVHRDLAARN 125
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994
VL A +SDFGL + T + + +PE + + +SDV+SFG
Sbjct: 126 VLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFG 185
Query: 995 IVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGV 1053
+++ E + G++P K ++ ++T+++E G P+ E + L
Sbjct: 186 VLMWEAFSYGQKPY-------------KGMKGNEVTQMIESGERMECPQRCPPEMYDL-- 230
Query: 1054 KVALLCTAPDPIDRPTMS 1071
LC +RP +
Sbjct: 231 --MKLCWTYGVDERPGFA 246
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 803 RQFDEENVLSRTRYGLVFKACYN---DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN 859
F + + + +G V+K N + + + I L + + ++E L +
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+T G Y L ++ +Y+ G+ LL+ ++ ++ I + +GL +
Sbjct: 64 ITRYYGSYLKGTKL-WIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDY 116
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
LH+ +H DIK NVL + L+DFG+ T + T VGT +++PE
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVI 173
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRP 1006
++D++S GI +EL G+ P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 47/146 (32%), Positives = 61/146 (41%), Gaps = 11/146 (7%)
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
V Y PD + D M G+L L Q G MR A + GL +H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMR-FYAAEIILGLEHMH 114
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
+V+ D+KP N+L D +SD GL AS VGT GY++PE
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQK 169
Query: 982 GETTKES-DVYSFGIVLLELLTGKRP 1006
G S D +S G +L +LL G P
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGM-VLSIRRLPDGSLDENLFR---KEAEFLGKVRHRN 859
+F+ V+ YG+V K + + +++I++ D +E + +E + L ++ N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ L+ + L LV++Y+ N+ LL+E +G V +R I + + + +
Sbjct: 62 IVELKEAFRRRGKL-YLVFEYVEK-NMLELLEE--MPNG-VPPEKVRSYI-YQLIKAIHW 115
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
H +++VH DIKP+N+L + L DFG R + + T V T Y SPE
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRSPELL 173
Query: 980 LTGETTKESDVYSFGIVLLELLTGK 1004
L K D++S G +L EL G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
+EA L ++H N+ +L L L V++Y+ L Q G L+
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTL-VFEYVHT----DLCQYMDKHPGG-LHPENV 105
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTST 965
L + RGL+++H ++H D+KPQN+L E L+DFGL R ++P+ T +
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS----HTYS 161
Query: 966 TAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTG 1003
V TL Y P+ L + E + D++ G + +E++ G
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
+ L V + L+ LH ++H DIK ++L D LSDFG E + V
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLV 177
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028
GT +++PE E D++S GI+++E++ G+ P +E +K +K I
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMK------MI 228
Query: 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPS 1088
+ L P L L S + FL + V DP R T ++++ + GP PS
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVR------DPAQRATAAELLKHPFLAKAGP--PS 280
Query: 1089 SADP 1092
P
Sbjct: 281 CIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ G+ LH+ ++V+ D+KP+NVL D LSD G L + + T T GT G
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLG---LAVELK-DGKTITQRAGTNG 159
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
Y++PE + D ++ G + E++ G+ P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 909 IALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
IA+ + L +L ++H D+KP N+L D + L DFG+ + + A+ T
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRD 167
Query: 968 VGTLGYVSPEAALTGETTK---ESDVYSFGIVLLELLTGKRP 1006
G Y++PE SDV+S GI L E+ TGK P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFR----KEAEFLGKVRHRN 859
F E + R ++ V++A C D ++++++ + + R KE + L ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV--ARGL 917
+ + +L + V + G+L +++ Q + P R + V +
Sbjct: 64 VIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLI---PERTVWKYFVQLCSAV 119
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
+H+ ++H DIKP NV A L D GL R ++ + + + VGT Y+SPE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPE 176
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
+SD++S G +L E+ + P + ++ +K I + P L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLFSLCQK------IEQCDYPPL- 228
Query: 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P E+ ++ +C PDP RP DI ++ +
Sbjct: 229 ---PTEHYSEKLR---ELVSMCIYPDPDQRP---DIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 15/118 (12%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ LH++ ++H D+KP N++ +D + DFGL R T + T V T Y +
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRA 185
Query: 976 PEAALTGETTKES-DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
PE L G KE+ D++S G ++ E++ G V+F + I +W K I E L
Sbjct: 186 PEVIL-GMGYKENVDIWSVGCIMGEMIRGT--VLFPGTDHIDQWNK-------IIEQL 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 811 LSRTRYGLVFKACYNDGMV---LSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
+ R YG V+KA DG +++++ + + R E L +++H N+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 868 AGAPDLRL-LVYDYMPNGNLGTLLQ--EASHQDGHVLNWP--MRHLIALGVARGLAFLHT 922
D ++ L++DY + +L +++ AS + + P M + + G+ +LH
Sbjct: 68 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 923 SNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+ ++H D+KP N+L + ++D G RL + V T Y +PE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 979 ALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
L TK D+++ G + ELLT + P+ + EDI
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 808 ENVLSRTRYGLVFKACYN-DG--MVLSIRRLPD--GSLDENLFRKEAEFLGKV-RHRNLT 861
E+V+ +G V +A DG M +I+ L + D F E E L K+ H N+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 862 VLRGYYAGAPDLRLLVY---DYMPNGNLGTLLQEA---------SHQDGHVLNWPMRHLI 909
L GA + R +Y +Y P GNL L+++ + + G + L+
Sbjct: 67 NL----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 910 --ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
A VA G+ +L +H D+ +NVL + + ++DFGL R E
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKT 176
Query: 968 VGTLG--YVSPEAALTGETTKESDVYSFGIVLLELLT 1002
+G L +++ E+ T +SDV+SFG++L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ +GL +LH+ +H DIK NVL + L+DFG+ T + + T VGT
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN---TFVGTPF 166
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
+++PE ++D++S GI +EL G+ P
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 917 LAFLHTSN-MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L +LH +VH D+ P N++ D + ++DFGL + S T+ VGT+ Y
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTILYSC 181
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPV----MFTQDEDIVKWVKKQLQKGQITEL 1031
PE +++DV++FG +L ++ T + P M + IV+ V + L +G +E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED 241
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+ ++ C PD RP DI+
Sbjct: 242 V---------------TDVITS-----CLTPDAEARP---DII 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 816 YGLVFK-ACYNDGMVLSIRRL-PDGSLDENLFRKEAEF---LGKVRHRNLTVLRGYYAGA 870
YG V+K DG + +++ L P +DE + EAE+ H N+ G + A
Sbjct: 35 YGKVYKVTNKKDGSLAAVKILDPISDVDEEI---EAEYNILQSLPNHPNVVKFYGMFYKA 91
Query: 871 PDL---RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
L +L + + NG T L + G L+ M I G GL LH + ++H
Sbjct: 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH 151
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKE 987
D+K N+L + L DFG+ T +TS VGT +++PE +
Sbjct: 152 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIACEQQYDY 208
Query: 988 S-----DVYSFGIVLLELLTGKRPV 1007
S DV+S GI +EL G P+
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH 907
E L RH LT L+ Y D V +Y N G L S + V +
Sbjct: 45 ENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY---ANGGELFFHLSRE--RVFSEDRAR 98
Query: 908 LIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+ L +LH+ N+V+ D+K +N++ D D ++DFGL + I + +T T
Sbjct: 99 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---KDGATMKT 155
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED------IVKWVK 1020
GT Y++PE + + D + G+V+ E++ G+ P + QD + +++ ++
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILMEEIR 214
Query: 1021 KQLQKGQITELLEPGLLELDP 1041
+ L GLL+ DP
Sbjct: 215 FPRTLSPEAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 46/186 (24%), Positives = 72/186 (38%), Gaps = 46/186 (24%)
Query: 862 VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
V++ YY+ L V DY+P G++ +LL + G R IA + + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIA-ELTCAIESV 117
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGL---------------------------DRL 953
H +H DIKP N+L D D L+DFGL +
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 954 TIPTPAEAST-------------STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
+ + + VGT Y++PE L T+ D +S G++L E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 1001 LTGKRP 1006
L G+ P
Sbjct: 238 LVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 41/238 (17%)
Query: 805 FDEENVLSRTRYG---LVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT 861
F+ V+ R +G LV K + I R D E + AE V +L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 862 VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
V++ +Y+ L L L+ +++P G++ TLL + L + +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSI 117
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGL-------------DRLTIPTPAE------- 960
H +H DIKP N+L D+ LSDFGL L P++
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 961 ----AST--------STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
A T + + VGT Y++PE + K D +S G+++ E+L G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ LH++ ++H D+KP N++ +D + DFGL R T T V T Y +
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVVTRYYRA 190
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK 1020
PE L + D++S G ++ EL+ G V+F + I +W K
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGS--VIFQGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
L FLH +++ D+K NVL DA+ L+D+G+ + I T++T GT Y++P
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI---RPGDTTSTFCGTPNYIAP 165
Query: 977 EAALTGETTKES-DVYSFGIVLLELLTGKRP 1006
E L GE S D ++ G+++ E++ G+ P
Sbjct: 166 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 6/111 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ LH++ ++H D+KP N++ +D + DFGL R T + T V T Y +
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRA 193
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
PE L + D++S G ++ E++ G V+F + I +W K Q G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTDHIDQWNKVIEQLG 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 31/102 (30%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+L + N+V+ D+KP+N+L D D ++DFG ++ + + T GT Y++PE
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYIAPEI 199
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK 1020
L K +D ++ GI + E+L G P F +E ++ + K
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP--FYANEPLLIYQK 239
|
Length = 340 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 65 NNRVTELRLPRLQLSGRISDHLSNLRM-LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQY 123
+T L L ++ I + L+ L++L L N ++P+ L L+ + L +
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSF 172
Query: 124 NSLSGNLPANIGNLSNLEILNVAANRLSG-EIANDLPRNLKYFDLSSNGFSGPIPTSISN 182
N LS +LP + NLSNL L+++ N++S +L L+ DLS+N + +S+SN
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSN 230
Query: 183 LSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKL 242
L L + S NK LP +I N S+L L N + ++G+L L
Sbjct: 231 LKNLSGLELSNNKLE---------DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNL 279
Query: 243 QVVSLAQNNLSGVVPAS 259
+ + L+ N+LS +P
Sbjct: 280 RELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 805 FDEENVLSRTRYGLVFKACYNDG---MVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT 861
F + + + +G VFK N + + I L + + ++E L + +T
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 862 VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
G Y D +L ++ +Y+ G+ LL+ + + I + +GL +L
Sbjct: 66 KYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYL 117
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H+ +H DIK NVL E L+DFG+ T + T VGT +++PE
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIK 174
Query: 981 TGETTKESDVYSFGIVLLELLTGKRP 1006
++D++S GI +EL G+ P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 816 YGLVFKA---CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
YG V+KA + + I +L G D +L ++E + + +H N+ G Y
Sbjct: 22 YGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR----GLAFLHTSNMVHG 928
L + + +Y G+L QD + + P+ L V R GLA+LH+ +H
Sbjct: 81 LWICM-EYCGGGSL---------QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL---TGETT 985
DIK N+L + + L+DFG+ T A+ + +GT +++PE A G
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 986 KESDVYSFGIVLLELLTGKRPVMF 1009
+ D+++ GI +E L +P MF
Sbjct: 188 QLCDIWAVGITAIE-LAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 1/90 (1%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VA G+ FL + N VH D+ +NVL + DFGL R + S +T + L
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-PLK 306
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT 1002
+++PE+ T SDV+SFGI+L E+ T
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 37/139 (26%), Positives = 61/139 (43%), Gaps = 27/139 (19%)
Query: 917 LAF--LHTSNMVHGDIKPQNVLFDADFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGY 973
LAF LH+ ++++ D+KP+N+L D ++DFG ++ T T GT Y
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-------FTLCGTPEY 181
Query: 974 VSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM----FTQDEDIV-------KWVKKQ 1022
++PE + K D ++ G++L E + G P F E I+ W +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGR 241
Query: 1023 LQKGQITELLEPGLLELDP 1041
+ L GLL+ D
Sbjct: 242 ARD------LVKGLLQTDH 254
|
Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 37/163 (22%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
L+ +++P G++ TLL + L+ + +H +H DIKP N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132
Query: 936 LFDADFEAHLSDFGL-------------DRLTIPTPAEAS-------------------T 963
L DA LSDFGL LT P++ S
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
+ + VGT Y++PE + K D +S G+++ E+L G P
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-07
Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 15/109 (13%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-----------LTIPTPAEA 961
+ + ++H+ ++H D+KP N+L E + D+G + +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 962 STSTTA----VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
+S T VGT Y++PE L ++ +D+Y+ G++L ++LT P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 21/186 (11%)
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLR-----LLVYDYMPNGNLGTLLQ-EASHQDGHV 900
+E + V H+N+ L + L LV + M + NL ++Q E H+
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY 123
Query: 901 LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
L + M G+ LH++ ++H D+KP N++ +D + DFGL R T
Sbjct: 124 LLYQM--------LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGT 171
Query: 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK 1020
+ T V T Y +PE L + D++S G ++ E++ K ++F + I +W K
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRDYIDQWNK 229
Query: 1021 KQLQKG 1026
Q G
Sbjct: 230 VIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
V+ G+ +L N VH D+ +NVL A +SDFGL + + + L
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP 1006
+ +PE + + SDV+S+GI + E + G++P
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VARG+ FL + N VH D+ +NVL + DFGL R + S +T + +
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVK 304
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLT 1002
+++PE+ T SDV+S+GI+L E+ +
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 58/280 (20%), Positives = 112/280 (40%), Gaps = 49/280 (17%)
Query: 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLR 864
F+ + V+ RT FK + VL ++ E + L ++ N+ +
Sbjct: 41 FNNKEVIIRT-----FKKFHKGHKVLI-----------DITENEIKNLRRIDSNNILKIY 84
Query: 865 GYYAGAPD--LRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
G+ D RL L+ +Y G L +L + +D L++ + +A+ +GL L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKD---LSFKTKLDMAIDCCKGLYNLY 139
Query: 922 TS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
N + ++ + L +++ + GL+++ +S V + Y S +
Sbjct: 140 KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL------SSPPFKNVNFMVYFSYKMLN 193
Query: 981 T--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038
E T + D+YS G+VL E+ TGK P ++I + + L P ++
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK-NNSLKLPLDCPLEIK 252
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ CT+ D I RP + +I++ L
Sbjct: 253 ---------------CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 39/143 (27%), Positives = 58/143 (40%), Gaps = 17/143 (11%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +Y+ G+ TLL+ L M + L +LH +VH D+KP N+
Sbjct: 78 MVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132
Query: 936 LFDADFEAHLSDFGLDRL------------TIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
L + L+DFGL ++ I GT Y++PE L
Sbjct: 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192
Query: 984 TTKESDVYSFGIVLLELLTGKRP 1006
K D ++ GI+L E L G P
Sbjct: 193 YGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 35/141 (24%), Positives = 60/141 (42%), Gaps = 7/141 (4%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ GL +LH ++H D+K +N+ + + + D G + + PA + GT+
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVE 221
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD---EDIVKWVKKQLQKGQIT 1029
+PE + ++D++S GIVL E+L + E+ VK L K T
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281
Query: 1030 ELLEPGLLELDPESSEWEEFL 1050
+ P DP S F+
Sbjct: 282 LKVHPEEFPRDPGSRLVRGFI 302
|
Length = 357 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 28/60 (46%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 584 LEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHL 642
L+ L+L +N LT IP L +L VLDLS NNLT P+ S SLRSL ++ N+L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 46/207 (22%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL--GVARGLAFLHTSNMVHGDIKP 932
+++ +M +G+L + L + D P + L+ +A G+ +L + + +H D+
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQY-LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA 140
Query: 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYS 992
+N + + + ++DFGL + I A + +++ E+ T +SDV+S
Sbjct: 141 RNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWS 199
Query: 993 FGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051
FG+ + E+ T G+ P ++ +I ++++ + Q + L+ GL L SS W
Sbjct: 200 FGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD-GLYSL--MSSCWLL--- 253
Query: 1052 GVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+P DRP+ + LE
Sbjct: 254 -----------NPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 841 DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEA------ 893
D F E E L K+ H N+ L G L L + +Y P+GNL L+++
Sbjct: 38 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETD 96
Query: 894 ---SHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
+ + + L+ A VARG+ +L +H D+ +N+L ++ A ++DF
Sbjct: 97 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156
Query: 949 GLDRLTIPTPAEASTSTTAVGTLG--YVSPEAALTGETTKESDVYSFGIVLLELLT 1002
GL R + +G L +++ E+ T SDV+S+G++L E+++
Sbjct: 157 GLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-06
Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL---TIPTPAEASTSTTA----- 967
G+ +LH ++++H DIK N+L D ++DFGL R P P T
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 968 VGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVM 1008
V T Y PE L GE T D++ G V E+ T RP++
Sbjct: 187 VVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTR-RPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 816 YGLVFKA-CYNDGMVLSIR--RLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
YG V+KA N G + +I+ +L G D + ++E + +H N+ G Y
Sbjct: 22 YGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR----GLAFLHTSNMVHG 928
L + + ++ G+L QD + + P+ V+R GL +LH+ +H
Sbjct: 81 LWICM-EFCGGGSL---------QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT---GETT 985
DIK N+L + L+DFG+ T A+ + +GT +++PE A G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 986 KESDVYSFGIVLLELLTGKRPVMF 1009
+ D+++ GI +E L +P MF
Sbjct: 188 QLCDIWAVGITAIE-LAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
+ L +H + + H DIKP+N+L D L+DFG R P T + T Y
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 975 SPEAALT-GETTKESDVYSFGIVLLELLT 1002
+PE LT G + D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 29/95 (30%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
++ L +LH +++ D+K NVL D++ L+D+G+ + + P + T++T GT
Sbjct: 105 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGD--TTSTFCGTPN 161
Query: 973 YVSPEAALTGETTKES-DVYSFGIVLLELLTGKRP 1006
Y++PE L GE S D ++ G+++ E++ G+ P
Sbjct: 162 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 5e-06
Identities = 25/61 (40%), Positives = 36/61 (59%), Gaps = 2/61 (3%)
Query: 607 HLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANN 665
+L LDLS N LT IPD +L+ L ++ N+L+ P++ + L +L LDLS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 666 L 666
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-06
Identities = 18/40 (45%), Positives = 25/40 (62%), Gaps = 2/40 (5%)
Query: 26 EIEALTSFKLNL-HDPLGALNGWDSSTPAAPCDWRGVACT 64
+ +AL +FK +L DP GAL+ W+ S+ PC W GV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSD-PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 832 IRRLPDGSLDEN---LFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
++ +P G L+ N +EA+ L K+ H + + D ++ +Y +L
Sbjct: 33 LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAFCIITEYCEGRDLDC 91
Query: 889 LLQEASHQ-----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943
L+E H + V W ++ L+ G+ ++H ++H D+K +N+ +
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLL------GVHYMHQRRILHRDLKAKNIFLKNNL-L 144
Query: 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
+ DFG+ RL + +TT GT Y+SPEA +SD++S G +L E+
Sbjct: 145 KIGDFGVSRLLM---GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 50/216 (23%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 801 ATRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN 859
+ + N++ +G+V++A C + ++I+++ D +E + + H N
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ---DPQYKNRELLIMKNLNHIN 120
Query: 860 LTVLRGYY------AGAPDLRL-LVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIA 910
+ L+ YY ++ L +V +++P T+ + H ++ H L + L +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ----TVHKYMKHYARNNHALPLFLVKLYS 176
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA-HLSDFGLDRLTIPTPAEASTSTTAVG 969
+ R LA++H+ + H D+KPQN+L D + L DFG + + S + +
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA----GQRSVSYIC 232
Query: 970 TLGYVSPEAALTGET--TKESDVYSFGIVLLELLTG 1003
+ Y +PE L G T T D++S G ++ E++ G
Sbjct: 233 SRFYRAPELML-GATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 41/147 (27%), Positives = 60/147 (40%), Gaps = 14/147 (9%)
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGT-LLQEASHQDGHVLNWPMRHLIALGVARGL 917
N+ L Y + D LV + G L + + + + + V W ++AL
Sbjct: 46 NMVCLHKYIV-SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
LH +V D+ P N+L D L+ F E S AV + Y +PE
Sbjct: 101 --LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS-----EVEDSCDGEAVENM-YCAPE 152
Query: 978 AALTGETTKESDVYSFGIVLLELLTGK 1004
E T+ D +S G +L ELLTGK
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 391 GLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450
LKSL L+ N + +F+ LP L+ L+L N+L+ PE G+ +L +LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 39/131 (29%), Positives = 56/131 (42%), Gaps = 32/131 (24%)
Query: 900 VLNWPM-------RHL--IALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFG 949
+L+W M RHL I L + HT +++H D+KP+N+L + SD
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMET------SDTV 271
Query: 950 LD----RLTIPTPA------------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSF 993
+D R P P E + T V T Y SPE L +D++S
Sbjct: 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331
Query: 994 GIVLLELLTGK 1004
G ++ EL TGK
Sbjct: 332 GCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
G+A LH + ++H D+K N+L + + DFGL R +P + T V TL Y
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE-YGSPLKPYTQL--VVTLWYR 173
Query: 975 SPEAAL-TGETTKESDVYSFGIVLLELLTGK 1004
+PE L E + D++S G + ELLT K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 23/114 (20%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA- 967
I + LA+LH ++H D+K +N+ D A L DFG A+ A
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG-----------AACKLDAH 238
Query: 968 ---------VGTLGYVSPE-AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011
GTL SPE AL K +D++S G+VL E+ + Q
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 1/100 (1%)
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
+H+ M+H D+K N+ L DFG + +++ GT Y++PE
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELW 243
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019
+K++D++S G++L ELLT RP +I++ V
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
|
Length = 478 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 27/237 (11%)
Query: 785 KLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRL-PDGSLDE 842
K ++F++ ++T E + + YG VFK +G +++ L P +DE
Sbjct: 6 KTIIFDSFPDPSDTWEIIE------TIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE 59
Query: 843 NLFRKEAEF---LGKVRHRNLTVLRGYY----AGAPDLRLLVYDYMPNGNLGTLLQEASH 895
+ EAE+ H N+ G Y D LV + + NG T L +
Sbjct: 60 EI---EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE-LCNGGSVTDLVKGFL 115
Query: 896 QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955
+ G + P+ I GL LH + +H D+K N+L + L DFG+
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 956 PTPAEASTSTTAVGTLGYVSPEA-----ALTGETTKESDVYSFGIVLLELLTGKRPV 1007
T +TS VGT +++PE L DV+S GI +EL G P+
Sbjct: 176 STRLRRNTS---VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 3/104 (2%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
I V R + +LH + ++H DIK +N+ + + L DFG P A+
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG--AACFPVDINANKYYGWA 244
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012
GT+ +PE D++S GIVL E+ T +F +D
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS-LFEKD 287
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 45/190 (23%), Positives = 72/190 (37%), Gaps = 50/190 (26%)
Query: 862 VLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
V+ YY+ L L+ +++P G+L T+L + V + M + + +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-----AIEAV 117
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLD----------------------------- 951
H +H DIKP N+L D LSDFGL
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 952 -------RLTIPTPAEAST--------STTAVGTLGYVSPEAALTGETTKESDVYSFGIV 996
LT+ + + +T + + VGT Y++PE L +E D +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 997 LLELLTGKRP 1006
+ E L G P
Sbjct: 238 MFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 26/58 (44%), Positives = 32/58 (55%)
Query: 487 KLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFN 544
L +LDLS + GLPNL+V+ L N L+ PE FS L SLR L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 32/138 (23%), Positives = 58/138 (42%), Gaps = 13/138 (9%)
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
N + I + L ++H + HGDIKP+N++ D + ++ D+G+ I
Sbjct: 124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 962 STSTTAV----GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV---MFTQDED 1014
S GTL Y +A T+ D+ S G +L+ + F + +
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGN 241
Query: 1015 IVKWVK----KQLQKGQI 1028
++ K K+L +G+I
Sbjct: 242 LIHAAKCDFIKRLHEGKI 259
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 367 SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSL 426
+L LDL NR + + LK L L+ N + P +F LP L +L+L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 85/328 (25%), Positives = 134/328 (40%), Gaps = 66/328 (20%)
Query: 413 LPGLENLNLRHNSLSGSLPEEVLGM-NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L GL N++LR + +P+ L M NL TL LS+ E+P+SI L++L ++S
Sbjct: 633 LTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690
Query: 472 NAFSGRIPA-----SLGNL-------LK--------LTTLDLSK---QNFSGELPIELAG 508
+P SL L LK ++ LDL + + F L +E
Sbjct: 691 CENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLE--N 748
Query: 509 LPNLQVIALQENKLSGNVPEGFSSLM-----SLRYLNLSFNGFVGQIPATFSFLRSVVVL 563
L L + ++ KL V + + LM SL L LS + ++P++ L +
Sbjct: 749 LDELILCEMKSEKLWERV-QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL--- 804
Query: 564 SFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL-DLSIN------ 616
H+ E+ NC +LE L N L D+S S L D+S N
Sbjct: 805 ----EHL------EIENCINLETLPTGIN-LESLESLDLSGCSRLRTFPDISTNISDLNL 853
Query: 617 NLTG--EIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSA---------NN 665
+ TG E+P I K S+L L +N + + +++KL +L +D S N
Sbjct: 854 SRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGALTEASWNG 913
Query: 666 LSGEIPANLSSIFGLMNFNVSSNNLQAF 693
E+ +I + V N + F
Sbjct: 914 SPSEVAMATDNIHSKLPSTVCINFINCF 941
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 511 NLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNH 569
NL+ + L N+L+ +P+G F L +L+ L+LS N P FS L S+ L SGN+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 570 I 570
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 21/59 (35%), Positives = 32/59 (54%), Gaps = 2/59 (3%)
Query: 415 GLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGN 472
L++L+L +N L+ +P+ G+ NL LDLS N + P + L L +LSGN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHV-LNW 903
F + A + +V H +L + G + ++V +++ +G L L++ + G V + W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSE-NIMVEEFVEHGPLDVCLRK---EKGRVPVAW 118
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP--TPAEA 961
+ +A +A L++L N+VHG++ +N+L L+ GL T P ++
Sbjct: 119 KI--TVAQQLASALSYLEDKNLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSDP 168
Query: 962 STSTTA------VGTLGYVSPEAALTGET-TKESDVYSFGIVLLEL 1000
S TA V + +++PE G + + +D +SFG LLE+
Sbjct: 169 GVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 39/164 (23%), Positives = 60/164 (36%), Gaps = 24/164 (14%)
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL---G 912
+H N+ + +L +V M G+ LL+ H IA
Sbjct: 57 QHPNILPYVTSFIVDSEL-YVVSPLMAYGSCEDLLKT------HFPEGLPELAIAFILKD 109
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT------ 966
V L ++H+ +H +K ++L D + LS R ++
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPK 166
Query: 967 -AVGTLGYVSPEA---ALTGETTKESDVYSFGIVLLELLTGKRP 1006
+V L ++SPE L G K SD+YS GI EL G P
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+ ++H ++H DIK +N+ + D + L DFG + EA VGT+ SP
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAF-DYGWVGTVATNSP 337
Query: 977 EAALTGETTKE-SDVYSFGIVLLELLT 1002
E L G+ E +D++S G++LL++L+
Sbjct: 338 E-ILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
LV +Y+ G++ +LL H G+ + M VA L +LH ++H D+KP N+
Sbjct: 81 LVMEYLIGGDVKSLL----HIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135
Query: 936 LFDADFEAHLSDFGLDRLTI 955
L + L+DFGL ++T+
Sbjct: 136 LISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 23/61 (37%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 559 SVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617
++ L S N ++ IP +L+VL+L N+LT P S L L LDLS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 618 L 618
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 18/59 (30%), Positives = 25/59 (42%)
Query: 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF 378
L LD+S N ++ GL L+ L ++ N+ P SL LDL GN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 68/290 (23%), Positives = 104/290 (35%), Gaps = 45/290 (15%)
Query: 137 LSNLEILNVAANRLSGEIANDL------PRNLKYFDLSSNGFSGPIPTSI-------SNL 183
L L++L + N L E A L +LK LS N +G IP + +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKG 80
Query: 184 SQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA----- 238
LQ ++ S N + E L S SSL L N LG +
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRS-----SSLQELKLNNNGLGDRGLRLLAKGLKDL 135
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYP--PSIRVVQLGFNAFTNVAGP---ETGSCS 293
P L+ + L +N L G AS ++ + L N + E +
Sbjct: 136 PPALEKLVLGRNRLEG---ASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 294 SVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISGKI-----PAQIGGLWRL 344
L+VLDL N + A L +L L++ N+++ A + L
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISL 252
Query: 345 EELKMANNSFG--GAVPVE--IKQCSSLSLLDLEGNRFSGEIPEFLGDIR 390
L ++ N GA + + + SL LDL GN+F E + L +
Sbjct: 253 LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 29/130 (22%), Positives = 47/130 (36%), Gaps = 24/130 (18%)
Query: 834 RLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR-LLVYDYMPNGNLGTLLQE 892
++ +E L + + L V + +G D L+ +++ G L E
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE----GETLDE 82
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM---VHGDIKPQNVLFDA-------DFE 942
S ++ IA +A LA LH + HGD+ P N+L D D+E
Sbjct: 83 VSEEE-----KED---IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134
Query: 943 -AHLSDFGLD 951
A D
Sbjct: 135 YAGYGPPAFD 144
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 37/168 (22%), Positives = 76/168 (45%), Gaps = 21/168 (12%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
F + A + ++ H++L + G + ++V +Y+ G+L T L+ ++ +++N
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMVQEYVKFGSLDTYLK----KNKNLINIS 100
Query: 905 MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH--------LSDFGLDRLTIP 956
+ +A +A L FL + HG++ +NVL + + LSD G+ +P
Sbjct: 101 WKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTG 1003
+ + +V PE + + +D +SFG L E+ +G
Sbjct: 161 -------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 59/255 (23%), Positives = 93/255 (36%), Gaps = 37/255 (14%)
Query: 232 IPPAIGALPKLQVVSLAQNNLSGV-----VPASMFCNVSGYPPSIRVVQLGFNAFT--NV 284
+ A+ P L+ + L+ N + G ++ + L NA
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG----LQELDLSDNALGPDGC 98
Query: 285 AGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA-----STLTRLDVSGNSISGKIPAQIG 339
E+ SS LQ L L N + L + L +L + N + G +
Sbjct: 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158
Query: 340 GLWR----LEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFSGE----IPEFLG 387
R L+EL +ANN G A + +K +L +LDL N + E + E L
Sbjct: 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA 218
Query: 388 DIRGLKSLTLAANLFSGSI-----PASFRNLPGLENLNLRHNSL----SGSLPEEVLGMN 438
++ L+ L L N + + A L L+L N + + L E +
Sbjct: 219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE 278
Query: 439 NLSTLDLSENKFSGE 453
+L LDL NKF E
Sbjct: 279 SLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 63/305 (20%), Positives = 101/305 (33%), Gaps = 77/305 (25%)
Query: 410 FRNLPGLENLNLRHNSLSGS----LPEEVLGMNNLSTLDLSENKFSGEVPASIG------ 459
L L+ L L N+L L + +L L LS N +G +P +
Sbjct: 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGL 77
Query: 460 -NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQ 518
L +LS NA L +LL+ ++L K N +G GL L L+
Sbjct: 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL---GDRGLRLLAK-GLK 133
Query: 519 ENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQ----IPATFSFLRSVVVLSFSGNHISGSI 574
+ +L L L N G + R + L+ + N I +
Sbjct: 134 DLP------------PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA- 180
Query: 575 PPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634
+ + +L VLDL+ N LT E
Sbjct: 181 -------------------GIRALAEGLKANCNLEVLDLNNNGLTDE------------- 208
Query: 635 LLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIF-----GLMNFNVSSNN 689
++ L+ + L +L VL+L NNL+ A L+S L+ ++S N+
Sbjct: 209 ---GASALAETLAS----LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 690 LQAFA 694
+
Sbjct: 262 ITDDG 266
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 51/250 (20%), Positives = 95/250 (38%), Gaps = 45/250 (18%)
Query: 836 PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH 895
D F A + ++ H++L L G ++ +V +Y+ G L L
Sbjct: 40 SDHRDSLAFFET-ASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREK- 95
Query: 896 QDGHV-LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL---FDADFE----AHLSD 947
+V L+W + +A +A L +L +VHG++ +N+L + + LSD
Sbjct: 96 --NNVSLHWKL--DVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151
Query: 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEA--ALTGETTKESDVYSFGIVLLELLT-GK 1004
G IP + V + +++PE T +D +SFG LLE+ + G+
Sbjct: 152 PG-----IPIT--VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 1005 RPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDP 1064
P+ + + + ++ P+ +E + C DP
Sbjct: 205 EPL---STLSSSEKERFYQDQHRLPM----------PDCAELANLINQ------CWTYDP 245
Query: 1065 IDRPTMSDIV 1074
RP+ I+
Sbjct: 246 TKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 68/286 (23%), Positives = 103/286 (36%), Gaps = 68/286 (23%)
Query: 432 EEVLGMNNLSTLDLSENKFSGE----VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLK 487
EE+ M+ L +DLS N E + I N+ L V N S +AF+GR L + L
Sbjct: 24 EELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFS-DAFTGRDKDELYSNLV 82
Query: 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS----LRYLNLSF 543
+ L K L P LQ + L +N PE L+S L +L L+
Sbjct: 83 M----LLKA---------LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNN 129
Query: 544 NGF----------------VGQIPATFSFLRSVVV-----LSFSGNHISGSIPPELGNCS 582
NG + A L V+ + S + +
Sbjct: 130 NGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHEN--- 186
Query: 583 DLEVLELRSNSLTGHIPTDISHLSH--------LNVLDLSINNLTGE----IPDEISKCS 630
L+ ++++ N + P ++ L+ L VLDL N T E + D + + +
Sbjct: 187 -LKEVKIQQNGIR---PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWN 242
Query: 631 SLRSLLVNSNHLSGGIPDSLAKLSN------LAVLDLSANNLSGEI 670
LR L +N LS S+ + N L L N G I
Sbjct: 243 LLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGI 288
|
Length = 388 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNS 593
+L+ L+LS N F L ++ VL SGN+++ SI PE L L+L N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 594 L 594
L
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1099 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.66 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.42 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-113 Score=1116.38 Aligned_cols=916 Identities=33% Similarity=0.560 Sum_probs=635.5
Q ss_pred ChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCcccceEecC-CcEeEEecCCCccccccccccccccccceEEccCCc
Q 047739 23 RSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTN-NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNS 101 (1099)
Q Consensus 23 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~ 101 (1099)
.++|+.||++||+++.||.+.+.+|+.++ +||.|.||+|++ ++|++|+|+++.+.|.+++.+..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~--~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSA--DVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCC--CCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 34899999999999999988999998543 489999999985 899999999999999999999999999999999999
Q ss_pred cCcccCcccc-cCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCC
Q 047739 102 FNGTIPATLA-QCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSI 180 (1099)
Q Consensus 102 ~~~~~p~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~ 180 (1099)
+.|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++| .+++.+|..+
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n----------------------~~~~~~p~~~ 160 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNN----------------------MLSGEIPNDI 160 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCC----------------------cccccCChHH
Confidence 9999987765 888888888888888887775 34555555555444 4445556666
Q ss_pred ccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCccc
Q 047739 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260 (1099)
Q Consensus 181 ~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 260 (1099)
+++++|++|+|++|.++ +.+|..++++++|++|+|++|++.+.+|..++.+++|++|+|++|++++.+|..+
T Consensus 161 ~~l~~L~~L~L~~n~l~--------~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 232 (968)
T PLN00113 161 GSFSSLKVLDLGGNVLV--------GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232 (968)
T ss_pred hcCCCCCEEECccCccc--------ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence 66666666666666665 4555556666666666666666666666666666666666666666554333211
Q ss_pred ccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCC
Q 047739 261 FCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGG 340 (1099)
Q Consensus 261 ~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~ 340 (1099)
..+++|++|+|++|++++.+|..|..+++|++|+|++|.+++.+|..+.+
T Consensus 233 ------------------------------~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 282 (968)
T PLN00113 233 ------------------------------GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282 (968)
T ss_pred ------------------------------hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhh
Confidence 01122333333333333334444445555555555555555445555555
Q ss_pred CCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEE
Q 047739 341 LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420 (1099)
Q Consensus 341 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 420 (1099)
+++|++|+|++|.+.+.+|..+.+ +++|++|++++|.+.+..|..+.++++|+.|+
T Consensus 283 l~~L~~L~Ls~n~l~~~~p~~~~~------------------------l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 338 (968)
T PLN00113 283 LQKLISLDLSDNSLSGEIPELVIQ------------------------LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338 (968)
T ss_pred ccCcCEEECcCCeeccCCChhHcC------------------------CCCCcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence 555555555555554444444444 44455555555544444555555555555555
Q ss_pred cccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc
Q 047739 421 LRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 421 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 500 (1099)
|++|.+++.+|..+..+.+|+.|++++|++++.+|..+..+.+|+.|++++|++.+.+|..+.++++|+.|++++|++++
T Consensus 339 L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~ 418 (968)
T PLN00113 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418 (968)
T ss_pred CcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence 55555555555555555666666666666655556556556666666666666666666666666666666666666666
Q ss_pred cCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCC
Q 047739 501 ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN 580 (1099)
Q Consensus 501 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~ 580 (1099)
..|..+..+++|+.|++++|.+++.+|..+..+++|++|++++|++.+.+|..+. .++|+.|++++|++++.+|..+.+
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhh
Confidence 6666666666677777777777666666666777777777777777777766553 478889999999999889999999
Q ss_pred CCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeee
Q 047739 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLD 660 (1099)
Q Consensus 581 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 660 (1099)
+++|+.|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|..+.++++|+.|+
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCcCCCCccccccccccccCCCCcccCCCCccCCCCCCCC---CCCCccchhhhhhheeeeeeehhhhhHHHHH
Q 047739 661 LSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLGR---KCENADDRDRRKKLILLIVIAASGACLLALC 737 (1099)
Q Consensus 661 ls~N~l~~~~p~~~~~~~~l~~l~l~~n~~~~~~~n~~l~~~~~~~---~c~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 737 (1099)
+++|+++|.+|..-. +..+. -..|.+|+.+||.+... .|... .+....+ +++++++++++++++
T Consensus 578 ls~N~l~~~~p~~~~----~~~~~-----~~~~~~n~~lc~~~~~~~~~~c~~~---~~~~~~~-~~~~~~~~~~~~~~~ 644 (968)
T PLN00113 578 ISHNHLHGSLPSTGA----FLAIN-----ASAVAGNIDLCGGDTTSGLPPCKRV---RKTPSWW-FYITCTLGAFLVLAL 644 (968)
T ss_pred ccCCcceeeCCCcch----hcccC-----hhhhcCCccccCCccccCCCCCccc---cccceee-eehhHHHHHHHHHHH
Confidence 999999999996521 11122 35678999999865432 34321 1112222 222222222222222
Q ss_pred HHHHhhhhHHHhhhhhhhHHHhhcCCCCccCCCCCCCCCCCcCCCCCceeeecccCCHHHHHHHHhccccccccccccce
Q 047739 738 CCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYG 817 (1099)
Q Consensus 738 ~~~~~~~~~r~r~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g 817 (1099)
+++++ .++|+|++... ..... ..+......... .....+++.+ ....|...++||+|+||
T Consensus 645 ~~~~~-~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~ig~G~~g 704 (968)
T PLN00113 645 VAFGF-VFIRGRNNLEL--KRVEN---------EDGTWELQFFDS-----KVSKSITIND---ILSSLKEENVISRGKKG 704 (968)
T ss_pred HHHHH-HHHHhhhcccc--ccccc---------cccccccccccc-----ccchhhhHHH---HHhhCCcccEEccCCCe
Confidence 22222 22222211110 00000 000000000000 0011233333 34567888999999999
Q ss_pred eEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccC
Q 047739 818 LVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ 896 (1099)
Q Consensus 818 ~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 896 (1099)
.||+|.+ .++..||+|++..... ...+|++++++++|||||+++|+|.++ ...++||||+++|+|.++++.
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---- 776 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIHEYIEGKNLSEVLRN---- 776 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcC-CCCEEEEeCCCCCcHHHHHhc----
Confidence 9999997 4689999999865332 224568899999999999999999855 456999999999999999963
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHc---cCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccc
Q 047739 897 DGHVLNWPMRHLIALGVARGLAFLH---TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973 (1099)
Q Consensus 897 ~~~~l~~~~~~~i~~~ia~~L~~LH---~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y 973 (1099)
++|..+.+|+.|+|+|++||| +.+|+|||+||+||+++.++.+++. ||.+.... ......||..|
T Consensus 777 ----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-------~~~~~~~t~~y 844 (968)
T PLN00113 777 ----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-------TDTKCFISSAY 844 (968)
T ss_pred ----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-------cCCCccccccc
Confidence 789999999999999999999 6699999999999999999888876 66554321 11233688999
Q ss_pred cCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCC--CchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHH
Q 047739 974 VSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT--QDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLL 1051 (1099)
Q Consensus 974 ~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 1051 (1099)
+|||++.+..++.++|||||||++|||+||+.||... ......+|.+...........+|+..... ...+.++...
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 922 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD--VSVNQNEIVE 922 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC--CCccHHHHHH
Confidence 9999999999999999999999999999999998532 22345566555444444444555544321 1223455667
Q ss_pred HHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1052 GVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1052 ~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.+++.+||+.||++||+|+||+++|+++..
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 7899999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-63 Score=639.61 Aligned_cols=516 Identities=35% Similarity=0.568 Sum_probs=463.2
Q ss_pred cccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccc-cCCCCceeecccccCCCcccCCcccccceeeCC
Q 047739 90 RMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIG-NLSNLEILNVAANRLSGEIANDLPRNLKYFDLS 168 (1099)
Q Consensus 90 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls 168 (1099)
.+++.|||++|.++|.+|..+..+++|++|+|++|+++|.+|..+. .+++|++|+|++|+++|.+|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p------------- 135 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP------------- 135 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccC-------------
Confidence 4688899999999988888888999999999999998888888754 77777777776666665443
Q ss_pred CCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcc
Q 047739 169 SNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248 (1099)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 248 (1099)
. +.+++|++|+|++|.++ +.+|..++++++|++|+|++|.+.+.+|.+|+++++|++|+|+
T Consensus 136 ---------~--~~l~~L~~L~Ls~n~~~--------~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 196 (968)
T PLN00113 136 ---------R--GSIPNLETLDLSNNMLS--------GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196 (968)
T ss_pred ---------c--cccCCCCEEECcCCccc--------ccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeecc
Confidence 2 34678888888888887 5677777788888888888888887888888777777777777
Q ss_pred cccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCC
Q 047739 249 QNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGN 328 (1099)
Q Consensus 249 ~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 328 (1099)
+|++++ .+|..+.++++|++|+|++|
T Consensus 197 ~n~l~~------------------------------------------------------~~p~~l~~l~~L~~L~L~~n 222 (968)
T PLN00113 197 SNQLVG------------------------------------------------------QIPRELGQMKSLKWIYLGYN 222 (968)
T ss_pred CCCCcC------------------------------------------------------cCChHHcCcCCccEEECcCC
Confidence 777654 34555667778888888888
Q ss_pred ccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCc
Q 047739 329 SISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA 408 (1099)
Q Consensus 329 ~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 408 (1099)
.+++.+|..|+++++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+.++++|++|++++|.+.+.+|.
T Consensus 223 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~ 302 (968)
T PLN00113 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302 (968)
T ss_pred ccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh
Confidence 88878888888888888888888888888888888888888888888888888888888889999999999999889999
Q ss_pred cCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCC
Q 047739 409 SFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKL 488 (1099)
Q Consensus 409 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 488 (1099)
.+.++++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+.+|
T Consensus 303 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L 382 (968)
T PLN00113 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL 382 (968)
T ss_pred hHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCC
Q 047739 489 TTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGN 568 (1099)
Q Consensus 489 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N 568 (1099)
+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|..+++|++|++++|.+++.+|..+..+++|+.|++++|
T Consensus 383 ~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 462 (968)
T PLN00113 383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462 (968)
T ss_pred CEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCCh
Q 047739 569 HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPD 648 (1099)
Q Consensus 569 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 648 (1099)
++.+.+|..++ .++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|.
T Consensus 463 ~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (968)
T PLN00113 463 KFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541 (968)
T ss_pred eeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence 99999888764 58999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCeeecCCCcCCCcCCCCccccccccccccCCCCccc
Q 047739 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA 692 (1099)
Q Consensus 649 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l~~n~~~~ 692 (1099)
.+..+++|+.|||++|+++|.+|..+..+..|+.+++++|++..
T Consensus 542 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred hHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999999999999999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=441.25 Aligned_cols=286 Identities=43% Similarity=0.710 Sum_probs=246.3
Q ss_pred cccCCHHHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEe
Q 047739 790 NNKITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYA 868 (1099)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~ 868 (1099)
...+++.++..+|++|+..++||+|+||.||+|...+|..||||++...... .++|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 3568999999999999999999999999999999999999999998766554 667999999999999999999999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC---CceecCCCCCCEEECCCCcEEE
Q 047739 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---NMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 869 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
+.++.+++|||||++|+|.++++..... .++|..|++||.++|+||+|||+. .||||||||+|||+|+++++||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 6554579999999999999999853221 789999999999999999999985 4999999999999999999999
Q ss_pred eccccccccCCCCCCCcccccc-ccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCC---CchhHHHHHHH
Q 047739 946 SDFGLDRLTIPTPAEASTSTTA-VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT---QDEDIVKWVKK 1021 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~---~~~~~~~~~~~ 1021 (1099)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+++|++||+.|.... ....++.|+..
T Consensus 219 sDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999654210 1111222 8999999999999999999999999999999999999988753 23458899988
Q ss_pred HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1022 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.+..+.+.+++|+.+.. ....+.+++.++++++.+|++.+|++||+|.||+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88888999999998753 1222226777889999999999999999999999999776554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=408.88 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=213.7
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.+...+.+|+|+||+||+|.|++...||||++.....+ .+.|.+|+.+|++++|||||+++|+|.+.+...++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455669999999999999996666999999765444 458999999999999999999999999665456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC-ceecCCCCCCEEECCCC-cEEEeccccccccCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-MVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 958 (1099)
|++|+|.++++.. ....+++..++.+|.|||+||.|||+.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999863 3466999999999999999999999999 99999999999999997 99999999998653221
Q ss_pred CCCccccccccCccccCccccc--cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL--TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||......+....+.....+..++...++
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~-- 273 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP-- 273 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH--
Confidence 3334478999999999999 568999999999999999999999999987765555554443333332222211
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.+..++.+||+.||+.||++.||+..|+.+..
T Consensus 274 --------------~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 274 --------------HLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --------------HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 23578889999999999999999999997754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=373.61 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=203.6
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCC--CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPD--GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.+..+.||+|..|+|||+.++ +++.+|+|.+.. +....+++.+|++++++.+||+||.+||.|.......+++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3455688999999999999986 589999999933 3344578999999999999999999999998665456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++|||.+++... .++++....+||.++++||.|||+ .+||||||||+|||++..|++||||||.++....
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 9999999999864 348999999999999999999995 8999999999999999999999999999987632
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCC--CchhHHHHHHHHhhhccccccccCccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT--QDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
....+.+||..|||||.+.+..|+.++||||||+.++|+++|+.||... ......+.+.. +..+..+...+..+
T Consensus 232 --S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~-Iv~~ppP~lP~~~f- 307 (364)
T KOG0581|consen 232 --SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA-IVDEPPPRLPEGEF- 307 (364)
T ss_pred --hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-HhcCCCCCCCcccC-
Confidence 2567789999999999999999999999999999999999999999764 11222222222 22222222211111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ..+..++..|+++||.+||++.|+++.
T Consensus 308 -------S----~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 308 -------S----PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------C----HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 123578999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=392.86 Aligned_cols=257 Identities=30% Similarity=0.495 Sum_probs=220.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.+.+...+.||+|.||.||.|.|+....||+|.+..+....+.|.+|+++|++++|++||+++|+|..++ ..|||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEec
Confidence 3445667899999999999999998889999999988888999999999999999999999999999544 569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
+.|+|.++|+. ..+..+...+.+.++.|||+||+||+++++|||||.++||||+++..+||+|||+|+.. .+...
T Consensus 284 ~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~--~d~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI--GDDEY 358 (468)
T ss_pred ccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc--CCCce
Confidence 99999999985 34566899999999999999999999999999999999999999999999999999943 22233
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......-+..|.|||.+..+.++.|+|||||||+||||+| |+.||.+....+.++.+.+..+.. .
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------------~ 425 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------------R 425 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-------------C
Confidence 33444556778999999999999999999999999999999 999999888877777666543322 2
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
|..++.+ +.++|..||+.+|++|||++.+...++++.
T Consensus 426 P~~CP~~----vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 PEGCPDE----VYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCHH----HHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 3334432 247899999999999999999999998664
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=404.46 Aligned_cols=270 Identities=27% Similarity=0.431 Sum_probs=221.0
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.+.+....+.||+|.||+||+|+.. +...||||.+++.... .++|++|++++..++|||||+++|+|..+ +
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-~ 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-D 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-C
Confidence 3455667889999999999999753 4578999999875544 57899999999999999999999999954 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCC---------CCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGH---------VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~---------~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
..++|+|||..|||.+||...+..... .++..+.+.||.|||.||+||.+..+|||||..+|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 569999999999999999865432222 38899999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
||+|||+++..-..+ +........-+.+|||||.|..++++.++|||||||++||+++ |+.||.+..+++.++.+++.
T Consensus 643 KIsDfGLsRdiYssD-YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSD-YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred Eecccccchhhhhhh-hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 999999998652221 1111223445789999999999999999999999999999999 99999999988887776653
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCC
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSS 1089 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 1089 (1099)
.+.. .|+.++. .+.++|..||+..|++||+++||-..|+....+...-++
T Consensus 722 ----~lL~---------~Pe~CP~----~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 722 ----QLLS---------CPENCPT----EVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred ----Cccc---------CCCCCCH----HHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 2211 1233333 235789999999999999999999999987766555443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.65 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=208.2
Q ss_pred HhccccccccccccceeEEEEE-ECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeE-EecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKAC-YNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~~~~l 876 (1099)
..+|.+.++||+|+||+|||+. ..+|..||.|.+.-+..+ .+....|+.++++++|||||+++++ +.++.+..++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3468889999999999999996 468999999999755444 3567899999999999999999984 4444444689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc--CC--ceecCCCCCCEEECCCCcEEEecccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT--SN--MVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
||||++.|+|...++..+. ..+.+++++++++..|+++||.++|+ .. |+||||||.||+++.+|.+|++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987654 45779999999999999999999999 45 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
++. .........+||+.||+||.+.+..|+.|+||||+||++|||+.-++||.+..-.++.+.|. .++.+...
T Consensus 177 ~l~---s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~----qgd~~~~p 249 (375)
T KOG0591|consen 177 FLS---SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE----QGDYPPLP 249 (375)
T ss_pred Hhc---chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH----cCCCCCCc
Confidence 873 23344556899999999999999999999999999999999999999998875444444433 34433333
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
+..+. ..+..+|..|+..||+.||+...+++.+
T Consensus 250 ~~~YS------------~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 250 DEHYS------------TDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHhh------------hHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 22221 2345688899999999999854444433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=382.19 Aligned_cols=247 Identities=20% Similarity=0.384 Sum_probs=212.5
Q ss_pred hccccccccccccceeEEEEEE-CCceEEEEEECCC----CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPD----GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+|...++||+|||+.||+++. ..|+.||+|++.+ .....+.+.+|+++.++++|||||+++++|++. ...|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-NNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-CceEEE
Confidence 5699999999999999999998 7799999999976 444567799999999999999999999999955 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
.|+|++|+|..++++. ..+++.+.+.+..||+.||.|||+.+|+|||||..|++++++.++||+|||+|.....
T Consensus 97 LELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~- 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY- 170 (592)
T ss_pred EEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-
Confidence 9999999999999842 4599999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......+.+||+-|+|||++....++..+||||+||++|-|++|++||+...-.+....++.. +..-|..
T Consensus 171 --~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------~Y~~P~~- 240 (592)
T KOG0575|consen 171 --DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------EYSMPSH- 240 (592)
T ss_pred --cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------Ccccccc-
Confidence 335567789999999999999999999999999999999999999999877666666665542 1111111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.-..+.++|..+++++|.+|||+++|+..
T Consensus 241 ----------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 ----------LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----------cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01234589999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.23 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=200.0
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--------cHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.+.|.+.+.+|+|+||.|-+|..+ +|+.||||.+..... ....+.+|+++|++++|||||++++++.. ++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CC
Confidence 445778899999999999999864 699999999954322 12346799999999999999999999984 55
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEeccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLSDFG 949 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~DfG 949 (1099)
..|+|||||+||+|.+++-.. ..+.+..-..+++|++.|+.|||+.||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 569999999999999999753 336666778899999999999999999999999999999655 789999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCC--C-CCcCchhhHHHHHHHHHhCCCCCCCCCchh-HHHHHHHHhhh
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE--T-TKESDVYSFGIVLLELLTGKRPVMFTQDED-IVKWVKKQLQK 1025 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~~~DV~S~G~il~elltg~~P~~~~~~~~-~~~~~~~~~~~ 1025 (1099)
+|+.. .....+.+.+||+.|.|||++.+.. + ..++|+||+||++|-+++|.+||....... +.+. +..
T Consensus 325 lAK~~----g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----I~~ 396 (475)
T KOG0615|consen 325 LAKVS----GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----ILK 396 (475)
T ss_pred hhhcc----ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH----Hhc
Confidence 99976 2456678899999999999998654 3 348899999999999999999997543332 3333 333
Q ss_pred ccccccccCcccCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1026 GQITELLEPGLLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
|.+. .....|.++ .++.++|.+|+..||++|||+.|+++.
T Consensus 397 G~y~-----------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA-----------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc-----------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3321 111223322 345689999999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=362.77 Aligned_cols=211 Identities=25% Similarity=0.459 Sum_probs=185.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
..+|...+.||+|+||+||+|+++ ++..||||.+...... .+....|+.+++.++|||||.+++++.. ++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence 457888889999999999999986 5899999999765433 3557799999999999999999999984 5567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC------CcEEEeccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD------FEAHLSDFGLD 951 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~------~~~kl~DfGla 951 (1099)
||||+||||.+|+++.+ .+++.+...++.|+|.||++||+++||||||||.|||++.. ..+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999998643 48999999999999999999999999999999999999764 56899999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~ 1022 (1099)
+... ......+.+|++-|||||++..++|+.|+|+||.|+|+|+|++|+.||......++..++++.
T Consensus 163 R~L~----~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 163 RFLQ----PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred hhCC----chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 9873 344556789999999999999999999999999999999999999999887777776655543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=386.35 Aligned_cols=452 Identities=29% Similarity=0.416 Sum_probs=316.6
Q ss_pred cccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCC
Q 047739 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGAL 239 (1099)
Q Consensus 160 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 239 (1099)
..++.|++++|.++ .+-+.+.++..|..|++.+|+++ ++|++|+.+..++.|+.++|.++ .+|.+++.+
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~---------~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~ 113 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS---------QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSL 113 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh---------hCCHHHHHHHHHHHhhcccchHh-hccHHHhhh
Confidence 45666777777766 44455677777777777777776 67777777777777777777776 667777777
Q ss_pred CCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCC
Q 047739 240 PKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST 319 (1099)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 319 (1099)
.+|..|+.++|.+. .+|.+.+. +..|+.|+..+|+++. .|+.+.++.+
T Consensus 114 ~~l~~l~~s~n~~~-el~~~i~~------------------------------~~~l~dl~~~~N~i~s-lp~~~~~~~~ 161 (565)
T KOG0472|consen 114 ISLVKLDCSSNELK-ELPDSIGR------------------------------LLDLEDLDATNNQISS-LPEDMVNLSK 161 (565)
T ss_pred hhhhhhhcccccee-ecCchHHH------------------------------Hhhhhhhhcccccccc-CchHHHHHHH
Confidence 77777777777776 33333221 3346667777777774 5556777777
Q ss_pred ccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccC
Q 047739 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA 399 (1099)
Q Consensus 320 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 399 (1099)
|..|++.+|+++...|+.+. ++.|++|+..+|.++ .+|+.++.+.+|+.|+|..|+|. .+| .|+.+..|++|+++.
T Consensus 162 l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 162 LSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGE 237 (565)
T ss_pred HHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcc
Confidence 88888888888754444444 778888888888776 67777888888888888888887 666 677777888888888
Q ss_pred ccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc--
Q 047739 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR-- 477 (1099)
Q Consensus 400 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-- 477 (1099)
|+|.-...+...++++|..|||++|+++ ..|+.++-+++|+.||+|+|.|+ ..|.+++++ .|+.|-+.+|.+...
T Consensus 238 N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr 314 (565)
T KOG0472|consen 238 NQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRR 314 (565)
T ss_pred cHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHH
Confidence 8887544445557888888888888887 67888888888888888888887 566778888 788888888776420
Q ss_pred ------------------------------------CCCCC---CCCCCCCEEEeccCcCcccCCcccCCCCc---ccee
Q 047739 478 ------------------------------------IPASL---GNLLKLTTLDLSKQNFSGELPIELAGLPN---LQVI 515 (1099)
Q Consensus 478 ------------------------------------~~~~l---~~l~~L~~L~L~~n~l~~~~~~~l~~l~~---L~~L 515 (1099)
.+..| ....+.+.|++++-+++ .+|........ .+..
T Consensus 315 ~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~V 393 (565)
T KOG0472|consen 315 EIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSV 393 (565)
T ss_pred HHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEE
Confidence 00111 12345677777777776 44544433333 6667
Q ss_pred eeccccccCCCchhhhcccccce-ecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcc
Q 047739 516 ALQENKLSGNVPEGFSSLMSLRY-LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594 (1099)
Q Consensus 516 ~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 594 (1099)
+++.|++. .+|..+..++.+.+ +.+++|.+ +.+|..++.+++|..|+|++|-+. .+|..++.+..|+.|++++|++
T Consensus 394 nfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrF 470 (565)
T KOG0472|consen 394 NFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRF 470 (565)
T ss_pred ecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccc
Confidence 77777776 66776666665544 34444444 467777777777777777777776 6777777777777777777777
Q ss_pred cCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCC
Q 047739 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 595 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
. .+|..+-.+..|+.+-.++|++....|+.+.+|.+|.+|||.+|.+. .+|+.+++|++|++|++++|+|.
T Consensus 471 r-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 471 R-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred c-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 6 67777666666777777777776444444777777777777777776 67777777777777777777776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.43 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=206.5
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
+.|+...++|+|+||+|||++.++ |+.||||++...+.+ .+-..||++++++++|||+|.++.+|... ...++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-rklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-RKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-ceeEEEe
Confidence 468888899999999999999875 899999999665443 35678999999999999999999999854 4469999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++. ++-+-+++.. ..++.....++++|+++|+.|+|++++|||||||+|||++.+|.+|+||||+|+....
T Consensus 81 E~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred eecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 99986 5555555432 3378889999999999999999999999999999999999999999999999998742
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc-----------
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG----------- 1026 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~----------- 1026 (1099)
.....+..+.|.||+|||.+.+ ..|...+||||.||++.||++|++-|.+.++-+..-.|++.+..-
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3345567789999999999887 679999999999999999999999999888877666665554321
Q ss_pred -cccccccCcccCCCCCChhHHH-HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1027 -QITELLEPGLLELDPESSEWEE-FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1027 -~~~~~~d~~~~~~~~~~~~~~~-~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+.-|....+.+-..-+.. ...+++++..|++.||.+|++.+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0111111111111111111111 124578999999999999999998874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=382.44 Aligned_cols=279 Identities=25% Similarity=0.414 Sum_probs=232.4
Q ss_pred eeeecccCCHHHHHHHHhcc---------ccccccccccceeEEEEEECC----ceEEEEEECCCCCcc--HHHHHHHHH
Q 047739 786 LVMFNNKITLAETVEATRQF---------DEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLD--ENLFRKEAE 850 (1099)
Q Consensus 786 ~~~~~~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~ 850 (1099)
...+-...||++..++.+.| .+.++||.|.||.||+|+++- ...||||.++.+..+ +.+|..|+.
T Consensus 603 ~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAs 682 (996)
T KOG0196|consen 603 TKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEAS 682 (996)
T ss_pred ceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhh
Confidence 34455677888777776666 467899999999999999863 468999999876554 467999999
Q ss_pred HhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCC
Q 047739 851 FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930 (1099)
Q Consensus 851 ~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dl 930 (1099)
||.+++||||+++.|+... ....++|.|||++|+|+.||+.. +..+++.+...|.++||.||+||.+.++|||||
T Consensus 683 IMGQFdHPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDL 757 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDL 757 (996)
T ss_pred hcccCCCCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcCchhhhh
Confidence 9999999999999999984 45568999999999999999863 234999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCC
Q 047739 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMF 1009 (1099)
Q Consensus 931 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~ 1009 (1099)
.++|||++.+..+||+|||++|...+++..........-+.+|.|||.+..++++.++||||||++|||.++ |..||+.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999999999977555434444444556679999999999999999999999999999887 9999999
Q ss_pred CCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1010 TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
...++....+.+..+-+ +|-.++. .+.++|..||++|-.+||.+.||+..|++....|+.
T Consensus 838 mSNQdVIkaIe~gyRLP-------------pPmDCP~----aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLP-------------PPMDCPA----ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred cchHHHHHHHHhccCCC-------------CCCCCcH----HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 88888777766653322 2222332 245899999999999999999999999988776654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.58 Aligned_cols=268 Identities=21% Similarity=0.281 Sum_probs=215.8
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 875 (1099)
...++|...++||.|.||+||+|+-. .|..||||+++..-. ++-.-.||+..++++. |||||++.+++.+.....|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678999999999999999999865 588999999965433 3344568999999998 9999999999997776789
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|||||+. +|++.++.. .+.+++.....|++||++||+|+|.+|+.|||+||+|||+.....+||+|||+||...
T Consensus 87 fVfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999974 999999852 5779999999999999999999999999999999999999999999999999999763
Q ss_pred CCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc-
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE- 1033 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d- 1033 (1099)
.....+..+-|.+|+|||++.. +-|+.++||||+|||++|+.+-++-|.+.++-+..-.|...+..+.......
T Consensus 162 ----SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 ----SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ----cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 2345567889999999998864 5689999999999999999999999998888777777776655433222111
Q ss_pred --------CcccCCCCCChh---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 --------PGLLELDPESSE---WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 --------~~~~~~~~~~~~---~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-.+....+..-. ...-..+++++.+|+++||.+|||+.|+++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111000000 0012345789999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=369.96 Aligned_cols=275 Identities=24% Similarity=0.378 Sum_probs=213.3
Q ss_pred cCCHHHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEe
Q 047739 792 KITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYA 868 (1099)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~ 868 (1099)
+....++....+++...+.||+|+||+||+|.|.+. ||||.+...... .+.|+.|+.++++-+|.||+-+.|||.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 334455666667778889999999999999999854 788887654433 377999999999999999999999998
Q ss_pred cCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 869 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
. +.. .+|+.+|+|-+|+.+++.. +..++..+.+.||+|||+||.|||.++|||||||+.||++.+++.|||+||
T Consensus 459 ~-p~~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 459 N-PPL-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred C-Cce-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecc
Confidence 4 444 8999999999999999853 356999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccC---CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG---ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
|++.....- ..........|..-|||||+++.+ .|+..+||||||+|+|||+||..||.....+++. -.+.+
T Consensus 533 GLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----fmVGr 607 (678)
T KOG0193|consen 533 GLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----FMVGR 607 (678)
T ss_pred cceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----EEecc
Confidence 998753211 222334455688899999999865 4899999999999999999999999844333322 22223
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC-CCCCCC
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV-GPDIPS 1088 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~-~~~~~~ 1088 (1099)
|.+. ++.... ......+ +.+++..||.+++++||.+.+|+..|+.+.. .|-...
T Consensus 608 G~l~----pd~s~~--~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 608 GYLM----PDLSKI--RSNCPKA---MKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred cccC----ccchhh--hccCHHH---HHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 3211 111111 1111112 3578889999999999999999999988877 444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.55 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=200.3
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..++||+|+||.||.++.++ ++.+|+|.+.+... +.+...+|..++.+++||.||+++-.|.+ ++..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence 4679999999999999999998764 88999999965432 34678899999999999999999988885 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|+||+.||.|..+|++. ..+++....-++..|+.||.|||+.||||||+||+|||+|++|+++++|||+++...
T Consensus 103 Vld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~- 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL- 176 (357)
T ss_pred EEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc-
Confidence 99999999999999864 347888888889999999999999999999999999999999999999999998642
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+...+.+.+.+.-. ...+..++
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~p~~ls--- 250 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLPPGYLS--- 250 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCCCccCC---
Confidence 223345568999999999999999999999999999999999999999988776666666554320 00011011
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 1068 (1099)
..+.+++.+.++.||++|-
T Consensus 251 -------------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 251 -------------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------------HHHHHHHHHHhccCHHHhc
Confidence 1235788899999999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=356.17 Aligned_cols=268 Identities=24% Similarity=0.337 Sum_probs=212.9
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~l 876 (1099)
.+.|+..++||+|.||.||+|+. .+|+.||+|++..+..+ ..-..||+.+|++++|||||++.+...+. ....|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688889999999999999986 46999999999654432 24467999999999999999999998866 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|+|||+. ||..++.. .+-.+++.++..+++|++.||+|||+.||+|||||.+|||||.+|.+||+|||+|+++.+
T Consensus 196 VFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999987 88888864 345699999999999999999999999999999999999999999999999999998733
Q ss_pred CCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc-----c
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT-----E 1030 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----~ 1030 (1099)
......+..+.|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.|.+..+-+....|.+....+... +
T Consensus 271 --~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 --SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred --CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 334457888999999999998875 69999999999999999999999998887766666666655433211 1
Q ss_pred cccCcccC-CCC-CChhHHHH----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLE-LDP-ESSEWEEF----LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~-~~~-~~~~~~~~----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+......+ ..+ ...-.|.+ ..+++++..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11101111 111 11111111 234688999999999999999998864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=378.59 Aligned_cols=484 Identities=30% Similarity=0.402 Sum_probs=317.7
Q ss_pred cceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCC
Q 047739 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSS 169 (1099)
Q Consensus 92 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~ 169 (1099)
|+.|++++|.+. .+-..+.++..|.+|++++|.++ ..|+++|.+..++.|++|+|+++ ++|+.+. .+++.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 344444555444 22234445555555555555554 44445555555555555555554 3333333 3455555555
Q ss_pred CccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEccc
Q 047739 170 NGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQ 249 (1099)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 249 (1099)
|.+. .+|++++.+..|+.|+..+|+++ ++|..++++++|..|++.+|.++...|..+. ++.|++||...
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~---------slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS---------SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc---------cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccch
Confidence 5555 66777888888888888888886 6777788888888888888888765555554 88888888888
Q ss_pred ccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCc
Q 047739 250 NNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS 329 (1099)
Q Consensus 250 N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 329 (1099)
|-++ ++|..+ +.+..|+.|+|.+|+|. ..| .|..+..|++|+++.|+
T Consensus 193 N~L~-tlP~~l------------------------------g~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~ 239 (565)
T KOG0472|consen 193 NLLE-TLPPEL------------------------------GGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQ 239 (565)
T ss_pred hhhh-cCChhh------------------------------cchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccH
Confidence 8776 455421 23456777777777777 345 58888888888888888
Q ss_pred cccCchhhhC-CCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCc
Q 047739 330 ISGKIPAQIG-GLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA 408 (1099)
Q Consensus 330 i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 408 (1099)
|+ .+|.... ++.++..|||..|+++ ..|+.+.-+.+|++||+|+|.|+ .+|..++++ .|+.|.+.+|.+..+-.+
T Consensus 240 i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ 315 (565)
T KOG0472|consen 240 IE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRRE 315 (565)
T ss_pred HH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHH
Confidence 87 5666655 7888888888888887 77888888888888888888888 677778888 788888888877532211
Q ss_pred cCCCCC--CCCEEE--cccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCC
Q 047739 409 SFRNLP--GLENLN--LRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGN 484 (1099)
Q Consensus 409 ~~~~l~--~L~~L~--L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 484 (1099)
-+.+=+ -|++|. +..-.++.. +.=.-+.-............+.+.+.|++++-+++ .+|+....
T Consensus 316 ii~~gT~~vLKyLrs~~~~dglS~s-----------e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfe 383 (565)
T KOG0472|consen 316 IISKGTQEVLKYLRSKIKDDGLSQS-----------EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFE 383 (565)
T ss_pred HHcccHHHHHHHHHHhhccCCCCCC-----------cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHH
Confidence 111100 011111 000011000 00000000000001112223445666777777766 44443322
Q ss_pred CC---CCCEEEeccCcCcccCCcccCCCCccce-eeeccccccCCCchhhhcccccceecccccccCCCCCCccccccee
Q 047739 485 LL---KLTTLDLSKQNFSGELPIELAGLPNLQV-IALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSV 560 (1099)
Q Consensus 485 l~---~L~~L~L~~n~l~~~~~~~l~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 560 (1099)
-. -....+++.|++. ++|..+..+..+.+ +.+++|+++ .+|..+..+++|..|+|++|.+. .+|..++.+..|
T Consensus 384 a~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L 460 (565)
T KOG0472|consen 384 AAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL 460 (565)
T ss_pred HhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhh
Confidence 22 2677788888877 77777777766554 455555554 77888888888888888888776 677788888888
Q ss_pred eEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCc
Q 047739 561 VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640 (1099)
Q Consensus 561 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 640 (1099)
+.|+++.|++. .+|+.+-.+..|+.+-.++|++....|..+.+|.+|..|||.+|.+. .+|+.+++|++|++|+|++|
T Consensus 461 q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gN 538 (565)
T KOG0472|consen 461 QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGN 538 (565)
T ss_pred heecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCC
Confidence 88888888887 77887777777787777889998555555899999999999999998 78999999999999999999
Q ss_pred ccc
Q 047739 641 HLS 643 (1099)
Q Consensus 641 ~l~ 643 (1099)
++.
T Consensus 539 pfr 541 (565)
T KOG0472|consen 539 PFR 541 (565)
T ss_pred ccC
Confidence 997
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=370.88 Aligned_cols=387 Identities=26% Similarity=0.279 Sum_probs=310.9
Q ss_pred cccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCC
Q 047739 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267 (1099)
Q Consensus 188 ~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 267 (1099)
.||++++.|.....+...|.+|+ .-+.|++++|.++.+.+..|.++++|+.++|.+|.|+ .||.
T Consensus 56 lldcs~~~lea~~~~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~--------- 119 (873)
T KOG4194|consen 56 LLDCSDRELEAIDKSRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPR--------- 119 (873)
T ss_pred eeecCccccccccccccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccc---------
Confidence 35666666665444444566765 4578999999999999999999999999999999998 5665
Q ss_pred CCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEE
Q 047739 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEEL 347 (1099)
Q Consensus 268 ~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L 347 (1099)
++....+|+.|+|.+|.|+.+-.+.++.++.|+.||||.|.|+.+--.+|..-.++++|
T Consensus 120 ---------------------f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L 178 (873)
T KOG4194|consen 120 ---------------------FGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKL 178 (873)
T ss_pred ---------------------ccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEE
Confidence 23345679999999999998888899999999999999999986655678777889999
Q ss_pred EccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc
Q 047739 348 KMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 348 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
+|++|.|+..--..|..+.+|.+|.|+.|+++...+..|.++++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.+.
T Consensus 179 ~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~ 258 (873)
T KOG4194|consen 179 NLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS 258 (873)
T ss_pred eeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc
Confidence 99999999888888999999999999999999666678888999999999999998666778999999999999999998
Q ss_pred cccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccC
Q 047739 428 GSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA 507 (1099)
Q Consensus 428 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 507 (1099)
......|.++.++++|+|+.|+++..-..++-++++|+.|+|+.|.|...-++.+.-+++|++|+|+.|+|+...+..|.
T Consensus 259 kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 259 KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH
Confidence 77778899999999999999999988888899999999999999999988888888999999999999999988888899
Q ss_pred CCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCC---cccccceeeEEEccCCcCCCCCCCCCCCCCCC
Q 047739 508 GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA---TFSFLRSVVVLSFSGNHISGSIPPELGNCSDL 584 (1099)
Q Consensus 508 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L 584 (1099)
.+..|++|+|++|.+...-...|..+++|+.|||++|.++..+.+ .|..+++|+.|.+.+|++..+...+|.++..|
T Consensus 339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L 418 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL 418 (873)
T ss_pred HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc
Confidence 999999999999999877777888999999999999988765543 34444555555555555543333344444555
Q ss_pred ceEEecCCcccCcCCcchhccCcccEEe
Q 047739 585 EVLELRSNSLTGHIPTDISHLSHLNVLD 612 (1099)
Q Consensus 585 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 612 (1099)
++|||.+|.|...-|..|..+ .|+.|-
T Consensus 419 E~LdL~~NaiaSIq~nAFe~m-~Lk~Lv 445 (873)
T KOG4194|consen 419 EHLDLGDNAIASIQPNAFEPM-ELKELV 445 (873)
T ss_pred ceecCCCCcceeecccccccc-hhhhhh
Confidence 555555554444444444444 444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.99 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=209.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.+|...+++|+|.||.||+|++. .|+.||||++..+... .....||++.++.++|+||+.++++|... +...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEEE
Confidence 46788899999999999999864 6899999999766544 35578999999999999999999999854 4458999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||+. +|+..++. ....++......++.++.+|++|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+.
T Consensus 81 Efm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p- 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP- 154 (318)
T ss_pred Eeccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC-
Confidence 99975 89988874 3456899999999999999999999999999999999999999999999999999987432
Q ss_pred CCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.......+.|.+|+|||.+++. .|+..+||||.|||+.||+-|.+-|.+..+-+....+.+....+.. ..++.+.
T Consensus 155 --~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~--~~WP~~~ 230 (318)
T KOG0659|consen 155 --NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP--DQWPEMT 230 (318)
T ss_pred --CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc--ccCcccc
Confidence 2233344899999999998875 5899999999999999999999888888776666666655443321 1112221
Q ss_pred CC------C-----CCChhH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 EL------D-----PESSEW-EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~------~-----~~~~~~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ . +...-. ..-..+.+++..|+..||.+|.++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 0 000000 012234789999999999999999999876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.11 Aligned_cols=385 Identities=24% Similarity=0.283 Sum_probs=302.4
Q ss_pred eecccccCCCc----ccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCce
Q 047739 143 LNVAANRLSGE----IANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL 218 (1099)
Q Consensus 143 L~ls~N~l~~~----i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L 218 (1099)
||.+.+.|... .+..++...+.||+|+|+++..-+..|.++++|+.+++.+|.++ .||...+....|
T Consensus 57 ldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt---------~IP~f~~~sghl 127 (873)
T KOG4194|consen 57 LDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT---------RIPRFGHESGHL 127 (873)
T ss_pred eecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh---------hcccccccccce
Confidence 44444444431 34455678889999999999888899999999999999999998 788877778889
Q ss_pred eEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeE
Q 047739 219 VHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298 (1099)
Q Consensus 219 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~ 298 (1099)
+.|+|.+|.|+.+-.+++..++.|+.||||.|.|+ .+|...|.. ...++.|+|++|+++++...-+.+. ++|..
T Consensus 128 ~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~----~~ni~~L~La~N~It~l~~~~F~~l-nsL~t 201 (873)
T KOG4194|consen 128 EKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPA----KVNIKKLNLASNRITTLETGHFDSL-NSLLT 201 (873)
T ss_pred eEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCC----CCCceEEeecccccccccccccccc-chhee
Confidence 99999999999999999999999999999999998 677655543 2467888888888888877665544 47888
Q ss_pred EEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcC
Q 047739 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF 378 (1099)
Q Consensus 299 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 378 (1099)
|.|+.|+|+.+.+..|.++++|+.|||..|+|.-.---.|.+|.+|+.|.|..|++...-...|..|.++++|+|+.|++
T Consensus 202 lkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l 281 (873)
T KOG4194|consen 202 LKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRL 281 (873)
T ss_pred eecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchh
Confidence 88888888887777888888888888888888643355678888888888888888877777788888888888888888
Q ss_pred CCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCccc
Q 047739 379 SGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASI 458 (1099)
Q Consensus 379 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 458 (1099)
+..-..++.++++|+.|+|++|.|..+.+++....++|++|+|++|+|+...+..|..+..|+.|+|++|.++..-..+|
T Consensus 282 ~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af 361 (873)
T KOG4194|consen 282 QAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF 361 (873)
T ss_pred hhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence 86666777788888888888888887777777777888888888888887777777788888888888888876666677
Q ss_pred CCCCcccEEEccCCcCCCcCCC---CCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccc
Q 047739 459 GNLSQLMVFNLSGNAFSGRIPA---SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535 (1099)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~~~---~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 535 (1099)
..+++|++|||++|.++..+.+ .|..++.|+.|++.+|++..+...+|.++++|+.|+|.+|.|..+-|++|..+ .
T Consensus 362 ~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~ 440 (873)
T KOG4194|consen 362 VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-E 440 (873)
T ss_pred HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-h
Confidence 7788888888888877755433 46667777777777777776666677777777777777777777777777766 6
Q ss_pred cceecccc
Q 047739 536 LRYLNLSF 543 (1099)
Q Consensus 536 L~~L~Ls~ 543 (1099)
|+.|.++.
T Consensus 441 Lk~Lv~nS 448 (873)
T KOG4194|consen 441 LKELVMNS 448 (873)
T ss_pred hhhhhhcc
Confidence 77666654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.57 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=209.2
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
...+|..++.||+|+|++||+|+.. .++.+|||++.+.- ...+.+.+|-++|.+| .||.|++++--|.++. ..
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-sL 149 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-SL 149 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-ce
Confidence 4567999999999999999999875 48999999985422 2235577899999999 8999999999998554 46
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+|+||+++|+|.+++++.+. +++...+.+|.+|+.|++|||+.|||||||||+|||+|+||++||+|||.|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998643 889999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCC------C--cc--ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 955 IPTPAE------A--ST--STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 955 ~~~~~~------~--~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
.+.... . .. ....+||..|++||++..+..++.+|+|+||||+|+|+.|++||....+--+.+.|...-.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 433221 1 11 2558999999999999999999999999999999999999999988777666766655311
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.+.+. ..+.+++.+.+..||.+|++..||-+.
T Consensus 305 ------~fp~~fp------------~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 ------EFPEGFP------------EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------cCCCCCC------------HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1222221 123578999999999999999888764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.08 Aligned_cols=260 Identities=24% Similarity=0.405 Sum_probs=203.4
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEecCCC-ceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD-LRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~lV~e 879 (1099)
.++...+.||+|+||+||++...+ |...|||.+...... .+.+.+|++++++++|||||+++|....... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356778899999999999999865 899999998654211 4568999999999999999999998554443 5689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~ 958 (1099)
|+++|+|.+++.+.+ + .+++..+..++.||++||+|||++|||||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999998643 2 4899999999999999999999999999999999999999 7999999999998664322
Q ss_pred CCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....++.........+.. ...+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~i-p~~l- 248 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEI-PDSL- 248 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCC-Cccc-
Confidence 223334567899999999999964 3445999999999999999999999753 2222333322222222211 1111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
. ..+.+++.+|++.||++|||+.++++.--...
T Consensus 249 -------s----~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 249 -------S----DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------C----HHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0 12357899999999999999999998765444
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=361.64 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=204.6
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|.+.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+++++++ +||||+++++++.....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999742 356899999865332 235688999999999 89999999999886666
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC--------------------------------------------------------
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-------------------------------------------------------- 896 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 896 (1099)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 678999999999999999753210
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccC
Q 047739 897 -DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975 (1099)
Q Consensus 897 -~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~a 975 (1099)
....+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++...... .........++..|+|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~~y~a 244 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSARLPLKWMA 244 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-chhcccCCCCCccccC
Confidence 01347888999999999999999999999999999999999999999999999997542211 1122233456788999
Q ss_pred ccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHH
Q 047739 976 PEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK 1054 (1099)
Q Consensus 976 PE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 1054 (1099)
||++.+..++.++|||||||++|||++ |..||......... ......+..... +.... ..+.+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~---~~~~~~~~~~~~---------~~~~~----~~l~~ 308 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---CQRLKDGTRMRA---------PENAT----PEIYR 308 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH---HHHHhcCCCCCC---------CCCCC----HHHHH
Confidence 999999999999999999999999997 99999765432211 111111111100 01111 12457
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1055 VALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1055 li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
++.+||+.||++|||+.|+++.|+++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.60 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=213.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecC-CCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~l 876 (1099)
.+.|+..+.|++|+||.||+|+++ ++++||+|+++.+.... -.-.||+.++.+++|||||.+..+..+. -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 346888899999999999999975 58999999997654221 2357999999999999999999988743 344699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||||+. +|.+.++..+ +.+...++..++.|+++|++|||...|+|||+|++|+|+...|.+||+|||+||.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg- 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG- 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc-
Confidence 9999986 9999998754 568999999999999999999999999999999999999999999999999999763
Q ss_pred CCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
......+..+.|.+|+|||.+.+. .|++.+|+||+|||+.||+++++-|.+....+..+.|.+.+. ...+.++++
T Consensus 229 --sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG--tPte~iwpg 304 (419)
T KOG0663|consen 229 --SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG--TPSEAIWPG 304 (419)
T ss_pred --CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC--CCccccCCC
Confidence 224456788999999999998875 589999999999999999999999998888777777766543 233444444
Q ss_pred ccCCCCC------ChhH-------HHH---HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPE------SSEW-------EEF---LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~------~~~~-------~~~---~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.+++.. ..++ ... ....+++...+..||++|-|+.|.++.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 4433211 0000 011 344688899999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.34 Aligned_cols=208 Identities=23% Similarity=0.390 Sum_probs=184.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..+.+|.|+||.|..++.+ .|..+|+|.+.....- .+....|..+++.+.||.++++.+.+.+. ...|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-SNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-CeEEE
Confidence 357889999999999999999976 4889999999654432 25577899999999999999999998854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||++||.|.+++++.+ ++++...+-+|.||+.|++|||+.+|++||+||+|||+|++|.+||+|||+|+..
T Consensus 122 vmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-- 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-- 194 (355)
T ss_pred EEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe--
Confidence 999999999999999754 4888999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
.....+.+||+.|+|||.+....|..++|.|||||++|||+.|.+||...+...+.+.|..
T Consensus 195 ----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 195 ----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred ----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 2336678999999999999999999999999999999999999999988777666666554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.71 Aligned_cols=243 Identities=24% Similarity=0.437 Sum_probs=196.5
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCC
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
....+-+|.|+.|.||+|+++ ++.||||++.. .-+.+++-|++++||||+.+.|+|...+- ++||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPc-yCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPC-YCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCce-eEEeeeccccc
Confidence 445678999999999999998 67889998743 22467889999999999999999996665 48999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 964 (1099)
-|++.|+. ++.++......+..+||.||.|||.+.|||||||+-||||..+..|||+|||-++... +....
T Consensus 198 qL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~----~~STk 268 (904)
T KOG4721|consen 198 QLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS----DKSTK 268 (904)
T ss_pred cHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh----hhhhh
Confidence 99999984 3557888888999999999999999999999999999999999999999999998652 22344
Q ss_pred cccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCCh
Q 047739 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044 (1099)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 1044 (1099)
...+||..|||||++.....++|+||||||||+|||+||..||...+...+ ...+....+. + +-|..+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGsNsL~-L-------pvPstc 336 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGSNSLH-L-------PVPSTC 336 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccCCccc-c-------cCcccC
Confidence 567899999999999999999999999999999999999999975443221 1122211111 1 111222
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1045 ~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+ +.+ .-+++.||+..|..||+|++|+..|+-.
T Consensus 337 P-~Gf---klL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 P-DGF---KLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred c-hHH---HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2 222 2367799999999999999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.94 Aligned_cols=271 Identities=23% Similarity=0.300 Sum_probs=213.0
Q ss_pred HHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc--cCCcceEEeeEEecC---CCc
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV--RHRNLTVLRGYYAGA---PDL 873 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~---~~~ 873 (1099)
....++....+.||+|.||.||+|.|+ |+.||||++. ..+++.+.+|.++++.+ +|+||+.+++.-..+ ...
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~--srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS--SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEec--ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 446778889999999999999999998 8899999995 45778899999999975 999999998764322 234
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--------CceecCCCCCCEEECCCCcEEE
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--------NMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
.++|.+|.+.|||+|||.+ ..++....++++..+|.||+|||.+ .|.|||||++||||..++.+.|
T Consensus 284 LwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6899999999999999986 3488999999999999999999954 6999999999999999999999
Q ss_pred eccccccccCCC-CCCCccccccccCccccCccccccC------CCCCcCchhhHHHHHHHHHhC----------CCCCC
Q 047739 946 SDFGLDRLTIPT-PAEASTSTTAVGTLGYVSPEAALTG------ETTKESDVYSFGIVLLELLTG----------KRPVM 1008 (1099)
Q Consensus 946 ~DfGla~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~G~il~elltg----------~~P~~ 1008 (1099)
+|+|+|...... +.-+...+..+||.+|||||++... +....+||||||.|+||++.+ +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999866433 3344567789999999999998653 345678999999999999752 45664
Q ss_pred CCCc-hhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1009 FTQD-EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1009 ~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
..-+ +.-.+.+++.+-..++...++.++ ...+.+..+.++|..||..+|..|-|+-.|-..|.++...++
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW-------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRW-------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCccc-------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 3211 112333333333333333333333 234567778899999999999999999999999988765433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=376.04 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=212.5
Q ss_pred HhccccccccccccceeEEEEEECC--c----eEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND--G----MVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
....+..+.||+|.||.||+|.+.+ | ..||+|.+... ..+..+|.+|+.+|++++|||||+++|+|.+ ...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCC
Confidence 3456678899999999999998754 3 35999998764 3455789999999999999999999999997 455
Q ss_pred eEEEEeecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
.++++|||++|+|..||++.+.. ....++....+.++.|||+|+.||+++++|||||.++|+|++....|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 69999999999999999975322 2456889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+..-. ...........-+..|||||.+..+.++.|+|||||||++||++| |..||...+..++...+... +.+
T Consensus 850 rDiy~-~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g---gRL-- 923 (1025)
T KOG1095|consen 850 RDIYD-KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG---GRL-- 923 (1025)
T ss_pred Hhhhh-chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC---Ccc--
Confidence 94321 122222222345578999999999999999999999999999999 89999887776665544432 211
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
+ .|..++. .+.++|..||+.+|++||++..|++.++.+...
T Consensus 924 --~------~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 --D------PPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --C------CCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1 1222332 234899999999999999999999998877644
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.98 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=202.8
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.+.|+..++||.|..++||+|+. ..+++||||++..+. .+-+.+++|+..|+.++||||+.++..|..+ ...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEee
Confidence 46799999999999999999986 457999999996433 3347899999999999999999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
.||.+||+.+.++..-. ..+++.....|.+++++||.|||.+|.||||||+.|||++.+|.|||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999987533 238999999999999999999999999999999999999999999999999876554333
Q ss_pred CCCccc-cccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTS-TTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
...... .+.+||+.|||||++.. ..|+.|+||||||++..||.+|..||....+-.+.- ..+. +..+... ..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl---~tLq-n~pp~~~-t~ 255 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL---LTLQ-NDPPTLL-TS 255 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH---HHhc-CCCCCcc-cc
Confidence 222222 67799999999999654 469999999999999999999999998655433221 1111 1111000 00
Q ss_pred ccCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. .......+ ..+.+++..|+++||.+|||+++++.
T Consensus 256 ~~----~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GL----DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cC----ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00000000 12356888999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.76 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=213.0
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.....+.++||+|.||.|..+....+..||||.++.+... .++|.+|+++|.+++|||||+++|+|..++ ..++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHH
Confidence 4456678999999999999999988899999999765433 478999999999999999999999999554 4589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
||++|+|.+|+.+... .........+|+.|||.||+||.+.++||||+.++|+|+|+++++||+|||+++-.-.. .
T Consensus 616 YmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg-~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG-D 691 (807)
T ss_pred HHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC-C
Confidence 9999999999986321 11455566779999999999999999999999999999999999999999999854222 2
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh--CCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT--GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........+-+.+|||||.+.-++++.++|||+||+++||+++ .+.||....+++.++........+....++
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l----- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL----- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-----
Confidence 2233445677889999999999999999999999999999865 888998888887777655544433222111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
..|..++.+ +.+++.+||..|-++||+++++...|.+.
T Consensus 767 -~~P~~cp~~----lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -SRPPACPQG----LYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cCCCcCcHH----HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112233332 34789999999999999999999988764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.01 Aligned_cols=263 Identities=26% Similarity=0.346 Sum_probs=211.0
Q ss_pred HHhccccccccccccceeEEEEEECC--c--eE-EEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND--G--MV-LSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
.-++....++||+|.||.||+|.++. + .. ||||..... ....++|.+|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455566899999999999998753 2 23 899998752 223477999999999999999999999998544
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++|||+|.||+|.++|++.+ ..++..++.+++.+.|+||+|||+.++|||||.++|+|++.++.+||+|||++
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 4599999999999999998643 25899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+... ..........-+..|+|||.+..+.|+.++|||||||++||+.+ |..||.+....+..+++...-.+-.
T Consensus 310 ~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~--- 383 (474)
T KOG0194|consen 310 RAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP--- 383 (474)
T ss_pred cCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC---
Confidence 8541 11222222346789999999999999999999999999999999 8899998887776666633211111
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
.+. ....+ +..++..||..+|++||+|.+|.+.++.+......+
T Consensus 384 ---------~~~-~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 384 ---------IPS-KTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ---------CCC-CCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111 11122 246777999999999999999999999887776653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.40 Aligned_cols=280 Identities=25% Similarity=0.342 Sum_probs=215.5
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCC---CCccHHHHHHHHHHhhhccCCcceEEeeEEec----CC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPD---GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG----AP 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~ 871 (1099)
.....|...+.||+|+||.|..|..+ +|+.||+|++.. .....++..+|+++++.++|+||+.+.+.+.. .-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 44566777889999999999999875 589999999962 34456788999999999999999999999864 33
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...|+|+|+|+ -+|...++.. +.++......+.+|+++||.|+|+.+|+|||+||+|++++.+...||+|||+|
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 45699999995 5899998752 33888899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI-- 1028 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 1028 (1099)
+..... ......+..+.|.+|+|||.+.. ..|+.++||||.|||++||++|+.-|.+.+.-+..+.+...+..+..
T Consensus 173 R~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 173 RYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 976443 44556688899999999998764 57999999999999999999999999887665544444443322110
Q ss_pred ---------cccccCcccCCCCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccCCCCCCCC
Q 047739 1029 ---------TELLEPGLLELDPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRVGPDIPSS 1089 (1099)
Q Consensus 1029 ---------~~~~d~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~ 1089 (1099)
...+. .+. .....++..+ ..+++++.+|+..||.+|+|++|+++. |.......+.|+.
T Consensus 252 l~~i~s~~ar~yi~-slp--~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 252 LQKIRSEKARPYIK-SLP--QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC 325 (359)
T ss_pred HHHhccHHHHHHHH-hCC--CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence 00000 000 0011112211 245789999999999999999999874 4544444444433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.64 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=205.9
Q ss_pred HHhccccccccccccceeEEEEEE-CCceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
....|...++||+|+.|.||.|.. ..+..||||++...... ++.+.+|+.+|+..+|+|||.+++.|... +..|.||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVM 349 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVM 349 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEE
Confidence 355688888999999999999975 46889999999655444 46688999999999999999999988755 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||++|+|.+.+... .+++.+...|+.++++||+|||..||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 350 Eym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~-- 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE-- 421 (550)
T ss_pred eecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc--
Confidence 999999999999753 388999999999999999999999999999999999999999999999999876632
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
......+.+||+.|||||++....|.+|+||||+|++++||+.|++||-....-.....+... +. +
T Consensus 422 -~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n---g~-P--------- 487 (550)
T KOG0578|consen 422 -EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GT-P--------- 487 (550)
T ss_pred -ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---CC-C---------
Confidence 233667789999999999999999999999999999999999999999875554433333322 11 0
Q ss_pred CCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+.+ ..+.++..+|+..||++||++.|+++.
T Consensus 488 ---~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 ---KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111111 123578889999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=327.60 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=201.3
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC----ceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD----LRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~~lV 877 (1099)
-.|+..+++|.|+||.||+|...+ ++.||||+...+.. .-.+|+++|++++|||||++.-+|....+ ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 357888999999999999998764 68999999865443 22479999999999999999988864322 23499
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~ 956 (1099)
||||+. +|.+.++...+ .++..+...+.-+++||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+...+
T Consensus 101 leymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 999985 99999986433 33557777788899999999999999999999999999999965 9999999999998743
Q ss_pred CCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc--c-
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL--L- 1032 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~- 1032 (1099)
+ ........|..|+|||.+.+. +|+.+.||||.|||+.||+-|++-|.+.+..+....+.+....+.-.++ +
T Consensus 179 ~----epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 G----EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred C----CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 3 233456788999999999875 5999999999999999999999999988777666666665543211111 0
Q ss_pred ----cCcccCCCCCChhHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 ----EPGLLELDPESSEWE------EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 ----d~~~~~~~~~~~~~~------~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+..+.++. ...|. .-...++++.++++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik--~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIK--AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccc--cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111110 01110 0123468899999999999999999884
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=342.82 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=220.2
Q ss_pred HHHHHHHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 796 AETVEATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 796 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.+++....+.....+||.|.||.||.|.|+. .-.||||.++.+....++|..|+.+|+.++|||+|+++|+|..++. +
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-F 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-F 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-e
Confidence 4555566677888999999999999999975 5789999999999999999999999999999999999999996655 5
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|||+|||.+|+|.+||+++.+ ..++....+.||.||+.||+||..+++||||+.++|+|+.++..+||+|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999997643 34677788999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.. ..........-++.|.|||.+....++.|+|||+|||++||+.| |..||.+.+-.+.+....+..+.
T Consensus 416 tg--DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-------- 485 (1157)
T KOG4278|consen 416 TG--DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-------- 485 (1157)
T ss_pred cC--CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc--------
Confidence 32 22333344455678999999999999999999999999999998 88899887666555554443322
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
-.++.|+.. +.++|+.||++.|.+||+++||-+.+|..
T Consensus 486 -----~~PeGCPpk----VYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 486 -----DGPEGCPPK----VYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -----cCCCCCCHH----HHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 223344432 34788999999999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.49 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=202.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|.+.+.||+|+||.||||+.+ +.++||+|.+.+....+ +.+.+|++++++++|||||.++++|+.. ...++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-AHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-ceEEEEe
Confidence 57888899999999999999876 47899999996654444 4578999999999999999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+.| +|..++... ..+++..+..|++|++.||.|||+.+|+|||+||.||+++..+.+|+||||+|+.+.
T Consensus 81 e~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--- 151 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--- 151 (808)
T ss_pred hhhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc---
Confidence 99976 999999853 458999999999999999999999999999999999999999999999999999652
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
......+...||+-|||||...++.|+..+|+||+|||+|||++|++||....-.+++..|... +. ..+
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v----~~p---- 220 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV----KPP---- 220 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC----CCc----
Confidence 2344556788999999999999999999999999999999999999999754443443333321 10 000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..-..+..++...+.+||..|-+..+++.
T Consensus 221 --~-----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 --S-----TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --c-----cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 0 11122357888999999999999998875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=309.18 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=210.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|++.+.||+|.||.||.|+.+ .+..||+|++.+... .++++.+|+++...++||||+++++|+.+.. ..|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeEE
Confidence 467999999999999999999976 578999999965432 3477899999999999999999999999654 4599
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
++||..+|++...|... ....+++.....+..|+|.|+.|+|..+||||||||+|+|++.++..|++|||.+...
T Consensus 100 ilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 99999999999999842 3345778888889999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
......+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.++.+.+.- ..+|..
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-------~~~p~~ 244 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-------LKFPST 244 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------ccCCcc
Confidence 2445567899999999999999999999999999999999999999999877777777776531 111110
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ..+.++|.+|+..+|.+|.+..|+++.
T Consensus 245 -------is----~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 -------IS----GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------cC----hhHHHHHHHHhccCccccccHHHHhhh
Confidence 00 123589999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=340.20 Aligned_cols=246 Identities=20% Similarity=0.315 Sum_probs=198.6
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccH----HHHHHHHHHhhhccCCcceEEeeEEec--C-CCceEEEEee
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE----NLFRKEAEFLGKVRHRNLTVLRGYYAG--A-PDLRLLVYDY 880 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~--~-~~~~~lV~e~ 880 (1099)
...||+|++|.||+|.+ +|+.||+|.+....... +.+.+|++++++++||||++++|++.+ . ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 58899999996544332 567799999999999999999999875 2 3356899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
+++|+|.+++... ..+++.....++.|++.|++|+|+ .+++||||||+||++++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~--- 175 (283)
T PHA02988 104 CTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS--- 175 (283)
T ss_pred CCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc---
Confidence 9999999999752 348899999999999999999998 4999999999999999999999999999875421
Q ss_pred CCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........ .+
T Consensus 176 ---~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~---- 244 (283)
T PHA02988 176 ---PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----LP---- 244 (283)
T ss_pred ---ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----CC----
Confidence 1123568899999999876 6799999999999999999999999987665554443322111110 00
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
...+ ..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 245 ----~~~~----~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 ----LDCP----LEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CcCc----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0111 12457899999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=344.03 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=206.7
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----C--ccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----S--LDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 872 (1099)
...+|...+.||+|+||.|+.|... .|..||+|.+... . ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567899999999999999999764 5899999976543 1 12456779999999999 9999999999985554
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLD 951 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla 951 (1099)
.|+||||+.+|+|.+++... .++.+.....++.|+++|++|||+.||+||||||+||++|.+ +.+||+|||++
T Consensus 95 -~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 -IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred -EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 79999999999999999862 347788899999999999999999999999999999999999 99999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCC-CC-CcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGE-TT-KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
.... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.......+...+.+. .-.++
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p 243 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIP 243 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCC
Confidence 8652 3345667789999999999999877 75 7899999999999999999999875554444442221 01111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+. + ..+..++.+|+..||.+|+++.||+ .-.-.+.
T Consensus 244 ~~~~---------S------~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLL---------S------PEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCcC---------C------HHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1110 1 1235789999999999999999999 4444443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.90 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=203.8
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|+..++||+|+||.||.|+-+ .|.++|+|++.+...- .+.++.|-.+|...++|.||+++-.|. +.+..|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-D~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-DKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-CCCeeE
Confidence 4578999999999999999999876 4999999999765432 366889999999999999999998888 456679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
|||||++||++..+|.+. ..+++.....++.+++.|++-+|+.|+|||||||+|+|||..|++|++|||++.-..
T Consensus 218 LiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999864 448888888899999999999999999999999999999999999999999985321
Q ss_pred CC--------------------CCCCc------------------------cccccccCccccCccccccCCCCCcCchh
Q 047739 956 PT--------------------PAEAS------------------------TSTTAVGTLGYVSPEAALTGETTKESDVY 991 (1099)
Q Consensus 956 ~~--------------------~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~ 991 (1099)
.. +.... .....+||+.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 00000 01235899999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC--
Q 047739 992 SFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-- 1069 (1099)
Q Consensus 992 S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-- 1069 (1099)
|+|||+|||+.|.+||......+..+.+..-......++..+ .. .++.++|.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~-----------~s---~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD-----------LS---DEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc-----------cc---HHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999998888877776654322221111111 11 234688998888 9999976
Q ss_pred -HHHHH
Q 047739 1070 -MSDIV 1074 (1099)
Q Consensus 1070 -~~evl 1074 (1099)
+.||-
T Consensus 438 G~~EIK 443 (550)
T KOG0605|consen 438 GAEEIK 443 (550)
T ss_pred cHHHHh
Confidence 44443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.07 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=210.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCc-ceEEeeEEecCCC----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRN-LTVLRGYYAGAPD---- 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~---- 872 (1099)
...|...++||+|.||+||+|+.+ +|..||+|++..... -.....+|+.++++++|+| ||.+++++.....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777889999999999999865 688999999965433 2345689999999999999 9999999986553
Q ss_pred -ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 873 -LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 873 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++||||++. +|..++....... ...+...+..++.||++|++|||+++|+||||||.||+++.+|.+|++|||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 66899999975 9999998754321 34667889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+... ......+..++|.+|+|||++.+. .|+..+||||+|||++||++++.-|.+..+.+....+.+.+..+..
T Consensus 168 ra~~---ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e-- 242 (323)
T KOG0594|consen 168 RAFS---IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE-- 242 (323)
T ss_pred HHhc---CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc--
Confidence 8542 122335678999999999999987 6899999999999999999999999888876666666655443211
Q ss_pred cccCccc----------CCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLL----------ELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~----------~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..++... +... ...... .....+++.+|++.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~-~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPG-PKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCC-ccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 1110 011111 1245789999999999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=338.39 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=203.5
Q ss_pred HhccccccccccccceeEEEEEECC-----------------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-----------------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTV 862 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~ 862 (1099)
..+|...++||+|+||.||+|.+++ +..||+|.+..... ....|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997642 34799999865322 2457899999999999999999
Q ss_pred EeeEEecCCCceEEEEeecCCCCHHHHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceec
Q 047739 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ--------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928 (1099)
Q Consensus 863 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~ 928 (1099)
+++++.+. ...++||||+++|+|.+++...... ....+++..+.+++.||+.||+|||+.||+||
T Consensus 84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEecC-CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999854 4569999999999999998653211 11347888999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh--CCCC
Q 047739 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT--GKRP 1006 (1099)
Q Consensus 929 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt--g~~P 1006 (1099)
||||+||+++.++.+||+|||+++...... .........++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999997542211 1112234456789999999998899999999999999999987 5678
Q ss_pred CCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1007 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
|......+....+.......... .... .+...+ ..+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~----~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQ-VYLF-----RPPPCP----QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccc-cccc-----CCCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 87666555554443332211110 0000 001111 134689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.94 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=205.9
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
.+|+..+.||+|+||.||+|.++++..+|+|.+.......+.+.+|++++++++||||+++++++... ...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEcCC
Confidence 46888899999999999999998888999999877666678899999999999999999999998754 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.++++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+|++|||.++..... ...
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~--~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYT 156 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC--cee
Confidence 999999987421 24789999999999999999999999999999999999999999999999998754211 111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+..... ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------~~~~------- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------LYRP------- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------CCCC-------
Confidence 2223345678999999988889999999999999999999 8999977665555554433211 0001
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.... ..+.+++.+||+.+|++||++.|+++.|.
T Consensus 224 ~~~~----~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLAS----MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCC----HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0001 23468999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.24 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=209.1
Q ss_pred HHhccccccccccccceeEEEEEE-CCceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
...+|++.+.+|+|.||.|-+|.. ..|+.||||.+..+... .-.+++|+++|..++||||+.++.+|... +...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEE
Confidence 355788999999999999999986 57999999999765433 34588999999999999999999999854 4468
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||..+|.|++|+.+. +.+++.+...++.||+.|+.|+|.++++|||+|.+|||+|+++++||+|||++..+
T Consensus 130 ivMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly- 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY- 203 (668)
T ss_pred EEEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh-
Confidence 999999999999999864 34899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.......+.+|.+-|.+||.+.+..| .+.+|-||+||++|.++.|..||.+.+...++..+.. |...+.--
T Consensus 204 ---~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~----GaYrEP~~- 275 (668)
T KOG0611|consen 204 ---ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR----GAYREPET- 275 (668)
T ss_pred ---ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc----ccccCCCC-
Confidence 23445678899999999999998887 4789999999999999999999998877666555443 32221111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
. ..+.-+|+||+..+|++|.|+.+|...-
T Consensus 276 -------P-------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 -------P-------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------C-------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1123589999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.89 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=207.4
Q ss_pred HHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---------------HHHHHHHHHHhhhccCCcceE
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---------------ENLFRKEAEFLGKVRHRNLTV 862 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~H~niv~ 862 (1099)
....++|++.+.||+|.||.|-+|+.. +++.||+|++.+.... .+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999865 6899999999643221 146889999999999999999
Q ss_pred EeeEEecC-CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC
Q 047739 863 LRGYYAGA-PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941 (1099)
Q Consensus 863 l~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~ 941 (1099)
++.+..+. .+..|||+|||..|.+...- .....+.+.+.+++..+++.||+|||.+|||||||||+|+|++++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 99998743 34569999999988664322 1223389999999999999999999999999999999999999999
Q ss_pred cEEEeccccccccCCCC--CCCccccccccCccccCccccccCC----CCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 942 EAHLSDFGLDRLTIPTP--AEASTSTTAVGTLGYVSPEAALTGE----TTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 942 ~~kl~DfGla~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
++||+|||.+....... .........+||+.|+|||...++. ...+.||||+||++|.|+.|+.||......++
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999987542221 1122334579999999999887633 35678999999999999999999987766666
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
.+.|...-. .++... +....+.+++.+++.+||+.|.+..+|...........
T Consensus 328 ~~KIvn~pL-------------~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 328 FDKIVNDPL-------------EFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred HHHHhcCcc-------------cCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 665554211 111111 22334568999999999999999999998877666533
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=347.54 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=200.8
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|++.+.||+|+||.||+|.+ ..+..||+|++.... ...+.+.+|+++++.+ +||||+++++++.+. .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-G 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-C
Confidence 45789999999999999999974 235689999986432 2346788999999999 899999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc---------------------------------------------------------
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH--------------------------------------------------------- 895 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 895 (1099)
..++||||+++|+|.+++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 56999999999999999975321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 896 -------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 896 -------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
.....+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 271 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYV 271 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc-ccc
Confidence 012357889999999999999999999999999999999999999999999999997552221 111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCch-hHHHHHHHHhhhccccccccCcccCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDE-DIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+.. +... . .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~--~-------~ 338 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRM--L-------S 338 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccC--C-------C
Confidence 1223345678999999999999999999999999999998 88898754332 22222221 1100 0 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+...+ ..+.+++.+||+.||++||++.||++.|++
T Consensus 339 ~~~~~----~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 PECAP----SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01011 134689999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.56 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=207.6
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..++||+|+||.||+|...++..|++|.+.......+.+.+|+.++++++|+||+++++++.+. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEecC
Confidence 457899999999999999999988888999999876666678899999999999999999999998754 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.++++.. ....+++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||+++..... ..
T Consensus 84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN--EY 158 (261)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC--ce
Confidence 999999999753 2345788999999999999999999999999999999999999999999999999764221 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++....++.++||||||+++|||++ |+.||...........+..... . +..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~----~~~---- 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----M----PRM---- 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----C----CCC----
Confidence 12223446778999999988889999999999999999998 9999976655544444322110 0 000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...+ ..+.+++.+||+.+|++||+++++.+.|++
T Consensus 227 -~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 -ENCP----DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001 124578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=347.92 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=200.9
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 871 (1099)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+++++++ +|||||++++++...
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 3457899999999999999999752 235799999865332 235688999999999 899999999999854
Q ss_pred CceEEEEeecCCCCHHHHHhhhcc--------------------------------------------------------
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASH-------------------------------------------------------- 895 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 895 (1099)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 456999999999999999864321
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccc
Q 047739 896 ---------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966 (1099)
Q Consensus 896 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 966 (1099)
.....+++....+++.||++||+|||+.||+||||||+||++++++.+||+|||+++..... ........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~-~~~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC-cceeeccC
Confidence 11234788899999999999999999999999999999999999999999999999754221 11112223
Q ss_pred cccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.............. .+. . ...+ ...+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~---~~~-~-~~~~-------~~~~ 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK---RGY-Q-MSRP-------DFAP 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH---ccc-C-ccCC-------CCCC
Confidence 345678999999998899999999999999999997 9999975443322211111 110 0 0000 0001
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
..+.+++.+||+.||++||++.||++.|+++
T Consensus 342 ----~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 ----PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=333.27 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=197.1
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
|+..+.||+|+||.||+|... +|+.||+|.+.... .....+.+|++++++++|+||+++.+++.+. +..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEEE
Confidence 677889999999999999874 68999999885432 1234578899999999999999999998754 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+.+|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--- 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---
Confidence 999999998886422 23588999999999999999999999999999999999999999999999999976421
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........||..|+|||++.+..++.++||||+||++|||++|+.||...........+......... ....
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~----- 226 (285)
T cd05631 155 -GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSE----- 226 (285)
T ss_pred -CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCc-----
Confidence 11223457999999999999999999999999999999999999999865543333333222221110 0000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
. .. ..+.+++.+||+.||++||+ ++|+++
T Consensus 227 --~-~s----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 --K-FS----EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --c-CC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0 00 13457899999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=370.41 Aligned_cols=383 Identities=26% Similarity=0.355 Sum_probs=199.2
Q ss_pred CCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCC
Q 047739 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSG 254 (1099)
Q Consensus 175 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 254 (1099)
..|.+..++.+|++|.|.+|.+. .+|.++..+++|++|+++.|++. .+|..+..++.+..+..++|....
T Consensus 82 ~vp~s~~~~~~l~~lnL~~n~l~---------~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~ 151 (1081)
T KOG0618|consen 82 SVPSSCSNMRNLQYLNLKNNRLQ---------SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ 151 (1081)
T ss_pred hCchhhhhhhcchhheeccchhh---------cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh
Confidence 45566666667777777766665 56666666666666666666665 556666666666666666662211
Q ss_pred ccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCc
Q 047739 255 VVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKI 334 (1099)
Q Consensus 255 ~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~ 334 (1099)
.++ ...++.++|..|.+.+.++..+..+.+ .|||++|.+.
T Consensus 152 ~lg-----------------------------------~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--- 191 (1081)
T KOG0618|consen 152 RLG-----------------------------------QTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--- 191 (1081)
T ss_pred hhc-----------------------------------cccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---
Confidence 111 112566777777777666666665555 5777777665
Q ss_pred hhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCC
Q 047739 335 PAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414 (1099)
Q Consensus 335 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 414 (1099)
-..+..+.+|+.|....|++.... -..++|+.|+.++|.++...+... -.+|+++++++|++++. |+++..+.
T Consensus 192 ~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~~l-p~wi~~~~ 264 (1081)
T KOG0618|consen 192 VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHPV--PLNLQYLDISHNNLSNL-PEWIGACA 264 (1081)
T ss_pred hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccccc--cccceeeecchhhhhcc-hHHHHhcc
Confidence 124555666666766666665321 123556666666666653222221 13455555555555533 35555555
Q ss_pred CCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCC-CCEEEe
Q 047739 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLK-LTTLDL 493 (1099)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L 493 (1099)
+|+.++..+|+++ .+|..+..+++|+.|++.+|.++ .+|.....+++|+.|+|..|+|....+..+.-... |..|+.
T Consensus 265 nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 265 NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhh
Confidence 5555555555554 45555555555555555555555 34444555555555555555555222212222221 444444
Q ss_pred ccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCC
Q 047739 494 SKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573 (1099)
Q Consensus 494 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~ 573 (1099)
+.|++....-..=..++.|+.|++.+|.+++..-..+.+.+.|+.|+|++|++.......+.++..|+.|+||+|+++ .
T Consensus 343 s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~ 421 (1081)
T KOG0618|consen 343 SSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T 421 (1081)
T ss_pred hhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence 444444221111112233444555555554444444444444555555555444333334444444444444444444 3
Q ss_pred CCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCcccc
Q 047739 574 IPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619 (1099)
Q Consensus 574 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 619 (1099)
+|..+.++..|+.|...+|++. ..| .+..+++|+.+|+|.|+|+
T Consensus 422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 4444444444444444444444 334 4444444444444444444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=339.83 Aligned_cols=242 Identities=23% Similarity=0.371 Sum_probs=202.4
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|...++||+|+||+|+.|..+ +++.+|||.++++.. +.+....|.+++... +||.++.++..|.. .+..
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEHL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCeE
Confidence 3567999999999999999999987 478999999976543 346677888888877 49999999999884 5567
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+.||++..+.+ ...+++....-+|..|+.||+|||++||||||||.+|||+|.+|++||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999443333 355899999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. .......+.+||+.|||||++.+..|+.++|.|||||++|||+.|+.||.+++++++.+.|... +..-|
T Consensus 519 m---~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------~~~yP 588 (694)
T KOG0694|consen 519 M---GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------EVRYP 588 (694)
T ss_pred C---CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------CCCCC
Confidence 2 2344677899999999999999999999999999999999999999999999998888877653 11111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
.+ .. .+++.++.+++..+|++|--+
T Consensus 589 ~~-------ls----~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RF-------LS----KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred Cc-------cc----HHHHHHHHHHhccCcccccCC
Confidence 11 11 123578899999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=329.79 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=202.1
Q ss_pred HhccccccccccccceeEEEEEEC----CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|++.+.||+|+||.||+|.++ .+..||+|.+..... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcE
Confidence 356889999999999999999864 367899999875432 235788999999999999999999998854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++..++.++.|++.|++|||+.+++||||||+||+++.++.+|++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999752 2358899999999999999999999999999999999999999999999999876431
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+..+.+.. +....
T Consensus 159 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~----~~~~~---- 228 (266)
T cd05064 159 S--EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED----GFRLP---- 228 (266)
T ss_pred c--cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC----CCCCC----
Confidence 1 11111223345678999999999999999999999999999775 9999987665554443321 11000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.+...+ ..+.+++..||+.+|++||++.||.+.|++.
T Consensus 229 -----~~~~~~----~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -----APRNCP----NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCC----HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011111 1245789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.01 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=198.0
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhh--ccCCcceEEeeEEecCC---CceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGK--VRHRNLTVLRGYYAGAP---DLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---~~~~lV~e 879 (1099)
....++||+|+||.||||.++ ++.||||+++. .+.+.|..|-++++. ++|+||++++++-.... ...++|+|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 445678999999999999998 48999999964 355778888888775 58999999999865322 24589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC---------CceecCCCCCCEEECCCCcEEEecccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---------NMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
|.+.|+|.+||.. ..++|....+|+..+++||+|||+. +|+|||||++||||..|+++.|+|||+
T Consensus 289 fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999985 4589999999999999999999975 699999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCC------CCCcCchhhHHHHHHHHHhCCCCCCC---------------
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE------TTKESDVYSFGIVLLELLTGKRPVMF--------------- 1009 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~G~il~elltg~~P~~~--------------- 1009 (1099)
|..+.+...... .-..+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-+..
T Consensus 363 Al~~~p~~~~~d-~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 363 ALRLEPGKPQGD-THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eEEecCCCCCcc-hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 988765443333 33489999999999987643 33578999999999999986543310
Q ss_pred --CCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1010 --TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1010 --~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
..-+++...+.+...++.+ ...+. ....+..+.+.+..||+.||+.|-|+.=|-+.+..+.....
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~----p~~W~-------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKI----PDAWR-------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCC----hhhhh-------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0112222322222222222 11121 11244556788899999999999999888888877765553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=371.44 Aligned_cols=506 Identities=25% Similarity=0.329 Sum_probs=384.3
Q ss_pred EEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCC
Q 047739 95 LSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174 (1099)
Q Consensus 95 L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~ 174 (1099)
+|.|..++. .||.-+-.-..++.|++++|.+-...-+.+...-.|+.||+|+|++ .
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~----------------------~- 58 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQI----------------------S- 58 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccc----------------------c-
Confidence 455555554 5665555545577777777776532222233333355555544444 3
Q ss_pred CCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCC
Q 047739 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSG 254 (1099)
Q Consensus 175 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 254 (1099)
.+|..+..+.+|+.|+++.|.|. .+|.++++.++|++|.|.+|.+. ..|..+..+.+|++|++|.|++.
T Consensus 59 ~fp~~it~l~~L~~ln~s~n~i~---------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~- 127 (1081)
T KOG0618|consen 59 SFPIQITLLSHLRQLNLSRNYIR---------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG- 127 (1081)
T ss_pred cCCchhhhHHHHhhcccchhhHh---------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-
Confidence 77888889999999999999987 67888999999999999999997 78889999999999999999986
Q ss_pred ccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCc
Q 047739 255 VVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKI 334 (1099)
Q Consensus 255 ~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~ 334 (1099)
.+|.-. ..+..+..++.++|.....++. .. ++.++|..|.+.+.+
T Consensus 128 ~~Pl~i------------------------------~~lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 128 PIPLVI------------------------------EVLTAEEELAASNNEKIQRLGQ----TS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred CCchhH------------------------------HhhhHHHHHhhhcchhhhhhcc----cc-chhhhhhhhhcccch
Confidence 444321 2245577788888833323332 22 888999999998888
Q ss_pred hhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCC
Q 047739 335 PAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414 (1099)
Q Consensus 335 p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 414 (1099)
+..+..++. .|+|.+|.+. -..+..+.+|+.|..+.|++... --..++|+.|+.++|.++...+... -.
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p~--p~ 241 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHPV--PL 241 (1081)
T ss_pred hcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccccc--cc
Confidence 888888776 7999999886 34567788999999999988732 1234789999999999884433222 26
Q ss_pred CCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEec
Q 047739 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS 494 (1099)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 494 (1099)
+|+++++++|+++ .+|++++.+.+|+.|+..+|+++ .+|..+..+++|+.|.+..|.++ .+|....+++.|++|+|.
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 7999999999999 57799999999999999999996 78888888999999999999999 677788889999999999
Q ss_pred cCcCcccCCcccCCCCc-cceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCC
Q 047739 495 KQNFSGELPIELAGLPN-LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573 (1099)
Q Consensus 495 ~n~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~ 573 (1099)
.|+|....+..+..+.. |..|+.+.|++....--.=..++.|+.|++.+|.+++..-..+.+...|+.|+|++|++...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 99998444434444443 78888888888743322223457899999999999988888888899999999999999844
Q ss_pred CCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCcccccc-CChhhhc
Q 047739 574 IPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG-IPDSLAK 652 (1099)
Q Consensus 574 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~ 652 (1099)
....+.++..|++|+||+|+++ .+|..+..++.|++|...+|++. ..| ++..++.|+.+|+|.|+|+.. +|.....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 4457888999999999999998 78999999999999999999998 678 788999999999999998743 3443333
Q ss_pred cCCCCeeecCCCcCCCcCCCCccccccccccccCCC
Q 047739 653 LSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSN 688 (1099)
Q Consensus 653 l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l~~n 688 (1099)
++|++|||++|.-....-..+..+..+..+++.-|
T Consensus 476 -p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 476 -PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 78999999999843333344445555566665555
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.73 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=206.4
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|.+.++..||+|.+.......+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeeecc
Confidence 457889999999999999999988888999999977666678899999999999999999999998854 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++... .+..+++..+..++.|++.|++|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (261)
T cd05068 84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED--IY 158 (261)
T ss_pred cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC--cc
Confidence 999999999753 2345899999999999999999999999999999999999999999999999999865311 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........+..|+|||++.+..++.++||||||++++||++ |+.||...........+.... .. ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~--~~~------- 226 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---RM--PCP------- 226 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CC--CCC-------
Confidence 11112233468999999998899999999999999999999 999997655444333322110 00 000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
... ...+.+++.+|++.+|++||++.++++.|+.
T Consensus 227 -~~~----~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 -PGC----PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CcC----CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000 1234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.75 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=203.8
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
-|..++.||.|+.|.|-.|++. .|+.+|||.+... ......+++|+-+|+-+.|||++++++++... ...|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-QHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-ceEEEEE
Confidence 3678899999999999999874 6999999999654 22346689999999999999999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|.|++++-+. ..+++.+..+++.||..|+.|+|..+|+|||+||+|+|+|.+..+||+|||+|..-
T Consensus 92 Eyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---- 162 (786)
T ss_pred EecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc----
Confidence 999999999999754 34889999999999999999999999999999999999999999999999999754
Q ss_pred CCCccccccccCccccCccccccCCCC-CcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETT-KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
..+....+-||.+.|.|||++.+..|. .++||||.|||+|.|+||+.||..+.-..+...++++.. +++..+.
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is---- 236 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNIS---- 236 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCC----
Confidence 223345567999999999999999884 789999999999999999999985554444444443211 1111111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
.++.+++.+|+..||++|.|++||++.-
T Consensus 237 ------------~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 237 ------------SEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ------------HHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1345799999999999999999999863
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.14 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=204.7
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|...+.||+|+||.||+|.++++..+|+|.+.......+.+.+|++++++++||||+++++++... ...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcCC
Confidence 46888899999999999999988777899999877666677899999999999999999999998754 44699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.... ..+++..++.++.||+.|++|||+.+++|+||||+||+++.++.+|++|||.++..... ...
T Consensus 83 ~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~--~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYT 156 (256)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC--cee
Confidence 999999997522 24899999999999999999999999999999999999999999999999998754221 111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||+..+..++.++||||||+++|||++ |+.||......+....+..... .. . +
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~-~--------~ 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR----LY-R--------P 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC----CC-C--------C
Confidence 1223346678999999988889999999999999999999 9999976665544444322111 00 0 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... -..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~----~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLA----SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCC----CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000 123468899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.17 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=205.3
Q ss_pred hccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
++|+..+.||+|+||.||+|.... ...|++|.+..... ..+.|.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-Cce
Confidence 468889999999999999998643 25799998864332 235689999999999999999999998854 456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCC-----------CCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDG-----------HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
+++|||+++|+|.+++........ ..+++..+..++.|++.||+|||+.+++||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999999999999976432221 458899999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
||+|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 164 ~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccc-cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997542221 1122334567889999999998899999999999999999998 99999876665554443321
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
..... +...+ ..+.+++.+||+.||++||++.||++.|+.
T Consensus 243 ----~~~~~---------~~~~~----~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 243 ----QLLPC---------PEDCP----ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----CcCCC---------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 01111 234688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.32 Aligned_cols=255 Identities=22% Similarity=0.390 Sum_probs=204.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.+|+..+.||+|+||.||+|.++ .+..|++|.+.....+.+.+.+|++++++++||||+++++++..+ ...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEeC
Confidence 45888899999999999999876 478999999877666667899999999999999999999998854 4559999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++... ....+++..++.++.|+++||+|||+.+++||||||+||++++++.+|++|||+++..... ..
T Consensus 85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~--~~ 159 (263)
T cd05052 85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TY 159 (263)
T ss_pred CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc--ee
Confidence 999999999753 2345899999999999999999999999999999999999999999999999999765221 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++....+..... . ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----~-----~~---- 226 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR----M-----ER---- 226 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----C-----CC----
Confidence 11122334678999999998899999999999999999998 9999876555444333222110 0 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+...+ ..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 227 ~~~~~----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111 2245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=335.53 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=198.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence 36888999999999999999986 58899999985422 234568899999999999999999998874 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 80 MEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 9999999999999753 3478889999999999999999999999999999999999999999999999975421
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......|++.|+|||++.+..++.++||||+||++|||++|+.||.........+.+... ..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~----~~--------- 215 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG----KL--------- 215 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----Cc---------
Confidence 122457899999999999888999999999999999999999999876655444433321 11
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1076 (1099)
.+.... . ..+.+++.+|++.||.+||+ +.|+++.
T Consensus 216 ~~~~~~-~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHL-D----LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccC-C----HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000000 0 12457999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.02 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=204.3
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|++.+.||+|+||.||+|... .++.||+|++..... ..+.+.+|+++++++ +|+||+++++++...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999642 247899999864322 235677899999999 79999999999886666
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC--------------------------------------------------------
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-------------------------------------------------------- 896 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 896 (1099)
..++||||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 778999999999999998642210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCc
Q 047739 897 DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976 (1099)
Q Consensus 897 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aP 976 (1099)
....+++..+..++.||+.||+|||+.+|+||||||+||++++++.+||+|||+++....... ........++..|+||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aP 244 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAP 244 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCccccCc
Confidence 013589999999999999999999999999999999999999999999999999986522211 1122344567889999
Q ss_pred cccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHH
Q 047739 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKV 1055 (1099)
Q Consensus 977 E~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~l 1055 (1099)
|++.+..++.++|||||||++|||++ |..||......+... .....+... ..+ ... ...+.++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~-~~~--------~~~----~~~~~~l 308 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC---RRLKEGTRM-RAP--------EYA----TPEIYSI 308 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH---HHHhccCCC-CCC--------ccC----CHHHHHH
Confidence 99999999999999999999999998 999997643322211 111111110 000 100 1234688
Q ss_pred HHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1056 ALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1056 i~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.+||+.+|++||++.|+++.|+++..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.97 Aligned_cols=249 Identities=31% Similarity=0.514 Sum_probs=193.0
Q ss_pred cccccccccceeEEEEEEC-----CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 807 EENVLSRTRYGLVFKACYN-----DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..+.||.|.||.||+|.++ .+..|+||.+..... ..+.|.+|++.+++++||||++++|++... ...++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-cccccccc
Confidence 4578999999999999987 257899999965332 257899999999999999999999999944 44699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.++++.. ....+++..+..|+.|||+||+|||+.+++|+||+++||+++.++.+||+|||+++..... .
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-S 157 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-S
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c
Confidence 99999999999864 2345899999999999999999999999999999999999999999999999999765211 1
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
.........+...|+|||.+....++.++||||||+++|||++ |+.||......+....+.+. ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----~~~~~-~~~--- 229 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----QRLPI-PDN--- 229 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----EETTS-BTT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccee-ccc---
Confidence 1223344567789999999999889999999999999999999 78998776555544444221 11110 110
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
.+ ..+.+++..||+.||++||++.+|++.|
T Consensus 230 -----~~----~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 -----CP----KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SB----HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----hh----HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 1235789999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.66 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=209.3
Q ss_pred HHHHhccccccccccccceeEEEEEECC-----ceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
....+.....++||+|.||.||+|.+.+ .-.||||..+.+ ..+.+.|..|+.+|++++|||||+++|+|.+.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P 464 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP 464 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence 3445566778899999999999998743 357999998652 234577999999999999999999999998654
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
.|+|||.++.|.|..|++.. ...++..+...+++||+.||+|||+.++|||||.++|||+.....+|++|||++
T Consensus 465 --~WivmEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 --MWIVMELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred --eeEEEecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence 59999999999999999863 355899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+...+. .........-+..|||||.+.-++++.++|||.|||++||++. |..||.+....+....+.++
T Consensus 539 R~~ed~--~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-------- 608 (974)
T KOG4257|consen 539 RYLEDD--AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-------- 608 (974)
T ss_pred hhcccc--chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC--------
Confidence 987432 2233334556778999999999999999999999999999876 99999876554433322221
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
-+-+.|..++.. +..++.+||++||.+||.+.|+...|.++..
T Consensus 609 -----eRlP~P~nCPp~----LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 -----ERLPCPPNCPPA----LYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCCCCCCCChH----HHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111223333332 3478899999999999999999988876643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.22 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=203.6
Q ss_pred hccccccccccccceeEEEEEEC-Cce----EEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGM----VLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.+|+..+.||+|+||.||+|.+. +|. .||+|.+.... ...+++.+|+.+++.++||||++++|++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence 46899999999999999999864 333 48999986432 2346788999999999999999999999743 358
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999999753 2347889999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+.. +... ..
T Consensus 161 ~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~--~~- 232 (316)
T cd05108 161 ADE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERL--PQ- 232 (316)
T ss_pred CCC-cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC----CCCC--CC-
Confidence 211 1111222345678999999999999999999999999999998 9999976655443332221 1100 00
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
+.... ..+.+++.+||+.+|.+||++.+++..+.++...+.
T Consensus 233 ------~~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 233 ------PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ------CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 01111 124578999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=302.68 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=203.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|++.++||+|.|+.||+.... .|+.+|+|.+... ..+-+.+.+|+++-+.++||||+++.+.+. +..+.|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-ccceeEEE
Confidence 467888899999999999998764 5777787777432 234577899999999999999999999887 45677999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDRLT 954 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~ 954 (1099)
+|+|+||+|..-+-.. ...++...-..++||++||.|+|.++|||||+||+|+++.. ...+|++|||+|...
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999998665431 33667777889999999999999999999999999999953 345899999999876
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. ........+||++|||||++....|+..+|||+.|||+|-++.|..||.+.+...+++.+.+.- .++..+
T Consensus 164 ~----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-----yd~~~~ 234 (355)
T KOG0033|consen 164 N----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-----YDYPSP 234 (355)
T ss_pred C----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-----cCCCCc
Confidence 3 3455667899999999999999999999999999999999999999999877777777665431 122222
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+....+ .+.+++.+|+..||.+|.|+.|++..
T Consensus 235 ~w~~is~---------~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 235 EWDTVTP---------EAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccCcCCH---------HHHHHHHHHhccChhhhccHHHHhCC
Confidence 3322221 23478999999999999999988754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=338.36 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=189.5
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.+|+..++||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++|+||+++++++... ...++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-GEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-CeEEEEEe
Confidence 45677889999999999999876 58899999985432 2246788999999999999999999998754 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+.. ...+.....++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 99999986532 2456778889999999999999999999999999999999999999999999765211
Q ss_pred CCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.......+||..|+|||++.. ...+.++|||||||++|||++|+.||......+....+... ........ .
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~-~- 297 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEA-P- 297 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCC-C-
Confidence 112334579999999998743 22456899999999999999999999744333322222111 11100000 0
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... -..+.+++.+||+.||++||++.|+++.
T Consensus 298 -------~~~----~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 -------ATA----SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------Ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1134688999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=339.71 Aligned_cols=244 Identities=18% Similarity=0.276 Sum_probs=197.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+|++.+.||+|+||.||+|.++ +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ ++..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEE
Confidence 56899999999999999999986 57899999985422 223568899999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 9999999999999753 3478888889999999999999999999999999999999999999999999975421
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +... +..
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~--~p~--- 236 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----GRLK--FPN--- 236 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----CCcC--CCC---
Confidence 12235799999999999999999999999999999999999999976655444333322 1110 000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1076 (1099)
... ..+.+++.+||+.||++||+ ++|++..
T Consensus 237 -----~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 -----WFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001 12357999999999999997 6777643
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.37 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=205.4
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|...++..+++|.+.......+.+.+|++++++++|+|++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEec
Confidence 35788899999999999999998888889999997766677889999999999999999999998753 3468999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.++++.. ....+++..+..++.|++.|++|||+.+|+||||||+||++++++.++++|||++....... .
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~--~ 157 (260)
T cd05070 83 SKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE--Y 157 (260)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc--c
Confidence 999999999742 23458999999999999999999999999999999999999999999999999997542211 1
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||+..+..++.++||||||+++|||++ |..||......+....+.... . .. .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~-~~---------~ 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---R-MP---------C 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---C-CC---------C
Confidence 11223345678999999988889999999999999999999 899997655444443332110 0 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+...+ ..+.+++.+|++.+|++|||++++.+.|+.
T Consensus 225 ~~~~~----~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCP----ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCC----HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111 234689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.34 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=202.5
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
.+|++.+.||+|+||.||+|.++++..+++|.+.........+.+|++++++++||||+++++++... ...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCC
Confidence 45888899999999999999988778899999876666667899999999999999999999998744 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+++|.+++.... ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+|++|||+++..... ...
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~--~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYT 156 (256)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc--ccc
Confidence 999999997422 25899999999999999999999999999999999999999999999999998754211 111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+....+..... ... +
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------~~~----~ 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---------LYR----P 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---------CCC----C
Confidence 1122234568999999998899999999999999999999 8999976655444333221100 000 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
...+ ..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 224 ~~~~----~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAP----TEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0111 13468999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.37 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=204.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
..+|++.++||+|+||.||+|.+.++..|++|.+.......+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEcC
Confidence 35689999999999999999998877789999998666667789999999999999999999998753 3468999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... ....+++..+..++.|++.||+|+|+.+|+||||||+||++++++.+||+|||.++...... .
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~--~ 157 (262)
T cd05071 83 SKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y 157 (262)
T ss_pred CCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc--c
Confidence 999999999742 22357899999999999999999999999999999999999999999999999997552211 1
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||...........+.. +... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~-~~~------- 225 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRM-PCP------- 225 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc----CCCC-CCc-------
Confidence 12223456778999999988899999999999999999999 8888876554443332211 1000 000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. +.-..+.+++.+|++.+|++||++.++++.|+..
T Consensus 226 -~----~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 -P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -c----ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0112346899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.88 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=198.0
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
...|+..+.||+|+||.||||.+. .++.||+|.+..+. .+.+++++|+.++.+++++||.++||.+..+ ...+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHH
Confidence 345777799999999999999875 58899999996543 3347899999999999999999999998844 4568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||.+|++.+.++.. ..+++.....|..++..|+.|+|.++.+|||||+.||++..+|.+|++|||.+.....
T Consensus 91 ey~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN-- 163 (467)
T ss_pred HHhcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec--
Confidence 999999999999753 2346677777899999999999999999999999999999999999999999976522
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
......+.+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+..... -+++-..|.+..
T Consensus 164 -~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---------lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 164 -TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---------LIPKSAPPRLDG 233 (467)
T ss_pred -hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---------eccCCCCCcccc
Confidence 2233377899999999999998899999999999999999999999997554411110 111112222211
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+. .+.+++..|++.+|+.||++.++++
T Consensus 234 --~~S~------~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --DFSP------PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ccCH------HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0111 1346788899999999999998875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.71 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=193.3
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
++||+|+||.||+|..+ +|+.||+|.+.... .....+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 46999999999999875 68899999986422 223567789999999999999999999885 4556999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.... ....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~---~~~~ 151 (323)
T cd05571 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS---DGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc---CCCc
Confidence 9999998752 3478999999999999999999999999999999999999999999999999875321 1222
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1043 (1099)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...+ ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~-----------p~~- 217 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRF-----------PRT- 217 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCC-----------CCC-
Confidence 34567999999999999999999999999999999999999999766554444333221 0000 000
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1044 SEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1044 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
.. ..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LS----PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CC----HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00 1245789999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.26 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=208.8
Q ss_pred HHhccccccccccccceeEEEEEECCceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
...+|+..++||.|+||.||+|.+.++..+++|.+..... ....+.+|++++++++||||+++++++.+. ...++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEEe
Confidence 3567899999999999999999998899999999876544 456789999999999999999999998854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... ....+++..+..++.|++.|++|||+.||+||||||+||+++.++.+|++|||.+......
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-- 157 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-- 157 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence 99999999999753 2345899999999999999999999999999999999999999999999999999764211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........++..|+|||++....++.++||||||+++++|++ |+.||......+....+...... . .
T Consensus 158 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~--~----- 225 (261)
T cd05148 158 -VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----P--C----- 225 (261)
T ss_pred -cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----C--C-----
Confidence 111223456778999999988889999999999999999998 89999776655555444321110 0 0
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+...+ ..+.+++.+||+.||++|||++++++.|+.+
T Consensus 226 --~~~~~----~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 --PAKCP----QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00111 1245889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.48 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=212.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|...+++|+|+||.++..+.+ ++..+++|.+..... .++....|+.++++++|||||.+.+.|..++...++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999999875 467888888855433 3456789999999999999999999999777768999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|+|++||++.+.+.+.+ +..+++...++++.|++.|+.|||+++|+|||||+.||+++.+..||++|||+|+...+.
T Consensus 83 m~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998643 566899999999999999999999999999999999999999999999999999987322
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.......+||+.||.||.+.+..|..|+||||+||++|||++-+++|...+...++..+.+..... +...
T Consensus 160 ---~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-----lp~~-- 229 (426)
T KOG0589|consen 160 ---DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-----LPSM-- 229 (426)
T ss_pred ---hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC-----CCcc--
Confidence 235567899999999999999999999999999999999999999998877777766665543110 1110
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....+..++..|++.+|+.||++.+++..
T Consensus 230 ----------ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 ----------YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----------ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 01233568899999999999999999876
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.30 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=206.4
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...... .+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CC
Confidence 3568888999999999999998643 478999998654433 46799999999999999999999999855 55
Q ss_pred eEEEEeecCCCCHHHHHhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 874 RLLVYDYMPNGNLGTLLQEASH---------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
.++||||+++|+|.++++..+. .....+++.....++.|++.|++|+|+.+++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 6999999999999999976431 2234578999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
++|||+++...... .........+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..
T Consensus 163 l~d~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~-- 239 (280)
T cd05049 163 IGDFGMSRDVYTTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ-- 239 (280)
T ss_pred ECCcccceecccCc-ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--
Confidence 99999987542211 1112233456788999999999999999999999999999998 9999977666555444332
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+..... . .... ..+.+++.+||+.||++||++.||++.|++
T Consensus 240 --~~~~~~-~--------~~~~----~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 240 --GRLLQR-P--------RTCP----SEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --CCcCCC-C--------CCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111110 0 0001 234589999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=339.09 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=202.2
Q ss_pred HHhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhcc-CCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 871 (1099)
..++|.+.++||+|+||.||+|.+.. +..||+|++..... ..+.+.+|++++++++ ||||+++++++.+.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 35678899999999999999998631 35799999864322 2467899999999996 99999999999854
Q ss_pred CceEEEEeecCCCCHHHHHhhhccC-------------------------------------------------------
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQ------------------------------------------------------- 896 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 896 (1099)
...|+||||+++|+|.++++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 4569999999999999998753210
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC
Q 047739 897 ------------------------------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940 (1099)
Q Consensus 897 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~ 940 (1099)
....+++..+..++.|+++|++|||+.+|+||||||+||+++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 11347888899999999999999999999999999999999999
Q ss_pred CcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchh-HHHH
Q 047739 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDED-IVKW 1018 (1099)
Q Consensus 941 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~-~~~~ 1018 (1099)
+.+|++|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 274 ~~~kL~DfGla~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDS-NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccc-cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 999999999997542211 1122233457788999999998899999999999999999997 999986543222 2221
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+. .+.... . +...+ ..+.+++.+||+.||++||++.+|.++|+++.
T Consensus 353 ~~----~~~~~~-~--------~~~~~----~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 353 IK----SGYRMA-K--------PDHAT----QEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred Hh----cCCCCC-C--------CccCC----HHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11 111000 0 00011 23467999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.31 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=207.6
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|.+.++||+|+||.||+|..+++..||+|.+.......+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEEcC
Confidence 45788899999999999999999889999999998777777889999999999999999999998753 3469999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... .+..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++++|||++...... ..
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN--EY 157 (260)
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC--Cc
Confidence 999999998642 2345889999999999999999999999999999999999999999999999998754211 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++....++.++||||||++++||++ |+.||......+....+..... ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~--------- 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR----MPR--------- 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC----CCC---------
Confidence 12223456788999999998889999999999999999999 9999976665544443322110 000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+...+ ..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCP----EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111 135689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=336.63 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=201.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.. +...|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEEE
Confidence 6889999999999999999986 48899999986432 223568889999999999999999999884 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999753 3478889999999999999999999999999999999999999999999999975421
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.............++.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--- 226 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR--- 226 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc---
Confidence 2345679999999999999999999999999999999999999998766555444433221110000000000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...-..+.+++.+|++.+|++||++.|+++.
T Consensus 227 -------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 -------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001234578899999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=330.32 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=201.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|+..+.||+|+||.||++... +|..||+|.+.... ...+.+.+|++++++++||||+++++++..+ +..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEe
Confidence 357999999999999999999986 57889999886432 2236789999999999999999999998854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 83 EHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999753 2478899999999999999999986 699999999999999999999999999875421
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc--ccccCc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT--ELLEPG 1035 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~d~~ 1035 (1099)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......++...+......+... ....+.
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 12234578999999999999899999999999999999999999997655544433222111100000 000000
Q ss_pred ----------------------------ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1036 ----------------------------LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1036 ----------------------------~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
.....+.......-..+.+++.+||+.||++|||+.|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000012356899999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.01 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=204.0
Q ss_pred HhccccccccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|+..+.||+|+||.||+|.+.. ...|++|.+..... ..+.|.+|+.++++++||||+++++++... ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceE
Confidence 3578899999999999999998753 46799998865432 235788999999999999999999998754 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++.... ..+++..+..++.|++.|++|||+.+|+||||||+||++++++.++++|||+++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 82 IITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999997522 258999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. ..........++..|+|||.+.+..++.++||||||+++|||++ |..||...........+....... .
T Consensus 158 ~~-~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----~--- 229 (266)
T cd05033 158 DS-EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----P--- 229 (266)
T ss_pred cc-ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----C---
Confidence 11 11112223345678999999998899999999999999999998 999997665555444433211100 0
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+.... ..+.+++.+||+.+|++||++.||++.|+++
T Consensus 230 ------~~~~~----~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ------PMDCP----SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00001 1246899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.85 Aligned_cols=238 Identities=21% Similarity=0.314 Sum_probs=189.5
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||+|+||.||+|... +++.||+|.+... ......+.+|++++++++||||+++++++.. +...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 699999999999986 4788999988532 2234567889999999999999999999874 456799999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~ 151 (312)
T cd05585 80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK---DDDKTN 151 (312)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---CCCccc
Confidence 99999752 3478999999999999999999999999999999999999999999999999975321 112234
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.. ... .+.. . ..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~~~--~~~~-------~-~~ 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPL--RFPD-------G-FD 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----CCC--CCCC-------c-CC
Confidence 56799999999999999999999999999999999999999976655443333221 110 0000 0 00
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCC---HHHHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPT---MSDIVF 1075 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs---~~evl~ 1075 (1099)
..+.+++.+||+.||++||+ +.|++.
T Consensus 218 ----~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 ----RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ----HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 12357899999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=326.83 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=198.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|...++||+|+||.||+|..+ ++..||+|.+.... .....+.+|++++++++||||+++++++..+ ...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEe
Confidence 46889999999999999999876 57899999885432 2235678999999999999999999998754 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ |+|.+++... ...+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--- 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--- 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC---
Confidence 997 5999988643 23478889999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc---ccccc-C
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---TELLE-P 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~d-~ 1034 (1099)
.........++..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+....... ....+ .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1122344578999999998875 56899999999999999999999999876655554444433221100 00000 0
Q ss_pred cccCC-CCC--ChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLEL-DPE--SSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~-~~~--~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+... .+. ...+. .-..+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000 00000 0123468999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=319.41 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=204.2
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|.+.+.||+|+||.||+|.+.++..+++|.+.......+.+.+|++++++++|||++++++++.. ...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcCC
Confidence 5688889999999999999998877789999987666666789999999999999999999998753 34689999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.++++.. ....+++..+..++.|++.|++|||+.|++||||||+||++++++.++++|||+++...... ..
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~--~~ 158 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE--YT 158 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc--cc
Confidence 99999999752 23447899999999999999999999999999999999999999999999999997542211 11
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||+..+..++.++||||||+++|||++ |+.||....+.+...++..... . ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----~-~~~-------- 225 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR----M-PCP-------- 225 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----C-CCC--------
Confidence 1223346778999999988899999999999999999999 8999976655444433322100 0 000
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
... -..+.+++.+||+.||++||++++|+++|++
T Consensus 226 ~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGC----PESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccc----CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1234678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=324.71 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=198.7
Q ss_pred hccccccccccccceeEEEEEEC--CceEEEEEECCCCCc---cHHHHHHHHHHhhhc---cCCcceEEeeEEec----C
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN--DGMVLSIRRLPDGSL---DENLFRKEAEFLGKV---RHRNLTVLRGYYAG----A 870 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----~ 870 (1099)
++|++.+.||+|+||.||+|... ++..||+|.+..... ....+.+|+++++++ +||||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 468899998854322 234567788877766 69999999998852 3
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345689999996 6999998753 224488999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
++.... ........||..|+|||++.+..++.++||||+||++|||++|+.||....+.+....+..........+
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccC----CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 975421 1233456789999999999888999999999999999999999999988776665555544322111000
Q ss_pred c------ccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1031 L------LEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1031 ~------~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ....+.... ....+. -..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000 000000 012357999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.34 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=201.0
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---c------HHHHHHHHHHhhhc-cCCcceEEeeEEec
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---D------ENLFRKEAEFLGKV-RHRNLTVLRGYYAG 869 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~------~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 869 (1099)
--..|+..+++|+|..++|-++..+ +|...|+|++..... . .+.-.+|+.+++++ .||+|+.+.++|.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye- 93 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE- 93 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-
Confidence 3456888999999999999988765 477788888743211 1 14466899999998 6999999999998
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
.+.+.++|+|.|+.|.|.|++... ..++++...+|+.|+.+|++|||...|||||+||+|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 456678999999999999999753 448899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccC------CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG------ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
+|.... ........+||++|.|||.+... .|+..+|+||.|||+|.++.|.+||+....--+. +.+
T Consensus 169 Fa~~l~----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML----R~I 240 (411)
T KOG0599|consen 169 FACQLE----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML----RMI 240 (411)
T ss_pred eeeccC----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH----HHH
Confidence 998763 34566778999999999988632 4788999999999999999999999754332222 222
Q ss_pred hhccccccccCcccCCCCCChhHHHHH-HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFL-LGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..|+ +...+.+|.++. ...++|.+|++.||.+|.|++|+++.
T Consensus 241 meGk-----------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGK-----------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcc-----------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 3332 122333444332 24579999999999999999999863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.08 Aligned_cols=245 Identities=21% Similarity=0.287 Sum_probs=197.8
Q ss_pred HhccccccccccccceeEEEEEECC--ceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND--GMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|+..+.||+|+||.||+|.++. +..||+|.+... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEE
Confidence 3468999999999999999998653 368999988532 22345688999999999999999999999854 5569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999999753 347889999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.. +.. .+++
T Consensus 183 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----~~~--~~p~- 249 (340)
T PTZ00426 183 T------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE----GII--YFPK- 249 (340)
T ss_pred C------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc----CCC--CCCC-
Confidence 1 12345799999999999988899999999999999999999999987655444443322 111 0111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
. .. ..+.+++.+|++.||++|+ +++|+++.
T Consensus 250 ------~-~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 ------F-LD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------C-CC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 01 1235789999999999995 88888764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=333.23 Aligned_cols=266 Identities=23% Similarity=0.354 Sum_probs=196.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCC----CceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 875 (1099)
+|++.++||+|+||.||+|... +|..||+|++... ......+.+|++++++++||||+++++++.... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999875 5889999998642 223356889999999999999999999886332 2368
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6899988642 348899999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc-------
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG------- 1026 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 1026 (1099)
............+||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 22222222345679999999999865 578999999999999999999999997655433332222211100
Q ss_pred ----cccccccCcccCCCCCChh--HH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 ----QITELLEPGLLELDPESSE--WE-EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 ----~~~~~~d~~~~~~~~~~~~--~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+... .+....+.... .. .-..+.+++.+||+.||++||+++|+++.
T Consensus 235 i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHH-hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 00000000000 00 00134589999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=325.22 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=207.2
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
++|...+.||+|+||.||+|... ++..+++|.+...... .+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-CceE
Confidence 46888899999999999999753 3567889998654433 36789999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 876 LVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
+||||+++++|.+++..... .....+++..++.++.||+.|++|||+.+|+||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999975321 1223589999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+.
T Consensus 164 l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--- 239 (291)
T cd05094 164 IGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT--- 239 (291)
T ss_pred ECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---
Confidence 99999997542211 1122334567889999999998899999999999999999999 999997766555443322
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.+...... ...+ ..+.+++.+||+++|++||++.+|+++|+++..
T Consensus 240 -~~~~~~~~---------~~~~----~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 -QGRVLERP---------RVCP----KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -CCCCCCCC---------ccCC----HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111100 0011 234689999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=330.81 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=208.4
Q ss_pred ccccccccccccceeEEEEEECC--c--eEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND--G--MVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
+....++||+|+||+|++|.|.. | ..||||.+..+... ..+|.+|+.+|.+++|||+|++||++.+. ...+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhHH
Confidence 44556789999999999999863 3 56999999776554 47899999999999999999999999853 34799
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||+++.|+|.+.|++ .....+.......++.|||.||.||.+++.||||+.++|+++.....+||+|||+.+-...+
T Consensus 189 ~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999986 23355778888999999999999999999999999999999999999999999999987555
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.............+.|+|||.+....++.++|||+|||++|||+| |+.||.+...-++.+.+.+..+ +
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-----------L 334 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-----------L 334 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-----------C
Confidence 554444555667889999999999999999999999999999999 8899988777666555442111 1
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..+..+. + ++.+++..||..+|.+||||..|.+.+-
T Consensus 335 --pRPk~cs-e---dIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 335 --PRPKYCS-E---DIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred --CCCCCCh-H---HHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1112222 2 2357899999999999999999985543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=324.38 Aligned_cols=264 Identities=24% Similarity=0.423 Sum_probs=207.9
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
..+|.+.+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Ccc
Confidence 35688899999999999999974 235678999886543 2346799999999999999999999999854 456
Q ss_pred EEEEeecCCCCHHHHHhhhcc--------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 875 LLVYDYMPNGNLGTLLQEASH--------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.|++||||||+||++++++.+|++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 999999999999999975331 122358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhh
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
|||+++..... ..........++..|+|||++.+..++.++||||||++++||++ |..||......+....+..
T Consensus 163 dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---- 237 (288)
T cd05093 163 DFGMSRDVYST-DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---- 237 (288)
T ss_pred cCCccccccCC-ceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence 99999754221 11122233456788999999998889999999999999999998 9999876655444433322
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+..... +.... ..+.+++.+||+.||.+|||+.|+.+.|+.+....
T Consensus 238 ~~~~~~---------~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 GRVLQR---------PRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCcCCC---------CCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 211110 01111 12468999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.13 Aligned_cols=260 Identities=21% Similarity=0.371 Sum_probs=202.7
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.+++|+..+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence 4678999999999999999999764 246799998854322 335688999999999999999999998744 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
..++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.+++||||||+||++++++.++++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 569999999999999999753221 123467889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
||+++...... .........++..|+|||++.++.++.++|||||||++|||++ |..||.....+...+.+.. .
T Consensus 163 fg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~ 237 (277)
T cd05062 163 FGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----G 237 (277)
T ss_pred CCCccccCCcc-eeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C
Confidence 99987542111 1111223456788999999998889999999999999999999 7889876655444433222 1
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
..... . .... ..+.+++.+||+.+|++||++.|+++.|++
T Consensus 238 ~~~~~--------~-~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDK--------P-DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCC--------C-CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110 0 0111 134679999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=318.53 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=195.4
Q ss_pred ccccccceeEEEEEEC---CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 810 VLSRTRYGLVFKACYN---DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
.||+|+||.||+|.++ ++..+|+|.+.....+ .+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence 5899999999999763 5788999998644322 3678899999999999999999999863 345899999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++... ..+++..+..++.|++.|++|+|+.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999999642 24789999999999999999999999999999999999999999999999999765322111111
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+..+.+.. +...+. +.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~----~~~~~~---------~~ 221 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES----GERMEC---------PQ 221 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC----CCCCCC---------CC
Confidence 223345678999999988889999999999999999998 9999976655544444332 111110 01
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
... ..+.+++.+||+.||++||++.+|++.|++.
T Consensus 222 ~~~----~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCP----PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCC----HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 1245899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.20 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=197.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|++.+.||+|+||.||+|+.+ ++..||+|++.... ...+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 36889999999999999999986 57889999986432 234668899999999999999999999875 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++++.+..+... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 153 (287)
T cd07848 80 EYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG- 153 (287)
T ss_pred ecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-
Confidence 99998766544331 234888999999999999999999999999999999999999999999999999865221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh------------c
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK------------G 1026 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~------------~ 1026 (1099)
.........|+..|+|||++.+..++.++||||+||++|||++|+.||......+....+...... .
T Consensus 154 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 -SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred -ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 112233457899999999999889999999999999999999999999865543332222221110 0
Q ss_pred cccccccCcccCCCCCChhHH----HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1027 QITELLEPGLLELDPESSEWE----EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~----~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.......+... .+...... .-..+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVN--HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCccc--CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 00000000 0123578999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.30 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=201.6
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|...+.||+|+||.||+|... |..|++|.+... ...+.+.+|+.++++++|+|++++++++.......++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 47888999999999999999876 777899988643 3456789999999999999999999987656666799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ....+++..+..++.|++.||+|||+.||+||||||+||++++++.+|++|||+++.....
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----- 155 (256)
T cd05082 84 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 155 (256)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-----
Confidence 99999999753 2234889999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+... ..... .
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~-~-------- 221 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----YKMDA-P-------- 221 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----CCCCC-C--------
Confidence 122345678999999998889999999999999999998 99998765554444433221 10000 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+ ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 ~~~~----~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCP----PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0001 1245789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.56 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=198.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.|+..++||+|+||.||++... +++.||+|.+..... ....+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence 3778899999999999999875 588999999864322 234577899999999999999999998754 4679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++... ....+++..+..++.|++.|++|||+.+|+||||||+||++++++.++|+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~-- 154 (285)
T cd05605 80 TLMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-- 154 (285)
T ss_pred eccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence 999999999988642 224589999999999999999999999999999999999999999999999999875421
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........|+..|+|||++.+..++.++||||+||++|||++|+.||...........+...+..... ...+.+
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~-- 228 (285)
T cd05605 155 --GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE--EYSEKF-- 228 (285)
T ss_pred --CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--ccCccc--
Confidence 11223457899999999999889999999999999999999999999875544333333332221110 000000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
-..+.+++.+||+.||++|| +++++++.
T Consensus 229 ----------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 229 ----------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----------CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11235789999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=342.08 Aligned_cols=387 Identities=28% Similarity=0.433 Sum_probs=318.6
Q ss_pred ccccccceEEccCCccCc-ccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCccccccee
Q 047739 87 SNLRMLRKLSLRSNSFNG-TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYF 165 (1099)
Q Consensus 87 ~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L 165 (1099)
|=|++.+-.|+|+|.|+| .+|.....++++++|-|....+. .+|..++.|.+|++|.+++|+|.
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-------------- 68 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-------------- 68 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH--------------
Confidence 457788999999999995 58999999999999999999987 79999999999999888888876
Q ss_pred eCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEE
Q 047739 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV 245 (1099)
Q Consensus 166 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 245 (1099)
.+-..++.|+.|+.+++.+|++.. ..||+.|-++..|+.|+|++|+++ ..|..+.+-+++-+|
T Consensus 69 ---------~vhGELs~Lp~LRsv~~R~N~LKn-------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVL 131 (1255)
T KOG0444|consen 69 ---------SVHGELSDLPRLRSVIVRDNNLKN-------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVL 131 (1255)
T ss_pred ---------hhhhhhccchhhHHHhhhcccccc-------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEE
Confidence 344557788999999999999873 358999999999999999999998 678888888999999
Q ss_pred EcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeC
Q 047739 246 SLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDV 325 (1099)
Q Consensus 246 ~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 325 (1099)
+||+|+|. +||..+|.++ ..|-.||||+|++.. +|..+.++.+|++|+|
T Consensus 132 NLS~N~Ie-tIPn~lfinL-----------------------------tDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 132 NLSYNNIE-TIPNSLFINL-----------------------------TDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKL 180 (1255)
T ss_pred EcccCccc-cCCchHHHhh-----------------------------HhHhhhccccchhhh-cCHHHHHHhhhhhhhc
Confidence 99999997 7888877763 346778888888884 5556888899999999
Q ss_pred CCCccccCchhhhCCCCCCCEEEccCCccC-ccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccc
Q 047739 326 SGNSISGKIPAQIGGLWRLEELKMANNSFG-GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG 404 (1099)
Q Consensus 326 s~N~i~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 404 (1099)
|+|.+.-.--..+..+++|+.|.+++.+-+ .-+|.++..+.+|..+|||.|.+. .+|+.+.++++|+.|+|++|+|+.
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 999876333334556778888999887643 247888999999999999999998 889999999999999999999983
Q ss_pred cCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCc-cccCcccCCCCcccEEEccCCcCCCcCCCCCC
Q 047739 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS-GEVPASIGNLSQLMVFNLSGNAFSGRIPASLG 483 (1099)
Q Consensus 405 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 483 (1099)
..-......+|++|+|++|+++ .+|.+++.+++|+.|.+.+|+++ .-+|+.++.+.+|+++..++|.+. ..|+.++
T Consensus 260 -L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglc 336 (1255)
T KOG0444|consen 260 -LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLC 336 (1255)
T ss_pred -eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhh
Confidence 3444556678999999999999 78999999999999999999886 347889999999999999999998 8899999
Q ss_pred CCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecc
Q 047739 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541 (1099)
Q Consensus 484 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 541 (1099)
.|.+|+.|.|++|++- .+|..+.-++.|+.|++.+|.--...|..-..-++|++-++
T Consensus 337 RC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 337 RCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred hhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 9999999999999987 78899999999999999988665344332222244554333
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.76 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=201.6
Q ss_pred hccccccccccccceeEEEEEE-----CCceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.+|+..+.||+|+||.||+|.+ .++..|++|.+...... .+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceE
Confidence 4678889999999999999985 24678999998643322 35788999999999999999999998754 4569
Q ss_pred EEEeecCCCCHHHHHhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 876 LVYDYMPNGNLGTLLQEASH------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
+||||+++|+|.+++..... .....+++.....++.|++.||+|||+.+|+||||||+||++++++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 99999999999999863221 012347889999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
|++|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.........+.+..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 241 (283)
T cd05090 164 KISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK- 241 (283)
T ss_pred EeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 9999999976432211 112233456778999999988889999999999999999998 9999976555444433322
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
..... . +...+ ..+.+++.+||+.||++||++.+|.+.|..
T Consensus 242 ---~~~~~-~--------~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 ---RQLLP-C--------SEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---CCcCC-C--------CCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11110 0 01111 134578899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=331.15 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=192.3
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
+.||+|+||.||++... +|..||+|.+... ......+.+|++++++++||||+++++++... +..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence 46999999999999875 5889999998542 22335677899999999999999999998854 556999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.... ....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~---~~~~ 151 (323)
T cd05595 80 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC---CCCc
Confidence 9999888642 3488999999999999999999999999999999999999999999999999875321 1122
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1043 (1099)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ...++ . .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p----~-------~- 217 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFP----R-------T- 217 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCC----C-------C-
Confidence 33457999999999999999999999999999999999999999766555444333211 00000 0 0
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1044 SEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1044 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
.. ..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CC----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 01 1235789999999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=332.14 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=202.3
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.++.++ +||||+++++++...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45799999999999999999974 3468899999865332 235688999999999 68999999999876666
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC--------------------------------------------------------
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-------------------------------------------------------- 896 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 896 (1099)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998742110
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccC
Q 047739 897 ------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970 (1099)
Q Consensus 897 ------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt 970 (1099)
....+++..+..++.|+++|++|||+.+|+||||||+||++++++.+|++|||+++...... .........++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~ 244 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc-chhhcCCCCCC
Confidence 01246888899999999999999999999999999999999999999999999987642211 11122233466
Q ss_pred ccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHH
Q 047739 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049 (1099)
Q Consensus 971 ~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 1049 (1099)
..|+|||++.+..++.++||||||+++|||++ |..||......... ......+..... + ....
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~--~-------~~~~---- 308 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRRLKEGTRMRA--P-------DYTT---- 308 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH---HHHHhccCCCCC--C-------CCCC----
Confidence 78999999988899999999999999999997 99998654332211 111111111000 0 0001
Q ss_pred HHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1050 LLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1050 ~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+.+++.+||+.||++||++.||++.|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 124688999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.31 Aligned_cols=258 Identities=19% Similarity=0.318 Sum_probs=198.2
Q ss_pred cccccccccccceeEEEEEECCc---eEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecC-----CCc
Q 047739 805 FDEENVLSRTRYGLVFKACYNDG---MVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PDL 873 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 873 (1099)
|.+.++||+|+||.||+|.+.+. ..||+|.+.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997643 368999886532 2346788999999999999999999987532 123
Q ss_pred eEEEEeecCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
.++||||+++|+|.+++..... .....+++.....++.|++.|++|||+.+|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 5899999999999998854322 223458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
...... .........++..|+|||+..+..++.++||||||+++|||++ |+.||......+....+. .+.....
T Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~~ 235 (272)
T cd05075 161 KIYNGD-YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR----QGNRLKQ 235 (272)
T ss_pred ccCccc-ceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----cCCCCCC
Confidence 652211 1111223356778999999999899999999999999999999 889987655444333322 2211100
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.+. .. ..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 --------~~~-~~----~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 --------PPD-CL----DGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCC-CC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 01 1245899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.19 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=206.2
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|...+.||+|+||.||+|.+.++..+++|.+.......+.+.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeC
Confidence 45788999999999999999998888889999987665566789999999999999999999999875 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.+. .....++..+..++.|++.|++|||+.|++||||||+||+++.++.+|++|||.+...... ..
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~~ 157 (260)
T cd05073 83 AKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--EY 157 (260)
T ss_pred CCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC--Cc
Confidence 999999999752 2345788999999999999999999999999999999999999999999999998754221 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++....++.++||||||++++|+++ |+.||......+...++... .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~--------- 224 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----YRMPR--------- 224 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----CCCCC---------
Confidence 12223456678999999998889999999999999999999 99999766555444433221 10000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+... -..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccC----CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000 1234688999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=331.20 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=192.9
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
++||+|+||.||++... +|..||+|.+... ......+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 46899999999999875 5889999998643 2233567889999999999999999999874 4556999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++... ..+++.....++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ....
T Consensus 80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~---~~~~ 151 (328)
T cd05593 80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT---DAAT 151 (328)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC---cccc
Confidence 9999888642 3488999999999999999999999999999999999999999999999999875321 1122
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1043 (1099)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.. ... .+.. .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~----~~~--~~p~-------~- 217 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EDI--KFPR-------T- 217 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc----CCc--cCCC-------C-
Confidence 3345799999999999988999999999999999999999999976655443332211 110 0000 0
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1044 SEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1044 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
.. ..+.+++.+|++.||++|| ++.|+++.
T Consensus 218 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LS----ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 1245789999999999997 88988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.73 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=201.3
Q ss_pred hccccccccccccceeEEEEEEC-Cce----EEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGM----VLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.+|+..+.||+|+||.||+|.+. ++. .+++|.+..... ...++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence 46888899999999999999874 233 478888754322 23567788889999999999999999863 3358
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+++||||||+||++++++.+|++|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999999752 2348999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
+.. .........++..|+|||++.++.++.++||||||+++|||++ |+.||.........+.+. .+... ..+
T Consensus 161 ~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~~~~--~~~ 233 (279)
T cd05111 161 PDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE----KGERL--AQP 233 (279)
T ss_pred CCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CCCcC--CCC
Confidence 221 1122334567789999999998899999999999999999998 999997655444333322 11111 001
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
..+. ..+.+++.+||+.+|++|||+.|+++.|+++...|
T Consensus 234 -------~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 -------QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -------CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111 12356888999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.12 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=199.0
Q ss_pred cccccccceeEEEEEECC--c--eEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND--G--MVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|++|.||+|.+.+ + ..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999998753 2 3699999976554 34678999999999999999999999885 56799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++..... ..+++...+.++.|++.||+|||+.+++||||||+||+++.++.+|++|||+++..........
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999975321 4589999999999999999999999999999999999999999999999999986532222112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||++.+..++.++||||||++++||++ |+.||......+....+....... . . +
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~--~-------~ 223 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL---E--R-------P 223 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---C--C-------C
Confidence 2224567889999999998899999999999999999999 999997665555444333211000 0 0 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... -..+.+++.+||+.+|++||++.|+++.|.
T Consensus 224 ~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EAC----PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccC----CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 100 123467899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.18 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=207.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|.+.++||+|+||.||+|..+++..|++|.+.......+.+.+|++++++++|+||+++++++... ...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEEEecc
Confidence 567899999999999999999988888999999987777778899999999999999999999998743 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++... ....+++..+..++.|++.|++|||+.+++|+||||+||+++.++.+|++|||.++..... ..
T Consensus 84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (261)
T cd05034 84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD--EY 158 (261)
T ss_pred CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch--hh
Confidence 999999999752 2345899999999999999999999999999999999999999999999999998765221 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||.+.+..++.++||||+|++++||++ |+.||.........+.+...... ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----~~-------- 225 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-----PR-------- 225 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----CC--------
Confidence 11122335678999999998889999999999999999998 99999765554444433221100 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+...+ ..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 ~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCP----EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011 134578999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.17 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=203.5
Q ss_pred ccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
+|.+.+.||+|+||.||+|... ....+++|.+..... ..+.+.+|++++++++||||+++++.+..+ ...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcE
Confidence 4677899999999999999863 235788888865432 235788999999999999999999998854 4469
Q ss_pred EEEeecCCCCHHHHHhhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEE
Q 047739 876 LVYDYMPNGNLGTLLQEASH-------------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL 936 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIl 936 (1099)
+||||+.+|+|.+++..... .....+++..++.++.|++.|++|||+.+|+||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 99999999999999875321 12245889999999999999999999999999999999999
Q ss_pred ECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhH
Q 047739 937 FDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDI 1015 (1099)
Q Consensus 937 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~ 1015 (1099)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||++++||++ |..||.....+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999754222111 12223456778999999988889999999999999999999 9999977665555
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.+.+...... . .+.... ..+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 239 ~~~~~~~~~~----~---------~~~~~~----~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 FNLLKTGYRM----E---------RPENCS----EEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHhCCCCC----C---------CCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 4443321110 0 001111 134578999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.83 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=208.3
Q ss_pred HhccccccccccccceeEEEEEECC-----ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|...++||+|+||.||+|.+.+ +..|++|.+.... ...+.+.+|+.++++++||||+++++++...+...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5678999999999999999999876 7889999886432 22466889999999999999999999988666677
Q ss_pred EEEEeecCCCCHHHHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
++++||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+++||||||+||++++++.+|++|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999999764221 1256899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+...+... ........++..|+|||++.+..++.++||||||+++||+++ |+.||......+...++.... ...
T Consensus 165 ~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~- 239 (280)
T cd05043 165 RDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLA- 239 (280)
T ss_pred ccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC---CCC-
Confidence 85532211 111123346778999999988889999999999999999999 999997655544443333210 000
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
. +...+ ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 240 ----~-----~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 240 ----Q-----PINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ----C-----CCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 00001 12457999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.21 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=198.8
Q ss_pred cccccccccccceeEEEEEE-----CCceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEE
Q 047739 805 FDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLL 876 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~l 876 (1099)
|...+.||+|+||+||++.+ .++..||+|.+..... ..+.+.+|++++++++||||+++++++... ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988764 3577899999865432 356788999999999999999999988644 345689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++.. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+|++|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999964 2389999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh---hhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL---QKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~---~~~~~~~~~d 1033 (1099)
............++..|+|||++.+..++.++||||||++++||++|..||...... ......... ......+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 111111122334567799999998888999999999999999999999998643321 111100000 0001111111
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.......+... ...+.+++..||+.+|++||++++|+++|+++.
T Consensus 239 ~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNC----PQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCC----CHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11110001111 123467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=329.50 Aligned_cols=240 Identities=23% Similarity=0.370 Sum_probs=191.2
Q ss_pred cccccccceeEEEEEEC----CceEEEEEECCCCC-----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYN----DGMVLSIRRLPDGS-----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.||+|+||.||+++.. .++.||+|.+.... .....+.+|++++++++||||+++++++..+ +..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEe
Confidence 67999999999999863 57899999985421 2235678899999999999999999998854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... ..+.+.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (323)
T cd05584 81 YLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-- 153 (323)
T ss_pred CCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence 99999999999753 24678888889999999999999999999999999999999999999999998743211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........||..|+|||++.+..++.++||||+||++|||++|+.||...........+.. +.. .+.+
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~----~~~--~~~~----- 221 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK----GKL--NLPP----- 221 (323)
T ss_pred -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCC--CCCC-----
Confidence 1223345799999999999988899999999999999999999999987655443333222 111 0111
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
.. . ..+.+++.+||+.||++|| ++.++++
T Consensus 222 --~~-~----~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 --YL-T----PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CC-C----HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 10 0 1235789999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.20 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=197.5
Q ss_pred cccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence 479999999999998643 26899999876554 45678999999999999999999998763 34689999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.... .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||+++..........
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999997532 478999999999999999999999999999999999999999999999999976532221111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+... ..... +
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----~~~~~---------~ 220 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----ERLPR---------P 220 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC----CcCCC---------C
Confidence 1222334568999999998899999999999999999998 99999766555544443321 10000 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.... ..+.+++.+||+.+|++||++.++++.|+++
T Consensus 221 ~~~~----~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECP----QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0011 2345899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.21 Aligned_cols=257 Identities=27% Similarity=0.478 Sum_probs=201.9
Q ss_pred HhccccccccccccceeEEEEEECC-c---eEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-G---MVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|+..+.||+|+||.||+|.... + ..+++|.+.... ...+.+..|++++++++||||+++.+++... +..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcE
Confidence 3468888999999999999998752 2 479999986542 2346788999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++++|.+++... ...+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 83 IITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999999742 2348899999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
..............+..|+|||++....++.++||||||+++|||++ |+.||...........+.... .. +
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~-----~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RL-----P 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CC-----C
Confidence 22211111122234567999999998889999999999999999997 999997665544444333210 00 0
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. +.... ..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~-----~~~~~----~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 A-----PMDCP----SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-----CCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00011 2346899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=328.02 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=188.0
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|... +++.||+|.+.... ...+.+..|.+++... +||||+++++++.. ....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999976 47889999885421 2234456677777654 89999999999874 456799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---~~ 151 (316)
T cd05592 80 GGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---EG 151 (316)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---CC
Confidence 99999998753 24788899999999999999999999999999999999999999999999999754211 12
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ... ++..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~----~~~~------- 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPH----FPRW------- 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC----CCCC-------
Confidence 334567999999999999889999999999999999999999999876655544433211 000 1110
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMS-DIV 1074 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1074 (1099)
.. ..+.+++.+||+.||++||++. ++.
T Consensus 219 -~~----~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 -IS----KEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CC----HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01 1235788999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.81 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=205.4
Q ss_pred HHhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 871 (1099)
..++|+..+.||+|+||.||+|.+.+ ...+++|.+..... ....+.+|+++++++ +|+||+++++++...
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 45678899999999999999998743 36899998865432 235688999999999 899999999998854
Q ss_pred CceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~ 940 (1099)
...++||||+++|+|.++++.... .....+++..++.++.|++.|++|||+.+|+||||||+||+++++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 456999999999999999975321 234568999999999999999999999999999999999999999
Q ss_pred CcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHH
Q 047739 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 941 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~ 1019 (1099)
+.+|++|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||......+..+.+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHID-YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCcccccccccccc-ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999998653211 1111223345678999999988889999999999999999998 99999766555444433
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
... .... . +... ...+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 248 ~~~----~~~~--------~-~~~~----~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 248 KEG----YRME--------K-PQNC----TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HcC----CcCC--------C-CCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 221 1000 0 0000 12346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=327.74 Aligned_cols=201 Identities=24% Similarity=0.403 Sum_probs=172.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|+..++||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++..+ +..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence 367999999999999999999986 57889999876432 2236688999999999999999999999854 5679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||+++|+|.+++... ..+++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 156 (333)
T cd06650 83 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (333)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence 999999999999753 2478889999999999999999975 799999999999999999999999999875421
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~ 1013 (1099)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 1123457899999999999888999999999999999999999999765443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=322.87 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=209.3
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 874 (1099)
....|++.+.||+|.||.||++..+. |..+|+|.+..... +.+.+.+|+++|+++. |||||.+++++.+. ...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-DSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-CeE
Confidence 45678889999999999999999875 99999999965433 3468999999999998 99999999999855 456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC----CCcEEEecccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA----DFEAHLSDFGL 950 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~----~~~~kl~DfGl 950 (1099)
++|||++.||.|.+.+.+. .+++.....++.|++.|++|||+.||+|||+||+|+|+.. ++.+|++|||+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999999863 2899999999999999999999999999999999999953 35799999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
|....+ .......+||+.|+|||++....|+..+||||.||++|.|++|..||...........+.. +.. +
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~----~~~-~ 256 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR----GDF-D 256 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc----CCC-C
Confidence 987632 4556778999999999999999999999999999999999999999998776665553332 222 1
Q ss_pred cccCcccCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ....|+.+ ..+.+++..|+..||.+|+|+.++++.
T Consensus 257 f----------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 F----------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C----------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 22223322 223578999999999999999999994
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=332.37 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=202.3
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhcc-CCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVR-HRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 871 (1099)
..++|.+.++||+|+||.||+|.++ .+..||+|++...... .+.+.+|++++.++. ||||+++++++...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 4557888899999999999999864 2468999999754322 356889999999997 99999999999854
Q ss_pred CceEEEEeecCCCCHHHHHhhhcc--------------------------------------------------------
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASH-------------------------------------------------------- 895 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 895 (1099)
...++||||+++|+|.+++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 456999999999999999975421
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC
Q 047739 896 -------------------------------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 896 -------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~ 938 (1099)
.....+++.....++.|++.||+|||+.+|+||||||+||+++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 0112467788899999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 047739 939 ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVK 1017 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~ 1017 (1099)
+++.+|++|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccc-cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999975422111 112233467889999999998889999999999999999998 889987544333221
Q ss_pred HHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1018 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.. +..+.... . +.... ..+.+++.+||+.+|.+||+++||++.|+++
T Consensus 353 ~~---~~~~~~~~--~-------p~~~~----~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 NA---IKRGYRMA--K-------PAHAS----DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH---HHcCCCCC--C-------CCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11111000 0 01111 2346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.62 Aligned_cols=248 Identities=20% Similarity=0.308 Sum_probs=194.5
Q ss_pred ccccccceeEEEEEEC---CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCC
Q 047739 810 VLSRTRYGLVFKACYN---DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|++++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence 3899999999999764 356799999865432 23668999999999999999999999863 3468999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 964 (1099)
+|.+++... ...+++..+.+++.|++.|++|||+.|++||||||+||+++.++.+|++|||+++............
T Consensus 80 ~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999998642 2358999999999999999999999999999999999999999999999999997542221111112
Q ss_pred cccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCC
Q 047739 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043 (1099)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1043 (1099)
....++..|+|||++....++.++||||||+++||+++ |+.||......+....+.. +.... .+ ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~-~~--------~~ 222 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ----GKRLD-CP--------AE 222 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC----CCCCC-CC--------CC
Confidence 22334678999999988889999999999999999996 9999987655544333322 11100 11 11
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1044 ~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.. ..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 ~~----~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CP----PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CC----HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11 2335789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.43 Aligned_cols=265 Identities=21% Similarity=0.309 Sum_probs=196.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++||||+++++++.+. ...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence 467999999999999999999986 588999999864332 234678899999999999999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++ ++|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 155 (303)
T cd07869 83 EYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-- 155 (303)
T ss_pred ECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--
Confidence 9995 6888888642 23478888999999999999999999999999999999999999999999999874321
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-hHHHHHHHHhhhccc--------
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQLQKGQI-------- 1028 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~-------- 1028 (1099)
.........|+..|+|||++.+ ..++.++||||+||++|||++|+.||....+. +....+.........
T Consensus 156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 156 -PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1122344678999999998865 45788999999999999999999999764432 222222221111000
Q ss_pred -cccccCcccCCCCCC--hhHHH---HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1029 -TELLEPGLLELDPES--SEWEE---FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1029 -~~~~d~~~~~~~~~~--~~~~~---~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.......+....+.. ..+.. ...+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000010000000 00000 123468999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=343.08 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=199.2
Q ss_pred ccccccccccccceeEEEEEEC-C-ceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-D-GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.|...+.||+|+||.||+|... + +..|++|.+..... ....+.+|++++++++|||||++++++... +..|+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence 4888999999999999999864 3 57788887644332 335678899999999999999999999854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.++++... .....+++.....++.|++.||+|+|+.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 147 ~~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~-~~ 224 (478)
T PTZ00267 147 GSGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS-VS 224 (478)
T ss_pred CCCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc-cc
Confidence 99999999987532 22345788999999999999999999999999999999999999999999999999865221 11
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.. +.....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----~~~~~~--------- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----GKYDPF--------- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCC---------
Confidence 1223456799999999999999999999999999999999999999976655444333322 111100
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.... ..+.+++.+||+.||++||++++++.
T Consensus 292 ~~~~s----~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVS----SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCC----HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00000 13467899999999999999999864
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.27 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=205.9
Q ss_pred HhccccccccccccceeEEEEEECC-----------------ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-----------------GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTV 862 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~ 862 (1099)
..+|++.+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999997643 2468999986543 23467889999999999999999
Q ss_pred EeeEEecCCCceEEEEeecCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEE
Q 047739 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL 936 (1099)
Q Consensus 863 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIl 936 (1099)
+++++..+ ...++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+|+||||||+||+
T Consensus 84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999855 4569999999999999999764421 1236899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh--CCCCCCCCCchh
Q 047739 937 FDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT--GKRPVMFTQDED 1014 (1099)
Q Consensus 937 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt--g~~P~~~~~~~~ 1014 (1099)
++.++.++++|||+++..... ..........++..|+|||++.+..++.++||||||+++|||++ +..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSS-DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccC-cceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999998754221 11122334556789999999988889999999999999999998 778887655555
Q ss_pred HHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
....+.............+. +...+ ..+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~------~~~~~----~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPR------PPNCP----KDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCCC------ccCCC----HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 44444332221111111100 00000 235689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.17 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=190.4
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||+|+||.||++..+ +|+.||+|.+..... ..+.+..|++++++++||||+++++++.. +...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 699999999999875 589999999854221 23456679999999999999999998874 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++.... ...+++..+..++.|++.|++|||+.||+||||||+||+++.++.++|+|||++..... .....
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~ 152 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD----GKTIT 152 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC----Cceee
Confidence 999886432 23488999999999999999999999999999999999999999999999999875421 11223
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.......... ..... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--------~~ 223 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQN--------FT 223 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-ccccc--------CC
Confidence 4578999999999998889999999999999999999999997543322211222211111110 00000 00
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..+.+++.+||+.||++||+++|+++...
T Consensus 224 ----~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 ----EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ----HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 12468999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.50 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=202.2
Q ss_pred HhccccccccccccceeEEEEEEC----CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|.+.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++..+ +..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccE
Confidence 357888999999999999999864 245799998865332 236789999999999999999999998754 5569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++.++..++.|++.|++|||+.+++||||||+||+++.++.++++|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999999752 2347899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+....+.+... . +
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~-----~ 229 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---L-----P 229 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---C-----C
Confidence 22211111222334568999999998899999999999999999887 9999976655444443332110 0 0
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. +...+ ..+.+++.+|++.+|++||++.++++.|+++
T Consensus 230 ~-----~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 A-----PMDCP----AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----CCCCC----HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00001 1235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=345.31 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=202.7
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCC----
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---- 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 872 (1099)
..++|.+.+.||+|+||.||+|... +|+.||+|.+..... ....+.+|+.++..++|+||+++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4568999999999999999999864 689999999854332 33567889999999999999999877653221
Q ss_pred ---ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 873 ---LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 873 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
..++||||+++|+|.++++.... ....+++.....++.|++.||+|+|+.+|+||||||+||+++.++.+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 25799999999999999975322 33568899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +...
T Consensus 189 ls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----~~~~ 263 (496)
T PTZ00283 189 FSKMYAATV-SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----GRYD 263 (496)
T ss_pred cCeeccccc-cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCC
Confidence 998653211 11223456799999999999999999999999999999999999999976654443333221 1111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. +.+ . .. ..+.+++.+||+.||++||++.++++.
T Consensus 264 ~-~~~-------~-~~----~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 P-LPP-------S-IS----PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-CCC-------C-CC----HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 111 1 11 124578999999999999999999763
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.55 Aligned_cols=259 Identities=23% Similarity=0.358 Sum_probs=205.1
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|.+++ +..|++|.+.... .....+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CC
Confidence 4578899999999999999998753 3689999986543 2235688999999999999999999998855 55
Q ss_pred eEEEEeecCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ-----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
.++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 69999999999999999753321 1234788999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+++...... .........++..|+|||.+.++.++.++||||||+++||+++ |+.||...........+. .+.
T Consensus 164 g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~~ 238 (277)
T cd05032 164 GMTRDIYETD-YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----DGG 238 (277)
T ss_pred ccchhhccCc-ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----cCC
Confidence 9987543221 1122334557889999999988889999999999999999998 999997666555444333 111
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
..... ... -..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ~~~~~---------~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 HLDLP---------ENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCC---------CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11110 001 1234589999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=288.10 Aligned_cols=263 Identities=20% Similarity=0.264 Sum_probs=205.4
Q ss_pred HhccccccccccccceeEEEEE-ECCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEec----CCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKAC-YNDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAG----APDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~~ 875 (1099)
.++|.+.+.+|+|||+.||.++ ..++..+|+|++.-.. .+.+...+|++..++++|||+++++++... .....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 4568899999986544 556788999999999999999999998753 334579
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
++++|...|+|.+.++... .++..+++.+.++|+.+|++||++||+.. ++||||||.||++.+++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998754 34556999999999999999999999987 99999999999999999999999998864
Q ss_pred cC---CCCCCC---ccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 954 TI---PTPAEA---STSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 954 ~~---~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
.. .+.... ..+.....|..|+|||.+. +...++++||||+||++|+|+.|..||+.. .+ +
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~--~ 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQ--Q 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hh--c
Confidence 31 111100 1234557899999999775 456799999999999999999999999631 11 1
Q ss_pred hcccc-ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1025 KGQIT-ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1025 ~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.+.+. ....+.+.. +.... +. ..+.+++.+|++.||.+||++.+++..++.+
T Consensus 248 GgSlaLAv~n~q~s~-P~~~~-ys--e~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 GGSLALAVQNAQISI-PNSSR-YS--EALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCeEEEeeecccccc-CCCCC-cc--HHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 22221 112222211 11111 11 2346899999999999999999999998865
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.68 Aligned_cols=260 Identities=19% Similarity=0.285 Sum_probs=202.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|... ++..||+|.+... ......+.+|++++++++||||+++++++... ...++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEE
Confidence 47889999999999999999875 6889999977432 12235688999999999999999999998854 456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999999999875322 2345788899999999999999999999999999999999999999999999998764211
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........|+..|+|||.+.+..++.++||||+|+++|||++|+.||...... .... ...+.........
T Consensus 160 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~-~~~~~~~~~~~~~----- 229 (267)
T cd08228 160 ---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSL-CQKIEQCDYPPLP----- 229 (267)
T ss_pred ---hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHH-HHHHhcCCCCCCC-----
Confidence 11223456888999999998888999999999999999999999998654321 1111 1111111111100
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
....-..+.+++.+||+.+|++||++.||++.+++++
T Consensus 230 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 -------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0001123468899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.66 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=201.4
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.+|...+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ce
Confidence 35777889999999999999864 2578999999754322 356889999999999999999999998544 46
Q ss_pred EEEEeecCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 875 LLVYDYMPNGNLGTLLQEAS-----------HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
++++||+++++|.+++.... ......+++..+..++.|++.||+|+|+.||+||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 89999999999999985321 1112357888999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
||+|||+++...... .........+++.|+|||++.+..++.++||||+|+++|||++ |..||......+..+.+..
T Consensus 164 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~- 241 (283)
T cd05091 164 KISDLGLFREVYAAD-YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN- 241 (283)
T ss_pred Eecccccccccccch-heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999987642221 1122234456789999999988889999999999999999998 8888876555444433332
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+..... +...+ ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 242 ---~~~~~~---------~~~~~----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 ---RQVLPC---------PDDCP----AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---CCcCCC---------CCCCC----HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111110 01111 123578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.62 Aligned_cols=269 Identities=23% Similarity=0.374 Sum_probs=197.9
Q ss_pred hccccccccccccceeEEEEEEC-----CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEec-CCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-----DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~~ 875 (1099)
..|...+.||+|+||.||+|.++ ++..|++|.+..... ..+.+.+|++++++++||||+++++++.. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999753 478999999865433 34678999999999999999999998753 334568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999743 2348999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc----ccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG----QITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~~~~ 1031 (1099)
.............++..|+|||+..+..++.++||||||++++||++|..|+...... ....+....... .+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHH
Confidence 2211111112233455699999999888999999999999999999998776432211 110000000000 00000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+........+.... ..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCP----AEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000001111 2346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=316.32 Aligned_cols=258 Identities=20% Similarity=0.332 Sum_probs=201.4
Q ss_pred cccccccccccceeEEEEEECC----ceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCC-----
Q 047739 805 FDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD----- 872 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 872 (1099)
|.+.+.||+|+||.||+|.... +..||+|++...... .+.+.+|++.+++++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998743 367999998654322 3568899999999999999999998864432
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++||||+++|+|.+++..... .....+++.....++.|++.||+|||+.+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 35899999999999999865322 12346899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+....... ........++..|+|||++.+..++.++||||||+++|||++ |..||......+..+.+.. +....
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~ 235 (273)
T cd05035 161 KKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH----GNRLK 235 (273)
T ss_pred eecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCC
Confidence 86532211 111222345678999999988889999999999999999999 8899876655444443322 11111
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.. ... ...+.+++.+||+.||++||++.|+++.|+++
T Consensus 236 ~~---------~~~----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QP---------EDC----LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------cCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011 12346889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=338.67 Aligned_cols=265 Identities=18% Similarity=0.332 Sum_probs=196.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC-------CCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-------PDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------~~~ 873 (1099)
.++|...++||+|+||.||+|... .++.||+|++.... ....+|+.++++++|||||++++++... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 467999999999999999999875 57899999885432 3356799999999999999999886421 123
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEecccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDR 952 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~ 952 (1099)
.++||||++ +++.+++.... .....+++.....++.||+.||+|||+.+|+||||||+||+++.++ .+||+|||+|+
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 568999997 57888876432 2345689999999999999999999999999999999999999664 69999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc--
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT-- 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 1029 (1099)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+.+........
T Consensus 220 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 220 NLLAG----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hccCC----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 65221 222345789999999998764 68999999999999999999999998766554444443322211100
Q ss_pred ccccCcccCCC--C-CChhHHH------HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELLEPGLLELD--P-ESSEWEE------FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~d~~~~~~~--~-~~~~~~~------~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+.+.... . ....+.. -..+.+++.+||+.||.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00011110000 0 0001110 124568999999999999999999984
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=313.26 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=190.8
Q ss_pred cccccccceeEEEEEECC---ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYND---GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
+.||+|+||.||+|.+.+ +..+++|.+..... ....+.+|+.++++++||||+++++++.+. ...++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCC
Confidence 368999999999998754 35789998865432 335788999999999999999999998754 456999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++...........++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||+++...... ....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~ 158 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-YYVT 158 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-eeec
Confidence 999999976433333456788888999999999999999999999999999999999999999999987532111 1112
Q ss_pred ccccccCccccCccccccC-------CCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 964 STTAVGTLGYVSPEAALTG-------ETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+....... .......++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 234 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR----EQQLKLPKPR 234 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh----cccCCCCCCc
Confidence 2345678899999988642 35789999999999999996 9999976554443322111 1111111111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.. ....+ .+.+++..|| .+|++|||++||++.|+
T Consensus 235 ~~-----~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LK-----LPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC-----CCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 00111 2346788899 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.07 Aligned_cols=262 Identities=21% Similarity=0.360 Sum_probs=203.8
Q ss_pred HHhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
..++|++.++||+|+||.||+|..++ +..||+|.+..... ....+.+|+.++++++||||+++++++.+. .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-Q 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence 46789999999999999999997542 45899998864432 234678899999999999999999998754 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
..++||||+++|+|.+++...... .....++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 569999999999999999753321 123456778889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
||+++...... .........++..|+|||++.++.++.++|||||||++|||++ |..||.....++..+.+.. +
T Consensus 163 fg~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~ 237 (288)
T cd05061 163 FGMTRDIYETD-YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----G 237 (288)
T ss_pred CCccccccccc-cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----C
Confidence 99987542211 1112223456778999999998899999999999999999998 7889876655444333221 1
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.... .. ...+ ..+.+++.+|++.||++||++.|+++.|+...
T Consensus 238 ~~~~--------~~-~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLD--------QP-DNCP----ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCC--------CC-CCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1110 00 1111 23468999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=316.42 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=201.1
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+..... ....|.+|+.++++++|+||+++++++.+.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-P 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-C
Confidence 4678999999999999999998753 57899998864332 2456899999999999999999999887544 4
Q ss_pred eEEEEeecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---cEEEecc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---EAHLSDF 948 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~~kl~Df 948 (1099)
.++||||+++|+|.++++..+.. ....+++..+.+++.||+.|++|||+.+++||||||+||+++.++ .+|++||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 58999999999999999764321 223589999999999999999999999999999999999998654 5999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+++..... ...........+..|+|||++.+..++.++|||||||++|||++ |+.||.....+.....+... ..
T Consensus 164 g~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~ 239 (277)
T cd05036 164 GMARDIYRA-SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG---GR 239 (277)
T ss_pred ccccccCCc-cceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---Cc
Confidence 999865211 11111223344568999999999999999999999999999997 99999876655443332211 10
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.. .. ...+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 240 -~~-~~--------~~~~----~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 -LD-PP--------KGCP----GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -CC-CC--------CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 00 1111 13457899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=332.65 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=196.0
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|+..++||+|+||.||+|... +++.||+|.+... ....+.+.+|+++++.++||||+++++++.+ +...|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEE
Confidence 3568999999999999999999986 4789999988532 2234568899999999999999999999884 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... .+++.....++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999642 37888899999999999999999999999999999999999999999999997652
Q ss_pred CCCCCCccccccccCccccCccccccCC----CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGE----TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.. ........+||+.|+|||++.+.. ++.++||||+||++|||++|+.||...........+.........+
T Consensus 194 ~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-- 269 (370)
T cd05621 194 ET--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-- 269 (370)
T ss_pred cC--CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC--
Confidence 21 112234567999999999987543 7889999999999999999999998765544443332211110000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
....- -..+.+++.+|+..++.+ ||++.|+++.
T Consensus 270 ---------~~~~~---s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 ---------EDVEI---SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---------CcccC---CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00000 012346778888755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=332.00 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=197.8
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|+..+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+++++.++||||+++++++.+ +...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence 3567999999999999999999876 5889999998532 1233557889999999999999999998874 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... .+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998642 36788888899999999999999999999999999999999999999999997642
Q ss_pred CCCCCCccccccccCccccCccccccC----CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG----ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.. ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.........
T Consensus 194 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--- 268 (370)
T cd05596 194 AN--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--- 268 (370)
T ss_pred CC--CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC---
Confidence 11 11223456799999999988653 4789999999999999999999999876654444333221110000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
+.. ...+ ..+.+++.+|++.+|++ ||++.|+++.
T Consensus 269 --~~~---~~~s------~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 --PDD---IEIS------KQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCc---CCCC------HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0001 13357899999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=333.70 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=193.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.|+..+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+ +...|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence 5788899999999999999875 57899999985432 223568899999999999999999999985 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 81 DYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999999753 247888888999999999999999999999999999999999999999999975321100
Q ss_pred CC--------------------------------------------CccccccccCccccCccccccCCCCCcCchhhHH
Q 047739 959 AE--------------------------------------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994 (1099)
Q Consensus 959 ~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G 994 (1099)
.. .......+||..|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 0011235799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHh--cCCCCCCCCCCHHH
Q 047739 995 IVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALL--CTAPDPIDRPTMSD 1072 (1099)
Q Consensus 995 ~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~--Cl~~dP~~RPs~~e 1072 (1099)
|++|||++|+.||......+....+......... .. . .... ..+.+++.+ |+..+|..||+++|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~-~-----~~~s----~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHI----PP-Q-----VKLS----PEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC----CC-C-----CCCC----HHHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999999876554433322211000000 00 0 0011 122456655 66777777999999
Q ss_pred HHHH
Q 047739 1073 IVFM 1076 (1099)
Q Consensus 1073 vl~~ 1076 (1099)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=336.07 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=200.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++.+ +...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 36889999999999999999986 58899999985432 234668899999999999999999999874 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999999753 34889999999999999999999999999999999999999999999999999765322
Q ss_pred C--------------------------CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC
Q 047739 958 P--------------------------AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011 (1099)
Q Consensus 958 ~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~ 1011 (1099)
. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 1 00112345679999999999999999999999999999999999999998766
Q ss_pred chhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 047739 1012 DEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-MSDIVFM 1076 (1099)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~~ 1076 (1099)
.......+.........+. ...-. ..+.+++.+|++ ||++||+ ++|+++.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~-----------~~~~~---~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYNKIINWKESLRFPP-----------DPPVS---PEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHHhccCCcccCCC-----------CCCCC---HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4443333322111111000 00000 123578889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.90 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=197.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc------cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
++|...+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|++++++++||||+++++++..+ ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-ETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-CeEE
Confidence 46888999999999999999875 588999998754321 124688899999999999999999999855 4679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++++|.+++... ..+++.....++.|++.|++|||+.+|+||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999998753 237888899999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.............++..|+|||++.+..++.++||||+|+++|||++|+.||............... .. ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~- 230 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---PT-NPQLPS- 230 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc---CC-CCCCCc-
Confidence 2211111113456788999999999988999999999999999999999999754433222221111 10 000110
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... ..+.+++.+||+.+|++||++.|+++.
T Consensus 231 -------~~~----~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 -------HVS----PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------cCC----HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 123578999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=331.02 Aligned_cols=211 Identities=23% Similarity=0.343 Sum_probs=176.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+. ...|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEE
Confidence 46889999999999999999876 48899999985422 1235678899999999999999999998854 456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 80 MEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999999752 34889999999999999999999999999999999999999999999999998754211
Q ss_pred CCC--------------------------------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCC
Q 047739 958 PAE--------------------------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005 (1099)
Q Consensus 958 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~ 1005 (1099)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 001124579999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHH
Q 047739 1006 PVMFTQDEDIVKWV 1019 (1099)
Q Consensus 1006 P~~~~~~~~~~~~~ 1019 (1099)
||......+....+
T Consensus 235 Pf~~~~~~~~~~~i 248 (363)
T cd05628 235 PFCSETPQETYKKV 248 (363)
T ss_pred CCCCCCHHHHHHHH
Confidence 99876655544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.93 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=201.4
Q ss_pred HhccccccccccccceeEEEEEECC-c--eEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-G--MVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|++.+.||+|+||.||+|.+++ + ..+++|.+.... ...+.+.+|++++.++ +||||+++++++..+ ...|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCce
Confidence 3468889999999999999998753 4 356777775432 2345788999999999 899999999998754 4569
Q ss_pred EEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 876 LVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
+||||+++|+|.++++..... ....+++..++.++.|++.|++|||+.||+||||||+||+++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 999999999999999764321 123578999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+|||+++... .........++..|+|||++.+..++.++|||||||+++||+| |..||......+..+.+..
T Consensus 165 l~dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-- 238 (303)
T cd05088 165 IADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 238 (303)
T ss_pred eCccccCcccc----hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence 99999986321 1111222334678999999988889999999999999999998 9999976555443332211
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+..... +.... ..+.+++.+||+.+|++||++.++++.++++....
T Consensus 239 --~~~~~~---------~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 239 --GYRLEK---------PLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --CCcCCC---------CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 100000 00011 12468999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.66 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=203.6
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
.+|+..+.||+|+||.||+|.+.++..+++|.+.........+.+|++++++++|||++++++++... ...++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEcCC
Confidence 46788899999999999999988788999999987777778899999999999999999999998754 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ...+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||.++..... ...
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYT 156 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC--ccc
Confidence 99999998742 134789999999999999999999999999999999999999999999999998754211 111
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......++..|+|||++.++.++.++||||+|+++|||++ |+.||.........+.+.... ....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~----- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------RLYKPRL----- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC------CCCCCCC-----
Confidence 1223345678999999998889999999999999999998 999997655544444332110 0011111
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.. ..+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 --~~----~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 --AS----QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CC----HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11 23568999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=329.38 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=193.1
Q ss_pred ccccccccccccceeEEEEEEC----CceEEEEEECCCC-----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCc
Q 047739 804 QFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDG-----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 873 (1099)
+|++.+.||+|+||.||+++.. ++..||+|.+... ....+.+.+|+++++++ +||||+++++++.. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence 4788899999999999999763 5789999988532 12235678899999999 59999999998874 455
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|+|.+++... ..+++.....++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 69999999999999999742 3478899999999999999999999999999999999999999999999999975
Q ss_pred cCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... .........||..|+|||++.+. .++.++|||||||++|||++|+.||...........+...+....
T Consensus 155 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (332)
T cd05614 155 FLSE--EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----- 227 (332)
T ss_pred cccc--CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----
Confidence 4221 12223346799999999998865 478899999999999999999999975433222222322222111
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
+.+. .. .. ..+.+++.+||+.||++|| ++.++++
T Consensus 228 -~~~~---~~-~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 -PPFP---SF-IG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCCC---CC-CC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1110 00 00 1235789999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.95 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=201.0
Q ss_pred hccccccccccccceeEEEEEECC-c--eEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-G--MVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~l 876 (1099)
++|++.++||+|+||.||+|..++ + ..+++|.+.... ...+.+.+|+++++++ +||||+++++++... ...++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceE
Confidence 468889999999999999998754 3 347888776422 2346788999999999 799999999998754 44699
Q ss_pred EEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 877 VYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.||+||||||+||++++++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999999999999753211 1235889999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||++.... ..........+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.....
T Consensus 161 ~dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 161 ADFGLSRGEE----VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred CCcCCCcccc----ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999986421 1111122233567999999988889999999999999999997 9999976655544433221100
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
.. .+.... ..+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 237 ----~~---------~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 237 ----ME---------KPRNCD----DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----CC---------CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 001111 12458999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=330.17 Aligned_cols=261 Identities=18% Similarity=0.231 Sum_probs=194.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+|++.+.||+|+||.||+|... .++.||+|... .+.+.+|++++++++||||+++++++.. ....++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEec
Confidence 357999999999999999999875 57899999753 3457899999999999999999999875 4456899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+. ++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+|+.... ..
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~--~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD--IN 236 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc--cc
Confidence 95 6898888642 3478999999999999999999999999999999999999999999999999975321 11
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-------hhHHHHHHHHhhhc--cc---
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD-------EDIVKWVKKQLQKG--QI--- 1028 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~-------~~~~~~~~~~~~~~--~~--- 1028 (1099)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....... ..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2223346799999999999988999999999999999999999988754221 11111111111000 00
Q ss_pred -----cccc---cCcccCCCCCChhHHH----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 -----TELL---EPGLLELDPESSEWEE----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 -----~~~~---d~~~~~~~~~~~~~~~----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... .............+.. -..+.+++.+|++.||++|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000000001111111 1235679999999999999999999863
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=318.71 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=202.1
Q ss_pred HhccccccccccccceeEEEEEECC---------------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND---------------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLR 864 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~ 864 (1099)
.++|++.+.||+|+||.||++...+ ...||+|.+..... ..+.|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987642 23589999865322 235689999999999999999999
Q ss_pred eEEecCCCceEEEEeecCCCCHHHHHhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE
Q 047739 865 GYYAGAPDLRLLVYDYMPNGNLGTLLQEASH-------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF 937 (1099)
Q Consensus 865 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll 937 (1099)
+++... ...++||||+++++|.+++..... .....+++..++.++.|++.|++|||+.+++||||||+||++
T Consensus 84 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999854 456999999999999999964321 111246889999999999999999999999999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh--CCCCCCCCCchhH
Q 047739 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT--GKRPVMFTQDEDI 1015 (1099)
Q Consensus 938 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt--g~~P~~~~~~~~~ 1015 (1099)
+.++.+|++|||++....... .........++..|+|||+..++.++.++||||||++++||++ +..||.....++.
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999987542211 1112233456788999999998899999999999999999998 6678876655554
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...+.+............ . +...+ ..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----~-~~~~~----~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLS-----Q-TPLCP----SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCC-----C-CCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 444333221111000000 0 00011 235689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=328.34 Aligned_cols=265 Identities=20% Similarity=0.261 Sum_probs=197.7
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP---- 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 871 (1099)
...++|...+.||+|+||.||+|... .|..||+|.+.... .....+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34678999999999999999999875 58899999985432 23456789999999999999999999986432
Q ss_pred -CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 872 -DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 872 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 235899999975 67666642 277888899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ--- 1027 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 1027 (1099)
++.... ........||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+........
T Consensus 170 a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 170 ARTACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cccccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 975421 1223445789999999999999999999999999999999999999986654333222222111000
Q ss_pred -------ccccc--cCcccCC-----------CC-CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 -------ITELL--EPGLLEL-----------DP-ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 -------~~~~~--d~~~~~~-----------~~-~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..... .+..... .. .......-..+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000000 00 00000011234689999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.63 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=187.8
Q ss_pred cccccccceeEEEEEECC---ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYND---GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
+.||+|+||.||+|...+ ...+++|.+..... ....+.+|+++++.++||||+++++++... ...++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCCC
Confidence 368999999999997543 35788888754332 235688999999999999999999998854 456999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.+++...........++.....++.||+.|++|||+.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~ 158 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-YYIT 158 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch-heec
Confidence 999999986443333445778888999999999999999999999999999999999999999999986532111 1111
Q ss_pred ccccccCccccCcccccc-------CCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 964 STTAVGTLGYVSPEAALT-------GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.....++..|+|||+... ..++.++||||+||++|||++ |..||....+.+....+... . ..+...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~ 234 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE---Q-DIKLPKPQ 234 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc---c-CccCCCCc
Confidence 234456778999998643 356889999999999999999 78888765544433322221 1 11111111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.. ... . ....+++..|| .||++||+++||++.|.
T Consensus 235 ~~----~~~-~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LD----LKY-S---DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc----ccC-C---HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 10 000 0 11235677888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=317.05 Aligned_cols=266 Identities=23% Similarity=0.369 Sum_probs=202.2
Q ss_pred HhccccccccccccceeEEEEEEC-----------------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-----------------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTV 862 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~ 862 (1099)
.++|++.+.||+|+||.||++.+. ++..||+|.+..... ..+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998643 235789999865322 3467899999999999999999
Q ss_pred EeeEEecCCCceEEEEeecCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEE
Q 047739 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL 936 (1099)
Q Consensus 863 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIl 936 (1099)
+++++.... ..++||||+++|+|.+++...... ....+++.+...++.|++.|++|||+.+|+||||||+||+
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 84 LLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999988544 469999999999999999764321 1235788899999999999999999999999999999999
Q ss_pred ECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh--CCCCCCCCCchh
Q 047739 937 FDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT--GKRPVMFTQDED 1014 (1099)
Q Consensus 937 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt--g~~P~~~~~~~~ 1014 (1099)
++.++.++++|||+++....... ........++..|+|||+...+.++.++|||||||++|||++ |..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999975422111 111223345678999999888889999999999999999998 778887655544
Q ss_pred HHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
.................. +. +...+ ..+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~-----~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQVYL-PK-----PALCP----DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccccC-CC-----CCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 443322221111100000 00 01111 234689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=337.01 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=203.5
Q ss_pred HhccccccccccccceeEEEEEECCc-eEEEEEECCCC-CccHHHHHHHHHHhhhcc-CCcceEEee-EEec---C--CC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDG-MVLSIRRLPDG-SLDENLFRKEAEFLGKVR-HRNLTVLRG-YYAG---A--PD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~---~--~~ 872 (1099)
..++++.++|.+|||+.||.|....+ ..||+|++... +..-+.+.+|+++|++|+ |||||.+++ .... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34677889999999999999998766 99999998543 334477899999999997 999999999 3221 1 23
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCcEEEecccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
..++.||||++|.|-|++.+... ..+++.++++|++|+++|+++||... |||||||-+|||++.++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 45799999999999999986433 33999999999999999999999875 99999999999999999999999999
Q ss_pred ccccCCCCCCC------ccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 951 DRLTIPTPAEA------STSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 951 a~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
|.-........ ...-....|+.|+|||++. +...++|+||||+||+||-|+....||+....-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 86433222111 1112346899999999874 5678999999999999999999999997543211
Q ss_pred HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1022 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
++...+. +++.. .-...+.+||..||++||.+||++.+|+.++-+++..+-
T Consensus 266 ---------Ilng~Y~-~P~~p---~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 ---------ILNGNYS-FPPFP---NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---------EEecccc-CCCCc---cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1111121 11111 112345689999999999999999999999988775543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.94 Aligned_cols=270 Identities=26% Similarity=0.356 Sum_probs=214.0
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+.|+..+.||+|.-|+||.++.++ +..+|+|++.+.... ..+.+.|.+||+.++||.+..+|+.++ .+++.|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-t~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-TDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-ccceeEE
Confidence 4568888999999999999999876 589999999765433 255778999999999999999999998 5667799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||||+||+|....++ +.+..+++....-+|..++-||+|||..|||+|||||+||||.++|++.++||.++.....
T Consensus 155 ~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999974 5678899999999999999999999999999999999999999999999999988643210
Q ss_pred CC---------------------------------C--------------------CCccccccccCccccCccccccCC
Q 047739 957 TP---------------------------------A--------------------EASTSTTAVGTLGYVSPEAALTGE 983 (1099)
Q Consensus 957 ~~---------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~ 983 (1099)
.+ . ........+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 001224568999999999999999
Q ss_pred CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCC
Q 047739 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPD 1063 (1099)
Q Consensus 984 ~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~d 1063 (1099)
.+.++|+|+|||++|||+.|.-||.+...++....|... . ..+. ... .....+.++|++.+.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--~--------l~Fp---~~~---~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--P--------LKFP---EEP---EVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--C--------CcCC---CCC---cchhHHHHHHHHHhccC
Confidence 999999999999999999999999988877665554432 0 1111 010 12234568999999999
Q ss_pred CCCCCC----HHHHHH---------HhhcccCCCCCCCCCC
Q 047739 1064 PIDRPT----MSDIVF---------MLEGCRVGPDIPSSAD 1091 (1099)
Q Consensus 1064 P~~RPs----~~evl~---------~L~~~~~~~~~~~~~~ 1091 (1099)
|++|-- +.||-+ .|-++..+|.+|....
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred hhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 999998 777654 2444555555554433
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.20 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=199.6
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecC-----CC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGA-----PD 872 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~ 872 (1099)
.+...|+..+.||+|+||.||+|... +++.||+|.+.........+.+|+.+++++ +||||+++++++... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35667888999999999999999875 578999999876655667889999999998 699999999998743 23
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+++|+|.+++... ....+++..+..++.|++.|++|||+.+|+|||+||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 468999999999999999752 23458899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
.... .........|+..|+|||++. ...++.++||||+||++|||++|+.||............. ...
T Consensus 160 ~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~----~~~ 232 (272)
T cd06637 160 QLDR---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----RNP 232 (272)
T ss_pred eccc---ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh----cCC
Confidence 5421 112334567899999999886 3357889999999999999999999996543322211111 110
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+ .... ..+.+++.+||+.+|.+||++.|+++.
T Consensus 233 ~~~~~~--------~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 APRLKS--------KKWS----KKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC--------CCcC----HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 0000 124578999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=321.13 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=205.4
Q ss_pred HHhccccccccccccceeEEEEEEC--------CceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEec
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAG 869 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 869 (1099)
..++|.+.+.||+|+||.||+|.+. ++..|++|...... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567889999999999999999742 34579999886432 2346788999999999 89999999999885
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~ 938 (1099)
. ...++||||+++|+|.+++...... ....+++..+..++.||++||+|||+.||+||||||+||+++
T Consensus 93 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 D-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred C-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 4 4569999999999999999763221 234578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHH
Q 047739 939 ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVK 1017 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~ 1017 (1099)
+++.+|++|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |..||......+...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred CCCcEEECCCccceeccccc-ccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 99999999999998652211 1112233456778999999988889999999999999999998 788887655544444
Q ss_pred HHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1018 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.+.. +..... +.... ..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 251 ~~~~----~~~~~~---------~~~~~----~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 251 LLKE----GHRMDK---------PANCT----NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHc----CCcCCC---------CCCCC----HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 3321 110000 01111 234578999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=316.58 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=203.1
Q ss_pred HhccccccccccccceeEEEEEEC-Cce----EEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGM----VLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|+..++||+|+||.||+|.+. +|. .||+|.+..... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence 457888999999999999999864 343 489998864322 346788999999999999999999998742 35
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
+++|||+++|+|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 8999999999999999742 235889999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.... .........++..|+|||...+..++.++|||||||++|||++ |..||...........+.. +..... .
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~-~ 233 (279)
T cd05109 160 DIDE-TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK----GERLPQ-P 233 (279)
T ss_pred cccc-ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----CCcCCC-C
Confidence 2211 1111222345678999999998899999999999999999998 8999876555444443322 110000 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
.... ..+.+++.+||+.||++||++.|+++.|+++...|
T Consensus 234 --------~~~~----~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 --------PICT----IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --------ccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0011 13457899999999999999999999999886665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=329.04 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=199.4
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-----
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----- 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 871 (1099)
..++|...+.||+|+||.||+|... .++.||+|++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999875 47889999986432 23456788999999999999999999876322
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...|+||||++ ++|.+++.. .+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 34589999996 477777752 2778889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc----
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---- 1027 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1027 (1099)
+.... ........||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+........
T Consensus 174 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCC----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 75421 1223445789999999999999999999999999999999999999987665544444332211100
Q ss_pred ------cccccc--Cc---------ccCC-CC--CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ------ITELLE--PG---------LLEL-DP--ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ------~~~~~d--~~---------~~~~-~~--~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....+. +. +... .+ ..........+.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00 0000 00 00000011245689999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.08 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=204.3
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||.|+||.||+|... |+.|++|.+.......+.+.+|+.++++++|+||+++++++.+ ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEec
Confidence 357888999999999999999876 7889999997665556789999999999999999999999885 55669999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++.... ...+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||.++.....
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---- 155 (256)
T cd05039 83 AKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---- 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence 9999999997532 235899999999999999999999999999999999999999999999999999764211
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.....++..|+|||++..+.++.++||||||++++||++ |+.||......+....+.... .... .
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~-~------- 221 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY----RMEA-P------- 221 (256)
T ss_pred --cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----CCCC-c-------
Confidence 112345678999999988889999999999999999997 999997665554433332210 0000 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+ ..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 222 -~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 -EGCP----PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -cCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0001 2345789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=295.83 Aligned_cols=277 Identities=22% Similarity=0.285 Sum_probs=210.6
Q ss_pred HHHHHHhccccccccccccceeEEEEEECC-----ceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEe
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYA 868 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~ 868 (1099)
+-++....|+....||+|.||.||+|.-++ ...+|+|+++..+. -.....+|+.+++.++|||++.+..++.
T Consensus 18 ~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 18 ERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred hhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 335567789999999999999999996542 23789999865422 1355789999999999999999999998
Q ss_pred cCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC----CcEE
Q 047739 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD----FEAH 944 (1099)
Q Consensus 869 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~----~~~k 944 (1099)
..+...++++||.+. +|...++..+......++...+..|..||+.|+.|||++=|+|||+||.|||+..+ |.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 767778999999986 89999987666666789999999999999999999999999999999999999877 8999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCch---------h
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDE---------D 1014 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~---------~ 1014 (1099)
|+|||+|+.+...-..-......+.|.+|+|||.+.+. .||.++||||.|||+.||+|-++-|.+.... +
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999874332223355678899999999998875 5899999999999999999988877553221 2
Q ss_pred HHHHHHHHhhhccccccccCcccCCCCCChh----------------HHHHH-----HHHHHHHhcCCCCCCCCCCHHHH
Q 047739 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSE----------------WEEFL-----LGVKVALLCTAPDPIDRPTMSDI 1073 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~----------------~~~~~-----~~~~li~~Cl~~dP~~RPs~~ev 1073 (1099)
..++|.+.+..+ .+.-++.+.+++.-... |-+.. ...++..+++..||.+|.|++++
T Consensus 257 Ql~rIf~vLG~P--t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 257 QLDRIFEVLGTP--TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHcCCC--ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 233333332221 12222222221111000 00101 14688899999999999999998
Q ss_pred HHH
Q 047739 1074 VFM 1076 (1099)
Q Consensus 1074 l~~ 1076 (1099)
++.
T Consensus 335 leh 337 (438)
T KOG0666|consen 335 LEH 337 (438)
T ss_pred hcc
Confidence 764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=311.15 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=193.0
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++... ...++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCc
Confidence 46999999999999875 68899999875432 2246789999999999999999999998854 45699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++... ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+|++|||+++..... .......
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 154 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGG 154 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc-cccccCC
Confidence 99999642 234789999999999999999999999999999999999999999999999998754211 1111111
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCCh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 1044 (1099)
...++..|+|||.+.++.++.++||||+|+++|||++ |..||...........+.. .... ... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~----~~~~-~~~--------~~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ----GVRL-PCP--------ELC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc----CCCC-CCc--------ccC
Confidence 2234567999999998889999999999999999998 8888875544333222221 1000 000 111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1045 ~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
+ ..+.+++.+|++.+|++||++.|+.++|+
T Consensus 222 ~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 P----DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred C----HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1 23467999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=323.75 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=207.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-C-----CcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-H-----RNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~~l 876 (1099)
+|++.++||+|+||.|.+|.+. .++.||||+++....--.+-..|+.+|..++ | -|+|++++||.... ..|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-ceee
Confidence 8999999999999999999875 5899999999876655566778999999996 4 48999999998554 4699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC--CcEEEecccccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD--FEAHLSDFGLDRLT 954 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~--~~~kl~DfGla~~~ 954 (1099)
|+|.++ -+|+++++.... ..++......|+.||+.||.+||+.+|||+||||+|||+.+. ..+||+|||.|.+.
T Consensus 266 VfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999996 599999997544 348999999999999999999999999999999999999643 47999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc--------
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG-------- 1026 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-------- 1026 (1099)
.. .....+.+..|+|||++.+..|+.+.||||||||++||++|.+-|.+.+..+....|.+.....
T Consensus 342 ~q------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQ------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CC------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 21 1125677889999999999999999999999999999999988888888777766666543211
Q ss_pred -cccccccC-----------------------------cccCCCC-CChhHH------HHHHHHHHHHhcCCCCCCCCCC
Q 047739 1027 -QITELLEP-----------------------------GLLELDP-ESSEWE------EFLLGVKVALLCTAPDPIDRPT 1069 (1099)
Q Consensus 1027 -~~~~~~d~-----------------------------~~~~~~~-~~~~~~------~~~~~~~li~~Cl~~dP~~RPs 1069 (1099)
.....++. ......+ ....++ +-..+++++.+|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00111111 0000111 222222 2234579999999999999999
Q ss_pred HHHHHHH
Q 047739 1070 MSDIVFM 1076 (1099)
Q Consensus 1070 ~~evl~~ 1076 (1099)
..|+++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.42 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=200.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
...|...+.||.|+||.||-|++. +.++||||++.... ... .++..|++.+++++|||+|.+.|+|.. +...|+
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWL 103 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWL 103 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHH
Confidence 445777889999999999999864 57899999996432 222 568899999999999999999999984 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||||- ||-.|.+.-.+ .++.+.++..|+.+.+.||+|||+.+.||||||+.|||+++.|.||++|||.|.+..
T Consensus 104 VMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 104 VMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 999995 68888887532 458888999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
+.+..+||+.|||||++. .+.|+-|+||||+|++..|+...++|+...........|.+. + .
T Consensus 178 ------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----e-----s 242 (948)
T KOG0577|consen 178 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----E-----S 242 (948)
T ss_pred ------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----C-----C
Confidence 345689999999999986 467999999999999999999999998765443333333221 1 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
| .-...+|.+.. ..++..|++.-|.+|||.++++..
T Consensus 243 P-----tLqs~eWS~~F--~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 P-----TLQSNEWSDYF--RNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C-----CCCCchhHHHH--HHHHHHHHhhCcccCCcHHHHhhc
Confidence 1 11355676654 479999999999999999988764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=330.68 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=197.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|... +|+.||+|.+..... ..+.+.+|+++++.++||||+++++++.+ ....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 36889999999999999999875 588999999864322 34568899999999999999999998875 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ...+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 80 MEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred ECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999999753 234889999999999999999999999999999999999999999999999999765221
Q ss_pred CCCCccccccccCccccCccccc------cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAAL------TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||...........+... ......
T Consensus 156 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~~~~~~ 230 (330)
T cd05601 156 --KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---QRFLKF 230 (330)
T ss_pred --CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---CCccCC
Confidence 111233457999999999986 456789999999999999999999999765554433332221 110000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+ ..... ..+.+++.+|++ +|++||++.++++
T Consensus 231 ~~--------~~~~~---~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 PE--------DPKVS---SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC--------CCCCC---HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00000 123568888997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.54 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=192.3
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|+.++ ++.||+|.+... ....+.+..|.++++.+ +||||+++++++... ...|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence 469999999999998864 789999998643 22235577889998876 799999999999854 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---~~~ 151 (321)
T cd05591 80 GGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---NGV 151 (321)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc---CCc
Confidence 99999988743 3478899999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||......+..+.+... .. ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----~~---~~p~~------ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----DV---LYPVW------ 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CC---CCCCC------
Confidence 234457999999999999889999999999999999999999999877665555443321 10 00000
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRP-------TMSDIVFM 1076 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RP-------s~~evl~~ 1076 (1099)
.. ..+.+++.+|++.||++|| ++.++++.
T Consensus 219 -~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 -LS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01 1245789999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=319.37 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=201.0
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|...+.||+|+||.||+|... .+..||+|.+..... ..+.+.+|+++++++ +||||+++++++... .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-G 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-C
Confidence 457999999999999999999752 346799998865432 235688999999999 799999999998854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+++|+|.++++... ...+++..+..++.|++.|++|||+.+|+|+||||+||+++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 5699999999999999997422 2338999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
...... .........++..|+|||++.+..++.++||||+||++|||++ |..||......+...... ..+... .
T Consensus 190 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~-~ 264 (302)
T cd05055 190 DIMNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI---KEGYRM-A 264 (302)
T ss_pred cccCCC-ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH---HcCCcC-C
Confidence 542211 1112223456788999999999899999999999999999998 999987544332221111 111000 0
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.+...+ ..+.+++.+|++.+|++||++.|+++.|++.
T Consensus 265 --------~~~~~~----~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 --------QPEHAP----AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000001 1346899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=325.79 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=191.5
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHh---hhccCCcceEEeeEEecCCCceEE
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFL---GKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++ ++++||||+++++++.. ....|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 567889999999999999875 58899999985422 2234566676655 56689999999999885 456699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|..+++. ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 v~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 80 VMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999988753 3489999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........+|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ... ...
T Consensus 154 ---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~----~~~--~p~-- 222 (324)
T cd05589 154 ---FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND----EVR--YPR-- 222 (324)
T ss_pred ---CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCC--CCC--
Confidence 122234567999999999999989999999999999999999999999876655444433221 100 000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
... ..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ------~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 ------FLS----REAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------CCC----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001 1235789999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.22 Aligned_cols=239 Identities=25% Similarity=0.383 Sum_probs=189.3
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|...+ +..||+|.+... ....+.+..|..+++.. +||||+++++++.+. +..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence 469999999999999864 788999998543 22335567788888764 899999999998854 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~ 151 (316)
T cd05619 80 GGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---GDA 151 (316)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC---CCC
Confidence 99999999752 3478899999999999999999999999999999999999999999999999874311 112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||......+..+.+... ... .+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~----~~~~~------ 219 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC----YPRWL------ 219 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC----CCccC------
Confidence 233457999999999999989999999999999999999999999876655444433211 000 01000
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMS-DIV 1074 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1074 (1099)
. ..+.+++.+||+.||++||++. ++.
T Consensus 220 ~------~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 T------REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C------HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0 1235789999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=325.35 Aligned_cols=235 Identities=23% Similarity=0.359 Sum_probs=188.5
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|..+ +++.||+|.+... ....+.+..|.++++.. +||||+++++++.. .+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999976 4789999998542 22335677888888876 69999999999875 455699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---~~~ 151 (320)
T cd05590 80 GGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---NGK 151 (320)
T ss_pred CchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc---CCC
Confidence 99999988753 3488999999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.. +.. ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~----~~~---~~~~~------ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEV---VYPTW------ 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCC---CCCCC------
Confidence 23446799999999999988999999999999999999999999987666554444332 111 00000
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
.. ..+.+++.+|++.||++||++
T Consensus 219 -~~----~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 -LS----QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CC----HHHHHHHHHHcccCHHHCCCC
Confidence 00 123578999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.85 Aligned_cols=239 Identities=22% Similarity=0.323 Sum_probs=189.4
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|.++ +|..||+|.+... ....+.+..|.+++... +||||+++++++.. .+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 46999999999999986 4789999998642 22335567788888764 89999999999885 456799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~ 151 (316)
T cd05620 80 GGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDN 151 (316)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc---CCC
Confidence 99999998752 3478889999999999999999999999999999999999999999999999874311 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||...+.....+.+... ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~------------ 217 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPR------------ 217 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCC------------
Confidence 234567999999999999999999999999999999999999999876655444433221 000000
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMS-DIV 1074 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1074 (1099)
... ..+.+++.+||+.||++||++. ++.
T Consensus 218 ~~~----~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WIT----KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC----HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 1235789999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.53 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=192.2
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
+.||+|+||.||++... +|..||+|.+.... .....+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 46999999999999875 58899999985421 223567789999999999999999998874 4556999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
|+|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---~~ 151 (325)
T cd05594 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GA 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---Cc
Confidence 9999988642 348899999999999999999997 79999999999999999999999999998753211 12
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||.....+.....+... ...+. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p----~-------~ 218 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFP----R-------T 218 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCC----C-------C
Confidence 233457999999999999999999999999999999999999999876655444333211 00000 0 0
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
.. ..+.+++.+|++.||++|+ ++.++++.
T Consensus 219 -~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 -LS----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CC----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01 1235789999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=315.07 Aligned_cols=246 Identities=21% Similarity=0.278 Sum_probs=190.1
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||+|+||+||++... +|+.||+|.+...... .+.+..|++++++++||||+++.+++.. ....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 699999999999875 5889999998543221 2457789999999999999999998874 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++.... .....+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 80 L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (280)
T cd05608 80 LRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTK 155 (280)
T ss_pred HHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC---Ccccc
Confidence 998886432 22345899999999999999999999999999999999999999999999999998754221 12233
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...||..|+|||++.+..++.++||||||+++|||++|+.||...........+......... ... ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~-~~~~ 225 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV---------TYP-DKFS 225 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC---------CCc-ccCC
Confidence 457899999999999999999999999999999999999999764432222222222111110 000 0000
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
..+.+++.+||+.||++|| +++++++
T Consensus 226 ----~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 ----PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1245788999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=333.01 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=193.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ +...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 36888999999999999999875 58899999985422 123567889999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 80 MEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999999743 34788888899999999999999999999999999999999999999999998633111
Q ss_pred CCCC--------------------------------------------ccccccccCccccCccccccCCCCCcCchhhH
Q 047739 958 PAEA--------------------------------------------STSTTAVGTLGYVSPEAALTGETTKESDVYSF 993 (1099)
Q Consensus 958 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~ 993 (1099)
.... ......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00012479999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCC---CCH
Q 047739 994 GIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDR---PTM 1070 (1099)
Q Consensus 994 G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Ps~ 1070 (1099)
||++|||++|+.||......+....+...... ... +.. .... ..+.+++.+|+. +|.+| +++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~--p~~-----~~~s----~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRET---LYF--PDD-----IHLS----VEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---cCC--CCC-----CCCC----HHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999766554433332211000 000 000 0001 123578888997 66665 599
Q ss_pred HHHHHH
Q 047739 1071 SDIVFM 1076 (1099)
Q Consensus 1071 ~evl~~ 1076 (1099)
.|+++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.68 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=203.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|++++++++||||+++++++... +..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-CeEEEE
Confidence 46888899999999999999864 78899999875422 2235788999999999999999999998854 456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.+++..... ....+++..++.++.|++.|++|||+.|++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999999875332 2346899999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........|+..|+|||++.+..++.++||||||+++|||++|..||...... ..... +..........
T Consensus 160 ---~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~------ 228 (267)
T cd08229 160 ---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLC-KKIEQCDYPPL------ 228 (267)
T ss_pred ---CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHh-hhhhcCCCCCC------
Confidence 11223356889999999998888999999999999999999999999654322 11111 11111111000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+.. .-..+.+++.+||+.+|++|||+.+|+++++++.
T Consensus 229 --~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --PSDH----YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --Cccc----ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0010 0113457889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=311.69 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=201.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|++|.||+|..+ ++..|++|.+... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence 4778899999999999999875 5889999987542 33456788999999999999999999998854 55699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ....+++..++.++.|++.|++|||+.||+|+||||+||+++.++.++++|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~-- 154 (256)
T cd08529 80 YAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-- 154 (256)
T ss_pred eCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--
Confidence 99999999999753 2345889999999999999999999999999999999999999999999999998765321
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||+..+..++.++||||||++++||++|+.||...........+.. +......
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~------- 222 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR----GVFPPVS------- 222 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCc-------
Confidence 1222345688999999999999999999999999999999999999976664443333222 1111000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ..-..+.+++.+||+.+|++||++.++++.
T Consensus 223 --~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 --Q----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --c----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 001234689999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.98 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=195.3
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCH
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
++||+|+||.||+|...++..+|+|.+...... ...+.+|++++++++||||+++++++... ...++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCCcH
Confidence 479999999999999888899999998654322 34688999999999999999999998854 456999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccc
Q 047739 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966 (1099)
Q Consensus 887 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 966 (1099)
.+++... ...+++..+..++.|++.|+.|+|+.|++||||||+||+++.++.+|++|||++...... .......
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~ 153 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG--IYSSSGL 153 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc--ccccCCC
Confidence 9998642 234789999999999999999999999999999999999999999999999998753211 1111122
Q ss_pred cccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
..++..|+|||++.+..++.++||||||+++||+++ |..||...........+.. +..... . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~----~~~~~~-~--------~~~- 219 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK----GYRMSC-P--------QKC- 219 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc----CCCCCC-C--------CCC-
Confidence 344678999999998889999999999999999998 9999976554443333221 110000 0 000
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
-..+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 ---PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123467999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=320.31 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=202.9
Q ss_pred HhccccccccccccceeEEEEEEC--------CceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|.+.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999753 23579999986532 2335688899999999 799999999999855
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 456999999999999999976321 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+|++|||.++...... .........++..|+|||++.+..++.++||||+||++|||++ |..||.....++....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccc-hhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 9999999999987542111 1111122334578999999998889999999999999999998 8889876554443333
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.. ....+. . ... ...+.+++.+||+.+|++||++.||++.|+++..
T Consensus 255 ~~~----~~~~~~--------~-~~~----~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 255 LKE----GHRMDK--------P-SNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHc----CCCCCC--------C-CcC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 221 111000 0 000 1234578999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=338.82 Aligned_cols=264 Identities=19% Similarity=0.208 Sum_probs=197.9
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCC------cceEEeeEEecCCC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHR------NLTVLRGYYAGAPD 872 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~~~~ 872 (1099)
...++|++.++||+|+||.||+|... .+..||||++.......+.+..|++++++++|. +++.+++++.....
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 34678999999999999999999875 578899999865433445567788888887654 58899999886666
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCC----------
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADF---------- 941 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~---------- 941 (1099)
..++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 778999998 67899988742 348899999999999999999998 5999999999999998765
Q ss_pred ------cEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 942 ------EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 942 ------~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
.+||+|||.+... .......+||..|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cCCCCceEEECCCCccccC------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 4999999987532 1223456899999999999999999999999999999999999999987665544
Q ss_pred HHHHHHHhhhcc--c---------ccccc------Ccc-----cCCCCC--ChhHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 047739 1016 VKWVKKQLQKGQ--I---------TELLE------PGL-----LELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1016 ~~~~~~~~~~~~--~---------~~~~d------~~~-----~~~~~~--~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1071 (1099)
...+.+...... + .+.++ +.. ...... .....+-..+.+++.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 443333211000 0 00000 000 000000 00000112356899999999999999999
Q ss_pred HHHH
Q 047739 1072 DIVF 1075 (1099)
Q Consensus 1072 evl~ 1075 (1099)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9987
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=322.85 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=203.8
Q ss_pred HhccccccccccccceeEEEEEECC--------ceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND--------GMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
..+|.+.+.||+|+||.||+|.+.+ +..||+|.+..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568899999999999999997521 24689998864322 236788999999999 799999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++.+... .....+++..+..++.|++.||+|||+.||+||||||+||+++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 456999999999999999975321 12345889999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ |..||.....++....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCcEEECCcccceeccccc-ccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999997542211 1111223345678999999999899999999999999999998 8889876555444433
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+.. +...+. +.... ..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 249 ~~~----~~~~~~---------~~~~~----~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 LKE----GHRMDK---------PANCT----HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHc----CCCCCC---------CCCCC----HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 321 111100 01111 13457899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.65 Aligned_cols=367 Identities=29% Similarity=0.417 Sum_probs=232.3
Q ss_pred ccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCccc
Q 047739 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260 (1099)
Q Consensus 181 ~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 260 (1099)
+-|+-.+-.|+++|.++| +.+|..+...++++.|.|...++. .+|+.++.+.+|++|.+++|+|..
T Consensus 4 gVLpFVrGvDfsgNDFsg-------~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~------ 69 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSG-------DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS------ 69 (1255)
T ss_pred cccceeecccccCCcCCC-------CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh------
Confidence 445666777888888774 567777777788888888777775 567777777777777777777751
Q ss_pred ccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccc-cCchhhhC
Q 047739 261 FCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSIS-GKIPAQIG 339 (1099)
Q Consensus 261 ~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~-~~~p~~~~ 339 (1099)
+-..++.++.|+.+++..|++. .-+|..+.
T Consensus 70 -------------------------------------------------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF 100 (1255)
T KOG0444|consen 70 -------------------------------------------------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIF 100 (1255)
T ss_pred -------------------------------------------------hhhhhccchhhHHHhhhccccccCCCCchhc
Confidence 1123455666777777777764 22555666
Q ss_pred CCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEE
Q 047739 340 GLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENL 419 (1099)
Q Consensus 340 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 419 (1099)
.+..|..|+|++|+++ ..|..+...+++-+|+||+|+|. .+| ...|.+++.|-.|
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIP-----------------------n~lfinLtDLLfL 155 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIP-----------------------NSLFINLTDLLFL 155 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCC-----------------------chHHHhhHhHhhh
Confidence 6666666666666666 55666666666666666666665 333 3334455666666
Q ss_pred EcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCC-CcCCCCCCCCCCCCEEEeccCcC
Q 047739 420 NLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS-GRIPASLGNLLKLTTLDLSKQNF 498 (1099)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~n~l 498 (1099)
||++|++. .+|+.+..+..|++|+|++|.+...--.-+..+++|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|++
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 66666666 56666666777777777777665333334445566666666665433 34566666666677777777666
Q ss_pred cccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCC
Q 047739 499 SGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPEL 578 (1099)
Q Consensus 499 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l 578 (1099)
. .+|..+.++++|+.|+|++|+|+ .+....+.+.+|++|+||.|+++ .+|.++
T Consensus 235 p-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-------------------------~LP~av 287 (1255)
T KOG0444|consen 235 P-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-------------------------VLPDAV 287 (1255)
T ss_pred C-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-------------------------cchHHH
Confidence 6 55666666666666666666655 33333444555555555555554 455555
Q ss_pred CCCCCCceEEecCCcccC-cCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCC
Q 047739 579 GNCSDLEVLELRSNSLTG-HIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLA 657 (1099)
Q Consensus 579 ~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 657 (1099)
+.+++|+.|++.+|+++- -+|..|++|.+|+.+..++|.+. ..|+.++.|..|+.|.|++|+|. .+|+++--|+.|+
T Consensus 288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~ 365 (1255)
T KOG0444|consen 288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK 365 (1255)
T ss_pred hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc
Confidence 556666666666665542 35666666666666666666666 56666666666777777777665 5666666667777
Q ss_pred eeecCCCc
Q 047739 658 VLDLSANN 665 (1099)
Q Consensus 658 ~L~ls~N~ 665 (1099)
.|||..|+
T Consensus 366 vLDlreNp 373 (1255)
T KOG0444|consen 366 VLDLRENP 373 (1255)
T ss_pred eeeccCCc
Confidence 77776665
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=333.53 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=195.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++.+ +...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 36889999999999999999986 58899999985422 223567889999999999999999999985 4566999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 80 MEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred ECCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999999752 24889999999999999999999999999999999999999999999999998753211
Q ss_pred CCCC-----------------------------------ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh
Q 047739 958 PAEA-----------------------------------STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT 1002 (1099)
Q Consensus 958 ~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt 1002 (1099)
.... ......+||+.|+|||++....++.++||||+||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 01113469999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHH
Q 047739 1003 GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT---MSDIVF 1075 (1099)
Q Consensus 1003 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs---~~evl~ 1075 (1099)
|+.||......+....+... ...-.... ...-.+ .+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~-------~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINW----KETLQFPD-------EVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcC----CCccCCCC-------CCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999876554443333211 10000000 000011 23467788886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.28 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=199.1
Q ss_pred hccccccccccccceeEEEEEEC-----CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-----DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
+-|...+.||+|+||.||++.+. ++..|++|.+..... ..+.+.+|++++++++||||+++++++... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34678899999999999999753 478899999864322 236789999999999999999999998754 3556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++++|.+++.+. ...+++..+..++.|++.||+|+|+.||+||||||+||+++.++.++++|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999999642 234799999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-----------hhHHHHHHHHh
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD-----------EDIVKWVKKQL 1023 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~-----------~~~~~~~~~~~ 1023 (1099)
..............++..|+|||++.+..++.++||||||+++|||++++.|+..... +..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 3222211122345677789999999888899999999999999999998776532111 00011111111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
..+... .. +... ...+.+++.+||+.+|++||++.++++.++++
T Consensus 240 ~~~~~~--------~~-~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL--------PR-PPNC----PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC--------CC-CCCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 00 0111 12356899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=324.67 Aligned_cols=240 Identities=24% Similarity=0.322 Sum_probs=191.2
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhccCC-cceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHR-NLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~lV 877 (1099)
+|++.+.||+|+||.||+|..++ ++.||+|.+... ....+.+..|.++++.++|+ +|+++++++.. .+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence 47888999999999999998764 678999998542 22345678899999999765 57788888774 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF- 153 (324)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence 9999999999998753 2478899999999999999999999999999999999999999999999999864321
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.........||..|+|||++.+..++.++||||+||++|||++|+.||......+....+... .... ..
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~----~~--- 222 (324)
T cd05587 154 --GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSY----PK--- 222 (324)
T ss_pred --CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC----CC---
Confidence 112234567999999999999999999999999999999999999999876655554443321 0000 00
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
. .. ..+.+++.+|++.||.+|++.
T Consensus 223 ----~-~~----~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 ----S-LS----KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----C-CC----HHHHHHHHHHhhcCHHHcCCC
Confidence 0 01 124578999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.68 Aligned_cols=260 Identities=21% Similarity=0.326 Sum_probs=204.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|... +|..|++|.+... ....+.+.+|++++++++|+|++++++++... ...++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence 47889999999999999999987 7889999987532 12246789999999999999999999999854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.... .....+++..+..++.+++.|++|||+.||+||||+|+||+++.++.++++|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 81 LELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999987532 22345889999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+. ......+.......
T Consensus 160 ---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~-~~~~~~~~~~~~~~---- 230 (267)
T cd08224 160 ---TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSL-CKKIEKCDYPPLPA---- 230 (267)
T ss_pred ---CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHH-HhhhhcCCCCCCCh----
Confidence 1222345688899999999988899999999999999999999999864332 11111 11111111111100
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
. ..-..+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 231 ----~----~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 ----D----HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----h----hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 01123457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=319.93 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=204.3
Q ss_pred HhccccccccccccceeEEEEEEC--------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|.+.+.||+|+||.||+|... .+..+|+|.+..... ....+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467889999999999999999752 245789998864322 235688999999999 699999999998754
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.||+||||||+||+++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 456999999999999999976321 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+|++|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999755221111 11122334567999999998889999999999999999999 8999976655544443
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.. +...+. . .... ..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 249 ~~~----~~~~~~--------~-~~~~----~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 LRE----GHRMDK--------P-SNCT----HELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHc----CCCCCC--------C-CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 322 111100 0 1111 134578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.76 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=202.5
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|+..+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++||||+++++++..+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-P 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-c
Confidence 467899999999999999999864 467899999865332 2466889999999999999999999988544 4
Q ss_pred eEEEEeecCCCCHHHHHhhhcc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEE
Q 047739 874 RLLVYDYMPNGNLGTLLQEASH-----------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL 936 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIl 936 (1099)
.++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 5999999999999999975321 11234788899999999999999999999999999999999
Q ss_pred ECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhH
Q 047739 937 FDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDI 1015 (1099)
Q Consensus 937 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~ 1015 (1099)
++.++.++++|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....++.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999875422111 111222345678999999998899999999999999999998 8889876555444
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...+. .+..... +... -..+.+++.+||+.||++||++.|+++.|++
T Consensus 242 ~~~~~----~~~~~~~---------~~~~----~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYVR----DGNVLSC---------PDNC----PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHh----cCCCCCC---------CCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 33322 2211100 0110 1234679999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=328.79 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=189.5
Q ss_pred cccccccceeEEEEEE----CCceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 809 NVLSRTRYGLVFKACY----NDGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+.||+|+||.||++.. .+|..||+|++.... .....+.+|++++++++||||+++++++... ...|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCC
Confidence 5799999999999875 357899999986432 2335577899999999999999999998854 5569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.+. ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---E 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---C
Confidence 999999998642 34889999999999999999999999999999999999999999999999998754221 1
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||......+....+... ...+. +
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p----~------- 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMP----Q------- 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCC----C-------
Confidence 2233467999999999999888999999999999999999999999876554444333221 00001 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1072 (1099)
. .. ..+.+++.+||+.||++||++.+
T Consensus 220 ~-~~----~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 F-LS----PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-CC----HHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 00 12357889999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.15 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=201.0
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
++|...++||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceE
Confidence 56788899999999999999642 35688999886433 3346799999999999999999999998854 4569
Q ss_pred EEEeecCCCCHHHHHhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 876 LVYDYMPNGNLGTLLQEASH----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
+||||+++|+|.+++..... .....+++..+..++.|++.|++|||+.+|+||||||+||++++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 99999999999999975321 01135889999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||+++...... .........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 164 ~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-- 240 (280)
T cd05092 164 GDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG-- 240 (280)
T ss_pred CCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC--
Confidence 9999987542211 1111223345788999999998899999999999999999998 99998765554443332221
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...... ...+ ..+.+++.+||+.||.+||++.||++.|++
T Consensus 241 --~~~~~~---------~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 241 --RELERP---------RTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --ccCCCC---------CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 100000 0111 124588999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=325.47 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=208.8
Q ss_pred cccccccccccceeEEEEEEC-C----ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 805 FDEENVLSRTRYGLVFKACYN-D----GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
....++||.|+||+||+|.|- + ..+||+|++...... ..++.+|+-+|.+++|||+++++|+|.... ..+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 345679999999999999872 3 357888888654433 578999999999999999999999998543 5799
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
++||+.|+|.++++.. ...+..+..+.+..|||+||.|||+++++||||.++||||.....+||+|||+|+...+.
T Consensus 776 tq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999999863 244788899999999999999999999999999999999999999999999999987443
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. .........-.+.|||-|.+....|+.++|||||||++||++| |..||.+...+++.+.+....+ +
T Consensus 852 ~-~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-----------L 919 (1177)
T KOG1025|consen 852 E-KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-----------L 919 (1177)
T ss_pred c-ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-----------C
Confidence 2 2333344456678999999999999999999999999999999 9999988877666555444321 1
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
..|..+.. .+..++.+||..|++.||+++++..++.+....|..
T Consensus 920 --sqPpiCti----DVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 920 --SQPPICTI----DVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred --CCCCCccH----HHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 12233332 234577889999999999999999999776655543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=319.74 Aligned_cols=201 Identities=22% Similarity=0.342 Sum_probs=163.1
Q ss_pred ccccccccceeEEEEEEC---CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEEEEeecCC
Q 047739 808 ENVLSRTRYGLVFKACYN---DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLLVYDYMPN 883 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~lV~e~~~~ 883 (1099)
.++||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++... +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 468999999999999865 457899999865432 34578899999999999999999988643 345689999996
Q ss_pred CCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----CCCCcEEEeccccccccC
Q 047739 884 GNLGTLLQEASH----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF----DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 884 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~~ 955 (1099)
++|.+++..... .....+++.....++.|++.||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 588888764321 112358889999999999999999999999999999999999 456789999999998653
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFT 1010 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~ 1010 (1099)
.............||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 222222233456889999999998764 5889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.70 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=193.6
Q ss_pred cccccccceeEEEEEECC-c--eEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND-G--MVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|..++ + ..+++|.+.... ...+.+.+|+++++++ +||||+++++++.... ..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCC
Confidence 468999999999999764 3 357888876432 2346788999999999 7999999999998544 4699999999
Q ss_pred CCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 883 NGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 883 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
+|+|.+++..... .....+++..+..++.|++.|++|||+.+++||||||+||++++++.+|++|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 9999999975321 11235789999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
.... ..........+..|+|||++....++.++||||||++++||++ |..||......+....+... ...
T Consensus 160 ~~~~----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----~~~- 230 (270)
T cd05047 160 RGQE----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----YRL- 230 (270)
T ss_pred cccc----hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----CCC-
Confidence 6321 1111122234667999999988889999999999999999997 99999765544433332211 000
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+ . +.... ..+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 231 --~-----~-~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 231 --E-----K-PLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --C-----C-CCcCC----HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0 0 00011 1346899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=327.61 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=196.2
Q ss_pred HHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
....++|++.+.||+|+||.||+|..+ +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCE
Confidence 334578999999999999999999986 4789999998532 1233557889999999999999999999874 456
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 79999999999999998642 377888889999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccccCccccCccccccC----CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTG----ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
... .........+||+.|+|||++... .++.++||||+||++|||++|+.||...........+.......
T Consensus 192 ~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--- 266 (371)
T cd05622 192 MNK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--- 266 (371)
T ss_pred cCc--CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc---
Confidence 521 112223456799999999998754 37899999999999999999999998766544443333211110
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
...+. ... -..+.+++.+|+..++.+ ||++.|+++.
T Consensus 267 ~~~~~-------~~~----s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFPDD-------NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCc-------CCC----CHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000 000 012347888999844433 7899988875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=328.12 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=198.0
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----CceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 875 (1099)
+|+..+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++.... ...|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 68999999985432 23467889999999999999999999987543 2568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 588887753 2358899999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc---
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL--- 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 1031 (1099)
.. .........++..|+|||++.+. .++.++||||+||++|||++|+.||......+....+..........+.
T Consensus 155 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PD--ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cC--ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 21 12223445788999999998774 4789999999999999999999999876655444443332211110000
Q ss_pred -------ccCcccCCCCC----ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 -------LEPGLLELDPE----SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 -------~d~~~~~~~~~----~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.......... ......-..+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 0000001234689999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.23 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=192.5
Q ss_pred cccccccceeEEEEEEC----CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN----DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 24679999885422 2346788999999999999999999988755556789999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC-CC
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA-EA 961 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 961 (1099)
+|+|.+++.... ...++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||+++....... ..
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997421 2367788899999999999999999999999999999999999999999999875422111 01
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhC-CCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTG-KRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++.+..++.++||||||+++|||++| ..||......+....+. .+.... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~ 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QGRRLL---------Q 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----cCCCCC---------C
Confidence 112234567789999999888999999999999999999995 55665444333332221 111000 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+...+ ..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 224 ~~~~~----~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEYCP----DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01011 12457999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=323.47 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=191.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV 877 (1099)
+|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+..|.+++..+ +|++|+++++++.. .+..|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence 4788899999999999999876 46799999886432 2234567788888877 58899999998874 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~- 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW- 153 (323)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-
Confidence 9999999999998753 2478899999999999999999999999999999999999999999999999874321
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .. .+..
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----~~--~~p~--- 222 (323)
T cd05616 154 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----NV--AYPK--- 222 (323)
T ss_pred --CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CC--CCCC---
Confidence 122234567999999999999999999999999999999999999999877665555444321 10 0000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
. .. ..+.+++.+|++.||++|++.
T Consensus 223 ----~-~s----~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 ----S-MS----KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----c-CC----HHHHHHHHHHcccCHHhcCCC
Confidence 0 01 124578999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=343.47 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=200.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.++||+|+||.||+|... .|+.||+|++..... ..+++.+|++++++++||||+++++++.+. +..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence 47899999999999999999976 488999999864322 245789999999999999999999998854 556999
Q ss_pred EeecCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQ------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
|||+++|+|.+++...... .....++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998753211 1234567788999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---------------CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHH
Q 047739 952 RLTIPTPA---------------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV 1016 (1099)
Q Consensus 952 ~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~ 1016 (1099)
+....... ........+||+.|+|||++.+..++.++||||+||++|||+||+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 75411110 001122357999999999999999999999999999999999999999764432221
Q ss_pred HHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHhhcccC
Q 047739 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1017 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~ 1082 (1099)
.. ...... .+ ..+ ... -. ..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 241 ~~--~~i~~P--~~-~~p-~~~------iP---~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 YR--DVILSP--IE-VAP-YRE------IP---PFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hhccCh--hh-ccc-ccc------CC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 100000 00 000 000 00 1235788999999999996 56777777776543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=321.84 Aligned_cols=239 Identities=19% Similarity=0.332 Sum_probs=185.5
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|..+ +++.||+|.+.... ...+.+.+|+.++.++ +||||+++++++... ...++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence 46999999999999976 47899999986432 2235577899988877 799999999998854 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~---~~ 151 (329)
T cd05618 80 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GD 151 (329)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---CC
Confidence 99999888642 34889999999999999999999999999999999999999999999999998753211 12
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC-----chhHHHHHHHHhhhccccccccCccc
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ-----DEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... ......++.+........ ++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~--- 226 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPR--- 226 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--CCC---
Confidence 2334679999999999999999999999999999999999999995311 111222222222221110 111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
. .. ..+.+++.+||+.||++||++
T Consensus 227 ----~-~~----~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 ----S-LS----VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----C-CC----HHHHHHHHHHhcCCHHHcCCC
Confidence 0 11 124578999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.29 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=200.1
Q ss_pred hccccccccccccceeEEEEEECC-c---eEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-G---MVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+|++.+.||+|+||.||+|.... + ..|++|.+.... ...+.|..|++++++++||||+++++++..+ ...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEE
Confidence 357888999999999999998753 2 469999986532 2346799999999999999999999998744 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ...+++..++.++.|++.|++|||+.|++||||||+||+++.++.+|++|||+++....
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999753 23478999999999999999999999999999999999999999999999999875532
Q ss_pred CCCCCcccccc--ccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTA--VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
........... ..+..|+|||++.+..++.++||||+|+++|||++ |..||......+...++.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~---- 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLP---- 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCC----
Confidence 22111111111 12457999999998899999999999999999886 999998766555444442210 000
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. +...+ ..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 232 -~-----~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 -P-----PMDCP----TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -C-----cccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01111 1235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.36 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=201.9
Q ss_pred cccccccceeEEEEEECC----ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|.... +..|++|.+...... .+.+.+|++++++++|+||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 479999999999998764 788999998765443 5788999999999999999999999985 556699999999
Q ss_pred CCCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 883 NGNLGTLLQEASH----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 883 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
+++|.+++..... .....+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999986321 113568999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
. ........++..|+|||.+....++.++||||+|++++||++ |..||......+..+.+.. +..... +
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~--~--- 229 (262)
T cd00192 160 Y-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK----GYRLPK--P--- 229 (262)
T ss_pred c-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCC--C---
Confidence 1 122344567889999999988889999999999999999999 6999987655554444332 110000 0
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... -..+.+++.+||+.+|++||++.|+++.|+
T Consensus 230 ----~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 ----EYC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----ccC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 123457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.17 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=192.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc------cHHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL------DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
.+|+..+.||+|+||.||+|... .+..|++|.+..... ..+.+.+|++++++++||||+++++++... ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999875 488999998753221 124688899999999999999999988643 4556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999753 23788899999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
..............++..|+|||++.+..++.++||||+||++|||++|+.||......... ........ .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~---~~~~~~~~-----~~ 228 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI---FKIATQPT-----NP 228 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH---HHHhcCCC-----CC
Confidence 22111112223356889999999999888999999999999999999999999754332211 11111110 11
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+. ... ...+..++ .||..+|++||+++||++
T Consensus 229 ~~~----~~~----~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 QLP----SHI----SEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCc----hhc----CHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 110 000 01122344 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=330.42 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=190.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.|+..++||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++++++||||+++++++.+ ....|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence 5888999999999999999875 578999999864321 23568899999999999999999999985 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++.+. ..+++.....++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 81 DYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999999753 247888888899999999999999999999999999999999999999999975321100
Q ss_pred C--------------------------------------------CCccccccccCccccCccccccCCCCCcCchhhHH
Q 047739 959 A--------------------------------------------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994 (1099)
Q Consensus 959 ~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G 994 (1099)
. ........+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 00011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC---HH
Q 047739 995 IVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT---MS 1071 (1099)
Q Consensus 995 ~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs---~~ 1071 (1099)
|++|||++|+.||......+....+......... +.. ..... .+.+++.+|+ .+|++|++ +.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----p~~-----~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI-----PPQ-----AKLSP----EASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC-----CCc-----ccCCH----HHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999876554333322211000000 000 00111 1235555555 49999997 77
Q ss_pred HHHH
Q 047739 1072 DIVF 1075 (1099)
Q Consensus 1072 evl~ 1075 (1099)
|+++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.05 Aligned_cols=244 Identities=20% Similarity=0.320 Sum_probs=189.8
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|..+ ++..||+|.+.... ...+.+.+|..+++++ +||||+++++++... ...|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCC
Confidence 46999999999999876 57899999986432 2235578899999998 799999999998854 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---~~~ 151 (329)
T cd05588 80 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---PGD 151 (329)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc---CCC
Confidence 99999988642 3489999999999999999999999999999999999999999999999999874311 112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-----hhHHHHHHHHhhhccccccccCccc
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD-----EDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......||..|+|||++.+..++.++||||+||++|||++|+.||..... .....+..+.+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-------- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--------
Confidence 23456799999999999999999999999999999999999999963211 11222222222221110
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPT------MSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs------~~evl~ 1075 (1099)
.+.. .. ..+.+++.+|++.||.+||+ ++|+++
T Consensus 224 -~p~~-~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRS-LS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCC-CC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0001 11 12457899999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=322.57 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=191.9
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|.++. +..||+|.+... ......+.+|.++++.+ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 469999999999998864 789999998643 22335577899999888 69999999999885 455799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.+. ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 151 (318)
T cd05570 80 GGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---GGV 151 (318)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc---CCC
Confidence 99999988753 2489999999999999999999999999999999999999999999999999874311 112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
.....+|+..|+|||++.+..++.++||||+||++|||++|+.||...........+... .. ....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----~~--~~~~-------- 217 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----EV--RYPR-------- 217 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CC--CCCC--------
Confidence 223457899999999999999999999999999999999999999876655444433221 10 0000
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTM-----SDIVF 1075 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1075 (1099)
... ..+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~----~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLS----KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCC----HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 001 123578999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=325.02 Aligned_cols=264 Identities=20% Similarity=0.236 Sum_probs=198.4
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC----
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP---- 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 871 (1099)
...++|...+.||+|+||.||+|... .++.||+|++..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999875 578999999864322 2356778999999999999999999886332
Q ss_pred -CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 872 -DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 872 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 245899999964 67776652 278888999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc----
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG---- 1026 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 1026 (1099)
++.... ........||..|+|||++.+..++.++||||+||++|||++|+.||......+....+.......
T Consensus 166 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCC----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975421 222344578999999999999899999999999999999999999997655433333222211100
Q ss_pred ----------------ccc-----ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 ----------------QIT-----ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 ----------------~~~-----~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... ........... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD-SEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccc-cccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00000000000 00000012345689999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.87 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=196.8
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
|+..+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|++++++++|+||+.+.+++.. ++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence 667788999999999999875 588999999854322 23457789999999999999999988874 456799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05632 81 IMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--- 154 (285)
T ss_pred eccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---
Confidence 999999999886432 23589999999999999999999999999999999999999999999999999865421
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||++.+..++.++||||+|+++|||++|+.||...........+......... ...+.+
T Consensus 155 -~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 228 (285)
T cd05632 155 -GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--VYSAKF--- 228 (285)
T ss_pred -CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--ccCccC---
Confidence 11223457999999999999889999999999999999999999999765544333333332222211 011111
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1076 (1099)
. ..+.+++.+|++.||++||+ +.+++..
T Consensus 229 -----~----~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 -----S----EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -----C----HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 12357899999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.77 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=202.0
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
++|+..+.||+|+||.||+|+.+ +...|++|.+...... .+.+.+|++++++++||||+++++++.+. ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence 57888999999999999999864 2467899988654333 36799999999999999999999998754 456
Q ss_pred EEEEeecCCCCHHHHHhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQD----GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999997543211 12589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
++.... ..........++..|+|||.+.+..++.++||||||++++||++ |..||....+......... +...
T Consensus 164 ~~~~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~----~~~~ 237 (275)
T cd05046 164 SKDVYN--SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA----GKLE 237 (275)
T ss_pred ccccCc--ccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc----CCcC
Confidence 874421 11222334466788999999988889999999999999999998 8889876555444333221 1111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.... ...+ ..+.+++.+||+.+|++||++.|+++.|.
T Consensus 238 ~~~~--------~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVP--------EGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCC--------CCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0111 13467999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=330.75 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=193.2
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEE
Confidence 6889999999999999999875 48899999985422 223568899999999999999999999985 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999999753 347888888899999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CCccccccccCccccCccccccCCCCCcCchhhHHHHHH
Q 047739 959 A----------------------------------------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLL 998 (1099)
Q Consensus 959 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ 998 (1099)
. ........+||+.|+|||++.+..++.++||||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 000112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC---CHHHHHH
Q 047739 999 ELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP---TMSDIVF 1075 (1099)
Q Consensus 999 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP---s~~evl~ 1075 (1099)
||++|+.||......+....+... ... ...+.. .... . .+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~----~~~-~~~~~~-----~~~s-~---~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINW----ETT-LHIPSQ-----AKLS-R---EASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhcc----Ccc-ccCCCC-----CCCC-H---HHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999876654433322211 000 000000 0001 1 1235666665 4999999 8888886
Q ss_pred H
Q 047739 1076 M 1076 (1099)
Q Consensus 1076 ~ 1076 (1099)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=324.25 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=185.5
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHH-HhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAE-FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|.. +++.++||||+++++++.. ....++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 46999999999999986 58999999985422 12234445544 5678999999999999874 455699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.+. ..+++.....++.||++||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---~~~ 151 (323)
T cd05575 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSK 151 (323)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc---CCC
Confidence 99999998742 3478889999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ... ...+ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~--~~~~-------~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----KPL--RLKP-------N 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCC--CCCC-------C
Confidence 33456799999999999999999999999999999999999999987655444333322 110 0011 1
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1071 (1099)
. . ..+.+++.+|++.||++||+++
T Consensus 219 ~-~----~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I-S----VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C-C----HHHHHHHHHHhhcCHHhCCCCC
Confidence 0 0 1235789999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=314.82 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=198.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..+.||+|+||.||++.+. ++..+++|.+..... ..+.+.+|++++++++||||+++++++.. ++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence 36889999999999999999876 578899998764322 23568899999999999999999999985 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|+++++|.++++.. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+|++|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc--
Confidence 99999999999753 347889999999999999999997 5999999999999999999999999999875421
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC----
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP---- 1034 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 1034 (1099)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||...........+...............
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 ---SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1123457889999999998888999999999999999999999999755443333222211110000000000
Q ss_pred ----------------cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 ----------------GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ----------------~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
......+.......-..+.+++.+||+.+|++||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000001135689999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.38 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=186.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHH-HHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEA-EFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|... ++..||+|.+.... .....+.+|. .+++.++||||+++++++... +..|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence 46999999999999986 46789999985422 1223344444 456788999999999998754 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+.+.....++.||++||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---~~~ 151 (325)
T cd05602 80 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---HNG 151 (325)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc---CCC
Confidence 99999999752 3367788888999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... .. ...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~--~~~~~~------ 219 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PL--QLKPNI------ 219 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC----Cc--CCCCCC------
Confidence 334567999999999999999999999999999999999999999876655544443221 10 011111
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+|++.||.+||++.+.+.
T Consensus 220 ~------~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 220 T------NSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C------HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 12357889999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.51 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=195.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhc---cCCcceEEeeEEecC----CC
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKV---RHRNLTVLRGYYAGA----PD 872 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~----~~ 872 (1099)
+|++.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 588999998854321 224566788877766 699999999987632 33
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 4689999997 5898988753 22348899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc---c
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---T 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~ 1029 (1099)
.... ........||..|+|||++.+..++.++||||+||++|||++|+.||......+....+......... .
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSC----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccC----cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 6521 12223457899999999999889999999999999999999999999776555444444332211100 0
Q ss_pred ccc---cCcccCCCCCC-hh--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELL---EPGLLELDPES-SE--WEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~---d~~~~~~~~~~-~~--~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ...+....+.. .. .+.-..+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000000 00 000123468999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=315.82 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=197.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|...+.||+|+||.||+|..+ ++..||+|.+.... .....+.+|++++++++||||+++++++..+ +..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence 46888999999999999999876 57889999885432 2235678899999999999999999999854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++ +|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--- 156 (309)
T cd07872 85 YLDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--- 156 (309)
T ss_pred CCCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC---
Confidence 9974 888888643 23478889999999999999999999999999999999999999999999999875321
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc---cc----
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT---EL---- 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~---- 1031 (1099)
.........++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+....+.......... ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1122234568899999998865 468899999999999999999999998766555444443332211100 00
Q ss_pred --ccCcccCCCCCCh--hHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 --LEPGLLELDPESS--EWE-EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 --~d~~~~~~~~~~~--~~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.......+... ... --..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000 000 0012458999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.92 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=203.7
Q ss_pred HHHHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCC-
Q 047739 795 LAETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP- 871 (1099)
Q Consensus 795 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 871 (1099)
+.++..+.++|+..+.||+|+||.||+|... +++.+|+|.+.......+.+.+|+.+++++ +|||++++++++...+
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3444456788999999999999999999875 588999999876555567788999999999 7999999999987432
Q ss_pred ---CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 872 ---DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 872 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
...++||||+++|+|.++++... .....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 34689999999999999987532 22345899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccC-----CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-----ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+++..... ........|+..|+|||++... .++.++|||||||++|||++|+.||...........+.
T Consensus 173 g~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~--- 246 (291)
T cd06639 173 GVSAQLTST---RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--- 246 (291)
T ss_pred ccchhcccc---cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---
Confidence 998754221 1122345688999999987543 36899999999999999999999997654332222111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+......++ . +....+.+++.+||+.+|++||++.|+++.
T Consensus 247 -~~~~~~~~~~-------~----~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 -RNPPPTLLHP-------E----KWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -cCCCCCCCcc-------c----ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111110 0 011235689999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.19 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=201.1
Q ss_pred hccccccccccccceeEEEEEECC----ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+|...++||+|+||.||+|.+.+ ...|++|...... ...+.+.+|++++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence 457888999999999999998753 3578899886543 234678999999999999999999999874 33589
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++.... ..+++..+..++.|++.|++|+|+.+++||||||+||+++.++.+|++|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997532 3489999999999999999999999999999999999999999999999999876522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. .........++..|+|||.+....++.++||||||++++||++ |..||......+....+.. +.....
T Consensus 160 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----~~~~~~---- 229 (270)
T cd05056 160 E--SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN----GERLPM---- 229 (270)
T ss_pred c--cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----CCcCCC----
Confidence 2 1111223345568999999988889999999999999999986 9999976655444433322 110000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+...+ ..+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus 230 -----~~~~~----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 -----PPNCP----PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111 134578999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.45 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=201.6
Q ss_pred CHHHHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEec--
Q 047739 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAG-- 869 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 869 (1099)
+..+...+...|+..+.||.|+||.||+|... +++.+|+|.+.........+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 44555567788999999999999999999975 578999999866555567788999999998 69999999999853
Q ss_pred ---CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 870 ---APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 870 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
.....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.+|+|+|+||+||++++++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 2345689999999999999997532 3447888889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
|||++...... ........|+..|+|||.+. ...++.++||||+||++|||++|+.||...........+
T Consensus 164 dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~-- 238 (282)
T cd06636 164 DFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 238 (282)
T ss_pred eCcchhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--
Confidence 99998754211 12233457899999999875 346788999999999999999999999654332211111
Q ss_pred HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1022 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
......... ....+ ..+.+++.+||+.||.+||++.|+++
T Consensus 239 --~~~~~~~~~--------~~~~~----~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 --PRNPPPKLK--------SKKWS----KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hhCCCCCCc--------ccccC----HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111000000 00001 13468899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.46 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=205.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.-|+..+.||+|.|.+|-.|++- .|+.||||++.+.+.+ ...+..|++.|+-++|||||++|.+.. .+...|+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-TQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-TQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-ccceEEEEE
Confidence 45788899999999999998754 6999999999765554 467889999999999999999999987 455579999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~ 957 (1099)
|+-++|+|++|+-+.. ..+.+.-..+++.||+.|+.|+|+..+||||+||+||++. .-|-+|++|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 9999999999997532 3478888889999999999999999999999999999875 568899999999976633
Q ss_pred CCCCccccccccCccccCccccccCCCC-CcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETT-KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
..+.++.+|...|-|||.+.+..|+ +++||||+|||+|.+++|+.||....+.+....|..... -+.
T Consensus 172 ---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------tvP--- 239 (864)
T KOG4717|consen 172 ---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------TVP--- 239 (864)
T ss_pred ---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------cCc---
Confidence 3456678999999999999998886 678999999999999999999998887776665544311 000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
..--....++|..|+..||++|.+.+||+..=
T Consensus 240 ---------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 240 ---------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ---------hhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 01112345799999999999999999998753
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=312.36 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=197.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.+|+..+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++.. +...++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecc
Confidence 47888899999999999999864 57899999886433 334678899999999999999999999885 4567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.. ..+++.++..++.|++.|++|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--- 169 (296)
T cd06654 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (296)
T ss_pred cCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc---
Confidence 999999999864 23788999999999999999999999999999999999999999999999998754221
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ....+ ......
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~~~-~~~~~~------- 238 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNG-TPELQN------- 238 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---HhcCC-CCCCCC-------
Confidence 1222345788999999999888899999999999999999999999975543221111 11111 000000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+. .....+.+++.+||..+|++||++.|+++.
T Consensus 239 ~~----~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PE----KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cc----ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 001234578999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.47 Aligned_cols=242 Identities=20% Similarity=0.365 Sum_probs=197.0
Q ss_pred ccccccccccceeEEEEEEC-CceEEEEEEC-----CCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC-ceEEEE
Q 047739 806 DEENVLSRTRYGLVFKACYN-DGMVLSIRRL-----PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD-LRLLVY 878 (1099)
Q Consensus 806 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~-----~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~lV~ 878 (1099)
....+||+|+|-+||||.+. +|..||--.+ .+.....++|..|+.+++.++|||||+++.+|.+... ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999875 4666664333 2333344889999999999999999999999885443 346999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--CceecCCCCCCEEECC-CCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--NMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~ 955 (1099)
|.|..|+|..|+++.++ .+.+....++.||++||.|||++ +|||||||-.||+|+. .|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999997543 78889999999999999999986 7999999999999985 5899999999998763
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCC-CCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM-FTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~-~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. ......+||+.|||||+.. -.|.+.+||||||++++||+|+..||. .....++++.+..++....+..+-|+
T Consensus 198 ~-----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 K-----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred c-----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 2 2233479999999999876 679999999999999999999999995 34555666666666555555544444
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. +.++|.+|+.. ..+|||+.|++.
T Consensus 272 e----------------vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 E----------------VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred H----------------HHHHHHHHhcC-chhccCHHHHhh
Confidence 3 24799999999 999999999985
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=309.26 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=204.4
Q ss_pred HhccccccccccccceeEEEEEECC-c----eEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-G----MVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
..+|...+.||+|+||.||+|.+++ | ..+++|....... ....+.+|++++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cce
Confidence 3568888999999999999998743 3 3688998865433 34678899999999999999999999985 456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+|++|||+++..
T Consensus 84 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 8999999999999999752 234899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.... .........++..|+|||.+....++.++||||||++++|+++ |+.||.....++..+.+.. +... ..
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~--~~ 232 (279)
T cd05057 160 DVDE-KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK----GERL--PQ 232 (279)
T ss_pred cCcc-cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC----CCCC--CC
Confidence 3211 1111122334678999999988889999999999999999998 9999987665554443332 1100 00
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+.... ..+.+++.+||..+|.+||++.++++.|+++...+
T Consensus 233 -------~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 233 -------PPICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred -------CCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 01111 12457889999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.89 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=195.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..+|++.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++..+ ...++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEe
Confidence 357899999999999999999974 68899999886433 2345688999999999999999999998854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.++++.. ..+++..+..++.|++.|++|||+.+|+|||+||+||+++.++.+|++|||+++.....
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06646 87 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-- 159 (267)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence 99999999998642 34789999999999999999999999999999999999999999999999999754211
Q ss_pred CCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 960 EASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........|+..|+|||.+. ...++.++||||+||++|||++|+.||...........+ .... ...+..
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~----~~~~---~~~~~~ 231 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----SKSN---FQPPKL 231 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee----ecCC---CCCCCC
Confidence 11223456889999999874 345788999999999999999999998643322111100 0000 000111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
. ....+ -..+.+++.+||+.+|++||++++|++.+
T Consensus 232 ~----~~~~~--~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K----DKTKW--SSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c----ccccc--CHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00011 12346899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.27 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=199.8
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHH---HHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~---~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
|+..+.||+|+||+||++.... +..+|+|.+......... ..+|+.++++++||||+++++++.. ....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence 5678899999999999999864 678999999766554433 3459999999999999999999986 4556899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++... ..+++..+..++.|+++||+|||+.+|+|+||||+||+++.++.++|+|||.+... ...
T Consensus 80 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL---SEN 151 (260)
T ss_dssp ETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES---TST
T ss_pred ccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc
Confidence 9999999999832 34799999999999999999999999999999999999999999999999998753 122
Q ss_pred CccccccccCccccCccccc-cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 961 ASTSTTAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||++. +..++.++||||+|+++++|++|..||......+....+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-Q----- 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-S-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-c-----
Confidence 33445678899999999998 7889999999999999999999999998663333333333322211100000 0
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+....+.+++.+||+.||++||++.++++
T Consensus 226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000134568999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.62 Aligned_cols=239 Identities=21% Similarity=0.344 Sum_probs=183.4
Q ss_pred cccccccceeEEEEEECC-------------ceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 809 NVLSRTRYGLVFKACYND-------------GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
+.||+|+||.||+|.+.+ ...|++|.+..... ..+.+.+|+.++++++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-EN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence 468999999999998532 23588888754322 2356888999999999999999999998554 45
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc-------EEEec
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE-------AHLSD 947 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~-------~kl~D 947 (1099)
++||||+++|+|..++... ...+++..+..++.||++|++|||+.+|+||||||+||+++.++. ++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999888642 234899999999999999999999999999999999999986654 89999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccc-cCCCCCcCchhhHHHHHHHHH-hCCCCCCCCCchhHHHHHHHHhhh
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELL-TGKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~G~il~ell-tg~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
||++.... ......++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+... .. .
T Consensus 156 ~g~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~----~ 223 (262)
T cd05077 156 PGIPITVL-------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FY----E 223 (262)
T ss_pred CCCCcccc-------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HH----h
Confidence 99986542 112346788999999886 466899999999999999998 5888876543222111 11 1
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... .. ..+. . ..+.+++.+||+.||++||++.+|++.+.
T Consensus 224 ~~~-~~-------~~~~---~---~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-ML-------VTPS---C---KELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-cC-------CCCC---h---HHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 00 0001 1 23467899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=310.02 Aligned_cols=261 Identities=24% Similarity=0.408 Sum_probs=202.1
Q ss_pred hccccccccccccceeEEEEEEC-----CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-----DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
+.|...+.||+|+||.||+|.+. .+..||+|.+...... .+.|.+|++++++++||||+++++++... ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 3688999999765543 67899999999999999999999988742 3456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 89999999999999997532 24899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH-----------HHHHHHHh
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI-----------VKWVKKQL 1023 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~-----------~~~~~~~~ 1023 (1099)
..............++..|+|||...+..++.++||||||++++||++|+.|+........ ...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 3221111112233456679999999888999999999999999999999999854322110 11111111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.... ... .+...+ ..+.+++.+||+.+|++||++.||+++|+.+
T Consensus 240 ~~~~-------~~~--~~~~~~----~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE-------RLP--RPPSCP----DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC-------cCC--CCccCC----HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1110 000 001111 2356899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.30 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=194.0
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
|+..++||+|+||.||++... +++.||+|.+..... ..+.+.+|+.++++++|++++++++.+... ...++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEE
Confidence 677789999999999999876 588999998854322 224577899999999999999999998754 46799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--- 154 (285)
T cd05630 81 LMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--- 154 (285)
T ss_pred ecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---
Confidence 999999999986432 23488999999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||++.+..++.++||||+|+++|||++|+.||................... .....
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~------ 225 (285)
T cd05630 155 -GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--QEEYS------ 225 (285)
T ss_pred -CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--hhhcC------
Confidence 112234579999999999999899999999999999999999999997543321111111111100 00000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
.... ..+.+++..||+.||++||+ ++|+++
T Consensus 226 --~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 --EKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --ccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001 12357899999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=318.64 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=192.2
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.++||+|+||.||++..+. ++.+|+|.+... ....+.+.+|+.++..++|++|+++++++.+ +...++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence 368899999999999999999864 678999998532 1223458889999999999999999999884 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 80 MDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999999753 234788899999999999999999999999999999999999999999999998754211
Q ss_pred CCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
........+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+........ +
T Consensus 156 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 229 (332)
T cd05623 156 --GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----F 229 (332)
T ss_pred --CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----C
Confidence 122233467999999999886 34578999999999999999999999986655444433322111100 0
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCC--CCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPD--PIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~d--P~~RPs~~evl~~ 1076 (1099)
.... .... ..+.+++.+|+..+ +..|+++.|+++.
T Consensus 230 p~~~-----~~~s----~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQV-----TDVS----EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCcc-----ccCC----HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 0001 12346677766544 4447899988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.56 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=198.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+|+..++||+|+||.||++... ++..+++|.+... ....+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence 4778899999999999999876 5788999987432 2344678899999999999999999999875 4567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++... ....+++.....++.|++.|++|||+.+|+|+||||+||++++++.++++|||.++.... .
T Consensus 80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~---~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS---P 153 (255)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc---c
Confidence 9999999988642 234578899999999999999999999999999999999999999999999999875421 1
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+. .+.... +.
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-~~------- 221 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC----QGSYKP-LP------- 221 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh----cCCCCC-CC-------
Confidence 122234578899999999998889999999999999999999999997654433322221 111110 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ..+.+++.+||+.||++||++.|++..
T Consensus 222 -~~~~----~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 -SHYS----YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cccC----HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1001 124578999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.78 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=199.6
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|++|.||++..+ +++.|++|.+..... ..+.+.+|++++++++|+|++++++.+.......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999875 478899999854332 335688999999999999999999987655556789999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ....+++.++..++.|++.|++|+|+.+|+||||||+||+++.++.++++|||++......
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-- 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-- 155 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence 99999999999752 2345899999999999999999999999999999999999999999999999998754211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||++.+..++.++||||+|++++||++|+.||...+.......+. .+..... ..
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~----~~~~~~~-~~----- 224 (257)
T cd08223 156 -CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----EGKLPPM-PK----- 224 (257)
T ss_pred -CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----hcCCCCC-cc-----
Confidence 122334568899999999999999999999999999999999999997654433322221 1111110 00
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .-..+.+++.+|++.+|++||++.|+++.
T Consensus 225 --~-----~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 --D-----YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --c-----cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 01234589999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=339.92 Aligned_cols=258 Identities=18% Similarity=0.271 Sum_probs=197.1
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~ 875 (1099)
...+|.+.+.||+|+||.||+|.... +..|++|.+.... .....+..|+.++++++|||||++++++... ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 35689999999999999999999764 6788999886432 2346688999999999999999999988643 34568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-------CceecCCCCCCEEECC---------
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-------NMVHGDIKPQNVLFDA--------- 939 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~iiH~Dlk~~NIll~~--------- 939 (1099)
+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+. +||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999975322 234589999999999999999999984 5999999999999964
Q ss_pred --------CCcEEEeccccccccCCCCCCCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCC
Q 047739 940 --------DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMF 1009 (1099)
Q Consensus 940 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~ 1009 (1099)
.+.+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~----~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI----ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc----cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34589999999975421 112234579999999999864 4588999999999999999999999975
Q ss_pred CCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHhhcc
Q 047739 1010 TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV--FMLEGC 1080 (1099)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl--~~L~~~ 1080 (1099)
...... +...+.... .... .... ..+.+++..||+.+|.+||++.|++ ..+..+
T Consensus 246 ~~~~~q---li~~lk~~p--~lpi--------~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFSQ---LISELKRGP--DLPI--------KGKS----KELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHHH---HHHHHhcCC--CCCc--------CCCC----HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 443221 111111110 0000 0000 2346789999999999999999998 455444
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.96 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=191.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..++||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEe
Confidence 35778899999999999999864 67889999885432 2235688999999999999999999999854 45689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|..+. .+++.....++.|++.|++|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~--- 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--- 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc---
Confidence 99999986543 267888889999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHH---HHHHHHhhhccccccccCcc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV---KWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ........... .+..
T Consensus 148 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 220 (279)
T cd06619 148 --SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL 220 (279)
T ss_pred --ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC
Confidence 1223457899999999999889999999999999999999999999653221110 01111111110 0000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... .. ..+.+++.+|++.+|++||+++|+++.
T Consensus 221 ---~~~~-~~---~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ---PVGQ-FS---EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCc-CC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 01 124688999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=318.88 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=197.7
Q ss_pred HHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC---
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP--- 871 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 871 (1099)
.+..++|...+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999874 578999999864322 2356778999999999999999998875321
Q ss_pred --CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 872 --DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 872 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
...|+++|++ +++|.++++. ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3358999998 6799888753 348899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
+++.... .....+||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+........
T Consensus 164 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (343)
T cd07878 164 LARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS- 236 (343)
T ss_pred cceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence 9975421 2234578999999999876 4688999999999999999999999976554443333322211110
Q ss_pred cccc-----------cCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELL-----------EPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~-----------d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.. ...+..... ..... -..+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQ--QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccc--hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 00000 0124689999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.79 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=201.3
Q ss_pred HHHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEec----
Q 047739 796 AETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAG---- 869 (1099)
Q Consensus 796 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---- 869 (1099)
.....+.++|++.+.||+|+||.||+|... +++.+++|.........+.+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 334456789999999999999999999875 478899998765444456788999999999 69999999998742
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
.+...++||||+++|+|.+++.... .....+++..+..++.|+++|+.|||+.+|+||||||+||+++.++.+|++|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 2345699999999999999886432 223457889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+++.... .........|+..|+|||++.. ..++.++||||+||++|||++|+.||............ .
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~----~ 242 (286)
T cd06638 170 VSAQLTS---TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI----P 242 (286)
T ss_pred ceeeccc---CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc----c
Confidence 9875421 1122334578999999998753 45788999999999999999999998754432211111 1
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
........++ .... ..+.+++.+||+.||++||++.||++.
T Consensus 243 ~~~~~~~~~~-------~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNPPPTLHQP-------ELWS----NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCcccCC-------CCcC----HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1110111111 1000 124578999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=317.89 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=191.6
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||++... +++.||+|.+... ....+.+.+|+.+++.++|+||+++++++.+ +...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence 46889999999999999999976 4889999998531 2233568899999999999999999999885 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 80 MDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999752 234788899999999999999999999999999999999999999999999998754221
Q ss_pred CCCCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+....+... ..... +
T Consensus 156 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---~~~~~-~ 229 (331)
T cd05597 156 --GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---KEHFQ-F 229 (331)
T ss_pred --CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCccc-C
Confidence 1122233579999999999863 45788999999999999999999999765544433332211 11000 0
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAP--DPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~--dP~~RPs~~evl~~ 1076 (1099)
.+... . .. + .+.+++.+|+.. ++..||++.++++.
T Consensus 230 ~~~~~----~-~~-~---~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDVT----D-VS-E---EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccC----C-CC-H---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11000 0 01 1 224566665544 44448899888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.11 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=196.2
Q ss_pred cccccccceeEEEEEECC-------ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYND-------GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.||+|+||.||+|...+ +..+++|.+.... .....+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEEe
Confidence 468999999999998753 2578999876543 3356788999999999999999999998754 45699999
Q ss_pred ecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-----cEEEecccccc
Q 047739 880 YMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-----EAHLSDFGLDR 952 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-----~~kl~DfGla~ 952 (1099)
|+++|+|.+++...... ....+++..+..++.|++.|++|||+.+++|+||||+||+++.++ .++++|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999753221 234578999999999999999999999999999999999999877 89999999987
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
..... ..........++..|+|||++.++.++.++||||||+++|||++ |+.||......+....+.. +....
T Consensus 160 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~- 233 (269)
T cd05044 160 DIYKS-DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA----GGRLQ- 233 (269)
T ss_pred ccccc-cccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc----CCccC-
Confidence 54221 11112233456788999999999999999999999999999998 9999976555444333221 11000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
. +... . ..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 234 -------~-~~~~-~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 -------K-PENC-P---DKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------C-cccc-h---HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0001 1 134589999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=314.48 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=202.5
Q ss_pred HhccccccccccccceeEEEEEEC-Cce----EEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGM----VLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+...... ...+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cc
Confidence 456788899999999999999864 343 5788887643322 34688999999999999999999998743 34
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 7999999999999998742 234788999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.... .........++..|+|||++.+..++.++||||||+++|||++ |+.||.........+.+.. +.... .
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~--~ 232 (303)
T cd05110 160 EGDE-KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK----GERLP--Q 232 (303)
T ss_pred cCcc-cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC----CCCCC--C
Confidence 3211 1112223456778999999998899999999999999999997 8999976554444333221 11000 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
+.... ..+.+++..||..+|++||+++|+++.|+++...+.
T Consensus 233 -------~~~~~----~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 233 -------PPICT----IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -------CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 00111 134578899999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.19 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+-|++..++|+|+||+||+|.++ .|.++|+|.++.+ .+-+++..|+.+|++++.|++|++||.|..+.+ .++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhhc
Confidence 34677889999999999999876 4999999999763 456788999999999999999999998875544 59999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
..|+..+.++. ....+.+.+...+..+.++||+|||...-||||||+.|||++.+|.+|++|||.|-..-+ .-
T Consensus 111 GAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD---TM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD---TM 183 (502)
T ss_pred CCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh---hH
Confidence 99999999974 335699999999999999999999999999999999999999999999999999975522 23
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
...++..||+.|||||++..-.|..++||||+|+...||..|++||..-.+....- -++.-..+.+.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPTF~---- 250 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPTFK---- 250 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCCCC----
Confidence 44567899999999999999999999999999999999999999996533211000 01111122222
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....|. ..+-++++.|+-..|++|.|+.++++.
T Consensus 251 KPE~WS--~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWS--SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhh--hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 112232 234578999999999999999888764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=306.99 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=193.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC------ccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
.+|+..++||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++.+. ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999875 48899999874321 1135688899999999999999999988643 3456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ..+++....+++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 7999999999999998743 23678888999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
..............|+..|+|||++.+..++.++||||||+++|||++|+.||......... .+...... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~-----~~ 228 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPT-----NP 228 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---HHHhcCCC-----CC
Confidence 32211112233456889999999998888999999999999999999999999754332222 11111110 00
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .+......+.+++.+|+. +|++||+++||++.
T Consensus 229 ~--------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 V--------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C--------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 011111234567788884 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.85 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=186.1
Q ss_pred ccccccceeEEEEEECCc---eEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCC
Q 047739 810 VLSRTRYGLVFKACYNDG---MVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
.||+|+||.||+|...++ ..+++|.+.... ...+.+.+|+.+++.++||||+++++++... ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCC
Confidence 699999999999975433 346667665432 2346799999999999999999999999854 4569999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 964 (1099)
+|.+++++.... ....++.....++.||+.||+|||+.+|+||||||+||+++.++.+|++|||++..... .......
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~-~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETE 158 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc-chhhhcc
Confidence 999999763221 23467777889999999999999999999999999999999999999999999864211 1111222
Q ss_pred cccccCccccCcccccc-------CCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 965 TTAVGTLGYVSPEAALT-------GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 965 ~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
....++..|+|||++.. ..++.++||||||+++|||++ |..||....+.+....+.. +......++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 234 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----DQQVKLFKPQL 234 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----hcccccCCCcc
Confidence 34568899999998753 245789999999999999997 5678865554443333222 11122222222
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... .. ..+.+++..|| .+|++||+++||++.|.
T Consensus 235 ~~~--~~------~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELP--YS------ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC--Cc------HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 100 01 12345778899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=308.67 Aligned_cols=238 Identities=20% Similarity=0.324 Sum_probs=183.7
Q ss_pred ccccccceeEEEEEECC-------------------------ceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEE
Q 047739 810 VLSRTRYGLVFKACYND-------------------------GMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVL 863 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l 863 (1099)
.||+|+||.||+|.+.. ...|++|.+.....+ ...+.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 145888888543322 3568889999999999999999
Q ss_pred eeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC--
Q 047739 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-- 941 (1099)
Q Consensus 864 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-- 941 (1099)
++++... ...++||||+++|+|.+++.+. ...+++..+..++.|+++||+|||+.+|+||||||+||+++..+
T Consensus 82 ~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRG-SENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeC-CceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 9999854 4569999999999999998642 23578999999999999999999999999999999999997643
Q ss_pred -----cEEEeccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHH-hCCCCCCCCCchh
Q 047739 942 -----EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELL-TGKRPVMFTQDED 1014 (1099)
Q Consensus 942 -----~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~ell-tg~~P~~~~~~~~ 1014 (1099)
.+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 489999998864311 122457788999998865 56899999999999999995 7999997654433
Q ss_pred HHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
........ .... .... ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 230 ~~~~~~~~---~~~~-----------~~~~-----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKK---HRLP-----------EPSC-----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhc---cCCC-----------CCCC-----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 32221110 0000 0000 13467899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=313.61 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=162.5
Q ss_pred ccccccccceeEEEEEECC---ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEec-CCCceEEEEeecCC
Q 047739 808 ENVLSRTRYGLVFKACYND---GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLRLLVYDYMPN 883 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~~lV~e~~~~ 883 (1099)
..+||+|+||.||+|..++ +..||+|.+.... ....+.+|++++++++||||+++++++.. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 3689999999999998753 5789999886543 23457899999999999999999998863 3445689999996
Q ss_pred CCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----CCCCcEEEeccccccccC
Q 047739 884 GNLGTLLQEASH----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF----DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 884 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~~ 955 (1099)
++|.+++..... .....+++..+..++.|++.||+|||+.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 588888753221 122358889999999999999999999999999999999999 566789999999998653
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFT 1010 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~ 1010 (1099)
.............||..|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 222222233456789999999998764 5789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.14 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=184.2
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHH-HhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAE-FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|+.. +++.||+|.+.... .....+.+|.. +++.++||||+++++++.+ .+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 46999999999999985 57899999985422 12234555554 6788999999999998874 456699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~ 151 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---PEE 151 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC---CCC
Confidence 99999888642 3477888889999999999999999999999999999999999999999999875311 112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.. ... ...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~---------~~~~~ 218 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH----KPL---------QLPGG 218 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc----CCC---------CCCCC
Confidence 23445799999999999988899999999999999999999999987654443333221 110 00111
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1071 (1099)
. -..+.+++.+|++.||.+||++.
T Consensus 219 ~-----~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 K-----TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-----CHHHHHHHHHHccCCHhhcCCCC
Confidence 0 11345789999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=317.54 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=190.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV 877 (1099)
+|+..+.||+|+||.||+|... +|+.||+|.+... ....+.+..|.++++.+. |++|+++++++.. .+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 3777899999999999999875 5889999998642 122356778999998886 5777888888774 4557999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~- 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV- 153 (323)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-
Confidence 9999999999998753 3488999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.........+.+.... ...+
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p-------- 221 (323)
T cd05615 154 --DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYP-------- 221 (323)
T ss_pred --CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--------
Confidence 1122334569999999999998899999999999999999999999998766655544433210 0000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
.... ..+.+++.+|++.+|.+|++.
T Consensus 222 ----~~~~----~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ----KSLS----KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----ccCC----HHHHHHHHHHcccCHhhCCCC
Confidence 0001 124578999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=318.01 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=192.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|..++..++|+||+++++++.+ +...|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 46889999999999999999976 5788999998542 1223457889999999999999999999884 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+.. ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999997532 34788899999999999999999999999999999999999999999999999754221
Q ss_pred CCCCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.........||+.|+|||++.+ +.++.++||||+||++|||++|+.||...+..+....+........ +
T Consensus 156 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 229 (331)
T cd05624 156 --GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ----F 229 (331)
T ss_pred --CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----C
Confidence 1122234579999999998875 4678899999999999999999999976554443333222110000 1
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
++.... . ...+.+++.+|+..++++ |++++++++.
T Consensus 230 p~~~~~---~------~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHITD---V------SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCcccc---C------CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111100 0 122456788888765544 5678887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.43 Aligned_cols=238 Identities=22% Similarity=0.366 Sum_probs=188.5
Q ss_pred cccccccceeEEEEEECCc-----------eEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 809 NVLSRTRYGLVFKACYNDG-----------MVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g-----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
+.||+|+||.||+|.+.+. ..|++|.+.........+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEE
Confidence 4689999999999998643 257778775544446789999999999999999999999886 445999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-------cEEEecccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-------EAHLSDFGL 950 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-------~~kl~DfGl 950 (1099)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++ .+|++|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999997532 2588999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccC--CCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
++.... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..........+.. ....
T Consensus 155 a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~ 224 (259)
T cd05037 155 PITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR 224 (259)
T ss_pred cccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence 875421 2234567789999998876 78999999999999999999 577776543322222111 0000
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
. . .+.. ..+.+++.+||+.+|.+||++.||++.|+
T Consensus 225 --------~-~-~~~~------~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --------L-P-MPDC------AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------C-C-CCCc------hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0011 34568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.05 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=197.4
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|++.+.||+|+||.||++.. .+..|++|..... ...+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEECCC
Confidence 5688999999999999999975 4778899988643 3456789999999999999999999998743 3589999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ....+++..+..++.|++.|++|+|+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 99999999753 2345789999999999999999999999999999999999999999999999998753211
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......+..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+.+ +...+. +
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~---------~ 219 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK----GYRMEP---------P 219 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC----CCCCCC---------C
Confidence 112334578999999988899999999999999999998 9999976554443332221 110000 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...+ ..+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCP----ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1001 234578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=321.65 Aligned_cols=240 Identities=25% Similarity=0.366 Sum_probs=187.3
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHH-HhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAE-FLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|... +|+.||+|.+.... ...+.+..|.. +++.++||||+++++++.. .+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 46999999999999875 58899999985421 22344555654 4677899999999999875 455699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---~~~ 151 (325)
T cd05604 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---QSD 151 (325)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC---CCC
Confidence 99999888642 3478999999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
.....+||..|+|||++.+..++.++||||+||++|||++|+.||...+..+..+.+.. ... .+.+ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~----~~~--~~~~-------~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPL--VLRP-------G 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc----CCc--cCCC-------C
Confidence 23456799999999999999999999999999999999999999987655444333222 110 0011 1
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. . ..+.+++.+|++.+|++||++++.++
T Consensus 219 ~-~----~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 A-S----LTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred C-C----HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 0 0 12357889999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=324.76 Aligned_cols=263 Identities=20% Similarity=0.214 Sum_probs=196.0
Q ss_pred HhccccccccccccceeEEEEEEC---CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN---DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..+|.+.+.||+|+||.||++... .+..|++|.+... +...+|++++++++||||+++++++.. ....++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEe
Confidence 457999999999999999999764 3578999988643 345789999999999999999999874 44569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|++. ++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~- 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH- 238 (392)
T ss_pred hhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc-
Confidence 9995 689888853 235899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH---HHHHHHHhhhcccc--c---
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI---VKWVKKQLQKGQIT--E--- 1030 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~---~~~~~~~~~~~~~~--~--- 1030 (1099)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+.+........ .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 112223356799999999999998999999999999999999999999976543221 12222211111000 0
Q ss_pred -----c---ccCcccC-C-CCC-ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 -----L---LEPGLLE-L-DPE-SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 -----~---~d~~~~~-~-~~~-~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ....... . .+. ......-..+.+++.+|+..||++||++.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000 0 000 0000001234578899999999999999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.89 Aligned_cols=251 Identities=21% Similarity=0.373 Sum_probs=196.2
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCCCcc-------HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
+|...+.||+|+||.||+|...++..+|+|.+...... .+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEE
Confidence 47788999999999999999888999999988543211 24588999999999999999999999854 56799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++.+. ..+++..+..++.|++.|++|||+.+|+|+||+|+||+++.++.++++|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 80 FMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999999752 2378889999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TP---AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.. ..........|+..|+|||++.+..++.++||||+|++++||++|+.||...+.......+.. ..+.... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~-~~ 231 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--HRGLMPR-LP 231 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh--ccCCCCC-CC
Confidence 11 111122345689999999999988899999999999999999999999975433222111111 1011111 11
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ... ..+.+++.+||+.+|++||++.|+++
T Consensus 232 ~--------~~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 D--------SFS----AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C--------CCC----HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 001 12357899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=323.62 Aligned_cols=210 Identities=22% Similarity=0.347 Sum_probs=175.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++.+++||+|+++++++.+ ....++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 36888999999999999999876 5889999998532 1223567889999999999999999999884 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++.....++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 80 MEFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999999742 34788999999999999999999999999999999999999999999999998744211
Q ss_pred CCC--------------------------------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCC
Q 047739 958 PAE--------------------------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005 (1099)
Q Consensus 958 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~ 1005 (1099)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 000 001124579999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHH
Q 047739 1006 PVMFTQDEDIVKW 1018 (1099)
Q Consensus 1006 P~~~~~~~~~~~~ 1018 (1099)
||...........
T Consensus 235 Pf~~~~~~~~~~~ 247 (360)
T cd05627 235 PFCSETPQETYRK 247 (360)
T ss_pred CCCCCCHHHHHHH
Confidence 9987665544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=310.65 Aligned_cols=279 Identities=22% Similarity=0.253 Sum_probs=205.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc------HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
+|+..+.||+|+||.||+|... +|+.|++|.+...... ...+..|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 4778889999999999999975 5889999998654332 3456789999999999999999999986 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+ +|+|.+++.... ..+++..+..++.||++||+|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 80 v~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999 899999997522 3589999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc----
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL---- 1031 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 1031 (1099)
. ........++..|+|||.+.+ ..++.++|||||||+++||++|..||....+.+....+............
T Consensus 155 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 P---NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred C---CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 1 122233456788999998865 45789999999999999999998888765554433333222111100000
Q ss_pred -ccCcccCCCCCChh-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCCCCCC
Q 047739 1032 -LEPGLLELDPESSE-----WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098 (1099)
Q Consensus 1032 -~d~~~~~~~~~~~~-----~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~p 1098 (1099)
.............. ...-..+.+++.+||+.||++||++.|+++. ++....+.+..++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~-------~~~~~~~~~~~~~~~ 297 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH-------PYFSNDPAPTPPSQL 297 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC-------ccccCCCCCCCCCCC
Confidence 00000000000000 0011345689999999999999999999985 455555555544444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=303.83 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=199.3
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|++++++++||||+++++++... ...|+|+||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecC
Confidence 578889999999999999999875 78999999865433 67899999999999999999999999855 5569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++... ...+++.....++.|+++|++|||+.+|+|||++|+||+++.++.++++|||++...... .
T Consensus 81 ~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---~ 153 (256)
T cd06612 81 GAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---M 153 (256)
T ss_pred CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC---c
Confidence 999999998642 245899999999999999999999999999999999999999999999999998764221 1
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...........+.. . ..+.+.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~-----~~~~~~---- 220 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----K-----PPPTLS---- 220 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----C-----CCCCCC----
Confidence 123345688899999999988999999999999999999999999975443221111100 0 000000
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....--..+.+++.+||+.+|++||++.||++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 --DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000123467899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.55 Aligned_cols=250 Identities=19% Similarity=0.295 Sum_probs=195.0
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.|++.+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|++++++++||||+++++++..+ ...++||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEec
Confidence 36778899999999999999864 77889998865432 346788999999999999999999998854 5569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.+. ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+|++|||++..... ..
T Consensus 85 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~---~~ 157 (282)
T cd06643 85 AGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TI 157 (282)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc---cc
Confidence 999999888642 23589999999999999999999999999999999999999999999999999875421 11
Q ss_pred ccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 962 STSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......++..|+|||++. +..++.++|||||||++|||++|+.||......+....+... .......+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~-- 231 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLAQP-- 231 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc----CCCCCCCc--
Confidence 2233456899999999874 345788999999999999999999999765443322222111 10000000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 232 -----~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 -----SRWS----SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----cccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 234588999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=325.24 Aligned_cols=263 Identities=18% Similarity=0.220 Sum_probs=194.1
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+|.+.+.||+|+||.||+|.+.. ++.||+|.... ..+.+|++++++++|+|||++++++... ...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence 3468999999999999999999864 78899996432 3467899999999999999999998754 456899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+. ++|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...... .
T Consensus 242 ~~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-S 315 (461)
T ss_pred cC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc-c
Confidence 95 7999888642 2358999999999999999999999999999999999999999999999999997652211 1
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC--------chhHHHHHHHHhhh-cccccc
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ--------DEDIVKWVKKQLQK-GQITEL 1031 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~--------~~~~~~~~~~~~~~-~~~~~~ 1031 (1099)
........||..|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+...... ......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 112234579999999999999999999999999999999999887653321 11222222221100 000000
Q ss_pred ccC-----------cccCCCCCChhHHHH----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 LEP-----------GLLELDPESSEWEEF----LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~-----------~~~~~~~~~~~~~~~----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... ...........|..+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000011122211 134679999999999999999999975
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=317.02 Aligned_cols=193 Identities=21% Similarity=0.305 Sum_probs=163.8
Q ss_pred HHHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
....+|++.+.||+|+||.||+|.... +..||+|..... ....|+.++++++||||+++++++... ...++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEE
Confidence 345679999999999999999999864 678999975432 345799999999999999999999854 4568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+. |+|.+++... ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 9995 6899888642 24589999999999999999999999999999999999999999999999999975321
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV 1007 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~ 1007 (1099)
........||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 12223457999999999999999999999999999999999966655
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=301.37 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=195.5
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCH
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
++||+|+||.||+|...++..|++|.+..... ..+.+.+|++++++++||||+++++++... ...++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCcH
Confidence 47999999999999987799999999865443 346789999999999999999999998854 456999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccc
Q 047739 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966 (1099)
Q Consensus 887 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 966 (1099)
.+++... ...+++..+..++.+++.|++|||+.+++||||||+||+++.++.+|++|||.++..... ........
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG-IYTVSDGL 154 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC-cceecccc
Confidence 9999642 234788999999999999999999999999999999999999999999999998754211 11111122
Q ss_pred cccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 967 ~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
..++..|+|||.+.++.++.++||||+|++++||++ |..||...........+.... .. . .+...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~---~~---~-------~~~~~~ 221 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---RM---P-------APQLCP 221 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC---CC---C-------CCccCC
Confidence 334667999999988889999999999999999999 888887655444333322110 00 0 001111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..+.+++.+|++.+|++||++.|+++.|+
T Consensus 222 ----~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 ----EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ----HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 23568999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=316.37 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=185.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++.++ +||||+++++++... ...++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCC
Confidence 46999999999999875 47889999986432 2235578899999888 699999999998744 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++..+..++.|++.|++|||+.||+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 151 (327)
T cd05617 80 GGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---PGD 151 (327)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC---CCC
Confidence 99999988642 3489999999999999999999999999999999999999999999999999874311 112
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch---hHHHHHHHHhhhccccccccCcccCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE---DIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.+........ +..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~p~----- 224 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPR----- 224 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--CCC-----
Confidence 234567999999999999999999999999999999999999999642211 1122222222111100 000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
... ..+.+++.+|++.||++||++
T Consensus 225 ---~~~----~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 ---FLS----VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---CCC----HHHHHHHHHHhccCHHHcCCC
Confidence 001 123578999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.21 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=198.6
Q ss_pred cccccccccccceeEEEEEEC----CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 805 FDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
|.+.++||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|++++++++||||+++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 368899998865332 3456889999999999999999999886432 1
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++++||+++|+|.+++..... .....+++.....++.|++.|++|||+.+|+||||||+||+++.++.+|++|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 23689999999999988764321 12235788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
+...... .........++..|++||.+....++.++||||||+++|||++ |+.||......+...++.. +....
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~ 235 (273)
T cd05074 161 KKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK----GNRLK 235 (273)
T ss_pred ccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc----CCcCC
Confidence 8542211 1112223345678999999998889999999999999999999 8899876554444333322 11000
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
..+. ....+.+++.+||+.+|++||++.|+++.|+++
T Consensus 236 --------~~~~-----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 --------QPPD-----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------CCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 012356899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=304.65 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=197.7
Q ss_pred ccccccccccccceeEEEEEECC--ceEEEEEECCCCC-----------ccHHHHHHHHHHhhh-ccCCcceEEeeEEec
Q 047739 804 QFDEENVLSRTRYGLVFKACYND--GMVLSIRRLPDGS-----------LDENLFRKEAEFLGK-VRHRNLTVLRGYYAG 869 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 869 (1099)
.|++.+.||+|+||.||+|.++. +..+++|.+.... .....+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999999865 6889999874211 112446778888875 799999999999985
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEecc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
+ ...++||||+++++|.+++.... .....+++..++.++.|++.|+.|||+ .+++|+||+|+||+++.++.+|++||
T Consensus 81 ~-~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 N-DRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred C-CeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 4 55699999999999999986532 223458899999999999999999996 68999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
|.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||...........+.. +..
T Consensus 159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----~~~ 230 (269)
T cd08528 159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE----AVY 230 (269)
T ss_pred cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh----ccC
Confidence 9997642211 33456788999999999988899999999999999999999999975544333332221 111
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..... ... -..+.+++.+||+.||++||++.|+.++++
T Consensus 231 ~~~~~--------~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPE--------GMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCc--------ccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10000 000 023457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=310.28 Aligned_cols=255 Identities=21% Similarity=0.324 Sum_probs=200.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..+|+..+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. +...++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeec
Confidence 467899999999999999999874 68899999986433 334678899999999999999999999985 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++++|||++....+.
T Consensus 97 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~-- 168 (297)
T cd06656 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (297)
T ss_pred ccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--
Confidence 9999999999864 23788899999999999999999999999999999999999999999999998754221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........+++.|+|||...+..++.++|||||||++|+|++|+.||...........+. .........
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~----~~~~~~~~~------ 237 (297)
T cd06656 169 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNGTPELQN------ 237 (297)
T ss_pred -ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec----cCCCCCCCC------
Confidence 112234568899999999998889999999999999999999999997544322111100 000000000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhccc
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCR 1081 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 1081 (1099)
+. ..-..+.+++.+||+.+|++||+++++++ .++.+.
T Consensus 238 -~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 238 -PE----RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 00 00112357889999999999999999998 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.97 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=198.6
Q ss_pred hccccccccccccceeEEEEEE-CCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.+|+..+.||.|+||.||+|.. .+++.|++|.+.... ...+.+.+|++++++++||||+++++++.. +...++||||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEe
Confidence 4688999999999999999986 468899999885433 234678899999999999999999999885 4556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++.. ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--- 168 (296)
T cd06655 98 LAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--- 168 (296)
T ss_pred cCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc---
Confidence 999999998864 23789999999999999999999999999999999999999999999999998754221
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ........+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~----~~~~~~~~~------ 238 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNP------ 238 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCcccCCc------
Confidence 1122345688999999999988899999999999999999999999976654332222211 100000000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ..+.+++.+||+.||++||++.+++..
T Consensus 239 -~~~~----~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 -EKLS----PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -ccCC----HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 124578999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=305.67 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=198.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+|+..+.||.|+||.||+|... ++..|++|.+.... .....+.+|++++++++|+||+++++++.++ ...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEe
Confidence 6788899999999999999976 58899999986433 2335688999999999999999999998854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++... .+++..+..++.|++.|+.|||+.+++||||+|+||++++++.++++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--- 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc---
Confidence 9999999999742 5899999999999999999999999999999999999999999999999999765321
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........++..|+|||++.+..++.++||||||+++|||++|+.||...........+.. .......+..
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~----- 222 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NNPPSLEGNK----- 222 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----cCCCCCcccc-----
Confidence 1223345788899999999988899999999999999999999999975543322222111 1111111000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ ..+.+++.+||..+|++||+++++++.
T Consensus 223 ---~~----~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 ---FS----KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---cC----HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 123578899999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.36 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=194.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----------HHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
+|...+.||+|+||.||+|... ++..|++|.+...... .+.+.+|++++++++||||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence 3677889999999999999875 5788999987543221 14688999999999999999999998854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+++++|.+++... ..+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++|+|||.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 568999999999999999753 237888899999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCC---CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 953 LTIPTPAE---ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 953 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
........ ........|+..|+|||.+.+..++.++||||+|+++|||++|+.||...........+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~--- 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE----N--- 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc----c---
Confidence 65321111 1112234588899999999988899999999999999999999999976543322221111 1
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+.. . ... -..+.+++.+||+.||++||++.||++
T Consensus 228 --~~~~~---~-~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --ASPEI---P-SNI----SSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCCcC---C-ccc----CHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00110 0 000 123457899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=310.12 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=197.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|...+.||+|+||.||+|..+ ++..||+|.+.... .....+.+|++++++++||||+++++++.. +...++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence 56889999999999999999876 57889999885432 233567889999999999999999999984 456799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ ++|.+++... ...+++.....++.|+++||+|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--- 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--- 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC---
Confidence 997 5899888653 23478899999999999999999999999999999999999999999999999875321
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---ccccccC-
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---ITELLEP- 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~d~- 1034 (1099)
.........++..|+|||++.+. .++.++||||+||++|||++|+.||......+....+........ .....+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11222344678899999988654 478899999999999999999999987665544444333221110 0000000
Q ss_pred cccC--CCCCCh-hHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLE--LDPESS-EWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~--~~~~~~-~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.. ...... ... --..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000000 000 0113457999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.79 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=191.5
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCH
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
-++|+|.||+||-|++.+ ...+|||.++.. +...+-...|+.+-++++|+|||+++|.+.++ ++.-+.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-Gf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-GFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-CeEEEEeecCCCCcH
Confidence 479999999999999865 567999999653 33446688899999999999999999998754 455789999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEEeccccccccCCCCCCCcccc
Q 047739 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 887 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
.+.++.. ...-.=.+.+.-.+.+||++||.|||+..|||||||-.|||++ ..|.+||+|||-++..... .....
T Consensus 660 SsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---nP~TE 734 (1226)
T KOG4279|consen 660 SSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---NPCTE 734 (1226)
T ss_pred HHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---Ccccc
Confidence 9999752 1111126677788999999999999999999999999999996 6899999999999876322 23344
Q ss_pred ccccCccccCccccccC--CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCC
Q 047739 966 TAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1043 (1099)
+..||..|||||++..+ .|..++|||||||++.||.||++||......+... ++-. +.+..|..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-FkVG-------------myKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-FKVG-------------MYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-hhhc-------------ceecCCCC
Confidence 57899999999999865 58899999999999999999999997554433211 1111 11111111
Q ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1044 ~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.+--..+..+|.+|+.+||.+||++.++++
T Consensus 801 -Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 -PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1222234567999999999999999999986
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.97 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=199.9
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||.|+||.||.++.. ++..+++|.+.... ...+.+.+|++++++++|+||+++++++.+ ....++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence 4788899999999999999864 47889999875432 234668899999999999999999999985 456799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++.... ...+++..+..++.|+++|++|||+.+++|+||+|+||++++++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~- 155 (256)
T cd08221 80 YANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY- 155 (256)
T ss_pred ecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence 999999999997531 3458999999999999999999999999999999999999999999999999987552211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.......|+..|+|||+..+..++.++||||+|++++||++|+.||......+....+.. +...... .
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~-~----- 223 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNYTPVV-S----- 223 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCCCCCc-c-----
Confidence 123445789999999999888899999999999999999999999976554443333221 1111110 0
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. . -..+.+++.+||+.+|++||++.|+++.
T Consensus 224 --~-~----~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 --V-Y----SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --c-c----CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 0 1124578999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.66 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=195.4
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.+.|++.++||.|+||.||+|.... +..|++|.+..... ..+.+.+|++++++++||||+++++++..+ ...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEe
Confidence 3568889999999999999999864 78999999865433 346788999999999999999999998754 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|..++.+. ...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 90 FCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999998887642 234889999999999999999999999999999999999999999999999988653211
Q ss_pred CCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 960 EASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
........++..|+|||++. ...++.++|||||||++|||++|+.||...........+ ..........
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~- 237 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----AKSEPPTLSQ- 237 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH----hcCCCccCCC-
Confidence 12223456888999999885 344688999999999999999999998754432222111 1111000000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.. -...+.+++.+||+.+|++||++.|+++.
T Consensus 238 ------~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 ------PSK----WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------Ccc----cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 01124578999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=311.43 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=198.1
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|...+ +..||+|.+...... .+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence 368889999999999999999864 889999998654332 3568899999999999999999999874 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999998742 2356899999999999999999999999999999999999999999999999998754211
Q ss_pred CCCC--------------------------ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC
Q 047739 958 PAEA--------------------------STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011 (1099)
Q Consensus 958 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~ 1011 (1099)
.... ......+|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 11123478999999999998889999999999999999999999997665
Q ss_pred chhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 047739 1012 DEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT----MSDIVF 1075 (1099)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs----~~evl~ 1075 (1099)
.......+.. ... .+. .... .-..+.+++.+||+.||++||+ ++|++.
T Consensus 237 ~~~~~~~~~~----~~~------~~~---~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDETFSNILK----KEV------TFP---GSPP---VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHHHHhc----CCc------cCC---Cccc---cCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 5433322221 000 000 0000 1123467899999999999999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=305.06 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=195.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|++|.||+|+.+ ++..|++|.+..... ..+.+.+|+.++++++||||+++++++.. +...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 4778899999999999999875 588999998854322 23668899999999999999999999985 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ ++|.+++.... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred cCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 997 68998886532 2345899999999999999999999999999999999999999999999999998754211
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc------cccc-
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ------ITEL- 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------~~~~- 1031 (1099)
........++..|+|||++.+. .++.++||||+|++++||++|+.||......+....+........ ....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1222344678899999988654 478899999999999999999999976544332222211111000 0000
Q ss_pred -ccCcccCCCCCCh-h-H-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 -LEPGLLELDPESS-E-W-EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 -~d~~~~~~~~~~~-~-~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
............. . . .--..+.+++.+||+.||++|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000 0 0 001233579999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.40 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=194.0
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+++.+.....||+|+||.||+|.+. ++..|++|.+.... ...+.+.+|++++++++|+||+++++++..+ ...++|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 83 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKIF 83 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEEE
Confidence 35566667789999999999999865 57889999886543 3456789999999999999999999998854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~ 956 (1099)
+||+++++|.+++.... .....++..+..++.|++.|++|||+.+|+||||||+||+++. ++.++|+|||.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 84 MEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999997521 1112378888899999999999999999999999999999986 67999999999875422
Q ss_pred CCCCCccccccccCccccCccccccCC--CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. ........|+..|+|||++.... ++.++||||||+++|||++|+.||..........+...... . ...++.
T Consensus 162 ~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-~~~~~~ 235 (268)
T cd06624 162 I---NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--I-HPEIPE 235 (268)
T ss_pred C---CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--c-CCCCCc
Confidence 1 11222346889999999986543 78999999999999999999999965433222111111000 0 000000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. -..+.+++.+||+.+|++||++.|+++.
T Consensus 236 --------~~----~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 --------SL----SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------cc----CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 1124578999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.88 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=195.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|...+.||+|+||.||+|... +++.|++|.+..... ....+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEe
Confidence 357888899999999999999875 588999998864432 33567889999999999999999999875 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ..+++.+...++.|++.|++|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--- 158 (267)
T cd06645 87 FCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--- 158 (267)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC---
Confidence 99999999998743 2488999999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 960 EASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.........|+..|+|||++. ...++.++||||+||++|||++|+.||.............. .... .+..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----~~~~---~~~~ 231 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----SNFQ---PPKL 231 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc----cCCC---CCcc
Confidence 112223457899999999874 45588999999999999999999999865433221111111 1100 0100
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ...+. ..+.+++.+|++.+|++||+++++++.
T Consensus 232 ~~----~~~~~--~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD----KMKWS--NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc----cCCCC--HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 00011 124578999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=320.73 Aligned_cols=239 Identities=21% Similarity=0.315 Sum_probs=183.3
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhc---cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKV---RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
||+|+||.||+|+.. ++..||+|++..... ....+..|..++.+. +||||+++++++... ...|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence 699999999999876 488999999854221 123345577777665 699999999998854 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ..+++.....++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---~~~ 151 (330)
T cd05586 80 GGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT---DNK 151 (330)
T ss_pred CChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC---CCC
Confidence 99999988742 3478999999999999999999999999999999999999999999999999875321 122
Q ss_pred cccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.....+||..|+|||++.+. .++.++||||+||++|||++|+.||......+....+.. +.. . + ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~----~~~-~-----~---~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF----GKV-R-----F---PK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc----CCC-C-----C---CC
Confidence 23456799999999998764 479999999999999999999999976655443333221 111 0 0 00
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPT----MSDIVF 1075 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs----~~evl~ 1075 (1099)
.... ..+.+++.+||+.||++||+ +.|+++
T Consensus 219 ~~~~----~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLS----DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCC----HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0000 12347899999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.87 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=194.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
+|+..+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++|+||+++++++..+ ...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence 4677889999999999999986 68899999874322 1235688999999999999999999998754 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++... ..+++..+..++.|++.|++|||+.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999999753 2478999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+.. ...... +.+.
T Consensus 155 ~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~~~~ 226 (258)
T cd06632 155 FS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR---SKELPP-IPDH 226 (258)
T ss_pred cc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh---cccCCC-cCCC
Confidence 11 233456889999999987766 89999999999999999999999965442222211111 011110 1110
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. -..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~------------~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 L------------SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred c------------CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 0223578899999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=305.41 Aligned_cols=239 Identities=21% Similarity=0.382 Sum_probs=183.5
Q ss_pred cccccccceeEEEEEECC--------ceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYND--------GMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.||+|+||.||+|..+. ...|++|.+.... ...+.+.+|+.++++++||||+++++++.... ..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEEEe
Confidence 469999999999998642 2347777775432 22367889999999999999999999998544 4599999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc--------EEEeccccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE--------AHLSDFGLD 951 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~--------~kl~DfGla 951 (1099)
|+++|+|.++++..+ ..+++..+..++.||+.|++|||+.+|+||||||+||+++.++. ++++|||.+
T Consensus 80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999997532 25789999999999999999999999999999999999987765 699999988
Q ss_pred cccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCC-CCCCCCCchhHHHHHHHHhhhcccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGK-RPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||............. ....+
T Consensus 156 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~- 224 (258)
T cd05078 156 ITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQL- 224 (258)
T ss_pred cccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---ccccC-
Confidence 65421 1234678899999998864 5789999999999999999985 5554433322111111 01100
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
+. ..+ ..+.+++.+||+.||++|||++++++.|+
T Consensus 225 ----------~~--~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 ----------PA--PKW---TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------CC--CCc---HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011 23468999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.11 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=196.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|...+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+||+++++++.. ....++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 4778899999999999999875 688999999865443 35678999999999999999999999874 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ..+++..+..++.|+++|++|||+.+|+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 80 YCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred cCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999742 3378889999999999999999999999999999999999999999999999876532222
Q ss_pred CCcc-ccccccCccccCccccccCC---CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 960 EAST-STTAVGTLGYVSPEAALTGE---TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 960 ~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.... .....++..|+|||++.+.. ++.++||||||++++||++|+.||...+.......... .+.... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~~-- 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG---AGHKPP-IP-- 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---cCCCCC-CC--
Confidence 1111 22456888999999988766 88999999999999999999999975433221111111 111000 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.... .-..+.+++.+||+.+|++||++.|++.
T Consensus 229 -----~~~~---~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 -----DSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----cccc---cCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0112357899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=299.62 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=198.7
Q ss_pred cccccccccccceeEEEEEECC-----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 805 FDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
|++.+.||.|+||.||++.+.+ +..||+|.+..... ..+.+..|++++++++|+||+++++++.+. ...++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence 3567889999999999999864 48899999965544 457899999999999999999999999855 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+.+++|+||||+||+++.++.++++|||+++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999975321 22899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. ........++..|+|||.+.+..++.++||||+|++++||++ |+.||......+..+.+... .....
T Consensus 157 ~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~----- 225 (258)
T smart00219 157 D--YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG----YRLPK----- 225 (258)
T ss_pred c--ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----CCCCC-----
Confidence 1 111112347789999999988889999999999999999998 88888765554444443321 11000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
+... -..+.+++.+|+..||++|||+.|+++.|
T Consensus 226 ----~~~~----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----PENC----PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCcC----CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0001 11345789999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=306.15 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=196.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.|+..+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEE
Confidence 34677788999999999999875 57889999876432 2335789999999999999999999998854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++.. ..+++..+..++.|+++|+.|||+.+++|+||+|+||++++++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-- 154 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--
Confidence 9999999998863 34788999999999999999999999999999999999999999999999998754221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||++.+..++.++||||||++++||++|+.||...........+. ... .+..
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~~-----~~~~--- 221 (277)
T cd06642 155 -QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----KNS-----PPTL--- 221 (277)
T ss_pred -chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh----cCC-----CCCC---
Confidence 112233568899999999998889999999999999999999999986543332222111 110 0100
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. . .....+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~-~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 E-G----QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C-c----ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 0 011234688999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.40 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=195.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|++++++++||||+++++++.. +...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence 36888899999999999999986 68899999886432 223578899999999999999999998875 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|+++++|.+++.... ....+++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.+|++|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 155 (286)
T cd06622 80 YMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-- 155 (286)
T ss_pred ecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence 999999999887521 23458999999999999999999997 5999999999999999999999999999875421
Q ss_pred CCCccccccccCccccCccccccCC------CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGE------TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.......++..|+|||++.+.. ++.++||||+||++|||++|+.||...........+... ..+.... +
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-~ 230 (286)
T cd06622 156 ---SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI-VDGDPPT-L 230 (286)
T ss_pred ---CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH-hhcCCCC-C
Confidence 1223346888999999885443 588999999999999999999999654433333222221 1111111 0
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ . .-..+.+++.+||+.+|++||++.+++..
T Consensus 231 ~~-------~-----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 PS-------G-----YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred Cc-------c-----cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00 0 01223578999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.51 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=197.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||.|+||.||+|.+. ++..|++|.+..... ..+.+.+|++++++++||||+++++++.. +...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence 457889999999999999999875 588999999865432 34578899999999999999999999885 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... +..+++.....++.|++.|++|||+.+|+|+||||+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 83 FCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999998753 234899999999999999999999999999999999999999999999999988654211
Q ss_pred CCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 960 EASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
........++..|+|||++. ...++.++||||||+++|||++|+.||...........+ ..+.......+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~ 231 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----LKSEPPTLDQP 231 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH----hcCCCCCcCCc
Confidence 12223456899999999875 344678999999999999999999999765443322221 11111000000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. + -..+.+++.+||+.+|.+||++.++++.
T Consensus 232 -------~~--~--~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 -------SK--W--SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cc--C--CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 0 0124578999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=310.90 Aligned_cols=202 Identities=22% Similarity=0.255 Sum_probs=163.8
Q ss_pred cccccccc--cceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 807 EENVLSRT--RYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 807 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.++||+| +||+||++..+ +|+.||+|++..... ..+.+.+|+++++.++||||+++++++..+ +..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEec
Confidence 45789999 68899999875 689999999865422 235677899999999999999999999854 456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999996422 234889999999999999999999999999999999999999999999999865432111100
Q ss_pred ----CccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCc
Q 047739 961 ----ASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012 (1099)
Q Consensus 961 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~ 1012 (1099)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 011123457788999999876 4588999999999999999999999975443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=301.91 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=200.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCC-----Cc
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP-----DL 873 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-----~~ 873 (1099)
++++|+..+.||+|+||.||+|..+ +++.+++|.+.......+.+.+|+++++++ +|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4678999999999999999999985 578899999876666667899999999999 6999999999987432 34
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+|++|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 6899999999999999875331 235589999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
... .........|+..|+|||++.. ..++.++||||+|++++||++|+.||...........+. ....
T Consensus 163 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~ 235 (275)
T cd06608 163 LDS---TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP----RNPP 235 (275)
T ss_pred ccc---chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh----ccCC
Confidence 421 1222334568999999998753 346789999999999999999999997543322222111 1110
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+... ....+ ...+.+++.+||+.||++|||+.|+++.
T Consensus 236 -----~~~~----~~~~~--~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 236 -----PTLK----SPENW--SKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CCCC----chhhc--CHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 00001 1234579999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=308.20 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=195.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.|.....||+|+||.||++... ++..||+|.+.... ...+.+.+|+.++++++||||+++++.+... +..++||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeC
Confidence 34455577999999999999875 57899999885433 2345688999999999999999999998754 556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++.. ..+++..+..++.||+.|++|||+.+|+||||||+||+++.++.++++|||++..... .
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~---~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---E 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc---c
Confidence 999999998853 2378899999999999999999999999999999999999999999999999875421 1
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........|+..|+|||+..+..++.++||||||+++|||++|+.||...........+.... .+......
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~ 242 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL---------PPRVKDSH 242 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------CCcccccc
Confidence 122234578999999999988889999999999999999999999997655443333222111 11110000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. -..+.+++.+||+.||.+|||++|+++.
T Consensus 243 ~~------~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KV------SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc------CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0123578889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.77 Aligned_cols=254 Identities=21% Similarity=0.378 Sum_probs=193.0
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-----------cHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-----------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
+|...+.||.|+||.||+|... +|+.||+|.+..... ..+.+.+|++++++++|||++++++++.. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence 4677889999999999999865 588999998743211 01457889999999999999999999875 4
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...++||||+++|+|.+++.+. ..+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++++|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 5569999999999999999753 34788899999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCccccCccccccCC--CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+..... ..........|+..|+|||.+.... ++.++||||+|++++|+++|..||........ ...... ....
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~ 230 (272)
T cd06629 156 KKSDDI-YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKLGN-KRSA 230 (272)
T ss_pred cccccc-ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHHhhc-cccC
Confidence 754211 1111223456889999999987654 78999999999999999999999864332211 111111 1111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..++.... .. -...+.+++.+||+++|++||+++||++.
T Consensus 231 ~~~~~~~~---~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVS---MN-----LSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcccc---cc-----CCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111110 00 01234578899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=301.40 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=197.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|+..+.||+|+||.||+|..+ +|+.||+|++.... ...+.+.+|++++++++|||++++++++.. +...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence 36888899999999999999986 58899999885432 223568899999999999999999999885 44569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++++.|..+.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 80 EYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred eccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887776532 248999999999999999999999999999999999999999999999999997652211
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc--ccccccC-
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ--ITELLEP- 1034 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~d~- 1034 (1099)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+........ .....+.
T Consensus 155 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 ---DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12234467889999999876 4578999999999999999999999976555443333222111100 0000000
Q ss_pred ----cccCCCC-CChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 ----GLLELDP-ESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ----~~~~~~~-~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
......+ .....+. -..+.+++.+||+.+|++||++.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 0000110 1234689999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=329.15 Aligned_cols=203 Identities=19% Similarity=0.244 Sum_probs=159.2
Q ss_pred HHhccccccccccccceeEEEEEECC--ceEEEEE------------------ECCCCCccHHHHHHHHHHhhhccCCcc
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND--GMVLSIR------------------RLPDGSLDENLFRKEAEFLGKVRHRNL 860 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~H~ni 860 (1099)
...+|++.+.||+|+||.||++..+. +..+++| .+.........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 2222222 122222234568899999999999999
Q ss_pred eEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC
Q 047739 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940 (1099)
Q Consensus 861 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~ 940 (1099)
+++++++... +..|+|+|++. +++.+++..................++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 226 v~l~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSE-ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEEC-CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999854 45699999995 588887764332222234456677899999999999999999999999999999999
Q ss_pred CcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCC
Q 047739 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV 1007 (1099)
Q Consensus 941 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~ 1007 (1099)
+.+||+|||+++.... .........+||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 304 ~~vkL~DFGla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEK--EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCc--ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999986522 1122233467999999999999999999999999999999999988644
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.16 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=197.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|++.+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEe
Confidence 56888899999999999999875 58889999875432 2346789999999999999999999999855 56799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|+++|+|.+++.+. ..+++.....++.+++.|+.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-- 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-- 156 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh--
Confidence 99999999998752 247899999999999999999997 5899999999999999999999999999864311
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh--------HHHHHHHHhhhccccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED--------IVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~--------~~~~~~~~~~~~~~~~ 1030 (1099)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+... ....
T Consensus 157 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--- 229 (284)
T cd06620 157 ---SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEP--- 229 (284)
T ss_pred ---hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-hhcc---
Confidence 11224578999999999988889999999999999999999999997544321 11111111 1110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
.+.+ ... +.-..+.+++.+|++.||++||++.|+++..
T Consensus 230 --~~~~---~~~----~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRL---PSS----DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCC---Cch----hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 000 0112346889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=281.80 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=205.6
Q ss_pred HHHhcccc-ccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEec---CCCc
Q 047739 800 EATRQFDE-ENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAG---APDL 873 (1099)
Q Consensus 800 ~~~~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---~~~~ 873 (1099)
..+++|.+ .++||-|-.|.|..+..+ .|+.+|+|.+.+. ...++|++.--.. .|||||.++++|.. ....
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35777776 367999999999888765 5889999998643 4467888876655 69999999999863 3344
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGL 950 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGl 950 (1099)
..+|||.|+||.|.+.++.. ....+++++...|+.||+.|++|||+.+|.||||||+|+|... +..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 56999999999999999864 3456999999999999999999999999999999999999964 56799999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
|+... ......+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......+..-++..+..+..
T Consensus 211 AK~t~----~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy-- 284 (400)
T KOG0604|consen 211 AKETQ----EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY-- 284 (400)
T ss_pred ccccC----CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc--
Confidence 98642 233445678899999999999999999999999999999999999999876655554445555444432
Q ss_pred cccCcccCCCCCChhHHHHHHHH-HHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGV-KVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+|..+.+.+ ++|+..+..+|.+|-|+.|+++.
T Consensus 285 ---------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 ---------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22345677666544 58999999999999999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=298.76 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=197.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|++++++++|||++++++++.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence 4788899999999999999875 57889999885432 234678899999999999999999998874 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~~ 958 (1099)
|+++++|.+++.... ...+++..+..++.++++|++|||+.+|+|+||+|+||+++.+ +.+|++|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~-- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-- 154 (256)
T ss_pred cCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC--
Confidence 999999999997532 3457899999999999999999999999999999999999855 4689999999976521
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ......+ ..
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~-- 225 (256)
T cd08220 155 --KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG----TFAPISD-RY-- 225 (256)
T ss_pred --CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc----CCCCCCC-Cc--
Confidence 12223456889999999999888999999999999999999999999765544433332221 1111100 00
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ----------~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 226 ----------SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----------CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1124578999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=298.77 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=198.6
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|+||.||++... +|..|++|.+... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence 4788899999999999999875 5789999988532 2234678999999999999999999999874 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ....+++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 80 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~-- 154 (256)
T cd08218 80 YCEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST-- 154 (256)
T ss_pred cCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--
Confidence 99999999998742 2234788999999999999999999999999999999999999999999999998754211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||+..++.++.++||||||+++++|++|+.||......+....+.. +..... .
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~-~------ 222 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR----GSYPPV-S------ 222 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc----CCCCCC-c------
Confidence 1122345688899999999988899999999999999999999999976554443332221 111100 0
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. .-..+.+++.+||+.+|.+||++.||++.
T Consensus 223 --~~----~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 --SH----YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --cc----CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 01234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=297.13 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
++|+..+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeC
Confidence 57889999999999999999875 477899998864332 34678999999999999999999999875 4456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++... ...+++..+..++.|++.|++|||+.+|+|+||+|+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 154 (262)
T cd06613 82 CGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--- 154 (262)
T ss_pred CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh---
Confidence 9999999998753 134889999999999999999999999999999999999999999999999998754211
Q ss_pred CccccccccCccccCccccccC---CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG---ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.. .... .+...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~----~~~~---~~~~~ 227 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK----SNFP---PPKLK 227 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----ccCC---Ccccc
Confidence 1122345788899999998776 789999999999999999999999976544332222111 1000 00000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.....-..+.+++.+||+.+|.+||++.+|+.
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 ------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111123568999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=300.12 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=197.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..|+..+.||.|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEe
Confidence 35777889999999999999875 58899999875432 234678899999999999999999999985 456799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++.. ..+++.....++.|++.|++|+|+.+++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-- 154 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--
Confidence 9999999999863 23788889999999999999999999999999999999999999999999999754221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||++.+..++.++||||||+++|||++|+.||...........+ ..... +.
T Consensus 155 -~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~-----~~---- 220 (277)
T cd06640 155 -QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----PKNNP-----PT---- 220 (277)
T ss_pred -ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----hcCCC-----CC----
Confidence 11223356888999999998888999999999999999999999999754433222111 11100 00
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....-..+.+++.+||+.+|++||++.|+++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 ----LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001112234689999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=297.95 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=200.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|++.+.||.|+||.||+|... ++..+++|++.... ...+.+.+|++++++++|+||+++++.+.. +...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence 46889999999999999999865 57889999985433 245778999999999999999999998875 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++.... ....+++.....++.|++.|++|||+.||+||||+|+||++++++.++++|||++........
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999997532 124588999999999999999999999999999999999999999999999999876532221
Q ss_pred CC-ccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 960 EA-STSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.. .......|+..|+|||++... .++.++||||||++++||++|+.||.............. .. .+.+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~------~~~~~ 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND------PPSLE 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CC------CCCcC
Confidence 11 123445789999999998877 789999999999999999999999976544332222111 10 00010
Q ss_pred CCCCCChhHHH-HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEE-FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~-~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. . ..+.. -..+.+++.+||+.||++||++.|+++.
T Consensus 229 ~---~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 T---G-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C---c-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0 00000 1223578999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=298.88 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEec-CCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~~lV~ 878 (1099)
+|+..+.||.|+||.||+|... ++..|++|.+..... ..+.+..|++++++++||||+++++++.. .....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 578899998864332 34568889999999999999999998764 344568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc-----cCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH-----TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
||+++++|.+++.... .....+++...+.++.|++.|++||| +.+++|+||||+||+++.++.+|++|||++..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999997642 23456899999999999999999999 88999999999999999999999999999886
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.... ........++..|+|||++.+..++.++||||||+++++|++|+.||.........+.+. .+.... +.
T Consensus 160 ~~~~---~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-~~ 231 (265)
T cd08217 160 LGHD---SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK----EGKFRR-IP 231 (265)
T ss_pred ccCC---cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh----cCCCCC-Cc
Confidence 5221 111334578999999999998889999999999999999999999998765443333322 221111 11
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. .-..+.+++.+|++.+|++||++.+|++.
T Consensus 232 ~~------------~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 YR------------YSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cc------------cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 01234588999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=312.40 Aligned_cols=272 Identities=20% Similarity=0.295 Sum_probs=199.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCC----Cce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 874 (1099)
.++|++.++||+|+||.||+|... +|..||+|.+... ......+.+|+.++++++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 5889999998532 223456788999999999999999999876432 246
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||++ +++.+.+.. ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 89999996 588877753 34889999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc---cc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---TE 1030 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~ 1030 (1099)
..............|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 322222222344578999999998754 46889999999999999999999999765443333333222111100 00
Q ss_pred cccCcc----cCCC-CCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcc
Q 047739 1031 LLEPGL----LELD-PESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGC 1080 (1099)
Q Consensus 1031 ~~d~~~----~~~~-~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 1080 (1099)
..+... .... ....++. .-..+.+++.+||+.||++||++.|+++. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 0000 0000111 11235689999999999999999999986 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=300.08 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=198.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~lV~e 879 (1099)
+|+..+.||.|++|.||++... ++..+|+|.+..... ....+.+|++++++++||||+++++++... ....++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 6788899999999999999985 578999998864332 346789999999999999999999988643 345689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++..... ....+++.....++.|++.||+|||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-- 158 (287)
T ss_pred ecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--
Confidence 9999999998875322 3455788999999999999999999999999999999999999999999999998754211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc--hhHHHHHHHHhhhccccccccCccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD--EDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+.. ........... ..
T Consensus 159 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~--- 230 (287)
T cd06621 159 ---LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPEL-KD--- 230 (287)
T ss_pred ---ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhh-cc---
Confidence 11234578899999999988999999999999999999999999975522 1111111 11111111100 00
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.......+. ..+.+++.+||+.+|.+|||+.|+++
T Consensus 231 -~~~~~~~~~--~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 -EPGNGIKWS--EEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCCCchH--HHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001111122 23468999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.57 Aligned_cols=265 Identities=21% Similarity=0.274 Sum_probs=200.8
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|++.+.||+|+||.||+|.+. +|..|++|++..... ..+.+.+|+.++++++||||+++++++.. +...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence 4788899999999999999975 588999999865432 24678999999999999999999999885 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+ +++|.+++.... ..+++..+..++.||++||+|||+.+++|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE- 153 (286)
T ss_pred cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-
Confidence 99 999999987532 458999999999999999999999999999999999999999999999999987652211
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc------cccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI------TELL 1032 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~ 1032 (1099)
........|+..|+|||++.+. .++.++||||+|++++||++|+.||....+.....++......... .+..
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 -PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1223445789999999998754 4689999999999999999998888766554444444332221100 0000
Q ss_pred cCcccCC-CCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLEL-DPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~-~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+-..... ......+. .-..+.+++.+|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00000011 11345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.41 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=195.4
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccH---HHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+.|++.+.||+||-+.||++...+...+|+|++.....+. .-|..|+..|.+++ |.+||++++|-.. +++.|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 45688899999999999999999888899998886544443 56899999999995 9999999999874 6678999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||-+ .+|..+|++... ...+| .+..+.+|++.|+.+.|++||||.||||.|+|+- +|.+|++|||+|.... .
T Consensus 439 mE~Gd-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~-~ 511 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ-P 511 (677)
T ss_pred eeccc-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC-c
Confidence 99985 599999986432 23445 7788999999999999999999999999999884 4799999999998653 2
Q ss_pred CCCCccccccccCccccCccccccCC-----------CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGE-----------TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
+.........+||+.||+||.+.... .++++||||+|||+|+|+-|+.||..-. ..+..+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~------ 583 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH------ 583 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH------
Confidence 33344556789999999999875332 5689999999999999999999996321 1122222
Q ss_pred cccccccCccc-CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 QITELLEPGLL-ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 ~~~~~~d~~~~-~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.++... +++.-...++ +++++..|++.||++||+..|+++.
T Consensus 584 ---aI~~P~~~Iefp~~~~~~~----li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 ---AITDPNHEIEFPDIPENDE----LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---hhcCCCccccccCCCCchH----HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222110 1111222222 6789999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=288.36 Aligned_cols=268 Identities=23% Similarity=0.324 Sum_probs=219.1
Q ss_pred CHHHHHHHHhccccccccccccceeEEEEEECC------ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEee
Q 047739 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRG 865 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~ 865 (1099)
..+++.....+++...++-+|.||.||+|.|.+ .+.|.+|.++... .+...+..|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 445666667788889999999999999997653 3556677765433 23466888999999999999999999
Q ss_pred EEecCCCceEEEEeecCCCCHHHHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc
Q 047739 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE 942 (1099)
Q Consensus 866 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~ 942 (1099)
++.++.+..+.+|.++.-|+|..|+..++. ...+.++..+...+|.|++.|++|||..||||.||.++|.+||+..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 998887888999999999999999985432 23456778888899999999999999999999999999999999999
Q ss_pred EEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHH
Q 047739 943 AHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 943 ~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~ 1021 (1099)
+|++|=.++|...+.+.. ......-.+..||+||.+....|+.++|||||||++|||+| |+.||..-++.++..++++
T Consensus 435 VkltDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCccccc-ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999987665432 23334456778999999999999999999999999999998 9999998888888777766
Q ss_pred HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1022 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+.+-. .|..++.+ +..++.-||+.+|++||+++|++.-|.+
T Consensus 514 GyRla-------------QP~NCPDe----Lf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 514 GYRLA-------------QPFNCPDE----LFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cceec-------------CCCCCcHH----HHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 54322 22334433 3467888999999999999999998865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=327.49 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=194.0
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecC------
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA------ 870 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 870 (1099)
....+|++.++||+||||.||+++.+ ||+.||||++.... ..-..+.+|+.++.+++|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567999999999999999999987 89999999997764 2235578999999999999999998633210
Q ss_pred --------------------------------------------------------------------------------
Q 047739 871 -------------------------------------------------------------------------------- 870 (1099)
Q Consensus 871 -------------------------------------------------------------------------------- 870 (1099)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 047739 871 ------------------------P--------DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918 (1099)
Q Consensus 871 ------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 918 (1099)
+ ...||-||||+.-.+.+++++..... .....++++.+|++||+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence 0 13478899999877777777543211 45677889999999999
Q ss_pred HHccCCceecCCCCCCEEECCCCcEEEeccccccccC------CC---------CCCCccccccccCccccCccccccC-
Q 047739 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI------PT---------PAEASTSTTAVGTLGYVSPEAALTG- 982 (1099)
Q Consensus 919 ~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~------~~---------~~~~~~~~~~~gt~~y~aPE~~~~~- 982 (1099)
|+|+.|||||||||.||++|.+..|||+|||+|.... .. .......+..+||.-|+|||.+.+.
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999999998611 00 0112245678999999999998765
Q ss_pred --CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcC
Q 047739 983 --ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCT 1060 (1099)
Q Consensus 983 --~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl 1060 (1099)
.|+.|+|+||+|+|++||+- ||... . +. ..+...++.+.++.. +.+. .++...-.++|.|++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-M-ER-a~iL~~LR~g~iP~~--~~f~--------~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS-M-ER-ASILTNLRKGSIPEP--ADFF--------DPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch-H-HH-HHHHHhcccCCCCCC--cccc--------cccchHHHHHHHHHh
Confidence 49999999999999999975 55321 1 11 223344556665544 1111 011122358999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 047739 1061 APDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1061 ~~dP~~RPs~~evl~~ 1076 (1099)
+.||.+|||+.|++.-
T Consensus 856 ~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLNS 871 (1351)
T ss_pred cCCCccCCCHHHHhhc
Confidence 9999999999998864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.92 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=193.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|+||.||+|... +|..|++|.+..... ..+.+.+|++++++++||||+++++++.+. ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence 4778899999999999999986 588999998854322 235678899999999999999999998854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ ++|.+++... ...+++.....++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--- 151 (284)
T cd07839 80 YCD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--- 151 (284)
T ss_pred cCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC---
Confidence 997 5888887642 23489999999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCC-CchhHHHHHHHHhhhcc------cccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFT-QDEDIVKWVKKQLQKGQ------ITEL 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~-~~~~~~~~~~~~~~~~~------~~~~ 1031 (1099)
.........++..|+|||++.+.. ++.++||||+||++|||++|+.|+... +.....+.+........ ....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112223456789999999987654 689999999999999999999986433 22233333222211100 0000
Q ss_pred ccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.......+....+.+ -..+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000001111111 123457999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=305.78 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=197.4
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
+|+..+.||+|+||.||++.... ++.|++|.+..... ..+.+.+|+++++.++||||+++++.+.. +...++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEE
Confidence 68888999999999999998764 78899998865432 23567899999999999999999999874 45669999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++... ..+++.....++.|++.|++|+|+.+++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999753 247889999999999999999999999999999999999999999999999987421110
Q ss_pred CC------------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 959 AE------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 959 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
.. ........++..|+|||++.+..++.++||||||+++|||++|+.||.+....+....... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~----~ 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----D 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----c
Confidence 00 0011234678899999999888899999999999999999999999976554443332222 1
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
... .+.. ....+ ..+.+++.+||+.||++||++.++.+.|+.
T Consensus 232 ~~~---~~~~----~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE---WPEG----DEALP----ADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC---CCCc----cccCC----HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 0000 00000 123579999999999999997777666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=303.67 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=195.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||++.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence 36888999999999999999876 57899999885432 2235688999999999999999999998854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 80 MEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999999753 34889999999999999999999999999999999999999999999999998765221
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.....|+..|+|||.+.+...+.++||||+|+++|+|++|+.||.........+.+. .+... +..
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~--~~~--- 219 (290)
T cd05580 155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----EGKVR--FPS--- 219 (290)
T ss_pred ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCcc--CCc---
Confidence 234568899999999988888999999999999999999999997655433333222 11110 000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
.. + ..+.+++.+||+.||.+|| +++|+++
T Consensus 220 ----~~-~----~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 220 ----FF-S----PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cC-C----HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 0 2335789999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=305.42 Aligned_cols=208 Identities=23% Similarity=0.336 Sum_probs=170.9
Q ss_pred ccccccccccccceeEEEEEECC---ceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND---GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~ 875 (1099)
+|+..+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+. +...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999754 7899999986532 1235678899999999999999999999854 25579
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC----CCcEEEeccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA----DFEAHLSDFGLD 951 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~----~~~~kl~DfGla 951 (1099)
+||||++ +++.+++..........+++.....++.|++.|++|||+.+|+||||||+||+++. ++.+|++|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999997 47888776543333346889999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~ 1012 (1099)
+................++..|+|||++.+. .++.++||||||++++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 8653222222233455788999999988764 578999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=307.60 Aligned_cols=281 Identities=23% Similarity=0.316 Sum_probs=204.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhc-cCCcceEEeeEEecC-CCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~ 874 (1099)
..++|+..+.||+|+||.||+|.+. ++..+++|++... ......+.+|+.+++++ +||||+++++++... ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568999999999999999999976 5789999988532 22335677899999999 999999999998643 3456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|++|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 89999997 5998888641 4788899999999999999999999999999999999999999999999999755
Q ss_pred CCCCCC--CccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc----
Q 047739 955 IPTPAE--ASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---- 1027 (1099)
Q Consensus 955 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1027 (1099)
...... ........|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322111 122334578999999998765 4578999999999999999999999976655444333322211000
Q ss_pred -------cccccc----CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccCCCCCCCCC
Q 047739 1028 -------ITELLE----PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRVGPDIPSSA 1090 (1099)
Q Consensus 1028 -------~~~~~d----~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~ 1090 (1099)
....++ ............ .-..+.+++.+||+.||++|||+.++++. ++......+.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~ 311 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPK--ASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLP 311 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccC--CCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCC
Confidence 000000 000000000000 01234689999999999999999999975 55554444444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=301.02 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=201.8
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++.|+..+.||+|+||.||+|.++ ++..|++|.+.......+.+.+|++++++++|+|++++++++... ...++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEe
Confidence 4556888899999999999999987 588899999865544567789999999999999999999998854 56799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+|++|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 999999999998632 35899999999999999999999999999999999999999999999999988654211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||++.+..++.++||||||+++|+|++|+.||...........+.. .......+.
T Consensus 170 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~----- 239 (286)
T cd06614 170 -KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----KGIPPLKNP----- 239 (286)
T ss_pred -hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCCCCcch-----
Confidence 1122334578899999999888899999999999999999999999976544332222211 111110000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. .+. ..+.+++.+||+.+|.+||++.++++
T Consensus 240 --~--~~~--~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 --E--KWS--PEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --h--hCC--HHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 000 13457899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=301.12 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=190.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHH-hhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEF-LGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|++.+.||+|+||.||+|.++ +|..||+|++..... ....+..|+.. ++..+||||+++++++..+ ...++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-GDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-CcEEEEh
Confidence 36888999999999999999986 589999999865432 23455566665 5667899999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||++ |+|.+++..... ....+++.....++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 9996 689888875332 235689999999999999999999997 999999999999999999999999999875421
Q ss_pred CCCCccccccccCccccCcccccc----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
........|+..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .+.+..... +.......
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~~~~~~ 230 (283)
T cd06617 157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVE-EPSPQLPA 230 (283)
T ss_pred ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHh-cCCCCCCc
Confidence 112233568899999998864 44688999999999999999999998643221 111111111 11111100
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.... ..+.+++.+||+.+|++||++.|+++
T Consensus 231 --------~~~~----~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 --------EKFS----PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------cccC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 12457899999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=308.54 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=198.6
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP---- 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 871 (1099)
...++|+..+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999875 68899999985422 22356778999999999999999999886332
Q ss_pred -CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 872 -DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 872 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
...|+||||+. ++|.+.+.. .+++.....++.|++.||+|||+.||+||||||+||+++.++.+|++|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 24589999996 588888753 178888999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ--- 1027 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 1027 (1099)
++.... ........++..|+|||++.+..++.++||||+||++++|++|+.||...+.......+........
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 165 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred ceeCCC----CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 976421 1223345688999999999999999999999999999999999999976554333333322111100
Q ss_pred -------ccccccCc-------ccCC------CCCCh--hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 -------ITELLEPG-------LLEL------DPESS--EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 -------~~~~~d~~-------~~~~------~~~~~--~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+.. +.+. ..... .......+.+++.+|++.||++||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 00000 00112234689999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=301.30 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=193.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..+.||+|++|.||+|..+ +++.|++|.+..... ....+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence 57889999999999999999976 578999999854322 23457789999999999999999999884 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ ++|.+++.+.. ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 84 YLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred cCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 997 59999887532 35788999999999999999999999999999999999999999999999998743111
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-hhHHHHHHHHhhhcccc---c----
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQD-EDIVKWVKKQLQKGQIT---E---- 1030 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~---~---- 1030 (1099)
........++..|+|||++.+ ..++.++||||+|+++|||++|+.||..... .+....+.......... .
T Consensus 157 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 -SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 111223456889999998875 4578999999999999999999999965442 22222222211110000 0
Q ss_pred --cccCcccCCCCCC-----hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1031 --LLEPGLLELDPES-----SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1031 --~~d~~~~~~~~~~-----~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..........+.. ........+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 00001134468999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=301.98 Aligned_cols=268 Identities=19% Similarity=0.239 Sum_probs=196.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCC----c
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPD----L 873 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----~ 873 (1099)
++|+..+.||+|+||.||+|.+. ++..||+|....... ....+.+|++++++++ ||||+++++++...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999975 588999998754322 2356888999999995 6999999998875433 2
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEecccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDR 952 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~ 952 (1099)
.|+||||+++ +|.+++..........+++..+..++.||+.||+|||+.+|+||||||+||+++. ++.+|++|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 5899999985 8999887543332456899999999999999999999999999999999999998 8999999999987
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
..... ........+++.|+|||++.+ ..++.++||||||+++|||++|..||....+......+........ ..
T Consensus 160 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~ 234 (295)
T cd07837 160 AFSIP---VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT--EQ 234 (295)
T ss_pred ecCCC---ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC--hh
Confidence 54211 112233467889999998865 4578999999999999999999999976555443333322221110 00
Q ss_pred ccCcc------cCCCC-CChh-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 LEPGL------LELDP-ESSE-----WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~------~~~~~-~~~~-----~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.. .+... .... ...-..+.+++.+||++||.+||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00000 0000 0011234689999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=296.29 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=194.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC------CccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG------SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
.+|+..+.||+|+||.||+|... ++..|++|.+... ....+.+.+|++++++++||||+++++++.+. ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999875 5889999987432 11235788999999999999999999998754 3456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||+++++|.+++... ..+++.....++.|++.|++|||+.+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999998742 23788889999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
..............++..|+|||++.+..++.++|||||||+++||++|+.||......... .+....+ ....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~-~~~~~p~ 232 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIATQP-TKPMLPD 232 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHcCC-CCCCCCc
Confidence 22111112223456889999999999888999999999999999999999999754332222 1111111 1111111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+ ...+.+++.+||+ +|..||++.+++.
T Consensus 233 ~~------------~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 233 GV------------SDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cc------------CHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 1224578899999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=303.64 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=195.0
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
|+....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++||||+++++++..+ ...++||||++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~ 101 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQ 101 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCC
Confidence 444568999999999999875 58899999985432 3346788999999999999999999998754 55699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+++|.+++.. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---~~ 172 (297)
T cd06659 102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VP 172 (297)
T ss_pred CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc---cc
Confidence 9999988753 23789999999999999999999999999999999999999999999999998654211 12
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
......|+..|+|||++.+..++.++||||||++++||++|+.||......+....+.. ... +...... .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~-----~~~~~~~-~ 242 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPP-----PKLKNAH-K 242 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----cCC-----CCccccC-C
Confidence 23345789999999999988899999999999999999999999976554433332221 100 0000000 0
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. -..+.+++.+||+.+|++||+++|+++.
T Consensus 243 ~-----~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 I-----SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred C-----CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0124578999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=299.46 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=195.3
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||.|++|.||+|... +|..|++|.+..... ..+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 4788899999999999999875 588999998864322 23568899999999999999999999874 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+. ++|.+++... ....+++..+..++.|++.|++|||+.+++||||+|+||+++.++.+|++|||+++.....
T Consensus 80 ~~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-- 153 (284)
T cd07860 80 FLH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 153 (284)
T ss_pred ccc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 996 6899888743 2345899999999999999999999999999999999999999999999999998754211
Q ss_pred CCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC----
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP---- 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 1034 (1099)
........++..|+|||++.+.. ++.++||||||+++|||+||+.||....+.+....+....... .....+
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 230 (284)
T cd07860 154 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVTS 230 (284)
T ss_pred -ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC--ChhhhhhhhH
Confidence 12223445788999999887644 5889999999999999999999997655443332222211110 000000
Q ss_pred ------cccCCCCCCh-hH--HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 ------GLLELDPESS-EW--EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ------~~~~~~~~~~-~~--~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+........ .. .--..+.+++.+||+.||++||+++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 00 000223578999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=296.06 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=195.5
Q ss_pred ccccccccccccceeEEEEEE-CCceEEEEEECCCCCc-------cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSL-------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
+|+..+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++|+||+++++++.+. ...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEE
Confidence 477789999999999999986 4588999998854321 135688999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEecccccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLT 954 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~ 954 (1099)
+||||+++++|.+++.+. ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++ .+|++|||.+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999999753 2478899999999999999999999999999999999998776 5999999998765
Q ss_pred CCCCC-CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPA-EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
..... .........++..|+|||++.+..++.++||||+|+++++|++|+.||...........+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT-APSIP 233 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-CCCCc
Confidence 32211 11122345788999999999888899999999999999999999999965443322222221111110 00000
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+ ..-..+.+++.+|++.+|.+||++.|++.
T Consensus 234 ~------------~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 234 E------------HLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred h------------hhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 01123457899999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=301.41 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=196.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|+..++||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++||||+++++++.. +...++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 36888899999999999999986 488999998754322 24568899999999999999999999974 45669999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.++.... ..+++..+..++.|++.|++|||+.+|+|+|++|+||++++++.++++|||++......
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~- 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP- 153 (286)
T ss_pred ecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC-
Confidence 999998888776531 23899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc--ccccccc--
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG--QITELLE-- 1033 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~d-- 1033 (1099)
........++..|+|||+..+ ..++.++||||||++++||++|+.||......+....+......- ...+..+
T Consensus 154 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 --GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 122334568899999998875 347889999999999999999999987654433222222111100 0000000
Q ss_pred ----Cc-ccCCCCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 ----PG-LLELDPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ----~~-~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ..... ...... .-..+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVK-EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhcccccccc-CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000 000000 01235689999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=254.55 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|...++||+|.||+||+|+.+ .++.||+|++..++.+ .....+|+.+++.++|+|||+++++...+ ....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-kkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-ceeEEeHH
Confidence 4677789999999999999865 4789999998654433 35678999999999999999999998744 44589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
||+. +|..+.... ...++......++.|+.+|+.++|++++.|||+||.|.+++.+|+.|++|||+|+.+. .
T Consensus 82 ~cdq-dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg---i 153 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG---I 153 (292)
T ss_pred HhhH-HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC---C
Confidence 9964 888887643 2347888999999999999999999999999999999999999999999999998651 1
Q ss_pred CCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc------ccccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG------QITEL 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~------~~~~~ 1031 (1099)
........+.|.+|++|+++.+.+ |+...|+||.|||+.|+.. |++-|.+.+-.+....+.+..... .+.+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 122334567899999999999865 7889999999999999987 555566655555555555443321 11222
Q ss_pred ccCcccCCCCCChhHHHHH-----HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFL-----LGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~-----~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.|-......+....|..+. ...++..+.+.-+|..|.++++.++.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222233344454331 23567778888899999999988764
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=297.29 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=195.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
-|+..+.||+|+||.||+|... ++..||+|....... ..+.+.+|++++++++||||+++++++..+ ...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEe
Confidence 4677889999999999999875 578999998754322 235788999999999999999999999854 556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.. ..+++.....++.|++.|++|||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--- 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--- 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc---
Confidence 999999999863 24789999999999999999999999999999999999999999999999998754221
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........++..|+|||++.+..++.++|||||||++|||++|..||...........+ ..... ..++..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~-~~~~~~----- 224 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI----PKNNP-PTLEGN----- 224 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH----hcCCC-CCCCcc-----
Confidence 11223356888999999998888999999999999999999999999754433222221 11111 001110
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 225 ---~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 ---YS----KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---cC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 123578999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=305.58 Aligned_cols=251 Identities=21% Similarity=0.368 Sum_probs=195.3
Q ss_pred hccccccccccccceeEEEEEECCc-eEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDG-MVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+-|++.-.+|.|+||.||+|..++. ...|-|.+.... .+-++|.-|++++..++||+||++++.|..+.. .++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-LwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-LWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-eEEEEee
Confidence 3466777899999999999998764 445566664433 234778999999999999999999987774444 5899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
|.||-....+-+. ++.+++..+..+++|+++||.|||+.+|||||+|+.|||++-+|.++++|||.+... ...
T Consensus 111 C~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn---~~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN---KST 183 (1187)
T ss_pred cCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc---hhH
Confidence 9999998887654 356999999999999999999999999999999999999999999999999987542 223
Q ss_pred CccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 961 ASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.......+||+.|||||+.. ...|+.++||||||+++.||..+.+|..........-.+. ..+.+.+.-|.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----KSePPTLlqPS 259 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KSEPPTLLQPS 259 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----hcCCCcccCcc
Confidence 34456789999999999875 4579999999999999999999999976554433222222 22222222111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-|.. .+.++..+|+..+|+.||+++++++.
T Consensus 260 ---------~Ws~--~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 ---------HWSR--SFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---------hhhh--HHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1221 22467889999999999999988753
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=299.71 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=197.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+|+..+.||+|+||.||+|..+ ++..|++|.+.... ...+.+.+|++++++++||||+++++++... ...++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEe
Confidence 5778889999999999999986 58899999886543 3346788999999999999999999998854 566999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
+++++|.+++.... ..+++.....++.|++.|++|+|+ .+++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~-- 154 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-- 154 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH--
Confidence 99999999997532 457889999999999999999999 99999999999999999999999999998654211
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc--hhHHHHHHHHhhhccccccccCccc
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD--EDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......++..|+|||++.+..++.++||||+|+++++|++|+.||..... +.....+..... ......
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~------ 224 (265)
T cd06605 155 ---LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRL------ 224 (265)
T ss_pred ---HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCC------
Confidence 11126788899999999988999999999999999999999999965421 222222222111 110000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... .-..+.+++.+||..+|++|||+.|++..
T Consensus 225 --~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 --PSGK----FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --Chhh----cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 01124578999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-34 Score=336.49 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=195.7
Q ss_pred hccccccccccccceeEEEEEE-CCceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
-++....+||.|.||.||.|.. .+|+..|+|.+....... +.+.+|+.++..++|||+|+++|+-.+. +..++.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHHHHH
Confidence 3556678999999999999986 468999999886544333 5578999999999999999999997744 4458999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||++|+|.+.++.. +..++.....+..|++.|++|||+.|||||||||.||+++.+|.+|.+|||.|+.....-
T Consensus 1314 EyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999853 335666677788999999999999999999999999999999999999999998764331
Q ss_pred -CCCccccccccCccccCccccccCC---CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 959 -AEASTSTTAVGTLGYVSPEAALTGE---TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 959 -~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.........+||+.|||||++.+.. ...++||||+|||+.||+||+.||...+.+=..-+ .+..|..+.....
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy---~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY---HVAAGHKPQIPER 1465 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh---HHhccCCCCCchh
Confidence 1223345678999999999998643 56789999999999999999999976544321111 1122222211111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+ -....+++..|+..||+.|-++.|+++.
T Consensus 1466 -l------------s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 -L------------SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -h------------hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 1223578999999999999888777765
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=294.78 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=200.4
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+|+..+.||+|++|.||+|...+ +..|++|++..... ..+.+.+|++.+++++|+|++++++++... ...++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEe
Confidence 57888999999999999999874 89999999865442 357799999999999999999999998854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
+++++|.+++... ..+++..+..++.|+++|++|+|+ .+++||||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~-- 153 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-- 153 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--
Confidence 9999999999753 448999999999999999999999 99999999999999999999999999998765221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||.+.+..++.++||||||+++|||++|+.||.........+.+... ........ +..
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~-~~~---- 226 (264)
T cd06623 154 -LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSL-PAE---- 226 (264)
T ss_pred -CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-hcCCCCCC-Ccc----
Confidence 11223456889999999999888999999999999999999999999765421222222211 11111110 100
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. -..+.+++.+||+++|++||++.|+++.
T Consensus 227 ---~~----~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 ---EF----SPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---cC----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 0234578999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=303.13 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=192.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+.|...+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++||||+++++++.+. +..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-HTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-CeEEE
Confidence 345888899999999999999875 588999998853221 225688999999999999999999999854 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||++ |++.+++... ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++....+
T Consensus 93 v~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 93 VMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999996 6887777542 13489999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.....++..|+|||++. ...++.++||||||+++|||++|+.||...........+.. .....
T Consensus 168 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----~~~~~--- 233 (307)
T cd06607 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPT--- 233 (307)
T ss_pred -------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----CCCCC---
Confidence 12346788999999874 35688999999999999999999999976544332222111 11000
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ...+. ..+.+++.+||+.+|++||++.+|+..
T Consensus 234 -----~~--~~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -----LS--SNDWS--DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CC--chhhC--HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00111 134688999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=300.51 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=197.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCC-CceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~lV 877 (1099)
++|+..+.||.|+||.||+|.++ +++.+++|.+...... ...+.+|++++++++||||+++++++.... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999986 5788999998643322 235678999999999999999999987442 567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 59999887532 25899999999999999999999999999999999999999999999999998765221
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---------
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ--------- 1027 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------- 1027 (1099)
........++..|+|||.+.+. .++.++||||+|++++||++|+.||......+....+........
T Consensus 160 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 ---LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred ---ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1222345678899999988754 468999999999999999999999987665544443332211100
Q ss_pred ccccc-----cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ITELL-----EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ~~~~~-----d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.... ................-..+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000000000001224578999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=298.41 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=194.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhcc---CCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVR---HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~lV 877 (1099)
.|+..+.||+|+||.||+|.+. ++..|++|.+... ....+.+.+|++++++++ |||++++++++.. ....++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence 4777889999999999999974 6889999988543 233467889999999997 9999999999875 4456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.++++. ..+++.....++.|++.|++|||+.||+|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998864 14889999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. .......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||...........+ ..... +.+
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----~~~~~-----~~~ 222 (277)
T cd06917 155 S---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI----PKSKP-----PRL 222 (277)
T ss_pred c---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----ccCCC-----CCC
Confidence 1 223345789999999988754 4689999999999999999999999754332211111 11100 111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ....+.+++.+||+.||++||++.|++..
T Consensus 223 ---~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 ---EDNG----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---Cccc----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 11234678999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=297.85 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=195.2
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.|...+.||+|++|.||+|... ++..+++|++..... ..+.+.+|+.++++++||||+++++++.. +...++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEecc
Confidence 3555679999999999999864 688899998754332 34568899999999999999999999875 45569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++.. ..+++..+..++.|++.|++|||+.+|+||||+|+||+++.++.++++|||.+..... ..
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~---~~ 169 (285)
T cd06648 99 EGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EV 169 (285)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc---CC
Confidence 99999999874 2378899999999999999999999999999999999999999999999998865421 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.......|+..|+|||...+..++.++||||||++++||++|+.||...........+... .. +......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~----~~-----~~~~~~~- 239 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN----LP-----PKLKNLH- 239 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc----CC-----CCCcccc-
Confidence 1223356889999999998888999999999999999999999999765543333322221 10 0000000
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. .-..+.+++.+||+.+|++||++.++++
T Consensus 240 ~-----~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 K-----VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c-----CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 0123468999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=300.29 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=197.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|+||.||+|.+. +++.|++|.+.... ...+.+.+|++++++++|+||+++++++.. ++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEe
Confidence 6888999999999999999986 47899999885432 224678999999999999999999999985 455799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++++.+..+... ...+++.....++.|++.|++|||+.+++|+|++|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 154 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP- 154 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-
Confidence 9998766655542 2337899999999999999999999999999999999999999999999999987653221
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc----cccccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI----TELLEP 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~d~ 1034 (1099)
........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.............. ....++
T Consensus 155 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 -ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 1133345788999999999888 7899999999999999999999999765544333222221110000 000000
Q ss_pred cccC--CCC--CChhHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLE--LDP--ESSEWE------EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~--~~~--~~~~~~------~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.. ... .....+ .-..+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000 000000 01335689999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=301.49 Aligned_cols=267 Identities=23% Similarity=0.317 Sum_probs=199.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCC-CceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~l 876 (1099)
.++|+..+.||+|+||.||+|..+ +|+.||+|.+...... ...+.+|++++++++|+||+++++++.+.. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999985 5889999988543222 234678999999999999999999987543 45689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||++ ++|.+++.... ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58988887532 4589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc--cccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT--ELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~d 1033 (1099)
.. .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....+.+....+.......... ..++
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 11 22233456788999999875 457899999999999999999999998766655555444432211000 0000
Q ss_pred ----CcccCCCCC-ChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 ----PGLLELDPE-SSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ----~~~~~~~~~-~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
......... ..... .-..+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00000 01234579999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=297.55 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=192.7
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++.+|...+.||+|+||.||+|... +|..|++|.+...... ...+.+|++++++++|+||+++++++.. +...++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence 3467999999999999999999875 5889999998543322 3467889999999999999999999884 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+. +++.+++... ...+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI- 155 (291)
T ss_pred Eeccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-
Confidence 99996 6887777532 12367888888999999999999999999999999999999999999999999875321
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCch-hHHHHHHHHhhhc---------
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQLQKG--------- 1026 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~--------- 1026 (1099)
.........++..|+|||++.+. .++.++||||+|+++|||++|+.||....+. +....+.......
T Consensus 156 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 --PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred --CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 11122344678999999998764 4788999999999999999999999754432 1111111110000
Q ss_pred cccccccCcccCCCCCCh--hH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1027 QITELLEPGLLELDPESS--EW---EEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~--~~---~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..............+... .+ .....+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 00 01123457899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=298.79 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=191.2
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|...+.||+|+||.||++... ++..||+|.+.... .....+.+|+.++.++. ||||+++++++.. +...++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence 5666789999999999999875 47899999986432 23467889999999996 9999999999875 445689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|+. +++.++...........+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 161 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS- 161 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC-
Confidence 986 4666654322122235689999999999999999999975 9999999999999999999999999998754211
Q ss_pred CCCccccccccCccccCccccccC---CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTG---ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.......|+..|+|||++.+. .++.++||||+|+++|||++|+.||.... .....+.+... +.......
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~~-- 233 (288)
T cd06616 162 ---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVK-GDPPILSN-- 233 (288)
T ss_pred ---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcC-CCCCcCCC--
Confidence 122334688899999998766 68999999999999999999999996543 22222222111 11111100
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ....-..+.+++.+||+.+|++||++.||++.
T Consensus 234 ------~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 ------SE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------cC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00011235689999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=300.37 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=195.5
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.|+..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|||++++++++.+. ...++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CeEEEEE
Confidence 4778889999999999999875 578999998854321 224688899999999999999999998854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+. |++.+.+... ...+++..+..++.|++.|+.|||+.+|+||||+|+||+++.++.+|++|||++.....
T Consensus 105 e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred eCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9996 5888877542 23489999999999999999999999999999999999999999999999998865421
Q ss_pred CCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...........+... .....
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~---- 244 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTL---- 244 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----cCCCC----
Confidence 22346888999999874 456889999999999999999999998765433332222211 10000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
....+. ..+.+++.+||+.+|.+||++.+|++........+
T Consensus 245 ------~~~~~~--~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 245 ------QSNEWS--DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ------CCcccc--HHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 000111 12457899999999999999999998766544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=289.88 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=200.0
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+|+..+.||+|++|.||++... ++..+++|+...... ..+.+.+|++++++++|+|++++++++... ...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 4778899999999999999986 688999999866543 457799999999999999999999998854 5569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++.... ..+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999987531 4589999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||.............. .......+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~------- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNP------- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcc-------
Confidence 3445788999999999988899999999999999999999999976543322222111 111111110
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+ -..+.+++.+||+.||++|||+.|+++.
T Consensus 221 --~~~--~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKW--SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --ccc--CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 1234678999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=299.50 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=196.5
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.+|...+.||+|+||.||++... ++..|++|.+... ....+.+.+|+.++++++||||+++++++... +..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEec
Confidence 57888999999999999999864 5788999988543 23346788999999999999999999998854 456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++++|.+++.+ ..+++..+..++.|++.|++|||+.|++|||+||+||+++.++.++|+|||++....+.
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--- 168 (293)
T cd06647 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (293)
T ss_pred CCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc---
Confidence 999999999864 23788899999999999999999999999999999999999999999999988754221
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........|+..|+|||.+....++.++||||||+++||+++|+.||...........+. .+... .+ .
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----~~~~~-----~~---~ 236 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNGTP-----EL---Q 236 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----cCCCC-----CC---C
Confidence 122234468889999999988889999999999999999999999997544322111110 00000 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ...-..+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NP---EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred Cc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0001134578999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=293.78 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=189.2
Q ss_pred cccccceeEEEEEECC-ceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYND-GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||.|+||.||+|.... +..|++|.+.... ...+.+.+|++++++++||||+++++++.+ +...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 6999999999999864 7899999985432 234678999999999999999999999874 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++.+. ..+++..+..++.|++.||+|+|+.+++|+||+|+||+++.++.++++|||+++..... ....
T Consensus 80 L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~----~~~~ 150 (262)
T cd05572 80 LWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----QKTW 150 (262)
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc----cccc
Confidence 99999753 23788999999999999999999999999999999999999999999999998765221 1223
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...++..|+|||.+....++.++|+||+|+++|||++|..||.....+. .............. ..+.. .
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--------~~~~~-~- 219 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKGNGKL--------EFPNY-I- 219 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhccCCCC--------CCCcc-c-
Confidence 4568889999999988889999999999999999999999997655211 11111111100000 00000 0
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
-..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 ---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 123468999999999999999 676665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=293.96 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=196.3
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|+||.||+|..+ +|..+++|.+... ....+.+.+|++++++++|+||+++++++.. ....++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 4788899999999999999986 4788999998543 2344678899999999999999999999875 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 958 (1099)
|+++++|.+++... ....+++..+..++.|+++|++|||+.+++|+||||+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (257)
T cd08225 80 YCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS- 155 (257)
T ss_pred cCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC-
Confidence 99999999999752 223579999999999999999999999999999999999999885 4699999998754221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........|++.|+|||+..+..++.++||||||++++||++|+.||......+....+. ......
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-------- 221 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC----QGYFAP-------- 221 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----cccCCC--------
Confidence 112233468899999999988889999999999999999999999997544333222111 111111
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.. . ..+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~-~----~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISPNF-S----RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCC-C----HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11110 0 134578899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=297.13 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=187.8
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||+|+||+||+|..+ +|+.|++|.+.... ...+.+.+|++++++++||||+++++++... +..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence 689999999999865 58899999885422 2245567899999999999999999998754 45699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++..... ..+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++++|||.+..... .....
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 152 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GKKIK 152 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc----CCccc
Confidence 9999975322 4588999999999999999999999999999999999999999999999999875421 22223
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...++..|+|||+..+..++.++||||+|+++++|++|+.||...........+........ . ..... ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~---~~~~~-~~ 222 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA------V---EYPDK-FS 222 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc------c---cCCcc-CC
Confidence 45678899999999888899999999999999999999999976543222222222111100 0 00000 00
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
..+.+++.+||+.+|.+|| ++.++++
T Consensus 223 ----~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 ----PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1235789999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=296.45 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=195.9
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
+|+..+.||.|+||.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++.+ +...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 4788899999999999999986 48899999886432 234678999999999999999999998874 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++... ..+++.....++.|+++||+|||+.+++|+||+|+||++++++.++++|||.+......
T Consensus 80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~- 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD- 153 (258)
T ss_pred eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-
Confidence 999999999999753 35889999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
.......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... ...+....... .....+.+
T Consensus 154 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--~~~~~~~~-- 225 (258)
T cd05578 154 ---TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQETA--DVLYPATW-- 225 (258)
T ss_pred ---ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhccc--cccCcccC--
Confidence 12334568889999999988889999999999999999999999998665431 12222211110 00111110
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTM--SDIV 1074 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~--~evl 1074 (1099)
+ ..+.+++.+||+.||.+||++ +|++
T Consensus 226 ------~----~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 226 ------S----TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------c----HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 234578999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=295.33 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=194.8
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
|+..+.||.|++|.||+|... +|..|++|++..... ..+.+.+|++++++++|||++++++++.+. ...++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence 567789999999999999875 689999998864432 235688999999999999999999998854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
++ ++|.+++.... ...+++..+..++.|+++||+|||+.+++||||+|+||+++.++.++++|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--- 152 (283)
T cd07835 80 LD-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--- 152 (283)
T ss_pred cC-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC---
Confidence 95 69999987532 245899999999999999999999999999999999999999999999999998754211
Q ss_pred CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---------ccc
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---------ITE 1030 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~~ 1030 (1099)
........++..|+|||++.+. .++.++||||||+++|||++|+.||....+......+.+...... ..+
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1122334678899999987664 468899999999999999999999976554333222222111000 000
Q ss_pred cccCcccCCCCCC-hh--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLELDPES-SE--WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~-~~--~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ..+....... .. ...-..+.+++.+|++.||++||+++|+++.
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YK-PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hh-hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000000000 00 0000234689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=274.75 Aligned_cols=250 Identities=21% Similarity=0.339 Sum_probs=193.7
Q ss_pred cccccccceeEEEEE-ECCceEEEEEECCCC-CccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 809 NVLSRTRYGLVFKAC-YNDGMVLSIRRLPDG-SLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
+.+|+|+|+.|-.+. ...|..+|||++.+. ...+.++.+|++++.+.+ |+||+++++||.++. .+|+|||-|.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~-~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT-RFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc-eEEEEEecccCch
Confidence 589999999998886 567999999999553 345678999999999995 999999999999654 4599999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---cEEEeccccccccCCCC----
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---EAHLSDFGLDRLTIPTP---- 958 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~~~~~~---- 958 (1099)
|..++++..+ +++.+..++.++||.||.|||.+||.|||+||+|||-.... -+|||||.+..-.....
T Consensus 163 lLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 163 LLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999986543 88999999999999999999999999999999999986543 48999998875332121
Q ss_pred CCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh-----------HHHHHHHH
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-----------IVKWVKKQ 1022 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~-----------~~~~~~~~ 1022 (1099)
.......+.+|...|||||+.. ...|+.++|.||+|||+|-|++|.+||.+...++ -.+.....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1223345678999999999764 2358899999999999999999999997643311 12222233
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHH-HHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLL-GVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+++|. .+. ...+|..+.. ..+++...+..|+.+|-++.+++.
T Consensus 318 IQEGk-YeF----------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGK-YEF----------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccC-CcC----------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 33332 122 2344554433 346888888999999999999887
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=323.53 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=205.0
Q ss_pred HHhccccccccccccceeEEEEEEC--------CceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEec
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAG 869 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 869 (1099)
..++..+.+.+|+|.||.||+|... ....||||..+... .+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444556669999999999999753 14679999986543 3457899999999998 59999999999996
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhc---------cCCCC--CCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEAS---------HQDGH--VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~ 938 (1099)
....++|+||++.|+|.+++++.+ ..... .++....+.++.|||.|++||++.++||||+.++|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 555699999999999999999765 11122 389999999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCC-chhHH
Q 047739 939 ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQ-DEDIV 1016 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~-~~~~~ 1016 (1099)
++..+||+|||+|+................-+..|||||.+....|+.|+||||||+++||++| |..||.+.. ..++.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999999865322222212111113566999999999999999999999999999999 888997644 44444
Q ss_pred HHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1017 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
++++.+.+.. .|..+. + .+..+|..||+.+|++||++.|+++.++..
T Consensus 533 ~~l~~G~r~~-------------~P~~c~-~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 533 EFLKEGNRME-------------QPEHCS-D---EIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHhcCCCCC-------------CCCCCC-H---HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 4333322111 112221 1 234789999999999999999999999883
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=307.37 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=171.6
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCC-----CceEE
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----DLRLL 876 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~~l 876 (1099)
+...+.||+|+||.||+|+.+ .|+.||||.+... ....+++.+|++++++++|||||+++++-.+.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 6999999998653 344678899999999999999999998855332 33479
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC--CCCc--EEEecccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD--ADFE--AHLSDFGLDR 952 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~--~~~~--~kl~DfGla~ 952 (1099)
|||||.+|||...+++ ......+++.+.+.+..+++.||.|||++||+||||||.||++- ++|+ -|++|||.|+
T Consensus 95 vmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999985 44556799999999999999999999999999999999999983 3444 6999999999
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCC
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFT 1010 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~ 1010 (1099)
.. .+.......+||..|.+||.... +.|+..+|.|||||++||.+||..||...
T Consensus 173 el----~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 EL----DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cC----CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 76 23447788999999999999984 78899999999999999999999999653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=304.00 Aligned_cols=282 Identities=23% Similarity=0.300 Sum_probs=210.3
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----CceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 875 (1099)
+|.+.+.||.|+||.||+|...+ +..|++|++.... ...+.+.+|++++++++||||+++++++.... ...|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999999864 8899999886532 23467899999999999999999999987543 3569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5888888642 258999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc---
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL--- 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 1031 (1099)
.............++..|+|||++.+. .++.++||||+|+++++|++|+.||......+....+............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 322111223445688899999999887 7899999999999999999999999876655544444332211110000
Q ss_pred ccCcc----cCCC-CCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccCCCCCCCCCC
Q 047739 1032 LEPGL----LELD-PESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRVGPDIPSSAD 1091 (1099)
Q Consensus 1032 ~d~~~----~~~~-~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~ 1091 (1099)
..... .... .....+. .-..+.+++.+||+.+|++||+++++++. +++....++.+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~ 306 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKP 306 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCC
Confidence 00000 0000 0000111 01234689999999999999999999984 776666555544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=294.16 Aligned_cols=262 Identities=21% Similarity=0.212 Sum_probs=193.4
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhcc-CCcceEEeeEEecCC-CceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAP-DLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~~lV~e 879 (1099)
|+..+.||+|+||.||+|... ++..||+|.+... ........+|+.+++++. |+|++++++++.+.. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999875 5889999988653 222334567899999885 999999999988541 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ |++.+++... ...+++..+..++.|++.||+|||+.+++||||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-- 152 (282)
T cd07831 81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-- 152 (282)
T ss_pred cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence 996 5888888642 135899999999999999999999999999999999999999 99999999999765221
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--ccc-----
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI--TEL----- 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~----- 1031 (1099)
.......++..|+|||++.. ..++.++||||+||++|||++|..||...+..+.+.++......... ...
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12223467889999997654 55788999999999999999999999876665555544432211100 000
Q ss_pred -ccCcccCCCCCCh-h--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 -LEPGLLELDPESS-E--WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 -~d~~~~~~~~~~~-~--~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+..+........ . ...-..+.+++.+||+++|++||+++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0 0012345689999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=292.66 Aligned_cols=266 Identities=21% Similarity=0.320 Sum_probs=198.7
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+|+..+.||.|++|.||+|+.. +|..|++|.+..... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEec
Confidence 4788899999999999999986 588999998865432 245678899999999999999999999855 456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
++ |+|.+++.... ....+++..+..++.|+++||+|||+.+++||||||+||++++++.++++|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--- 153 (284)
T cd07836 80 MD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--- 153 (284)
T ss_pred CC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence 98 48988886532 2345899999999999999999999999999999999999999999999999998754211
Q ss_pred CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc---ccccc-Cc
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---TELLE-PG 1035 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~d-~~ 1035 (1099)
........++..|++||++.+. .++.++||||+|+++|||++|+.||......+....+......... ..... +.
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1122345678899999988654 5788999999999999999999999876655544443322211100 00000 00
Q ss_pred c-cCCCCC-ChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 L-LELDPE-SSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~-~~~~~~-~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+ ...... ...... -..+.+++.+|++.||.+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000000 000001 1234689999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=295.07 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=198.7
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~lV~e 879 (1099)
|++.+.||.|+||.||+|...+ +..+++|.+.... ...+.+.+|++++++++|||++++++++... ....++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999864 8899999996542 2235688999999999999999999999855 256799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ ++|.+++... ...+++..+..++.|+++|++|||+.+++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~- 154 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN- 154 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC-
Confidence 997 4888888642 1358999999999999999999999999999999999999999999999999997653221
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc---cc--
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL---LE-- 1033 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~d-- 1033 (1099)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+............ .+
T Consensus 155 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 -SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 112334567889999998765 45789999999999999999999999876655444444332221110000 00
Q ss_pred --CcccCCCCCChhH----HH--HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 --PGLLELDPESSEW----EE--FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 --~~~~~~~~~~~~~----~~--~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
............. .. -..+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000000 00 2345689999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=289.86 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=172.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
+.|+.-++||+||||.||-+..+ .|+.+|.|++.+. ...+.....|-+++.++..+.||.+--.|. ..+..++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-Tkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-TKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-CCCceEEE
Confidence 45778899999999999998765 5888888877432 234456778999999999999998844444 66777999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
+..|.||+|.-+|...+ ...+++....-+|.+|+.||+|||..+||+||+||+|||+|+.|+++|+|.|+|..+
T Consensus 264 LtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei--- 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI--- 337 (591)
T ss_pred EEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec---
Confidence 99999999998887543 356999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~ 1011 (1099)
........++||.+|||||++....|+...|.||+||++|||+.|+.||....
T Consensus 338 -~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 338 -PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred -CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 23344556799999999999999999999999999999999999999996543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=298.28 Aligned_cols=269 Identities=19% Similarity=0.238 Sum_probs=196.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC-----
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----- 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 871 (1099)
..++|+..++||+|+||.||+|... ++..||+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999876 588999998854321 2345678999999999999999999986432
Q ss_pred --CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 872 --DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 872 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
...++||||+. +++.+++... ...+++.+...++.|++.||+|||+.+++|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 23589999996 5888887642 2348999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 950 LDRLTIPTPAE-ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 950 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
++......... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...........+..... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~--~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG--S 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--C
Confidence 99765322111 1222345678899999988664 468899999999999999999999976655443333332211 1
Q ss_pred ccccccCccc--------CCCCCC--hhHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ITELLEPGLL--------ELDPES--SEWE------EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ~~~~~d~~~~--------~~~~~~--~~~~------~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....+.+... ...... ...+ ....+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100000000 000000 0000 01234589999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=279.03 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|+..+++|+|.||.|..++.+ .|+.+|+|++++... +.+.-..|-++++..+||.+..+.-.|. ..+..+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-t~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-TQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-cCceEE
Confidence 3567999999999999999999876 588999999865432 2345667999999999999998876666 445569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+.||.|.-++.+. +.+++.....+...|+.||.|||+.+||+||+|.+|.|+|.+|++||+|||+++..+
T Consensus 245 FVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999888753 457777777788999999999999999999999999999999999999999998543
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.......+.+||+.|.|||++....|..++|.|.+||++|||++|+.||...+.+.+...+...-. ..
T Consensus 320 ---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kF------- 387 (516)
T KOG0690|consen 320 ---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KF------- 387 (516)
T ss_pred ---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cC-------
Confidence 344566788999999999999999999999999999999999999999998888877776654311 11
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
+....+ .+..+....+..||++|. .++||.+
T Consensus 388 ----Pr~ls~-----eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 ----PRTLSP-----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ----CccCCH-----HHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111111 123577788999999995 3555543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=295.71 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=193.6
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|+..+.||+|++|.||+|..+ +|+.|++|.+..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence 46889999999999999999976 588999998854322 235688999999999999999999999854 5679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~ 957 (1099)
||++ ++|.+++... .....++.....++.||+.||+|||+.+|+||||+|+||+++. ++.+|++|||++......
T Consensus 81 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 5888887542 2233578888899999999999999999999999999999985 567999999999754211
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc---
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE--- 1033 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 1033 (1099)
........++..|+|||++.+. .++.++||||+|+++|+|+||+.||......+....+......+. ....+
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (294)
T PLN00009 157 ---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN-EETWPGVT 232 (294)
T ss_pred ---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hhhccccc
Confidence 1122334678899999988764 578999999999999999999999976555433333222111110 00000
Q ss_pred ------CcccCCCCCCh---hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 ------PGLLELDPESS---EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ------~~~~~~~~~~~---~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
........... ....-..+.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00001224679999999999999999999863
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=294.26 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=194.6
Q ss_pred cccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||.|+||.||++...+ |..+++|.+..... ..+.+.+|++++++++||||+++++.+.. +...|+||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6899999999999875 89999999865433 34678899999999999999999998874 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC-----
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE----- 960 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----- 960 (1099)
|.+++.+.. .+++..+..++.|+++||+|||+.+++|+||+|+||+++.++.++++|||++.........
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999997532 4899999999999999999999999999999999999999999999999998754221110
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
........++..|+|||......++.++||||||++++|+++|+.||...........+.. +... .+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~---~~------ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN----GKIE---WP------ 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCcC---CC------
Confidence 1123445688899999999888899999999999999999999999976665544433322 1110 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
.... .-..+.+++.+||+.+|++||++.++.+.|+
T Consensus 222 -~~~~--~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -EDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cccc--CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 0123357899999999999999966666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=303.18 Aligned_cols=275 Identities=22% Similarity=0.304 Sum_probs=201.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCC----Cc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 873 (1099)
.++|...+.||+|+||.||+|... ++..||+|.+... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999875 5889999988542 223456778999999999999999999876432 24
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+. ++|.+++... ..+++.....++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 689999996 6898888642 3488999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---cc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---IT 1029 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~ 1029 (1099)
.... ........++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.......+........ ..
T Consensus 158 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEK---GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCC---cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 4221 122334567889999998865 4688999999999999999999999976544333322222211100 00
Q ss_pred ccccCccc-------CCC-CCChh--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccCCCC
Q 047739 1030 ELLEPGLL-------ELD-PESSE--WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRVGPD 1085 (1099)
Q Consensus 1030 ~~~d~~~~-------~~~-~~~~~--~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~ 1085 (1099)
...+.... ... ..... ...-..+.+++.+||+.+|++||+++|+++. ++.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 00000000 000 00000 0011234689999999999999999999987 665544333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=300.04 Aligned_cols=273 Identities=22% Similarity=0.294 Sum_probs=201.8
Q ss_pred ccCCHHHHHHHHhccccccccccccceeEEEEEE-CCceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeE
Q 047739 791 NKITLAETVEATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGY 866 (1099)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~ 866 (1099)
++....++..++++|+..+.||+|+||.||+|.. .++..||+|++..... ..+.+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4455566777889999999999999999999986 4688999999864322 24567889999999999999999998
Q ss_pred EecCC-----CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC
Q 047739 867 YAGAP-----DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941 (1099)
Q Consensus 867 ~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~ 941 (1099)
+.... ...++|++++ +++|.+++.. ..+++..+..++.|+++|++|||+.+|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC
Confidence 76322 3357888887 7899888763 2388999999999999999999999999999999999999999
Q ss_pred cEEEeccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHH
Q 047739 942 EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVK 1020 (1099)
Q Consensus 942 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~ 1020 (1099)
.+|++|||+++... .......++..|+|||.+.+ ..++.++||||+||+++||++|+.||...........+.
T Consensus 158 ~~kl~dfg~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 158 ELKILDFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CEEEeccccccccc------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999987531 12234567889999998866 467889999999999999999999997655443333322
Q ss_pred HHhhhc--cccccccCc--------ccCCCCCChhH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1021 KQLQKG--QITELLEPG--------LLELDPESSEW---EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1021 ~~~~~~--~~~~~~d~~--------~~~~~~~~~~~---~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...... .....+... ........... ..-..+.+++.+|++.||.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 211100 000000000 00000000000 001134689999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=301.98 Aligned_cols=271 Identities=19% Similarity=0.302 Sum_probs=194.5
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCC---------
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP--------- 871 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------- 871 (1099)
.+|...+.||.|+||.||+|... +|..|++|.+..... ..+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57899999999999999999875 588999998854433 3466889999999999999999998765432
Q ss_pred ----CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEe
Q 047739 872 ----DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLS 946 (1099)
Q Consensus 872 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~ 946 (1099)
...++||||++ ++|.+++.. ..+++.....++.||+.||+|||+.||+||||||+||+++. ++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 23589999997 588888753 24789999999999999999999999999999999999974 5678999
Q ss_pred ccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
|||.++................++..|+|||++.. ..++.++|||||||++|||++|+.||....+......+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99998754222111222233467889999998654 56788999999999999999999999765543333222211100
Q ss_pred c------cccccccCccc-CCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1026 G------QITELLEPGLL-ELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1026 ~------~~~~~~d~~~~-~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
. ........... ........... -..+.+++.+|++.||++||++.|++. .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 00000000000 00000000000 123467999999999999999999984 44433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=288.54 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=199.6
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-CceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~lV~ 878 (1099)
+|...+.||+|++|.||+|... ++..|++|.+.... ...+.+.+|++++++++||||+++++++.... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 68899999986544 23577899999999999999999999988542 5568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++.... .+++..+..++.|+++|++|||+.+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997532 58999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
. ........++..|+|||...+...+.++||||+|+++++|++|+.||....... ..+........... +..
T Consensus 156 ~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-~~~---- 227 (260)
T cd06606 156 T-GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSSGEPPE-IPE---- 227 (260)
T ss_pred c-cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccccCCCcC-CCc----
Confidence 1 012344678899999999988889999999999999999999999997655211 11111110011000 000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. -..+.+++.+|++.+|++||++.|++..
T Consensus 228 ----~~----~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 ----HL----SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----cc----CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00 1234678999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=292.06 Aligned_cols=263 Identities=23% Similarity=0.287 Sum_probs=196.3
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCCcc---HHHHHHHHHHhhhc---cCCcceEEeeEEecCCC----c
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD---ENLFRKEAEFLGKV---RHRNLTVLRGYYAGAPD----L 873 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----~ 873 (1099)
|++.+.||+|+||.||+|.++. +..||+|.+...... ...+.+|+.+++++ +|||++++++++...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999875 889999998643222 24566788887766 59999999999875433 3
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+++|+|++|+||+++.++.+|++|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 689999997 58999887532 23589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.... .......++..|+|||++.+..++.++||||||+++|||++|+.||......+....+..............
T Consensus 157 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFE----MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCC----cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 4211 122334578899999999988999999999999999999999999987666555444433222111000000
Q ss_pred ------CcccCCCC---CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 ------PGLLELDP---ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ------~~~~~~~~---~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+..... ......-...+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0000011234468999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=299.98 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
..+|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999875 58999999986432 12356789999999999999999999886432 2
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+|++|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 35899999964 6766542 237889999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc--ccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG--QIT 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~ 1029 (1099)
... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....... ...
T Consensus 166 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HAD------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCC------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 541 11233467889999999876 458899999999999999999999998655433333222211100 000
Q ss_pred ccccC--------cccCCCCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHH--HhhcccCCC
Q 047739 1030 ELLEP--------GLLELDPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCRVGP 1084 (1099)
Q Consensus 1030 ~~~d~--------~~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~~~ 1084 (1099)
+.... ...... ..... .-..+.+++.+||+.||++||+++|++. .++.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYP--RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHhcccchHHHHhhcCCcc--cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00000 000000 00000 0123468999999999999999999994 477776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=293.48 Aligned_cols=255 Identities=16% Similarity=0.209 Sum_probs=182.0
Q ss_pred hccccccccccccceeEEEEEECCc----eEEEEEECCCCCcc---H---------HHHHHHHHHhhhccCCcceEEeeE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDG----MVLSIRRLPDGSLD---E---------NLFRKEAEFLGKVRHRNLTVLRGY 866 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~---~---------~~~~~E~~~l~~l~H~niv~l~~~ 866 (1099)
++|.+.++||+|+||.||+|.+.++ ..+++|........ + .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999997653 45566654222111 0 111233344556789999999987
Q ss_pred EecCCC---ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 867 YAGAPD---LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 867 ~~~~~~---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
+..... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+.+|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 653332 3367778774 4666666532 124678888999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCC----CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-hhHHHH
Q 047739 944 HLSDFGLDRLTIPTPAE----ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD-EDIVKW 1018 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~-~~~~~~ 1018 (1099)
+|+|||+|+........ ........||+.|+|||+..+..++.++||||+||+++||++|+.||..... ......
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999865322111 1122335799999999999999999999999999999999999999976632 222222
Q ss_pred HHH----HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1019 VKK----QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1019 ~~~----~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
... .+..+.. .. ...+ ..+.+++..|++.+|++||++.++.+.++
T Consensus 246 ~~~~~~~~~~~~~~---------~~--~~~~----~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHEGKI---------KI--KNAN----KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhhhhh---------cc--CCCC----HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 211 1111111 00 1111 12357889999999999999999998764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=294.96 Aligned_cols=270 Identities=23% Similarity=0.278 Sum_probs=198.8
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP---- 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 871 (1099)
...++|++.+.||+|+||.||+|..+ +|+.|++|.+.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999986 47899999985432 22356788999999999999999999987433
Q ss_pred -----CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 872 -----DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 872 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
...++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 256899999975 777777542 2358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
|||++........ .......++..|+|||++.+. .++.++||||+||+++||++|+.||......+....+.+....
T Consensus 159 dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999876522211 122334567889999988653 4789999999999999999999999766554444444433221
Q ss_pred cccc---ccccC-cccCCCC------CC-hhHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1026 GQIT---ELLEP-GLLELDP------ES-SEWE-EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1026 ~~~~---~~~d~-~~~~~~~------~~-~~~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... +.... .+..... .. ..++ .-..+.+++.+||+.||.+||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 00000 0000000 00 0000 01234689999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=294.41 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=193.9
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCC
Q 047739 807 EENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
...+||+|+||.||+|..+ ++..|++|.+..... ..+.+.+|+.++++++|+||+++++++... +..++||||++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCC
Confidence 3468999999999999875 688999998854332 345688999999999999999999998854 5669999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 964 (1099)
+|.+++.. ..+++.....++.|++.|++|||+.|++||||+|+||+++.++.++++|||++..... .....
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~---~~~~~ 173 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---EVPRR 173 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc---ccccc
Confidence 99998753 2378899999999999999999999999999999999999999999999998865421 11122
Q ss_pred cccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCCh
Q 047739 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044 (1099)
Q Consensus 965 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 1044 (1099)
....|+..|+|||++.+..++.++||||+|+++|||++|+.||...........+..... +.+......
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~-- 242 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PKLKNLHKV-- 242 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---------cccCCcccC--
Confidence 345688999999999888899999999999999999999999976554443333322111 111010000
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1045 ~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-..+.+++.+||+.+|.+||++.|+++.
T Consensus 243 ----~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 ----SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ----CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0123578899999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=291.03 Aligned_cols=241 Identities=21% Similarity=0.246 Sum_probs=181.4
Q ss_pred ccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhh---ccCCcceEEeeEEecCCCceEEEEeec
Q 047739 810 VLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGK---VRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+||+|+||.||++... +++.+|+|.+..... ....+.+|..+++. .+||||+.+++++..+ +..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecC
Confidence 4899999999999875 588999998854322 12334455544443 3799999999988754 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||++++++.++++|||++......
T Consensus 80 ~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 80 NGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 999999988742 34899999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
......|+..|+|||...+ ..++.++||||+||+++||++|+.||......... .+....... ...+.+.
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~--~~~~~~~----- 221 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTV--NVELPDS----- 221 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcC--CcCCccc-----
Confidence 1223468999999998864 55889999999999999999999999654332211 111111100 0001110
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
. -..+.+++.+|++.||++|| +++|+++.
T Consensus 222 ---~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 ---F----SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---c----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0 12345788999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=286.39 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=197.2
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence 4778899999999999999876 578899999866543 446789999999999999999999998754 56699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++... ..+++..+..++.|++.|+.|||+.||+||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (254)
T cd06627 80 YAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS- 153 (254)
T ss_pred cCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc-
Confidence 99999999999753 348999999999999999999999999999999999999999999999999998653221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.......++..|+|||...+..++.++||||+|+++++|++|+.||............. . .... .+.+
T Consensus 154 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~-~~~~-~~~~----- 221 (254)
T cd06627 154 --KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---Q-DDHP-PLPE----- 221 (254)
T ss_pred --ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---c-cCCC-CCCC-----
Confidence 11234568889999999988888999999999999999999999997554322221111 1 1100 0111
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. . -..+.+++.+|++.+|++||++.|++.
T Consensus 222 --~-~----~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 --G-I----SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --C-C----CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 0 113357899999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=287.20 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=201.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|+..+.||.|+||.||++... ++..+++|++.... ...+.+.+|++++++++|||++++.+.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 4778899999999999999986 58899999986543 3446788999999999999999999998855 56699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++..... ....+++..+..++.+++.|++|||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~-- 156 (258)
T cd08215 80 YADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-- 156 (258)
T ss_pred ecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC--
Confidence 9999999999986422 2356899999999999999999999999999999999999999999999999998765221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........|+..|+|||...+..++.++||||+|+++++|++|+.||............ ........
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~-------- 223 (258)
T cd08215 157 -VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI----LKGQYPPI-------- 223 (258)
T ss_pred -cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH----hcCCCCCC--------
Confidence 12233457889999999998888999999999999999999999999765543333222 11111111
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .... ..+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~-~~~~----~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 P-SQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C-CCCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000 123578999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=288.05 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=200.1
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|++.++||+|+||.||++... ++..+++|.+.... .....+.+|++++++++|+||+++++++.+. ...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 4788899999999999999865 57889999986432 2345678899999999999999999998854 56799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++++|.+++.+.. .....+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.+|++|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 80 YAPFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hcCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999999997633 22355899999999999999999999999999999999999999999999999999765221
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
......++..|+|||...+..++.++|+||+|++++||++|+.||.....+.....+. .+.......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~------ 223 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ----RGKYPPIPP------ 223 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCCch------
Confidence 2223568889999999998889999999999999999999999997665443333221 111111100
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..-..+.+++.+|++.+|++||++.|+++.
T Consensus 224 -------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 -------IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111235689999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=295.75 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=197.4
Q ss_pred HHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
...+++|+..+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++.+++.......
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 6889999987432 223467889999999999999999999987655667
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||+ +++|.++++. ..+++.....++.|+++||+|||+.+|+||||+|+||+++.++.++++|||.+...
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999999 5689888763 23678888899999999999999999999999999999999999999999998743
Q ss_pred CCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh--------
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-------- 1025 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 1025 (1099)
.. ......++..|+|||.+.+ ..++.++||||+|++++||++|+.||...........+.+....
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 159 DP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred CC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 11 1223467889999998766 56899999999999999999999999765543332222221110
Q ss_pred ---ccccccccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1026 ---GQITELLEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1026 ---~~~~~~~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....+... ..... ...+..+ -..+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQ-SLPKR--EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHh-hcccc--CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000 0000000 1245689999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=268.29 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=188.4
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.+....+|.|+-|.||+++++ .|..+|||.+..... +.+++...+.++.+-+ .|+||+.+|||..+.+. ++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV-~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV-FICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH-HHHHH
Confidence 3455677999999999999986 489999999976443 3466778888877765 89999999999966554 78899
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
.|.- ....++++.. .++++...-++...+..||.||-++ +|+|||+||+|||+|+.|++|+||||++-+..+.
T Consensus 172 lMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 9953 4555555432 4488888889999999999999875 8999999999999999999999999999776332
Q ss_pred CCCccccccccCccccCccccccC---CCCCcCchhhHHHHHHHHHhCCCCCCCCC-chhHHHHHHHHhhhccccccccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTG---ETTKESDVYSFGIVLLELLTGKRPVMFTQ-DEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~G~il~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
...+...|-+.|||||.+... .|+.++||||||+.++|+.||+.||.+-. +.+....+... .+..++.
T Consensus 246 ---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-----ePP~L~~ 317 (391)
T KOG0983|consen 246 ---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-----EPPLLPG 317 (391)
T ss_pred ---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-----CCCCCCc
Confidence 233445788899999998744 68899999999999999999999998633 33444443331 1111221
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. ..+. .+.+++..|++.|+.+||...++++
T Consensus 318 ~~----gFSp------~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HM----GFSP------DFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc----CcCH------HHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 0111 2356788899999999999988775
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=301.32 Aligned_cols=266 Identities=21% Similarity=0.324 Sum_probs=198.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEec---CCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAG---APDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~ 874 (1099)
.++|+..+.||+|+||.||+|... +|..|++|++.... ...+.+.+|+.++++++||||+++++++.. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999875 58899999986432 234567789999999999999999988753 23456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 89999995 6898888642 33899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCC-CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc-----
Q 047739 955 IPTPA-EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ----- 1027 (1099)
Q Consensus 955 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 1027 (1099)
..... .........|+..|+|||++.+ ..++.++||||+|+++|||++|+.||...........+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 22211 1122234578999999998765 4688999999999999999999999976554333333222211100
Q ss_pred ------ccccccCcccCCCCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ------ITELLEPGLLELDPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ------~~~~~d~~~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+..+ .+... ....+. .-..+.+++.+||+.+|++||++++++..
T Consensus 238 ~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQ-NLPRK--QPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHh-hcccC--CCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 00000 001111 11335689999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=291.16 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=196.3
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCCc--cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL--DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
|++.+.||+|+||.||+|...+ ++.|++|++..... +.....+|+..+++++ |||++++++++.+ +...++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence 5677899999999999999864 78899999854332 3345567999999999 9999999999885 5566999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+ +|+|.+++.... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--- 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--- 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence 9 789999887532 345899999999999999999999999999999999999999999999999998754221
Q ss_pred CccccccccCccccCccccc-cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc---------ccc
Q 047739 961 ASTSTTAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---------ITE 1030 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~~ 1030 (1099)
.......++..|+|||++. ...++.++||||||++++||++|+.||......+....+........ ...
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1223456888999999875 45578999999999999999999999976655444333322211100 000
Q ss_pred cccCcccCCCCC-ChhH--HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLELDPE-SSEW--EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~-~~~~--~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+..+....+. ..+. ..-..+.+++.+||+.+|++||+++|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0000 011345689999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=295.21 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=192.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+.|+..+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|++++++++|+|++++.+++... ...++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEE
Confidence 344777889999999999999975 57889999875321 1235678899999999999999999998854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+. |++.+++... ...+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++++|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999996 6888877532 23478999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...........+.. ........
T Consensus 168 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 236 (308)
T cd06634 168 -------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQS 236 (308)
T ss_pred -------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----cCCCCcCc
Confidence 12346888999999874 34678899999999999999999999865443322221111 11110000
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. .+ -..+.+++.+||+.+|++||++.++++.-.-.
T Consensus 237 --------~--~~--~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 237 --------G--HW--SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred --------c--cc--cHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0 01 12245789999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=297.17 Aligned_cols=269 Identities=24% Similarity=0.277 Sum_probs=196.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCC-----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD----- 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 872 (1099)
.++|++.++||+|+||.||+|.++ +++.+++|.+..... ....+.+|++++++++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999976 578899998854322 23457889999999999999999998754332
Q ss_pred --ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 873 --LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 873 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
..++||||+.+ ++.+.+... ...+++..+..++.|+++||+|||+.||+|+||||+||++++++.+|++|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 36899999964 777777532 23589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC--------CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 951 DRLTIPTPAE--------ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 951 a~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.........+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9754222111 1122345678899999987654 578999999999999999999999976665444433332
Q ss_pred Hhhhccc---------cccccCc-ccCCCCCChh-H-HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1022 QLQKGQI---------TELLEPG-LLELDPESSE-W-EEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1022 ~~~~~~~---------~~~~d~~-~~~~~~~~~~-~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....... ....+.. .....+.... . .....+.+++.+|++.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 2211100 0000000 0000000000 0 01134568999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=291.98 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=191.3
Q ss_pred ccccccccccccceeEEEEEE----CCceEEEEEECCCCC-----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCc
Q 047739 804 QFDEENVLSRTRYGLVFKACY----NDGMVLSIRRLPDGS-----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 873 (1099)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ...+.+.+|+++++++ +|+||+++++++..+ ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-Ce
Confidence 377889999999999999986 368899999986432 2236688899999999 599999999888744 55
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++++|.+++... ..+++.....++.|+++||+|||+.+++||||+|+||+++.++.+||+|||+++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 68999999999999999752 3478888899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCccccCccccccC--CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.... .........|+..|+|||++... .++.++||||||+++|+|++|+.||...........+..........
T Consensus 155 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 230 (290)
T cd05613 155 FHED--EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-- 230 (290)
T ss_pred cccc--cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--
Confidence 4221 11222345688999999998753 46789999999999999999999996543322222222222111100
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
.. ... -..+.+++.+||+.||++|| ++++++..
T Consensus 231 ~~--------~~~----~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YP--------QEM----SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC--------ccC----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 000 01335789999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=294.36 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=186.7
Q ss_pred cccccccccceeEEEEEECCceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 807 EENVLSRTRYGLVFKACYNDGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
+.+.+|.|+++.||++.. +++.||+|++... ....+.+.+|++++++++||||+++++++... +..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCC
Confidence 334455555555555544 5889999998643 23346799999999999999999999998854 456999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC----
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA---- 959 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---- 959 (1099)
|+|.+++.... ...+++.....++.|+++||+|||+.+|+||||||+||+++.++.+|++|||.+........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999997532 23478889999999999999999999999999999999999999999999998865422111
Q ss_pred CCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc----
Q 047739 960 EASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE---- 1033 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 1033 (1099)
.........++..|+|||++.. ..++.++|||||||++|||++|+.||.......... ... .+......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~---~~~-~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL---EKV-RGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-hccCccccccCch
Confidence 1112234567889999999875 357899999999999999999999997654322211 111 000000000
Q ss_pred ----------------CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 ----------------PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ----------------~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+..............-..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000000000111245689999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.78 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=186.2
Q ss_pred cccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHh-hhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFL-GKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|... +|+.||+|.+...... ...+..|..++ ...+|+|++++++++.. .+..|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 56999999999999875 5889999998653321 12344555544 34589999999999984 456699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+++|.++++.. ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+|++|||+++....
T Consensus 81 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 81 GGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999999753 2478899999999999999999999999999999999999999999999999875321
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
.....++..|+|||...+..++.++||||+|+++|||++|..||...........+... ... ...... .
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~--~~~~~~----~ 218 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR----RIN--WPEEVK----E 218 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----ccC--CCCccc----c
Confidence 22346888999999998888999999999999999999999999766554443332211 110 000000 0
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..+ ..+.+++.+||+.+|++||++.++.+.+.
T Consensus 219 ~~~----~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCS----PEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCC----HHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 001 12458999999999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.44 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=198.5
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
|+..+.||.|++|.||+|... +++.+++|.+...... ...+.+|++++++++|+||+++++++... ...++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence 566788999999999999875 6889999998654332 46788999999999999999999998854 566999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++ ++.+++.... ..+++..+..++.|+++|++|||+.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred cCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 974 8888887522 358999999999999999999999999999999999999999999999999987653221
Q ss_pred CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--cccccC---
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI--TELLEP--- 1034 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~d~--- 1034 (1099)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+....+......... ......
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122335678899999998876 7899999999999999999999999776655444443332221100 000000
Q ss_pred ----cccCCCCCC--hhH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 ----GLLELDPES--SEW-EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ----~~~~~~~~~--~~~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+....... ... ..-..+.+++.+||++||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000 000 112345689999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=286.03 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=188.5
Q ss_pred CHHHHHHHHhcccccccc--ccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEec
Q 047739 794 TLAETVEATRQFDEENVL--SRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAG 869 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 869 (1099)
+..+.....++|++.+.+ |+|+||.||++..+ ++..+++|......... .|+.....+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 344555566778887776 99999999999875 57889999875432221 122222222 79999999999985
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEecc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDF 948 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~Df 948 (1099)
. ...++||||+++|+|.+++... ..+++.....++.|+++|++|||+.+++||||||+||+++.++ .++++||
T Consensus 81 ~-~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 81 L-KGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred C-CeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 4 4579999999999999999753 2589999999999999999999999999999999999999988 9999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHH-HHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV-KWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~-~~~~~~~~~~~ 1027 (1099)
|+++.... .....++..|+|||++.+..++.++||||+|++++||++|+.||....++... ....... ...
T Consensus 155 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 226 (267)
T PHA03390 155 GLCKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK 226 (267)
T ss_pred ccceecCC-------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc
Confidence 99875421 12346889999999999888999999999999999999999999754443321 1111111 100
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-MSDIVF 1075 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~ 1075 (1099)
.... . ..-..+.+++.+||+.+|.+||+ ++|+++
T Consensus 227 -~~~~---------~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 -LPFI---------K----NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -CCcc---------c----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 0 00123467899999999999996 588874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=292.99 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=195.0
Q ss_pred ccccccccccccceeEEEEEEC----CceEEEEEECCCCC-----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCc
Q 047739 804 QFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGS-----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 873 (1099)
+|+..+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+++++++ +||||+++.+.+.. +..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence 3677899999999999999753 56789999885422 1235688999999999 59999999988874 455
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|+|.+++... ..+++.....++.|+++||+|||+.+++||||+|+||+++.++.++++|||+++.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 68999999999999998642 3478889999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccccCccccCccccccCC--CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.... .........|+..|+|||...+.. .+.++||||||++++||++|..||...........+.+.......
T Consensus 155 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 229 (288)
T cd05583 155 FLAE--EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--- 229 (288)
T ss_pred cccc--cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC---
Confidence 4222 111223356889999999987655 788999999999999999999999643332222222222211110
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
.. +.... ..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 230 ---~~----~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 ---PF----PKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CC----CcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 01111 123578999999999999999999888774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=293.12 Aligned_cols=200 Identities=22% Similarity=0.274 Sum_probs=160.6
Q ss_pred cccccc--cceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRT--RYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
..||+| +||+||+|.+. .|+.||+|.+...... .+.+.+|+.+++.++||||+++++++... ...++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEeccc
Confidence 456666 89999999875 6899999998643322 36688999999999999999999999854 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC-
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA- 961 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~- 961 (1099)
+|++.+++.... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999987642 2347889999999999999999999999999999999999999999999998654321111100
Q ss_pred ---ccccccccCccccCccccccC--CCCCcCchhhHHHHHHHHHhCCCCCCCCCc
Q 047739 962 ---STSTTAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLTGKRPVMFTQD 1012 (1099)
Q Consensus 962 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~elltg~~P~~~~~~ 1012 (1099)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 011123456779999998763 478999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=292.54 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=198.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~l 876 (1099)
++|...+.||+|+||.||+|... +|..|++|.+.... ...+.+.+|++++++++ ||||+++++++.. .+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence 36888999999999999999876 68899999886422 22466889999999998 9999999999874 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 80 VLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999999753 2589999999999999999999999999999999999999999999999999875532
Q ss_pred CCCC-----------------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 047739 957 TPAE-----------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 957 ~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~ 1019 (1099)
.... ........++..|+|||......++.++||||+|++++++++|+.||.........+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 2110 12233456889999999998888999999999999999999999999766543333322
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM----SDIVF 1075 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~----~evl~ 1075 (1099)
... ..... ..+ -..+.+++.+||+.+|.+||++ +|+++
T Consensus 235 ~~~--~~~~~----~~~------------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LKL--EYSFP----PNF------------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hhc--CCCCC----Ccc------------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 210 00011 100 0124589999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-33 Score=276.07 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=194.3
Q ss_pred ccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeec
Q 047739 806 DEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 806 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.....||.|+||+|+|..++ .|+..|||++.... .+.+++..|.++..+- +.||||+++|.+..+++ .|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeeeHHHH
Confidence 34567999999999999876 58999999996543 3456788888876655 68999999999885554 59999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+ -|+..+.+.........+++...-.|+.-.++||.||-+. .|||||+||+|||+|..|.+|+||||++-... .
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv----~ 220 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV----D 220 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH----H
Confidence 6 4777666543333445688988899999999999999875 89999999999999999999999999986542 2
Q ss_pred CccccccccCccccCccccccC--CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
....+..+|-..|||||.+... .|+-++||||+|++++|+.||+.||..++. ..+.+...+... .+.+.
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gd-pp~l~------ 291 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGD-PPILL------ 291 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCC-CCeec------
Confidence 2334556788899999998753 489999999999999999999999976544 455554443322 11111
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
......+--..+++++..|+.+|-..||...++..+
T Consensus 292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111112345789999999999999999988654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=295.39 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=202.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
...|.+.+.||+|.|+.|..|+.. .+..||+|.+.+...+. +.+.+|+++|+.++|||||+++.+... +...|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEE
Confidence 456888999999999999999875 58999999997655443 448899999999999999999999884 4557999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+.+|.+++++.+.++ ..+.....+..|+.+|++|||++.|||||||++||+++.+..+||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999987543 3346777788999999999999999999999999999999999999999998773
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
......+.+|++.|.|||.+.+.+| .+++|+||+|+++|-|+.|..||++..-..+...+.... -.++..
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~----- 277 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFY----- 277 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--ecccce-----
Confidence 3445667899999999999998776 689999999999999999999998654433322221110 011111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
-++++ -+++++++-.+|.+|+++++|.+--....
T Consensus 278 -----ms~dc------e~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 278 -----MSCDC------EDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred -----eechh------HHHHHHhhccCccccCCHHHhhhhcccch
Confidence 12222 26788899999999999999987654443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=291.93 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=189.9
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
|...+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|||++++++++.+. ...|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence 566678999999999999875 578999998854222 224678899999999999999999999854 55699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+. |++.+++... ...+++..+..++.|++.|++|||+.||+|+||+|+||+++.++.+|++|||++....
T Consensus 102 ~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 102 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred cCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 995 6888887642 2348899999999999999999999999999999999999999999999999886431
Q ss_pred CCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 960 EASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
......|+..|+|||++. ...++.++||||||+++|||++|..||...........+.. ..........
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~- 244 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNE- 244 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccc-
Confidence 123456889999999974 45688899999999999999999999876544333332221 1111111110
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+. ..+.+++.+||+.+|++||++.+++..
T Consensus 245 ---------~~--~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 245 ---------WT--DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------cC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 124578999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=295.73 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=196.7
Q ss_pred hccc-cccccccccceeEEEEEEC-CceEEEEEECCCCCccH---------------HHHHHHHHHhhhccCCcceEEee
Q 047739 803 RQFD-EENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---------------NLFRKEAEFLGKVRHRNLTVLRG 865 (1099)
Q Consensus 803 ~~~~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~H~niv~l~~ 865 (1099)
++|. ..+.||.|+||.||+|... +++.||+|.+....... ..+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4577999999999999875 58899999885432221 24778999999999999999999
Q ss_pred EEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 866 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
++.. +...++||||++ |+|.+++... ..+++.....++.|++.||+|||+.||+||||+|+||+++.++.+++
T Consensus 88 ~~~~-~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVE-GDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEec-CCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 9884 456699999996 6999988642 34788999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCC-----------CCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCch
Q 047739 946 SDFGLDRLTIPTP-----------AEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013 (1099)
Q Consensus 946 ~DfGla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~ 1013 (1099)
+|||.++...... ..........++..|+|||++.+. .++.++||||+|+++|||++|+.||....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987542100 011122334578899999998764 4689999999999999999999999877666
Q ss_pred hHHHHHHHHhhhcccccccc----CcccCCCC-CChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1014 DIVKWVKKQLQKGQITELLE----PGLLELDP-ESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d----~~~~~~~~-~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+....+.............+ +....... ...... .-..+.+++.+|++.+|++||+++|++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 55555444332221100000 00000000 000000 01234689999999999999999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=292.11 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=189.6
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc--cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL--DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|+..+.||+|+||.||+|.+++ +..||+|.+..... ....+.+|+.++.+.. ||||+++++++.+. ...++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEE
Confidence 3568889999999999999999875 88999999865332 2345667887777765 99999999999854 456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||+. +++.+++.... ..+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.+||+|||++.....
T Consensus 93 ~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99985 57777775421 358999999999999999999997 5999999999999999999999999999875421
Q ss_pred CCCCCccccccccCccccCccccccCC----CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGE----TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
. .......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+........ .....
T Consensus 168 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~~~- 239 (296)
T cd06618 168 S----KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQE-EPPSL- 239 (296)
T ss_pred C----CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcC-CCCCC-
Confidence 1 1122345788999999987554 789999999999999999999999653221 1111111111 11100
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...... ...+.+++.+||+.||++||++.++++.
T Consensus 240 -------~~~~~~---~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 -------PPNEGF---SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCC---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 1134678999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=294.03 Aligned_cols=270 Identities=23% Similarity=0.282 Sum_probs=197.7
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCC----
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---- 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 872 (1099)
..++|...+.||+|+||.||+|... +|..||+|++..... ..+.+.+|++++++++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999864 688999998854322 23567899999999999999999998864432
Q ss_pred -ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 873 -LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 873 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+.||+||||||+||+++.++.+|++|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 348999999 6799888753 24889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc--c
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ--I 1028 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~ 1028 (1099)
..... ......++..|+|||++.+ ..++.++||||+|++++++++|+.||...........+........ .
T Consensus 166 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 75421 1223467889999998876 4588999999999999999999999976544333222221110000 0
Q ss_pred ccccc--------CcccCCCCCCh-h--HHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHhhcccCC
Q 047739 1029 TELLE--------PGLLELDPESS-E--WEEFLLGVKVALLCTAPDPIDRPTMSDIV--FMLEGCRVG 1083 (1099)
Q Consensus 1029 ~~~~d--------~~~~~~~~~~~-~--~~~~~~~~~li~~Cl~~dP~~RPs~~evl--~~L~~~~~~ 1083 (1099)
.+.+. .......+... . ...-..+.+++.+|++.||++|||+.+++ ..++.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00000 00000000000 0 00011356899999999999999999999 455554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=285.46 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=181.7
Q ss_pred ccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHH---hhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 810 VLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEF---LGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+||+|+||.||+|... .++.||+|.+...... ...+..|..+ ++...||+|+.+++++... +..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence 4899999999999875 5889999988543221 2234445444 4445799999999988854 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... ..+++..+..++.|+++|++|||+.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 80 NGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 999999988642 34899999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
......|+..|+|||++.++ .++.++||||+|+++|||++|+.||.......... +....... ...+.
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~--- 219 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM------AVELP--- 219 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc------CCCCC---
Confidence 12245789999999998754 68999999999999999999999997653322111 11111110 00010
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1076 (1099)
.... ..+.+++.+|+..+|.+|| ++.|+++.
T Consensus 220 -~~~s----~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 -DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CcCC----HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0000 1345788999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=269.62 Aligned_cols=268 Identities=21% Similarity=0.278 Sum_probs=203.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecC-------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA------- 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 870 (1099)
...|+...+||+|.||.||+|+.+ +|+.||+|++... ..-.....+|++++..++|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 445777789999999999999875 4777888876331 11124567899999999999999999887521
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
....|+||++|+. +|...+.. ....++..+..+++.++..||.|+|...|+|||+||.|+||+.++.+|++|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2236899999986 88888864 235588999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-CCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 951 DRLTIP-TPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 951 a~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
|+.+.. ........+.++.|.+|++||.+.+ ++|+++.|||+.|||+.||+||.+-+.+.........+.... |.+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc--Gs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC--GSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh--ccC
Confidence 975432 2223344677889999999998876 569999999999999999999999888777666666555443 223
Q ss_pred cccccCcccCC--------CCC-ChhH---HH-H------HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLEL--------DPE-SSEW---EE-F------LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~--------~~~-~~~~---~~-~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...++|...++ .|- .... +. . ..+.+++..++..||.+|+++.+++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 33333332211 000 0000 00 1 135689999999999999999998864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=286.46 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.1
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
|+..+.||+|+||.||+|.... ++.|++|.+.... ...+.+..|++++++++|+|++++++++.+. ...++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 5567889999999999999864 8999999986542 2235678899999999999999999998854 556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
++ ++|.+++.+.. ..+++..+..++.|++.|++|||+.+|+||||+|+||++++++.++|+|||.++.....
T Consensus 80 ~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 151 (282)
T cd07829 80 CD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--- 151 (282)
T ss_pred cC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC---
Confidence 97 59999997532 34899999999999999999999999999999999999999999999999998754221
Q ss_pred CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc------ccc--
Q 047739 961 ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI------TEL-- 1031 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~-- 1031 (1099)
........++..|+|||.+.+. .++.++||||+|++++||++|+.||...........+......... ...
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1122334567889999998776 7899999999999999999999999776554444433332211100 000
Q ss_pred ccCcccCCCCCCh--hH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 LEPGLLELDPESS--EW-EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~--~~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+..+........ .. ..-..+.+++.+||+.||++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0111110000000 00 001245789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.52 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=189.1
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECC---CC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLP---DG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~---~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
+|.+.+.||+|+||.||++.... +..+++|.+. .. ......+.+|+.++++++||||+++++++.+. ...++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEE
Confidence 47788999999999999998753 3334444432 21 12334577899999999999999999998754 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++..... ....+++..+..++.|++.|++|||+.|++|+|++|+||+++. +.++++|||.++....
T Consensus 80 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999999875322 3356899999999999999999999999999999999999975 5699999999876532
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. ........|+..|+|||...+..++.++||||||+++|+|++|..||...........+ ..+..... +
T Consensus 158 ~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~--- 226 (260)
T cd08222 158 S---CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI----VEGPTPSL-P--- 226 (260)
T ss_pred C---cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HcCCCCCC-c---
Confidence 2 12223456788999999998888899999999999999999999998654332222211 11111100 0
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ..-..+.+++.+||+.+|++||++.|+++.
T Consensus 227 -----~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 -----E----TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----c----hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 001234578999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=295.55 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=196.4
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCC----
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---- 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 872 (1099)
..++|+..+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++|||++++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999986 57899999885432 223567789999999999999999987764332
Q ss_pred -ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 873 -LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 873 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
..++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+.||+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 368999999 5799998864 34899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
..... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+....... .+
T Consensus 166 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~--~~ 237 (343)
T cd07851 166 RHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP--DE 237 (343)
T ss_pred ccccc------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CH
Confidence 75421 1233467889999998865 367899999999999999999999997655544433333221100 00
Q ss_pred cccCccc---------CCC-CCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLL---------ELD-PESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~---------~~~-~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+...+. ... ....... .-..+.+++.+|+++||++|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 000 0000000 01245689999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=289.90 Aligned_cols=267 Identities=25% Similarity=0.312 Sum_probs=193.3
Q ss_pred ccccccccccccceeEEEEEECC---ceEEEEEECCCCC---ccHHHHHHHHHHhhhc-cCCcceEEeeEEec---CCCc
Q 047739 804 QFDEENVLSRTRYGLVFKACYND---GMVLSIRRLPDGS---LDENLFRKEAEFLGKV-RHRNLTVLRGYYAG---APDL 873 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---~~~~ 873 (1099)
+|+..+.||+|+||.||++.... +..||+|++.... ...+.+.+|+++++++ +||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999753 6789999885421 2245678899999999 59999999987542 2344
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688899986 689988863 23488999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCC-CccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc---
Q 047739 954 TIPTPAE-ASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI--- 1028 (1099)
Q Consensus 954 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 1028 (1099)
....... ........|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||...+.......+.........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5322111 112234578999999998765 46889999999999999999999999766544433333322111000
Q ss_pred cccccC-------cccCCCCCChhH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEP-------GLLELDPESSEW---EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~-------~~~~~~~~~~~~---~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+ ............ ..-..+.+++.+|++.||++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 000000000000 001235689999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=275.92 Aligned_cols=211 Identities=25% Similarity=0.398 Sum_probs=177.6
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|....+||+|+||.|..|..++ .+.+|||+++.+.. +.+.-..|-+++.-- +-|.+++++.++. ..+..|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-TmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-TMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-hhhhee
Confidence 3478999999999999999998774 56799998865432 223344566666655 5788999988877 455679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+.||+|--.+++.++ +.++...-+|..||-||-+||++|||+||+|..|||+|.+|++||+|||+++...
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999988887654 5666777889999999999999999999999999999999999999999998542
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
.......+.+||+.|+|||.+..+.|...+|.|||||++|||+.|++||++.+++++.+.+..
T Consensus 502 ---~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 502 ---FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred ---cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 234456678999999999999999999999999999999999999999999998888887765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=292.26 Aligned_cols=241 Identities=20% Similarity=0.222 Sum_probs=191.0
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++.|+....+|.|+|+.|-.+... .+...++|++... ..+..+|+.++... +||||+++.+.+.+. ...|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-KEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCC-ceeeeee
Confidence 3677888888999999999888765 4778899998654 22345677666665 699999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE-CCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll-~~~~~~kl~DfGla~~~~~~ 957 (1099)
|++.+|-+.+.+.... .....+..|+.+|+.|+.|||++||||||+||+|||+ +.+++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998877776421 2236777899999999999999999999999999999 68999999999999865221
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
..+.+-|..|.|||+....+|++++|+||+|+++|+|++|+.||...... ..+...+..+...+.+.
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s~~vS---- 536 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFSECVS---- 536 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccccccC----
Confidence 34456788999999999999999999999999999999999999865554 22333444443321111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.+++.+|++.||.+||+|.++...
T Consensus 537 ------------~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 537 ------------DEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------------HHHHHHHHHhccCChhhCcChhhhccC
Confidence 123578999999999999999999876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=279.05 Aligned_cols=235 Identities=25% Similarity=0.369 Sum_probs=189.0
Q ss_pred cccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 811 LSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
||+|+||.||++... +++.+++|.+..... ..+.+..|++++++++||||+++++.+.. +...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 689999999999986 488999998865432 33578899999999999999999998874 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcccc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST 965 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 965 (1099)
|.+++... ..+++.....++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 80 L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 151 (250)
T cd05123 80 LFSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTN 151 (250)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---Cccc
Confidence 99999753 248899999999999999999999999999999999999999999999999987642211 2234
Q ss_pred ccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 966 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
...++..|+|||...+...+.++|+||||+++||+++|+.||...+.......+.. ....+....
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~------------- 216 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFL------------- 216 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCC-------------
Confidence 55788899999999888889999999999999999999999976554333333322 001111110
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSD 1072 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~e 1072 (1099)
-..+.+++.+||..||++||++++
T Consensus 217 ---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 012357899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=308.11 Aligned_cols=217 Identities=28% Similarity=0.357 Sum_probs=182.1
Q ss_pred HHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCC----CCccHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPD----GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
+...-.++|++.++||+|+||.|..++++ .+++||+|++.+ ...+..-|..|-.+|.--+.+=||.++-.|. ++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-D~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-DE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-Cc
Confidence 34445778999999999999999999986 478999999965 2334567899999998888899999877776 45
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
.+.|+|||||+||+|-.++.+.. ++++.....++..|+-||.-+|+.|+|||||||.|||+|..|++|++|||.+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 67799999999999999998643 4888888888999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCccccccccCccccCccccc----c-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAAL----T-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
-.+. ..........+|||.|++||++. + +.|.+.+|.||+||++|||+.|.-||....-.+.+..|..
T Consensus 223 lkm~--~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMD--ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred HhcC--CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 6552 22344567789999999999885 3 5789999999999999999999999986555445554443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=313.72 Aligned_cols=144 Identities=22% Similarity=0.341 Sum_probs=127.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|.+.++||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence 57899999999999999999986 588999999864322 13568899999999999999999988874 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
|||+.+++|.+++... ..+++...+.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999753 237888899999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.66 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=192.9
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccH--------HHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDE--------NLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.++|-...++|+|||+.||+|.+ .+.+.||+|+-...+.+. +...+|.++-+.++||.||++|+|+.-+.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45677788999999999999975 457888988764333222 346689999999999999999999987777
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--CceecCCCCCCEEEC---CCCcEEEec
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--NMVHGDIKPQNVLFD---ADFEAHLSD 947 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--~iiH~Dlk~~NIll~---~~~~~kl~D 947 (1099)
.++-|+|||+|.+|.-+++.. ...++.+...|+.||+.||.||.+. +|||-|+||.|||+- .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 789999999999999999853 3478899999999999999999975 799999999999983 458899999
Q ss_pred cccccccCCCCCC----CccccccccCccccCccccccC----CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 047739 948 FGLDRLTIPTPAE----ASTSTTAVGTLGYVSPEAALTG----ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 948 fGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~ 1019 (1099)
||+++++.+.... -.......||++|++||.+.-+ ..+.|+||||.|||+|..+.|+.||...... +.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHH
Confidence 9999987433221 1234567899999999987533 4688999999999999999999999754332 222
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1074 (1099)
.+. ..+...-.- .+++...-. ..+..+|++|+++.-++|.+..++.
T Consensus 694 Lqe---NTIlkAtEV---qFP~KPvVs---seAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQE---NTILKATEV---QFPPKPVVS---SEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhh---hchhcceec---cCCCCCccC---HHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 221 111111110 111111111 1235789999999999998877664
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=280.03 Aligned_cols=242 Identities=21% Similarity=0.374 Sum_probs=192.1
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCC
Q 047739 808 ENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPN 883 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~ 883 (1099)
.+++|.|.||+||-|..+ .|+.||||.+.+.. ..+...++|+.++++++||.||.+.-.|+ .++..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-T~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-TPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-CCceEEEEehhhcc
Confidence 579999999999999864 69999999995532 34577899999999999999999987777 45566999999965
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEeccccccccCCCCCC
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~~~~~~~~~ 960 (1099)
+..+.+-. .+..+++++....+..||+.||+|||.++|+|+|+||+|||+... .++|+||||+|++. .+
T Consensus 648 -DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI----gE 719 (888)
T KOG4236|consen 648 -DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII----GE 719 (888)
T ss_pred -hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec----ch
Confidence 55555432 234568888888899999999999999999999999999999643 57999999999986 23
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|.|||++..+.|...-|+||.|||+|.-++|..||.. ++++-+.+... . +-
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNA----a-----------FM 782 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNA----A-----------FM 782 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhcc----c-----------cc
Confidence 4455678999999999999999999999999999999999999999864 34444433321 1 11
Q ss_pred CCChhHHHHH-HHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1041 PESSEWEEFL-LGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1041 ~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+|.++. .++++|...++..-++|.+..+.+.
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1233455432 3568888888888899988876653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-31 Score=281.74 Aligned_cols=247 Identities=19% Similarity=0.285 Sum_probs=205.7
Q ss_pred hccccccccccccceeEEEEEECCce-EEEEEECCC----CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGM-VLSIRRLPD----GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++.....+|-|+||.|-.++.+... .+|+|.+++ +....+.+..|-.+|...+.|.||++|.-|.+ ..+.|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence 34556678999999999998876543 477777643 23345678899999999999999999999884 5667999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||-|-||.+...++..+ .++..+...++.-+.+|++|||++|||+||+||+|.++|.+|-+|+.|||+|+..
T Consensus 499 mEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki--- 570 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI--- 570 (732)
T ss_pred HHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh---
Confidence 99999999999998643 3667777778888999999999999999999999999999999999999999976
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.....+.+.+||+.|.|||.+.....+.++|.||+|+++||+++|.+||.+.++...+..+.+.+....++..+..
T Consensus 571 -~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k--- 646 (732)
T KOG0614|consen 571 -GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK--- 646 (732)
T ss_pred -ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch---
Confidence 2345667889999999999999999999999999999999999999999999988888888887766554433221
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
.+.+++++.+..+|.+|-- +.||-+
T Consensus 647 -------------~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 647 -------------TATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred -------------hHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 2357888888999999976 555544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=288.23 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=206.8
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEe----cCCCc
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYA----GAPDL 873 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~----~~~~~ 873 (1099)
..+..|++.++||.|.+|.||+++.. +|+.+|+|++......+++++.|.++++.. +|||++.++|++. ..++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34567889999999999999999864 688899999877777778899999999987 6999999999986 34567
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+|||||.+||.-|+++... +..+.|.....|+..++.|+.|||...++|||||-.|||++.++.||++|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 799999999999999998754 67799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
. +.......+.+||+.|||||++.. ..|+..+|+||+|++..||..|.+|+....+.... . .+
T Consensus 173 l---dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F---~I 240 (953)
T KOG0587|consen 173 L---DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------F---LI 240 (953)
T ss_pred e---ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------c---cC
Confidence 5 233455677899999999999864 34788999999999999999999998654331110 0 01
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.-..+.+. ....|. ..+.++|..|+..|-++||++.++++.
T Consensus 241 pRNPPPkLk----rp~kWs--~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 PRNPPPKLK----RPKKWS--KKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCcccc----chhhHH--HHHHHHHHHHHhhccccCcchhhhccC
Confidence 111112111 111222 234579999999999999999988754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=266.84 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=198.3
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccC--Cc----ceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRH--RN----LTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~~~~~~~~~~~ 874 (1099)
+.+|.+.+.+|+|.||.|-.+.++. +..||+|+++.-..-.+...-|+++++++.+ |+ +|.+.+|+.-.+. .
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh-i 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH-I 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc-e
Confidence 6789999999999999999987654 6899999997655555677889999999942 32 6888888875544 5
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---------------
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA--------------- 939 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~--------------- 939 (1099)
++|+|.+ |-|+++++... .-.+++...+..|++|++++++|||+.+++|.|+||+||++-.
T Consensus 167 Civfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 55999999853 3356899999999999999999999999999999999999821
Q ss_pred -----CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh
Q 047739 940 -----DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014 (1099)
Q Consensus 940 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~ 1014 (1099)
+..++|+|||.|++.. ......+.|..|+|||++.+-.++..+||||+|||++|+.||..-|..-++.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceec------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2358999999998642 22366789999999999999999999999999999999999999887554433
Q ss_pred HHHHHHHHhh-----------------hcccc--ccccCc----ccCC-----CCCChhHHHHHHHHHHHHhcCCCCCCC
Q 047739 1015 IVKWVKKQLQ-----------------KGQIT--ELLEPG----LLEL-----DPESSEWEEFLLGVKVALLCTAPDPID 1066 (1099)
Q Consensus 1015 ~~~~~~~~~~-----------------~~~~~--~~~d~~----~~~~-----~~~~~~~~~~~~~~~li~~Cl~~dP~~ 1066 (1099)
-...+...+. .+.+. +....+ ..+. .......++...+.+++.+|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 1111111111 01000 000000 0000 001122234556789999999999999
Q ss_pred CCCHHHHHHH
Q 047739 1067 RPTMSDIVFM 1076 (1099)
Q Consensus 1067 RPs~~evl~~ 1076 (1099)
|+|++|++..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=258.27 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=195.6
Q ss_pred ccccccccccccceeEEEEEE-CCceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCC----CceE
Q 047739 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 875 (1099)
+.+..+.||-|.||+||..++ ++|+.|+.|++..- -...+.+.+|.+++.-.+|.|++..++...... ...|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345668899999999999987 57999999998642 223578999999999999999998887654211 1236
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
.|+|.|. .+|...+- ..+.++...+.-+.+||++||.|||+.+|.||||||.|.+++.+...||||||+|+..
T Consensus 134 V~TELmQ-SDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve- 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW- 206 (449)
T ss_pred HHHHHHH-hhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc-
Confidence 8888885 46766664 2345788888889999999999999999999999999999999999999999999865
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc-------
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ------- 1027 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------- 1027 (1099)
.......++..+.|..|+|||.+++. .|+.++||||.|||+.|++.++.-|....+-+..+.+...+....
T Consensus 207 -e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 -DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred -chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 22334556777899999999999875 589999999999999999999988876555444444443322111
Q ss_pred ----cccccc--------CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1028 ----ITELLE--------PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1028 ----~~~~~d--------~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
-..++. +.+..+... ...-...+.+...++.+||++|.+.++.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~---~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASP---DDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCC---cccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111 111111111 11112234677789999999999999988765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=267.65 Aligned_cols=220 Identities=20% Similarity=0.183 Sum_probs=171.0
Q ss_pred ccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhh
Q 047739 814 TRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE 892 (1099)
Q Consensus 814 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 892 (1099)
|.||.||++... +++.||+|++.... .+.+|...+....||||+++++++.+. ...++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 57899999986542 244555666666799999999998854 556999999999999999875
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCcc
Q 047739 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972 (1099)
Q Consensus 893 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~ 972 (1099)
. ..+++.....++.|+++||+|+|+.+|+||||||+||+++.++.++++|||.+..... ......++..
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------~~~~~~~~~~ 147 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENM 147 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc------ccccCCcCcc
Confidence 3 2388999999999999999999999999999999999999999999999998765421 1223345678
Q ss_pred ccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHH
Q 047739 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052 (1099)
Q Consensus 973 y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 1052 (1099)
|+|||.+.+..++.++||||+|+++|||++|+.|+...... .... .. + ..++. . -..+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~--~~-----~-~~~~~-~----~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTH--TT-----L-NIPEW-V----SEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccc--cc-----c-CCccc-C----CHHH
Confidence 99999998888999999999999999999999886432110 0000 00 0 00000 0 0234
Q ss_pred HHHHHhcCCCCCCCCCCHH
Q 047739 1053 VKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1053 ~~li~~Cl~~dP~~RPs~~ 1071 (1099)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 5789999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=242.98 Aligned_cols=261 Identities=19% Similarity=0.317 Sum_probs=197.0
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCC-CceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAP-DLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~~lV~ 878 (1099)
.++|++.+++|+|.|+.||.|.. .+.+.++||.++ ....+.+.+|+.+++.++ ||||+.+++...+.. ....+|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 45788999999999999999974 567889999985 345678999999999997 999999999987432 3346999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~ 957 (1099)
||+++.+....... ++.........+++.||.|+|+.||+|||+||.|+++|.. -..+++|||+|.+..+.
T Consensus 115 E~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999777666643 6667778889999999999999999999999999999964 56999999999988543
Q ss_pred CCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCC-CchhHHHHHHHHhhhcccccc----
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFT-QDEDIVKWVKKQLQKGQITEL---- 1031 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~---- 1031 (1099)
...+.++.+..|.-||.+-. ..|+..-|+|||||+++.|+..+.||... +..+..-.+.+.+...++...
T Consensus 187 ----~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 187 ----KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred ----ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 33455677788999998865 45788999999999999999999998543 333333333333332222111
Q ss_pred ---ccCcccCC--CCCChhHHHH----------HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 ---LEPGLLEL--DPESSEWEEF----------LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ---~d~~~~~~--~~~~~~~~~~----------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+|+.+..+ .-....|+.+ ..+++++.+.+..|-.+|||++|+++.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 22222210 0012223222 345789999999999999999998753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=294.65 Aligned_cols=263 Identities=17% Similarity=0.223 Sum_probs=166.8
Q ss_pred HHhccccccccccccceeEEEEEECC-----ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeE----E-ecC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY----Y-AGA 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~----~-~~~ 870 (1099)
..++|+..++||+|+||.||+|.+.+ +..||+|++..... .+.+..| .+++..+.+++.+... . ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 45689999999999999999999854 68899998754321 1111111 1112222222222111 1 123
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCE
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQ---------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NI 935 (1099)
+...++||||+.+++|.+++...... ............++.|++.||+|||+.+|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 45569999999999999998743210 001112334567999999999999999999999999999
Q ss_pred EECC-CCcEEEeccccccccCCCCCCCccccccccCccccCccccccC----------------------CCCCcCchhh
Q 047739 936 LFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG----------------------ETTKESDVYS 992 (1099)
Q Consensus 936 ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DV~S 992 (1099)
|++. ++.+||+|||+|+..... .........+++.|+|||.+... .++.++||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~--~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVG--INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccc--cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9985 589999999999754221 12233456789999999965322 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc-----ccccccCcccCCCCCCh-hHH----HHHHHHHHHHhcCCC
Q 047739 993 FGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ-----ITELLEPGLLELDPESS-EWE----EFLLGVKVALLCTAP 1062 (1099)
Q Consensus 993 ~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~~~~~~~~~~~-~~~----~~~~~~~li~~Cl~~ 1062 (1099)
+||++|||+++..|+.. +..... ..+.... ......+.. .+... ..+ .-....+++.+|++.
T Consensus 365 lGviL~el~~~~~~~~~----~~~~~~-~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS----NLIQFN-RQLKRNDYDLVAWRKLVEPRA---SPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHhCcCCCch----HHHHHH-HHHHhcCCcHHHHHHhhcccc---chhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999997766431 111111 1111100 000111110 00000 000 011234799999999
Q ss_pred CCCCCCCHHHHHHH
Q 047739 1063 DPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1063 dP~~RPs~~evl~~ 1076 (1099)
||++|||++|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=239.06 Aligned_cols=203 Identities=22% Similarity=0.355 Sum_probs=164.9
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCC--CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDG--SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+.......||+|+||.|-+.++ ..|...|+|++... ....++..+|+.+..+. .+|.+|.++|.+....+ .++.
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-vwIc 123 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-VWIC 123 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-EEEe
Confidence 34455667899999999988876 46999999999653 33446677888876654 79999999998775544 5999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||.|+- ||..+..+.- ..+...++...-+||..+..||.|||++ .|||||+||+|||++.+|++|+||||.+-...+
T Consensus 124 ME~M~t-Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHHhhh-hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999964 8887776543 3456689999999999999999999986 899999999999999999999999999876522
Q ss_pred CCCCCccccccccCccccCcccccc----CCCCCcCchhhHHHHHHHHHhCCCCCCCCC
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT----GETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~G~il~elltg~~P~~~~~ 1011 (1099)
....+...|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.||..+.
T Consensus 202 ----SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 ----SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ----hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 222333567789999998863 368999999999999999999999997544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=262.49 Aligned_cols=236 Identities=30% Similarity=0.412 Sum_probs=188.2
Q ss_pred cceeEEEEEECC-ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHh
Q 047739 815 RYGLVFKACYND-GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ 891 (1099)
Q Consensus 815 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~ 891 (1099)
+||.||+|.+.+ |+.+++|.+...... .+.+.+|++.+++++|+|++++++++... ...++||||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence 589999999875 889999998654332 57899999999999999999999998854 45699999999999999987
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCc
Q 047739 892 EASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971 (1099)
Q Consensus 892 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~ 971 (1099)
... .+++..+..++.+++++++|||+.+++|+||+|+||+++.++.++++|||.+...... .......++.
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~ 150 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG----GLLTTFVGTP 150 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc----cccccccCCc
Confidence 532 2789999999999999999999999999999999999999999999999999765221 1334567888
Q ss_pred cccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCC-CCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHH
Q 047739 972 GYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF-TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFL 1050 (1099)
Q Consensus 972 ~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 1050 (1099)
.|++||...+..++.++||||+|++++++++|..||.. .......+.... +..... .. ... .-.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~-~~-------~~~---~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPPFP-PP-------EWK---ISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCCCc-cc-------ccc---CCH
Confidence 99999999888889999999999999999999999976 333333322221 111000 00 000 012
Q ss_pred HHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1051 LGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1051 ~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 3467999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=282.10 Aligned_cols=267 Identities=18% Similarity=0.222 Sum_probs=177.6
Q ss_pred HhccccccccccccceeEEEEEE-----------------CCceEEEEEECCCCCcc---------------HHHHHHHH
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-----------------NDGMVLSIRRLPDGSLD---------------ENLFRKEA 849 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~---------------~~~~~~E~ 849 (1099)
.++|++.++||+|+||.||+|.+ ..++.||||++...... .+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 23568999998543221 12234577
Q ss_pred HHhhhccCCcc-----eEEeeEEecC-------CCceEEEEeecCCCCHHHHHhhhcc-------------------CCC
Q 047739 850 EFLGKVRHRNL-----TVLRGYYAGA-------PDLRLLVYDYMPNGNLGTLLQEASH-------------------QDG 898 (1099)
Q Consensus 850 ~~l~~l~H~ni-----v~l~~~~~~~-------~~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~ 898 (1099)
.++.+++|.++ +++++||... ....++||||+++|+|.++++.... ...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876654 6777777531 2346899999999999999974211 011
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccc
Q 047739 899 HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978 (1099)
Q Consensus 899 ~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~ 978 (1099)
..+++..+..++.|++.||+|+|+.+|+||||||+||+++.++.+||+|||+++..... .........+++.|+|||.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG--INFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC--CccCccccCCCcceeChhh
Confidence 23577888999999999999999999999999999999999999999999999754221 1111223345789999998
Q ss_pred cccCC----------------------CCCcCchhhHHHHHHHHHhCCC-CCCCCCchhH-HHHHHHHhhhccccccccC
Q 047739 979 ALTGE----------------------TTKESDVYSFGIVLLELLTGKR-PVMFTQDEDI-VKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 979 ~~~~~----------------------~~~~~DV~S~G~il~elltg~~-P~~~~~~~~~-~~~~~~~~~~~~~~~~~d~ 1034 (1099)
+.... ...+.||||+||+++||++|.. |+........ ...............-...
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75432 1235799999999999999875 6643211100 0000000000000000000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDP---IDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP---~~RPs~~evl~~ 1076 (1099)
.+...... -....+++.+++..+| .+|+|++|+++.
T Consensus 462 ~~~~~d~~------s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 DFSLLDRN------KEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred Cccccccc------ChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 01000000 1223578888888765 689999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=284.65 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=186.8
Q ss_pred ccccccccccccce-eEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYG-LVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
-|...+++|.|+.| .||+|.+. |+.||||++..+. .....+|+..++.- +|||||++++.-. ++.+.|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEEehHh
Confidence 35567789999987 48999997 7799999985432 23467999999988 5999999988755 566779999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---C--CcEEEeccccccccCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---D--FEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~--~~~kl~DfGla~~~~~ 956 (1099)
. .+|.++++... .+.....-...+.+..|+++||+|||+.+||||||||.||||+. + ..++|+|||+++....
T Consensus 586 ~-~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 A-CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 6 59999998631 11111111345667899999999999999999999999999965 3 5689999999998755
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhC-CCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTG-KRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
....-.......||.+|+|||++....-+.++||||+||++|+.++| .+||...-..+ .-| ..+.. .
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NI----l~~~~------~ 731 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANI----LTGNY------T 731 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhh----hcCcc------c
Confidence 44444446678899999999999998889999999999999999885 99997432211 111 11111 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+..+.+.. ++ .+.++|.+|+++||..||++.+|+.
T Consensus 732 L~~L~~~~-d~----eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVHLEPLP-DC----EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeeeccCc-hH----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111111 11 4568999999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=247.70 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=190.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|+..++||+|+|+.|..++++ ..+.+|+|++++. +.+...++.|-.+..+. +||.+|.+..+|..+ ...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-srlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-SRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-ceEE
Confidence 467999999999999999999875 4788999988543 23335577788888776 699999999888744 4568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|.||++||+|--++++. +.+++.....+...|.-||.|||+.|||+||+|..|+|+|..|++|++|+|+++...
T Consensus 328 fvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999997777643 348888888889999999999999999999999999999999999999999997532
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCC----CCchhHHHHHHHHhhhcccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF----TQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~----~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
.......+.+||+.|+|||.+.+.+|...+|.|++||+++||+.|+.||.. ..+++..++..+.+.+.++.
T Consensus 403 ---~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-- 477 (593)
T KOG0695|consen 403 ---GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-- 477 (593)
T ss_pred ---CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--
Confidence 233456678999999999999999999999999999999999999999963 22333444444433322221
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 1068 (1099)
+...+ -.++..+...-+.+||++|.
T Consensus 478 iprsl------------svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSL------------SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccee------------ehhhHHHHHHhhcCCcHHhc
Confidence 00000 11234577788899999884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=265.99 Aligned_cols=206 Identities=23% Similarity=0.359 Sum_probs=168.9
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
-|..++.||-|+||.|.+++-.| ...+|+|.+.+.+. ....++.|-.||...+.+=||+++-.|.+. +..|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-dnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-CceEEEE
Confidence 46678899999999999997544 66789998865432 235688999999999999999999888854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++||++-++|-+.+ .+.+.....++..+++|+++.|..|+|||||||.|||||.+|++|++|||++.-+.+..
T Consensus 709 dYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999997653 36666666677899999999999999999999999999999999999999976433222
Q ss_pred CCCc---------------------------------------cccccccCccccCccccccCCCCCcCchhhHHHHHHH
Q 047739 959 AEAS---------------------------------------TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLE 999 (1099)
Q Consensus 959 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~e 999 (1099)
.... ..-..+||..|+|||++....|+..+|.||.|||+||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1000 0013489999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCchhH
Q 047739 1000 LLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 1000 lltg~~P~~~~~~~~~ 1015 (1099)
|+.|+.||......+.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999976555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=247.37 Aligned_cols=260 Identities=21% Similarity=0.247 Sum_probs=193.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
..+|...+.+|.|.- .|-.|.+. .++.||+|++... ....++..+|..++..+.|+||++++.++.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 446777788888888 55555543 4788999988442 223466789999999999999999999987322 2
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+|||||. ++|...+.. .++-.+...|.+|+++|++|+|+.||+|||+||+||++..++.+||.|||+|+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 3589999996 589888862 26677888899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc------
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG------ 1026 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 1026 (1099)
... .....+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+.+..+.+.....
T Consensus 167 ~e~----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 167 TED----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred ccC----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 542 2245677899999999999999889999999999999999999999887654433222222221110
Q ss_pred -------------------ccccc-ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 -------------------QITEL-LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 -------------------~~~~~-~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+. .|..+..-... +..+-..+.+++.+|+-.+|++|-+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccC--CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00011 11111100000 11122344578899999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=247.80 Aligned_cols=132 Identities=20% Similarity=0.308 Sum_probs=113.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-----C---CcceEEeeEEec---
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-----H---RNLTVLRGYYAG--- 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 869 (1099)
..+|.+.++||-|.|++||+|.+. ..+.||+|+.+....-.+....|++++++++ | .+||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 367889999999999999999864 5789999999876666677889999999994 3 469999999973
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEE
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLF 937 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll 937 (1099)
++...++|+|++ |.+|-.++..+.. +.++...+.+|++||+.||.|||.+ ||||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 345678999999 6799999987654 3488999999999999999999986 99999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=252.95 Aligned_cols=195 Identities=24% Similarity=0.344 Sum_probs=165.9
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCccH---------HHHHHHHHHhhhcc---CCcceEEeeEEec
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDE---------NLFRKEAEFLGKVR---HRNLTVLRGYYAG 869 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~---H~niv~l~~~~~~ 869 (1099)
.+|+..+.+|.|+||.|+.|.++. ...|++|.+.+...-. ..+-.|+++|.+++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468889999999999999999875 5678888886543322 22456999999997 9999999999995
Q ss_pred CCCceEEEEeec-CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 870 APDLRLLVYDYM-PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 870 ~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
+ ++.|++||-. ++.+|.++++.. ..+++.+...|..|++.|++|||+.||||||||-+||.++.+|.+|++||
T Consensus 641 d-d~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 D-DYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred C-CeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 4 5569999966 445999999853 34889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCC-CcCchhhHHHHHHHHHhCCCCCC
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT-KESDVYSFGIVLLELLTGKRPVM 1008 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~G~il~elltg~~P~~ 1008 (1099)
|.|... ...+....+||..|.|||++.+..|- ..-|||++|+++|.++....||.
T Consensus 715 gsaa~~-----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT-----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh-----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765 23456678999999999999988874 55699999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=232.72 Aligned_cols=209 Identities=30% Similarity=0.470 Sum_probs=179.0
Q ss_pred cccccceeEEEEEECC-ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHH
Q 047739 811 LSRTRYGLVFKACYND-GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLG 887 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~ 887 (1099)
||+|++|.||++...+ ++.+++|........ .+.+.+|++.+++++|++++++++++... ...++||||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence 6899999999999865 889999998765542 57799999999999999999999999854 5569999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccccCCCCCCCccccc
Q 047739 888 TLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTT 966 (1099)
Q Consensus 888 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 966 (1099)
+++.... ..+++..+..++.+++++++|||+.+++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhc
Confidence 9997532 34789999999999999999999999999999999999999 89999999999875522111 2334
Q ss_pred cccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChh
Q 047739 967 AVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045 (1099)
Q Consensus 967 ~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1045 (1099)
..+...|++||..... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5678899999998877 888999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1046 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 123478889999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=228.03 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=184.2
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..+.|.+.+.+|+|.||.+-.+.++. .+.+++|.++......++|.+|...=-.+ .|.||+.-+++..+..+..++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 45678899999999999999999875 67899999988777889999998765555 58999998877665666767999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC--CCCcEEEeccccccccCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD--ADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~ 956 (1099)
||++.|+|.+-+... .+.+....+++.|+++|+.|||++++||||||.+||||- +...+|+||||.++....
T Consensus 102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999888642 367788889999999999999999999999999999993 334799999999875421
Q ss_pred CCCCCccccccccCccccCccccccC-----CCCCcCchhhHHHHHHHHHhCCCCCCCCC--chhHHHHHHHHhhhcccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTG-----ETTKESDVYSFGIVLLELLTGKRPVMFTQ--DEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~G~il~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~ 1029 (1099)
......-+-.|.|||..... ...+.+|||.||++++.++||+.||.... +...+.|.... .+...
T Consensus 176 ------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~rk~~ 247 (378)
T KOG1345|consen 176 ------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KRKNP 247 (378)
T ss_pred ------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cccCc
Confidence 11122345578999976532 35788999999999999999999997432 23334443322 22211
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ev 1073 (1099)
. +...+..+. .++.++..+-+.++|++|=...++
T Consensus 248 ~-~P~~F~~fs---------~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 248 A-LPKKFNPFS---------EKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred c-CchhhcccC---------HHHHHHHHHhcCCcccccchhHHH
Confidence 1 111111111 234577788899999998443333
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-28 Score=254.01 Aligned_cols=93 Identities=29% Similarity=0.423 Sum_probs=78.2
Q ss_pred cccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccC-CcCCcc
Q 047739 153 EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG-NALGGV 231 (1099)
Q Consensus 153 ~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~-N~l~~~ 231 (1099)
+||..+|+....++|..|+|+...|.+|+.+++|+.||||+|+|+.+.|.+|.| |.+|..|-+.+ |+|+.+
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G--------L~~l~~Lvlyg~NkI~~l 131 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG--------LASLLSLVLYGNNKITDL 131 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh--------hHhhhHHHhhcCCchhhh
Confidence 789999999999999999999777889999999999999999999888888876 55666665555 888876
Q ss_pred ChhhhcCCCCccEEEcccccCC
Q 047739 232 IPPAIGALPKLQVVSLAQNNLS 253 (1099)
Q Consensus 232 ~p~~~~~l~~L~~L~Ls~N~l~ 253 (1099)
..++|++|.+|+.|.+.-|++.
T Consensus 132 ~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 132 PKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred hhhHhhhHHHHHHHhcChhhhc
Confidence 6678888888888888777775
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-27 Score=248.49 Aligned_cols=389 Identities=24% Similarity=0.246 Sum_probs=271.6
Q ss_pred CCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccC-CccCccCCccccCCCCCCEE
Q 047739 293 SSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN-NSFGGAVPVEIKQCSSLSLL 371 (1099)
Q Consensus 293 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L 371 (1099)
+..-..++|..|+|+.+.|.+|+.+++|++||||+|.|+.+-|++|.++.+|..|-+.+ |+|+......|..+.+|+.|
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 45567889999999988889999999999999999999999999999999988887777 89998777889999999999
Q ss_pred EccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc------------cccchhhhCCCC
Q 047739 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS------------GSLPEEVLGMNN 439 (1099)
Q Consensus 372 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~ 439 (1099)
.+.-|++.-...+.|..+++|..|.+.+|.+..+...+|..+..++.+.+..|.+. ...|..+++...
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 99999998777788999999999999999998777779999999999999888732 223444555555
Q ss_pred CCEEEccCCcCccccCcccCCC-CcccEEEccCCcCCCcCC-CCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeee
Q 047739 440 LSTLDLSENKFSGEVPASIGNL-SQLMVFNLSGNAFSGRIP-ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIAL 517 (1099)
Q Consensus 440 L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 517 (1099)
..-..+.++++..+.+..|... ..+..-..+.+...+..| ..|..+++|+.|+|++|+++++-+.+|.++..+++|+|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 5555566666654444444321 122111112222222333 36777888888888888888777888888888888888
Q ss_pred ccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCC-----CCCCC-----------CCC
Q 047739 518 QENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS-----IPPEL-----------GNC 581 (1099)
Q Consensus 518 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~-----~p~~l-----------~~l 581 (1099)
..|++...-...|.++..|+.|+|.+|+++...|..|..+.+|.+|++-.|.+... +.+|+ +.-
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p 385 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSP 385 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCC
Confidence 88888766666777888888888888888877788888888888888877765410 00011 111
Q ss_pred CCCceEEecCCcccC---cCCcchhc---------cCccc-EEeccCccccccCCcccCCCCCCCEEECcCccccccCCh
Q 047739 582 SDLEVLELRSNSLTG---HIPTDISH---------LSHLN-VLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPD 648 (1099)
Q Consensus 582 ~~L~~L~L~~N~l~~---~~p~~~~~---------l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 648 (1099)
..++.+.++.+.+.. ..|++.+. ++-+. +..-|++.++ .+|..+. ..-.+|++.+|.++ .+|.
T Consensus 386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~ 461 (498)
T KOG4237|consen 386 GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPD 461 (498)
T ss_pred chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCH
Confidence 245566666555431 12222211 12222 2223444444 5665543 34567888888887 7777
Q ss_pred hhhccCCCCeeecCCCcCCCcCCCCccccccccccccCCC
Q 047739 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSN 688 (1099)
Q Consensus 649 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l~~n 688 (1099)
+ .+.+| .+|+|+|+++..--..++++.+|.+|-++.|
T Consensus 462 ~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 462 E--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred H--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 6 56677 7888888887665666777777777776654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=230.06 Aligned_cols=198 Identities=27% Similarity=0.428 Sum_probs=169.1
Q ss_pred cccccccccccceeEEEEEECC-ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 805 FDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
|+..+.||.|++|.||++...+ +..+++|....... ..+.+.+|++.+++++|+|++++++++... ...++|+||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence 5567889999999999999875 88999999976543 357889999999999999999999998754 5569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++++|.+++..... .+++..+..++.+++.++.|+|+.+++|+|++|+||+++.++.++++|||.+....... .
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~--~ 153 (225)
T smart00221 80 EGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL--A 153 (225)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--c
Confidence 99999999975321 17889999999999999999999999999999999999999999999999987653221 1
Q ss_pred ccccccccCccccCcccc-ccCCCCCcCchhhHHHHHHHHHhCCCCCCC
Q 047739 962 STSTTAVGTLGYVSPEAA-LTGETTKESDVYSFGIVLLELLTGKRPVMF 1009 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~G~il~elltg~~P~~~ 1009 (1099)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 123445678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-24 Score=275.31 Aligned_cols=340 Identities=24% Similarity=0.279 Sum_probs=219.6
Q ss_pred cchhccCCCCccEEeCCCCcc------ccCchhhhCCCC-CCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCC
Q 047739 310 FPLWLTRASTLTRLDVSGNSI------SGKIPAQIGGLW-RLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEI 382 (1099)
Q Consensus 310 ~~~~~~~l~~L~~L~Ls~N~i------~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 382 (1099)
.+..|..+++|+.|.+.++.. ...+|..|..++ +|+.|++.++.++ .+|..+ ...+|+.|+|++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 445677778888887765532 234566666553 5788888777776 556555 4577888888888776 56
Q ss_pred CccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCC
Q 047739 383 PEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLS 462 (1099)
Q Consensus 383 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 462 (1099)
|..+..+++|+.|+|++|.....+| .+..+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 7777777788888887765444455 36677788888887776555677777777888888887764444566554 677
Q ss_pred cccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc-------CCCchhhhcccc
Q 047739 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS-------GNVPEGFSSLMS 535 (1099)
Q Consensus 463 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~ 535 (1099)
+|+.|++++|.....+|.. ..+|++|++++|.+. .+|..+ .+++|+.|++.++... ...+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 7788888777654444432 346777777777776 455444 4667777777653321 111222223456
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccC
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI 615 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 615 (1099)
|+.|++++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~ 855 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR 855 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence 7777777776666667777777777777777765444566554 5667777777766544344432 24566777777
Q ss_pred ccccccCCcccCCCCCCCEEECcCcc-ccccCChhhhccCCCCeeecCCCc
Q 047739 616 NNLTGEIPDEISKCSSLRSLLVNSNH-LSGGIPDSLAKLSNLAVLDLSANN 665 (1099)
Q Consensus 616 N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~ls~N~ 665 (1099)
|.++ .+|..+..+++|+.|+|++|+ +. .+|..+..+++|+.++++++.
T Consensus 856 n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 7776 567677777777777776643 44 566666667777777776663
|
syringae 6; Provisional |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=251.68 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=194.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..++|+....+|.|.||.||||++. .++..|+|.++.... +-...+.|+-+++..+|||||.++|.+...+. .++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-cEEEE
Confidence 3457889999999999999999875 578888888865433 33667889999999999999999999885544 59999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+.+|+|.+..+-. ..+++.+...+++...+|++|+|+.|-+|||||-.||++++.|.+|++|||.+..+ .
T Consensus 92 EycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi---t 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI---T 163 (829)
T ss_pred EecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh---h
Confidence 999999999887643 45788888889999999999999999999999999999999999999999988644 1
Q ss_pred CCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
....+.....||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|.....+......+.+- .-+ .+.
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS--~~q-----pp~ 236 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS--GFQ-----PPT 236 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--CCC-----CCc
Confidence 2234455678999999999764 567999999999999999999988886544332222211111 001 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1074 (1099)
+. +...|.+. +.++++.|+..+|++||+++..+
T Consensus 237 lk----Dk~kws~~--fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LK----DKTKWSEF--FHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cc----CCccchHH--HHHHHHHHhcCCCccCCChhhhe
Confidence 11 11223332 34788999999999999997654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=272.02 Aligned_cols=348 Identities=21% Similarity=0.269 Sum_probs=237.9
Q ss_pred ChhhhcCCCCccEEEcccccCCC------ccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCc
Q 047739 232 IPPAIGALPKLQVVSLAQNNLSG------VVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ 305 (1099)
Q Consensus 232 ~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~ 305 (1099)
.+.+|..|.+|+.|.+..+.... .+|.. +...+..|+.|++.+|.
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~-----------------------------~~~lp~~Lr~L~~~~~~ 600 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEG-----------------------------FDYLPPKLRLLRWDKYP 600 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcc-----------------------------hhhcCcccEEEEecCCC
Confidence 45678889999999887665321 12211 11123457777777777
Q ss_pred cccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCcc
Q 047739 306 IRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF 385 (1099)
Q Consensus 306 l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 385 (1099)
++. +|..| ...+|++|+|++|++. .++..+..+++|++|+|++|.....+| .+..+++|++|+|++|.....+|..
T Consensus 601 l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~s 676 (1153)
T PLN03210 601 LRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSS 676 (1153)
T ss_pred CCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchh
Confidence 763 45555 4678888888888887 567777888888888888775444555 4777888888888887666677888
Q ss_pred ccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCccc
Q 047739 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLM 465 (1099)
Q Consensus 386 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 465 (1099)
++++++|+.|++++|..-..+|..+ ++++|+.|+|++|.....+|.. ..+|++|+|++|.+. .+|..+ .+++|+
T Consensus 677 i~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~ 750 (1153)
T PLN03210 677 IQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLD 750 (1153)
T ss_pred hhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccc
Confidence 8888888888888765444555544 6777777777777654444432 346677777777765 344433 355566
Q ss_pred EEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccc
Q 047739 466 VFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG 545 (1099)
Q Consensus 466 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 545 (1099)
.|++.++... .+.. .+....+......++|+.|+|++|.....+|..++++++|+.|++++|.
T Consensus 751 ~L~l~~~~~~-~l~~----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 751 ELILCEMKSE-KLWE----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred cccccccchh-hccc----------------cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 6665543322 1110 0111111122234677788888877666778888888888888888775
Q ss_pred cCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCc-cccccCCc
Q 047739 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN-NLTGEIPD 624 (1099)
Q Consensus 546 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~ 624 (1099)
..+.+|..+ .+++|+.|++++|..-..+|.. .++|++|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|.
T Consensus 814 ~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~ 887 (1153)
T PLN03210 814 NLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSL 887 (1153)
T ss_pred CcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCc
Confidence 555666655 6788888888887655455543 357889999999998 78889999999999999984 555 6888
Q ss_pred ccCCCCCCCEEECcCcc
Q 047739 625 EISKCSSLRSLLVNSNH 641 (1099)
Q Consensus 625 ~l~~l~~L~~L~Ls~N~ 641 (1099)
.+..+++|+.|++++|.
T Consensus 888 ~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 888 NISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccccccCCCeeecCCCc
Confidence 88899999999999885
|
syringae 6; Provisional |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=233.91 Aligned_cols=267 Identities=22% Similarity=0.356 Sum_probs=194.1
Q ss_pred HHHhccccccccccccceeEEEEEEC----CceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCce
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 874 (1099)
...+.|...++||+|.|++||+|.+. ..+.||+|.+... ....++..|++++..+. +.||+++.+++.. .+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRN-NDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhcc-CCee
Confidence 34567888999999999999999754 3678999998653 23466899999999995 8999999998874 4556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRL 953 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~ 953 (1099)
.+|+||++..+-.++... ++......+...+..||+|+|..|||||||||+|++.+. .+.-.|.|||+|..
T Consensus 111 ~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999888888864 677888889999999999999999999999999999974 56789999999871
Q ss_pred cC-----------------C-C-----------------------CCCCccccccccCccccCccccccC-CCCCcCchh
Q 047739 954 TI-----------------P-T-----------------------PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVY 991 (1099)
Q Consensus 954 ~~-----------------~-~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~ 991 (1099)
.. + . ...........||++|.|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0 0000112356799999999998754 578999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCch--hHHHHHH----HHh-----hhcc--ccc---------c------cc-CcccCC-C-
Q 047739 992 SFGIVLLELLTGKRPVMFTQDE--DIVKWVK----KQL-----QKGQ--ITE---------L------LE-PGLLEL-D- 1040 (1099)
Q Consensus 992 S~G~il~elltg~~P~~~~~~~--~~~~~~~----~~~-----~~~~--~~~---------~------~d-~~~~~~-~- 1040 (1099)
|.|||+..+++++.||....++ .+.+.+. ..+ ..+. +.+ . ++ +...+. .
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999999754432 1111111 000 0111 111 0 00 000000 0
Q ss_pred -CCChhHHHHH--HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 -PESSEWEEFL--LGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 -~~~~~~~~~~--~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....++.+.. .+.++..+|+..||.+|-|++|++..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0112222322 56799999999999999999998863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=238.52 Aligned_cols=269 Identities=20% Similarity=0.215 Sum_probs=205.4
Q ss_pred HHHHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhcc------CCcceEEeeEEecCC
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVR------HRNLTVLRGYYAGAP 871 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~ 871 (1099)
+....+|.+....|+|-|++|.+|.+.. |..||||++.....-.+.=.+|+++|+++. --|.++++..|.. .
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-k 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-K 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-c
Confidence 3456789999999999999999998754 789999999766555556678999999994 3467888877774 4
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEecccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGL 950 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGl 950 (1099)
...|+|||-+. -+|.+.+++++.. ..+....+..+++|+.-||.+|-..||+|.||||.||||++. ..+||||||.
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 45699999885 5999999987654 347788999999999999999999999999999999999875 5689999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHH--------
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQ-------- 1022 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~-------- 1022 (1099)
|.+... ...+.......|.|||.+.+..|+...|+||.||++||+.||+.-|.+....++...+...
T Consensus 584 A~~~~e-----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 584 ASFASE-----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccc-----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 976532 2233345567899999999999999999999999999999999999988877776655432
Q ss_pred hhhcccc-ccccCccc-------------------CCCC--------------CChhHHHHHHHHHHHHhcCCCCCCCCC
Q 047739 1023 LQKGQIT-ELLEPGLL-------------------ELDP--------------ESSEWEEFLLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1023 ~~~~~~~-~~~d~~~~-------------------~~~~--------------~~~~~~~~~~~~~li~~Cl~~dP~~RP 1068 (1099)
+..+.+. .-+|..+. ...| .......+..+.++...|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 1122111 11111110 0001 111122344566789999999999999
Q ss_pred CHHHHHHH
Q 047739 1069 TMSDIVFM 1076 (1099)
Q Consensus 1069 s~~evl~~ 1076 (1099)
|..+++..
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=252.24 Aligned_cols=335 Identities=20% Similarity=0.290 Sum_probs=180.3
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCC----CCCCCCCCCCcccc----------------eEecCCcEeEEecCCCccccc
Q 047739 22 DRSPEIEALTSFKLNLHDPLGALNG----WDSSTPAAPCDWRG----------------VACTNNRVTELRLPRLQLSGR 81 (1099)
Q Consensus 22 ~~~~~~~~l~~~k~~~~~~~~~l~~----w~~~~~~~~c~w~g----------------v~c~~~~v~~l~l~~~~l~g~ 81 (1099)
+..+|..++++..+.+.-| +.+++ |+..++ .|.=.. |.|.++.||.+..-+..-...
T Consensus 60 ~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~~~--fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 60 ASPEEIKSKFECLRMLAFP-AYADNIQYSRGGADQ--YCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCHHHHHHHHHHHHHhcCC-chhhccccccCCCCc--ccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 3447999999999999766 34455 987554 786555 889988888887665332222
Q ss_pred cccccccccccceEE-ccCCccCcc----------cCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccC
Q 047739 82 ISDHLSNLRMLRKLS-LRSNSFNGT----------IPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRL 150 (1099)
Q Consensus 82 ~~~~l~~l~~L~~L~-L~~n~~~~~----------~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l 150 (1099)
-..+-..-.....-+ =..+.-.++ +..++ ..+...|+|+++.++ .+|..+. +.|+.|+|++|++
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl--~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~L 211 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCL--KNNKTELRLKILGLT-TIPACIP--EQITTLILDNNEL 211 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhc--ccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCC
Confidence 111100000000000 000111100 11121 134567777777777 3565543 4677777777777
Q ss_pred CCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCc
Q 047739 151 SGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGG 230 (1099)
Q Consensus 151 ~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~ 230 (1099)
+ .+|..+..+|++|++++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+|+.
T Consensus 212 t-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~---------~LP~~l~--s~L~~L~Ls~N~L~~ 276 (754)
T PRK15370 212 K-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT---------ELPERLP--SALQSLDLFHNKISC 276 (754)
T ss_pred C-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC---------cCChhHh--CCCCEEECcCCccCc
Confidence 6 466666667777777777777 4555443 36777777777776 3444432 467777777777773
Q ss_pred cChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCc
Q 047739 231 VIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAF 310 (1099)
Q Consensus 231 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 310 (1099)
+|..+. ++|++|+|++|+|++ +|.. +|++++.|++++|.++.++.
T Consensus 277 -LP~~l~--~sL~~L~Ls~N~Lt~-LP~~-------lp~sL~~L~Ls~N~Lt~LP~------------------------ 321 (754)
T PRK15370 277 -LPENLP--EELRYLSVYDNSIRT-LPAH-------LPSGITHLNVQSNSLTALPE------------------------ 321 (754)
T ss_pred -cccccC--CCCcEEECCCCcccc-Cccc-------chhhHHHHHhcCCccccCCc------------------------
Confidence 455443 478888888887763 3431 12233334444443333322
Q ss_pred chhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCC
Q 047739 311 PLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIR 390 (1099)
Q Consensus 311 ~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 390 (1099)
.+ .++|+.|++++|.+++ +|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+++ .+|..+. .
T Consensus 322 --~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~ 388 (754)
T PRK15370 322 --TL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--A 388 (754)
T ss_pred --cc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--H
Confidence 11 1344444444444442 333332 34555555555544 2333332 34555555555555 3443332 2
Q ss_pred CCCeeeccCcccccc---CCccCCCCCCCCEEEcccCcCc
Q 047739 391 GLKSLTLAANLFSGS---IPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 391 ~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
+|+.|++++|++... +|..+..++++..|+|.+|.++
T Consensus 389 sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 389 ALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 455555555555521 2223344577888888888876
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-24 Score=267.70 Aligned_cols=199 Identities=17% Similarity=0.218 Sum_probs=139.5
Q ss_pred hccC-CcceEEeeEEecC------CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCce
Q 047739 854 KVRH-RNLTVLRGYYAGA------PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926 (1099)
Q Consensus 854 ~l~H-~niv~l~~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ii 926 (1099)
.++| +||+++++++... .+..+.++||+ +++|.++++.. ...+++..+..++.||++||+|||+.||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4456 6888888877311 13346888988 56999999742 34589999999999999999999999999
Q ss_pred ecCCCCCCEEECC-------------------CCcEEEeccccccccCCCCC-------------CCccccccccCcccc
Q 047739 927 HGDIKPQNVLFDA-------------------DFEAHLSDFGLDRLTIPTPA-------------EASTSTTAVGTLGYV 974 (1099)
Q Consensus 927 H~Dlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~-------------~~~~~~~~~gt~~y~ 974 (1099)
||||||+|||++. ++.+|++|||+++....... ........+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566677776653211000 000112246899999
Q ss_pred CccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHH
Q 047739 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK 1054 (1099)
Q Consensus 975 aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 1054 (1099)
|||++.+..++.++|||||||++|||++|..|+.... .....+... . .++.. .........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~----~~~~~---------~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----V----LPPQI---------LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----h----cChhh---------hhcCHHHHH
Confidence 9999999999999999999999999999988864211 111111111 0 11100 001122346
Q ss_pred HHHhcCCCCCCCCCCHHHHHHH
Q 047739 1055 VALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1055 li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
++.+||+++|.+||++.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 7889999999999999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=245.25 Aligned_cols=264 Identities=27% Similarity=0.355 Sum_probs=152.7
Q ss_pred CCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcc
Q 047739 343 RLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLR 422 (1099)
Q Consensus 343 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 422 (1099)
.-..|+|++|.|+ .+|..+. .+|+.|++++|+|+ .+|.. .++|++|+|++|+|+.+ |.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 3556677777666 4555443 35666666666666 34432 24455555555555532 221 2344455555
Q ss_pred cCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccC
Q 047739 423 HNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGEL 502 (1099)
Q Consensus 423 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 502 (1099)
+|.++ .+|.. . .+|+.|++++|+++ .+|.. .++|+.|++++|++++ +
T Consensus 271 ~N~L~-~Lp~l---p------------------------~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-L 317 (788)
T PRK15387 271 SNPLT-HLPAL---P------------------------SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-L 317 (788)
T ss_pred CCchh-hhhhc---h------------------------hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-C
Confidence 55444 22221 1 23444455555544 22321 2345555555555553 2
Q ss_pred CcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCC
Q 047739 503 PIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582 (1099)
Q Consensus 503 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~ 582 (1099)
|.. ..+|+.|++++|++++ +|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|... .
T Consensus 318 p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~ 382 (788)
T PRK15387 318 PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---S 382 (788)
T ss_pred CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---c
Confidence 221 1235555666666652 3321 1356677777777763 3432 245666777777777 355432 4
Q ss_pred CCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecC
Q 047739 583 DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662 (1099)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls 662 (1099)
+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 6778888888887 45543 256788888888887 46653 246777888888887 678888888888888888
Q ss_pred CCcCCCcCCCCc
Q 047739 663 ANNLSGEIPANL 674 (1099)
Q Consensus 663 ~N~l~~~~p~~~ 674 (1099)
+|+|++.+|..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 888887766654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=241.25 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=191.1
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
..-..|||++|.++ .+|..+.. +|+.|++.+|+++. +|.. .++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 45678999999998 67887764 79999999999995 5542 589999999999999 56653 368999999
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
++|.++. +|..+ ++|+.|+|++|+++ .+|.. .++|+.|+|++|++++ +|... .+|+.|++++|++++
T Consensus 270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLTH-LPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchhh-hhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-
Confidence 9999984 34433 57889999999998 45542 4678889999998884 34322 346666777777763
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCccccc
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 557 (1099)
+|.. ..+|+.|+|++|+|++ +| .. ..+|+.|++++|++++ +|.. .
T Consensus 337 LP~l---p~~Lq~LdLS~N~Ls~-LP------------------------~l---p~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 337 LPTL---PSGLQELSVSDNQLAS-LP------------------------TL---PSELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred cccc---ccccceEecCCCccCC-CC------------------------CC---Ccccceehhhcccccc-Cccc---c
Confidence 3431 1345555555555552 22 21 1244555555555552 3332 2
Q ss_pred ceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEEC
Q 047739 558 RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637 (1099)
Q Consensus 558 ~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 637 (1099)
.+|+.|++++|+|+ .+|... ++|+.|++++|+++ .+|... .+|+.|++++|+|+ .+|..++++++|+.|+|
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 35667777777776 355432 57888899999988 467543 46788999999998 78998999999999999
Q ss_pred cCccccccCChhhhccC
Q 047739 638 NSNHLSGGIPDSLAKLS 654 (1099)
Q Consensus 638 s~N~l~~~~p~~l~~l~ 654 (1099)
++|+|++..|..+..+.
T Consensus 453 s~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 453 EGNPLSERTLQALREIT 469 (788)
T ss_pred CCCCCCchHHHHHHHHh
Confidence 99999988888775543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=205.53 Aligned_cols=168 Identities=20% Similarity=0.206 Sum_probs=125.9
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 884 GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 884 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
|+|.++++.. +..+++..++.++.|+++||+|||+.+ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 6899999752 245899999999999999999999998 999999999999999 9998765221
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-hHHHHHHHHhhhccccccccCcccCCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQLQKGQITELLEPGLLELDPE 1042 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1042 (1099)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........ +.. ...
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~---~~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PRD---RSN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------ccc---ccc
Confidence 126889999999999999999999999999999999999999654321 22222221111100 000 001
Q ss_pred ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1043 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.....+...+.+++.+||+.+|++||++.|+++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111112467899999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-21 Score=217.60 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=195.4
Q ss_pred ccccccccccccceeEEEEEECCc--eEEEEEECCCCCc-cHHHHHHHHHHhhhccC----CcceEEeeEEecCCCceEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDG--MVLSIRRLPDGSL-DENLFRKEAEFLGKVRH----RNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H----~niv~l~~~~~~~~~~~~l 876 (1099)
+|.+.++||+|+||.||.+..... ..+|+|....... ....+..|+.++..+.. +++..+++.....+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887754322 22268889999999873 5888888887435566799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-----CcEEEeccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-----FEAHLSDFGLD 951 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-----~~~kl~DfGla 951 (1099)
||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++|+.|++||||||.|+++... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 779999886533 4669999999999999999999999999999999999999765 46999999999
Q ss_pred cccC--CCCC----CCcc-ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 952 RLTI--PTPA----EAST-STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 952 ~~~~--~~~~----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+... .... .... .....||.+|+++....+.+.+++.|+||+++++.|+..|..||...........+.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 1111 1111 2345699999999999999999999999999999999999999976544333333222222
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
...... . .....+++. ++...+-..+..++|....+...++++.....
T Consensus 255 ~~~~~~-----~-----~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 255 KLLTDR-----F-----GDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred hhcccc-----c-----cCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 111110 0 111222332 33333445789999999999999877665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=220.80 Aligned_cols=165 Identities=24% Similarity=0.236 Sum_probs=128.3
Q ss_pred HHhccccccccccccceeEEEEEEC--CceEEEEEECCCC------CccHHHHHHHHHHhhhccCCcceE-EeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN--DGMVLSIRRLPDG------SLDENLFRKEAEFLGKVRHRNLTV-LRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~ 871 (1099)
...+|...+.||+|+||+||+|.++ +++.||+|++... ....+.|.+|++++++++|+|+++ ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 4567999999999999999999875 5788899986432 112456899999999999999985 4432
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCC-CCCCEEECCCCcEEEecccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI-KPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dl-k~~NIll~~~~~~kl~DfGl 950 (1099)
...|+||||+++++|.. .. .. . ...++.++++||+|||+.||+|||| ||+||+++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~~-----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---PH-----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---cc-----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 23599999999999962 21 00 0 1357789999999999999999999 99999999999999999999
Q ss_pred ccccCCCCCCCc-----cccccccCccccCccccccC
Q 047739 951 DRLTIPTPAEAS-----TSTTAVGTLGYVSPEAALTG 982 (1099)
Q Consensus 951 a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~ 982 (1099)
|+.......... ......+++.|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 987643321111 11456788999999988654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-22 Score=241.15 Aligned_cols=171 Identities=27% Similarity=0.503 Sum_probs=106.7
Q ss_pred CcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccc
Q 047739 56 CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIG 135 (1099)
Q Consensus 56 c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~ 135 (1099)
+.|....|-...++.|++.++++.. +|..+. +.|+.|+|++|.++ .+|..+. ++|++|+|++|+|+ .+|..+.
T Consensus 168 a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~ 240 (754)
T PRK15370 168 AVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP 240 (754)
T ss_pred HHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh
Confidence 3456667766677888888877763 554443 46788888888877 5666554 47788888888777 4565443
Q ss_pred cCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCcccccc
Q 047739 136 NLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANC 215 (1099)
Q Consensus 136 ~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l 215 (1099)
.+|+.|+|++|+++ .+|..++.+|+.|++++|+|+ .+|..+. ++|++|++++|+|+ .+|..+.
T Consensus 241 --~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt---------~LP~~lp-- 303 (754)
T PRK15370 241 --DTIQEMELSINRIT-ELPERLPSALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR---------TLPAHLP-- 303 (754)
T ss_pred --ccccEEECcCCccC-cCChhHhCCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc---------cCcccch--
Confidence 35777777777776 566666667777777777776 4555443 46777777777665 2332221
Q ss_pred CceeEEEccCCcCCccChhhhcCCCCccEEEcccccCC
Q 047739 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLS 253 (1099)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 253 (1099)
++|+.|++++|+++. +|..+ .++|+.|++++|.++
T Consensus 304 ~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 304 SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALT 338 (754)
T ss_pred hhHHHHHhcCCcccc-CCccc--cccceeccccCCccc
Confidence 245566666666653 23222 145555555555554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=199.70 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=182.2
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.....+|.+...|..|+|+|+... +++|++... ..-.++|..|.-.++-+.||||.+++|.|...+ ...+|..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeeee
Confidence 3445567889999999999998543 444555322 222367899999999999999999999998654 45899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-Cc-eecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NM-VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~i-iH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|+.|+|+..+++ +.....+..+..++|.++|+|++|||+. .+ -.--+.++.+++|++.+++|+ .+-+++.
T Consensus 269 mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs---- 340 (448)
T KOG0195|consen 269 MPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS---- 340 (448)
T ss_pred ccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee----
Confidence 999999999985 3456678888999999999999999986 33 344588999999999988764 1111111
Q ss_pred CCCccccccccCccccCccccccCCC---CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGET---TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.+.....-.+.||+||.+..... -+++|+|||++++||+.|...||...++.+.--.+.-+..+. -+.|+
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv----~ippg 413 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV----HIPPG 413 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc----cCCCC
Confidence 11122344578999999876543 467899999999999999999998766654333332221111 11222
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. . .-+.+++.-|+..||.+||.+..|+-.||+.
T Consensus 414 i-------s-----~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 414 I-------S-----RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred c-------c-----HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1 1 1245788899999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=191.61 Aligned_cols=205 Identities=18% Similarity=0.289 Sum_probs=169.7
Q ss_pred hccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
-.|.+.++||+|+||+++.|+. -+++.||||.-+..+ +..++..|.+.++.+. .+.|...+-|.. .+.+..+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGq-eG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-EGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeecc-ccchhhhhhhh
Confidence 3688999999999999999974 468999999876543 4456889999999885 577777654433 44445799999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-----cEEEeccccccccC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-----EAHLSDFGLDRLTI 955 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-----~~kl~DfGla~~~~ 955 (1099)
+ |.||+|++.-++ +.++..++..||.|+..-++|+|++..|+|||||+|+||...+ .+.++|||+|+.+.
T Consensus 106 L-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9 779999998764 4599999999999999999999999999999999999997543 48999999999875
Q ss_pred CCCCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh
Q 047739 956 PTPAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014 (1099)
Q Consensus 956 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~ 1014 (1099)
+..... .......||.+||+-....+++.+.+.|+-|+|.+++..+-|..||.+.....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 443222 23455679999999999999999999999999999999999999998765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=182.82 Aligned_cols=206 Identities=20% Similarity=0.275 Sum_probs=166.9
Q ss_pred HHhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhccC-CcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRH-RNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~lV~ 878 (1099)
...+|...++||.|+||.+|.|.. .+|+.||+|.-... ........|.++++.++| ..|..+..|.. +..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~-e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGT-EKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhcc-ccccceeee
Confidence 456799999999999999999974 67999999986542 334567889999999986 34444444444 556668999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~~~~ 955 (1099)
|.. |.||.+.+.-+. +.++..+++.+|-|++.-++|+|..++|||||||+|+|+.-+ ..+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 779999998654 348999999999999999999999999999999999999633 458999999998764
Q ss_pred CCCCC----CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch
Q 047739 956 PTPAE----ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013 (1099)
Q Consensus 956 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~ 1013 (1099)
+.... ........||.+|.+-....+.+.+.+.|+-|+|.++..+--|..||.+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 33221 12334567999999988888888899999999999999999999999875443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-18 Score=198.85 Aligned_cols=258 Identities=26% Similarity=0.383 Sum_probs=194.1
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCc----cHHHHHHHHHHhhhccCC-cceEEeeEEecCCCceEEEEe
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHR-NLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~lV~e 879 (1099)
|...+.+|.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+++.. ....+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEe
Confidence 567788999999999999987 7788888854332 256799999999999988 79999999853 333689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 958 (1099)
|+.++++.+++...... ..+.......+..|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999999777643211 3588889999999999999999999999999999999999988 79999999997542222
Q ss_pred CCC---ccccccccCccccCcccccc---CCCCCcCchhhHHHHHHHHHhCCCCCCCCCc----hhHHHHHHHHhhhccc
Q 047739 959 AEA---STSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQD----EDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 959 ~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~G~il~elltg~~P~~~~~~----~~~~~~~~~~~~~~~~ 1028 (1099)
... .......|+..|+|||.+.+ ..+....|+||+|++++++++|..||..... ......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 111 13467789999999999987 5788999999999999999999999766543 2222222221111 00
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
........ .........+++..|+..+|..|.+..+....
T Consensus 236 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN--------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc--------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01112334578889999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-20 Score=220.57 Aligned_cols=252 Identities=19% Similarity=0.197 Sum_probs=177.6
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEECC----CCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 807 EENVLSRTRYGLVFKACYN-DGMVLSIRRLP----DGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..+++|.|.+|.|+.+... .....+.|... ...... ..+..|+.+-.+++|||++.....+.+.... +-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhhh
Confidence 4578999999988777643 22222222221 111111 2255688888889999998887776654443 4459
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC-
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT- 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~- 957 (1099)
||+++ +|..++... ..+....+..+..|+..|++|+|+.||.|||+|++|++++.+|.+||+|||.+....-.
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99998 999999753 23777888889999999999999999999999999999999999999999998754322
Q ss_pred CCCCccccccccCccccCccccccCCCCC-cCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTK-ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
..........+|.-.|+|||++.+.+|.+ ..||||.|+++..|.+|+.||......+... ..... ....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~-------~~~~ 544 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNY-------SDQR 544 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcc-------cccc
Confidence 12225567789999999999999999876 4699999999999999999996543322110 00000 0000
Q ss_pred cCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1037 LELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.........+..+ .....++.+|++.||.+|-|+.+|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001111111111 22356888999999999999999975
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=186.51 Aligned_cols=177 Identities=15% Similarity=0.165 Sum_probs=134.4
Q ss_pred HHHHHH--HHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHH----------HHHHHHHhhhccCCcceE
Q 047739 795 LAETVE--ATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENL----------FRKEAEFLGKVRHRNLTV 862 (1099)
Q Consensus 795 ~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~H~niv~ 862 (1099)
+.++.. ...+|...+++|.|+||.||.+.. ++..+|+|.+.......+. +++|++.+.++.||+|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 444443 467899999999999999999766 4668999998643322222 689999999999999999
Q ss_pred EeeEEecCC-------CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCE
Q 047739 863 LRGYYAGAP-------DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935 (1099)
Q Consensus 863 l~~~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NI 935 (1099)
+.+++.... ...++||||++|.+|.++.. ++. ....+++.++..+|+.|++|||+||+||
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Ni 166 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNF 166 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHE
Confidence 998865332 24689999999999987742 222 2456899999999999999999999999
Q ss_pred EECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHH
Q 047739 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELL 1001 (1099)
Q Consensus 936 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ell 1001 (1099)
+++.++ ++++|||..+........ ..+.....+..++|+||+|+.+....
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999988 999999987644111000 11344455678999999999987653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=175.41 Aligned_cols=187 Identities=17% Similarity=0.088 Sum_probs=139.3
Q ss_pred ccccccccccceeEEEEEECCceEEEEEECCCCCccHH-----HHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEe
Q 047739 806 DEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDEN-----LFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 806 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.+...+++|+||+||.+.. ++.+++.+.+.......+ .+.+|++++++++ |+++.+++++. ..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----GRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----CEEEEEe
Confidence 3557899999999997766 577888787766554333 6889999999995 58899998862 2589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCC-CCCCEEECCCCcEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI-KPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dl-k~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|++|.+|.+.... ....++.|++++++++|+.||+|||| ||.||+++.++.++|+|||+|....+..
T Consensus 79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999888654321 01346788999999999999999999 7999999999999999999998653222
Q ss_pred CCC---cc-------ccccccCccccCccccccC-CCC-CcCchhhHHHHHHHHHhCCCCCCCC
Q 047739 959 AEA---ST-------STTAVGTLGYVSPEAALTG-ETT-KESDVYSFGIVLLELLTGKRPVMFT 1010 (1099)
Q Consensus 959 ~~~---~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DV~S~G~il~elltg~~P~~~~ 1010 (1099)
... .. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 100 00 1122356778888754322 222 4568899999999999999987643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.2e-19 Score=180.17 Aligned_cols=138 Identities=17% Similarity=0.199 Sum_probs=107.1
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCc---c-------HHH-----------------HHHHHHHhhhccCCcc
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---D-------ENL-----------------FRKEAEFLGKVRHRNL 860 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~H~ni 860 (1099)
...||+|+||.||+|...+|+.||+|++..... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999988899999999854321 1 112 2349999999988776
Q ss_pred eEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-ccCCceecCCCCCCEEECC
Q 047739 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL-HTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 861 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~iiH~Dlk~~NIll~~ 939 (1099)
.....+.. . . .++||||++++++...... ...+++.....++.|++.+|.|+ |+.||+||||||+||+++
T Consensus 82 ~~p~~~~~-~-~-~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL-K-S-HVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe-c-C-CEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 43333222 1 2 3899999998776554321 13478889999999999999999 699999999999999998
Q ss_pred CCcEEEecccccccc
Q 047739 940 DFEAHLSDFGLDRLT 954 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~ 954 (1099)
++.++++|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=184.03 Aligned_cols=200 Identities=18% Similarity=0.234 Sum_probs=139.0
Q ss_pred cCCcceEEeeEEecC--------------------------CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHH
Q 047739 856 RHRNLTVLRGYYAGA--------------------------PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909 (1099)
Q Consensus 856 ~H~niv~l~~~~~~~--------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 909 (1099)
+|||||++.++|.+. +...|+||...+. +|.+++... ..+...+..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 699999999877532 3456899998864 999999742 2566677778
Q ss_pred HHHHHHHHHHHccCCceecCCCCCCEEE--CCCC--cEEEeccccccccCCC---CCCCccccccccCccccCccccccC
Q 047739 910 ALGVARGLAFLHTSNMVHGDIKPQNVLF--DADF--EAHLSDFGLDRLTIPT---PAEASTSTTAVGTLGYVSPEAALTG 982 (1099)
Q Consensus 910 ~~~ia~~L~~LH~~~iiH~Dlk~~NIll--~~~~--~~kl~DfGla~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~ 982 (1099)
..|+++|+.|||.+||.|||+|++|||+ |+|+ ...|+|||++--.... -.........-|...-||||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 8999999999999999999999999999 3443 4789999987532110 0111222334577789999987643
Q ss_pred C------CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHH
Q 047739 983 E------TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVA 1056 (1099)
Q Consensus 983 ~------~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li 1056 (1099)
. ...|+|.|+.|-+.||+++...||.......+...- .++.+++.+.+. .+ ..+.+++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~~---------vp----p~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPSR---------VP----PVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCccc---------CC----hHHHHHH
Confidence 2 367999999999999999999999863332211111 222222222211 11 1234788
Q ss_pred HhcCCCCCCCCCCHHHHHHHhh
Q 047739 1057 LLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1057 ~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
...++.||.+||+..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8899999999999876555543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=174.92 Aligned_cols=137 Identities=18% Similarity=0.210 Sum_probs=109.2
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCcc---------------------------HHHHHHHHHHhhhccCCcc
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---------------------------ENLFRKEAEFLGKVRHRNL 860 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~H~ni 860 (1099)
...||+|+||.||+|...+|+.||+|.+...... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998643211 1224679999999999987
Q ss_pred eEEeeEEecCCCceEEEEeecCCCCHHHH-HhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEEC
Q 047739 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTL-LQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 861 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~ 938 (1099)
.....+.... .++||||++++++... +.. ..++......++.|++.++.|+|+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK---NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC---CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 5544443322 3899999998755433 322 236778889999999999999999 9999999999999999
Q ss_pred CCCcEEEecccccccc
Q 047739 939 ADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~ 954 (1099)
++.++++|||+|+..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-20 Score=207.80 Aligned_cols=275 Identities=25% Similarity=0.347 Sum_probs=127.3
Q ss_pred EEEccCCcCC-CCCCccccCCCCCCeeeccCccccc----cCCccCCCCCCCCEEEcccCcCcc------ccchhhhCCC
Q 047739 370 LLDLEGNRFS-GEIPEFLGDIRGLKSLTLAANLFSG----SIPASFRNLPGLENLNLRHNSLSG------SLPEEVLGMN 438 (1099)
Q Consensus 370 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 438 (1099)
.|+|..+.++ ......+..+.+|+.|+++++.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 2334445555556666666666532 133344455556666666555541 1223334444
Q ss_pred CCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc----cCCcccCCC-Cccc
Q 047739 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG----ELPIELAGL-PNLQ 513 (1099)
Q Consensus 439 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l-~~L~ 513 (1099)
+|+.|++++|.+.+..+..+..+.+ . ++|++|++++|++++ .+...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCce
Confidence 5555555555444333332222222 0 124444444444431 111223333 4555
Q ss_pred eeeeccccccCC----CchhhhcccccceecccccccCCC----CCCcccccceeeEEEccCCcCCCC----CCCCCCCC
Q 047739 514 VIALQENKLSGN----VPEGFSSLMSLRYLNLSFNGFVGQ----IPATFSFLRSVVVLSFSGNHISGS----IPPELGNC 581 (1099)
Q Consensus 514 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~ls~N~l~~~----~p~~l~~l 581 (1099)
.|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 555555555421 222334444555666665555432 111222333555555555554421 22234445
Q ss_pred CCCceEEecCCcccCcCCcchhc-----cCcccEEeccCcccc----ccCCcccCCCCCCCEEECcCcccccc----CCh
Q 047739 582 SDLEVLELRSNSLTGHIPTDISH-----LSHLNVLDLSINNLT----GEIPDEISKCSSLRSLLVNSNHLSGG----IPD 648 (1099)
Q Consensus 582 ~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~ 648 (1099)
++|++|++++|.+++.....+.. .+.|+.|++++|.++ ..+...+..+++|+.+++++|.++.. +..
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 56666666666665422222221 245666666666654 12233344445566666666665532 233
Q ss_pred hhhcc-CCCCeeecCCCc
Q 047739 649 SLAKL-SNLAVLDLSANN 665 (1099)
Q Consensus 649 ~l~~l-~~L~~L~ls~N~ 665 (1099)
.+... +.|+.+++.+|+
T Consensus 301 ~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 301 SLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHhhcCCchhhcccCCCC
Confidence 33333 455555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-19 Score=208.24 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=175.8
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCC-C-CccHHHHHHHHHH--hhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPD-G-SLDENLFRKEAEF--LGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~-~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+|...+.+|.+.|=.|.+|++++|. |+||++.. + ...-+.|.++++- ...++|||.+++.-+-. .+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~-t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV-TDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH-hhHHHHHHHH
Confidence 5777889999999999999999997 66676633 2 3333445444333 44568999999877644 4455589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc-CCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT-IPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~-~~~~ 958 (1099)
|+.. +|+|.+... .-+...++..||.|++.|+..+|..||+|||||.+|||++.=.=+.++||..-+.. .+.+
T Consensus 102 yvkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9965 999999752 33777888999999999999999999999999999999998878899999755422 1111
Q ss_pred CCC---ccccccccCccccCccccccC-----------CCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 959 AEA---STSTTAVGTLGYVSPEAALTG-----------ETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 959 ~~~---~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
... ....+...-..|+|||.+... ..+++.||||+||+++|+++ |++||.- .+....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH--
Confidence 111 112233334579999977542 15688999999999999988 6777742 111111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.+. .+.....+.++.. .....++..|++.||.+|-++++.++.-++..+
T Consensus 248 r~~~-~~~~e~~Le~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIED--------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred hccC-ccCHHHHHHhCcC--------ccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 1110 0000000101100 023478899999999999999999998776654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-19 Score=205.52 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=110.8
Q ss_pred EEcCCCccc-cCcchhccCCCCccEEeCCCCccccC----chhhhCCCCCCCEEEccCCccCc------cCCccccCCCC
Q 047739 299 LDLQQNQIR-GAFPLWLTRASTLTRLDVSGNSISGK----IPAQIGGLWRLEELKMANNSFGG------AVPVEIKQCSS 367 (1099)
Q Consensus 299 L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~n~l~~------~~~~~l~~l~~ 367 (1099)
|+|..+.++ ......|..+..|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 555566665 23444455566677777777776432 44445566667777777776652 12344556667
Q ss_pred CCEEEccCCcCCCCCCccccCCCC---CCeeeccCccccc----cCCccCCCC-CCCCEEEcccCcCccc----cchhhh
Q 047739 368 LSLLDLEGNRFSGEIPEFLGDIRG---LKSLTLAANLFSG----SIPASFRNL-PGLENLNLRHNSLSGS----LPEEVL 435 (1099)
Q Consensus 368 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~ 435 (1099)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 777777777776555554444443 6666666666552 222334445 6666666666666632 233344
Q ss_pred CCCCCCEEEccCCcCccc----cCcccCCCCcccEEEccCCcCCCcC----CCCCCCCCCCCEEEeccCcCc
Q 047739 436 GMNNLSTLDLSENKFSGE----VPASIGNLSQLMVFNLSGNAFSGRI----PASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
.+.+|++|++++|.+++. ++..+..+++|+.|++++|.+++.. ...+..+++|++|++++|.++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 555666666666666531 2223334455666666666554221 223334455555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=188.88 Aligned_cols=219 Identities=26% Similarity=0.382 Sum_probs=160.4
Q ss_pred hhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCc-eecCC
Q 047739 852 LGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM-VHGDI 930 (1099)
Q Consensus 852 l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~i-iH~Dl 930 (1099)
|+.+.|.|+.+++|.+.+. ...+.|.+|+..|+|.|.+.. ....++|.....+..+|+.||+|+|...| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4578999999999999966 455899999999999999975 34568999999999999999999999876 99999
Q ss_pred CCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCC-------CCCcCchhhHHHHHHHHHhC
Q 047739 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE-------TTKESDVYSFGIVLLELLTG 1003 (1099)
Q Consensus 931 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DV~S~G~il~elltg 1003 (1099)
+++|.++|....+|++|||+....... ..........-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999998765321 1111112223445799999887642 46789999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1004 KRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1004 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
+.||...........+...+..+ ....+.|...... +....+..++..||..+|+.||++++|-..++.+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN------ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh------hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99997532221112222222221 1111112111100 1112456789999999999999999999998876543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-19 Score=168.25 Aligned_cols=161 Identities=32% Similarity=0.584 Sum_probs=84.7
Q ss_pred ccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccc
Q 047739 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543 (1099)
Q Consensus 464 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 543 (1099)
.+.|.|++|+++ .+|..+.++.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. ..|..|++++.|+.|||++
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 333344444444 33334444444444444444444 44445555555555555555554 5556666666666666666
Q ss_pred cccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCC
Q 047739 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIP 623 (1099)
Q Consensus 544 N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 623 (1099)
|.+.. ..+|..|..++.|+-|+|+.|.+. .+|..++++++|+.|.+..|.+. .+|
T Consensus 112 nnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lp 166 (264)
T KOG0617|consen 112 NNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLP 166 (264)
T ss_pred ccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCc
Confidence 65542 134444444555555555555554 55555555555555555555555 455
Q ss_pred cccCCCCCCCEEECcCccccccCChhhhcc
Q 047739 624 DEISKCSSLRSLLVNSNHLSGGIPDSLAKL 653 (1099)
Q Consensus 624 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 653 (1099)
.+++.+..|++|.+++|+++ .+|++++++
T Consensus 167 keig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 167 KEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred HHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 55555555566666666655 555555543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=177.42 Aligned_cols=234 Identities=20% Similarity=0.280 Sum_probs=146.5
Q ss_pred ccccccccccccceeEEEEEECC-ceEEEEEECCCCC----ccHHHHHHHHHHhhhccC----------CcceEEeeEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRH----------RNLTVLRGYYA 868 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~ 868 (1099)
.+...+.||.|+++.||.+++.+ |+.+|+|...... .+.+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667899999999999999875 8999999873222 123566677655554322 12222222211
Q ss_pred ---------cCC--C-----ceEEEEeecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCC
Q 047739 869 ---------GAP--D-----LRLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930 (1099)
Q Consensus 869 ---------~~~--~-----~~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dl 930 (1099)
... . ..+++|+-+. +||.+++...... ....+....+..+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 011 1 1257888884 6898886542211 1233556677888899999999999999999999
Q ss_pred CCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccC--------CCCCcCchhhHHHHHHHHHh
Q 047739 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG--------ETTKESDVYSFGIVLLELLT 1002 (1099)
Q Consensus 931 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DV~S~G~il~ellt 1002 (1099)
+|+|++++.+|.++++||+...... ........+..|.+||..... .++.+.|.|++|+++|.|++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999776431 111113455779999976432 47889999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCCh-hHHHHHHHHHHHHhcCCCCCCCC
Q 047739 1003 GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS-EWEEFLLGVKVALLCTAPDPIDR 1067 (1099)
Q Consensus 1003 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~-~~~~~~~~~~li~~Cl~~dP~~R 1067 (1099)
|+.||.....+....+ .+ ..| ..++ .+..+|..+++++|++|
T Consensus 246 ~~lPf~~~~~~~~~~~----------------~f-----~~C~~~Pe--~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----------------DF-----SRCRDMPE--PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----------------GG-----TTSS---H--HHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----------------cc-----hhcCCcCH--HHHHHHHHHccCCcccC
Confidence 9999976543321111 11 111 1112 23478999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-19 Score=166.88 Aligned_cols=165 Identities=29% Similarity=0.502 Sum_probs=148.6
Q ss_pred cCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCc
Q 047739 506 LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585 (1099)
Q Consensus 506 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~ 585 (1099)
+.++.+++.|.|++|+++ .+|..+..+.+|+.|++++|++. ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445677888889999998 67778889999999999999997 78888999999999999999998 8999999999999
Q ss_pred eEEecCCcccC-cCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCC
Q 047739 586 VLELRSNSLTG-HIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664 (1099)
Q Consensus 586 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 664 (1099)
.|||++|++.. .+|+.|..+..|+.|+|++|.+. .+|.+++++++|+.|.+..|.+. .+|.+++.++.|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999963 68999999999999999999998 89999999999999999999998 89999999999999999999
Q ss_pred cCCCcCCCCccc
Q 047739 665 NLSGEIPANLSS 676 (1099)
Q Consensus 665 ~l~~~~p~~~~~ 676 (1099)
+++ .+|..+..
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 999 46655544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-18 Score=192.46 Aligned_cols=185 Identities=28% Similarity=0.364 Sum_probs=149.8
Q ss_pred ccccccceeEEEEE----ECCceEEEEEECCCCCc---cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEeec
Q 047739 810 VLSRTRYGLVFKAC----YNDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
++|+|.||.|+... .+.|..+|+|...+... .......|..++..++ ||.+|++.-.+.. +...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence 47899999998764 23467777777644222 1225667888999887 9999999776664 44569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
.+|++...+... ..++......+...+|-|++++|+.+|+|||+|++||+++.+|++++.|||+++......
T Consensus 80 rgg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred ccchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999998888643 336667777777889999999999999999999999999999999999999998653221
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF 1009 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~ 1009 (1099)
..+||+.|||||++. .....+|.||||++++||+||..||..
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999988 567899999999999999999999976
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=165.40 Aligned_cols=137 Identities=15% Similarity=0.178 Sum_probs=103.4
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCC-CccHHHHHHHHHHhhhc-----cCCcceEEeeEEecCCC--c-eE
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDG-SLDENLFRKEAEFLGKV-----RHRNLTVLRGYYAGAPD--L-RL 875 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~~--~-~~ 875 (1099)
.+..+.||+|+||.||. .-.++.. +||++... ....+.+.+|+++++++ .||||++++|++.++.+ . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44567899999999996 2233444 57776543 23456799999999999 57999999999986542 2 23
Q ss_pred EEEee--cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHccCCceecCCCCCCEEECC----CCcEEEecc
Q 047739 876 LVYDY--MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL-AFLHTSNMVHGDIKPQNVLFDA----DFEAHLSDF 948 (1099)
Q Consensus 876 lV~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~iiH~Dlk~~NIll~~----~~~~kl~Df 948 (1099)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+.+|+||||||+||+++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999642 14444 34567777777 9999999999999999999974 347999995
Q ss_pred ccc
Q 047739 949 GLD 951 (1099)
Q Consensus 949 Gla 951 (1099)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-17 Score=197.55 Aligned_cols=150 Identities=34% Similarity=0.585 Sum_probs=128.3
Q ss_pred CCCChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--CcccceEecC------CcEeEEecCCCccccccccccccccc
Q 047739 20 AVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAP--CDWRGVACTN------NRVTELRLPRLQLSGRISDHLSNLRM 91 (1099)
Q Consensus 20 ~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~--c~w~gv~c~~------~~v~~l~l~~~~l~g~~~~~l~~l~~ 91 (1099)
..+..+|..||++||+++.+|.. .+|+.+ ++.| |.|.||+|+. .+|+.|+|+++++.|.+|+.+++|++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 34456799999999999977643 489742 2111 2799999952 25999999999999999999999999
Q ss_pred cceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc---cccceeeCC
Q 047739 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP---RNLKYFDLS 168 (1099)
Q Consensus 92 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~---~~L~~L~ls 168 (1099)
|+.|+|++|++.|.+|..++.+++|+.|||++|+++|.+|..++++++|++|+|++|+++|.+|..+. .++..++++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999988765 245567777
Q ss_pred CCcc
Q 047739 169 SNGF 172 (1099)
Q Consensus 169 ~N~l 172 (1099)
+|..
T Consensus 524 ~N~~ 527 (623)
T PLN03150 524 DNAG 527 (623)
T ss_pred CCcc
Confidence 7754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=166.17 Aligned_cols=133 Identities=19% Similarity=0.344 Sum_probs=109.2
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCc---------cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
+.||+|++|.||+|.+ .|..|++|....... ....+.+|++++.+++|+++.....++.... ..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEEE
Confidence 5799999999999988 466777887543221 1245778999999999999877666665433 4589999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
|++|++|.+++... .+ .+..++.+++.++.++|+.+++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998641 12 7888999999999999999999999999999999 78999999998875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=187.84 Aligned_cols=197 Identities=19% Similarity=0.230 Sum_probs=155.6
Q ss_pred HHHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhcc---CCcceEEeeEEecCCCceEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR---HRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~l 876 (1099)
...+.|.+.+.||+|+||+||+|...+|+.||+|.-......+ |.-=.+++.|++ -+-|+.+...+.. .+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVF-QNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHcc-CCccee
Confidence 3456788999999999999999999889999999976544332 332334555665 1233333333332 233489
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-------CCcEEEeccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-------DFEAHLSDFG 949 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-------~~~~kl~DfG 949 (1099)
|+||.+.|+|.+++.. ....+|.-++.++.|+++-+++||..+|||+||||+|.++.. ...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999983 355889999999999999999999999999999999999932 3458999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCC
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~ 1005 (1099)
.+-.+.. -.........++|-.+-.+|+..++..++.+|.|.++-+++.|+.|+.
T Consensus 847 ~siDm~l-fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKL-FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeE-cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9865421 123356667788999999999999999999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.9e-17 Score=177.95 Aligned_cols=176 Identities=22% Similarity=0.363 Sum_probs=131.4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
+.|+.|++++..+|.+|+.+ .......++.....++.|++.|++| ++.+|||+||.||+...+.++||+|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~r--r~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR--RRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC--CCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 45899999999999999975 2344557888899999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhC-CCCCCCCCchhHHHHHHHHhhhccc
Q 047739 953 LTIPTP---AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTG-KRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 953 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
...... ......+..+||..||+||.+.+..|+.|+||||+|++++|++.- .-+++ .. .....++.+.+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~-~t~~d~r~g~i 477 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RI-ATLTDIRDGII 477 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HH-HhhhhhhcCCC
Confidence 543222 112355678999999999999999999999999999999999872 11111 11 11122333433
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ev 1073 (1099)
++.+.... -.-..+..+++.+.|.+||++.++
T Consensus 478 p~~~~~d~-------------p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 478 PPEFLQDY-------------PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ChHHhhcC-------------cHHHHHHHHhcCCCcccCchHHHH
Confidence 32221111 112367789999999999955544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.3e-16 Score=164.22 Aligned_cols=140 Identities=15% Similarity=0.135 Sum_probs=109.0
Q ss_pred ccccccccccccceeEEEEE--ECCceEEEEEECCCCCcc-------------------------HHHHHHHHHHhhhcc
Q 047739 804 QFDEENVLSRTRYGLVFKAC--YNDGMVLSIRRLPDGSLD-------------------------ENLFRKEAEFLGKVR 856 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 856 (1099)
-|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ...+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 467999999988543210 123568999999997
Q ss_pred CCc--ceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC-ceecCCCCC
Q 047739 857 HRN--LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-MVHGDIKPQ 933 (1099)
Q Consensus 857 H~n--iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-iiH~Dlk~~ 933 (1099)
+.. +.+++++ . ..++||||++++++....... ..........++.|++.+++|+|+.| |+||||||+
T Consensus 109 ~~~i~~p~~~~~---~--~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW---R--RNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe---c--CceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 633 3344433 1 238999999998887654221 22455566789999999999999999 999999999
Q ss_pred CEEECCCCcEEEecccccccc
Q 047739 934 NVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~ 954 (1099)
||+++ ++.++++|||.|...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=159.46 Aligned_cols=136 Identities=15% Similarity=0.102 Sum_probs=107.7
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCc-----------------------cHHHHHHHHHHhhhccCCc
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-----------------------DENLFRKEAEFLGKVRHRN 859 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~H~n 859 (1099)
..|...+.||+|+||.||+|...+|+.||||++..... ....+.+|..++.++.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34778899999999999999988899999998643221 0123677899999998874
Q ss_pred --ceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE
Q 047739 860 --LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF 937 (1099)
Q Consensus 860 --iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll 937 (1099)
+...++. ...++||||+++++|.+.... .....++.+++.++.++|+.||+||||||+||++
T Consensus 95 i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV 158 (198)
T ss_pred CCCCceeec-----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE
Confidence 4444332 224899999999988765421 2345688999999999999999999999999999
Q ss_pred CCCCcEEEecccccccc
Q 047739 938 DADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 938 ~~~~~~kl~DfGla~~~ 954 (1099)
++++.++|+|||.+...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=183.63 Aligned_cols=138 Identities=23% Similarity=0.330 Sum_probs=110.0
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCC-C-------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDG-S-------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
...|...+.||+|+||.||+|.+.+...++.++.... . ...+++.+|++++++++|++++....++.... .
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-E 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-C
Confidence 3445678899999999999998875544333333211 1 11356889999999999999988777766433 4
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++++|.+++. ....++.++++++.|||+.+|+|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 589999999999999885 245689999999999999999999999999999 678999999999875
Q ss_pred c
Q 047739 954 T 954 (1099)
Q Consensus 954 ~ 954 (1099)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=159.67 Aligned_cols=129 Identities=22% Similarity=0.380 Sum_probs=102.2
Q ss_pred ccccccceeEEEEEECCceEEEEEECCCCCc---------cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 810 VLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.||+|+||.||+|.+. |..|++|....... ...++.+|++++++++|+++.....++... ...++||||
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEE
Confidence 4899999999999864 66778887543211 125577899999999988755444444433 334899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
+++++|.+++.... . .++.+++.++.++|+.|++|+|++|+||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998876411 0 7889999999999999999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-16 Score=186.04 Aligned_cols=214 Identities=24% Similarity=0.379 Sum_probs=147.5
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+|+.++.|..|+||.||..++++ .+.+|+| +.+.. . +++ ||..+ .+.+ +.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----l------ilR-----nilt~----a~np---fvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----L------ILR-----NILTF----AGNP---FVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----h------hhh-----ccccc----cCCc---cee---
Confidence 4578899999999999999998875 5567763 32211 1 111 12211 1111 222
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC--
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP-- 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-- 958 (1099)
|+-.+.++..+.. +- +++.+++|+|+.||+|||+||+|.+|+.=|++|++|||+++......
T Consensus 136 ---gDc~tllk~~g~l-----Pv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPL-----PV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCC-----cc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444555533222 11 22678999999999999999999999999999999999987531111
Q ss_pred ----------CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 959 ----------AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 959 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
.........+||+.|+|||++..+.|...+|+|++|+|+||.+.|..||.++..++++..+......+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-
Confidence 111123456899999999999999999999999999999999999999999988888777665433211
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1072 (1099)
+- |. ..+ .++.+++...++.+|..|--...
T Consensus 279 -E~-de---a~p---------~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 279 -EE-DE---ALP---------PEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred -cc-Cc---CCC---------HHHHHHHHHHHHhChHhhcccch
Confidence 11 11 111 12356777888999999864443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.3e-14 Score=171.90 Aligned_cols=119 Identities=40% Similarity=0.692 Sum_probs=98.7
Q ss_pred CCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecC
Q 047739 583 DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662 (1099)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls 662 (1099)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46788999999998899999999999999999999998899889999999999999999999999999999999999999
Q ss_pred CCcCCCcCCCCcccc-ccccccccCCCCcccCCCCccCCCCCCCCCCC
Q 047739 663 ANNLSGEIPANLSSI-FGLMNFNVSSNNLQAFANNQDLCGKPLGRKCE 709 (1099)
Q Consensus 663 ~N~l~~~~p~~~~~~-~~l~~l~l~~n~~~~~~~n~~l~~~~~~~~c~ 709 (1099)
+|+++|.+|..+... ..+..++ +.+|..+|+.|....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~--------~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFN--------FTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEE--------ecCCccccCCCCCCCCc
Confidence 999999999876542 1233344 55677889877656675
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-13 Score=146.86 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=103.5
Q ss_pred ccccc-cccceeEEEEEECCceEEEEEECCCCC--------------ccHHHHHHHHHHhhhccCCcc--eEEeeEEecC
Q 047739 808 ENVLS-RTRYGLVFKACYNDGMVLSIRRLPDGS--------------LDENLFRKEAEFLGKVRHRNL--TVLRGYYAGA 870 (1099)
Q Consensus 808 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 870 (1099)
..+|| .||.|+||++... +..+++|+..... .....+.+|++++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999886 5567777663211 223567889999999998875 6667665433
Q ss_pred CCce---EEEEeecCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 871 PDLR---LLVYDYMPN-GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 871 ~~~~---~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
.... ++||||+++ .+|.+++... .++.. .+.+++.++.+||+.||+||||||.|||++.++.++++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence 3322 499999997 6898888631 23332 35689999999999999999999999999998999999
Q ss_pred ccccccc
Q 047739 947 DFGLDRL 953 (1099)
Q Consensus 947 DfGla~~ 953 (1099)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.3e-14 Score=145.23 Aligned_cols=134 Identities=16% Similarity=0.161 Sum_probs=97.3
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccH---HH----------------------HHHHHHHhhhccCCc--c
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE---NL----------------------FRKEAEFLGKVRHRN--L 860 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~----------------------~~~E~~~l~~l~H~n--i 860 (1099)
.+.||+|+||.||+|...+|+.||+|.+....... .. ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999875432211 11 135666666665443 3
Q ss_pred eEEeeEEecCCCceEEEEeecCCCCHHH-HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEEC
Q 047739 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGT-LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 861 v~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~ 938 (1099)
.+.+++. ..++||||++++.+.. .+.... .. .....++.+++.++.++|. .+|+|||+||+||+++
T Consensus 82 ~~~~~~~-----~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDLN-----RHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEecC-----CCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3343321 2489999999854432 122110 01 4567789999999999999 9999999999999999
Q ss_pred CCCcEEEecccccccc
Q 047739 939 ADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~ 954 (1099)
++.++++|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.3e-13 Score=133.56 Aligned_cols=132 Identities=17% Similarity=0.165 Sum_probs=109.8
Q ss_pred cccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccC--CcceEEeeEEecCCCceEEEEeecCCC
Q 047739 807 EENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRH--RNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.+++++.... +..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCCe
Confidence 34679999999999999865 6788898865443 5678999999999987 5888888887644 4569999999887
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC---CceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---NMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.+..+ +......++.+++++++++|.. +++|+|++|+||+++..+.+++.|||.++.
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4456677889999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.9e-15 Score=162.08 Aligned_cols=175 Identities=31% Similarity=0.504 Sum_probs=129.5
Q ss_pred CCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEE
Q 047739 485 LLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLS 564 (1099)
Q Consensus 485 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 564 (1099)
+..-...||+.|++. ++|..+..+..|+.+.|..|.+. .+|..+.++..|++|||+.|+++ ..|..++.++ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 444556677777777 67777777777777777777777 67777777777777777777776 6666666664 77777
Q ss_pred ccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccc
Q 047739 565 FSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG 644 (1099)
Q Consensus 565 ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 644 (1099)
+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.+++ .-.|..||+|+|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-
Confidence 7777777 67777777777777777777777 67777777777777777777777 5677776 345777777777777
Q ss_pred cCChhhhccCCCCeeecCCCcCCC
Q 047739 645 GIPDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 645 ~~p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
.||-.|.+|..|++|-|.+|+|..
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCC
Confidence 777777777777777777777763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-14 Score=170.99 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=181.7
Q ss_pred ccccccccccccceeEEEEEECC--ceEEEEEECCCCCc---cHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND--GMVLSIRRLPDGSL---DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV 877 (1099)
.|...+-||+|+|+.|-...... ...+|+|.+..... ..+....|..+-+.+. |+|++.+++... +++..+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-SPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-CCcccccc
Confidence 46667779999999998776533 45667776644322 2244556888888886 999999999887 45566899
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc-cCCceecCCCCCCEEECCCC-cEEEeccccccccC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH-TSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTI 955 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~ 955 (1099)
.+|.++|++.+.+.. .+....+......+..|+..++.|+| ..++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988831 11112445556667899999999999 99999999999999999999 99999999998764
Q ss_pred CCCCCCcccccccc-CccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchh--HHHHHHHHhhhcccccc
Q 047739 956 PTPAEASTSTTAVG-TLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDED--IVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~ 1031 (1099)
............+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||....... ...|+... .....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~- 252 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFTQ- 252 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccccc-
Confidence 42334445556778 99999999988754 4678899999999999999999997654432 11121111 00000
Q ss_pred ccCcccCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..|..+ ....++..+++..+|..|.+.+++..
T Consensus 253 ------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 ------------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------------CccccCChhhhhcccccccCCchhccccccccc
Confidence 111110 12246677888899999999887654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.8e-15 Score=163.72 Aligned_cols=191 Identities=28% Similarity=0.468 Sum_probs=125.8
Q ss_pred cEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceeccccc
Q 047739 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFN 544 (1099)
Q Consensus 465 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 544 (1099)
...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|+.|+|+.|+++ ..|..+..|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34444555554 44444555555555555555554 45555555555556666666655 4555555543 666666666
Q ss_pred ccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCc
Q 047739 545 GFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPD 624 (1099)
Q Consensus 545 ~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 624 (1099)
+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+++.|+ |..||+|+|+++ .||-
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPV 228 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecch
Confidence 665 56666666666777777777776 67777888888888888888887 6777777665 888888888888 7888
Q ss_pred ccCCCCCCCEEECcCccccccCChhhhccC---CCCeeecCCCc
Q 047739 625 EISKCSSLRSLLVNSNHLSGGIPDSLAKLS---NLAVLDLSANN 665 (1099)
Q Consensus 625 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~---~L~~L~ls~N~ 665 (1099)
+|.+|..|++|-|.+|.|. ..|..++-.- =.++|+...++
T Consensus 229 ~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 8888888888888888887 6666655432 24566665553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=152.62 Aligned_cols=193 Identities=37% Similarity=0.583 Sum_probs=99.6
Q ss_pred EEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCC-cccEEEccCCcCCCcCCCCCCCCCCCCEEEeccC
Q 047739 418 NLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLS-QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496 (1099)
Q Consensus 418 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n 496 (1099)
.+++..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4566666653 12233444456666666666666 3444444443 6666666666666 44445566666666666666
Q ss_pred cCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCC
Q 047739 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP 576 (1099)
Q Consensus 497 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~ 576 (1099)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+..+.++..+.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 666 44444445566666666666665 44444434444666666666422 33334444444444444444444 2233
Q ss_pred CCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCcccc
Q 047739 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619 (1099)
Q Consensus 577 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 619 (1099)
.++.++++++|++++|+++ .++. ++.+.+|+.||+++|.++
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCcccc
Confidence 4444444444444444444 2222 444444444444444444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.4e-12 Score=146.68 Aligned_cols=140 Identities=21% Similarity=0.230 Sum_probs=103.3
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCcc-----------------------------------------HHHHH
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-----------------------------------------ENLFR 846 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------------------------------~~~~~ 846 (1099)
.+.||.|++|.||+|++++|+.||||+...+... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998543211 01245
Q ss_pred HHHHHhhhcc----CCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHc
Q 047739 847 KEAEFLGKVR----HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR-GLAFLH 921 (1099)
Q Consensus 847 ~E~~~l~~l~----H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH 921 (1099)
+|++.+.+++ |.+-+.+-.++.+.....++||||++|++|.++...... .. .+.+++.++++ .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 5666666663 333444444444334456999999999999887653211 11 24456777766 478899
Q ss_pred cCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 922 ~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
..|++|+|+||.||+++.++.++++|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=152.70 Aligned_cols=242 Identities=33% Similarity=0.408 Sum_probs=136.5
Q ss_pred CCCCEEEcccCcCccccchhhhCCC-CCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEE
Q 047739 414 PGLENLNLRHNSLSGSLPEEVLGMN-NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLD 492 (1099)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 492 (1099)
+.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..++.|+.|++++|+++ .+|...+..+.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44555555555555 3444444442 5555555555555 33345555566666666666665 3444444556666666
Q ss_pred eccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCC
Q 047739 493 LSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG 572 (1099)
Q Consensus 493 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 572 (1099)
+++|+++ .+|........|++|.+++|.+. ..+..+..+.++..+.+.+|++. ..+..++.+++++.|++++|.++
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~- 268 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS- 268 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-
Confidence 6666666 44544444555677777777433 35556667777777777777775 33666777777888888888877
Q ss_pred CCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhc
Q 047739 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAK 652 (1099)
Q Consensus 573 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 652 (1099)
.++. ++.+.+|+.|++++|.++...|..... ......... +.++ ..+........+....+..+... ..+..+..
T Consensus 269 ~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~-~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 343 (394)
T COG4886 269 SISS-LGSLTNLRELDLSGNSLSNALPLIALL-LLLLELLLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSI 343 (394)
T ss_pred cccc-ccccCccCEEeccCccccccchhhhcc-chhHHhhhh-hhhh-ccccccccccccccccccccccc-ccchhhcc
Confidence 4444 777888888888888888554443322 222222222 3333 22223333344444455555544 45555555
Q ss_pred cCCCCeeecCCCcCC
Q 047739 653 LSNLAVLDLSANNLS 667 (1099)
Q Consensus 653 l~~L~~L~ls~N~l~ 667 (1099)
...+..+++..+...
T Consensus 344 ~~~~~~~~~~~~~~~ 358 (394)
T COG4886 344 LESLNNLWTLDNALD 358 (394)
T ss_pred cccccCceecccccc
Confidence 555555555555544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-11 Score=142.57 Aligned_cols=145 Identities=18% Similarity=0.167 Sum_probs=98.1
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc---------------------------------------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD--------------------------------------- 841 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--------------------------------------- 841 (1099)
...|+. +.||.|++|.||+|+.++ |+.||||+...+...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999987 999999998643110
Q ss_pred --HHHHHHHHHHhhhcc----CCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH
Q 047739 842 --ENLFRKEAEFLGKVR----HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915 (1099)
Q Consensus 842 --~~~~~~E~~~l~~l~----H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 915 (1099)
+-+|.+|+..+.+++ +...+.+-.++.+-....++||||++|+.+.+.-.-. . ...+. ..++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~---~g~d~---~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-A---AGTDM---KLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-h---cCCCH---HHHHHHHHH
Confidence 012445666555553 4555555555554445568999999999998742210 1 01111 122222222
Q ss_pred -HHHHHccCCceecCCCCCCEEECCCC----cEEEecccccccc
Q 047739 916 -GLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDFGLDRLT 954 (1099)
Q Consensus 916 -~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~DfGla~~~ 954 (1099)
-+..+...|++|+|+||.||+++.++ .+++.|||++...
T Consensus 271 ~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 271 VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 23334568999999999999999888 9999999998765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-11 Score=127.18 Aligned_cols=203 Identities=19% Similarity=0.332 Sum_probs=139.1
Q ss_pred hhhccCCcceEEeeEEecCC----CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--Cc
Q 047739 852 LGKVRHRNLTVLRGYYAGAP----DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--NM 925 (1099)
Q Consensus 852 l~~l~H~niv~l~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--~i 925 (1099)
+-++.|-|||+++.|+.+.. ....++.|||..|++.++|++.... ...+......+++.||..||.|||+. .|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 44557999999999987432 2346899999999999999986543 34577778888999999999999985 79
Q ss_pred eecCCCCCCEEECCCCcEEEeccccccccCC-CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCC
Q 047739 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIP-TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK 1004 (1099)
Q Consensus 926 iH~Dlk~~NIll~~~~~~kl~DfGla~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~ 1004 (1099)
+|+++..+-|++..++-+|++--.-...... ............+-++|.|||+-.....+..+|||+||+...||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999999998753211111000 001112223345678999999887777888999999999999998887
Q ss_pred CC-CCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1005 RP-VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1005 ~P-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.- -.....-.....+...+.. .-+ .+ -..++.+|++..|..||+|++.+..
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~-----len-~l---------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIG-----LEN-GL---------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eccCCCcceeehhhhhhhheee-----ccC-cc---------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 63 2111111111111111110 000 00 0246778999999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=7e-11 Score=120.22 Aligned_cols=128 Identities=19% Similarity=0.140 Sum_probs=96.2
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceE-EeeEEecCCCceEEEEeecCCCCH
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV-LRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
.+.++.|.++.||++... +..|++|...........+.+|+++++.+.+.++++ ++.+.. . ..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--E-TGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--C-CCeEEEEecCCCcc
Confidence 356889999999999876 677999987654333345789999999997655544 444322 2 24899999999876
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCc-----eecCCCCCCEEECCCCcEEEeccccccc
Q 047739 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM-----VHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 887 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~i-----iH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.+. . . ....++.+++++++.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 0 112356789999999999875 9999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.7e-13 Score=138.29 Aligned_cols=92 Identities=26% Similarity=0.377 Sum_probs=48.9
Q ss_pred ccceeeCCCCccC----CCCCCCCcccccccccccccccccc---ccccccccccCccccccCceeEEEccCCcCCccCh
Q 047739 161 NLKYFDLSSNGFS----GPIPTSISNLSQLQLINFSFNKFSR---EVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIP 233 (1099)
Q Consensus 161 ~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~ls~N~l~~---~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p 233 (1099)
.++.++||+|.|. ..+.+.+.+.++|+..++|+=-... .+|++.. .+-+.+..++.|++|+||+|-++..-+
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~-~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK-MLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH-HHHHHHhcCCceeEeeccccccCccch
Confidence 3444555555553 1233445555666666666432111 1121111 111233345577778888877765444
Q ss_pred hh----hcCCCCccEEEcccccCC
Q 047739 234 PA----IGALPKLQVVSLAQNNLS 253 (1099)
Q Consensus 234 ~~----~~~l~~L~~L~Ls~N~l~ 253 (1099)
.. +.++..|++|+|.+|.+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCC
Confidence 33 456778888888888776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.1e-11 Score=126.65 Aligned_cols=135 Identities=25% Similarity=0.280 Sum_probs=97.0
Q ss_pred hhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCc
Q 047739 528 EGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSH 607 (1099)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 607 (1099)
..+..+..|+.||||+|.++ .+.....-.++++.|++|+|.|... ..+..+++|+.||||+|.++ .+-++=.++.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 33444567777888888776 5566666777778888888877632 33777788888888888887 55566667778
Q ss_pred ccEEeccCccccccCCcccCCCCCCCEEECcCccccccC-ChhhhccCCCCeeecCCCcCCC
Q 047739 608 LNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGI-PDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 608 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
.+.|.|+.|.|.. + ..++++-+|..||+++|+|...- ...+++|+.|+.+.|.+|++.+
T Consensus 354 IKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 354 IKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred EeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 8888888888762 2 45777778888888888876311 3567888888888888888874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=126.29 Aligned_cols=139 Identities=23% Similarity=0.269 Sum_probs=103.4
Q ss_pred cccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCC
Q 047739 504 IELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583 (1099)
Q Consensus 504 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~ 583 (1099)
..+...+.|++++|++|.|+ .+.++..-++.++.|++|+|.+... ..+..+++|+.|+||+|.++ .+-.+-..+-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 33444566777777777776 5666666677788888888877632 22667778888888888877 45556666778
Q ss_pred CceEEecCCcccCcCCcchhccCcccEEeccCccccc-cCCcccCCCCCCCEEECcCccccccCChh
Q 047739 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTG-EIPDEISKCSSLRSLLVNSNHLSGGIPDS 649 (1099)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 649 (1099)
.+.|.|+.|.+... ..++++-+|..||+++|+|.. .--..++++|.|+.|.|.+|++.+ +|+.
T Consensus 354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vdY 417 (490)
T KOG1259|consen 354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVDY 417 (490)
T ss_pred EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc-cchH
Confidence 88999999998732 567888999999999999973 122469999999999999999984 4543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-11 Score=129.94 Aligned_cols=233 Identities=23% Similarity=0.340 Sum_probs=129.4
Q ss_pred ccCCCCccEEeCCCCccccC----chhhhCCCCCCCEEEccCCc---cCccCCc-------cccCCCCCCEEEccCCcCC
Q 047739 314 LTRASTLTRLDVSGNSISGK----IPAQIGGLWRLEELKMANNS---FGGAVPV-------EIKQCSSLSLLDLEGNRFS 379 (1099)
Q Consensus 314 ~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~n~---l~~~~~~-------~l~~l~~L~~L~Ls~N~l~ 379 (1099)
+.....+++|+||+|.|... +...+.+.++|+.-++++-. +...+|+ .+..++.|++||||.|-|.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 33445566666666655422 23334445555555555421 1112222 2344557777777777765
Q ss_pred CCCCc----cccCCCCCCeeeccCcccccc-------------CCccCCCCCCCCEEEcccCcCccc----cchhhhCCC
Q 047739 380 GEIPE----FLGDIRGLKSLTLAANLFSGS-------------IPASFRNLPGLENLNLRHNSLSGS----LPEEVLGMN 438 (1099)
Q Consensus 380 ~~~p~----~~~~l~~L~~L~L~~n~l~~~-------------~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~ 438 (1099)
...+. .+..+..|++|+|.+|.+.-. ......+-++|+++...+|++... +...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 43333 334556677777777766411 122234457788888888887643 223455567
Q ss_pred CCCEEEccCCcCcc----ccCcccCCCCcccEEEccCCcCCCc----CCCCCCCCCCCCEEEeccCcCcccCCccc----
Q 047739 439 NLSTLDLSENKFSG----EVPASIGNLSQLMVFNLSGNAFSGR----IPASLGNLLKLTTLDLSKQNFSGELPIEL---- 506 (1099)
Q Consensus 439 ~L~~L~Ls~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~l---- 506 (1099)
.|+.+.++.|.|.. .+...+..+++|++|||++|-++.. +...+..+++|+.|++++|.+...-...+
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 88888888887742 1234566777777777777777632 23345556667777777776664333222
Q ss_pred -CCCCccceeeeccccccCC----Cchhhhcccccceeccccccc
Q 047739 507 -AGLPNLQVIALQENKLSGN----VPEGFSSLMSLRYLNLSFNGF 546 (1099)
Q Consensus 507 -~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 546 (1099)
...++|++|.|.+|.++.. +...+...+.|+.|+|++|.+
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 1245666666666666521 112233345566666666665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.7e-10 Score=129.84 Aligned_cols=247 Identities=23% Similarity=0.253 Sum_probs=170.6
Q ss_pred cccccccccc--ccceeEEEEEE---CCceEEEEEECCC---CCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCce
Q 047739 804 QFDEENVLSR--TRYGLVFKACY---NDGMVLSIRRLPD---GSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 804 ~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 874 (1099)
.|.....+|. |.+|.||.+.. .++..+|+|+-.. ......+=.+|+...++++ |++.++.+..+.+ .+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcc
Confidence 4566778999 99999999976 3577888887422 1223344456777777775 9999997777764 4455
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHccCCceecCCCCCCEEECCC-CcEEEeccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR----GLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFG 949 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfG 949 (1099)
++-+|++. .++.++.+.. ...++....+.+..+..+ |+.++|+.+++|-|+||.||+...+ ...+.+|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 88889885 6777776643 233566677777777777 9999999999999999999999998 889999999
Q ss_pred cccccCCCCC-CCcc-ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 950 LDRLTIPTPA-EAST-STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 950 la~~~~~~~~-~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
+.....+..- .... .....|...|++||... +.++...|+|++|.++.+..++..+....-.. .| .....+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---~W--~~~r~~~ 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS---SW--SQLRQGY 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC---Cc--ccccccc
Confidence 9876543331 1111 22236888999999764 56789999999999999999987765432110 01 0111111
Q ss_pred cc-ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1028 IT-ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1028 ~~-~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+. +.++.. -..+..++..|++.+|..|++...+..
T Consensus 343 ip~e~~~~~-------------s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 IPLEFCEGG-------------SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CchhhhcCc-------------chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 111110 011223677899999999999886654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=86.74 Aligned_cols=41 Identities=41% Similarity=0.988 Sum_probs=31.2
Q ss_pred hhhHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCCcccceEec
Q 047739 24 SPEIEALTSFKLNLH-DPLGALNGWDSSTPAAPCDWRGVACT 64 (1099)
Q Consensus 24 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~~~~~c~w~gv~c~ 64 (1099)
++|++||++||+++. ||.+.+.+|+.+.+.+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999997 67899999998644679999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-11 Score=141.35 Aligned_cols=245 Identities=29% Similarity=0.350 Sum_probs=124.5
Q ss_pred CCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEc
Q 047739 390 RGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNL 469 (1099)
Q Consensus 390 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 469 (1099)
..++.+.+..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+.+|++|+|++|.|+.+ ..+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhee
Confidence 334444444444432 12224445556666666666652 222245566666666666666533 23445555666666
Q ss_pred cCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCC-cccCCCCccceeeeccccccCCCchhhhcccccceecccccccCC
Q 047739 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELP-IELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG 548 (1099)
Q Consensus 470 ~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 548 (1099)
++|.|+.. ..+..+..|+.+++++|++...-+ . ...+.+++.+++.+|.+... +.+..+..+..+++..|.++
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~- 221 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS- 221 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce-
Confidence 66666521 234445566666666666653322 1 34455555555555555421 22333333334444444443
Q ss_pred CCCCcccccceeeEEEccCCcCCCCCCCCCCCCC--CCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCccc
Q 047739 549 QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS--DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI 626 (1099)
Q Consensus 549 ~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 626 (1099)
..-+ +..+. .|+.+++++|.+. .++..+..+.++..||+++|++... ..+
T Consensus 222 -----------------------~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~ 273 (414)
T KOG0531|consen 222 -----------------------KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGL 273 (414)
T ss_pred -----------------------eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccc
Confidence 1111 11111 2566666666665 3334555666666666666666531 224
Q ss_pred CCCCCCCEEECcCccccc--cC-Chh-hhccCCCCeeecCCCcCCCcCCC
Q 047739 627 SKCSSLRSLLVNSNHLSG--GI-PDS-LAKLSNLAVLDLSANNLSGEIPA 672 (1099)
Q Consensus 627 ~~l~~L~~L~Ls~N~l~~--~~-p~~-l~~l~~L~~L~ls~N~l~~~~p~ 672 (1099)
.....+..+.++.|.+.. .+ ... ......++.+++.+|++....+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred cccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 445566666666666542 11 111 45566777788888877765553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-11 Score=141.76 Aligned_cols=268 Identities=27% Similarity=0.285 Sum_probs=137.5
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
++.++...+.+.+.--. ...+..++.+++..|.|+ .+-..+..+.+|+.|++.+|+|... ...+..+++|++|+|++
T Consensus 51 ~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~ 127 (414)
T KOG0531|consen 51 LEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSF 127 (414)
T ss_pred hhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccc
Confidence 44444444444321111 134556666667777776 2334466677777777777777632 22256677777777777
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccc-hhhhCCCCCCEEEccCCcCcccc
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP-EEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
|+|+... .+..++.|+.|++.+|.|+.. ..+..+++|+.+++++|+++...+ . ...+.+++.+++..|.+..
T Consensus 128 N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~-- 200 (414)
T KOG0531|consen 128 NKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE-- 200 (414)
T ss_pred ccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--
Confidence 7776432 244555566677777766532 334446666777777777664322 1 3556666666666666642
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCC--CCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLL--KLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSS 532 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 532 (1099)
...+..+..+..+++..|.++..-+ +..+. .|+.+++++|++. ..+..+..+..+..|++.+|++... ..+..
T Consensus 201 i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~ 275 (414)
T KOG0531|consen 201 IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLER 275 (414)
T ss_pred ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccc
Confidence 2233344444444555665552211 11112 2555555555554 2223344444455555555544422 12223
Q ss_pred ccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCC-CCCCCCCCceEEecCCcccCcCC
Q 047739 533 LMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP-ELGNCSDLEVLELRSNSLTGHIP 599 (1099)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p 599 (1099)
...+..+....|.+.... ..... ..+..+.++...+..|.+....+
T Consensus 276 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 276 LPKLSELWLNDNKLALSE---------------------AISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cchHHHhccCcchhcchh---------------------hhhccccccccccccccccccCccccccc
Confidence 333444444444432110 01111 14445677777777777765443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-10 Score=142.15 Aligned_cols=149 Identities=28% Similarity=0.391 Sum_probs=104.4
Q ss_pred CcceEEEeccccccccCCCCCCCCCCceeEEEcCCCc--cccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCE
Q 047739 269 PSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ--IRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346 (1099)
Q Consensus 269 ~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 346 (1099)
...+...+-+|.+..++.... .+.|++|-+..|. +.....+.|..++.|++|||++|.=-+.+|..+++|-+|++
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~~---~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSSE---NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchhhccCCCC---CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 345666666666665554332 3468888888886 55556666888888999999888655688888888888888
Q ss_pred EEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccc--cccCCccCCCCCCCCEEEc
Q 047739 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLF--SGSIPASFRNLPGLENLNL 421 (1099)
Q Consensus 347 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l--~~~~~~~~~~l~~L~~L~L 421 (1099)
|+|++..+. .+|..+.++.+|.+||+.++.-...+|.....+.+|++|.+..... +...-..+.++.+|+.+..
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 888888888 7888888888888888888876556666677788888887776542 1222233344444554444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.8e-09 Score=103.86 Aligned_cols=131 Identities=26% Similarity=0.405 Sum_probs=94.9
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCc----c----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL----D----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+++|+-+.+|.+.+.+..+|...++++.-. + ..+..+|++++.+++--.|--..-|.. ++....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-D~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-DPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-cCCCCEEEEEE
Confidence 46889999999999887555444445543222 2 245678999999986443322222222 33444799999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
++|-.|.+.+... +..++..+-.-+.-||..||+|+|+.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888752 234566677777889999999999999999998765 99999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4e-09 Score=121.12 Aligned_cols=163 Identities=22% Similarity=0.240 Sum_probs=120.2
Q ss_pred CCceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCH
Q 047739 825 NDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNW 903 (1099)
Q Consensus 825 ~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~ 903 (1099)
.++.+|.|........ ..+...+-++-++.+|||||+++++.+..++ ..|+|+|-+. -|..++++ +..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHH--------hHH
Confidence 3566666666644332 2345678889999999999999999888554 5699999995 57788876 335
Q ss_pred HHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccC
Q 047739 904 PMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982 (1099)
Q Consensus 904 ~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 982 (1099)
......+.||+.||.|||+ .+++|++|.-.-|+|+..|..||++|.++........ ......--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCcc
Confidence 5677788999999999984 6899999999999999999999999998764321111 11111222346666654332
Q ss_pred CCCCcCchhhHHHHHHHHHhC
Q 047739 983 ETTKESDVYSFGIVLLELLTG 1003 (1099)
Q Consensus 983 ~~~~~~DV~S~G~il~elltg 1003 (1099)
+ -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-11 Score=129.10 Aligned_cols=208 Identities=25% Similarity=0.275 Sum_probs=101.6
Q ss_pred CCCCCCEEEcccCcCccccc-hhhhCCCCCCEEEccCCcCccc--cCcccCCCCcccEEEccCCcCCCcCCCCC-CCCCC
Q 047739 412 NLPGLENLNLRHNSLSGSLP-EEVLGMNNLSTLDLSENKFSGE--VPASIGNLSQLMVFNLSGNAFSGRIPASL-GNLLK 487 (1099)
Q Consensus 412 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~ 487 (1099)
++.+|+...|.+..+..... .....+++++.|||+.|-+... +-....++++|+.|+|+.|++.-...... ..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34455555555555542111 2334456666666666655421 22234456666666666666552111111 13455
Q ss_pred CCEEEeccCcCcc-cCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEcc
Q 047739 488 LTTLDLSKQNFSG-ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFS 566 (1099)
Q Consensus 488 L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls 566 (1099)
|+.|.|+.|.++- .+...+..+|+|+.|+|..|.....-.....-+..|+.|||++|++.....
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~--------------- 263 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ--------------- 263 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc---------------
Confidence 6666666666651 122233445666666666663221222223334556666666665542110
Q ss_pred CCcCCCCCCCCCCCCCCCceEEecCCcccCc-CCcc-----hhccCcccEEeccCccccccCCc--ccCCCCCCCEEECc
Q 047739 567 GNHISGSIPPELGNCSDLEVLELRSNSLTGH-IPTD-----ISHLSHLNVLDLSINNLTGEIPD--EISKCSSLRSLLVN 638 (1099)
Q Consensus 567 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls 638 (1099)
-...+.++.|+.|+++.+.++.. .|.. ...+++|++|+++.|++. ..+. .+..+++|+.|.+.
T Consensus 264 --------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 264 --------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred --------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcc
Confidence 02234455555555555555421 1221 234566677777777664 2222 34455666777777
Q ss_pred Ccccc
Q 047739 639 SNHLS 643 (1099)
Q Consensus 639 ~N~l~ 643 (1099)
.|.|+
T Consensus 335 ~n~ln 339 (505)
T KOG3207|consen 335 LNYLN 339 (505)
T ss_pred ccccc
Confidence 77765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-09 Score=102.57 Aligned_cols=143 Identities=16% Similarity=0.264 Sum_probs=99.3
Q ss_pred cccccccccceeEEEEEECCceEEEEEECCCCC--------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 807 EENVLSRTRYGLVFKACYNDGMVLSIRRLPDGS--------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
....+-+|+-+.|+++.+.+...+..++..+.- ...++..+|++.+.+++--.|--..-++.+... -.++|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeEEE
Confidence 456889999999999999844444444443321 123667889999999874444332223332323 27999
Q ss_pred eecCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---cEEEeccccccc
Q 047739 879 DYMPN-GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---EAHLSDFGLDRL 953 (1099)
Q Consensus 879 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~ 953 (1099)
||+++ .++.+++...... . ........++..|-+.+.-||..+|||+|+..+||++..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--E-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC--c-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4888888753221 1 22223366788899999999999999999999999996554 358999999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-09 Score=107.96 Aligned_cols=134 Identities=17% Similarity=0.166 Sum_probs=95.3
Q ss_pred cccccccceeEEEEEECC-------ceEEEEEECCCCCc-----------------------cHHHHH----HHHHHhhh
Q 047739 809 NVLSRTRYGLVFKACYND-------GMVLSIRRLPDGSL-----------------------DENLFR----KEAEFLGK 854 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~-----------------------~~~~~~----~E~~~l~~ 854 (1099)
..||.|.-+.||.|...+ +..+|+|....... ..+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47889997632110 012233 89999999
Q ss_pred ccC--CcceEEeeEEecCCCceEEEEeecCCCCHHH-HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-ccCCceecCC
Q 047739 855 VRH--RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT-LLQEASHQDGHVLNWPMRHLIALGVARGLAFL-HTSNMVHGDI 930 (1099)
Q Consensus 855 l~H--~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~iiH~Dl 930 (1099)
+.. -++...+++. ..++||||+.++.+.. .++. ..++......+..+++.+|.++ |+.||||+|+
T Consensus 83 l~~~Gv~vP~pi~~~-----~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----KHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEec-----CCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 853 3455555541 2489999997654422 2221 1234455667788999999999 8999999999
Q ss_pred CCCCEEECCCCcEEEecccccccc
Q 047739 931 KPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 931 k~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++.||+++ ++.++++|||.|...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-09 Score=136.24 Aligned_cols=291 Identities=23% Similarity=0.241 Sum_probs=136.1
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCc--cccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEE
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS--ISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLL 371 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~--i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 371 (1099)
...+...+-+|++... +.. ...++|+.|-+..|. +.....+.|..++.|+.|||++|.=.+.+|..++.+-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~-~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHI-AGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhc-cCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 3455555555555422 211 122356666666664 333333345556666666666555444566666666666666
Q ss_pred EccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcC--ccccchhhhCCCCCCEEEccCCc
Q 047739 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSL--SGSLPEEVLGMNNLSTLDLSENK 449 (1099)
Q Consensus 372 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~~L~~L~Ls~N~ 449 (1099)
+|++..+. .+|..+++++.|.+|++..+.-...+|.....|++|++|.+..... +...-..+..+..|+.+
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~l------ 673 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENL------ 673 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhh------
Confidence 66666665 5566666666666666655554444455555555555555544331 11111222233333333
Q ss_pred CccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCC----EEEeccCcCcccCCcccCCCCccceeeeccccccCC
Q 047739 450 FSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLT----TLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN 525 (1099)
Q Consensus 450 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 525 (1099)
....... .+-..+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+...
T Consensus 674 ------------------s~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 674 ------------------SITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred ------------------eeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 3322211 0001111111111 1221122222 3344455566666666666665432
Q ss_pred Cchhhhc------ccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCc-C
Q 047739 526 VPEGFSS------LMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH-I 598 (1099)
Q Consensus 526 ~p~~~~~------l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~ 598 (1099)
....+.. ++++..+...++... ..+.+....++|+.|++..++....+++....+..+..+.+..+.+.+. .
T Consensus 733 ~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~ 811 (889)
T KOG4658|consen 733 VIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRM 811 (889)
T ss_pred hcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccccee
Confidence 2211111 112222222222211 2233333456777777777776656665566666666666666666654 2
Q ss_pred CcchhccCcccEEeccC
Q 047739 599 PTDISHLSHLNVLDLSI 615 (1099)
Q Consensus 599 p~~~~~l~~L~~L~Ls~ 615 (1099)
-.+.+.++++..+.+++
T Consensus 812 ~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 812 LCSLGGLPQLYWLPLSF 828 (889)
T ss_pred eecCCCCceeEecccCc
Confidence 34445555555555544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-10 Score=125.71 Aligned_cols=212 Identities=23% Similarity=0.255 Sum_probs=114.5
Q ss_pred ccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccCh--hhhcCCCCccEEEcccccCCCccCc
Q 047739 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIP--PAIGALPKLQVVSLAQNNLSGVVPA 258 (1099)
Q Consensus 181 ~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~ 258 (1099)
.++.+|+...|.+...... | .-.....|++++.|+|++|-+....+ .....||+|+.|+|+.|.+.-...+
T Consensus 118 sn~kkL~~IsLdn~~V~~~------~-~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s 190 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDA------G-IEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS 190 (505)
T ss_pred hhHHhhhheeecCcccccc------c-hhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc
Confidence 4678888888887766511 1 00244567788888888888876554 3456788888888888887621111
Q ss_pred ccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccC-cchhccCCCCccEEeCCCCccccCchhh
Q 047739 259 SMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGA-FPLWLTRASTLTRLDVSGNSISGKIPAQ 337 (1099)
Q Consensus 259 ~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~ 337 (1099)
.....++.|+.|.|+.|.++.. +......+++|+.|+|+.|..-..-...
T Consensus 191 -----------------------------~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~ 241 (505)
T KOG3207|consen 191 -----------------------------NTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATS 241 (505)
T ss_pred -----------------------------cchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecch
Confidence 1111345566666666666532 1222334556666666666322222222
Q ss_pred hCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccC-Ccc-----CC
Q 047739 338 IGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI-PAS-----FR 411 (1099)
Q Consensus 338 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~-----~~ 411 (1099)
..-+..|++|+|++|++-.. + .-...+.++.|+.|+++.+.+..+- |+. ..
T Consensus 242 ~~i~~~L~~LdLs~N~li~~-~----------------------~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~ 298 (505)
T KOG3207|consen 242 TKILQTLQELDLSNNNLIDF-D----------------------QGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTH 298 (505)
T ss_pred hhhhhHHhhccccCCccccc-c----------------------cccccccccchhhhhccccCcchhcCCCccchhhhc
Confidence 33344455555555554321 1 0022334444444444444443221 111 24
Q ss_pred CCCCCCEEEcccCcCccc-cchhhhCCCCCCEEEccCCcCc
Q 047739 412 NLPGLENLNLRHNSLSGS-LPEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 412 ~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
.+++|++|++..|++..- .-..+..+.+|+.|....|.++
T Consensus 299 ~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 299 TFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 457778888888877521 1123344567777777777776
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-09 Score=109.35 Aligned_cols=105 Identities=29% Similarity=0.379 Sum_probs=21.8
Q ss_pred cccceecccccccCCCCCCccc-ccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcch-hccCcccEE
Q 047739 534 MSLRYLNLSFNGFVGQIPATFS-FLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVL 611 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L 611 (1099)
.+++.|+|++|.++. +. .++ .+.+|+.|++++|.|+. +. .+..+++|++|++++|+|+ .+...+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 344555555555542 11 122 23444444444444442 21 2444455555555555555 232223 234555555
Q ss_pred eccCcccccc-CCcccCCCCCCCEEECcCcccc
Q 047739 612 DLSINNLTGE-IPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 612 ~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
+|++|+|... .-..+..+++|+.|+|.+|+++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 5555555420 0112333444444444444443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.4e-09 Score=110.01 Aligned_cols=139 Identities=24% Similarity=0.294 Sum_probs=103.4
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCc--ceEEeeEEecCC--CceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRN--LTVLRGYYAGAP--DLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~--~~~~lV~e~~~ 882 (1099)
+.++.|.++.||++...+|..+++|....... ....+.+|+++++.+++.+ +.+++.+..... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998765433 3467899999999997643 566667665322 23489999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc----------------------------------------
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT---------------------------------------- 922 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------- 922 (1099)
++++.+.+.. ..++...+..++.++++++.+||+
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9877665421 124555666667777777777763
Q ss_pred ----------------CCceecCCCCCCEEECC--CCcEEEeccccccc
Q 047739 923 ----------------SNMVHGDIKPQNVLFDA--DFEAHLSDFGLDRL 953 (1099)
Q Consensus 923 ----------------~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~ 953 (1099)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.9e-10 Score=109.84 Aligned_cols=84 Identities=31% Similarity=0.460 Sum_probs=24.6
Q ss_pred CCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhh-hCCCCCCEEEccCCcCcccc-CcccCCCCcccE
Q 047739 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEV-LGMNNLSTLDLSENKFSGEV-PASIGNLSQLMV 466 (1099)
Q Consensus 389 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~ 466 (1099)
+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+. +.+.+ ..+++|+.|+|++|+|.... -..++.+++|+.
T Consensus 41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 34444444444444422 134445666666666666663 33333 24566666666666664211 123344455555
Q ss_pred EEccCCcCC
Q 047739 467 FNLSGNAFS 475 (1099)
Q Consensus 467 L~L~~N~l~ 475 (1099)
|+|.+|.++
T Consensus 118 L~L~~NPv~ 126 (175)
T PF14580_consen 118 LSLEGNPVC 126 (175)
T ss_dssp EE-TT-GGG
T ss_pred eeccCCccc
Confidence 555555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.4e-09 Score=120.90 Aligned_cols=245 Identities=18% Similarity=0.192 Sum_probs=165.3
Q ss_pred HHhccccccccccccceeEEEEEEC--CceEEEEEECCCCCcc---HHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN--DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
...+|.....||.|.|+.||+...+ ++..+++|.....-.. +..-..|+.+...+ -|.+++..+..+...+. .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence 3557889999999999999998754 5778888887543322 11123455555555 48888876666553333 4
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRL 953 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~ 953 (1099)
|+--||+++++....... ...+++..++++..|++.++.++|+..++|+|+||+||++..+ +..+++|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 788999999988776632 2347778889999999999999999999999999999999876 7789999998863
Q ss_pred cCCCCCCCccccccccCcccc--CccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYV--SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
. ........+.-+++ +|+......+-.+.|+||||.-+.|.+++..--.. ..+|.. +..+....
T Consensus 417 ~------~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~~~~~--i~~~~~p~- 482 (524)
T KOG0601|consen 417 L------AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GVQSLT--IRSGDTPN- 482 (524)
T ss_pred c------ceecccccccccccccchhhccccccccccccccccccccccccCcccCcc-----ccccee--eecccccC-
Confidence 2 00111112223333 45555566788999999999999999998763211 111111 11111100
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
..... .....+...+..+++..||.+.+.....+
T Consensus 483 ----------~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 ----------LPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----------CCchH---HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 22235666788999999999988776544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.1e-09 Score=126.86 Aligned_cols=249 Identities=21% Similarity=0.193 Sum_probs=155.7
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCC----CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPD----GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|++.+-+-.|.++.++.+.-.. |...+.|.... ...+.+...++-.+.-..++|-++...--+. .....++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcch
Confidence 4556777788899999998875432 22222222111 1111122223333333334555554433322 2233589
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|++|..+++|...++...... ....|. ....+..+.+|||...+.|||++|.|++...+++.+++|||......-
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~s----aepaRs-~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLS----AEPARS-PILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcc----cccccc-hhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998654221 122222 334567789999999999999999999999999999999984322100
Q ss_pred C---CCC-------------------------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCC
Q 047739 957 T---PAE-------------------------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008 (1099)
Q Consensus 957 ~---~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~ 1008 (1099)
. ... .......+||..|.+||...+......+|+|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 000 011234579999999999999999999999999999999999999998
Q ss_pred CCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 047739 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1071 (1099)
....+..++-+......+ +.- +.+.-..+.+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~f~ni~~~~~~~-------p~g--------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPW-------PEG--------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhccccCCCCC-------CCC--------ccccChhhhhhhhhhhccCchhccCcc
Confidence 776665554333221111 100 001111234566667788888887765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=102.04 Aligned_cols=141 Identities=9% Similarity=0.070 Sum_probs=98.6
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCcc------------HHHHHHHHHHhhhccCCcc--eEEeeEEecC----
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD------------ENLFRKEAEFLGKVRHRNL--TVLRGYYAGA---- 870 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~---- 870 (1099)
+.+-+-....|++..+ +|+.+.+|+....... ...+.+|.+.+.++...+| ...+++....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 4678888876432211 1147899999988853332 3334444321
Q ss_pred CCceEEEEeecCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-------CCc
Q 047739 871 PDLRLLVYDYMPNG-NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-------DFE 942 (1099)
Q Consensus 871 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-------~~~ 942 (1099)
....++|+|++++- +|.+++.... ....+...+..++.+++..+..||..||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCce
Confidence 22358999999875 8999886421 123456677789999999999999999999999999999975 468
Q ss_pred EEEeccccccc
Q 047739 943 AHLSDFGLDRL 953 (1099)
Q Consensus 943 ~kl~DfGla~~ 953 (1099)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.4e-08 Score=97.48 Aligned_cols=124 Identities=21% Similarity=0.284 Sum_probs=81.1
Q ss_pred eEEEEEECCceEEEEEECCCCCcc---------------------------HHHHHHHHHHhhhccCC--cceEEeeEEe
Q 047739 818 LVFKACYNDGMVLSIRRLPDGSLD---------------------------ENLFRKEAEFLGKVRHR--NLTVLRGYYA 868 (1099)
Q Consensus 818 ~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~H~--niv~l~~~~~ 868 (1099)
.||.|...+|..+|+|....+..+ ....++|++.|.++..- ++.+.+++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 489999999999999986432110 13466899999999765 4555555421
Q ss_pred cCCCceEEEEeecC--CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HccCCceecCCCCCCEEECCCCcEEE
Q 047739 869 GAPDLRLLVYDYMP--NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF-LHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 869 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
.++||||++ |..+..+... . ++......++.+++..+.. +|..||+|+|+.+.||+++++ .+.+
T Consensus 81 -----~~ivME~I~~~G~~~~~l~~~-~------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 81 -----NVIVMEYIGEDGVPLPRLKDV-D------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp -----TEEEEE--EETTEEGGCHHHC-G------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred -----CEEEEEecCCCccchhhHHhc-c------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 389999998 5444443321 1 1123445567777775555 579999999999999999988 9999
Q ss_pred ecccccccc
Q 047739 946 SDFGLDRLT 954 (1099)
Q Consensus 946 ~DfGla~~~ 954 (1099)
+|||.|...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.1e-09 Score=109.30 Aligned_cols=186 Identities=25% Similarity=0.311 Sum_probs=108.6
Q ss_pred cCCcccEEEeccccCC--CccCcccccCCCCceeecccccCCCcccCC-cc-cccceeeCCCCccCC-CCCCCCcccccc
Q 047739 112 QCTLLRAVFLQYNSLS--GNLPANIGNLSNLEILNVAANRLSGEIAND-LP-RNLKYFDLSSNGFSG-PIPTSISNLSQL 186 (1099)
Q Consensus 112 ~l~~L~~L~l~~n~l~--g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~-~~-~~L~~L~ls~N~l~~-~~p~~~~~l~~L 186 (1099)
.++.++.|||.+|.++ ..|-..+.+++.|++|+||.|.|+..|... ++ .+|++|-|.+.++.- .....+.+++.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 4567777777777777 455555677777777777777777666543 44 678888887777763 344667788888
Q ss_pred ccccccccccccccccccccccCccccccCceeEEEccCCcCCccChh--hhcCCCCccEEEcccccCCCccCccccccc
Q 047739 187 QLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP--AIGALPKLQVVSLAQNNLSGVVPASMFCNV 264 (1099)
Q Consensus 187 ~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 264 (1099)
+.|.+|.|.+. .+++..|-+...-|. .+..++.+..++++.|+++..+
T Consensus 149 telHmS~N~~r----------------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------- 198 (418)
T KOG2982|consen 149 TELHMSDNSLR----------------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF-------- 198 (418)
T ss_pred hhhhhccchhh----------------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc--------
Confidence 88888888543 334455554433322 2334556666666666665332
Q ss_pred CCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccC-cchhccCCCCccEEeCCCCccc
Q 047739 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGA-FPLWLTRASTLTRLDVSGNSIS 331 (1099)
Q Consensus 265 ~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~ 331 (1099)
|++..+.+..+.++.....+-....+.+.-|+|+.|+|.+. --+.+..++.|..|.+++|.+.
T Consensus 199 ----pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 199 ----PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ----ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 33444455555555555554444455555555555555431 1123444444555555555443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-07 Score=103.53 Aligned_cols=170 Identities=21% Similarity=0.271 Sum_probs=126.1
Q ss_pred ceeEEEEEE-CCceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEec---CCCceEEEEeecCC-CCHHHH
Q 047739 816 YGLVFKACY-NDGMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAG---APDLRLLVYDYMPN-GNLGTL 889 (1099)
Q Consensus 816 ~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~~lV~e~~~~-gsL~~~ 889 (1099)
-.+.||+.. .||..|++|++...... ...-..-+++++++.|+|+|++..++.. ++-..++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788875 47999999999433221 1123445789999999999999998762 23445799999987 578775
Q ss_pred Hhhhc----------cCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 890 LQEAS----------HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 890 l~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
--... ...+...++...|.++.|++.||.++|+.|..-+-+.+++|+++++.+++|+..|........+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 43211 12334578899999999999999999999999999999999999999999998887655432210
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~ 1005 (1099)
|-+ +-..+-|.-.+|.+++.+.||..
T Consensus 449 -----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 449 -----------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred -----------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 001 12346688899999999999855
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-08 Score=82.30 Aligned_cols=60 Identities=28% Similarity=0.405 Sum_probs=35.7
Q ss_pred ceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCcc
Q 047739 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l 354 (1099)
+|++|++++|+|+.+.+.+|..+++|++|++++|.|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555666666666666666666655555566666666666655543
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.7e-07 Score=96.93 Aligned_cols=264 Identities=15% Similarity=0.132 Sum_probs=157.7
Q ss_pred ccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEE----e--cCCCceEEEE
Q 047739 806 DEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYY----A--GAPDLRLLVY 878 (1099)
Q Consensus 806 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~----~--~~~~~~~lV~ 878 (1099)
...+-+|+|+.+.+|-.-.-.+. || |+...-... .-...++.|.+. .||-+-.=+.|- . .......+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~-VA-KIYh~Pppa--~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQ-VA-KIYHAPPPA--AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhch-hh-eeecCCCch--HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45678999999999975432232 22 333221111 111223333333 465443312221 1 1222245778
Q ss_pred eecCCC-CHHHHHhh-hccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 879 DYMPNG-NLGTLLQE-ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 879 e~~~~g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
..+.+. -..+++.. .+++.-...+|...++++..+|.+.+-||+.|.+-+|+.++|+|+.+++.+.+.|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-- 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-- 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec--
Confidence 877664 22222221 12233355899999999999999999999999999999999999999999999885432221
Q ss_pred CCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhC-CCCCCCCCc-----hhHHHHHHHHhhh
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTG-KRPVMFTQD-----EDIVKWVKKQLQK 1025 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg-~~P~~~~~~-----~~~~~~~~~~~~~ 1025 (1099)
.........+|...|.+||.-. +.+.+...|.|.+|+++++++.| ++||.+... ......| ..
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I----a~ 241 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI----AH 241 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----hc
Confidence 2334456678999999999543 44668889999999999999886 999975321 1111112 22
Q ss_pred ccccccccCcc-cCCCCCChhHHHHH-HHHHHHHhcCCCC--CCCCCCHHHHHHHhhccc
Q 047739 1026 GQITELLEPGL-LELDPESSEWEEFL-LGVKVALLCTAPD--PIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1026 ~~~~~~~d~~~-~~~~~~~~~~~~~~-~~~~li~~Cl~~d--P~~RPs~~evl~~L~~~~ 1081 (1099)
+...+..+.+. ....+...+++-+. .+..+...|+... +.-||+++-.+..|..+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 22222222221 12333444444221 1233455666543 568999988777766543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-08 Score=81.80 Aligned_cols=61 Identities=30% Similarity=0.447 Sum_probs=44.6
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcC
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF 378 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l 378 (1099)
++|++|++++|+|+...+..|.++++|++|++++|.++...+..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3577777777777765556777777777777777777766667777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=96.86 Aligned_cols=133 Identities=16% Similarity=0.126 Sum_probs=96.9
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCc-----------------------cHHHHHHHHHHhhhccCC--c
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-----------------------DENLFRKEAEFLGKVRHR--N 859 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~H~--n 859 (1099)
..+.+.||.|.-+.||.|....|..+++|.=..+.. .....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996432211 123356899999998654 5
Q ss_pred ceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 860 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
+.+.+++ +..++||||++|--|...- ++......++..|.+-+...-..||||+|+.+-||++++
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 6655555 2248999999885443321 122233345555666666666899999999999999999
Q ss_pred CCcEEEecccccc
Q 047739 940 DFEAHLSDFGLDR 952 (1099)
Q Consensus 940 ~~~~kl~DfGla~ 952 (1099)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-09 Score=123.64 Aligned_cols=126 Identities=31% Similarity=0.363 Sum_probs=63.7
Q ss_pred eeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCc-ccCCCCCCCEEEC
Q 047739 559 SVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPD-EISKCSSLRSLLV 637 (1099)
Q Consensus 559 ~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L 637 (1099)
.|.+.+.++|.+. .+...+.-++.|+.|||++|+++.. ..+..+++|++|||++|.++ .+|. ....+. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3444555555554 3444455555566666666666532 24555666666666666665 3443 122222 666666
Q ss_pred cCccccccCChhhhccCCCCeeecCCCcCCCcCC-CCccccccccccccCCCCcc
Q 047739 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP-ANLSSIFGLMNFNVSSNNLQ 691 (1099)
Q Consensus 638 s~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p-~~~~~~~~l~~l~l~~n~~~ 691 (1099)
++|.++.. ..+.+|.+|+.|||++|-|++--- ..+..+-.|..|.|.+|++.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 66665421 235556666666666665543110 11333344555566666554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.6e-09 Score=123.50 Aligned_cols=126 Identities=32% Similarity=0.380 Sum_probs=83.4
Q ss_pred ccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCC-CCCCCCCCceEEe
Q 047739 511 NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP-ELGNCSDLEVLEL 589 (1099)
Q Consensus 511 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~~L~L 589 (1099)
.|...+.+.|.+. .+.+++.-++.|+.|+|++|+++... .+..+++|++|||++|+++ .+|. ....+. |..|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3566666677766 55666666777777777777776433 6667777777777777776 3443 223343 777888
Q ss_pred cCCcccCcCCcchhccCcccEEeccCcccccc-CCcccCCCCCCCEEECcCcccc
Q 047739 590 RSNSLTGHIPTDISHLSHLNVLDLSINNLTGE-IPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 590 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
++|.++.. ..+.+|.+|+.|||++|-|.+. --..++.|..|+.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88887732 4567778888888888877641 1123556677777777777775
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.3e-09 Score=105.72 Aligned_cols=183 Identities=26% Similarity=0.296 Sum_probs=100.6
Q ss_pred CCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccC
Q 047739 178 TSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVP 257 (1099)
Q Consensus 178 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 257 (1099)
+.+..+++|+..+||+|.+....|. .+-+-|++-+.|++|.|++|.++-+-..-++. .|++ |.+|+=-
T Consensus 86 ~aLlkcp~l~~v~LSDNAfg~~~~e----~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~~--la~nKKa---- 153 (388)
T COG5238 86 KALLKCPRLQKVDLSDNAFGSEFPE----ELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALFH--LAYNKKA---- 153 (388)
T ss_pred HHHhcCCcceeeeccccccCcccch----HHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHHH--HHHHhhh----
Confidence 3455677777778887777643332 23345566777888888888775221111110 0000 1111110
Q ss_pred cccccccCCCCCcceEEEeccccccccCCCCCC---CCCCceeEEEcCCCccccC-----cchhccCCCCccEEeCCCCc
Q 047739 258 ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG---SCSSVLQVLDLQQNQIRGA-----FPLWLTRASTLTRLDVSGNS 329 (1099)
Q Consensus 258 ~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~---~~~~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~ 329 (1099)
.--|.+++...+.|++.+.+..... .....|+++.+.+|.|... .-..+..+++|+.|||+.|.
T Consensus 154 --------a~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNt 225 (388)
T COG5238 154 --------ADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNT 225 (388)
T ss_pred --------ccCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccc
Confidence 0013344444444444444332111 1124688888888888632 22234567889999999998
Q ss_pred cccC----chhhhCCCCCCCEEEccCCccCccCCccc----c--CCCCCCEEEccCCcCCC
Q 047739 330 ISGK----IPAQIGGLWRLEELKMANNSFGGAVPVEI----K--QCSSLSLLDLEGNRFSG 380 (1099)
Q Consensus 330 i~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~l----~--~l~~L~~L~Ls~N~l~~ 380 (1099)
++-. +...+...+.|++|.+..|-++..-..++ . ..++|+.|-+.+|.+.+
T Consensus 226 ft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 226 FTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred hhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcC
Confidence 8732 23344455668888888887765433322 1 23667777777776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.9e-06 Score=84.91 Aligned_cols=137 Identities=15% Similarity=0.121 Sum_probs=100.4
Q ss_pred cccccceeEEEEEECCceEEEEEECCC-------CCccHHHHHHHHHHhhhccCCc--ceEEeeEEe---cC-CCceEEE
Q 047739 811 LSRTRYGLVFKACYNDGMVLSIRRLPD-------GSLDENLFRKEAEFLGKVRHRN--LTVLRGYYA---GA-PDLRLLV 877 (1099)
Q Consensus 811 lg~G~~g~Vy~~~~~~g~~vavK~~~~-------~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~---~~-~~~~~lV 877 (1099)
-|+||-+-|++..+.+. .+-+|+-.. -...+..|.+|...++++..-+ +.+.. ++. .. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36688888999877644 677777641 1345688999999999995322 33333 322 11 1123699
Q ss_pred EeecCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc--EEEecccccc
Q 047739 878 YDYMPN-GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE--AHLSDFGLDR 952 (1099)
Q Consensus 878 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~ 952 (1099)
+|-+++ .+|.+++... .....+...+..+..+++..++-||+.|+.|+|+.++||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 5899888642 1234677788899999999999999999999999999999986666 9999998665
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.4e-08 Score=100.96 Aligned_cols=84 Identities=29% Similarity=0.379 Sum_probs=43.8
Q ss_pred CCCCCEEEccCCcCcc--ccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc-ccCCcccCCCCccc
Q 047739 437 MNNLSTLDLSENKFSG--EVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS-GELPIELAGLPNLQ 513 (1099)
Q Consensus 437 l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~ 513 (1099)
.+.++.|||.+|.|+. .+...+.+++.|+.|+|+.|++...+-..-....+|++|-|.+..+. ......+..+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3456666666666651 23334456666666666666665332211134456666666655544 12223344555566
Q ss_pred eeeeccc
Q 047739 514 VIALQEN 520 (1099)
Q Consensus 514 ~L~L~~N 520 (1099)
.|+++.|
T Consensus 150 elHmS~N 156 (418)
T KOG2982|consen 150 ELHMSDN 156 (418)
T ss_pred hhhhccc
Confidence 6666655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.2e-06 Score=98.94 Aligned_cols=139 Identities=20% Similarity=0.254 Sum_probs=97.1
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCcc-----------------------------------------HHHHHH
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-----------------------------------------ENLFRK 847 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------------------------------~~~~~~ 847 (1099)
+.|+.++-|.||+|++++|+.||||+...+-.. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999997543211 011446
Q ss_pred HHHHhhhcc----CCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHH-HHHHcc
Q 047739 848 EAEFLGKVR----HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG-LAFLHT 922 (1099)
Q Consensus 848 E~~~l~~l~----H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~ 922 (1099)
|+.-+.+++ ...=+.+-.+|.+-.....++|||++|-.+.+...-.. ...+ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 666666663 22223344445443445689999999988887743211 1133 33455545443 444556
Q ss_pred CCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 923 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
.|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 89999999999999999999999999998755
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1099 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-58 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-26 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-07 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 3e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 1e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-05 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3v44_A | 407 | Crystal Structure Of The N-Terminal Fragment Of Zeb | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 1e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 5e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 589 bits (1520), Expect = 0.0
Identities = 223/781 (28%), Positives = 335/781 (42%), Gaps = 100/781 (12%)
Query: 16 FSSCAVDRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTEL---- 71
+S + EI L SFK L D L W S+ PC + GV C +++VT +
Sbjct: 3 QASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKN--PCTFDGVTCRDDKVTSIDLSS 59
Query: 72 ---------------RLPRLQ-------------------------------LSGRISD- 84
L L+ LSG ++
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 85 -HLSNLRMLRKLSLRSNSFNGTIPAT-LAQCTLLRAVFLQYNSLSGNLPANI---GNLSN 139
L + L+ L++ SN+ + + + L + L NS+SG
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 140 LEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSRE 199
L+ L ++ N++SG++ NL++ D+SSN FS IP + + S LQ ++ S NK S
Sbjct: 180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS-- 236
Query: 200 VPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPAS 259
G AI+ C+ L L+ N G IPP L LQ +SLA+N +G +P
Sbjct: 237 ------GDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDF 288
Query: 260 MFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPL-WLTRAS 318
+ ++ + L N F P GSCS L+ L L N G P+ L +
Sbjct: 289 LSGACD----TLTGLDLSGNHFYGAVPPFFGSCSL-LESLALSSNNFSGELPMDTLLKMR 343
Query: 319 TLTRLDVSGNSISGKIPAQIGGLW-RLEELKMANNSFGGAVPVEIKQC--SSLSLLDLEG 375
L LD+S N SG++P + L L L +++N+F G + + Q ++L L L+
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL 435
N F+G+IP L + L SL L+ N SG+IP+S +L L +L L N L G +P+E++
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 436 GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSK 495
+ L TL L N +GE+P+ + N + L +LS N +G IP +G L L L LS
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 496 QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFS 555
+FSG +P EL +L + L N +G +P ++ N G+
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIK 579
Query: 556 FLRSVVVLSFSGN--HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613
+GN G +L S + S GH + + LD+
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN 673
S N L+G IP EI L L + N +SG IPD + L L +LDLS+N L G IP
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 674 LSSIFGLMNFNVSSNNLQ---------------AFANNQDLCGKPLGRKCENADDRDRRK 718
+S++ L ++S+NNL F NN LCG PL R + D
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 759
Query: 719 K 719
+
Sbjct: 760 Q 760
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-119
Identities = 136/655 (20%), Positives = 226/655 (34%), Gaps = 46/655 (7%)
Query: 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127
+T L L QL + + + L L + N+ + P + +L+ + LQ+N LS
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDL--PRNLKYFDLSSNGFSGPIPTSISNLSQ 185
+NL L++ +N + N +NL DLS NG S + L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 186 LQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV 245
LQ + S NK I SSL L N + P A+ +L +
Sbjct: 147 LQELLLSNNKIQALKSEEL------DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 246 SLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNV-AGPETGSCSSVLQVLDLQQN 304
L L + + ++ SIR + L + + G + L +LDL N
Sbjct: 201 FLNNVQLGPSLTEKLCLELAN--TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 305 QIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ 364
+ L + N+I + GL+ + L + +
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS------------ 306
Query: 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN 424
+ + ++ L+ L + N G F L L+ L+L ++
Sbjct: 307 ---FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 425 SLS-GSLPEEV---LGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480
S +L E L + L L+L++NK S + L L V +L N +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 481 S-LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG--NVPEGFSSLMSLR 537
L + + LS + A +P+LQ + L+ L + P F L +L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 538 YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS--------GSIPPELGNCSDLEVLEL 589
L+LS N L + +L N+++ G L S L +L L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 590 RSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDS 649
SN L L ++DL +NNL + SL+SL + N ++
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 650 LAK-LSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKP 703
NL LD+ N SI +N+ ++ ++ LC P
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 6e-93
Identities = 112/580 (19%), Positives = 197/580 (33%), Gaps = 68/580 (11%)
Query: 139 NLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSR 198
+ E+ + + +L+ ++ +DLP N+ +L+ N + + SQL ++ FN S+
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 199 EVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPA 258
P L L+ Q N L + L + L N++ +
Sbjct: 64 LEPELC--------QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 259 SMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAS 318
F N L LDL N + +
Sbjct: 116 P------------------FVKQKN------------LITLDLSHNGLSSTKLGTQVQLE 145
Query: 319 TLTRLDVSGNSISGKIPA--QIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376
L L +S N I I L++L++++N P L L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 377 RFSGEIPEFLGDIRGLKSLT---LAANLFSGSIPASFRNLPG--LENLNLRHNSLSGSLP 431
+ + E L S+ L+ + S + +F L L L+L +N+L+
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 432 EEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTL 491
+ + L L N S+ L + NL + T
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQ 310
Query: 492 DLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFN--GFVGQ 549
+S + L L+ + +++N + G F+ L++L+YL+LS +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 550 IPATFSFL--RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD-ISHLS 606
TF L + +L+ + N IS LEVL+L N + + L
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG--GIPDSLAKLSNLAVLDLSAN 664
++ + LS N + + SL+ L++ L P L NL +LDLS N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 665 NLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPL 704
N++ L + L ++ NNL + + G
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 7e-76
Identities = 85/419 (20%), Positives = 153/419 (36%), Gaps = 23/419 (5%)
Query: 292 CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351
C+ +V D ++ P L + +T L+++ N + A +L L +
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR 411
N+ P ++ L +L+L+ N S + L L L +N F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA--SIGNLSQLMVFNL 469
L L+L HN LS + + + NL L LS NK I S L L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA---GLPNLQVIALQENKLSGNV 526
S N P + +L L L+ L +L +++ ++L ++LS
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 527 PEGFSSL--MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDL 584
F L +L L+LS+N +F++L + N+I L ++
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 585 EVLELRSN---------SLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSL 635
L L+ + SL L L L++ N++ G + + +L+ L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 636 LVNSNHLSGGIPDSLA----KLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
++++ S + S L +L+L+ N +S S + L ++ N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-62
Identities = 100/538 (18%), Positives = 168/538 (31%), Gaps = 97/538 (18%)
Query: 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRM--LRKLSLRSNSFNGTIPATLAQ 112
+ + N + L L QLS + L+ L L L N+ N + A
Sbjct: 211 LTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW 270
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
L FL+YN++ ++ L N+ LN L R+ +S
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN-------------LKRSFTKQSISLASL 317
Query: 173 SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVI 232
S L L+ +N N G+
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIP--------------------------------GIK 345
Query: 233 PPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSC 292
L L+ +SL+ + S L F ++
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSL-------------------RTLTNETFVSL-------A 379
Query: 293 SSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMAN 351
S L +L+L +N+I + L LD+ N I ++ Q GL + E+ ++
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSG--EIPEFLGDIRGLKSLTLAANLFSGSIPAS 409
N + SL L L P +R L L L+ N +
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 410 FRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNL 469
L LE L+L+HN+L+ L ++ G + LS L + NL
Sbjct: 500 LEGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG 529
N F +L +L +DL N + +L+ + LQ+N ++ +
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 530 FSSLM-SLRYLNLSFNGFVGQIPATFSFLRSV----VVLSFSGNHISGSIPPELGNCS 582
F +L L++ FN F + F+ + + +H + PP
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-57
Identities = 70/350 (20%), Positives = 116/350 (33%), Gaps = 35/350 (10%)
Query: 364 QCS-SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLR 422
+C+ S + D + + ++P+ L + L L N A+F L +L++
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 423 HNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL 482
N++S PE + L L+L N+ S + + L +L N+
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 483 GNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542
L TLDLS N LS L +L+ L LS
Sbjct: 118 VKQKNLITLDLSH------------------------NGLSSTKLGTQVQLENLQELLLS 153
Query: 543 FNGFVGQIPATFSFL--RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPT 600
N S+ L S N I P L L L + L +
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 601 DIS---HLSHLNVLDLSINNLTGEIPDEIS--KCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
+ + + L LS + L+ K ++L L ++ N+L+ DS A L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLG 705
L L NN+ +L +F + N+ + + + L
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-103
Identities = 123/558 (22%), Positives = 207/558 (37%), Gaps = 41/558 (7%)
Query: 153 EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI 212
+I ++LP + K DLS N S + +LQ+++ S + A
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ--------TIEDGAY 72
Query: 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIR 272
+ S L L GN + + A L LQ + + NL+ + ++ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP-IGHL----KTLK 127
Query: 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT----RLDVSGN 328
+ + N + PE S + L+ LDL N+I+ + L + LD+S N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 329 SISGKIPAQIGGLWRLEELKMANNSFGGAVP-VEIKQCSSLSLLDLEGNRFSGEIPEFLG 387
++ I RL +L + NN V I+ + L + L F E
Sbjct: 188 PMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 388 D---IRGLKSLTLAAN------LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMN 438
D + GL +LT+ + I F L + + +L ++
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNF 304
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS--KQ 496
L+L KF + +L +L + G S +L L LDLS
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGL 359
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFS 555
+F G G +L+ + L N + + F L L +L+ + F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 556 FLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLS 614
LR+++ L S H + S LEVL++ NS + DI + L +L LDLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674
L P + SSL+ L ++ N+ L++L VLD S N++ L
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 675 SSIFG-LMNFNVSSNNLQ 691
L N++ N+
Sbjct: 539 QHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = 2e-98
Identities = 119/574 (20%), Positives = 203/574 (35%), Gaps = 44/574 (7%)
Query: 119 VFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSGPI 176
+ +P N+ + + L+++ N L + L+ DLS
Sbjct: 12 YQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 177 PTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAI 236
+ +LS L + + N A + SSL L A L + I
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQ--------SLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 237 GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSS-- 294
G L L+ +++A N + F N+ ++ + L N ++ +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNL----TNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 295 -VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMANN 352
+ LDL N + P + L +L + N S + I GL LE ++
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 353 SFGGAVPVE------IKQCSSLSLLDLEGNR---FSGEIPEFLGDIRGLKSLTLAANLFS 403
F +E ++ +L++ + + +I + + + S +L +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
F G ++L L + L + +L L + NK S +L
Sbjct: 296 RVKD--FSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGN--AFSEVDLPS 348
Query: 464 LMVFNLSGNA--FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
L +LS N F G S L LDLS + GL L+ + Q +
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407
Query: 522 LSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LG 579
L F SL +L YL++S F+ L S+ VL +GN + P+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 580 NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNS 639
+L L+L L PT + LS L VL++S NN +SL+ L +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 640 NHLSGGIPDSLAKL-SNLAVLDLSANNLSGEIPA 672
NH+ L S+LA L+L+ N+ +
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = 4e-96
Identities = 112/617 (18%), Positives = 201/617 (32%), Gaps = 68/617 (11%)
Query: 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLS 151
+ L L N + L+ + L + +LS+L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 152 GEIANDL--PRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLP 209
+L+ + I +L L+ +N + N LP
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-------FKLP 142
Query: 210 SAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV----SLAQNNLSGVVPASMFCNVS 265
+N ++L HL N + + + L ++ ++ L+ N ++ + P + F +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA-FKEIR 201
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST---LTR 322
+ + L N + + L+V L + R L S L
Sbjct: 202 -----LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 323 LDVSGNSIS------GKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376
L + ++ I L + + + + L+L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNC 314
Query: 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS--GSLPEEV 434
+F L + LK LT G S +LP LE L+L N LS G +
Sbjct: 315 KFGQFPTLKL---KSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 435 LGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAS-LGNLLKLTTLDL 493
G +L LDLS N + ++ L QL + + S +L L LD+
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 494 SKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI-PA 552
S F+ L SL L ++ N F P
Sbjct: 429 S------------------------HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 553 TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLD 612
F+ LR++ L S + P + S L+VL + N+ L+ L VLD
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 613 LSINNLTGEIPDEISKC-SSLRSLLVNSNHLSGGIP--DSLAKLSNLAVLDLSANNLSGE 669
S+N++ E+ SSL L + N + L + + L + +
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584
Query: 670 IPANLSSIFGLMNFNVS 686
P++ + +++ N++
Sbjct: 585 TPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = 3e-94
Identities = 120/620 (19%), Positives = 203/620 (32%), Gaps = 70/620 (11%)
Query: 66 NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNS 125
L L L S + L+ L L + L + L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 126 LSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGF-SGPIPTSISN 182
+ LS+L+ L L+ + + LK +++ N S +P SN
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 183 LSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL----VHLSAQGNALGGVIPPAIGA 238
L+ L+ ++ S NK + + + + L N + I P
Sbjct: 148 LTNLEHLDLSSNKIQ--------SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
+L ++L N S V + ++G L+V
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAG-----------------------------LEV 229
Query: 299 LDLQQNQIRGAFPLWLTRAST---LTRLDVSGNSIS------GKIPAQIGGLWRLEELKM 349
L + R L S L L + ++ I L + +
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 350 ANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS 409
+ + L+L +F L + LK LT G S
Sbjct: 290 VSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTF--TSNKGGNAFS 342
Query: 410 FRNLPGLENLNLRHNSLS--GSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVF 467
+LP LE L+L N LS G + G +L LDLS N + ++ L QL
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 401
Query: 468 NLSGNAFSGRIPAS-LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
+ + S +L L LD+S + GL +L+V+ + N N
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 527 -PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585
P+ F+ L +L +L+LS P F+ L S+ VL+ S N+ + L+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521
Query: 586 VLELRSNSLTGHIPTDISHL-SHLNVLDLSINNLTGEIPDE--ISKCSSLRSLLVNSNHL 642
VL+ N + ++ H S L L+L+ N+ + + R LLV +
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 581
Query: 643 SGGIPDSLAKLSNLAVLDLS 662
P + + L+++
Sbjct: 582 ECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-52
Identities = 70/351 (19%), Positives = 118/351 (33%), Gaps = 29/351 (8%)
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH 423
QC L+ +IP+ L K+L L+ N SF + P L+ L+L
Sbjct: 13 QCMELNFY---------KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 424 NSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLG 483
+ +++LSTL L+ N + LS L + +G
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 484 NLLKLTTLDLSKQNF-SGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRY---- 538
+L L L+++ S +LP + L NL+ + L NK+ L +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 539 LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGH 597
L+LS N P F +R + L+ N S ++ + + LEV L
Sbjct: 182 LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 598 I---PTDISHLSHLNVLDLSINNLT------GEIPDEISKCSSLRSLLVNSNHLSGGIPD 648
D S L L L + L +I D + +++ S + S +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VK 298
Query: 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDL 699
+ L+L L S+ L + N + + L
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-32
Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 9/187 (4%)
Query: 509 LPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGN 568
+PN+ E +P+ S + L+LSFN +F + VL S
Sbjct: 7 VPNITYQ-CMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 569 HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISK 628
I + S L L L N + S LS L L NL I
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 629 CSSLRSLLVNSNHLSGG-IPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGL----MNF 683
+L+ L V N + +P+ + L+NL LDLS+N + +L + + ++
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 684 NVSSNNL 690
++S N +
Sbjct: 183 DLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 45/276 (16%), Positives = 91/276 (32%), Gaps = 33/276 (11%)
Query: 63 CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
+ +L L G S L+ L L N T+ + L + Q
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404
Query: 123 YNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPI-PT 178
+++L ++ +L NL L+++ +L+ ++ N F P
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA 238
+ L L ++ S + P+A + SSL L+ N +
Sbjct: 465 IFTELRNLTFLDLSQCQLE--------QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV--- 295
L LQV+ + N++ + +P S+ + L N F +C
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQ----HFPSSLAFLNLTQNDF-------ACTCEHQSFL 565
Query: 296 -----LQVLDLQQNQIRGAFPLWLTRASTLTRLDVS 326
+ L ++ ++ A P + + L+++
Sbjct: 566 QWIKDQRQLLVEVERMECATPSDK-QGMPVLSLNIT 600
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-101
Identities = 97/697 (13%), Positives = 196/697 (28%), Gaps = 120/697 (17%)
Query: 26 EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDH 85
+ S AL + +G
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQ--------------------P 56
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
+N ++L + + +L + + L+ SG +P IG L+ LE+L +
Sbjct: 57 GANWNFNKEL----DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 146 AANRLSGEIANDLP------RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSRE 199
++ P + + + LI N
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP-- 170
Query: 200 VPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPAS 259
+ ++ + + N + + A+ L KL+ + +
Sbjct: 171 ----QQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-- 223
Query: 260 MFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST 319
+ + + Q L
Sbjct: 224 ---------------------------------CEAWENENSEYAQQYKTEDLKWDNLKD 250
Query: 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS 379
LT ++V K+P + L ++ + +A N + E +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR----------------GISGEQLKDD 294
Query: 380 GEIPEFLGDIRGLKSLTLAAN-LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMN 438
+ ++ + + N L + + S + + L L +N L G
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEI 353
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL--GNLLKLTTLDLSKQ 496
L++L+L+ N+ + G Q+ + + N IP ++ ++ +D S
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYN 412
Query: 497 NFSG-------ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG- 548
L N+ I L N++S E FS+ L +NL N
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 549 ------QIPATFSFLRSVVVLSFSGNHISGSIPPEL--GNCSDLEVLELRSNSLTGHIPT 600
F + + N ++ + + L ++L NS + PT
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 601 DISHLSHL------NVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLS 654
+ S L N D N E P+ I+ C SL L + SN + + + +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TP 587
Query: 655 NLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
N++VLD+ N + + + + + Q
Sbjct: 588 NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-77
Identities = 70/408 (17%), Positives = 134/408 (32%), Gaps = 32/408 (7%)
Query: 313 WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGG----AVPVEIKQCSSL 368
L +T L + G SG++P IG L LE L + ++ P I S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 369 SLLDLEGNRFSGEIPEFLG--DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSL 426
+ ++ D L + ++ SI S R + N++
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 427 SGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLL 486
+ + + V+ + L + + F E N NL
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLK 249
Query: 487 KLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKL--------SGNVPEGFSSLMSLRY 538
LT +++ +LP L LP +Q+I + N+ ++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 539 LNLSFNGF-VGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH 597
+ + +N + + ++ + +L N + G P G+ L L L N +T
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEI 368
Query: 598 IPTDISHLSHLNVLDLSINNLTGEIPD--EISKCSSLRSLLVNSNHLSG-------GIPD 648
+ L + N L IP+ + S + ++ + N + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+ K N++ ++LS N +S S+ L + N+ N L N
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-40
Identities = 40/267 (14%), Positives = 82/267 (30%), Gaps = 16/267 (5%)
Query: 443 LDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGEL 502
L+ G N + ++ G + SL + ++T L L SG +
Sbjct: 42 LNGKNWSQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRV 97
Query: 503 PIELAGLPNLQVIALQENKLSGN----VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLR 558
P + L L+V+AL + N P+G S+ MS +
Sbjct: 98 PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRED 157
Query: 559 --SVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN 616
++ + + SI + SN++T + + L+ L + +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
Query: 617 NLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSS 676
E E + + L +L +++ ++P L +
Sbjct: 217 PFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 677 IFGLMNFNVSSNNLQAFANNQDLCGKP 703
+ + NV+ N + +D
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQAL 298
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 9e-93
Identities = 123/564 (21%), Positives = 214/564 (37%), Gaps = 31/564 (5%)
Query: 141 EILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREV 200
+ N L+ EI LP + + + S N T+ S L L ++ + +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 201 PATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260
TF + L L N L + A+ L+ + Q +S +
Sbjct: 74 EDTF--------QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI-DFIP 124
Query: 261 FCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLT--RAS 318
N ++ + LG N +++ P+ L+VLD Q N I ++ + +
Sbjct: 125 LHNQ----KTLESLYLGSNHISSIKLPKGFPTEK-LKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCS--SLSLLDLEGN 376
T L+++GN I+G I + L + +K + SL L E
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 377 RFSGEIPEFLGDIRG--LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEV 434
P + ++S+ L + F +F GL+ L+L LS LP +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 435 LGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI-PASLGNLLKLTTLDL 493
+G++ L L LS NKF S N L ++ GN + L NL L LDL
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 494 SKQN--FSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP 551
S + S ++L L +LQ + L N+ E F L L+L+F +
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 552 -ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHI---PTDISHLSH 607
+ F L + VL+ S + + S L+ L L+ N + L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 608 LNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
L +L LS +L+ + + + ++ N L+ ++L+ L + L+L++N++S
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536
Query: 668 GEIPANLSSIFGLMNFNVSSNNLQ 691
+P+ L + N+ N L
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 7e-91
Identities = 110/566 (19%), Positives = 192/566 (33%), Gaps = 33/566 (5%)
Query: 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSG 174
+ + L+ +P + ++ E L + N L R NL + DL+
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
+ + +L + + N + +L HL + +
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETAL--------SGPKALKHLFFIQTGISSIDFI 123
Query: 235 AIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSS 294
+ L+ + L N++S + ++V+ NA ++ + S
Sbjct: 124 PLHNQKTLESLYLGSNHISSI-KLPKGFPT----EKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 295 -VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGG--LWRLEELKMAN 351
L+L N I G ++ L+ G I + + L +
Sbjct: 179 ATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
Query: 352 NSFGGAVPVEIKQCSSLSL--LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS 409
P + +S+ ++L+ + F GL+ L L A S +P+
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296
Query: 410 FRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV-PASIGNLSQLMVFN 468
L L+ L L N +L+ L + N E+ + NL L +
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 469 LSGNA--FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
LS + S L NL L +L+LS P L+++ L +L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 527 PEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI---PPELGNCS 582
+ F +L L+ LNLS + F L ++ L+ GNH L
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 583 DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHL 642
LE+L L L+ + L +N +DLS N LT + +S + L + SNH+
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 643 SGGIPDSLAKLSNLAVLDLSANNLSG 668
S +P L LS ++L N L
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 7e-81
Identities = 112/588 (19%), Positives = 186/588 (31%), Gaps = 72/588 (12%)
Query: 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127
L L + S L L L L T L + L N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQ 185
+ L+ L +S L + L+ L SN S +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 186 LQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV 245
L++++F N L ++ + L+ GN + G I P Q +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSS-LQQ-----ATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207
Query: 246 SLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ 305
+ V+ L + + L + +
Sbjct: 208 NFGGTQNLLVIFKG----------------LKNSTIQS------------LWLGTFEDMD 239
Query: 306 IRG--AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIK 363
++ +++ + N+F
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISS----------------NTFHC------- 276
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH 423
S L LDL S E+P L + LK L L+AN F S N P L +L+++
Sbjct: 277 -FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 424 NSLSGSLPEEVL-GMNNLSTLDLSENK--FSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480
N+ L L + NL LDLS + S + NLS L NLS N
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 481 SLGNLLKLTTLDLSKQNFSG-ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYL 539
+ +L LDL+ + L L+V+ L + L + + F L +L++L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
Query: 540 NLSFN---GFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG 596
NL N Q + L + +L S +S + + ++L N LT
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 597 HIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG 644
+SHL + L+L+ N+++ +P + S R++ + N L
Sbjct: 515 SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-68
Identities = 111/612 (18%), Positives = 194/612 (31%), Gaps = 104/612 (16%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
L L L LS + L+ L + L L +++L N +S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQL 188
L++L D +N +S+L Q
Sbjct: 144 IKLPKGFPTEKLKVL----------------------DFQNNAIHYLSKEDMSSLQQATN 181
Query: 189 I--NFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIG--ALPKLQV 244
+ N + N + + + + L+ G VI + + L +
Sbjct: 182 LSLNLNGNDIA---------GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN 304
+ + + P G C ++ ++LQ++
Sbjct: 233 GTFEDMDDEDISP----------------------------AVFEGLCEMSVESINLQKH 264
Query: 305 QIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ 364
S L LD++ +S ++P+ + GL L++L ++ N F +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN 424
SL+ L ++GN E+ NL L L+L H+
Sbjct: 324 FPSLTHLSIKGNTKRLELG-----------------------TGCLENLENLRELDLSHD 360
Query: 425 SL--SGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAS- 481
+ S ++ +++L +L+LS N+ + QL + +L+ + S
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV---PEGFSSLMSLRY 538
NL L L+LS GLP LQ + LQ N +L L
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 539 LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHI 598
L LSF F+ L+ + + S N ++ S L + + L L SN ++ +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 599 PTDISHLSHLNVLDLSINNLTGEIPDEISKCSS---LRSLLVNSNHLSGGIPDSLAKLSN 655
P+ + LS ++L N L CS+ L N L
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCT-------CSNIYFLEWYKENMQKLEDTEDTLCENPPL 592
Query: 656 LAVLDLSANNLS 667
L + LS LS
Sbjct: 593 LRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-64
Identities = 79/414 (19%), Positives = 132/414 (31%), Gaps = 14/414 (3%)
Query: 287 PETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346
+ V + + + + P L ++ L+ S N + L L
Sbjct: 5 DQKCIEKEVNKTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI 406
L + + L L L N L + LK L S
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 407 PASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL-- 464
N LE+L L N +S + L LD N + +L Q
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAG--LPNLQVIALQENKL 522
+ NL+GN +G I + +L+ + L + +L + ++
Sbjct: 182 LSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 523 SGNVPEGFSSL--MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN 580
P F L MS+ +NL + F TF + L + H+S +P L
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE-ISKCSSLRSLLVNS 639
S L+ L L +N S+ L L + N E+ + +LR L ++
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 640 NHL--SGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
+ + S L LS+L L+LS N L +++ L+
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-51
Identities = 69/337 (20%), Positives = 109/337 (32%), Gaps = 11/337 (3%)
Query: 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430
+ E + EIP L + L + N+ +F L L L+L +
Sbjct: 17 YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 431 PEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTT 490
+ + L TL L+ N ++ L S L N L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 491 LDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLR--YLNLSFNGFVG 548
L L + S + L+V+ Q N + E SSL LNL+ N +
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN-DIA 192
Query: 549 QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS--DLEVLELRSNSLTGHIPTDISHLS 606
I L+F G I L N + L + P L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 607 HLNV--LDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664
++V ++L + + S L+ L + + HLS +P L LS L L LSAN
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 665 NLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCG 701
+ S+ L + ++ N + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-38
Identities = 47/269 (17%), Positives = 85/269 (31%), Gaps = 15/269 (5%)
Query: 442 TLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGE 501
T + + E+P ++ + S N + L+ LT LDL++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 502 LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVV 561
L + L N L S +L++L G +++
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 562 VLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN-NLTG 620
L NHIS P+ L+VL+ ++N++ D+S L L L++N N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 621 EIPDEISKCSSLRSLLVNSNHLSGGIPDSLA--KLSNLAVLDLSANNLSGEIPANLSSIF 678
I + +SL I L + +L + + +I +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGL 251
Query: 679 GLMN---FNVSSNNLQ-----AFANNQDL 699
M+ N+ + F L
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGL 280
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 4e-92
Identities = 112/297 (37%), Positives = 173/297 (58%), Gaps = 20/297 (6%)
Query: 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL--DENLFRKEAEF 851
+L E A+ F +N+L R +G V+K DG +++++RL + E F+ E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL 911
+ HRNL LRG+ P RLLVY YM NG++ + L+E L+WP R IAL
Sbjct: 81 ISMAVHRNLLRLRGFCM-TPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRIAL 138
Query: 912 GVARGLAFLH---TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
G ARGLA+LH ++H D+K N+L D +FEA + DFGL +L + + TTAV
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAV 195
Query: 969 -GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-----QDEDIVKWVKKQ 1022
GT+G+++PE TG++++++DV+ +G++LLEL+TG+R D ++ WVK
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079
L++ ++ L++ L + EE ++VALLCT P++RP MS++V MLEG
Sbjct: 256 LKEKKLEALVDVDLQGNYKD----EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 8e-89
Identities = 95/321 (29%), Positives = 157/321 (48%), Gaps = 17/321 (5%)
Query: 768 SSGASGGRRSSTD--NGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYN 825
S S S D + + + ++ L + EAT FD + ++ +G V+K
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 826 DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882
DG ++++R S ++E F E E L RH +L L G+ + +L+Y YM
Sbjct: 62 DGAKVALKRRTPESSQGIEE--FETEIETLSFCRHPHLVSLIGFCD-ERNEMILIYKYME 118
Query: 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE 942
NGNL L + ++W R I +G ARGL +LHT ++H D+K N+L D +F
Sbjct: 119 NGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV 177
Query: 943 AHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT 1002
++DFG+ + + ST GTLGY+ PE + G T++SDVYSFG+VL E+L
Sbjct: 178 PKITDFGISKKG-TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 1003 GKRPVMFTQDED---IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLC 1059
+ ++ + + + +W + GQ+ ++++P L +F A+ C
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP-NLADKIRPESLRKFG---DTAVKC 292
Query: 1060 TAPDPIDRPTMSDIVFMLEGC 1080
A DRP+M D+++ LE
Sbjct: 293 LALSSEDRPSMGDVLWKLEYA 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 5e-86
Identities = 112/580 (19%), Positives = 205/580 (35%), Gaps = 41/580 (7%)
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQ 187
G+L I + N+ +LS ++ +D+P + K DLS N S SN S+LQ
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSL 247
++ S + + L +L GN + P + L L+ +
Sbjct: 60 WLDLSRCEIETIEDKAW--------HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 248 AQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR 307
+ L+ + + + +++ + + N + P S + L +DL N I+
Sbjct: 112 VETKLASL-ESFPIGQL----ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 308 G----AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE-I 362
LD+S N I I Q +L EL + N + +
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 363 KQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT--------LAANLFSGSIPASFRNLP 414
+ + L + L F E + + ++ L L F L
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474
+ ++L S+ E+V +L + + + P +L L L+ N
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKG 340
Query: 475 SGRIPASLGNLLKLTTLDLS--KQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSS 532
S I L L+ LDLS +FSG G +L+ + L N + F
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 533 LMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
L L++L+ + F L ++ L S + + L L++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 592 NSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSL 650
NS + +++ ++ ++L LDLS L L+ L ++ N+L
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 651 AKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
+L +L+ LD S N + L FN+++N++
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 3e-85
Identities = 116/582 (19%), Positives = 203/582 (34%), Gaps = 43/582 (7%)
Query: 104 GTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--N 161
G++ + + LS +P +I S+ + ++++ N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 162 LKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHL 221
L++ DLS + L L + + N P + + +SL +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ--------SFSPGSFSGLTSLENL 109
Query: 222 SAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281
A L + IG L L+ +++A N + + F N+ ++ V L +N
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL----TNLVHVDLSYNYI 165
Query: 282 TNVAGPETG---SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPA-Q 337
+ + V LD+ N I + L L + GN S I
Sbjct: 166 QTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
Query: 338 IGGLWRLEELKMANNSFGGAVPVEIKQCSSLS--------LLDLEGNRFSGEIPEFLGDI 389
+ L L ++ F +EI + S + L + +
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 390 RGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENK 449
+ +++LA ++L++ L P L + L +L L+ NK
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNK 339
Query: 450 FSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL--LKLTTLDLSKQNFSGELPIELA 507
S + L L +LS NA S S +L L LDLS N + +
Sbjct: 340 GS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS-FNGAIIMSANFM 396
Query: 508 GLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFS 566
GL LQ + Q + L F SL L YL++S+ F L S+ L +
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456
Query: 567 GNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE 625
GN + N ++L L+L L L L +L++S NNL
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
Query: 626 ISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
++ SL +L + N + +LA +L+ N+++
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-58
Identities = 94/481 (19%), Positives = 161/481 (33%), Gaps = 36/481 (7%)
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPET 289
G + P I +P + LS V P + P S + + L FN +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSKV-PDDI-------PSSTKNIDLSFNPLKILKSYSF 52
Query: 290 GSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKM 349
+ S LQ LDL + +I L+ L ++GN I P GL LE L
Sbjct: 53 SNFSE-LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 350 ANNSFGGAVPVEIKQCSSLSLLDLEGNRFSG-EIPEFLGDIRGLKSLTLAANLFSGSIPA 408
I Q +L L++ N ++P + ++ L + L+ N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 409 SFRNLPGL----ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA-SIGNLSQ 463
+ L +L++ N + + ++ L L L N S + + NL+
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
Query: 464 LMVFNLSGNAFSGRI------PASLGNL--LKLTTLDLSKQNFSGELPIELAGLPNLQVI 515
L V L F P+ + L + + L+ N + ++ L N+ +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 516 ALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIP 575
+L + E + L++ Q P L + L+ + N S I
Sbjct: 291 SLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFP--TLDLPFLKSLTLTMNKGS--IS 343
Query: 576 PELGNCSDLEVLELRSNSLT--GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLR 633
+ L L+L N+L+ G + L LDLS N + L+
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402
Query: 634 SLLVNSNHLSGGIPDS-LAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA 692
L + L S L L LD+S N + + L ++ N+ +
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 693 F 693
Sbjct: 463 N 463
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-54
Identities = 80/427 (18%), Positives = 132/427 (30%), Gaps = 28/427 (6%)
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350
++ P + S+ +D+S N + L+ L ++
Sbjct: 8 IEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS 64
Query: 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASF 410
LS L L GN P + L++L +
Sbjct: 65 RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
Query: 411 RNLPGLENLNLRHNSLSG-SLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL----M 465
L L+ LN+ HN + LP + NL +DLS N + L + +
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184
Query: 466 VFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELP-IELAGLPNLQVIALQENKLSG 524
++S N I +KL L L S + L L L V L +
Sbjct: 185 SLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 525 NV------PEGFSSLMSLRY--LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP 576
P L + L++ F L +V +S +G I
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LE 301
Query: 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL 636
++ + L + L PT L L L L++N + I + SL L
Sbjct: 302 DVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLD 356
Query: 637 VNSNHLSGGIPDSLA--KLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFA 694
++ N LS S + ++L LDLS N + AN + L + + + L+
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT 415
Query: 695 NNQDLCG 701
Sbjct: 416 EFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-40
Identities = 56/306 (18%), Positives = 113/306 (36%), Gaps = 19/306 (6%)
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
GS+ +P + LS +P+++ ++ +DLS N S N S+
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
L +LS + L L+ L L+ P +GL +L+ + E KL+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVG-QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582
L++L+ LN++ N ++PA FS L ++V + S N+I +L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 583 DL----EVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE-ISKCSSLRSL-- 635
+ L++ N + I L+ L L N + I + + L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 636 ----LVNSNHLSGGIPDSLAKLSNLAV--LDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
+ +L P + L ++ + L+ N + + + +++ +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 690 LQAFAN 695
++ +
Sbjct: 297 IKYLED 302
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-37
Identities = 57/390 (14%), Positives = 108/390 (27%), Gaps = 92/390 (23%)
Query: 64 TNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQY 123
+ + E RL L + +SL S + + +++ +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIR 316
Query: 124 NSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFS--GPIPTSIS 181
L +L L+ L + N+ S +L Y DLS N S G S
Sbjct: 317 CQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
+ L+ ++ SFN ++ L +
Sbjct: 374 GTNSLRHLDLSFNGAI---------------------------------IMSANFMGLEE 400
Query: 242 LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301
LQ + + L V S F ++ L LD+
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEK-----------------------------LLYLDI 431
Query: 302 QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE 361
+ F ++L L ++GNS + +
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV----------------------- 468
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
++L+ LDL + + L+ L ++ N + + L L L+
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
N + S +L+ +L+ N +
Sbjct: 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 5e-85
Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 19/309 (6%)
Query: 405 SIPASFRNLPGL----ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE--VPASI 458
I N L + + + G L + ++ LDLS +P+S+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 459 GNLSQLMVFNLSG-NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIAL 517
NL L + G N G IP ++ L +L L ++ N SG +P L+ + L +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 518 QENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRS-VVVLSFSGNHISGSIPP 576
N LSG +P SSL +L + N G IP ++ ++ S N ++G IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL 636
N + L ++L N L G + + L+ N+L ++ ++ +L L
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 637 VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+ +N + G +P L +L L L++S NNL GEIP L F+VS+ +ANN
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP----QGGNLQRFDVSA-----YANN 301
Query: 697 QDLCGKPLG 705
+ LCG PL
Sbjct: 302 KCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 1e-77
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 9/288 (3%)
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG--KIPAQIGGLWRLEELKMAN-NSFG 355
D G T+ + LD+SG ++ IP+ + L L L + N+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
G +P I + + L L + SG IP+FL I+ L +L + N SG++P S +LP
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLST-LDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474
L + N +SG++P+ + L T + +S N+ +G++P + NL+ L +LS N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
G G+ + L+K + + +L ++ NL + L+ N++ G +P+G + L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582
L LN+SFN G+IP + + V +++ N P L C+
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNL-QRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 2e-77
Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 9/284 (3%)
Query: 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGE--IPEFLGDIRGLKSLTLA-ANLFSGSIP 407
N ++ G + Q ++ LDL G IP L ++ L L + N G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 408 ASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVF 467
+ L L L + H ++SG++P+ + + L TLD S N SG +P SI +L L+
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 468 NLSGNAFSGRIPASLGNLLKLTT-LDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
GN SG IP S G+ KL T + +S+ +G++P A L NL + L N L G+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEV 586
F S + + ++L+ N + +++ L N I G++P L L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCS 630
L + N+L G IP +L +V + N P + C+
Sbjct: 273 LNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 8e-68
Identities = 83/424 (19%), Positives = 140/424 (33%), Gaps = 128/424 (30%)
Query: 26 EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDH 85
+ +AL K +L +P L+ W +T W GV C D
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLC--------------------DT 45
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
+ + L L + P +P+++ NL L L +
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYI 83
Query: 146 AANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE 205
N GPIP +I+ L+QL + + S
Sbjct: 84 G---------------------GINNLVGPIPPAIAKLTQLHYLYITHTNVS-------- 114
Query: 206 GTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265
G +P ++ +LV L NAL G +PP+I +LP L ++ N +SG +P S
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY----- 169
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDV 325
GS S + + + +N+
Sbjct: 170 ------------------------GSFSKLFTSMTISRNR-------------------- 185
Query: 326 SGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF 385
++GKIP L L + ++ N G V + + L N + ++ +
Sbjct: 186 ----LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239
Query: 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDL 445
+G + L L L N G++P L L +LN+ N+L G +P+ +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAY 298
Query: 446 SENK 449
+ NK
Sbjct: 299 ANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 9e-11
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
++ L + L+ + + + L L LR+N GT+P L Q L ++ + +N+L G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 129 NLPANIGNLSNLEILNVAANR-LSG 152
+P GNL ++ A N+ L G
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 3e-80
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 34/305 (11%)
Query: 794 TLAETVEATRQFDEE------NVLSRTRYGLVFKACYNDGMV----LSIRRLPDGSLDEN 843
+ E T FDE N + +G+V+K N+ V L+ +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 75
Query: 844 LFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH----QDGH 899
F +E + + K +H NL L G+ + D LVY YMPNG+L
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSL------LDRLSCLDGTP 128
Query: 900 VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959
L+W MR IA G A G+ FLH ++ +H DIK N+L D F A +SDFGL R +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEK 185
Query: 960 EAST--STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-IV 1016
A T ++ VGT Y++PE AL GE T +SD+YSFG+VLLE++TG V ++ ++
Sbjct: 186 FAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 1017 KWVKKQLQ-KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075
++ + I + ++ + + D VA C RP + +
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADS-----TSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 1076 MLEGC 1080
+L+
Sbjct: 300 LLQEM 304
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-79
Identities = 109/701 (15%), Positives = 200/701 (28%), Gaps = 125/701 (17%)
Query: 25 PEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISD 84
+ +AL + L + +W + +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDM-----------WGDQPGV 317
Query: 85 HLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILN 144
L N + LSL G +P + Q T L+ + +S + + ++
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 145 VAANRLSGEIAN---DLPRNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREV 200
+R+ D + L DL + + P I S++ L
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISL------------ 425
Query: 201 PATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASM 260
+ N + I AI L KLQ++ A + + A
Sbjct: 426 ----------------KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV- 467
Query: 261 FCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTL 320
+ + L ++L P +L L
Sbjct: 468 ---------DWEDANSDYAKQYENEELSWSNLKD-LTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSG 380
L+++ N RL + + + + N
Sbjct: 518 QSLNIACNRGIS-AAQLKADWTRL--------------ADDEDTGPKIQIFYMGYNNLE- 561
Query: 381 EIPE--FLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GM 437
E P L + L L N + +F L +L L +N + +PE+
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFT 618
Query: 438 NNLSTLDLSENKFSGEVP--ASIGNLSQLMVFNLSGNAFSG---RIPASLG--NLLKLTT 490
+ + L S NK +P + ++ + + S N I S+ + +T
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 491 LDLSKQNFSGELPIELAGLPNLQVIALQENKLS-------GNVPEGFSSLMSLRYLNLSF 543
+ LS A + I L N ++ + + L ++L F
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737
Query: 544 NGFVGQIPATFSF--LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
N + F L + + S N S S P + N S L+ +R
Sbjct: 738 NKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ--------- 786
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
D N + + P I+ C SL L + SN + + + L L +LD+
Sbjct: 787 ---------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDI 834
Query: 662 SANNL-SGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCG 701
+ N S ++ + I M + + QD+ G
Sbjct: 835 ADNPNISIDVTSVCPYIEAGM-------YVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-18
Identities = 40/326 (12%), Positives = 97/326 (29%), Gaps = 45/326 (13%)
Query: 411 RNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLS 470
R L+ + + + S + + ++ + +PA + ++ S
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQS 227
Query: 471 GNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-----------AGLPNLQVIALQE 519
G + T +D +K +PI+L A + + +
Sbjct: 228 GIK-RSELETQSVRGESFTVID-NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKN 285
Query: 520 NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579
+ ++ N + + Q V LS +G G +P +G
Sbjct: 286 WRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 580 NCSDLEVLELRSNSLTGHIPTD-------------------------ISHLSHLNVLDLS 614
++L+VL ++S T + + LN+ DL
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 615 INNLT-----GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGE 669
+ + I + + +N ++ I ++ +L+ L ++ + + + +
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYD 463
Query: 670 IPANLSSIFGLMNFNVSSNNLQAFAN 695
A N +++N
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSN 489
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 17/157 (10%), Positives = 45/157 (28%), Gaps = 1/157 (0%)
Query: 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS 627
+ I + E L+ ++ + H + N + ++ + ++
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLD 320
Query: 628 KCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSS 687
+ L + G +PD++ +L+ L VL ++ +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 688 NNLQAFANNQDLCGKPLGRKCENADDRDRRKKLILLI 724
+ ++ L + D R + I
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-62
Identities = 119/534 (22%), Positives = 202/534 (37%), Gaps = 42/534 (7%)
Query: 153 EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI 212
+I ++LP + K DLS N S + +LQ+++ S + + A
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IE-------DGAY 72
Query: 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIR 272
+ S L L GN + + A L LQ + + NL+ + ++ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHL----KTLK 127
Query: 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT----RLDVSGN 328
+ + N + PE S + L+ LDL N+I+ + L + LD+S N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 329 SISGKIPAQIGGLWRLEELKMANNSFGGAVP-VEIKQCSSLSLLDLEGNRFSGE--IPEF 385
++ I RL +L + NN V I+ + L + L F E + +F
Sbjct: 188 PMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 386 -LGDIRGLKSLTLAAN------LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMN 438
+ GL +LT+ + I F L + + +L ++
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS--KQ 496
L+L KF + +L +L + N S +L L LDLS
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAF--SEVDLPSLEFLDLSRNGL 359
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA--TF 554
+F G G +L+ + L N + + F L L +L+ + Q+ F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417
Query: 555 SFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDL 613
LR+++ L S H + S LEVL++ NS + DI + L +L LDL
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
S L P + SSL+ L + SN L +L++L + L N
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-51
Identities = 104/564 (18%), Positives = 183/564 (32%), Gaps = 54/564 (9%)
Query: 61 VACTNNRVTEL--RLP----RLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNGTIPAT 109
C ++ LP L LS + + L+ L L
Sbjct: 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 110 LAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLP--RNLKYFD 166
+ L + L N + +L LS+L+ L L+ + + LK +
Sbjct: 72 YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 167 LSSNGF-SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
++ N S +P SNL+ L+ ++ S NK L + L
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMP---LLNLSLDLSL 186
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTN-- 283
N + I P +L ++L N S V + ++ + V +L F N
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA----GLEVHRLVLGEFRNEG 241
Query: 284 -----VAGPETGSCSSVLQVLDLQQNQIRG-AFPLWLTRASTLTRLDVSGNSISGKIPAQ 337
G C+ ++ L + ++ + +I ++
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF 300
Query: 338 IGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397
+ + L++ N FG + SL L N+ + + L+ L L
Sbjct: 301 S-YNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDL 354
Query: 398 AANL--FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455
+ N F G S L+ L+L N + ++ LG+ L LD +
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 456 ASI-GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQ 513
S+ +L L+ ++S L L L ++ +F + L NL
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 514 VIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573
+ L + +L P F+SL SL+ LN++ N F L S+ + N S
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 574 IPPELGNCSDLEVLE--LRSNSLT 595
C ++ L L NS
Sbjct: 534 -------CPRIDYLSRWLNKNSQK 550
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-45
Identities = 94/469 (20%), Positives = 164/469 (34%), Gaps = 41/469 (8%)
Query: 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLD 324
P S + + L FN ++ S LQVLDL + +I+ S L+ L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82
Query: 325 VSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF-SGEIP 383
++GN I GL L++L + I +L L++ N S ++P
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 384 EFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN----LNLRHNSLSGSLPEEVLGMNN 439
E+ ++ L+ L L++N R L + L+L N ++ +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201
Query: 440 LSTLDLSENKFSGEVPA-SIGNLSQLMVFNLSGNAFSG-----RIPAS-LGNL--LKLTT 490
L L L N S V I L+ L V L F + S L L L +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 491 LDLSKQNFSGELPIEL-AGLPNLQVIALQENKLSGNVPEGF-SSLMSLRYLNLSFNGFVG 548
L+ ++ + I+L L N+ +L + + L +N F F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 549 QIPA----------------TFSFLRSVVVLSFSGNHIS--GSIPPELGNCSDLEVLELR 590
+ L S+ L S N +S G + L+ L+L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 591 SNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI--SKCSSLRSLLVNSNHLSGGIPD 648
N + + ++ L L LD +NL ++ + +L L ++ H
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 649 SLAKLSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQAFANN 696
LS+L VL ++ N+ + + + L ++S L+ +
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 67/345 (19%), Positives = 119/345 (34%), Gaps = 28/345 (8%)
Query: 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431
F +IP+ L K+L L+ N SF + P L+ L+L + ++
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 432 EEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTT 490
+ +++LSTL L+ N + LS L + +G+L L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 491 LDLSK-QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRY----LNLSFNG 545
L+++ S +LP + L NL+ + L NK+ L + L+LS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGH---IPTD 601
P F + + L+ N S ++ + + LEV L D
Sbjct: 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 602 ISHLSHLNVLDLSINNLTG------EIPDEISKCSSLRSLLVNSNHLSGGIPDS-LAKLS 654
S L L L + L +I D + +++ S + S + S
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307
Query: 655 NLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDL 699
+L +++ +L + +SN + DL
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRL------TFTSNKGGNAFSEVDL 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-21
Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 9/193 (4%)
Query: 509 LPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGN 568
+PN+ E +P+ S + L+LSFN +F + VL S
Sbjct: 7 VPNITY-QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 569 HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISK 628
I + S L L L N + S LS L L NL I
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 629 CSSLRSLLVNSNHL-SGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGL----MNF 683
+L+ L V N + S +P+ + L+NL LDLS+N + +L + + ++
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 684 NVSSNNLQAFANN 696
++S N +
Sbjct: 183 DLSLNPMNFIQPG 195
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-14
Identities = 29/136 (21%), Positives = 47/136 (34%), Gaps = 3/136 (2%)
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE 625
+ IP L + L+L N L L VLDLS +
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 626 ISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNV 685
S L +L++ N + + + LS+L L NL+ + + L NV
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 686 SSNNLQAFANNQDLCG 701
+ N +Q+F +
Sbjct: 132 AHNLIQSFKLPEYFSN 147
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 64/309 (20%), Positives = 115/309 (37%), Gaps = 31/309 (10%)
Query: 793 ITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFL 852
+ + V +R R+G V+KA + V +++ P E L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVYSL 72
Query: 853 GKVRHRNLTVLRGYYAGAPDL---RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909
++H N+ G + L+ + G+L L+ +V++W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHI 126
Query: 910 ALGVARGLAFLHTS----------NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959
A +ARGLA+LH + H DIK +NVL + A ++DFGL +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 960 EASTSTTAVGTLGYVSPEAA-----LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
T VGT Y++PE + D+Y+ G+VL EL + DE
Sbjct: 187 AGDT-HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 1015 IVKWVKKQLQKGQITELLEPGLLE-LDPE-SSEWEEFLLGVKVALL---CTAPDPIDRPT 1069
++ + ++ Q + ++ E + + P W++ + C D R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 1070 MSDIVFMLE 1078
+ +
Sbjct: 306 AGCVGERIT 314
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-60
Identities = 139/681 (20%), Positives = 238/681 (34%), Gaps = 88/681 (12%)
Query: 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFSG 174
R F ++ +L+ +P L+ E L ++ N + A+ P L+ +L S
Sbjct: 7 RIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 175 PI-PTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIP 233
I + NL L++++ +K P F+G L L L +
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQG--------LFHLFELRLYFCGLSDAVL 114
Query: 234 P--AIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPE-TG 290
L L + L++N + + F + S++ + N V E
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL----NSLKSIDFSSNQIFLVCEHELEP 170
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRAS------TLTRLDVSGNSISGKIPAQIGGLWRL 344
L L N + + + L LDVSGN + +
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT------------V 218
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPE--FLGDIR-GLKSLTLAANL 401
+ +N+ + + + + + + F G R ++ L L+
Sbjct: 219 DITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGF 277
Query: 402 FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNL 461
F L L+ LNL +N ++ E G++NL L+LS N ++ L
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
Query: 462 SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
++ +L N + + L KL TLDL + + +P++ I L NK
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK 392
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVG-QIPATFSFLRSVVVLSFSGNHISGSIPPE--L 578
L +P+ ++ ++LS N I + + +L + N S S +
Sbjct: 393 LV-TLPKIN---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTP 447
Query: 579 GNCSDLEVLELRSNSLTGHIPTDI-----SHLSHLNVLDLSINNLTGEIPDEISKCSSLR 633
LE L L N L T++ LSHL VL L+ N L P S ++LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 634 SLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSG---EIPANLSSIFGLMNFNVSSNNL 690
L +NSN L+ + L +NL +LD+S N L ++ +LS + N + L
Sbjct: 508 GLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565
Query: 691 QAFAN-----NQDLCGKPLGRKC----------------ENADDRDRRKKLILLIVIAAS 729
F N N + G P C E D+ + K L + I +
Sbjct: 566 STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 730 GACLLALCCCFYIFSLLRWRR 750
L L + +
Sbjct: 626 VTLTLFLMTILTVTKFRGFCF 646
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-54
Identities = 124/618 (20%), Positives = 214/618 (34%), Gaps = 65/618 (10%)
Query: 56 CDWRGVACTNNRVTEL--RLP---RLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNGT 105
D R +T++ L RL LS I L L+ L L S T
Sbjct: 4 FDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 106 I-PATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLP---- 159
I LR + L + + L + L +L L + LS + D
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 160 RNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL 218
+ L DLS N + S L+ L+ I+FS N+ E +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL------QGKTL 176
Query: 219 VHLSAQGNALGGVIPPAIGALPK------LQVVSLAQNNLSGVVPASMFCNVSG------ 266
S N+L + G L+++ ++ N + + + +S
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 267 -YPPSIRVVQLGFNAFTNV-AGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLD 324
I GF+ + G S ++ LDL + L L+
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 325 VSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPE 384
++ N I+ GL L+ L ++ N G ++ +DL+ N + +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 385 FLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLD 444
+ L++L L N + + +P + ++ L N L +LP+ L + +
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINL---TANLIH 407
Query: 445 LSENKFSG-EVPASIGNLSQLMVFNLSGNAFSG-RIPASLGNLLKLTTLDLSKQNFSGEL 502
LSEN+ ++ + + L + L+ N FS + L L L +
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 503 PIEL-----AGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557
EL GL +LQV+ L N L+ P FS L +LR L+L+ N +
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH-NDLP 525
Query: 558 RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617
++ +L S N + + P+ L VL++ N + + +N L+ +
Sbjct: 526 ANLEILDISRNQLL-APNPD--VFVSLSVLDITHNKFI----CECELSTFINWLNHTNVT 578
Query: 618 LTGEIPDEISKCSSLRSL 635
+ G P C S
Sbjct: 579 IAG--PPADIYCVYPDSF 594
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-23
Identities = 75/415 (18%), Positives = 143/415 (34%), Gaps = 62/415 (14%)
Query: 65 NNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYN 124
+ V L L + S L+ L+ L+L N N L+ + L YN
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 125 SLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISN 182
L +N L + +++ N ++ L+ DL N T+I
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHF 379
Query: 183 LSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKL 242
+ + I S NK +L ++ N +
Sbjct: 380 IPSIPDIFLSGNKL-------------------VTLPKINLTANLI-------------- 406
Query: 243 QVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQ 302
L++N L + V P ++++ L N F++ +G +T S + L+ L L
Sbjct: 407 ---HLSENRLENLDILYFLLRV----PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 303 QNQIRGAFPLWLTRA-----STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGA 357
+N ++ A+ L S L L ++ N ++ P L L L + +N
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TV 518
Query: 358 VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIP-ASFRNLPGL 416
+ ++L +LD+ N+ P+ L L + N F ++F N
Sbjct: 519 LSHNDLP-ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNH 574
Query: 417 ENLNLRHN--SLSGSLPEEVLGMN--NLSTLDLSENKFSGEVPASIGNLSQLMVF 467
N+ + + P+ G++ +LST E + + S+ + + +
Sbjct: 575 TNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-57
Identities = 115/543 (21%), Positives = 179/543 (32%), Gaps = 98/543 (18%)
Query: 133 NIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFS 192
L+ + ++ ++ + G + L+ L INFS
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFS 76
Query: 193 FNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNL 252
N+ + I P + L KL + + N +
Sbjct: 77 NNQLTD---------------------------------ITP-LKNLTKLVDILMNNNQI 102
Query: 253 SGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPL 312
+ + P TN L L L NQI PL
Sbjct: 103 ADITP--------------------LANLTN------------LTGLTLFNNQITDIDPL 130
Query: 313 W-LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLL 371
LT L RL++S N+IS + GL L++L N + ++L L
Sbjct: 131 KNLTN---LNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERL 182
Query: 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431
D+ N+ S L + L+SL N S P L L+ L+L N L
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 432 EEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTL 491
+ + NL+ LDL+ N+ S P + L++L L N S P L L LT L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 492 DLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP 551
+L++ ++ L NL + L N +S SSL L+ L N
Sbjct: 293 ELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKV--SDV 346
Query: 552 ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL 611
++ + L ++ LS N IS P L N + + L L + T +++S N +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 612 DLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671
L P IS S + N S + S + SG +
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
Query: 672 ANL 674
L
Sbjct: 462 QPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-55
Identities = 94/458 (20%), Positives = 181/458 (39%), Gaps = 41/458 (8%)
Query: 234 PAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCS 293
AL + L + N++ V + + +Q ++ +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDL-------DQVTTLQADRLGIKSI--DGVEYLN 68
Query: 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNS 353
+ L ++ NQ+ PL + L + ++ N I+ P + L L L + NN
Sbjct: 69 N-LTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ 123
Query: 354 FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
P +K ++L+ L+L N S L + L+ L+ + + NL
Sbjct: 124 ITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDLKPLANL 176
Query: 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473
LE L++ N +S + + NL +L + N+ S P +G L+ L +L+GN
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 232
Query: 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533
+L +L LT LDL+ S L+GL L + L N++S + L
Sbjct: 233 LKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGL 286
Query: 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
+L L L+ N P S L+++ L+ N+IS P + + + L+ L +N
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKL 653
++ + +++L+++N L N ++ P ++ + + L +N + + A +
Sbjct: 343 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398
Query: 654 SNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
S + L PA +S +++ N
Sbjct: 399 SIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-53
Identities = 98/492 (19%), Positives = 179/492 (36%), Gaps = 52/492 (10%)
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
+ L K L + T+ + + + + L+NL +N
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 146 AANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE 205
+ N+L+ L +++N + P ++NL+ L + N+ +
Sbjct: 76 SNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD------- 126
Query: 206 GTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265
+ N ++L L N + + A+ L LQ +S N ++ + P +
Sbjct: 127 ---IDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDLKPLANL---- 176
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDV 325
++ + + N +++ ++ L+ L NQI P L + L L +
Sbjct: 177 ---TTLERLDISSNKVSDI--SVLAKLTN-LESLIATNNQISDITP--LGILTNLDELSL 228
Query: 326 SGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF 385
+GN + I + L L +L +ANN P + + L+ L L N+ S P
Sbjct: 229 NGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282
Query: 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDL 445
L + L +L L N P NL L L L N++S V + L L
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFF 338
Query: 446 SENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE 505
NK S +S+ NL+ + + N S P L NL ++T L L+ Q ++
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
Query: 506 LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFN--GFVGQIPATFSFLRSVVVL 563
A + + L P S S ++++N + ++ TFS V +
Sbjct: 395 KANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQP---VTI 449
Query: 564 SFSGNHISGSIP 575
SG++
Sbjct: 450 GKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-49
Identities = 105/486 (21%), Positives = 183/486 (37%), Gaps = 71/486 (14%)
Query: 66 NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNS 125
++VT L+ RL + D + L L +++ +N P L T L + + N
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101
Query: 126 LSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQ 185
++ + NL+NL L + N+++ NL +LSSN S +S L+
Sbjct: 102 IAD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISA--LSGLTS 157
Query: 186 LQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV 245
LQ ++F T +AN ++L L N + + L L+ +
Sbjct: 158 LQQLSFGNQV-----------TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 204
Query: 246 SLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ 305
N +S + P TN L L L NQ
Sbjct: 205 IATNNQISDITP--------------------LGILTN------------LDELSLNGNQ 232
Query: 306 IRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQC 365
++ L + LT LD++ N IS P + GL +L ELK+ N P +
Sbjct: 233 LKDIGTLA--SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGL 286
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
++L+ L+L N+ P + +++ L LTL N S P +L L+ L +N
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
+S + + N++ L N+ S P + NL+++ L+ A++ N+
Sbjct: 343 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS--GNVPEGFSSLMSLRYLNLSF 543
T+ P ++ + + N S V FS +++ +F
Sbjct: 399 SIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTF 456
Query: 544 NGFVGQ 549
+G V Q
Sbjct: 457 SGTVTQ 462
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-14
Identities = 34/205 (16%), Positives = 72/205 (35%), Gaps = 25/205 (12%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
N+++ + L L+L+ ++ D +SNL+ L L+L N+ + P ++
Sbjct: 272 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 329
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
T L+ +F N +S +++ NL+N+ L+ N++S + L+ +
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387
Query: 173 SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVI 232
+ +N+S + P+ I++ S N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL----------IAPATISDGGSYTEPDITWNLPSY-T 436
Query: 233 PPAIGALPKLQVVSLAQNNLSGVVP 257
+ + SG V
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-55
Identities = 57/333 (17%), Positives = 118/333 (35%), Gaps = 28/333 (8%)
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
E L ++ + Q D + + T
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK 69
Query: 404 GSIPASFRNL--PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNL 461
+ + PG L LR L P++ +++L + + E+P ++
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 462 SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
+ L L+ N +PAS+ +L +L L + ELP LA
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------------ 173
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNC 581
+ L++L+ L L + G +PA+ + L+++ L + +S ++ P + +
Sbjct: 174 ---DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
LE L+LR + + P + L L L + +P +I + + L L +
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674
+P +A+L ++ + +L ++ +
Sbjct: 289 NLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 48/297 (16%), Positives = 93/297 (31%), Gaps = 21/297 (7%)
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
GS + G ENL + ++ + + D + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 464 LMVFNLSGNAFSGRIPASLGNL--LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
+ +G A L + L+L + P + L +LQ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNC 581
L +P+ L L L+ N +PA+ + L + LS +P L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 582 SD---------LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSL 632
L+ L L + +P I++L +L L + + L+ + I L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 633 RSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
L + P + L L L + +P ++ + L ++
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 60/358 (16%), Positives = 110/358 (30%), Gaps = 60/358 (16%)
Query: 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219
+ + P +S + + + AN ++
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH------------SAWRQANSNNPQ 59
Query: 220 HLSAQGNALGGVIPPAIGAL--PKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLG 277
+ G AL + P + L L P
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF------------PDQA------ 100
Query: 278 FNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ 337
S LQ + + + P + + + L L ++ N + +PA
Sbjct: 101 ------------FRLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS 145
Query: 338 IGGLWRLEELKMANNSFGGAVPVEIKQCS---------SLSLLDLEGNRFSGEIPEFLGD 388
I L RL EL + +P + +L L LE +P + +
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSEN 448
++ LKSL + + S ++ + +LP LE L+LR + + P G L L L +
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 449 KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL 506
+P I L+QL +L G R+P+ + L + + + +L
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 42/263 (15%), Positives = 76/263 (28%), Gaps = 55/263 (20%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
+ + L + D + L L+L N +PA++A LR + ++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQL 188
LP + + NL+ L G +P SI+NL L+
Sbjct: 165 ELPEPLASTDASGEHQGL-------------VNLQSLRLEWTGIRS-LPASIANLQNLKS 210
Query: 189 INFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248
+ + S L AI + L L +G PP G L+ + L
Sbjct: 211 LKIRNSPLS---------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 249 QNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG 308
+ +P + + L+ LDL+
Sbjct: 262 DCSNLLTLPLDI-----------------------------HRLTQ-LEKLDLRGCVNLS 291
Query: 309 AFPLWLTRASTLTRLDVSGNSIS 331
P + + + V + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 39/188 (20%), Positives = 59/188 (31%), Gaps = 38/188 (20%)
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVF----LQYNSLSGN----LPANIGNL 137
+++L LR+LS+R+ +P LA LQ L LPA+I NL
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANL 205
Query: 138 SNLEILNVAANRLSGEIANDLP------RNLKYFDLSSNGFSGPIPTSISNLSQLQLINF 191
NL+ L + + LS L L+ DL P + L+ +
Sbjct: 206 QNLKSLKIRNSPLSA-----LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 192 SFNKFSREVPATFE----------------GTLPSAIANCSSLVHLSAQGNALGGVI--- 232
+P LPS IA + + + +
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
Query: 233 PPAIGALP 240
P A A P
Sbjct: 321 PVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 23/139 (16%), Positives = 44/139 (31%), Gaps = 9/139 (6%)
Query: 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN 616
L F G+ L + ++ ++ + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 617 NLTGEIPDEISKCSS--LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674
L D + + +L + S L PD +LS+L + + A L E+P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 675 SSIFGLMNFNVSSNNLQAF 693
GL ++ N L+A
Sbjct: 124 QQFAGLETLTLARNPLRAL 142
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
EL L L++L L+ S T+P + + T L + L+
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNL 162
LP+ I L I+ V + + L ++
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQA-----QLDQHR 320
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 191 bits (489), Expect = 3e-54
Identities = 79/372 (21%), Positives = 151/372 (40%), Gaps = 27/372 (7%)
Query: 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS 379
L I+ P L + S V ++ S++ L + G + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 380 GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNN 439
+ + + L+ L L N + P NL L NL + N ++ + + N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111
Query: 440 LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499
L L L+E+ S + + NL+++ NL N + L N+ L L +++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 500 GELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRS 559
+A L +L ++L N++ +SL SL Y N P + +
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 560 VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619
+ L N I+ P L N S L LE+ +N ++ + L+ L +L++ N ++
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 620 GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG 679
++ S L SL +N+N L + + L+NL L LS N+++ P L+S+
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 680 LMNFNVSSNNLQ 691
+ + + ++ ++
Sbjct: 335 MDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-50
Identities = 79/348 (22%), Positives = 133/348 (38%), Gaps = 25/348 (7%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
LQ+ + + ++T+L V+G ++ I I L LE L + N
Sbjct: 24 GIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT 79
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
P + L+ L + N+ + L ++ L+ L L + S P NL
Sbjct: 80 DISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTK 133
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
+ +LNL N S + M L+ L ++E+K I NL+ L +L+ N
Sbjct: 134 MYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIE 190
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
P L +L L + +A + L + + NK++ ++L
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD--LSPLANLSQ 244
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L +L + N I A L + +L+ N IS L N S L L L +N L
Sbjct: 245 LTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
I L++L L LS N++T P ++ S + S + +
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 78/388 (20%), Positives = 148/388 (38%), Gaps = 63/388 (16%)
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
++L + L+ S + + + + + ++ ++ I L+NLE LN+
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73
Query: 146 AANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE 205
N+++ L + +N + +++ NL+ L+ + + + S
Sbjct: 74 NGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD------- 124
Query: 206 GTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265
S +AN + + L+ N + P + + L +++ ++ + V P
Sbjct: 125 ---ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP-------- 172
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLW-LTRASTLTRLD 324
T+ L L L NQI PL LT L
Sbjct: 173 ------------IANLTD------------LYSLSLNYNQIEDISPLASLTS---LHYFT 205
Query: 325 VSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPE 384
N I+ P + + RL LK+ NN P + S L+ L++ N+ S
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--IN 259
Query: 385 FLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLD 444
+ D+ LK L + +N S + NL L +L L +N L E + G+ NL+TL
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 445 LSENKFSGEVPASIGNLSQLMVFNLSGN 472
LS+N + P + +LS++ + +
Sbjct: 318 LSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 67/296 (22%), Positives = 120/296 (40%), Gaps = 39/296 (13%)
Query: 415 GLENLNLRHNSLSGSLPEEVL--------------------GMNNLSTLDLSENKFSGEV 454
G L ++ P+ L + +++ L ++ K +
Sbjct: 1 GAATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS-- 58
Query: 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQV 514
I L+ L NL+GN + P L NL+KLT L + + L L NL+
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRE 114
Query: 515 IALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI 574
+ L E+ +S ++L + LNL N + + S + + L+ + + +
Sbjct: 115 LYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVT 171
Query: 575 PPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634
P + N +DL L L N + P ++ L+ L+ +N +T P ++ + L S
Sbjct: 172 P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225
Query: 635 LLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
L + +N ++ LA LS L L++ N +S I A + + L NV SN +
Sbjct: 226 LKIGNNKITD--LSPLANLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQI 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-20
Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 19/189 (10%)
Query: 72 RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
L L ++ ++ D ++NL L LSL N P LA T L N ++
Sbjct: 156 GLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT- 212
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQL 188
++ + N++ L L + N+++ L + ++ +N S ++ +L++L++
Sbjct: 213 DIT-PVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKM 269
Query: 189 INFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248
+N N+ S S + N S L L N LG IG L L + L+
Sbjct: 270 LNVGSNQISD----------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 249 QNNLSGVVP 257
QN+++ + P
Sbjct: 320 QNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 18/146 (12%)
Query: 65 NNRVTEL-------RLPRLQLSG-RISDH--LSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
N++T++ RL L++ +I+D L+NL L L + +N + I A + T
Sbjct: 208 VNQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DINA-VKDLT 265
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGF 172
L+ + + N +S + + NLS L L + N+L E + NL LS N
Sbjct: 266 KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 173 SGPIPTSISNLSQLQLINFSFNKFSR 198
+ P +++LS++ +F+ +
Sbjct: 324 TDIRP--LASLSKMDSADFANQVIKK 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 8e-51
Identities = 88/532 (16%), Positives = 178/532 (33%), Gaps = 38/532 (7%)
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
D S F+ IP+ ++ + ++ ++ SFNK + + + C++L L +
Sbjct: 11 DGRSRSFTS-IPSGLT--AAMKSLDLSFNKIT-YIG-------HGDLRACANLQVLILKS 59
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVA 285
+ + + A +L L+ + L+ N+LS + +S F + S++ + L N + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPL----SSLKYLNLMGNPYQTLG 114
Query: 286 GPETGSCSSVLQVLDL-QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL 344
+ LQ L + + ++L L++ S+ + + +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG 404
L + + + + SS+ L+L + L + A S
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
SF L L L + + D + ++ +
Sbjct: 235 LTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
++ + L K+ + + L +L+ + L EN +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 525 NV---PEGFSSLMSLRYLNLSFNGF--VGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579
+ SL+ L LS N + + L+++ L S N +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 580 NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNS 639
+ L L S + + T I L VLD+S NNL + L+ L ++
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLP---RLQELYISR 460
Query: 640 NHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
N L +PD+ + L V+ +S N L + L + +N
Sbjct: 461 NKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-45
Identities = 98/625 (15%), Positives = 185/625 (29%), Gaps = 133/625 (21%)
Query: 56 CDWRGVA-CTNNRVTEL------RLPRLQLSG-RIS----DHLSNLRMLRKLSLRSNSFN 103
CD GV + T + + L LS +I+ L L+ L L+S+ N
Sbjct: 4 CDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 104 GTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLK 163
L + L N LS + G LS+L+ LN+ N
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ------------ 111
Query: 164 YFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSA 223
+ + + NL+ LQ + + E+ A +SL L
Sbjct: 112 ---------TLGVTSLFPNLTNLQTLRIGNVETFSEIR-------RIDFAGLTSLNELEI 155
Query: 224 QGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTN 283
+ +L ++ ++ + ++L + + ++ + ++
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF------------------ADILSS 197
Query: 284 VAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWR 343
++ L+L+ + L + + S L +
Sbjct: 198 ------------VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
L I + S + D N +
Sbjct: 246 LLRY--------------ILELSEVEFDDCTLNGL----------------GDFNPSESD 275
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
+ L++ L L + + + + +K + +L
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
L +LS N + L G P+LQ + L +N L
Sbjct: 336 LEFLDLSEN--------------LMVEEYLKNSACKG-------AWPSLQTLVLSQNHLR 374
Query: 524 --GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNC 581
E +L +L L++S N F +P + + + L+ S I + +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--P 430
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
LEVL++ +N+L L L L +S N L +PD S L + ++ N
Sbjct: 431 QTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQ 484
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNL 666
L +L++L + L N
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-43
Identities = 76/429 (17%), Positives = 148/429 (34%), Gaps = 32/429 (7%)
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350
SC + V D + + P LT + + LD+S N I+ + L+ L +
Sbjct: 3 SCDA-SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG-SIPAS 409
++ SL LDL N S + G + LK L L N + + +
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 410 FRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFN 468
F NL L+ L + + + G+ +L+ L++ S+ ++ +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 469 LSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG---- 524
L + + + L + L+L N + L + + S
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 525 ------NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLR--------SVVVLSFSGNHI 570
+ L + + + + NG P+ + ++ L ++
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 571 SGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDE---I 626
+ ++ + + ++ + +P HL L LDLS N + E
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 627 SKCSSLRSLLVNSNHLS--GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFN 684
SL++L+++ NHL + L L NL LD+S N +P + + N
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 685 VSSNNLQAF 693
+SS ++
Sbjct: 417 LSSTGIRVV 425
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-25
Identities = 48/239 (20%), Positives = 94/239 (39%), Gaps = 5/239 (2%)
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQE 519
+ V + +F+ IP+ L + +LDLS + +L NLQV+ L+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 520 NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG-SIPPEL 578
++++ + F SL SL +L+LS N + F L S+ L+ GN +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 579 GNCSDLEVLELRSNSLTGHIP-TDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637
N ++L+ L + + I D + L+ LN L++ +L + + L +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+ + + + LS++ L+L NL+ + L + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-21
Identities = 54/357 (15%), Positives = 106/357 (29%), Gaps = 59/357 (16%)
Query: 34 KLNLHD-PLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRML 92
L L D L + +A + +T+ L R LS +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD 259
Query: 93 RKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGN-----LPANIGNLSNLEILNVAA 147
FN + +++ + V ++ + L L ++ + V
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 148 NRLSGEIANDLPR---NLKYFDLSSNGFS---GPIPTSISNLSQLQLINFSFNKFSREVP 201
+++ + + +L++ DLS N LQ + S N
Sbjct: 320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL----- 373
Query: 202 ATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMF 261
+ +L L N +P + K++ ++L+ + VV +
Sbjct: 374 -RSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP 430
Query: 262 CNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT 321
L+VLD+ N + +F L+L R L
Sbjct: 431 QT--------------------------------LEVLDVSNNNLD-SFSLFLPR---LQ 454
Query: 322 RLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF 378
L +S N + +P L +K++ N + +SL + L N +
Sbjct: 455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-50
Identities = 96/580 (16%), Positives = 186/580 (32%), Gaps = 135/580 (23%)
Query: 88 NLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAA 147
+ L++ S++ +P + ++ N P G + +
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS---- 63
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
+ + L R +L++ G S +P +L L S N +
Sbjct: 64 -----RLRDCLDRQAHELELNNLGLS-SLPELPPHLESLVA---SCNSLT---------E 105
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
LP + SL+ + AL + P L+ + ++ N L +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLP-------PLLEYLGVSNNQLEKL------------ 146
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327
PE + S L+++D+ N ++ P L +
Sbjct: 147 -------------------PELQNSSF-LKIIDVDNNSLK-KLPDLPPS---LEFIAAGN 182
Query: 328 NSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLG 387
N + ++P E++ L+ + + N ++P+
Sbjct: 183 NQLE-ELP-------------------------ELQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447
L+S+ N+ +NLP L + +N L +LP+ +L L++ +
Sbjct: 216 ---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRD 266
Query: 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA 507
N + ++P +L+ L V + + N L L+ S N L
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFS----GLSELPPN---LYYLNASS-NEIRSLCDL-- 315
Query: 508 GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG 567
P+L+ + + NKL +P + L L SFN ++P L+ L
Sbjct: 316 -PPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQNLKQ---LHVEY 366
Query: 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS 627
N + P + DL + ++ L +P +L L + N L E PD
Sbjct: 367 NPLR-EFPDIPESVEDLRM----NSHLA-EVPELPQNLKQ---LHVETNPLR-EFPDIP- 415
Query: 628 KCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
S+ L +NS + + L ++
Sbjct: 416 --ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-47
Identities = 97/531 (18%), Positives = 173/531 (32%), Gaps = 96/531 (18%)
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
I + + LQ + + +P N S + PP
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT---------EMPVEAENVKSKTEYYNAWSEWERNAPPG 53
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295
G ++ V L ++L +++ PE
Sbjct: 54 NGEQREMAVSRLRDCL----------------DRQAHELELNNLGLSSL--PE--LPPH- 92
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
L+ L N + P +L + + ++S P LE L ++NN
Sbjct: 93 LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE 144
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
+P E++ S L ++D++ N ++P+ L+ + N +P +NLP
Sbjct: 145 -KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPF 196
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L + +NSL LP+ +L ++ N + NL L N
Sbjct: 197 LTAIYADNNSLK-KLPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
+P +L L D N+ +LP L L V + LS +
Sbjct: 251 -TLPDLPPSLEALNVRD----NYLTDLPELPQSLTFLDVSENIFSGLS-------ELPPN 298
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L YLN S N +I + S+ L+ S N + +P LE L N L
Sbjct: 299 LYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA 350
Query: 596 GHIPTDISHLSHLNVLD---------------LSINNLTGEIPDEISKCSSLRSLLVNSN 640
+P +L L+V L +N+ E+P+ +L+ L V +N
Sbjct: 351 -EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ---NLKQLHVETN 406
Query: 641 HLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
L PD + +L +++ + + + +V ++
Sbjct: 407 PLRE-FPDIPESVEDL---RMNSERVV-DPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-43
Identities = 97/479 (20%), Positives = 170/479 (35%), Gaps = 87/479 (18%)
Query: 232 IPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGS 291
I P + LQ +NL+ +P S ++ + A P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEA-----ENVKSKTEYYNAWSEWERNAPPGNG- 55
Query: 292 CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351
+ ++ +++R L+++ +S +P LE L +
Sbjct: 56 -----EQREMAVSRLRDCLDR------QAHELELNNLGLS-SLPELPP---HLESLVASC 100
Query: 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR 411
NS +P + SL + + S P L+ L ++ N +P +
Sbjct: 101 NSL-TELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQ 150
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
N L+ +++ +NSL LP+ +L + N+ E+P + NL L
Sbjct: 151 NSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
N+ ++P + L ++ ELP EL LP L I N L +P+
Sbjct: 205 NSLK-KLPDLPLS---LESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLR-----------------SVVVLSFSGNHISGSI 574
SL +L + +P L ++ L+ S N I S+
Sbjct: 258 SLEALNVRDNYLT----DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SL 312
Query: 575 PPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634
+ LE L + +N L +P + L L S N+L E+P+ +L+
Sbjct: 313 CDLPPS---LEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELP---QNLKQ 361
Query: 635 LLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
L V N L PD + +L + N+ E+P + L +V +N L+ F
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQN---LKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-41
Identities = 90/488 (18%), Positives = 154/488 (31%), Gaps = 86/488 (17%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNG------------TIPATLAQCTLL 116
TE + R + LR ++P L
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESL 96
Query: 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPI 176
NSL+ LP +L +L + N LS DLP L+Y +S+N +
Sbjct: 97 V---ASCNSLT-ELPELPQSLKSLLVDNNNLKALS-----DLPPLLEYLGVSNNQLEK-L 146
Query: 177 PTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAI 236
P + N S L++I+ N + LP + L ++A N L P +
Sbjct: 147 P-ELQNSSFLKIIDVDNNSLKK---------LPDLPPS---LEFIAAGNNQL--EELPEL 191
Query: 237 GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVL 296
LP L + N+L + P S+ + G N + PE + L
Sbjct: 192 QNLPFLTAIYADNNSLK---------KLPDLPLSLESIVAGNNILEEL--PELQNLPF-L 239
Query: 297 QVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGG 356
+ N ++ P +L L+V N ++ +P L L+ + +
Sbjct: 240 TTIYADNNLLK-TLPDLP---PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL-- 292
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416
+L L+ N + + L+ L ++ N +PA P L
Sbjct: 293 --SELPP---NLYYLNASSNEIR-SLCDLPP---SLEELNVSNNKLI-ELPAL---PPRL 339
Query: 417 ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSG 476
E L N L+ +PE NL L + N E P ++ L + +
Sbjct: 340 ERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSH-----LA 389
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536
+P N L L + N E P + +L+ + ++ + L
Sbjct: 390 EVPELPQN---LKQLHVE-TNPLREFPDIPESVEDLR---MNSERVVDPYEFAHETTDKL 442
Query: 537 RYLNLSFN 544
+
Sbjct: 443 EDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 54/305 (17%), Positives = 103/305 (33%), Gaps = 44/305 (14%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVL-------------GMNNLSTLDLSENKFS 451
+P N+ + + P L+L+ S
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511
+P +L L S N+ + +P +L L + + + S +LP P
Sbjct: 85 -SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLP------PL 132
Query: 512 LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571
L+ + + N+L +PE + L+ +++ N + S+ ++ N +
Sbjct: 133 LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNN----SLKKLPDLPPSLEFIAAGNNQL- 185
Query: 572 GSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631
PEL N L + +NSL +P L + N L E+
Sbjct: 186 -EELPELQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNILE--ELPELQNLPF 238
Query: 632 LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
L ++ ++N L +PD +L L++ N L+ ++P S+ L + L
Sbjct: 239 LTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
Query: 692 AFANN 696
N
Sbjct: 294 ELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 78/407 (19%), Positives = 129/407 (31%), Gaps = 87/407 (21%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
L + QL ++ + L N L+ + + +NS +P L + N L
Sbjct: 134 EYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE- 186
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQL 188
LP + NL L + N L DLP +L+ +N + NL L
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLKKLP--DLPLSLESIVAGNNILE--ELPELQNLPFLTT 241
Query: 189 INFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248
I N TLP + +L L P +L L V
Sbjct: 242 IYADNNLLK---------TLPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVSENI 288
Query: 249 QNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG 308
+ LS + P L L+ N+IR
Sbjct: 289 FSGLSELPPN-------------------------------------LYYLNASSNEIRS 311
Query: 309 AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSL 368
L +L L+VS N + ++PA RLE L + N VP +L
Sbjct: 312 LCDLP----PSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELP---QNL 359
Query: 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG 428
L +E N E P+ ++ L + ++L +P +N L+ L++ N L
Sbjct: 360 KQLHVEYNPLR-EFPDIPE---SVEDLRMNSHL--AEVPELPQN---LKQLHVETNPLR- 409
Query: 429 SLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
P+ ++ L ++ + + +L +
Sbjct: 410 EFPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 69/408 (16%), Positives = 136/408 (33%), Gaps = 20/408 (4%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
++ + + ++ A A + LD+SGN +S A + +LE L +++N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
++++ S+L LDL N L +++L A N S + S G
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCS--RGQG 121
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG-EVPASIGNLSQLMVFNLSGNAF 474
+N+ L +N ++ + + + LDL N+ + L NL N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
+ + KL TLDLS N + E + I+L+ NKL + +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLS-SNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594
+L + +L NGF F F ++ V + + + C+ + +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 595 TGHIPTDISHLSHLNVLDLSINNLTG----EIPDEISKCSSLRSLLVNSNHLSGGIPDSL 650
L L + ++ + G + E + R + I
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 651 AKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQD 698
+ L+ L ++ + L + + +
Sbjct: 357 LRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-42
Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 24/294 (8%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
+I +N + + +SL +L N+ LDLS N S A + ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
+ NLS N L +L L TLDL+ EL P+++ + N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG-SIPPELGNCSD 583
V S + + L+ N V L N I + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
LE L L+ N + + + + L LDLS N L + E + + + + +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 644 GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQ 697
I +L NL DL N L +F + +Q A
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGT---------LRDFFSKNQRVQTVAKQT 271
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-42
Identities = 73/555 (13%), Positives = 167/555 (30%), Gaps = 70/555 (12%)
Query: 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLE 141
I + N + + +S + + ++ + L N LS A++ + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 142 ILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVP 201
+LN+++N L + + L+ DL++N + ++ ++ + N SR
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSC 116
Query: 202 ATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMF 261
+ ++ N + + G ++Q + L N + V A +
Sbjct: 117 SRG-----------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 262 CNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT 321
+ S L+ L+LQ N I + + L
Sbjct: 166 AS-----------------------------SDTLEHLNLQYNFIY-DVKGQVV-FAKLK 194
Query: 322 RLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGE 381
LD+S N ++ + + + + + NN + ++ +L DL GN F
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 382 IPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLS 441
+ + T+A + + LP + L
Sbjct: 253 TLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFA--DRLI 308
Query: 442 TLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGE 501
L E+ + G+ R+ N + +D K+ +
Sbjct: 309 ALKRKEHALL----------------SGQGSETE-RLECERENQARQREIDALKEQYRTV 351
Query: 502 LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVV 561
+ + ++ L V G + L G + AT +
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL 411
Query: 562 VLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
+ + + + + + + ++ + T + DL++ +
Sbjct: 412 LRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANAT 471
Query: 622 IPDEISKCSSLRSLL 636
+ + + + +L S L
Sbjct: 472 LQELVVREQNLASQL 486
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 55/327 (16%), Positives = 107/327 (32%), Gaps = 16/327 (4%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
+ + + + + +K L L+ N S A LE LNL N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
L ++ ++ L TLDL+ N + + + + N S R+ S G
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ- 120
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG-NVPEGFSSLMSLRYLNLSFN 544
+ L+ + ++ +Q + L+ N++ N E +S +L +LNL +N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 545 GFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604
+ + L S N ++ + PE + + + + LR+N L I +
Sbjct: 180 FIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 605 LSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664
+L DL N + R V + + + + + A
Sbjct: 236 SQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 665 NLSGEIPANLSSIFGLMNFNVSSNNLQ 691
+ L + + Q
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQ 321
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-40
Identities = 50/316 (15%), Positives = 102/316 (32%), Gaps = 16/316 (5%)
Query: 382 IPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLS 441
I E + K + + ++ + ++ ++ L+L N LS ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 442 TLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGE 501
L+LS N + +LS L +L+ N L + TL + N S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 502 LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG-QIPATFSFLRSV 560
+ + + I L NK++ ++YL+L N + ++
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 561 VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTG 620
L+ N I + ++ + L+ L+L SN L + + + + + L N L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 621 EIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGL 680
I + +L + N G N V ++ + N
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 681 MNFNVSSNNLQAFANN 696
+ + +
Sbjct: 287 TLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 20/81 (24%), Positives = 30/81 (37%), Gaps = 3/81 (3%)
Query: 622 IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLM 681
I + + + V + L + N+ LDLS N LS A+L+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 682 NFNVSSNNLQ---AFANNQDL 699
N+SSN L + L
Sbjct: 62 LLNLSSNVLYETLDLESLSTL 82
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 67/335 (20%), Positives = 109/335 (32%), Gaps = 54/335 (16%)
Query: 801 ATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAE--FLGKVRHR 858
++ R RYG V+K ++ V +++ + F E + + H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANRQN--FINEKNIYRVPLMEHD 67
Query: 859 NLTVLRGY----YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914
N+ A LLV +Y PNG+L L H +W +A V
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVT 121
Query: 915 RGLAFLHTS---------NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS--- 962
RGLA+LHT + H D+ +NVL D +SDFGL
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 963 --TSTTAVGTLGYVSPE-------AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013
+ + VGT+ Y++PE K+ D+Y+ G++ E+ + +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 1014 DIVK-----WVKKQLQKGQITEL-----LEPGLLELDPESSEWEEFLLGVKVALLCTAPD 1063
+ V + L P E E+S L + C D
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL--KETIEDCWDQD 299
Query: 1064 PIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
R T + ++ + SP
Sbjct: 300 AEARLTAQXAEERMA------ELMMIWERNKSVSP 328
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-46
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 45/289 (15%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRN 859
+Q + L+ G ++K + + ++ L F +E L H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 860 LTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
+ + G P L+ +MP G+L +L E V++ AL +ARG+A
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMA 125
Query: 919 FLHTSN--MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
FLHT + + ++V+ D D A +S + S + +V+P
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--------QSPGRMYAPAWVAP 177
Query: 977 EAALTGE----TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG---QIT 1029
EA L + + +D++SF ++L EL+T + P F D ++ K +G I
Sbjct: 178 EA-LQKKPEDTNRRSADMWSFAVLLWELVTREVP--F-ADLSNMEIGMKVALEGLRPTIP 233
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ P + +L +C DP RP IV +LE
Sbjct: 234 PGISPHVSKL----------------MKICMNEDPAKRPKFDMIVPILE 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
+G V +A ++ V +++ L + F +E + ++RH N+ + G P+
Sbjct: 50 FGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDI 930
L +V +Y+ G+L LL L+ R +A VA+G+ +LH N +VH ++
Sbjct: 109 L-SIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESD 989
K N+L D + + DFGL RL T +S +A GT +++PE L E ++SD
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEV-LRDEPSNEKSD 221
Query: 990 VYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
VYSFG++L EL T ++P +V V + ++ +I L P + +
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI---------- 271
Query: 1050 LLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
C +P RP+ + I+ +L + SA P S
Sbjct: 272 ------IEGCWTNEPWKRPSFATIMDLLR------PLIKSAVPPPNRSD 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 29/271 (10%)
Query: 815 RYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAGAP 871
+G V+K ++ G V +++ L + F+ E L K RH N+ + G
Sbjct: 36 SFGTVYKGKWH-GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTA 91
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
+V + +L L H IA ARG+ +LH +++H D+K
Sbjct: 92 PQLAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET---TKES 988
N+ D + DFGL + + G++ +++PE ++ + +S
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 989 DVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE-SSEWE 1047
DVY+FGIVL EL+TG+ P + D + + +G L P L ++ +
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQIIE---MVGRGS----LSPDLSKVRSNCPKRMK 259
Query: 1048 EFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ C +RP+ I+ +E
Sbjct: 260 RLM------AECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 44/297 (14%)
Query: 815 RYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAGAP 871
R+G V+ ++ G V +IR + +E+ F++E + RH N+ + G P
Sbjct: 45 RFGQVYHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
L ++ L +++ VL+ IA + +G+ +LH ++H D+K
Sbjct: 103 HL-AIITSLCKGRTLYSVV----RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS--TTAVGTLGYVSPE---------AAL 980
+NV +D + + ++DFGL ++ A G L +++PE
Sbjct: 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+K SDV++ G + EL + P + K I + G+
Sbjct: 217 KLPFSKHSDVFALGTIWYELHAREWP-----------F--KTQPAEAIIWQMGTGMKPNL 263
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPS 1097
+ +E + L C A + +RPT + ++ MLE +P + P
Sbjct: 264 SQIGMGKEI---SDILLFCWAFEQEERPTFTKLMDMLE------KLPKRNRRLSHPG 311
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 42/290 (14%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G+V KA + V +I+++ S + F E L +V H N+ L G
Sbjct: 21 FGVVCKAKWRAKDV-AIKQIESESERKA-FIVELRQLSRVNHPNIVKLYGACLNPV---C 75
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN---MVHGDIKP 932
LV +Y G+L +L + L ++G+A+LH+ ++H D+KP
Sbjct: 76 LVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 933 QNVLFDADFE-AHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDV 990
N+L A + DFG + T G+ +++PE G +++ DV
Sbjct: 134 PNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGSAAWMAPEV-FEGSNYSEKCDV 186
Query: 991 YSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---ITELLEPGLLELDPESSEWE 1047
+S+GI+L E++T ++P F + + + G + + L + L
Sbjct: 187 FSWGIILWEVITRRKP--FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-------- 236
Query: 1048 EFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPS 1097
C + DP RP+M +IV ++ P + +P P
Sbjct: 237 --------MTRCWSKDPSQRPSMEEIVKIMTHLMR--YFPGADEPLQYPC 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 68/300 (22%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENL--------FRKEAEFLGK 854
+ + E + + +GLV K D V++I+ L G + F++E +
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 855 VRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914
+ H N+ L G P +V +++P G+L L H + W ++ + L +A
Sbjct: 80 LNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIA 132
Query: 915 RGLAFLHTSN--MVHGDIKPQNVLFD-----ADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
G+ ++ N +VH D++ N+ A A ++DFGL + + +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVSGL 186
Query: 968 VGTLGYVSPEAALTGET---TKESDVYSFGIVLLELLTGKRP---VMFTQDEDIVKWVKK 1021
+G +++PE + E T+++D YSF ++L +LTG+ P + + +K++
Sbjct: 187 LGNFQWMAPET-IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINM 241
Query: 1022 QLQKGQ---ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
++G I E P L + LC + DP RP S IV L
Sbjct: 242 IREEGLRPTIPEDCPPRLRNV----------------IELCWSGDPKKRPHFSYIVKELS 285
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 24/294 (8%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
+I +N + + +SL +L N+ LDLS N S A + ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
+ NLS N L +L L TLDL+ EL P+++ + N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG-SIPPELGNCSD 583
V S + + L+ N V L N I + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
LE L L+ N + + + + L LDLS N L + E + + + + +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 644 GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQ 697
I +L NL DL N L +F + +Q A
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGT---------LRDFFSKNQRVQTVAKQT 271
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-43
Identities = 56/293 (19%), Positives = 107/293 (36%), Gaps = 16/293 (5%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
+ + + + + +K L L+ N S A LE LNL N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
L ++ ++ L TLDL+ N + + + + N S R+ S G
Sbjct: 70 LY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ- 120
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG-NVPEGFSSLMSLRYLNLSFN 544
+ L+ + ++ +Q + L+ N++ N E +S +L +LNL +N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 545 GFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604
+ + L S N ++ + PE + + + + LR+N L I +
Sbjct: 180 FIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 605 LSHLNVLDLSINNLT-GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNL 656
+L DL N G + D SK ++++ + G + + L
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 50/305 (16%), Positives = 104/305 (34%), Gaps = 16/305 (5%)
Query: 382 IPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLS 441
I E + K + + ++ + ++ ++ L+L N LS ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 442 TLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGE 501
L+LS N + +LS L +L+ N L + TL + N S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 502 LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG-QIPATFSFLRSV 560
+ + + I L NK++ ++YL+L N + ++
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 561 VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTG 620
L+ N I + ++ + L+ L+L SN L + + + + + L N L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 621 EIPDEISKCSSLRSLLVNSNHLSGG-IPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG 679
I + +L + N G + D +K + + ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 680 LMNFN 684
L ++
Sbjct: 288 LGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 52/371 (14%), Positives = 119/371 (32%), Gaps = 57/371 (15%)
Query: 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLE 141
I + N + + +S + + ++ + L N LS A++ + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 142 ILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVP 201
+LN+++N L + + L+ DL++N + ++ ++ + N S
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS---- 112
Query: 202 ATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMF 261
+ + ++ N + + G ++Q + L N + V A +
Sbjct: 113 -----RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 262 CNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT 321
S + L+ L+LQ N I + + L
Sbjct: 166 ----------------------------ASSDT-LEHLNLQYNFIY-DVKGQVV-FAKLK 194
Query: 322 RLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS-G 380
LD+S N ++ + + + + + NN + ++ +L DL GN F G
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 381 EIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNL 440
+ +F + ++++ +P L + +
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL----GHYGAYCCEDLPAPFA---D 305
Query: 441 STLDLSENKFS 451
+ L +
Sbjct: 306 RLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 54/332 (16%), Positives = 108/332 (32%), Gaps = 54/332 (16%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
EL L LS + L+ L L+L SN L + LR + L N +
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ- 93
Query: 129 NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQL 188
+ ++E L+ A N +S ++ + K L++N + S++Q
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 189 INFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248
++ N+ A+ +L HL+ Q N + + + KL+ + L+
Sbjct: 149 LDLKLNEID-------TVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV-FAKLKTLDLS 199
Query: 249 QNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG 308
N L+ + P S + + + L+ N++
Sbjct: 200 SNKLAFM------------GPEF------------------QSAAG-VTWISLRNNKLV- 227
Query: 309 AFPLWLTRASTLTRLDVSGNSIS-GKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSS 367
L + L D+ GN G + R++ + + + ++ +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECT 284
Query: 368 LSLLDLEGNRFSGEIPE-FLGDIRGLKSLTLA 398
+ L G ++P F + L
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 22/140 (15%), Positives = 36/140 (25%), Gaps = 18/140 (12%)
Query: 65 NNRVTEL-------RLPRLQLSG----RISDHLSNLRMLRKLSLRSNSFNGTIPATLAQC 113
N + ++ +L L LS + + + +SLR+N I L
Sbjct: 178 YNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 114 TLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSG-----EIANDLPRNLKYFDLS 168
L L+ N N + VA + E +P Y
Sbjct: 237 QNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 169 SNGFSGPIPTSISNLSQLQL 188
P + L
Sbjct: 296 CEDLPAPFADRLIALGHHHH 315
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 43/278 (15%)
Query: 816 YGLVFKACYNDGMV----LSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
+G V++A + V D S R+EA+ ++H N+ LRG P
Sbjct: 20 FGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN---MVHG 928
+L LV ++ G L +L G + + A+ +ARG+ +LH ++H
Sbjct: 80 NL-CLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 929 DIKPQNVLFDADFEAH--------LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
D+K N+L E ++DFGL R +T +A G +++PE
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMSAAGAYAWMAPEVIR 187
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+K SDV+S+G++L ELLTG+ P + V I +L
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL- 246
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
C PDP RP+ ++I+ L
Sbjct: 247 ---------------MEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 60/303 (19%), Positives = 105/303 (34%), Gaps = 47/303 (15%)
Query: 816 YGLVFKACYND-GMVLSIRRLPD-GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
+G K + + G V+ ++ L + F KE + + + H N+ G L
Sbjct: 23 FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
+ +Y+ G L ++ W R A +A G+A+LH+ N++H D+
Sbjct: 83 -NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEAST-----------STTAVGTLGYVSPEAALTG 982
N L + ++DFGL RL + + T VG +++PE
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 983 ETTKESDVYSFGIVLLELLTGKRP----VMFTQDEDIVKWVKKQLQKGQ---ITELLEPG 1035
++ DV+SFGIVL E++ + T D ++ P
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDRYCPPNCPPS 251
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQ 1095
+ + C DP RP+ + LE R+ P +
Sbjct: 252 FFPI----------------TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 1096 PSP 1098
Sbjct: 296 QLD 298
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-43
Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 10/307 (3%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
+ LLDL NR + L+ L L N+ S P +F NL L L LR N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 426 LSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA-SLG 483
L +P V G++NL+ LD+SENK + +L L + N I +
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
Query: 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
L L L L K N + L+ L L V+ L+ ++ F L L+ L +S
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI 602
++ + + ++ LS + +++ ++P + + L L L N ++ I +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSM 267
Query: 603 -SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLD 660
L L + L L + + LR L V+ N L+ + NL L
Sbjct: 268 LHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326
Query: 661 LSANNLS 667
L +N L+
Sbjct: 327 LDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-40
Identities = 70/336 (20%), Positives = 125/336 (37%), Gaps = 11/336 (3%)
Query: 287 PETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346
P CS+ + + + + A P + + LD+ N I + LEE
Sbjct: 4 PPRCECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI 406
L++ N P +L L L NR + L L ++ N +
Sbjct: 61 LELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILL 120
Query: 407 PASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLM 465
F++L L++L + N L + G+N+L L L + + ++ +L L+
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI 179
Query: 466 VFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN 525
V L + S L +L L++S + + NL +++ L+
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238
Query: 526 VPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSD 583
VP L+ LR+LNLS+N + L + + G ++ + P +
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNY 297
Query: 584 LEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNL 618
L VL + N LT + + + +L L L N L
Sbjct: 298 LRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 73/300 (24%), Positives = 116/300 (38%), Gaps = 18/300 (6%)
Query: 405 SIPASFRNLP-GLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLS 462
++P +P L+L N + +L ++ +L L+L+EN S P + NL
Sbjct: 25 AVP---EGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80
Query: 463 QLMVFNLSGNAFSGRIPA-SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
L L N IP L LT LD+S+ L L NL+ + + +N
Sbjct: 81 NLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139
Query: 522 LSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-L 578
L + FS L SL L L IP S L ++VL +I+ +I
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSF 196
Query: 579 GNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE-ISKCSSLRSLLV 637
L+VLE+ + + + +L L ++ NLT +P + LR L +
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNL 255
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQAFANN 696
+ N +S L +L L + L L+ + + L NVS N L +
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEES 314
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 57/331 (17%), Positives = 125/331 (37%), Gaps = 21/331 (6%)
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
R + +P + DL N ++ L+ + + N S V
Sbjct: 21 KRFV-AVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE------ 72
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
P A N +L L + N L + L L + +++N + ++ MF ++
Sbjct: 73 -PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL--- 127
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327
+++ +++G N ++ S + L+ L L++ + L+ L L +
Sbjct: 128 -YNLKSLEVGDNDLVYIS-HRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 328 NSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF- 385
+I+ I L+RL+ L++++ + + +L+ L + + +P
Sbjct: 186 LNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLD 444
+ + L+ L L+ N S + L L+ + L L+ + G+N L L+
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLN 302
Query: 445 LSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
+S N+ + + ++ L L N +
Sbjct: 303 VSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 80/402 (19%), Positives = 126/402 (31%), Gaps = 83/402 (20%)
Query: 56 CDWRG--VACTNNRVTEL--RLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLA 111
C + V C R + +P R L L N A
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTE---------------TRLLDLGKNRIKTLNQDEFA 53
Query: 112 QCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSN 170
L + L N +S + NL NL L + +NRL +
Sbjct: 54 SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK--------------LIPLG 98
Query: 171 GFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGG 230
F+G LS L ++ S NK + F+ +L L N L
Sbjct: 99 VFTG--------LSNLTKLDISENKIVILLDYMFQDL--------YNLKSLEVGDNDLVY 142
Query: 231 VIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG 290
+ A L L+ ++L + NL+ +P ++ G
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG------------------------ 177
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350
L VL L+ I R L L++S + L L +
Sbjct: 178 -----LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASF 410
+ + + ++ L L+L N S L ++ L+ + L + P +F
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 411 RNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFS 451
R L L LN+ N L+ +L E V + NL TL L N +
Sbjct: 293 RGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 66/361 (18%), Positives = 126/361 (34%), Gaps = 24/361 (6%)
Query: 334 IPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393
I + + ++ + + E ++ ++ + + L R ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSG 452
L L +F ++ L + N++ LP V + L+ L L N S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 453 EVPASI-GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511
+P I N +L ++S N + L L LS + ++L+ +P+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 187
Query: 512 LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571
L + N LS + +++ L+ S N L L N+++
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT 239
Query: 572 GSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCS 630
L N L ++L N L I + L L +S N L +
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 631 SLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
+L+ L ++ NHL + + + L L L N++ + LS+ L N +S N+
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
Query: 691 Q 691
Sbjct: 352 D 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-41
Identities = 76/332 (22%), Positives = 130/332 (39%), Gaps = 25/332 (7%)
Query: 368 LSLLDLEGNRFSGEIPEFLGDI--RGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
D+ + + ++ DI K +T + A + +E LNL
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 426 LSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL-G 483
+ + + + L + N P N+ L V L N S +P +
Sbjct: 81 IE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
Query: 484 NLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542
N KLTTL +S N + + +LQ + L N+L+ +V S + SL + N+S
Sbjct: 139 NTPKLTTLSMS-NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 543 FNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI 602
+N +T + +V L S N I+ + + +L +L+L+ N+LT +
Sbjct: 195 YNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-L 244
Query: 603 SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
+ L +DLS N L +I K L L +++N L + + L VLDL
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302
Query: 662 SANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
S N+L + N L N + N++
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 70/423 (16%), Positives = 135/423 (31%), Gaps = 61/423 (14%)
Query: 121 LQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSI 180
+Y + NL + ++ I + G L N K ++ +
Sbjct: 8 PEYKCIDSNLQYDC-VFYDVHIDMQTQDVYFGFEDITLN-NQKIVTFKNSTMRKLPAALL 65
Query: 181 SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240
+ Q++L+N + + E+ A A ++ L NA+ + P +P
Sbjct: 66 DSFRQVELLNLNDLQIE-EID-------TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 241 KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLD 300
L V+ L +N+LS +P +F N L L
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPK-----------------------------LTTLS 147
Query: 301 LQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPV 360
+ N + ++L L +S N ++ + + + L ++ N
Sbjct: 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS----- 199
Query: 361 EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420
+ ++ LD N + + L L L N + N PGL ++
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVD 254
Query: 421 LRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP 479
L +N L + M L L +S N+ + + L V +LS N +
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 480 ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRY 538
+ +L L L + ++L+ L+ + L N N F ++
Sbjct: 312 RNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAV 368
Query: 539 LNL 541
+
Sbjct: 369 DDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 57/315 (18%), Positives = 107/315 (33%), Gaps = 26/315 (8%)
Query: 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIG 459
I ++ + ++++ + E + +NN + + A +
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQE 519
+ Q+ + NL+ + + L + P +P L V+ L+
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126
Query: 520 NKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP-- 576
N LS ++P G F + L L++S N TF S+ L S N ++ +
Sbjct: 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 577 ---------------ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
L +E L+ NS+ + + L +L L NNLT +
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-D 240
Query: 622 IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLM 681
+ L + ++ N L + K+ L L +S N L + I L
Sbjct: 241 TA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 682 NFNVSSNNLQAFANN 696
++S N+L N
Sbjct: 299 VLDLSHNHLLHVERN 313
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 72/387 (18%), Positives = 127/387 (32%), Gaps = 80/387 (20%)
Query: 66 NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNS 125
N + + + L + R + L+L A ++ +++ +N+
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 126 LSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLS 184
+ LP ++ N+ L +L + N LS LPR + N
Sbjct: 105 IR-YLPPHVFQNVPLLTVLVLERNDLS-----SLPRGI-----------------FHNTP 141
Query: 185 QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQV 244
+L ++ S N R TF+ LQ
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQA--------------------------------TTSLQN 169
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN 304
+ L+ N L+ V S+ PS+ + +N + +A P ++ LD N
Sbjct: 170 LQLSSNRLT-HVDLSLI-------PSLFHANVSYNLLSTLAIP------IAVEELDASHN 215
Query: 305 QIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ 364
I LT L + N+++ + L E+ ++ N + +
Sbjct: 216 SINVVRGPVNVE---LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVK 270
Query: 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN 424
L L + NR + + I LK L L+ N + + LENL L HN
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328
Query: 425 SLSGSLPEEVLGMNNLSTLDLSENKFS 451
S+ +L + L L LS N +
Sbjct: 329 SIV-TLKLSTH--HTLKNLTLSHNDWD 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-39
Identities = 68/362 (18%), Positives = 127/362 (35%), Gaps = 26/362 (7%)
Query: 334 IPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393
I + + ++ + + E ++ ++ + + L R ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSG 452
L L +F ++ L + N++ LP V + L+ L L N S
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 453 EVPASI-GNLSQLMVFNLSGNAFSGRIPAS-LGNLLKLTTLDLSKQNFSGELPIELAGLP 510
+P I N +L ++S N RI L L LS + ++L+ +P
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIP 192
Query: 511 NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHI 570
+L + N LS + +++ L+ S N L L N++
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNL 244
Query: 571 SGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKC 629
+ L N L ++L N L I + L L +S N L +
Sbjct: 245 TD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 630 SSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
+L+ L ++ NHL + + + L L L N++ + LS+ L N +S N+
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 356
Query: 690 LQ 691
Sbjct: 357 WD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 76/332 (22%), Positives = 130/332 (39%), Gaps = 25/332 (7%)
Query: 368 LSLLDLEGNRFSGEIPEFLGDIR--GLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
D+ + + ++ DI K +T + A + +E LNL
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 426 LSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL-G 483
+ + + + L + N P N+ L V L N S +P +
Sbjct: 87 IE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
Query: 484 NLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542
N KLTTL +S N + + +LQ + L N+L+ +V S + SL + N+S
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 200
Query: 543 FNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI 602
+N +T + +V L S N I+ + + +L +L+L+ N+LT +
Sbjct: 201 YNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-L 250
Query: 603 SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
+ L +DLS N L +I K L L +++N L + + L VLDL
Sbjct: 251 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 308
Query: 662 SANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
S N+L + N L N + N++
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 339
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 8e-39
Identities = 84/581 (14%), Positives = 173/581 (29%), Gaps = 82/581 (14%)
Query: 122 QYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSIS 181
+Y + NL + ++ I + G L N K ++ +
Sbjct: 15 EYKCIDSNLQYDC-VFYDVHIDMQTQDVYFGFEDITLN-NQKIVTFKNSTMRKLPAALLD 72
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
+ Q++L+N + + E+ A A ++ L NA+ + P +P
Sbjct: 73 SFRQVELLNLNDLQIE-EID-------TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 242 LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301
L V+ L +N+LS +P +F N L L +
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPK-----------------------------LTTLSM 154
Query: 302 QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE 361
N + ++L L +S N ++ + + + L ++ N
Sbjct: 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----T 206
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
+ ++ LD N + + L L L N + N PGL ++L
Sbjct: 207 LAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDL 261
Query: 422 RHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480
+N L + M L L +S N+ + + L V +LS N +
Sbjct: 262 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318
Query: 481 SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYL 539
+ +L L L + ++L+ L+ + L N N F ++
Sbjct: 319 NQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVD 375
Query: 540 NLSFNGFVGQI-------PATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
+ + + + ++ + + + G CS + + +
Sbjct: 376 DADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQS 435
Query: 593 SLTGHIPTDISHLSHLNVLDLSINNLTGEI----PDEISKCSSLRSLLVNSNHLSGGIPD 648
L L+ +N L E+ ++I + L+ L +
Sbjct: 436 LSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID-------- 487
Query: 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
L + S + + + F +
Sbjct: 488 --TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-32
Identities = 57/310 (18%), Positives = 107/310 (34%), Gaps = 26/310 (8%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
I ++ + ++++ + E + +NN + + A + + Q+
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
+ NL+ + + L + P +P L V+ L+ N LS
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 525 NVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP------- 576
++P G F + L L++S N TF S+ L S N ++ +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLF 195
Query: 577 ----------ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI 626
L +E L+ NS+ + + L +L L NNLT + +
Sbjct: 196 HANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-L 250
Query: 627 SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVS 686
L + ++ N L + K+ L L +S N L + I L ++S
Sbjct: 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 687 SNNLQAFANN 696
N+L N
Sbjct: 310 HNHLLHVERN 319
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-29
Identities = 81/490 (16%), Positives = 150/490 (30%), Gaps = 92/490 (18%)
Query: 66 NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNS 125
N + + + L + R + L+L A ++ +++ +N+
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 126 LSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLS 184
+ LP ++ N+ L +L + N LS LPR + N
Sbjct: 111 IR-YLPPHVFQNVPLLTVLVLERNDLS-----SLPRGI-----------------FHNTP 147
Query: 185 QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQV 244
+L ++ S N R TF+ LQ
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQA--------------------------------TTSLQN 175
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN 304
+ L+ N L+ V S+ PS+ + +N + +A P ++ LD N
Sbjct: 176 LQLSSNRLT-HVDLSLI-------PSLFHANVSYNLLSTLAIPIA------VEELDASHN 221
Query: 305 QIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ 364
I LT L + N+++ + L E+ ++ N + +
Sbjct: 222 SINVVRGPVNVE---LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN 424
L L + NR + + I LK L L+ N + + LENL L HN
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334
Query: 425 SLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGN 484
S+ +L + L L LS N + ++ + + +I L +
Sbjct: 335 SIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
Query: 485 LLKLTTLD----------LSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
L D ++ + ++ I ++ +G L
Sbjct: 390 GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQ 449
Query: 535 SLRYLNLSFN 544
L N
Sbjct: 450 GNEQLEAEVN 459
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 23/143 (16%), Positives = 50/143 (34%), Gaps = 16/143 (11%)
Query: 65 NNRVTEL-------RLPRLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
+N +T+ L + LS + ++ L +L + +N +
Sbjct: 241 HNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
L+ + L +N L ++ N LE L + N + + LK LS N +
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDW 357
Query: 173 SG-PIPTSISNLSQLQLINFSFN 194
+ N+++ + + +
Sbjct: 358 DCNSLRALFRNVARPAVDDADQH 380
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 61/302 (20%), Positives = 107/302 (35%), Gaps = 37/302 (12%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEF--LGKVRHRNL 860
+Q + + RYG V+ + V +++ +E + +E E +RH N+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGEKV-AVKVFFTT--EEASWFRETEIYQTVLMRHENI 93
Query: 861 TVLRGYYAGAPDLR---LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
L+ DY NG+L L+ L+ +A GL
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGL 147
Query: 918 AFLHTSN--------MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA-V 968
LHT + H D+K +N+L + ++D GL I E V
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 969 GTLGYVSPE------AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI--VKWVK 1020
GT Y+ PE ++ +D+YSFG++L E+ ++ + V
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 1021 KQLQKGQITELLEPGLLELDPE-SSEWEEFLLGVKVALL---CTAPDPIDRPTMSDIVFM 1076
+ E++ + +L P + W ++ L C A +P R T +
Sbjct: 268 SDPSYEDMREIV--CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 1077 LE 1078
L
Sbjct: 326 LA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 61/303 (20%), Positives = 109/303 (35%), Gaps = 37/303 (12%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEF--LGKVRHRN 859
R + + RYG V++ + V +++ DE + +E E +RH N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENV-AVKIFSSR--DEKSWFRETELYNTVMLRHEN 63
Query: 860 LTVLRGY---YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
+ + L+ Y G+L LQ L+ I L +A G
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASG 117
Query: 917 LAFLHTS--------NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST-STTA 967
LA LH + H D+K +N+L + + ++D GL + + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 968 VGTLGYVSPE------AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI--VKWV 1019
VGT Y++PE ++ K D+++FG+VL E+ +D V
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 1020 KKQLQKGQITELLEPGLLELDPE-SSEWEEFLLGVKVALL---CTAPDPIDRPTMSDIVF 1075
+ +++ + + P + W +A L C +P R T I
Sbjct: 238 PNDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 1076 MLE 1078
L
Sbjct: 296 TLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 57/311 (18%), Positives = 99/311 (31%), Gaps = 55/311 (17%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
R + + + R+G V++ + V +++ E +RH N+
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 863 LRGYYAGAPDLR---LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
LV DY +G+L L + + +AL A GLA
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 154
Query: 920 LHTS--------NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST-STTAVGT 970
LH + H D+K +N+L + ++D GL VGT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 971 LGYVSPE------AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD------------ 1012
Y++PE E+ K +D+Y+ G+V E+ +D
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 1013 ---EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALL--CTAPDPIDR 1067
E++ K V +Q + I P + + ++ C + R
Sbjct: 275 PSVEEMRKVVCEQKLRPNI-----PNRWQSCEALRVMAK--------IMRECWYANGAAR 321
Query: 1068 PTMSDIVFMLE 1078
T I L
Sbjct: 322 LTALRIKKTLS 332
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-38
Identities = 75/371 (20%), Positives = 134/371 (36%), Gaps = 48/371 (12%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
VL++ ++ + P L + +T L + N+++ +PA L L+++ N
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT 94
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
++PV LS+ GL L + N + S+P PG
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVL---PPG 142
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L+ L++ N L+ SLP + L L N+ + +P L +L ++S N +
Sbjct: 143 LQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA 194
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
+P L KL + N LP A L+ + + N+L+ ++P
Sbjct: 195 -SLPTLPSELYKLWAYN----NRLTSLP---ALPSGLKELIVSGNRLT-SLPV---LPSE 242
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L+ L +S N +P S L S LS N ++ +P L + S + L N L+
Sbjct: 243 LKELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSL-LVNSNHLSGGIPDSLAKLS 654
+ ++ + S R+L L ++ L A
Sbjct: 298 ERTLQALREITS---APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 655 NLAVLDLSANN 665
+ N
Sbjct: 355 RWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-37
Identities = 67/369 (18%), Positives = 127/369 (34%), Gaps = 68/369 (18%)
Query: 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375
+ L+V + ++ +P + + ++ L +
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP--------------------------AHITTLVIPD 70
Query: 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL 435
N + +P L++L ++ N + S+P L L + L
Sbjct: 71 NNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS---- 121
Query: 436 GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSK 495
L L + N+ + +P L +L ++S N + +PA L L
Sbjct: 122 ---GLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSEL---CKLWAYN 170
Query: 496 QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFS 555
+ LP+ LQ +++ +N+L+ ++P S L L N +PA S
Sbjct: 171 NQLT-SLPMLP---SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLT----SLPALPS 221
Query: 556 FLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI 615
L+ L SGN ++ S+P L+ L + N LT +P S L L +
Sbjct: 222 GLKE---LIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLPSGLLSL---SVYR 270
Query: 616 NNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLS 675
N LT +P+ + SS ++ + N LS +L ++++ +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 676 SIFGLMNFN 684
L
Sbjct: 330 ETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 54/293 (18%)
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474
G LN+ + L+ +LP+ + +++TL + +N + +PA L L +SGN
Sbjct: 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQL 93
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
+ +P LL+L+ + L + + N+L+ ++P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPV---LPP 141
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594
L+ L++S N +PA S L L N ++ S+P L+ L + N L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCK---LWAYNNQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKL- 653
+PT S L L + + +L S L+ L+V+ N L+ +P ++L
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLTS-LPVLPSELK 244
Query: 654 ----------------SNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
S L L + N L+ +P +L + N+ N L
Sbjct: 245 ELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-27
Identities = 85/443 (19%), Positives = 147/443 (33%), Gaps = 93/443 (20%)
Query: 43 ALNGWDSSTPAAPCDWRGVA------CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLS 96
+ W + PA R C NN L + L+ + D L + L
Sbjct: 11 VWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLV 67
Query: 97 LRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN 156
+ N+ ++PA + L + N L+ +LP L L I + L
Sbjct: 68 IPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP----- 117
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
LP L + N + +P L +L + S N+ + +LP+ +
Sbjct: 118 ALPSGLCKLWIFGNQLTS-LPVLPPGLQELSV---SDNQLA---------SLPALPSE-- 162
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276
L L A N L +P L +L S++ N L+ + P
Sbjct: 163 -LCKLWAYNNQL-TSLPMLPSGLQEL---SVSDNQLASL------------PTLP----- 200
Query: 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPA 336
S L L N++ + P + L L VSGN ++ +P
Sbjct: 201 -----------------SELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPV 238
Query: 337 QIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT 396
L+EL ++ N ++P+ S L L + N+ + +PE L + ++
Sbjct: 239 LPS---ELKELMVSGNRL-TSLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 397 LAANLFSGSIPASFRNLPGLENLN---LRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453
L N S + R + + +R + S P E ++ + L +
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
Query: 454 VPA----SIGNLSQLMVFNLSGN 472
PA G F+L +
Sbjct: 351 APADRWHMFGQEDNADAFSLFLD 373
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 39/195 (20%), Positives = 63/195 (32%), Gaps = 34/195 (17%)
Query: 25 PEIEALTSFKLNLHD-PLGALNGWDSSTPAAPCDWRGVACTNNRVTEL-----RLPRLQL 78
L L++ D L +L P P + + NNR+T L L L +
Sbjct: 178 MLPSGLQE--LSVSDNQLASL-------PTLPSELYKLWAYNNRLTSLPALPSGLKELIV 228
Query: 79 SG----RISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI 134
SG + S L+ +L + N ++P + L + N L+ LP ++
Sbjct: 229 SGNRLTSLPVLPSELK---ELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESL 280
Query: 135 GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFS------GPIPTSISNLSQLQL 188
+LS+ +N+ N LS E R + S P L
Sbjct: 281 IHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
Query: 189 INFSFNKFSREVPAT 203
+ PA
Sbjct: 340 DWLVPAREGEPAPAD 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 20/92 (21%), Positives = 42/92 (45%), Gaps = 8/92 (8%)
Query: 605 LSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664
+ VL++ + LT +PD + + + +L++ N+L+ +P L L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALP---PELRTLEVSGN 91
Query: 665 NLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
L+ +P + L F+ +L A +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-37
Identities = 73/403 (18%), Positives = 147/403 (36%), Gaps = 41/403 (10%)
Query: 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNS 353
+++ + + +TLT LD +SI+ + I L L +L +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 354 FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
+++ Q ++L+ L + N+ + + + + L L N + + S
Sbjct: 76 ITT---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QN 126
Query: 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473
P L LN N+L+ + V L+ LD NK ++ + +QL + S N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533
+ + L L+ N + ++L L + NKL+ + + L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
L Y + S N +T S L + L + I L + + L +
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTT---LHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKL 653
+ D++H + L +LD +T E+ +S+ L L +N+ L+ + ++
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 654 SNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+ L L ++ + ++ I L N +
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 78/404 (19%), Positives = 151/404 (37%), Gaps = 43/404 (10%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
L LD + I + + + LT+L + N+I+ + + L L +N
Sbjct: 44 LTSLDCHNSSITDMTGI--EKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT 98
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
+++ + L+ L+ + N+ + ++ + L L A N + I S +
Sbjct: 99 N---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVS--HNTQ 149
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L L+ N L V L+TLD S NK + + L N N +
Sbjct: 150 LTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT 204
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
++ L ++LT LD S + I++ L L N L+ + S+L
Sbjct: 205 -KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L L+ + +I + ++ G + ++ + + L +L+ ++ +T
Sbjct: 256 LTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT 310
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
D+S L L L+ LT E+ +S + L+SL + H+ S+ K+
Sbjct: 311 ---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPA 362
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDL 699
L + L++ + VS + L F N ++
Sbjct: 363 LNNNFEAEGQTITMPKETLTN--NSLTIAVSPDLLDQFGNPMNI 404
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 68/431 (15%), Positives = 141/431 (32%), Gaps = 53/431 (12%)
Query: 269 PSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGN 328
++ + ++ T++ + L L N I L L++ + LT L N
Sbjct: 42 ATLTSLDCHNSSITDM--TGIEKLTG-LTKLICTSNNITT---LDLSQNTNLTYLACDSN 95
Query: 329 SISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGD 388
++ + + L +L L N +++ Q L+ L+ N + EI +
Sbjct: 96 KLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSH 146
Query: 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSEN 448
L L N + L L+ N ++ L V L+ L+ N
Sbjct: 147 NTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTN 201
Query: 449 KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAG 508
+ ++ + QL + S N + I + L +LT D S + ++++
Sbjct: 202 NIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVST 252
Query: 509 LPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGN 568
L L + + L + + L Y + ++ + + +L
Sbjct: 253 LSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAA 307
Query: 569 HISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISK 628
I+ + L L L L + LT + D+SH + L L ++ + + K
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQ-DFS-SVGK 359
Query: 629 CSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSN 688
+L + + + L+ N+L+ + +L FG +
Sbjct: 360 IPALNNNFEAEG-----------QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
Query: 689 NLQAFANNQDL 699
+
Sbjct: 409 GGVYDQATNTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 71/477 (14%), Positives = 148/477 (31%), Gaps = 57/477 (11%)
Query: 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLS 151
+ T + Q L ++ +S++ ++ I L+ L L +N ++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 152 GEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSA 211
+ NL Y SN + ++ L++L +N NK + L
Sbjct: 78 TLDLSQNT-NLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT---------KLD-- 122
Query: 212 IANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSI 271
++ L +L+ N L + + +L + N + + +
Sbjct: 123 VSQNPLLTYLNCARNTLTEID---VSHNTQLTELDCHLNKKITKLDVTPQ-------TQL 172
Query: 272 RVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSIS 331
+ FN T + + L L+ N I L L + LT LD S N ++
Sbjct: 173 TTLDCSFNKITEL---DVSQNKL-LNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
Query: 332 GKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRG 391
+I + L +L + N +++ S L+ L EI L
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQ 276
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
L + + L L+ + ++ L + L L L+ + +
Sbjct: 277 LIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511
E+ + + ++L + S+G + L ++ L
Sbjct: 332 -ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSL 386
Query: 512 LQVIALQENKLSGN---VPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLS 564
++ GN + G + +++ PA T++F +
Sbjct: 387 TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIV 443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 82/574 (14%), Positives = 173/574 (30%), Gaps = 154/574 (26%)
Query: 116 LRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGP 175
+ + + L+ L L+ + ++ D+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-----DMT---------------- 58
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
I L+ L + + N + TL ++ ++L +L+ N L +
Sbjct: 59 ---GIEKLTGLTKLICTSNNIT---------TLD--LSQNTNLTYLACDSNKLTNLD--- 101
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295
+ L KL ++ N L+ +L +
Sbjct: 102 VTPLTKLTYLNCDTNKLT---------------------KLDVSQNPL------------ 128
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
L L+ +N + + ++ + LT LD N K+ + +L L + N
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI- 182
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
+++ Q L+ L+ + N + L L
Sbjct: 183 --TELDVSQNKLLNRLNCDTNN--------------ITKLDLN-------------QNIQ 213
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L L+ N L+ + V + L+ D S N + E+ + LS+L +
Sbjct: 214 LTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQT--- 264
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
L +DL+ N Q+I Q +
Sbjct: 265 -----------DLLEIDLTH---------------NTQLIYFQAEGCRKIKELDVTHNTQ 298
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L L+ G ++ S +V L + ++ + + + + L+ L + +
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
+ + + LN + +P E +SL ++ V+ + L + +
Sbjct: 353 D-FSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGD 408
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
V D + N ++ NLS+ + + +S N
Sbjct: 409 GGVYDQATNTIT---WENLSTDNPAVTYTFTSEN 439
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-22
Identities = 70/455 (15%), Positives = 141/455 (30%), Gaps = 110/455 (24%)
Query: 63 CTNNRVTEL------RLPRLQLSG-RISD-HLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
CT+N +T L L L ++++ ++ L L L+ +N + ++Q
Sbjct: 71 CTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNP 127
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
LL + N+L+ + + + + L L+ N+ ++ L D S N +
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE 184
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
+S L +N N + L + L L N L I
Sbjct: 185 ---LDVSQNKLLNRLNCDTNNIT---------KLD--LNQNIQLTFLDCSSNKLTE-ID- 228
Query: 235 AIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSS 294
+ L +L + N L+ +L + +
Sbjct: 229 -VTPLTQLTYFDCSVNPLT---------------------ELDVSTLSK----------- 255
Query: 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
L L Q L +D++ N+ +L +
Sbjct: 256 -LTTLHCIQTD--------------LLEIDLTHNT-------------QLIYFQAEGCRK 287
Query: 355 GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414
+++ + L LLD + + E+ L L L L + + S +
Sbjct: 288 IK--ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS--HNT 339
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV------FN 468
L++L+ + + V + L+ +E + +P + L + +
Sbjct: 340 KLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLD 396
Query: 469 LSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELP 503
GN + I G + T ++ +N S + P
Sbjct: 397 QFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 94/517 (18%), Positives = 177/517 (34%), Gaps = 61/517 (11%)
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
DL + ++S N S + I +LS+L+++ S N+ + F+
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK--------FNQ 69
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276
L +L N L + + L+ + L+ N + F N+
Sbjct: 70 ELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNM------------ 114
Query: 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPA 336
S L+ L L + + L + + L V G + K
Sbjct: 115 -----------------SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157
Query: 337 ---QIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393
Q L + N F + V +K ++L L +++ + FL + L+
Sbjct: 158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217
Query: 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453
+ +NL +I ++ + + L + H ++ ++S + L +
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQL-VWHTTVW---------YFSISNVKLQGQLDFRD 267
Query: 454 VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQ 513
S +L L + + + F + + + + + +
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 514 VIALQENKLSGNVPEGFSSLMSLRYLNLSFNGF--VGQIPATFSFLRSVVVLSFSGNHIS 571
+ N L+ V E L L L L N + +I + ++S+ L S N +S
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 572 GSIPPEL-GNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCS 630
L L + SN LT I + + VLDL N + IP ++ K
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 631 SLRSLLVNSNHLSGGIPD-SLAKLSNLAVLDLSANNL 666
+L+ L V SN L +PD +L++L + L N
Sbjct: 445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-33
Identities = 82/474 (17%), Positives = 157/474 (33%), Gaps = 59/474 (12%)
Query: 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275
L+ N + + I +L KL+++ ++ N + + S+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL------------DISV---- 64
Query: 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSI-SGKI 334
F L+ LDL N++ L LD+S N+ + I
Sbjct: 65 --FKFNQE------------LEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPI 107
Query: 335 PAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSL-LDLEGNRFSGEIPEFLGDIR--G 391
+ G + +L+ L ++ + + I + + L L E PE L D
Sbjct: 108 CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG------SLPEEVLGMNNLSTLDL 445
L + F + S + + LE N++ S+ ++ LS L L
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227
Query: 446 SENKFSGEVPASIGNL---SQLMVFNLSGNAFSG-----RIPASLGNLLKLTTLDLSKQN 497
+ + + I L + + F++S G S +L L+ +
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557
F N+ + + S + +L+ S N + L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 558 RSVVVLSFSGNHISGSIPPELG---NCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDL 613
+ L N + + L+ L++ NS++ S L L++
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
S N LT I + ++ L ++SN + IP + KL L L++++N L
Sbjct: 407 SSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 94/496 (18%), Positives = 171/496 (34%), Gaps = 59/496 (11%)
Query: 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127
T L + + +S + + +L LR L + N + +VF
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI---------SVFKF----- 67
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF-SGPIPTSISNLSQL 186
LE L+++ N+L +I+ NLK+ DLS N F + PI N+SQL
Sbjct: 68 ---------NQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 187 QLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVS 246
+ + S + A+ + L G G P L S
Sbjct: 118 KFLGLSTTHLEKSSVLPI--------AHLNISKVLLVLGETYGEKEDP--EGLQDFNTES 167
Query: 247 LAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQI 306
L + + ++ + + N + + L +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227
Query: 307 RGAFPLW--------LTRASTLTRLDVSGNSISGKIPAQIG-----GLWRLEELKMANNS 353
W L +T+ +S + G++ + L L ++ ++
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 354 FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
FG + S++++ + + I L + NL + ++ + +L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 414 PGLENLNLRHNSLSGSLPEEV---LGMNNLSTLDLSENKFSGEVPASI-GNLSQLMVFNL 469
LE L L+ N L L + M +L LD+S+N S + L+ N+
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG 529
S N + I L ++ LDL +P ++ L LQ + + N+L +VP+G
Sbjct: 407 SSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462
Query: 530 -FSSLMSLRYLNLSFN 544
F L SL+ + L N
Sbjct: 463 IFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 79/419 (18%), Positives = 155/419 (36%), Gaps = 26/419 (6%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
+L++ QN I + + S L L +S N I + LE L +++N
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 356 GAVPVEIKQCSSLSLLDLEGNRF-SGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414
+ +L LDL N F + I + G++ LK L L+ S +L
Sbjct: 83 -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 415 GLENLNLRHNSLSGSLPEEVL---GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
+ L + + E L +L + + +F + S+ ++ L + N+
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 472 NAFSGRIPASLGNLLKLTT------LDLSKQNFSGELPIEL---AGLPNLQVIALQENKL 522
+ L L KL T L L+ + I + + ++ KL
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 523 SGNVPEG-----FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE 577
G + +SL +L + + F + ++ + +F+ +
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 578 LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT--GEIPDEISKCSSLRSL 635
S L+ +N LT + + HL+ L L L +N L +I + ++ SL+ L
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL 379
Query: 636 LVNSNHLSGGIPDSL-AKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
++ N +S + +L L++S+N L+ I L + ++ SN +++
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKSI 436
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 57/356 (16%), Positives = 115/356 (32%), Gaps = 27/356 (7%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416
VP ++ ++L++ N S + + L+ L ++ N + F+ L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 417 ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF-SGEVPASIGNLSQLMVFNLSGNAFS 475
E L+L HN L + NL LDLS N F + + GN+SQL LS
Sbjct: 72 EYLDLSHNKLV-KISCHPTV--NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN-----VPEGF 530
+ +L L + + + + GL + +L + +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 531 SSLMSLRYLNLSFNGFVGQIPATFSFLRSVVV------LSFSGNHISGSIPPELGNC--- 581
++ +L N+ + S L + L+ + + + +
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSH-----LNVLDLSINNLTGEIPDEISKCSSLRSLL 636
+ + + + L G + S L++ + + S++
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 637 VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA 692
+ +K+S LD S N L+ + N + L + N L+
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 56/293 (19%), Positives = 104/293 (35%), Gaps = 29/293 (9%)
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
++ N L +P+++ + L++S+N S + I +LS+L + +S N
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 479 PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG--FSSLMSL 536
+ +L LDLS N ++ NL+ + L N +P F ++ L
Sbjct: 62 ISVFKFNQELEYLDLS-HNKLVKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 537 RYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG 596
++L LS + L VL G P D L T
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTN 175
Query: 597 HIPTDISHLSHLNVLDLSINNLTG-----------EIPDEISKCSSLRSLLVNSNHLSG- 644
I +S V +L ++N+ I ++ L +L +N+ +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 645 GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQ 697
L + + V S +N+ L +F+ S +L+A + +Q
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVK------LQGQLDFRDFDYSGTSLKALSIHQ 282
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 8e-13
Identities = 50/234 (21%), Positives = 91/234 (38%), Gaps = 20/234 (8%)
Query: 462 SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
S+ +V + S N +P L K T L++S+ S ++ L L+++ + N+
Sbjct: 1 SEFLV-DRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPP--EL 578
+ F L YL+LS N ++ + ++ L S N ++P E
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHN----KLVKISCHPTVNLKHLDLSFNAFD-ALPICKEF 111
Query: 579 GNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
GN S L+ L L + L I+HL+ VL + + E L+
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE-----GLQDFNTE 166
Query: 639 SNHL---SGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
S H+ + + +S V +L +N+ + N S F + + +N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 42/191 (21%), Positives = 68/191 (35%), Gaps = 11/191 (5%)
Query: 517 LQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP 576
+N L +VP+ S LN+S N + L + +L S N I +
Sbjct: 7 RSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI 62
Query: 577 E-LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPD--EISKCSSLR 633
+LE L+L N L I +L LDLS N +P E S L+
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLK 118
Query: 634 SLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
L +++ HL +A L+ VL + + F + ++ + F
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 694 ANNQDLCGKPL 704
D+ K +
Sbjct: 179 HFILDVSVKTV 189
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 34/168 (20%), Positives = 64/168 (38%), Gaps = 9/168 (5%)
Query: 539 LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHI 598
++ S NG + +P S + +L+ S N+IS ++ + S L +L + N + ++
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60
Query: 599 PTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHL-SGGIPDSLAKLSNL 656
+ L LDLS N L +I +L+ L ++ N + I +S L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 657 AVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPL 704
L LS +L ++ + V + + L
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 39/232 (16%), Positives = 77/232 (33%), Gaps = 24/232 (10%)
Query: 58 WRGVACTNNRVTELRLPRL---QLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
+R + + L + ++ S + + + ++ +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLS----GEIANDLPRNLKYFDLSSN 170
+ N L+ + N G+L+ LE L + N+L ++L+ D+S N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384
Query: 171 GFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALG 229
S S L +N S N + + + L N +
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP----------PRIKVLDLHSNKI- 433
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281
IP + L LQ +++A N L VP +F + S++ + L N +
Sbjct: 434 KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRL----TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 586 VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645
+++ N L H+P D+S +L++S N ++ +I S LR L+++ N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 646 IPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
L LDLS N L + L + ++S N
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 39/273 (14%), Positives = 82/273 (30%), Gaps = 52/273 (19%)
Query: 64 TNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQY 123
++ ++L ++L+ L + S+ F + +
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 124 NSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPR--NLKYFDLSSNGFS--GPIPTS 179
+ +S L+ + N L+ + + L+ L N I
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 180 ISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGAL 239
+ + LQ ++ S N S + + SL+ L+ N L I +
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEK-------KGDCSWTKSLLSLNMSSNILTDTIFRCL--P 420
Query: 240 PKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVL 299
P+++V+ L N + +P + LQ L
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVV------------------KLEA------------LQEL 449
Query: 300 DLQQNQI----RGAFPLWLTRASTLTRLDVSGN 328
++ NQ+ G F R ++L ++ + N
Sbjct: 450 NVASNQLKSVPDGIFD----RLTSLQKIWLHTN 478
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 80/421 (19%), Positives = 135/421 (32%), Gaps = 72/421 (17%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSF 354
+ +DL N I +R L L V + I GL L LK+ N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 355 GGAVPVEI-KQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
+ ++L +L L L L+ N F + L
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCN--------------LDGAVLSGNFF--------KPL 128
Query: 414 PGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGN 472
LE L LR N++ P M LDL+ NK + N L
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--- 185
Query: 473 AFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSS 532
L +T D+++ E ++ + L N ++ + F
Sbjct: 186 -----------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 533 LMS---LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLEL 589
++ ++ L LS + +G + + +F G S ++ +L
Sbjct: 235 AIAGTKIQSLILSNSYNMGS-SFGHTNFKDPDNFTFKGLE-----------ASGVKTCDL 282
Query: 590 RSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIP 647
+ + + + SH + L L L+ N + +I D + L L ++ N L
Sbjct: 283 SKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 648 DSLAKLSNLAVLDLSANNLSGEIPA----NLSSIFGLMNFNVSSNNLQ-----AFANNQD 698
L L VLDLS N++ + L + L + +N L+ F
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPN---LKELALDTNQLKSVPDGIFDRLTS 396
Query: 699 L 699
L
Sbjct: 397 L 397
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 92/420 (21%), Positives = 150/420 (35%), Gaps = 73/420 (17%)
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA-TFEG--------- 206
+LP ++ Y DLS N + TS S L LQ + + TF G
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 207 ------TLPSAI-ANCSSLVHLSAQGNAL-GGVIPPAI-GALPKLQVVSLAQNNLSGVVP 257
L + ++L L+ L G V+ L L+++ L NN+ + P
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 258 ASMFCNVSGYPPSIRVVQLGFNAFTNV-AGPETGSCSSVLQVLDLQQNQIRGAFPLWLT- 315
AS F N+ V+ L FN ++ +L L ++ WL
Sbjct: 147 ASFFLNM----RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 316 -------RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSL 368
+ +++T LD+SGN + + +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA-SFRNLPGLENLNLRHNSLS 427
+ D + F G G+K+ L+ + ++ F + LE L L N ++
Sbjct: 260 NFKDPDNFTFKGLEA------SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
Query: 428 GSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLL 486
+ + G+ +L L+LS+N ++ F L
Sbjct: 313 -KIDDNAFWGLTHLLKLNLSQNFLG----------------SIDSRMFEN--------LD 347
Query: 487 KLTTLDLSKQNFSGELPIEL-AGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
KL LDLS N L + GLPNL+ +AL N+L +VP+G F L SL+ + L N
Sbjct: 348 KLEVLDLS-YNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 83/411 (20%), Positives = 138/411 (33%), Gaps = 53/411 (12%)
Query: 56 CDWRGVACTNNRVTEL-RLP----RLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNGT 105
C N + ++ LP + LS I+ S L+ L+ L + +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 106 IPA-TLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPR--- 160
I T + L + L YN L L+NLE+L + L G + L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV---LSGNFF 125
Query: 161 ----NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANC 215
+L+ L N P S N+ + +++ +FNK
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 216 S--SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYP----- 268
S+ LG + + L+ N + F ++G
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 269 ---PSIRVVQLGFNAFTN-VAGPETGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTL 320
G F + G +S ++ DL +++I F T L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF-SHFTD---L 301
Query: 321 TRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEI-KQCSSLSLLDLEGNRF 378
+L ++ N I+ KI GL L +L ++ N G ++ + + L +LDL N
Sbjct: 302 EQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359
Query: 379 SGEIPE--FLGDIRGLKSLTLAANLFSGSIPAS-FRNLPGLENLNLRHNSL 426
+ + FLG + LK L L N S+P F L L+ + L N
Sbjct: 360 R-ALGDQSFLG-LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 559 SVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSIN 616
V + S N I+ + DL+ L++ + I + LS L +L L N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 617 NLTGEIPDEI-SKCSSLRSLLVNSNHLSGGI--PDSLAKLSNLAVLDLSANNLS 667
++ + ++L L + +L G + + L++L +L L NN+
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 37/168 (22%), Positives = 57/168 (33%), Gaps = 26/168 (15%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-SKCSS 631
+P + ++L NS+ T S L L L + I + SS
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 632 LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNL-SGEIPA----NLSSIFGLMNFNVS 686
L L ++ N + L+NL VL L+ NL + L+S L +
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS---LEMLVLR 137
Query: 687 SNNLQ------AFANNQ-----DLCGKPLGRKCENADDRDRRKKLILL 723
NN++ F N + DL + CE + K LL
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 57/243 (23%), Positives = 91/243 (37%), Gaps = 15/243 (6%)
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS--KQ 496
+ + + + + VP I S L N L +LT L LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA--TF 554
+F G G +L+ + L N + + F L L +L+ + Q+ F
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122
Query: 555 SFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLD 612
LR+++ L S H S LEVL++ NS + DI + L +L LD
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 613 LSINNLTGEIPDEISKC-SSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671
LS L ++ SSL+ L ++ N+ L++L VLD S N++
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK 239
Query: 672 ANL 674
Sbjct: 240 KQE 242
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/259 (23%), Positives = 98/259 (37%), Gaps = 30/259 (11%)
Query: 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377
S+ TRL++ N + L +L +L +++N LS
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG--------------LSFKGCCSQS 73
Query: 378 FSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-G 436
G LK L L+ N ++ ++F L LE+L+ +H++L V
Sbjct: 74 DFG--------TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 437 MNNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNAFSGRIPA-SLGNLLKLTTLDLS 494
+ NL LD+S I LS L V ++GN+F L LT LDLS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 495 KQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPAT 553
+ +L L +LQV+ + N + L SL+ L+ S N +
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 554 F-SFLRSVVVLSFSGNHIS 571
F S+ L+ + N +
Sbjct: 243 LQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 50/245 (20%), Positives = 94/245 (38%), Gaps = 20/245 (8%)
Query: 116 LRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLS----GEIANDLPRNLKYFDLSSN 170
+ L+ N L +LP + L+ L L++++N LS ++ +LKY DLS N
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 171 GFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGG 230
G + ++ L QL+ ++F + + + S + +L++L
Sbjct: 89 GVIT-MSSNFLGLEQLEHLDFQHSNLKQ-MSE------FSVFLSLRNLIYLDISHTHTRV 140
Query: 231 VIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG 290
L L+V+ +A N+ +F + ++ + L ++ P
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL----RNLTFLDLSQCQLEQLS-PTAF 195
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWR-LEELKM 349
+ S LQVL++ N ++L LD S N I ++ L L +
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 350 ANNSF 354
N F
Sbjct: 256 TQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 34/286 (11%)
Query: 56 CDWRGVACTNNRVTEL--RLP----RLQLSG-RIS----DHLSNLRMLRKLSLRSN--SF 102
C + C + +T + +P RL+L ++ L L KLSL SN SF
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 103 NGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDL---P 159
G + T L+ + L +N + + +N L LE L+ + L +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219
RNL Y D+S + LS L+++ + N F P +L
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-------PDIFTELRNLT 178
Query: 220 HLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFN 279
L L + P A +L LQV++++ NN + + + S++V+ N
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCL----NSLQVLDYSLN 233
Query: 280 AFTNVAGPETGSCSSVLQVLDLQQNQIR-----GAFPLWLTRASTL 320
E S L L+L QN +F W+ L
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL 279
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 9/176 (5%)
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS--GSIPPELGNCSD 583
VP G S S L L N F L + LS S N +S G +
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE--ISKCSSLRSLLVNSNH 641
L+ L+L N + + ++ L L LD +NL ++ + +L L ++ H
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTH 137
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQAFANN 696
LS+L VL ++ N+ + + + L ++S L+ +
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 43/310 (13%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
+LLDL+ N+ + +++ L +L L N S P +F L LE L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
L LPE++ L L + EN+ + + L+Q++V L N
Sbjct: 112 LK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN------------- 155
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG 545
L + + F G+ L I + + ++ +P+G SL L+L N
Sbjct: 156 -PLKSSGIENGAFQ--------GMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNK 203
Query: 546 FVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDIS 603
++ A + L ++ L S N IS ++ L N L L L +N L +P ++
Sbjct: 204 I-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 604 HLSHLNVLDLSINNLTGEIPDE-------ISKCSSLRSLLVNSNHLSGGI--PDSLAKLS 654
++ V+ L NN++ I +K +S + + SN + P + +
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 655 NLAVLDLSAN 664
A + L
Sbjct: 320 VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 17/262 (6%)
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L + L +P+++ + + LDL NK + NL L L N S
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLM 534
P + L+KL L LSK ELP ++ LQ + + EN+++ V + F+ L
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 535 SLRYLNLSFNGF-VGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
+ + L N I F ++ + + + +I+ +IP L L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 593 SLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLA 651
+T + L++L L LS N+++ ++ LR L +N+N L +P LA
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 260
Query: 652 KLSNLAVLDLSANNLSGEIPAN 673
+ V+ L NN+S I +N
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 65/326 (19%), Positives = 114/326 (34%), Gaps = 42/326 (12%)
Query: 139 NLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSR 198
+L ++ + L ++ DLP + DL +N + NL L + NK S+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 199 EVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPA 258
P F L L N L +P LQ + + +N ++ V
Sbjct: 91 ISPGAFAPL--------VKLERLYLSKNQL-KELPE--KMPKTLQELRVHENEIT-KVRK 138
Query: 259 SMFCNVSGYPPSIRVVQLGFNAFTNVA-GPETGSCSSVLQVLDLQQNQIR----GAFPLW 313
S+F + + VV+LG N + L + + I G P
Sbjct: 139 SVFNGL----NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP-- 192
Query: 314 LTRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLD 372
+LT L + GN I+ K+ A GL L +L ++ NS + L L
Sbjct: 193 -----SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 373 LEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS-------FRNLPGLENLNLRHNS 425
L N+ ++P L D + ++ + L N S +I ++ ++L N
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNP 304
Query: 426 LS-GSLPEEVL-GMNNLSTLDLSENK 449
+ + + + + L K
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 18/221 (8%)
Query: 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFV 547
LDL + + L NL + L NK+S P F+ L+ L L LS N
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 548 GQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLT-GHIPTDI-S 603
++P L+ L N I+ + + + V+EL +N L I
Sbjct: 114 -ELPEKMPKTLQE---LRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 604 HLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSA 663
+ L+ + ++ N+T IP + SL L ++ N ++ SL L+NLA L LS
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 664 NNLSGEIPAN-LSSIFGLMNFNVSSNNLQ----AFANNQDL 699
N++S + L++ L ++++N L A+++ +
Sbjct: 226 NSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 265
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 63/321 (19%), Positives = 115/321 (35%), Gaps = 46/321 (14%)
Query: 56 CDWRGVACTNNRVTEL--RLP----RLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNG 104
C R V C++ + ++ LP L L +I+ NL+ L L L +N +
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 105 TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP---RN 161
P A L ++L N L LP + L+ L V N ++ ++ +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 162 LKYFDLSSNGF-SGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219
+ +L +N S I + +L I + + SL
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP-----------PSLT 195
Query: 220 HLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFN 279
L GN + V ++ L L + L+ N++S V N P +R + L N
Sbjct: 196 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANT----PHLRELHLNNN 250
Query: 280 AFTNVAGPETGSCSSVLQVLDLQQNQIR----GAF--PLWLTRASTLTRLDVSGNSIS-G 332
V P + +QV+ L N I F P + T+ ++ + + + N +
Sbjct: 251 KLVKV--PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308
Query: 333 KIPAQI-GGLWRLEELKMANN 352
+I ++ +++ N
Sbjct: 309 EIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 580 NCS-DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
C L V++ L +P D+ +LDL N +T + +L +L++
Sbjct: 28 RCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+N +S P + A L L L LS N L E+P + L V N + +
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKS 139
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 29/137 (21%), Positives = 48/137 (35%), Gaps = 11/137 (8%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
TEL L +++ + L L L KL L NS + +LA LR + L N L
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 129 NLPANIGNLSNLEILNVAANRLS--------GEIANDLPRNLKYFDLSSNGFS-GPIPTS 179
+P + + ++++ + N +S N + L SN I S
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 180 I-SNLSQLQLINFSFNK 195
+ + K
Sbjct: 314 TFRCVYVRAAVQLGNYK 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 60/275 (21%), Positives = 101/275 (36%), Gaps = 26/275 (9%)
Query: 405 SIPASFRNLP-GLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLS 462
++P + + L+L++N +S L ++ G+ +L L L NK S + L
Sbjct: 47 AVP---KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLR 102
Query: 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKL 522
+L +S N IP +L L L + +GL N+ I + N L
Sbjct: 103 KLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159
Query: 523 -SGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGN 580
+ G + L YL +S G L L N I +I E L
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE---LHLDHNKIQ-AIELEDLLR 215
Query: 581 CSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNS 639
S L L L N + I S L L L L N L+ +P + L+ + +++
Sbjct: 216 YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 640 NHLSGGIPDS-------LAKLSNLAVLDLSANNLS 667
N+++ + + K + + L N +
Sbjct: 274 NNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 64/320 (20%), Positives = 113/320 (35%), Gaps = 48/320 (15%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEF-LGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
AVP EI +LLDL+ N S E+ + ++ L +L L N S +F L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF- 474
L+ L + N L +P + ++L L + +N+ L + + GN
Sbjct: 104 LQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSL 533
+ + LKL L +S+ + +P +L L + L NK+ +
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRY 216
Query: 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
L L L N +R + S S L L L +N
Sbjct: 217 SKLYRLGLGHNQ-----------IRMIENGSLS-------------FLPTLRELHLDNNK 252
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-------SKCSSLRSLLVNSNHLSGGI 646
L+ +P + L L V+ L NN+T ++ K + + + +N +
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 647 --PDSLAKLSNLAVLDLSAN 664
P + +++ +
Sbjct: 311 VQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 23/281 (8%)
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L + L ++P+E+ + + LDL N S L L L N S
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLM 534
+ L KL L +SK + E+P L +L + + +N++ VP+G FS L
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 535 SLRYLNLSFN--GFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
++ + + N G P F L + L S ++ IP +L L L L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 593 SLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSL 650
+ I + S L L L N + I + S +LR L +++N LS +P L
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGL 260
Query: 651 AKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
L L V+ L NN++ ++ N F + F V
Sbjct: 261 PDLKLLQVVYLHTNNIT-KVGVN---DFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 52/325 (16%), Positives = 104/325 (32%), Gaps = 41/325 (12%)
Query: 139 NLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSR 198
+L ++ + L + ++ + DL +N S L L + NK S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91
Query: 199 EVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPA 258
++ A + L L N L IPP L + + N + VP
Sbjct: 92 KIH-------EKAFSPLRKLQKLYISKNHL-VEIPP--NLPSSLVELRIHDNRIR-KVPK 140
Query: 259 SMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFPLWL 314
+F + ++ +++G N N L L + + ++
Sbjct: 141 GVFSGL----RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---- 192
Query: 315 TRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373
TL L + N I I + +L L + +N + +L L L
Sbjct: 193 ---ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS-------FRNLPGLENLNLRHNSL 426
+ N+ S +P L D++ L+ + L N + + + ++L +N +
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
Query: 427 S-GSLPEEV-LGMNNLSTLDLSENK 449
+ + + + K
Sbjct: 307 PYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 65/294 (22%), Positives = 101/294 (34%), Gaps = 45/294 (15%)
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
S + +P L++L + S P +L + S+ VP I
Sbjct: 4 ASGAETTSGIPDLDSLPP---TYSAMCPFGCH--CHLRVVQCSDLGLK-AVPKEI----- 52
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
T LDL + S + GL +L + L NK+S
Sbjct: 53 ---------------SPDT------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNC 581
+ FS L L+ L +S N V +IP S L L N I +P
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVE---LRIHDNRIR-KVPKGVFSGL 146
Query: 582 SDLEVLELRSNSLT-GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
++ +E+ N L LN L +S LT IP ++ +L L ++ N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHN 203
Query: 641 HLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQAF 693
+ + L + S L L L N + I LS + L ++ +N L
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRV 256
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 55/309 (17%), Positives = 91/309 (29%), Gaps = 69/309 (22%)
Query: 56 CDWRGVACTNNRVTEL--RLP----RLQLSG-RIS----DHLSNLRMLRKLSLRSNSFNG 104
C R V C++ + + + L L IS D L+ L L L +N +
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 105 TIPATLAQCTLLRAVFLQYN---SLSGNLPANI------------------GNLSNLEIL 143
+ L+ +++ N + NLP+++ L N+ +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 144 NVAANRLSG------------------------EIANDLPRNLKYFDLSSNGFSGPIPTS 179
+ N L I DLP L L N
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELED 212
Query: 180 ISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGAL 239
+ S+L + N+ + + +L L N L +P + L
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSL--------SFLPTLRELHLDNNKL-SRVPAGLPDL 263
Query: 240 PKLQVVSLAQNNLSGVVPASMFCNVSGYP--PSIRVVQLGFNAFTNVA-GPETGSCSSVL 296
LQVV L NN++ V + FC V + L N P T C +
Sbjct: 264 KLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322
Query: 297 QVLDLQQNQ 305
+ +
Sbjct: 323 LAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 12/139 (8%)
Query: 564 SFSGNHISGSIPPELG-----NCS-DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617
+ SG S+PP C L V++ L +P +IS +LDL N+
Sbjct: 9 TTSGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNND 65
Query: 618 LTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSI 677
++ D+ L +L++ +N +S + + L L L +S N+L EIP NL S
Sbjct: 66 ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS- 123
Query: 678 FGLMNFNVSSNNLQAFANN 696
L+ + N ++
Sbjct: 124 -SLVELRIHDNRIRKVPKG 141
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 40/359 (11%), Positives = 81/359 (22%), Gaps = 57/359 (15%)
Query: 750 RRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEEN 809
+R +E ++ + ++ + V + + R+
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTV-------DSLLSQGERKLKLVE 68
Query: 810 VLSRTRYGLVFKA-CYNDGM-----VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
L +VF V ++ S E L + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL-HEATFAAARLLGESPEEA 127
Query: 864 RGYYAGAPDLRLL----------------------VYDYMP--NGNLGTLLQEASH--QD 897
R + MP + +L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 898 GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957
H++ + R A L + +VHG P N+ D L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----- 242
Query: 958 PAEASTSTTAVGTLGYVSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
+ + + Y E T + + G+ + + P F
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+K K+ P + + L D R + +
Sbjct: 300 IKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGR----FLN--FDRRRRLLPLEAM 351
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 38/290 (13%)
Query: 393 KSLTLAANLFSGSIPASFRNLPG----LENLNL---RHNSLSGSLPEEVLGMNNLSTLDL 445
+ +L+ N F +I ++ + E L N L E ++ N S L L
Sbjct: 9 NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQL 66
Query: 446 SENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE 505
+ S +P ++ Q+ V ++ NA +P +L LD S LP
Sbjct: 67 NRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPEL 118
Query: 506 LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565
A L +L + N+L+ +PE L Y+N N +P + L LS
Sbjct: 119 PASLKHLD---VDNNQLT-MLPE---LPALLEYINADNNQLT-MLPELPTSLEV---LSV 167
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHL----NVLDLSINNLTGE 621
N ++ +P + LE L++ +N L +P H N +T
Sbjct: 168 RNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-H 221
Query: 622 IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671
IP+ I ++++ N LS I +SL++ + S
Sbjct: 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-28
Identities = 60/348 (17%), Positives = 111/348 (31%), Gaps = 52/348 (14%)
Query: 323 LDVSGNSISGKIPAQIGGLW-RLEELKMANNSFGGAVPVEIKQC--SSLSLLDLEGNRFS 379
+ N+IS A W + E+ + + AV +K+C + S L L S
Sbjct: 15 QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVS-LLKECLINQFSELQLNRLNLS 72
Query: 380 GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNN 439
+P+ L + L + N S+P +L E L+ N LS +LPE +
Sbjct: 73 -SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPEL---PAS 121
Query: 440 LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499
L LD+ N+ + +P L + N N + +P +L L + N
Sbjct: 122 LKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTSL---EVLSVR-NNQL 172
Query: 500 GELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRS 559
LP +L+ + + N L ++P +
Sbjct: 173 TFLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEI------------------ 210
Query: 560 VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619
N I+ IP + + + L N L+ I +S + +
Sbjct: 211 --FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 620 GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
+ + L + ++++ + + AN S
Sbjct: 268 MSDGQQNTLHRPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-26
Identities = 59/268 (22%), Positives = 107/268 (39%), Gaps = 36/268 (13%)
Query: 435 LGMNNLSTL--DLSENKFSG---EVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLT 489
L +NN +L + N SG + ++ + + + N + L + + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 490 TLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQ 549
L L++ N S LP L P + V+ + +N L ++PE +SL YL+ N
Sbjct: 63 ELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-T 114
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609
+P + L+ L N ++ +P LE + +N LT +P + L
Sbjct: 115 LPELPASLKH---LDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSLE--- 163
Query: 610 VLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNL----AVLDLSANN 665
VL + N LT +P+ SL +L V++N L +P + + N
Sbjct: 164 VLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 666 LSGEIPANLSSIFGLMNFNVSSNNLQAF 693
++ IP N+ S+ + N L +
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSR 245
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-26
Identities = 59/380 (15%), Positives = 110/380 (28%), Gaps = 59/380 (15%)
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
+ N I G + + + + + G + N
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENR--------------------NE-----A 49
Query: 359 PVEIKQC--SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416
+K+C + S L L S +P+ L + L + N S+P + L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---L 102
Query: 417 ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSG 476
E L+ N LS +LPE +L LD+ N+ + +P L + N N +
Sbjct: 103 EYLDACDNRLS-TLPEL---PASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT- 153
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536
+P + L L + N LP +L+ + + N L ++P
Sbjct: 154 MLPELPTS---LEVLSVR-NNQLTFLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 537 R----YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
+ N IP L + N +S I L +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 593 SLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAK 652
+ + H + D ++S+ ++N S D L+
Sbjct: 265 YFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSD 321
Query: 653 LSNLAVLDLSANNLSGEIPA 672
+ ++ +
Sbjct: 322 TVSARNTSGFREQVAAWLEK 341
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-21
Identities = 77/428 (17%), Positives = 132/428 (30%), Gaps = 58/428 (13%)
Query: 121 LQYNSLSG---NLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIP 177
YN++SG + + + N + L L+ S +P
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LP 75
Query: 178 TSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIG 237
++ Q+ ++ + N +LP A+ L +L A N L +P
Sbjct: 76 DNL--PPQITVLEITQNALI---------SLPELPAS---LEYLDACDNRL-STLPELPA 120
Query: 238 ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQ 297
+L L + N L+ ++P P + + N T + PE +S L+
Sbjct: 121 SLKHLD---VDNNQLT-MLPEL--------PALLEYINADNNQLTML--PE--LPTS-LE 163
Query: 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE----LKMANNS 353
VL ++ NQ+ P L LDVS N + +PA EE + N
Sbjct: 164 VLSVRNNQLT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENR 218
Query: 354 FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
+P I + LE N S I E L T + I S +
Sbjct: 219 I-THIPENILSLDPTCTIILEDNPLSSRIRESLSQ------QTAQPDYHGPRIYFSMSDG 271
Query: 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473
++++ PE + + + A + LS + +
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTS-G 330
Query: 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-----LAGLPNLQVIALQENKLSGNVPE 528
F ++ A L L L + + NL+ L G
Sbjct: 331 FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDN 390
Query: 529 GFSSLMSL 536
+L+SL
Sbjct: 391 DTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 27/164 (16%), Positives = 50/164 (30%), Gaps = 12/164 (7%)
Query: 49 SSTPAAPCDWRGVACTNNRVTEL-----RLPRLQLSG-RISDHLSNLRMLRKLSLRSNSF 102
+ P P + NN++T L L L + +++ L L + +N
Sbjct: 133 TMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLL 192
Query: 103 NGTIPATLAQCTLLRAVFLQYNSLSGN----LPANIGNLSNLEILNVAANRLSGEIANDL 158
++PA + + + N +P NI +L + + N LS I L
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFR-CRENRITHIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 159 PRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA 202
+ D + N L + F +
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV 968
+ + L F H + ++H D+KP N++ A + DFG+ R + + + +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028
GT Y+SPE A SDVYS G VL E+LTG+ P FT D + + +
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQ------HV 232
Query: 1029 TELLEPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVFMLEGCRV 1082
E P S++ + V L A +P +R +D+V + G
Sbjct: 233 REDPIP-PSARHEGLSADLDA------VVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285
Query: 1083 G-PDIPSSADPTTQPSPA 1099
P + + A+ T+ S A
Sbjct: 286 EAPKVLTDAERTSLLSSA 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/263 (22%), Positives = 100/263 (38%), Gaps = 41/263 (15%)
Query: 845 FRKEAEFLGKVRHRNL-TVLRGYYAG-APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLN 902
F +E ++ H+N+ ++ D LV +Y+ L ++ L+
Sbjct: 58 FEREVHNSSQLSHQNIVSM---IDVDEEDDCYYLVMEYIEGPTLSEYIES-----HGPLS 109
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ G+ H +VH DIKPQN+L D++ + DFG+ + A +
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK------ALSE 163
Query: 963 TSTTA----VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKW 1018
TS T +GT+ Y SPE A T + +D+YS GIVL E+L G+ P F + +
Sbjct: 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP--FNGETAVSIA 221
Query: 1019 VKKQLQKGQITELLEPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPT-----MSD 1072
+K I + + ++ + V L T D +R D
Sbjct: 222 IK------HIQDSVPNVTTDVRKDIPQSLSN------VILRATEKDKANRYKTIQEMKDD 269
Query: 1073 IVFMLEGCRVG-PDIPSSADPTT 1094
+ +L R T
Sbjct: 270 LSSVLHENRANEDVYELDKMKTI 292
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G V+ YN ++++ L GS+ + F EA + +++H+ L L P
Sbjct: 26 FGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP--IY 83
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
++ +YM NG+L L+ G L +A +A G+AF+ N +H D++ N+
Sbjct: 84 IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALTGETTKESD 989
L ++DFGL RL A TA PEA G T +SD
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA--------PEAINYGTFTIKSD 192
Query: 990 VYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
V+SFGI+L E++T G+ P M + V + L++G + P++
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERG---YRMVR------PDNCPE 237
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
E + ++ LC P DRPT + +LE D ++ + QP P
Sbjct: 238 ELY----QLMRLCWKERPEDRPTFDYLRSVLE------DFFTATEGQYQPQP 279
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 59/260 (22%), Positives = 99/260 (38%), Gaps = 40/260 (15%)
Query: 845 FRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLN 902
++EA G+++ ++ + + G D +L + + +L +L+
Sbjct: 81 MQREARTAGRLQEPHVVPI---HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA----- 132
Query: 903 WPMRHL-IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
P R + I + L H + H D+KP+N+L AD A+L DFG+ A
Sbjct: 133 -PPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS------ATT 185
Query: 962 STSTT----AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
T VGTL Y++PE T +D+Y+ VL E LTG P + D+ V
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP--YQGDQLSV- 242
Query: 1018 WVKKQLQKGQITELLEPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDR-PTMSDIVF 1075
+ + + I P + P ++ V A +P DR T D+
Sbjct: 243 -MGAHINQ-AI-----PRPSTVRPGIPVAFDA------VIARGMAKNPEDRYVTCGDLSA 289
Query: 1076 MLEGCRVGPDIPSSADPTTQ 1095
D + D +
Sbjct: 290 AAHAALATADQDRATDILRR 309
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 41/274 (14%)
Query: 816 YGLVFKACYNDGMVL-SIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
+G VF L +++ + + F +EA L + H N+ L G
Sbjct: 127 FGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKP 932
+ +V + + G+ T L+ +G L + A G+ +L + +H D+
Sbjct: 187 I-YIVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SPEAALTGETTKE 987
+N L +SDFG+ R EA A G L V +PEA G + E
Sbjct: 242 RNCLVTEKNVLKISDFGMSRE------EADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 988 SDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044
SDV+SFGI+L E + G P + Q ++ ++KG L PE
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKG---GRLPC------PELC 340
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
F ++ C A +P RP+ S I L+
Sbjct: 341 PDAVF----RLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 58/299 (19%), Positives = 108/299 (36%), Gaps = 49/299 (16%)
Query: 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL 860
F+E VL + +G V KA D +I+++ + E L + H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 861 TVLRGYYAGAPDLRL------------LVYDYMPNGNLGTLLQEASHQD--GHVLNWPMR 906
+ + + +Y NG L L+ + R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-FR 123
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS-- 964
++ L+++H+ ++H D+KP N+ D + DFGL + +
Sbjct: 124 QIL-----EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 965 ---------TTAVGTLGYVSPE-AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
T+A+GT YV+ E TG ++ D+YS GI+ E++ T E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTGMER 234
Query: 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + K+L+ I P + D + ++ + L+ DP RP +
Sbjct: 235 VN--ILKKLRSVSIE---FPPDFD-DNKMKVEKKIIR----LLID--HDPNKRPGARTL 281
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 84/296 (28%), Positives = 130/296 (43%), Gaps = 43/296 (14%)
Query: 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
E L + +G V+ +N ++I+ L G++ F +EA+ + K+RH L L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
+ P +V +YM G+L L+ + G L P +A +A G+A++ N VH
Sbjct: 249 SEEP--IYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALT 981
D++ N+L + ++DFGL RL A TA PEAAL
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA--------PEAALY 355
Query: 982 GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
G T +SDV+SFGI+L EL T G+ P + + V Q+++G + P
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYR--MPCP---PEC 406
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQP 1096
PES + C +P +RPT + LE D +S +P QP
Sbjct: 407 PESL--------HDLMCQCWRKEPEERPTFEYLQAFLE------DYFTSTEPQYQP 448
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 60/308 (19%), Positives = 115/308 (37%), Gaps = 28/308 (9%)
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH 423
C + + IP L + +KSL L+ N + + + L+ L L
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 424 NSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNAFSGRIPAS 481
N ++ ++ E+ + +L LDLS N S + +S LS L NL GN + S
Sbjct: 86 NGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143
Query: 482 L-GNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYL 539
L +L KL L + + ++ + AGL L+ + + + L P+ S+ ++ +L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 540 NLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIP 599
L + + SV L + + L+
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGET 247
Query: 600 TDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDS-LAKLSNLAV 658
+ + ++ +L ++ +++ S L L + N L +PD +L++L
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQK 305
Query: 659 LDLSANNL 666
+ L N
Sbjct: 306 IWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 55/277 (19%), Positives = 104/277 (37%), Gaps = 21/277 (7%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA-SFRNLPG 415
++P + ++ LDL NR + L L++L L +N + +I SF +L
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 416 LENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNA 473
LE+L+L +N LS +L +++L+ L+L N + S+ +L++L + +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 474 FSGRIPA-SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FS 531
+I L L L++ + P L + N+ + L + + E
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 532 SLMSLRYLNLSFNGFVG----QIPA----TFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583
S+ L L ++ + + + + + + L S
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 584 LEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLT 619
L LE N L +P I L+ L + L N
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 61/307 (19%), Positives = 105/307 (34%), Gaps = 60/307 (19%)
Query: 405 SIPASFRNLP-GLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLS 462
SIP+ L +++L+L +N ++ + L NL L L+ N +
Sbjct: 45 SIPS---GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN----------- 89
Query: 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-AGLPNLQVIALQENK 521
+ ++FS L L LDLS N+ L L +L + L N
Sbjct: 90 -----TIEEDSFSS--------LGSLEHLDLS-YNYLSNLSSSWFKPLSSLTFLNLLGNP 135
Query: 522 LSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-L 578
FS L L+ L + +I F+ L + L + + S P+ L
Sbjct: 136 YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSL 194
Query: 579 GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637
+ ++ L L + S + L+L +L
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT----------------F 237
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ-----A 692
+ + LS G +SL K + ++ +L ++ L+ I GL+ S N L+
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGI 296
Query: 693 FANNQDL 699
F L
Sbjct: 297 FDRLTSL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 57/348 (16%), Positives = 118/348 (33%), Gaps = 60/348 (17%)
Query: 203 TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFC 262
+ E + A +C +L IP + ++ + L+ N ++ + S
Sbjct: 18 SKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQ 73
Query: 263 NVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV--LQVLDLQQNQIRGAFPLWLTRASTL 320
+++ + L N + E S SS+ L+ LDL N + W S+L
Sbjct: 74 RC----VNLQALVLTSNGINTI---EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSL 126
Query: 321 TRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEI-KQCSSLSLLDLEGNRF 378
T L++ GN + L +L+ L++ N + + + L L+++ +
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 379 SGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GM 437
P S +++ + +L L L E +
Sbjct: 187 Q-SYE-----------------------PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221
Query: 438 NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN 497
+++ L+L + + S SL + ++ ++
Sbjct: 222 SSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
++ L + L + N+L +VP+G F L SL+ + L N
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 43/303 (14%), Positives = 93/303 (30%), Gaps = 47/303 (15%)
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
L +K DLS+N + + + LQ + + N + + + ++
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE-------EDSFSSLG 100
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMF-------CNVSGYPP 269
SL HL N L + L L ++L N + S+F G
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 270 SIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS 329
+ +Q F + L+ L++ + ++ P L ++ L +
Sbjct: 161 TFTKIQRK--DFAGLTF---------LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 330 ISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGD 388
+ +E L++ + + +L + L
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDT-----------DLDTFHFSELSTGETNS-----LIK 252
Query: 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSE 447
+++ + + + GL L N L S+P+ + + +L + L
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310
Query: 448 NKF 450
N +
Sbjct: 311 NPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 50/276 (18%), Positives = 106/276 (38%), Gaps = 29/276 (10%)
Query: 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRL 150
++ L L +N + L +C L+A+ L N ++ + + +L +LE L+++ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 151 SGEIANDLPR-------NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPA 202
S +L +L + +L N + TS+ S+L++LQ++ ++
Sbjct: 113 S-----NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ- 166
Query: 203 TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFC 262
A + L L + L P ++ ++ + + L ++
Sbjct: 167 ------RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 263 NVSG-YPPSIRVVQLGFNAFTNVAGPETGSCS--SVLQVLDLQQNQIRGAFPLWLTRAST 319
S +R L F+ ++ ET S + + + + L + S
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 320 LTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSF 354
L L+ S N + +P I L L+++ + N +
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 47/275 (17%), Positives = 97/275 (35%), Gaps = 31/275 (11%)
Query: 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPA-TLAQCTLLRAVFLQYNSL 126
V L L +++ + L L+ L L SN N TI + + L + L YN L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 127 SGNLPANI-GNLSNLEILNVAANRLS---GEIANDLPRNLKYFDLSSNGFSGPIPTSI-S 181
S NL ++ LS+L LN+ N L+ + + I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
L+ L+ + + + P ++ + ++ HL ++ +
Sbjct: 172 GLTFLEELEIDASDL-QSYE-------PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 242 LQVVSLAQNNLSGV----VPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQ 297
++ + L +L + ++ + R V++ + V + + S L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKK-FTFRNVKITDESLFQV--MKLLNQISGLL 280
Query: 298 VLDLQQNQI----RGAFPLWLTRASTLTRLDVSGN 328
L+ +NQ+ G F ++L ++ + N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRL----TSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 24/168 (14%), Positives = 45/168 (26%), Gaps = 25/168 (14%)
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILN 144
+ L L +L + ++ P +L + + L L S++E L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 145 VAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATF 204
+ L ++L S+ + + +
Sbjct: 229 LRDTDLDTFHFSELSTGE--------------TNSLIKKFTFRNVKITDESLF------- 267
Query: 205 EGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNL 252
+ + S L+ L N L V L LQ + L N
Sbjct: 268 --QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 59/257 (22%), Positives = 93/257 (36%), Gaps = 33/257 (12%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
++ LL+L N+ +R L+ L L+ N +F L L L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 426 LSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGN 484
L+ ++P ++ L L L N ++ AF+
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE----------------SIPSYAFNR-------- 158
Query: 485 LLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
+ L LDL + + GL NL+ + L L +P + L+ L L+LS
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSG 216
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI 602
N P +F L + L + I I N L + L N+LT +P D+
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 603 -SHLSHLNVLDLSINNL 618
+ L HL + L N
Sbjct: 275 FTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 64/259 (24%), Positives = 102/259 (39%), Gaps = 14/259 (5%)
Query: 438 NNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
N S + EVP I N L NL N S +L L L LS+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRLL---NLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFS 555
+ GL NL + L +N+L+ +P G F L L+ L L N F+
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 556 FLRSVVVLSFSG-NHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613
+ S+ L +S I S+L L L +L IP ++ L L+ LDL
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214
Query: 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN 673
S N+L+ P L+ L + + + ++ L +L ++L+ NNL+ +P +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
Query: 674 -LSSIFGLMNFNVSSNNLQ 691
+ + L ++ N
Sbjct: 274 LFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 59/307 (19%), Positives = 106/307 (34%), Gaps = 76/307 (24%)
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
L E+ + + N + +L N S +L L+++ S N F G
Sbjct: 53 KNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNG- 110
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
++L L N L + A L KL+ + L N + +P+ F +
Sbjct: 111 -------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS- 161
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQ-NQIR----GAFPLWLTRASTLTR 322
L+ LDL + ++ GAF S L
Sbjct: 162 ----------------------------LRRLDLGELKRLSYISEGAF----EGLSNLRY 189
Query: 323 LDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEI 382
L+++ ++ +IP + L +L+EL ++ N P + L L + ++ I
Sbjct: 190 LNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VI 246
Query: 383 PEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLS 441
+F NL L +NL HN+L+ LP ++ +++L
Sbjct: 247 E-----------------------RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282
Query: 442 TLDLSEN 448
+ L N
Sbjct: 283 RIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 53/267 (19%), Positives = 87/267 (32%), Gaps = 36/267 (13%)
Query: 56 CDWRG--VACTNNR-----------VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSF 102
C + V C L L Q+ + +LR L L L N
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 103 NGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPR- 160
L + L N L+ +P LS L+ L + N + I +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 161 --NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSS 217
+L+ DL I LS L+ +N + E+P +
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP---------NLTPLIK 208
Query: 218 LVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLG 277
L L GN L + P + L LQ + + Q+ + V+ + F N+ S+ + L
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNL----QSLVEINLA 263
Query: 278 FNAFTNVAGPETGSCSSVLQVLDLQQN 304
N T + + + L+ + L N
Sbjct: 264 HNNLTLLP-HDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 51/250 (20%), Positives = 94/250 (37%), Gaps = 35/250 (14%)
Query: 116 LRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIA----NDLPRNLKYFDLSSN 170
R + L N + + N +L +LEIL ++ N + I N L NL +L N
Sbjct: 66 TRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLA-NLNTLELFDN 122
Query: 171 GFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLS-AQGNALG 229
+ + LS+L+ + N F SL L + L
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR--------IPSLRRLDLGELKRLS 174
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPET 289
+ A L L+ ++LA NL + + + + L N + + P +
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLREI---PNLTPL----IKLDELDLSGNHLSAI-RPGS 226
Query: 290 GSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRL 344
LQ L + Q+QI+ AF +L ++++ N+++ +P + L L
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAF----DNLQSLVEINLAHNNLT-LLPHDLFTPLHHL 281
Query: 345 EELKMANNSF 354
E + + +N +
Sbjct: 282 ERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 46/245 (18%), Positives = 84/245 (34%), Gaps = 49/245 (20%)
Query: 65 NNRVTEL------RLPRLQ---LSG-----RISDH-LSNLRMLRKLSLRSNSFNGTIPAT 109
NN + + R+P L+ L IS+ L LR L+L + IP
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-N 202
Query: 110 LAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIA----NDLPRNLKY 164
L L + L N LS + L +L+ L + +++ I ++L +L
Sbjct: 203 LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQ-SLVE 259
Query: 165 FDLSSNGFSGPIPTSISNLSQLQLINFSFNKFS--------REVPATFEGTLPSAIANCS 216
+L+ N + + L L+ I+ N ++ + + A C+
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKDMAPSNTACCARCN 319
Query: 217 SLVHLSAQGNALGGV-------IPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPP 269
+ +L +G +G + P I P V+ A + C S
Sbjct: 320 TPPNL--KGRYIGELDQNYFTCYAPVIVEPPADLNVTEGMA-------AELKCRASTSLT 370
Query: 270 SIRVV 274
S+ +
Sbjct: 371 SVSWI 375
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
E L ++G V+ A YN ++++ + GS+ F EA + ++H L L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
P ++ ++M G+L L+ +G P + +A G+AF+ N +H
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGET 984
D++ N+L A ++DFGL R+ E + T G + +PEA G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 985 TKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
T +SDV+SFGI+L+E++T G+ P M + V + L++G + P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERG---YRMPR------P 407
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E+ E + + + C P +RPT I +L+
Sbjct: 408 ENCPEELY----NIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 98/520 (18%), Positives = 165/520 (31%), Gaps = 71/520 (13%)
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI-ANC 215
DLP K LS N S IS LS+L+++ S N+ +L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR---------SLDFHVFLFN 99
Query: 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275
L +L N L I + L+ + L+ N+ + F N
Sbjct: 100 QDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGN------------ 144
Query: 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTR-LDVSGNSISGKI 334
T L L L + R L + LD+ I G
Sbjct: 145 -----LTK------------LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGE 187
Query: 335 PAQIGGL--WRLEELKMANNSFGGAVPVEIKQCSSLSL--LDLEGNRFSGEIPEFLGDIR 390
+ L + N+ F V + + L L + L + R
Sbjct: 188 TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 391 GLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450
G L + + S + + + N+ L ++E
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY--------------LNIYNLTITERID 293
Query: 451 SGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLP 510
E S L LM+ ++ F A ++ LS + +
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 511 NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHI 570
+ + +N + +V +G S+L L+ L L NG +++ L +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412
Query: 571 ----SGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI 626
S + + VL L SN LTG + + + VLDL N + IP ++
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDV 469
Query: 627 SKCSSLRSLLVNSNHLSGGIPD-SLAKLSNLAVLDLSANN 665
+ +L+ L V SN L +PD +L++L + L N
Sbjct: 470 THLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 85/446 (19%), Positives = 150/446 (33%), Gaps = 52/446 (11%)
Query: 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSV--LQVLDLQQNQIR----GAF-------P 311
PP + + L N+ + + S + L+VL L N+IR F
Sbjct: 48 KDLPPRTKALSLSQNSISEL---RMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104
Query: 312 LWLT----------RASTLTRLDVSGNSI-SGKIPAQIGGLWRLEELKMANNSFGGAVPV 360
L ++ ++L LD+S N + + G L +L L ++ F +
Sbjct: 105 LDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 361 EIKQCS-SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN---LFSGSIPASFRNLPGL 416
+ S LLDL G E L L L + LFS + S L L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 417 ENLNLRHNSLSG----SLPEEVLGMNNLSTLDLSENKFSGEVPASIGNL---SQLMVFNL 469
+ N++ N + + E+ L + L + + + + + N+
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 470 SGNAFSGRIP-----ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
+ RI S L L + Q F + + + L +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDL 584
S S +LN + N F + S L+ + L N + + ++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 585 EVLELRSNSLTGHIPTDISHL----SHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
LE SL + VL+LS N LTG + + ++ L +++N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNN 460
Query: 641 HLSGGIPDSLAKLSNLAVLDLSANNL 666
+ IP + L L L++++N L
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 91/496 (18%), Positives = 177/496 (35%), Gaps = 71/496 (14%)
Query: 121 LQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP-------RNLKYFDLSSNGFS 173
L NS+S +I LS L +L ++ NR+ L ++L+Y D+S N
Sbjct: 59 LSQNSISELRMPDISFLSELRVLRLSHNRIR-----SLDFHVFLFNQDLEYLDVSHNRL- 112
Query: 174 GPIPTSIS--NLSQLQLINFSFNKFSREVPATFEGTLP--SAIANCSSLVHLSAQGNALG 229
+IS ++ L+ ++ SFN F LP N + L L
Sbjct: 113 ----QNISCCPMASLRHLDLSFNDFD---------VLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPET 289
+ + + L + + + +S + ++ ++ + N+ +V +
Sbjct: 160 QL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 290 GSCSSVLQVLDLQQNQIRGA----FPLWLTRASTLTRLDVSGNSISGKIPAQIGGL---W 342
+ LQ+ +++ N F LTR TL + + + K ++
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 343 RLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLF 402
+E L + N + + E S +L L + +F
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEH-------------------VKNQVF 317
Query: 403 SGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG-MNNLSTLDLSENKFSGEVPASIGNL 461
S A + + L + + ++ + L+ ++N F+ V L
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 462 SQLMVFNLSGNAFS--GRIPASLGNLLKLTTLDLSKQNF-SGELPIELAGLPNLQVIALQ 518
+L L N ++ N+ L TLD+S + S A ++ V+ L
Sbjct: 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 519 ENKLSGNVPEGFSSL-MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE 577
N L+G+V F L ++ L+L N IP + L+++ L+ + N + S+P
Sbjct: 437 SNMLTGSV---FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDG 491
Query: 578 -LGNCSDLEVLELRSN 592
+ L+ + L N
Sbjct: 492 VFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 99/471 (21%), Positives = 174/471 (36%), Gaps = 31/471 (6%)
Query: 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRL 150
+ LSL NS + ++ + LR + L +N + +L ++ +LE L+V+ NRL
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 151 SGEIANDLPRNLKYFDLSSNGF-SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLP 209
I+ +L++ DLS N F P+ NL++L + S KF +
Sbjct: 113 Q-NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV--AHL 169
Query: 210 SAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPP 269
LV +G + I L +V + S V S+
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQ---IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 270 SIRVVQLGFNAFTNVAGPETGS---CSSVLQVLDLQQNQIRGAF-PLWLTRASTLTRLDV 325
+I++ T + LQ ++ F W + L++
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP---RPVEYLNI 283
Query: 326 SGNSISGKIPAQIGG-----LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSG 380
+I+ +I + L L + N F + + +++ L +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 381 EIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPE---EVLGM 437
L N+F+ S+ L L+ L L+ N L + + M
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 438 NNLSTLDLSENKF-SGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
++L TLD+S N S + ++V NLS N +G + L K+ LDL
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNN 460
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGF 546
+P ++ L LQ + + N+L +VP+G F L SL+Y+ L N +
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-20
Identities = 78/397 (19%), Positives = 135/397 (34%), Gaps = 64/397 (16%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT---LAANLFSGSIPAS-FRN 412
VP ++ L L N S E+ DI L L L+ N S+ F
Sbjct: 45 HVPKDL--PPRTKALSLSQNSIS-ELRM--PDISFLSELRVLRLSHNRIR-SLDFHVFLF 98
Query: 413 LPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF-SGEVPASIGNLSQLMVFNLSG 471
LE L++ HN L ++ + +L LDLS N F V GNL++L LS
Sbjct: 99 NQDLEYLDVSHNRLQ-NISCCPMA--SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGE----LPIELAGLPNLQVIALQENKLSGNVP 527
F ++ L L+ + L ++ + +++ L ++ + S V
Sbjct: 156 AKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 528 EGFSSLMSL--RYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP-----ELGN 580
++L L + L+ + R +L+ + HI + +
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 581 CSDLEVLELRSNSLTGHIPTDI-----------------------------SHLSHLNVL 611
+E L + + ++T I + S + +N+
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 612 DLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS---- 667
LSI++ SS L N + + + L L L L N L
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK 394
Query: 668 -GEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKP 703
+ N+SS L +VS N+L + A ++ C
Sbjct: 395 VALMTKNMSS---LETLDVSLNSLNSHAYDR-TCAWA 427
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 14/162 (8%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPAT---LAQCTLLRAVFLQYNS 125
T L + + + S L+ L+ L L+ N + L + + NS
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS 414
Query: 126 L-SGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLS 184
L S ++ +LN+++N L+G + LP +K DL +N IP +++L
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQ 473
Query: 185 QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGN 226
LQ +N + N+ + VP +SL ++ N
Sbjct: 474 ALQELNVASNQL-KSVP-------DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 42/187 (22%), Positives = 72/187 (38%), Gaps = 20/187 (10%)
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQI----PATFSFLRSVVVLSFSGNHISGSIPPEL-GN 580
VP+ + L+LS N I SFL + VL S N I S+ +
Sbjct: 46 VPKDLPP--RTKALSLSQN----SISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLF 98
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPD--EISKCSSLRSLLVN 638
DLE L++ N L +I ++ L LDLS N+ +P E + L L ++
Sbjct: 99 NQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLS 154
Query: 639 SNHLSGGIPDSLAKLS-NLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQ 697
+ +A L + +LDL + ++ G +L ++ + F+
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQV 213
Query: 698 DLCGKPL 704
++ L
Sbjct: 214 NMSVNAL 220
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 51/297 (17%), Positives = 91/297 (30%), Gaps = 69/297 (23%)
Query: 65 NNRVTELRLPRLQLSGRI-----SDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAV 119
V L + L ++ RI + + L+ L +++ F + A + +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 120 FLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTS 179
L + + S+ LN N + D G
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT--------------DSVFQGC------- 373
Query: 180 ISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALG-GVIPPAIGA 238
S L +LQ + N T N SSL L N+L
Sbjct: 374 -STLKRLQTLILQRNGLK-NFFKVALMT-----KNMSSLETLDVSLNSLNSHAYDRTCAW 426
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
+ V++L+ N L+G V + ++V
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLPPK--------------------------------VKV 454
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSF 354
LDL N+I + P +T L L+V+ N + +P + L L+ + + +N +
Sbjct: 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 10/263 (3%)
Query: 407 PASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV 466
P+ + LS +P+ + +N L+L EN + +L L V
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGN 525
L N+ + L L TL+L N+ +P L L+ + L+ N + +
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFD-NWLTVIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 526 VPEG-FSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583
+P F+ + SL L+L + I F L ++ L+ +I +P L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
LE LE+ N P LS L L + + ++ + +SL L + N+LS
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
Query: 644 GGIPDSLAKLSNLAVLDLSANNL 666
D L L L L N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 18/261 (6%)
Query: 438 NNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
N S + + S EVP I N L NL N + +L L L L +
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLG-R 108
Query: 497 NFSGELPIE-LAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPA-T 553
N ++ + GL +L + L +N L+ +P G F L LR L L N IP+
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 554 FSFLRSVVVLSFSG-NHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL 611
F+ + S++ L + I +L+ L L ++ +P ++ L L L
Sbjct: 167 FNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEEL 223
Query: 612 DLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671
++S N+ P SSL+ L V ++ +S ++ L++L L+L+ NNLS +P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282
Query: 672 AN-LSSIFGLMNFNVSSNNLQ 691
+ + + L+ ++ N
Sbjct: 283 HDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 9e-21
Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 37/262 (14%)
Query: 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275
S+ +L+ N + + L L+V+ L +N++ +
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV------------------ 116
Query: 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIP 335
AF +A L L+L N + S L L + N I IP
Sbjct: 117 ---GAFNGLAS---------LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP 163
Query: 336 AQI-GGLWRLEELKMANNSFGGAVPVEI-KQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393
+ + L L + + + +L L+L ++P + GL+
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLE 221
Query: 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSG 452
L ++ N F P SF L L+ L + ++ +S + G+ +L L+L+ N S
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSS 280
Query: 453 EVPASIGNLSQLMVFNLSGNAF 474
L L+ +L N +
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 68/281 (24%), Positives = 103/281 (36%), Gaps = 44/281 (15%)
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
LS E+ +P N +Y +L N + +L L+++ N + F G
Sbjct: 64 RGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG- 121
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
+SL L N L + A L KL+ + L N + +P+ F V
Sbjct: 122 -------LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV--- 170
Query: 268 PPSIRVVQLG-FNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVS 326
PS+ + LG ++ L+ L+L I+ P LT L L++S
Sbjct: 171 -PSLMRLDLGELKKLEYIS-EGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 327 GNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFL 386
GN P GL L++L + N+ + +E N F G
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQ----------------VSLIERNAFDG------ 264
Query: 387 GDIRGLKSLTLAANLFSGSIPAS-FRNLPGLENLNLRHNSL 426
+ L L LA N S S+P F L L L+L HN
Sbjct: 265 --LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 53/297 (17%), Positives = 84/297 (28%), Gaps = 68/297 (22%)
Query: 56 CDWRG--VACTNNRVTEL------RLPRLQLSG-RIS----DHLSNLRMLRKLSLRSNSF 102
C + V CT ++E+ L L I D +L L L L NS
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 103 NGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPR- 160
L + L N L+ +P+ LS L L + N + I +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 161 --NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSS 217
+L DL I L L+ +N ++P +
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP---------NLTPLVG 219
Query: 218 LVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLG 277
L L GN + P + L L+ + + + +S +
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER-------------------- 259
Query: 278 FNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSI 330
NAF + + L L+L N + F L L + N
Sbjct: 260 -NAFDGL---------ASLVELNLAHNNLSSLPHDLFTPL----RYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 41/263 (15%)
Query: 116 LRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
R + L N++ + A+ +L +LE+L + N + + F+G
Sbjct: 77 TRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR--------------QIEVGAFNG 121
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
L+ L + N + FE S L L + N + +
Sbjct: 122 --------LASLNTLELFDNWLTVIPSGAFEYL--------SKLRELWLRNNPIESIPSY 165
Query: 235 AIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSS 294
A +P L + L + + F + +++ + LG ++ P
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGL----FNLKYLNLGMCNIKDM--PNLTPLVG 219
Query: 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
L+ L++ N P S+L +L V + +S GL L EL +A+N+
Sbjct: 220 -LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 355 GGAVPVEI-KQCSSLSLLDLEGN 376
++P ++ L L L N
Sbjct: 279 -SSLPHDLFTPLRYLVELHLHHN 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 62/273 (22%), Positives = 113/273 (41%), Gaps = 43/273 (15%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDLR 874
+G+V + ++++ + +GS+ E+ F +EA+ + K+ H L G P
Sbjct: 21 FGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--I 78
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
+V +Y+ NG L L+ G L + V G+AFL + +H D+ +N
Sbjct: 79 YIVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALTGETTKES 988
L D D +SDFG+ R + +S T +A PE + + +S
Sbjct: 135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA--------PEVFHYFKYSSKS 186
Query: 989 DVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045
DV++FGI++ E+ + GK P + + V ++ +G L P +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQG---HRLYR------PHLAS 231
Query: 1046 WEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ ++ C P RPT ++ +E
Sbjct: 232 DTIY----QIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 62/298 (20%), Positives = 105/298 (35%), Gaps = 54/298 (18%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGM--VLSIRRLPDGSLDENLFRKEAEFLGKVRHRN- 859
F+ L R +G+VF+A D + RLP+ L +E + L K+ H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 860 -------LTVLRGYYAGAPDLRLLVY---DYMPNGNLGTLLQEASHQ----DGHVLNWPM 905
L ++ +Y NL + L+
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-F 124
Query: 906 RHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL---------TIP 956
+ A + FLH+ ++H D+KP N+ F D + DFGL +
Sbjct: 125 LQI-----AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
+ T VGT Y+SPE + G + + + D++S G++L ELL P TQ E +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY---P-FSTQMERV 234
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++ + L + + +P P++RP +I
Sbjct: 235 RTL--TDVRNLKFPPL-------FTQKYPCEYVMV------QDMLSPSPMERPEAINI 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-27
Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
E L + +G V+ +N ++I+ L G++ F +EA+ + K+RH L L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
+ P +V +YM G+L L+ + G L P +A +A G+A++ N VH
Sbjct: 332 SEEP--IYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALT 981
D++ N+L + ++DFGL RL A TA PEAAL
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA--------PEAALY 438
Query: 982 GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
G T +SDV+SFGI+L EL T G+ P + + V Q+++G +
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG---YRMPC------ 485
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P + C +P +RPT + LE
Sbjct: 486 PPECPESLH----DLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 11/220 (5%)
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536
+P + + L S NL ++ L N L+ F+ L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 537 RYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSL 594
L+LS N + + TF L + L + + P + L+ L L+ N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 595 TGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAK 652
+P D L +L L L N ++ +P+ SL LL++ N ++ P +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 653 LSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQ 691
L L L L ANNLS +P L+ + L ++ N
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 70/312 (22%), Positives = 106/312 (33%), Gaps = 69/312 (22%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
++ + L GNR S R L L L +N+ + A+F L LE L+L N+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 426 LSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGN 484
S+ G+ L TL L L F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ----------------ELGPGLF---------- 125
Query: 485 LLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSF 543
GL LQ + LQ+N L +P+ F L +L +L L
Sbjct: 126 ----------------------RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI 602
N F L S+ L N ++ + P + L L L +N+L+ +PT+
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA 220
Query: 603 -SHLSHLNVLDLSINNLTGEIPDEISKCS----SLRSLLVNSNHLSGGIP-DSLAKLSNL 656
+ L L L L+ N C L + L S +P +L+
Sbjct: 221 LAPLRALQYLRLNDNPWV---------CDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 657 AVLDLSANNLSG 668
+ L+AN+L G
Sbjct: 272 DLKRLAANDLQG 283
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/284 (20%), Positives = 91/284 (32%), Gaps = 66/284 (23%)
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
G +P I + Q I N+ S A+F C +L L
Sbjct: 17 SCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASF--------RACRNLTILWLHS 65
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVA 285
N L + A L L+ + L+ N V + F +
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGR------------------- 106
Query: 286 GPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLE 345
L L L + ++ P + L L + N++ +P
Sbjct: 107 ----------LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPD--------- 146
Query: 346 ELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGS 405
++F +L+ L L GNR S + L L L N +
Sbjct: 147 ------DTFRD--------LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 406 IPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSEN 448
P +FR+L L L L N+LS +LP E L + L L L++N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 15/191 (7%)
Query: 67 RVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPA-TLAQCTLLRAVFLQYNS 125
+T L L L+ + + L +L +L L N+ ++ T L + L
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 126 LSGNLPANI-GNLSNLEILNVAANRLSGEIANDL---PRNLKYFDLSSNGFSGPIPTSIS 181
L L + L+ L+ L + N L + +D NL + L N S +
Sbjct: 117 LQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241
L L + N+ + P F L+ L N L + A+ L
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRD--------LGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 242 LQVVSLAQNNL 252
LQ + L N
Sbjct: 227 LQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 48/237 (20%), Positives = 76/237 (32%), Gaps = 31/237 (13%)
Query: 61 VACTNNR-----------VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPAT 109
+C + L ++S + R L L L SN A
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 110 LAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPR---NLKYF 165
LL + L N+ ++ L L L++ L E+ L R L+Y
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 166 DLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQ 224
L N +P +L L + N+ S F SL L
Sbjct: 135 YLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAF--------RGLHSLDRLLLH 185
Query: 225 GNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281
N + V P A L +L + L NNLS +P + +++ ++L N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPL----RALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 57/250 (22%)
Query: 116 LRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIA----NDLPRNLKYFDLSSN 170
+ +FL N +S ++PA NL IL + +N L+ I L L+ DLS N
Sbjct: 34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA-LLEQLDLSDN 90
Query: 171 GFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALG 229
+ + L +L ++ P F G ++L +L Q NAL
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG--------LAALQYLYLQDNALQ 142
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPET 289
+ L L + L N +S VP F +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS----------------------- 178
Query: 290 GSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRL 344
L L L QN++ AF L L + N++S +P + L L
Sbjct: 179 ------LDRLLLHQNRVAHVHPHAF----RDLGRLMTLYLFANNLS-ALPTEALAPLRAL 227
Query: 345 EELKMANNSF 354
+ L++ +N +
Sbjct: 228 QYLRLNDNPW 237
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 37/270 (13%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDLR 874
+GLV + + ++I+ + +G++ E F +EAE + K+ H L L G AP
Sbjct: 21 FGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--I 78
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
LV ++M +G L L+ + + L V G+A+L + ++H D+ +N
Sbjct: 79 CLVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGETTKESDVY 991
L + +SDFG+ R T++ GT V SPE + +SDV+
Sbjct: 135 CLVGENQVIKVSDFGMTRFV-----LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 992 SFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEE 1048
SFG+++ E+ + GK P + V + + G L P +
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG---FRLYK------PRLASTHV 234
Query: 1049 FLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ ++ C P DRP S ++ L
Sbjct: 235 Y----QIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 38/270 (14%)
Query: 816 YGLVFKA-CYNDGMVL-----SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG 869
+ V++A C DG+ + I L D + KE + L ++ H N+ +
Sbjct: 45 FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC-IKEIDLLKQLNHPNVIKYYASFIE 103
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGH-----VLNWPMRHLIALGVARGLAFLHTSN 924
+L +V + G+L +++ Q V + L L +H+
Sbjct: 104 DNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-FVQL-----CSALEHMHSRR 156
Query: 925 MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA-ALTGE 983
++H DIKP NV A L D GL R A + VGT Y+SPE G
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGY 213
Query: 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
K SD++S G +L E+ + P F D+ + + K++++ L S
Sbjct: 214 NFK-SDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPSDHY------S 264
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
E + + +C PDP RP ++ +
Sbjct: 265 EELRQLV------NMCINPDPEKRPDVTYV 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 55/270 (20%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDLR 874
+G+V + ++I+ + +GS+ E+ F +EA+ + + H L L G P
Sbjct: 37 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--I 94
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
++ +YM NG L L+E H+ + V + +L + +H D+ +N
Sbjct: 95 FIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGETTKESDVY 991
L + +SDFGL R T++VG+ V PE + + + +SD++
Sbjct: 151 CLVNDQGVVKVSDFGLSRY-----VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 992 SFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEE 1048
+FG+++ E+ + GK P + + + +G L P + +
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG---LRLYR------PHLASEKV 250
Query: 1049 FLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + C +RPT ++ +
Sbjct: 251 Y----TIMYSCWHEKADERPTFKILLSNIL 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 44/207 (21%), Positives = 76/207 (36%), Gaps = 38/207 (18%)
Query: 880 YMPNGNLGTLLQEASHQD----GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
NL + + G L+ + + FLH+ ++H D+KP N+
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHI-FIQIA-----EAVEFLHSKGLMHRDLKPSNI 195
Query: 936 LFDADFEAHLSDFGL---------DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
F D + DFGL ++ + +T T VGT Y+SPE +
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 987 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
+ D++S G++L ELL TQ E + ++ + L + +
Sbjct: 256 KVDIFSLGLILFELLYS----FSTQMERVRII--TDVRNLKFPLL-------FTQKYPQE 302
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ +P P +RP +DI
Sbjct: 303 HMMV------QDMLSPSPTERPEATDI 323
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 51/265 (19%), Positives = 98/265 (36%), Gaps = 38/265 (14%)
Query: 816 YGLVFKACYN--DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870
+ V+K + + ++ L D L + F++EAE L ++H N+ +
Sbjct: 39 FKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97
Query: 871 PDLRLLVY---DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM-- 925
+ + + M +G L T L+ + + + +GL FLHT
Sbjct: 98 VKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 926 VHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
+H D+K N+ + D GL L AS + +GT +++PE
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYEEKYD 207
Query: 985 TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044
DVY+FG+ +LE+ T + P + + +++ G +
Sbjct: 208 ES-VDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFD------KVAIP 257
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPT 1069
E +E + C + +R +
Sbjct: 258 EVKEII------EGCIRQNKDERYS 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 54/290 (18%)
Query: 803 RQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT 861
F E ++ +G VFKA DG I+R+ + +E + L K+ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDHVNIV 67
Query: 862 VLRGYYAGAPDLRL---------------LVYDYMPNGNLGTLLQEASHQ---DGHVLNW 903
G + G + ++ G L +++ + L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
+ +G+ ++H+ +++ D+KP N+ + + DFGL
Sbjct: 128 -FEQI-----TKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND----GK 177
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023
T + GTL Y+SPE + + KE D+Y+ G++L ELL T L
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------FFTDL 231
Query: 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ G I+++ + + L LL P DRP S+I
Sbjct: 232 RDGIISDIF----------DKKEKTLLQK----LLS--KKPEDRPNTSEI 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 37/276 (13%), Positives = 69/276 (25%), Gaps = 31/276 (11%)
Query: 830 LSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTL 889
L + + F + + + + + +R L NL T
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 890 LQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947
+ L R + L V R LA LH +VH ++P +++ D L+
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLT 1002
F L + S + T D ++ G+ + +
Sbjct: 255 FEH--LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 1003 GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAP 1062
P T D + E L G L
Sbjct: 313 ADLP--NTDDAAL--------------GGSEWIFRSCKNIPQPVRALLEG----FL--RY 350
Query: 1063 DPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098
DR + E ++ ++ ++
Sbjct: 351 PKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 56/285 (19%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
+ + P++ +L + + V L+ + + +
Sbjct: 1 MGETITVSTPIKQIFPDDAF--AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
+ + L +T L L+ + P L L NL + L ENK+ ++ L
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L+ L+L N IS I L + LE L L +N +T
Sbjct: 111 LKSLSLE------------------------HNGIS-DING-LVHLPQLESLYLGNNKIT 144
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
T +S L+ L+ L L N ++ +I ++ + L++L ++ NH+S +LA L N
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKN 198
Query: 656 LAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLC 700
L VL+L + + + S++ + +L D
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG 243
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.5 bits (203), Expect = 4e-16
Identities = 48/369 (13%), Positives = 114/369 (30%), Gaps = 64/369 (17%)
Query: 116 LRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGP 175
+ + + + N+ ++ + + ++ +++
Sbjct: 1 MGETITVSTPIK-QIF-PDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI--- 55
Query: 176 IPTSISNLS---QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVI 232
S+ + + + + NK + + N +L L N + +
Sbjct: 56 --KSVQGIQYLPNVTKLFLNGNKLTDI----------KPLTNLKNLGWLFLDENKIKDLS 103
Query: 233 PPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSC 292
+ L KL+ +SL N +S +++ G
Sbjct: 104 S--LKDLKKLKSLSLEHNGIS---------DIN-----------GLVHLPQ--------- 132
Query: 293 SSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANN 352
L+ L L N+I L+R + L L + N IS I + GL +L+ L ++ N
Sbjct: 133 ---LESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN 185
Query: 353 SFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRN 412
+ + +L +L+L + ++ ++ S +
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--D 241
Query: 413 LPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGN 472
E N++ + L E T+ ++ +F G V + + +++ G
Sbjct: 242 DGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE-VYTVSYDVDGT 299
Query: 473 AFSGRIPAS 481
++ A
Sbjct: 300 VIKTKVEAG 308
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 48/300 (16%), Positives = 92/300 (30%), Gaps = 60/300 (20%)
Query: 81 RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLS 138
I K +L+ S + + + + + + ++ I L
Sbjct: 10 PIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLP 65
Query: 139 NLEILNVAANRLSGEIAN--DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKF 196
N+ L + N+L+ +I +L NL + L N + +S+ +L +L+ ++ N
Sbjct: 66 NVTKLFLNGNKLT-DIKPLTNLK-NLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGI 121
Query: 197 SREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVV 256
S + + + L L N + + + L KL +SL N +S +V
Sbjct: 122 SD----------INGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIV 169
Query: 257 PASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTR 316
P + LQ L L +N I L
Sbjct: 170 PLAGLTK--------------------------------LQNLYLSKNHISDLRA--LAG 195
Query: 317 ASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376
L L++ K L +K + S P I +++ +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 31/147 (21%), Positives = 62/147 (42%), Gaps = 16/147 (10%)
Query: 65 NNRVTELR-------LPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
N++T+++ L L L +I D L +L+ L+ LSL N + I L
Sbjct: 74 GNKLTDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLP 131
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
L +++L N ++ + L+ L+ L++ N++S + L+ LS N S
Sbjct: 132 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS- 188
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVP 201
+++ L L ++ + +
Sbjct: 189 -DLRALAGLKNLDVLELFSQECLNKPI 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 14/162 (8%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
+N ++++ +L L L +I+D LS L L LSL N + I LA
Sbjct: 116 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAG 173
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
T L+ ++L N +S +L + L NL++L + + + N + + +
Sbjct: 174 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 173 SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIAN 214
S P IS+ + N ++ +F P I
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-25
Identities = 47/261 (18%), Positives = 85/261 (32%), Gaps = 47/261 (18%)
Query: 845 FRKEAEFLGKVRHRNLTVLR--GYYAGAPDLRL--LVYDYMPNGNLGTLLQEASHQDGHV 900
E +FL +V H ++ + + + +V +Y+ +L +
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------- 178
Query: 901 LNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
L L + L++LH+ +V+ D+KP+N++ + + L D G
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA--------VS 229
Query: 961 ASTSTTAV-GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019
S + GT G+ +PE T +D+Y+ G L L
Sbjct: 230 RINSFGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT--RNGR------- 279
Query: 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLE 1078
GL E DP ++ + ++ PDP R T ++ L
Sbjct: 280 ------------YVDGLPEDDPVLKTYDSY---GRLLRRAIDPDPRQRFTTAEEMSAQLT 324
Query: 1079 GCRVGPDIPSSADPTTQPSPA 1099
G + P S
Sbjct: 325 GVLREVVAQDTGVPRPGLSTI 345
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 27/271 (9%)
Query: 368 LSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS---FRNLPGLENLNLRHN 424
L +D E + + + + + LK LT+ A I + GL+ L L +
Sbjct: 49 LKRVDTEADLG--QFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISGLQELTLENL 105
Query: 425 SLSGSLPEEVL--GMNNLSTLDLSENKFSGEVPASIGNLSQLM-----VFNLSGNAFSGR 477
++G+ P +L +L+ L+L ++ A + L Q + V +++
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELA----GLPNLQVIALQENK---LSGNVPEGF 530
+ L+TLDLS GE + A P LQV+AL+ SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 531 SSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLEL 589
++ + L+ L+LS N A + + + L+ S + +P L + L VL+L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDL 281
Query: 590 RSNSLTGHIPTDISHLSHLNVLDLSINNLTG 620
N L P L + L L N
Sbjct: 282 SYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/299 (20%), Positives = 103/299 (34%), Gaps = 39/299 (13%)
Query: 384 EFLGDIRGLKSLTLAANLFSGSIP-ASFRNLPGLENLNLRHNSLSGSLPE---EVLGMNN 439
E G R L+ L + + L+ L +R + + VLG++
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 440 LSTLDLSENKFSGEVPASIGNLS--QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN 497
L L L + +G P + + L + NL +++ R
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD------------------A 138
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI------- 550
+ EL L P L+V+++ + E +L L+LS N +G+
Sbjct: 139 WLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196
Query: 551 PATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLN 609
P F L+ + + + SG L+ L+L NSL S LN
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 610 VLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSG 668
L+LS L ++P + + L L ++ N L P +L + L L N
Sbjct: 257 SLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 57/246 (23%), Positives = 83/246 (33%), Gaps = 22/246 (8%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRA---STLTRLDVSGNSISGKIPAQIGGLW--RLEELKMA 350
L+ L ++ +I R S L L + ++G P + L L +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 351 NNSFGG--AVPVEIKQCSSLSL--LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI 406
N S+ A E++Q L L + E + L +L L+ N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 407 P----ASFRNLPGLENLNLRHN---SLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASI- 458
P L+ L LR+ + SG L LDLS N A
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 459 GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQ 518
SQL NLS ++P L KL+ LDLS P LP + ++L+
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLK 304
Query: 519 ENKLSG 524
N
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 56/309 (18%), Positives = 101/309 (32%), Gaps = 24/309 (7%)
Query: 35 LNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRK 94
N DP + + AA + G + R+ G+ +D + +L L++
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYG-GGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKR 72
Query: 95 LSLRSNSFNGTIPATLAQ---CTLLRAVFLQYNSLSGNLPANIGNLS--NLEILNVAANR 149
L++R+ I + + L+ + L+ ++G P + + +L ILN+
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 150 LSG------EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPAT 203
+ E+ L LK ++ + L ++ S N E
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-L 191
Query: 204 FEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCN 263
P L +A GV A +LQ + L+ N+L A
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC-- 249
Query: 264 VSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRL 323
+P + + L F V + L VLDL N++ P + L
Sbjct: 250 --DWPSQLNSLNLSFTGLKQV----PKGLPAKLSVLDLSYNRLDR-NPS-PDELPQVGNL 301
Query: 324 DVSGNSISG 332
+ GN
Sbjct: 302 SLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 49/325 (15%), Positives = 86/325 (26%), Gaps = 67/325 (20%)
Query: 105 TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKY 164
T +++++ L+ ++ + L +L ++ L+
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS--------------GLQE 99
Query: 165 FDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQ 224
L + +G P + + L + S + L + L LS
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK--PGLKVLSIA 157
Query: 225 GNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNV 284
+ P L + L+ N G +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-----------------------LISA 194
Query: 285 AGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL 344
P VL + + G L LD+S NS+ W
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AAGAPSCDW-- 251
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG 404
S L+ L+L ++P+ L L L L+ N
Sbjct: 252 --------------------PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD- 287
Query: 405 SIPASFRNLPGLENLNLRHNSLSGS 429
P S LP + NL+L+ N S
Sbjct: 288 RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 31/193 (16%), Positives = 62/193 (32%), Gaps = 19/193 (9%)
Query: 512 LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571
+ + +L G G S L+ ++ + L+ L+ I
Sbjct: 28 FNCLGAADVELYGG---GRSLEYLLKRVDTEADLGQFTDIIKSLSLKR---LTVRAARIP 81
Query: 572 GSIPP---ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS- 627
I + S L+ L L + +TG P + + ++ L++ N++ D
Sbjct: 82 SRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA 141
Query: 628 -----KCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG--- 679
L+ L + H + + L+ LDLS N GE +
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 680 -LMNFNVSSNNLQ 691
L + + ++
Sbjct: 202 TLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 37/227 (16%), Positives = 67/227 (29%), Gaps = 41/227 (18%)
Query: 482 LGNLLKLTTLDLSKQNFSGELPI-ELAGLPNLQVIALQENKLSGNVPEGFSSLMS---LR 537
G L L + ++ +L+ + ++ ++ + G ++ L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 538 YLNLSFNGFVGQIPATFSFL--RSVVVLSFSGNHISG--SIPPELGNCS--DLEVLELRS 591
L L G P + +L+ + + EL L+VL +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKC----SSLRSLLVNSNH---LSG 644
+ L+ LDLS N GE + C +L+ L + + SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 645 GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
A L LDL S N+L+
Sbjct: 219 VCSALAAARVQLQGLDL------------------------SHNSLR 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 49/306 (16%)
Query: 816 YGLVFKACYNDG------MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY- 866
+G V++ + + ++++ LP+ +++ F EA + K H+N+ G
Sbjct: 43 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 102
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSN 924
P R ++ + M G+L + L+E + + M L+ A +A G +L ++
Sbjct: 103 LQSLP--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160
Query: 925 MVHGDIKPQNVLFDADFEAHL---SDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SP 976
+H DI +N L + DFG+ R S G + P
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGGCAMLPVKWMPP 214
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
EA + G T ++D +SFG++L E+ + G P +++ V + + G ++P
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG---RMDP- 266
Query: 1036 LLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPT 1093
P+ + C P DRP + I+ +E C PD+ ++A P
Sbjct: 267 -----PKNCPGPVYRIM------TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315
Query: 1094 TQPSPA 1099
Sbjct: 316 EYGPLV 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 835 LPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-YAGAPDLRLLVYDYMPNGNLGTLLQ 891
LP+ +++ F EA + K H+N+ G P R ++ + M G+L + L+
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLR 166
Query: 892 EASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL---S 946
E + + M L+ A +A G +L ++ +H DI +N L +
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226
Query: 947 DFGLDRLTIPTPAEASTSTTAVGTLGYV-----SPEAALTGETTKESDVYSFGIVLLELL 1001
DFG+ R G + PEA + G T ++D +SFG++L E+
Sbjct: 227 DFGMARDI------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 1002 T-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALL 1058
+ G P +++ V + + G ++P P+ +
Sbjct: 281 SLGYMPYPSKSNQE----VLEFVTSGG---RMDP------PKNCPGPVYRIM------TQ 321
Query: 1059 CTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
C P DRP + I+ +E C PD+ ++A P
Sbjct: 322 CWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLV 362
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 65/277 (23%), Positives = 95/277 (34%), Gaps = 39/277 (14%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLP---DGSLDENLFRKEAEFLGKV-RHR 858
F + L YG VFK DG + +++R G D E KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARG 916
L + L L + +L + + V + +R
Sbjct: 118 CCVRLEQAWEEGGIL-YLQTELC-GPSLQQHCEAWGASLPEAQVWGY-LRDT-----LLA 169
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
LA LH+ +VH D+KP N+ L DFGL A G Y++P
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAP 225
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
E L G +DV+S G+ +LE+ E +QL++G + GL
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGEGW-----QQLRQGYLPPEFTAGL 277
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
SSE L+ PDP R T +
Sbjct: 278 ------SSELRSVLVM------MLEPDPKLRATAEAL 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 45/275 (16%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
YG K +DG +L + L GS+ E + E L +++H N+
Sbjct: 19 YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78
Query: 872 DLRL-LVYDYMPNGNLGTLLQEASHQDGH-----VLNWPMRHLIALGVARGLAFLHTSN- 924
+ L +V +Y G+L +++ + + + + VL M L L H +
Sbjct: 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQL-----TLALKECHRRSD 132
Query: 925 ----MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
++H D+KP NV D L DFGL R+ + A T VGT Y+SPE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF---VGTPYYMSPEQMN 189
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
++SD++S G +L EL P F + K +++G+ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP--F-TAFSQKELAGK-IREGKFRRI--------- 236
Query: 1041 PE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
P S E E + RP++ +I
Sbjct: 237 PYRYSDELNEIITR------MLNLKDYHRPSVEEI 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 61/269 (22%), Positives = 117/269 (43%), Gaps = 33/269 (12%)
Query: 816 YGLVFKACYNDGMVL-SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-YAGAPDL 873
YG V++ + + +++ L + +++ F KEA + +++H NL L G P
Sbjct: 233 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-- 290
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
++ ++M GNL L+E + ++ + +A ++ + +L N +H ++ +
Sbjct: 291 FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGETTKESDV 990
N L + ++DFGL RL T T G + +PE+ + + +SDV
Sbjct: 348 NCLVGENHLVKVADFGLSRL-----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 991 YSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEF 1049
++FG++L E+ T G P V + L+K + P E PE
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYR--MERP---EGCPEKV----- 448
Query: 1050 LLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
++ C +P DRP+ ++I E
Sbjct: 449 ---YELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 38/279 (13%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRN 859
++ + +G DG I+ + + R+E L ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMRHLIALGVARG 916
+ R + L +V DY G+L + + +L+W +
Sbjct: 85 IVQYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-FVQI-----CLA 137
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
L +H ++H DIK QN+ D L DFG+ R+ T A +GT Y+SP
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPYYLSP 194
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
E +SD+++ G VL EL T K F + + V K + G +
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLK-IISGSFPPV----- 245
Query: 1037 LELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S + + +P DRP+++ I
Sbjct: 246 ----SLHYSYDLRSLVSQ------LFKRNPRDRPSVNSI 274
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 45/272 (16%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875
+G V Y V +++ + + + + F EA + ++RH NL L G
Sbjct: 34 FGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+V +YM G+L L+ + VL +L V + +L +N VH D+ +NV
Sbjct: 92 IVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 148
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALTGETTKESD 989
L D A +SDFGL + + + TA PEA + + +SD
Sbjct: 149 LVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTA--------PEALREKKFSTKSD 196
Query: 990 VYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEW 1046
V+SFGI+L E+ + G+ P + +D V +++KG ++ P+
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYK---MDA------PDGCPP 241
Query: 1047 EEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ +V C D RP+ + LE
Sbjct: 242 AVY----EVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 7e-25
Identities = 37/243 (15%), Positives = 65/243 (26%), Gaps = 42/243 (17%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH--QDGHVLN 902
F + + + + + +R L NL T + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
R + L V R LA LH +VH ++P +++ D L+ F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------RDG 257
Query: 963 TSTTAVGTLGYVSPEAALTGET-----------TKESDVYSFGIVLLELLTGKRPVMFTQ 1011
+ + G+ PE T T D ++ G+V+ + P T+
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITK 315
Query: 1012 DEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071
D + + + LL L DR
Sbjct: 316 DAALGGSEW---------------IFRSCKNIPQPVRALLE---GFLR--YPKEDRLLPL 355
Query: 1072 DIV 1074
+
Sbjct: 356 QAM 358
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 39/303 (12%)
Query: 816 YGLVFKACY-----NDGMVLSIRRL-PDGSLDENLFRKEAEFLGKVRHRNLTVLRG--YY 867
+G V Y N G ++++++L G + F++E + L + + RG Y
Sbjct: 36 FGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
G LRL V +Y+P+G L LQ + L+ L + + +G+ +L + VH
Sbjct: 96 PGRQSLRL-VMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---------TAVGTLGYVSPEA 978
D+ +N+L +++ ++DFGL +L +P + A PE+
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKL-LPLDKDYYVVREPGQSPIFWYA--------PES 201
Query: 979 ALTGETTKESDVYSFGIVLLELLT-GKRP-VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+++SDV+SFG+VL EL T + + ++ + ++ ELLE G
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 1037 -LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQ 1095
L P + E ++ LC AP P DRP+ S + L+ G + T
Sbjct: 262 RLPA-PPACPAEVH----ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAH 316
Query: 1096 PSP 1098
P
Sbjct: 317 PEG 319
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 816 YGLVFKACYNDGMVLS-----IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-Y 867
+G V+K I+ L G ++ F EA +G+ H N+ L G
Sbjct: 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
P +++ +YM NG L L+E + + + G+A G+ +L N VH
Sbjct: 117 KYKP--MMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGET 984
D+ +N+L +++ +SDFGL R+ + + T G + +PEA +
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRV---LEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 985 TKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
T SDV+SFGIV+ E++T G+RP + + V K + G L P
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDG---FRLPT------P 272
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD----IPSSADPTTQPS 1097
+ ++ + C + RP +DIV +L+ PD + +
Sbjct: 273 MDCPSAIY----QLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRL 328
Query: 1098 P 1098
P
Sbjct: 329 P 329
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 60/277 (21%), Positives = 116/277 (41%), Gaps = 49/277 (17%)
Query: 816 YGLVFKACYNDGMVL-SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYA----GA 870
YG V++ + + +++ L + +++ F KEA + +++H NL L
Sbjct: 26 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGVCTREP 82
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
P ++ ++M GNL L+E + ++ + +A ++ + +L N +H D+
Sbjct: 83 P--FYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALTGET 984
+N L + ++DFGL RL A TA PE+ +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA--------PESLAYNKF 189
Query: 985 TKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
+ +SDV++FG++L E+ T G P + V + L+K +E P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR---MER------P 234
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E + + ++ C +P DRP+ ++I E
Sbjct: 235 EGCPEKVY----ELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 40/295 (13%)
Query: 803 RQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNL 860
+ + L + V +DG +++R+ D ++EA+ H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 861 TVLRGYYAGAPDLR---LLVYDYMPNGNLGTLLQEASHQDGH-----VLNWPMRHLIALG 912
L Y + L+ + G L ++ + +L LG
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL------LLG 142
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST------T 966
+ RGL +H H D+KP N+L + + L D G + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 967 AVGTLGYVSPE---AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023
T+ Y +PE + +DV+S G VL ++ G+ P + V +
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAV 260
Query: 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
Q P+S L + +++ DP RP + ++ LE
Sbjct: 261 QNQLS-----------IPQSPRHSSALWQLLNSMM--TVDPHQRPHIPLLLSQLE 302
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 42/275 (15%)
Query: 816 YGLVFKACY----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G V + Y N + ++I+ + + D F +EA + + H ++ L G
Sbjct: 28 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
P ++ + G L + LQ + L+ L A ++ LA+L + VH D
Sbjct: 88 NP--VWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLESKRFVHRD 141
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGETTK 986
I +NVL ++ L DFGL R E ST A + +PE+ T
Sbjct: 142 IAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 987 ESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
SDV+ FG+ + E+L G +P + D V +++ G E L P +
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG---ERLPM------PPN 241
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + C A DP RP +++ L
Sbjct: 242 CPPTLY----SLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 24/275 (8%)
Query: 816 YGLVFKACYND-----GMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRG--Y 866
+G V CY+ G +++++ L + ++ +++E + L + H ++ +G
Sbjct: 44 FGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
AGA L LV +Y+P G+L L H + L A + G+A+LH + +
Sbjct: 104 DAGAASL-QLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
H D+ +NVL D D + DFGL + + + +PE +
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY 216
Query: 987 ESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVK-KQLQKGQITELLEPG-LLELDPES 1043
SDV+SFG+ L ELLT + + Q+ ++TELLE G L P+
Sbjct: 217 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR-PDK 275
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E + L C + RPT +++ +L+
Sbjct: 276 CPAEVYHL----MKNCWETEASFRPTFENLIPILK 306
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/278 (17%), Positives = 107/278 (38%), Gaps = 45/278 (16%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L + ++++ ++ + ++ ++TL + + G
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT----------------TIEG 58
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
+ L L L+L + +L L L + + L N L +
Sbjct: 59 ----------VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIA 104
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
L S++ L+L+ P + L ++ VL N I+ +I P L ++L+ L + +
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGN 160
Query: 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLA 651
++ P +++LS L L N ++ +I ++ +L + + +N +S LA
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLA 214
Query: 652 KLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
SNL ++ L+ ++ + ++ L+ NV
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNN---LVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 65/302 (21%), Positives = 134/302 (44%), Gaps = 25/302 (8%)
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
+ + + ++ +L G+ L+ ++ ++ E V +NNL L+L +N+ +
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQIT 76
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511
P + NL+++ LSGN + A + L + TLDL+ + LAGL N
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLAGLSN 130
Query: 512 LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571
LQV+ L N+++ + L +L+YL++ V + + L + L N IS
Sbjct: 131 LQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQ-VSDLTP-LANLSKLTTLKADDNKIS 186
Query: 572 GSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631
I P L + +L + L++N ++ P +++ S+L ++ L+ +T + +
Sbjct: 187 -DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN--- 239
Query: 632 LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
LV N + G +A + ++ NL+ + + ++++ N +V+ N
Sbjct: 240 ----LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTT 295
Query: 692 AF 693
Sbjct: 296 VP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 19/221 (8%)
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
L + K N + + A L + ++ ++ EG L +L L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLEL 70
Query: 542 SFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
N + + L + L SGN + ++ + ++ L+L S +T T
Sbjct: 71 KDNQ-ITDLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTP 124
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
++ LS+L VL L +N +T I ++ ++L+ L + + +S LA LS L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKA 180
Query: 662 SANNLSGEIPANLSSIFGLMNFNVSSN---NLQAFANNQDL 699
N +S +I L+S+ L+ ++ +N ++ AN +L
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNL 219
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 18/249 (7%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
+ ++ + +T L G ++ I + L L L++ +N
Sbjct: 21 AIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
P +K + ++ L+L GN + ++ +K+L L + + P L
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L+ L L N ++ + G+ NL L + + S P + NLS+L N S
Sbjct: 131 LQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
I L +L L + L S P LA NL ++ L ++ ++L+
Sbjct: 187 D-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 536 LRYLNLSFN 544
+
Sbjct: 243 PNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 60/323 (18%), Positives = 109/323 (33%), Gaps = 35/323 (10%)
Query: 133 NIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFS 192
L+N + + ++ + + G + I + L+ L +
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELK 71
Query: 193 FNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNL 252
N+ + + + N + + L GN L V I L ++ + L +
Sbjct: 72 DNQITD----------LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI 119
Query: 253 SGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPL 312
+ V P + +++V+ L N TN+ ++ LQ L + Q+ P
Sbjct: 120 TDVTPLAGL-------SNLQVLYLDLNQITNI--SPLAGLTN-LQYLSIGNAQVSDLTP- 168
Query: 313 WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLD 372
L S LT L N IS I + L L E+ + NN P + S+L ++
Sbjct: 169 -LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 373 LEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI-PASFRNLPGLENLNLRHNSLSGSLP 431
L + + + + L + I PA+ + + NL N S +
Sbjct: 224 LTNQTITNQPVFYNNN---LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS-FIN 279
Query: 432 EEVLGMNNLSTLDLSENKFSGEV 454
N T + FSG V
Sbjct: 280 NVSYTFNQSVTFKNTTVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 48/264 (18%), Positives = 98/264 (37%), Gaps = 54/264 (20%)
Query: 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127
++ + ++ ++ ++L + LS TI + L + L+ N ++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQ 187
+L + NL+ + L ++ N L A +++K DL+S + P ++ LS LQ
Sbjct: 77 -DLA-PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSL 247
++ N+ + S +A ++L +LS + + P + L KL +
Sbjct: 133 VLYLDLNQITNI----------SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 248 AQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR 307
N +S + P + N L + L+ NQI
Sbjct: 181 DDNKISDISP--------------------LASLPN------------LIEVHLKNNQIS 208
Query: 308 GAFPLWLTRASTLTRLDVSGNSIS 331
P L S L + ++ +I+
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 34/145 (23%), Positives = 58/145 (40%), Gaps = 16/145 (11%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
+ N + + + L L+ +I+D L+ L L+ L L N P LA
Sbjct: 92 LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAG 149
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
T L+ + + +S +L + NLS L L N++S NL L +N
Sbjct: 150 LTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207
Query: 173 SGPIPTSISNLSQLQLINFSFNKFS 197
S P ++N S L ++ + +
Sbjct: 208 SDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 16/141 (11%)
Query: 65 NNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
N++T + L L + ++SD L+NL L L N + I LA
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISP-LASLP 195
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
L V L+ N +S ++ + N SNL I+ + ++ NL ++
Sbjct: 196 NLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGA 252
Query: 175 PI-PTSISNLSQLQLINFSFN 194
PI P +IS+ N ++N
Sbjct: 253 PIAPATISDNGTYASPNLTWN 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 66/275 (24%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 816 YGLVFKACYNDGMVLSIR----RLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G V++ Y + I +N F EA + + H ++ L G
Sbjct: 25 FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
P ++ + P G LG L+ + L L +L + + +A+L + N VH D
Sbjct: 85 EP--TWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV---SPEAALTGETTK 986
I +N+L + L DFGL R E A T + SPE+ T
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYI-----EDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 987 ESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
SDV+ F + + E+L+ GK+P + +D V L+KG + L P+
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKG---DRLPK------PDL 238
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + C DP DRP +++V L
Sbjct: 239 CPPVLY----TLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 816 YGLVFKACY-----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRG--Y 866
+G V Y N G ++++ L S ++ +KE E L + H N+ +G
Sbjct: 34 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
G ++L + +++P+G+L L + ++ +N + A+ + +G+ +L + V
Sbjct: 94 EDGGNGIKL-IMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYLGSRQYV 148
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---------TAVGTLGYVSPE 977
H D+ +NVL +++ + + DFGL + I T E T A PE
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDRDSPVFWYA--------PE 199
Query: 978 AALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVK-KQLQKGQITELLEPG 1035
+ + SDV+SFG+ L ELLT + Q+ ++ L+ G
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 1036 -LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P + E + ++ C P +R + +++ E
Sbjct: 260 KRLPC-PPNCPDEVY----QLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 61/256 (23%), Positives = 108/256 (42%), Gaps = 33/256 (12%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
VL +L ++ L R E E +RH N+ L GY+ A + L+ +Y P G +
Sbjct: 41 VLFKAQLEKAGVEHQLRR-EVEIQSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYR 98
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
LQ+ I +A L++ H+ ++H DIKP+N+L + E ++DF
Sbjct: 99 ELQKL----SKFDEQRTATYITE-LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
G A +S T GTL Y+ PE ++ D++S G++ E L GK P
Sbjct: 154 GWS-----VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-- 206
Query: 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP 1068
F + + K+ + + + T P + + + + LL +P RP
Sbjct: 207 F-EANTYQETYKR-ISRVEFT---FPDFV-----TEGARDLISR----LLK--HNPSQRP 250
Query: 1069 TMSDIV---FMLEGCR 1081
+ +++ ++
Sbjct: 251 MLREVLEHPWITANSS 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 816 YGLVFKACY----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-YA 868
G V + ++I+ L G + F EA +G+ H N+ L G
Sbjct: 62 SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMV 926
G ++V +YM NG+L T L+ Q + + L+ GV G+ +L V
Sbjct: 122 GRL--AMIVTEYMENGSLDTFLRTHDGQ------FTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST--------TAVGTLGYVSPEA 978
H D+ +NVL D++ +SDFGL R+ P A T+T TA PEA
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA--------PEA 225
Query: 979 ALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
+ SDV+SFG+V+ E+L G+RP M +D V +++G L
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEG---YRLPA- 275
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTT 1094
P ++ L C D RP S IV +L+ P+ + +
Sbjct: 276 -----PMGCPHALH----QLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 816 YGLVFKACY-----NDGMVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVLRG--YY 867
+G V Y N G V+++++L + + F +E E L ++H N+ +G Y
Sbjct: 23 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
AG +L+L + +Y+P G+L LQ + ++ + +G+ +L T +H
Sbjct: 83 AGRRNLKL-IMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---------TAVGTLGYVSPEA 978
D+ +N+L + + + DFGL ++ +P E A PE+
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYA--------PES 188
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK---QLQKGQITELLEPG 1035
+ + SDV+SFG+VL EL T E + Q+ + ELL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 1036 L-LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P+ E +++ C + RP+ D+ ++
Sbjct: 249 GRLPR-PDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVD 287
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 45/301 (14%), Positives = 92/301 (30%), Gaps = 43/301 (14%)
Query: 797 ETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRL-------PDGSLDENLFRKEA 849
E ++ ++L + V++A D ++ P + + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 850 EFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909
E L + + +LV + G L + + V+ +
Sbjct: 119 ERLKPSMQHMFMKFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH-----------LSDFGLDRLTIPTP 958
A+ + + +H ++HGDIKP N + F L D G P
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 959 AEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
+ + T T G+ E L+ + + D + + +L G ++E +
Sbjct: 238 -KGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEG-GE 292
Query: 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
+ L + P W EF ++ PD P++ + L
Sbjct: 293 CKPEGLFRRL-------------PHLDMWNEF-----FHVMLNIPDCHHLPSLDLLRQKL 334
Query: 1078 E 1078
+
Sbjct: 335 K 335
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 816 YGLVFKACY-----NDGMVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVLRG--YY 867
+G V Y N G V+++++L + + F +E E L ++H N+ +G Y
Sbjct: 54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
AG +L+L + +Y+P G+L LQ+ + ++ + +G+ +L T +H
Sbjct: 114 AGRRNLKL-IMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLGTKRYIH 168
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---------TAVGTLGYVSPEA 978
D+ +N+L + + + DFGL ++ +P E A PE+
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYA--------PES 219
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK---QLQKGQITELLEPG 1035
+ + SDV+SFG+VL EL T E + Q+ + ELL+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 1036 -LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P+ E +++ C + RP+ D+ ++
Sbjct: 280 GRLPR-PDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVD 318
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 40/295 (13%)
Query: 816 YGLVFKACYN----DGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-YA 868
+G V + ++I+ L G ++ F EA +G+ H N+ L G
Sbjct: 58 FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMV 926
P ++V +YM NG+L + L++ Q + + L+ G+A G+ +L V
Sbjct: 118 SKP--VMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTK 986
H D+ +N+L +++ +SDFGL R+ P A T+ + + SPEA + T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 987 ESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
SDV+S+GIVL E+++ G+RP M QD V K + +G L P P
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEG---YRLPP------PMD 274
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD-IPSSADPTTQPS 1097
+ L L C D +RP IV +L+ P + +PS
Sbjct: 275 CPAALYQL----MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPS 325
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/296 (18%), Positives = 103/296 (34%), Gaps = 49/296 (16%)
Query: 816 YGLVFKACYNDG---MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGA 870
+G V + Y + ++I+ L G+ + +EA+ + ++ + + L G
Sbjct: 23 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 82
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
+LV + G L L + + + V+ G+ +L N VH D+
Sbjct: 83 A--LMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST--------TAVGTLGYVSPEAALTG 982
+NVL A +SDFGL + + + + A PE
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA--------PECINFR 188
Query: 983 ETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ + SDV+S+G+ + E L+ G++P M + V +++G + +E
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQG---KRMEC----- 234
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQ 1095
P E + + C DRP + + C
Sbjct: 235 -PPECPPELY----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 53/279 (18%), Positives = 92/279 (32%), Gaps = 31/279 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTV 862
F ++VL G + D ++++R+ +E + L + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--FADREVQLLRESDEHPNVIR 82
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
+ + + TL + +D L L+ GLA LH+
Sbjct: 83 YFCTEKD-RQFQYIAIELCA----ATLQEYVEQKDFAHLGLEPITLL-QQTTSGLAHLHS 136
Query: 923 SNMVHGDIKPQNVLF-----DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
N+VH D+KP N+L +A +SDFGL + S + GT G+++PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 978 ---AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
T D++S G V +++ + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL--------D 248
Query: 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
L E E + A DP RP+ +
Sbjct: 249 CLHPEKHEDVIARELIEK------MIAMDPQKRPSAKHV 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 53/276 (19%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYA----GAP 871
+G V Y V +++ + + + + F EA + ++RH NL L
Sbjct: 206 FGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSNLVQL---LGVIVEEKG 260
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIK 931
L +V +YM G+L L+ + VL +L V + +L +N VH D+
Sbjct: 261 GL-YIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 932 PQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST------TAVGTLGYVSPEAALTGETT 985
+NVL D A +SDFGL + + + TA PEA + +
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTA--------PEALREKKFS 364
Query: 986 KESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042
+SDV+SFGI+L E+ + G+ P + +D V +++KG ++ P+
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGY---KMDA------PD 409
Query: 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ V C D RPT + LE
Sbjct: 410 GCPPAVY----DVMKNCWHLDAATRPTFLQLREQLE 441
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 73/370 (19%), Positives = 132/370 (35%), Gaps = 50/370 (13%)
Query: 736 LCCCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLV-MFNNKIT 794
C + R KE A + + + + + + + T
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376
Query: 795 LAETVEATRQFDEENV-LSRT----RYGLVFKACY----NDGMVLSIRRLPDGSLDENL- 844
+ E + L R ++G V + Y N M ++I+ + + D
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 845 -FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNW 903
F +EA + + H ++ L G P ++ + G L + LQ
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFS------L 488
Query: 904 PMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ LI A ++ LA+L + VH DI +NVL ++ L DFGL R ++
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDS 544
Query: 962 STSTTAVGTL--GYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIV 1016
+ + G L +++PE+ T SDV+ FG+ + E+L G +P + D
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---- 600
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076
V +++ G E L P + + + C A DP RP +++
Sbjct: 601 --VIGRIENG---ERLPM------PPNCPPTLY----SLMTKCWAYDPSRRPRFTELKAQ 645
Query: 1077 LEGCRVGPDI 1086
L +
Sbjct: 646 LSTILEEEKL 655
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 45/279 (16%)
Query: 816 YGLVFKACYNDG----MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G V+ D + +++ L + + F E + H N+ L G
Sbjct: 38 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
+ L+V YM +G+L ++ +H L VA+G+ +L + VH D
Sbjct: 98 SEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLASKKFVHRD 153
Query: 930 IKPQNVLFDADFEAHLSDFGLDRL---TIPTPAEASTST------TAVGTLGYVSPEAAL 980
+ +N + D F ++DFGL R T A E+
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA--------LESLQ 205
Query: 981 TGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
T + T +SDV+SFG++L EL+T G P DI L +G+ L
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR---RLLQ----- 253
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE + + L C P RP+ S++V +
Sbjct: 254 -PEYCPDPLYEV----MLKCWHPKAEMRPSFSELVSRIS 287
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 51/282 (18%)
Query: 816 YGLVFKACYNDGMVLS---IRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G V K Y V+ ++ L + + D L EA + ++ + + + G
Sbjct: 30 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 89
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
+LV + G L LQ+ H + + V+ G+ +L SN VH D
Sbjct: 90 ES--WMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 930 IKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST--------TAVGTLGYVSPEAALT 981
+ +NVL A +SDFGL + T A PE
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA--------PECINY 194
Query: 982 GETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038
+ + +SDV+SFG+++ E + G++P M + V L+KG E +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKG---ERMGC---- 241
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
P E + + LC D +RP + + L
Sbjct: 242 --PAGCPREMY----DLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 53/297 (17%)
Query: 816 YGLVFKACYNDG------MVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVLRGY-Y 867
+G VF A ++ M+++++ L + S F++EAE L ++H+++ G
Sbjct: 54 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL----------IALGVARGL 917
G P L+V++YM +G+L L+ + +A VA G+
Sbjct: 114 EGRP--LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV--- 974
+L + VH D+ +N L + DFG+ R ST VG +
Sbjct: 172 VYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVGGRTMLPIR 225
Query: 975 --SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
PE+ L + T ESDV+SFG+VL E+ T GK+P + + + + +G+
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT----QGRE--- 278
Query: 1032 LEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086
LE P E + G C +P R ++ D+ L+ P +
Sbjct: 279 LER------PRACPPEVYAIMRG------CWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 54/296 (18%)
Query: 816 YGLVFKACYNDG------MVLSIRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVLRGY-Y 867
+G VF A + M+++++ L D +L F++EAE L ++H ++ G
Sbjct: 28 FGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 87
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEAS-----------HQDGHVLNWPMRHLIALGVARG 916
G P ++V++YM +G+L L+ Q L IA +A G
Sbjct: 88 DGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-- 974
+ +L + + VH D+ +N L A+ + DFG+ R ST VG +
Sbjct: 146 MVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY------STDYYRVGGHTMLPI 199
Query: 975 ---SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITE 1030
PE+ + + T ESDV+SFG++L E+ T GK+P + + V + + +G++
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIECITQGRV-- 253
Query: 1031 LLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084
LE P E + +LG C +P R + +I +L
Sbjct: 254 -LER------PRVCPKEVYDVMLG------CWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 67/306 (21%), Positives = 119/306 (38%), Gaps = 58/306 (18%)
Query: 816 YGLVFKACYNDGMVLS-----IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYA 868
+G V K + I+ + D S ++ +G + H ++ L G
Sbjct: 26 FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMV 926
G+ LV Y+P G+L +++ G + + L+ + +A+G+ +L MV
Sbjct: 86 GSS--LQLVTQYLPLGSLLDHVRQ---HRGAL---GPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-------TAVGTLGYVSPEAA 979
H ++ +NVL + + ++DFG+ L P + S A E+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA--------LESI 189
Query: 980 LTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
G+ T +SDV+S+G+ + EL+T G P + + V L+KG E L
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKG---ERLAQ-- 238
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP----DIPSSADP 1092
P+ + +++ VK C D RPT ++ P I + P
Sbjct: 239 ----PQICTIDVYMVMVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGP 290
Query: 1093 TTQPSP 1098
P P
Sbjct: 291 GIAPGP 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 67/279 (24%), Positives = 106/279 (37%), Gaps = 45/279 (16%)
Query: 816 YGLVFKACYNDG----MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G+V+ Y D + +I+ L + + + F +E + + H N+ L G
Sbjct: 34 FGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
L ++ YM +G+L ++ L VARG+ +L VH D
Sbjct: 94 PEGLPHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149
Query: 930 IKPQNVLFDADFEAHLSDFGLDRL---TIPTPAEASTST------TAVGTLGYVSPEAAL 980
+ +N + D F ++DFGL R + TA E+
Sbjct: 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA--------LESLQ 201
Query: 981 TGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
T T +SDV+SFG++L ELLT G P D+ L +G+ L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----HFLAQGRR---LPQ----- 249
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE + +V C DP RPT +V +E
Sbjct: 250 -PEYCPDSLY----QVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 46/284 (16%)
Query: 816 YGLVFKACYNDGMVLSIR----RLPDGSLDENL---FRKEAEFLGKVRHRNLT-----VL 863
+G V +A ++ L + + F +EA + + H ++ L
Sbjct: 36 FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHT 922
R G + +++ +M +G+L L + ++ L + +A G+ +L +
Sbjct: 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS 155
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SPE 977
N +H D+ +N + D ++DFGL R S G + + E
Sbjct: 156 RNFIHRDLAARNCMLAEDMTVCVADFGLSRKI------YSGDYYRQGCASKLPVKWLALE 209
Query: 978 AALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ T SDV++FG+ + E++T G+ P ++ +I L G L+
Sbjct: 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----NYLIGGN---RLKQ-- 260
Query: 1037 LELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P E + + C + DP RP+ + + LE
Sbjct: 261 ----PPECMEEVYDLM------YQCWSADPKQRPSFTCLRMELE 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 54/282 (19%)
Query: 816 YGLVFKACY-----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYA 868
+G V+K + + ++I+ L + + + EA + V + ++ L G
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMV 926
+ L+ MP G L ++E ++ ++L+ + +A+G+ +L +V
Sbjct: 88 TST--VQLITQLMPFGCLLDYVRE---HKDNI---GSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-------TAVGTLGYVSPEAA 979
H D+ +NVL ++DFGL +L E A E+
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--------LESI 191
Query: 980 LTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
L T +SDV+S+G+ + EL+T G +P + + + L+KG E L
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKG---ERLPQ-- 240
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
P + + + C D RP +++
Sbjct: 241 ----PPICTIDVY----MIMRKCWMIDADSRPKFRELIIEFS 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 58/333 (17%), Positives = 109/333 (32%), Gaps = 61/333 (18%)
Query: 763 SPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTR------- 815
S +A S AS + +G KL + E V T + + R
Sbjct: 6 SSGQAHSLAS--LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63
Query: 816 -------YGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYY 867
+G V + G +++++ L+ +E + + L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR---LEVFR-VEELVACAGLSSPRIVPLYGAV 119
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVH 927
P + + + + G+LG L+++ + + + GL +LHT ++H
Sbjct: 120 REGPWVNI-FMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-----EGLEYLHTRRILH 173
Query: 928 GDIKPQNVLFDAD-FEAHLSDFGL-DRLT-IPTPAEASTSTTAVGTLGYVSPEAALTGET 984
GD+K NVL +D A L DFG L T GT +++PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 985 TKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ D++S ++L +L G P + I +I
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK----IASEPPPIR---EIPPSC---- 282
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPT 1069
+ + + +P+ R +
Sbjct: 283 ------APLTAQAI------QEGLRKEPVHRAS 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 27/224 (12%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
VL +L ++ L R E E +RH N+ + Y+ + L+ ++ P G L
Sbjct: 46 VLFKSQLEKEGVEHQLRR-EIEIQSHLRHPNILRMYNYFHDRKRI-YLMLEFAPRGELYK 103
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
LQ + G + +A L + H ++H DIKP+N+L E ++DF
Sbjct: 104 ELQ----KHGRFDEQRSATFMEE-LADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
G A + T GTL Y+ PE ++ D++ G++ E L G P
Sbjct: 159 GWSVH-----APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-- 211
Query: 1009 FTQDEDIVKWVKKQLQKGQIT----------ELLEPGLLELDPE 1042
F + ++ + + +L+ LL P
Sbjct: 212 F-DSPSHTETHRR-IVNVDLKFPPFLSDGSKDLIS-KLLRYHPP 252
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 35/274 (12%)
Query: 816 YGLVFKACYNDG----MVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAG 869
+G V+ D + +++ L + + F E + H N+ L G
Sbjct: 102 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161
Query: 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVH 927
+ L+V YM +G+L ++ +H ++ LI L VA+G+ FL + VH
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFLASKKFVH 215
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL--GYVSPEAALTGETT 985
D+ +N + D F ++DFGL R + S L +++ E+ T + T
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 986 KESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044
+SDV+SFG++L EL+T G P DI L +G L PE
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----VYLLQG---RRLLQ------PEYC 321
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + L C P RP+ S++V +
Sbjct: 322 PDPLYEV----MLKCWHPKAEMRPSFSELVSRIS 351
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQ 518
++ + NL + + + L + + + + ++ + LPN+ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---VQGIQYLPNVTKLFLN 76
Query: 519 ENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPEL 578
NKL+ + ++L +L +L L N V + + L+ + LS N IS I L
Sbjct: 77 GNKLT--DIKPLANLKNLGWLFLDENK-VKDLSS-LKDLKKLKSLSLEHNGIS-DING-L 130
Query: 579 GNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
+ LE L L +N +T T +S L+ L+ L L N ++ +I ++ + L++L ++
Sbjct: 131 VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 186
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
NH+S +LA L NL VL+L + + + S++ + +L
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 59/250 (23%), Positives = 97/250 (38%), Gaps = 20/250 (8%)
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
L + ++ L ++ + ++ + S+ + + + N++ L L+ NK +
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLP 510
P + NL L L N + SL +L KL +L L S I L LP
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD---INGLVHLP 134
Query: 511 NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHI 570
L+ + L NK++ S L L L+L N + I + L + L S NHI
Sbjct: 135 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ-ISDIVP-LAGLTKLQNLYLSKNHI 190
Query: 571 SGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCS 630
S + L +L+VLEL S S+L N + + +L P+ IS
Sbjct: 191 S-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDG 246
Query: 631 SLRSLLVNSN 640
V +
Sbjct: 247 DYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 16/255 (6%)
Query: 296 LQVLDLQQNQIRGAFPL-WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
+ + + I+ + +L +T+L ++GN ++ I + L L L + N
Sbjct: 48 IDQIIANNSDIKSVQGIQYLPN---VTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV 102
Query: 355 GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414
+K L L LE N S +I L + L+SL L N + I L
Sbjct: 103 KDLSS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLT 156
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474
L+ L+L N +S + + G+ L L LS+N S ++ A + L L V L
Sbjct: 157 KLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQEC 212
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
+ NL+ T+ + + I G + + + V F +
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 272
Query: 535 SLRYLNLSFNGFVGQ 549
++ F+G V Q
Sbjct: 273 TIGKAKARFHGRVTQ 287
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 47/325 (14%), Positives = 104/325 (32%), Gaps = 61/325 (18%)
Query: 133 NIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLS---QLQLI 189
+ + N+ ++ + + ++ +++ S+ + + +
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI-----KSVQGIQYLPNVTKL 73
Query: 190 NFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQ 249
+ NK + +AN +L L N + + + L KL+ +SL
Sbjct: 74 FLNGNKLTDI----------KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEH 121
Query: 250 NNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGA 309
N +S +++ G L+ L L N+I
Sbjct: 122 NGIS---------DIN-----------GLVHLPQ------------LESLYLGNNKITDI 149
Query: 310 FPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLS 369
L+R + L L + N IS I + GL +L+ L ++ N + + +L
Sbjct: 150 TV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN--HISDLRALAGLKNLD 203
Query: 370 LLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGS 429
+L+L + ++ ++ P + E N++ + L
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH-LPEF 260
Query: 430 LPEEVLGMNNLSTLDLSENKFSGEV 454
E T+ ++ +F G V
Sbjct: 261 TNEVSFIFYQPVTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 44/270 (16%), Positives = 83/270 (30%), Gaps = 54/270 (20%)
Query: 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
K +L+ S + + + + + + ++ I L N+ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 146 AANRLSGEIANDLP-RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATF 204
N+L+ +I +NL + L N +S+ +L +L+ ++ N S
Sbjct: 76 NGNKLT-DIKPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD------ 126
Query: 205 EGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNV 264
+ + + L L N + + + L KL +SL N +S +VP +
Sbjct: 127 ----INGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLAGLTK- 179
Query: 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLD 324
LQ L L +N I L L L+
Sbjct: 180 -------------------------------LQNLYLSKNHISDLRA--LAGLKNLDVLE 206
Query: 325 VSGNSISGKIPAQIGGLWRLEELKMANNSF 354
+ K L +K + S
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 21/113 (18%), Positives = 48/113 (42%), Gaps = 8/113 (7%)
Query: 578 LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637
++ L+ S+T + L+ ++ + + +++ + I ++ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
N N L+ P LA L NL L L N + ++ +L + L + ++ N +
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI 124
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 30/145 (20%), Positives = 64/145 (44%), Gaps = 16/145 (11%)
Query: 65 NNRVTELR-------LPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
N++T+++ L L L ++ D L +L+ L+ LSL N + I L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLP 134
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
L +++L N ++ ++ + L+ L+ L++ N++S + L+ LS N S
Sbjct: 135 QLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192
Query: 175 PIPTSISNLSQLQLINFSFNKFSRE 199
+++ L L ++ + +
Sbjct: 193 --LRALAGLKNLDVLELFSQECLNK 215
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 16/143 (11%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
+N ++++ +L L L +I+D LS L L LSL N + I LA
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAG 176
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
T L+ ++L N +S +L + L NL++L + + + N NL + N
Sbjct: 177 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQ-SNLVVPNTVKNTD 233
Query: 173 SGPI-PTSISNLSQLQLINFSFN 194
+ P IS+ + N ++
Sbjct: 234 GSLVTPEIISDDGDYEKPNVKWH 256
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 53/298 (17%), Positives = 110/298 (36%), Gaps = 56/298 (18%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVL---SIRRLPDGSLDENLFRKEAEFLGKV-R 856
T +F E + +G VFK DG + ++ GS+DE +E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 857 HRNLTVLRGYY-AGAPDLRLLVY-DYMPNGNLGTLLQEASHQDGH-----VLNWPMRHLI 909
H ++ Y+ A A D +L+ +Y G+L + E + + + + +
Sbjct: 70 HSHVV---RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL-LLQV- 124
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP----------- 958
RGL ++H+ ++VH DIKP N+ + + D +
Sbjct: 125 ----GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 959 -AEASTSTTAVGTLGYVSPE--AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015
S+ G +++ E K +D+++ + ++ + +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPL--PRNGDQW 237
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++++G++ + P +L S E+ E L + PDP RP+ +
Sbjct: 238 -----HEIRQGRLPRI--PQVL-----SQEFTELL------KVMIHPDPERRPSAMAL 277
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 53/274 (19%), Positives = 104/274 (37%), Gaps = 40/274 (14%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLR--GYYAGA 870
VF+ + +I+ + D + +R E +L K++ + ++R Y
Sbjct: 41 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
+ +V + N +L + L++ ++ R + + +H +VH D+
Sbjct: 101 QYI-YMVMECG-NIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA-----------A 979
KP N L D L DFG+ + + + VGT+ Y+ PEA
Sbjct: 154 KPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ + +SDV+S G +L + GK P F Q + + + + E P +
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEF--PDIP-- 265
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ ++ L C DP R ++ ++
Sbjct: 266 ---EKDLQDVLKC------CLKRDPKQRISIPEL 290
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 63/388 (16%), Positives = 121/388 (31%), Gaps = 52/388 (13%)
Query: 732 CLLALCCCFYIFSLLRWRRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNN 791
L C S A P R + +
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 792 KITLAETVEATRQFDEENVLSRTR-----------------YGLVFKACY---NDGMVLS 831
E+ EE + +G V + Y + ++
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367
Query: 832 IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTL 889
I+ L G+ + +EA+ + ++ + + L G +LV + G L
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKF 425
Query: 890 LQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949
L + + + V+ G+ +L N VH ++ +NVL A +SDFG
Sbjct: 426 LVGKREE----IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP-- 1006
L + + + + L + +PE + + SDV+S+G+ + E L+ G++P
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
Query: 1007 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID 1066
M + V +++G + +E P E + + C D
Sbjct: 542 KMKGPE------VMAFIEQG---KRMEC------PPECPPELY----ALMSDCWIYKWED 582
Query: 1067 RPTMSDIVFMLEGCRVGPDIPSSADPTT 1094
RP + + C S + +
Sbjct: 583 RPDFLTVEQRMRACYYSLA--SKVEGGS 608
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 45/285 (15%)
Query: 816 YGLVFKACYNDGMVLSIR----RLPDGSLDENL---FRKEAEFLGKVRHRNLT-----VL 863
+G V + S++ + + + F EA + H N+ +
Sbjct: 47 FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLH 921
G P +++ +M G+L T L + + G + P++ L+ + +A G+ +L
Sbjct: 107 EMSSQGIPKP-MVILPFMKYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVDIALGMEYLS 164
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SP 976
N +H D+ +N + D ++DFGL + S G + + +
Sbjct: 165 NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI------YSGDYYRQGRIAKMPVKWIAI 218
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E+ T +SDV++FG+ + E+ T G P Q+ ++ L G L+
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY----DYLLHGH---RLKQ- 270
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
PE E + ++ C DP+DRPT S + LE
Sbjct: 271 -----PEDCLDELY----EIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 53/274 (19%), Positives = 104/274 (37%), Gaps = 40/274 (14%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLR--GYYAGA 870
VF+ + +I+ + D + +R E +L K++ + ++R Y
Sbjct: 22 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
+ +V + N +L + L++ ++ R + + +H +VH D+
Sbjct: 82 QYI-YMVMEC-GNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134
Query: 931 KPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA-----------A 979
KP N L D L DFG+ + + + VGT+ Y+ PEA
Sbjct: 135 KPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ + +SDV+S G +L + GK P F Q + + + + E P +
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEF--PDIP-- 246
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ ++ L C DP R ++ ++
Sbjct: 247 ---EKDLQDVLKC------CLKRDPKQRISIPEL 271
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 32/188 (17%), Positives = 67/188 (35%), Gaps = 14/188 (7%)
Query: 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
L + + + I A + +L I L ++ G +++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINN 75
Query: 544 NGFVGQIP--ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
S L ++ L G ++ P L + L +L++ ++ I T
Sbjct: 76 I----HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
I+ L +N +DLS N +I + L+SL + + + + L L
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 662 SANNLSGE 669
+ + G+
Sbjct: 189 FSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 28/185 (15%), Positives = 69/185 (37%), Gaps = 10/185 (5%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
N L +S + + MN+L+ + L+ + I + ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
+ P + L L L + ++ + + L+GL +L ++ + + ++ +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
+L + ++LS+NG + I L + L+ + + + + L L S
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFS 190
Query: 592 NSLTG 596
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 31/182 (17%), Positives = 66/182 (36%), Gaps = 9/182 (4%)
Query: 510 PNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNH 569
+ S + + SL Y+ L+ V + + ++ L+ + H
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANIN-VTDLTG-IEYAHNIKDLTINNIH 77
Query: 570 ISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKC 629
+ + P + S+LE L + +T ++S L+ L +LD+S + I +I+
Sbjct: 78 AT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 630 SSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP-ANLSSIFGLMNFNVSSN 688
+ S+ ++ N I L L L L++ + + + L S
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPK---LNQLYAFSQ 191
Query: 689 NL 690
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 32/181 (17%), Positives = 63/181 (34%), Gaps = 7/181 (3%)
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
+ + Q +SL+ + L + ++ + +K LT+ +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT 79
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ 463
P L LE L + ++ + G+ +L+ LD+S + + I L +
Sbjct: 80 NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
+ +LS N I L L +L +L++ IE P L + +
Sbjct: 138 VNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIG 194
Query: 524 G 524
G
Sbjct: 195 G 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 29/171 (16%), Positives = 60/171 (35%), Gaps = 17/171 (9%)
Query: 87 SNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVA 146
+ + L ++L + + + ++ + + + I LSNLE L +
Sbjct: 41 AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIM 96
Query: 147 ANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATF 204
++ + +L +L D+S + I T I+ L ++ I+ S+N
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI------- 149
Query: 205 EGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255
T + L L+ Q + + I PKL + + G
Sbjct: 150 --TDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 23/147 (15%), Positives = 52/147 (35%), Gaps = 15/147 (10%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
N VT+L + L ++ ++ +S L L +L + L+
Sbjct: 51 LANINVTDLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSG 110
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN--DLPRNLKYFDLSSN 170
T L + + +++ ++ I L + ++++ N +I LP LK ++ +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP-ELKSLNIQFD 169
Query: 171 GFSGPIPTSISNLSQLQLINFSFNKFS 197
G I + +L +
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 27/158 (17%), Positives = 57/158 (36%), Gaps = 29/158 (18%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
++ L + P+ + S L RL + G ++ + GL L L +++++
Sbjct: 68 IKDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
++ +I ++ +DL N + DI LK LP
Sbjct: 126 DSILTKINTLPKVNSIDLSYNG-------AITDIMPLK------------------TLPE 160
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453
L++LN++ + + + L+ L G+
Sbjct: 161 LKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 27/221 (12%), Positives = 61/221 (27%), Gaps = 45/221 (20%)
Query: 161 NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVH 220
K + G S + + ++ L I + + G I ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-----DLTG-----IEYAHNIKD 70
Query: 221 LSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNA 280
L+ P I L L+ + + +++ + +
Sbjct: 71 LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPN------------------LSG 110
Query: 281 FTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGG 340
T+ L +LD+ + + + + +D+S N I +
Sbjct: 111 LTS------------LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKT 157
Query: 341 LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGE 381
L L+ L + + I+ L+ L G+
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 15/106 (14%), Positives = 34/106 (32%), Gaps = 21/106 (19%)
Query: 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSG 128
LR+ ++ +LS L L L + ++ + +I + + ++ L YN
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 129 NLPA---------------------NIGNLSNLEILNVAANRLSGE 153
++ I + L L + + G+
Sbjct: 151 DIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 51/292 (17%), Positives = 106/292 (36%), Gaps = 70/292 (23%)
Query: 816 YGLVFKACYNDGMVLS--------IRRLPDGSLDENL-FRKEAEFLGKVRHRNLTVLRGY 866
+ +FK + ++ L + + F + A + K+ H++L + G
Sbjct: 21 FTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGV 80
Query: 867 -YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
G +LV +++ G+L T L++ + + +N + +A +A + FL + +
Sbjct: 81 CVCGDE--NILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 926 VHGDIKPQNVLFDADFEAH--------LSDFGLDRLTIPTPAEASTSTTAVGTLGY---- 973
+HG++ +N+L + + LSD G+ +P
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------DILQER 180
Query: 974 ---VSPEAALTGET-TKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKG 1026
V PE + +D +SFG L E+ + G +P + +Q + +
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYEDR 234
Query: 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P+++E + C +P RP+ I+ L
Sbjct: 235 ---HQLPA------PKAAELANLI------NNCMDYEPDHRPSFRAIIRDLN 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 62/306 (20%), Positives = 117/306 (38%), Gaps = 57/306 (18%)
Query: 816 YGLVFKACY-----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYA 868
+G V+K + + ++I+ L + + + EA + V + ++ L G
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMV 926
+ L+ MP G L ++E ++ ++L+ + +A+G+ +L +V
Sbjct: 88 TST--VQLITQLMPFGCLLDYVRE---HKDNI---GSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 927 HGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-------TAVGTLGYVSPEAA 979
H D+ +NVL ++DFGL +L E A E+
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--------LESI 191
Query: 980 LTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
L T +SDV+S+G+ + EL+T G +P + + + L+KG E L
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKG---ERLPQ-- 240
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD---IPSSADPT 1093
P + +++ VK C D RP +++ P + +
Sbjct: 241 ----PPICTIDVYMIMVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 292
Query: 1094 TQPSPA 1099
PSP
Sbjct: 293 HLPSPT 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 43/243 (17%), Positives = 86/243 (35%), Gaps = 28/243 (11%)
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQD----GHVL 901
+ E + + +++ G ++ ++Y+YM N ++ + D +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEV-YIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 902 NWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960
++ +I V +++H N+ H D+KP N+L D + LSDFG
Sbjct: 150 IQVIKCIIK-SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY-----MV 203
Query: 961 ASTSTTAVGTLGYVSPEAALTGETT---KESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
+ GT ++ PE + E++ + D++S GI L + P F+ +V+
Sbjct: 204 DKKIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVE 260
Query: 1018 WVKKQLQKGQIT----ELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTM 1070
++ I L + L +P +R T
Sbjct: 261 LFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR--KNPAERITS 317
Query: 1071 SDI 1073
D
Sbjct: 318 EDA 320
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 61/287 (21%), Positives = 115/287 (40%), Gaps = 49/287 (17%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY- 866
+G+V++ + I+ + + + F EA + + ++ L G
Sbjct: 38 FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL-----IALGVARGLAFLH 921
G P L++ + M G+L + L+ + L +A +A G+A+L+
Sbjct: 98 SQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 155
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SP 976
+ VH D+ +N + DF + DFG+ R T G G + SP
Sbjct: 156 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 209
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E+ G T SDV+SFG+VL E+ T ++P +E ++++V +G + L+
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EGGL---LDK- 261
Query: 1036 LLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
P+ E + C +P RP+ +I+ ++
Sbjct: 262 -----PDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIKEE 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 3e-21
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 35/211 (16%)
Query: 832 IRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY-------YAGAPDLRLLVYDYMPNG 884
R+ E E + + K+ H N V+ DL LL +Y G
Sbjct: 47 CRQELSPKNRERWCL-EIQIMKKLNHPN--VVSAREVPDGLQKLAPNDLPLLAMEYCEGG 103
Query: 885 NLGTLLQEASHQDG-------HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF 937
+L L + + G + + + + L +LH + ++H D+KP+N++
Sbjct: 104 DLRKYLNQFENCCGLKEGPIRTL----LSDISS-----ALRYLHENRIIHRDLKPENIVL 154
Query: 938 DADFEAH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFG 994
+ + D G + T VGTL Y++PE + T D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQG----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 995 IVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025
+ E +TG RP F + V+W K +K
Sbjct: 211 TLAFECITGFRP--FLPNWQPVQWHGKVREK 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 64/282 (22%), Positives = 104/282 (36%), Gaps = 51/282 (18%)
Query: 816 YGLVFKACYNDGMVLSIR----RLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYY 867
+G+V + ++ ++ L L + F +E + + HRNL L G
Sbjct: 31 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNM 925
P +V + P G+L L++ GH + L A+ VA G+ +L +
Sbjct: 91 LTPP--MKMVTELAPLGSLLDRLRK---HQGHF---LLGTLSRYAVQVAEGMGYLESKRF 142
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST--------TAVGTLGYVSPE 977
+H D+ +N+L + DFGL R A PE
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA--------PE 194
Query: 978 AALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ T + SD + FG+ L E+ T G+ P + I+ + K+ G E L
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---G---ERLPR-- 246
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE + + V + C A P DRPT + L
Sbjct: 247 ----PEDCPQDIY----NVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 51/289 (17%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY- 866
+G V+K I+ L D + FR EA +++H N+ L G
Sbjct: 22 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL-----------IALGVAR 915
P +++ Y +G+L L S R + + +A
Sbjct: 82 TKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV- 974
G+ +L + ++VH D+ +NVL +SD GL R + + +
Sbjct: 140 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY------AADYYKLLGNSLLP 193
Query: 975 ----SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
+PEA + G+ + +SD++S+G+VL E+ + G +P ++D V + ++ Q+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VVEMIRNRQV- 248
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L P+ + L + C P RP DI L
Sbjct: 249 --LPC------PDDCPAWVYAL----MIECWNEFPSRRPRFKDIHSRLR 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 56/336 (16%), Positives = 113/336 (33%), Gaps = 51/336 (15%)
Query: 754 ESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSR 813
+ AA K S + + + + + +
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR-----------IYSILKQIGS 66
Query: 814 TRYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNLTVLR--GYYA 868
VF+ + +I+ + D +R E +L K++ + ++R Y
Sbjct: 67 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
+ +V + N +L + L++ ++ R + + +H +VH
Sbjct: 127 TDQYI-YMVMEC-GNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA---------- 978
D+KP N L D L DFG+ + + + VG + Y+ PEA
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 979 -ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
+ + +SDV+S G +L + GK P F Q + + + + E P +
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEF--PDIP 293
Query: 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ ++ L C DP R ++ ++
Sbjct: 294 -----EKDLQDVLKC------CLKRDPKQRISIPEL 318
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-20
Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 24/206 (11%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLP-DGSLDENL--FRKEAEFLGKVRHRNLTVLRGYYAGAP 871
V A G +++RR+ + +E + + E H N+ R +
Sbjct: 40 LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR-HLIAL---GVARGLAFLHTSNMVH 927
+L +V +M G+ L+ M IA GV + L ++H VH
Sbjct: 100 EL-WVVTSFMAYGSAKDLICTH-------FMDGMNELAIAYILQGVLKALDYIHHMGYVH 151
Query: 928 GDIKPQNVLFDADFEAHLSDFG----LDRLTIPTPAEASTSTTAVGTLGYVSPE---AAL 980
+K ++L D + +LS + +V L ++SPE L
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 981 TGETTKESDVYSFGIVLLELLTGKRP 1006
G K SD+YS GI EL G P
Sbjct: 212 QGYDAK-SDIYSVGITACELANGHVP 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 35/238 (14%), Positives = 81/238 (34%), Gaps = 19/238 (7%)
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA-SFRNLPGLENLNLR 422
+C + IP ++L L +IP+ +F NLP + + +
Sbjct: 9 ECHQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63
Query: 423 HNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASI-GNLSQLMVFNLSGNAFSGRIPA 480
+ L ++ ++ +++ + + L L + P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 481 --SLGNLLKLTTLDLSKQNFSGELPIE-LAGLPN-LQVIALQENKLSGNVPEGFSSLMSL 536
+ + L+++ + +P+ GL N + L N + +V + L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 537 RYLNLSFNGFVGQIPA-TFSFLRSV-VVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
+ L+ N ++ I F + S +L S ++ ++P + L+ L R+
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 36/206 (17%), Positives = 76/206 (36%), Gaps = 12/206 (5%)
Query: 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGF 546
TL L + + + LPN+ I + + + F +L + ++ +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 547 VGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE--LGNCSDLEVLELRSNSLTGHIPTDI- 602
+ I L + L + P + + +LE+ N IP +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 603 SHL-SHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN-HLSGGIPDSLAKL-SNLAVL 659
L + L L N T + + L ++ +N N +L+ D+ + S ++L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 660 DLSANNLSGEIPAN-LSSIFGLMNFN 684
D+S +++ +P+ L + L+ N
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 7/125 (5%)
Query: 555 SFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLD 612
S S L H+ +IP N ++ + + + + + +LS + ++
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 613 LSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPD--SLAKLSNLAVLDLSANNLSGE 669
+ I + + L+ L + + L PD + +L+++ N
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 670 IPANL 674
IP N
Sbjct: 146 IPVNA 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 37/264 (14%), Positives = 78/264 (29%), Gaps = 68/264 (25%)
Query: 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275
S L L + A LP + + ++ + + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES----------------- 73
Query: 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQI-----RGAFPLWLTRASTLTRLDVSGNSI 330
++F N+ S + ++++ + A L L + +
Sbjct: 74 ---HSFYNL---------SKVTHIEIRNTRNLTYIDPDAL----KELPLLKFLGIFNTGL 117
Query: 331 SGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPE--FLGD 388
P + +L++ N + IP F G
Sbjct: 118 K-MFPDLTK----------------------VYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG--MNNLSTLDLS 446
+L L N F+ S+ N L+ + L N + ++ G + S LD+S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 447 ENKFSGEVPASI-GNLSQLMVFNL 469
+ + +P+ +L +L+ N
Sbjct: 214 QTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 44/275 (16%), Positives = 78/275 (28%), Gaps = 79/275 (28%)
Query: 52 PAAPCD---WRGVACTNNRVT----------ELRLPRLQLSGRISDHLSNLRMLRKLSLR 98
+ PC+ T + L+L L S SNL + ++ +
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 99 SNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAND- 157
+ + + F NLS + + + R I D
Sbjct: 64 IDVTLQQLESH---------SFY--------------NLSKVTHIEIRNTRNLTYIDPDA 100
Query: 158 ---LPRNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPA-TFEGTLPSAI 212
LP LK+ + + G P T + + ++ + N + +P F+G
Sbjct: 101 LKELP-LLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL----- 154
Query: 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIR 272
C+ + L N + KL V L +N V+
Sbjct: 155 --CNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDK-------------- 197
Query: 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR 307
+AF V S +LD+ Q +
Sbjct: 198 ------DAFGGV--------YSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 23/122 (18%), Positives = 47/122 (38%), Gaps = 11/122 (9%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-SKCSS 631
S+PP + L+L L S+L +++ + +SI+ ++ S
Sbjct: 28 SLPP------STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 632 LRSL-LVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN--LSSIFGLMNFNVSSN 688
+ + + N+ +L+ PD+L +L L L + L P + S ++ N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140
Query: 689 NL 690
Sbjct: 141 PY 142
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 34/232 (14%)
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKF 450
K+L L+ N SF + P L+ L+L + ++ + +++LSTL L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 451 SGEVPASI-GNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFSGELPIE--L 506
+ LS L + + G+L L L+++ N +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA-HNLIQSFKLPEYF 145
Query: 507 AGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565
+ L NL+ + L NK+ ++ L + LNLS L
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS--------------------LDL 184
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSIN 616
S N ++ I P L+ L L +N L +P I L+ L + L N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 16/221 (7%)
Query: 453 EVPASI-GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-AGLP 510
++P ++ + L +LS N S + +L LDLS+ + L
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 511 NLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNH 569
+L + L N + ++ G FS L SL+ L L+++ L+ + N
Sbjct: 77 HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 570 ISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNV----LDLSINNLTGEIP 623
I PE N ++LE L+L SN + I L + + LDLS+N + I
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 624 DEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664
K L+ L +++N L +L++L + L N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 29/218 (13%)
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSL 536
+P S LDLS P LQV+ L ++ + +G + SL L
Sbjct: 26 LPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 537 RYLNLSFNGFVGQI----PATFSFLRSVVVLSFSGNHISGSIPPEL-GNCSDLEVLELRS 591
L L+ N I FS L S+ L +++ S+ G+ L+ L +
Sbjct: 79 STLILTGN----PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133
Query: 592 NSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLR----SLLVNSNHLSGG 645
N + + S+L++L LDLS N + I + SL ++ N ++
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF- 191
Query: 646 IPDSLAKLSNLAVLDLSANNLS---GEIPANLSSIFGL 680
I K L L L N L I L+S+ +
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKI 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 41/195 (21%), Positives = 69/195 (35%), Gaps = 34/195 (17%)
Query: 507 AGLP-NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLS 564
LP + + + L N L F S L+ L+LS + I + L + L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLI 82
Query: 565 FSGNHISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIP 623
+GN I S+ S L+ L +L I HL L L+++ N +
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK 140
Query: 624 DEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPA----NLSSI-F 678
+P+ + L+NL LDLS+N + I L +
Sbjct: 141 ----------------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPL 177
Query: 679 GLMNFNVSSNNLQAF 693
++ ++S N +
Sbjct: 178 LNLSLDLSLNPMNFI 192
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 20/225 (8%)
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
+LP + K DLS N S + +LQ+++ S + ++ S
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL--------S 76
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276
L L GN + + A L LQ + + NL+ + G+ +++ + +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPI----GHLKTLKELNV 131
Query: 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISG 332
N + PE S + L+ LDL N+I+ + LD+S N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 333 KIPAQIGGLWRLEELKMANNSFGGAVPVEI-KQCSSLSLLDLEGN 376
I RL+EL + N +VP I + +SL + L N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 50/241 (20%), Positives = 76/241 (31%), Gaps = 30/241 (12%)
Query: 56 CDWRGVACTNNR-----------VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNG 104
C L L L S + L+ L L
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 105 TIPA-TLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANR---LSGEIANDLP 159
TI + L + L N + +L LS+L+ L L L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 160 RNLKYFDLSSNGF-SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL 218
LK +++ N S +P SNL+ L+ ++ S NK L SL
Sbjct: 125 -TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSL 182
Query: 219 VHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGF 278
LS N + I P +L+ ++L N L VP +F + S++ + L
Sbjct: 183 -DLS--LNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRL----TSLQKIWLHT 233
Query: 279 N 279
N
Sbjct: 234 N 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-20
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 44/279 (15%)
Query: 808 ENVLSRTRYGLVFKACYN-DGMVL---SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
L YG V + IR+ + + +E L + H N+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFL 920
++ + L V + G L + D V+ ++ ++ G+ +L
Sbjct: 102 YDFFEDKRNYYL-VMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVL-----SGVTYL 152
Query: 921 HTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
H N+VH D+KP+N+L + D + DFGL + +GT Y++PE
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ----KKMKERLGTAYYIAPE 208
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
L + ++ DV+S G++L LL G P D++I++ V+K
Sbjct: 209 -VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--------------- 252
Query: 1038 ELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
+ +S EW+ G K +L D R +
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQ--FDSQRRISAQQA 289
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-20
Identities = 76/451 (16%), Positives = 136/451 (30%), Gaps = 70/451 (15%)
Query: 293 SSVLQVLDLQQNQIRGAFPLWLTRA-STLTRLDVSGNSISGK----IPAQIGGLWRLEEL 347
S +Q LD+Q ++ A L + + ++ I + + L EL
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 348 KMANNSFGGAVPVEIKQC-----SSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLA 398
+ +N G + Q + L L+ +G + L + L+ L L+
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 399 ANLFSGS-----IPASFRNLPGLENLNLRHNSLS----GSLPEEVLGMNNLSTLDLSENK 449
NL + LE L L + SLS L + + L +S N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 450 FSGEVPASIG-----NLSQLMVFNLSGNAFSGRIPASLGNLLK----LTTLDLSKQNFSG 500
+ + + QL L + L ++ L L L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 501 ELPIELA-----GLPNLQVIALQENKLSGNVPEGFSSLM-------SLRYLNLSFNGF-- 546
EL L+ + + E ++ +G L SL+ L+L+ N
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGIT---AKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 547 --VGQI-PATFSFLRSVVVLSFSGNHISG----SIPPELGNCSDLEVLELRSNSLTGHIP 599
+ + L + L L L++ +N L
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358
Query: 600 TDIS-----HLSHLNVLDLSINNLTGE----IPDEISKCSSLRSLLVNSNHLSGGIPDSL 650
++ S L VL L+ +++ + + SLR L +++N L L
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 418
Query: 651 AKL-----SNLAVLDLSANNLSGEIPANLSS 676
+ L L L S E+ L +
Sbjct: 419 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 449
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-20
Identities = 74/435 (17%), Positives = 130/435 (29%), Gaps = 75/435 (17%)
Query: 160 RNLKYFDLSSNGFSGP-IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL 218
+++ D+ S + L Q Q++ + + SA+ +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT----EARCKDISSALRVNPAL 58
Query: 219 VHLSAQGNALGGVIPPAIGAL-----PKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRV 273
L+ + N LG V + K+Q +SL L + + P+++
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL-TGAGCGVLSSTLRTLPTLQE 117
Query: 274 VQLGFNAFTNVAGPE----TGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDV 325
+ L N + L+ L L+ + L L V
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 326 SGNSISGKIPAQIGGL-----WRLEELKMANNSFGGAVPVEI----KQCSSLSLLDLEGN 376
S N I+ + +LE LK+ + ++ +SL L L N
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237
Query: 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS----GSLPE 432
+ G+ L P L L + ++ G L
Sbjct: 238 KLGDV---------GMAEL----------CPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 433 EVLGMNNLSTLDLSENKFSGEVPASIGNL-----SQLMVFNLSGNAFSGRIPASLGNLLK 487
+ +L L L+ N+ E + QL + +F+ + ++L
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 488 ----LTTLDLSKQNFSGELPIELA-----GLPNLQVIALQENKLSGNVPEGFSSL----- 533
L L +S EL L+V+ L + +S SSL
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS---DSSCSSLAATLL 395
Query: 534 --MSLRYLNLSFNGF 546
SLR L+LS N
Sbjct: 396 ANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-19
Identities = 75/427 (17%), Positives = 145/427 (33%), Gaps = 73/427 (17%)
Query: 318 STLTRLDVSGNSISGKIPAQIG-GLWRLEELKMANNSFG--GAVPV--EIKQCSSLSLLD 372
+ LD+ +S A++ L + + +++ + + ++ +L+ L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 373 LEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS----G 428
L N LGD G+ + L + S ++ L+L++ L+ G
Sbjct: 63 LRSNE--------LGD-VGVHCV--LQGLQTPS--------CKIQKLSLQNCCLTGAGCG 103
Query: 429 SLPEEVLGMNNLSTLDLSENKFSGEVPASIG-----NLSQLMVFNLSGNAFSGRIPASLG 483
L + + L L LS+N + +L L + S L
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 484 NLLK----LTTLDLSKQNFSGELPIELA-GLP----NLQVIALQENKLS----GNVPEGF 530
++L+ L +S + + L GL L+ + L+ ++ ++
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 531 SSLMSLRYLNLSFN-----GFVGQIPATFSFLRSVVVLSFSGNHIS----GSIPPELGNC 581
+S SLR L L N G P + L I+ G + L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 582 SDLEVLELRSNSLTGH-----IPTDISHLSHLNVLDLSINNLTGE----IPDEISKCSSL 632
L+ L L N L T + L L + + T +++ L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 633 RSLLVNSNHLSGGIPDSLAKL-----SNLAVLDLSANNLSGEIPANLSSIFG----LMNF 683
L +++N L L + S L VL L+ ++S ++L++ L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 684 NVSSNNL 690
++S+N L
Sbjct: 404 DLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-12
Identities = 73/427 (17%), Positives = 128/427 (29%), Gaps = 94/427 (22%)
Query: 59 RGVACTNNRVTELRLPRLQLSGR----ISDHLSNLRMLRKLSLRSNSFNGT-----IPAT 109
+G+ + ++ +L L L+G +S L L L++L L N
Sbjct: 78 QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 137
Query: 110 LAQCTLLRAVFLQYNSLS----GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYF 165
L L + L+Y SLS L + + + + L V+ N ++ L + LK
Sbjct: 138 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK-- 195
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
+ QL+ + + + L +A+ +SL L+
Sbjct: 196 ---------------DSPCQLEALKLESCGVTSDNCR----DLCGIVASKASLRELALGS 236
Query: 226 NALG--GVIPPAIGAL---PKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNA 280
N LG G+ G L +L+ + + + + C V S++ + L N
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGI-TAKGCGDLCRVLRAKESLKELSLAGNE 295
Query: 281 FTNVAGPETG----SCSSVLQVLDLQQNQI--RGAFPL--WLTRASTLTRLDVSGNSISG 332
+ L+ L ++ L + L L +S N +
Sbjct: 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355
Query: 333 KIPAQIGGLWRL-EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRG 391
G+ L + L S L +L L S
Sbjct: 356 A------GVRELCQGLGQPG--------------SVLRVLWLADCDVSDS---------S 386
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGS---LPEEVLGMNN--LSTLDLS 446
SL L L+L +N L + E + L L L
Sbjct: 387 CSSLAAT-----------LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435
Query: 447 ENKFSGE 453
+ +S E
Sbjct: 436 DIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-12
Identities = 59/330 (17%), Positives = 104/330 (31%), Gaps = 61/330 (18%)
Query: 92 LRKLSLRSNSFNGT----IPATLAQCTLLRAVFLQYNSLSGN-----LPANIGNLSNLEI 142
L KL L S + + + L + + + N ++ + LE
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 143 LNVAANRLSGE----IANDLPRN--LKYFDLSSN-----GFSGPIPTSISNLSQLQLINF 191
L + + ++ + + + L+ L SN G + P + S+L+ +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 192 SFNKFSREVPATFEG--TLPSAIANCSSLVHLSAQGNALGGVIPPAIGAL-----PKLQV 244
T +G L + SL LS GN LG + +L+
Sbjct: 264 WECGI------TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPE----TGSCSSVLQVLD 300
+ + + S F +V + +Q+ N + E G SVL+VL
Sbjct: 318 LWVKSCSF-TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 301 LQQNQIR--GAFPL--WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGG 356
L + L L +L LD+S N + G+ +L E
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA------GILQLVESVRQPG---- 426
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFL 386
L L L +S E+ + L
Sbjct: 427 ---------CLLEQLVLYDIYWSEEMEDRL 447
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 57/294 (19%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGY 866
+G V +A + ++ L + E + L + H N+ L G
Sbjct: 36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95
Query: 867 YA-GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP-----------MRHLI--ALG 912
G P L++ +Y G+L L+ P + L+ +
Sbjct: 96 CTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VA+G+AFL + N +H D+ +N+L + DFGL R + S V
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDSNYVVKGNA 207
Query: 973 YV-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQ 1024
+ +PE+ T ESDV+S+GI L EL + G P M + K ++
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 262
Query: 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+G + PE + E + + C DP+ RPT IV ++E
Sbjct: 263 EGFR---MLS------PEHAPAEMY----DIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 47/264 (17%), Positives = 91/264 (34%), Gaps = 44/264 (16%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGH 899
++ +E E L K+ H+N+ L L+ ++ P G+L T+L+E + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAY 107
Query: 900 VLNWP-----MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH----LSDFGL 950
L +R ++ G+ L + +VH +IKP N++ + L+DFG
Sbjct: 108 GLPESEFLIVLRDVVG-----GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 951 DRLTIPTPAEASTSTTAVGTLGYVSPE--------AALTGETTKESDVYSFGIVLLELLT 1002
R + + GT Y+ P+ + D++S G+ T
Sbjct: 163 AR----ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 1003 GKRPVMFTQDEDIVKWVKKQLQKGQ------ITELLEPGLLELDPESSEWEEFLLGVK-- 1054
G P + K V ++ G+ + E G ++ + G++
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 1055 -----VALLCTAPDPIDRPTMSDI 1073
+L D
Sbjct: 279 LTPVLANILEA--DQEKCWGFDQF 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 56/289 (19%)
Query: 816 YGLVFKACYNDG---MVLSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGY-YA 868
+G V KA M +I+R+ + + ++ F E E L K+ H N+ L G
Sbjct: 38 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQE-----------ASHQDGHVLNWPMRHLIALGVARGL 917
L +Y P+GNL L++ ++ L+ A VARG+
Sbjct: 98 RGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV--- 974
+L +H D+ +N+L ++ A ++DFGL R T+G +
Sbjct: 156 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVR 206
Query: 975 --SPEAALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQKGQIT 1029
+ E+ T SDV+S+G++L E+++ G P M + + ++L +G
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGY-- 258
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
LE P + + E + L C P +RP+ + I+ L
Sbjct: 259 -RLEK------PLNCDDEVYDL----MRQCWREKPYERPSFAQILVSLN 296
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 63/297 (21%)
Query: 816 YGLVFKACY------NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGY 866
+G V +A + + ++++ L + + E + + + +H N+ L G
Sbjct: 59 FGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG- 117
Query: 867 YA---GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWP-------MRHLI--ALGVA 914
A G P L++ +Y G+L L+ S + R L+ + VA
Sbjct: 118 -ACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA-EASTST------TA 967
+G+AFL + N +H D+ +NVL A + DFGL R + + A
Sbjct: 175 QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 234
Query: 968 VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP---VMFTQDEDIVKWVKKQL 1023
PE+ T +SDV+S+GI+L E+ + G P ++ K +
Sbjct: 235 --------PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLV 280
Query: 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
+ G + P + + + C A +P RPT I L+
Sbjct: 281 KDGYQ---MAQ------PAFAPKNIY----SIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRG- 865
+G V +A + ++ L +G+ E + L + H N+ L G
Sbjct: 40 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99
Query: 866 -YYAGAPDLRLLVYDYMPNGNLGTLLQEASH---------QDGHVLNWPMRHLI--ALGV 913
G P +++ ++ GNL T L+ + +D + + HLI + V
Sbjct: 100 CTKPGGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
A+G+ FL + +H D+ +N+L + DFGL R
Sbjct: 158 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY------KDPDYVRKGDAR 211
Query: 974 V-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVKWVKKQLQK 1025
+ +PE T +SDV+SFG++L E+ + G P + +E ++L++
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKE 266
Query: 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
G + P+ + E + + L C +P RPT S++V L
Sbjct: 267 GTR---MRA------PDYTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 52/290 (17%), Positives = 87/290 (30%), Gaps = 64/290 (22%)
Query: 829 VLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLG 887
+++ ++ + D + E + K+ H N+ L Y + LV + G+L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI-CLVMELCHGGHLL 116
Query: 888 TLLQEASHQDGHVLNWPMRHLIALG----------------------------------- 912
L +
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLDR-LTIPTPAEASTSTTAVG 969
+ L +LH + H DIKP+N LF + + DFGL + E TT G
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 970 TLGYVSPEAALTGET---TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
T +V+PE L + D +S G++L LL G P D D + V +
Sbjct: 237 TPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK---- 291
Query: 1027 QITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
+L E+ + + LL + +R
Sbjct: 292 -----------KLCFENPNYNVLSPLARDLLSNLLN--RNVDERFDAMRA 328
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 55/300 (18%), Positives = 115/300 (38%), Gaps = 43/300 (14%)
Query: 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFR---KEAEFLGKVRHRN 859
F++ + L G+VFK + G+V++ + + + + +E + L +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPY 92
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ G + ++ + ++M G+L +L++A +L +++ V +GL +
Sbjct: 93 IVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 146
Query: 920 LHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
L ++H D+KP N+L ++ E L DFG + S + + VGT Y+SPE
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSMANSFVGTRSYMSPER 201
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038
+ +SD++S G+ L+E+ G+ P+ +++ Q++ P
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 1039 LDPESSEWEEFLLGVKVALL--------------------------CTAPDPIDRPTMSD 1072
+ LL C +P +R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 45/282 (15%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLP-DGSLDENLFRKEAEFLGKVRHRN 859
+++ + + G V+ A G ++IR++ + L E + + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ Y +L +V +Y+ G+L ++ E +G + + + L F
Sbjct: 79 IVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQI------AAVCRECLQALEF 131
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGYVSPEA 978
LH++ ++H DIK N+L D L+DFG ++T E S +T VGT +++PE
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEV 187
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITE 1030
+ D++S GI+ +E++ G+ P ++ I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----------------LIAT 230
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
P L + S+ + +FL C D R + +
Sbjct: 231 NGTPELQNPEKLSAIFRDFL------NRCLEMDVEKRGSAKE 266
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-19
Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 40/242 (16%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QD 897
E L + H N+ L + LV ++ G L + D
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF-YLVTEFYEGGELFEQIINRHKFDECD 147
Query: 898 GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLT 954
+ M+ + G+ +LH N+VH DIKP+N+L ++ + DFGL
Sbjct: 148 AANI---MKQ-----ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
+GT Y++PE L + ++ DV+S G+++ LL G P D+D
Sbjct: 200 SKD----YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMS 1071
I+K V+K + + ++W+ K +L D R T
Sbjct: 255 IIKKVEKG---------------KYYFDFNDWKNISDEAKELIKLMLT--YDYNKRCTAE 297
Query: 1072 DI 1073
+
Sbjct: 298 EA 299
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 62/277 (22%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDE-NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
YG+V+ + ++I+ +P+ +E ++H+N+ G ++ +
Sbjct: 35 YGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94
Query: 874 RLLVYDYMPNGNLGTLLQEA----SHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
++ + + +P G+L LL+ + + + + ++ GL +LH + +VH D
Sbjct: 95 KIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFY-TKQIL-----EGLKYLHDNQIVHRD 147
Query: 930 IKPQNVLFDA-DFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGYVSPE---AALTGET 984
IK NVL + +SDFG RL + T GTL Y++PE G
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLA----GINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 985 TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP-------GLL 1037
+D++S G ++E+ TGK P + EL EP G+
Sbjct: 204 KA-ADIWSLGCTIIEMATGKPP-----------F----------YELGEPQAAMFKVGMF 241
Query: 1038 ELDPE-----SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
++ PE S+E + F+ L C PDP R
Sbjct: 242 KVHPEIPESMSAEAKAFI------LKCFEPDPDKRAC 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLP--DGSLDENLFRKEAEFLGKVRHR 858
F + + + +G VFK N V++I+ + + + ++E L +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
+T G Y L ++ +Y+ G+ LL+ + + I + +GL
Sbjct: 81 YVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQI------ATILREILKGLD 133
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD-RLTIPTPAEASTSTTAVGTLGYVSPE 977
+LH+ +H DIK NVL E L+DFG+ +LT T VGT +++PE
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNTFVGTPFWMAPE 189
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRP 1006
++D++S GI +EL G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 7e-19
Identities = 47/264 (17%), Positives = 91/264 (34%), Gaps = 44/264 (16%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGH 899
++ +E E L K+ H+N+ L L+ ++ P G+L T+L+E + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAY 107
Query: 900 VLNWP-----MRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH----LSDFGL 950
L +R ++ G+ L + +VH +IKP N++ + L+DFG
Sbjct: 108 GLPESEFLIVLRDVVG-----GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 951 DRLTIPTPAEASTSTTAVGTLGYVSPE--------AALTGETTKESDVYSFGIVLLELLT 1002
R + + GT Y+ P+ + D++S G+ T
Sbjct: 163 AR----ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 1003 GKRPVMFTQDEDIVKWVKKQLQKGQ------ITELLEPGLLELDPESSEWEEFLLGVK-- 1054
G P + K V ++ G+ + E G ++ + G++
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 1055 -----VALLCTAPDPIDRPTMSDI 1073
+L D
Sbjct: 279 LTPVLANILEA--DQEKCWGFDQF 300
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 39/211 (18%), Positives = 73/211 (34%), Gaps = 19/211 (9%)
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
L +L KQ+ + + L +Q + + G +L+ L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 542 SFNGFVGQIP--ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIP 599
S N QI + L + LS + N + ++ + + L L L +N L
Sbjct: 71 SHN----QISDLSPLKDLTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELRD--T 121
Query: 600 TDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVL 659
+ HL +L +L + N L I + S L L ++ N ++ L +L + +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWI 177
Query: 660 DLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
DL+ E ++
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 41/234 (17%), Positives = 76/234 (32%), Gaps = 21/234 (8%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L NL S++ + ++ ++ + + + A + + L +LS
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSH 72
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
N S + L +L KL L +++ + L + L N+L +
Sbjct: 73 NQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLI 125
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
L +L L++ N + I FL + VL GN I+ + L + ++L
Sbjct: 126 HLKNLEILSIRNNK-LKSIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTG 181
Query: 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEI--PDEISKCSSLRSLLVNSNHLS 643
L N ++ + G P IS S V
Sbjct: 182 QKCVNEPVKYQPELYITN----TVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 53/276 (19%), Positives = 102/276 (36%), Gaps = 33/276 (11%)
Query: 301 LQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPV 360
+ I FP + + ++ S++ + L ++ N++
Sbjct: 4 QRPTPINQVFPD--PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG- 58
Query: 361 EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420
++ ++L L L N+ S ++ L D+ L+ L++ N NL G+ +
Sbjct: 59 -MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK--------NLNGIPSAC 107
Query: 421 LRHNSLSG---SLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477
L L + ++ + NL L + NK V +G LS+L V +L GN +
Sbjct: 108 LSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNT 165
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV--PEGFSSLMS 535
L L K+ +DL+ Q P++ P L + ++ G P S+ S
Sbjct: 166 GG--LTRLKKVNWIDLTGQKCV-NEPVKY--QPELYITNTVKD-PDGRWISPYYISNGGS 219
Query: 536 LRYLNLSFN--GFVGQIPATFSFLRSV--VVLSFSG 567
+ + + ++ FS +V F G
Sbjct: 220 YVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 36/186 (19%), Positives = 63/186 (33%), Gaps = 37/186 (19%)
Query: 506 LAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565
GL N L + ++ L ++ N + + + F ++ L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSN-IQSLAG-MQFFTNLKELHL 70
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE 625
S N IS + P L + + LE L + N L +++ +
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSAC---------------- 107
Query: 626 ISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNV 685
L L +++N L DSL L NL +L + N L I L + L ++
Sbjct: 108 ------LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDL 157
Query: 686 SSNNLQ 691
N +
Sbjct: 158 HGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 33/199 (16%), Positives = 68/199 (34%), Gaps = 29/199 (14%)
Query: 65 NNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
+ ++ + L ++D L ++ + +++ + T
Sbjct: 6 PTPINQVFPDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFT 63
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSG 174
L+ + L +N +S +L + +L+ LE L+V NRL + L L +N
Sbjct: 64 NLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELRD 120
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
S+ +L L++++ NK + S L L GN +
Sbjct: 121 T--DSLIHLKNLEILSIRNNKLKS----------IVMLGFLSKLEVLDLHGNEITNTGG- 167
Query: 235 AIGALPKLQVVSLAQNNLS 253
+ L K+ + L
Sbjct: 168 -LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 42/278 (15%), Positives = 85/278 (30%), Gaps = 34/278 (12%)
Query: 178 TSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIG 237
L+ N + V S + + + + + + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS----------QKELSGVQNFNGDNSNIQSLAG--MQ 60
Query: 238 ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQ 297
L+ + L+ N +S + P + + + N N+ G S+ L
Sbjct: 61 FFTNLKELHLSHNQISDLSPLKDL-------TKLEELSVNRNRLKNLNGIP----SACLS 109
Query: 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGA 357
L L N++R L L L + N + I +G L +LE L + N
Sbjct: 110 RLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT 165
Query: 358 VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT-LAANLFSGSIPASFRNLPGL 416
+ + ++ +DL G + E ++ ++ ++ S P N
Sbjct: 166 GG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSY 220
Query: 417 ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454
+ + L E + + +E F G V
Sbjct: 221 VDGCVLWE-LPVYTDEVSYKFSEYINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 42/245 (17%), Positives = 77/245 (31%), Gaps = 53/245 (21%)
Query: 110 LAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN-DLPRNLKYFDLS 168
L S++ + LS ++ N + + +A NLK LS
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLS 71
Query: 169 SNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNAL 228
N S P + +L++L+ ++ + N+ + I + L L N L
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNRNRLKN----------LNGIPSA-CLSRLFLDNNEL 118
Query: 229 GGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPE 288
+ L L+++S+ N L +V
Sbjct: 119 RDTDS--LIHLKNLEILSIRNNKLKSIVMLGFLSK------------------------- 151
Query: 289 TGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELK 348
L+VLDL N+I LTR + +D++G + L+ +K
Sbjct: 152 -------LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVK 202
Query: 349 MANNS 353
+
Sbjct: 203 DPDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 38/149 (25%), Positives = 61/149 (40%), Gaps = 21/149 (14%)
Query: 63 CTNNRVTEL-------RLPRLQLSG-RISD--HLSNLRMLRKLSLRSNSFNGTIPATLAQ 112
N+ + L L L LS +ISD L +L L +LS+ N + +
Sbjct: 48 GDNSNIQSLAGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLK-NLNG-IPS 105
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN--DLPRNLKYFDLSSN 170
L +FL N L ++ +L NLEIL++ N+L I L L+ DL N
Sbjct: 106 ACL-SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLS-KLEVLDLHGN 160
Query: 171 GFSGPIPTSISNLSQLQLINFSFNKFSRE 199
+ ++ L ++ I+ + K E
Sbjct: 161 EITNTGG--LTRLKKVNWIDLTGQKCVNE 187
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 41/187 (21%), Positives = 69/187 (36%), Gaps = 43/187 (22%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFD-------------ADFEAHLSDFGL-DRLTIPTP 958
+A G+A LH+ ++H D+KPQN+L + +SDFGL +L
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 959 AEASTSTTAVGTLGYVSPE-------AALTGETTKESDVYSFGIVLLELLT-GKRPVMFT 1010
+ + GT G+ +PE T+ D++S G V +L+ GK P F
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP--FG 241
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLLELDP-ESSEWEEFLLGVK---VALLCTAPDPID 1066
+ + G+ LD + + ++ DP+
Sbjct: 242 DKYSRESNIIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMID--HDPLK 286
Query: 1067 RPTMSDI 1073
RPT +
Sbjct: 287 RPTAMKV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 51/265 (19%), Positives = 100/265 (37%), Gaps = 45/265 (16%)
Query: 816 YGLVFKACYND-GMVLSIRRLP-DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
G+V A G ++++ + L E + +H N+ + Y +L
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
++ +++ G L ++ + + + + V + LA+LH ++H DIK
Sbjct: 118 -WVLMEFLQGGALTDIVSQVRLNEEQI------ATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 934 NVLFDADFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYS 992
++L D LSDFG +++ + + VGT +++PE E D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCAQIS----KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 993 FGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESS 1044
GI+++E++ G+ P M ++ + P L S
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMK-----------------RLRDSPPPKLKNSHKVSP 269
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPT 1069
+FL DP +R T
Sbjct: 270 VLRDFL------ERMLVRDPQERAT 288
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 47/281 (16%)
Query: 808 ENVLSRTRYGLVFKA-CYNDGM-----VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT 861
+ VL + +G V G V+S R++ D+ +E + L ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIM 89
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLA 918
L ++ L V + G L + D + +R ++ G+
Sbjct: 90 KLYEFFEDKGYFYL-VGEVYTGGELFDEIISRKRFSEVDAARI---IRQVL-----SGIT 140
Query: 919 FLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
++H + +VH D+KP+N+L D + DFGL + +GT Y++
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIA 196
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
PE L G ++ DV+S G++L LL+G P + DI+K V+K
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG------------- 242
Query: 1036 LLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
+ E +W++ K +L P R + D
Sbjct: 243 --KYTFELPQWKKVSESAKDLIRKMLT--YVPSMRISARDA 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 61/294 (20%), Positives = 109/294 (37%), Gaps = 58/294 (19%)
Query: 816 YGLVFKACYNDGMVLS--------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLR 864
+G V A ++ L D + +++L E E + + +H+N+ L
Sbjct: 94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153
Query: 865 GY-YAGAPDLRLLVYDYMPNGNLGTLLQEAS-----------HQDGHVLNWPMRHLIALG 912
G P ++ +Y GNL L+ + +
Sbjct: 154 GACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ARG+ +L + +H D+ +NVL + ++DFGL R + T G
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN------NIDYYKKTTNG 265
Query: 973 YV-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026
+ +PEA T +SDV+SFG+++ E+ T G P E+ + K L++G
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLLKEG 321
Query: 1027 QITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
++ P ++E + C P RPT +V L+
Sbjct: 322 H---RMDK------PANCTNELYM------MMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 23/264 (8%)
Query: 751 RLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENV 810
R + ++ AE + + S A G + S D G K+ + + V
Sbjct: 4 RPRTTSFAESCKPVQQPS--AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 811 LSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG 869
+ +G+V++A + G +++I+++ +N +E + + K+ H N+ LR ++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRLRYFFYS 118
Query: 870 APDLRL-----LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH--LIALGVARGLAFLHT 922
+ + + LV DY+P T+ + A H P+ + L + R LA++H+
Sbjct: 119 SGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 923 SNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
+ H DIKPQN+L D D L DFG + + + + + + Y +PE
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFG 230
Query: 982 GET-TKESDVYSFGIVLLELLTGK 1004
T DV+S G VL ELL G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 58/294 (19%)
Query: 816 YGLVFKACYNDGMVLS--------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLR 864
+G V A ++ L D + +++L E E + + +H+N+ L
Sbjct: 48 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107
Query: 865 GY-YAGAPDLRLLVYDYMPNGNLGTLLQ-----------EASHQDGHVLNWPMRHLIALG 912
G P ++ +Y GNL L+ + + + +
Sbjct: 108 GACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ARG+ +L + +H D+ +NVL + ++DFGL R + T G
Sbjct: 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------NNIDYYKKTTNG 219
Query: 973 YV-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026
+ +PEA T +SDV+SFG+++ E+ T G P E+ + K L++G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKLLKEG 275
Query: 1027 QITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
++ P ++E + C P RPT +V L+
Sbjct: 276 H---RMDK------PANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLD 314
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 24/180 (13%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA-LGVARGLAFLHTSNMVHGDIKPQN 934
+V D + G+L LQ Q+ H ++ I L +A L +L ++H D+KP N
Sbjct: 92 MVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMA--LDYLQNQRIIHRDMKPDN 145
Query: 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET---TKESDVY 991
+L D H++DF + + + TT GT Y++PE + + + D +
Sbjct: 146 ILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 992 SFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK---------GQITELLEPGLLELDPE 1042
S G+ ELL G+RP + V ++ LL+ LLE +P+
Sbjct: 202 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK-KLLEPNPD 260
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 55/366 (15%), Positives = 117/366 (31%), Gaps = 75/366 (20%)
Query: 765 ARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKA-C 823
A S R +D G + + ++ + VL+ + V++A
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTVELGELRLRV------------RRVLAEGGFAFVYEAQD 49
Query: 824 YNDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLR------- 874
G +++RL +E F+ K+ H N+ + +
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 875 LLV--------YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-- 924
LL+ +++ L VL I R + +H
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCD-----TVLK------IFYQTCRAVQHMHRQKPP 158
Query: 925 MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST---------TAVGTLGYVS 975
++H D+K +N+L L DFG P + ++ T T Y +
Sbjct: 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT 218
Query: 976 PE---AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
PE ++ D+++ G +L L + P F +D K ++ G+ +
Sbjct: 219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F-EDG-----AKLRIVNGKYS--- 267
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADP 1092
+ D + + + + +P +R +++++V L+ ++ +
Sbjct: 268 ---IPPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318
Query: 1093 TTQPSP 1098
T
Sbjct: 319 TELLEQ 324
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 51/247 (20%), Positives = 98/247 (39%), Gaps = 31/247 (12%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
++ + + + + + E + +++H ++ L Y+ + + LV + NG +
Sbjct: 43 MIDKKAMYKAGMVQRVQN-EVKIHCQLKHPSILELYNYFEDSNYV-YLVLEMCHNGEMNR 100
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
L+ + RH + + G+ +LH+ ++H D+ N+L + ++DF
Sbjct: 101 YLKN---RVKPFSENEARHFMH-QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADF 156
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
G L T GT Y+SPE A ESDV+S G + LL G+ P
Sbjct: 157 G---LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP-- 211
Query: 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPID 1066
F + + + K + P S E ++ + LL +P D
Sbjct: 212 F-DTDTVKNTLNK-VVLADYEM----------PSFLSIEAKDLIHQ----LL--RRNPAD 253
Query: 1067 RPTMSDI 1073
R ++S +
Sbjct: 254 RLSLSSV 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 68/299 (22%), Positives = 111/299 (37%), Gaps = 63/299 (21%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY- 866
+G V KA + ++ L + + L E L +V H ++ L G
Sbjct: 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNW-----------------PMRHLI 909
P LL+ +Y G+L L+E+ L M LI
Sbjct: 96 SQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153
Query: 910 --ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
A +++G+ +L +VH D+ +N+L + +SDFGL R +
Sbjct: 154 SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY------EEDSYV 207
Query: 968 VGTLGYV-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKK 1021
+ G + + E+ T +SDV+SFG++L E++T G P E +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF----N 263
Query: 1022 QLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
L+ G +E P+ S E + L C +P RP +DI LE
Sbjct: 264 LLKTGHR---MER------PDNCSEEMYRLM------LQCWKQEPDKRPVFADISKDLE 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 50/303 (16%)
Query: 791 NKITLAETVEATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEA 849
++I L+ + F+ ++ YG V+K + G + +I+ + +E ++E
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEI 71
Query: 850 EFLGKV-RHRNLTVLRGYY----AGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
L K HRN+ G + D +L LV ++ G++ L++ G+ L
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKE 128
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
I + RGL+ LH ++H DIK QNVL + E L DFG+ T +T
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 964 STTAVGTLGYVSPEAALTGETTKES-----DVYSFGIVLLELLTGKRP--------VMFT 1010
+GT +++PE E + D++S GI +E+ G P +F
Sbjct: 189 F---IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070
I + L+ S +++ F+ C + RP
Sbjct: 246 ----IPRN--------------PAPRLKSKKWSKKFQSFI------ESCLVKNHSQRPAT 281
Query: 1071 SDI 1073
+
Sbjct: 282 EQL 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-17
Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 44/279 (15%)
Query: 808 ENVLSRTRYGLVFKACYN-DGMVL---SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
+L + +G V K I + + D + +E E L K+ H N+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFL 920
+ + V + G L + + D + ++ + G+ ++
Sbjct: 87 FEILEDSSSFYI-VGELYTGGELFDEIIKRKRFSEHDAARI---IKQVF-----SGITYM 137
Query: 921 HTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
H N+VH D+KP+N+L + D + + DFGL + +GT Y++PE
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPE 193
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
L G ++ DV+S G++L LL+G P + DI+K V+
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--------------- 237
Query: 1038 ELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
+ + +W K +L P R T +
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQC 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 47/283 (16%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHR 858
FD L YG V+KA + + G +++I+++P ++ +L KE + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSP 84
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
++ G Y DL +V +Y G++ +++ L I +GL
Sbjct: 85 HVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLE 139
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL-DRLTIPTPAEASTSTTAVGTLGYVSPE 977
+LH +H DIK N+L + + A L+DFG+ +LT + T +GT +++PE
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT----DTMAKRNTVIGTPFWMAPE 195
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQIT 1029
+D++S GI +E+ GK P +F I
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----------------MIP 238
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
P + + S + +F+ C P R T +
Sbjct: 239 TNPPPTFRKPELWSDNFTDFV------KQCLVKSPEQRATATQ 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 32/271 (11%), Positives = 72/271 (26%), Gaps = 61/271 (22%)
Query: 836 PDGSLDENL---FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQ 891
P G L +++ L ++ V R +V +++ G+L +
Sbjct: 66 PQGVLPDDVLQETLSRTLRLSRIDKPG--VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD 123
Query: 892 EASHQDGHVLNWPMRHL-IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950
+ P+ + +A H + + P V D + L+
Sbjct: 124 TSPS--------PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA- 174
Query: 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT 1010
+ + D+ G L LL + P+
Sbjct: 175 ----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA 205
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLL--ELDPESSEWEEFLLGVKVALLCTAPDPIDRP 1068
+ ++ + +EP + ++ + S VA D R
Sbjct: 206 GVRSGLAPAERDTA----GQPIEPADIDRDIPFQISA---------VAARSVQGDGGIRS 252
Query: 1069 TMSDIVFMLEGCRVGPDIPSSADPTTQPSPA 1099
S ++ +++ D P + +
Sbjct: 253 A-STLLNLMQQATAVADRTEVLGPIDEAPVS 282
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/273 (21%), Positives = 111/273 (40%), Gaps = 48/273 (17%)
Query: 816 YGLVFKACYND-GMVLSIRRLP-DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873
+G V+KA + G + + + + + + E E L H + L G Y L
Sbjct: 32 FGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933
++ ++ P G + ++ E L P ++ + L FLH+ ++H D+K
Sbjct: 92 -WIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146
Query: 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKES----- 988
NVL + + L+DFG+ + T + + +GT +++PE + ET K++
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSF---IGTPYWMAPEVVMC-ETMKDTPYDYK 202
Query: 989 -DVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
D++S GI L+E+ + P V+ ++ K LL P
Sbjct: 203 ADIWSLGITLIEMAQIEPPHHELNPMRVLL------------KIAKSDPPTLLTPSKW-- 248
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
S E+ +FL + +P RP+ +
Sbjct: 249 ---SVEFRDFL------KIALDKNPETRPSAAQ 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/303 (20%), Positives = 104/303 (34%), Gaps = 66/303 (21%)
Query: 816 YGLVFKACYNDGMVLS------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLRGY 866
+G V A ++ L + + E + + ++ H N+ L G
Sbjct: 58 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117
Query: 867 -YAGAPDLRLLVYDYMPNGNLGTLLQE------------------ASHQDGHVLNWPMRH 907
P L+++Y G+L L+ +D +VL +
Sbjct: 118 CTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA-EASTST- 965
A VA+G+ FL + VH D+ +NVL + DFGL R + +
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235
Query: 966 -----TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRP--VMFTQDEDIVK 1017
A PE+ G T +SDV+S+GI+L E+ + G P +
Sbjct: 236 LPVKWMA--------PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---- 283
Query: 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
K +Q G ++ P + E + + C A D RP+ ++ L
Sbjct: 284 -FYKLIQNGFK---MDQ------PFYATEEIY----IIMQSCWAFDSRKRPSFPNLTSFL 329
Query: 1078 EGC 1080
Sbjct: 330 GCQ 332
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E + + ++ H L Y+ D +L Y NG L ++ + G R
Sbjct: 80 ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTR 133
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
A + L +LH ++H D+KP+N+L + D ++DFG ++ P +A ++
Sbjct: 134 FYTA-EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
VGT YVSPE K SD+++ G ++ +L+ G P F + +K + K
Sbjct: 193 -VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FR-AGNEYLIFQKII-KL 247
Query: 1027 QIT----------ELLEPGLLELDP 1041
+ +L+E LL LD
Sbjct: 248 EYDFPEKFFPKARDLVE-KLLVLDA 271
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 38/276 (13%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLP--DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
+V A C ++I+R+ + KE + + + H N+ + +
Sbjct: 28 TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR-HLIAL---GVARGLAFLHTSNMVHG 928
L LV + G++ +++ G + + IA V GL +LH + +H
Sbjct: 88 L-WLVMKLLSGGSVLDIIKHI-VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145
Query: 929 DIKPQNVLFDADFEAHLSDFGLD-RLT-IPTPAEASTSTTAVGTLGYVSPE--AALTGET 984
D+K N+L D ++DFG+ L T VGT +++PE + G
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 205
Query: 985 TKESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
K +D++SFGI +EL TG P V+ ++ L+ G + +
Sbjct: 206 FK-ADIWSFGITAIELATGAAPYHKYPPMKVLML----TLQNDPPSLETGVQDKEMLKKY 260
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
+ + ++ LC DP RPT ++
Sbjct: 261 ------GKSFRKM-----IS-LCLQKDPEKRPTAAE 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 54/247 (21%), Positives = 93/247 (37%), Gaps = 47/247 (19%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGH- 899
E E L + H N+ + + ++ + V + G L + A +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI-VMETCEGGELLERIVSAQARGKAL 121
Query: 900 ------VLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGL 950
L M+ ++ LA+ H+ ++VH D+KP+N+LF + DFGL
Sbjct: 122 SEGYVAEL---MKQMMN-----ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT 1010
L ST A GT Y++PE + T + D++S G+V+ LLTG P T
Sbjct: 174 AELFKSD----EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 1011 QDEDIVKWVKKQLQKGQITELLEPGLLELDPE----SSEWEEFLLGVKVALLCTAPDPID 1066
E++ + E + + + L +L DP
Sbjct: 229 SLEEVQQKATY-------------KEPNYAVECRPLTPQAVDLLKQ----MLT--KDPER 269
Query: 1067 RPTMSDI 1073
RP+ + +
Sbjct: 270 RPSAAQV 276
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 13/215 (6%)
Query: 489 TTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG 548
+ + E+P +L N + KL FS L + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 549 QIPA-TFSFLRSVVVLSFS-GNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI-SH 604
I A FS L + + N++ I PE N +L+ L + + + H+P H
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 605 LSHLNVLDLSINNLTGEIPDEISK--CSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662
+LD+ N I L +N N + I +S + L L+LS
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 663 ANNLSGEIPAN-LSSIFGLMNFNVSSNNLQAFANN 696
NN E+P + G + ++S + + +
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 48/262 (18%), Positives = 84/262 (32%), Gaps = 41/262 (15%)
Query: 290 GSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKM 349
C +V Q++++ P L R L + I
Sbjct: 5 RICHCSNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQK------------- 47
Query: 350 ANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT----LAANLFSGS 405
+F G L +++ N I L L AN
Sbjct: 48 --GAFSG--------FGDLEKIEISQNDVLEVIEA--DVFSNLPKLHEIRIEKANNLL-Y 94
Query: 406 IPAS-FRNLPGLENLNLRHNSLSGSLPEEV-LGMNNLSTLDLSENKFSGEVP--ASIGNL 461
I F+NLP L+ L + + + LP+ + LD+ +N + + +G
Sbjct: 95 INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 462 SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQEN 520
+ ++ L+ N I S N +L L+LS N ELP + G ++ +
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212
Query: 521 KLSGNVPEGFSSLMSLRYLNLS 542
++ G +L LR +
Sbjct: 213 RIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 55/301 (18%), Positives = 99/301 (32%), Gaps = 67/301 (22%)
Query: 139 NLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSR 198
+ + ++++ EI +DLPRN + S L+ I S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 199 EVPATFEGTLPSAIANCSSLVHLS-AQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVP 257
+ +N L + + N L + P A LP LQ + ++ + +P
Sbjct: 69 VIE-------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120
Query: 258 ASMFCNVSGYPPSIRVVQLGFN---------AFTNVAGPETGSCSSVLQVLDLQQNQIR- 307
+ ++ + N +F S +L L +N I+
Sbjct: 121 DVHKIH----SLQKVLLDIQDNINIHTIERNSFVG--------LSFESVILWLNKNGIQE 168
Query: 308 ---GAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ 364
AF + L L++S N+ LEEL N+ F GA
Sbjct: 169 IHNSAFNG-----TQLDELNLSDNN-------------NLEELP--NDVFHGA------- 201
Query: 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN 424
S +LD+ R L +++ L++ + +P + L L +L +
Sbjct: 202 -SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256
Query: 425 S 425
S
Sbjct: 257 S 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 53/319 (16%), Positives = 84/319 (26%), Gaps = 81/319 (25%)
Query: 52 PAAPCDWRG--VACTNNRVTE-----------LRLPRLQLSGRISDHLSNLRMLRKLSLR 98
C C ++VTE LR +L S L K+ +
Sbjct: 3 HHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 62
Query: 99 SNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDL 158
N I A VF +N+ L + I AN L I +
Sbjct: 63 QNDVLEVIEAD---------VF-----------SNLPKLHEIRIEK--ANNLL-YINPEA 99
Query: 159 PR---NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA-TFEGTLPSAIAN 214
+ NL+Y +S+ G + Q L++ N + +F G
Sbjct: 100 FQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG-------L 152
Query: 215 CSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVV 274
V L N + + A ++ NNL +
Sbjct: 153 SFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN----------------- 195
Query: 275 QLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKI 334
+ F S +LD+ + +I L L K+
Sbjct: 196 ----DVFHGA---------SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 239
Query: 335 PAQIGGLWRLEELKMANNS 353
P + L L E + S
Sbjct: 240 PT-LEKLVALMEASLTYPS 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 50/170 (29%), Positives = 71/170 (41%), Gaps = 16/170 (9%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
FR+E + L R +T L ++A + L LV +Y G+L TLL + G +
Sbjct: 108 FREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS----KFGERIPA 161
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
M + + +H VH DIKP N+L D L+DFG
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD--GTVR 219
Query: 964 STTAVGTLGYVSPE-------AALTGETTKESDVYSFGIVLLELLTGKRP 1006
S AVGT Y+SPE TG E D ++ G+ E+ G+ P
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 47/193 (24%), Positives = 73/193 (37%), Gaps = 13/193 (6%)
Query: 479 PA-SLGNLLKLTTLDLSKQNFSGELPIELAGLP-NLQVIALQENKLSGNVPEGFSSLMSL 536
P + + ++ K+N + LP LP + ++ L EN L L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRL 57
Query: 537 RYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG 596
LNL + ++ L + L S N + S+P L VL++ N LT
Sbjct: 58 TQLNLDRAE-LTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 597 HIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLS 654
+P L L L L N L +P + + L L + +N+L+ L L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 655 NLAVLDLSANNLS 667
NL L L N+L
Sbjct: 173 NLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 60/262 (22%), Positives = 87/262 (33%), Gaps = 61/262 (23%)
Query: 285 AGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL 344
+ S ++ + + A P L T L +S N + A + RL
Sbjct: 3 ICEVSKVAS--HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRL 57
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG 404
+L + + V+ L LDL N+
Sbjct: 58 TQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ------------------------- 90
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQ 463
S+P + LP L L++ N L+ SLP L G+ L L L N+
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK------------ 137
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-AGLPNLQVIALQENKL 522
L + KL L L+ N + ELP L GL NL + LQEN L
Sbjct: 138 ----TLPPGLLTP--------TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 523 SGNVPEGFSSLMSLRYLNLSFN 544
+P+GF L + L N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 50/229 (21%), Positives = 77/229 (33%), Gaps = 58/229 (25%)
Query: 106 IPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYF 165
+P + L N L A + + L LN+ L+ + L
Sbjct: 29 LPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI-ANCSSLVHLSAQ 224
DLS N +P L L +++ SFN+ + +LP L L +
Sbjct: 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT---------SLPLGALRGLGELQELYLK 132
Query: 225 GNALGGVIPPAI-GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTN 283
GN L +PP + PKL+ +SLA NNL+ +PA + +
Sbjct: 133 GNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN----------------- 173
Query: 284 VAGPETGSCSSVLQVLDLQQNQI----RGAFPLWLTRASTLTRLDVSGN 328
L L LQ+N + +G F L + GN
Sbjct: 174 ------------LDTLLLQENSLYTIPKGFFGS-----HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 46/246 (18%), Positives = 83/246 (33%), Gaps = 53/246 (21%)
Query: 136 NLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNK 195
+++ +N L+ + DLP++ LS N ++ ++L +N +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 196 FSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255
+ L L L N L +P LP L V+ ++ N L+ +
Sbjct: 67 LT---------KLQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 256 VPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFP 311
P LQ L L+ N+++ G
Sbjct: 116 ------------PLGA------LRGLGE------------LQELYLKGNELKTLPPGLL- 144
Query: 312 LWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSL 370
T L +L ++ N+++ ++PA + GL L+ L + NS +P L
Sbjct: 145 ---TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPF 199
Query: 371 LDLEGN 376
L GN
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 44/223 (19%), Positives = 69/223 (30%), Gaps = 43/223 (19%)
Query: 52 PAAP----CDWRGVACTNNR-----------VTELRLPRLQLSGRISDHLSNLRMLRKLS 96
P V C T L L L L L +L+
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 97 LRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN 156
L + +L + L +N L +LP L L +L+V+ NRL+
Sbjct: 62 LDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT----- 113
Query: 157 DLPR-------NLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTL 208
LP L+ L N +P + + +L+ ++ + N + L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT---------EL 163
Query: 209 PSAI-ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQN 250
P+ + +L L Q N+L IP L L N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSL 632
++PP+L D +L L N L + + L L+L LT ++ L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79
Query: 633 RSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL-SSIFGLMNFNVSSNNLQ 691
+L ++ N L +P L L VLD+S N L+ +P + L + N L+
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 692 A 692
Sbjct: 138 T 138
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 53/277 (19%), Positives = 108/277 (38%), Gaps = 36/277 (12%)
Query: 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFR---KEAEFLGK-VRHR 858
+ + G V+K + G V++++++ S ++ + + + + K
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
+ G + D+ + + M GT ++ + + + + + + + L
Sbjct: 85 YIVQCFGTFITNTDVFI-AMELM-----GTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 919 FLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
+L ++H D+KP N+L D + L DFG+ + A+ + G Y++PE
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPE 194
Query: 978 ----AALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
T +DV+S GI L+EL TG+ P + + + L ++ +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDF----EVLT--KVLQEE 246
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT 1069
P L S +++ F VK C D RP
Sbjct: 247 PPLLPGHMGFSGDFQSF---VK---DCLTKDHRKRPK 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 56/283 (19%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
++ L E + E + H+++ G++ + +V + +L
Sbjct: 47 IVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGFHGFFEDNDFV-FVVLELCRRRSLLE 104
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
L + + +R ++ G +LH + ++H D+K N+ + D E + DF
Sbjct: 105 LHKRRKALTEPEARYYLRQIVL-----GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 159
Query: 949 GL--------DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLEL 1000
GL +R GT Y++PE + E DV+S G ++ L
Sbjct: 160 GLATKVEYDGERK-----------KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 1001 LTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALL 1058
L GK P F + + + + ++K + + P+ + + +L
Sbjct: 209 LVGKPP--F-ETSCLKETYLR-IKKNEYSI----------PKHINPVAASLI----QKML 250
Query: 1059 CTAPDPIDRPTMSDIV---FMLEGCRVGPDIPSSADPTTQPSP 1098
DP RPT+++++ F G IP+ T P
Sbjct: 251 --QTDPTARPTINELLNDEFFTSGY-----IPARLPITCLTIP 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 68/294 (23%), Positives = 110/294 (37%), Gaps = 58/294 (19%)
Query: 816 YGLVFKACYNDGMVLS--------IRRLPDGSLDENL--FRKEAEFLGKV-RHRNLTVLR 864
+G V A ++ L + +++L E E + + +H+N+ L
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141
Query: 865 GY-YAGAPDLRLLVYDYMPNGNLGTLLQE-----------ASHQDGHVLNWPMRHLIALG 912
G P ++ +Y GNL LQ SH L+ A
Sbjct: 142 GACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
VARG+ +L + +H D+ +NVL D ++DFGL R T G
Sbjct: 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------HIDYYKKTTNG 253
Query: 973 YV-----SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026
+ +PEA T +SDV+SFG++L E+ T G P E+ + K L++G
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLLKEG 309
Query: 1027 QITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
++ P ++E + C P RPT +V L+
Sbjct: 310 H---RMDK------PSNCTNELYM------MMRDCWHAVPSQRPTFKQLVEDLD 348
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 37/278 (13%)
Query: 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFR---KEAEFLGK-VRHR 858
+ L R YG+V K + G +++++R+ +++ + + + + V
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL--IALGVARG 916
G D+ + + M + +L ++ + + P L IA+ + +
Sbjct: 67 FTVTFYGALFREGDVWI-CMELM-DTSLDKFYKQVIDKGQTI---PEDILGKIAVSIVKA 121
Query: 917 LAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L LH+ +++H D+KP NVL +A + + DFG+ + A+ G Y++
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMA 177
Query: 976 PEAALTGETTKE----SDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
PE K SD++S GI ++EL + P + +QL+ Q+ E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPF----QQLK--QVVEE 229
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT 1069
P L D S+E+ +F C + +RPT
Sbjct: 230 PSPQLPA-DKFSAEFVDFT------SQCLKKNSKERPT 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 816 YGLVFKACYND---GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872
YG V+KA D +++++ + + R E L +++H N+ L+ + D
Sbjct: 34 YGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVFLSHAD 92
Query: 873 LRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWP---------MRHLIALGVARGLAFLHT 922
++ L++DY + +L +++ + + ++ G+ +LH
Sbjct: 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-----DGIHYLHA 146
Query: 923 SNMVHGDIKPQNVLFDADFEAH----LSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPE 977
+ ++H D+KP N+L + ++D G RL P A V T Y +PE
Sbjct: 147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPE 205
Query: 978 AALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK---QLQKGQITELL 1032
L G TK D+++ G + ELLT P+ + EDI QL + I ++
Sbjct: 206 -LLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDR--IFNVM 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 40/275 (14%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
++ L E + E + H+++ G++ + +V + +L
Sbjct: 73 IVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGFHGFFEDNDFV-FVVLELCRRRSLLE 130
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
L + + R+ + + G +LH + ++H D+K N+ + D E + DF
Sbjct: 131 LHKRR----KALTEPEARYYLR-QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
GL + E GT Y++PE + E DV+S G ++ LL GK P
Sbjct: 186 GLATK-VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-- 240
Query: 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPID 1066
F + + + + ++K + + P+ + + +L DP
Sbjct: 241 F-ETSCLKETYLR-IKKNEYSI----------PKHINPVAASLI----QKML--QTDPTA 282
Query: 1067 RPTMSDIV---FMLEGCRVGPDIPSSADPTTQPSP 1098
RPT+++++ F G IP+ T P
Sbjct: 283 RPTINELLNDEFFTSGY-----IPARLPITCLTIP 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-17
Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
FR+E + L + +T L +YA D L LV DY G+L TLL + + +
Sbjct: 121 FREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEE 175
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
R +A + + +H + VH DIKP N+L D + L+DFG +
Sbjct: 176 MARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQ 232
Query: 964 STTAVGTLGYVSPEAALTGET-----TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
S+ AVGT Y+SPE E E D +S G+ + E+L G+ P F E +V+
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FY-AESLVE 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 57/282 (20%)
Query: 835 LPDGSLDENL--FRKEAEFLGKVRHRNLTVLRGY-YAGAPDLRLLVYDYMPNGNLGTLLQ 891
L + + + F++EA + + + N+ L G G P L+++YM G+L L+
Sbjct: 85 LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLR 142
Query: 892 EASHQDGHVLNWPMRHL-------------------IALGVARGLAFLHTSNMVHGDIKP 932
S L+ IA VA G+A+L VH D+
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202
Query: 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV-----SPEAALTGETTKE 987
+N L + ++DFGL R S + PE+ T E
Sbjct: 203 RNCLVGENMVVKIADFGLSRNI------YSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256
Query: 988 SDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE--SS 1044
SDV+++G+VL E+ + G +P E+++ +V+ G I L PE
Sbjct: 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR----DGNI---LAC------PENCPL 303
Query: 1045 EWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086
E + C + P DRP+ I +L+ +
Sbjct: 304 ELYNLMRL------CWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 33/278 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFR---KEAEFLGK-VRHR 858
+ + R YG V K + G +++++R+ ++DE + + + + +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
+ G D + + M + + + V+ + I L + L
Sbjct: 82 YIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 919 FLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
L + ++H DIKP N+L D L DFG+ + + A+ T G Y++PE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPE 195
Query: 978 ---AALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
+ + + SDV+S GI L EL TG+ P + + + QL Q+ +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVF----DQLT--QVVKGDP 247
Query: 1034 PGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
P L + S + F V LC D RP
Sbjct: 248 PQLSNSEEREFSPSFINF-----VN-LCLTKDESKRPK 279
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 29/250 (11%)
Query: 773 GGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTR---------YGLVFKAC 823
G S + + V A+ E +G+VF+A
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 824 YNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-----LVY 878
+ ++I+++ +N +E + + V+H N+ L+ ++ D + LV
Sbjct: 61 LVESDEVAIKKVLQDKRFKN---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRH--LIALGVARGLAFLHTSNMVHGDIKPQNVL 936
+Y+P T+ + + H PM L + R LA++H+ + H DIKPQN+L
Sbjct: 118 EYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 937 FDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFG 994
D L DFG ++ I + + + + Y +PE T D++S G
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 995 IVLLELLTGK 1004
V+ EL+ G+
Sbjct: 230 CVMAELMQGQ 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 53/250 (21%), Positives = 89/250 (35%), Gaps = 52/250 (20%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLL-QE 892
E E L K+ H + ++ ++ A D +V + M G L L
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDY-YIVLELMEGGELFDKVVGNKRLKEAT 240
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFG 949
++ + +LH + ++H D+KP+NVL + D ++DFG
Sbjct: 241 CKLY--------FYQML-----LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 950 LDRLTIPTPAEASTSTTAVGTLGYVSPE---AALTGETTKESDVYSFGIVLLELLTGKRP 1006
++ E S T GT Y++PE + T + D +S G++L L+G P
Sbjct: 288 HSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
Query: 1007 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPD 1063
F+ + +K Q+ G+ W E LL D
Sbjct: 344 --FS-EHRTQVSLKDQITSGKYNF-----------IPEVWAEVSEKALDLVKKLLV--VD 387
Query: 1064 PIDRPTMSDI 1073
P R T +
Sbjct: 388 PKARFTTEEA 397
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 52/242 (21%), Positives = 96/242 (39%), Gaps = 40/242 (16%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QD 897
D + +E E L K+ H N+ L + + V + G L + + D
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI-VGELYTGGELFDEIIKRKRFSEHD 122
Query: 898 GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLT 954
+ ++ + + G+ ++H N+VH D+KP+N+L + D + + DFGL
Sbjct: 123 AARI---IKQVFS-----GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
+ +GT Y++PE L G ++ DV+S G++L LL+G P F +
Sbjct: 175 QQN----TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP--FYGKNE 227
Query: 1015 IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMS 1071
+ K+++ G + + +W K +L P R T +
Sbjct: 228 --YDILKRVETG-----------KYAFDLPQWRTISDDAKDLIRKMLT--FHPSLRITAT 272
Query: 1072 DI 1073
Sbjct: 273 QC 274
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 17/186 (9%)
Query: 489 TTLDLSKQNFSGELPIELAGLP-NLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGF 546
L SKQ +P LP ++ L N LS E + L +L L LS N
Sbjct: 21 NILSCSKQQLP-NVP---QSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH- 75
Query: 547 VGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHIPTDI-S 603
+ I + F + ++ L S NH+ ++ + LEVL L +N + + +
Sbjct: 76 LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133
Query: 604 HLSHLNVLDLSINNLTGEIPDEI----SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVL 659
++ L L LS N ++ P E+ +K L L ++SN L L KL
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 660 DLSANN 665
L +N
Sbjct: 193 GLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPE--LGNCSDLEVLELRSNSLTGHIPTDI-SHLS 606
+P + +L S N++S + E ++L L L N L I ++ +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 607 HLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANN 665
+L LDLS N+L + + + S +L LL+ +NH+ ++ ++ L L LS N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 666 LSGEIPA----NLSSIFGLMNFNVSSNNLQ 691
+S P + + + LM ++SSN L+
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 50/217 (23%), Positives = 72/217 (33%), Gaps = 54/217 (24%)
Query: 405 SIPASFRNLP-GLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLS 462
++P +LP L+L HN+LS E + NL +L LS N +
Sbjct: 32 NVPQ---SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN----------- 77
Query: 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENK 521
+S AF + L LDLS N L + L L+V+ L N
Sbjct: 78 -----FISSEAFVP--------VPNLRYLDLS-SNHLHTLDEFLFSDLQALEVLLLYNNH 123
Query: 522 LSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN 580
+ V F + L+ L LS N + V
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQN-----------QISRFPVELIKD----------GNK 161
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617
L +L+L SN L TD+ L L ++N
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 38/181 (20%), Positives = 58/181 (32%), Gaps = 33/181 (18%)
Query: 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQI----RGAFPLWLTRASTL 320
P ++ L N + + T + + L L L N + AF L
Sbjct: 35 QSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF----VPVPNL 90
Query: 321 TRLDVSGNSISGKIPAQI-GGLWRLEELKMANN--------SFGGAVPVEIKQCSSLSLL 371
LD+S N + + + L LE L + NN +F + L L
Sbjct: 91 RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED--------MAQLQKL 141
Query: 372 DLEGNRFSGEIPE----FLGDIRGLKSLTLAANLFSGSIPASFRNLPGL--ENLNLRHNS 425
L N+ S P + L L L++N + LP L L +N
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200
Query: 426 L 426
L
Sbjct: 201 L 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 45/211 (21%), Positives = 70/211 (33%), Gaps = 44/211 (20%)
Query: 56 CDWRGVACTNNRVTEL--RLP----RLQLSG------RISDHLSNLRMLRKLSLRSNSFN 103
C ++C+ ++ + LP L LS R + L L L L N N
Sbjct: 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 104 GTIPA-TLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLSGEIANDLPRN 161
I + LR + L N L L + +L LE+L + N + + RN
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-----VVDRN 130
Query: 162 LKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHL 221
F+ +++QLQ + S N+ SR + L+ L
Sbjct: 131 A--FE---------------DMAQLQKLYLSQNQISRFPVELIKD-----GNKLPKLMLL 168
Query: 222 SAQGNALGGVIPPAIGALPKLQVVSLA-QNN 251
N L + + LP L NN
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKC--SSLRSLLVN 638
C+ + L ++P + S+ +LDLS NNL+ + E + ++L SLL++
Sbjct: 18 CASNIL-SCSKQQLP-NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLS 72
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN-LSSIFGLMNFNVSSNNLQA 692
NHL+ ++ + NL LDLS+N+L + S + L + +N++
Sbjct: 73 HNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV 126
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 43/223 (19%), Positives = 75/223 (33%), Gaps = 55/223 (24%)
Query: 166 DLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225
S +P S+ S L++ S N SR ++L L
Sbjct: 24 SCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEW-------TPTRLTNLHSLLLSH 73
Query: 226 NALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVA 285
N L + A +P L+ + L+ N+L + +F ++
Sbjct: 74 NHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA------------------- 113
Query: 286 GPETGSCSSVLQVLDLQQNQI----RGAFPLWLTRASTLTRLDVSGNSISGKIPAQI--- 338
L+VL L N I R AF + L +L +S N IS + P ++
Sbjct: 114 ----------LEVLLLYNNHIVVVDRNAF----EDMAQLQKLYLSQNQIS-RFPVELIKD 158
Query: 339 -GGLWRLEELKMANNSFGGAVPVEIKQCSSLSL--LDLEGNRF 378
L +L L +++N ++++ + L L N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 55/272 (20%), Positives = 103/272 (37%), Gaps = 34/272 (12%)
Query: 810 VLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLF---RKEAEFLGKVRHRNLTVLRGY 866
VLS+ + + +E L K+ H N+ L
Sbjct: 45 VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV 104
Query: 867 YAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNM 925
+ L +V++ + G + + + + + LI G+ +LH +
Sbjct: 105 LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY-FQDLIK-----GIEYLHYQKI 158
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT 985
+H DIKP N+L D ++DFG+ ++A S T GT +++PE +L+
Sbjct: 159 IHRDIKPSNLLVGEDGHIKIADFGVSNE--FKGSDALLSNTV-GTPAFMAPE-SLSETRK 214
Query: 986 ----KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
K DV++ G+ L + G+ P F DE I+ K ++ L P ++
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCP--F-MDERIMCLHSK-IKSQ---ALEFPDQPDIAE 267
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + L+ +L +P R + +I
Sbjct: 268 DL----KDLIT---RMLD--KNPESRIVVPEI 290
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 51/248 (20%), Positives = 94/248 (37%), Gaps = 42/248 (16%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENL----FRKEAEFLGK 854
+++ + G+V A ++I++L ++ +R E +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 80
Query: 855 VRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMR 906
V H+N+ L + L +V + M L + M
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER-----MS 130
Query: 907 HLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTS 964
+L+ L G+ LH++ ++H D+KP N++ +D + DFGL R +
Sbjct: 131 YLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----M 183
Query: 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024
T V T Y +PE L + D++S G ++ E++ G V+F + I Q
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTDHI-----DQWN 236
Query: 1025 KGQITELL 1032
K + E L
Sbjct: 237 K--VIEQL 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-16
Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 27/285 (9%)
Query: 750 RRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLV----MFNNKITLAETVEATRQF 805
+ ++ G+ + + N + + + + +
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 806 DEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVL 863
D L +G+V + G + + + D+ RKE + + +RH L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 864 RGYYAGAPDLRLLVYDYMPNGNL-GTLLQEASH---QDGHVLNWPMRHLIALGVARGLAF 919
+ ++ +++Y++M G L + E + + MR + +GL
Sbjct: 220 HDAFEDDNEM-VMIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVC-----KGLCH 270
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
+H +N VH D+KP+N++F L DFGL P + GT + +PE
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPE 326
Query: 978 AALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
G+ +D++S G++ LL+G P D++ ++ VK
Sbjct: 327 -VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 41/248 (16%)
Query: 841 DENLFRKEAEFLGKV-RHRNLTVLRGYY---AGAPDLRLLVYDYMPNGNLGTLLQEASHQ 896
D R+E + + ++ + Y L++ + M G L + +QE Q
Sbjct: 64 DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 897 -----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDF 948
+ + MR + + FLH+ N+ H D+KP+N+L+ + D L+DF
Sbjct: 124 AFTEREAAEI---MRDI-----GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
G + T T T YV+PE + K D++S G+++ LL G P
Sbjct: 176 GFAKETTQNAL-----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230
Query: 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPI 1065
+ I +K++++ GQ + EW E K LL T DP
Sbjct: 231 SNTGQAISPGMKRRIRLGQY-----------GFPNPEWSEVSEDAKQLIRLLLKT--DPT 277
Query: 1066 DRPTMSDI 1073
+R T++
Sbjct: 278 ERLTITQF 285
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 36/192 (18%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
V + H+ +VH DIK +N+L D A L DFG L P T GT
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-----TDFDGTR 202
Query: 972 GYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
Y PE ++ + V+S GI+L +++ G P F +D++I++
Sbjct: 203 VYSPPE-WISRHQYHALPATVWSLGILLYDMVCGDIP--FERDQEILEA----------- 248
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV---FMLEGCRVGPDI 1086
EL P + S + + C AP P RP++ +I+ +M P
Sbjct: 249 ELHFPAHV-----SPDCCALIRR------CLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
Query: 1087 PSSADPTTQPSP 1098
PS P
Sbjct: 298 PSKGGPAPLAWS 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 36/203 (17%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLL-QE 892
E E L K+ H + ++ ++ A D +V + M G L L
Sbjct: 58 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDY-YIVLELMEGGELFDKVVGNKRLKEAT 115
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH---LSDFG 949
++ + +LH + ++H D+KP+NVL + E ++DFG
Sbjct: 116 CKLY--------FYQMLL-----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 950 LDRLTIPTPAEASTSTTAVGTLGYVSPE---AALTGETTKESDVYSFGIVLLELLTGKRP 1006
++ E S T GT Y++PE + T + D +S G++L L+G P
Sbjct: 163 HSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
Query: 1007 VMFTQDEDIVKWVKKQLQKGQIT 1029
F+ + +K Q+ G+
Sbjct: 219 --FS-EHRTQVSLKDQITSGKYN 238
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 50/186 (26%), Positives = 74/186 (39%), Gaps = 34/186 (18%)
Query: 845 FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNW 903
F +E + + + L +YA D L +V +YMP G+L L+
Sbjct: 116 FWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS------------ 161
Query: 904 PMRHLIALGVAR--------GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955
+ + AR L +H+ +H D+KP N+L D L+DFG
Sbjct: 162 --NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 956 PTPAEASTSTTAVGTLGYVSPE----AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ 1011
TAVGT Y+SPE G +E D +S G+ L E+L G P F
Sbjct: 220 KE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FY- 274
Query: 1012 DEDIVK 1017
+ +V
Sbjct: 275 ADSLVG 280
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 54/182 (29%), Positives = 75/182 (41%), Gaps = 10/182 (5%)
Query: 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKF 450
K L L +N S +F L L L L N L +LP + + NL TL +++NK
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 451 SGEVPASI-GNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFSGELPIEL-A 507
+P + L L L N +P + +L KLT L L N LP +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG-YNELQSLPKGVFD 154
Query: 508 GLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFS 566
L +L+ + L N+L VPEG F L L+ L L N F L + +L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 567 GN 568
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 507 AGLP-NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLS 564
+ +P + + + LQ NKLS + F L LR L L+ N +PA F L+++ L
Sbjct: 33 SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLW 91
Query: 565 FSGNHISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEI 622
+ N + ++P + +L L L N L +P + L+ L L L N L +
Sbjct: 92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 623 PDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN 673
P + K +SL+ L + +N L + KL+ L L L N L +P
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 23/239 (9%)
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQN 497
+ LDL NK S + L++L + L+ N +PA + L L TL ++
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 498 FSGELPIEL-AGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQI----P 551
LPI + L NL + L N+L ++P F SL L YL+L +N ++
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN----ELQSLPK 150
Query: 552 ATFSFLRSVVVLSFSGNHISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLN 609
F L S+ L N + +P ++L+ L+L +N L +P L L
Sbjct: 151 GVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLK 208
Query: 610 VLDLSINNLTGEIPDEISKCSSLRSLLV-NSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
+L L N I + L ++ GG+ + + AVL+++ + +
Sbjct: 209 MLQLQENPWDCTCNGII----YMAKWLKKKADEGLGGVDTAGCEKGGKAVLEITEKDAA 263
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 49/177 (27%), Positives = 71/177 (40%), Gaps = 17/177 (9%)
Query: 92 LRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRL 150
+KL L+SN + + T LR ++L N L LPA I L NLE L V N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 151 SGEIAN--DLPRNLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGT 207
D NL L N +P + +L++L ++ +N+ +
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ---------S 147
Query: 208 LPS-AIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCN 263
LP +SL L N L V A L +L+ + L N L VP F +
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDS 203
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 10/116 (8%)
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSN 640
+D + L+L+SN L+ L+ L +L L+ N L +P I + +L +L V N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 641 HLS---GGIPDSLAKLSNLAVLDLSANNLSGEIPANL-SSIFGLMNFNVSSNNLQA 692
L G+ D +L NLA L L N L +P + S+ L ++ N LQ+
Sbjct: 96 KLQALPIGVFD---QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS 147
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 49/225 (21%), Positives = 80/225 (35%), Gaps = 50/225 (22%)
Query: 158 LPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI-ANCS 216
+P + K DL SN S + L++L+L+ + NK TLP+ I
Sbjct: 35 IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ---------TLPAGIFKELK 85
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276
+L L N L + L L + L +N L + PP +
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSL------------PPRV----- 128
Query: 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISG 332
F++ T L L L N+++ G F + ++L L + N +
Sbjct: 129 -FDSLTK------------LTYLSLGYNELQSLPKGVF----DKLTSLKELRLYNNQLK- 170
Query: 333 KIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376
++P L L+ LK+ NN L +L L+ N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 61/275 (22%), Positives = 102/275 (37%), Gaps = 42/275 (15%)
Query: 810 VLSRTRYGLVFKACY-NDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYY 867
+ R +G V A + + +++P + D + F++E E + + H N+ L +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFLHTSN 924
D+ L V + G L + D + M+ +++ +A+ H N
Sbjct: 76 EDNTDIYL-VMELCTGGELFERVVHKRVFRESDAARI---MKDVLS-----AVAYCHKLN 126
Query: 925 MVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
+ H D+KP+N LF D L DFGL P T VGT YVSP+ L
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG----KMMRTKVGTPYYVSPQ-VLE 181
Query: 982 GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
G E D +S G+++ LL G P D +++ +++
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG---------------TFTF 226
Query: 1042 ESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
+W + LL P R T
Sbjct: 227 PEKDWLNVSPQAESLIRRLLT--KSPKQRITSLQA 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 78/336 (23%), Positives = 121/336 (36%), Gaps = 69/336 (20%)
Query: 757 AAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRY 816
E +GGR S + P + K + + F + + +
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKD--PDVAELFFK------DDPEKLFSDLREIGHGSF 67
Query: 817 GLVFKACYND-GMVLSIRRLP----DGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
G V+ A V++I+++ + KE FL K+RH N RG Y
Sbjct: 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR-HLIAL---GVARGLAFLHTSNMVH 927
LV +Y G+ LL+ V P++ IA G +GLA+LH+ NM+H
Sbjct: 128 TA-WLVMEYCL-GSASDLLE--------VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 928 GDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT-- 985
D+K N+L L DFG + + + + VGT +++PE L +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGS-------ASIMAPANSFVGTPYWMAPEVILAMDEGQY 230
Query: 986 -KESDVYSFGIVLLELLTGKRP--------VMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ DV+S GI +EL K P ++ I + LQ G
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHW-------- 278
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072
S + F+ C P DRPT
Sbjct: 279 ------SEYFRNFV------DSCLQKIPQDRPTSEV 302
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 56/258 (21%), Positives = 97/258 (37%), Gaps = 45/258 (17%)
Query: 797 ETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE---NLFRK------ 847
E + + +S YG V ++G+ ++I+R+ + D N+
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 848 ---EAEFLGKVRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLL--QEASHQD 897
E L H N+ LR + + LV + M +L ++ Q
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISP 133
Query: 898 GHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955
H+ ++ + L GL LH + +VH D+ P N+L + + + DF L R
Sbjct: 134 QHI-----QYFMYHIL---LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 956 PTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
T V Y +PE + + TK D++S G V+ E+ K +F +
Sbjct: 186 ADAN----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK--ALF-RGST 238
Query: 1015 IVKWVKKQLQKGQITELL 1032
QL K I E++
Sbjct: 239 FY----NQLNK--IVEVV 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 9/171 (5%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E + L KV R + L YA L LV M G++ + +
Sbjct: 235 EKKILAKVHSRFIVSL--AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
A + GL LH N+++ D+KP+NVL D D +SD GL + +
Sbjct: 293 FYTA-QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKG 348
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
GT G+++PE L E D ++ G+ L E++ + P F + V+
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVE 397
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 31/188 (16%)
Query: 831 SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL---- 886
I + D +EA K++H N+ L L V+D + G L
Sbjct: 38 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDI 96
Query: 887 ---GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADF 941
+ASH ++ ++ +A+ H++ +VH ++KP+N+L
Sbjct: 97 VAREFYSEADASHC--------IQQIL-----ESIAYCHSNGIVHRNLKPENLLLASKAK 143
Query: 942 EAHL--SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLL 998
A + +DFGL ++ GT GY+SPE L + +K D+++ G++L
Sbjct: 144 GAAVKLADFGLAIEV----NDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILY 198
Query: 999 ELLTGKRP 1006
LL G P
Sbjct: 199 ILLVGYPP 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 22/237 (9%)
Query: 782 GGPKLVMFNNKITLAETV-EATRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGS 839
G ++ N E + +F E + + +G V + GM ++I+++
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP 60
Query: 840 LDENLFRKEAEFLGKVRHRNLTVLRGYY-----AGAPDLRL-LVYDYMPNGNLGTLLQEA 893
N + + L + H N+ L+ Y+ D+ L +V +Y+P+ TL +
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----TLHRCC 116
Query: 894 SHQDGHVLNWPMRH--LIALGVARGLAFLHTS--NMVHGDIKPQNVLFD-ADFEAHLSDF 948
+ + P + + R + LH N+ H DIKP NVL + AD L DF
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGK 1004
G + P+ E + + + + Y +PE + T D++S G + E++ G+
Sbjct: 177 GSAKKLSPS--EPNVAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 42/216 (19%), Positives = 84/216 (38%), Gaps = 28/216 (12%)
Query: 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL 860
++ L R +G+V + + + D+ L +KE L RHRN+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLLQEASHQDGHVLNWPMRHLIALGV 913
L + +L +++++++ ++ L E + + V
Sbjct: 64 LHLHESFESMEEL-VMIFEFISGLDIFERINTSAFELNER---EIVSY---VHQ-----V 111
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLDRLTIPTPAEASTSTTAVGTL 971
L FLH+ N+ H DI+P+N+++ + + +FG R P
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAP 167
Query: 972 GYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
Y +PE + + +D++S G ++ LL+G P
Sbjct: 168 EYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 64/312 (20%), Positives = 126/312 (40%), Gaps = 51/312 (16%)
Query: 758 AEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYG 817
+ S +++ G ++ + I + + F+ E+ L R
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 818 LVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876
+V++ +++ L ++D+ + R E L ++ H N+ L+ + ++ L
Sbjct: 68 IVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI-SL 125
Query: 877 VYDYMPNGNL-------GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
V + + G L G ++A+ ++ + +A+LH + +VH
Sbjct: 126 VLELVTGGELFDRIVEKGYYSERDAADA--------VKQ-----ILEAVAYLHENGIVHR 172
Query: 929 DIKPQNVLF-DADFEAHL--SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET- 984
D+KP+N+L+ +A L +DFGL ++ T GT GY +PE L G
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPE-ILRGCAY 227
Query: 985 TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP---------- 1034
E D++S GI+ LL G P F DE +++ +++ + + P
Sbjct: 228 GPEVDMWSVGIITYILLCGFEP--FY-DERGDQFMFRRILNCEY-YFISPWWDEVSLNAK 283
Query: 1035 ----GLLELDPE 1042
L+ LDP+
Sbjct: 284 DLVRKLIVLDPK 295
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 49/243 (20%), Positives = 94/243 (38%), Gaps = 32/243 (13%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENL----FRKEAEFLGK 854
+++ + G+V A ++I++L ++ +R E +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117
Query: 855 VRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909
V H+N+ L + L LV + M L + + L+ +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME---LDHERMSYL 169
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
+ G+ LH++ ++H D+KP N++ +D + DFGL R + T V
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVV 225
Query: 970 TLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
T Y +PE L + D++S G ++ E++ K ++F + I Q K +
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRDYI-----DQWNK--VI 276
Query: 1030 ELL 1032
E L
Sbjct: 277 EQL 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 52/186 (27%), Positives = 73/186 (39%), Gaps = 35/186 (18%)
Query: 837 DGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GT 888
+ KE + L KV H N+ L+ Y LV+D M G L T
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYLTEKVT 120
Query: 889 LL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947
L +E MR L+ + LH N+VH D+KP+N+L D D L+D
Sbjct: 121 LSEKETRKI--------MRALL-----EVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167
Query: 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-------TKESDVYSFGIVLLEL 1000
FG P GT Y++PE + KE D++S G+++ L
Sbjct: 168 FGFSCQLDPG----EKLREVCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 1001 LTGKRP 1006
L G P
Sbjct: 223 LAGSPP 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 61/369 (16%), Positives = 114/369 (30%), Gaps = 79/369 (21%)
Query: 344 LEELKMANNSFG--GAVPV--EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA 399
+E + ++ V + + S+ + L GN E + L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE---------AARWLSEN- 55
Query: 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIG 459
+ LE E + L ++
Sbjct: 56 ----------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALL 91
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLK----LTTLDLSKQNFSGELPIELAGLPNLQVI 515
+L LS NAF L + L L L L + ++A
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR------- 144
Query: 516 ALQENKLSGNVPEGFSSLMSLRYLNLSFNGF----VGQIPATFSFLRSVVVLSFSGNHI- 570
ALQE ++ + LR + N + + TF R + + N I
Sbjct: 145 ALQELAVNKKA----KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
Query: 571 ----SGSIPPELGNCSDLEVLELRSNSLTG----HIPTDISHLSHLNVLDLSINNLTGE- 621
+ L C +L+VL+L+ N+ T + + +L L L+ L+
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260
Query: 622 ---IPDEISKCS--SLRSLLVNSNHLSG----GIPDSLA-KLSNLAVLDLSANNLS--GE 669
+ D SK L++L + N + + + K+ +L L+L+ N S +
Sbjct: 261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320
Query: 670 IPANLSSIF 678
+ + +F
Sbjct: 321 VVDEIREVF 329
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 65/405 (16%), Positives = 122/405 (30%), Gaps = 94/405 (23%)
Query: 134 IGNLSNLEILNVAANRLSGEIANDL------PRNLKYFDLSSNGFSGP----IPTSISNL 183
+ S +E ++ + ++ E + ++K LS N + +I++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 184 SQLQLINFSFNKFSREVPATFEG--TLPSAIANCSSLVHLSAQGNALG--GVIP--PAIG 237
L++ FS R E L A+ C L + NA G P +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 238 ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQ 297
L+ + L N L G + A +A + + L+
Sbjct: 120 KHTPLEHLYLHNNGL-GPQAGAKIAR----------------ALQELAVNKKAKNAPPLR 162
Query: 298 VLDLQQNQIR--GAFPL--WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNS 353
+ +N++ L + + N I + G L E
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE-----GIEHLLLEG------ 211
Query: 354 FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
+ C L +LDL+ N F+ G +L +A ++
Sbjct: 212 --------LAYCQELKVLDLQDNTFTHL---------GSSALAIA-----------LKSW 243
Query: 414 PGLENLNLRHNSLSG----SLPEEVLGMNN--LSTLDLSENKFSGEVPASIG-----NLS 462
P L L L LS ++ + + N L TL L N+ + ++ +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 463 QLMVFNLSGNAFS--GRIPASLGNLLK----LTTLDLSKQNFSGE 501
L+ L+GN FS + + + +L +
Sbjct: 304 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 50/339 (14%), Positives = 89/339 (26%), Gaps = 53/339 (15%)
Query: 82 ISDHLSNLRMLRKLSLRSNSFNGT----IPATLAQCTLLRAVFLQYNSLSGNLPANIGNL 137
+ L ++++ L N+ + +A L G +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF--------TGRV 75
Query: 138 SNLEILNVAANRLSGEIANDLPRN--LKYFDLSSNGFSG----PIPTSISNLSQLQLINF 191
+ + + L + L LS N F P+ +S + L+ +
Sbjct: 76 KDEIPEALRL------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129
Query: 192 SFNKFSRE-----VPATFEGTLPSAIANCSSLVHLSAQGNALGGV----IPPAIGALPKL 242
N + A E + N L + N L + L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189
Query: 243 QVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSC---SSVLQVL 299
V + QN + + Y ++V+ L N FT++ L+ L
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249
Query: 300 DLQQNQIR--GAFP----LWLTRASTLTRLDVSGNSISGK-----IPAQIGGLWRLEELK 348
L + GA L L + N I + L L+
Sbjct: 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309
Query: 349 MANNSFG--GAVPVEI----KQCSSLSLLDLEGNRFSGE 381
+ N F V EI L +L+ +
Sbjct: 310 LNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 6e-15
Identities = 42/139 (30%), Positives = 59/139 (42%), Gaps = 13/139 (9%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
+ D M G+L L Q G MR A + GL +H +V+ D+KP N+
Sbjct: 269 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAA-EIILGLEHMHNRFVVYRDLKPANI 323
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFG 994
L D +SD GL +VGT GY++PE G +D +S G
Sbjct: 324 LLDEHGHVRISDLGLACDFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 995 IVLLELLTGKRPVMFTQDE 1013
+L +LL G P F Q +
Sbjct: 379 CMLFKLLRGHSP--FRQHK 395
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 44/251 (17%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRK---------EA 849
+ ++ + + YG+V A N + ++I+++ + F E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-------SPFEHQTYCQRTLREI 76
Query: 850 EFLGKVRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQDGHVLNWP 904
+ L + RH N+ + AP + +V D M +L LL+ + H+
Sbjct: 77 KILLRFRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHI---- 130
Query: 905 MRHLI--ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962
+ + L RGL ++H++N++H D+KP N+L + + + DFGL R+ P
Sbjct: 131 -CYFLYQIL---RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 963 TSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
T V T Y +PE L + TK D++S G +L E+L+ + +F + +
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR--PIF-PGKHYL----D 239
Query: 1022 QLQKGQITELL 1032
QL I +L
Sbjct: 240 QLNH--ILGIL 248
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-15
Identities = 69/322 (21%), Positives = 111/322 (34%), Gaps = 32/322 (9%)
Query: 709 ENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAAAEKKRSPARAS 768
E D D+RK + L + +RL++ + + R +
Sbjct: 91 EVTPD-DKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLT 149
Query: 769 SGASGGRRSSTDNGGPKLVMF-------NNKITLAETVEATRQFDEENVLSRTRYGLVFK 821
+ F +T F + VL + +G V
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTK-------NTFRQYRVLGKGGFGEVCA 202
Query: 822 ACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL- 875
G + + ++L + E + E + L KV R + L YA L
Sbjct: 203 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETKDALC 260
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
LV M G+L + H A + GL LH +V+ D+KP+N+
Sbjct: 261 LVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D +SD GL E T VGT+GY++PE T D ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373
Query: 996 VLLELLTGKRPVMFTQDEDIVK 1017
+L E++ G+ P F Q + +K
Sbjct: 374 LLYEMIAGQSP--FQQRKKKIK 393
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 29/187 (15%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
+ + H +VH D+K +N+L DAD ++DFG G Y +
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV----GGKLDAFCGAPPYAA 181
Query: 976 PEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
PE G+ E DV+S G++L L++G P F D +K +++++ +G+
Sbjct: 182 PE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP--F--DGQNLKELRERVLRGKYR---I 233
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV---FMLEGCRVGPDIPSSA 1090
P + S++ E L L +PI R T+ I+ ++ G ++
Sbjct: 234 PFYM-----STDCENLL----KRFLV--LNPIKRGTLEQIMKDRWINAGHEE-DELKPFV 281
Query: 1091 DPTTQPS 1097
+P S
Sbjct: 282 EPELDIS 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 22/178 (12%)
Query: 839 SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLLQ 891
L ++EA ++H ++ L Y+ L +V+++M +L
Sbjct: 67 GLSTEDLKREASICHMLKHPHIVELLETYSSDGML-YMVFEFMDGADLCFEIVKRADAGF 125
Query: 892 EASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH---LSDF 948
S MR ++ L + H +N++H D+KP VL + + L F
Sbjct: 126 VYSEAVASHY---MRQIL-----EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
G+ + + VGT +++PE K DV+ G++L LL+G P
Sbjct: 178 GVAIQ-LGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 1e-14
Identities = 53/257 (20%), Positives = 88/257 (34%), Gaps = 35/257 (13%)
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
+ L +L + S + L + L+ L +I R L L
Sbjct: 342 CRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
S + + + LD +KF E + + V +L+ + +
Sbjct: 401 EKETLQYFSTL---KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456
Query: 479 PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRY 538
L LL +T LDLS LP LA L L+V+ +N L NV G ++L L+
Sbjct: 457 C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512
Query: 539 LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT--- 595
L L N ++ + ++ L +C L +L L+ NSL
Sbjct: 513 LLLCNN----RL-QQSAAIQ------------------PLVSCPRLVLLNLQGNSLCQEE 549
Query: 596 GHIPTDISHLSHLNVLD 612
G L ++ +
Sbjct: 550 GIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 9e-11
Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 9/202 (4%)
Query: 502 LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVV 561
+ A L L K + + S L+ L + I L ++
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 562 VLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
+ + S + + +LRS L + + + + + VL L+ +LT
Sbjct: 400 YEKETLQYFSTLK--AVDPMRAAYLDDLRSKFLLENSVLKMEY-ADVRVLHLAHKDLT-- 454
Query: 622 IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLM 681
+ + + + L ++ N L +P +LA L L VL S N L + ++++ L
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQ 511
Query: 682 NFNVSSNNLQAFANNQDLCGKP 703
+ +N LQ A Q L P
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCP 533
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 8/138 (5%)
Query: 65 NNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYN 124
R L R + S +R L L T+ L Q L+ + L +N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHN 473
Query: 125 SLSGNLPANIGNLSNLEILNVAANRLSGEIAN--DLPRNLKYFDLSSNGFSG-PIPTSIS 181
L LP + L LE+L + N L + +LP L+ L +N +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLP-RLQELLLCNNRLQQSAAIQPLV 530
Query: 182 NLSQLQLINFSFNKFSRE 199
+ +L L+N N +E
Sbjct: 531 SCPRLVLLNLQGNSLCQE 548
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 5e-10
Identities = 31/175 (17%), Positives = 60/175 (34%), Gaps = 27/175 (15%)
Query: 342 WRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANL 401
R L + F V + + + +L L + + L + + L L+ N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474
Query: 402 FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG-EVPASIGN 460
++P + L LE L N+L ++ V + L L L N+ + +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 461 LSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVI 515
+L++ NL GN+ + L ++ LP++ I
Sbjct: 532 CPRLVLLNLQGNSLC-QEEGIQERLAEM--------------------LPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 8e-09
Identities = 30/187 (16%), Positives = 63/187 (33%), Gaps = 41/187 (21%)
Query: 73 LPRLQLSGRISDHLSNLRMLRKLSL-----RSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127
L L + S L+ + + + F + +R + L + L+
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQ 187
+ ++ L + L+++ NRL +P +++ L L+
Sbjct: 455 --VLCHLEQLLLVTHLDLSHNRLRA-----------------------LPPALAALRCLE 489
Query: 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGV-IPPAIGALPKLQVVS 246
++ S N +G +AN L L N L + + P+L +++
Sbjct: 490 VLQASDNALE-----NVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539
Query: 247 LAQNNLS 253
L N+L
Sbjct: 540 LQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 2e-08
Identities = 36/201 (17%), Positives = 64/201 (31%), Gaps = 32/201 (15%)
Query: 66 NRVTELRLPRLQLSGRISDH----LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFL 121
+ T+ +L R +LS S L + + L++L + TI + L
Sbjct: 344 DSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA--------L 395
Query: 122 QYNSLSGNLPANIGNLSNLEILNVAANRLSG-------EIANDLPRNLKYFDLSSNGFSG 174
L ++ + A + +++ L+ +
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455
Query: 175 PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP 234
+ L + ++ S N+ LP A+A L L A NAL V
Sbjct: 456 LC--HLEQLLLVTHLDLSHNRLR---------ALPPALAALRCLEVLQASDNALENV--D 502
Query: 235 AIGALPKLQVVSLAQNNLSGV 255
+ LP+LQ + L N L
Sbjct: 503 GVANLPRLQELLLCNNRLQQS 523
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 47/255 (18%), Positives = 76/255 (29%), Gaps = 54/255 (21%)
Query: 177 PTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAI 236
+ QL S K + L S + +C L L + I I
Sbjct: 342 CRDSATDEQLFRCELSVEKSTV---------LQSELESCKELQELEPENKWCLLTI---I 389
Query: 237 GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVL 296
+ L + + L F + P + + + +
Sbjct: 390 LLMRALDPLLYEKETLQY------FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 297 QVLDLQQNQIRGAFPL-WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANN--- 352
+VL L + L L +T LD+S N + +P + L LE L+ ++N
Sbjct: 444 RVLHLAHKDLTVLCHLEQLLL---VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
Query: 353 SFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRN 412
+ G + L L L NR L ++ L +
Sbjct: 500 NVDG-----VANLPRLQELLLCNNR--------LQQSAAIQPL---------------VS 531
Query: 413 LPGLENLNLRHNSLS 427
P L LNL+ NSL
Sbjct: 532 CPRLVLLNLQGNSLC 546
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 45/282 (15%)
Query: 751 RLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENV 810
R ++ A A + + + + + A E +++D ++V
Sbjct: 42 RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV 101
Query: 811 LSRTRYGLVFKACYND-GM-----VLSIRRLP----DGSLDENLFRKEAEFLGKVR-HRN 859
+ R +V + + G ++ + R+E L +V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLL-QEASHQDGHVLNWPMRHLIAL 911
+ L Y + + LV+D M G L L +E MR L+
Sbjct: 162 IITLIDSYESSSFM-FLVFDLMRKGELFDYLTEKVALSEKETRSI--------MRSLL-- 210
Query: 912 GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
++FLH +N+VH D+KP+N+L D + + LSDFG P GT
Sbjct: 211 ---EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG----EKLRELCGTP 263
Query: 972 GYVSPEAALTGET-------TKESDVYSFGIVLLELLTGKRP 1006
GY++PE L KE D+++ G++L LL G P
Sbjct: 264 GYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 41/247 (16%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRK----EAEFLGK 854
E + + + YG V A G ++I++L +F K E L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKH 79
Query: 855 VRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMR 906
++H N+ L + A LR LV +M T LQ+ + + + +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKI-QYLVY 133
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
++ +GL ++H++ +VH D+KP N+ + D E + DFGL R T
Sbjct: 134 QML-----KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTG 182
Query: 967 AVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025
V T Y +PE L+ + D++S G ++ E+LTGK +F + + QL +
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK--TLFKGKDYL-----DQLTQ 235
Query: 1026 GQITELL 1032
I ++
Sbjct: 236 --ILKVT 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRK----EAEFLGK 854
E + + + YG V A G ++I++L LF K E L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKH 80
Query: 855 VRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909
+RH N+ L + L LV +M +LG L++ + + + L+
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRI-----QFLV 134
Query: 910 --ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA 967
L +GL ++H + ++H D+KP N+ + D E + DFGL R S T
Sbjct: 135 YQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA------DSEMTGY 185
Query: 968 VGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
V T Y +PE L T+ D++S G ++ E++TGK +F + + QL++
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSDHL-----DQLKE- 237
Query: 1027 QITELL 1032
I ++
Sbjct: 238 -IMKVT 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 30/188 (15%)
Query: 831 SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL---- 886
I + D +EA ++H N+ L + L ++D + G L
Sbjct: 43 IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDI 101
Query: 887 ---GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DA 939
+ASH ++ ++ + H +VH ++KP+N+L
Sbjct: 102 VAREYYSEADASHC--------IQQIL-----EAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLL 998
L+DFGL E GT GY+SPE L + K D+++ G++L
Sbjct: 149 GAAVKLADFGLAIEVEG---EQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILY 204
Query: 999 ELLTGKRP 1006
LL G P
Sbjct: 205 ILLVGYPP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 34/192 (17%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ + +L +++H DIK +N++ DF L DFG T GT+
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY----LERGKLFYTFCGTIE 194
Query: 973 YVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030
Y +PE L G E +++S G+ L L+ + P F + E+ V + I
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP--FCELEETV--------EAAIH- 242
Query: 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV---FMLEGCRVGPDIP 1087
P L+ S E + G LL P P R T+ +V ++ + +
Sbjct: 243 --PPYLV-----SKELMSLVSG----LLQ--PVPERRTTLEKLVTDPWVTQPVNLADYTW 289
Query: 1088 SSADPTTQPSPA 1099
+P
Sbjct: 290 EEVFRVNKPESG 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 31/287 (10%)
Query: 749 RRRLKESAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLA--ETVEATRQFD 806
R E+ S + + F+++I A V +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 807 EENVLSRTRYGLVFKACYND-GMVLSIRRLP-DGSLDENLFRKEAEFLGKVRHRNLTVLR 864
+ +L R+G V K G+ L+ + + G D+ + E + ++ H NL L
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 865 GYYAGAPDLRLLVYDYMPNGNL-------GTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
+ D+ +LV +Y+ G L L E D + M+ + G+
Sbjct: 153 DAFESKNDI-VLVMEYVDGGELFDRIIDESYNLTEL---DTILF---MKQ-----ICEGI 200
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
+H ++H D+KP+N+L + DFGL R P GT +++
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGTPEFLA 256
Query: 976 PEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
PE + + + +D++S G++ LL+G P + D + + +
Sbjct: 257 PE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 47/160 (29%), Positives = 68/160 (42%), Gaps = 19/160 (11%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ +LH + H DIKP+N+L D +SDFGL + E + GTL YV+
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVA 175
Query: 976 PEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
PE L + DV+S GIVL +L G+ P + Q D + +K
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYL---- 228
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++D LL +L +P R T+ DI
Sbjct: 229 NPWKKIDSAP----LALLH---KILV--ENPSARITIPDI 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI--ALGVARGLAFLHTSNMVHGDIKPQNV 935
++ +L + +E + +D + + HLI + VA+G+ FL + +H D+ +N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L + DFGL R I + A L +++PE T +SDV+SFG+
Sbjct: 225 LLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 996 VLLELLT-GKRP-VMFTQDEDIVKWVKK--QLQKGQITELLEPGLLELDPESSEWEEFLL 1051
+L E+ + G P DE+ + +K+ +++ P+ + E +
Sbjct: 284 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---------------PDYTTPEMY-- 326
Query: 1052 GVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
+ L C +P RPT S++V L
Sbjct: 327 --QTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 52/249 (20%), Positives = 102/249 (40%), Gaps = 36/249 (14%)
Query: 774 GRRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYND-GMVL-- 830
G ++ GG ++ + + + + + +D + L + + +V + + G+
Sbjct: 1 GPHMASMTGGQQMGRGSEFMM-NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 831 -SIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL--- 886
I + D +EA K++H N+ L L V+D + G L
Sbjct: 60 KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFED 118
Query: 887 ----GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941
+ASH ++ ++ +A+ H++ +VH ++KP+N+L +
Sbjct: 119 IVAREFYSEADASHC--------IQQIL-----ESIAYCHSNGIVHRNLKPENLLLASKA 165
Query: 942 EAH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVL 997
+ L+DFGL + GT GY+SPE L + +K D+++ G++L
Sbjct: 166 KGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVIL 220
Query: 998 LELLTGKRP 1006
LL G P
Sbjct: 221 YILLVGYPP 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 40/191 (20%), Positives = 78/191 (40%), Gaps = 27/191 (14%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLLQEA 893
D+ + E + ++ H L L + ++ +L+ +++ G L + EA
Sbjct: 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM-VLILEFLSGGELFDRIAAEDYKMSEA 149
Query: 894 SHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLD 951
+ MR GL +H ++VH DIKP+N++ + + + DFGL
Sbjct: 150 ---EVINY---MRQACE-----GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFT 1010
P T + +PE + E +D+++ G++ LL+G P
Sbjct: 199 TKLNPD----EIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253
Query: 1011 QDEDIVKWVKK 1021
D + ++ VK+
Sbjct: 254 DDLETLQNVKR 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 33/164 (20%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
V + H ++H DIK +N+L D + E L DFG L T T GT
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTR 212
Query: 972 GYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
Y PE + + + V+S GI+L +++ G P F DE+I++
Sbjct: 213 VYSPPE-WIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRG----------- 258
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
++ + SSE + + C A P DRPT +I
Sbjct: 259 QVFFRQRV-----SSECQHLIRW------CLALRPSDRPTFEEI 291
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 34/244 (13%)
Query: 800 EATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRK----EAEFLGK 854
E ++ + + YG V A G+ +++++L + K E L
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 84
Query: 855 VRHRNLTVLRGYYAGAPDLRL-----LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLI 909
++H N+ L + A L LV M +L +++ D HV + + ++
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHV-QFLIYQIL 142
Query: 910 ALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
RGL ++H+++++H D+KP N+ + D E + DFGL R T A T V
Sbjct: 143 -----RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------ADEMTGYVA 191
Query: 970 TLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028
T Y +PE L + D++S G ++ ELLTG+ +F + I QL+ I
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHI-----DQLKL--I 242
Query: 1029 TELL 1032
L+
Sbjct: 243 LRLV 246
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 42/188 (22%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 829 VLSIRRL--PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886
+ RRL + +E L ++RH N+ L + D+ +L+ + + G L
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV-VLILELVSGGEL 95
Query: 887 GTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFE 942
L E + ++ + G+ +LH+ + H D+KP+N++ D +
Sbjct: 96 FDFLAEKESLTEDEATQF---LKQ-----ILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147
Query: 943 AH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLL 998
L DFG+ + GT +V+PE + E E+D++S G++
Sbjct: 148 NPRIKLIDFGIAHKIEAG----NEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITY 202
Query: 999 ELLTGKRP 1006
LL+G P
Sbjct: 203 ILLSGASP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 57/257 (22%), Positives = 99/257 (38%), Gaps = 43/257 (16%)
Query: 842 ENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QD 897
+FR E E L + + HRN+ L ++ LV++ M G++ + + + H +
Sbjct: 55 SRVFR-EVEMLYQCQGHRNVLELIEFFEEEDRF-YLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 898 GHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLT 954
V+ ++ VA L FLH + H D+KP+N+L + + DF L
Sbjct: 113 ASVV---VQD-----VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 955 IP----TPAEASTSTTAVGTLGYVSPE--AALTGETT---KESDVYSFGIVLLELLTGKR 1005
+P T G+ Y++PE A + E + K D++S G++L LL+G
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 1006 PVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE------LDPESSEWEEFLLGVK---VA 1056
P F +G+ + L E + +W K
Sbjct: 225 P--FVGRCG----SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 1057 LLCTAPDPIDRPTMSDI 1073
LL D R + + +
Sbjct: 279 LLV--RDAKQRLSAAQV 293
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH--LIALGVARGLAFLHTSNMVHGDIKPQ 933
++ +Y+P+ TL + + PM + + R + F+H+ + H DIKPQ
Sbjct: 115 VIMEYVPD----TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 934 NVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVY 991
N+L ++ D L DFG + IP+ E S + + + Y +PE L T D++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAY--ICSRFYRAPELMLGATEYTPSIDLW 226
Query: 992 SFGIVLLELLTGK 1004
S G V EL+ GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 22/189 (11%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ +LH + H DIKP+N+L D +SDFGL + E + GTL YV+
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVA 175
Query: 976 PEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
PE L + DV+S GIVL +L G+ P + Q D + +K
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYL---- 228
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV---FMLEGCRVGPDIPSSA 1090
++D LL +L +P R T+ DI + + + G P
Sbjct: 229 NPWKKIDSAP----LALLH---KILV--ENPSARITIPDIKKDRWYNKPLKKGAKRPRVT 279
Query: 1091 DPTTQPSPA 1099
SP+
Sbjct: 280 SGGVSESPS 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 40/221 (18%)
Query: 846 RKEAEFLGK-VRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVL 901
+E E L + +H N+ L+ Y + +V + M G L + ++ +
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYV-YVVTELMKGGELLDKILRQKFFSEREASAV 121
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH----LSDFGLDRLTIPT 957
+ + + + +LH +VH D+KP N+L+ + + DFG +
Sbjct: 122 ---LFTI-----TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ---L 170
Query: 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMF-TQDEDI 1015
AE T T +V+PE L + D++S G++L +LTG P F +D
Sbjct: 171 RAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDDT 227
Query: 1016 VKWVKKQLQKGQITELLEP--------------GLLELDPE 1042
+ + ++ G+ L +L +DP
Sbjct: 228 PEEILARIGSGKF-SLSGGYWNSVSDTAKDLVSKMLHVDPH 267
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 36/240 (15%)
Query: 846 RKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVL 901
+KE L H N+ L + LV + + G L +++ H + +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEVFHDQLHT-FLVMELLNGGELFERIKKKKHFSETEASYI 111
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTP 958
MR + ++ +H +VH D+KP+N+LF + + E + DFG RL P
Sbjct: 112 ---MRK-----LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL---KP 160
Query: 959 AEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMF-TQDEDIV 1016
+ T TL Y +PE L + D++S G++L +L+G+ P F + D +
Sbjct: 161 PDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVP--FQSHDRSLT 217
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPIDRPTMSDI 1073
++ K +I + G + W+ K LL DP R MS +
Sbjct: 218 CTSAVEIMK-KIKK----GDFSFE--GEAWKNVSQEAKDLIQGLLT--VDPNKRLKMSGL 268
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 49/227 (21%)
Query: 841 DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL-------GTLL-QE 892
++ E L K++H N+ L Y + LV + G L G ++
Sbjct: 49 RDSSLENEIAVLKKIKHENIVTLEDIYE-STTHYYLVMQLVSGGELFDRILERGVYTEKD 107
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFG 949
AS + V + +LH + +VH D+KP+N+L+ + + + ++DFG
Sbjct: 108 ASL-------------VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF 1009
L ++ + +TA GT GYV+PE +K D +S G++ LL G P F
Sbjct: 155 LSKME-----QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP--F 207
Query: 1010 TQDEDIVKWVKKQLQKGQITELLEP--------------GLLELDPE 1042
+E K + +++++G E P LLE DP
Sbjct: 208 -YEETESK-LFEKIKEGYY-EFESPFWDDISESAKDFICHLLEKDPN 251
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 14/120 (11%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
+ L + H+ ++H D+KP NV+ D + + L D+GL P V + +
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF 196
Query: 974 VSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
PE + + D++S G +L ++ K P D QL + I ++L
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY------DQLVR--IAKVL 248
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 50/253 (19%)
Query: 841 DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR---LLVYDYMPNGNL-------GTL 889
D R+E E + + ++ + Y R L+V + + G L G
Sbjct: 97 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 156
Query: 890 L---QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFEAHL 945
+EAS M+ + + +LH+ N+ H D+KP+N+L+ A L
Sbjct: 157 AFTEREASEI--------MKS-----IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203
Query: 946 --SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTG 1003
+DFG + T + TT T YV+PE + K D++S G+++ LL G
Sbjct: 204 KLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
Query: 1004 KRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCT 1060
P I +K +++ GQ + + EW E VK LL T
Sbjct: 260 YPPFYSNHGLAISPGMKTRIRMGQY-----------EFPNPEWSEVSEEVKMLIRNLLKT 308
Query: 1061 APDPIDRPTMSDI 1073
+P R T+++
Sbjct: 309 --EPTQRMTITEF 319
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 39/244 (15%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG+V K D G +++I++ + D+ + R E + L ++RH NL L
Sbjct: 38 YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKK 96
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
LV++++ + + L+ + V + + +I G+ F H+ N++H
Sbjct: 97 KRW-YLVFEFVDH-TILDDLELFPNGLDYQVVQKY-LFQII-----NGIGFCHSHNIIHR 148
Query: 929 DIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALTGET--T 985
DIKP+N+L L DFG R L P V T Y +PE L G+
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYDDEVATRWYRAPE-LLVGDVKYG 203
Query: 986 KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045
K DV++ G ++ E+ G P +F D DI QL I L G +
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EP-LFPGDSDI-----DQLYH--IMMCL--G----NLIPRH 248
Query: 1046 WEEF 1049
E F
Sbjct: 249 QELF 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 23/161 (14%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL +LH+ +VH DIKP N+L +S G+ P A T T+ G+ +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF-AADDTCRTSQGSPAFQP 179
Query: 976 PEAALTGETT---KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
PE G T + D++S G+ L + TG P F + ++I K + + KG
Sbjct: 180 PE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYP--F-EGDNIYKLFEN-IGKGSYA--- 231
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
PG + L G +L +P R ++ I
Sbjct: 232 IPGDC-----GPPLSDLLKG----MLE--YEPAKRFSIRQI 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 24/188 (12%)
Query: 829 VLSIRRL--PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886
+ R+ + +E L +V H N+ L Y D+ +L+ + + G L
Sbjct: 44 FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGEL 102
Query: 887 GTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFE 942
L + ++ ++ ++ G+ +LHT + H D+KP+N++ D +
Sbjct: 103 FDFLAQKESLSEEEATSF---IKQIL-----DGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
Query: 943 AH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLL 998
L DFGL GT +V+PE + E E+D++S G++
Sbjct: 155 IPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITY 209
Query: 999 ELLTGKRP 1006
LL+G P
Sbjct: 210 ILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 48/244 (19%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYND-GM-----VLSIRRL--PDGSLDENLF 845
T+ +D L ++ +V K G+ + RR +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 846 RKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASH---QDGHVLN 902
+E L +++H N+ L Y D+ +L+ + + G L L E ++
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFLAEKESLTEEEATEF- 119
Query: 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFEAH---LSDFGLDRLTIPTP 958
++ + G+ +LH+ + H D+KP+N++ D + + DFGL
Sbjct: 120 --LKQ-----ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG- 171
Query: 959 AEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017
+ GT +V+PE + E E+D++S G++ LL+G P + ++ +
Sbjct: 172 ---NEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 1018 WVKK 1021
V
Sbjct: 228 NVSA 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 39/237 (16%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENLFRK----EAEFLGKVRHRNLTVLR------ 864
GLVF A ND ++I+++ L + K E + + ++ H N+ +
Sbjct: 24 NGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80
Query: 865 GYYAGAPDLRL-------LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
G L +V +YM +L +L++ + H L + RGL
Sbjct: 81 GSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHA------RLFMYQLLRGL 133
Query: 918 AFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
++H++N++H D+KP N+ + D + DFGL R+ P + + + T Y SP
Sbjct: 134 KYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193
Query: 977 EAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
L+ TK D+++ G + E+LTGK +F ++ +Q+Q I E +
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK--TLFAGAHEL-----EQMQL--ILESI 241
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 39/244 (15%)
Query: 816 YGLVFKACYND-GMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG+VFK D G +++I++ + D + R E L +++H NL L +
Sbjct: 16 YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRK 74
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
L LV++Y + + L + V + + + + F H N +H
Sbjct: 75 RRL-HLVFEYCDH-TVLHELDRYQRGVPEHLVKSI-TWQTL-----QAVNFCHKHNCIHR 126
Query: 929 DIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTLGYVSPEAALTGET--T 985
D+KP+N+L L DFG R LT P+ V T Y SPE L G+T
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSD----YYDDEVATRWYRSPE-LLVGDTQYG 181
Query: 986 KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSE 1045
DV++ G V ELL+G P ++ D+ QL I + L G D
Sbjct: 182 PPVDVWAIGCVFAELLSG-VP-LWPGKSDV-----DQLYL--IRKTL--G----DLIPRH 226
Query: 1046 WEEF 1049
+ F
Sbjct: 227 QQVF 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHL--SDFGLDRLTIPTPAEASTSTTAVGTLGY 973
G+++ H+ + H D+K +N L D L DFG + S + VGT Y
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAY 183
Query: 974 VSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031
++PE L + K +DV+S G+ L +L G P F +D + + +K +Q+ +
Sbjct: 184 IAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYP--F-EDPEEPRDYRKTIQRILSVKY 239
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
P + + PE L+ + DP R ++ +I
Sbjct: 240 SIPDDIRISPEC----CHLIS---RIFV--ADPATRISIPEI 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGA 870
+G VFKA G ++++++ + E R E + L ++H N+ L
Sbjct: 30 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTK 88
Query: 871 PDLRL-------LVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLH 921
LV+D+ + +L LL + + M+ L+ GL ++H
Sbjct: 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-MQMLL-----NGLYYIH 141
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAAL 980
+ ++H D+K NVL D L+DFGL R ++ ++ + T V TL Y PE L
Sbjct: 142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE-LL 200
Query: 981 TGET--TKESDVYSFGIVLLELLTGKRPVM 1008
GE D++ G ++ E+ T P+M
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMWTRS-PIM 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 35/238 (14%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGAP 871
YG+V+KA + G +++++R+ + DE + R E L ++ H N+ L
Sbjct: 34 YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSER 92
Query: 872 DLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
L LV+++M +L +L E QD + + + L+ RG+A H ++H D
Sbjct: 93 CL-TLVFEFMEK-DLKKVLDENKTGLQDSQIKIY-LYQLL-----RGVAHCHQHRILHRD 144
Query: 930 IKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAALTGET--TK 986
+KPQN+L ++D L+DFGL R IP + T V TL Y +P+ L G +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPD-VLMGSKKYST 199
Query: 987 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQITELLEPGLLEL 1039
D++S G + E++TGK P +F D QL K G P + EL
Sbjct: 200 SVDIWSIGCIFAEMITGK-P-LFPGVTDD-----DQLPKIFSILGTPNPREWPQVQEL 250
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 47/251 (18%), Positives = 91/251 (36%), Gaps = 43/251 (17%)
Query: 775 RRSSTDNGGPKLVMFNNKITLAETVEATRQFDEENVLSRTRYGLVFKACYND-GMVL--- 830
SS + G + + F + E + L R ++ +V + G
Sbjct: 6 HHSSGVDLGTENLYFQSM----ENFNNFYILTSK-ELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 831 SIRRLPDGSLDENLFRKEAEFLGKVRHR-NLTVLRGYYAGAPDLRLLVYDYMPNGNL--- 886
+++ G E L + + L Y ++ +L+ +Y G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI-ILILEYAAGGEIFSL 119
Query: 887 ------GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939
+ + ++ + G+ +LH +N+VH D+KPQN+L +
Sbjct: 120 CLPELAEMVSENDVIRL--------IKQ-----ILEGVYYLHQNNIVHLDLKPQNILLSS 166
Query: 940 DFEAH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGI 995
+ + DFG+ R +GT Y++PE L + T +D+++ GI
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHA----CELREIMGTPEYLAPE-ILNYDPITTATDMWNIGI 221
Query: 996 VLLELLTGKRP 1006
+ LLT P
Sbjct: 222 IAYMLLTHTSP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 44/193 (22%), Positives = 78/193 (40%), Gaps = 34/193 (17%)
Query: 829 VLSIRRL--PDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886
+ R+ + +E L +V H N+ L Y D+ +L+ + + G L
Sbjct: 44 FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV-VLILELVSGGEL 102
Query: 887 -------GTLL-QEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF- 937
+L +EA+ ++ + G+ +LHT + H D+KP+N++
Sbjct: 103 FDFLAQKESLSEEEATSF--------IKQ-----ILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 938 DADFEAH---LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSF 993
D + L DFGL GT +V+PE + E E+D++S
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSI 204
Query: 994 GIVLLELLTGKRP 1006
G++ LL+G P
Sbjct: 205 GVITYILLSGASP 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-13
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 35/239 (14%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG VFKA +++++R+ DE + R E L +++H+N+ L
Sbjct: 15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSD 73
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928
L LV+++ +L + V ++ + L+ +GL F H+ N++H
Sbjct: 74 KKL-TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF-LFQLL-----KGLGFCHSRNVLHR 125
Query: 929 DIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAALTGET--T 985
D+KPQN+L + + E L++FGL R IP + V TL Y P+ L G +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVR----CYSAEVVTLWYRPPD-VLFGAKLYS 180
Query: 986 KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQITELLEPGLLEL 1039
D++S G + EL RP +F ++ QL++ G TE P + +L
Sbjct: 181 TSIDMWSAGCIFAELANAGRP-LFPGNDVD-----DQLKRIFRLLGTPTEEQWPSMTKL 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 17/126 (13%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL-GY 973
R + LH SN++H D+KP N+L +++ + + DFGL R+ + A+ S T + +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 974 VS------PEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
V+ PE LT ++ DV+S G +L EL + +F D QL
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR--PIF-PGRDYR----HQLLL- 234
Query: 1027 QITELL 1032
I ++
Sbjct: 235 -IFGII 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA 910
L RH LT L YA RL V +Y G L L V
Sbjct: 59 LQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYG 111
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970
+ L +LH+ ++V+ DIK +N++ D D ++DFGL + I ++ +T T GT
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKTFCGT 168
Query: 971 LGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
Y++PE L + D + G+V+ E++ G+ P F QD +
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 852 LGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIA 910
L RH LT L Y+ RL V +Y G L L V +
Sbjct: 202 LQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYG 254
Query: 911 LGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVG 969
+ L +LH+ N+V+ D+K +N++ D D ++DFGL + I + +T T G
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---KDGATMKTFCG 311
Query: 970 TLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
T Y++PE + + D + G+V+ E++ G+ P F QD +
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 355
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-12
Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 6/103 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+A L LH+ +++ D+KP+N+L D + L+DFGL + +I + + GT+
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---DHEKKAYSFCGTVE 191
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
Y++PE T+ +D +SFG+++ E+LTG P F +D
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKDRK 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 4e-12
Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 11/140 (7%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
V +Y+ G+L +Q+ P A +A GL FL + +++ D+K NV
Sbjct: 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
+ D++ ++DFG+ + I + T+ T GT Y++PE K D ++FG+
Sbjct: 474 MLDSEGHIKIADFGMCKENI---WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 996 VLLELLTGKRPVMFT-QDED 1014
+L E+L G+ P F +DED
Sbjct: 531 LLYEMLAGQAP--FEGEDED 548
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 35/238 (14%)
Query: 816 YGLVFKACYNDGMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGAP 871
YG+V+KA N G +++++ DE + R E L +++H N+ L
Sbjct: 15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKK 73
Query: 872 DLRLLVYDYMPNGNLGTLLQEASH--QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGD 929
L +LV++++ +L LL + ++ + L+ G+A+ H ++H D
Sbjct: 74 RL-VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL-----NGIAYCHDRRVLHRD 125
Query: 930 IKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAALTGET--TK 986
+KPQN+L + + E ++DFGL R IP T + TL Y +P+ L G +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVR----KYTHEIVTLWYRAPD-VLMGSKKYST 180
Query: 987 ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQITELLEPGLLEL 1039
D++S G + E++ G P +F + QL + G P + EL
Sbjct: 181 TIDIWSVGCIFAEMVNG-TP-LFPGVSEA-----DQLMRIFRILGTPNSKNWPNVTEL 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 38/242 (15%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYAGA 870
YG V+KA ++I+R+ +E + R E L +++HRN+ L+
Sbjct: 47 YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHN 105
Query: 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDI 930
L L+++Y N +L + + V+ + LI G+ F H+ +H D+
Sbjct: 106 HRL-HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI-----NGVNFCHSRRCLHRDL 158
Query: 931 KPQNVLFDADFEAH-----LSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
KPQN+L + + DFGL R IP T + TL Y PE L G
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR----QFTHEIITLWYRPPE-ILLGSR 213
Query: 985 --TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQITELLEPGLL 1037
+ D++S + E+L P +F D +I QL K G + PG+
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKT-P-LFPGDSEI-----DQLFKIFEVLGLPDDTTWPGVT 266
Query: 1038 EL 1039
L
Sbjct: 267 AL 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L LH +++ D+KP+N++ + L+DFGL + +I + + + T GT+ Y++
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI---HDGTVTHTFCGTIEYMA 189
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
PE + + D +S G ++ ++LTG P FT ++
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRK 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 36/249 (14%)
Query: 829 VLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGT 888
+L+ +++ + + R E + L RH ++ L + D +V +Y+ G L
Sbjct: 43 ILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLYQVISTPTDF-FMVMEYVSGGELFD 100
Query: 889 LLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948
+ + + + +++ + + H +VH D+KP+NVL DA A ++DF
Sbjct: 101 YICKHGRVEEMEARRLFQQILS-----AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 155
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRP 1006
GL + ++ T+ G+ Y +PE ++G E D++S G++L LL G P
Sbjct: 156 GLSNM----MSDGEFLRTSCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 1007 VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCT--APDP 1064
F DE + KK ++ G P L + LL DP
Sbjct: 211 --F-DDEHVPTLFKK-IRGGVFY---IPEYLNRSVAT-------------LLMHMLQVDP 250
Query: 1065 IDRPTMSDI 1073
+ R T+ DI
Sbjct: 251 LKRATIKDI 259
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 31/156 (19%)
Query: 393 KSLTLAANLFSGSIP-ASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKF 450
L L N F+ F+ LP L +N +N ++ + E G + ++ + L+ N+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 451 SGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-AGL 509
N+ F G L L TL L N + + GL
Sbjct: 94 E----------------NVQHKMFKG--------LESLKTLMLR-SNRITCVGNDSFIGL 128
Query: 510 PNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
++++++L +N+++ V G F +L SL LNL N
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 17/147 (11%)
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPAT--FSFLRSVVVLSFSGNHISGSIPP----ELG 579
+PE L L+ N F + AT F L + ++FS N I+ I
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 580 NCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLV 637
+ + L SN L + + L L L L N +T + ++ SS+R L +
Sbjct: 82 G---VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSAN 664
N ++ P + L +L+ L+L AN
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 25/122 (20%), Positives = 48/122 (39%), Gaps = 13/122 (10%)
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPE--LGNCSDLEVLELRSNSLTGHIPTDI-SHLS 606
IP L + N + + L + +N +T I S
Sbjct: 30 IPQY------TAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 607 HLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANN 665
+N + L+ N L + ++ SL++L++ SN ++ DS LS++ +L L N
Sbjct: 82 GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 666 LS 667
++
Sbjct: 141 IT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 32/166 (19%), Positives = 57/166 (34%), Gaps = 36/166 (21%)
Query: 265 SGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR----GAFPLWLTRASTL 320
P ++L N FT + L+ ++ N+I GAF AS +
Sbjct: 28 EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF----EGASGV 83
Query: 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSG 380
+ ++ N + + ++ LE LK L L NR +
Sbjct: 84 NEILLTSNRLEN-VQHKM--FKGLESLK---------------------TLMLRSNRIT- 118
Query: 381 EIPEFLGD-IRGLKSLTLAANLFSGSIPA-SFRNLPGLENLNLRHN 424
+ + ++ L+L N + ++ +F L L LNL N
Sbjct: 119 CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 580 NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVN 638
C V + + L IP I + L L+ N T I K LR + +
Sbjct: 10 RCEGTTV-DCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL-SSIFGLMNFNVSSNNLQA 692
+N ++ + S + + L++N L + + + L + SN +
Sbjct: 66 NNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC 119
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 11/140 (7%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
V +Y+ G+L +Q H + A + GL FLH+ +V+ D+K N+
Sbjct: 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGI 995
L D D ++DFG+ + + + + T GT Y++PE L + D +SFG+
Sbjct: 150 LLDKDGHIKIADFGMCKENM---LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206
Query: 996 VLLELLTGKRPVMFT-QDED 1014
+L E+L G+ P F QDE+
Sbjct: 207 LLYEMLIGQSP--FHGQDEE 224
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 20/138 (14%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
+ + H +VH D+KP+N+L D + ++DFGL + + + T+ G+ Y +
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI----MTDGNFLKTSCGSPNYAA 175
Query: 976 PEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT---- 1029
PE + G+ E DV+S GIVL +L G+ P F DE I KK +
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP--F-DDEFIPNLFKK-VNSCVYVMPDF 230
Query: 1030 -----ELLEPGLLELDPE 1042
+ L ++ DP
Sbjct: 231 LSPGAQSLIRRMIVADPM 248
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 6/103 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+A GL FL + +++ D+K NV+ D++ ++DFG+ + I + T+ T GT
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI---WDGVTTKTFCGTPD 186
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
Y++PE K D ++FG++L E+L G+ P F +DED
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDED 227
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 6/101 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L LH +++ DIK +N+L D++ L+DFGL + + E + GT+ Y++
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYDFCGTIEYMA 228
Query: 976 PEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
P+ G++ K D +S G+++ ELLTG P FT D +
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGE 267
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 47/133 (35%), Positives = 65/133 (48%), Gaps = 20/133 (15%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGY 973
RGLA+ H ++H D+KPQN+L + E L+DFGL R +IPT T V TL Y
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----TYDNEVVTLWY 166
Query: 974 VSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----G 1026
P+ L G T + + D++ G + E+ TG RP +F +QL G
Sbjct: 167 RPPD-ILLGSTDYSTQIDMWGVGCIFYEMATG-RP-LFPGSTVE-----EQLHFIFRILG 218
Query: 1027 QITELLEPGLLEL 1039
TE PG+L
Sbjct: 219 TPTEETWPGILSN 231
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 64/503 (12%), Positives = 154/503 (30%), Gaps = 82/503 (16%)
Query: 207 TLPSAIANCSSLVHLSAQGN---ALGGVIPPAIGALPKLQVVSLAQN-------NLSG-V 255
+ + I + + +G A ++P G + +++ + L V
Sbjct: 57 SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116
Query: 256 VPASMFCNVSGYPPSIRVVQL-GFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWL 314
V ++ + +V+ L F+ + L+ LDL+++ + WL
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176
Query: 315 T----RASTLTRLDVSG--NSISGKIPAQIGGLWR-LEELKMANNSFGGAVPVEIKQCSS 367
+ ++L L++S + +S ++ L+ LK+ + +++
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236
Query: 368 LSLLDLEGNRFSGE------IPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
L L G + L + L+ L+ + +PA + L LNL
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPAS 481
+ ++ ++ + +L + +
Sbjct: 297 SYATVQSY-----------------------DLVKLLCQCPKLQRLWVLDYIEDAGLEVL 333
Query: 482 LGNLLKLTTLDLSK---QNFSGELPIELAGL-------PNLQVIALQENKLSGNVPEGFS 531
L L + + + GL P L+ + +++
Sbjct: 334 ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN---AALI 390
Query: 532 SLM----SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVL 587
++ ++ L + + + + +C DL L
Sbjct: 391 TIARNRPNMTRFRL-------------CIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437
Query: 588 ELRSNSLTGHIPTDIS-HLSHLNVLDLSINNLTGEIPDEISK-CSSLRSL-LVNSNHLSG 644
L S LT + I + + +L ++ + + C SLR L + +
Sbjct: 438 SL-SGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496
Query: 645 GIPDSLAKLSNLAVLDLSANNLS 667
+ + +KL + L +S+ ++S
Sbjct: 497 ALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 89/563 (15%), Positives = 175/563 (31%), Gaps = 61/563 (10%)
Query: 30 LTSFKLNLHDPLGALNGWDSSTPAAPCDW-RGVACTNNRVTELRLPRLQLS----GRISD 84
+ S +L N W ++ + + E+RL R+ ++ I+
Sbjct: 68 VRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAK 127
Query: 85 HLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGN----LPANIGNLSNL 140
N ++L LS + A A C L+ + L+ + + L ++L
Sbjct: 128 SFKNFKVL-VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186
Query: 141 EILNVA--ANRLSGE----IANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFN 194
LN++ A+ +S + P NLK L+ + T + QL+ +
Sbjct: 187 VSLNISCLASEVSFSALERLVTRCP-NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG- 244
Query: 195 KFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLS- 253
++ EV L A++ C L LS +A+ +P +L ++L+ +
Sbjct: 245 -YTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQS 303
Query: 254 -GVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPL 312
+V C P ++ + + + + S L+ L + + P
Sbjct: 304 YDLVKLLCQC------PKLQRLWV-LDYIEDAGLEVLASTCKDLRELRV-----FPSEPF 351
Query: 313 WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEI-KQCSSLSLL 371
+ LT + S+S G +LE + A + I + +++
Sbjct: 352 VMEPNVALT--EQGLVSVS-------MGCPKLESVLYFCRQMTNAALITIARNRPNMTRF 402
Query: 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431
L I L A + L L+L
Sbjct: 403 RLCI-------------IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFE 449
Query: 432 EEVLGMNNLSTLDLSENKFSGE-VPASIGNLSQLMVFNLSGNAFSGR-IPASLGNLLKLT 489
+ L ++ S + + L + F + + A+ L +
Sbjct: 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509
Query: 490 TLDLSKQNFSGELPIELA-GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG 548
+L +S + S L +P L V + E + PE Y + G
Sbjct: 510 SLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFIY--RTVAGPRF 567
Query: 549 QIPATFSFLRSVVVLSFSGNHIS 571
+P + + FS I+
Sbjct: 568 DMPGFVWNMDQDSTMRFSRQIIT 590
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-09
Identities = 47/288 (16%), Positives = 92/288 (31%), Gaps = 44/288 (15%)
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG 452
+ + + N ++ S R P + ++ L+ G +
Sbjct: 46 RKVFIG-NCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA----- 99
Query: 453 EVPASIGNLSQLMVFNLSGNAFSGRIPASLG-NLLKLTTLDLSK-QNFSGELPIELA-GL 509
+ +S L ++ L + + + L LS + FS + +A
Sbjct: 100 -MSSSYTWLEEI---RLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC 155
Query: 510 PNLQVIALQENKLSGNVPEGFSSLM----SLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565
NL+ + L+E+ + S SL LN+S ++ +FS L +V
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS--CLASEV--SFSALERLV---- 207
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLS------INNLT 619
C +L+ L+L + T + L L ++
Sbjct: 208 -------------TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254
Query: 620 GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
+ +S C LR L + + +P + S L L+LS +
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 46/133 (34%), Positives = 69/133 (51%), Gaps = 20/133 (15%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGY 973
+GLAF H + ++H D+KPQN+L + + L DFGL R IP T ++ V TL Y
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN----TFSSEVVTLWY 174
Query: 974 VSPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----G 1026
+P+ L G + D++S G +L E++TGK P +F D +QL+ G
Sbjct: 175 RAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK-P-LFPGTNDE-----EQLKLIFDIMG 226
Query: 1027 QITELLEPGLLEL 1039
E L P + +L
Sbjct: 227 TPNESLWPSVTKL 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+A L +LH+ N+V+ D+KP+N+L D+ L+DFGL + I ST++T GT
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---EHNSTTSTFCGTPE 204
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDED 1014
Y++PE + D + G VL E+L G P F ++
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTA 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 5e-11
Identities = 93/590 (15%), Positives = 158/590 (26%), Gaps = 197/590 (33%)
Query: 518 QENKLSGNVPEGFS---------------SLMSLR-YLNLSFNGFVG---QIPATFSFLR 558
Q ++L N + F+ +L+ LR N+ +G +G A
Sbjct: 115 QRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-DVCL 172
Query: 559 SVVVLSFSGNHI---SGSIPPELGNCSDLEVLELRSNSLTGHI-PTDISHLSHLNVLDLS 614
S V I + L NC+ E + L I P S H + + L
Sbjct: 173 SYKVQCKMDFKIFWLN------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN------LAVLDLS------ 662
I+++ E LR LL + + + L L N +LS
Sbjct: 227 IHSIQAE----------LRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 663 ------ANNLSGEIPANLSSIFGLMNFNVSSNNLQAFAN-----NQDL----C-GKPLGR 706
+ LS ++S M QDL P
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPR-- 328
Query: 707 KCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAAAEKKRSPAR 766
L +IA S L W K +
Sbjct: 329 ---------------RLSIIAES-----------IRDGLATWDN-WKHVNCDKLTTI--- 358
Query: 767 ASSGASGGRRSSTDNGGP--------KLVMF--NNKITLAETVE----ATRQFDEENVLS 812
SS + P +L +F + I + + D V++
Sbjct: 359 --------IESSLNVLEPAEYRKMFDRLSVFPPSAHIP-TILLSLIWFDVIKSDVMVVVN 409
Query: 813 R-TRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871
+ +Y LV K +SI P L+ + + E + HR++ +Y
Sbjct: 410 KLHKYSLVEK--QPKESTISI---PSIYLE---LKVKLENEYAL-HRSI---VDHYN--- 454
Query: 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR----------GLAFL- 920
+ + +L + D + + HL + FL
Sbjct: 455 -----IPKTFDSDDLIPP-----YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 921 ----HTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
H S + N L F + ++ D P V +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICD------NDPKYERL------VNAILDFL 552
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025
P+ +K +D+ + +DE I + KQ+Q+
Sbjct: 553 PKIEENLICSKYTDLLRIA-------------LMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 1e-09
Identities = 97/562 (17%), Positives = 172/562 (30%), Gaps = 180/562 (32%)
Query: 169 SNGFSGPIPTSISNLSQLQLINFSFNKF--SREVPATFEGTLPSAIANCSSLVHLSAQGN 226
S I +L N F K+ SR P L A+ ++ G
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL---KLRQALLELRPAKNVLIDG- 157
Query: 227 ALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVV-QLGFNAF-TNV 284
+ G G K V A C S +V ++ F F N+
Sbjct: 158 -VLG-----SG---K-TWV------------ALDVCL------SYKVQCKMDFKIFWLNL 189
Query: 285 AGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL 344
+C+S VL++ Q + P W +R+ + + + +SI + L RL
Sbjct: 190 -----KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-------LRRL 237
Query: 345 EELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGL-----KSLTLAA 399
+ K N LL L + + F + L K +T
Sbjct: 238 LKSKPYEN----------------CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL 281
Query: 400 NLFSGSIPASFRNLPGL---ENLNLRHNSLS---GSLPEEVLGMN-------------NL 440
+ + + + + L E +L L LP EVL N L
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 441 STLD----LSENKFSGEVPASIGNLS---------QLMVFNLSGNAFSGRIPASLGNLL- 486
+T D ++ +K + + +S+ L +L VF S + IP L +L+
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-----IPTILLSLIW 396
Query: 487 -KLTTLD-------------LSKQNFSG---------ELPIELAGLPNL--QVI------ 515
+ D + KQ EL ++L L ++
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 516 -ALQENKLSGNVPEG--FS---------------SLMSLRYLNLSFNGFVGQ-------- 549
+ L + +S +L + +L+ F+ Q
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR---FLEQKIRHDSTA 513
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHL---S 606
A+ S L ++ L F +I + P E N++ +P +L
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDNDP----------KYERLVNAILDFLPKIEENLICSK 563
Query: 607 HLNVLDLSINNLTGEIPDEISK 628
+ ++L +++ I +E K
Sbjct: 564 YTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-09
Identities = 81/571 (14%), Positives = 158/571 (27%), Gaps = 154/571 (26%)
Query: 6 FLFFVLLCAPFSSCAVDRSPEIEALTSFKLNLHDPLGALN-GW-------DSSTPAAPC- 56
LF+ LL E E + F + N + + P+
Sbjct: 66 RLFWTLL----------SKQE-EMVQKFVEEVLRI----NYKFLMSPIKTEQRQPSMMTR 110
Query: 57 ---DWRGVACTNNRV-TELRLPRLQLSGRISDHLSNLR---------M-------LRKLS 96
+ R +N+V + + RLQ ++ L LR + +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 97 LRSNSFNGTIP-----ATLAQCTLLRAVFLQYNSL----SGNLPANIGNLSNLEI-LNVA 146
S + L C V L N + + SN+++ ++
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 147 ANRLSGEIA-----NDL--------PRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSF 193
L + N L + F+LS + T ++ +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL---LTTRFKQVTDFLSAATTT 287
Query: 194 NKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPP-AIGALPKLQVVSLAQNNL 252
+ T T + + Q +P + P + +S+
Sbjct: 288 HISLDHHSMTL--TPDEVKSLLLKYLDCRPQD------LPREVLTTNP--RRLSI----- 332
Query: 253 SGVVPASMFCNVSGYPPSI-RVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN-QIRGAF 310
+ S+ + + + T + S +VL+ + ++ F
Sbjct: 333 ---IAESI----RDGLATWDNWKHVNCDKLTTI----IESSLNVLEPAEYRKMFDRLSVF 381
Query: 311 PLWLTRASTLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMANNSFGGAVPVEIKQCSSLS 369
P IP + +W + V V + + S
Sbjct: 382 P-----------PSA-------HIPTILLSLIW--------FDVIKSDVMVVVNKLHKYS 415
Query: 370 LLDLEGNRFSGEIPEFLGDIRG--LKSLTLAANLFSG-SIPASFRN----LPGLEN---- 418
L++ + + IP +++ L ++ +IP +F + P L+
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 419 -LNLRHNSLSGSLPEEVLGMNNLSTLDLS--ENK-----FSGEVPASIGN-LSQLMVFN- 468
+ H L E + + + LD E K + SI N L QL +
Sbjct: 476 HIG-HH--LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 469 ---LSGNAFSGRIPASLGNLLKL-TTLDLSK 495
+ + + A L L K+ L SK
Sbjct: 533 YICDNDPKYERLVNAILDFLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 112/723 (15%), Positives = 185/723 (25%), Gaps = 230/723 (31%)
Query: 121 LQYNS-LSGNLPANIGNLSNLEILNVAANRLSGE-------IANDLPRNLKYFD-LSSNG 171
QY LS A + N ++ ++ + LS E + + L+ F L S
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 172 ------FSGPIPTSISNLSQLQLINFSF--NKFSREVPATFEGTLPSAIANCSSLVHLSA 223
F L+ IN+ F + E PS +
Sbjct: 76 EEMVQKFVE---------EVLR-INYKFLMSPIKTEQRQ------PSMMT-----RMYIE 114
Query: 224 QGNALGGVIPPAIGALPKLQV-----VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGF 278
Q + L K V + L + PA NV ++ G
Sbjct: 115 QRDRLYNDNQV----FAKYNVSRLQPYLKLRQALLELRPAK---NV--------LID-G- 157
Query: 279 NAFTNVAGPETG-SC--SSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIP 335
V G +G + V +Q F WL N S P
Sbjct: 158 -----VLG--SGKTWVALDVCLSYKVQCKMDFKIF--WLN----------LKNCNS---P 195
Query: 336 AQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395
+ L+M P + S + L + E+ L L
Sbjct: 196 ETV--------LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455
+ N+ + +F NL+ + +L L+T
Sbjct: 248 LVLLNVQNAKAWNAF-------NLSCK-----------IL----LTTRFKQ--------- 276
Query: 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVI 515
V + A + I SL + T D K L LP
Sbjct: 277 ----------VTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE--- 321
Query: 516 ALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI- 574
L N +S+ + AT+ + V + I S+
Sbjct: 322 VLTTNPR----------RLSI------IAESIRDGLATWDNWKHVNCDKLT-TIIESSLN 364
Query: 575 ---PPELGNC-SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI--NNLTGEIPDEI-S 627
P E L V ++ HIPT + LS+ ++ + +
Sbjct: 365 VLEPAEYRKMFDRLSVF--PPSA---HIPTIL----------LSLIWFDVIKSDVMVVVN 409
Query: 628 KCSSLRSLLV-NSNHLSGGIPD----SLAKLSNLAVL-----------------DLSANN 665
K SL+ + IP KL N L DL
Sbjct: 410 KLHK-YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 666 LSG----------------EIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLG---- 705
L E +F ++F ++ + + G L
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVF--LDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 706 ----RK--CENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRWRRRLKESAAAE 759
+ C+N +R IL + + + +L+ + E A +
Sbjct: 527 LKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
Query: 760 KKR 762
+R
Sbjct: 587 VQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 2e-04
Identities = 67/459 (14%), Positives = 128/459 (27%), Gaps = 152/459 (33%)
Query: 681 MNFNVS----------SNNLQAFANNQDLCG------KPLGRKCE-----NADDRDRRKK 719
M+F S AF +N D C K + K E + D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 720 LILLIVIAASGACLLALCCCFYIFSLLR----WRRRLKESAAAEKKRSPARASSGASGGR 775
L + + ++ ++ +LR + L E+ R P+ + +
Sbjct: 66 R-LFWTLLSKQEEMVQK----FVEEVLRINYKF---LMSPIKTEQ-RQPSMMTRMYIE-Q 115
Query: 776 RSSTDNGGPKLVMFNNKITLAETVEATRQF-----DEENVLSRTRYG--------LVFKA 822
R N +N ++ + RQ +NV G +
Sbjct: 116 RDRLYNDNQVFAKYN--VSRLQPYLKLRQALLELRPAKNV---LIDGVLGSGKTWVALDV 170
Query: 823 CYNDGMV---------LSIRRL--PDGSLD--ENLFRK-EAEFLGKVRHRNLTVLRGYYA 868
C + + L+++ P+ L+ + L + + + + H + LR +
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLN--WPMRHLIAL-------------GV 913
A RLL N LL VL + A V
Sbjct: 231 QAELRRLLKSKPYENC----LL---------VLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT---PAEASTSTTAVGT 970
L+ T+++ L + ++ L + L P E T
Sbjct: 278 TDFLSAATTTHISLDHHSM--TLTPDEVKSLLLKY----LDCRPQDLPREVLT------- 324
Query: 971 LGYVSPEA-ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029
+P ++ E+ ++ + W K + ++T
Sbjct: 325 ---TNPRRLSIIAESIRD-----------------GLATWDN------W--KHVNCDKLT 356
Query: 1030 ELLEPGLLELDPESSEWEE-------FLLGVKV--ALLC 1059
++E L L+P E+ + F + LL
Sbjct: 357 TIIESSLNVLEPA--EYRKMFDRLSVFPPSAHIPTILLS 393
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-11
Identities = 45/173 (26%), Positives = 68/173 (39%), Gaps = 31/173 (17%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGY 973
RGL FLH + +VH D+KP+N+L + L+DFGL R+ + T V TL Y
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-----TPVVVTLWY 185
Query: 974 VSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQ 1027
+PE L T D++S G + E+ K P +F + + QL K G
Sbjct: 186 RAPE-VLLQSTYATPVDMWSVGCIFAEMFRRK-P-LFCGNSEA-----DQLGKIFDLIGL 237
Query: 1028 ITELLEPGLLEL-DPESSEWEEFLLGVKVALLCTAP----------DPIDRPT 1069
E P + L + V + + +P R +
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNV 935
V +++ G+L +Q++ + A + L FLH +++ D+K NV
Sbjct: 101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155
Query: 936 LFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFG 994
L D + L+DFG+ + I T+ T GT Y++PE L D ++ G
Sbjct: 156 LLDHEGHCKLADFGMCKEGI---CNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211
Query: 995 IVLLELLTGKRPVMFT-QDED 1014
++L E+L G P F ++ED
Sbjct: 212 VLLYEMLCGHAP--FEAENED 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 27/92 (29%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L +LH +++ D+K NVL D++ L+D+G+ + + T++T GT Y++
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIA 178
Query: 976 PEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
PE L GE D ++ G+++ E++ G+ P
Sbjct: 179 PE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
G+ + H +VH D+KP+NVL DA A ++DFGL + ++ T+ G+ Y +
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRTSCGSPNYAA 183
Query: 976 PEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
PE ++G E D++S G++L LL G P F D+ + KK + G
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLCGTLP--F-DDDHVPTLFKK-ICDGIFY---T 235
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
P L + L +L DP+ R T+ DI
Sbjct: 236 PQYL-----NPSVISLLKH----MLQ--VDPMKRATIKDI 264
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGY 973
RGL FLH+ +VH D+KPQN+L + + L+DFGL R+ + T+ V TL Y
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-----MALTSVVVTLWY 185
Query: 974 VSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK-----GQ 1027
+PE L + D++S G + E+ K P +F D+ QL K G
Sbjct: 186 RAPE-VLLQSSYATPVDLWSVGCIFAEMFRRK-P-LFRGSSDV-----DQLGKILDVIGL 237
Query: 1028 ITELLEPGLLEL-DPESSEWEEFLLGVKVALLCTAP----------DPIDRPT 1069
E P + L + V + +P R +
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 14/160 (8%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRH 907
E L V L L + +L +V +Y+ G + + L+ + P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNL-YMVMEYVAGGEMFSHLRRIGR-----FSEPHAR 144
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTST-T 966
A + +LH+ ++++ D+KP+N+L D ++DFG + T T
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWT 197
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
GT ++PE L+ K D ++ G+++ E+ G P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENL-------FRKEAEFLGKVRHRNLTVLRGYY 867
+ V+KA N +++I+++ G E R E + L ++ H N+ L +
Sbjct: 23 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAF 81
Query: 868 AGAPDLRLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNM 925
++ LV+D+M +L ++++ S H+ + M + +GL +LH +
Sbjct: 82 GHKSNI-SLVFDFMET-DLEVIIKDNSLVLTPSHIKAY-MLMTL-----QGLEYLHQHWI 133
Query: 926 VHGDIKPQNVLFDADFEAHLSDFGLDRL-TIPTPAEASTSTTAVGTLGYVSPEAALTGET 984
+H D+KP N+L D + L+DFGL + P T V T Y +PE L G
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----AYTHQVVTRWYRAPE-LLFGAR 188
Query: 985 --TKESDVYSFGIVLLELLTGK 1004
D+++ G +L ELL
Sbjct: 189 MYGVGVDMWAVGCILAELLLRV 210
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
++ L +LH +++ D+K NVL D++ L+D+G+ + + T++T GT
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---RPGDTTSTFCGTPN 218
Query: 973 YVSPEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
Y++PE L GE D ++ G+++ E++ G+ P
Sbjct: 219 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 69/370 (18%), Positives = 130/370 (35%), Gaps = 76/370 (20%)
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRA-----STLTRLDVSGNSISGKIPAQIGGLWRLE 345
S + LDL N + + L +A +++T L++SGNS+ K L
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDELV 72
Query: 346 ELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDI-----RGLKSLTLAAN 400
++ A ++++ L+L GN S + + L + L L N
Sbjct: 73 QILAAIP-------------ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 401 LFSGS----IPASFRNLP-GLENLNLRHNSLSG----SLPEEVLGMN-NLSTLDLSENKF 450
FS +F NLP + +LNLR N L L + + + N+++L+L N
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
Query: 451 SGEVPASIGNL-----SQLMVFNLSGNAFSGRIPASLGNLLK-----LTTLDLSKQNFSG 500
+ + A + + + +LS N + A L + + +L+L G
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239
Query: 501 E----LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS-------LRYLNLSFNGFVGQ 549
L + L +LQ + L + + E +L + + ++ +
Sbjct: 240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
Query: 550 IPATFSFLRSVVVLSFSGNHISGSI-PPELGNCSDLEVLELRSNSLTGHIPTDISHLSHL 608
+ +S +SG P L N + + ++N +IP L
Sbjct: 300 ---------HSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIP------DEL 344
Query: 609 NVLDLSINNL 618
+ L
Sbjct: 345 RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 48/360 (13%), Positives = 111/360 (30%), Gaps = 88/360 (24%)
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
++ LDL N L + + +LNL
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQ--AFAN-----------------TPASVTSLNL 58
Query: 422 RHNSLSGSLPE---EVLGMNN--LSTLDLSENKFSGE-----VPASIGNLSQLMVFNLSG 471
NSL + ++L +++L+LS N S + V + V +L
Sbjct: 59 SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 472 NAFSGRIPASLGNLLK-----LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526
N FS + + +T+L+L + + EL L
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ-------ILAAIPA---- 167
Query: 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEV 586
++ LNL N S + ++ + + +
Sbjct: 168 --------NVNSLNLRGNNLA----------------SKNCAELAKFLA---SIPASVTS 200
Query: 587 LELRSNSLTGHIPTDISHL-----SHLNVLDLSINNLTGE----IPDEISKCSSLRSLLV 637
L+L +N L +++++ +H+ L+L +N L G + L+++ +
Sbjct: 201 LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260
Query: 638 NSNHLSG-------GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
+ + + + + + + ++D + + +S++ ++ +L
Sbjct: 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSL 320
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 48/339 (14%), Positives = 98/339 (28%), Gaps = 52/339 (15%)
Query: 136 NLSNLEILNVAANRLSGEIANDL-------PRNLKYFDLSSNGFSGPIPTSI-----SNL 183
+ L+++ N L +L P ++ +LS N + +
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 184 SQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALG--GV--IPPAIGAL 239
+ + +N S N S + TL + ++ L N A L
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAA---IPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 240 PK-LQVVSLAQNNLSGVVPASMFCNV-SGYPPSIRVVQLGFNAFTNVAGPETG----SCS 293
P + ++L N+L G+ + + + P ++ + L N + E S
Sbjct: 137 PASITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195
Query: 294 SVLQVLDLQQNQIRGAFPLWLTRA-----STLTRLDVSGNSISGKIPAQIGGL----WRL 344
+ + LDL N + L + + L++ N + G + L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 345 EELKMANNSFGGAVPVE-------IKQCSSLSLLDLEGNRFSGE----IPEFLGDIRG-L 392
+ + + + + + L+D G I + ++ G
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 393 KSLTLAANLF----SGSIPASFRNLPG-LENLNLRHNSL 426
+L N+P L L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 59/290 (20%)
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGL-----PNLQVIALQE 519
M + L+ + S + +T+LDLS N +EL ++ + L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 520 NKLSGNVPEGFSSLM-----SLRYLNLSFNGF----VGQIPATFSFLRSVV-VLSFSGNH 569
N L + ++ ++ LNLS N ++ T + + + VL N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 570 ISGSIPPELG------NCSDLEVLELRSNSLTGHIPTDISHLS--------HLNVLDLSI 615
S E S + L LR N L L ++N L+L
Sbjct: 121 FSSKSSSEFKQAFSNLPAS-ITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRG 176
Query: 616 NNLTGEIPDEISK-----CSSLRSLLVNSNHLSGGIPDSLAKL-----SNLAVLDLSANN 665
NNL + E++K +S+ SL +++N L LA + +++ L+L N
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236
Query: 666 LSGEIPANLSSIFG----LMNFNVSSNNL------------QAFANNQDL 699
L G NL + L + + + AF N Q +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL--- 971
+ + +LH+ ++H D+KP N+L +A+ ++DFGL R + + ++
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 972 ---------GYVS------PEAALTGET-TKESDVYSFGIVLLELLTGK 1004
YV+ PE L TK D++S G +L E+L GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 13/141 (9%)
Query: 507 AGLP-NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI----PATFSFLRSVV 561
LP + I L++N + P FS LR ++LS N QI P F LRS+
Sbjct: 28 TNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN----QISELAPDAFQGLRSLN 83
Query: 562 VLSFSGNHISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLT 619
L GN I+ +P L L++L L +N + + D L +LN+L L N L
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 620 GEIPDEISKCSSLRSLLVNSN 640
S +++++ + N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 14/145 (9%)
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP----ELGNC 581
+P ++ + L N P FS + + + S N IS + P L +
Sbjct: 26 IPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS- 81
Query: 582 SDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNS 639
L L L N +T +P + L L +L L+ N + + + +L L +
Sbjct: 82 --LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD 137
Query: 640 NHLSGGIPDSLAKLSNLAVLDLSAN 664
N L + + L + + L+ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 468 NLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL-AGLPNLQVIALQENKLSGNV 526
L N P + KL +DLS N EL + GL +L + L NK++ +
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLS-NNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 527 PEG-FSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE-LGNCSD 583
P+ F L SL+ L L+ N + + F L ++ +LS N + +I
Sbjct: 96 PKSLFEGLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRA 153
Query: 584 LEVLELRSN 592
++ + L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 39/161 (24%), Positives = 65/161 (40%), Gaps = 42/161 (26%)
Query: 297 QVLDLQQNQIR----GAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANN 352
+ L+QN I+ GAF + L R+D+S N IS ++ L L
Sbjct: 35 TEIRLEQNTIKVIPPGAF----SPYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNS--- 84
Query: 353 SFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT---LAANLFSGSIPA- 408
L L GN+ + E+P+ GL SL L AN + +
Sbjct: 85 ------------------LVLYGNKIT-ELPK--SLFEGLFSLQLLLLNANKIN-CLRVD 122
Query: 409 SFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSEN 448
+F++L L L+L N L ++ + + + T+ L++N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 30/128 (23%), Positives = 53/128 (41%), Gaps = 12/128 (9%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI-SKCSS 631
IP L + + L N++ P S L +DLS N ++ E+ + S
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 632 LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPA----NLSSIFGLMNFNVSS 687
L SL++ N ++ L +L +L L+AN ++ + +L + L ++
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN---LNLLSLYD 137
Query: 688 NNLQAFAN 695
N LQ A
Sbjct: 138 NKLQTIAK 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 9/138 (6%)
Query: 480 ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYL 539
A N ++ LDL + A L I +N++ +GF L L+ L
Sbjct: 13 AQYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 69
Query: 540 NLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS--GSIPPELGNCSDLEVLELRSNSLT-- 595
++ N L + L + N + G + P L + L L + N +T
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVTNK 128
Query: 596 -GHIPTDISHLSHLNVLD 612
+ I + + VLD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 22/106 (20%), Positives = 42/106 (39%), Gaps = 5/106 (4%)
Query: 562 VLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
++ + I + + N L+LR + I + L + +D S N + +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 622 IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
+ L++LLVN+N + L +L L L+ N+L
Sbjct: 57 LDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 22/140 (15%), Positives = 45/140 (32%), Gaps = 13/140 (9%)
Query: 408 ASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLS---QL 464
A + N L+LR + + ++ +D S+N+ + +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQEN--- 520
++ N L LT L L+ + ++ LA L +L + + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
Query: 521 KLSGNVPEGFSSLMSLRYLN 540
+ +R L+
Sbjct: 127 NKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 21/109 (19%), Positives = 33/109 (30%), Gaps = 4/109 (3%)
Query: 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN 616
L G I I + ++ N + L L L ++ N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN 74
Query: 617 NLTGEIPDEISKCSSLRSLLVNSNHLSG-GIPDSLAKLSNLAVLDLSAN 664
+ L L++ +N L G D LA L +L L + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 83 SDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS--GNLPANIGNLSNL 140
+ +N R+L LR I A A+ N + P L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRL 66
Query: 141 EILNVAANRLS--GEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQ 187
+ L V NR+ GE + +L L++N + L+ L+
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLK 113
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
+ LDL+ +I L T +D S N I K+ L RL+ L + NN
Sbjct: 21 DRELDLRGYKIPVIENLGATLDQ-FDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRIC 77
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFS--GEIPEFLGDIRGLKSLTLAAN 400
+ L+ L L N G++ + L ++ L L + N
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 19/114 (16%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 361 EIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420
+ LDL G + I + ++ + N + F L L+ L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 421 LRHNSLSGSLPEEVLGMNNLSTLDLSENKFS--GEVPASIGNLSQLMVFNLSGN 472
+ +N + + +L+ L L+ N G++ + +L L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 38/178 (21%), Positives = 67/178 (37%), Gaps = 25/178 (14%)
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG 545
+ L ++ L+ L + +AL N + S + +LR L+L N
Sbjct: 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNL 81
Query: 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHL 605
+I + ++ L S N I+ S+ + +L VL + +N +T +I L
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKL 136
Query: 606 SHLN---VLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLD 660
+ L+ L L+ N L E + S R + + +L NL LD
Sbjct: 137 AALDKLEDLLLAGNPLY-NDYKENNATSEYRIEV-------------VKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 20/166 (12%)
Query: 560 VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619
V L I + L + L L +N++ I + +S + +L +L L N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 620 GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFG 679
+I + + +L L ++ N ++ + KL NL VL +S N ++ N I
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT-----NWGEIDK 135
Query: 680 LMNFNVSSNNLQAFANNQDLCGKPLGRK-CENADDRDRRKKLILLI 724
L + L+ L G PL EN + R +++ +
Sbjct: 136 LAAL----DKLEDL----LLAGNPLYNDYKENNATSEYRIEVVKRL 173
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 34/150 (22%), Positives = 57/150 (38%), Gaps = 24/150 (16%)
Query: 406 IPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLS--- 462
+ A+ L ++L L N++ + + GM NL L L N I NL
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-----KIENLDAVA 92
Query: 463 -QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQEN 520
L +S N + + + + L+ L L +S + I+ LA L L+ + L N
Sbjct: 93 DTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 521 KLSGNVPEG----------FSSLMSLRYLN 540
L + E L +L+ L+
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 22/150 (14%)
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLM- 534
++ A+L L L LS N I L+G+ NL++++L N + E ++
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIK--KIENLDAVAD 93
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS--GSIPPELGNCSDLEVLELRSN 592
+L L +S+N + + L ++ VL S N I+ G I L LE L L N
Sbjct: 94 TLEELWISYN-QIASLSG-IEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
Query: 593 SLTGHIPTD----------ISHLSHLNVLD 612
L + + L +L LD
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 34/143 (23%), Positives = 54/143 (37%), Gaps = 18/143 (12%)
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
+ + L L N +I L + L+ L+L NL I LE L +
Sbjct: 44 LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFS--GEVPASIGNLSQLMVFNLSGNAFSGRIP 479
+N ++ SL + + NL L +S NK + GE+ + L +L L+GN
Sbjct: 101 SYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYK 157
Query: 480 AS----------LGNLLKLTTLD 492
+ + L L LD
Sbjct: 158 ENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/172 (19%), Positives = 63/172 (36%), Gaps = 37/172 (21%)
Query: 92 LRKLSLRSNSFNG--TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANR 149
K+ L + ATL+ + + L N++ + +++ + NL IL++ N
Sbjct: 25 AEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81
Query: 150 LSGEIAN--DLPRNLKYFDLSSNGFSGPIPTSISNLS---QLQLINFSFNKFS--REVPA 202
+ +I N + L+ +S N + S+S + L+++ S NK + E+
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEI-- 133
Query: 203 TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA----------IGALPKLQV 244
+A L L GN L + LP L+
Sbjct: 134 -------DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 32/171 (18%), Positives = 66/171 (38%), Gaps = 22/171 (12%)
Query: 64 TNNRVTELRLPRLQLSG----RISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAV 119
+ TE L ++ LS L+ + L+L +N+ I ++L+ LR +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRIL 75
Query: 120 FLQYNSLSGNLPANIGNLSN----LEILNVAANRLSGEIAN--DLPRNLKYFDLSSNGFS 173
L N + I NL LE L ++ N+++ ++ L NL+ +S+N +
Sbjct: 76 SLGRNLIK-----KIENLDAVADTLEELWISYNQIA-SLSGIEKLV-NLRVLYMSNNKIT 128
Query: 174 GPIP-TSISNLSQLQLINFSFNKFSREVPATFEGTL--PSAIANCSSLVHL 221
++ L +L+ + + N + + + +L L
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 269 PSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGN 328
+ + + L N ++ + L++L L +N I+ A TL L +S N
Sbjct: 48 KACKHLALSTNNIEKISSLS--GMEN-LRILSLGRNLIK-KIENLDAVADTLEELWISYN 103
Query: 329 SISGKIPAQIGGLWRLEELKMANNSFGGAVPVE-IKQCSSLSLLDLEGNRFSGEIPE 384
I+ + I L L L M+NN ++ + L L L GN + E
Sbjct: 104 QIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 22/158 (13%), Positives = 61/158 (38%), Gaps = 22/158 (13%)
Query: 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA 238
+ +++L + + + + ++ + HL+ N + + +
Sbjct: 21 VATEAEKVEL-HGMIPPIEK---------MDATLSTLKACKHLALSTNNIEKISS--LSG 68
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
+ L+++SL +N + + N+ ++ + + +N +++G E + L+V
Sbjct: 69 MENLRILSLGRNLIKKI------ENLDAVADTLEELWISYNQIASLSGIE--KLVN-LRV 119
Query: 299 LDLQQNQIRGAFPLW-LTRASTLTRLDVSGNSISGKIP 335
L + N+I + L L L ++GN +
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 29/112 (25%), Positives = 41/112 (36%), Gaps = 20/112 (17%)
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL--- 971
G F+H S ++H D+KP N L + D + DFGL R +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 972 ----------GYVS------PEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
+V PE L E TK D++S G + ELL +
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIP-EFLGDIRGLKSLTLAANLFSGSIPA-SFRNLP 414
+ +L+ L +E + + L + L++LT+ + + +F P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 415 GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450
L LNL N+L SL + + +L L LS N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 27/95 (28%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQENKLSGNVPEGFSSLMS 535
L LT L + Q L + L GL L+ + + ++ L P+ F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHI 570
L LNLSFN T L S+ L SGN +
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 19/112 (16%), Positives = 33/112 (29%), Gaps = 3/112 (2%)
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE-ISKCSSLRSLLVNS 639
L + + +L L + + + LR+L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 640 NHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
+ L PD+ L+ L+LS N L + L +S N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 16/102 (15%), Positives = 30/102 (29%), Gaps = 4/102 (3%)
Query: 520 NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPE- 577
+ + +L L + + + L + L+ + + + P+
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 578 LGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619
L L L N+L + L L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 19/95 (20%), Positives = 28/95 (29%), Gaps = 2/95 (2%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFSGEVPASIGNLSQ 463
L L + + L L G+ L L + ++ P + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNF 498
L NLS NA + L L L LS
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 17/101 (16%), Positives = 34/101 (33%), Gaps = 2/101 (1%)
Query: 423 HNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA-SIGNLSQLMVFNLSGNAFSGRIPAS 481
+ + G NL+ L + + + + L +L + + P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKL 522
+L+ L+LS L + +LQ + L N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 15/107 (14%), Positives = 32/107 (29%), Gaps = 13/107 (12%)
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
+ L + + + + + L +L+ + L V P A
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLE-------LRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFT 282
P+L ++L+ N L + S++ + L N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTV-----QGLSLQELVLSGNPLH 116
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 59/324 (18%), Positives = 108/324 (33%), Gaps = 44/324 (13%)
Query: 360 VEIKQCSSLSLLDLEGNRFSGEIPEFLGDI----RGLKSLTLAANLFS--GSIPASFRNL 413
+++K ++ +L + G + ++ +I R LKS+ + S +
Sbjct: 78 LKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARA 137
Query: 414 PGLENLNLRHNSL--SGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQ----LMVF 467
LE L L S + L V + TL + E+ FS + + L+Q L V
Sbjct: 138 DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197
Query: 468 NLSGNAFSGRIPASLGNLLK----LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
N F+ P L + + L ++ + + NL+
Sbjct: 198 NFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNED 256
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQ--IPATFSFLRSVVVLSFSG-NHISGSIPPELGN 580
+PE + +L+ R L ++G +P F F + L + +
Sbjct: 257 IGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQK 316
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
C +LEVLE R N + D + L C L+ L +
Sbjct: 317 CPNLEVLETR-NVIG----------------DRGLEVLA-------QYCKQLKRLRIERG 352
Query: 641 HLSGGIPDSLAKLSNLAVLDLSAN 664
G+ D +S ++ L+
Sbjct: 353 ADEQGMEDEEGLVSQRGLIALAQG 376
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 78/533 (14%), Positives = 155/533 (29%), Gaps = 83/533 (15%)
Query: 99 SNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDL 158
+ + T + LR++ L G A + NL ++ EI+N+L
Sbjct: 58 ALCYTATPDRLSRRFPNLRSL-----KLKGKPRAAMFNLIPENWGGYVTPWVT-EISNNL 111
Query: 159 PR----NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIAN 214
+ + + +S +L L+L S F+ L S + +
Sbjct: 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCS--GFT-------TDGLLSIVTH 162
Query: 215 CSSLVHLSAQGNALGGVIPPAIGAL----PKLQVVSLAQNNLSGVVPASMFCNVSGYPPS 270
C + L + ++ + L L+V++ + + P + S
Sbjct: 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR-S 221
Query: 271 IRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSI 330
+ V++G + G A+ L +
Sbjct: 222 LVSVKVGDFEILELVGF--------------------------FKAAANLEEFCGGSLNE 255
Query: 331 SGKIPAQIGGLWRLEELKMANNSF--GGAVPVEIKQCSSLSLLDLEGNRFSGE-IPEFLG 387
+P + L +L S+ +P+ + + LDL E +
Sbjct: 256 DIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQ 315
Query: 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEE------------VL 435
L+ L + + + L+ L + + + +E
Sbjct: 316 KCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375
Query: 436 GMNNLSTLDLSENKFSGEVPASIG-NLSQLMVFNLSGNAFSGRI---------PASLGNL 485
G L + + + + E SIG L L F L RI + L
Sbjct: 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC 435
Query: 486 LKLTTLDLSK--QNFSGELPIELA-GLPNLQVIALQENKLSGN-VPEGFSSLMSLRYLNL 541
KL + + PN++ + L S + E +L+ L +
Sbjct: 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM 495
Query: 542 SFNGFVGQ-IPATFSFLRSVVVLSFSGNHISGSIPPELG---NCSDLEVLELR 590
F + I A + L S+ L G S + + ++E++ R
Sbjct: 496 RGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 50/292 (17%), Positives = 102/292 (34%), Gaps = 52/292 (17%)
Query: 755 SAAAEKKRSPARASSGASGGRRSSTDNGGPKLVMFNNKITLAETV-EATRQFDEENVLSR 813
AA ++ + SG ++ + + + +++ +++
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 814 TRYGLVFKACYND-GMVLSIRRLPDGSLDENL----FRKEAEFLGKVRHRNLTVLRGYYA 868
YG V +A V++I+++ D R E L ++ H ++ +
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVI 122
Query: 869 GAPDLRL----LVYDYMPNGNLGTLLQEASHQ---DGHVLNWPMRHLI--ALGVARGLAF 919
+ +V + + + L + + + H+ + L+ L G+ +
Sbjct: 123 PKDVEKFDELYVVLEIADS-DFKKLFR--TPVYLTELHI-----KTLLYNLL---VGVKY 171
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA------------ 967
+H++ ++H D+KP N L + D + DFGL R S +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 968 ------------VGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRP 1006
V T Y +PE L E T+ DV+S G + ELL +
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 6e-09
Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 30/168 (17%)
Query: 848 EAEFLGKVRHRNLTVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E L V H + + + ++ ++ DY+ G L +LL+++ V
Sbjct: 56 ERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------ 107
Query: 907 HLIALGVAR--------GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
A+ L +LH+ ++++ D+KP+N+L D + ++DFG +
Sbjct: 108 -------AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK------ 154
Query: 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
+ T GT Y++PE T K D +SFGI++ E+L G P
Sbjct: 155 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 4/112 (3%)
Query: 363 KQCSSLSLLDLEGNRFS-GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
+ S + L L+ +R + G++ + L+ L+ + SI A+ L L+ L L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFSG-EVPASIGNLSQLMVFNLSGN 472
N +SG L NL+ L+LS NK + L L +L
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 4/104 (3%)
Query: 563 LSFSGNHIS-GSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
L + + G + +LE L + LT I ++ L+ L L+LS N ++G
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 622 IPDEISKCSSLRSLLVNSNHLSG-GIPDSLAKLSNLAVLDLSAN 664
+ KC +L L ++ N + + L KL NL LDL
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 580 NCSDLEVLELRSNSLT-GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
SD++ L L ++ G + L L LT I + + K + L+ L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
N +SGG+ K NL L+LS N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 34/137 (24%), Positives = 47/137 (34%), Gaps = 13/137 (9%)
Query: 411 RNLPGLENLNLRHNSLSGSLPEEVLG-MNNLSTLDLSENKFSGEVPASIGNLS---QLMV 466
R ++ L L ++ + E + L L + SI NL +L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKK 68
Query: 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQEN---KL 522
LS N SG + LT L+LS IE L L NL+ + L L
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128
Query: 523 SGNVPEGFSSLMSLRYL 539
+ F L L YL
Sbjct: 129 NDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 28/134 (20%), Positives = 46/134 (34%), Gaps = 7/134 (5%)
Query: 484 NLLKLTTLDLSK-QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542
+ L L ++ G+L L+ ++ L+ L L+ L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 543 FNGFVGQIPATFSFLRSVVVLSFSGNHISG-SIPPELGNCSDLEVLELRSNSLTGHI--- 598
N G + ++ L+ SGN I S L +L+ L+L + +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 599 PTDISHLSHLNVLD 612
L L LD
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGA 357
VLD ++ G L L ++ I A + L +L++L++++N G
Sbjct: 23 VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 358 VPVEIKQCSSLSLLDLEGNRFSG-EIPEFLGDIRGLKSLTLAAN 400
+ V ++C +L+ L+L GN+ E L + LKSL L
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/114 (21%), Positives = 41/114 (35%), Gaps = 10/114 (8%)
Query: 316 RASTLTRLDVSGNSIS-GKIPAQIGGLWRLEELKMANN---SFGGAVPVEIKQCSSLSLL 371
S + L + + + GK+ LE L N S + + + L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKL 69
Query: 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG-SIPASFRNLPGLENLNLRHN 424
+L NR SG + L L L+ N S + L L++L+L +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 27/161 (16%)
Query: 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEA 943
NL L+++ + + I+ + GL ++H ++H DIKP+NVL +
Sbjct: 115 NLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171
Query: 944 H------LSDFGLDRLTIPTPAEAS----TSTTAVGTLGYVSPEAALTGETTKESDVYSF 993
++D G A T ++ T Y SPE L +D++S
Sbjct: 172 ENLIQIKIADLG----------NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWST 221
Query: 994 GIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
++ EL+TG +F + ++ + K QI ELL
Sbjct: 222 ACLIFELITGD--FLF-EPDEGHSYTKDDDHIAQIIELLGE 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 9/107 (8%)
Query: 909 IALGVARGLAFLHTSNMVHGDIKPQNVLF--DADFEAHLSDFGLDRLTIPTPAEASTSTT 966
A + + L LH + ++H D+KP+N+L + DFG E T
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY------EHQRVYT 258
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013
+ + Y +PE L D++S G +L ELLTG P++ +DE
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY-PLLPGEDE 304
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 48/235 (20%)
Query: 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRF 378
+ ++ S++ Q L ++++ N+ +V I+ ++ L L GN+
Sbjct: 20 ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL 75
Query: 379 SGEIPEF--LGDIRGLKSLTLAANLFSGSIPAS-FRNLPGLENLNLRHNSLSGSLPEEVL 435
+I L + L L L N S+P F L L+ L L N L SLP+ V
Sbjct: 76 H-DISALKELTN---LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF 129
Query: 436 -GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS 494
+ NL+ L+L+ N+ +P VF+ L LT LDLS
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKG--------VFD---------------KLTNLTELDLS 165
Query: 495 KQNFSGELPIELAG----LPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
N LP G L L+ + L +N+L +VP+G F L SL+Y+ L N
Sbjct: 166 -YNQLQSLP---EGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 51/205 (24%), Positives = 77/205 (37%), Gaps = 42/205 (20%)
Query: 468 NLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVP 527
NL + + L + + + + I+ LPN++ +AL NKL
Sbjct: 25 NLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLHD--I 78
Query: 528 EGFSSLMSLRYLNLSFNGFVGQIPAT-FSFLRSVVVLSFSGNHISGSIPP----ELGNCS 582
L +L YL L+ N +P F L ++ L N + S+P +L N
Sbjct: 79 SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN-- 134
Query: 583 DLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
L L L N L +P + L++L LDLS N L +P+
Sbjct: 135 -LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPE----------------- 174
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNL 666
G+ D KL+ L L L N L
Sbjct: 175 ---GVFD---KLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 42/200 (21%), Positives = 68/200 (34%), Gaps = 45/200 (22%)
Query: 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536
A +L K++ + + L ++ I + + +G L ++
Sbjct: 16 DAFAET------IKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNV 65
Query: 537 RYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG 596
RYL L N ++ + +L L L N L
Sbjct: 66 RYLALGGN----KLHDISALKELT----------------------NLTYLILTGNQLQ- 98
Query: 597 HIPTDI-SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG---GIPDSLAK 652
+P + L++L L L N L K ++L L + N L G+ D K
Sbjct: 99 SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD---K 155
Query: 653 LSNLAVLDLSANNLSGEIPA 672
L+NL LDLS N L +P
Sbjct: 156 LTNLTELDLSYNQLQ-SLPE 174
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 6e-08
Identities = 39/217 (17%), Positives = 66/217 (30%), Gaps = 44/217 (20%)
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGF--SSLMS 535
+ L + L L + + L I PNL+ + + L +V E S L +
Sbjct: 164 LSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
L L L + R + +L+ L +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLF---------------SKDRFPNLKWLGIVDAEEQ 265
Query: 596 GHIPTDISH---LSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAK 652
+ L L +D+S LT E R LL D + K
Sbjct: 266 NVVVEMFLESDILPQLETMDISAGVLTDE---------GARLLL-----------DHVDK 305
Query: 653 LSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
+ +L +++ N LS E+ L + +VS +
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPM-KIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 33/201 (16%), Positives = 62/201 (30%), Gaps = 20/201 (9%)
Query: 316 RASTLTRLDVSGNSISGKIPAQIGGLWR-LEELKMANNSFGGAVPVEIKQCSSLSLLDLE 374
+D IS + + + L + + K +L L++
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEII 201
Query: 375 GNRFSGEIPEFLG--DIRGLKSLTLAAN----LFSGSIPA-----SFRNLPGLENLNLRH 423
+ E + D+ L+ L L F G + S P L+ L +
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 424 NSLSGSLPEEVLG---MNNLSTLDLSENKFSGE----VPASIGNLSQLMVFNLSGNAFSG 476
+ E L + L T+D+S + E + + + L N+ N S
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
Query: 477 RIPASLGNLLKLTTLDLSKQN 497
+ L L + +D+S
Sbjct: 322 EMKKELQKSLPM-KIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 29/183 (15%), Positives = 67/183 (36%), Gaps = 28/183 (15%)
Query: 290 GSCSSVLQVL-DLQQNQIRGAFPLWLT--RASTLTRLDVSGNSISGKIPAQIGG--LWRL 344
S VL + L +I+G L + L L++ + + I G L L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 345 EELKM---ANNSFGGAVPVEI------KQCSSLSLLDLEGNRFSGEIPEFLGD---IRGL 392
E+L + + + +L L + + E + + L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 393 KSLTLAANLFSGS----IPASFRNLPGLENLNLRHNSLSGSLPE---EVLGMNNLSTLDL 445
+++ ++A + + + + L+ +N+++N LS + + + L M +D+
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK----IDV 337
Query: 446 SEN 448
S++
Sbjct: 338 SDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 8e-04
Identities = 13/84 (15%), Positives = 32/84 (38%), Gaps = 7/84 (8%)
Query: 87 SNLRMLRKLSLRSNSFNGTIPATLAQCTL---LRAVFLQYNSLSGN----LPANIGNLSN 139
L+ L + + + + L + + L+ L ++ + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 140 LEILNVAANRLSGEIANDLPRNLK 163
L+ +N+ N LS E+ +L ++L
Sbjct: 309 LKFINMKYNYLSDEMKKELQKSLP 332
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 393 KSLTLAANLFSGSIPASFRNLP-GLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
KSL S+P+ +P E L+L+ L+ G+ L+ L+L N+
Sbjct: 24 KSLD--------SVPS---GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ 72
Query: 452 GEVPASI-GNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFSGELPIELAG- 508
+ A + +L++L L+ N + +P + +L +L L L N LP +G
Sbjct: 73 T-LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLG-GNQLKSLP---SGV 126
Query: 509 ---LPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLS 564
L L+ + L N+L ++P G F L +L+ L+LS N F L + ++
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 565 FSGN 568
GN
Sbjct: 186 LFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 507 AGLP-NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLS 564
+G+P + + + LQ L+ F L L +LNL +N + A F L + L
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 565 FSGNHISGSIPPEL-GNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEI 622
+ N ++ S+P + + + L+ L L N L +P+ + L+ L L L+ N L I
Sbjct: 90 LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SI 146
Query: 623 PDEI-SKCSSLRSLLVNSNHLSG---GIPDSLAKLSNL 656
P K ++L++L +++N L G D L KL +
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 297 QVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFG 355
+ LDLQ + + LT L++ N + + A + L L L +ANN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95
Query: 356 GAVPVEI-KQCSSLSLLDLEGNRFSGEIPEFLGD-IRGLKSLTLAANLFSGSIPAS-FRN 412
++P+ + + L L L GN+ +P + D + LK L L N SIPA F
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 413 LPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSEN 448
L L+ L+L N L S+P + L T+ L N
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 10/124 (8%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSL 632
S+P G +D E L+L+S L L+ L L+L N L + L
Sbjct: 28 SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 633 RSLLVNSNHLS---GGIPDSLAKLSNLAVLDLSANNLSGEIPANL-SSIFGLMNFNVSSN 688
+L + +N L+ G+ D L +L L L N L +P+ + + L +++N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDK---LYLGGNQLK-SLPSGVFDRLTKLKELRLNTN 141
Query: 689 NLQA 692
LQ+
Sbjct: 142 QLQS 145
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 14/162 (8%)
Query: 93 RKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI-GNLSNLEILNVAANRLS 151
KL L+S AT T L + L YN L L A + +L+ L L +A N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 152 G--EIANDLPRNLKYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTL 208
D L L N +P+ + L++L+ + + N+ +PA
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPA------ 148
Query: 209 PSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQN 250
A ++L LS N L V A L KLQ ++L N
Sbjct: 149 -GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 6/113 (5%)
Query: 363 KQCSSLSLLDLEGNRFS-GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421
+ +++ L L+ + + G+I + L+ L+L S+ ++ LP L+ L L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLEL 78
Query: 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFS--GEVPASIGNLSQLMVFNLSGN 472
N + G L + NL+ L+LS NK + + L L +L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 580 NCSDLEVLELRSNSLT-GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVN 638
+ + L L + G I + +L L L L + + + K L+ L ++
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 639 SNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
N + GG+ KL NL L+LS N L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 9/132 (6%)
Query: 535 SLRYLNLSFNGF-VGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
++R L L G+I + ++ LS + S+ L L+ LEL N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLT--GEIPDEISKCSSLRSLLVNSN---HLSGGIPD 648
+ G + L +L L+LS N L + + + K L+SL + + +L+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRES 141
Query: 649 SLAKLSNLAVLD 660
L L LD
Sbjct: 142 VFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGA 357
VLD ++ G L L + + + + + L +L++L+++ N G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86
Query: 358 VPVEIKQCSSLSLLDLEGNRFS--GEIPEFLGDIRGLKSLTLAAN 400
+ + ++ +L+ L+L GN+ + E L + LKSL L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 7/114 (6%)
Query: 582 SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641
S +++ L P + L VLD +N G+I ++ +L L + +
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVG 60
Query: 642 LSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFAN 695
L +L KL L L+LS N + G + + L + N+S N L+ +
Sbjct: 61 LI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIST 112
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 55/276 (19%), Positives = 84/276 (30%), Gaps = 83/276 (30%)
Query: 882 PNGN--------LG-TLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIK 931
NG LG LL+ + L P I V +GL +LHT ++H DIK
Sbjct: 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK 174
Query: 932 PQNVLFDAD---------------------------------------FEAHLSDFGLDR 952
P+N+L + + +
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234
Query: 953 LTIPTPAEASTS----TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR--- 1005
+ I A T + T Y S E + +D++S + EL TG
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 1006 ---PVMFTQDEDIV----------------------KWVKKQLQKGQITELLEPGLLELD 1040
+T+DED + ++ K+ IT+L GL E+
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354
Query: 1041 PESSEW--EEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
E EW EE L P R T ++ +
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 29/141 (20%), Positives = 56/141 (39%), Gaps = 9/141 (6%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEA--HLSDFGLDRLTIPT----PAEASTSTTAVGT 970
L FLH + VHG++ +N+ D + ++ L+ +G P+ + + G
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD 231
Query: 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030
L ++S + ++ SD+ S G +L+ L G P +KQ +
Sbjct: 232 LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
Query: 1031 LLEP-GLLELDPESSEWEEFL 1050
+ P G E +++L
Sbjct: 292 FVGPCGHWIRPSE--TLQKYL 310
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 49/248 (19%), Positives = 92/248 (37%), Gaps = 61/248 (24%)
Query: 841 DENLFRKEAEFLGKV-RHRNLTVLRGYY---AGAPDLRLLVYDYMPNGNLGTLLQEASHQ 896
D R+E E + + ++ + Y L+V + + G L + +Q+ Q
Sbjct: 53 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 897 -----DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDF 948
+ + M+ + + +LH+ N+ H D+KP+N+L+ + L+DF
Sbjct: 113 AFTEREASEI---MKSI-----GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
G + E + K D++S G+++ LL G P
Sbjct: 165 GF------------------------AKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFY 199
Query: 1009 FTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVK---VALLCTAPDPI 1065
I +K +++ GQ + + EW E VK LL T +P
Sbjct: 200 SNHGLAISPGMKTRIRMGQY-----------EFPNPEWSEVSEEVKMLIRNLLKT--EPT 246
Query: 1066 DRPTMSDI 1073
R T+++
Sbjct: 247 QRMTITEF 254
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 29/154 (18%)
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFS 451
+ L L N + P F +L L+ L L N L +LP V + L+ LDL N+ +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511
+P++ VF+ L+ L L + N ELP + L +
Sbjct: 102 -VLPSA--------VFD---------------RLVHLKELFMC-CNKLTELPRGIERLTH 136
Query: 512 LQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
L +AL +N+L ++P G F L SL + L N
Sbjct: 137 LTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 31/155 (20%)
Query: 507 AGLP-NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565
AG+P N Q++ L +N+++ P F SL++L+ L L N L ++
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-----------LGAL----- 79
Query: 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHLNVLDLSINNLTGEIPD 624
+ L L VL+L +N LT +P+ + L HL L + N LT E+P
Sbjct: 80 -----PVGVFDSLTQ---LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPR 129
Query: 625 EISKCSSLRSLLVNSNHLSG---GIPDSLAKLSNL 656
I + + L L ++ N L G D L+ L++
Sbjct: 130 GIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 20/134 (14%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT---GEIPDEISKC 629
S+P G ++ ++L L N +T P L +L L L N L + D +++
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ- 89
Query: 630 SSLRSLLVNSNHLS---GGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVS 686
L L + +N L+ + D +L +L L + N L+ E+P + + L + +
Sbjct: 90 --LTVLDLGTNQLTVLPSAVFD---RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 687 SNNLQ-----AFAN 695
N L+ AF
Sbjct: 144 QNQLKSIPHGAFDR 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 10/98 (10%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFE--AHLSDFGL------DRLTIPTPAEASTSTTAV 968
L ++H + VHGDIK N+L +L+D+GL +
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN-- 221
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006
GT+ + S +A ++ SDV G +L L GK P
Sbjct: 222 GTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 18/126 (14%)
Query: 904 PMRHL--IALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFEAHLSDFGLDRLTIPTPA- 959
P+ H+ +A + L FLH + + H D+KP+N+LF +++FE ++
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 960 -----------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
+ TT V T Y PE L + DV+S G +L E G +
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF--TL 238
Query: 1009 F-TQDE 1013
F T +
Sbjct: 239 FQTHEN 244
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 53/284 (18%), Positives = 90/284 (31%), Gaps = 35/284 (12%)
Query: 336 AQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395
A LW+ +L N + + + + + E R
Sbjct: 43 ASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCP---RSFMDQPLAEHFSPFRVQHMD 99
Query: 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE-NKFSGEV 454
+ + ++ L+NL+L LS + + +NL L+LS + FS
Sbjct: 100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 159
Query: 455 PASIG-NLSQLMVFNLSGNAF---SGRIPASLGNLLKLTTLDLSK--QNFSGELPIELA- 507
++ + S+L NLS A +T L+LS +N L
Sbjct: 160 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219
Query: 508 GLPNLQVIALQE-NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFS 566
PNL + L + L + + F L L++L+LS
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC---------------------- 257
Query: 567 GNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNV 610
I ELG L+ L++ G + L HL +
Sbjct: 258 -YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 50/229 (21%), Positives = 80/229 (34%), Gaps = 31/229 (13%)
Query: 439 NLSTLDLSENKFS-GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN 497
+ +DLS + + + S+L +L G S I +L L L+LS
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS--- 150
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFV---GQIPATF 554
G ALQ L SS L LNLS+ A
Sbjct: 151 ----------GCSGFSEFALQ--TLL-------SSCSRLDELNLSWCFDFTEKHVQVAVA 191
Query: 555 SFLRSVVVLSFSG--NHISGSIPPELG-NCSDLEVLELRS-NSLTGHIPTDISHLSHLNV 610
++ L+ SG ++ S L C +L L+L L + L++L
Sbjct: 192 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251
Query: 611 LDLS-INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAV 658
L LS ++ E E+ + +L++L V G + L +L +
Sbjct: 252 LSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 46/227 (20%), Positives = 74/227 (32%), Gaps = 29/227 (12%)
Query: 296 LQVLDLQQNQI-RGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
+Q +DL + I L++ S L L + G +S I + L L ++ S
Sbjct: 95 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154
Query: 355 --GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRN 412
A+ + CS L L+L + + ++
Sbjct: 155 FSEFALQTLLSSCSRLDELNLSWCF-------DFTE-KHVQVAVA-------------HV 193
Query: 413 LPGLENLNLRHNSLS---GSLPEEVLGMNNLSTLDLSE-NKFSGEVPASIGNLSQLMVFN 468
+ LNL + L V NL LDLS+ + L+ L +
Sbjct: 194 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 253
Query: 469 LSG-NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQV 514
LS LG + L TL + G L + LP+LQ+
Sbjct: 254 LSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 10/100 (10%)
Query: 909 IALGVARGLAFLHTS--NMVHGDIKPQNVLF--DADFEAHLSDFGLDRLTIPTPAEASTS 964
A + L FL T +++H D+KP+N+L + DFG +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLGQRI 215
Query: 965 TTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK 1004
+ + Y SPE L D++S G +L+E+ TG+
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 28/125 (22%), Positives = 50/125 (40%), Gaps = 10/125 (8%)
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFE--AHLSDFGL------DRLTIPTPAEASTSTTAV 968
L ++H VHGDIK N+L + +L D+GL + + A+
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD-- 222
Query: 969 GTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028
GT+ + S +A ++ D+ G +++ LTG P + K + I
Sbjct: 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENI 282
Query: 1029 TELLE 1033
L++
Sbjct: 283 ASLMD 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 24/132 (18%)
Query: 904 PMRHL--IALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ + + + + L +L ++ H D+KP+N+L D +
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 962 STSTTAV-----G--------------TLGYVSPEAALTGETTKESDVYSFGIVLLELLT 1002
T +T + G T Y +PE L SD++SFG VL EL T
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 1003 GKRPVMF-TQDE 1013
G ++F T +
Sbjct: 255 GS--LLFRTHEH 264
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 45/158 (28%), Positives = 62/158 (39%), Gaps = 36/158 (22%)
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFS 451
L L N F L L L L N L SLP V + +L+ L+LS N+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAG--- 508
+P VF+ L +L L L+ N LP G
Sbjct: 90 -SLPNG--------VFD---------------KLTQLKELALN-TNQLQSLP---DGVFD 121
Query: 509 -LPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFN 544
L L+ + L +N+L +VP+G F L SL+Y+ L N
Sbjct: 122 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 18/126 (14%)
Query: 904 PMRHL--IALGVARGLAFLHTSNMVHGDIKPQNVLF-DADFEAHLSDFGLDRLTIPTPA- 959
+ H+ +A + + + FLH++ + H D+KP+N+LF +D+ +
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 960 -----------EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008
+ +T V T Y +PE L ++ DV+S G +L+E G +
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF--TV 233
Query: 1009 F-TQDE 1013
F T D
Sbjct: 234 FPTHDS 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 39/233 (16%), Positives = 60/233 (25%), Gaps = 58/233 (24%)
Query: 816 YGLVFKACYNDGMV------LSIRRLPDGS--------LDENLFRKEAEFLGKV---RHR 858
+G VF+ + V + L +GS L E + KE L R
Sbjct: 33 FGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92
Query: 859 NLTVLRGYY---AGAPDLRLLVYDYMPNG-----------------------NLGTLLQE 892
L + P L L +D+ + G L
Sbjct: 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDL-- 150
Query: 893 ASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLD 951
+ + I + LA S H D+ NVL L
Sbjct: 151 -EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNG 209
Query: 952 R-LTIPT------PAEASTSTTAVGT----LGYVSPEAALTGETTKESDVYSF 993
+ TIP+ + + S E TG+ + D+Y
Sbjct: 210 KSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 17/120 (14%)
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDI-SHLSHL 608
IP V L GN + +P EL N L +++L +N ++ + S+++ L
Sbjct: 29 IPRD------VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 609 NVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSG---GIPDSLAKLSNLAVLDLSAN 664
L LS N L IP SLR L ++ N +S G + L+ LS+LA + AN
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA---IGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 7/104 (6%)
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENKFS 451
L L N F+ +P N L ++L +N +S +L + M L TL LS N+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 452 GEVPASI-GNLSQLMVFNLSGNAFSGRIP-ASLGNLLKLTTLDL 493
+P L L + +L GN S +P + +L L+ L +
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 32/106 (30%), Positives = 45/106 (42%), Gaps = 9/106 (8%)
Query: 393 KSLTLAANLFSGSIPAS--FRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENK 449
L L N I + F LP L L L+ N L+ + G +++ L L ENK
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89
Query: 450 FSGEVPASI-GNLSQLMVFNLSGNAFSGRIP-ASLGNLLKLTTLDL 493
E+ + L QL NL N S + S +L LT+L+L
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 15/118 (12%)
Query: 908 LIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH---LSDFGL--------DRLTIP 956
L+A + + ++H+ N +H D+KP N L + + + DFGL IP
Sbjct: 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
+ GT Y S L E ++ D+ S G VL+ G P +
Sbjct: 169 YRENKNL----TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 42/274 (15%), Positives = 72/274 (26%), Gaps = 66/274 (24%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMN-NLSTLDLSENKFSGEVPASIG-----NLSQLM 465
LP E L+ + +L L+L+ + + + L
Sbjct: 45 VLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALD 104
Query: 466 VFNLSGNAFSGRIPASLGNLLK----LTTLDLSKQNFSGELPIELAGLPNLQVIALQENK 521
NL+ PA L LL L L + E +L L ++
Sbjct: 105 EVNLASCQLD---PAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD-------LLLHDQ 154
Query: 522 LSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG-NHISGSIPPELGN 580
+ L LS N L+ +G + L
Sbjct: 155 CQ------------ITTLRLSNNP-----------------LTAAGVAVLMEG----LAG 181
Query: 581 CSDLEVLELRSNSLT----GHIPTDISHLSHLNVLDLSINNLTGE----IPDEISKCSSL 632
+ + L L L + + L L+++ N + + SL
Sbjct: 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241
Query: 633 RSLLVNSNHLS----GGIPDSLAKLSNLAVLDLS 662
L + N LS + D A + +S
Sbjct: 242 ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVS 275
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 17/109 (15%)
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEA-----HLSDFGL-----DRLT---IPTPAEASTST 965
++H+ N+++ D+KP+N L H+ DF L D T IP S
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-- 177
Query: 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
GT Y+S L E ++ D+ + G + + L G P + +
Sbjct: 178 --TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 17/109 (15%)
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEA-----HLSDFGL-----DRLT---IPTPAEASTST 965
+H ++V+ DIKP N L ++ DFG+ D +T IP + +
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL-- 178
Query: 966 TAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014
GT Y+S L E ++ D+ + G V + L G P +
Sbjct: 179 --SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1099 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.15 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.03 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.99 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.97 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.35 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.92 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.58 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.29 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.08 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.65 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.6 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.96 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-90 Score=871.05 Aligned_cols=669 Identities=32% Similarity=0.497 Sum_probs=426.5
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCcccceEecCCcEeEEecCCCccccc---cccccccccccceEEcc
Q 047739 22 DRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGR---ISDHLSNLRMLRKLSLR 98 (1099)
Q Consensus 22 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~---~~~~l~~l~~L~~L~L~ 98 (1099)
+.++|++||++||+++.||. ++++|+.++ +||+|.||+|+.+||++|+|+++++.|. +++++++|++|+.++++
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~~~--~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSSNK--NPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCTTS--CGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCCCC--CCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 35589999999999999998 999998544 5999999999999999999999999998 87766666666666666
Q ss_pred CCccCcccCcccccCCcccEEEeccccCCCccCc--ccccCCCCceeecccccCCCcccCCcc---cccceeeCCCCccC
Q 047739 99 SNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPA--NIGNLSNLEILNVAANRLSGEIANDLP---RNLKYFDLSSNGFS 173 (1099)
Q Consensus 99 ~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~--~~~~l~~L~~L~ls~N~l~~~i~~~~~---~~L~~L~ls~N~l~ 173 (1099)
.|.+. .+|..++++++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+. ++|++|+|++|+++
T Consensus 86 ~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 86 NSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred CCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 55543 2445666666666666666666666666 566666666666666666666555431 45666666666666
Q ss_pred CCCCCC---Ccccccccccccccccccccccc--------------ccccccCccccccCceeEEEccCCcCCccChhhh
Q 047739 174 GPIPTS---ISNLSQLQLINFSFNKFSREVPA--------------TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAI 236 (1099)
Q Consensus 174 ~~~p~~---~~~l~~L~~L~ls~N~l~~~~~~--------------~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~ 236 (1099)
+.+|.. +.++++|++|++++|++++..+. .+.+.+|. ++++++|++|++++|++++.+|.+|
T Consensus 165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l 243 (768)
T 3rgz_A 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 243 (768)
T ss_dssp EETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHT
T ss_pred CcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHH
Confidence 555544 45555555555555555422110 00023333 5555555555555555555555555
Q ss_pred cCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccC
Q 047739 237 GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTR 316 (1099)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 316 (1099)
+.+++|++|+|++|++++.+|.. ..++++.|++++|.+...........+++|++|+|++|++++.+|..|..
T Consensus 244 ~~l~~L~~L~Ls~n~l~~~~~~~-------~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 244 STCTELKLLNISSNQFVGPIPPL-------PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp TTCSSCCEEECCSSCCEESCCCC-------CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred hcCCCCCEEECCCCcccCccCcc-------ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 55555555555555555544432 12445555555555553222222333355555555555555555555555
Q ss_pred CCCccEEeCCCCccccCchhh-hCCCCCCCEEEccCCccCccCCccccCCC-CCCEEEccCCcCCCCCCccccC--CCCC
Q 047739 317 ASTLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMANNSFGGAVPVEIKQCS-SLSLLDLEGNRFSGEIPEFLGD--IRGL 392 (1099)
Q Consensus 317 l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L 392 (1099)
+++|++|+|++|.+++.+|.. |+++++|++|+|++|++++.+|..+.+++ +|++|+|++|++++.+|..+.. +++|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 555555555555555445443 55555555555555555555555555554 5555555555555555555444 4555
Q ss_pred CeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCC
Q 047739 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGN 472 (1099)
Q Consensus 393 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 472 (1099)
++|++++|.+++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|+|++|
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 55666655555555555555555666666666555555555555555666666666555555555555555666666666
Q ss_pred cCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCC
Q 047739 473 AFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA 552 (1099)
Q Consensus 473 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 552 (1099)
++++.+|..+.++++|++|++++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|++|++++|+++|.+|.
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 55555555555555566666666655555555555555566666666655555555555555566666666655555555
Q ss_pred cccccceee----------------------------------------------EEEccCCcCCCCCCCCCCCCCCCce
Q 047739 553 TFSFLRSVV----------------------------------------------VLSFSGNHISGSIPPELGNCSDLEV 586 (1099)
Q Consensus 553 ~l~~l~~L~----------------------------------------------~L~ls~N~l~~~~p~~l~~l~~L~~ 586 (1099)
.+.....+. .++++.|.++|.+|..++.+++|+.
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~ 636 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence 443322211 1222334445555666677788888
Q ss_pred EEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcC
Q 047739 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNL 666 (1099)
Q Consensus 587 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l 666 (1099)
|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.||+++|++
T Consensus 637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 89999998888888888888899999999998888888888888899999999998888888888888899999999999
Q ss_pred CCcCCCCccccccccccccCCCCcccCCCCccCCCCCCCCCCCCcc
Q 047739 667 SGEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLGRKCENAD 712 (1099)
Q Consensus 667 ~~~~p~~~~~~~~l~~l~l~~n~~~~~~~n~~l~~~~~~~~c~~~~ 712 (1099)
+|.+|..- .+.++. ...|.+|+++||.|+. .|....
T Consensus 717 ~g~iP~~~----~~~~~~-----~~~~~gN~~Lcg~~l~-~C~~~~ 752 (768)
T 3rgz_A 717 SGPIPEMG----QFETFP-----PAKFLNNPGLCGYPLP-RCDPSN 752 (768)
T ss_dssp EEECCSSS----SGGGSC-----GGGGCSCTEEESTTSC-CCCSCC
T ss_pred cccCCCch----hhccCC-----HHHhcCCchhcCCCCc-CCCCCc
Confidence 88888652 122333 3468899999999987 787543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-73 Score=715.36 Aligned_cols=588 Identities=31% Similarity=0.486 Sum_probs=367.1
Q ss_pred cccceEEccCCccCcc---cCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccC--Ccc--ccc
Q 047739 90 RMLRKLSLRSNSFNGT---IPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN--DLP--RNL 162 (1099)
Q Consensus 90 ~~L~~L~L~~n~~~~~---~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~--~~~--~~L 162 (1099)
.+++.|||+++.+.|. +|+.++++++|+.++++.|.+. .+|..++.+++|++|||++|.++|.+|. .+. ++|
T Consensus 50 ~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L 128 (768)
T 3rgz_A 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128 (768)
T ss_dssp TEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTC
T ss_pred CcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCC
Confidence 3678999999999998 9999999999999998888775 4668999999999999999999999988 776 799
Q ss_pred ceeeCCCCccCCCCCCCC-ccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCC
Q 047739 163 KYFDLSSNGFSGPIPTSI-SNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPK 241 (1099)
Q Consensus 163 ~~L~ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 241 (1099)
++|+|++|.+++.+|..+ .++++|++|+|++|++++..+..+. .++++++|++|++++|.+++..|. ..+++
T Consensus 129 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~ 201 (768)
T 3rgz_A 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV-----LSDGCGELKHLAISGNKISGDVDV--SRCVN 201 (768)
T ss_dssp CEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHH-----HTTCCTTCCEEECCSSEEESCCBC--TTCTT
T ss_pred CEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhh-----hhccCCCCCEEECCCCcccccCCc--ccCCc
Confidence 999999999999999876 8999999999999999854443210 034455555555555555544332 44555
Q ss_pred ccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCc----------------
Q 047739 242 LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ---------------- 305 (1099)
Q Consensus 242 L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~---------------- 305 (1099)
|++|+|++|++++.+|. |.. .++|++|++++|.+...... ....+++|++|+|++|+
T Consensus 202 L~~L~Ls~n~l~~~~~~--l~~----l~~L~~L~Ls~n~l~~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L 274 (768)
T 3rgz_A 202 LEFLDVSSNNFSTGIPF--LGD----CSALQHLDISGNKLSGDFSR-AISTCTELKLLNISSNQFVGPIPPLPLKSLQYL 274 (768)
T ss_dssp CCEEECCSSCCCSCCCB--CTT----CCSCCEEECCSSCCCSCHHH-HTTTCSSCCEEECCSSCCEESCCCCCCTTCCEE
T ss_pred CCEEECcCCcCCCCCcc--ccc----CCCCCEEECcCCcCCCcccH-HHhcCCCCCEEECCCCcccCccCccccCCCCEE
Confidence 55555555555544443 221 23445555555544422111 11223444445555544
Q ss_pred ------cccCcchhccCC-CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCcc-ccCCCCCCEEEccCCc
Q 047739 306 ------IRGAFPLWLTRA-STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE-IKQCSSLSLLDLEGNR 377 (1099)
Q Consensus 306 ------l~~~~~~~~~~l-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~Ls~N~ 377 (1099)
+++.+|..+... ++|++|+|++|.+++.+|..|+++++|++|+|++|.+.+.+|.. +..+++|++|+|++|+
T Consensus 275 ~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~ 354 (768)
T 3rgz_A 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354 (768)
T ss_dssp ECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSE
T ss_pred ECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCc
Confidence 444444444332 44555555555444444444444444555555555444444433 4444445555555554
Q ss_pred CCCCCCccccCCC-CCCeeeccCccccccCCccCCC--CCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 378 FSGEIPEFLGDIR-GLKSLTLAANLFSGSIPASFRN--LPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 378 l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
+++.+|..+.+++ +|++|++++|.+++.+|..+.. +++|++|++++|++++.+|..+.++++|++|+|++|.+++.+
T Consensus 355 l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 434 (768)
T 3rgz_A 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434 (768)
T ss_dssp EEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred cCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcc
Confidence 4444444444443 4455555555444444444443 444555555555554444444444555555555555554444
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 534 (1099)
|..++++++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|+.|+|++|++++.+|..|+.++
T Consensus 435 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 514 (768)
T 3rgz_A 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred cHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCC
Confidence 44444455555555555555444444444445555555555555444444444455555555555555444444444455
Q ss_pred ccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCc-----------------------------
Q 047739 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE----------------------------- 585 (1099)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~----------------------------- 585 (1099)
+|++|++++|++++.+|..++.+++|+.|++++|+++|.+|..+..+..+.
T Consensus 515 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594 (768)
T ss_dssp TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEE
T ss_pred CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccc
Confidence 555555555555444444455555555555555555444444433322211
Q ss_pred -----------------eEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCCh
Q 047739 586 -----------------VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPD 648 (1099)
Q Consensus 586 -----------------~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 648 (1099)
.++++.|.++|.+|..++.+++|+.|||++|+++|.+|..++.+++|+.|+|++|+++|.+|.
T Consensus 595 ~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~ 674 (768)
T 3rgz_A 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674 (768)
T ss_dssp ECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence 112222444444555566678899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCeeecCCCcCCCcCCCCccccccccccccCCCCccc
Q 047739 649 SLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQA 692 (1099)
Q Consensus 649 ~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l~~n~~~~ 692 (1099)
.++++++|+.|||++|+++|.+|..+..+..|+.+++++|++..
T Consensus 675 ~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 99999999999999999999999999999999999999999875
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=613.95 Aligned_cols=583 Identities=22% Similarity=0.230 Sum_probs=410.5
Q ss_pred CcccceEecC-----------CcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccc
Q 047739 56 CDWRGVACTN-----------NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYN 124 (1099)
Q Consensus 56 c~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n 124 (1099)
|.++-|.|++ .+++.|+|+++.+.+..+..++++++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 6666677764 24555555555555544445555556666666655555555555555556666666555
Q ss_pred cCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCcccccccccccccccccccccc
Q 047739 125 SLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA 202 (1099)
Q Consensus 125 ~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 202 (1099)
++++..+..++++++|++|+|++|.+++..|..+. ++|++|+|++|.+++..|..++++++|++|++++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 55543333455555566666655555544444443 4555555555555555555555555555555555555522221
Q ss_pred ccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEecccccc
Q 047739 203 TFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFT 282 (1099)
Q Consensus 203 ~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~ 282 (1099)
.+. ...+++|++|++++|++++..|.+|+.+++|+.|++++|++.+.........
T Consensus 164 ~~~------~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~------------------- 218 (680)
T 1ziw_A 164 ELD------IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE------------------- 218 (680)
T ss_dssp HHG------GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHH-------------------
T ss_pred Hhh------ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHH-------------------
Confidence 110 1123455555555555555555555555555555555555442211110000
Q ss_pred ccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCC--ccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCc
Q 047739 283 NVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST--LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPV 360 (1099)
Q Consensus 283 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 360 (1099)
-..+.|++|++++|++++..|.+|..++. |++|+|++|.+++..|..|+++++|++|+|++|++.+..|.
T Consensus 219 --------l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 290 (680)
T 1ziw_A 219 --------LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290 (680)
T ss_dssp --------HTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTT
T ss_pred --------hhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChh
Confidence 01256888899999888888888887754 99999999998888888888899999999999998888888
Q ss_pred cccCCCCCCEEEccCCcCCC-----CCCc----cccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccc--
Q 047739 361 EIKQCSSLSLLDLEGNRFSG-----EIPE----FLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGS-- 429 (1099)
Q Consensus 361 ~l~~l~~L~~L~Ls~N~l~~-----~~p~----~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-- 429 (1099)
.+..+++|++|+|++|...+ .+|. .|..+++|++|++++|.+++..+..|.++++|++|++++|.+...
T Consensus 291 ~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l 370 (680)
T 1ziw_A 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370 (680)
T ss_dssp TTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEE
T ss_pred hhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhc
Confidence 88889999999998876553 2333 677888888888888888888888888888888888888875422
Q ss_pred cchhhhC--CCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCC-CCCCCCCCCCEEEeccCcCcccCCccc
Q 047739 430 LPEEVLG--MNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP-ASLGNLLKLTTLDLSKQNFSGELPIEL 506 (1099)
Q Consensus 430 ~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l 506 (1099)
....+.. ..+|+.|++++|++++..|..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+..+..+
T Consensus 371 ~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 450 (680)
T 1ziw_A 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450 (680)
T ss_dssp CTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTT
T ss_pred chhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhh
Confidence 2223333 3578888888888888888888888888888888888876555 578888888888888888888888888
Q ss_pred CCCCccceeeecccccc--CCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCC--------CC
Q 047739 507 AGLPNLQVIALQENKLS--GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI--------PP 576 (1099)
Q Consensus 507 ~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~--------p~ 576 (1099)
..+++|+.|++++|.++ +..|..|..+++|++|++++|++++..+..+..+++|+.|++++|++++.. +.
T Consensus 451 ~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 530 (680)
T 1ziw_A 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530 (680)
T ss_dssp TTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCC
T ss_pred hcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcch
Confidence 88888888888888876 467788888888888888888888777778888888888888888887531 22
Q ss_pred CCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhh-ccCC
Q 047739 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLA-KLSN 655 (1099)
Q Consensus 577 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~ 655 (1099)
.++++++|++|+|++|+++...+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+. .+++
T Consensus 531 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 610 (680)
T 1ziw_A 531 FLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTT
T ss_pred hhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccc
Confidence 477888888888888888843334688888888888888888865555677888888888888888877777777 7888
Q ss_pred CCeeecCCCcCCCcCC
Q 047739 656 LAVLDLSANNLSGEIP 671 (1099)
Q Consensus 656 L~~L~ls~N~l~~~~p 671 (1099)
|+.|++++|++.+..+
T Consensus 611 L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 611 LTELDMRFNPFDCTCE 626 (680)
T ss_dssp CSEEECTTCCCCBCCC
T ss_pred cCEEEccCCCcccCCc
Confidence 8888888888876544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=607.02 Aligned_cols=582 Identities=24% Similarity=0.266 Sum_probs=503.5
Q ss_pred eEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccc
Q 047739 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAAN 148 (1099)
Q Consensus 69 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N 148 (1099)
+.++.++++++ .||+.+. +.+++|+|++|++++..|..++++++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45788888875 4776664 78999999999999877788999999999999999999999999999999999999999
Q ss_pred cCCCcccCCcc--cccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCC
Q 047739 149 RLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGN 226 (1099)
Q Consensus 149 ~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N 226 (1099)
.+++..+..+. ++|++|+|++|++++..|..|+++++|++|+|++|+++ +..|..++++++|++|++++|
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~--------~~~~~~~~~l~~L~~L~L~~n 155 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS--------STKLGTQVQLENLQELLLSNN 155 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS--------CCCCCSSSCCTTCCEEECCSS
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc--------ccCchhhcccccCCEEEccCC
Confidence 99865554555 79999999999999877788999999999999999998 445566778999999999999
Q ss_pred cCCccChhhhc--CCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCC
Q 047739 227 ALGGVIPPAIG--ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN 304 (1099)
Q Consensus 227 ~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n 304 (1099)
.+++..+..++ .+++|++|++++|++++..|. .|. ....|+.|++++|
T Consensus 156 ~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-~~~-----------------------------~l~~L~~L~l~~~ 205 (680)
T 1ziw_A 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPG-CFH-----------------------------AIGRLFGLFLNNV 205 (680)
T ss_dssp CCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTT-GGG-----------------------------GSSEECEEECTTC
T ss_pred cccccCHHHhhccccccccEEECCCCcccccChh-hhh-----------------------------hhhhhhhhhcccc
Confidence 99988887765 568999999999999865443 222 2467899999999
Q ss_pred ccccCcchhcc---CCCCccEEeCCCCccccCchhhhCCCCC--CCEEEccCCccCccCCccccCCCCCCEEEccCCcCC
Q 047739 305 QIRGAFPLWLT---RASTLTRLDVSGNSISGKIPAQIGGLWR--LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS 379 (1099)
Q Consensus 305 ~l~~~~~~~~~---~l~~L~~L~Ls~N~i~~~~p~~~~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 379 (1099)
++.+.....+. ..++|++|++++|.+++..|..|.+++. |++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 206 ~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 285 (680)
T 1ziw_A 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285 (680)
T ss_dssp CCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBS
T ss_pred ccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccC
Confidence 88643322221 3578999999999999999999998865 999999999999989999999999999999999999
Q ss_pred CCCCccccCCCCCCeeeccCccccc-----cCC----ccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcC
Q 047739 380 GEIPEFLGDIRGLKSLTLAANLFSG-----SIP----ASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450 (1099)
Q Consensus 380 ~~~p~~~~~l~~L~~L~L~~n~l~~-----~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 450 (1099)
+..|..|..+++|++|++++|...+ .+| ..|..+++|++|++++|++++..+..|.++++|++|++++|.+
T Consensus 286 ~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp EECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBS
T ss_pred ccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCch
Confidence 9999999999999999999886553 223 3789999999999999999998888999999999999999986
Q ss_pred cc--ccCcccCCC--CcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCC-cccCCCCccceeeeccccccCC
Q 047739 451 SG--EVPASIGNL--SQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELP-IELAGLPNLQVIALQENKLSGN 525 (1099)
Q Consensus 451 ~~--~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~ 525 (1099)
+. .....|..+ ++|+.|++++|++++..|..|..+++|++|++++|.+++.+| ..+.++++|+.|++++|++.+.
T Consensus 366 ~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 445 (680)
T 1ziw_A 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445 (680)
T ss_dssp CCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEEC
T ss_pred hhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCccee
Confidence 42 223344433 589999999999999989999999999999999999987665 7899999999999999999988
Q ss_pred CchhhhcccccceecccccccC--CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCC----
Q 047739 526 VPEGFSSLMSLRYLNLSFNGFV--GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIP---- 599 (1099)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p---- 599 (1099)
.+..|..+++|++|++++|.+. +.+|..+..+++|+.|++++|++++..+..+.++++|++|+|++|++++..+
T Consensus 446 ~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 525 (680)
T 1ziw_A 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525 (680)
T ss_dssp CTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTST
T ss_pred ChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhcc
Confidence 8999999999999999999987 5789999999999999999999998888889999999999999999985422
Q ss_pred ----cchhccCcccEEeccCccccccCCc-ccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCc
Q 047739 600 ----TDISHLSHLNVLDLSINNLTGEIPD-EISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674 (1099)
Q Consensus 600 ----~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~ 674 (1099)
..+..+++|+.|+|++|+++ .+|. .|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++..|..+
T Consensus 526 ~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 604 (680)
T 1ziw_A 526 GGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604 (680)
T ss_dssp TSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHH
T ss_pred CCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHh
Confidence 23789999999999999999 4554 68999999999999999997767778999999999999999998777766
Q ss_pred c-ccccccccccCCCCccc
Q 047739 675 S-SIFGLMNFNVSSNNLQA 692 (1099)
Q Consensus 675 ~-~~~~l~~l~l~~n~~~~ 692 (1099)
. .+.+|+.+++++|++.|
T Consensus 605 ~~~~~~L~~l~l~~N~~~c 623 (680)
T 1ziw_A 605 GPAFRNLTELDMRFNPFDC 623 (680)
T ss_dssp HHHHTTCSEEECTTCCCCB
T ss_pred cccccccCEEEccCCCccc
Confidence 6 67889999988887764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=573.88 Aligned_cols=516 Identities=20% Similarity=0.293 Sum_probs=360.6
Q ss_pred hhHHHHHHHHHhCCCC--------CCCCCCCCCCCCCCCCcc---cceEecC-CcEeEEecCCCcccccccccccccccc
Q 047739 25 PEIEALTSFKLNLHDP--------LGALNGWDSSTPAAPCDW---RGVACTN-NRVTELRLPRLQLSGRISDHLSNLRML 92 (1099)
Q Consensus 25 ~~~~~l~~~k~~~~~~--------~~~l~~w~~~~~~~~c~w---~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L 92 (1099)
.|+.||.+||+++.+| +....+|+.+ .+||.| .||+|+. +||++|+|++++++|.+|+++++|++|
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 5999999999998544 2345689975 458999 9999976 899999999999999999999999999
Q ss_pred ceEEccCCcc------Cc------ccCcccccCCcccEEEeccccCCCccCccccc-CCCCceeecccccCCCcccCCcc
Q 047739 93 RKLSLRSNSF------NG------TIPATLAQCTLLRAVFLQYNSLSGNLPANIGN-LSNLEILNVAANRLSGEIANDLP 159 (1099)
Q Consensus 93 ~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~-l~~L~~L~ls~N~l~~~i~~~~~ 159 (1099)
++|+|++|.+ .| .+|.+. +..|+ +++++|.+.+.+|..++. +..+..+++....+.. .-.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----~~~ 180 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----SSR 180 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----CCC
T ss_pred eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----ccc
Confidence 9999999987 44 566555 77888 999999999999988763 3445555555444321 111
Q ss_pred cccceeeC--CCCccCCCCCCCCccccccccccccccccccc-cccc--------cccccCcccc--ccCceeEEEccCC
Q 047739 160 RNLKYFDL--SSNGFSGPIPTSISNLSQLQLINFSFNKFSRE-VPAT--------FEGTLPSAIA--NCSSLVHLSAQGN 226 (1099)
Q Consensus 160 ~~L~~L~l--s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~--------~~g~lp~~l~--~l~~L~~L~l~~N 226 (1099)
..++.+.+ .+|+++| +|++|+++++|++|+|++|++++. ++.. ..+.+|+.++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 23333333 4689998 999999999999999999999841 0000 0011899999 9999999999999
Q ss_pred cCCccChhhhcCCCCccEEEccccc-CCC-ccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCC
Q 047739 227 ALGGVIPPAIGALPKLQVVSLAQNN-LSG-VVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN 304 (1099)
Q Consensus 227 ~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n 304 (1099)
++.+.+|..|+++++|++|+|++|+ ++| .+|..+..- . ....+++|++|+|++|
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L-~-----------------------~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL-A-----------------------DAPVGEKIQIIYIGYN 315 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH-H-----------------------HSGGGGTCCEEECCSS
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh-h-----------------------ccccCCCCCEEECCCC
Confidence 9999999999999999999999998 888 777654210 0 0011356888888888
Q ss_pred ccccCcch--hccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCC-CCEEEccCCcCCCC
Q 047739 305 QIRGAFPL--WLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSS-LSLLDLEGNRFSGE 381 (1099)
Q Consensus 305 ~l~~~~~~--~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~ 381 (1099)
+++ .+|. .|..+++|++|+|++|+++|.+| .|+++++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .
T Consensus 316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~ 391 (636)
T 4eco_A 316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y 391 (636)
T ss_dssp CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence 888 5676 78888888888888888887777 7888888888888888887 67777888887 888888888887 6
Q ss_pred CCccccCCC--CCCeeeccCccccccCCccCC-------CCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcc
Q 047739 382 IPEFLGDIR--GLKSLTLAANLFSGSIPASFR-------NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG 452 (1099)
Q Consensus 382 ~p~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 452 (1099)
+|..+..++ +|++|++++|.+++..|..|. .+++|++|+|++|+++...+..+..+++|++|+|++|+++
T Consensus 392 lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~- 470 (636)
T 4eco_A 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT- 470 (636)
T ss_dssp CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-
T ss_pred cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-
Confidence 777766554 677777777777777777776 6667777777777777333333445677777777777776
Q ss_pred ccCcc-cCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccC--CCCccceeeeccccccCCCchh
Q 047739 453 EVPAS-IGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA--GLPNLQVIALQENKLSGNVPEG 529 (1099)
Q Consensus 453 ~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~ 529 (1099)
.+|.. +.... ..+.++++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..
T Consensus 471 ~i~~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~ 531 (636)
T 4eco_A 471 EIPKNSLKDEN-----------------ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531 (636)
T ss_dssp BCCSSSSEETT-----------------EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred CcCHHHhcccc-----------------ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChh
Confidence 33332 22111 01122335666666666666 4555554 66666666666666664 5666
Q ss_pred hhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCccc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 609 (1099)
+..+++|++|+|++|+ ++++|++.+.+|..++++++|++|+|++|++ +.+|..+. ++|+
T Consensus 532 ~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~ 590 (636)
T 4eco_A 532 PLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNIS 590 (636)
T ss_dssp GGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCC
T ss_pred hhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCC
Confidence 6666667777665554 2344555555555555555555555555555 24554443 4555
Q ss_pred EEeccCcccc
Q 047739 610 VLDLSINNLT 619 (1099)
Q Consensus 610 ~L~Ls~N~l~ 619 (1099)
.|||++|++.
T Consensus 591 ~L~Ls~N~l~ 600 (636)
T 4eco_A 591 VLDIKDNPNI 600 (636)
T ss_dssp EEECCSCTTC
T ss_pred EEECcCCCCc
Confidence 5555555444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=573.75 Aligned_cols=500 Identities=20% Similarity=0.253 Sum_probs=293.7
Q ss_pred ChhhHHHHHHHHHhCCCCCCCCCCCCCCC---CCCC--Ccc------------cceEecC-CcEeEEecCCCcccccccc
Q 047739 23 RSPEIEALTSFKLNLHDPLGALNGWDSST---PAAP--CDW------------RGVACTN-NRVTELRLPRLQLSGRISD 84 (1099)
Q Consensus 23 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~---~~~~--c~w------------~gv~c~~-~~v~~l~l~~~~l~g~~~~ 84 (1099)
..+|+.||++||+++.|| +|+.++ ..+| |.| .||+|+. +||++|+|+++++.|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 346999999999999887 898765 2345 999 9999985 9999999999999999999
Q ss_pred ccccccccceEEc-cCCccCcccCccccc---------------------------------------------------
Q 047739 85 HLSNLRMLRKLSL-RSNSFNGTIPATLAQ--------------------------------------------------- 112 (1099)
Q Consensus 85 ~l~~l~~L~~L~L-~~n~~~~~~p~~~~~--------------------------------------------------- 112 (1099)
++++|++|++||| ++|.++|..|-....
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 999998875533111
Q ss_pred CCcccEEEec--cccCCCccCcccccCCCCceeecccccCCC-cccCCcccccceeeCCCCccCCCCCCCCc--cccccc
Q 047739 113 CTLLRAVFLQ--YNSLSGNLPANIGNLSNLEILNVAANRLSG-EIANDLPRNLKYFDLSSNGFSGPIPTSIS--NLSQLQ 187 (1099)
Q Consensus 113 l~~L~~L~l~--~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~-~i~~~~~~~L~~L~ls~N~l~~~~p~~~~--~l~~L~ 187 (1099)
...++.+.+. .|+++| ||..++++++|++|+|++|.++| .+|..+. .++.|.++|.+|..++ ++++|+
T Consensus 422 ~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~------~~s~n~~~g~iP~~l~f~~L~~L~ 494 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE------DANSDYAKQYENEELSWSNLKDLT 494 (876)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS------CTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred ccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc------ccccccccccCChhhhhccCCCCC
Confidence 1122222332 266666 66666666666666666666665 2332211 1222444444555544 555555
Q ss_pred cccccccccccccccccccccCccccccCceeEEEccCCc-CCc-cChhhhcCCCCccEEEcccccCCCccCcccccccC
Q 047739 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNA-LGG-VIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265 (1099)
Q Consensus 188 ~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 265 (1099)
+|+|++|++. |.+|..++++++|++|+|++|+ +++ .+|..++.++.
T Consensus 495 ~L~Ls~N~l~--------~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~------------------------ 542 (876)
T 4ecn_A 495 DVELYNCPNM--------TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD------------------------ 542 (876)
T ss_dssp EEEEESCTTC--------CSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHH------------------------
T ss_pred EEECcCCCCC--------ccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhh------------------------
Confidence 5555555544 3444444444444444444444 444 34443332220
Q ss_pred CCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcch--hccCCCCccEEeCCCCccccCchhhhCCCCC
Q 047739 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPL--WLTRASTLTRLDVSGNSISGKIPAQIGGLWR 343 (1099)
Q Consensus 266 ~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~ 343 (1099)
....+++|++|+|++|+++ .+|. .|..+++|++|+|++|.++ .+| .|+++++
T Consensus 543 -----------------------~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 543 -----------------------DEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp -----------------------CTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred -----------------------cccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 0011344566666666666 4555 6677777777777777776 566 6777777
Q ss_pred CCEEEccCCccCccCCccccCCCC-CCEEEccCCcCCCCCCccccCCCC--CCeeeccCccccccCCccC---C--CCCC
Q 047739 344 LEELKMANNSFGGAVPVEIKQCSS-LSLLDLEGNRFSGEIPEFLGDIRG--LKSLTLAANLFSGSIPASF---R--NLPG 415 (1099)
Q Consensus 344 L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~ 415 (1099)
|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..++. |+.|+|++|++.+.+|... . .+++
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 777777777776 66666777776 777777777776 66666655543 6677777776665544322 2 2346
Q ss_pred CCEEEcccCcCccccchhh-hCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEec
Q 047739 416 LENLNLRHNSLSGSLPEEV-LGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLS 494 (1099)
Q Consensus 416 L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 494 (1099)
|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++ .+|..+.... +..+.++++|+.|+|+
T Consensus 675 L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~----------------~~~l~nl~~L~~L~Ls 736 (876)
T 4ecn_A 675 ASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK----------------DGNYKNTYLLTTIDLR 736 (876)
T ss_dssp EEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT----------------TSCCTTGGGCCEEECC
T ss_pred cCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc----------------cccccccCCccEEECC
Confidence 777777777777 444444 36777777777777776 3443322111 0012233355555555
Q ss_pred cCcCcccCCcccC--CCCccceeeeccccccCCCchhhhcccccceecccc------cccCCCCCCcccccceeeEEEcc
Q 047739 495 KQNFSGELPIELA--GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF------NGFVGQIPATFSFLRSVVVLSFS 566 (1099)
Q Consensus 495 ~n~l~~~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~~~~l~~l~~L~~L~ls 566 (1099)
+|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |.+.+.+|..+..+++|+.|+|+
T Consensus 737 ~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls 814 (876)
T 4ecn_A 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814 (876)
T ss_dssp SSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECC
Confidence 55555 4455554 55556666666666554 455555666666666655 44444444444444444444444
Q ss_pred CCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCcc
Q 047739 567 GNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617 (1099)
Q Consensus 567 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 617 (1099)
+|++ +.+|..+. ++|+.|+|++|++....+..+.....+..+.|++|.
T Consensus 815 ~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~ 862 (876)
T 4ecn_A 815 SNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862 (876)
T ss_dssp SSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCT
T ss_pred CCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCC
Confidence 4444 34444433 344444444444443333333333334444444443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=555.56 Aligned_cols=522 Identities=23% Similarity=0.246 Sum_probs=357.3
Q ss_pred cccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--
Q 047739 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP-- 159 (1099)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~-- 159 (1099)
+|..+.. .+++|+|++|.+++..|..++++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+.
T Consensus 27 iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 104 (606)
T 3t6q_A 27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104 (606)
T ss_dssp CCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSC
T ss_pred CcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccc
Confidence 4444432 689999999999988899999999999999999999998899999999999999999999988787775
Q ss_pred cccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCC
Q 047739 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGAL 239 (1099)
Q Consensus 160 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 239 (1099)
++|++|++++|++++..|..++++++|++|++++|++++. .+|... .+++|++|++++|.+++..|..|+.+
T Consensus 105 ~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~-------~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l 176 (606)
T 3t6q_A 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI-------KLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSL 176 (606)
T ss_dssp TTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCC-------CCCTTC-CCTTCCEEECCSSCCCEECHHHHHTT
T ss_pred ccccEeeccccCcccCCcchhccCCcccEEECCCCccccc-------Cccccc-CCcccCEEEcccCcccccChhhhhhh
Confidence 7899999999999877778889999999999999998842 223333 38889999999999998888889999
Q ss_pred CCcc--EEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCC
Q 047739 240 PKLQ--VVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA 317 (1099)
Q Consensus 240 ~~L~--~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 317 (1099)
++|+ .|++++|++++..|.. |. ...|++|++++|. ..+..+..+
T Consensus 177 ~~L~~l~L~l~~n~l~~~~~~~-~~------------------------------~~~L~~L~l~~~~---~~~~~~~~l 222 (606)
T 3t6q_A 177 QQATNLSLNLNGNDIAGIEPGA-FD------------------------------SAVFQSLNFGGTQ---NLLVIFKGL 222 (606)
T ss_dssp TTCCSEEEECTTCCCCEECTTT-TT------------------------------TCEEEEEECTTCS---CHHHHHHHT
T ss_pred cccceeEEecCCCccCccChhH-hh------------------------------hccccccccCCch---hHHHHhhhc
Confidence 9888 8888888887544331 21 2357777777776 234445555
Q ss_pred CCccEEeCCCCcccc-----CchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCC
Q 047739 318 STLTRLDVSGNSISG-----KIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGL 392 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~-----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 392 (1099)
.++....+..+.+.+ ..+..|.++. . .+|+.|++++|++++..+..|..+++|
T Consensus 223 ~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~---------------------~-~~L~~L~l~~n~l~~~~~~~~~~l~~L 280 (606)
T 3t6q_A 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLC---------------------E-MSVESINLQKHYFFNISSNTFHCFSGL 280 (606)
T ss_dssp TTCEEEEEECCCCTTSCCCCCCGGGGGGGG---------------------G-SEEEEEECTTCCCSSCCTTTTTTCTTC
T ss_pred cccchhheechhhccccccccChhHhchhh---------------------c-CceeEEEeecCccCccCHHHhccccCC
Confidence 554444433322221 1111222221 1 145555555555554444445555555
Q ss_pred CeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCc-ccCCCCcccEEEccC
Q 047739 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA-SIGNLSQLMVFNLSG 471 (1099)
Q Consensus 393 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~ 471 (1099)
++|++++|.++ .+|..+.++++|++|++++|++++..|..+..+++|++|++++|.+.+.++. .+.++++|++|++++
T Consensus 281 ~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 359 (606)
T 3t6q_A 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359 (606)
T ss_dssp SEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCS
T ss_pred CEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCC
Confidence 55555555554 3444555556666666666666555555556666666666666655543333 355666666666666
Q ss_pred CcCCCcC--CCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCch-hhhcccccceecccccccCC
Q 047739 472 NAFSGRI--PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPE-GFSSLMSLRYLNLSFNGFVG 548 (1099)
Q Consensus 472 N~l~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 548 (1099)
|.+++.. +..+.++++|++|++++|++.+..|..+..+++|+.|++++|++++..+. .|..+++|++|++++|.+.+
T Consensus 360 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 439 (606)
T 3t6q_A 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439 (606)
T ss_dssp SCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBT
T ss_pred CccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCC
Confidence 6665443 45566666666666666666656566666666666666666666654433 35666666666666666666
Q ss_pred CCCCcccccceeeEEEccCCcCCC---CCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcc
Q 047739 549 QIPATFSFLRSVVVLSFSGNHISG---SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE 625 (1099)
Q Consensus 549 ~~~~~l~~l~~L~~L~ls~N~l~~---~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 625 (1099)
..|..+..+++|+.|++++|++++ ..+..+..+++|++|+|++|++++..|..++.+++|+.|+|++|++++..|..
T Consensus 440 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp TCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred cCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 666666666666666666666654 22345677778888888888887777777777888888888888887777777
Q ss_pred cCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCC
Q 047739 626 ISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 626 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
+..+++| .|+|++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 520 l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 520 LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp GTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred hCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 8888888 88888888887777777888888888888888776443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=552.24 Aligned_cols=530 Identities=22% Similarity=0.290 Sum_probs=410.6
Q ss_pred eeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEE
Q 047739 142 ILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHL 221 (1099)
Q Consensus 142 ~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L 221 (1099)
.++.++..++ .+|..+++++++|+|++|+|++..|..|+++++|++|+|++|++++ ..|..++.+++|++|
T Consensus 16 ~~~c~~~~l~-~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~--------~~~~~~~~l~~L~~L 86 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW--------IHEDTFQSQHRLDTL 86 (606)
T ss_dssp EEECTTSCCS-SCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE--------ECTTTTTTCTTCCEE
T ss_pred eEECCCCCcc-cCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccce--------eChhhccCccccCee
Confidence 4444555554 4666666667777777777776666677777777777777777662 334445566677777
Q ss_pred EccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEc
Q 047739 222 SAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301 (1099)
Q Consensus 222 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L 301 (1099)
+|++|++++..|.+|+.+++|++|+|++|++++..|. .|.. .++|+.|++++|.+..++.+.... +++|++|+|
T Consensus 87 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~-~~~~----l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L 160 (606)
T 3t6q_A 87 VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI-PLHN----QKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDF 160 (606)
T ss_dssp ECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGS-CCTT----CTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEEC
T ss_pred eCCCCcccccChhhhcccccccEeeccccCcccCCcc-hhcc----CCcccEEECCCCcccccCcccccC-CcccCEEEc
Confidence 7777777766677777777777777777777642222 1221 233444444444444433332222 556677777
Q ss_pred CCCccccCcchhccCCCCcc--EEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCC
Q 047739 302 QQNQIRGAFPLWLTRASTLT--RLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFS 379 (1099)
Q Consensus 302 ~~n~l~~~~~~~~~~l~~L~--~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 379 (1099)
++|++++..|..|..+++|+ +|++++|.+++..|..|.. .+|++|++++|. ..+..+..+.++....+..+.+.
T Consensus 161 ~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~ 236 (606)
T 3t6q_A 161 QNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFE 236 (606)
T ss_dssp CSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCT
T ss_pred ccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhc
Confidence 77777666666666666666 6677777776655555443 466677776665 12333334444333333222221
Q ss_pred -----CCCCccccCCC--CCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcc
Q 047739 380 -----GEIPEFLGDIR--GLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG 452 (1099)
Q Consensus 380 -----~~~p~~~~~l~--~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 452 (1099)
...+..+..+. +|+.|++++|.+++..+..|.++++|++|++++|+++ .+|..+.++++|++|++++|.+++
T Consensus 237 ~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~ 315 (606)
T 3t6q_A 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315 (606)
T ss_dssp TSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSB
T ss_pred cccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCc
Confidence 12233344443 7999999999999999999999999999999999999 788899999999999999999998
Q ss_pred ccCcccCCCCcccEEEccCCcCCCcCCC-CCCCCCCCCEEEeccCcCcccC--CcccCCCCccceeeeccccccCCCchh
Q 047739 453 EVPASIGNLSQLMVFNLSGNAFSGRIPA-SLGNLLKLTTLDLSKQNFSGEL--PIELAGLPNLQVIALQENKLSGNVPEG 529 (1099)
Q Consensus 453 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~ 529 (1099)
..|..+.++++|+.|++++|.+.+.++. .+.++++|++|++++|++++.. +..+..+++|+.|++++|++++..|..
T Consensus 316 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 395 (606)
T 3t6q_A 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395 (606)
T ss_dssp GGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT
T ss_pred CchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH
Confidence 8899999999999999999999866655 5999999999999999999766 788999999999999999999888999
Q ss_pred hhcccccceecccccccCCCCCC-cccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCc---CCcchhcc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH---IPTDISHL 605 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~---~p~~~~~l 605 (1099)
|..+++|++|++++|++.+..+. .+..+++|+.|++++|++++..|..++.+++|++|+|++|++++. .+..+..+
T Consensus 396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 99999999999999999987665 489999999999999999999999999999999999999999862 33679999
Q ss_pred CcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCcccccccccccc
Q 047739 606 SHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNV 685 (1099)
Q Consensus 606 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l 685 (1099)
++|+.|++++|++++..|..++.+++|+.|+|++|++++..|..+.++++| .|++++|++++..|..+..+.+|+.+++
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 999999999999998889999999999999999999999999999999999 9999999999988888899999999999
Q ss_pred CCCCccc
Q 047739 686 SSNNLQA 692 (1099)
Q Consensus 686 ~~n~~~~ 692 (1099)
++|++.|
T Consensus 555 ~~N~~~c 561 (606)
T 3t6q_A 555 RQNPLDC 561 (606)
T ss_dssp TTCCEEC
T ss_pred CCCCccc
Confidence 8887763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=566.32 Aligned_cols=510 Identities=23% Similarity=0.232 Sum_probs=357.6
Q ss_pred ccccceEEccCCccCcccCcccccCCcccEEEeccccCCCcc-CcccccCCCCceeecccccCCCcccCCcccccceeeC
Q 047739 89 LRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNL-PANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDL 167 (1099)
Q Consensus 89 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~l 167 (1099)
.+.|+.|||++|.+++..|..++++++|++|||++|.+.+.| |..++++++|++|+|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~L---------------------- 80 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL---------------------- 80 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEEC----------------------
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEEC----------------------
Confidence 456667777777766666666666777777777666665555 445666666555555
Q ss_pred CCCccCCCCCCCCccccccccccccccccccccccccccccCcc--ccccCceeEEEccCCcCCccCh-hhhcCCCCccE
Q 047739 168 SSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSA--IANCSSLVHLSAQGNALGGVIP-PAIGALPKLQV 244 (1099)
Q Consensus 168 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~--l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~ 244 (1099)
++|.+++..|.+|+++++|++|+|++|+++ +.+|.. ++++++|++|+|++|.+++..+ ..|+++++|++
T Consensus 81 s~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~--------~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~ 152 (844)
T 3j0a_A 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLS--------DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152 (844)
T ss_dssp TTCCCCEECTTSSCSCSSCCCEECTTCCCS--------SCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCE
T ss_pred CCCcCcccCHhHccCCcccCEeeCcCCCCC--------cccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCE
Confidence 455555567889999999999999999998 344444 7889999999999999998765 68999999999
Q ss_pred EEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCC-----
Q 047739 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST----- 319 (1099)
Q Consensus 245 L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~----- 319 (1099)
|+|++|.+++..|..+ ..+ ..++|+.|+|++|.+.+..|..+..+.+
T Consensus 153 L~Ls~N~i~~~~~~~l-~~l---------------------------~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~ 204 (844)
T 3j0a_A 153 IDFSSNQIFLVCEHEL-EPL---------------------------QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204 (844)
T ss_dssp EEEESSCCCCCCSGGG-HHH---------------------------HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTC
T ss_pred EECCCCcCCeeCHHHc-ccc---------------------------cCCccceEECCCCccccccccchhhcCCccccC
Confidence 9999999986655432 110 0146889999999999888877766665
Q ss_pred -ccEEeCCCCccccCchhhhCCC---CCCCEEEccCCcc---------CccCCccccCC--CCCCEEEccCCcCCCCCCc
Q 047739 320 -LTRLDVSGNSISGKIPAQIGGL---WRLEELKMANNSF---------GGAVPVEIKQC--SSLSLLDLEGNRFSGEIPE 384 (1099)
Q Consensus 320 -L~~L~Ls~N~i~~~~p~~~~~l---~~L~~L~L~~n~l---------~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~ 384 (1099)
|++|+|++|.+++..+..+... .+++.|.++++.+ .+.....|..+ ++|++|+|++|.+.+..|.
T Consensus 205 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~ 284 (844)
T 3j0a_A 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284 (844)
T ss_dssp CBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC
T ss_pred ceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChh
Confidence 9999999999988888777643 6788888874433 22233334443 5677777777777777777
Q ss_pred cccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcc
Q 047739 385 FLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464 (1099)
Q Consensus 385 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 464 (1099)
.|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|++++|.+++..+..|.++++|
T Consensus 285 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 364 (844)
T 3j0a_A 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364 (844)
T ss_dssp CSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCC
T ss_pred hhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCC
Confidence 77777777777777777777777777777777777777777776667777777777777777777776666677777777
Q ss_pred cEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCC-chhhhcccccceecccc
Q 047739 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV-PEGFSSLMSLRYLNLSF 543 (1099)
Q Consensus 465 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 543 (1099)
+.|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+..+++|++|+|++
T Consensus 365 ~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~ 435 (844)
T 3j0a_A 365 QTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435 (844)
T ss_dssp CEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEES
T ss_pred CEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCC
Confidence 7777777777632 22667777777777776 33432 356677777777776532 22344667777777777
Q ss_pred cccCCCCCC-cccccceeeEEEccCCcCC-----CCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCcc
Q 047739 544 NGFVGQIPA-TFSFLRSVVVLSFSGNHIS-----GSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINN 617 (1099)
Q Consensus 544 N~l~~~~~~-~l~~l~~L~~L~ls~N~l~-----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 617 (1099)
|++++..+. .+..+++|+.|++++|.++ +..+..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+
T Consensus 436 N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 515 (844)
T 3j0a_A 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515 (844)
T ss_dssp CCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCC
T ss_pred CcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCC
Confidence 777654332 3445667777777777765 3334556667777777777777776666666777777777777777
Q ss_pred ccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcC
Q 047739 618 LTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEI 670 (1099)
Q Consensus 618 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 670 (1099)
|++..|..+. ++|+.|+|++|+|++.+|..+ .+|+.|++++|++.+..
T Consensus 516 l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 516 LTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICEC 563 (844)
T ss_dssp CSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSS
T ss_pred CCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccc
Confidence 7654444443 667777777777776666554 35666777777766543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=549.17 Aligned_cols=518 Identities=20% Similarity=0.195 Sum_probs=342.8
Q ss_pred cccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeC
Q 047739 90 RMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDL 167 (1099)
Q Consensus 90 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~l 167 (1099)
+.|++|+|++|++++..|..++++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+. ++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 7889999999999988888899999999999999999988888899999999998888888876666654 56777777
Q ss_pred CCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCcc----
Q 047739 168 SSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQ---- 243 (1099)
Q Consensus 168 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---- 243 (1099)
++|++++..|..++++++|++|++++|++++ ..+|..++++++|++|++++|++++..|..|+.+++|+
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~ 184 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHS-------CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCC-------CCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccc-------eechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccc
Confidence 7777766665667777777777777777652 24566666667777777777777666666665555443
Q ss_pred EEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccc-cCcchhccCCCCccE
Q 047739 244 VVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR-GAFPLWLTRASTLTR 322 (1099)
Q Consensus 244 ~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~ 322 (1099)
+|++++|++++ +|...|. ..+|++|++++|.++ +.+|.++..++.|+.
T Consensus 185 ~L~l~~n~l~~-~~~~~~~------------------------------~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 233 (606)
T 3vq2_A 185 SLDMSLNPIDF-IQDQAFQ------------------------------GIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233 (606)
T ss_dssp EEECTTCCCCE-ECTTTTT------------------------------TCEEEEEEEESCCSCHHHHHHHHHTTTTCEE
T ss_pred eeeccCCCcce-eCccccc------------------------------CceeeeeeccCCccchhHHHHHhcccccccc
Confidence 56666666652 2222221 124666666666665 345556666666666
Q ss_pred EeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc-cCCcCCCCCCccccCCCCCCeeeccCcc
Q 047739 323 LDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL-EGNRFSGEIPEFLGDIRGLKSLTLAANL 401 (1099)
Q Consensus 323 L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~L~~n~ 401 (1099)
+++..+.+.+.. .+.. +....+..+..+ +++.+++ ..|.+.+.+|. +..+++|+.|++++|.
T Consensus 234 l~l~~~~~~~~~--------~l~~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~ 296 (606)
T 3vq2_A 234 HRLILGEFKDER--------NLEI-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVS 296 (606)
T ss_dssp EEEEEECCTTSC--------CCSC-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCC
T ss_pred ccccccccccCC--------cccc-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCcc
Confidence 666544333110 0000 000011111111 3444455 44555555554 5555556666666555
Q ss_pred ccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc--CC
Q 047739 402 FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR--IP 479 (1099)
Q Consensus 402 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~ 479 (1099)
+.. +| .+..+++|++|++++|++ +.+| .+ .+++|+.|++++|...+.. .+..+++|+.|++++|++++. .+
T Consensus 297 ~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~ 369 (606)
T 3vq2_A 297 IKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCS 369 (606)
T ss_dssp CCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECC
T ss_pred chh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchh
Confidence 543 22 555566666666666666 3455 33 6666666666666443222 455666666666666666644 25
Q ss_pred CCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCc-hhhhcccccceecccccccCCCCCCcccccc
Q 047739 480 ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVP-EGFSSLMSLRYLNLSFNGFVGQIPATFSFLR 558 (1099)
Q Consensus 480 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 558 (1099)
..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..|..+++|++|++++|.+++..|..+..++
T Consensus 370 ~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 448 (606)
T 3vq2_A 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448 (606)
T ss_dssp HHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred hhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC
Confidence 556666667777777666663 44666667777777777777766655 5667777777777777777777777777777
Q ss_pred eeeEEEccCCcCCC-CCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEEC
Q 047739 559 SVVVLSFSGNHISG-SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637 (1099)
Q Consensus 559 ~L~~L~ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 637 (1099)
+|+.|++++|++++ .+|..++.+++|++|+|++|++++..|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 528 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence 77777777777776 36777778888888888888888777777888888888888888888777778888888888888
Q ss_pred cCccccccCChhhhccC-CCCeeecCCCcCCCcCC
Q 047739 638 NSNHLSGGIPDSLAKLS-NLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 638 s~N~l~~~~p~~l~~l~-~L~~L~ls~N~l~~~~p 671 (1099)
++|+++ .+|..+..++ +|+.|++++|++.+..+
T Consensus 529 ~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 529 SFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 888887 6676677776 58888888888876544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=558.49 Aligned_cols=526 Identities=22% Similarity=0.228 Sum_probs=389.7
Q ss_pred CcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCccc-CcccccCCcccEEEeccccCCCccCccc
Q 047739 56 CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTI-PATLAQCTLLRAVFLQYNSLSGNLPANI 134 (1099)
Q Consensus 56 c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~l~~n~l~g~~p~~~ 134 (1099)
|.|..|-+-..+++.|+|+++.+++..+..+++|++|++|||++|.+.+.+ |..++++++|++|+|++|++++..|..+
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 678888884478999999999999988999999999999999999888888 7889999999999999999999999999
Q ss_pred ccCCCCceeecccccCCCcccCC--cc--cccceeeCCCCccCCCCC-CCCccccccccccccccccccccccccccccC
Q 047739 135 GNLSNLEILNVAANRLSGEIAND--LP--RNLKYFDLSSNGFSGPIP-TSISNLSQLQLINFSFNKFSREVPATFEGTLP 209 (1099)
Q Consensus 135 ~~l~~L~~L~ls~N~l~~~i~~~--~~--~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp 209 (1099)
+++++|++|+|++|.+++.+|.. +. ++|++|+|++|.+++..+ ..|+++++|++|+|++|+++ +..|
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~--------~~~~ 165 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF--------LVCE 165 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC--------CCCS
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC--------eeCH
Confidence 99999999999999999877654 33 678888888888876654 46778888888888888777 3344
Q ss_pred cccccc--CceeEEEccCCcCCccChhhhcCCCC------ccEEEcccccCCCccCcccccccCCCCCcceEEEeccccc
Q 047739 210 SAIANC--SSLVHLSAQGNALGGVIPPAIGALPK------LQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281 (1099)
Q Consensus 210 ~~l~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~ 281 (1099)
..++.+ ++|+.|++++|.+.+..|..++.+++ |++|+|++|++++.+|..+.....
T Consensus 166 ~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~---------------- 229 (844)
T 3j0a_A 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS---------------- 229 (844)
T ss_dssp GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSC----------------
T ss_pred HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcC----------------
Confidence 555555 67778888888877777766665554 777777777777666554332211
Q ss_pred cccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCC--CCCCEEEccCCccCccCC
Q 047739 282 TNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGL--WRLEELKMANNSFGGAVP 359 (1099)
Q Consensus 282 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~ 359 (1099)
...++.|.++.+.+.. +.+.|.+.+..+..|.++ ++|++|+|++|.+.+..+
T Consensus 230 -----------~~~l~~L~l~~~~~~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~ 283 (844)
T 3j0a_A 230 -----------KSQAFSLILAHHIMGA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283 (844)
T ss_dssp -----------SCCBSEEECCSSCCBC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS
T ss_pred -----------cccccceecccccccc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccCh
Confidence 1234444444322211 112333333344445444 456666666666666666
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCC
Q 047739 360 VEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNN 439 (1099)
Q Consensus 360 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 439 (1099)
..+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+..|.++++|+.|+|++|++.+..+..|.++++
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 66666666666666666666666666666666666666666666666666666677777777777666555556666677
Q ss_pred CCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccC-CcccCCCCccceeeec
Q 047739 440 LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGEL-PIELAGLPNLQVIALQ 518 (1099)
Q Consensus 440 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~ 518 (1099)
|++|+|++|.+++ +..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+..+++|+.|+|+
T Consensus 364 L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls 434 (844)
T 3j0a_A 364 LQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434 (844)
T ss_dssp CCEEEEETCCSCC-----CSSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEE
T ss_pred CCEEECCCCCCCc-----ccCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCC
Confidence 7777777776663 222666777777777777 34433 456788888888887532 2335578888889999
Q ss_pred cccccCCCch-hhhcccccceecccccccC-----CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCC
Q 047739 519 ENKLSGNVPE-GFSSLMSLRYLNLSFNGFV-----GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592 (1099)
Q Consensus 519 ~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N 592 (1099)
+|++++..+. .+..+++|++|++++|.++ +..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 435 ~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 514 (844)
T 3j0a_A 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514 (844)
T ss_dssp SCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESC
T ss_pred CCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCC
Confidence 8888855433 3556789999999999997 445577899999999999999999999999999999999999999
Q ss_pred cccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCcccccc
Q 047739 593 SLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645 (1099)
Q Consensus 593 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 645 (1099)
++++..|..+. ++|+.|||++|+|++.+|..+ .+|+.|++++|++...
T Consensus 515 ~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 515 RLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICE 562 (844)
T ss_dssp CCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCS
T ss_pred CCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccc
Confidence 99976666665 899999999999999888765 4899999999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=541.32 Aligned_cols=524 Identities=21% Similarity=0.204 Sum_probs=382.7
Q ss_pred cEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCcccccccccccccc
Q 047739 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFN 194 (1099)
Q Consensus 117 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N 194 (1099)
++++.+++.++ .+|..+. ++|++|+|++|.+++..+..+. ++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 45555555555 3444332 4455555555555544443433 45555555555555444455555555555555555
Q ss_pred ccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCC-ccCcccccccCCCCCcceE
Q 047739 195 KFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSG-VVPASMFCNVSGYPPSIRV 273 (1099)
Q Consensus 195 ~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~~~~l~~ 273 (1099)
+++ +..|..++.+++|++|++++|++++..+..|+.+++|++|+|++|++++ .+|.
T Consensus 91 ~l~--------~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~--------------- 147 (606)
T 3vq2_A 91 PIQ--------SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA--------------- 147 (606)
T ss_dssp CCC--------CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCG---------------
T ss_pred ccc--------ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechH---------------
Confidence 554 2223344445555555555555554444445555555555555555542 2232
Q ss_pred EEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCcc----EEeCCCCccccCchhhhCCCCCCCEEEc
Q 047739 274 VQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLT----RLDVSGNSISGKIPAQIGGLWRLEELKM 349 (1099)
Q Consensus 274 l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 349 (1099)
....+++|++|+|++|++++..|..|..+.+|+ +|++++|.+++..+..+... +|++|++
T Consensus 148 ---------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L 211 (606)
T 3vq2_A 148 ---------------YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTL 211 (606)
T ss_dssp ---------------GGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEE
T ss_pred ---------------hHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeec
Confidence 122356677777777777776666666555443 67777777775544444444 6777777
Q ss_pred cCCccC-ccCCccccCCCCCCEEEccCCcCCC------CCCccccCCC--CCCeeec-cCccccccCCccCCCCCCCCEE
Q 047739 350 ANNSFG-GAVPVEIKQCSSLSLLDLEGNRFSG------EIPEFLGDIR--GLKSLTL-AANLFSGSIPASFRNLPGLENL 419 (1099)
Q Consensus 350 ~~n~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~--~L~~L~L-~~n~l~~~~~~~~~~l~~L~~L 419 (1099)
++|.+. +..|..+.++++|+.+++..+.+.+ ..+..+..+. +++.+++ ..|.+.+..|. +..+++|+.|
T Consensus 212 ~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L 290 (606)
T 3vq2_A 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAM 290 (606)
T ss_dssp ESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEE
T ss_pred cCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEE
Confidence 777765 3456666777777777765544432 1112222222 3555556 67788887777 9999999999
Q ss_pred EcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 420 NLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 420 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
++++|.+. .+| .+..+++|+.|++++|.+ +.+| .+ .+++|+.|++++|+..+.. .+..+++|++|++++|+++
T Consensus 291 ~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 363 (606)
T 3vq2_A 291 SLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALS 363 (606)
T ss_dssp EEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEE
T ss_pred EecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccC
Confidence 99999997 456 788899999999999999 4777 45 9999999999999665443 6778999999999999998
Q ss_pred cc--CCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCC-CcccccceeeEEEccCCcCCCCCCC
Q 047739 500 GE--LPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP-ATFSFLRSVVVLSFSGNHISGSIPP 576 (1099)
Q Consensus 500 ~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~ls~N~l~~~~p~ 576 (1099)
+. .+..+..+++|+.|++++|.+++ +|..|..+++|++|++++|++.+..| ..+..+++|+.|++++|++++..|.
T Consensus 364 ~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 442 (606)
T 3vq2_A 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442 (606)
T ss_dssp EEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTT
T ss_pred CCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchh
Confidence 66 47889999999999999999984 66889999999999999999998877 6899999999999999999999999
Q ss_pred CCCCCCCCceEEecCCcccC-cCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCC
Q 047739 577 ELGNCSDLEVLELRSNSLTG-HIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655 (1099)
Q Consensus 577 ~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 655 (1099)
.++++++|++|++++|++++ .+|..++.+++|+.|+|++|++++..|..+..+++|++|+|++|++++.+|..+.++++
T Consensus 443 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 522 (606)
T 3vq2_A 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522 (606)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTT
T ss_pred hhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCc
Confidence 99999999999999999997 47889999999999999999999888899999999999999999999888999999999
Q ss_pred CCeeecCCCcCCCcCCCCccccc-cccccccCCCCccc
Q 047739 656 LAVLDLSANNLSGEIPANLSSIF-GLMNFNVSSNNLQA 692 (1099)
Q Consensus 656 L~~L~ls~N~l~~~~p~~~~~~~-~l~~l~l~~n~~~~ 692 (1099)
|+.||+++|+++ .+|..+..++ +|+.+++++|++.|
T Consensus 523 L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 523 LSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp CCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred CCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCccc
Confidence 999999999999 6888788886 59999988887764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=490.98 Aligned_cols=502 Identities=21% Similarity=0.247 Sum_probs=306.9
Q ss_pred eeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEE
Q 047739 142 ILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHL 221 (1099)
Q Consensus 142 ~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L 221 (1099)
..+-++.+++ .||..+++++++|+|++|++++..+.+|+++++|++|+|++|++++. .|..++.+++|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i--------~~~~~~~l~~L~~L 81 (570)
T 2z63_A 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI--------EDGAYQSLSHLSTL 81 (570)
T ss_dssp EEECCSSCCS-SCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEE--------CTTTTTTCTTCCEE
T ss_pred EEEeCCCCcc-ccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCcc--------CcccccCchhCCEE
Confidence 3444555554 56777777888888888888877777888888888888888888732 23456678888888
Q ss_pred EccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEc
Q 047739 222 SAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301 (1099)
Q Consensus 222 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L 301 (1099)
++++|++++..|.+|+.+++|++|++++|++++ +|...| ..+++|++|+|
T Consensus 82 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~-----------------------------~~l~~L~~L~L 131 (570)
T 2z63_A 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPI-----------------------------GHLKTLKELNV 131 (570)
T ss_dssp ECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC-STTCSC-----------------------------TTCTTCCEEEC
T ss_pred eCcCCcCCccCHhhhcCcccccccccccccccc-CCCccc-----------------------------cccccccEEec
Confidence 888888888777888888888888888888873 222112 23566777777
Q ss_pred CCCcccc-CcchhccCCCCccEEeCCCCccccCchhhhCCCCCC----CEEEccCCccCccCCccccCCCCCCEEEccCC
Q 047739 302 QQNQIRG-AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL----EELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 302 ~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 376 (1099)
++|++++ .+|..|.++++|++|++++|.+++..+..|+.+++| ++|++++|.+++..+..+..+ +|+.|++++|
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n 210 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccc
Confidence 7777776 357777777888888888888777667777777777 778888887777666666655 6778887777
Q ss_pred cCCC-CCCccccCCCCCCeeeccCccc------cccCCccCCCCCC--CCEEEcccC-cCccccchhhhCCCCCCEEEcc
Q 047739 377 RFSG-EIPEFLGDIRGLKSLTLAANLF------SGSIPASFRNLPG--LENLNLRHN-SLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 377 ~l~~-~~p~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
.... .++..+..+++++.+.+..+.+ .......+.++++ ++.+++++| .+.+..|..+..+++|+.|+++
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 4331 2334445555555444332211 1111222222221 344555555 4455555555555666666666
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCC
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 526 (1099)
+|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|+.|++++|++++..
T Consensus 291 ~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~ 363 (570)
T 2z63_A 291 SVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKG 363 (570)
T ss_dssp SCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEE
T ss_pred Cccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccc
Confidence 66555 345555555 5666666666555 3332 3455566666666655544333 45555666666666555332
Q ss_pred --chhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCC-CCCCCCCCCceEEecCCcccCcCCcchh
Q 047739 527 --PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIP-PELGNCSDLEVLELRSNSLTGHIPTDIS 603 (1099)
Q Consensus 527 --p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 603 (1099)
+..+..+++|++|++++|.+.+..+. +..+++|+.|++++|++++..| ..+.++++|++|++++|.+++..|..+.
T Consensus 364 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 442 (570)
T 2z63_A 364 CCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442 (570)
T ss_dssp EEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred cccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhh
Confidence 45555556666666666655543333 5555666666666666554444 3455556666666666666555555555
Q ss_pred ccCcccEEeccCcccc-ccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCccccccccc
Q 047739 604 HLSHLNVLDLSINNLT-GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMN 682 (1099)
Q Consensus 604 ~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~ 682 (1099)
.+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+.++++|+.|++++|++++..|..+..+.+|+.
T Consensus 443 ~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 522 (570)
T 2z63_A 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK 522 (570)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcE
Confidence 6666666666666655 345555666666666666666666555556666666666666666666555555555555666
Q ss_pred cccCCCCcc
Q 047739 683 FNVSSNNLQ 691 (1099)
Q Consensus 683 l~l~~n~~~ 691 (1099)
+++++|++.
T Consensus 523 L~l~~N~~~ 531 (570)
T 2z63_A 523 IWLHTNPWD 531 (570)
T ss_dssp EECCSSCBC
T ss_pred EEecCCccc
Confidence 665555544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=499.86 Aligned_cols=516 Identities=19% Similarity=0.252 Sum_probs=262.0
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCCCCCCCC--Cccc-ceEecC----CcEeEEecCCCccccccccccccccccceEEc
Q 047739 25 PEIEALTSFKLNLHDPLGALNGWDSSTPAAP--CDWR-GVACTN----NRVTELRLPRLQLSGRISDHLSNLRMLRKLSL 97 (1099)
Q Consensus 25 ~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~--c~w~-gv~c~~----~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L 97 (1099)
.+...-.++++-...-.+ .+|....+..| |.|. +..|.. .-|+. . .. .+++.|+|
T Consensus 27 ~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~---------~~----~~V~~L~L 88 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---N---------SN----GRVTGLSL 88 (636)
T ss_dssp HHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE---C---------TT----CCEEEEEC
T ss_pred hHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE---c---------CC----CCEEEEEe
Confidence 556666666655533344 47886544334 5895 333321 22332 0 00 46789999
Q ss_pred cCCccCcccCcccccCCcccEEEeccccC------CC------ccCcccccCCCCceeecccccCCCcccCCcc---ccc
Q 047739 98 RSNSFNGTIPATLAQCTLLRAVFLQYNSL------SG------NLPANIGNLSNLEILNVAANRLSGEIANDLP---RNL 162 (1099)
Q Consensus 98 ~~n~~~~~~p~~~~~l~~L~~L~l~~n~l------~g------~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~---~~L 162 (1099)
++|.++|.+|+++++|++|++|||++|.+ .| .+|... +..|+ +++++|.+.+.+|..+. .++
T Consensus 89 ~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l 165 (636)
T 4eco_A 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDC 165 (636)
T ss_dssp TTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHH
T ss_pred cCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHH
Confidence 99999999999999999999999999987 33 444443 45555 66666666666665544 233
Q ss_pred ceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCc
Q 047739 163 KYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKL 242 (1099)
Q Consensus 163 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 242 (1099)
..+++....+.. .....++.+.+.. .+|++++ +|.+|+++++|
T Consensus 166 ~~~~l~~~~~~~------~~~~~l~~l~l~~------------------------------~~n~l~~-ip~~l~~l~~L 208 (636)
T 4eco_A 166 INSDPQQKSIKK------SSRITLKDTQIGQ------------------------------LSNNITF-VSKAVMRLTKL 208 (636)
T ss_dssp HHHCTTSCCCCC------CCCCCCCTTTTTC------------------------------CSCEEEE-ECGGGGGCTTC
T ss_pred hhcCcccccccc------ccccchhhhhhcc------------------------------ccCCCcc-CCHHHhcccCC
Confidence 333333332221 1112222222221 1344444 44555555555
Q ss_pred cEEEcccccCCCc-cCcccccccCCCCCcceEEEeccccc-cccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCc
Q 047739 243 QVVSLAQNNLSGV-VPASMFCNVSGYPPSIRVVQLGFNAF-TNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTL 320 (1099)
Q Consensus 243 ~~L~Ls~N~l~~~-~p~~~~~~~~~~~~~l~~l~l~~n~~-~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 320 (1099)
++|+|++|++++. ++..... .. .+.. ..++.......+++|++|+|++|++.+.+|..|.++++|
T Consensus 209 ~~L~Ls~n~l~~~~~~~~~~~------~~-------~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 275 (636)
T 4eco_A 209 RQFYMGNSPFVAENICEAWEN------EN-------SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275 (636)
T ss_dssp CEEEEESCCCCGGGBSSSCSC------TT-------SHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSC
T ss_pred CEEECcCCccccccccccccc------cc-------cchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCC
Confidence 5555555555542 1100000 00 0000 000000000012233333333333334444445555555
Q ss_pred cEEeCCCCc-ccc-CchhhhCCC------CCCCEEEccCCccCccCCc--cccCCCCCCEEEccCCcCCCCCCccccCCC
Q 047739 321 TRLDVSGNS-ISG-KIPAQIGGL------WRLEELKMANNSFGGAVPV--EIKQCSSLSLLDLEGNRFSGEIPEFLGDIR 390 (1099)
Q Consensus 321 ~~L~Ls~N~-i~~-~~p~~~~~l------~~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 390 (1099)
++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+.++++|++|+|++|+++|.+| .++.++
T Consensus 276 ~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~ 353 (636)
T 4eco_A 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353 (636)
T ss_dssp CEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEE
T ss_pred CEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCC
Confidence 555555555 555 455555444 45555555555555 4444 45555555555555555554444 444444
Q ss_pred CCCeeeccCccccccCCccCCCCCC-CCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEc
Q 047739 391 GLKSLTLAANLFSGSIPASFRNLPG-LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNL 469 (1099)
Q Consensus 391 ~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 469 (1099)
+|++|+|++|+++ .+|..+.++++ |++|++++|+++ .+|..+..+. +++|+.|++
T Consensus 354 ~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~----------------------l~~L~~L~L 409 (636)
T 4eco_A 354 KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS----------------------VSVMSAIDF 409 (636)
T ss_dssp EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTC----------------------SSCEEEEEC
T ss_pred CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcc----------------------cCccCEEEC
Confidence 4444444444444 33444444444 444444444444 3444333322 114444444
Q ss_pred cCCcCCCcCCCCCC-------CCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchh-hh-------ccc
Q 047739 470 SGNAFSGRIPASLG-------NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FS-------SLM 534 (1099)
Q Consensus 470 ~~N~l~~~~~~~l~-------~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~-------~l~ 534 (1099)
++|++++..|..+. .+.+|++|++++|+++...+..+..+++|+.|+|++|+++ .+|.. +. +++
T Consensus 410 s~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~ 488 (636)
T 4eco_A 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTY 488 (636)
T ss_dssp CSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGG
T ss_pred cCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccC
Confidence 44444444444444 4445555555555555322222334555555555555555 23322 22 223
Q ss_pred ccceecccccccCCCCCCccc--ccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecC------CcccCcCCcchhccC
Q 047739 535 SLRYLNLSFNGFVGQIPATFS--FLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS------NSLTGHIPTDISHLS 606 (1099)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~------N~l~~~~p~~~~~l~ 606 (1099)
+|++|+|++|+++ .+|..+. .+++|+.|++++|++++ +|..++++++|++|+|++ |++.+.+|..++.++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 7777777777777 5666665 77777777777777775 777777777777777755 445555555555555
Q ss_pred cccEEeccCccccccCCcccCCCCCCCEEECcCcccc
Q 047739 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 607 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
+|+.|+|++|++ +.+|..+. ++|+.|+|++|++.
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred CCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 555555555555 24555443 45555555555443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=485.07 Aligned_cols=489 Identities=19% Similarity=0.249 Sum_probs=350.3
Q ss_pred CCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCccc
Q 047739 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI 134 (1099)
Q Consensus 55 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~ 134 (1099)
.|.|.|| |+. ++++++ .||+.+. +.|++|+|++|++++..|..++++++|++|+|++|++++..|..+
T Consensus 3 ~C~~~~~-c~~--------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 70 (549)
T 2z81_A 3 SCDASGV-CDG--------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70 (549)
T ss_dssp EECTTSE-EEC--------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred cCCCCce-EEC--------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence 4999999 964 233332 4666554 789999999999998888999999999999999999999888999
Q ss_pred ccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCC-CCCCCCccccccccccccccccccccccccccccC-c
Q 047739 135 GNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLP-S 210 (1099)
Q Consensus 135 ~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp-~ 210 (1099)
+++++|++|+|++|.+++..|..+. ++|++|+|++|++++ .+|..++++++|++|++++|++. +.+| .
T Consensus 71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~--------~~~~~~ 142 (549)
T 2z81_A 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF--------SEIRRI 142 (549)
T ss_dssp TTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC--------CEECTT
T ss_pred cccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc--------cccCHh
Confidence 9999999999999999987776555 789999999999986 46788999999999999999854 3444 4
Q ss_pred cccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCC
Q 047739 211 AIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG 290 (1099)
Q Consensus 211 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~ 290 (1099)
.++.+++|++|++++|++++..|..++.+++|++|+++.|.+. .+|...+..
T Consensus 143 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~--------------------------- 194 (549)
T 2z81_A 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADI--------------------------- 194 (549)
T ss_dssp TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHS---------------------------
T ss_pred hhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhh---------------------------
Confidence 6778899999999999999999999999999999999999875 444433322
Q ss_pred CCCCceeEEEcCCCccccCc--c-hhccCCCCccEEeCCCCccccCchhh----hCCCCCCCEEEccCCccCccC-----
Q 047739 291 SCSSVLQVLDLQQNQIRGAF--P-LWLTRASTLTRLDVSGNSISGKIPAQ----IGGLWRLEELKMANNSFGGAV----- 358 (1099)
Q Consensus 291 ~~~~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~Ls~N~i~~~~p~~----~~~l~~L~~L~L~~n~l~~~~----- 358 (1099)
+++|++|++++|++++.. | .....+++|++|++++|.+++..+.. +..+.+|+.|++++|.+.+..
T Consensus 195 --l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~ 272 (549)
T 2z81_A 195 --LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272 (549)
T ss_dssp --TTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCC
T ss_pred --cccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccccccccc
Confidence 345666666666666531 1 12234566777777777776544433 345667777777777665421
Q ss_pred -CccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhh-hC
Q 047739 359 -PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEV-LG 436 (1099)
Q Consensus 359 -~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~ 436 (1099)
...+..+.+|+.|+++++.+.... .+.+ .+..+..+++|+.|++++|+++ .+|..+ ..
T Consensus 273 ~~~~~~~l~~L~~L~l~~~~i~~~~--~~~~-----------------l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~ 332 (549)
T 2z81_A 273 ESDVVSELGKVETVTIRRLHIPQFY--LFYD-----------------LSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332 (549)
T ss_dssp TTTCCCCCTTCCEEEEESCBCSCGG--GSCC-----------------CCHHHHHSTTCCEEEEESSCCC-CCCHHHHHH
T ss_pred chhhhhhhcccccccccccccchhh--hccc-----------------chhhhhhcccceEEEeccCccc-cCCHHHHhc
Confidence 122344555556665555543110 0000 1111222356677777777766 455554 45
Q ss_pred CCCCCEEEccCCcCccccC---cccCCCCcccEEEccCCcCCCcCC--CCCCCCCCCCEEEeccCcCcccCCcccCCCCc
Q 047739 437 MNNLSTLDLSENKFSGEVP---ASIGNLSQLMVFNLSGNAFSGRIP--ASLGNLLKLTTLDLSKQNFSGELPIELAGLPN 511 (1099)
Q Consensus 437 l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 511 (1099)
+++|++|+|++|++++..| ..++.+++|+.|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++
T Consensus 333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~ 411 (549)
T 2z81_A 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411 (549)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTT
T ss_pred CccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccccc
Confidence 7777777777777765543 335667777777777777764322 34666777777777777777 56666777777
Q ss_pred cceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecC
Q 047739 512 LQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591 (1099)
Q Consensus 512 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~ 591 (1099)
|+.|++++|+++ .+|..+ .++|++|++++|++++.+ ..+++|++|++++|+++ .+|. ...+++|++|+|++
T Consensus 412 L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~ 482 (549)
T 2z81_A 412 MRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISR 482 (549)
T ss_dssp CCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCS
T ss_pred ccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCC
Confidence 777777777776 334333 257888888888887543 46778888888888888 6666 46788999999999
Q ss_pred CcccCcCCcchhccCcccEEeccCccccccCC
Q 047739 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEIP 623 (1099)
Q Consensus 592 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 623 (1099)
|++++..|..+..+++|+.|++++|++++..|
T Consensus 483 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99998777888999999999999999887665
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=450.34 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=210.2
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|...++||+|+||+||+|+++ +++.||||++..... ..+.|.+|++++++++|||||+++|+|.+. ...
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEE
Confidence 356788899999999999999875 478999999976543 347799999999999999999999999854 456
Q ss_pred EEEEeecCCCCHHHHHhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQ----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
|+|||||++|+|.++++..... ....++|.++..|+.|||+||+|||+.+||||||||+|||+++++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999999864321 234699999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+|||+|+..... .........+||+.|||||++.+..++.++|||||||++|||+| |+.||......+....+....
T Consensus 199 i~DFGla~~~~~~-~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 199 IGDFGMSRDIYST-DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EcccccceeccCC-CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865322 12223345689999999999999999999999999999999999 899998877766665554321
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
. .+. +...+ ..+.+++.+||+.||++||||+||++.|+.+...|+
T Consensus 278 ~----~~~---------p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 278 E----LER---------PRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp C----CCC---------CTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred C----CCC---------ccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 1 100 11111 124578999999999999999999999999877654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=479.66 Aligned_cols=463 Identities=21% Similarity=0.224 Sum_probs=247.0
Q ss_pred ccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCC
Q 047739 91 MLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLS 168 (1099)
Q Consensus 91 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls 168 (1099)
.++.|+|++|++++..|..+.++++|++|||++|++++..|..++++++|++|+|++|.+++..|..+. ++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 456666666666655555566666666666666666655555566666666666666666554444443 566666666
Q ss_pred CCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCc----cE
Q 047739 169 SNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKL----QV 244 (1099)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L----~~ 244 (1099)
+|++++..+..++++++|++|++++|+++. ..+|..++++++|++|++++|++++..+..|+.+++| ++
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-------~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~ 181 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQS-------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCC-------CCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCE
T ss_pred ccccccCCCccccccccccEEecCCCccce-------ecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhh
Confidence 666664444456666666666666666652 1345556666666666666666666656666655555 56
Q ss_pred EEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCcccc-CcchhccCCCCc---
Q 047739 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG-AFPLWLTRASTL--- 320 (1099)
Q Consensus 245 L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L--- 320 (1099)
|++++|.+++..|. .|.. ..|+.|++++|.... .++..+..++++
T Consensus 182 L~l~~n~l~~~~~~-~~~~------------------------------~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~ 230 (570)
T 2z63_A 182 LDLSLNPMNFIQPG-AFKE------------------------------IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230 (570)
T ss_dssp EECTTCCCCEECTT-TTTT------------------------------CEEEEEEEESCCSCTTHHHHHHHTTTTCEEE
T ss_pred cccCCCCceecCHH-Hhcc------------------------------CcceeEecccccccccchhhhhcCcccccee
Confidence 66666666533222 2211 123333333332211 122233333333
Q ss_pred -----------------------------cEEeCCCC-ccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCE
Q 047739 321 -----------------------------TRLDVSGN-SISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSL 370 (1099)
Q Consensus 321 -----------------------------~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 370 (1099)
+.+++++| .+.+..|..|..+++|++|++++|.++ .+|..+..+ +|++
T Consensus 231 ~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~ 308 (570)
T 2z63_A 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQH 308 (570)
T ss_dssp EEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSE
T ss_pred eeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccE
Confidence 34444444 344444444444444555555444444 244444444 4555
Q ss_pred EEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc--chhhhCCCCCCEEEccCC
Q 047739 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL--PEEVLGMNNLSTLDLSEN 448 (1099)
Q Consensus 371 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N 448 (1099)
|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|++|++++|++++.. +..+.++++|++|++++|
T Consensus 309 L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n 383 (570)
T 2z63_A 309 LELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383 (570)
T ss_dssp EEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSC
T ss_pred EeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCC
Confidence 555555444 3332 2344444444444444433332 34444555555555444322 344444444555555444
Q ss_pred cCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCC-cccCCCCccceeeeccccccCCCc
Q 047739 449 KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELP-IELAGLPNLQVIALQENKLSGNVP 527 (1099)
Q Consensus 449 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p 527 (1099)
.+++..+ . +.++++|++|++++|.+.+..+ ..+..+++|+.|++++|.+.+..|
T Consensus 384 ~l~~~~~------------------------~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 438 (570)
T 2z63_A 384 GVITMSS------------------------N-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438 (570)
T ss_dssp SEEEEEE------------------------E-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCT
T ss_pred ccccccc------------------------c-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccch
Confidence 4443222 2 4444555555555555444333 234455555555555555555555
Q ss_pred hhhhcccccceecccccccC-CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccC
Q 047739 528 EGFSSLMSLRYLNLSFNGFV-GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS 606 (1099)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 606 (1099)
..|..+++|++|++++|.++ +.+|..+..+++|+.|++++|++++..|..++++++|++|+|++|++++..|..+..++
T Consensus 439 ~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 518 (570)
T 2z63_A 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518 (570)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred hhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhccc
Confidence 55555566666666666655 34556666666666666666666666666666677777777777777665556666777
Q ss_pred cccEEeccCccccccCC
Q 047739 607 HLNVLDLSINNLTGEIP 623 (1099)
Q Consensus 607 ~L~~L~Ls~N~l~~~~p 623 (1099)
+|+.|++++|++++..|
T Consensus 519 ~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 519 SLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TCCEEECCSSCBCCCTT
T ss_pred CCcEEEecCCcccCCCc
Confidence 77777777777766544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=444.83 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=212.9
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
++|.+.+.||+|+||+||+|++. ++..||||++..... ..++|.+|++++++++|||||+++|+|.+. +..|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEE
Confidence 57888999999999999999874 478999999976443 347799999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhc--------cCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 876 LVYDYMPNGNLGTLLQEAS--------HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
+|||||++|+|.++++..+ ......++|..+..|+.|||+||+|||+.+||||||||+|||+++++.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 9999999999999998643 12345699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
||+|+...... .........||+.|||||++.+..|+.++|||||||++|||+| |+.||......++...+...
T Consensus 172 FGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~---- 246 (299)
T 4asz_A 172 FGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---- 246 (299)
T ss_dssp CSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT----
T ss_pred cccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Confidence 99998652211 1122334579999999999999999999999999999999999 89999887776665555432
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
..... +...+ ..+.+++.+||+.||++||||+||.+.|+++...
T Consensus 247 ~~~~~---------p~~~~----~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQR---------PRTCP----QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCC---------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---------Cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11110 11111 1245899999999999999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=437.34 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=202.3
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|.+.++||+|+||+||+|++++ .||||+++.... ..+.|.+|++++++++|||||+++|++.+ + ..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~-~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D-NLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-SCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C-eEEEEE
Confidence 3567888999999999999999864 488998864333 23679999999999999999999999874 3 369999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||++|+|.++++.. ...++|..+..|+.|||+||+|||+.+||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~- 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW- 185 (307)
T ss_dssp ECCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC-
Confidence 999999999999742 245999999999999999999999999999999999999999999999999999865321
Q ss_pred CCCccccccccCccccCcccccc---CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...........+.. .+.. .+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~---~~~~----~p~ 258 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG---RGYA----SPD 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---TTCC----CCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh---cCCC----CCC
Confidence 12233456789999999999864 3589999999999999999999999987655443332221 1111 111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.....+ ..+ ..+.+++.+||+.||++||||.||++.|+.++..
T Consensus 259 ~~~~~~-~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 259 LSKLYK-NCP----KAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp STTSCT-TSC----HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cccccc-cch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111111 111 1245789999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=442.56 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=210.8
Q ss_pred hccccccccccccceeEEEEEEC------CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++.+.+.||+|+||+||+|.+. +++.||||++.... ...+.|.+|++++++++|||||+++|+|.+. ...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-CEE
Confidence 35667789999999999999873 46899999996543 2357899999999999999999999999854 446
Q ss_pred EEEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
++|||||++|+|.+++...... ....++|..+..|+.|||+||+|||+.+||||||||+|||+++++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 9999999999999999753211 12458999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
||+|||+|+..... .........+||+.|||||++.++.|+.++|||||||++|||+| |+.||......++...+..
T Consensus 185 Ki~DFGlar~~~~~-~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~- 262 (308)
T 4gt4_A 185 KISDLGLFREVYAA-DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN- 262 (308)
T ss_dssp EECCSCCBCGGGGG-GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-
T ss_pred EECCcccceeccCC-CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999865322 12233455789999999999999999999999999999999999 8999988777666555443
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+..... +..++ ..+.+++.+||+.||++||||+||++.|+..
T Consensus 263 ---~~~~~~---------p~~~~----~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 ---RQVLPC---------PDDCP----AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---TCCCCC---------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCCCCC---------cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 211111 11111 1245789999999999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=481.92 Aligned_cols=481 Identities=20% Similarity=0.242 Sum_probs=270.2
Q ss_pred ecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEc
Q 047739 144 NVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSA 223 (1099)
Q Consensus 144 ~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l 223 (1099)
|.++|.++ .+|..++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..++.+++|++|+|
T Consensus 11 ~~~~~~l~-~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~--------~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 11 DGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT--------IEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp ECTTSCCS-SCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCE--------ECTTTTTTCTTCCEEEC
T ss_pred ECCCCccc-cccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCc--------cChhhccccccCCEEEC
Confidence 33334443 3444444455555555555555545555555555555555555552 22233444555555555
Q ss_pred cCCcCCccChhhhcCCCCccEEEcccccCCCc-cCcccccccCCCCCcceEEEecccc-ccccCCCCCCCCCCceeEEEc
Q 047739 224 QGNALGGVIPPAIGALPKLQVVSLAQNNLSGV-VPASMFCNVSGYPPSIRVVQLGFNA-FTNVAGPETGSCSSVLQVLDL 301 (1099)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~~~~l~~l~l~~n~-~~~~~~~~~~~~~~~L~~L~L 301 (1099)
++|++++..|.+|+.+++|++|+|++|++++. +|. .|.. .++++.|++++|. +..++.. ....+++|++|++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~~----l~~L~~L~L~~n~~~~~~~~~-~~~~l~~L~~L~L 155 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS-LFPN----LTNLQTLRIGNVETFSEIRRI-DFAGLTSLNELEI 155 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSC-SCTT----CTTCCEEEEEESSSCCEECTT-TTTTCCEEEEEEE
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhh-hhhc----cCCccEEECCCCccccccCHh-hhhcccccCeeec
Confidence 55555555555555555555555555555431 111 1111 0111111111111 0111000 0112344555555
Q ss_pred CCCccccCcchhccCCCCccEEeCCCCccccCchhh-hCCCCCCCEEEccCCccCccC--C-ccccCCCCCCEEEccCCc
Q 047739 302 QQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMANNSFGGAV--P-VEIKQCSSLSLLDLEGNR 377 (1099)
Q Consensus 302 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~L~~n~l~~~~--~-~~l~~l~~L~~L~Ls~N~ 377 (1099)
++|++++..|..+..+++|++|++++|.+.. +|.. ++.+++|++|++++|++++.. + .....+++|+.|++++|.
T Consensus 156 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp EETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred cCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 5555555555555555555555555555542 2222 234455555555555554321 1 112233444444444444
Q ss_pred CCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc------chhhhCCCCCCEEEccCCcCc
Q 047739 378 FSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL------PEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
+++..+.. ++..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+.
T Consensus 235 l~~~~~~~--------------------l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~ 294 (549)
T 2z81_A 235 LTDESFNE--------------------LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294 (549)
T ss_dssp EEHHHHHH--------------------HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCS
T ss_pred cchhHHHH--------------------HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccc
Confidence 44322211 1122233445555555555444311 112334455555555555543
Q ss_pred cc-----cCcccCCCCcccEEEccCCcCCCcCCCCC-CCCCCCCEEEeccCcCcccCC---cccCCCCccceeeeccccc
Q 047739 452 GE-----VPASIGNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFSGELP---IELAGLPNLQVIALQENKL 522 (1099)
Q Consensus 452 ~~-----~~~~l~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~---~~l~~l~~L~~L~L~~N~l 522 (1099)
.. ++..+....+|+.|++++|.++ .+|..+ .++++|++|++++|++++..| ..++.+++|+.|++++|++
T Consensus 295 ~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 373 (549)
T 2z81_A 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373 (549)
T ss_dssp CGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCC
T ss_pred hhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcc
Confidence 21 1111223356777777777766 455444 457777777777777776553 2366777788888888877
Q ss_pred cCCCc--hhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCc
Q 047739 523 SGNVP--EGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPT 600 (1099)
Q Consensus 523 ~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 600 (1099)
++..+ ..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|..+. ++|++|+|++|++++.+
T Consensus 374 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~-- 447 (549)
T 2z81_A 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS-- 447 (549)
T ss_dssp CCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC--
T ss_pred cccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc--
Confidence 75432 45777888888888888887 56777778888888888888887 4454442 58888999999888532
Q ss_pred chhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCC
Q 047739 601 DISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 601 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
..+++|+.|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|..+..+++|+.|++++|++++..|
T Consensus 448 --~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 --LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp --CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred --ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 56788899999999888 6776 4678889999999999988888888889999999999999887665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=489.86 Aligned_cols=481 Identities=19% Similarity=0.223 Sum_probs=293.4
Q ss_pred cccceEEccCCccCcccCcccccCCcccEEEe-ccccCCCccCcccccC----CCCc--eeec----------ccccCCC
Q 047739 90 RMLRKLSLRSNSFNGTIPATLAQCTLLRAVFL-QYNSLSGNLPANIGNL----SNLE--ILNV----------AANRLSG 152 (1099)
Q Consensus 90 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l-~~n~l~g~~p~~~~~l----~~L~--~L~l----------s~N~l~~ 152 (1099)
.++..|+|++|.+.|.+|+.+++|++|++||| ++|.++|..|-..... +..+ .+.. ....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9999998865432211 0000 0000 0011111
Q ss_pred cc-----------cCCcc--cccceeeCC--CCccCCCCCCCCccccccccccccccccccccccccccccCccccccCc
Q 047739 153 EI-----------ANDLP--RNLKYFDLS--SNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSS 217 (1099)
Q Consensus 153 ~i-----------~~~~~--~~L~~L~ls--~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~ 217 (1099)
.+ +.... ..++.+.+. +|+++| +|..|+++++|++|+|++|+|++. .+|..+..
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~-------~i~~~~~~--- 471 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYD-------NIAVDWED--- 471 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGG-------GBSSSCSC---
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCC-------cccccccc---
Confidence 01 00000 123333333 256665 666666666666666666666531 00000000
Q ss_pred eeEEEccCCcCCccChhhhc--CCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCc
Q 047739 218 LVHLSAQGNALGGVIPPAIG--ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295 (1099)
Q Consensus 218 L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~ 295 (1099)
++.|.+.+.+|..++ ++++|++|+|++|++.+.+|..+ .. +++
T Consensus 472 -----~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l-~~-----------------------------L~~ 516 (876)
T 4ecn_A 472 -----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL-YD-----------------------------LPE 516 (876)
T ss_dssp -----TTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGG-GG-----------------------------CSS
T ss_pred -----cccccccccCChhhhhccCCCCCEEECcCCCCCccChHHH-hC-----------------------------CCC
Confidence 000111123555544 55555555555555554433211 10 122
Q ss_pred eeEEEcCCCc-ccc-Ccchhcc-------CCCCccEEeCCCCccccCchh--hhCCCCCCCEEEccCCccCccCCccccC
Q 047739 296 LQVLDLQQNQ-IRG-AFPLWLT-------RASTLTRLDVSGNSISGKIPA--QIGGLWRLEELKMANNSFGGAVPVEIKQ 364 (1099)
Q Consensus 296 L~~L~L~~n~-l~~-~~~~~~~-------~l~~L~~L~Ls~N~i~~~~p~--~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 364 (1099)
|++|+|++|+ +++ .+|..+. .+++|++|+|++|.++ .+|. .|+++++|++|+|++|+++ .+| .+..
T Consensus 517 L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~ 593 (876)
T 4ecn_A 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGT 593 (876)
T ss_dssp CCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCT
T ss_pred CCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcC
Confidence 3333333333 333 2333332 3346666666666666 5555 6666666666666666666 455 5666
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCCC-CCeeeccCccccccCCccCCCCCC--CCEEEcccCcCccccchhhhCCCCCC
Q 047739 365 CSSLSLLDLEGNRFSGEIPEFLGDIRG-LKSLTLAANLFSGSIPASFRNLPG--LENLNLRHNSLSGSLPEEVLGMNNLS 441 (1099)
Q Consensus 365 l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~ 441 (1099)
+++|++|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|..+..++. |+.|+|++|++++.+|...
T Consensus 594 L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~------- 664 (876)
T 4ecn_A 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS------- 664 (876)
T ss_dssp TSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCS-------
T ss_pred CCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccch-------
Confidence 666666666666666 55555555555 555555555555 34444444332 5555555555544333211
Q ss_pred EEEccCCcCccccCcccC--CCCcccEEEccCCcCCCcCCCC-CCCCCCCCEEEeccCcCcccCCccc--------CCCC
Q 047739 442 TLDLSENKFSGEVPASIG--NLSQLMVFNLSGNAFSGRIPAS-LGNLLKLTTLDLSKQNFSGELPIEL--------AGLP 510 (1099)
Q Consensus 442 ~L~Ls~N~l~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~l--------~~l~ 510 (1099)
..+. .+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++ .+|..+ .+++
T Consensus 665 --------------~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~ 728 (876)
T 4ecn_A 665 --------------CSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTY 728 (876)
T ss_dssp --------------SCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGG
T ss_pred --------------hhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccC
Confidence 1111 2235556666666655 33332 235566666666666666 334332 2345
Q ss_pred ccceeeeccccccCCCchhhh--cccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEE
Q 047739 511 NLQVIALQENKLSGNVPEGFS--SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLE 588 (1099)
Q Consensus 511 ~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~ 588 (1099)
+|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+ +
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ 788 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------D 788 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------C
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------C
Confidence 9999999999999 7888887 89999999999999986 78888888999999998887 5
Q ss_pred ecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCC
Q 047739 589 LRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 589 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
+++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++....+..+.....+..+.|.+|++.
T Consensus 789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred cccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 678888888999999999999999999999 58888876 69999999999998666777777777888888888876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=438.68 Aligned_cols=270 Identities=22% Similarity=0.329 Sum_probs=215.9
Q ss_pred CHHHHHHHHhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhccC-CcceEEe
Q 047739 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRH-RNLTVLR 864 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H-~niv~l~ 864 (1099)
...+++...++|++.+.||+|+||.||+|.+.. ++.||||.+..... ..+.|.+|++++++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344455567889999999999999999998743 46899999976443 24679999999999965 8999999
Q ss_pred eEEecCCCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCC
Q 047739 865 GYYAGAPDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933 (1099)
Q Consensus 865 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~ 933 (1099)
|+|.......++|||||++|+|.++++.... .....++|..+..++.|||+||+|||+.+||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 9998666667999999999999999986432 12345899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCc
Q 047739 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~ 1012 (1099)
|||+++++.+||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~-~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ceeeCCCCCEEECcchhhhhcccC-CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999865322 22233456789999999999999999999999999999999998 9999987554
Q ss_pred hh-HHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1013 ED-IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1013 ~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+ +...+.. +..... +...+ ..+.+++.+||+.||++||||.||++.|+++.
T Consensus 294 ~~~~~~~i~~----g~~~~~---------p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 294 DEEFCRRLKE----GTRMRA---------PDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp SHHHHHHHHH----TCCCCC---------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHc----CCCCCC---------CccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 33 3333222 211111 11111 12457899999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=433.58 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=201.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|++.+.||+|+||+||+|++. +|+.||||++..... ..+.+.+|++++++++|||||++++++.+ ++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 58999999999999999999975 589999999865433 24678999999999999999999999985 45579999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|||++|+|.+++... ....+++.....++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp ECCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred eCCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 999999999999753 234578899999999999999999999999999999999999999999999999986521
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||......++...+... .... ....+
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~~~-~~~~~-- 249 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPP-VSLHY-- 249 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCCC-CCTTS--
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----CCCC-CCccC--
Confidence 112334578999999999999999999999999999999999999999887766655544432 2111 01111
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|||++|+++
T Consensus 250 ------s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 ------S----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------C----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12457899999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=464.80 Aligned_cols=453 Identities=21% Similarity=0.243 Sum_probs=358.2
Q ss_pred ceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCc
Q 047739 163 KYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKL 242 (1099)
Q Consensus 163 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 242 (1099)
++||+++|+++ .+|..+. ++|++|+|++|+++ +..|..++.+++|++|+|++|++++..|.+|+.+++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~--------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 71 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS--------ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCC--------CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTC
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCccc--------ccChhhccccccccEEecCCCccCCcChHHhhcccCC
Confidence 34555566555 4555444 66666666666665 2223455566777777777777777777778888888
Q ss_pred cEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCcccc-CcchhccCCCCcc
Q 047739 243 QVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG-AFPLWLTRASTLT 321 (1099)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 321 (1099)
++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|..|..+++|+
T Consensus 72 ~~L~Ls~N~l~-~lp~~--------------------------------~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 118 (520)
T 2z7x_B 72 EYLDLSHNKLV-KISCH--------------------------------PTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118 (520)
T ss_dssp CEEECCSSCCC-EEECC--------------------------------CCCCCSEEECCSSCCSSCCCCGGGGGCTTCC
T ss_pred CEEecCCCcee-ecCcc--------------------------------ccCCccEEeccCCccccccchhhhccCCcce
Confidence 88888888776 34431 24668888888888877 4678899999999
Q ss_pred EEeCCCCccccCchhhhCCCCCC--CEEEccCCcc--CccCCccccCCC-CCCEEEccCCcCCCCCCc-cccCCCCCCee
Q 047739 322 RLDVSGNSISGKIPAQIGGLWRL--EELKMANNSF--GGAVPVEIKQCS-SLSLLDLEGNRFSGEIPE-FLGDIRGLKSL 395 (1099)
Q Consensus 322 ~L~Ls~N~i~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L 395 (1099)
+|+|++|.|++ ..|..+++| ++|++++|.+ .+..|..+..+. +...+++++|++.+.++. .+.++++|+.|
T Consensus 119 ~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L 195 (520)
T 2z7x_B 119 FLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195 (520)
T ss_dssp EEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEEC
T ss_pred EEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeec
Confidence 99999999875 457777777 9999999999 777888877765 345678899988876654 67789999999
Q ss_pred eccCcc-------ccccCCccCCCCCCCCEEEcccCcCccccchhhh---CCCCCCEEEccCCcCccccCccc-----CC
Q 047739 396 TLAANL-------FSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL---GMNNLSTLDLSENKFSGEVPASI-----GN 460 (1099)
Q Consensus 396 ~L~~n~-------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~l-----~~ 460 (1099)
++++|. +.+.++ .+.++++|+.|++++|.+++..+..+. ..++|++|++++|++++.+|..+ ++
T Consensus 196 ~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~ 274 (520)
T 2z7x_B 196 NIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274 (520)
T ss_dssp CEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCC
T ss_pred cccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhccccc
Confidence 999997 666666 788999999999999998865443332 25689999999999998899888 89
Q ss_pred CCcccEEEccCCcCCCcCC-CCCCCC---CCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccccc
Q 047739 461 LSQLMVFNLSGNAFSGRIP-ASLGNL---LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536 (1099)
Q Consensus 461 l~~L~~L~L~~N~l~~~~~-~~l~~l---~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 536 (1099)
+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|+.|++++|++++..|..+..+++|
T Consensus 275 l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 350 (520)
T 2z7x_B 275 LKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350 (520)
T ss_dssp CCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC
T ss_pred CceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCC
Confidence 99999999999998 344 344443 67999999999887432 12688899999999999998888999999999
Q ss_pred ceecccccccCC--CCCCcccccceeeEEEccCCcCCCCCCC-CCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 537 RYLNLSFNGFVG--QIPATFSFLRSVVVLSFSGNHISGSIPP-ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 537 ~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
++|++++|++++ .+|..+..+++|+.|++++|++++.+|. .+..+++|++|++++|++++.+|..+. ++|+.|+|
T Consensus 351 ~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~L 428 (520)
T 2z7x_B 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428 (520)
T ss_dssp CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEEC
T ss_pred CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEEC
Confidence 999999999986 5567788999999999999999975665 478889999999999999877776664 68999999
Q ss_pred cCccccccCCcccCCCCCCCEEECcCccccccCChh-hhccCCCCeeecCCCcCCCcCC
Q 047739 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDS-LAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|++++..+
T Consensus 429 s~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 429 HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 999998 78888889999999999999998 56655 8889999999999999987544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=459.93 Aligned_cols=454 Identities=17% Similarity=0.205 Sum_probs=294.6
Q ss_pred eEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccc
Q 047739 69 TELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAAN 148 (1099)
Q Consensus 69 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N 148 (1099)
+.|++++++++ .||+.+. ++|++|+|++|.+.+..|..+.++++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46888888888 5887776 89999999999999877788999999999999999999888889999999999999999
Q ss_pred cCCCcccCCcccccceeeCCCCccCC-CCCCCCccccccccccccccccccccccccccccCccccccCce--eEEEccC
Q 047739 149 RLSGEIANDLPRNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL--VHLSAQG 225 (1099)
Q Consensus 149 ~l~~~i~~~~~~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L--~~L~l~~ 225 (1099)
+++ .+|..-.++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..++.+++| ++|++++
T Consensus 80 ~l~-~lp~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-----------~~~~~l~~L~L~~L~l~~ 147 (520)
T 2z7x_B 80 KLV-KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-----------SSVLPIAHLNISKVLLVL 147 (520)
T ss_dssp CCC-EEECCCCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-----------GGGGGGTTSCEEEEEEEE
T ss_pred cee-ecCccccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch-----------hhccccccceeeEEEeec
Confidence 998 5666644788888888888886 577888888888888888888873 134455566 8888888
Q ss_pred CcC--CccChhhhcCCC-CccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcC
Q 047739 226 NAL--GGVIPPAIGALP-KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQ 302 (1099)
Q Consensus 226 N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~ 302 (1099)
|.+ .+..|..|..+. +...+++++|++.+.++...|. .++.|+.|+++
T Consensus 148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~-----------------------------~l~~L~~L~l~ 198 (520)
T 2z7x_B 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK-----------------------------TVANLELSNIK 198 (520)
T ss_dssp CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCT-----------------------------TCSEEEECCEE
T ss_pred ccccccccccccccccccceEEEEeccCcchhhhhhhhhh-----------------------------cccceeecccc
Confidence 888 777777776665 3445667777776655543332 24567777777
Q ss_pred CCc-------cccCcchhccCCCCccEEeCCCCccccCchhhhC---CCCCCCEEEccCCccCccCCccc-----cCCCC
Q 047739 303 QNQ-------IRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIG---GLWRLEELKMANNSFGGAVPVEI-----KQCSS 367 (1099)
Q Consensus 303 ~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~---~l~~L~~L~L~~n~l~~~~~~~l-----~~l~~ 367 (1099)
+|+ +.+.+| .+..+++|++|++++|.+++..+..+. ..++|++|++++|++++.+|..+ ..+++
T Consensus 199 ~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~ 277 (520)
T 2z7x_B 199 CVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277 (520)
T ss_dssp ECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCE
T ss_pred ccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCce
Confidence 766 555444 566677777777777766643322221 13466777777777666666666 66666
Q ss_pred CCEEEccCCcCCCCCC-ccccCC---CCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEE
Q 047739 368 LSLLDLEGNRFSGEIP-EFLGDI---RGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTL 443 (1099)
Q Consensus 368 L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 443 (1099)
|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++.+|..+..+++|++|
T Consensus 278 L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 353 (520)
T 2z7x_B 278 LSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353 (520)
T ss_dssp EEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEE
T ss_pred eEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEE
Confidence 66666666666 333 333332 34555555555554221 11344555555555555554445555555555555
Q ss_pred EccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCc-ccCCCCccceeeeccccc
Q 047739 444 DLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPI-ELAGLPNLQVIALQENKL 522 (1099)
Q Consensus 444 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~N~l 522 (1099)
+|++|++++.. .+|..+.++++|++|++++|++++.+|. .+..+++|+.|++++|++
T Consensus 354 ~L~~N~l~~l~----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l 411 (520)
T 2z7x_B 354 ILQMNQLKELS----------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411 (520)
T ss_dssp ECCSSCCCBHH----------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCC
T ss_pred EccCCccCccc----------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCC
Confidence 55555554310 2233344444455555555554442332 244455555555555555
Q ss_pred cCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCC-CCCCCCCceEEecCCcccCc
Q 047739 523 SGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGH 597 (1099)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~ 597 (1099)
++..|..+. ++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|.. +..+++|++|++++|.+++.
T Consensus 412 ~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 412 TDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred Ccchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 544444332 46666666666666 55555556677777777777776 34443 77788888888888888753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=428.61 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=206.6
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.|+..++||+|+||+||+|.++ +|+.||||++... ....+.+.+|++++++++|||||++++++.++ +..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeC
Confidence 56999999999999999999986 5899999998532 23346789999999999999999999999854 557999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
|++|+|.+++.+ ..+++.....++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+.... .
T Consensus 153 ~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~---~ 223 (346)
T 4fih_A 153 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---E 223 (346)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS---S
T ss_pred CCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC---C
Confidence 999999999975 2389999999999999999999999999999999999999999999999999986522 2
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+..... +.+....
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~~~~ 294 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PRLKNLH 294 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---------CCCSCGG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------CCCCccc
Confidence 2344567999999999999999999999999999999999999999987766655554443211 0110000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.-+ ..+.+++.+||+.||++|||++|+++.
T Consensus 295 ~~s------~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVS------PSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 124578999999999999999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=427.65 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=204.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.+.|+..++||+|+||.||+|+++ +|+.||||++..... ..+|++++++++|||||++++++.+ +...|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEec
Confidence 356888899999999999999986 589999999965332 3579999999999999999999985 4556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~ 959 (1099)
|++|+|.+++++. ..+++.....++.||+.||+|||+.+||||||||+|||++.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999864 2489999999999999999999999999999999999999987 699999999987633221
Q ss_pred CC--ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 960 EA--STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 960 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......++...+..... .. ..+.+.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~-~~~~~~~- 282 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP--PI-REIPPSC- 282 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC--GG-GGSCTTS-
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC--Cc-hhcCccC-
Confidence 11 123446899999999999999999999999999999999999999987666555554443210 00 0111111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. ..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 283 -------s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 283 -------A----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -------C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------C----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 1245789999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=428.36 Aligned_cols=269 Identities=21% Similarity=0.250 Sum_probs=201.3
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC---ceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---LRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~lV~e 879 (1099)
++|.+.++||+|+||+||+|+++ |+.||||++.........+++|+..+.+++|||||+++|++.+... ..|+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 56888999999999999999985 8899999996544333444566777788999999999999985432 4689999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--------CceecCCCCCCEEECCCCcEEEeccccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--------NMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
||++|+|.++++. ..++|..+.+++.|+|+||+|||+. +||||||||+|||+|.++.+||+|||+|
T Consensus 82 y~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999975 2489999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCCC-CccccccccCccccCccccccC------CCCCcCchhhHHHHHHHHHhCCCCCCCCCch-----------
Q 047739 952 RLTIPTPAE-ASTSTTAVGTLGYVSPEAALTG------ETTKESDVYSFGIVLLELLTGKRPVMFTQDE----------- 1013 (1099)
Q Consensus 952 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~G~il~elltg~~P~~~~~~~----------- 1013 (1099)
+........ .......+||+.|||||++.+. .++.++|||||||++|||+||+.||....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 865322211 1223456899999999998754 3678999999999999999998776432211
Q ss_pred hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1014 DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
.....+.+.+..... ++.+. ......+....+.+++.+||+.||++||||.||++.|+++....+
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred chHHHHHHHHhcccC----CCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 011222222222211 11111 111112233445789999999999999999999999998866543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=462.10 Aligned_cols=560 Identities=21% Similarity=0.218 Sum_probs=318.1
Q ss_pred CCCCCCCCCCCCCCCCCCCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCccc
Q 047739 38 HDPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLR 117 (1099)
Q Consensus 38 ~~~~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~ 117 (1099)
.|+...+++|+.+. |..|+.-.|....+ +.+=++.+|+ .||+.+- +.+++||||+|++++..|..|.++++|+
T Consensus 7 ~~~~~~~~~~~~~~---p~~~~~c~~~~~~~-~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~ 79 (635)
T 4g8a_A 7 KDDDDKLAAANSSI---PESWEPCVEVVPNI-TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQ 79 (635)
T ss_dssp ---------------------CCSEEEETTT-EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCcchhhcccCCC---CCCCCCccccCCCC-EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence 45666778887533 44454433321110 1122233333 3554432 4789999999999976677899999999
Q ss_pred EEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCccccccccccccccc
Q 047739 118 AVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNK 195 (1099)
Q Consensus 118 ~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 195 (1099)
+|||++|+|++..|..|+++++|++|+|++|++++..+..+. ++|++|+|++|+|++..+..|+++++|++|+|++|+
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 999999999987777899999999998888888754433333 455556666665555444555555555555555555
Q ss_pred cccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEE
Q 047739 196 FSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275 (1099)
Q Consensus 196 l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~ 275 (1099)
++. ..+|..++.+++|++|++++|++++..+..|..+.+++
T Consensus 160 l~~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~-------------------------------- 200 (635)
T 4g8a_A 160 IQS-------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP-------------------------------- 200 (635)
T ss_dssp CCC-------CCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT--------------------------------
T ss_pred ccc-------CCCchhhccchhhhhhcccCccccccccccccchhhhh--------------------------------
Confidence 542 12344444555555555555555554444443332221
Q ss_pred eccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCcccc-CchhhhCCCCCCCEEEccCCcc
Q 047739 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG-KIPAQIGGLWRLEELKMANNSF 354 (1099)
Q Consensus 276 l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~~n~l 354 (1099)
.....++++.|.++.+.+..+. ...+..+++++|.... ..+..+.++..++...+..+..
T Consensus 201 ------------------~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~ 261 (635)
T 4g8a_A 201 ------------------LLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 261 (635)
T ss_dssp ------------------TCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred ------------------hhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCccccccccccccc
Confidence 1122344444444433333222 2334555665554432 2334455566665555543322
Q ss_pred ------CccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcc
Q 047739 355 ------GGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG 428 (1099)
Q Consensus 355 ------~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 428 (1099)
.......+..+..+..+++..+...... ......+..+.+++.+++.+|.+..
T Consensus 262 ~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~---------------------~~~~~~~~~~~~l~~l~~~~~~~~~ 320 (635)
T 4g8a_A 262 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL---------------------DGIIDLFNCLTNVSSFSLVSVTIER 320 (635)
T ss_dssp TTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCE---------------------EECTTTTGGGTTCSEEEEESCEEEE
T ss_pred ccccccccccccccccccchhhhhhhhhhhcccc---------------------cchhhhhhhhccccccccccccccc
Confidence 2122333344444444444444332111 1112223334455555555555542
Q ss_pred ccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc--ccCCccc
Q 047739 429 SLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS--GELPIEL 506 (1099)
Q Consensus 429 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~l 506 (1099)
. ..+.....|+.|++.+|.+....+. .+..|+.+++.+|.+... ....++++|+.|++++|.+. +..+..+
T Consensus 321 ~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 321 V--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp C--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred c--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccch
Confidence 2 2234445566666666655533222 234555666666655422 23345666666666666664 2334455
Q ss_pred CCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCC-CcccccceeeEEEccCCcCCCCCCCCCCCCCCCc
Q 047739 507 AGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP-ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585 (1099)
Q Consensus 507 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~ 585 (1099)
..+.+|+.+++..|.+. ..+..+..+++|+.++++.|......+ ..+..+++++.+++++|++.+..+..+..+++|+
T Consensus 394 ~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~ 472 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 472 (635)
T ss_dssp HSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred hhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence 56666777777766665 334456666777777777666554433 4566677777777777777777777777777777
Q ss_pred eEEecCCcc-cCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCC
Q 047739 586 VLELRSNSL-TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664 (1099)
Q Consensus 586 ~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 664 (1099)
.|+|++|++ .+..|..+..+++|+.|||++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|||++|
T Consensus 473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 552 (635)
T 4g8a_A 473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 552 (635)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence 777777764 3346667777777777777777777767777777777777777777777766777777777777777777
Q ss_pred cCCCcCCCCcccc-ccccccccCCCCcc
Q 047739 665 NLSGEIPANLSSI-FGLMNFNVSSNNLQ 691 (1099)
Q Consensus 665 ~l~~~~p~~~~~~-~~l~~l~l~~n~~~ 691 (1099)
+|++..|..+..+ .+|+.+++++|++.
T Consensus 553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 553 HIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred cCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 7777777777666 46777777666554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=423.60 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=207.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.++||+|+||+||+|+.. +|+.||+|.+... ....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 57999999999999999999975 5899999998532 2234679999999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++.....++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999864 24899999999999999999999999999999999999999999999999999876322
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..++...+... .+. ++..+
T Consensus 186 -~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----~~~--~p~~~- 257 (311)
T 4aw0_A 186 -SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----EYD--FPEKF- 257 (311)
T ss_dssp -TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCC--CCTTC-
T ss_pred -CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCC--CCccc-
Confidence 2233455679999999999999999999999999999999999999999877766665555432 110 11111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1074 (1099)
. ..+.+++.+|++.||++|||++|+.
T Consensus 258 -------s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 -------F----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------C----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------C----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 1245799999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=417.43 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=195.7
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecC---CCceEEE
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA---PDLRLLV 877 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---~~~~~lV 877 (1099)
|...++||+|+||+||+|.+. ++..||+|.+.... ...+.|.+|++++++++|||||++++++.+. +...|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999986 48899999985432 2346799999999999999999999998642 3446899
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECC-CCcEEEecccccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDA-DFEAHLSDFGLDRLT 954 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~ 954 (1099)
||||++|+|.+++++. ..+++.....++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999864 34899999999999999999999998 999999999999984 799999999999854
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||........ +...+..+..+..++.
T Consensus 183 ~-----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 183 R-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDK 253 (290)
T ss_dssp C-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGG
T ss_pred C-----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---HHHHHHcCCCCCCCCc
Confidence 2 223456789999999998865 699999999999999999999999975443322 1122222211111111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. . ..+.+++.+||+.||++|||++|+++
T Consensus 254 ~~--------~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 VA--------I----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC--------C----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC--------C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 0 12457899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=429.81 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=207.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.|+..+.||+|+||.||+|.++ +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+. +..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeC
Confidence 56999999999999999999986 58999999985433 3456799999999999999999999999854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
|++|+|.++++. ..+++.....++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+.... .
T Consensus 230 ~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~---~ 300 (423)
T 4fie_A 230 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---E 300 (423)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS---S
T ss_pred CCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC---C
Confidence 999999999974 2389999999999999999999999999999999999999999999999999986522 2
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+..... +.+....
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~~~~ 371 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PRLKNLH 371 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------CCCSCTT
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------CCCcccc
Confidence 2344567999999999999999999999999999999999999999987766665554443211 1111000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.-+ ..+.+++.+||+.||++|||+.|+++
T Consensus 372 ~~s------~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVS------PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSC------HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC------HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011 12457899999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=407.70 Aligned_cols=244 Identities=19% Similarity=0.290 Sum_probs=190.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+|++.+.||+|+||+||+|... +|+.||+|.+.... ...+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence 57999999999999999999975 58999999985432 224679999999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+ +|+|.+++.+. ..+++.....++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 9999 68999999753 3489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+||+.|||||++.+..+ +.++||||+||++|||++|+.||......++.+.+... ... ++..+
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~----~~~--~p~~~ 235 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG----VYT--LPKFL 235 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCC--CCTTS
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC----CCC--CCCCC
Confidence 223445789999999999998876 57999999999999999999999876665555544332 110 11111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+ ..+.+++.+||+.||++|||++|+++
T Consensus 236 --------s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 --------S----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------C----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------C----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 12357899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=414.47 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred hccccccccccccceeEEEEEEC----CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
++|++.+.||+|+||+||+|+.. .++.||+|.+..... +...+.+|++++++++|||||++++++.+ ++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence 57999999999999999999863 468999999864322 23568899999999999999999999985 45579
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|||||++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 103 ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999864 248999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..++...+.+. ... +.+.
T Consensus 178 ~---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~~--~p~~ 248 (304)
T 3ubd_A 178 D---HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----KLG--MPQF 248 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCTT
T ss_pred C---CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----CCC--CCCc
Confidence 2 223345678999999999999999999999999999999999999999887766665555432 110 0110
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM-----SDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1075 (1099)
.. ..+.+++.+||+.||++|||+ +|+++
T Consensus 249 --------~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 --------LS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --------SC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --------CC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 124579999999999999984 66664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=442.99 Aligned_cols=523 Identities=21% Similarity=0.199 Sum_probs=353.3
Q ss_pred cceEecC-----------CcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCC
Q 047739 59 RGVACTN-----------NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLS 127 (1099)
Q Consensus 59 ~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~ 127 (1099)
.-|.|++ ..++.|||++|.+++--+..+.+|++|++|||++|++++..|..|++|++|++|+|++|+|+
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 3577874 35899999999999776778999999999999999999777788999999999999999999
Q ss_pred CccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCC-CCCCCCcccccccccccccccccccccccc
Q 047739 128 GNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPATF 204 (1099)
Q Consensus 128 g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 204 (1099)
+..|..++++++|++|+|++|++++..+..+. ++|++|+|++|++++ .+|..++++++|++|+|++|++++..+.
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-- 191 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT-- 191 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG--
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc--
Confidence 87778899999999999999999987666665 799999999999986 5788899999999999999999955443
Q ss_pred ccccCccccccCc----eeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEecccc
Q 047739 205 EGTLPSAIANCSS----LVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNA 280 (1099)
Q Consensus 205 ~g~lp~~l~~l~~----L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~ 280 (1099)
.+..+.+ +..++++.|.++.+.+..+. ...++.+++..|..+..++...|..+ ..++...+..+.
T Consensus 192 ------~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l----~~l~~~~l~~~~ 260 (635)
T 4g8a_A 192 ------DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGL----AGLEVHRLVLGE 260 (635)
T ss_dssp ------GGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTT----TTCEEEEEEEEC
T ss_pred ------cccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCC----cccccccccccc
Confidence 3333333 35789999999877666554 45678899999887755555444442 223333332222
Q ss_pred ccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCcccc---CchhhhCCCCCCCEEEccCCccCcc
Q 047739 281 FTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG---KIPAQIGGLWRLEELKMANNSFGGA 357 (1099)
Q Consensus 281 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~---~~p~~~~~l~~L~~L~L~~n~l~~~ 357 (1099)
.... ..+.......+.....+..+++..+.... ..+..+..+.+++.+.+.++.+...
T Consensus 261 ~~~~-------------------~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~ 321 (635)
T 4g8a_A 261 FRNE-------------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV 321 (635)
T ss_dssp CTTS-------------------CCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC
T ss_pred cccc-------------------cccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc
Confidence 2111 11112222333444445555544433221 2233445556667777766666532
Q ss_pred CCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcc--ccchhhh
Q 047739 358 VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG--SLPEEVL 435 (1099)
Q Consensus 358 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~ 435 (1099)
..+....+|+.|++++|.+....+. .+..|+.+++..|.+... ..+..+++|+.|++++|.+.. ..+..+.
T Consensus 322 --~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 322 --KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp --GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred --cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchh
Confidence 2344556677777777766533322 244556666666655432 233456667777777766642 2345555
Q ss_pred CCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCcccee
Q 047739 436 GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVI 515 (1099)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 515 (1099)
.+.+|+.|+++.|.+. ..+..+..+++|+.+++.+|......+ +..+..+++++.+
T Consensus 395 ~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~-----------------------~~~~~~l~~l~~l 450 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE-----------------------FSVFLSLRNLIYL 450 (635)
T ss_dssp SCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTS-----------------------SCTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccc-cccccccccccccchhhhhcccccccc-----------------------ccccccccccccc
Confidence 6666666666666655 233445555556666555554443322 1223444444555
Q ss_pred eeccccccCCCchhhhcccccceecccccccC-CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcc
Q 047739 516 ALQENKLSGNVPEGFSSLMSLRYLNLSFNGFV-GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594 (1099)
Q Consensus 516 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 594 (1099)
+++.|.+.+..+..+..+++|++|++++|.+. +..|..|..+++|+.|+|++|++++..|..|+++++|++|+|++|+|
T Consensus 451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l 530 (635)
T 4g8a_A 451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 530 (635)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence 55555555445555555566666666666532 34566667777777777777777777777888888888888888888
Q ss_pred cCcCCcchhccCcccEEeccCccccccCCcccCCC-CCCCEEECcCccccc
Q 047739 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKC-SSLRSLLVNSNHLSG 644 (1099)
Q Consensus 595 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~ 644 (1099)
++..|..+..+++|+.|||++|+|++..|..+..+ ++|+.|+|++|++..
T Consensus 531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 87777778888888888888888888878888877 578888888888863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=404.53 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=189.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCC-------
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD------- 872 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------- 872 (1099)
.+|++.+.||+|+||+||+|+++ +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999985 58999999985433 234678999999999999999999999864332
Q ss_pred ----ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 873 ----LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 873 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
..|+||||+++|+|.++++.... ....++...+.++.||++||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 35899999999999999985322 223566778899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC---------CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 047739 949 GLDRLTIPTPAE---------ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 949 Gla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~ 1019 (1099)
|+|+........ ....+..+||+.|||||++.+..|+.++||||+||++|||++ ||... .+....+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 999875322111 112345689999999999999999999999999999999996 77532 1212211
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
. .......+... ........+++.+||+.||++|||+.|+++ .++++
T Consensus 238 ~-~~~~~~~p~~~-------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 T-DVRNLKFPPLF-------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp H-HHHTTCCCHHH-------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred H-HHhcCCCCCCC-------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 1 11222111110 011122357899999999999999999987 44433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=441.71 Aligned_cols=414 Identities=19% Similarity=0.206 Sum_probs=287.2
Q ss_pred cccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCC
Q 047739 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSC 292 (1099)
Q Consensus 213 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~ 292 (1099)
+.+++|++|+|++|++++..|.+|+.+++|++|+|++|+++ .+|.. .
T Consensus 73 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--------------------------------~ 119 (562)
T 3a79_B 73 SFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--------------------------------P 119 (562)
T ss_dssp TTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--------------------------------C
T ss_pred ccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--------------------------------c
Confidence 33444444444444444444555555566666666666554 23321 1
Q ss_pred CCceeEEEcCCCccccC-cchhccCCCCccEEeCCCCccccCchhhhCCCCCC--CEEEccCCcc--CccCCccccCCC-
Q 047739 293 SSVLQVLDLQQNQIRGA-FPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRL--EELKMANNSF--GGAVPVEIKQCS- 366 (1099)
Q Consensus 293 ~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~l~~l~- 366 (1099)
+++|++|+|++|++++. +|..|.++++|++|+|++|++++. .+.++++| ++|++++|.+ ++..|..+..+.
T Consensus 120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~ 196 (562)
T 3a79_B 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196 (562)
T ss_dssp CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCE
T ss_pred cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCc
Confidence 34456666666666552 356677777777777777777643 34444444 7777777777 666777766654
Q ss_pred -CCCEEEccCCcCCCCCCc-cccCCCCCCeeeccCcccc----ccCCccCCCCCCCCEEEcccCcCccccchh---hhCC
Q 047739 367 -SLSLLDLEGNRFSGEIPE-FLGDIRGLKSLTLAANLFS----GSIPASFRNLPGLENLNLRHNSLSGSLPEE---VLGM 437 (1099)
Q Consensus 367 -~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~l 437 (1099)
.+ .+++++|.+.+.++. .+..+++|+.|++++|+.. ......+.++++|+.|+++++.+.+..... ....
T Consensus 197 ~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~ 275 (562)
T 3a79_B 197 TVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275 (562)
T ss_dssp EEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTT
T ss_pred ceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhc
Confidence 33 557778877765554 4566777888888877421 112234667788888888877766432111 1234
Q ss_pred CCCCEEEccCCcCccccCccc-----CCCCcccEEEccCCcCCCcCC-CCCCC---CCCCCEEEeccCcCcccCCcccCC
Q 047739 438 NNLSTLDLSENKFSGEVPASI-----GNLSQLMVFNLSGNAFSGRIP-ASLGN---LLKLTTLDLSKQNFSGELPIELAG 508 (1099)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~l~~---l~~L~~L~L~~n~l~~~~~~~l~~ 508 (1099)
.+|++|++++|.+++.+|..+ .+++.|+.++++.|.+ .+| ..+.. ..+|++|++++|.+.... ....
T Consensus 276 ~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~ 351 (562)
T 3a79_B 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPS 351 (562)
T ss_dssp SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSS
T ss_pred ccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccC
Confidence 588889999888888888777 7777788888877776 233 22222 256888889888876322 1267
Q ss_pred CCccceeeeccccccCCCchhhhcccccceecccccccCCC--CCCcccccceeeEEEccCCcCCCCCCC-CCCCCCCCc
Q 047739 509 LPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQ--IPATFSFLRSVVVLSFSGNHISGSIPP-ELGNCSDLE 585 (1099)
Q Consensus 509 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~ 585 (1099)
+++|+.|++++|++++..|..+..+++|++|++++|++++. +|..+..+++|+.|++++|++++.+|. .+..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 78888888888888887888888888888899988888863 346688888888888888888874554 577888899
Q ss_pred eEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChh-hhccCCCCeeecCCC
Q 047739 586 VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDS-LAKLSNLAVLDLSAN 664 (1099)
Q Consensus 586 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~ls~N 664 (1099)
+|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|
T Consensus 432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC
T ss_pred EEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC
Confidence 999999988877666554 68889999999888 68887888889999999999988 56655 888888999999999
Q ss_pred cCCCcCC
Q 047739 665 NLSGEIP 671 (1099)
Q Consensus 665 ~l~~~~p 671 (1099)
++++..|
T Consensus 508 ~~~c~c~ 514 (562)
T 3a79_B 508 PWDCTCP 514 (562)
T ss_dssp CBCCCHH
T ss_pred CcCCCcc
Confidence 8887555
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=433.24 Aligned_cols=456 Identities=20% Similarity=0.215 Sum_probs=298.0
Q ss_pred EeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeeccc
Q 047739 68 VTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAA 147 (1099)
Q Consensus 68 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~ 147 (1099)
...++++++++++ ||+.+. +.|+.|+|++|.+++..|..++++++|++|+|++|++++..|..++++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 4788999999986 777665 8999999999999988888999999999999999999998899999999999999999
Q ss_pred ccCCCcccCCcccccceeeCCCCccCC-CCCCCCccccccccccccccccccccccccccccCccccccCc--eeEEEcc
Q 047739 148 NRLSGEIANDLPRNLKYFDLSSNGFSG-PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSS--LVHLSAQ 224 (1099)
Q Consensus 148 N~l~~~i~~~~~~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~--L~~L~l~ 224 (1099)
|.++ .+|..-.++|++|+|++|++++ .+|..|+++++|++|++++|+++.. .++.+++ |++|+++
T Consensus 110 N~l~-~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-----------~~~~l~~L~L~~L~L~ 177 (562)
T 3a79_B 110 NRLQ-NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-----------DLLPVAHLHLSCILLD 177 (562)
T ss_dssp SCCC-EECSCCCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-----------TTGGGTTSCEEEEEEE
T ss_pred CcCC-ccCccccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC-----------chhhhhhceeeEEEee
Confidence 9998 5666645788899999998886 4567888888888888888888731 2233344 4888888
Q ss_pred CCcC--CccChhhhcCCC-CccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEc
Q 047739 225 GNAL--GGVIPPAIGALP-KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDL 301 (1099)
Q Consensus 225 ~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L 301 (1099)
+|.+ ++..|..|..+. +.-.++++.|.+.+.++...+.. ++.|+.|++
T Consensus 178 ~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~-----------------------------l~~L~~L~l 228 (562)
T 3a79_B 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA-----------------------------LGHLQLSNI 228 (562)
T ss_dssp ESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESS-----------------------------EEEEEEEEE
T ss_pred cccccccccCcccccccCcceEEEEecCccchhhhhhhcccc-----------------------------cceEEEecc
Confidence 8888 777777777665 22245777777766555433322 345667777
Q ss_pred CCCc-----cccCcchhccCCCCccEEeCCCCccccCc----hhhhCCCCCCCEEEccCCccCccCCccc-----cCCCC
Q 047739 302 QQNQ-----IRGAFPLWLTRASTLTRLDVSGNSISGKI----PAQIGGLWRLEELKMANNSFGGAVPVEI-----KQCSS 367 (1099)
Q Consensus 302 ~~n~-----l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~----p~~~~~l~~L~~L~L~~n~l~~~~~~~l-----~~l~~ 367 (1099)
++|+ +.+ ....+..+++|+.|+|+++.+++.. +..+ ...+|++|++++|.+++.+|..+ .++++
T Consensus 229 ~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~ 306 (562)
T 3a79_B 229 KLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKS 306 (562)
T ss_dssp ECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCE
T ss_pred cccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchh
Confidence 7664 121 1223556666666666666554321 1112 12356666666666665555554 44555
Q ss_pred CCEEEccCCcCCCCCC-ccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEcc
Q 047739 368 LSLLDLEGNRFSGEIP-EFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 368 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
|+.++++.|.+ .+| +.+..+ + ...+|++|++++|.+.... ....+++|++|+++
T Consensus 307 L~~~~~~~~~~--~~p~~~~~~~--------------------~-~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~ 361 (562)
T 3a79_B 307 LMIEHVKNQVF--LFSKEALYSV--------------------F-AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFT 361 (562)
T ss_dssp EEEEEEEECCC--SSCHHHHHHH--------------------H-HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECC
T ss_pred eehhhccccee--ecChhhhhhh--------------------h-ccCcceEEEccCCCccccc--CccCCCCceEEECC
Confidence 55555555544 223 111111 0 0133555555555443211 11344555555555
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCCCc--CCCCCCCCCCCCEEEeccCcCcccCC-cccCCCCccceeeecccccc
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFSGR--IPASLGNLLKLTTLDLSKQNFSGELP-IELAGLPNLQVIALQENKLS 523 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 523 (1099)
+|.+++..|..++++++|+.|+|++|++++. +|..+.++++|++|++++|++++.+| ..+..+++|+.|++++|+++
T Consensus 362 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 441 (562)
T 3a79_B 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441 (562)
T ss_dssp SSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCC
T ss_pred CCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCC
Confidence 5555555555555555555555555555532 23445556666666666666665333 23556666666666666666
Q ss_pred CCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCC-CCCCCCCceEEecCCcccCcC
Q 047739 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE-LGNCSDLEVLELRSNSLTGHI 598 (1099)
Q Consensus 524 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~ 598 (1099)
+..|..+. ++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|.. +..+++|+.|+|++|.+.+..
T Consensus 442 ~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 442 GSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp GGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred cchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 55544433 57778888888777 56665667788888888888888 45554 888899999999999988543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=401.64 Aligned_cols=274 Identities=19% Similarity=0.301 Sum_probs=210.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecC-----CC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 872 (1099)
.++|++.+.||+|+||+||+|.+. +|+.||||++..... ..+.+.+|+++|++++|||||++++++... ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999985 689999999965432 235688999999999999999999987632 34
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+|||||+ |+|.+++... ..+++.....++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 5699999996 6899999742 458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-CCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 953 LTIPTP-AEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 953 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
...... .........+||+.|||||++.+.. ++.++||||+||++|||++|+.||.+.+..+....+...........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 653222 2233455679999999999988754 68999999999999999999999998877777766665443221110
Q ss_pred ccc-------CcccCC-CCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhccc
Q 047739 1031 LLE-------PGLLEL-DPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCR 1081 (1099)
Q Consensus 1031 ~~d-------~~~~~~-~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 1081 (1099)
... .....+ ......++.+ ..+.+++.+||+.||++|||+.|+++ ++.+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 000 000000 0011112211 23568999999999999999999987 344443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=411.29 Aligned_cols=419 Identities=22% Similarity=0.318 Sum_probs=241.5
Q ss_pred cccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCC-------------ceeecccc
Q 047739 82 ISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNL-------------EILNVAAN 148 (1099)
Q Consensus 82 ~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L-------------~~L~ls~N 148 (1099)
|.|.-.+.++|+.|++++|.+ |.+|++++++++|++|+|++|+++|.+|..++++.+| ++|++++|
T Consensus 3 ~~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~ 81 (454)
T 1jl5_A 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL 81 (454)
T ss_dssp --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS
T ss_pred ccccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCC
Confidence 445556678899999999988 7899889999999999999999998999988888875 88999999
Q ss_pred cCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcC
Q 047739 149 RLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNAL 228 (1099)
Q Consensus 149 ~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l 228 (1099)
.+++ +|. ++++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++
T Consensus 82 ~l~~-lp~-~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~---------l~~~---~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 82 GLSS-LPE-LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA---------LSDL---PPLLEYLGVSNNQL 143 (454)
T ss_dssp CCSC-CCS-CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC---------CCSC---CTTCCEEECCSSCC
T ss_pred cccc-CCC-CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc---------ccCC---CCCCCEEECcCCCC
Confidence 9886 343 56789999999999987 6754 3789999999998873 2221 15889999999999
Q ss_pred CccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCcccc
Q 047739 229 GGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG 308 (1099)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~ 308 (1099)
++ +| +|+.+++|++|++++|++++ +|.. ..+|++|++++|++++
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---------------------------------~~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---------------------------------PPSLEFIAAGNNQLEE 187 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---------------------------------CTTCCEEECCSSCCSS
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---------------------------------cccccEEECcCCcCCc
Confidence 86 56 58899999999999998874 4431 1357777777777776
Q ss_pred CcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccC
Q 047739 309 AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGD 388 (1099)
Q Consensus 309 ~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 388 (1099)
+| .+..+++|++|++++|++++ +|... .+|++|++++|.++ .+| .+..+++|++|++++|++++ +|..
T Consensus 188 -l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~--- 255 (454)
T 1jl5_A 188 -LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL--- 255 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---
T ss_pred -Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---
Confidence 44 47777777777777777774 34322 46777777777777 455 37777778888888777774 4442
Q ss_pred CCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCC-CcccEE
Q 047739 389 IRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNL-SQLMVF 467 (1099)
Q Consensus 389 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L 467 (1099)
+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++. + .+ ++|+.|
T Consensus 256 ~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L 322 (454)
T 1jl5_A 256 PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSL-C----DLPPSLEEL 322 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEE
T ss_pred ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEE
Confidence 3677777777777775 3332 3677888888888775 2211 25778888888887742 2 23 478888
Q ss_pred EccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccC--CCchhhhcccccceecccccc
Q 047739 468 NLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG--NVPEGFSSLMSLRYLNLSFNG 545 (1099)
Q Consensus 468 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 545 (1099)
++++|++++ +|.. +++|++|++++|+++ .+|. .+++|+.|++++|++++ .+|..+..+ +.|.
T Consensus 323 ~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~ 386 (454)
T 1jl5_A 323 NVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNS 386 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC
T ss_pred ECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcc
Confidence 888888875 4543 467888888888887 4554 46778888888888876 556554432 3455
Q ss_pred cCCCCCCcccccceeeEEEccCCcCCC--CCCCCCCCCCCCceEEecCCcccCcCCcchhcc
Q 047739 546 FVGQIPATFSFLRSVVVLSFSGNHISG--SIPPELGNCSDLEVLELRSNSLTGHIPTDISHL 605 (1099)
Q Consensus 546 l~~~~~~~l~~l~~L~~L~ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 605 (1099)
+.+.+|.. +++|+.|++++|++++ .+|. +++.|.+.+|.+.+.++.+...+
T Consensus 387 ~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~~~~~~ 439 (454)
T 1jl5_A 387 HLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEFAHETT 439 (454)
T ss_dssp --------------------------------------------------------------
T ss_pred cccccccc---cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCccccCHHHh
Confidence 66666653 4678888888888886 5554 45566788888877666555443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=394.60 Aligned_cols=220 Identities=30% Similarity=0.502 Sum_probs=161.1
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCc--ccceEecC----CcEeEEecCCCcccc--ccccccccccccc
Q 047739 22 DRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPCD--WRGVACTN----NRVTELRLPRLQLSG--RISDHLSNLRMLR 93 (1099)
Q Consensus 22 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~--w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 93 (1099)
|.++|++||++||+++.||. .+++|+.++ +||. |.||+|+. ++|+.|+|+++++.| .+|+.++++++|+
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~--~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTT--DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTS--CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCCCC--CCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 56699999999999999887 789998644 4788 99999985 799999999999999 9999999999999
Q ss_pred eEEccC-CccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCC
Q 047739 94 KLSLRS-NSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSN 170 (1099)
Q Consensus 94 ~L~L~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N 170 (1099)
+|+|++ |.+.|.+|..++++++|++|+|++|+++|.+|..++++++|++|+|++|.+++.+|..+. ++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 999999999999999999999999999999999999999999888888887765555443 45555555555
Q ss_pred ccCCCCCCCCcccc-ccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEccc
Q 047739 171 GFSGPIPTSISNLS-QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQ 249 (1099)
Q Consensus 171 ~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 249 (1099)
+++|.+|..+++++ +|++|++++|+++ |.+|..++.++ |++|++++|++++.+|..|..+++|++|+|++
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~--------~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 230 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLT--------GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEE--------EECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeee--------ccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC
Confidence 55555555555554 5555555555544 23333333343 44444444444444444444444444444444
Q ss_pred ccCC
Q 047739 250 NNLS 253 (1099)
Q Consensus 250 N~l~ 253 (1099)
|+++
T Consensus 231 N~l~ 234 (313)
T 1ogq_A 231 NSLA 234 (313)
T ss_dssp SEEC
T ss_pred Ccee
Confidence 4443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=397.87 Aligned_cols=410 Identities=23% Similarity=0.316 Sum_probs=209.8
Q ss_pred cccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCce-------------eEEEccCC
Q 047739 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL-------------VHLSAQGN 226 (1099)
Q Consensus 160 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L-------------~~L~l~~N 226 (1099)
..|++|++++|++ |.+|++++++++|++|++++|+++ |.+|..++.+++| ++|++++|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~--------~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~ 81 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWE--------RNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL 81 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHH--------HTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCccc--------ccCCcccccchhcchhhhhhhhccCCCEEEecCC
Confidence 3455566666666 566666777777777777777666 5566666666655 66666666
Q ss_pred cCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCcc
Q 047739 227 ALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQI 306 (1099)
Q Consensus 227 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l 306 (1099)
.+++. |.. .++|++|++++|++++ +|. ..++|++|++++|++
T Consensus 82 ~l~~l-p~~---~~~L~~L~l~~n~l~~-lp~---------------------------------~~~~L~~L~l~~n~l 123 (454)
T 1jl5_A 82 GLSSL-PEL---PPHLESLVASCNSLTE-LPE---------------------------------LPQSLKSLLVDNNNL 123 (454)
T ss_dssp CCSCC-CSC---CTTCSEEECCSSCCSS-CCC---------------------------------CCTTCCEEECCSSCC
T ss_pred ccccC-CCC---cCCCCEEEccCCcCCc-ccc---------------------------------ccCCCcEEECCCCcc
Confidence 66643 221 2566666666666654 332 124466666666666
Q ss_pred ccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccc
Q 047739 307 RGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFL 386 (1099)
Q Consensus 307 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 386 (1099)
++. |.. .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+
T Consensus 124 ~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~ 191 (454)
T 1jl5_A 124 KAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-EL 191 (454)
T ss_dssp SCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CC
T ss_pred Ccc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cc
Confidence 542 211 1466666666666664 45 46666666666666666664 33322 366667777776664 44 46
Q ss_pred cCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccE
Q 047739 387 GDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV 466 (1099)
Q Consensus 387 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 466 (1099)
+++++|++|++++|++++ +|... ++|++|++++|+++ .+| .+..+++|++|++++|++++ +|.. +++|+.
T Consensus 192 ~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~ 261 (454)
T 1jl5_A 192 QNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEA 261 (454)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCE
T ss_pred cCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCE
Confidence 666667777777766664 23222 46777777777776 455 36677777777777777764 3332 356777
Q ss_pred EEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc-cccceecccccc
Q 047739 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL-MSLRYLNLSFNG 545 (1099)
Q Consensus 467 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~ 545 (1099)
|++++|++++ +|.. .++|++|++++|++++. |. ..++|+.|++++|++++ ++ .+ ++|++|++++|+
T Consensus 262 L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~ 328 (454)
T 1jl5_A 262 LNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNK 328 (454)
T ss_dssp EECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSC
T ss_pred EECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cC---cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCc
Confidence 7777777774 4433 25677777777777752 11 12567777777777764 22 22 478888888888
Q ss_pred cCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccC--cCCcchhccCcccEEeccCccccccCC
Q 047739 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG--HIPTDISHLSHLNVLDLSINNLTGEIP 623 (1099)
Q Consensus 546 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p 623 (1099)
+++ +|.. +++|+.|++++|+++ .+|. .+++|++|++++|++++ .+|.++..+ +.|.+.|.+|
T Consensus 329 l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~ 392 (454)
T 1jl5_A 329 LIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVP 392 (454)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC------
T ss_pred ccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccc
Confidence 875 4443 467888888888888 4665 36788888888888887 566655432 3466777777
Q ss_pred cccCCCCCCCEEECcCccccc--cCChhhhccCCCCeeecCCCcCCCcCCCCccc
Q 047739 624 DEISKCSSLRSLLVNSNHLSG--GIPDSLAKLSNLAVLDLSANNLSGEIPANLSS 676 (1099)
Q Consensus 624 ~~l~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~ 676 (1099)
.. +++|+.|++++|++++ .+|.+ ++.|.+.+|.+.+.+|.....
T Consensus 393 ~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 393 EL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -------------------------------------------------------
T ss_pred cc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCccccCHHH
Confidence 63 4789999999999986 66654 556678889988887766544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=388.98 Aligned_cols=202 Identities=23% Similarity=0.353 Sum_probs=170.0
Q ss_pred HHhccccccccccccceeEEEEEEC----CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|++.++||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++++++ +|||||++++++.+ .+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEEE
Confidence 4578999999999999999999863 47899999986543 456688999999998 69999999999985 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEecccccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLT 954 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~ 954 (1099)
+||||+++|+|.++++. +++.....++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999852 7899999999999999999999999999999999999876 79999999999754
Q ss_pred CCCCCC-------------------------CccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCC
Q 047739 955 IPTPAE-------------------------ASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVM 1008 (1099)
Q Consensus 955 ~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~ 1008 (1099)
.+.... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 322110 1123456899999999999875 48999999999999999999999996
Q ss_pred CCCc
Q 047739 1009 FTQD 1012 (1099)
Q Consensus 1009 ~~~~ 1012 (1099)
...+
T Consensus 249 ~~~~ 252 (361)
T 4f9c_A 249 KASD 252 (361)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 5443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=399.48 Aligned_cols=373 Identities=22% Similarity=0.218 Sum_probs=229.7
Q ss_pred EEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCc-hhhhCCCCCCCEEEccC
Q 047739 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKI-PAQIGGLWRLEELKMAN 351 (1099)
Q Consensus 273 ~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~L~~ 351 (1099)
.++..++.++.++. ..++|++|+|++|++++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus 14 ~~~c~~~~l~~lp~-----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 14 NAICINRGLHQVPE-----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp EEECCSSCCSSCCC-----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred ccCcCCCCcccCCC-----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 34444555555443 1244555555555555544555555555555555555554322 33445555555555555
Q ss_pred CccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccc
Q 047739 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431 (1099)
Q Consensus 352 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 431 (1099)
|++++..|..|.++++|++|+|++|++++..+.. ..|.++++|++|+|++|++++..|
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------~~~~~l~~L~~L~L~~n~l~~~~~ 146 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------NFFKPLTSLEMLVLRDNNIKKIQP 146 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS----------------------STTTTCTTCCEEECCSSBCCSCCC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCc----------------------ccccCcccCCEEECCCCccCccCc
Confidence 5555444445555555555555555554333222 114444555555555555544434
Q ss_pred hh-hhCCCCCCEEEccCCcCccccCcccCCC--CcccEEEccCCcCCCcCCCC--------CCCCCCCCEEEeccCcCcc
Q 047739 432 EE-VLGMNNLSTLDLSENKFSGEVPASIGNL--SQLMVFNLSGNAFSGRIPAS--------LGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 432 ~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~--------l~~l~~L~~L~L~~n~l~~ 500 (1099)
.. +.++++|++|++++|.+++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|++++|++++
T Consensus 147 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 226 (455)
T 3v47_A 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226 (455)
T ss_dssp CGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH
T ss_pred ccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc
Confidence 33 4445555555555555544444444433 34555555555554333222 1234455555555555555
Q ss_pred cCCcccCCC---CccceeeeccccccC----------CCchhhhcc--cccceecccccccCCCCCCcccccceeeEEEc
Q 047739 501 ELPIELAGL---PNLQVIALQENKLSG----------NVPEGFSSL--MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSF 565 (1099)
Q Consensus 501 ~~~~~l~~l---~~L~~L~L~~N~l~~----------~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 565 (1099)
..|..+... ++|+.|++++|.+.+ ..+..+..+ ++|++|++++|.+++..|..++.+++|+.|++
T Consensus 227 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 306 (455)
T 3v47_A 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306 (455)
T ss_dssp HHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEEC
Confidence 444444332 455555555553332 222233332 57888999999888888888888888999999
Q ss_pred cCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCcccccc
Q 047739 566 SGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645 (1099)
Q Consensus 566 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 645 (1099)
++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++++.
T Consensus 307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 99988887788888888999999999998877778888888999999999999877788888889999999999998876
Q ss_pred CChhhhccCCCCeeecCCCcCCCcCCC
Q 047739 646 IPDSLAKLSNLAVLDLSANNLSGEIPA 672 (1099)
Q Consensus 646 ~p~~l~~l~~L~~L~ls~N~l~~~~p~ 672 (1099)
.+..+..+++|+.|++++|++++..|.
T Consensus 387 ~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 387 PDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CHhHhccCCcccEEEccCCCcccCCCc
Confidence 666778888999999999999887774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=397.33 Aligned_cols=383 Identities=19% Similarity=0.189 Sum_probs=257.8
Q ss_pred cccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCC
Q 047739 188 LINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267 (1099)
Q Consensus 188 ~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 267 (1099)
.++.+++.++ .+|. + .++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.++...|.+
T Consensus 14 ~~~c~~~~l~---------~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~---- 77 (455)
T 3v47_A 14 NAICINRGLH---------QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG---- 77 (455)
T ss_dssp EEECCSSCCS---------SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTT----
T ss_pred ccCcCCCCcc---------cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccc----
Confidence 4556666665 4444 2 2577778888888877777788888888888888888776655443332
Q ss_pred CCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhh--hCCCCCCC
Q 047739 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ--IGGLWRLE 345 (1099)
Q Consensus 268 ~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~--~~~l~~L~ 345 (1099)
+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+.. |+++++|+
T Consensus 78 -------------------------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 78 -------------------------LSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp -------------------------CTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred -------------------------cccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 456777777777777777777888888888888888887655554 77888888
Q ss_pred EEEccCCccCccCCcc-ccCCCCCCEEEccCCcCCCCCCccccCC--CCCCeeeccCccccccCCcc--------CCCCC
Q 047739 346 ELKMANNSFGGAVPVE-IKQCSSLSLLDLEGNRFSGEIPEFLGDI--RGLKSLTLAANLFSGSIPAS--------FRNLP 414 (1099)
Q Consensus 346 ~L~L~~n~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~--------~~~l~ 414 (1099)
+|+|++|.+++..|.. +.++++|++|+|++|++++..|..+..+ .+|+.|++++|.+.+..+.. +..++
T Consensus 133 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 8888888887776665 7778888888888888877777766655 56777777777776554433 23456
Q ss_pred CCCEEEcccCcCccccchhhhCC---CCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEE
Q 047739 415 GLENLNLRHNSLSGSLPEEVLGM---NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTL 491 (1099)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 491 (1099)
+|++|++++|++++..|..+... .+|+.|++++|.+.+.. +..+.+.+..+..+..+
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~------ 272 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGL------ 272 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGG------
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccc------
Confidence 66677777776666666655443 55666666665544221 01111221111111111
Q ss_pred EeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCC
Q 047739 492 DLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571 (1099)
Q Consensus 492 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~ 571 (1099)
..++|+.|++++|++++..|..|..+++|++|++++|++++..|..|..+++|+.|++++|+++
T Consensus 273 ----------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 336 (455)
T 3v47_A 273 ----------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336 (455)
T ss_dssp ----------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ----------------cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccC
Confidence 1245555555555555555555666666666666666666666666666666777777777776
Q ss_pred CCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCC
Q 047739 572 GSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIP 647 (1099)
Q Consensus 572 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 647 (1099)
+..|..++++++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 337 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 337 SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 6666677777888888888888887777788888888888888888886555566788888888888888887766
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=403.30 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=207.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|..+ +|+.||+|.+.... .+.+.+.+|+++|++++|||||++++++.+ +...|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence 368999999999999999999986 58999999986543 345678999999999999999999999985 456799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC--CcEEEeccccccccCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD--FEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~--~~~kl~DfGla~~~~~~ 957 (1099)
||++|+|.+++... ...+++.....++.||+.||+|||+.+|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 235 ~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 235 FMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp CCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred ecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999999999642 2358999999999999999999999999999999999999854 8999999999987632
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+.... ........+.+
T Consensus 310 ---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~- 383 (573)
T 3uto_A 310 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--WNMDDSAFSGI- 383 (573)
T ss_dssp ---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCSGGGTTS-
T ss_pred ---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC--CCCCcccccCC-
Confidence 233455689999999999999999999999999999999999999998877766555443321 11111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 384 -----s------~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 -----S------EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -----C------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 124578999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=399.25 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=195.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHH---HHHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRK---EAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
++|++.++||+|+||.||+|+.+ +|+.||+|++.... .....+.+ ++++++.++|||||++++++.+ ++..
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEE
Confidence 57999999999999999999986 58999999985321 12233334 4666777899999999999985 4567
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+|||||+||+|.+++.+. ..+++.....++.||+.||+|||+.|||||||||+|||++.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999864 34899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.. ......+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+..... ......... +.
T Consensus 343 ~~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-~~i~~~~~~--~p 414 (689)
T 3v5w_A 343 SK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVE--LP 414 (689)
T ss_dssp SS-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-HHHHHCCCC--CC
T ss_pred CC-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhhcCCCCC--CC
Confidence 22 22345789999999999975 57999999999999999999999999764433332222 222211110 11
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
..+ . ..+.+++.+||+.||++|++ ++||.+
T Consensus 415 ~~~--------S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSF--------S----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTS--------C----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccC--------C----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111 1 12458999999999999998 677764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.15 Aligned_cols=288 Identities=38% Similarity=0.671 Sum_probs=232.6
Q ss_pred ccCCHHHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEe
Q 047739 791 NKITLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYA 868 (1099)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~ 868 (1099)
..+++.++....++|+..+.||+|+||.||+|..++|+.||+|++..... ....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 36788999999999999999999999999999988899999999965432 2346899999999999999999999998
Q ss_pred cCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC---CceecCCCCCCEEECCCCcEEE
Q 047739 869 GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---NMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 869 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
... ..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 98 ~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 98 TPT-ERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CSS-CCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred cCC-ceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 544 4599999999999999998632 2345589999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCC-----CCchhHHHHHH
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMF-----TQDEDIVKWVK 1020 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~-----~~~~~~~~~~~ 1020 (1099)
+|||+++.... ..........||+.|+|||++.+..++.++||||+|+++|||++|+.||.. ........++.
T Consensus 176 ~Dfg~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 176 GDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCCSSCEECCS--SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred ccCccccccCc--ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999986522 222334456699999999999888899999999999999999999999952 22333444444
Q ss_pred HHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1021 KQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1021 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
............+.... .....+....+.+++.+||+.||++|||+.||++.|++.......
T Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQ----GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp TTTSSCCSTTSSCTTCT----TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred HHhhchhhhhhcChhhc----cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 44444444444443332 222334455677899999999999999999999999987655543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=373.06 Aligned_cols=280 Identities=32% Similarity=0.562 Sum_probs=225.3
Q ss_pred HHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 796 AETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 796 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++...+++|+..+.||+|+||.||+|.+++|..||+|++.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-NEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-TCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CeE
Confidence 33445678999999999999999999999889999999986543 3357799999999999999999999999854 456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++.... .....+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999999997532 23345899999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch---hHHHHHHHHhhhcccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE---DIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~ 1031 (1099)
... ..........||..|+|||++.+..++.++||||||+++|||++|+.||...... ....+.......+.+...
T Consensus 190 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 190 TEL-DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SSS-SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred ccc-cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 221 1122234456899999999999899999999999999999999999999754332 234444444444555555
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+++.... ....+....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 269 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLAD----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCTT----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhcc----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 5544321 1223344456789999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.38 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=203.5
Q ss_pred HHHhccccccccccccceeEEEEEECCceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
....+|++.+.||+|+||.||+|.+. |..||+|.+....... +.+.+|++++++++||||+++++++.... ..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceEE
Confidence 34678999999999999999999874 7889999986554332 56889999999999999999999998554 4599
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+.| |+||||||+||+++.++.+||+|||+++..
T Consensus 112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999997532 1134899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. .........||+.|+|||++.+..++.++||||+|+++|||++|+.||......+....+............+
T Consensus 190 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 264 (309)
T 3p86_A 190 AS---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL-- 264 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS--
T ss_pred cc---cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC--
Confidence 21 1223345679999999999999999999999999999999999999998776655544433221111111111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+ ..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 265 ----------~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 265 ----------N----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----------C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----------C----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1 12458999999999999999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=370.62 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=210.9
Q ss_pred HhccccccccccccceeEEEEEEC----CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|.+.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|++++++++||||+++++++.+.. ..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-ccE
Confidence 467889999999999999999984 45679999997543 23467999999999999999999999998544 459
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.++++.. ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 127 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999642 2358999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+....... ..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~- 276 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-----AP- 276 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-----CC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-----CC-
Confidence 33333333444567889999999998899999999999999999999 999998776665554443321100 00
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
.... ..+.+++.+||+.||++|||+.||++.|+++...+...
T Consensus 277 -------~~~~----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 277 -------MGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp -------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred -------CCcC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 0111 13457899999999999999999999999987665543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=372.37 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=211.2
Q ss_pred HhccccccccccccceeEEEEEEC--------CceEEEEEECCCCCcc--HHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999862 4678999999764332 35789999999999 899999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...|+||||+++|+|.+++..... .....+++..+..++.||++||+|||+.||+||||||+||+++.
T Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred -CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 456999999999999999986432 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999998653221 1223344567889999999999999999999999999999999 9999987766665544
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+..... ... +.... ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 318 ~~~~~~----~~~---------~~~~~----~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 318 LKEGHR----MDK---------PANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHTTCC----CCC---------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCC----CCC---------CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 332211 000 01111 12457899999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.52 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=214.2
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||+|+||.||+|.+.++..||+|++.......+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEEeC
Confidence 457999999999999999999998899999999988777788999999999999999999999999854 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQY 161 (269)
T ss_dssp TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC--HHH
T ss_pred CCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc--ccc
Confidence 999999999742 23589999999999999999999999999999999999999999999999999986521 112
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+..... ...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~------~~~~------ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKP------ 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------CCCC------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc------CCCC------
Confidence 23344567888999999998999999999999999999999 9999987766555444332211 0000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
...+ ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 230 -~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 -RLAS----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcCC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1111 124578999999999999999999999997753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=384.52 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=213.4
Q ss_pred HHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..++|...+.||+|+||.||+|.++++..||||.+.......+.|.+|++++++++||||+++++++.. ...++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--CccEEEEee
Confidence 356899999999999999999999989999999998777778899999999999999999999999873 346999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.++++... ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 264 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~--~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NE 338 (454)
T ss_dssp CTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC--HH
T ss_pred cCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC--Cc
Confidence 99999999997532 12478899999999999999999999999999999999999999999999999986521 11
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........+|..|+|||++....++.++||||||+++|||++ |+.||......+....+.......
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------- 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 112233456789999999998999999999999999999999 999998776665555443321100
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+...+ ..+.+++.+||+.||++|||+++|++.|+++.
T Consensus 406 ~~~~~~----~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 011111 12457899999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.94 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=214.2
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||+|+||.||+|.++++..||+|.+.......+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEcc
Confidence 46799999999999999999999999999999998877778889999999999999999999999975 44569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 86 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QY 159 (268)
T ss_dssp TTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT--CE
T ss_pred CCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh--hh
Confidence 9999999997642 34899999999999999999999999999999999999999999999999999865221 22
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||...........+... .. ...+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~--~~~~------ 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----HR--LYRP------ 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----CC--CCCC------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC----CC--CCCC------
Confidence 23344567788999999998889999999999999999999 99999876655444333221 10 0000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
...+ ..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 228 -~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 -HLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -TTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1111 1245789999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=372.37 Aligned_cols=266 Identities=23% Similarity=0.285 Sum_probs=207.6
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC---ceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---LRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~lV~ 878 (1099)
.++|++.++||+|+||.||+|++. ++.||+|++.........+.+|+.++++++||||+++++++..... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468999999999999999999987 7899999997665556667789999999999999999999985432 358999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC----------CceecCCCCCCEEECCCCcEEEecc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS----------NMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
||+++|+|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999975 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccC-----CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHH-------
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-----ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV------- 1016 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~------- 1016 (1099)
|+++...... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||....+....
T Consensus 176 g~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 176 GLALKFEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TTCEEECTTS-CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred Cccccccccc-CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9997653221 22233446899999999998863 4567889999999999999999999764332111
Q ss_pred -----HHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1017 -----KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1017 -----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+................+ ........+.+++.+||+.||++|||+.||++.|+++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYW-------QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG-------GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccc-------cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111111111100 111223345789999999999999999999999998754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=373.95 Aligned_cols=364 Identities=17% Similarity=0.230 Sum_probs=188.1
Q ss_pred cccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCC
Q 047739 78 LSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAND 157 (1099)
Q Consensus 78 l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~ 157 (1099)
..+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++. | ++.+++|++|+|++|.+++. |-.
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~~~ 103 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-DVT 103 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-CCT
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-ecC
Confidence 344455677888888888888888886 46 688888888888888888873 4 77788888877777777652 211
Q ss_pred cccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhc
Q 047739 158 LPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIG 237 (1099)
Q Consensus 158 ~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 237 (1099)
-.++|++|++++|++++ +| ++++++|++|++++|++++ +| ++.+++|++|++++|+..+.+ .++
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~---------l~--l~~l~~L~~L~l~~n~~~~~~--~~~ 167 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE---------ID--VSHNTQLTELDCHLNKKITKL--DVT 167 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC---------CC--CTTCTTCCEEECTTCSCCCCC--CCT
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce---------ec--cccCCcCCEEECCCCCccccc--ccc
Confidence 11445555555555543 22 4455555555555555441 11 334444444444444322222 233
Q ss_pred CCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCC
Q 047739 238 ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA 317 (1099)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 317 (1099)
.+++|+ +|++++|++++. | +..+
T Consensus 168 ~l~~L~------------------------------------------------------~L~ls~n~l~~l-~--l~~l 190 (457)
T 3bz5_A 168 PQTQLT------------------------------------------------------TLDCSFNKITEL-D--VSQN 190 (457)
T ss_dssp TCTTCC------------------------------------------------------EEECCSSCCCCC-C--CTTC
T ss_pred cCCcCC------------------------------------------------------EEECCCCcccee-c--cccC
Confidence 444444 444444444432 2 4444
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
++|++|++++|++++. .++.+++|++|++++|++++ +| +..+++|++|++++|++++.. ++.+++|+.|++
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l 261 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHC 261 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEEC
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEec
Confidence 5555555555555432 24455555555555555554 23 445555555555555555322 233444555544
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
+.| +|+.|++++|.+.+.+| +..+++|+.|++++|...+.+|.. ..+|+.|++++|
T Consensus 262 ~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~l~~~----- 317 (457)
T 3bz5_A 262 IQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITELDLSQN----- 317 (457)
T ss_dssp TTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSCCCCTTC-----
T ss_pred cCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceEechhhc-----
Confidence 443 23444555555444444 234455555555555544444421 122222222222
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCccccc
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 557 (1099)
++|++|++++|++++. .++.+++|+.|++++|++++ ++.|+.|++++|.+.|. +.+
T Consensus 318 --------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~ 373 (457)
T 3bz5_A 318 --------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQT 373 (457)
T ss_dssp --------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEE
T ss_pred --------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----cee
Confidence 3455555555555542 24555555555555555543 13444455555555443 233
Q ss_pred ceeeEEEccCCcCCCCCCCC
Q 047739 558 RSVVVLSFSGNHISGSIPPE 577 (1099)
Q Consensus 558 ~~L~~L~ls~N~l~~~~p~~ 577 (1099)
..|..+++++|+++|.+|..
T Consensus 374 ~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 374 ITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp EECCCBCCBTTBEEEECCTT
T ss_pred eecCccccccCcEEEEcChh
Confidence 44444555555555555543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=374.00 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=198.6
Q ss_pred HhccccccccccccceeEEEEEEC----CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|++.+.||+|+||.||+|++. ++..||+|.+..... ..+.|.+|++++++++||||+++++++... ...+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceE
Confidence 457899999999999999999875 578899999975432 346799999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.++++.. ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999752 2458999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.............++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+.......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-------- 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-------- 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 32222222233456788999999999999999999999999999998 999998766655444433211100
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
.+...+ ..+.+++.+||+.||++||++.||++.|+++...+
T Consensus 271 -----~~~~~~----~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 271 -----PPMDCP----AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----CCTTCB----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----CCcccc----HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001111 13467899999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=380.70 Aligned_cols=267 Identities=28% Similarity=0.447 Sum_probs=212.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|...+.||+|+||.||+|.++++..||+|.+.......+.|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhh
Confidence 56789999999999999999999988899999998777777889999999999999999999999875 3469999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 261 ~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EY 335 (452)
T ss_dssp TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC--ce
Confidence 9999999997532 234889999999999999999999999999999999999999999999999999865221 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..... .. .
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----~~---------~ 402 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----MP---------C 402 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CC---------C
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CC---------C
Confidence 22334567889999999999999999999999999999999 9999987666554444332111 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCCCCCC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPSP 1098 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~p 1098 (1099)
+...+ ..+.+++.+||+.||++|||++++++.|+++ ..+.+++++|.+
T Consensus 403 ~~~~~----~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~------~~~~~~~~~~~~ 450 (452)
T 1fmk_A 403 PPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY------FTSTEPQYQPGE 450 (452)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT------TSCSCCCCCCSC
T ss_pred CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH------hccCCccccccc
Confidence 01111 1245789999999999999999999999966 344555555543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=361.33 Aligned_cols=247 Identities=18% Similarity=0.243 Sum_probs=204.3
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
..+|.+.+.||+|+||.||+|.+ .+|+.||+|++..... ..+.+.+|++++++++||||+++++++.. ....|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence 45799999999999999999998 4689999999854322 34568899999999999999999999984 4557999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 9999999999999754 2388999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCccccccccCccccCccccccCCCC-CcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETT-KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+||+.|+|||++.+..++ .++||||+||++|||++|+.||......+....+... ... .+.
T Consensus 167 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~--~p~-- 235 (328)
T 3fe3_A 167 ---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----KYR--IPF-- 235 (328)
T ss_dssp ---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCT--
T ss_pred ---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCC--CCC--
Confidence 2234567899999999999888775 7899999999999999999999877665555444332 110 000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .. ..+.+++.+||+.||++|||++|+++.
T Consensus 236 -----~-~s----~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 -----Y-MS----TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----T-SC----HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----C-CC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 01 124578999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.61 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=203.8
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+... ....+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-CEEEEEEE
Confidence 45799999999999999999986 46899999998532 33457789999999999999999999999854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 168 (297)
T 3fxz_A 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--- 168 (297)
T ss_dssp CCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred CCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC---
Confidence 99999999999752 388999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.........||+.|+|||++.+..++.++||||+|+++|||++|+.||...........+..... ......+.+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~--- 242 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---PELQNPEKL--- 242 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS---CCCSCGGGS---
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCcccc---
Confidence 22234456899999999999999999999999999999999999999987655443333322111 000000000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-..+.+++.+||+.||++|||++|+++.
T Consensus 243 ---------~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 243 ---------SAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---------CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0124578999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=355.10 Aligned_cols=256 Identities=20% Similarity=0.353 Sum_probs=210.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||+|+||.||+|.++++..||+|.+.......+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEecc
Confidence 56899999999999999999999999999999998877788899999999999999999999999985 44569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 102 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~--~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEY 175 (283)
T ss_dssp TTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC--HHH
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc--ccc
Confidence 9999999997532 3489999999999999999999999999999999999999999999999999986521 112
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+...... ..+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------~~~------ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------YRP------ 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------CCC------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC------CCC------
Confidence 22334567788999999998899999999999999999998 99999876665544443322110 000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.... ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 244 -~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 -HLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CcCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1111 13457899999999999999999999998764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=376.63 Aligned_cols=309 Identities=21% Similarity=0.217 Sum_probs=181.8
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
|++|+|++|++++. + +..+++|++|+|++|++++. | ++.+++|++|++++|++++. .+..+++|++|++++
T Consensus 87 L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~ 157 (457)
T 3bz5_A 87 LTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL 157 (457)
T ss_dssp CSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTT
T ss_pred CCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCC
Confidence 44444444444432 1 44445555555555555432 2 45555555555555555542 144555555555555
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|+..+.+ .++.+++|++|++++|++++. | +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +|
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 5333333 244555555555555555542 2 55556666666666666543 25556666666666666664 33
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 535 (1099)
++.+++|+.|++++|++++.. ++.+++|+.|+++.| +|+.|++++|.+.+.+| ++.+++
T Consensus 229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~ 287 (457)
T 3bz5_A 229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRK 287 (457)
T ss_dssp --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTT
T ss_pred --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cccccc
Confidence 556666666666666666432 344556666666554 24456666666665555 455677
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccC
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI 615 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 615 (1099)
|++|++++|.+.+.+|.. .++|+.|++ +++++|++|++++|++++ ++ ++.+++|+.||+++
T Consensus 288 L~~L~Ls~n~~l~~l~~~---~~~L~~L~l-------------~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 288 IKELDVTHNTQLYLLDCQ---AAGITELDL-------------SQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVN 348 (457)
T ss_dssp CCCCCCTTCTTCCEEECT---TCCCSCCCC-------------TTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCS
T ss_pred CCEEECCCCcccceeccC---CCcceEech-------------hhcccCCEEECCCCcccc-cc--cccCCcCcEEECCC
Confidence 777777777766555532 233333333 334677888888888876 33 77788888888888
Q ss_pred ccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCcc
Q 047739 616 NNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLS 675 (1099)
Q Consensus 616 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 675 (1099)
|++++ ++.|+.|++++|.++|. .++..|+.+++++|+++|.+|..+.
T Consensus 349 N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 349 AHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp SCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 88875 24566667888888765 3566778888999999888887643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=371.17 Aligned_cols=272 Identities=21% Similarity=0.297 Sum_probs=214.4
Q ss_pred CCHHHHHHHHhccccccccccccceeEEEEEE------CCceEEEEEECCCCCcc--HHHHHHHHHHhhhc-cCCcceEE
Q 047739 793 ITLAETVEATRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKV-RHRNLTVL 863 (1099)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l 863 (1099)
+...++....++|.+.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555678999999999999999999974 24689999999754332 35799999999999 79999999
Q ss_pred eeEEecCCCceEEEEeecCCCCHHHHHhhhccC-----------------------------------------------
Q 047739 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ----------------------------------------------- 896 (1099)
Q Consensus 864 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~----------------------------------------------- 896 (1099)
++++.......++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987666679999999999999999864321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 897 --------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 897 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
....+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~ 250 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYV 250 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-TTCE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc-ccch
Confidence 0122899999999999999999999999999999999999999999999999999865322 2223
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......||..|+|||++.+..++.++||||||+++|||++ |+.||.......................
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 319 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----------- 319 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT-----------
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCC-----------
Confidence 3445678999999999999999999999999999999998 9999987654433322222111111110
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
... ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 320 -~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 320 -YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 011 12457899999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=355.94 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=211.4
Q ss_pred cccCCHHHHHHHHhc----------cccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccC
Q 047739 790 NNKITLAETVEATRQ----------FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRH 857 (1099)
Q Consensus 790 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H 857 (1099)
...++++++..+++. |+..+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 346788888887764 777889999999999999987 68999999985433 345778999999999999
Q ss_pred CcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE
Q 047739 858 RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF 937 (1099)
Q Consensus 858 ~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll 937 (1099)
|||+++++++... ...++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.||+||||||+||++
T Consensus 102 ~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 9999999999854 456999999999999999864 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHH
Q 047739 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017 (1099)
Q Consensus 938 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~ 1017 (1099)
+.++.+||+|||+++.... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISK---DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp CTTCCEEECCCTTCEECCS---SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCCCcEEEeeeeeeeeccc---CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999976522 1223345689999999999999999999999999999999999999998766554443
Q ss_pred HHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1018 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+... .. +.+.. ..... ..+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~----~~-----~~~~~---~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDS----PP-----PKLKN---SHKVS---PVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHS----SC-----CCCTT---GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcC----CC-----CCcCc---cccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33221 10 00000 00000 124578999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.71 Aligned_cols=280 Identities=31% Similarity=0.512 Sum_probs=221.9
Q ss_pred ccCCHHHHHHHHhccccc------cccccccceeEEEEEECCceEEEEEECCCCC-----ccHHHHHHHHHHhhhccCCc
Q 047739 791 NKITLAETVEATRQFDEE------NVLSRTRYGLVFKACYNDGMVLSIRRLPDGS-----LDENLFRKEAEFLGKVRHRN 859 (1099)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~n 859 (1099)
..+++.++..++.+|... +.||+|+||.||+|.+ ++..||+|++.... ...+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 467899999999999887 8999999999999987 47889999885421 22467899999999999999
Q ss_pred ceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 860 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
|+++++++... ...++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+.||+||||||+||+++.
T Consensus 92 i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecC-CceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC
Confidence 99999999854 45699999999999999997532 2345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~ 1019 (1099)
++.+||+|||+++..... ..........||+.|+|||.+.+ .++.++||||+|+++|||++|+.||...........+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKF-AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSC-SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCcEEEeecccccccccc-cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999765221 11222344679999999998764 5899999999999999999999999765544333333
Q ss_pred HHHhhh--ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1020 KKQLQK--GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1020 ~~~~~~--~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
...... ..+.+.+++.+.. ........+.+++.+||+.||++|||++||++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSC-----CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhhhhhhhhccccccc-----cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 332222 1223333333221 12223344568999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=371.92 Aligned_cols=269 Identities=23% Similarity=0.374 Sum_probs=214.1
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++||||+++++++... ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 467999999999999999999853 46789999996532 2345688999999999999999999999854 44
Q ss_pred eEEEEeecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---cEEEecc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---EAHLSDF 948 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~~kl~Df 948 (1099)
.++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.||+||||||+||+++.++ .+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 59999999999999999875432 234589999999999999999999999999999999999999555 5999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+++..... ..........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+.....
T Consensus 229 G~a~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~--- 304 (367)
T 3l9p_A 229 GMARDIYRA-GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 304 (367)
T ss_dssp HHHHHHHHH-SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---
T ss_pred ccccccccc-cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 999753211 11223345678999999999999999999999999999999998 9999987766655544433211
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCC
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSS 1089 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 1089 (1099)
... +.... ..+.+++.+||+.||++||++.||++.|+.+...++....
T Consensus 305 -~~~---------~~~~~----~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~ 352 (367)
T 3l9p_A 305 -MDP---------PKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352 (367)
T ss_dssp -CCC---------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred -CCC---------CccCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence 000 01111 1245789999999999999999999999998876654433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.55 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=204.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|...++||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.++ ...++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEE
Confidence 467899999999999999999986 58899999875433 3457799999999999999999999999854 55699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.++++.. ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 88 YIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999853 24589999999999999999999999999999999999999999999999999986532211
Q ss_pred CC-----------ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH--HHHHHHHhhhc
Q 047739 960 EA-----------STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI--VKWVKKQLQKG 1026 (1099)
Q Consensus 960 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~ 1026 (1099)
.. .......||+.|+|||++.+..++.++||||||+++|||++|..||........ ......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-R 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-H
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-c
Confidence 11 111256799999999999999999999999999999999999999864322110 000000000 0
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.....+.+ .+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 243 ~~~~~~~~----------------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 YCPPNCPP----------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp TCCTTCCT----------------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCH----------------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000111 23578999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=381.03 Aligned_cols=259 Identities=21% Similarity=0.374 Sum_probs=214.8
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+|+..+.||+|+||.||+|.++. +..||+|.+.......+.|.+|++++++++||||+++++++... ...++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEEEEEc
Confidence 4678999999999999999999875 88999999987777788899999999999999999999999854 446999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.++++.. ....+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 298 ~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DT 372 (495)
T ss_dssp CTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT--CC
T ss_pred cCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC--Cc
Confidence 9999999999853 234589999999999999999999999999999999999999999999999999986522 12
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+..+.+...... .
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------~ 439 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------E 439 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------C
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------C
Confidence 222334557789999999998899999999999999999999 99999877666555443321110 0
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.+...+ ..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 440 ~~~~~~----~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 RPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 011111 1245789999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.16 Aligned_cols=252 Identities=18% Similarity=0.287 Sum_probs=208.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|++.+.||+|+||.||+|... ++..||+|.+.....+.+.+.+|++++++++||||+++++++.+. ...++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEEe
Confidence 467999999999999999999986 588999999987666677899999999999999999999999854 556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC--CCcEEEeccccccccCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA--DFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~ 958 (1099)
+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 83 ISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 9999999999642 235899999999999999999999999999999999999987 78999999999986532
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||......+....+...... ......+..
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~-- 230 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEI-- 230 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTS--
T ss_pred --CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC--CChhhhccC--
Confidence 22344567999999999999888899999999999999999999999877666555544432110 000000000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ----------s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 231 ----------SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0234689999999999999999999983
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=354.54 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=204.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|+.+ +|+.||+|.+... ....+.+.+|++++++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEE
Confidence 357999999999999999999986 5899999998542 22346788999999999999999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999999753 3488999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+... ... +..
T Consensus 158 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~--~p~-- 226 (337)
T 1o6l_A 158 ---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----EIR--FPR-- 226 (337)
T ss_dssp ---TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCT--
T ss_pred ---CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCC--CCC--
Confidence 223345678999999999999999999999999999999999999999876665555444321 110 000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. .. ..+.+++.+||+.||++|| +++||++
T Consensus 227 -----~-~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 -----T-LS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----T-SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----C-CC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0 01 1245789999999999999 8999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=366.01 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=212.9
Q ss_pred HhccccccccccccceeEEEEEEC--------CceEEEEEECCCCCcc--HHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|.+.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999862 3468999998654332 36788999999999 899999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++..... .....+++..+..++.|+++||+|||+.+|+||||||+||+++.
T Consensus 148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred -CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 446999999999999999986432 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++...... .........+|..|+|||++.+..++.++|||||||++|||++ |+.||......+..+.
T Consensus 227 ~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998653221 1223345567899999999999999999999999999999999 9999987766555444
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+..... ... . .... ..+.+++.+||+.||++|||++||++.|+++....
T Consensus 306 ~~~~~~----~~~-~--------~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 306 LKEGHR----MDK-P--------SNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHTTCC----CCC-C--------SSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHcCCC----CCC-C--------ccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 332211 000 0 1111 13457899999999999999999999999886433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=353.74 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=211.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||+|+||.||+|..+++..||+|.+.......+.+.+|++++++++||||+++++++.++ ..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC--CcEEEEecC
Confidence 468999999999999999999999888999999987777788899999999999999999999998733 358999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--EY 164 (279)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS--CE
T ss_pred CCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc--cc
Confidence 9999999997532 124899999999999999999999999999999999999999999999999999865321 11
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||.+.+..++.++||||+|++++||++ |+.||......+....+..... . ..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----~-~~-------- 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----M-VR-------- 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----C-CC--------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----C-CC--------
Confidence 22334567889999999998889999999999999999999 9999987666554443322110 0 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+...+ ..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 232 ~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccc----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 01111 13457899999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=351.23 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=204.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence 357999999999999999999975 58899999884322 223678899999999999999999999884 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 89 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999764 2489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
..........||+.|+|||.+.+..++.++||||+|+++|||++|+.||........... .... ....... ..
T Consensus 164 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~---~~~~-~~~~~~~-~~ 236 (294)
T 4eqm_A 164 --TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---HIQD-SVPNVTT-DV 236 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH---HHSS-CCCCHHH-HS
T ss_pred --ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---Hhhc-cCCCcch-hc
Confidence 122233456799999999999999999999999999999999999999977654333221 1111 1111000 00
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHhhcccCCCCC
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~~ 1086 (1099)
.+.. + ..+.+++.+|++.||++|| ++.++.+.|+.+......
T Consensus 237 ---~~~~-~----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 237 ---RKDI-P----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp ---CTTS-C----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred ---ccCC-C----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 0000 0 1245789999999999998 999999999987655443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=370.74 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=207.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|...+.||+|+||.||+|.+. +++.||+|.+..... ..+.|.+|++++++++||||+++++++... ...++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEEE
Confidence 468899999999999999999986 689999999875432 235688999999999999999999999854 4469999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.++++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~- 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG- 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS-
T ss_pred EcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC-
Confidence 9999999999997532 34889999999999999999999999999999999999999999999999999754211
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.. +....
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~------- 335 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK----GGRLP------- 335 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT----TCCCC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCC-------
Confidence 11111122346778999999998899999999999999999998 9999987665554443322 11000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+...+ ..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 336 --~~~~~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 --CPELCP----DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 011111 12457899999999999999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=374.48 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=209.1
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|...+.||+|+||.||+|.++ |+.||||.+.... ..+.|.+|++++++++||||+++++++.......++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 467889999999999999999987 7799999997644 55779999999999999999999999886665679999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.++++... ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 270 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 341 (450)
T 1k9a_A 270 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 341 (450)
T ss_dssp TTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----
Confidence 9999999998642 23478999999999999999999999999999999999999999999999999985421
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..... .. .
T Consensus 342 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----~~---------~ 407 (450)
T 1k9a_A 342 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MD---------A 407 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----CC---------C
T ss_pred -cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CC---------C
Confidence 1223367889999999999999999999999999999998 9999987766655544432211 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+...+ ..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 408 p~~~~----~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 PDGCP----PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11111 134578999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.85 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=204.0
Q ss_pred HhccccccccccccceeEEEEEECC-ce----EEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GM----VLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|+..++||+|+||.||+|.+.. +. +||+|.+.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--Ce
Confidence 4579999999999999999999753 33 46888885432 3457799999999999999999999999853 35
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||+++|+|.+++... ...+++..++.++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+|+..
T Consensus 92 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 8999999999999999753 245899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... ..........+|..|+|||++.+..++.++|||||||++|||++ |+.||...........+....... .
T Consensus 168 ~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----~- 240 (327)
T 3poz_A 168 GAE-EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-----Q- 240 (327)
T ss_dssp TTT-CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----C-
T ss_pred cCC-cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-----C-
Confidence 322 12223334567889999999999999999999999999999999 999998776666554433221100 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+.... ..+.+++.+||+.||++||++.|+++.|+.+...+
T Consensus 241 -------~~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 241 -------PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -------CTTBC----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -------CccCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 01111 13457899999999999999999999998876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.09 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=205.1
Q ss_pred HhccccccccccccceeEEEEEECC-ce----EEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GM----VLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|+..++||+|+||.||+|.+.. +. +|++|.+.... ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Ccc
Confidence 3578999999999999999999753 33 48888875432 223567899999999999999999999863 346
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 8999999999999999753 235889999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... ..........||..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..... ........
T Consensus 166 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (325)
T 3kex_A 166 PPD-DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-LAQPQICT 243 (325)
T ss_dssp CCC-TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-CCCCTTBC
T ss_pred Ccc-cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCCCCcCc
Confidence 322 22233445678889999999999999999999999999999999 9999987666555544432211 11111111
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+ .+.+++.+||+.||++||++.|+++.|+++...+
T Consensus 244 ~----------------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 244 I----------------DVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp T----------------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred H----------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 1247899999999999999999999999886544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=358.26 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=204.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-------cHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|... +|..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCE
Confidence 467999999999999999999986 589999999854322 34679999999999999999999999985 456
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC----cEEEeccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDFG 949 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~DfG 949 (1099)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 79999999999999999642 3589999999999999999999999999999999999998776 79999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+++.... .......+||+.|+|||++.+..++.++||||+||++|||++|..||......+....+..... ...
T Consensus 165 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~ 238 (361)
T 2yab_A 165 LAHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY--DFD 238 (361)
T ss_dssp SCEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CCC
T ss_pred CceEcCC----CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCC
Confidence 9986532 2233456799999999999988999999999999999999999999987766555544332110 000
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+.. -..+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~~~~~------------s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEFFSQT------------SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHTTS------------CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhccCC------------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 013457999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.50 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=213.0
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|...+.||+|+||.||+|.+.++..||+|.+.......+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEeCC
Confidence 467899999999999999999998899999999988777778899999999999999999999999854 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.... ...
T Consensus 86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~--~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQY 159 (267)
T ss_dssp TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC--HHH
T ss_pred CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc--ccc
Confidence 999999999753 23488999999999999999999999999999999999999999999999999986521 111
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..... .. .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----~~-~------- 226 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----LY-K------- 226 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----CC-C-------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----CC-C-------
Confidence 22334567889999999998899999999999999999999 8999987665554443332110 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+.... ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 227 ~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLAS----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCc----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01111 124578999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.72 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.++||+|+||.||+|.+.+|+.||+|++...... .+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEEE
Confidence 4689999999999999999999988999999998654332 36788999999999999999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||++ |+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 171 (311)
T 3niz_A 99 EFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171 (311)
T ss_dssp ECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred cCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence 9997 5888888642 24489999999999999999999999999999999999999999999999999986521
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc-----
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL----- 1032 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1032 (1099)
.........||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.............
T Consensus 172 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 -PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp -CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred -CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 1223345678999999999876 568999999999999999999999998877766666655543322111100
Q ss_pred ----cCcccCCCCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 ----EPGLLELDPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 ----d~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....... ....+... ..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVF--EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccc--cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 01111111 23468999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=351.21 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=201.9
Q ss_pred HhccccccccccccceeEEEEEE-----CCceEEEEEECCCCCcc-HHHHHHHHHHhhhccCCcceEEeeEEecC-CCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGSLD-ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~ 874 (1099)
.++|++.+.||+|+||.||+|++ .+++.||+|++...... .+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999985 25899999998754433 36789999999999999999999998632 2346
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999997632 34899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh------------HHHHHHHH
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED------------IVKWVKKQ 1022 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~------------~~~~~~~~ 1022 (1099)
..............++..|+|||.+.+..++.++||||||+++|||++|..|+.....+. ....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 333222233345567888999999999999999999999999999999999985432110 00111111
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
...+.. ...+...+ ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 245 ~~~~~~---------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGR---------LPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHTTCC---------CCCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCc---------CCCCcCcC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111110 00011111 134578999999999999999999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=365.14 Aligned_cols=348 Identities=25% Similarity=0.370 Sum_probs=278.0
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 373 (1099)
+.++.|++++|.++. +| .+..+++|++|||++|.+++..+ +.++++|++|++++|.+.+..+ +.++++|++|+|
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 457888888888875 34 37778888888888888886544 8888888888888888886544 888888888888
Q ss_pred cCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccc
Q 047739 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453 (1099)
Q Consensus 374 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1099)
++|++++. +. +..+++|++|++++|.+.+. ..+.++++|++|+++ |.+.+.. .+.++++|+.|++++|.+++.
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC
Confidence 88888854 33 78888888888888888764 248888888888886 4555332 378888888888888888754
Q ss_pred cCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc
Q 047739 454 VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533 (1099)
Q Consensus 454 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 533 (1099)
..+.++++|+.|++++|.+++..| ++.+++|++|++++|++++. ..+..+++|+.|++++|.+++..+ +..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 264 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 264 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence 347888888888888888886655 67788889999998888753 357788889999999998886544 7888
Q ss_pred cccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
++|++|++++|.+++..+ +..+++|+.|++++|++++..+ ++.+++|++|+|++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 889999999998886544 7788889999999998886544 7888899999999999986554 788899999999
Q ss_pred cCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCC
Q 047739 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPAN 673 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~ 673 (1099)
++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++ +|..
T Consensus 339 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~ 393 (466)
T 1o6v_A 339 YNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN 393 (466)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred CCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence 99998864 468889999999999999987766 8888999999999999886 3443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=352.95 Aligned_cols=277 Identities=19% Similarity=0.208 Sum_probs=208.6
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-CceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~lV~ 878 (1099)
++|.+.++||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.... ...++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578999999999999999999864 8999999986433 23467889999999999999999999987543 3568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----CCCCcEEEecccccccc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF----DADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~ 954 (1099)
||+++|+|.+++..... ...+++..+..++.|+++||+|||+.||+||||||+||++ +.++.+||+|||+++..
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999986432 2348999999999999999999999999999999999999 78888999999999865
Q ss_pred CCCCCCCccccccccCccccCccccc--------cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAAL--------TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
.. ........||..|+|||++. +..++.++|||||||++|||++|+.||...........+...+..+
T Consensus 167 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 167 ED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CT----TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred CC----CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 22 22334567999999999886 5678999999999999999999999997543322212222221111
Q ss_pred cccc----cc---cCc--cc-CCCC-CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1027 QITE----LL---EPG--LL-ELDP-ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1027 ~~~~----~~---d~~--~~-~~~~-~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
.... .. ... +. .... .......-..+.+++.+||+.||++|||++|+++...+.....+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 1100 00 000 00 0011 11112222345689999999999999999999999887655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=382.05 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=211.3
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|.+.++||+|+||.||+|.++++..||||++.......+.|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehh
Confidence 56789999999999999999999988899999998777777889999999999999999999999875 3469999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.++++... ...+++..+..|+.||++||+|||+.+|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 344 ~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 418 (535)
T ss_dssp TTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC--HHH
T ss_pred cCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC--Cce
Confidence 9999999997532 23488999999999999999999999999999999999999999999999999986521 111
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......++..|+|||++....++.++|||||||++|||++ |+.||......+....+..... .. .
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----~~-~-------- 485 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----MP-C-------- 485 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----CC-C--------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CC-C--------
Confidence 12234457789999999999999999999999999999999 9999987666555444332111 00 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+.... ..+.+++.+||+.||++|||+++|++.|+++
T Consensus 486 ~~~~~----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 486 PPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01111 1245789999999999999999999999966
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=371.56 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=208.0
Q ss_pred HHHHHHhccccccccccccceeEEEEEECC-ceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
+.....++|+..++||+|+||.||+|++++ ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~ 146 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-D 146 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-S
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-C
Confidence 333456789999999999999999999875 7899999985321 122448899999999999999999999985 4
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 5579999999999999999752 245899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
+.... .........+||+.|+|||++. ...++.++||||+||++|||++|+.||......+....+.......
T Consensus 223 ~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 223 LKLME--DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp EECCT--TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhccc--CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 76522 2222334568999999999987 4568999999999999999999999998877666665554332222
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
..+... .. .. ..+.+++.+|+..+|++ ||+++|+++.
T Consensus 301 ~~p~~~----~~---~s------~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 301 QFPTQV----TD---VS------ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSSC----CC---SC------HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCccc----cc---CC------HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111110 00 01 12357899999888888 9999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=359.61 Aligned_cols=253 Identities=17% Similarity=0.267 Sum_probs=193.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|...+.||+|+||.||+|... +++.||+|.+.......+.+.+|+.++++++||||+++++++.. +...++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEEe
Confidence 457999999999999999999986 68999999997666666789999999999999999999999985 4557999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc--EEEeccccccccCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE--AHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~~~~~~~ 958 (1099)
+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 98 ASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 9999999999753 24899999999999999999999999999999999999987765 9999999997431
Q ss_pred CCCccccccccCccccCccccccCCCCCc-CchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKE-SDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........+||+.|+|||++.+..++.+ +||||+||++|||++|+.||...............+.........+..
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-- 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC--
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC--
Confidence 1222345679999999999988887665 899999999999999999997654433232222222221110000000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ..+.+++.+||+.||++|||+.|+++.
T Consensus 247 ------~s----~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ------IS----PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------CC----HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CC----HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 124579999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.60 Aligned_cols=269 Identities=17% Similarity=0.197 Sum_probs=203.1
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCCCcc------------HHHHHHHHHHhhhccCCcceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSLD------------ENLFRKEAEFLGKVRHRNLTVL 863 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~H~niv~l 863 (1099)
.++|.+.+.||+|+||.||+|.+.. ++.||+|.+...... ...+..|+..+++++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999999865 478999998654321 1123345566677789999999
Q ss_pred eeEEecCC---CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC--
Q 047739 864 RGYYAGAP---DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-- 938 (1099)
Q Consensus 864 ~~~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-- 938 (1099)
++++.... ...++||||+ +|+|.+++... ...+++..+..++.||+.||+|||+.+|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 99987532 3468999999 99999999753 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCC----CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC-ch
Q 047739 939 ADFEAHLSDFGLDRLTIPTPAE----ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ-DE 1013 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~-~~ 1013 (1099)
.++.+||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... +.
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765322111 112244569999999999999999999999999999999999999998533 33
Q ss_pred hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1014 DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
......... ....+.+.+++.+.. ...+ ..+.+++..||+.||++||++.+|++.|+++...
T Consensus 269 ~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYVRDSKIR-YRENIASLMDKCFPA---ANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHH-HHHCHHHHHHHHSCT---TCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-hhhhHHHHHHHhccc---ccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 333222222 222233333322210 0001 1345789999999999999999999998876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=346.98 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=193.2
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCc-----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|+..+.||+|+||.||+|.+. |..||+|.+..... ..+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEEE
Confidence 57899999999999999999986 88899999864322 236789999999999999999999999854 446999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC---ceecCCCCCCEEECC--------CCcEEEe
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN---MVHGDIKPQNVLFDA--------DFEAHLS 946 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---iiH~Dlk~~NIll~~--------~~~~kl~ 946 (1099)
|||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999863 34899999999999999999999998 999999999999986 6789999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
|||+++.... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...........+.. .
T Consensus 159 Dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~ 229 (271)
T 3dtc_A 159 DFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM----N 229 (271)
T ss_dssp CCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT----S
T ss_pred cCCccccccc-----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc----C
Confidence 9999975422 122345799999999999999999999999999999999999999987655443332221 1
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
....... ...+ ..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ~~~~~~~--------~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLALPIP--------STCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCCC--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCC--------cccC----HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1110011 1111 1345789999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=357.17 Aligned_cols=273 Identities=20% Similarity=0.329 Sum_probs=199.7
Q ss_pred HHhccccccccccccceeEEEEEECCc----eEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYNDG----MVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
..++|+..+.||+|+||.||+|.+... ..||+|.+... ....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356799999999999999999987643 27999998653 23357799999999999999999999998754322
Q ss_pred -----eEEEEeecCCCCHHHHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 874 -----RLLVYDYMPNGNLGTLLQEASHQ-DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 874 -----~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
.++||||+++|+|.+++...... ....+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 38999999999999999764322 223589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
||+++...... .........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+.....
T Consensus 181 fg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-- 257 (323)
T 3qup_A 181 FGLSRKIYSGD-YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-- 257 (323)
T ss_dssp CCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred ccccccccccc-cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--
Confidence 99998652221 1122334567889999999999999999999999999999999 9999987776665554432211
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCC
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSAD 1091 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 1091 (1099)
... .+ . .. ..+.+++.+||+.||++|||+.|+++.|+++...++......
T Consensus 258 --~~~-~~-------~-~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 258 --LKQ-PP-------E-CM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp --CCC-CT-------T-CC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred --CCC-CC-------c-cC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 000 00 0 00 134689999999999999999999999999988877655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=359.23 Aligned_cols=264 Identities=24% Similarity=0.395 Sum_probs=210.5
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
..++|+..+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|++++++++||||+++++++... .
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-K 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-S
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-C
Confidence 4678999999999999999999975 358999999975432 246789999999999999999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ-------------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~ 933 (1099)
..++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.+|+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 569999999999999999864211 1256899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCc
Q 047739 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~ 1012 (1099)
||+++.++.+||+|||+++...... .........+|..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999999997542211 1122344578899999999999899999999999999999999 9999987666
Q ss_pred hhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1013 EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.+....+.. +..... . ...+ ..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 283 ~~~~~~~~~----~~~~~~-~--------~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 EEVIYYVRD----GNILAC-P--------ENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHT----TCCCCC-C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHHHhC----CCcCCC-C--------CCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 554443322 211111 0 1111 1345789999999999999999999999988654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=350.69 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=196.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcC
Confidence 357899999999999999999986 788999998643 345779999999999999999999998863 258999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc---CCceecCCCCCCEEECCCCc-EEEeccccccccCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT---SNMVHGDIKPQNVLFDADFE-AHLSDFGLDRLTIPT 957 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---~~iiH~Dlk~~NIll~~~~~-~kl~DfGla~~~~~~ 957 (1099)
++|+|.+++.... ....+++..++.++.|+++||+|||+ .||+||||||+||+++.++. +||+|||+++....
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~- 158 (307)
T 2eva_A 82 EGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 158 (307)
T ss_dssp TTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-
Confidence 9999999997532 22347889999999999999999999 89999999999999998886 79999999975421
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......||..|+|||++.+..++.++||||||+++|||++|+.||......... .. .....+...... .
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~~-~--- 227 (307)
T 2eva_A 159 -----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM-WAVHNGTRPPLI-K--- 227 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH-HHHHTTCCCCCB-T---
T ss_pred -----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH-HHHhcCCCCCcc-c---
Confidence 123456999999999999999999999999999999999999999754332211 11 111111111110 0
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+ ..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 228 -----~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 228 -----NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -----ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001 124578999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.38 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=204.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~lV 877 (1099)
.++|...+.||+|+||.||+|.++ +..||+|.+...... .+.+.+|++++++++||||+++++++.+. ....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357999999999999999999986 888999998654332 35789999999999999999999999754 2456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
|||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF- 163 (271)
T ss_dssp EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-
Confidence 9999999999999752 2235899999999999999999999999 999999999999999999999999987542
Q ss_pred CCCCCCccccccccCccccCccccccCCCCC---cCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTK---ESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
......||+.|+|||.+.+..++. ++||||+|+++|||++|+.||......+....+........ .
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 232 (271)
T 3kmu_A 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----I 232 (271)
T ss_dssp -------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC----C
T ss_pred -------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC----C
Confidence 122357899999999998765544 79999999999999999999987665544333322211111 1
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
... .+ ..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 233 ~~~--------~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 PPG--------IS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTT--------CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCC--------CC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11 124578999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=347.69 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=197.2
Q ss_pred HhccccccccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence 4689999999999999999998753 56799999865432 24678999999999999999999999853 3458
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999753 2358999999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. .........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||......+....+... .... ..+
T Consensus 168 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~----~~~~-~~~ 240 (281)
T 1mp8_A 168 DS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----ERLP-MPP 240 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CCCC-CCT
T ss_pred cc--cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC----CCCC-CCC
Confidence 21 1222334567889999999998899999999999999999997 99999877766655544321 1100 001
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
. .+ ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 -------~-~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 241 -------N-CP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -------T-CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------C-CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 11 12457899999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=358.47 Aligned_cols=271 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred HhccccccccccccceeEEEEEE-----CCceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEec-CCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~ 874 (1099)
.++|+..+.||+|+||.||+|.+ .++..||+|++..... ..+.+.+|++++++++||||+++++++.. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999985 3588999999865443 34668999999999999999999998864 34556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 89999999999999998632 24899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH-----------HHHHHHHh
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI-----------VKWVKKQL 1023 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~-----------~~~~~~~~ 1023 (1099)
..............||..|+|||++.+..++.++||||+|+++|||++|+.||.....+.. ...+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 3322222334456788999999999988899999999999999999999999864332211 01111111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSS 1089 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 1089 (1099)
..+... ..+.... ..+.+++.+||+.||++|||+.|+++.|+.+.........
T Consensus 258 ~~~~~~---------~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 258 EEGQRL---------PAPPACP----AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HTTCCC---------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred hcccCC---------CCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 111100 0001111 1245889999999999999999999999988765544333
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.63 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=204.5
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
..++|...+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 87 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KT 87 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence 3467999999999999999999986 58899999885422 135779999999999999999999999985 45
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC----cEEEecc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDF 948 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~Df 948 (1099)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 569999999999999999742 3489999999999999999999999999999999999999887 7999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
|+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+..... ..
T Consensus 163 g~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~ 236 (326)
T 2y0a_A 163 GLAHKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--EF 236 (326)
T ss_dssp TTCEECCT----TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC--CC
T ss_pred CCCeECCC----CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC--Cc
Confidence 99986522 1223456799999999999988999999999999999999999999987665554444332110 00
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+.. -..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~------------~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 EDEYFSNT------------SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CHHHHTTS------------CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CccccccC------------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0134578999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.84 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=201.0
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..+.||+|+||.||+|...+|+.||+|++.....+ .+.+.+|++++++++||||+++++++... ...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEE
Confidence 478999999999999999999988999999998654433 36788999999999999999999999854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++ +|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 152 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--- 152 (288)
T ss_dssp CCSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ecCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc---
Confidence 9975 999988742 23488999999999999999999999999999999999999999999999999976421
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc--------
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE-------- 1030 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------- 1030 (1099)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.+.........
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 11223445789999999998764 589999999999999999999999987766655555544332211100
Q ss_pred cccCcccCCCCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..++.+....+. .++ .-..+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPL--PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCC--CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCc--cHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011111100000 000 00234589999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.52 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=200.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH--------HHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE--------NLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.++|+..+.||+|+||.||+|.+. +++.||+|.+....... +.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 357999999999999999999985 68999999985433221 67899999999999999999999986432
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCc-----EEE
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFE-----AHL 945 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~-----~kl 945 (1099)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred --eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7999999999999988642 345899999999999999999999999 999999999999988776 999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccc--cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL--TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
+|||+++... .......||+.|+|||++. ...++.++||||+|+++|||++|+.||........... ...
T Consensus 171 ~Dfg~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~- 242 (287)
T 4f0f_A 171 ADFGLSQQSV------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMI- 242 (287)
T ss_dssp CCCTTCBCCS------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHH-
T ss_pred CCCCcccccc------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHH-
Confidence 9999997431 2234567999999999984 45578999999999999999999999976554433211 111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
............ .+ ..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~--------~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLRPTIPED--------CP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCCCCCCTT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCCCCCCcc--------cC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111111 11 1345899999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=352.14 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=208.5
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|+..+.||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 46899999999999999999985 3478999999965432 346789999999999 9999999999998544
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH-------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
..++||||+++|+|.+++..... .....+++..++.++.|+++||+|||+.||+||||||+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 45999999999999999986432 11235899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++...... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 9999999999998653221 1222344567889999999999999999999999999999999 9999976654433322
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
........ ... ...+ ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 260 ~~~~~~~~----~~~--------~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 260 MIKEGFRM----LSP--------EHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHTCCC----CCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCC----CCc--------ccCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 22211110 000 0011 13457899999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=350.26 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=195.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---------------------------cHHHHHHHHHHhh
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---------------------------DENLFRKEAEFLG 853 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~ 853 (1099)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999875 589999999854321 1256889999999
Q ss_pred hccCCcceEEeeEEecC-CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCC
Q 047739 854 KVRHRNLTVLRGYYAGA-PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKP 932 (1099)
Q Consensus 854 ~l~H~niv~l~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~ 932 (1099)
+++||||+++++++.+. ....++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+.+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 99999999999999753 4567899999999999876532 3589999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCC---CCCcCchhhHHHHHHHHHhCCCCCCC
Q 047739 933 QNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE---TTKESDVYSFGIVLLELLTGKRPVMF 1009 (1099)
Q Consensus 933 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~G~il~elltg~~P~~~ 1009 (1099)
+||+++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++||||+|+++|||++|+.||..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS---DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS---SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEECCCCCEEEecCCCccccccc---cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999865321 22334568999999999987655 37789999999999999999999976
Q ss_pred CCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1010 TQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.........+.. ........+ . .. ..+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~----~~~~~~~~~-------~-~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCLHSKIKS----QALEFPDQP-------D-IA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHHHHHHHH----CCCCCCSSS-------C-CC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHHHHHHhc----ccCCCCCcc-------c-cC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 654443333222 111000000 0 01 12457899999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=363.69 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=205.6
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
...++|++.+.||+|+||.||+|... +|..||+|.+..... +.+.+.+|++++++++||||+++++++.+ +...|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence 34678999999999999999999875 689999999865443 23568899999999999999999999984 45669
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC---CCCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD---ADFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ..+++.....++.||++||+|||+.||+||||||+||+++ .++.+||+|||+|+
T Consensus 87 lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999999753 3489999999999999999999999999999999999998 46789999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+...... ..
T Consensus 162 ~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~ 233 (444)
T 3soa_A 162 EVEG---EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-----FP 233 (444)
T ss_dssp CCCT---TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----CC
T ss_pred EecC---CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----CC
Confidence 6522 222334568999999999999989999999999999999999999999877766655554432111 11
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.+... . ..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~-----s----~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SPEWDTV-----T----PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTTTS-----C----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccC-----C----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111 1 124578999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.36 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=200.8
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhh--ccCCcceEEeeEEecC---CCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGK--VRHRNLTVLRGYYAGA---PDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~---~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|.+ +++.||+|++... ..+.+.+|.+++.. ++||||+++++++... ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 56899999999999999999998 5889999998643 44566777777776 7999999999987532 334689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc--------cCCceecCCCCCCEEECCCCcEEEecc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH--------TSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
||||+++|+|.++++. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999963 34899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCC-CccccccccCccccCccccccC------CCCCcCchhhHHHHHHHHHhC----------CCCCCCCC
Q 047739 949 GLDRLTIPTPAE-ASTSTTAVGTLGYVSPEAALTG------ETTKESDVYSFGIVLLELLTG----------KRPVMFTQ 1011 (1099)
Q Consensus 949 Gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~G~il~elltg----------~~P~~~~~ 1011 (1099)
|+|+........ ........||+.|+|||++.+. .++.++||||||+++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999764322111 1123345899999999999876 455799999999999999999 88886432
Q ss_pred ch-hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1012 DE-DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1012 ~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.. .....+.............. ...........+.+++.+||+.||++|||+.||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIP-------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCC-------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCC-------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21 11222222222111111111 1111112234456899999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=352.48 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=210.4
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++||||+++++++... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-Cc
Confidence 56899999999999999999986 3458999999975432 236788999999999999999999999854 44
Q ss_pred eEEEEeecCCCCHHHHHhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCC
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ-------------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~N 934 (1099)
.++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+.+|+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 69999999999999999864321 12458999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCch
Q 047739 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDE 1013 (1099)
Q Consensus 935 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~ 1013 (1099)
|+++.++.+||+|||+++..... ..........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEE-DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTT-SCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCCEEEcccccccccccc-ccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865322 11222344567889999999998889999999999999999999 99999877766
Q ss_pred hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1014 DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.....+..... ... . .... ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 260 ~~~~~~~~~~~----~~~-~--------~~~~----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 260 RLFNLLKTGHR----MER-P--------DNCS----EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GHHHHHHTTCC----CCC-C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcCCc----CCC-C--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 65544332211 000 0 0011 13457899999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=348.58 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=214.7
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..++|+..+.||+|+||.||+|.+.. +..||+|.+.......+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEEEE
Confidence 45689999999999999999999875 88999999987777778899999999999999999999999854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.... .
T Consensus 90 ~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--D 164 (288)
T ss_dssp CCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS--S
T ss_pred cCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC--C
Confidence 99999999999753 234589999999999999999999999999999999999999999999999999986522 2
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
.........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...........+....... ..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~----- 234 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-----RP----- 234 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-----CC-----
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC-----CC-----
Confidence 2233445567889999999999999999999999999999999 999998776665555443321100 00
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
...+ ..+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 235 ---~~~~----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 235 ---EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCC----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0011 13457899999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.91 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=204.9
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
...++|++.+.||+|+||.||+|..+ +|..||+|.+...... .+.+.+|++++++++||||+++++++.+ ....|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence 34678999999999999999999986 5899999998654332 3568899999999999999999999985 45569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ..+++..+..++.||++||+|||+.||+||||||+||+++.+ +.+||+|||+++
T Consensus 105 lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999998742 348999999999999999999999999999999999999865 459999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+... ... ..
T Consensus 180 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~----~~~-~~ 250 (362)
T 2bdw_A 180 EVND----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----AYD-YP 250 (362)
T ss_dssp CCTT----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCC-CC
T ss_pred EecC----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----CCC-CC
Confidence 6532 22234568999999999999989999999999999999999999999877665555444332 110 01
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.+... . ..+.+++.+||+.||++||++.|+++.
T Consensus 251 ~~~~~~~-----~----~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWDTV-----T----PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGGGS-----C----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccCC-----C----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111100 0 124579999999999999999998864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=348.85 Aligned_cols=269 Identities=19% Similarity=0.290 Sum_probs=215.3
Q ss_pred hcccccc-ccccccceeEEEEEEC---CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEEN-VLSRTRYGLVFKACYN---DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEE
Confidence 4566665 9999999999999864 57889999997643 234678999999999999999999999953 34699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999999642 34589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+... .... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~----~~~~-~~~- 236 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----KRME-CPP- 236 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----CCCC-CCT-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC----CcCC-CCC-
Confidence 2222223344567899999999988889999999999999999999 99999876665554443321 1110 011
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTT 1094 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 1094 (1099)
..+ ..+.+++.+||+.||++||++.|+++.|+.+......+.+..+..
T Consensus 237 -------~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 284 (287)
T 1u59_A 237 -------ECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 284 (287)
T ss_dssp -------TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCCT
T ss_pred -------CcC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCccc
Confidence 011 134578999999999999999999999999877666666655443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=354.68 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=199.0
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +...++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence 468999999999999999999986 689999999854322 23678999999999999999999999984 45669999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 158 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN- 158 (323)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET-
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC-
Confidence 999999999998642 34899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
..........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.............. ..... .. .+.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~---~~-~~~ 232 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKTY---LN-PWK 232 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--TTCTT---ST-TGG
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--ccccc---CC-ccc
Confidence 12223345689999999999987775 7789999999999999999999976554322111111 11100 00 000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. . ..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~-----~----~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 KI-----D----SAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GS-----C----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cC-----C----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0 123578999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=356.22 Aligned_cols=261 Identities=15% Similarity=0.210 Sum_probs=207.5
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|+++++++ +||||+++++++.. +...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEE
Confidence 35799999999999999999997 468999999986433 335689999999999 99999999999885 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc-----EEEecccccccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE-----AHLSDFGLDRLT 954 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~-----~kl~DfGla~~~ 954 (1099)
|+ +|+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 89999999853 245899999999999999999999999999999999999998887 999999999865
Q ss_pred CCCCCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc--cc
Q 047739 955 IPTPAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG--QI 1028 (1099)
Q Consensus 955 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~ 1028 (1099)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 3222111 12346789999999999999999999999999999999999999998755444333322211110 00
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
.+.... . .+ .+.+++..||+.||.+||++.+|.+.|+++..
T Consensus 241 ~~~~~~--------~--~p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 IEVLCE--------N--FP---EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHTT--------T--CH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhc--------c--Ch---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 000000 0 01 34688999999999999999999999986653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=365.88 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=205.9
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
...++|+..++||+|+||.||+|+.+ +++.||+|++... ....+.+.+|+++++.++||||+++++++.+ +...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEE
Confidence 34678999999999999999999986 4889999998532 1223458899999999999999999999985 5567
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.++++.. .+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|+..
T Consensus 145 ~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999999742 3789999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCccccccccCccccCccccccCC----CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGE----TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
.. .........+||+.|+|||++.+.. ++.++||||+||++|||++|+.||...+..+....+.........+.
T Consensus 219 ~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 219 NK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp CT--TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred cc--CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 21 1222344678999999999998665 78999999999999999999999987776666655544322111110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPID--RPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1076 (1099)
+..+ . ..+.+++.+|++.+|++ ||+++||++.
T Consensus 297 --~~~~------s------~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 --DNDI------S------KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --TCCC------C------HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --cccc------c------HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0001 1 12457899999999988 9999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=358.90 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=198.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|++.++||+|+||.||+|+.+ +|+.||+|++.... ...+.+.+|.++++++ +||||+++++++.+ ....
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEE
Confidence 3568999999999999999999986 48999999985421 2345678899999988 69999999999985 4557
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|+..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999864 34899999999999999999999999999999999999999999999999999853
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. .........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... ... +..
T Consensus 175 ~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~--~p~ 245 (353)
T 3txo_A 175 I---CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----EVV--YPT 245 (353)
T ss_dssp C---C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCT
T ss_pred c---cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCC--CCC
Confidence 2 1223345678999999999999888999999999999999999999999887766665554432 110 000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM------SDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~ 1075 (1099)
.+ . ..+.+++.+|++.||++||++ .||++
T Consensus 246 ~~--------~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 WL--------H----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TS--------C----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC--------C----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00 0 124578999999999999998 67764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=360.48 Aligned_cols=350 Identities=25% Similarity=0.389 Sum_probs=297.8
Q ss_pred CCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCC
Q 047739 238 ALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA 317 (1099)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 317 (1099)
.+++|+.|++++|.+.. +|. ...+++|++|+|++|++++..+ +..+
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-------------------------------~~~l~~L~~L~Ls~n~l~~~~~--~~~l 89 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-------------------------------VEYLNNLTQINFSNNQLTDITP--LKNL 89 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-------------------------------GGGCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred HhccccEEecCCCCCcc-Ccc-------------------------------hhhhcCCCEEECCCCccCCchh--hhcc
Confidence 35678888888887762 332 1235679999999999997655 8999
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
++|++|++++|.+++..+ ++++++|++|++++|.+++..+ +.++++|++|+|++|++++ ++ .+..+++|++|++
T Consensus 90 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l 163 (466)
T 1o6v_A 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSF 163 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEE
T ss_pred ccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeec
Confidence 999999999999986554 9999999999999999986533 8899999999999999985 44 4889999999999
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
+ |.+.+.. .+.++++|++|++++|.+++. ..+..+++|++|++++|.+++..+ ++.+++|+.|++++|++++.
T Consensus 164 ~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 164 G-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp E-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred C-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 6 5555443 389999999999999999854 458899999999999999987665 77899999999999999853
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCccccc
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 557 (1099)
..+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+
T Consensus 237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l 308 (466)
T 1o6v_A 237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL 308 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCC
Confidence 468889999999999999986655 8899999999999999996544 8899999999999999987655 8899
Q ss_pred ceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEEC
Q 047739 558 RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLV 637 (1099)
Q Consensus 558 ~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 637 (1099)
++|+.|++++|++++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++
T Consensus 309 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 382 (466)
T 1o6v_A 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEEC
T ss_pred CCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEec
Confidence 999999999999997765 78999999999999999964 578999999999999999998766 899999999999
Q ss_pred cCccccccCChh
Q 047739 638 NSNHLSGGIPDS 649 (1099)
Q Consensus 638 s~N~l~~~~p~~ 649 (1099)
++|++++ +|..
T Consensus 383 ~~n~~~~-~p~~ 393 (466)
T 1o6v_A 383 NDQAWTN-APVN 393 (466)
T ss_dssp CCEEEEC-CCBC
T ss_pred cCCcccC-Cchh
Confidence 9999995 4433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=354.27 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=202.0
Q ss_pred HhccccccccccccceeEEEEEECC-----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
..+|...+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|++++++++||||+++++++.. ....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCc
Confidence 3467788999999999999998653 35699999865432 34568899999999999999999999985 4556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999752 245899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
..............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..... .. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~--~- 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LP--T- 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CC--C-
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CC--C-
Confidence 332222223334457889999999998999999999999999999999 9999987666554443332110 00 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
+.... ..+.+++.+||+.||++||++.|+++.|+++...++
T Consensus 272 -------~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 272 -------PMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -------CTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------cccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 00111 124578999999999999999999999988765443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=359.58 Aligned_cols=280 Identities=18% Similarity=0.216 Sum_probs=215.2
Q ss_pred hccccccccccccceeEEEEEECC---------ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceE-----------
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND---------GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV----------- 862 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~----------- 862 (1099)
++|.+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 579999999999999999999864 789999998643 46889999999999999987
Q ss_pred ----EeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC
Q 047739 863 ----LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 863 ----l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~ 938 (1099)
+++++.......++||||+ +|+|.+++.... ...+++..+..++.||++||+|||+.||+||||||+||+++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6677776567779999999 999999998531 24589999999999999999999999999999999999999
Q ss_pred CCC--cEEEeccccccccCCCCC----CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC-
Q 047739 939 ADF--EAHLSDFGLDRLTIPTPA----EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ- 1011 (1099)
Q Consensus 939 ~~~--~~kl~DfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~- 1011 (1099)
.++ .+||+|||+++....... .........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 899999999986532211 1112244589999999999999999999999999999999999999997653
Q ss_pred chhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCC
Q 047739 1012 DEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSAD 1091 (1099)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 1091 (1099)
............. .......+.... . ...+ ..+.+++.+||+.||++||++.||++.|+++..........+
T Consensus 274 ~~~~~~~~~~~~~-~~~~~~~~~~~~-~--~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 274 NTEDIMKQKQKFV-DKPGPFVGPCGH-W--IRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp CHHHHHHHHHHHH-HSCCCEECTTSC-E--ECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CHHHHHHHHHhcc-CChhhhhhhccc-c--CCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 2222222222111 111111111000 0 0000 234578999999999999999999999999987777766666
Q ss_pred CCCCCCC
Q 047739 1092 PTTQPSP 1098 (1099)
Q Consensus 1092 ~~~~~~p 1098 (1099)
..|...|
T Consensus 346 ~dw~~~p 352 (352)
T 2jii_A 346 IGLPMVP 352 (352)
T ss_dssp CCCCC--
T ss_pred ccCcCCC
Confidence 6666554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=355.83 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=203.2
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|...++||+|+||.||+|+.+ +|+.||+|.+... ....+.+.+|.++++++ +||||+++++++.+ ....
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~~ 93 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENL 93 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCEE
Confidence 4578999999999999999999986 5899999998543 22346678899999987 89999999999985 4557
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999863 24899999999999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... .... ..
T Consensus 169 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~----p~ 239 (345)
T 1xjd_A 169 ML---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFY----PR 239 (345)
T ss_dssp CC---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC----CT
T ss_pred cc---CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCC----Cc
Confidence 21 122345678999999999999999999999999999999999999999877666555544331 0100 11
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMS-DIV 1074 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1074 (1099)
.+ . ..+.+++.+||+.||++||++. ||.
T Consensus 240 ~~--------s----~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 240 WL--------E----KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp TS--------C----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred cc--------C----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 1 1245789999999999999997 664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=356.45 Aligned_cols=266 Identities=22% Similarity=0.299 Sum_probs=207.0
Q ss_pred HHhccccccccccccceeEEEEEE------CCceEEEEEECCCCC--ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGS--LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 871 (1099)
..++|+..+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 457899999999999999999986 246789999986432 2346799999999999 899999999999854
Q ss_pred CceEEEEeecCCCCHHHHHhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCC
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQ------------------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~ 933 (1099)
+..++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 4569999999999999999764221 1134799999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCc
Q 047739 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~ 1012 (1099)
||+++.++.+||+|||+++..... ..........||+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccC-ccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999865322 12223345568889999999999999999999999999999998 9999977654
Q ss_pred hhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1013 EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
.......... +... ... ...+ ..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 281 ~~~~~~~~~~---~~~~-~~~--------~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DANFYKLIQN---GFKM-DQP--------FYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHHHHHHHHT---TCCC-CCC--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHHhc---CCCC-CCC--------CCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 4333222221 1100 000 0011 12457899999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.41 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=193.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.++||+|+||.||+|.+.+ .||+|.+...... .+.+.+|++++++++||||+++++++.. ...++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEEE
Confidence 4579999999999999999998764 4888888654332 3678999999999999999999997653 3458999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW- 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc-
Confidence 999999999999642 345899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
..........||..|+|||.+. +..++.++||||+|+++|||++|+.||......+...... ..+.......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-- 248 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV---GRGSLSPDLS-- 248 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH---HHTSCCCCTT--
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh---cccccCcchh--
Confidence 1122334567999999999986 5668889999999999999999999998755443322222 1221111111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..... .+ ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 249 --~~~~~-~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 --KVRSN-CP----KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --SSCTT-SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --hcccc-CC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11101 11 134688999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.87 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=196.1
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCC---c
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---L 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~ 873 (1099)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+...... .+.+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45799999999999999999997 46899999999654322 2568899999999999999999999874432 2
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||+++|+|.++++.. ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 48999999999999999753 2489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc-ccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT-ELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1032 (1099)
...............||+.|+|||++.+..++.++||||+|+++|||++|+.||.............. ..... ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~ 242 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---EDPIPPSAR 242 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---CCCCCHHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCCCCcccc
Confidence 53332222334456799999999999999999999999999999999999999987665443322221 11110 000
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHhhcccC
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV-FMLEGCRV 1082 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl-~~L~~~~~ 1082 (1099)
.+.+ . ..+.+++.+||+.||++||++.+++ +.+.+...
T Consensus 243 ~~~~------~------~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 243 HEGL------S------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp STTC------C------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cCCC------C------HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0000 0 1245789999999999999665544 55555443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=352.88 Aligned_cols=270 Identities=22% Similarity=0.324 Sum_probs=213.0
Q ss_pred CHHHHHHHHhccccccccccccceeEEEEEE------CCceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEe
Q 047739 794 TLAETVEATRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLR 864 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~ 864 (1099)
...+.....++|.+.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445578899999999999999999985 3468999999975433 235788999999999 799999999
Q ss_pred eEEecCCCceEEEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCC
Q 047739 865 GYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933 (1099)
Q Consensus 865 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~ 933 (1099)
+++.......++||||+++|+|.+++...... ....+++..+..++.|+++||+|||+.||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 99986666679999999999999999863221 0223789999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCc
Q 047739 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQD 1012 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~ 1012 (1099)
||+++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eEEECCCCCEEECCCccccccccC-ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999865322 12223345678899999999999999999999999999999998 9999976554
Q ss_pred hhH-HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1013 EDI-VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1013 ~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
... ...+.. +..... . .... ..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 257 ~~~~~~~~~~----~~~~~~-~--------~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 257 DEEFCRRLKE----GTRMRA-P--------DYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SHHHHHHHHH----TCCCCC-C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHhcc----CccCCC-C--------CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 332 222221 111000 0 0001 12457899999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=344.58 Aligned_cols=268 Identities=22% Similarity=0.247 Sum_probs=204.6
Q ss_pred HHhccccccccccccceeEEEEEE-CCceEEEEEECCCCC------ccHHHHHHHHHHhhhcc---CCcceEEeeEEecC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGS------LDENLFRKEAEFLGKVR---HRNLTVLRGYYAGA 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 870 (1099)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999997 468899999985221 12356778888888775 99999999998754
Q ss_pred CC----ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 871 PD----LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 871 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
.. ..++||||+. |+|.+++... ....+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 43 3589999997 6999999753 22348999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
|||+++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.......
T Consensus 163 Dfg~a~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYS----YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTST----TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccC----CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998652 2223355689999999999999999999999999999999999999998877766666655543322
Q ss_pred cccccccCc---ccCCCC-CChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 QITELLEPG---LLELDP-ESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 ~~~~~~d~~---~~~~~~-~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
......... ...+.+ ....... -..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111100000 000000 0000000 1234689999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=344.63 Aligned_cols=267 Identities=17% Similarity=0.195 Sum_probs=210.1
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|+++++++ +|+|++++++++.. ....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEE
Confidence 45799999999999999999997 468999999985432 345688999999999 79999999999874 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc-----EEEecccccccc
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE-----AHLSDFGLDRLT 954 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~-----~kl~DfGla~~~ 954 (1099)
|+ +|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 89999999853 234899999999999999999999999999999999999987776 999999999865
Q ss_pred CCCCCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh---HHHHHHHHhhhcc
Q 047739 955 IPTPAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED---IVKWVKKQLQKGQ 1027 (1099)
Q Consensus 955 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~---~~~~~~~~~~~~~ 1027 (1099)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 3222111 12355679999999999999999999999999999999999999998744322 2222222222111
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCC
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPS 1088 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1088 (1099)
..+.. +.+ + ..+.+++.+||+.||++||++++|++.|+++........
T Consensus 242 ~~~~~-~~~--------~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 242 LRELC-AGF--------P----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HHHHT-TTS--------C----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHH-hhC--------c----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 11111 111 0 134578999999999999999999999998765544333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.72 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=202.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|+.. +|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEE
Confidence 367999999999999999999986 58999999985421 234668899999999999999999999985 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~- 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP- 157 (318)
T ss_dssp EECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-
T ss_pred EEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-
Confidence 99999999999999753 348899999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+... ... +.+.+
T Consensus 158 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~--~p~~~ 226 (318)
T 1fot_A 158 -----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----ELR--FPPFF 226 (318)
T ss_dssp -----SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC----CCC--CCTTS
T ss_pred -----CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCC--CCCCC
Confidence 1234568999999999999999999999999999999999999999876655544443321 110 00100
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. ..+.+++.+|++.||++|| +++|+++
T Consensus 227 --------~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 --------N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------C----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 1245789999999999999 8899884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=359.73 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=196.9
Q ss_pred ccccccccccccceeEEEEEEC--C--ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN--D--GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.|...++||+|+||.||+|.+. + +..||+|.+.... ...+.+.+|++++++++||||+++++++...+...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999864 2 3578999986432 33477999999999999999999999987555667999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.++++.. ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999742 244789999999999999999999999999999999999999999999999999865322
Q ss_pred CCC-CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 958 PAE-ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 958 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||......+....+... .. ...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~----~~--~~~-- 317 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RR--LLQ-- 317 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT----CC--CCC--
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC----CC--CCC--
Confidence 111 122344567889999999999999999999999999999999 77788766555544433221 10 000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
+...+ ..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 318 -----p~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 318 -----PEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 1245789999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=349.00 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=194.4
Q ss_pred HhccccccccccccceeEEEEEE----CCceEEEEEECCCCC-----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY----NDGMVLSIRRLPDGS-----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.++|+..++||+|+||.||+|+. .+|+.||+|.+.... .....+.+|++++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-G 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-C
Confidence 46799999999999999999987 468999999986542 2335678999999999999999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+||||+++|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 569999999999999999753 247899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... ........+||+.|+|||++.+..++.++||||+|+++|||++|+.||...........+.... ...
T Consensus 170 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~---- 240 (327)
T 3a62_A 170 ESIH---DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNL---- 240 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCC----
T ss_pred cccc---CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCC----
Confidence 5321 1223345679999999999999899999999999999999999999998776655554443321 000
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
.+.+ . ..+.+++.+||+.||++|| ++.|+++
T Consensus 241 p~~~--------~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 PPYL--------T----QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CTTS--------C----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC--------C----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1100 0 1245789999999999999 7888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=351.24 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=209.2
Q ss_pred HhccccccccccccceeEEEEEEC--------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999873 467899999975432 236788999999999 899999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.||+||||||+||+++.
T Consensus 114 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp -SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred -CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 4569999999999999999864321 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++...... .........+|..|+|||++.+..++.++||||+|+++|||++ |+.||......+....
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEccccccccccccc-cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 9999999999998653211 1122344567889999999998889999999999999999999 9999987766555444
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+..... .. .. .... ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 272 ~~~~~~----~~-~~--------~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 272 LKEGHR----MD-KP--------ANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHTCC----CC-CC--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC----CC-CC--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 333211 00 00 0111 124578999999999999999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=358.95 Aligned_cols=281 Identities=21% Similarity=0.322 Sum_probs=200.9
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhcc-CCcceEEeeEEecCC-Cc
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAP-DL 873 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~ 873 (1099)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ...+.+.+|+.+++++. ||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999875 58999999985432 23466789999999997 999999999987433 35
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 799999997 699999875 2488999999999999999999999999999999999999999999999999986
Q ss_pred cCCCC------------------CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh
Q 047739 954 TIPTP------------------AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014 (1099)
Q Consensus 954 ~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~ 1014 (1099)
..... .........+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 43211 01122345689999999999886 678999999999999999999999998877666
Q ss_pred HHHHHHHHhhhccccccc---cC---------------cccCCCCCChhHHH-----------HHHHHHHHHhcCCCCCC
Q 047739 1015 IVKWVKKQLQKGQITELL---EP---------------GLLELDPESSEWEE-----------FLLGVKVALLCTAPDPI 1065 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~---d~---------------~~~~~~~~~~~~~~-----------~~~~~~li~~Cl~~dP~ 1065 (1099)
....+............. .+ ...........+.. -..+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 655554433221110000 00 00000000000100 12356899999999999
Q ss_pred CCCCHHHHHHH--hhcccCCCCCC
Q 047739 1066 DRPTMSDIVFM--LEGCRVGPDIP 1087 (1099)
Q Consensus 1066 ~RPs~~evl~~--L~~~~~~~~~~ 1087 (1099)
+|||++|+++. +.......+.+
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~~~~~ 342 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNPNEEP 342 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCGGGCC
T ss_pred cCCCHHHHhCCHHHHHhcCCccCC
Confidence 99999999876 44443333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=347.28 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=193.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|+..+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence 457899999999999999999875 58899999985432 234678899999999999999999999985 45669999
Q ss_pred eecCCCCHHHHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQ-DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||++ |+|.+++...... ....+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 160 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI- 160 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS-
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC-
Confidence 9998 6999999764322 234589999999999999999999999999999999999999999999999999986521
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc------c
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT------E 1030 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------~ 1030 (1099)
.........||..|+|||++.+. .++.++||||+||++|||++|+.||......+....+.......... .
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 11223456789999999998764 68999999999999999999999998877766666555443221100 0
Q ss_pred c--ccCcccCCCCC-ChhH-------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1031 L--LEPGLLELDPE-SSEW-------EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1031 ~--~d~~~~~~~~~-~~~~-------~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. ..+......+. .... ..-..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 00000000000 0000 000235689999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=353.23 Aligned_cols=264 Identities=21% Similarity=0.348 Sum_probs=210.6
Q ss_pred HHHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
...++|+..+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG- 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-
Confidence 34678999999999999999999865 368899999975433 235688999999999999999999999854
Q ss_pred CceEEEEeecCCCCHHHHHhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEe
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASH-----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
...++||||+++|+|.+++..... .....+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 456999999999999999976331 112347899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhh
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
|||+++...... .........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..
T Consensus 181 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 255 (322)
T 1p4o_A 181 DFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME---- 255 (322)
T ss_dssp CTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT----
T ss_pred cCcccccccccc-ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc----
Confidence 999997542211 1122334567889999999999999999999999999999999 8999987665554443322
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+...... ...+ ..+.+++.+||+.||++|||+.|+++.|++...
T Consensus 256 ~~~~~~~---------~~~~----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLDKP---------DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCCCC---------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCCCC---------CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111100 0011 124578999999999999999999999998755
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.17 Aligned_cols=244 Identities=20% Similarity=0.259 Sum_probs=203.0
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|+.. +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.+ ....|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEE
Confidence 357999999999999999999986 58999999985322 234678899999999999999999999985 455799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 119 v~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999998642 389999999999999999999999999999999999999999999999999986521
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... ... +...+
T Consensus 194 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~--~p~~~ 261 (350)
T 1rdq_E 194 ------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVR--FPSHF 261 (350)
T ss_dssp ------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCTTC
T ss_pred ------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC----CCC--CCCCC
Confidence 233568999999999999999999999999999999999999999877665555444332 110 01111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
. ..+.+++.+||+.||++||+ ++||++
T Consensus 262 --------~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 --------S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------C----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 12458899999999999998 888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.11 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=198.8
Q ss_pred HhccccccccccccceeEEEEEECC-c-------eEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-G-------MVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
.++|...+.||+|+||.||+|.+.. + ..||+|.+.... ...+.+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD- 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence 4579999999999999999998753 2 579999986433 34577999999999999999999999998544
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc--------EE
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE--------AH 944 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~--------~k 944 (1099)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++. +|
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 4599999999999999998632 34899999999999999999999999999999999999998877 99
Q ss_pred EeccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+|||+++... ......||..|+|||++.+ ..++.++||||+|+++|||++|..|+..............
T Consensus 162 l~Dfg~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-- 232 (289)
T 4fvq_A 162 LSDPGISITVL-------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-- 232 (289)
T ss_dssp ECCCCSCTTTS-------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--
T ss_pred eccCccccccc-------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--
Confidence 99999986541 1233568899999999987 6789999999999999999996555443333222111111
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
..........+ .+.+++.+||+.||++|||+.|+++.|+++..+..
T Consensus 233 ~~~~~~~~~~~----------------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 DRHQLPAPKAA----------------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp TTCCCCCCSSC----------------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ccCCCCCCCCH----------------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11111111111 13578999999999999999999999998865433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=350.92 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=202.9
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|+..++||+|+||.||+|+.+. |+.||+|.+... ....+.+.+|.++++.+ +||||+++++++.+ .+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEE
Confidence 34689999999999999999999875 789999998542 22346688999999988 79999999999985 4567
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999864 24899999999999999999999999999999999999999999999999999853
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..+.+... ... +..
T Consensus 172 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~--~p~ 242 (353)
T 2i0e_A 172 IW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----NVA--YPK 242 (353)
T ss_dssp CC---TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCT
T ss_pred cc---CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----CCC--CCC
Confidence 21 222345678999999999999999999999999999999999999999877666555544431 110 011
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
.+ . ..+.+++.+||+.||++||+ ++||++
T Consensus 243 ~~--------s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 SM--------S----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TS--------C----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CC--------C----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 1 13457899999999999995 577764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=349.73 Aligned_cols=254 Identities=19% Similarity=0.305 Sum_probs=201.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCC------CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPD------GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|++.+.||+|+||.||+|... +|+.||+|.+.. .....+.+.+|++++++++||||+++++++.+ ....
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence 467999999999999999999875 589999999842 12245779999999999999999999999985 4556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc---EEEeccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE---AHLSDFGLD 951 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla 951 (1099)
|+||||+++|+|.+++..... ....+++..+..++.||++||+|||+.+|+||||||+||+++.++. +||+|||++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999999988875332 2345899999999999999999999999999999999999986654 999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
+.... ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......+.. +... .
T Consensus 181 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~----~~~~-~ 251 (351)
T 3c0i_A 181 IQLGE---SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIK----GKYK-M 251 (351)
T ss_dssp EECCT---TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHH----TCCC-C
T ss_pred eEecC---CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHc----CCCC-C
Confidence 86532 1223345689999999999999899999999999999999999999997643 222222222 1110 0
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+... -..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~---------s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQWSHI---------SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHTTS---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccccccC---------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 023457999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=351.63 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=187.3
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... ...+.+.+|++++++++||||+++++++.. +...++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-hhHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEE
Confidence 3567999999999999999999987 4789999998653 245678899999999999999999999985 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEeccccccccCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~~~~ 956 (1099)
|+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999742 34899999999999999999999999999999999999975 88999999999986421
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh-HHHHHHHHhhhccccccccCc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-IVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. ..... ...+.
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~----~~~~~-~~~~~ 274 (349)
T 2w4o_A 204 ----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----NCEYY-FISPW 274 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH----TTCCC-CCTTT
T ss_pred ----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH----hCCCc-cCCch
Confidence 222345679999999999999999999999999999999999999997655443 222221 11110 11111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.. .. ..+.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~-----~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDE-----VS----LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTT-----SC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh-----CC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 00 134579999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=377.81 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=201.4
Q ss_pred cccccc-ccccccceeEEEEEEC---CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEEN-VLSRTRYGLVFKACYN---DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++...+ .||+|+||.||+|.++ ++..||||++.... ...+.|.+|++++++++|||||++++++.. +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEE
Confidence 344444 7999999999999874 56789999997543 345789999999999999999999999975 346999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999642 345899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... .....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~----~~~~~----- 560 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----KRMEC----- 560 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT----CCCCC-----
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----CCCCC-----
Confidence 222222334456789999999999999999999999999999998 99999887766655544332 11000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+...+ ..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 561 ----p~~~~----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 ----PPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ----CTTCC----HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111 13457899999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=361.83 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=205.3
Q ss_pred HHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCC
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 871 (1099)
+.....++|+..++||+|+||.||+|+.+ +|+.||+|++.... ...+.+.+|.+++.+++||||+++++++.+ .
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~ 133 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-E 133 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-S
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-C
Confidence 33345678999999999999999999986 68999999985422 122458899999999999999999999985 4
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 56799999999999999998642 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccc-------cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAAL-------TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+..... ........+||+.|+|||++. ...++.++||||+||++|||++|+.||......+....+.....
T Consensus 210 ~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 210 LKLRAD--GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp EECCTT--SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred eeccCC--CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 865221 122234568999999999987 35689999999999999999999999988776666555543221
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDR---PTMSDIVF 1075 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Ps~~evl~ 1075 (1099)
....+. .+..+ . ..+.+++.+||. +|++| |+++||++
T Consensus 288 ~~~~p~-~~~~~--------s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 HLSLPL-VDEGV--------P----EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HCCCC-----CC--------C----HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CcCCCc-cccCC--------C----HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111110 00111 0 134578999999 99998 68999876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=353.39 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=204.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... .+...+.+|++++++++||||+++++++.+ ....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence 467999999999999999999986 58899999986543 344678999999999999999999999985 455699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC--CCcEEEeccccccccCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA--DFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~ 957 (1099)
|+++|+|.+++... ...+++..+..++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 129 FLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp CCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 99999999998742 235899999999999999999999999999999999999974 57899999999986522
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... ... .....+.
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----~~~-~~~~~~~ 275 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----DWE-FDEDAFS 275 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC----CCC-CCSSTTT
T ss_pred ---CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCC-CCccccc
Confidence 12234457999999999999999999999999999999999999999876665554443332 110 0000000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... ..+.+++.+||+.||++|||+.|+++.
T Consensus 276 -----~~s----~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 -----SVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -----TSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----cCC----HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001 124589999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.62 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=200.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|+..+.||+|+||.||+|.+. |+.||+|.+.... ..+.+.+|++++++++||||+++++++.......++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999886 8899999997543 55779999999999999999999999876655679999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++..... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 169 (278)
T 1byg_A 98 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 169 (278)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc-----
Confidence 99999999975321 2378899999999999999999999999999999999999999999999999875421
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
......++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+.. +.... ..
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----~~~~~-~~------- 236 (278)
T 1byg_A 170 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMD-AP------- 236 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----TCCCC-CC-------
T ss_pred -cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----CCCCC-Cc-------
Confidence 1223467889999999998999999999999999999998 9999987666555443322 11000 00
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
...+ ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 237 -~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 237 -DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCC----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 0011 124578999999999999999999999987753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.21 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=204.6
Q ss_pred HhccccccccccccceeEEEEEECC----ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|...+.||+|+||.||+|.+.+ +..||+|.+.... ...+.+.+|++++++++||||+++++++.++ ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCE
Confidence 4689999999999999999998643 4579999987543 2346789999999999999999999998743 348
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997532 348899999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. .........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+....+...... ..
T Consensus 165 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~~------ 235 (281)
T 3cc6_A 165 DE--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-PK------ 235 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-CC------
T ss_pred cc--cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-CC------
Confidence 21 1222344567889999999998899999999999999999998 99999876666655444332110 00
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+...+ ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 236 ------~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 ------PDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00011 12457899999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=353.08 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=195.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|++.++||+|+||.||+|+.+ +++.||+|++.... ...+.+.+|..+++++ +||||+++++++.+ ....|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence 467999999999999999999986 47899999985432 2234588999999887 89999999999985 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|+...
T Consensus 130 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999999863 348999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh-----HHHHHHHHhhhccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-----IVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~-----~~~~~~~~~~~~~~~~ 1030 (1099)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+.+.+......
T Consensus 205 ---~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 205 ---RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp ---CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred ---cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 12233456789999999999999999999999999999999999999996432211 112222222222110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
++.. .. ..+.+++.+||+.||++||++
T Consensus 281 --------~p~~-~s----~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 --------IPRS-LS----VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCTT-SC----HHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCc-CC----HHHHHHHHHHhcCCHhHcCCC
Confidence 0001 01 124588999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=342.55 Aligned_cols=274 Identities=15% Similarity=0.177 Sum_probs=214.0
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|++++++++|++++..+.++.......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46899999999999999999997 568999999885433 3356899999999999999888888776667777999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~ 957 (1099)
+ +|+|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 87 L-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9 89999999743 2358999999999999999999999999999999999999 48889999999999865322
Q ss_pred CCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc---hhHHHHHHHHhhhccccc
Q 047739 958 PAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQD---EDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 958 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~ 1030 (1099)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2111 123456899999999999999999999999999999999999999976332 223333332211111110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCC
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTT 1094 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 1094 (1099)
..+.+ + ..+.+++.+||+.||++|||+.||++.|+++.............|
T Consensus 242 -~~~~~--------~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 242 -LCKGY--------P----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp -HTTTS--------C----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred -HHhhC--------C----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 01111 0 124578999999999999999999999998876655544444433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=352.25 Aligned_cols=248 Identities=20% Similarity=0.291 Sum_probs=196.1
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
|...++||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~ 169 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVD 169 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCC
Confidence 344678999999999999875 58999999986544 345779999999999999999999999985 455799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE--CCCCcEEEeccccccccCCCCCC
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF--DADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+|+|.+++.... ..+++..+..++.||++||+|||+.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 170 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~---- 241 (373)
T 2x4f_A 170 GGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---- 241 (373)
T ss_dssp TCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT----
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC----
Confidence 999999987532 348999999999999999999999999999999999999 6778999999999986532
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+....+..... .. .+..+...
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~---~~~~~~~~- 315 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW--DL---EDEEFQDI- 315 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CS---CSGGGTTS-
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CC---ChhhhccC-
Confidence 1223445799999999999988899999999999999999999999987766555444433211 00 01111000
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|||+.|+++
T Consensus 316 ----~----~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 ----S----EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----C----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----C----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 13468999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=352.15 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=199.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++|||||++++++.+. ...|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEE
Confidence 367999999999999999999986 4789999998532 22346788999999999999999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP- 166 (384)
T ss_dssp EECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc-
Confidence 99999999999999752 348999999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCccccccccCccccCcccccc---CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
........+||+.|+|||++.. ..++.++||||+||++|||++|+.||...........+... ...... ..
T Consensus 167 ---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~--~p 240 (384)
T 4fr4_A 167 ---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ETTVVT--YP 240 (384)
T ss_dssp ---TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HHCCCC--CC
T ss_pred ---CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hhcccC--CC
Confidence 2233456789999999999874 45899999999999999999999999765443332222221 111100 00
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-MSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~ 1075 (1099)
..+ . ..+.+++.+||+.||++||+ ++++.+
T Consensus 241 ~~~--------s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAW--------S----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTS--------C----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcC--------C----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 0 13468899999999999998 777764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=348.38 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=197.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCC------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD------ 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 872 (1099)
.++|+..+.||+|+||.||+|+++ +|+.||+|++... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 6899999998533 3345779999999999999999999999864332
Q ss_pred --------------------------------------------------ceEEEEeecCCCCHHHHHhhhccCCCCCCC
Q 047739 873 --------------------------------------------------LRLLVYDYMPNGNLGTLLQEASHQDGHVLN 902 (1099)
Q Consensus 873 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~ 902 (1099)
..++||||+++|+|.+++.... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchh
Confidence 2689999999999999998633 223457
Q ss_pred HHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC---------CccccccccCccc
Q 047739 903 WPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE---------ASTSTTAVGTLGY 973 (1099)
Q Consensus 903 ~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~---------~~~~~~~~gt~~y 973 (1099)
+..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........ ........||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 7788999999999999999999999999999999999999999999999865332111 1223456799999
Q ss_pred cCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHH
Q 047739 974 VSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGV 1053 (1099)
Q Consensus 974 ~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 1053 (1099)
+|||++.+..++.++||||+|+++|||++|..|+. +... ............. .......+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~-~~~~~~~~~~~~~-------------~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVR-IITDVRNLKFPLL-------------FTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHH-HHHHHHTTCCCHH-------------HHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHH-HHHHhhccCCCcc-------------cccCChhHH
Confidence 99999999999999999999999999999887642 1111 1111111111110 111112346
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1054 KVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1054 ~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+++.+||+.||++|||+.|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 79999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=353.04 Aligned_cols=267 Identities=17% Similarity=0.183 Sum_probs=199.1
Q ss_pred HhccccccccccccceeEEEEEEC----CceEEEEEECCCCCcc------------HHHHHHHHHHhhhccCCcceEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLD------------ENLFRKEAEFLGKVRHRNLTVLRG 865 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~H~niv~l~~ 865 (1099)
.++|.+.+.||+|+||.||+|.+. .+..||+|........ .+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999986 5788999988654321 134667888999999999999999
Q ss_pred EEecC---CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-
Q 047739 866 YYAGA---PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF- 941 (1099)
Q Consensus 866 ~~~~~---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~- 941 (1099)
++... ....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 98752 45679999999 999999997532 589999999999999999999999999999999999998877
Q ss_pred -cEEEeccccccccCCCCC----CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCC-CchhH
Q 047739 942 -EAHLSDFGLDRLTIPTPA----EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDEDI 1015 (1099)
Q Consensus 942 -~~kl~DfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~-~~~~~ 1015 (1099)
.+||+|||+++....... .........||..|+|||++.+..++.++|||||||++|||++|+.||... .....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999976532211 112234568999999999999999999999999999999999999999643 22222
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
......... ..+......... ....+ ..+.+++.+||+.||++||++.+|++.|+....
T Consensus 270 ~~~~~~~~~-~~~~~~~~~~~~---~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLL-DELPQSVLKWAP---SGSSC----CEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHH-HTTTHHHHHHSC---TTSCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhc-ccccHHHHhhcc---ccccH----HHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 222222211 111111110000 00000 134678999999999999999999999998765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.87 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=202.7
Q ss_pred Hhcccccc-ccccccceeEEEEEEC---CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEEN-VLSRTRYGLVFKACYN---DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|.+.+ .||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|++++++++||||+++++++. .+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence 46788887 9999999999999653 468899999865432 2467899999999999999999999994 3446
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 8999999999999999753 34889999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
..............++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+.. +..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~~~~~-~ 242 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGC-P 242 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCC-C
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCC-C
Confidence 332222222334557789999999988889999999999999999999 9999987666554443332 111100 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. ..+ ..+.+++.+||+.||++||++.|+++.|+++
T Consensus 243 ~--------~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 243 A--------GCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp T--------TCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C--------CCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 001 1345789999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.96 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=203.5
Q ss_pred hccccccccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+|...++||+|+||.||+|.+.+ +..||+|.+..... ..+.+.+|++++++++||||+++++++...+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998643 34689999865332 346789999999999999999999997766667799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999742 34578999999999999999999999999999999999999999999999999986532
Q ss_pred CCC-CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 957 TPA-EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 957 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||......+....+..... ...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 253 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------LLQ- 253 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC------CCC-
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC------CCC-
Confidence 211 1122345568889999999999999999999999999999999 5666665555444433322110 000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+...+ ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 254 ------~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 254 ------PEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111 124678999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=344.34 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=203.8
Q ss_pred HhccccccccccccceeEEEEEE-----CCceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-Cc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~ 873 (1099)
.++|+..+.||+|+||.||+|.+ .+++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999985 358999999986432 23477999999999999999999999987542 44
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 689999999999999996532 3489999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC-----------chhHHHHHHHH
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ-----------DEDIVKWVKKQ 1022 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~-----------~~~~~~~~~~~ 1022 (1099)
...............||..|+|||++.+..++.++||||+|+++|||++|..|+.... .......+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6433222234455678899999999999899999999999999999999999864211 01111111111
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+.... . +.... ..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 256 ~~~~~~~~--------~-~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLP--------C-PPNCP----DEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCC--------C-CTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCC--------C-CCCCC----HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111000 0 01111 1346899999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.27 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=202.6
Q ss_pred HhccccccccccccceeEEEEEECC-ce----EEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GM----VLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
.++|+..++||+|+||.||+|.+.. ++ +|++|.+... ....+.+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence 3579999999999999999999753 33 4688877543 334578999999999999999999999998543 6
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++|+||+++|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred eEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 8999999999999999753 234899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... ..........+|..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+....... .
T Consensus 168 ~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----~- 240 (327)
T 3lzb_A 168 GAE-EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-----Q- 240 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----C-
T ss_pred cCc-cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----C-
Confidence 322 12223334567889999999999999999999999999999999 999998877666554443321100 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+.... ..+.+++.+||+.||++||++.|+++.|+++...+
T Consensus 241 -------~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 241 -------PPICT----IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -------CTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -------CccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 01111 12457899999999999999999999999887544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=361.69 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=199.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999875 58999999986432 23467889999999999999999999987432 3
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+||||+++ ++.+.+.. .+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 46999999975 57666642 28899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc---
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT--- 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 1029 (1099)
.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+.+........
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 6521 223455789999999999999999999999999999999999999998877666555554433221000
Q ss_pred -------ccccC--ccc----------CCCCCChhHH--HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 -------ELLEP--GLL----------ELDPESSEWE--EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 -------~~~d~--~~~----------~~~~~~~~~~--~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.. ... ...+...... .-..+.+++.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000 0000011111 12346789999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=346.50 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=203.3
Q ss_pred ccccccccccccceeEEEEEEC-----CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecC-CCceE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-----DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRL 875 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~ 875 (1099)
.|...+.||+|+||.||++.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.+. ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3589999999999999999763 57899999997543 2346789999999999999999999999864 35568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999999752 38999999999999999999999999999999999999999999999999998763
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh-----------HHHHHHHHhh
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-----------IVKWVKKQLQ 1024 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~-----------~~~~~~~~~~ 1024 (1099)
.............+|..|+|||++.+..++.++||||+|+++|||++|+.||....... ....+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 32222233445678889999999999899999999999999999999999986432210 0111111111
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+... ..+.... ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 266 ~~~~~---------~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGERL---------PRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCCC---------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCC---------CCCcccc----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11100 0011111 23468999999999999999999999998774
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=345.23 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=197.1
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|.+.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|++++++++||||+++++++.. +...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEE
Confidence 3578999999999999999999986 6899999998643222 3678899999999999999999999985 45569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999999863 248999999999999999999999999999999999999999999999999997652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ..........|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.. .........+.
T Consensus 186 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~ 260 (309)
T 2h34_A 186 D--EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AIPRPSTVRPG 260 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CCCCGGGTSTT
T ss_pred c--cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CCCCccccCCC
Confidence 2 112233456799999999999998999999999999999999999999976544322221111 00000111111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHhhcccCCCCCCCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLEGCRVGPDIPSS 1089 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~~~~~ 1089 (1099)
+. ..+.+++.+||+.||++|| +++++++.|++.....+...+
T Consensus 261 ~~------------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~ 303 (309)
T 2h34_A 261 IP------------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303 (309)
T ss_dssp CC------------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred CC------------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence 10 1235789999999999999 999999999988666654443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=346.92 Aligned_cols=273 Identities=23% Similarity=0.290 Sum_probs=204.3
Q ss_pred HHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc--cCCcceEEeeEEecCC---C
Q 047739 798 TVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV--RHRNLTVLRGYYAGAP---D 872 (1099)
Q Consensus 798 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~---~ 872 (1099)
.....++|++.+.||+|+||.||+|++. ++.||+|++... ....+.+|.+++... +||||+++++++.... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3445678999999999999999999987 889999998543 334455666666554 8999999999987543 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC--------CceecCCCCCCEEECCCCcEE
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS--------NMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~iiH~Dlk~~NIll~~~~~~k 944 (1099)
..++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred ceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 56999999999999999975 2489999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCCCCC-CccccccccCccccCccccccCCCCCc------CchhhHHHHHHHHHhC----------CCCC
Q 047739 945 LSDFGLDRLTIPTPAE-ASTSTTAVGTLGYVSPEAALTGETTKE------SDVYSFGIVLLELLTG----------KRPV 1007 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DV~S~G~il~elltg----------~~P~ 1007 (1099)
|+|||+++........ ........||+.|+|||++.+..++.+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999765322111 122335689999999999988776665 9999999999999999 6777
Q ss_pred CCCCch-hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1008 MFTQDE-DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1008 ~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
...... .....+................+ ........+.+++.+||+.||++|||+.||++.|+++....+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRW-------SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-------GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccc-------hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 543221 11222222222111111111111 0112223456899999999999999999999999988766543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=349.81 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=198.2
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+.|+..+.||+|+||.||+|.. .+|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEE
Confidence 45699999999999999999997 46899999998543222 25688999999999999999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+. |++.+++.... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 132 v~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999997 68888886432 3589999999999999999999999999999999999999999999999999976521
Q ss_pred CCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.. ........
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 275 (348)
T 1u5q_A 207 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQS 275 (348)
T ss_dssp -------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCCC
T ss_pred -------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCC
Confidence 23457999999999985 56789999999999999999999999976654443332222 11111111
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHh
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1077 (1099)
.. .+ ..+.+++.+||+.||++|||++|+++.-
T Consensus 276 ~~--------~~----~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 GH--------WS----EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC--------CC----HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 10 01 1235789999999999999999998653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=361.69 Aligned_cols=321 Identities=21% Similarity=0.240 Sum_probs=220.0
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
-+.++.++++++. +|..+. +++++|||++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 13 DRAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TTEEECCSCCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 3578888888884 454443 5788999999998887788888888888888888888888888888888888888888
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|.+++..+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 88886555667888888888888888887777788888888888888888877777777777788888888887776666
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 535 (1099)
..+.++++|+.|+|++|.+.+..+..|.++++|+.|++++|.+.+.++.......+|+.|+|++|++++..+..|..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 66777777777777777777666667777777777777777666555555554555666666666665443345555555
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccC
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI 615 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 615 (1099)
|++|+|++|.+++..+ ..|.++++|++|+|++|++++..|..+..+++|+.|+|++
T Consensus 250 L~~L~Ls~n~l~~~~~------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (477)
T 2id5_A 250 LRFLNLSYNPISTIEG------------------------SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305 (477)
T ss_dssp CCEEECCSSCCCEECT------------------------TSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred cCeeECCCCcCCccCh------------------------hhccccccCCEEECCCCccceECHHHhcCcccCCEEECCC
Confidence 5555555555544333 3444444555555555555544444555555555555555
Q ss_pred ccccccCCcccCCCCCCCEEECcCcccc
Q 047739 616 NNLTGEIPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 616 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
|++++..+..+..+++|+.|+|++|++.
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555433334445555555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=361.11 Aligned_cols=321 Identities=23% Similarity=0.235 Sum_probs=278.4
Q ss_pred ceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEcc
Q 047739 271 IRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350 (1099)
Q Consensus 271 l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 350 (1099)
-+.++...+.++.+|.. ..+.+++|+|++|+|++..+..|..+++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 13 ~~~v~c~~~~l~~ip~~----~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 88 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEG----IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88 (477)
T ss_dssp TTEEECCSCCCSSCCSC----CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcCcCCCC----CCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence 35788888999988763 24689999999999999989999999999999999999998889999999999999999
Q ss_pred CCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc
Q 047739 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430 (1099)
Q Consensus 351 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 430 (1099)
+|+++...+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..
T Consensus 89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 99999877778999999999999999999888999999999999999999999999999999999999999999999877
Q ss_pred chhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCC
Q 047739 431 PEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLP 510 (1099)
Q Consensus 431 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 510 (1099)
+..+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.++..+....+|++|++++|++++..+..+..++
T Consensus 169 ~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 248 (477)
T 2id5_A 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248 (477)
T ss_dssp HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCT
T ss_pred hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcc
Confidence 78899999999999999999988888999999999999999998888888777778999999999999966667899999
Q ss_pred ccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEec
Q 047739 511 NLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELR 590 (1099)
Q Consensus 511 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~ 590 (1099)
+|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..+++|++|+|+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 328 (477)
T 2id5_A 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328 (477)
T ss_dssp TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence 99999999999998888888888999999988888876666666555555555555555554444444444455555555
Q ss_pred CCccc
Q 047739 591 SNSLT 595 (1099)
Q Consensus 591 ~N~l~ 595 (1099)
+|.+.
T Consensus 329 ~N~l~ 333 (477)
T 2id5_A 329 SNPLA 333 (477)
T ss_dssp SSCEE
T ss_pred CCCcc
Confidence 55444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=346.99 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=200.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
.++|...+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999985 589999999854332 2366889999999999999999999987542 2
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+||||+ +++|.++++. ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 359999999 7899999975 248899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc----
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---- 1027 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1027 (1099)
.... .....+||..|+|||++.+ ..++.++||||+||+++||++|+.||.+.+..+....+........
T Consensus 177 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 6421 2345688999999999887 6799999999999999999999999987776655555444322110
Q ss_pred --------------ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HhhcccCCCC
Q 047739 1028 --------------ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCRVGPD 1085 (1099)
Q Consensus 1028 --------------~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~ 1085 (1099)
+.......+....+.. -..+.+++.+|++.||++|||++|+++ .++......+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNA-----SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTC-----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCC-----CHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 0000011111111111 123468999999999999999999998 4555544333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.64 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=197.0
Q ss_pred hccccccccccccceeEEEEEE-CCceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+|.+.+.||+|+||.||+|.+ .+++.||+|.+.... ...+.+.+|++++++++||||+++++++.. +...++|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 5799999999999999999997 468999999985321 123578999999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+ +|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 9999 68999998753 2489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......... .+....
T Consensus 161 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------~i~~~~ 224 (336)
T 3h4j_B 161 ---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------KVNSCV 224 (336)
T ss_dssp ---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------CCCSSC
T ss_pred ---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHHcCC
Confidence 223345689999999999988776 689999999999999999999997543322111 111111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+.. .. ..+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~p~~-~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDF-LS----PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTT-SC----HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCccc-CC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 11 124578999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.71 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=198.3
Q ss_pred HhccccccccccccceeEEEEEEC--Cc--eEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--DG--MVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|.+. ++ ..||+|.+.... ...+.+.+|++++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 467999999999999999999863 23 468999886432 23467899999999999999999999998543
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 589999999999999997632 3488999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
...............+|..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+... .. ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~ 246 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GE-RLPR 246 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---CC-CCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc---CC-CCCC
Confidence 5333222223345568889999999998889999999999999999999 99999877665544433221 10 0000
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
. ...+ ..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 247 ~--------~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 247 P--------EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred C--------cCcC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0 0011 13457899999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=342.43 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=204.2
Q ss_pred ccccccccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.|...++||+|+||.||+|.+.+ +..||+|.+..... ..+.+.+|++++++++||||+++++++.......++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998632 34799999865333 2367889999999999999999999998666656899
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+.+|+|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999752 345889999999999999999999999999999999999999999999999999754221
Q ss_pred CC-CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCC-CCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 958 PA-EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP-VMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 958 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.. .........+|..|+|||.+.+..++.++||||+|+++|||++|..| |......+....+..... ... .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~----~-- 250 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LPQ----P-- 250 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CCC----C--
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CCC----C--
Confidence 11 12233456788999999999999999999999999999999995555 444444444433332211 000 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.... ..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 251 ------~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 251 ------EYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------ccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0001 1345789999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.94 Aligned_cols=269 Identities=16% Similarity=0.199 Sum_probs=207.0
Q ss_pred HHHhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
...++|+..+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|++++++++|++++..++++.......++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3457899999999999999999997 568999999864432 23458899999999999998888888766777789999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~ 955 (1099)
||+ +|+|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 89999999753 2348999999999999999999999999999999999999 788999999999998653
Q ss_pred CCCCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch---hHHHHHHHHhhhccc
Q 047739 956 PTPAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE---DIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 956 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~ 1028 (1099)
...... .......||..|+|||.+.+..++.++||||+||++|||++|+.||...... .....+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 322111 2234568999999999999999999999999999999999999999764332 222222222111111
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
. .....+. ..+.+++.+||+.||++|||+.||++.|+++.......
T Consensus 240 ~-~~~~~~~------------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 240 E-VLCKGYP------------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp H-HHTTTSC------------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred h-hhhccCC------------HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 0 0001110 13468899999999999999999999999876544433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=346.35 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=198.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|+..+.||+|+||.||+|+.+ +++.||+|.+.... ...+.+.+|.++++++ +||||+++++++.+ ....|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEE
Confidence 357999999999999999999986 58999999986432 1235688999999988 89999999999985 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999999753 248999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-----hHHHHHHHHhhhccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE-----DIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~-----~~~~~~~~~~~~~~~~~ 1030 (1099)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.+.+......
T Consensus 162 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 162 R---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp C---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-
T ss_pred C---CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-
Confidence 1 122345568999999999999999999999999999999999999999642211 1111222222222110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM------SDIVF 1075 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~ 1075 (1099)
+.. . .. ..+.+++.+||+.||++||++ .|+++
T Consensus 238 -~p~-------~-~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 -IPR-------S-LS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCT-------T-SC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCC-------C-CC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 011 1 11 124578999999999999995 56654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.15 Aligned_cols=265 Identities=19% Similarity=0.243 Sum_probs=207.3
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-----CCcceEEeeEEecCCCc
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-----HRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~ 873 (1099)
...++|.+.++||+|+||.||+|.+. +++.||+|++.......+.+..|++++++++ ||||+++++++... +.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~ 110 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DH 110 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-Ce
Confidence 34678999999999999999999984 5889999999765555677889999999996 99999999999854 55
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC--------------
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-------------- 939 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-------------- 939 (1099)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 69999999 899999998532 234899999999999999999999999999999999999975
Q ss_pred -----------CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCC
Q 047739 940 -----------DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVM 1008 (1099)
Q Consensus 940 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~ 1008 (1099)
++.+||+|||+|+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999985421 2235679999999999999999999999999999999999999998
Q ss_pred CCCchhHHHHHHHHhhhcc-----------ccccccCc-cc-CCCCCChhHHH---------------HHHHHHHHHhcC
Q 047739 1009 FTQDEDIVKWVKKQLQKGQ-----------ITELLEPG-LL-ELDPESSEWEE---------------FLLGVKVALLCT 1060 (1099)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~-----------~~~~~d~~-~~-~~~~~~~~~~~---------------~~~~~~li~~Cl 1060 (1099)
.....+....+........ ....++.. .. ........... -..+.+++.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 7766655554443321100 00000000 00 00000000000 033568999999
Q ss_pred CCCCCCCCCHHHHHH
Q 047739 1061 APDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1061 ~~dP~~RPs~~evl~ 1075 (1099)
+.||++|||++|+++
T Consensus 341 ~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 341 QIDPTLRPSPAELLK 355 (360)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=343.07 Aligned_cols=264 Identities=19% Similarity=0.291 Sum_probs=201.4
Q ss_pred HHHhccccccccccccceeEEEEEEC----CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
...++|...+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|++++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35678999999999999999999864 3568999998654332 3568899999999999999999999875432
Q ss_pred ----ceEEEEeecCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 873 ----LRLLVYDYMPNGNLGTLLQEASH-QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 873 ----~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
..++||||+++|+|.+++..... .....+++..++.++.|+++||+|||+.+|+||||||+||+++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 34899999999999999964322 2345689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhc
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+.....
T Consensus 191 fg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 267 (313)
T 3brb_A 191 FGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-- 267 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--
T ss_pred cCcceeccccc-ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--
Confidence 99997652211 1122344567889999999999999999999999999999999 8999987766665554432211
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
... .+ ... ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 268 --~~~-~~--------~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 268 --LKQ-PE--------DCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp --CCC-BT--------TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC-Cc--------ccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 00 001 13467899999999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.53 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|...+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEE
Confidence 468999999999999999999985 5889999988543 2345789999999999999999999999984 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~ 955 (1099)
||+++|+|.+++..... ....+++..+..++.|+++||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 100 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999999975422 23458999999999999999999999999999999999999 456889999999997652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ........||..|+|||.+. +.++.++||||+|+++|||++|+.||......+....+.... .... ..
T Consensus 179 ~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~--~~-- 247 (285)
T 3is5_A 179 S----DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--PNYA--VE-- 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC--C---
T ss_pred C----cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--cccc--cc--
Confidence 2 22334567999999999875 578999999999999999999999998766555443332211 0000 00
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+.. ..+.+++.+||+.||++|||+.|+++
T Consensus 248 ---~~~~~------~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRPLT------PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCC------HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCcCC------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001 12457899999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=342.91 Aligned_cols=268 Identities=19% Similarity=0.290 Sum_probs=198.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
..+|.+.+.||+|+||.||+|... +|..||+|++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEE
Confidence 457999999999999999999974 68999999986422 2346688999999999999999999999854 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999999976432 234589999999999999999999999999999999999999999999999999876422
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.........|+..|+|||++.+..++.++||||||+++|||++|+.||....... .. +...+...........
T Consensus 189 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~-- 261 (310)
T 2wqm_A 189 ---KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS-LCKKIEQCDYPPLPSD-- 261 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HH-HHHHHHTTCSCCCCTT--
T ss_pred ---CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HH-HHHHhhcccCCCCccc--
Confidence 1122334578999999999999999999999999999999999999997543221 11 1122222221111111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCC
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPS 1088 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1088 (1099)
... ..+.+++.+||+.||++|||+.||++.|+++.+....+.
T Consensus 262 ------~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 262 ------HYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ------TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ------ccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 011 124578999999999999999999999999876655543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=339.27 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=204.2
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEec----------
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG---------- 869 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 869 (1099)
...+|+..+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 4568999999999999999999986 68999999986532 467899999999999999999998753
Q ss_pred -----CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 870 -----APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 870 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
.....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 1234589999999999999997532 24589999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
|+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|..|+... . .......
T Consensus 163 l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~-~~~~~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S-KFFTDLR 232 (284)
T ss_dssp ECCCTTCEESSCC----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H-HHHHHHH
T ss_pred ECcchhheecccc----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H-HHHHHhh
Confidence 9999999765321 2234457999999999999999999999999999999999999886421 1 1111122
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
.+.+...++ ..+.+++.+||+.||++||++.|+++.|+.+...+...
T Consensus 233 ~~~~~~~~~----------------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 233 DGIISDIFD----------------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp TTCCCTTSC----------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred cccccccCC----------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 221111111 12357899999999999999999999999887766543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=377.26 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=197.5
Q ss_pred cccccccceeEEEEEEC---CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYN---DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
+.||+|+||.||+|.+. .+..||||++..... ..+.+.+|++++++++|||||++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence 47999999999999763 468899999975433 24779999999999999999999999973 33689999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.++++.. ..+++..+..|+.||+.||+|||+.+|+||||||+||+++.++.+||+|||+|+..........
T Consensus 453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999752 3489999999999999999999999999999999999999999999999999986633322223
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+..... ... .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----~~~-p-------- 594 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGC-P-------- 594 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCC-C--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCC-C--------
Confidence 3344567889999999999999999999999999999998 9999987776655544433211 100 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+ ..+.+++.+||+.||++||++.+|++.|+++
T Consensus 595 ~~~~----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 595 AGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 1345789999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=350.64 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=207.1
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|...+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+++++++ +||||+++++++... .
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-G 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-C
Confidence 5689999999999999999999753 24799999865432 346789999999999 899999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcE
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQ---------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
..++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+.||+||||||+||+++.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 569999999999999999764311 12457999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~ 1022 (1099)
||+|||+++..... ..........||+.|+|||++.+..++.++||||||+++|||++ |..||...........+...
T Consensus 204 kl~Dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 204 KIGDFGLARDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EBCCCGGGCCGGGC-TTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EECccccccccccc-cceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 99999999865322 12223344567889999999999999999999999999999999 99999765544333322221
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
..... . +...+ ..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 283 ~~~~~-----~-------~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 283 GYQMA-----Q-------PAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp TCCCC-----C-------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC-----C-------CCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11100 0 01111 13457899999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=340.24 Aligned_cols=265 Identities=20% Similarity=0.307 Sum_probs=198.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|+..+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence 47899999999999999999986 588999999854332 236788999999999999999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++ ++.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 153 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-- 153 (292)
T ss_dssp ECCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--
T ss_pred ecCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--
Confidence 99975 676666542 24589999999999999999999999999999999999999999999999999986521
Q ss_pred CCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCC-CCCchhHHHHHHHHhhhccccccc---c
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVM-FTQDEDIVKWVKKQLQKGQITELL---E 1033 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~-~~~~~~~~~~~~~~~~~~~~~~~~---d 1033 (1099)
.........||..|+|||++.+.. ++.++||||+||++|||++|..||. .....+....+............. .
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 223334568899999999998766 7999999999999999999888854 444444444444332221110000 0
Q ss_pred -CcccCC--CCCC-----hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 -PGLLEL--DPES-----SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 -~~~~~~--~~~~-----~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+..... .+.. .....-..+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 0000 000001234589999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=343.17 Aligned_cols=245 Identities=22% Similarity=0.234 Sum_probs=190.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..++||+|+||+||+|.+. +|+.||||++...... ...+.+|+..+.++ +||||+++++++.+ ....++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEE
Confidence 468999999999999999999987 6899999998543322 23455666666655 89999999999985 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 135 v~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 679999987642 4589999999999999999999999999999999999999999999999999876522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .... +..+..........
T Consensus 210 ----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~----~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 210 ----AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQ----LRQGYLPPEFTAGL 277 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHH----HTTTCCCHHHHTTS
T ss_pred ----CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHH----HhccCCCcccccCC
Confidence 223345579999999998875 78999999999999999999977664321 1111 11111111111111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
-..+.+++.+||+.||++|||++|+++.
T Consensus 278 ------------~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 ------------SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ------------CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------------CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0234689999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=360.45 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=204.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.+|.+.+.||+|+||.||+|.+. +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.. +...++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence 57899999999999999999986 68999999985432 123578899999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 9999999999999742 3489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...........+... ... . +
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----~~~--~-p-- 236 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----IFY--T-P-- 236 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT----CCC--C-C--
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----CcC--C-C--
Confidence 223345689999999999988765 68999999999999999999999876665554443321 110 0 0
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhc
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEG 1079 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~ 1079 (1099)
.... ..+.+++.+||+.||++|||+.||++ .+.+
T Consensus 237 -----~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 237 -----QYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -----TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -----ccCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 0001 12457899999999999999999997 4543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=341.62 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=204.3
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-------cHHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-------DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
..++|++.+.||+|+||.||+|... +|..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 88 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RT 88 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CC
Confidence 3567999999999999999999986 588999998854321 35779999999999999999999999985 45
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC----cEEEecc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDF 948 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~Df 948 (1099)
..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++ .+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 569999999999999999742 3489999999999999999999999999999999999999887 7999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
|+++.... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||......+....+..... ..
T Consensus 164 g~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~ 237 (321)
T 2a2a_A 164 GLAHEIED----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY--DF 237 (321)
T ss_dssp TTCEECCT----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CC
T ss_pred ccceecCc----cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--cc
Confidence 99986522 1223456799999999999999999999999999999999999999987665554443322110 00
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
........ -..+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 DEEFFSHT------------SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHHHTTC------------CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred Chhhhccc------------CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0134689999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=357.65 Aligned_cols=275 Identities=20% Similarity=0.211 Sum_probs=207.9
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-CceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~lV~ 878 (1099)
++|.+.++||+|+||.||+|.+.. |+.||+|++.... ...+.+.+|++++++++||||+++++++.... ...++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578999999999999999999864 8999999986433 23467889999999999999999999987543 3568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----CCCCcEEEecccccccc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF----DADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll----~~~~~~kl~DfGla~~~ 954 (1099)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+.||+||||||+||++ +.++.+||+|||+++..
T Consensus 89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999986322 2348999999999999999999999999999999999999 78888999999999865
Q ss_pred CCCCCCCccccccccCccccCcccccc--------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT--------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
.. ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...+..+
T Consensus 167 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 167 ED----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CC----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred cC----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 22 223345679999999998865 467889999999999999999999996533222111111112211
Q ss_pred cccccc-------cCc--cc-CCCC-CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1027 QITELL-------EPG--LL-ELDP-ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1027 ~~~~~~-------d~~--~~-~~~~-~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
...... ... +. .... .......-..+.+++.+||+.||++||++.|+++.++++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111000 000 00 0011 111122233456899999999999999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=352.14 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=192.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHH-hhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEF-LGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|+..++||+|+||.||+|+.+ +++.||+|++..... ..+.+.+|..+ ++.++||||+++++++.+ .+..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEE
Confidence 467999999999999999999986 478999999854322 23456677776 577899999999999985 45679
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 116 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999999863 247889999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..+.+... .. .+.+.
T Consensus 191 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~--~~~~~ 261 (373)
T 2r5t_A 191 E---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PL--QLKPN 261 (373)
T ss_dssp C---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----CC--CCCSS
T ss_pred c---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----cc--CCCCC
Confidence 1 122345678999999999999999999999999999999999999999877665555544332 11 01111
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1072 (1099)
+ . ..+.+++.+||+.||++||++.+
T Consensus 262 ~--------~----~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 I--------T----NSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp S--------C----HHHHHHHHHHTCSSGGGSTTTTT
T ss_pred C--------C----HHHHHHHHHHcccCHHhCCCCCC
Confidence 1 1 12457899999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=360.48 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=194.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..++||+|+||.||+|... +|+.||+|.+... ......+.+|++++++++||||+++++++... +..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEE
Confidence 467999999999999999999975 5899999998532 22335678899999999999999999999854 45699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
||||+++|+|.+++... ..+++..+..++.||++||+|||+ .||+||||||+||+++.++.+||+|||+|+...
T Consensus 226 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999753 348999999999999999999998 999999999999999999999999999997532
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.... ...+ .
T Consensus 301 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p----~- 370 (446)
T 4ejn_A 301 ---KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFP----R- 370 (446)
T ss_dssp ---C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC----T-
T ss_pred ---CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCC----c-
Confidence 12233455789999999999999999999999999999999999999998776665555443321 0111 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. .. ..+.+++.+||+.||++|| +++|+++
T Consensus 371 ------~-~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 371 ------T-LG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------T-SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------c-CC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 01 1245899999999999999 9999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.51 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=199.5
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|++++++++||||+++++++.+. ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence 4689999999999999999998764 67899999854221 245688999999999999999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~- 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC-
Confidence 99999999999999764 238899999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........||..|+|||.+.+..++.++||||+|+++|||++|+.||......+....+.... ......
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~----- 229 (279)
T 3fdn_A 161 ----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDF----- 229 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTT-----
T ss_pred ----cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCCc-----
Confidence 122344679999999999999999999999999999999999999998766555444433210 000000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. ..+.+++.+||+.||++|||+.|+++.
T Consensus 230 -------~~----~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 -------VT----EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------SC----HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------CC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 123578999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.72 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=203.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|++.+.||+|+||.||+|... +|..||+|.+..... ..+.+.+|++++++++||||+++++++.. +...++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEE
Confidence 467999999999999999999986 488999999854332 23668899999999999999999999984 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc---EEEecccccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE---AHLSDFGLDRLT 954 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla~~~ 954 (1099)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999998753 34899999999999999999999999999999999999986655 999999999765
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||...........+...... ...+
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~ 229 (284)
T 3kk8_A 159 ND----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----YPSP 229 (284)
T ss_dssp CS----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCTT
T ss_pred cc----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-----CCch
Confidence 22 22334567999999999999999999999999999999999999999877665555444332111 1111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.. .. ..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~-----~~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDT-----VT----PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTT-----SC----HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcc-----cC----HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1100 01 124578999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.90 Aligned_cols=250 Identities=24% Similarity=0.279 Sum_probs=202.1
Q ss_pred HHhccccccccccccceeEEEEEECC-ceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..++|.+.+.||+|+||.||+|.... +..||+|++... ....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEE
Confidence 45689999999999999999999864 678999988543 3345789999999999999999999999984 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~ 955 (1099)
||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999998753 338999999999999999999999999999999999999 788999999999997652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. ........||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+....+..... .........
T Consensus 161 ~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 233 (277)
T 3f3z_A 161 P----GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF--TFPEKDWLN 233 (277)
T ss_dssp T----TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCHHHHTT
T ss_pred C----ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CCCchhhhc
Confidence 2 223345679999999998765 489999999999999999999999987666554444333211 000000000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. -..+.+++.+|++.||++||++.|+++
T Consensus 234 ~------------~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 234 V------------SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp S------------CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C------------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 023457899999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=348.89 Aligned_cols=267 Identities=22% Similarity=0.369 Sum_probs=207.3
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.++++++||||+++++++.... .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-C
Confidence 468999999999999999999842 46789999996432 33467889999999999999999999998544 4
Q ss_pred eEEEEeecCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQ--DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDF 948 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~Df 948 (1099)
.++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+.||+||||||+||+++. +..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 59999999999999999864322 2245899999999999999999999999999999999999984 446999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+++..... ..........||..|+|||++.+..++.++||||||+++|||++ |+.||......+....+... .
T Consensus 188 g~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~ 262 (327)
T 2yfx_A 188 GMARDIYRA-SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----G 262 (327)
T ss_dssp HHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----C
T ss_pred ccccccccc-cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC----C
Confidence 998754211 11223345678999999999998999999999999999999998 99999876655544433321 1
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
... .. ...+ ..+.+++.+||+.||++||++.|+++.|+.+...++..
T Consensus 263 ~~~-~~--------~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 263 RMD-PP--------KNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp CCC-CC--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred CCC-CC--------CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 100 00 0011 12457899999999999999999999999887665543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=349.45 Aligned_cols=263 Identities=24% Similarity=0.266 Sum_probs=201.3
Q ss_pred HHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCC------CccHHHHHHHHHHhhhccCCcceEEeeEEecC
Q 047739 798 TVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG------SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870 (1099)
Q Consensus 798 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 870 (1099)
+....++|.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 3567789999999999999999999985 5789999988432 2344779999999999999999999999985
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccC-----------------------------------CCCCCCHHHHHHHHHHHHH
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQ-----------------------------------DGHVLNWPMRHLIALGVAR 915 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~ 915 (1099)
....++||||+++|+|.+++...... ....+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 45679999999999999999632111 0122457778889999999
Q ss_pred HHHHHccCCceecCCCCCCEEECCCC--cEEEeccccccccCCCC-CCCccccccccCccccCcccccc--CCCCCcCch
Q 047739 916 GLAFLHTSNMVHGDIKPQNVLFDADF--EAHLSDFGLDRLTIPTP-AEASTSTTAVGTLGYVSPEAALT--GETTKESDV 990 (1099)
Q Consensus 916 ~L~~LH~~~iiH~Dlk~~NIll~~~~--~~kl~DfGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV 990 (1099)
||+|||+.+|+||||||+||+++.++ .+||+|||+++...... ..........||+.|+|||.+.+ ..++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998766 89999999998542221 12223456679999999999875 678999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH
Q 047739 991 YSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM 1070 (1099)
Q Consensus 991 ~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1070 (1099)
||+|+++|||++|+.||......+....+....... ..+..... -..+.+++.+||+.||++||++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF-----ENPNYNVL---------SPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT-----TSGGGGGS---------CHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc-----CCcccccC---------CHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999998776655444433321100 00110000 0134578999999999999999
Q ss_pred HHHHH
Q 047739 1071 SDIVF 1075 (1099)
Q Consensus 1071 ~evl~ 1075 (1099)
.|+++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=354.90 Aligned_cols=210 Identities=21% Similarity=0.259 Sum_probs=176.9
Q ss_pred Hhccccccccccc--cceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRT--RYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..+|++.++||+| +||.||+|+.. +|+.||+|++...... .+.+.+|++++++++|||||++++++... ...+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEE
Confidence 4579999999999 99999999987 6899999998643322 35688899999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ....+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999753 22348999999999999999999999999999999999999999999999999886432
Q ss_pred CCC----CCCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 956 PTP----AEASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 956 ~~~----~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
... .........+||..|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 245 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 111 11122234579999999999987 5799999999999999999999999976555443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=348.55 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=191.8
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccC--CcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRH--RNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~l 876 (1099)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++| |||+++++++.. +...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEE
Confidence 4579999999999999999999988999999998644333 3668899999999986 999999999984 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||+ .+|+|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++ ++.+||+|||+++....
T Consensus 87 v~e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EECC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEeC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9995 578999999853 3488999999999999999999999999999999999997 57899999999986532
Q ss_pred CCCCCccccccccCccccCcccccc-----------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhh
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT-----------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 1025 (1099)
. .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+......
T Consensus 160 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~ 236 (343)
T 3dbq_A 160 D-TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDP 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCT
T ss_pred c-cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcC
Confidence 2 11223345689999999999865 67889999999999999999999999754332 1111111111
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.. .... . .... ..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~-~~~~-------~-~~~~----~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NH-EIEF-------P-DIPE----KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TS-CCCC-------C-CCSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc-ccCC-------c-ccCC----HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 10 0000 0 1111 124578999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.42 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=207.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEec-CCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++++++||||+++++++.+ .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 589999999865432 34668899999999999999999998753 3456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC-----ceecCCCCCCEEECCCCcEEEeccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-----MVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999986432 3345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
+.... .........||..|+|||.+.+..++.++||||+|+++|||++|+.||......+....+.. +.....
T Consensus 164 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~----~~~~~~ 236 (279)
T 2w5a_A 164 RILNH---DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKFRRI 236 (279)
T ss_dssp HHC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCC
T ss_pred eeecc---ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh----cccccC
Confidence 76421 11223345789999999999998999999999999999999999999987665554444333 211111
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
... .+ ..+.+++.+||+.||++||++.|+++.+....+.
T Consensus 237 -~~~--------~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 237 -PYR--------YS----DELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp -CTT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred -Ccc--------cC----HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 110 01 1345789999999999999999999987654433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=347.03 Aligned_cols=272 Identities=22% Similarity=0.327 Sum_probs=198.8
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|+..+.||+|+||.||+|.+++. ||+|.+..... ..+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESSS--EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcCe--EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEEEe
Confidence 46799999999999999999998753 88888854322 2356889999999999999999999998554 469999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999742 24588999999999999999999999999999999999998 6799999999987542111
Q ss_pred --CCCccccccccCccccCcccccc---------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 959 --AEASTSTTAVGTLGYVSPEAALT---------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 959 --~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
..........||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. +.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~ 259 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT----GM 259 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT----TC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc----CC
Confidence 11223345569999999998864 3578899999999999999999999987665544433322 11
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCCCCC
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPS 1097 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 1097 (1099)
......... . ..+.+++.+||+.||++|||+.|+++.|+++.......+.....++++
T Consensus 260 ~~~~~~~~~---~---------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~~ 317 (319)
T 2y4i_B 260 KPNLSQIGM---G---------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317 (319)
T ss_dssp CCCCCCSSC---C---------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------------
T ss_pred CCCCCcCCC---C---------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccccc
Confidence 111111111 0 013578999999999999999999999999988776666555555554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=337.82 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=198.8
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|+..+.||+|+||.||+|.+.. |+.||+|++...... .+.+.+|++++++++||||+++++++.. ....++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEE
Confidence 579999999999999999999864 899999988654433 3568899999999999999999999985 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-- 154 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--
Confidence 999999998887642 3489999999999999999999999999999999999999999999999999976521
Q ss_pred CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--------c
Q 047739 959 AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI--------T 1029 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------~ 1029 (1099)
.........||..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+......... .
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 -PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred -cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 1223345679999999999876 56899999999999999999999999887766655554443221100 0
Q ss_pred cccc-CcccCCCCCChhHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 ELLE-PGLLELDPESSEWE-----EFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d-~~~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ....... .....+ .-..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCS-SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCcc-ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000000 000000 01124689999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.84 Aligned_cols=269 Identities=20% Similarity=0.299 Sum_probs=199.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH--HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE--NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|...+.||+|+||.||+|... +++.||+|++....... ..+.+|++++++++||||+++++++... ...++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEec
Confidence 47899999999999999999986 68899999986433222 2456899999999999999999999854 45699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++ |+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--- 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--- 152 (324)
T ss_dssp CCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC---
Confidence 997 5999998753 24589999999999999999999999999999999999999999999999999975421
Q ss_pred CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc---cccC-
Q 047739 960 EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE---LLEP- 1034 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~d~- 1034 (1099)
.........||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+........... ....
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 1223345678999999999876 5689999999999999999999999988777776666655433221100 0000
Q ss_pred -----cccCCCCCChhH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1035 -----GLLELDPESSEW---EEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1035 -----~~~~~~~~~~~~---~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
.+.......... ..-..+.+++.+||+.||++|||++|+++ .+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000000000000 00123468999999999999999999987 44444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=343.57 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=203.9
Q ss_pred HHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---------HHHHHHHHHHhhhc-cCCcceEEee
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---------ENLFRKEAEFLGKV-RHRNLTVLRG 865 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~H~niv~l~~ 865 (1099)
......++|.+.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33455678999999999999999999986 6899999988543211 35678999999999 7999999999
Q ss_pred EEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 866 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
++.. ....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||
T Consensus 168 ~~~~-~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYES-SSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEB-SSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEee-CCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 9985 45679999999999999999753 34899999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCccccccccCccccCcccccc------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~ 1019 (1099)
+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 242 ~DfG~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 242 SDFGFSCHLEP----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CCCTTCEECCT----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EecCcccccCC----CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999976532 123345689999999998863 35889999999999999999999999876655444433
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ... ...+.+.. . -..+.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~----~~~-~~~~~~~~---~------~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEG----QYQ-FSSPEWDD---R------SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHT----CCC-CCHHHHSS---S------CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhC----CCC-CCCccccc---C------CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321 110 00000000 0 012457999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=353.14 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=189.9
Q ss_pred Hhccccc-cccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhh-ccCCcceEEeeEEec---CCCceE
Q 047739 802 TRQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGK-VRHRNLTVLRGYYAG---APDLRL 875 (1099)
Q Consensus 802 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~---~~~~~~ 875 (1099)
.++|... ++||+|+||.||+|... +|+.||+|++.. ...+.+|++++.+ .+||||+++++++.. +....|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3466665 78999999999999986 588999999853 3467889988755 489999999998863 244568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999752 2345899999999999999999999999999999999999987 7899999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...............+..+... ..
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~ 287 (400)
T 1nxk_A 213 ETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FP 287 (400)
T ss_dssp ECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CC
T ss_pred ccCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-CC
Confidence 6421 223345689999999999999999999999999999999999999997654322111111111111110 01
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+.+.. .. ..+.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~-----~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPEWSE-----VS----EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTT-----SC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cccccc-----CC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100 01 124579999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=361.84 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=202.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|+..++||+|+||.||+|... +|+.||+|++... ....+.+.+|++++++++||||+++++++.+ ....|+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEE
Confidence 457999999999999999999986 6899999998532 2234668899999999999999999999985 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|+....
T Consensus 262 VmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999997532 23489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+...+..... .+...+
T Consensus 339 ----~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~ 412 (576)
T 2acx_A 339 ----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERF 412 (576)
T ss_dssp ----TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTS
T ss_pred ----CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccC
Confidence 12234568999999999999989999999999999999999999999765432222222222221110 011111
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|| +++||++
T Consensus 413 --------s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 413 --------S----PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --------C----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --------C----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 1345789999999999999 7888875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=348.67 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=194.2
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHH--hhhccCCcceEEeeEEec----CCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEF--LGKVRHRNLTVLRGYYAG----APDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~----~~~~~~ 875 (1099)
.++|.+.+.||+|+||.||+|++ +++.||+|++.... ...+..|.++ +..++||||+++++++.. .....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46799999999999999999987 58899999986433 3344444444 556899999999976532 233458
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC---------CceecCCCCCCEEECCCCcEEEe
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS---------NMVHGDIKPQNVLFDADFEAHLS 946 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~iiH~Dlk~~NIll~~~~~~kl~ 946 (1099)
+||||+++|+|.+++... ..++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 999999999999999752 258899999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCC-----CCCccccccccCccccCcccccc-------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-
Q 047739 947 DFGLDRLTIPTP-----AEASTSTTAVGTLGYVSPEAALT-------GETTKESDVYSFGIVLLELLTGKRPVMFTQDE- 1013 (1099)
Q Consensus 947 DfGla~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~- 1013 (1099)
|||+++...... ..........||..|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998653221 11222335679999999999876 34667899999999999999998776432211
Q ss_pred hH-------------HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1014 DI-------------VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1014 ~~-------------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.. ...+............+...+ ... ......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW----KEN--SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC----CCC--SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc----ccc--cchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 00 011111111111111111111 011 11122356899999999999999999999999987
Q ss_pred cCCC
Q 047739 1081 RVGP 1084 (1099)
Q Consensus 1081 ~~~~ 1084 (1099)
...-
T Consensus 317 l~~~ 320 (336)
T 3g2f_A 317 MMIW 320 (336)
T ss_dssp HHCC
T ss_pred HHHH
Confidence 6443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.30 Aligned_cols=256 Identities=19% Similarity=0.293 Sum_probs=202.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCe
Confidence 467999999999999999999987 58899999885332 135779999999999999999999999985 455
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC----cEEEeccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDFG 949 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~DfG 949 (1099)
.++||||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 69999999999999999753 3489999999999999999999999999999999999998877 89999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+++.... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||......+....+..... ...
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~ 231 (283)
T 3bhy_A 158 IAHKIEA----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY--DFD 231 (283)
T ss_dssp TCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--CCC
T ss_pred cceeccC----CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc--CCc
Confidence 9976522 1223445799999999999988999999999999999999999999987665544433322100 000
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhccc
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCR 1081 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 1081 (1099)
....+.. -..+.+++.+||+.||++||++.|+++ .++.+.
T Consensus 232 ~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 232 EEYFSNT------------SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHTTC------------CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred chhcccC------------CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000000 013467999999999999999999997 444443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=351.57 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=192.1
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCc---cHHHHHHHHHHhhhcc--CCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVR--HRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++ ||||+++++++... ...|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEEE
Confidence 46999999999999999999988899999999854332 2367899999999996 59999999998854 457999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|| +.+|+|.+++... ..+++..+..++.||++||+|||+.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 4578999999853 2478889999999999999999999999999999999996 589999999999865321
Q ss_pred CCCCccccccccCccccCcccccc-----------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT-----------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+..... +
T Consensus 208 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~~-~ 283 (390)
T 2zmd_A 208 -TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIID-P 283 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHC-T
T ss_pred -CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHHhC-c
Confidence 11122345689999999999865 36889999999999999999999999754332 111111111 1
Q ss_pred cccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1027 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...... . .... ..+.+++.+||+.||++||++.|+++.
T Consensus 284 ~~~~~~-------~-~~~~----~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEF-------P-DIPE----KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCC-------C-CCSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCC-------C-ccch----HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 110000 0 1011 134578999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=346.82 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=206.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCC----Cce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 874 (1099)
..+|+..+.||+|+||.||+|... ++..||+|++...... .+.+.+|++++++++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999875 6889999998643322 367889999999999999999999986432 356
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 599999874 23899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc--
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL-- 1031 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 1031 (1099)
.............+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+............
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 333222233455689999999998764 45899999999999999999999999887777666665543322111000
Q ss_pred -cc---Cc--ccCCCCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 -LE---PG--LLELDPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 -~d---~~--~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ .. ..........+... ..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 00000011111111 235689999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.21 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=200.0
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc------HHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
..++|...+.||+|+||.||+|.+. +|+.||+|.+...... .+.+.+|++++++++||||+++++++... ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-Cc
Confidence 4578999999999999999999986 5899999998643221 24688999999999999999999999854 45
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 6999999985 888888642 34588899999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
... .........||+.|+|||++.+. .++.++||||+||++|||++|..||......+....+.............
T Consensus 162 ~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 162 FGS---PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTS---CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccC---CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 522 12233456799999999998764 47899999999999999999999998877666655555443222111100
Q ss_pred c----CcccCCCC-CChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 E----PGLLELDP-ESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d----~~~~~~~~-~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+ +....... ....... -..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000 0001111 1235689999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=352.97 Aligned_cols=195 Identities=22% Similarity=0.329 Sum_probs=152.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecC----CCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA----PDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~ 873 (1099)
.++|++.++||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++|||||++++++... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999876 589999999865322 346788999999999999999999998533 245
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||+. |+|.+++... ..+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 699999984 7999998742 3489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC------------------------CccccccccCccccCccccc-cCCCCCcCchhhHHHHHHHHHh
Q 047739 954 TIPTPAE------------------------ASTSTTAVGTLGYVSPEAAL-TGETTKESDVYSFGIVLLELLT 1002 (1099)
Q Consensus 954 ~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~G~il~ellt 1002 (1099)
....... .......+||++|+|||++. ...++.++||||+||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 5322111 01234568999999999864 5669999999999999999999
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=335.02 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=196.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecC---CCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGA---PDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---~~~~~ 875 (1099)
+.|...+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999885 57889999885432 2346789999999999999999999988642 34568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEEC-CCCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFD-ADFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~-~~~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999763 34889999999999999999999999 99999999999998 78999999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
... ........||+.|+|||.+. +.++.++||||+|+++|||++|+.||......... ......+......
T Consensus 181 ~~~-----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 181 LKR-----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASF 251 (290)
T ss_dssp GCC-----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGG
T ss_pred ccc-----ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH---HHHHhccCCcccc
Confidence 542 12234457999999999876 45899999999999999999999999764443221 1111222111111
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+... ...+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~------------~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DKVA------------IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCC------------CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC------------CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 0134689999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=351.21 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=207.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc------cCCcceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV------RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~ 874 (1099)
..+|++.++||+|+||.||+|... +++.||+|++.......+.+.+|+++++.+ .|+||+++++++... ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeE
Confidence 457999999999999999999876 489999999977655567788999999888 467999999999854 556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc--EEEecccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE--AHLSDFGLDR 952 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~ 952 (1099)
++||||+. |+|.+++.... ...+++..+..++.||++||+|||+.+|+||||||+||+++.++. +||+|||+|+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999998632 234899999999999999999999999999999999999999887 9999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc----
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---- 1028 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 1028 (1099)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.........
T Consensus 251 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 251 YEH------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp ETT------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ecC------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 542 1233468999999999999999999999999999999999999999887776655555443221100
Q ss_pred -----cccccCc--------------------------ccCCCCCChhHHHH------HHHHHHHHhcCCCCCCCCCCHH
Q 047739 1029 -----TELLEPG--------------------------LLELDPESSEWEEF------LLGVKVALLCTAPDPIDRPTMS 1071 (1099)
Q Consensus 1029 -----~~~~d~~--------------------------~~~~~~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~ 1071 (1099)
...++.. .....+....+... ..+.+++.+||+.||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000000 00011122222222 2356899999999999999999
Q ss_pred HHHHH
Q 047739 1072 DIVFM 1076 (1099)
Q Consensus 1072 evl~~ 1076 (1099)
|+++.
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.73 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=203.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEE
Confidence 367999999999999999999986 5789999998532 1224678999999999999999999999985 456699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999864 2488999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.......|+..|+|||++.+..++.++||||+|+++|||++|+.||......+....+.. ... .+
T Consensus 167 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~------~~ 231 (284)
T 2vgo_A 167 -----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN----VDL------KF 231 (284)
T ss_dssp -----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCC------CC
T ss_pred -----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc----ccc------CC
Confidence 123346799999999999999999999999999999999999999987655444333221 110 00
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
.+.. + ..+.+++.+|++.||++||++.|+++ .+...
T Consensus 232 ---~~~~-~----~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 ---PPFL-S----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---CTTS-C----HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---CCcC-C----HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0010 1 12357899999999999999999986 44433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=349.22 Aligned_cols=254 Identities=13% Similarity=0.134 Sum_probs=203.0
Q ss_pred HhccccccccccccceeEEEEE------ECCceEEEEEECCCCCccHHHHHHHHHHhhhcc---CCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKAC------YNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR---HRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~ 872 (1099)
.++|.+.++||+|+||.||+|. ..+++.||+|++... ....+.+|++++++++ |+||+++++++... +
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-N 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-S
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-C
Confidence 4679999999999999999994 446889999998653 4567888999888887 99999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-----------CC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-----------DF 941 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-----------~~ 941 (1099)
..++||||+++|+|.++++.........+++..++.++.||++||+|||+.||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 4699999999999999998765555667999999999999999999999999999999999999998 89
Q ss_pred cEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHH
Q 047739 942 EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021 (1099)
Q Consensus 942 ~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~ 1021 (1099)
.+||+|||+|+..... .........+||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLF-PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGS-CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CEEEeeCchhhhhhcc-CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 9999999999754211 22334456789999999999999999999999999999999999999986432210
Q ss_pred HhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHhhccc
Q 047739 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDR-PTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1022 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R-Ps~~evl~~L~~~~ 1081 (1099)
.. ....+... +.. + ...+++..|++.+|.+| |++.++.+.|++..
T Consensus 293 ----~~----~~~~~~~~-~~~---~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ----CK----PEGLFRRL-PHL---D---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ----EE----ECSCCTTC-SSH---H---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ----ee----echhcccc-CcH---H---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00 11111111 111 1 22367888999999998 67888888887654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.97 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=203.8
Q ss_pred HhccccccccccccceeEEEEEE-----CCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCC-Cce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-----NDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-DLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~ 874 (1099)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999985 358999999986543 33467999999999999999999999986443 356
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 8999999999999999753 234899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch------------hHHHHHHHH
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE------------DIVKWVKKQ 1022 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~------------~~~~~~~~~ 1022 (1099)
..............++..|+|||.+.+..++.++||||+|+++|||++|..||.....+ .....+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 33222112233456788899999999888999999999999999999999987532110 001111111
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+..+... ..+...+ ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 276 ~~~~~~~---------~~~~~~~----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRL---------PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCC---------CCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCC---------CCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111100 0011111 23457899999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.94 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=203.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceE--EEEEECCCC--CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMV--LSIRRLPDG--SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|...+.||+|+||.||+|.+. ++.. |++|.+... ....+.+.+|+++++++ +||||+++++++.+. ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceE
Confidence 367999999999999999999875 4554 588887542 23346789999999999 899999999999854 5569
Q ss_pred EEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEE
Q 047739 876 LVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAH 944 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~k 944 (1099)
+||||+++|+|.+++..... .....+++..++.++.|+++||+|||+.||+||||||+||+++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 99999999999999975421 2234689999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHh
Q 047739 945 LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 945 l~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
|+|||+++... .........++..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+.
T Consensus 183 L~Dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--- 255 (327)
T 1fvr_A 183 IADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 255 (327)
T ss_dssp ECCTTCEESSC----EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred EcccCcCcccc----ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh---
Confidence 99999987431 1222334567889999999988889999999999999999998 999998766544333222
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.+.... . +...+ ..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 256 -~~~~~~--------~-~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 256 -QGYRLE--------K-PLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -GTCCCC--------C-CTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCC--------C-CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111000 0 01111 1245789999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=339.06 Aligned_cols=268 Identities=19% Similarity=0.228 Sum_probs=206.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecC-------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA------- 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 870 (1099)
..+|++.+.||+|+||.||+|... +|+.||+|++..... ....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999984 689999999854332 235688999999999999999999998753
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
....++||||++ |+|.+.+... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 335689999997 4888877642 23489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 951 DRLTIPTP-AEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 951 a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
++...... ..........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT- 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 98653221 12233455689999999999876 4579999999999999999999999988777666655554432211
Q ss_pred cccccCcc---------cCCCCC-ChhHHHH------HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGL---------LELDPE-SSEWEEF------LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~---------~~~~~~-~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....+.. ...... ....+.+ ..+.+++.+||+.||++|||++|+++.
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 -PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp -TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1110000 000000 1111111 125689999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.20 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=198.6
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecC-----CC
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGA-----PD 872 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~ 872 (1099)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+.......+.+.+|+++++++ +||||+++++++... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 34678999999999999999999984 689999999876666678899999999999 799999999998753 35
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 6799999999999999998532 2458899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
.... .........||..|+|||++. +..++.++||||||+++|||++|+.||...........+.. ..
T Consensus 178 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~ 250 (326)
T 2x7f_A 178 QLDR---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NP 250 (326)
T ss_dssp ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SC
T ss_pred ecCc---CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----Cc
Confidence 6421 112234457999999999987 56789999999999999999999999976554433322221 11
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
........+ . ..+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~~~~--------~----~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 APRLKSKKW--------S----KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCSCSCS--------C----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccCCcccc--------C----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111 1 13457899999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=336.79 Aligned_cols=258 Identities=19% Similarity=0.283 Sum_probs=192.9
Q ss_pred hccccc-cccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|.+. ++||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++++ +||||+++++++.+. +..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEE
Confidence 467774 78999999999999865 68999999985443 3457799999999985 799999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc---EEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE---AHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~---~kl~DfGla~~~~ 955 (1099)
||+++|+|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999863 24889999999999999999999999999999999999988766 9999999987542
Q ss_pred CCCC----CCccccccccCccccCcccccc-----CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh-----------H
Q 047739 956 PTPA----EASTSTTAVGTLGYVSPEAALT-----GETTKESDVYSFGIVLLELLTGKRPVMFTQDED-----------I 1015 (1099)
Q Consensus 956 ~~~~----~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~-----------~ 1015 (1099)
.... ........+||..|+|||++.+ ..++.++||||+||++|||++|+.||......+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2111 1112234569999999999875 458899999999999999999999997643211 0
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+...+..+... .....+... -..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~i~~~~~~-~~~~~~~~~---------~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDKDWAHI---------SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHHHHTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcc-cCchhcccC---------CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11112222222110 000000000 0234689999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.32 Aligned_cols=266 Identities=19% Similarity=0.243 Sum_probs=195.4
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
...++|.+.++||+|+||.||+|... +++.||+|++...... .+.+.+|++++++++||||+++++++.+. ...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEE
Confidence 34678999999999999999999875 6899999999654332 35678999999999999999999999854 5569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE-----CCCCcEEEecccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF-----DADFEAHLSDFGL 950 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll-----~~~~~~kl~DfGl 950 (1099)
+||||++ |+|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+||++ +.++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999997 5999999753 238999999999999999999999999999999999999 4556699999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
++.... .........||..|+|||++.+. .++.++||||+||++|||++|+.||......+....+..........
T Consensus 184 a~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGI---PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccCC---cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 976521 12233456789999999999875 48999999999999999999999998776665555544432211100
Q ss_pred cc--------ccCcccCCCCCChhHH----HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 EL--------LEPGLLELDPESSEWE----EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~--------~d~~~~~~~~~~~~~~----~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. ....+........... .-..+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000000000000000 0123468999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.25 Aligned_cols=242 Identities=19% Similarity=0.314 Sum_probs=197.4
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---------cHHHHHHHHHHhhhccCCcceEEeeEEecC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 870 (1099)
..++|+..+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4678999999999999999999875 589999999865432 22457889999999999999999999984
Q ss_pred CCceEEEEeecCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 871 PDLRLLVYDYMPNG-NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 871 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
....++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 45669999999777 999999753 348999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
+++.... ........||+.|+|||++.+..+ +.++||||+|+++|||++|+.||......
T Consensus 176 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 176 SAAYLER----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TCEECCT----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred cceECCC----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 9986522 223345679999999999988876 78999999999999999999999642110
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
....... +.... ..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~~~~~--~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIHP--PYLVS----KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCCC--SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccCC--CcccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00011 124578999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=349.34 Aligned_cols=271 Identities=20% Similarity=0.257 Sum_probs=186.3
Q ss_pred Hhcccc-ccccccccceeEEEEEEC---CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEec-CCCceEE
Q 047739 802 TRQFDE-ENVLSRTRYGLVFKACYN---DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLRLL 876 (1099)
Q Consensus 802 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~~l 876 (1099)
.+.|+. .++||+|+||.||+|.++ ++..||+|++..... .+.+.+|++++++++||||+++++++.. .....++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 345665 568999999999999976 478999999975433 3568899999999999999999999863 4556789
Q ss_pred EEeecCCCCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----CCCCcEEEecc
Q 047739 877 VYDYMPNGNLGTLLQEASH----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF----DADFEAHLSDF 948 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll----~~~~~~kl~Df 948 (1099)
||||++ |+|.+++..... .....+++..+..++.||+.||+|||+.+|+||||||+||++ +.++.+||+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999996 588888864321 122348999999999999999999999999999999999999 67889999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCch---------hHHHH
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDE---------DIVKW 1018 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~---------~~~~~ 1018 (1099)
|+|+...............+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 9998653222222334567899999999999874 4899999999999999999999999755432 22333
Q ss_pred HHHHhhhccccccccCcccCCC-------------CCChhHHH---------HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1019 VKKQLQKGQITELLEPGLLELD-------------PESSEWEE---------FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~-------------~~~~~~~~---------~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+......... ...+.+.... ........ -..+.+++.+||+.||++|||++|+++.
T Consensus 257 i~~~~g~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPAD--KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCT--TTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCCh--hhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 3322221110 0000000000 00000000 1234689999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=348.43 Aligned_cols=267 Identities=20% Similarity=0.350 Sum_probs=201.2
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC--------
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-------- 870 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 870 (1099)
...++|...+.||+|+||.||+|... +|+.||+|++.... +...+|++++++++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 34678999999999999999999874 68999999985432 2345799999999999999999998532
Q ss_pred -----------------------------CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc
Q 047739 871 -----------------------------PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921 (1099)
Q Consensus 871 -----------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 921 (1099)
....++||||++ |+|.+.+..... ....+++..+..++.||++||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 223689999998 588888875432 3356899999999999999999999
Q ss_pred cCCceecCCCCCCEEEC-CCCcEEEeccccccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHH
Q 047739 922 TSNMVHGDIKPQNVLFD-ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLE 999 (1099)
Q Consensus 922 ~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~e 999 (1099)
+.||+||||||+||+++ .++.+||+|||+|+.... ........||..|+|||.+.+. .++.++||||+||++||
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999998 689999999999986522 2233456789999999998875 48999999999999999
Q ss_pred HHhCCCCCCCCCchhHHHHHHHHhhhcccccc--ccCcccCC---CCCChhHHHH------HHHHHHHHhcCCCCCCCCC
Q 047739 1000 LLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL--LEPGLLEL---DPESSEWEEF------LLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1000 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~~~~~---~~~~~~~~~~------~~~~~li~~Cl~~dP~~RP 1068 (1099)
|++|+.||......+....+.+.......... .++.+.+. ......+... ..+.+++.+||+.||++||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999999887766655555443322111000 00000000 0001111111 2356899999999999999
Q ss_pred CHHHHHH
Q 047739 1069 TMSDIVF 1075 (1099)
Q Consensus 1069 s~~evl~ 1075 (1099)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=353.71 Aligned_cols=261 Identities=18% Similarity=0.216 Sum_probs=203.4
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|.+.++||+|+||.||+|.+ .+++.||||.+.... ..+.+.+|+++++.++|++.+..+.++.......++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46799999999999999999997 468999999875433 2345889999999998865555555554456677999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~~~ 957 (1099)
+ +++|.+++... ...+++..++.|+.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 ~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 85 L-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred C-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9 89999999753 2358999999999999999999999999999999999999 68899999999999865332
Q ss_pred CCCC----ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH---HHHhhhccccc
Q 047739 958 PAEA----STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV---KKQLQKGQITE 1030 (1099)
Q Consensus 958 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~---~~~~~~~~~~~ 1030 (1099)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||.........+.+ ........+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2111 1233678999999999999999999999999999999999999999875543332222 22211111111
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.. ..+. ..+.+++.+||+.||++||++.+|++.|+++.
T Consensus 240 l~-~~~p------------~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 240 LC-RGYP------------TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HH-TTSC------------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred Hh-cCCc------------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 1110 13468999999999999999999999998773
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=341.39 Aligned_cols=272 Identities=21% Similarity=0.277 Sum_probs=209.2
Q ss_pred HHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhh--ccCCcceEEeeEEecCC---
Q 047739 797 ETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGK--VRHRNLTVLRGYYAGAP--- 871 (1099)
Q Consensus 797 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~--- 871 (1099)
......++|.+.+.||+|+||.||+|.+. |+.||+|.+.. ...+.+.+|+++++. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~--~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG--GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc--hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 34456789999999999999999999985 88999999853 345678889999988 78999999999998554
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc--------cCCceecCCCCCCEEECCCCcE
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH--------TSNMVHGDIKPQNVLFDADFEA 943 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~iiH~Dlk~~NIll~~~~~~ 943 (1099)
...++||||+++|+|.+++++. .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 2579999999999999999752 3899999999999999999999 8999999999999999999999
Q ss_pred EEeccccccccCCCCCC-CccccccccCccccCccccccCC------CCCcCchhhHHHHHHHHHhC----------CCC
Q 047739 944 HLSDFGLDRLTIPTPAE-ASTSTTAVGTLGYVSPEAALTGE------TTKESDVYSFGIVLLELLTG----------KRP 1006 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~G~il~elltg----------~~P 1006 (1099)
||+|||+++........ ........||..|+|||++.+.. ++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999765322111 11234567999999999987653 33689999999999999999 778
Q ss_pred CCCCCchh-HHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1007 VMFTQDED-IVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1007 ~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
|....... ....+............+...+ ...+....+.+++.+||+.||++|||+.||++.|+++....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-------QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccc-------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 86542211 1222222222221111111111 11123344578999999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=353.72 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=190.1
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---------cHHHHHHHHHHhhhccCCcceEEeeEEec
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVRHRNLTVLRGYYAG 869 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 869 (1099)
...++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999876 478999999853211 12358899999999999999999999863
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEe
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLS 946 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~ 946 (1099)
...++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.+ +.+||+
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred --CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 3368999999999999988642 358999999999999999999999999999999999999754 459999
Q ss_pred ccccccccCCCCCCCccccccccCccccCcccccc---CCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-hHHHHHHHH
Q 047739 947 DFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQ 1022 (1099)
Q Consensus 947 DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~G~il~elltg~~P~~~~~~~-~~~~~~~~~ 1022 (1099)
|||+|+... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 285 DFG~a~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~- 359 (419)
T 3i6u_A 285 DFGHSKILG----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 359 (419)
T ss_dssp CSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred ecccceecC----CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence 999998652 2223345689999999999863 56788999999999999999999999754432 22222221
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+... ...+.+... -..+.+++.+||+.||++||+++|+++.
T Consensus 360 ---~~~~-~~~~~~~~~---------~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ---GKYN-FIPEVWAEV---------SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---TCCC-CCHHHHTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCC-CCchhhccc---------CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1110 000000000 1234689999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=344.06 Aligned_cols=264 Identities=20% Similarity=0.288 Sum_probs=201.8
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEec---CCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAG---APDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~~l 876 (1099)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999998 568999999885433 345678999999999999999999999863 2335689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 9999999999999986432 345689999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCC------ccccccccCccccCccccccCC---CCCcCchhhHHHHHHHHHhCCCCCCCCC--chhHHHHHHHHhhh
Q 047739 957 TPAEA------STSTTAVGTLGYVSPEAALTGE---TTKESDVYSFGIVLLELLTGKRPVMFTQ--DEDIVKWVKKQLQK 1025 (1099)
Q Consensus 957 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~G~il~elltg~~P~~~~~--~~~~~~~~~~~~~~ 1025 (1099)
..... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.... .......+. .
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----N 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----c
Confidence 10000 0112346799999999987554 6899999999999999999999985311 111111111 1
Q ss_pred ccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1026 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
... . +. ....+ ..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 263 -~~~-~--~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 263 -QLS-I--PQ-----SPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -C---C--CC-----CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -cCC-C--Cc-----cccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 0 00 00001 1346799999999999999999999999988643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=356.11 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=202.6
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCC---CCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPD---GSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
..++|.+.++||+|+||.||+|... +++.||+|++.. .....+.+.+|++++++++||||+++++++.+ ....|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEE
Confidence 4568999999999999999999986 689999999843 22345778999999999999999999999985 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC---CCCcEEEeccccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD---ADFEAHLSDFGLDRL 953 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~ 953 (1099)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++ .++.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999998753 3489999999999999999999999999999999999995 456799999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... .......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+........ .
T Consensus 174 ~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----~ 243 (486)
T 3mwu_A 174 FQQ----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----L 243 (486)
T ss_dssp BCC----C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----S
T ss_pred CCC----CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----C
Confidence 522 223345689999999999875 589999999999999999999999988776665555443211110 0
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.+... . ..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~---s------~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWRTI---S------DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGGS---C------HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccCCC---C------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111100 0 124589999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.45 Aligned_cols=249 Identities=20% Similarity=0.340 Sum_probs=179.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..... ..+.+.+|++++++++||||+++++++.+ ....++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEE
Confidence 457999999999999999999974 689999999853221 23678999999999999999999999985 456699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999742 24589999999999999999999999999999999999999999999999999976521
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+....+ ... ..
T Consensus 165 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~--------~~ 229 (278)
T 3cok_A 165 P---HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VLA--------DY 229 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----CSS--------CC
T ss_pred C---CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----hhc--------cc
Confidence 1 12233467899999999999888999999999999999999999999765443322111 000 00
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... .... ..+.+++.+||+.||++||+++|+++.
T Consensus 230 -~~~-~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMP-SFLS----IEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCC-TTSC----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCc-cccC----HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000 1111 134579999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=338.97 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=198.9
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecC-CCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGA-PDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~-~~~~~lV~ 878 (1099)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.. ...+.+.+|++++++++ ||||+++++++.+. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46799999999999999999987 4689999999864 34577999999999997 99999999999853 44568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 957 (1099)
||+++++|.++++. +++..+..++.|+++||+|||+.||+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998863 78899999999999999999999999999999999999776 8999999999865322
Q ss_pred CCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-hhHHHHHHHHhhhccccccccC-
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQD-EDIVKWVKKQLQKGQITELLEP- 1034 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~- 1034 (1099)
.......||..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+....+..........+.++.
T Consensus 185 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 ----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp ----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ----CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 22345679999999999887 6689999999999999999999999954333 2222222222111111111000
Q ss_pred ------------------cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 ------------------GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ------------------~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+............-..+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000123468999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.44 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=176.0
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEeecCCCC
Q 047739 808 ENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
.+.||+|+||.||+|.+. +++.||+|.+.. .....+.+|+++++++. ||||+++++++.+ +...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCCc
Confidence 378999999999999986 589999999853 24567889999999997 9999999999985 455699999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---cEEEeccccccccCCCCCCCc
Q 047739 886 LGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---EAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 886 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~~~ 962 (1099)
|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP---DNQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC---CCC
Confidence 99999853 3489999999999999999999999999999999999997665 899999999986422 222
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh---HHHHHHHHhhhccccccccCcccCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED---IVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.....+||..|+|||++.+..++.++||||+|+++|||++|+.||....... ....+...+..+...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---------- 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---------- 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC----------
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC----------
Confidence 3345678999999999999999999999999999999999999997543311 111222222222111
Q ss_pred CCCChhHHH-HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1040 DPESSEWEE-FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1040 ~~~~~~~~~-~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.....+.. -..+.+++.+||+.||++|||++|+++.
T Consensus 235 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 -FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01111111 1234689999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.87 Aligned_cols=256 Identities=20% Similarity=0.255 Sum_probs=200.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-----ccHHHHHHHHHHhhhccCCcceEEeeEEec-CCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-----LDENLFRKEAEFLGKVRHRNLTVLRGYYAG-APDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~ 874 (1099)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 58899999986432 234679999999999999999999999853 34456
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++| |.+++... ....+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77877653 2345899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCC--CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.+. ..........||..|+|||++.+.. ++.++||||+|+++|||++|+.||...........+.. +... .
T Consensus 160 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~----~~~~--~ 232 (305)
T 2wtk_C 160 HPF-AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK----GSYA--I 232 (305)
T ss_dssp CTT-CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCC--C
T ss_pred Ccc-ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc----CCCC--C
Confidence 322 1223334567999999999987644 37799999999999999999999987665544443332 1110 0
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcc
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGC 1080 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 1080 (1099)
. .... ..+.+++.+||+.||++|||++|+++. +.+.
T Consensus 233 ~--------~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 233 P--------GDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp C--------SSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred C--------CccC----HHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 0 0011 123578999999999999999999964 5444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=347.52 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=165.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCC----Cc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAP----DL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 873 (1099)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 58899999996532 23467889999999999999999999987543 45
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||++ |+|.+++... ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 799999996 6999999742 3489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC-------------------CccccccccCccccCcccc-ccCCCCCcCchhhHHHHHHHHHhCCCCC
Q 047739 954 TIPTPAE-------------------ASTSTTAVGTLGYVSPEAA-LTGETTKESDVYSFGIVLLELLTGKRPV 1007 (1099)
Q Consensus 954 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~G~il~elltg~~P~ 1007 (1099)
....... .......+||++|+|||++ ....++.++||||+||++|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5322111 0123567899999999986 4566999999999999999999854444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.26 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=202.9
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|...+.||+|+||.||++.+.+ ++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence 4689999999999999999999864 7899999985432 234678899999999999999999999985 456799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 119 v~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999998753 3489999999999999999999999999999999999999999999999999986522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. ........||..|+|||++.+..++.++||||||+++|||++|+.||......+....+... ...+. .
T Consensus 194 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~----~-- 262 (335)
T 2owb_A 194 D---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIP----K-- 262 (335)
T ss_dssp T---TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCC----T--
T ss_pred C---cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCC----c--
Confidence 1 22334567999999999999989999999999999999999999999876554443333221 00000 0
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. .. ..+.+++.+||+.||++||++.|+++
T Consensus 263 -----~-~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 -----H-IN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----T-SC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----c-CC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01 12357899999999999999999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.62 Aligned_cols=252 Identities=18% Similarity=0.274 Sum_probs=197.2
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..++|+..+.||+|+||.||+|..+ +|+.||+|.+..... ...+|++++.++ +||||+++++++.+ +...|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEE
Confidence 4678999999999999999999986 589999999865432 346788999888 79999999999984 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC----CcEEEecccccccc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRLT 954 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~~ 954 (1099)
||+++|+|.+++... ..+++.....++.||+.||+|||+.||+||||||+||++..+ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999742 348999999999999999999999999999999999998433 35999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......... .+...+..+... ....
T Consensus 171 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~~~~-~~~~ 245 (342)
T 2qr7_A 171 RAE---NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-EILARIGSGKFS-LSGG 245 (342)
T ss_dssp BCT---TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH-HHHHHHHHCCCC-CCST
T ss_pred cCC---CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH-HHHHHHccCCcc-cCcc
Confidence 321 22334568999999999998888899999999999999999999999764332222 222222222211 0000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.. .. ..+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~-----~s----~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 YWNS-----VS----DTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTT-----SC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccc-----CC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00 12457899999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=342.83 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=187.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecC-----CC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 872 (1099)
.++|...+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999874 589999999965322 346788999999999999999999998643 24
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+|+||+ +++|.++++. ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 468999999 6899988864 348999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc--
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT-- 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 1029 (1099)
... ......+||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+........
T Consensus 181 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTA------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccc------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 642 12345689999999999887 678999999999999999999999998877766665555443221100
Q ss_pred -cccc-------CcccCCCCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 -ELLE-------PGLLELDPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 -~~~d-------~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ..+.... ...+... ..+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMP--KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCC--CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCC--CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0000000 0011111 234689999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=346.37 Aligned_cols=272 Identities=20% Similarity=0.279 Sum_probs=204.3
Q ss_pred CHHHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCcc------------HHHHHHHHHHhhhccCCcce
Q 047739 794 TLAETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD------------ENLFRKEAEFLGKVRHRNLT 861 (1099)
Q Consensus 794 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~H~niv 861 (1099)
..++.....++|...+.||+|+||.||+|...+|..||+|++...... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355677788999999999999999999999988999999998532211 26789999999999999999
Q ss_pred EEeeEEecC----CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE
Q 047739 862 VLRGYYAGA----PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF 937 (1099)
Q Consensus 862 ~l~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll 937 (1099)
++++++... ....++||||++ |+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence 999998532 235689999997 6888888742 3458999999999999999999999999999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHH
Q 047739 938 DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV 1016 (1099)
Q Consensus 938 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~ 1016 (1099)
+.++.+||+|||+++... .........||..|+|||++.+ ..++.++||||+||++|||++|+.||......+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDT----ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp CTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCCCCEEEEecCcccccc----cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999997542 1223345678999999999877 67899999999999999999999999887766655
Q ss_pred HHHHHHhhhccccc-----------cccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1017 KWVKKQLQKGQITE-----------LLEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1017 ~~~~~~~~~~~~~~-----------~~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+........... ........... ..+.. -..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA--RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC--CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh--hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 55544333221111 01111111100 01111 1234689999999999999999999973
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=346.62 Aligned_cols=269 Identities=20% Similarity=0.308 Sum_probs=200.1
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC-----ceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD-----LRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~~l 876 (1099)
..+|...++||+|+||.||+|++.++..||+|++.... +...+|++++++++||||+++++++..... ..++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 34799999999999999999999877778888875432 223479999999999999999999864322 2579
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEEeccccccccC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~~ 955 (1099)
||||+++ ++.+.+..... ....+++..+..++.||++||+|||+.||+||||||+||+++ .++.+||+|||+|+...
T Consensus 116 v~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999986 45444433221 234589999999999999999999999999999999999999 79999999999998652
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc------
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI------ 1028 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------ 1028 (1099)
.. ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+.+.......
T Consensus 194 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AG----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TT----CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CC----CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 223456789999999998765 5899999999999999999999999887766555554443221110
Q ss_pred -cccccCcccCCCCCChhHHH------HHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhccc
Q 047739 1029 -TELLEPGLLELDPESSEWEE------FLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCR 1081 (1099)
Q Consensus 1029 -~~~~d~~~~~~~~~~~~~~~------~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~ 1081 (1099)
.......+.... ...+.. -..+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 270 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYMEHKFPQIR--PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSSSCCCCCC--CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred Chhhhhhcccccc--CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 001111111100 011111 1235689999999999999999999974 55443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=358.90 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=201.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|...++||+|+||.||+|+.+ +|+.||+|++.... ...+.+.+|++++++++||||+++++++.. ....|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEEE
Confidence 67888999999999999999986 58999999985422 234668899999999999999999999885 4557999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++..... ....+++.....++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 999999999999975322 2345899999999999999999999999999999999999999999999999999865221
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.+.+...... ..+.+
T Consensus 343 ---~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~--~p~~~- 416 (543)
T 3c4z_A 343 ---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--YPDKF- 416 (543)
T ss_dssp ---CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC--CCTTS-
T ss_pred ---CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC--CCccc-
Confidence 222344689999999999999999999999999999999999999997653321122222222222110 00111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM-----SDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1075 (1099)
. ..+.+++.+||+.||++||++ .||.+
T Consensus 417 -------s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 -------S----PASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------C----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------C----HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 123578999999999999975 66653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=335.14 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEE
Confidence 4578999999999999999999986 68999999986543 234678999999999999999999999985 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~~~~ 955 (1099)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999999753 248899999999999999999999999999999999999 788999999999987541
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||...........+...... ...+.
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~ 230 (304)
T 2jam_A 161 -----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-----FESPF 230 (304)
T ss_dssp -----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----CCTTT
T ss_pred -----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----CCccc
Confidence 12234457999999999999989999999999999999999999999876655544444332110 00000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. . .+ ..+.+++.+||+.||++||++.|+++
T Consensus 231 ~~----~-~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WD----D-IS----ESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT----T-SC----HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc----c-CC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 01 13457999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=334.46 Aligned_cols=248 Identities=20% Similarity=0.347 Sum_probs=202.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.++|...+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence 467999999999999999999986 47889999885432 234678899999999999999999999985 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999998753 2489999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
. ........||..|+|||.+.+..++.++||||+|+++|||++|+.||......+....+.. .... ...
T Consensus 168 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~--~~~-- 236 (294)
T 2rku_A 168 D---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYS--IPK-- 236 (294)
T ss_dssp T---TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCC--CCT--
T ss_pred C---ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----ccCC--Ccc--
Confidence 1 2223446799999999999988899999999999999999999999987655443332221 1100 000
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .+ ..+.+++.+||+.||++|||++|+++.
T Consensus 237 -----~-~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 -----H-IN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----T-SC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----c-cC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 01 124578999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.81 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=199.2
Q ss_pred HhccccccccccccceeEEEEEE----CCceEEEEEECCCCC-----ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY----NDGMVLSIRRLPDGS-----LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 871 (1099)
.++|++.++||+|+||.||+|+. .+|+.||+|++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 46899999999999999999998 368999999986432 2345678899999999 699999999998854
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
...++||||+++|+|.+++... ..+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 4569999999999999999753 24889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+.... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..........
T Consensus 207 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T 1vzo_A 207 KEFVA--DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284 (355)
T ss_dssp EECCG--GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred eeccc--CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence 76421 12223345679999999999985 347899999999999999999999997544332222222222211100
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHh
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVFML 1077 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~L 1077 (1099)
..+ .. . ..+.+++.+||+.||++|| ++.|+++..
T Consensus 285 --~~~-------~~-~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 --YPQ-------EM-S----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CCT-------TS-C----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --CCc-------cc-C----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 10 0 1245789999999999999 999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=349.52 Aligned_cols=269 Identities=23% Similarity=0.346 Sum_probs=200.6
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC-----CCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~~l 876 (1099)
.+|+..++||+|+||.||+|.+. +|+.||+|++.... +.+.+|++++++++|||||++++++... ....++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 46899999999999999999986 58999999985432 2345799999999999999999988532 123469
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-CcEEEeccccccccC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTI 955 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-~~~kl~DfGla~~~~ 955 (1099)
||||+++ ++.+.+..... ....+++..+..++.||++||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 131 v~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 9999975 77777664322 33568999999999999999999999999999999999999965 678999999998652
Q ss_pred CCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc--cc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE--LL 1032 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1032 (1099)
.. ......+||..|+|||++.+. .++.++||||+||++|||++|+.||......+....+.+......... ..
T Consensus 209 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TT----CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cC----CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 223346789999999998765 689999999999999999999999987766554444443322111000 00
Q ss_pred cCcccCC---CCCChhHHHH------HHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1033 EPGLLEL---DPESSEWEEF------LLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1033 d~~~~~~---~~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
.+.+.++ ......|... ..+.+++.+||+.||++||++.|+++ .++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1111110 0011122211 24568999999999999999999986 44444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=360.30 Aligned_cols=244 Identities=17% Similarity=0.154 Sum_probs=187.9
Q ss_pred HhccccccccccccceeEEEEEE-CCceEEEEEECCC----CCccHHHHHHHH---HHhhhccCCcceEEe-------eE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPD----GSLDENLFRKEA---EFLGKVRHRNLTVLR-------GY 866 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 866 (1099)
.++|...+.||+|+||.||+|.+ .+|+.||+|++.. .....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999997 4689999999852 223457789999 555566899999998 55
Q ss_pred EecCCC----------------ceEEEEeecCCCCHHHHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHccCCceec
Q 047739 867 YAGAPD----------------LRLLVYDYMPNGNLGTLLQEASHQD--GHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928 (1099)
Q Consensus 867 ~~~~~~----------------~~~lV~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~ 928 (1099)
+...+. ..|+||||+ +|+|.+++....... ...+++..++.|+.||++||+|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 553321 258999999 689999998643322 1345568888999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccC-----------CCCCcCchhhHHHHH
Q 047739 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-----------ETTKESDVYSFGIVL 997 (1099)
Q Consensus 929 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~G~il 997 (1099)
||||+||+++.++.+||+|||+|+.. .......+| ..|+|||++.+. .++.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~------~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD------GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET------TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec------CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999853 123345577 999999999887 799999999999999
Q ss_pred HHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 998 LELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 998 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
|||++|+.||........... ....... . + ..+.+++.+||+.||++||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~-------------~~~~~~~---~--~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEW-------------IFRSCKN---I--P----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSGG-------------GGSSCCC---C--C----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchhh-------------hhhhccC---C--C----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999965432211110 0010000 0 1 12457899999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=342.11 Aligned_cols=346 Identities=19% Similarity=0.205 Sum_probs=214.9
Q ss_pred CCCCCCCCCCCC-CcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCc-ccccCCcccEEEe
Q 047739 44 LNGWDSSTPAAP-CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPA-TLAQCTLLRAVFL 121 (1099)
Q Consensus 44 l~~w~~~~~~~~-c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~L~l 121 (1099)
+++|.+..+ | |.|.+..|... .+.+..........+.-..++.|+.|++++|.+.. +|. .+..+++|++|+|
T Consensus 3 ~~~~~~~~~--C~~~~~~~~c~~~---~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 3 VKPRQPEYK--CIDSNLQYDCVFY---DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76 (390)
T ss_dssp ----CCEEC--BCC------EEEE---SCEECSSCCCCEESCSSGGGCCCSEEEEESCEESE-ECTHHHHHCCCCSEEEC
T ss_pred cCCCCCccc--eehhhhhhcccee---eeeeecccccccccccccccCCceEEEecCCchhh-CChhHhcccccCcEEEC
Confidence 578987543 4 45766666521 11122222233333444568999999999999884 554 4789999999999
Q ss_pred ccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCccccccccccccccccccc
Q 047739 122 QYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSRE 199 (1099)
Q Consensus 122 ~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 199 (1099)
++|++++..|..++.+++|++|+|++|.+++..|..+. ++|++|+|++|+++...+..|+++++|++|++++|++++
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~- 155 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER- 155 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCc-
Confidence 99999988888999999999999999999987776665 788889999998885544557888889999998888873
Q ss_pred cccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccc
Q 047739 200 VPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFN 279 (1099)
Q Consensus 200 ~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n 279 (1099)
..|..++.+++|++|++++|++++.. ++.+++|++|++++|.+++. ..++.++.+++++|
T Consensus 156 -------~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~----------~~~~~L~~L~l~~n 215 (390)
T 3o6n_A 156 -------IEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL----------AIPIAVEELDASHN 215 (390)
T ss_dssp -------CCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEE----------ECCSSCSEEECCSS
T ss_pred -------cChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccccc----------CCCCcceEEECCCC
Confidence 33445667888888888888888653 55678888888888887632 12345566666666
Q ss_pred cccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCC
Q 047739 280 AFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVP 359 (1099)
Q Consensus 280 ~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~ 359 (1099)
.+..++... .++|+.|+|++|++++. .++..+++|++|+|++|.+++..|..|.++++|++|+|++|++++ ++
T Consensus 216 ~l~~~~~~~----~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~ 288 (390)
T 3o6n_A 216 SINVVRGPV----NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288 (390)
T ss_dssp CCCEEECCC----CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EE
T ss_pred eeeeccccc----cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cC
Confidence 555554321 24555555555555542 345555555555555555555555555555555555555555553 23
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc
Q 047739 360 VEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 360 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
..+..+++|++|+|++|+++ .+|..+..+++|++|++++|.++... +..+++|+.|++++|.+.
T Consensus 289 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred cccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCcc
Confidence 33444555555555555555 34444444445555555555444321 333444444444444443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.25 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=193.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
.++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999875 589999999864322 2356889999999999999999999987543 2
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 5699999997 578888852 37899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc----
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI---- 1028 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 1028 (1099)
.... .......+||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.........
T Consensus 176 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccc----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 5421 22234568999999999999999999999999999999999999999877665544443322111000
Q ss_pred ------cccc--cCccc-----------CCCCCChh-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 ------TELL--EPGLL-----------ELDPESSE-WEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ------~~~~--d~~~~-----------~~~~~~~~-~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... .+.+. ..+..... ...-..+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 00000 00001111 1112346789999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=343.86 Aligned_cols=203 Identities=24% Similarity=0.412 Sum_probs=174.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|+..+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence 357999999999999999999986 58899999986542 2346789999999999999999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 111 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred ECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999999998642 488999999999999999999996 999999999999999999999999999865411
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+.
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 123345799999999999999999999999999999999999999987655443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=358.66 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=204.4
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|+..++||+|+||.||+|... +|+.||+|++... ....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFY 102 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence 3568999999999999999999986 6899999998433 3345779999999999999999999999985 45669
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE---CCCCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---DADFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---~~~~~~kl~DfGla~ 952 (1099)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||++ +.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999999742 348999999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... .......+||+.|+|||++.+ .++.++||||+||++|||++|+.||......+....+........
T Consensus 178 ~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 247 (484)
T 3nyv_A 178 HFEA----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE----- 247 (484)
T ss_dssp HBCC----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred Eccc----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 6522 223345679999999998875 689999999999999999999999988776665555443211100
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.+.... ..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~s---------~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQWKKVS---------ESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGGGGSC---------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccccCC---------HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 01111000 12458999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=355.24 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=199.1
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
..++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+|++++++++||||+++++++.+ ....|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 3567999999999999999999986 58899999985432 234678999999999999999999999985 455699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEeccccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDRL 953 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~~ 953 (1099)
||||+++|+|.+++... ..+++..+..++.||++||+|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 114 v~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999998753 34889999999999999999999999999999999999976 45599999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... .......+||+.|+|||++. +.++.++||||+||++|||++|+.||......+....+...... ...
T Consensus 189 ~~~----~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~~ 258 (494)
T 3lij_A 189 FEN----QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-----FDS 258 (494)
T ss_dssp CBT----TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCS
T ss_pred CCC----CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCc
Confidence 522 22334568999999999876 56999999999999999999999999887766655554432111 011
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.+... . ..+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~---s------~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNV---S------EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTS---C------HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccC---C------HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111100 0 12457899999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=333.38 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=206.1
Q ss_pred HHhccccccccccccceeEEEEEE--CCceEEEEEECCCCC---ccHHHHHHHHHHhhhc---cCCcceEEeeEEec---
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACY--NDGMVLSIRRLPDGS---LDENLFRKEAEFLGKV---RHRNLTVLRGYYAG--- 869 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~--- 869 (1099)
+.++|++.+.||+|+||.||+|.+ .+|+.||+|++.... .....+.+|+++++++ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 368899999885322 1234577888888877 89999999999862
Q ss_pred -CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 870 -APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 870 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
.....++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 3445689999997 69999997532 234899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
|+++... .........||..|+|||++.+..++.++||||+|+++|||++|+.||......+....+.........
T Consensus 165 g~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCC----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ccccccc----CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9997642 122344567999999999999999999999999999999999999999887766665555543322111
Q ss_pred ccccc--------------CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1029 TELLE--------------PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1029 ~~~~d--------------~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
..... .......+.. + ..+.+++.+||+.||++||++.|+++ .+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDI-D----ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSC-C----HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCccccccchhhhcccCcchhhhccccC-C----HHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 11000 0000000000 0 12457899999999999999999995 35444
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=356.17 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=201.2
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--------------ccHHHHHHHHHHhhhccCCcceEEee
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--------------LDENLFRKEAEFLGKVRHRNLTVLRG 865 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~ 865 (1099)
..++|.+.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999986 47899999985432 22467889999999999999999999
Q ss_pred EEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC---c
Q 047739 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF---E 942 (1099)
Q Consensus 866 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~---~ 942 (1099)
++.+ ....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .
T Consensus 114 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFED-KKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEC-SSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEc-CCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9984 45669999999999999999753 3489999999999999999999999999999999999998775 6
Q ss_pred EEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHH
Q 047739 943 AHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQ 1022 (1099)
Q Consensus 943 ~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~ 1022 (1099)
+||+|||+++.... .......+||+.|+|||++. +.++.++||||+||++|+|++|+.||......+....+...
T Consensus 188 ~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 188 IKIVDFGLSSFFSK----DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp EEECCCTTCEECCT----TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEEEECCCCEEcCC----CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986522 22344567999999999876 56999999999999999999999999887766655554432
Q ss_pred hhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1023 LQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1023 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..... .+.+... -..+.+++.+||+.||.+|||++|+++.
T Consensus 263 ----~~~~~-~~~~~~~---------s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 ----KYYFD-FNDWKNI---------SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----CCCCC-HHHHTTS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CCCCC-ccccCCC---------CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11000 0000000 0234689999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=330.34 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=200.1
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
..++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++||||+++++++.+ +...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEE
Confidence 4578999999999999999999986 6889999998532 2334778999999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999998642 34899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhH-HHHHHHHhhhccccccccCc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDI-VKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. .........||..|+|||.+.+..+ +.++||||+|+++|||++|+.||........ ...+.. .... .. .
T Consensus 159 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~---~~-~ 230 (276)
T 2yex_A 159 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKTY---LN-P 230 (276)
T ss_dssp T-EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---TCTT---ST-T
T ss_pred c-chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---cccc---cC-c
Confidence 1 1122345679999999999987765 7789999999999999999999976544321 111111 1000 00 0
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... + ..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~-----~----~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 WKKI-----D----SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGGS-----C----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhhc-----C----HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000 0 123578999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=337.79 Aligned_cols=265 Identities=22% Similarity=0.369 Sum_probs=198.5
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|+..+.||+|+||.||+|.... |+.||+|++...... .+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEE
Confidence 4689999999999999999999864 899999988544332 3567899999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA- 176 (331)
T ss_dssp EECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC-
Confidence 9999998888876532 3489999999999999999999999999999999999999999999999999976422
Q ss_pred CCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc----------
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG---------- 1026 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~---------- 1026 (1099)
.........||..|+|||++.+. .++.++||||+|+++|||++|+.||......+....+.......
T Consensus 177 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 --PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred --CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 12233456799999999998875 68999999999999999999999998776655444443321110
Q ss_pred --cccccccCcccCCCCCChhHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1027 --QITELLEPGLLELDPESSEWE-EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1027 --~~~~~~d~~~~~~~~~~~~~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.......+......+....+. .-..+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000111100000000000 0123568999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.16 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=193.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|.+.+.||+|+||.||+|.+. +|+.||+|.+.... ...+.+.+|++++++++||||+++++++.. +...++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 89 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFMV 89 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEEE
Confidence 57899999999999999999986 68999999985322 224578899999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 9999999999999753 2388999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
........|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||.........+.+... ... ..
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~--~~--- 231 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----VFY--IP--- 231 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CC---
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----ccc--Cc---
Confidence 122334578999999999987765 58999999999999999999999776555444433321 100 00
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 232 -----~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 -----EYLN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----hhcC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0001 124578999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.34 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=203.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.+.|+..+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence 457999999999999999999875 5889999998543 23457899999999999999999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 172 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc-
Confidence 99999999999864 34899999999999999999999999999999999999999999999999999765221
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........||..|+|||++.+..++.++||||||+++|||++|+.||...........+.. .... .....
T Consensus 173 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~-~~~~~--- 242 (303)
T 3a7i_A 173 --QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----NNPP-TLEGN--- 242 (303)
T ss_dssp --BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCC-CCCSS---
T ss_pred --ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----CCCC-CCccc---
Confidence 2233456799999999999999999999999999999999999999976655444333222 1111 01111
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 243 -----~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 -----YS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----cC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 124578999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=365.93 Aligned_cols=256 Identities=22% Similarity=0.352 Sum_probs=204.6
Q ss_pred HHhccccccccccccceeEEEEEECC----ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|+..+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++.+ +..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence 35678999999999999999998742 578999998654322 3678999999999999999999999863 346
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999999753 234899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+..... .. ..
T Consensus 542 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----~~-~~ 614 (656)
T 2j0j_A 542 EDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LP-MP 614 (656)
T ss_dssp CC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----CC-CC
T ss_pred CCC--cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----CC-CC
Confidence 221 2222334567889999999998999999999999999999997 9999987766665554433211 00 00
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+ ..+ ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 615 ~--------~~~----~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 P--------NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp T--------TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c--------ccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 111 13457899999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.84 Aligned_cols=269 Identities=21% Similarity=0.312 Sum_probs=196.7
Q ss_pred HhccccccccccccceeEEEEEECC-ceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEec----------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAG---------- 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 869 (1099)
.++|...+.||+|+||.||+|.... |+.||+|++..... ..+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4579999999999999999999875 89999998865432 34678999999999999999999998742
Q ss_pred ---CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEE
Q 047739 870 ---APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHL 945 (1099)
Q Consensus 870 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl 945 (1099)
.....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.||+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 2345689999997 699999863 3488999999999999999999999999999999999997 5679999
Q ss_pred eccccccccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||+++................+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999865332222233445678999999998865 6789999999999999999999999987766555444433211
Q ss_pred hcc----------ccccccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1025 KGQ----------ITELLEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1025 ~~~----------~~~~~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
... +.......... ....... -..+.+++.+||+.||++|||++|+++ .+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTE---PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTS---CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCchhhhhhhhhcCcccccccccC---CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 000 00000000000 0000000 123468999999999999999999987 45443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=342.47 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=187.0
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhcc-CCcceEEeeEEe-------cCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVR-HRNLTVLRGYYA-------GAP 871 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~-------~~~ 871 (1099)
..+|++.++||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++++. ||||+++++++. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999975 58899999885433 33467889999999996 999999999984 233
Q ss_pred CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEECCCCcEEEeccc
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
...++||||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 44689999996 79999997532 2345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCC---------ccccccccCccccCcccc---ccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHH
Q 047739 950 LDRLTIPTPAEA---------STSTTAVGTLGYVSPEAA---LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVK 1017 (1099)
Q Consensus 950 la~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~ 1017 (1099)
+++......... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998653222111 112245699999999998 56678899999999999999999999996543321111
Q ss_pred HHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1018 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
. ........ ... ..+.+++.+||+.||++||++.|+++.|+.+......
T Consensus 264 ---~-----~~~~~~~~------~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 264 ---G-----KYSIPPHD------TQY------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ----------CCCCTTC------CSS------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred ---C-----cccCCccc------ccc------hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 0 00000000 000 1135789999999999999999999999988755443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.20 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=185.6
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEE
Confidence 3568999999999999999999864 68899999986432 23467889999999999999999999998554 56999
Q ss_pred EeecCCCCHHHHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 878 YDYMPNGNLGTLLQEASH---QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|||+++|+|.+++..... .....+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999975321 12345899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCC--CCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 955 IPTPA--EASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 955 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
..... .........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 32211 1122344679999999999875 56899999999999999999999999876554433222111000000000
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.++... .. .. ..+.+++.+||+.||.+||++.|+++.
T Consensus 252 ~~~~~~---~~-~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 252 QDKEML---KK-YG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ---CCC---CC-CC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccchhh---hh-hh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000 00 00 124578999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.57 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=201.2
Q ss_pred HHHHhccccc-cccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCC
Q 047739 799 VEATRQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 799 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 872 (1099)
....++|.+. +.||+|+||.||+|... +|+.||+|.+... ......+.+|+.++++++ ||||+++++++.. ..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~ 102 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TS 102 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CC
Confidence 4455677776 89999999999999986 5899999998542 223577899999999995 6999999999984 45
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEeccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFG 949 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfG 949 (1099)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.||+||||||+||+++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 569999999999999998632 2355899999999999999999999999999999999999987 7899999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+++.... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||......+....+..... ..
T Consensus 180 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~- 252 (327)
T 3lm5_A 180 MSRKIGH----ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--DY- 252 (327)
T ss_dssp GCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CC-
T ss_pred cccccCC----ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc--cc-
Confidence 9986522 2223446799999999999999999999999999999999999999987666554444333211 00
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+.+. ... ..+.+++.+||+.||++|||++|+++.
T Consensus 253 --~~~~~~-----~~~----~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 --SEETFS-----SVS----QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CTTTTT-----TSC----HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --Cchhhc-----ccC----HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 000 124578999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.52 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=194.5
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---------cHHHHHHHHHHhhhccCCcceEEeeEEecC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVRHRNLTVLRGYYAGA 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 870 (1099)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999986 479999999864321 124588999999999999999999998743
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc---EEEec
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE---AHLSD 947 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~---~kl~D 947 (1099)
. .++||||+++|+|.+++... ..+++.....++.||++||+|||+.||+||||||+||+++.++. +||+|
T Consensus 88 -~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 -D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 3 69999999999999998642 35899999999999999999999999999999999999987654 99999
Q ss_pred cccccccCCCCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch-hHHHHHHHHh
Q 047739 948 FGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQL 1023 (1099)
Q Consensus 948 fGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~-~~~~~~~~~~ 1023 (1099)
||+++... .........||..|+|||++. ...++.++||||+|+++|||++|+.||...... .....+....
T Consensus 161 fg~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 161 FGHSKILG----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CTTCEECC----CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred Cccceecc----cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 99998652 122234467999999999874 466889999999999999999999999754433 2222222210
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ....+ ..... -..+.+++.+||+.||++||++.|+++
T Consensus 237 ~-~~~~~-~~~~~------------~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 Y-NFIPE-VWAEV------------SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-CCCHH-HHTTS------------CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-ccCch-hhhhc------------CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00000 00000 123468999999999999999999884
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=337.86 Aligned_cols=279 Identities=18% Similarity=0.248 Sum_probs=199.9
Q ss_pred HHHHHHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC--
Q 047739 796 AETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD-- 872 (1099)
Q Consensus 796 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 872 (1099)
.+.....++|.+.+.||+|+||.||+|.+. +|..||+|++.........+.+|++.+++++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345667889999999999999999999985 58999999986655555667888999999999999999999864222
Q ss_pred ----ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc--cCCceecCCCCCCEEECC-CCcEEE
Q 047739 873 ----LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH--TSNMVHGDIKPQNVLFDA-DFEAHL 945 (1099)
Q Consensus 873 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~iiH~Dlk~~NIll~~-~~~~kl 945 (1099)
..++||||+++ +|.+.+.... .....+++..+..++.|++.|+.||| +.||+||||||+||+++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 25799999975 6665554322 23455889999999999999999999 999999999999999996 899999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||+++.... ........||..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.+...
T Consensus 174 ~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 174 CDFGSAKKLSP----SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp CCCTTCBCCCT----TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeCCCceecCC----CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 99999986532 22234567899999999987654 89999999999999999999999988776666555544322
Q ss_pred hccc--cccccCccc---CCCCCChhHHH---------HHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcc
Q 047739 1025 KGQI--TELLEPGLL---ELDPESSEWEE---------FLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGC 1080 (1099)
Q Consensus 1025 ~~~~--~~~~d~~~~---~~~~~~~~~~~---------~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 1080 (1099)
.... ....++... ........+.. -..+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 1110 000000000 00001111111 1345689999999999999999999974 4444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=367.45 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCce
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 874 (1099)
..++|++.++||+|+||.||+|.++ +++.||+|++... ....+.+..|.+++..+ +||+|+++++++.+ .+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence 3568999999999999999999986 4789999998532 22345678899999987 79999999999874 4567
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999999864 24899999999999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++.+.+... ... +..
T Consensus 493 ~~---~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----~~~--~p~ 563 (674)
T 3pfq_A 493 IW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----NVA--YPK 563 (674)
T ss_dssp CC---TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS----CCC--CCT
T ss_pred cc---CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----CCC--CCc
Confidence 21 223345678999999999999999999999999999999999999999887766655554331 110 001
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTM-----SDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1075 (1099)
.+ . ..+.+++.+||+.||++||++ +||.+
T Consensus 564 ~~--------s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 564 SM--------S----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TS--------C----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred cC--------C----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 00 1 134689999999999999997 77764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=330.94 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=197.1
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..++|+..+.||+|+||.||+|.+. +|+.||+|.+.... ..+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEee
Confidence 4568999999999999999999986 48999999986533 34678999999999999999999999985 445699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT---
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh---
Confidence 99999999999742 23589999999999999999999999999999999999999999999999999976422
Q ss_pred CCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
.........||..|+|||.+.+..++.++||||+|+++|||++|+.||...........+.. ........+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~----- 248 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT----NPPPTFRKP----- 248 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSSG-----
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCCcccCCc-----
Confidence 12233456799999999999998999999999999999999999999976554333222211 110000000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+. ..+.+++.+||+.||++|||+.|+++
T Consensus 249 ----~~~~--~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ----ELWS--DNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGSC--HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----ccCC--HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 13457899999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.25 Aligned_cols=252 Identities=19% Similarity=0.287 Sum_probs=184.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|+..+.||+|+||.||+|... +|+.||+|++....... +.+.++...++.++||||+++++++.+. ...++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-GDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-CCEEEE
Confidence 468999999999999999999984 68999999986543222 3344555568888999999999999854 456999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||++ |+|.+++..... ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred Eehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99997 599888875322 335689999999999999999999998 999999999999999999999999999976522
Q ss_pred CCCCCccccccccCccccCcccc----ccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAA----LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
........||+.|+|||++ .+..++.++||||+|+++|||++|+.||....... ..+........ ....
T Consensus 163 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~~ 235 (290)
T 3fme_A 163 ----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPS-PQLP 235 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSCC-CCCC
T ss_pred ----cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccCC-CCcc
Confidence 2223345799999999996 45678999999999999999999999997533321 11112211111 1111
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. ... ..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~--------~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 AD--------KFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TT--------TSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc--------cCC----HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 10 001 12467899999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=334.51 Aligned_cols=270 Identities=21% Similarity=0.280 Sum_probs=202.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecC----CCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGA----PDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~~ 874 (1099)
.++|...+.||+|+||.||+|.+. +|+.||+|.+..... ....+.+|++++++++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999986 589999999864332 235688999999999999999999988643 2556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 699999875 24899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCC-------ccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc
Q 047739 955 IPTPAEA-------STSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026 (1099)
Q Consensus 955 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1026 (1099)
....... ......+||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 3221111 11234578999999998765 678999999999999999999999998776655444443332211
Q ss_pred ccccccc-----------CcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhcc
Q 047739 1027 QITELLE-----------PGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGC 1080 (1099)
Q Consensus 1027 ~~~~~~d-----------~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~ 1080 (1099)
....... ....... ....+. -..+.+++.+||+.||++|||++|+++ .++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYP--AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCC--CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCC--CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1000000 0000000 000000 123468999999999999999999997 44443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.51 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=200.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----------ccHHHHHHHHHHhhhcc-CCcceEEeeEEec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----------LDENLFRKEAEFLGKVR-HRNLTVLRGYYAG 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 869 (1099)
.++|+..+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999986 58999999985432 11356789999999996 9999999999974
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 96 -~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 -NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred -CCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 45679999999999999999753 348999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccc------cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHh
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAAL------TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~ 1023 (1099)
++..... ........|+..|+|||++. ...++.++||||+|+++|||++|+.||...........+...
T Consensus 170 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 244 (298)
T 1phk_A 170 FSCQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 244 (298)
T ss_dssp TCEECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred chhhcCC----CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC-
Confidence 9976532 12334567999999999885 456889999999999999999999999876655444433322
Q ss_pred hhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1024 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ...+..... -..+.+++.+||+.||++|||+.|+++
T Consensus 245 ---~~~-~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 ---NYQ-FGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---CCC-CCTTTGGGS---------CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---Ccc-cCccccccc---------CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110 000100000 013458999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.80 Aligned_cols=254 Identities=13% Similarity=0.037 Sum_probs=178.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhc--cCCcceEEe-------eEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKV--RHRNLTVLR-------GYY 867 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 867 (1099)
..+|...+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346889999999999999999976 689999999976443 235677886555555 599988855 333
Q ss_pred ecCC----------------CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHccCCc
Q 047739 868 AGAP----------------DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR------HLIALGVARGLAFLHTSNM 925 (1099)
Q Consensus 868 ~~~~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~i 925 (1099)
...+ ...|+||||++ |+|.+++..... .+.+..+ ..++.||++||+|||+.||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 3211 23689999998 899999986432 2455566 7888999999999999999
Q ss_pred eecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhC
Q 047739 926 VHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTG 1003 (1099)
Q Consensus 926 iH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg 1003 (1099)
+||||||+||+++.++.+||+|||+|+... .......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETT------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecC------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999998541 12224567799999999987 6799999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1004 KRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1004 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.||.......... ......................+ ..+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS-----WKRPSLRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC-----CCBCCTTSCCCCSCCCTTSSCCC----HHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc-----hhhhhhhhccccccchhhccCCC----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99997653321100 00000000000000000000111 13457899999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.52 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=193.2
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
+|....+||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeC
Confidence 3555669999999999999975 57899999986543 3357799999999999999999999999854 4569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEeccccccccCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~ 960 (1099)
++++|.+++... .....+++..+..++.|+++||+|||+.||+||||||+||+++. ++.+||+|||+++.....
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--- 176 (295)
T 2clq_A 102 PGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--- 176 (295)
T ss_dssp SEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC---
Confidence 999999999753 22334678889999999999999999999999999999999987 899999999999765221
Q ss_pred CccccccccCccccCccccccCC--CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGE--TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........||..|+|||++.+.. ++.++||||||+++|||++|+.||........... ..... .. .+.+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~-~~-----~~~~-- 247 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMF-KV-----HPEI-- 247 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHHH-CC-----CCCC--
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhccc-cc-----cccc--
Confidence 12234567999999999987643 78999999999999999999999975443322111 11111 00 0000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .... ..+.+++.+||+.||++||++.|+++.
T Consensus 248 -~-~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 -P-ESMS----AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -C-TTSC----HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -c-ccCC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0011 124578999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=338.08 Aligned_cols=263 Identities=19% Similarity=0.217 Sum_probs=204.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-CC-----cceEEeeEEecCCCce
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HR-----NLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~ 874 (1099)
.++|++.+.||+|+||.||+|... +++.||+|++.......+.+.+|+++++.++ |+ +|+++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-NHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-TEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-Cce
Confidence 468999999999999999999876 5889999999765555577888999999885 55 499999998854 556
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc--CCceecCCCCCCEEEC--CCCcEEEecccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT--SNMVHGDIKPQNVLFD--ADFEAHLSDFGL 950 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~iiH~Dlk~~NIll~--~~~~~kl~DfGl 950 (1099)
++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999996 59999998532 2348999999999999999999994 6999999999999994 578899999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI-- 1028 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 1028 (1099)
|+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.........
T Consensus 208 a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 208 SCQLGQ------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CEETTC------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeccc------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986521 233468999999999999999999999999999999999999999887776666655543221100
Q ss_pred -----------cccccCccc----------CCCCC-----------------------ChhHHHHHHHHHHHHhcCCCCC
Q 047739 1029 -----------TELLEPGLL----------ELDPE-----------------------SSEWEEFLLGVKVALLCTAPDP 1064 (1099)
Q Consensus 1029 -----------~~~~d~~~~----------~~~~~-----------------------~~~~~~~~~~~~li~~Cl~~dP 1064 (1099)
....+..+. ...+. .....+...+.+++.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 000000000 00000 0111233456789999999999
Q ss_pred CCCCCHHHHHH
Q 047739 1065 IDRPTMSDIVF 1075 (1099)
Q Consensus 1065 ~~RPs~~evl~ 1075 (1099)
++|||++|+++
T Consensus 362 ~~Rpta~e~L~ 372 (382)
T 2vx3_A 362 KTRIQPYYALQ 372 (382)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=333.11 Aligned_cols=264 Identities=17% Similarity=0.247 Sum_probs=203.6
Q ss_pred HhccccccccccccceeEEEEEE-C-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCc------ceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY-N-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN------LTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|.. . +++.||+|.+.......+.+.+|++++++++|++ ++++++++... ..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-GH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-TE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-Cc
Confidence 35799999999999999999987 3 5899999999765555678899999999997654 99999999854 45
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC--------------
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-------------- 939 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-------------- 939 (1099)
.++||||+ +++|.+++.... ...+++..+..++.|+++||+|||+.||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 69999999 889999997532 235889999999999999999999999999999999999987
Q ss_pred -----CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh
Q 047739 940 -----DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014 (1099)
Q Consensus 940 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~ 1014 (1099)
++.+||+|||+++.... ......||..|+|||++.+..++.++||||+|+++|||++|+.||...+..+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999976421 2234679999999999999999999999999999999999999998776655
Q ss_pred HHHHHHHHhhhccc--------cccccCcccCCCCC------------------ChhHHHHHHHHHHHHhcCCCCCCCCC
Q 047739 1015 IVKWVKKQLQKGQI--------TELLEPGLLELDPE------------------SSEWEEFLLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~~--------~~~~d~~~~~~~~~------------------~~~~~~~~~~~~li~~Cl~~dP~~RP 1068 (1099)
....+......... .......-...... ......-..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 54444332211000 00000000000000 00001123456899999999999999
Q ss_pred CHHHHHHH
Q 047739 1069 TMSDIVFM 1076 (1099)
Q Consensus 1069 s~~evl~~ 1076 (1099)
|+.|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.71 Aligned_cols=252 Identities=20% Similarity=0.337 Sum_probs=196.5
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEE
Confidence 3568999999999999999999986 48899999986543 3457789999999999999999999999854 4569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred EeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 9999999999987532 3489999999999999999999999999999999999999999999999998753210
Q ss_pred CCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 959 AEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.........||..|+|||++. +..++.++||||+|+++|||++|+.||...........+.. ........
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 244 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----SDPPTLLT 244 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSS
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc----cCCcccCC
Confidence 011223457899999999883 56789999999999999999999999987655443332222 11111100
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+ ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-------~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 P-------SKWS----VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp G-------GGSC----HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c-------cccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0000 12457899999999999999999876
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=355.85 Aligned_cols=347 Identities=18% Similarity=0.169 Sum_probs=224.3
Q ss_pred CCCCCCCCCCCCCCCc----ccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCccc
Q 047739 42 GALNGWDSSTPAAPCD----WRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLR 117 (1099)
Q Consensus 42 ~~l~~w~~~~~~~~c~----w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~ 117 (1099)
..+++|.++.+ ||. |.+|.|+. + ++-... .......-..++.++.|++++|.+.+..+..++.+++|+
T Consensus 7 ~~l~~~~~~~~--C~~~~~~~~c~~~~~-~---i~~~~~--~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~ 78 (597)
T 3oja_B 7 YNVKPRQPEYK--CIDSNLQYDCVFYDV-H---IDMQTQ--DVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78 (597)
T ss_dssp ----CCCSEEC--CCCC--CCSEEECSC-E---ECSSCC--CCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred ccccCCCCCCc--CcccCcCceeEecCc-e---eccccc--ccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence 45689987543 442 66655541 1 111111 122222334578999999999999865555688999999
Q ss_pred EEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCccccccccccccccc
Q 047739 118 AVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNK 195 (1099)
Q Consensus 118 ~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 195 (1099)
+|+|++|.+++..|..++.+++|++|+|++|.+++..|..+. ++|++|+|++|.|++..+..|+++++|++|+|++|+
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence 999999999998888999999999999999999987776655 788888888888886666667888888888888888
Q ss_pred cccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEE
Q 047739 196 FSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQ 275 (1099)
Q Consensus 196 l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~ 275 (1099)
++ +..|..++.+++|++|++++|.+++.. ++.+++|++|++++|.+++. + .|++++.|+
T Consensus 159 l~--------~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-~---------~~~~L~~L~ 217 (597)
T 3oja_B 159 LE--------RIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-A---------IPIAVEELD 217 (597)
T ss_dssp CC--------BCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-E---------CCTTCSEEE
T ss_pred CC--------CCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-c---------CCchhheee
Confidence 87 344556777888888888888888753 45578888888888887632 1 223444444
Q ss_pred eccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccC
Q 047739 276 LGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355 (1099)
Q Consensus 276 l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~ 355 (1099)
+++|.+..++... .++|+.|+|++|.+++ +..++.+++|++|+|++|.++
T Consensus 218 ls~n~l~~~~~~~----------------------------~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 218 ASHNSINVVRGPV----------------------------NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267 (597)
T ss_dssp CCSSCCCEEECSC----------------------------CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred ccCCccccccccc----------------------------CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence 4444444433221 1345555555555543 244555555555555555555
Q ss_pred ccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhh
Q 047739 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVL 435 (1099)
Q Consensus 356 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 435 (1099)
+..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++. + +.
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~ 342 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LS 342 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CC
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hh
Confidence 5555555555555555555555553 3444455555555555555555 3444455566666666666666533 2 44
Q ss_pred CCCCCCEEEccCCcCcc
Q 047739 436 GMNNLSTLDLSENKFSG 452 (1099)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~ 452 (1099)
.+++|+.|+|++|.+.+
T Consensus 343 ~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 343 THHTLKNLTLSHNDWDC 359 (597)
T ss_dssp TTCCCSEEECCSSCEEH
T ss_pred hcCCCCEEEeeCCCCCC
Confidence 56667777777776653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.53 Aligned_cols=247 Identities=19% Similarity=0.282 Sum_probs=194.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+..+.++ +||||+++++++.+. +..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEE
Confidence 4578999999999999999999986 6899999998643 33456788999999999 999999999999854 5569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---------------
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD--------------- 940 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~--------------- 940 (1099)
+||||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999986432 12458999999999999999999999999999999999999844
Q ss_pred ----CcEEEeccccccccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 941 ----FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 941 ----~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
..+||+|||.+..... .....||..|+|||++.+. .++.++||||+|+++|||++|..|+.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred cCCceEEEEcccccccccCC-------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 4799999999976521 1234599999999998765 56689999999999999999998764321 1
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...+ ..+..... .+ . .+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~----~~~~~~~~-~~-------~-~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHEI----RQGRLPRI-PQ-------V-LS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH----HTTCCCCC-SS-------C-CC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH----HcCCCCCC-Cc-------c-cC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 2211 11211111 11 1 01 124578999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=342.58 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=200.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc--------CCcceEEeeEEec---
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR--------HRNLTVLRGYYAG--- 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~~--- 869 (1099)
.++|++.++||+|+||.||+|... +++.||+|++.......+.+.+|++++++++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 367999999999999999999875 5899999999766555678899999999996 7889999998862
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCC-------
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADF------- 941 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~------- 941 (1099)
.....++||||+ +|++.+++... ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 334568999999 56777777642 224589999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEeccccccccCCCCCCCccccccccCccccCcccc
Q 047739 942 ------------------------------------------EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979 (1099)
Q Consensus 942 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 979 (1099)
.+||+|||+++.... .....+||..|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCCCCcccCChhh
Confidence 799999999986521 23445799999999999
Q ss_pred ccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch------hHHHHHHHHhhh--------cccc-ccccC--cc---cCC
Q 047739 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE------DIVKWVKKQLQK--------GQIT-ELLEP--GL---LEL 1039 (1099)
Q Consensus 980 ~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~------~~~~~~~~~~~~--------~~~~-~~~d~--~~---~~~ 1039 (1099)
.+..++.++|||||||++|||++|+.||...... .....+...... +... +.+.. .+ ...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999764432 122222221111 0000 00000 00 000
Q ss_pred CCC----------ChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1040 DPE----------SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1040 ~~~----------~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+. ....+.-..+.+++.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 001222344678999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=335.78 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=198.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCc----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL---- 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 873 (1099)
.++|...+.||+|+||.||+|.+. +|+.||+|++...... .+.+.+|++++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999875 5899999999654333 36788999999999999999999999754332
Q ss_pred -eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 874 -RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 874 -~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
.++||||++ |+|.+++.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 389999997 688877742 38999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc--c
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI--T 1029 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~ 1029 (1099)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+......... .
T Consensus 193 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HAD------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccc------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 542 12344678999999999887 67899999999999999999999999877665555544432221100 0
Q ss_pred cccc--------CcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1030 ELLE--------PGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1030 ~~~d--------~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
..+. ...... ....+.. -..+.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQT--PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCC--CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCC--cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000 0000000 1235689999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=330.35 Aligned_cols=256 Identities=21% Similarity=0.267 Sum_probs=197.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCC-----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD----- 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 872 (1099)
.++|...+.||+|+||.||+|.+. +|+.||+|.+...... .+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357899999999999999999985 5899999998654332 3568899999999999999999999875432
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||++ |+|.+++.. .+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 2489999997 688877742 38999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc----
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---- 1027 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1027 (1099)
... .......||..|+|||++.+ ..++.++||||+|+++|||++|+.||......+....+........
T Consensus 175 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HAD------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CCC------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 542 12334578999999999887 6789999999999999999999999987766555444443221110
Q ss_pred --------------ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 --------------ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 --------------~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+.......+....+.. -..+.+++.+|++.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-----SPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTS-----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCc-----CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000001111111110 1234688999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=328.06 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=190.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC---------
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA--------- 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 870 (1099)
..++|+..+.||+|+||.||+|... +|+.||+|.+.......+.+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3568999999999999999999975 689999999865444457789999999999999999999988643
Q ss_pred ---CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEec
Q 047739 871 ---PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSD 947 (1099)
Q Consensus 871 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~D 947 (1099)
....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.||+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 34568999999999999999752 23478889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-----------CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhH
Q 047739 948 FGLDRLTIPTPA-----------EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI 1015 (1099)
Q Consensus 948 fGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~ 1015 (1099)
||+++....... .........||..|+|||++.+. .++.++||||+|+++|||++ ||.... +.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 999976532110 01223456799999999998764 68999999999999999998 553211 11
Q ss_pred HHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... ...+..... ...+.+. .. ....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~-~~~~~~~~~--~~~~~~~----~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNI-LKKLRSVSI--EFPPDFD----DN----KMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH-HHHHHSTTC--CCCTTCC----TT----TSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH-HHhcccccc--ccCcccc----cc----chHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111 111111110 0111110 00 01224578999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.89 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCC---CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG---SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
...++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEE
Confidence 45678999999999999999999986 6889999998532 2345778999999999999999999999985 45569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC---CcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD---FEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~---~~~kl~DfGla~ 952 (1099)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999998753 248999999999999999999999999999999999999754 479999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
..... .......||..|+|||.+.+ .++.++||||+|+++|||++|+.||......+....+.. +......
T Consensus 173 ~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~ 243 (287)
T 2wei_A 173 CFQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET----GKYAFDL 243 (287)
T ss_dssp TBCCC----SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCS
T ss_pred eecCC----CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCc
Confidence 65221 22234568999999998865 589999999999999999999999987665554443332 2111000
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.+... . ..+.+++.+||+.||++|||+.|+++
T Consensus 244 -~~~~~~---~------~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 -PQWRTI---S------DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGGTTS---C------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhhc---C------HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000 0 12457999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=340.25 Aligned_cols=263 Identities=17% Similarity=0.285 Sum_probs=201.3
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCcc------------------HHHHHHHHHHhhhccCCcceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD------------------ENLFRKEAEFLGKVRHRNLTVL 863 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~H~niv~l 863 (1099)
.++|.+.+.||+|+||.||+|.+ +|+.||+|.+...... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999999 8999999998532211 1789999999999999999999
Q ss_pred eeEEecCCCceEEEEeecCCCCHHHHHhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECC
Q 047739 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEA---SHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 864 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~ 939 (1099)
++++.+. +..++||||+++|+|.+++... .......+++..+..++.|++.||+|||+ .||+||||||+||+++.
T Consensus 109 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 9999854 5679999999999999983321 11124568999999999999999999999 99999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccC-CCCC-cCchhhHHHHHHHHHhCCCCCCCCCc-hhHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTK-ESDVYSFGIVLLELLTGKRPVMFTQD-EDIV 1016 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~S~G~il~elltg~~P~~~~~~-~~~~ 1016 (1099)
++.+||+|||.++.... .......||..|+|||.+.+. .++. ++||||+|+++|||++|+.||..... .+..
T Consensus 188 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVD-----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBT-----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred CCcEEEecccccccccc-----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999976422 134456799999999999877 5666 99999999999999999999987655 3333
Q ss_pred HHHHHHhhhcccccccc--CcccCCCCC--Chh-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1017 KWVKKQLQKGQITELLE--PGLLELDPE--SSE-WEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1017 ~~~~~~~~~~~~~~~~d--~~~~~~~~~--~~~-~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+.. +......+ ......... ... ...-..+.+++.+||+.||.+||++.|+++
T Consensus 263 ~~i~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIRT----KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHTS----CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhc----cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33222 21110000 000000000 000 000123468999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=339.63 Aligned_cols=269 Identities=17% Similarity=0.206 Sum_probs=201.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-----------CCcceEEeeEEec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-----------HRNLTVLRGYYAG 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 869 (1099)
..+|.+.+.||+|+||.||+|... +++.||+|.+.......+.+.+|++++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 357999999999999999999974 6899999999876666678899999999986 8999999999874
Q ss_pred CC---CceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEEC------C
Q 047739 870 AP---DLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFD------A 939 (1099)
Q Consensus 870 ~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~------~ 939 (1099)
.. ...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 32 2568999999 889999998632 23489999999999999999999998 999999999999994 4
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch------
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE------ 1013 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~------ 1013 (1099)
.+.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 174 ~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp EEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cceEEEcccccccccCC------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 45899999999976521 233457899999999999999999999999999999999999999754321
Q ss_pred hHHHHHHHHhhhcccccc-----------cc-----CcccCCCC----------CChhHHHHHHHHHHHHhcCCCCCCCC
Q 047739 1014 DIVKWVKKQLQKGQITEL-----------LE-----PGLLELDP----------ESSEWEEFLLGVKVALLCTAPDPIDR 1067 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~-----------~d-----~~~~~~~~----------~~~~~~~~~~~~~li~~Cl~~dP~~R 1067 (1099)
+....+..... ..+.. +. ........ ...+...-..+.+++.+||+.||++|
T Consensus 248 ~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLG--ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHC--SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcC--CCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11222222111 11000 00 00000000 00011222345689999999999999
Q ss_pred CCHHHHHH--HhhcccC
Q 047739 1068 PTMSDIVF--MLEGCRV 1082 (1099)
Q Consensus 1068 Ps~~evl~--~L~~~~~ 1082 (1099)
||++|+++ .+.+...
T Consensus 326 pt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp BCHHHHHTCGGGTTCTT
T ss_pred CCHHHHhhChhhhcccC
Confidence 99999998 4554433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=331.18 Aligned_cols=308 Identities=19% Similarity=0.216 Sum_probs=171.9
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 373 (1099)
++++.|++++|.++.+.+..|..+++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..+..+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 45566666666665544444555666666666666665555555556666666666666655555555555555555555
Q ss_pred cCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccc
Q 047739 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453 (1099)
Q Consensus 374 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1099)
++|+++...+..|.++++|++|++++|.+++..+..|.++++|++|++++|++++. .+..+++|+.|++
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l-------- 193 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV-------- 193 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEEC--------
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeec--------
Confidence 55555533233345555555555555555544444555555555555555555432 1233444444444
Q ss_pred cCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc
Q 047739 454 VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533 (1099)
Q Consensus 454 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 533 (1099)
++|.+++. ....+|++|++++|.+... |.. ..++|+.|++++|.+++. ..+..+
T Consensus 194 ----------------~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l 247 (390)
T 3o6n_A 194 ----------------SYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNY 247 (390)
T ss_dssp ----------------CSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGC
T ss_pred ----------------cccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCC
Confidence 44444321 1123455555555555532 211 234566666666666532 355666
Q ss_pred cccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
++|++|++++|.+++..|..+..+++|+.|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 666666666666666556666666666666666666653 4555566667777777777776 45666666677777777
Q ss_pred cCccccccCCcccCCCCCCCEEECcCcccc
Q 047739 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
++|++++ +| +..+++|+.|++++|++.
T Consensus 326 ~~N~i~~-~~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 326 DHNSIVT-LK--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CSSCCCC-CC--CCTTCCCSEEECCSSCEE
T ss_pred CCCccce-eC--chhhccCCEEEcCCCCcc
Confidence 7776663 33 455556666666666555
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.35 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=201.9
Q ss_pred HhccccccccccccceeEEEEEEC-C-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCc------ceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-D-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN------LTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|... + +..||+|.+.......+.+.+|++++++++|++ ++.+++++... ..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-GH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-TE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-Ce
Confidence 468999999999999999999975 3 479999999765555678899999999998766 89999988754 45
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEE----------------
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLF---------------- 937 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll---------------- 937 (1099)
.++||||+ +|++.+++... ....+++..+..++.||++||+|||+.||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 69999999 67888887653 22458999999999999999999999999999999999999
Q ss_pred ---CCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh
Q 047739 938 ---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED 1014 (1099)
Q Consensus 938 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~ 1014 (1099)
+.++.+||+|||+++.... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999975421 2234679999999999999999999999999999999999999998776655
Q ss_pred HHHHHHHHhhhcc--------ccccccCcccCCCCC------------------ChhHHHHHHHHHHHHhcCCCCCCCCC
Q 047739 1015 IVKWVKKQLQKGQ--------ITELLEPGLLELDPE------------------SSEWEEFLLGVKVALLCTAPDPIDRP 1068 (1099)
Q Consensus 1015 ~~~~~~~~~~~~~--------~~~~~d~~~~~~~~~------------------~~~~~~~~~~~~li~~Cl~~dP~~RP 1068 (1099)
....+........ ........-...... ......-..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 5444433321100 000000000000000 00011122456899999999999999
Q ss_pred CHHHHHH
Q 047739 1069 TMSDIVF 1075 (1099)
Q Consensus 1069 s~~evl~ 1075 (1099)
|++|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=327.67 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=191.1
Q ss_pred HHhccccccccccccceeEEEEEECCceEEEEEECCCCCc---cHHHHHHHHHHhhhcc--CCcceEEeeEEecCCCceE
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---DENLFRKEAEFLGKVR--HRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~ 875 (1099)
..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++ ||||+++++++.. +...+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEE
Confidence 3567999999999999999999998899999999854332 3467899999999997 5999999999985 45579
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||| +.+++|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||++++ +.+||+|||+++...
T Consensus 105 lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999 5578999999853 34889999999999999999999999999999999999965 899999999998653
Q ss_pred CCCCCCccccccccCccccCcccccc-----------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALT-----------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+.....
T Consensus 178 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 254 (313)
T 3cek_A 178 PDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHC
T ss_pred Ccc-ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHHHh
Confidence 221 1122345679999999999875 468889999999999999999999997543321 11111111
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... .. .+ . ...+ ..+.+++.+||+.||++||++.|+++.
T Consensus 255 ~~~-~~----~~---~-~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNH-EI----EF---P-DIPE----KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTS-CC----CC---C-CCSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc-cc----CC---c-ccch----HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 110 00 00 0 1111 134578999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=329.63 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=173.0
Q ss_pred HHhccccc-cccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEec---CCCceE
Q 047739 801 ATRQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAG---APDLRL 875 (1099)
Q Consensus 801 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~~ 875 (1099)
..++|.+. ++||+|+||.||+|.+. +|+.||+|++.... ....+....++.++||||+++++++.. .....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 35678884 56999999999999987 58999999985432 222233344566799999999999864 233468
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ....+++..+..++.|+++||+|||+.||+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999853 2346899999999999999999999999999999999999976 4559999999997
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..................+.. ...
T Consensus 180 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 253 (336)
T 3fhr_A 180 ETT-----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GFP 253 (336)
T ss_dssp EC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCC
T ss_pred ecc-----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-ccC
Confidence 542 12233467899999999998888999999999999999999999999765544332222222111111 001
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhccc
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCR 1081 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 1081 (1099)
.+.+. ... ..+.+++.+||+.||++|||+.|+++ .+.+..
T Consensus 254 ~~~~~-----~~~----~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 254 NPEWS-----EVS----EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TTTST-----TCC----HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred chhhc-----cCC----HHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 11110 001 12457899999999999999999998 555443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=331.02 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=175.6
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHH-HhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAE-FLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ....+.+|+. +++.++||||+++++++... +..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEE
Confidence 367899999999999999999985 689999999865432 2344556665 77778999999999999854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||++ |+|.+++..........+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 99997 4888888754333446689999999999999999999999 999999999999999999999999999976522
Q ss_pred CCCCCccccccccCccccCcccc----ccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAA----LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
........||..|+|||++ .+..++.++||||||+++|||++|+.||...... ...+.. ...+......
T Consensus 179 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~-~~~~~~~~~~ 251 (327)
T 3aln_A 179 ----SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQ-VVKGDPPQLS 251 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC-CCCSCCCCCC
T ss_pred ----ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHH-HhcCCCCCCC
Confidence 1222344799999999998 4567899999999999999999999999754321 111110 1111111110
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ..... ..+.+++.+||+.||++||++.|+++
T Consensus 252 ~~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSE-----EREFS----PSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCS-----SCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc-----cccCC----HHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 00011 13467899999999999999999975
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.49 Aligned_cols=276 Identities=23% Similarity=0.295 Sum_probs=210.5
Q ss_pred CChhhHHHHHHHHHhC-CCCCCCCCCCCC--CCCCCCCcccceEecC----------CcEeEEecCCCcccccccccccc
Q 047739 22 DRSPEIEALTSFKLNL-HDPLGALNGWDS--STPAAPCDWRGVACTN----------NRVTELRLPRLQLSGRISDHLSN 88 (1099)
Q Consensus 22 ~~~~~~~~l~~~k~~~-~~~~~~l~~w~~--~~~~~~c~w~gv~c~~----------~~v~~l~l~~~~l~g~~~~~l~~ 88 (1099)
+..+|+.||++||+++ .||.+.+.+|.. .....+|.|.||+|+. .+|+.|+|+++++. .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 3458999999999999 688888889941 1234579999999952 78999999999998 89999999
Q ss_pred ccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCC
Q 047739 89 LRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLS 168 (1099)
Q Consensus 89 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls 168 (1099)
+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+...
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------- 173 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------- 173 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-------
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-------
Confidence 999999999999999 89999999999999999999999 889999999999999999999988888765421
Q ss_pred CCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcc
Q 047739 169 SNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA 248 (1099)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 248 (1099)
.++..|+++++|++|+|++|+++ .+|..++.+++|++|++++|++++ +|..|+.+++|++|+|+
T Consensus 174 ------~~~~~~~~l~~L~~L~L~~n~l~---------~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 174 ------DASGEHQGLVNLQSLRLEWTGIR---------SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR 237 (328)
T ss_dssp ------C-CCCEEESTTCCEEEEEEECCC---------CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECT
T ss_pred ------cchhhhccCCCCCEEECcCCCcC---------cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECc
Confidence 22345677899999999999887 577788889999999999999986 55578899999999999
Q ss_pred cccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCC
Q 047739 249 QNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGN 328 (1099)
Q Consensus 249 ~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 328 (1099)
+|++.+.+|..+ ..+++|++|+|++|.+.+.+|..+..+++|++|+|++|
T Consensus 238 ~n~~~~~~p~~~------------------------------~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n 287 (328)
T 4fcg_A 238 GCTALRNYPPIF------------------------------GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287 (328)
T ss_dssp TCTTCCBCCCCT------------------------------TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTC
T ss_pred CCcchhhhHHHh------------------------------cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCC
Confidence 988876554421 11334555555555554455555555555555555555
Q ss_pred ccccCchhhhCCCCCCCEEEccCCc
Q 047739 329 SISGKIPAQIGGLWRLEELKMANNS 353 (1099)
Q Consensus 329 ~i~~~~p~~~~~l~~L~~L~L~~n~ 353 (1099)
.+.+.+|..|+++++|+.+++..+.
T Consensus 288 ~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 288 VNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp TTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred CchhhccHHHhhccCceEEeCCHHH
Confidence 5555555555555555555544443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=347.30 Aligned_cols=311 Identities=20% Similarity=0.191 Sum_probs=229.1
Q ss_pred CCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEE
Q 047739 341 LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420 (1099)
Q Consensus 341 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 420 (1099)
+.+++.|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788999999999877777788889999999999999877777888888888888888888888888888888888888
Q ss_pred cccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc
Q 047739 421 LRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 421 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 500 (1099)
|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|+.|+|++|.+++. .++.+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence 888888865555568888888888888888888888888888888888888888754 25566778888888887763
Q ss_pred cCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCC
Q 047739 501 ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN 580 (1099)
Q Consensus 501 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~ 580 (1099)
+...++|+.|++++|.++.. +..+ .++|+.|+|++|.+++ +..+..+++|+.|++++|.+++.+|..|++
T Consensus 207 -----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 276 (597)
T 3oja_B 207 -----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276 (597)
T ss_dssp -----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred -----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence 23345677777777777633 2222 2567777777777764 355666677777777777776666666666
Q ss_pred CCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeee
Q 047739 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLD 660 (1099)
Q Consensus 581 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 660 (1099)
+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..++.+++|+.|+|++|++++. | +..+++|+.|+
T Consensus 277 l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~ 351 (597)
T 3oja_B 277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLT 351 (597)
T ss_dssp CSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEE
T ss_pred ccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEE
Confidence 7777777777777763 4555566667777777777766 4666666667777777777776633 2 45566666777
Q ss_pred cCCCcCCCc
Q 047739 661 LSANNLSGE 669 (1099)
Q Consensus 661 ls~N~l~~~ 669 (1099)
+++|++++.
T Consensus 352 l~~N~~~~~ 360 (597)
T 3oja_B 352 LSHNDWDCN 360 (597)
T ss_dssp CCSSCEEHH
T ss_pred eeCCCCCCh
Confidence 777766643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.76 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=183.8
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
..+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+ ....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEEC
Confidence 346889999999999997666666789999999865432 3467899999999 79999999999884 4556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-----CCcEEEeccccccccC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-----DFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~ 955 (1099)
+. |+|.+++.... ....+.....++.||++||+|||+.+|+||||||+||+++. ...+||+|||+|+...
T Consensus 100 ~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 69999997532 22444556789999999999999999999999999999943 3468899999998653
Q ss_pred CCCCCCccccccccCccccCccccc---cCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAAL---TGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
............+||+.|+|||++. ...++.++||||+||++|||++ |..||.......... ....... .
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----~~~~~~~-~- 248 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----LLGACSL-D- 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----HTTCCCC-T-
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----HhccCCc-c-
Confidence 3222223345578999999999987 4567889999999999999999 999986543322111 1111100 0
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
...+... .-..+.+++.+||+.||++|||+.||++
T Consensus 249 ------~~~~~~~---~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 ------CLHPEKH---EDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------TSCTTCH---HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCcccc---ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111111 1122457999999999999999999984
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=318.41 Aligned_cols=307 Identities=24% Similarity=0.372 Sum_probs=172.8
Q ss_pred ccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCC
Q 047739 314 LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393 (1099)
Q Consensus 314 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 393 (1099)
+..+++|++|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 3455667777777776653 33 35566666666666666653322 5566666666666666552 22 344444444
Q ss_pred eeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCc
Q 047739 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473 (1099)
Q Consensus 394 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 473 (1099)
+|++++|.+++..+ + ..+++|+.|++++|.....+ ..+..+++|+.|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~------------------------~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~ 166 (347)
T 4fmz_A 114 ELYLNEDNISDISP--L------------------------ANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESK 166 (347)
T ss_dssp EEECTTSCCCCCGG--G------------------------TTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSC
T ss_pred EEECcCCcccCchh--h------------------------ccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCC
Confidence 44444444443222 4 44444444444444332222 224444455555555554
Q ss_pred CCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCc
Q 047739 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPAT 553 (1099)
Q Consensus 474 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (1099)
+.+..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 443222 4455555555555555543222 4555555556666555553322 5556666666666666654333
Q ss_pred ccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCC
Q 047739 554 FSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLR 633 (1099)
Q Consensus 554 l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 633 (1099)
+..+++|+.|++++|++++. +.+..+++|++|++++|++++ + ..+..+++|+.|++++|++++..|..++.+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 55566666666666666532 346666777777777777764 3 3466777777777777777766666677777777
Q ss_pred EEECcCccccccCChhhhccCCCCeeecCCCcCC
Q 047739 634 SLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 634 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
.|++++|++++..| +..+++|+.||+++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777777775444 667777777777777764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=340.35 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=182.3
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEEEEeecC
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+ +...|+||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC
Confidence 45567889999999998877778999999998542 245678999999987 89999999999874 456799999995
Q ss_pred CCCHHHHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC-------------CcEEEec
Q 047739 883 NGNLGTLLQEASHQDG--HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD-------------FEAHLSD 947 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~-------------~~~kl~D 947 (1099)
|+|.+++........ ...++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 699999986432211 112344567899999999999999999999999999999654 4899999
Q ss_pred cccccccCCCCCC-CccccccccCccccCcccccc-------CCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 948 FGLDRLTIPTPAE-ASTSTTAVGTLGYVSPEAALT-------GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 948 fGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
||+++........ ........||+.|+|||++.+ ..++.++||||+||++|||++ |+.||....... ..
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~ 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH
Confidence 9999865322111 112345689999999999875 568999999999999999999 999996543322 11
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
+.. +... .+... .......-..+.+++.+||+.||++|||+.||++
T Consensus 250 i~~----~~~~---~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIR----GIFS---LDEMK----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH----TCCC---CCCCT----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Hhc----CCCC---ccccc----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 1100 00000 0011111234568999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=325.82 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=188.6
Q ss_pred HHHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-------cHHHHHHHHHHhhhc----cCCcceEEeeEE
Q 047739 800 EATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-------DENLFRKEAEFLGKV----RHRNLTVLRGYY 867 (1099)
Q Consensus 800 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~H~niv~l~~~~ 867 (1099)
...++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+++++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34678999999999999999999874 688999999965432 224466899999999 899999999998
Q ss_pred ecCCCceEEEEee-cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEE
Q 047739 868 AGAPDLRLLVYDY-MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHL 945 (1099)
Q Consensus 868 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl 945 (1099)
... +..++|||| +.+++|.+++... ..+++..+..++.|+++||+|||+.||+||||||+||+++ .++.+||
T Consensus 108 ~~~-~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQ-EGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecC-CeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 754 445899999 7889999999863 2489999999999999999999999999999999999999 8899999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCCCC-CcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETT-KESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||+++.... .......||..|+|||++.+..+. .++||||+|+++|||++|+.||.... . +..
T Consensus 182 ~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~--- 247 (312)
T 2iwi_A 182 IDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILE--- 247 (312)
T ss_dssp CCCSSCEECCS-----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH---
T ss_pred EEcchhhhccc-----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhh---
Confidence 99999986522 123456799999999998877664 58999999999999999999996421 1 111
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
... .+.. . .. ..+.+++.+||+.||++|||++|+++.
T Consensus 248 -~~~--~~~~-------~-~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -AEL--HFPA-------H-VS----PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -TCC--CCCT-------T-SC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hcc--CCcc-------c-CC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 0000 0 01 124578999999999999999999984
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=318.41 Aligned_cols=305 Identities=23% Similarity=0.333 Sum_probs=221.5
Q ss_pred CCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEE
Q 047739 292 CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLL 371 (1099)
Q Consensus 292 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 371 (1099)
.+++|++|++++|.+... + .+..+++|++|++++|.+++. +. |.++++|++|++++|.+++. ..+..+++|++|
T Consensus 42 ~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L 115 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLREL 115 (347)
T ss_dssp HHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEE
T ss_pred hcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEE
Confidence 457899999999999864 4 388999999999999999864 44 99999999999999999853 469999999999
Q ss_pred EccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCc
Q 047739 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 372 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
+|++|++++ ++. +..+++|++|++++|......+ .+.++++|++|++++|.+.+..+ +..+++|+.|++++|.++
T Consensus 116 ~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 116 YLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp ECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred ECcCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 999999985 444 8899999999999996654443 38888889999999888875433 777888888888888887
Q ss_pred cccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhh
Q 047739 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531 (1099)
Q Consensus 452 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 531 (1099)
+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++.
T Consensus 191 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~------ 258 (347)
T 4fmz_A 191 DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI------ 258 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC------
T ss_pred cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC------
Confidence 4433 6667777777777777764433 5566666666666666653322 44555555555555555432
Q ss_pred cccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEE
Q 047739 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL 611 (1099)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 611 (1099)
..+..+++|+.|++++|++++. +.+..+++|++|++++|++++..|..++.+++|+.|
T Consensus 259 --------------------~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 259 --------------------NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp --------------------GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred --------------------hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 2344445555555555555532 346667777778888887777667777778888888
Q ss_pred eccCccccccCCcccCCCCCCCEEECcCcccc
Q 047739 612 DLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 612 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
++++|++++..| +..+++|++|++++|+++
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888775444 677788888888888765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.86 Aligned_cols=241 Identities=23% Similarity=0.348 Sum_probs=193.9
Q ss_pred HHhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-------cHHHHHHHHHHhhhcc--CCcceEEeeEEecC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-------DENLFRKEAEFLGKVR--HRNLTVLRGYYAGA 870 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~ 870 (1099)
..++|.+.+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++++++ ||||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 4568999999999999999999874 689999999854322 2255778999999996 5999999999985
Q ss_pred CCceEEEEeecCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC-CCCcEEEecc
Q 047739 871 PDLRLLVYDYMPN-GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD-ADFEAHLSDF 948 (1099)
Q Consensus 871 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~-~~~~~kl~Df 948 (1099)
+...++||||+.+ ++|.+++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++ .++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 4556999999986 8999999753 3488999999999999999999999999999999999999 7899999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+++.... .......||..|+|||++.+..+ +.++||||||+++|||++|+.||.... . +. ...
T Consensus 195 g~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~----~~~ 259 (320)
T 3a99_A 195 GSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----II----RGQ 259 (320)
T ss_dssp TTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH----HCC
T ss_pred cccccccc-----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hh----ccc
Confidence 99986521 22334579999999999887765 688899999999999999999996421 1 11 111
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
. .....+ + ..+.+++.+||+.||++|||++|+++.
T Consensus 260 ~--~~~~~~--------~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V--FFRQRV--------S----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C--CCSSCC--------C----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--cccccC--------C----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011110 1 124578999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=316.99 Aligned_cols=249 Identities=18% Similarity=0.267 Sum_probs=175.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccH---HHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDE---NLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
.++|+..+.||+|+||.||+|.+. +|+.||+|.+....... +.+.++..+++.++||||+++++++... ...++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence 467999999999999999999986 68999999986543322 3344555678888999999999999854 566999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
|||+ ++.+..+.... ...+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp ECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred Eecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999 45555555432 23489999999999999999999995 999999999999999999999999999975422
Q ss_pred CCCCCccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCc-hhHHHHHHHHhhhccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQD-EDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~ 1030 (1099)
........||..|+|||++. ...++.++||||||+++|||++|+.||..... .+....+.. +....
T Consensus 178 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~ 249 (318)
T 2dyl_A 178 ----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ----EEPPL 249 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH----SCCCC
T ss_pred ----CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc----cCCCC
Confidence 12233457999999999984 45688999999999999999999999976332 222222221 11110
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. .. . ...+ ..+.+++.+||+.||.+||++.|+++
T Consensus 250 ~-~~-~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L-PG-H-----MGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-CS-S-----SCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-Cc-c-----CCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 00 0 0001 12457899999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=315.42 Aligned_cols=234 Identities=12% Similarity=0.047 Sum_probs=179.3
Q ss_pred hccccccccccccceeEEEEEECC-ceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|.+.+.||+|+||.||+|.+.. |+.||+|.+...... .+.+.+|++++++++||||+++++++... +..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEE
Confidence 579999999999999999999864 899999999764332 26789999999999999999999999854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++++|.++++.. ....+..+++.|+++||+|||+.||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999631 3555788899999999999999999999999999999999999998554
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
|++ .++.++|||||||++|||++|+.||.............+.. .+... ...
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~-----~~~ 226 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPI-----EPA 226 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBC-----CHH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCC-----Chh
Confidence 233 26889999999999999999999997654322100000000 00000 000
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCC
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDI 1086 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1086 (1099)
...+.. + ..+.+++.+||+.||++| |+.|+++.|+++....+.
T Consensus 227 ~~~~~~-~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 227 DIDRDI-P----FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp HHCTTS-C----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred hcccCC-C----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 000000 0 124689999999999999 999999999998766553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=342.90 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=191.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEec-----CCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAG-----APDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~ 873 (1099)
..+|++.++||+|+||.||+|.+. +|..||+|++.... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999875 58999999986532 234678999999999999999999998764 2445
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCc---EEEecccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFE---AHLSDFGL 950 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~---~kl~DfGl 950 (1099)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 689999999999999998532 2345889999999999999999999999999999999999987664 99999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc----
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG---- 1026 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 1026 (1099)
++.... ........||..|+|||.+.+..++.++||||+|+++|||++|+.||...... ..|........
T Consensus 171 a~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQ----GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTS----CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HHSSTTCC------C
T ss_pred cccccc----ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hhhhhhhhcccchhh
Confidence 986522 22234568999999999999999999999999999999999999999754322 11111000000
Q ss_pred cccccccCc--ccCC--CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 047739 1027 QITELLEPG--LLEL--DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSD 1072 (1099)
Q Consensus 1027 ~~~~~~d~~--~~~~--~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1072 (1099)
...+..... +... .+.......-..+.+++.+||+.||++|||++|
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000 0000 000011111223468999999999999999976
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.69 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=182.4
Q ss_pred CCCEEEccCCcCcc--ccCcccCCCCcccEEEccC-CcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCcccee
Q 047739 439 NLSTLDLSENKFSG--EVPASIGNLSQLMVFNLSG-NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVI 515 (1099)
Q Consensus 439 ~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 515 (1099)
+++.|+|++|.+++ .+|..++++++|++|+|++ |.+.+.+|..|+++++|++|++++|++++.+|..+..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 34445555555544 4455555555555555553 55555555555556666666666666665666666666666666
Q ss_pred eeccccccCCCchhhhcccccceecccccccCCCCCCcccccc-eeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcc
Q 047739 516 ALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLR-SVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594 (1099)
Q Consensus 516 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 594 (1099)
+|++|.+++.+|..|..+++|++|++++|++++.+|..+..++ +|+.|++++|++++.+|..++.++ |++|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 6666666666666666667777777777777666666666666 677777777777777777777776 88888888888
Q ss_pred cCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCc
Q 047739 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674 (1099)
Q Consensus 595 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~ 674 (1099)
++.+|..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 877888888888888888888888866555 778888899999999888888888888889999999999998888876
Q ss_pred cccccccccccCCCCcccCCCCccCCCCCCC
Q 047739 675 SSIFGLMNFNVSSNNLQAFANNQDLCGKPLG 705 (1099)
Q Consensus 675 ~~~~~l~~l~l~~n~~~~~~~n~~l~~~~~~ 705 (1099)
..+.+|+.++++ +|+.+||.|+.
T Consensus 288 ~~l~~L~~l~l~--------~N~~lc~~p~~ 310 (313)
T 1ogq_A 288 GNLQRFDVSAYA--------NNKCLCGSPLP 310 (313)
T ss_dssp TTGGGSCGGGTC--------SSSEEESTTSS
T ss_pred ccccccChHHhc--------CCCCccCCCCC
Confidence 677777777744 45567887765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=343.26 Aligned_cols=239 Identities=19% Similarity=0.285 Sum_probs=188.6
Q ss_pred HhccccccccccccceeEEEEEEC--CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN--DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL---- 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 873 (1099)
.++|.+.++||+|+||.||+|.+. +|+.||+|.+.... ...+.+.+|++++++++||||+++++++......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999986 58999999986432 2235688999999999999999999999854432
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||+++++|.+++.. .+++..++.++.||++||+|||+.||+||||||+||+++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5999999999999887753 48999999999999999999999999999999999999986 999999999986
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
... .....||+.|+|||++.+. ++.++|||||||++|||++|..||...... .+
T Consensus 231 ~~~-------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~~----- 284 (681)
T 2pzi_A 231 INS-------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------GL----- 284 (681)
T ss_dssp TTC-------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------SC-----
T ss_pred ccc-------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------cc-----
Confidence 521 1446799999999998765 488999999999999999999887531110 00
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHhhcc
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-MSDIVFMLEGC 1080 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~~L~~~ 1080 (1099)
............+.+++.+||+.||++||+ ++++.+.+..+
T Consensus 285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 001111111123568999999999999995 56666665543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-31 Score=304.17 Aligned_cols=288 Identities=19% Similarity=0.272 Sum_probs=165.2
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEcc
Q 047739 367 SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
+++.+++++|.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4555555555555 4444332 455555555555555555555666666666666666665555556666666666666
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc--ccCCcccCCCCccceeeeccccccC
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS--GELPIELAGLPNLQVIALQENKLSG 524 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~N~l~~ 524 (1099)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..+..+..+ +|+.|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 66665 3333332 45666666666665444445566666666666666654 2444555555 56666666666653
Q ss_pred CCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhc
Q 047739 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604 (1099)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1099)
+|..+. ++|++|++++|.+++..+..+..+++|+.|++++|++++..+..++.+++|++|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 333332 45666666666666555556666666666666666666555556666666666666666666 56666666
Q ss_pred cCcccEEeccCccccccCCcccCC------CCCCCEEECcCcccc--ccCChhhhccCCCCeeecCCCc
Q 047739 605 LSHLNVLDLSINNLTGEIPDEISK------CSSLRSLLVNSNHLS--GGIPDSLAKLSNLAVLDLSANN 665 (1099)
Q Consensus 605 l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~ls~N~ 665 (1099)
+++|+.|++++|++++..+..+.. ..+|+.|++++|++. +..|..+..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 666666666666666444444433 245666666666665 4455666666666666666653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-31 Score=302.29 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=165.1
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEcc
Q 047739 367 SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
+|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 4444444444444443444444444555555555544444555555555555555555555 3333332 455555555
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCC--CcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccC
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFS--GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 524 (1099)
+|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++++ +|..+. ++|+.|++++|++++
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~ 207 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA 207 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence 55555444445555566666666666554 2445555555 66666666666663 343333 567777777777776
Q ss_pred CCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhc
Q 047739 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604 (1099)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1099)
..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|+++ .+|..++.+++|++|++++|++++..+..+..
T Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 286 (332)
T 2ft3_A 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286 (332)
T ss_dssp CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence 66667777777777777777777666667777777777777777777 67777777788888888888887555555543
Q ss_pred ------cCcccEEeccCcccc--ccCCcccCCCCCCCEEECcCcc
Q 047739 605 ------LSHLNVLDLSINNLT--GEIPDEISKCSSLRSLLVNSNH 641 (1099)
Q Consensus 605 ------l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~Ls~N~ 641 (1099)
..+|+.|++++|.+. +..|..+..+++|+.|++++|+
T Consensus 287 ~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 287 VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 356888888888876 5566778888888888888875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-31 Score=300.29 Aligned_cols=290 Identities=21% Similarity=0.261 Sum_probs=165.4
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 373 (1099)
..++.++++++.++. +|..+. ++|++|+|++|.|++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|
T Consensus 31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 356677777777764 343332 46777777777777666666777777777777777777666777777777777777
Q ss_pred cCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcc--ccchhhhCCCCCCEEEccCCcCc
Q 047739 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG--SLPEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 374 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.++. ..+..+.++++|++|++++|.++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 777776 4444333 455555555555555555555555555555555555532 34444555555555555555554
Q ss_pred cccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhh
Q 047739 452 GEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531 (1099)
Q Consensus 452 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 531 (1099)
. +|..+. ++ |++|++++|++++..+..+..+++|+.|++++|.+++..+..|.
T Consensus 185 ~-l~~~~~--~~------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 185 T-IPQGLP--PS------------------------LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp S-CCSSCC--TT------------------------CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred c-CCcccc--cc------------------------CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 2 222222 34 44444444444444444444444455555555554444444455
Q ss_pred cccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCC------CCCCceEEecCCcccC--cCCcchh
Q 047739 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGN------CSDLEVLELRSNSLTG--HIPTDIS 603 (1099)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~------l~~L~~L~L~~N~l~~--~~p~~~~ 603 (1099)
.+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|+. ...|+.|++++|.+.. ..|..+.
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~ 316 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence 5555555555555554 44444555555555555555555444444432 3567778888887752 4456777
Q ss_pred ccCcccEEeccCcc
Q 047739 604 HLSHLNVLDLSINN 617 (1099)
Q Consensus 604 ~l~~L~~L~Ls~N~ 617 (1099)
.+.+|+.++|++|+
T Consensus 317 ~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 317 CVYVRAAVQLGNYK 330 (330)
T ss_dssp TCCCGGGEEC----
T ss_pred cccceeEEEecccC
Confidence 78888888888774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-35 Score=352.72 Aligned_cols=356 Identities=20% Similarity=0.184 Sum_probs=218.3
Q ss_pred CceeEEEcCCCccccCcch-hccCCCCccEEeCCCCcccc----CchhhhCCCCCCCEEEccCCccCccCCcccc-CCC-
Q 047739 294 SVLQVLDLQQNQIRGAFPL-WLTRASTLTRLDVSGNSISG----KIPAQIGGLWRLEELKMANNSFGGAVPVEIK-QCS- 366 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l~- 366 (1099)
+.|++|||++|+++..... .+..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. .+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4677888888887754333 36777888888888888874 3466677778888888888887754333332 234
Q ss_pred ---CCCEEEccCCcCCC----CCCccccCCCCCCeeeccCccccccCCcc-----CCCCCCCCEEEcccCcCcccc----
Q 047739 367 ---SLSLLDLEGNRFSG----EIPEFLGDIRGLKSLTLAANLFSGSIPAS-----FRNLPGLENLNLRHNSLSGSL---- 430 (1099)
Q Consensus 367 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~---- 430 (1099)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+.. +...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 68888888888874 44777778888888888888876443332 233567888888888887643
Q ss_pred chhhhCCCCCCEEEccCCcCccccCcccC-----CCCcccEEEccCCcCCCc----CCCCCCCCCCCCEEEeccCcCccc
Q 047739 431 PEEVLGMNNLSTLDLSENKFSGEVPASIG-----NLSQLMVFNLSGNAFSGR----IPASLGNLLKLTTLDLSKQNFSGE 501 (1099)
Q Consensus 431 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~ 501 (1099)
+..+..+++|++|++++|.++...+..+. ..++|+.|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 55566678888888888888755444443 255788888888877753 355566677788888888877643
Q ss_pred C-----CcccCCCCccceeeeccccccCC----CchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCC
Q 047739 502 L-----PIELAGLPNLQVIALQENKLSGN----VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG 572 (1099)
Q Consensus 502 ~-----~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 572 (1099)
. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+.+..+..+...
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--------------- 307 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET--------------- 307 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH---------------
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH---------------
Confidence 2 22233567777777777777643 45556667777777777777654433333221
Q ss_pred CCCCCCCCCCCCceEEecCCcccCc----CCcchhccCcccEEeccCccccccCCcccCC-----CCCCCEEECcCcccc
Q 047739 573 SIPPELGNCSDLEVLELRSNSLTGH----IPTDISHLSHLNVLDLSINNLTGEIPDEISK-----CSSLRSLLVNSNHLS 643 (1099)
Q Consensus 573 ~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~ 643 (1099)
.....++|++|+|++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+|++|+++
T Consensus 308 ----l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 308 ----LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp ----HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred ----hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 000113444444444444432 2333444455555555555554332222221 345555555555554
Q ss_pred c----cCChhhhccCCCCeeecCCCcCCC
Q 047739 644 G----GIPDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 644 ~----~~p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
+ .+|..+..+++|+.||+++|++++
T Consensus 384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 384 DSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 3 444555555555555555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=303.70 Aligned_cols=238 Identities=19% Similarity=0.304 Sum_probs=177.9
Q ss_pred Hhccccc-cccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHh-hhccCCcceEEeeEEec---CCCceE
Q 047739 802 TRQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFL-GKVRHRNLTVLRGYYAG---APDLRL 875 (1099)
Q Consensus 802 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~---~~~~~~ 875 (1099)
.++|.+. ++||+|+||.||+|... +++.||+|.+.. ...+.+|++++ +..+||||+++++++.. .....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567776 78999999999999984 688999999853 35678899988 55689999999999864 244568
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~ 952 (1099)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+|+||||||+||+++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999863 2345899999999999999999999999999999999999998 7889999999986
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
... +..++.++||||+||++|||++|+.||............ ....
T Consensus 169 ~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------~~~~ 214 (299)
T 3m2w_A 169 ETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------KTRI 214 (299)
T ss_dssp ECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---------CCSS
T ss_pred ccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---------HHHH
Confidence 431 134678999999999999999999999754332211000 0000
Q ss_pred cCcccCCCCCChhHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH--HhhcccC
Q 047739 1033 EPGLLELDPESSEWE-EFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCRV 1082 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~ 1082 (1099)
....... ....+. .-..+.+++.+||+.||++|||+.|+++ .+.+...
T Consensus 215 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 215 RMGQYEF--PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CTTCCSS--CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred hhccccC--CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0000000 000000 0123467999999999999999999997 4444433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=295.57 Aligned_cols=289 Identities=20% Similarity=0.272 Sum_probs=202.4
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+.+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5677777777766 3444332 356666666666665555555666666666666666655545555555555555555
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCC--
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSG-- 476 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-- 476 (1099)
+|+++. +|..+. ++|++|++++|.+++..+..+.++++|+.|++++|.++.
T Consensus 109 ~n~l~~-------------------------l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLKE-------------------------LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCSB-------------------------CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCCc-------------------------cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 555542 232222 344555555555544444444555555555555555532
Q ss_pred cCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccc
Q 047739 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSF 556 (1099)
Q Consensus 477 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 556 (1099)
..+..+.++++|++|++++|.++ .+|..+. ++|+.|++++|++++..+..|..+++|++|++++|.+++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 44556666777777777777776 3444443 78999999999999888999999999999999999999888889999
Q ss_pred cceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhc------cCcccEEeccCccccc--cCCcccCC
Q 047739 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH------LSHLNVLDLSINNLTG--EIPDEISK 628 (1099)
Q Consensus 557 l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~l~~ 628 (1099)
+++|+.|++++|+++ .+|..+..+++|++|+|++|++++..+..+.. ...|+.|++++|.+.. ..|..+..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 999999999999999 78999999999999999999999766666643 4789999999999863 55678899
Q ss_pred CCCCCEEECcCcc
Q 047739 629 CSSLRSLLVNSNH 641 (1099)
Q Consensus 629 l~~L~~L~Ls~N~ 641 (1099)
+.+++.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 9999999999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=319.23 Aligned_cols=243 Identities=16% Similarity=0.118 Sum_probs=177.9
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC----ccHHHHHHHHHHhhhccC-Ccce--------------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS----LDENLFRKEAEFLGKVRH-RNLT-------------- 861 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H-~niv-------------- 861 (1099)
.++|...++||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346788899999999999999965 68999999986322 224679999999999987 3211
Q ss_pred -E------EeeEEecC----CCceEEEEeecCCCCHHHHHhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHccCCceec
Q 047739 862 -V------LRGYYAGA----PDLRLLVYDYMPNGNLGTLLQEAS--HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHG 928 (1099)
Q Consensus 862 -~------l~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~ 928 (1099)
. +..++... ....+++|+++ +++|.++++... ......+++..+..++.|+++||+|||+.+|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1 11111111 12246777766 689999986432 1223457888999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCcccc----------ccCCCCCcCchhhHHHHHH
Q 047739 929 DIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA----------LTGETTKESDVYSFGIVLL 998 (1099)
Q Consensus 929 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~S~G~il~ 998 (1099)
||||+|||++.++.+||+|||+++... ......+| +.|+|||++ .+..++.++|||||||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDG------ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT------EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecC------CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999987542 12345577 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 047739 999 ELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074 (1099)
Q Consensus 999 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1074 (1099)
||++|+.||.......... ..+. ..... + ..+.+++.+||+.||++||++.|++
T Consensus 309 elltg~~Pf~~~~~~~~~~------------~~~~-~~~~~-----~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE------------WIFR-SCKNI-----P----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG------------GGGS-SCCCC-----C----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhHH------------HHHh-hcccC-----C----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999997544322111 0111 00011 1 2346789999999999999976653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-35 Score=350.08 Aligned_cols=355 Identities=19% Similarity=0.196 Sum_probs=245.3
Q ss_pred CCccEEeCCCCccccCchhh-hCCCCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCCcCCCCCCccc-cCCC-
Q 047739 318 STLTRLDVSGNSISGKIPAQ-IGGLWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFSGEIPEFL-GDIR- 390 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 390 (1099)
++|++|||++|+++...... +..+++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46899999999997544333 77888999999999998753 46667788899999999998875444333 2343
Q ss_pred ---CCCeeeccCccccc----cCCccCCCCCCCCEEEcccCcCccccchhhhC-----CCCCCEEEccCCcCccccCccc
Q 047739 391 ---GLKSLTLAANLFSG----SIPASFRNLPGLENLNLRHNSLSGSLPEEVLG-----MNNLSTLDLSENKFSGEVPASI 458 (1099)
Q Consensus 391 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~~~~l 458 (1099)
+|++|+|++|.++. .++..+.++++|++|+|++|.+++..+..+.. .++|++|+|++|.+++....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 57777777777663 44666666667777777777665443433322 34566666666655542211
Q ss_pred CCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccC-----CCCccceeeeccccccCC----Cchh
Q 047739 459 GNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA-----GLPNLQVIALQENKLSGN----VPEG 529 (1099)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~p~~ 529 (1099)
.++..+..+++|++|++++|.+++..+..+. ..++|+.|++++|.+++. ++..
T Consensus 161 ------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 161 ------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp ------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 1122333344555555555554433222222 234666666666666543 3555
Q ss_pred hhcccccceecccccccCCCC-----CCcccccceeeEEEccCCcCCCC----CCCCCCCCCCCceEEecCCcccCcCCc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQI-----PATFSFLRSVVVLSFSGNHISGS----IPPELGNCSDLEVLELRSNSLTGHIPT 600 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~-----~~~l~~l~~L~~L~ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~ 600 (1099)
+..+++|++|++++|.+++.. +..+..+++|+.|++++|+++.. ++..+..+++|++|+|++|.+++..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 666677777777777765432 22233467788888888887743 566677789999999999999765555
Q ss_pred chhcc-----CcccEEeccCcccccc----CCcccCCCCCCCEEECcCccccccCChhhhc-----cCCCCeeecCCCcC
Q 047739 601 DISHL-----SHLNVLDLSINNLTGE----IPDEISKCSSLRSLLVNSNHLSGGIPDSLAK-----LSNLAVLDLSANNL 666 (1099)
Q Consensus 601 ~~~~l-----~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~ls~N~l 666 (1099)
.+... ++|+.|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|++++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 55543 6999999999999865 5677788899999999999998766666654 67999999999999
Q ss_pred CC----cCCCCccccccccccccCCCCccc
Q 047739 667 SG----EIPANLSSIFGLMNFNVSSNNLQA 692 (1099)
Q Consensus 667 ~~----~~p~~~~~~~~l~~l~l~~n~~~~ 692 (1099)
++ .+|..+..+++|+.+++++|++..
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 97 788888889999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=309.34 Aligned_cols=191 Identities=14% Similarity=0.105 Sum_probs=159.3
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCc---------cHHHHHHHHHHhhhcc---------CCcceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL---------DENLFRKEAEFLGKVR---------HRNLTVL 863 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------H~niv~l 863 (1099)
.++|++.+.||+|+||.||+|++ +|+.||+|++..... ..+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 689999999854321 2377899999999986 7777777
Q ss_pred eeEEe-----------------c------------CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHH
Q 047739 864 RGYYA-----------------G------------APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914 (1099)
Q Consensus 864 ~~~~~-----------------~------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 914 (1099)
.+++. . +....|+||||+++|++.+.+.+ ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 66542 1 14567999999999977766643 3479999999999999
Q ss_pred HHHHHHc-cCCceecCCCCCCEEECCCC--------------------cEEEeccccccccCCCCCCCccccccccCccc
Q 047739 915 RGLAFLH-TSNMVHGDIKPQNVLFDADF--------------------EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973 (1099)
Q Consensus 915 ~~L~~LH-~~~iiH~Dlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y 973 (1099)
.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.... ...+||..|
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999999 89999999999999999887 899999999986521 235899999
Q ss_pred cCccccccCCCCCcCchhhHHHH-HHHHHhCCCCCC
Q 047739 974 VSPEAALTGETTKESDVYSFGIV-LLELLTGKRPVM 1008 (1099)
Q Consensus 974 ~aPE~~~~~~~~~~~DV~S~G~i-l~elltg~~P~~ 1008 (1099)
+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998665 889999998777 777888999974
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-33 Score=341.00 Aligned_cols=454 Identities=17% Similarity=0.138 Sum_probs=259.3
Q ss_pred CCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCcc---CcccCcccc------------cCCcccEE
Q 047739 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSF---NGTIPATLA------------QCTLLRAV 119 (1099)
Q Consensus 55 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L~~L 119 (1099)
|++|.+|.+...+...+ . +......+..+..++.|++|+|+++.. .|.+|..++ .+++|++|
T Consensus 41 ck~W~~~~~~~~~~l~~--~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L 117 (592)
T 3ogk_B 41 CRRWFKIDSETREHVTM--A-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSV 117 (592)
T ss_dssp CHHHHHHHHHHCCEEEE--S-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEE
T ss_pred hHHHHHhhhccccEEEE--e-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeE
Confidence 45899997654433332 2 223334445577899999999988543 245555444 78899999
Q ss_pred EeccccCCCccCcccccC-C-CCceeeccccc-CCCc-ccCC--cccccceeeCCCCccCCC----CCCCCccccccccc
Q 047739 120 FLQYNSLSGNLPANIGNL-S-NLEILNVAANR-LSGE-IAND--LPRNLKYFDLSSNGFSGP----IPTSISNLSQLQLI 189 (1099)
Q Consensus 120 ~l~~n~l~g~~p~~~~~l-~-~L~~L~ls~N~-l~~~-i~~~--~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L 189 (1099)
+|++|.+++..+..++.. + +|++|+|++|. ++.. ++.. -.++|++|+|++|.+++. ++..+.++++|++|
T Consensus 118 ~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L 197 (592)
T 3ogk_B 118 HFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197 (592)
T ss_dssp EEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEE
T ss_pred EeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEE
Confidence 999999988877777664 4 49999998876 2211 1111 116888888888888755 44455677888888
Q ss_pred cccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCC
Q 047739 190 NFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPP 269 (1099)
Q Consensus 190 ~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~ 269 (1099)
++++|.+++... +.++..+.++++|++|++++|.+.+ +|..+..+++|++|+++.+... ++...
T Consensus 198 ~L~~n~~~~~~~----~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~--~~~~~--------- 261 (592)
T 3ogk_B 198 NFYMTEFAKISP----KDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNED--IGMPE--------- 261 (592)
T ss_dssp ECTTCCCSSCCH----HHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCC--TTCTT---------
T ss_pred EeeccCCCccCH----HHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccc--cchHH---------
Confidence 888888763322 2455556677888888888888875 6677888888888888763322 11000
Q ss_pred cceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCch-hhhCCCCCCCEEE
Q 047739 270 SIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIP-AQIGGLWRLEELK 348 (1099)
Q Consensus 270 ~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~ 348 (1099)
.......+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+.++++|++|+
T Consensus 262 ----------------~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~ 324 (592)
T 3ogk_B 262 ----------------KYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLE 324 (592)
T ss_dssp ----------------SSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEE
T ss_pred ----------------HHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEe
Confidence 0011122456777777765333 456666677777777777777654333 3356777777777
Q ss_pred ccCCccCccCCccccCCCCCCEEEccC-----------CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCC
Q 047739 349 MANNSFGGAVPVEIKQCSSLSLLDLEG-----------NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLE 417 (1099)
Q Consensus 349 L~~n~l~~~~~~~l~~l~~L~~L~Ls~-----------N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 417 (1099)
++++...+.++..+..+++|++|+|++ |.+++... +..+.++++|+
T Consensus 325 L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~-----------------------~~l~~~~~~L~ 381 (592)
T 3ogk_B 325 TRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL-----------------------IALAQGCQELE 381 (592)
T ss_dssp EEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH-----------------------HHHHHHCTTCS
T ss_pred ccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH-----------------------HHHHhhCccCe
Confidence 773322222333334566677777762 33332111 11122244555
Q ss_pred EEEcccCcCccccchhhhC-CCCCCEEEcc----CCcCccc-----cCcccCCCCcccEEEccCCc--CCCcCCCCCC-C
Q 047739 418 NLNLRHNSLSGSLPEEVLG-MNNLSTLDLS----ENKFSGE-----VPASIGNLSQLMVFNLSGNA--FSGRIPASLG-N 484 (1099)
Q Consensus 418 ~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~l~~l~~L~~L~L~~N~--l~~~~~~~l~-~ 484 (1099)
+|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|+.|+|++|. +++..+..+. .
T Consensus 382 ~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~ 461 (592)
T 3ogk_B 382 YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY 461 (592)
T ss_dssp EEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHS
T ss_pred EEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHh
Confidence 5555555555444444443 5555555553 4444432 22223445555555554322 3333222222 2
Q ss_pred CCCCCEEEeccCcCcc-cCCcccCCCCccceeeeccccccCC-CchhhhcccccceecccccccCCCCCCcc-cccceee
Q 047739 485 LLKLTTLDLSKQNFSG-ELPIELAGLPNLQVIALQENKLSGN-VPEGFSSLMSLRYLNLSFNGFVGQIPATF-SFLRSVV 561 (1099)
Q Consensus 485 l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~ 561 (1099)
+++|++|++++|++++ .++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|++++.....+ ..++.+.
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~ 541 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWN 541 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEE
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcE
Confidence 4556666666666654 2233345566666666666665433 22333456666677777666654433222 2334444
Q ss_pred EEEccC
Q 047739 562 VLSFSG 567 (1099)
Q Consensus 562 ~L~ls~ 567 (1099)
...+..
T Consensus 542 ~~~~~~ 547 (592)
T 3ogk_B 542 IELIPS 547 (592)
T ss_dssp EEEECC
T ss_pred EEEecC
Confidence 444433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=293.49 Aligned_cols=278 Identities=21% Similarity=0.288 Sum_probs=176.7
Q ss_pred HHHhCCCCCCCCCCCCCCCCCCCCcccceEecC----CcEeEEecCCCcccccccccc--ccccccceEEccCCccCccc
Q 047739 33 FKLNLHDPLGALNGWDSSTPAAPCDWRGVACTN----NRVTELRLPRLQLSGRISDHL--SNLRMLRKLSLRSNSFNGTI 106 (1099)
Q Consensus 33 ~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~c~~----~~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~L~~n~~~~~~ 106 (1099)
.|.++.|+..+|..|+..-..+||.|.++-|.. ..+.. ..+..+ ..++..+ ...+.++.|+|++|.+. .+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~--~~g~~~-~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET--RTGRAL-KATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC--SHHHHH-HHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc--cCCcch-hhhHHHHhcccccceeEEEccCCCch-hc
Confidence 455666777788899854334579999998842 11111 111111 1111222 24578999999999998 88
Q ss_pred CcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCcccccc
Q 047739 107 PATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQL 186 (1099)
Q Consensus 107 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L 186 (1099)
|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-----------------------~lp~~l~~l~~L 152 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-----------------------ALPASIASLNRL 152 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-----------------------CCCGGGGGCTTC
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-----------------------cCcHHHhcCcCC
Confidence 988999999999999999999 88988998888888888777765 456667777788
Q ss_pred ccccccccccccccccccccccCcccc---------ccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccC
Q 047739 187 QLINFSFNKFSREVPATFEGTLPSAIA---------NCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVP 257 (1099)
Q Consensus 187 ~~L~ls~N~l~~~~~~~~~g~lp~~l~---------~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 257 (1099)
++|++++|++. +.+|..++ .+++|++|++++|+++ .+|..++.+++|++|+|++|++
T Consensus 153 ~~L~L~~n~~~--------~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l----- 218 (328)
T 4fcg_A 153 RELSIRACPEL--------TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL----- 218 (328)
T ss_dssp CEEEEEEETTC--------CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC-----
T ss_pred CEEECCCCCCc--------cccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC-----
Confidence 88888877766 34444333 3444555555555544 3444444444444444444444
Q ss_pred cccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhh
Q 047739 258 ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQ 337 (1099)
Q Consensus 258 ~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~ 337 (1099)
++ +|..+..+++|++|+|++|.+.+.+|..
T Consensus 219 -------------------------------------------------~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~ 248 (328)
T 4fcg_A 219 -------------------------------------------------SA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248 (328)
T ss_dssp -------------------------------------------------CC-CCGGGGGCTTCCEEECTTCTTCCBCCCC
T ss_pred -------------------------------------------------Cc-CchhhccCCCCCEEECcCCcchhhhHHH
Confidence 32 2334555666666666666666666666
Q ss_pred hCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccc
Q 047739 338 IGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLF 402 (1099)
Q Consensus 338 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l 402 (1099)
|+++++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|+.++++++|+.+++..+.+
T Consensus 249 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 66666666666666666666666666666666666666666666666666666666666555544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-32 Score=330.45 Aligned_cols=81 Identities=9% Similarity=0.041 Sum_probs=41.3
Q ss_pred CceeEEEcCCCccccC----cchhccCCCCccEEeCCCCcccc----CchhhhCCCCCCCEEEccCCccCccCCccccCC
Q 047739 294 SVLQVLDLQQNQIRGA----FPLWLTRASTLTRLDVSGNSISG----KIPAQIGGLWRLEELKMANNSFGGAVPVEIKQC 365 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 365 (1099)
++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+ ++..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 4455555555555443 22233445556666666665542 233334455555555555555553 34445555
Q ss_pred CCCCEEEccC
Q 047739 366 SSLSLLDLEG 375 (1099)
Q Consensus 366 ~~L~~L~Ls~ 375 (1099)
++|++|+++.
T Consensus 243 ~~L~~L~l~~ 252 (592)
T 3ogk_B 243 ANLEEFCGGS 252 (592)
T ss_dssp TTCCEEEECB
T ss_pred hHHHhhcccc
Confidence 5555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=284.41 Aligned_cols=284 Identities=20% Similarity=0.209 Sum_probs=151.4
Q ss_pred CCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEc
Q 047739 342 WRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL 421 (1099)
Q Consensus 342 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 421 (1099)
+.....++++|.++ .+|..+. ++|++|+|++|++++..+..+.++++|++|++++|++++..+..|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 34445666666666 3444443 36666666666666554556666666666666666666666666666666666666
Q ss_pred ccCcCccccchhhhCCCCCCEEEccCCcCccccC-cccCCCCcccEEEccCC-cCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 422 RHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP-ASIGNLSQLMVFNLSGN-AFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 422 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
++|++++..+..+.++++|++|++++|++++..+ ..+.++++|+.|++++| .+++..+..|.++++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 6666664444446666666666666666664333 35556666666666665 344444455555556666666666555
Q ss_pred ccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCC
Q 047739 500 GELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579 (1099)
Q Consensus 500 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~ 579 (1099)
+..|..+..+++|+.|++++|+++...+..+..+++|++|++++|.+++..+..+.. ..
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------~~ 246 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST---------------------GE 246 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------
T ss_pred ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc---------------------cc
Confidence 555555555555555555555554222222233445555555555444322221110 11
Q ss_pred CCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChh-hhccCCCCe
Q 047739 580 NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDS-LAKLSNLAV 658 (1099)
Q Consensus 580 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~ 658 (1099)
....++.++|++|.+++ |.+. .+|..+..+++|+.|+|++|+++ .+|.. +.++++|+.
T Consensus 247 ~~~~l~~l~L~~~~l~~-------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~ 305 (353)
T 2z80_A 247 TNSLIKKFTFRNVKITD-------------------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQK 305 (353)
T ss_dssp CCCCCCEEEEESCBCCH-------------------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred ccchhhccccccccccC-------------------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCE
Confidence 23445555555555443 1221 23444455555555555555555 33333 355555555
Q ss_pred eecCCCcCCCcC
Q 047739 659 LDLSANNLSGEI 670 (1099)
Q Consensus 659 L~ls~N~l~~~~ 670 (1099)
|++++|++++..
T Consensus 306 L~L~~N~~~~~~ 317 (353)
T 2z80_A 306 IWLHTNPWDCSC 317 (353)
T ss_dssp EECCSSCBCCCH
T ss_pred EEeeCCCccCcC
Confidence 555555555433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=300.94 Aligned_cols=294 Identities=26% Similarity=0.342 Sum_probs=216.6
Q ss_pred CCCCCCCCCCCCCCCCCCcccceEec--------CCcEeEEecCCCccccccccccccccccceEEccCCccCcccCccc
Q 047739 39 DPLGALNGWDSSTPAAPCDWRGVACT--------NNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATL 110 (1099)
Q Consensus 39 ~~~~~l~~w~~~~~~~~c~w~gv~c~--------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~ 110 (1099)
|.....++|.... .||.|+|..|. ...++.|+++++++. .+|+.+. ++|+.|+|++|.++ .+|.
T Consensus 7 ~~~~~w~~W~~~~--~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-- 78 (622)
T 3g06_A 7 EYDAVWSAWRRAA--PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-- 78 (622)
T ss_dssp ---CHHHHHHHTC--CGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC--
T ss_pred HHHHHHHHHHhcC--CcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC--
Confidence 3455667887543 47999775442 256889999999988 7887776 89999999999988 5776
Q ss_pred ccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCcccccccccc
Q 047739 111 AQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLIN 190 (1099)
Q Consensus 111 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 190 (1099)
.+++|++|+|++|+|+ .+|. .+++|++|+|++|.+++ +|. ..++|+.|++++|+|++ +|.. +++|++|+
T Consensus 79 -~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 79 -LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp -CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred -cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 6789999999999998 4666 67889999999999886 444 56788899999998884 5554 48888888
Q ss_pred ccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCc
Q 047739 191 FSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPS 270 (1099)
Q Consensus 191 ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~ 270 (1099)
|++|++++ +|. .+++|+.|++++|.+++ +| ..+++|++|+|++|+|++ +|.
T Consensus 148 Ls~N~l~~---------l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~------------ 198 (622)
T 3g06_A 148 VSDNQLAS---------LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT------------ 198 (622)
T ss_dssp CCSSCCSC---------CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC------------
T ss_pred CcCCcCCC---------cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC------------
Confidence 88888873 333 23578888888888876 34 456788888888888873 332
Q ss_pred ceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEcc
Q 047739 271 IRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350 (1099)
Q Consensus 271 l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~ 350 (1099)
..++|+.|++++|.++. +|. .+++|++|+|++|+|++ +| ..+++|++|+|+
T Consensus 199 ---------------------~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls 249 (622)
T 3g06_A 199 ---------------------LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVS 249 (622)
T ss_dssp ---------------------CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECC
T ss_pred ---------------------ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECC
Confidence 12457777777777774 332 23678888888888875 44 455778888888
Q ss_pred CCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCC
Q 047739 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLP 414 (1099)
Q Consensus 351 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 414 (1099)
+|+|+. +|. .+++|++|+|++|+|+ .+|..+.++++|+.|+|++|.+++..|..+.+++
T Consensus 250 ~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 250 GNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 888874 444 5677888888888888 6777888888888888888888887777766554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=281.71 Aligned_cols=286 Identities=19% Similarity=0.229 Sum_probs=227.4
Q ss_pred CCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCee
Q 047739 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395 (1099)
Q Consensus 316 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 395 (1099)
.++.....|+++|.++ .+|..+. ++|++|++++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 3455667999999998 5777665 489999999999998878799999999999999999998888899999999999
Q ss_pred eccCccccccCCccCCCCCCCCEEEcccCcCccccc-hhhhCCCCCCEEEccCC-cCccccCcccCCCCcccEEEccCCc
Q 047739 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP-EEVLGMNNLSTLDLSEN-KFSGEVPASIGNLSQLMVFNLSGNA 473 (1099)
Q Consensus 396 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N~ 473 (1099)
+|++|++++..+..|.++++|++|+|++|++++..+ ..+..+++|++|++++| .++...+..+.++++|+.|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999998777779999999999999999995433 47889999999999999 5777778899999999999999999
Q ss_pred CCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCc
Q 047739 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPAT 553 (1099)
Q Consensus 474 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 553 (1099)
+++..|..+.++++|++|++++|++....+..+..+++|+.|++++|++++..+..+...
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~-------------------- 245 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG-------------------- 245 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-------------------------
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccc--------------------
Confidence 998889999999999999999999975544445668999999999999987654433211
Q ss_pred ccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcc-cCCCCCC
Q 047739 554 FSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDE-ISKCSSL 632 (1099)
Q Consensus 554 l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L 632 (1099)
.....++.++++++.+ ++|.+. .+|..+..+++|+.|+|++|+++ .+|.. +..+++|
T Consensus 246 -~~~~~l~~l~L~~~~l-------------------~~~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L 303 (353)
T 2z80_A 246 -ETNSLIKKFTFRNVKI-------------------TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSL 303 (353)
T ss_dssp --CCCCCCEEEEESCBC-------------------CHHHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTC
T ss_pred -cccchhhccccccccc-------------------cCcchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCC
Confidence 1122344455544433 334444 45566666777777777777776 45555 3677777
Q ss_pred CEEECcCccccccC
Q 047739 633 RSLLVNSNHLSGGI 646 (1099)
Q Consensus 633 ~~L~Ls~N~l~~~~ 646 (1099)
++|+|++|++.+..
T Consensus 304 ~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 304 QKIWLHTNPWDCSC 317 (353)
T ss_dssp CEEECCSSCBCCCH
T ss_pred CEEEeeCCCccCcC
Confidence 77777777777543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=287.18 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=142.4
Q ss_pred cccccccceEEccCCccCcccCcccccCCcccEEEeccccC-CCccCcccc-------cCCCCceeecccccCCCcccCC
Q 047739 86 LSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSL-SGNLPANIG-------NLSNLEILNVAANRLSGEIAND 157 (1099)
Q Consensus 86 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l-~g~~p~~~~-------~l~~L~~L~ls~N~l~~~i~~~ 157 (1099)
.+..+.|+.|+|++|.+ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566677777777776 666655554 66777777777 355665554 5666666666655555444432
Q ss_pred cccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCcccccc-----CceeEEEccCCcCCccC
Q 047739 158 LPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANC-----SSLVHLSAQGNALGGVI 232 (1099)
Q Consensus 158 ~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l-----~~L~~L~l~~N~l~~~~ 232 (1099)
+. ++.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..
T Consensus 115 ~~--------------------~~~l~~L~~L~Ls~N~l~~~---------~~~~~~l~~~~~~~L~~L~L~~N~l~~~~ 165 (312)
T 1wwl_A 115 LL--------------------EATGPDLNILNLRNVSWATR---------DAWLAELQQWLKPGLKVLSIAQAHSLNFS 165 (312)
T ss_dssp SS--------------------SCCSCCCSEEEEESCBCSSS---------SSHHHHHHTTCCTTCCEEEEESCSCCCCC
T ss_pred HH--------------------HhcCCCccEEEccCCCCcch---------hHHHHHHHHhhcCCCcEEEeeCCCCccch
Confidence 20 14444444444444444411 2223333 45555555555555555
Q ss_pred hhhhcCCCCccEEEcccccCCCcc--CcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCcccc--
Q 047739 233 PPAIGALPKLQVVSLAQNNLSGVV--PASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG-- 308 (1099)
Q Consensus 233 p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~-- 308 (1099)
|..|+.+++|++|+|++|++.+.+ |... ....+++|++|+|++|+|++
T Consensus 166 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----------------------------~~~~l~~L~~L~L~~N~l~~~~ 217 (312)
T 1wwl_A 166 CEQVRVFPALSTLDLSDNPELGERGLISAL----------------------------CPLKFPTLQVLALRNAGMETPS 217 (312)
T ss_dssp TTTCCCCSSCCEEECCSCTTCHHHHHHHHS----------------------------CTTSCTTCCEEECTTSCCCCHH
T ss_pred HHHhccCCCCCEEECCCCCcCcchHHHHHH----------------------------HhccCCCCCEEECCCCcCcchH
Confidence 555555555555555555554331 1110 00113445555555555552
Q ss_pred -CcchhccCCCCccEEeCCCCccccCch-hhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccc
Q 047739 309 -AFPLWLTRASTLTRLDVSGNSISGKIP-AQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFL 386 (1099)
Q Consensus 309 -~~~~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 386 (1099)
.....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+. ++|++|||++|+|++. |. +
T Consensus 218 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~ 292 (312)
T 1wwl_A 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-P 292 (312)
T ss_dssp HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-T
T ss_pred HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-H
Confidence 122334456677777777777766554 34555677777777777776 5555555 6777777777777744 55 6
Q ss_pred cCCCCCCeeeccCccccc
Q 047739 387 GDIRGLKSLTLAANLFSG 404 (1099)
Q Consensus 387 ~~l~~L~~L~L~~n~l~~ 404 (1099)
..+++|++|+|++|++++
T Consensus 293 ~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 293 DELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TTSCEEEEEECTTCTTTC
T ss_pred hhCCCCCEEeccCCCCCC
Confidence 777777777777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=270.33 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=191.1
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccC--chhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEE
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGK--IPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLL 371 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 371 (1099)
++|++|+|++|+++.+.+..|..+++|++|+|++|.++.. .+..+.++++|++|+|++|.+. .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 5678888888888866666678888888888888888733 3566777888888888888887 456667788888888
Q ss_pred EccCCcCCCCCC-ccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcc-ccchhhhCCCCCCEEEccCCc
Q 047739 372 DLEGNRFSGEIP-EFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG-SLPEEVLGMNNLSTLDLSENK 449 (1099)
Q Consensus 372 ~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~ 449 (1099)
+|++|++++..+ ..+..+++|++|++++|.+.+..+..|.++++|++|+|++|.+++ ..|..+..+++|++|+|++|.
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 888888875544 567778888888888888887777778888888888888888775 467777778888888888888
Q ss_pred CccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCC-ccceeeeccccccCCCch
Q 047739 450 FSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLP-NLQVIALQENKLSGNVPE 528 (1099)
Q Consensus 450 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~ 528 (1099)
+++..|..+..+++|+.|+|++|++++..+..+..+++|++|++++|++++..|..+..++ +|+.|+|++|.+++..+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 8777777778888888888888888766666777778888888888888777777777774 788888888877654321
Q ss_pred -h-hhcccccceecccccccCCCCCCccc
Q 047739 529 -G-FSSLMSLRYLNLSFNGFVGQIPATFS 555 (1099)
Q Consensus 529 -~-~~~l~~L~~L~Ls~N~l~~~~~~~l~ 555 (1099)
. ..-+...+.+....+.+....|..+.
T Consensus 267 ~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 267 QSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp HHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred HHHHHHHHhhhhhhccccccccCCchhhC
Confidence 1 12233444455555555544454443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=272.72 Aligned_cols=182 Identities=27% Similarity=0.386 Sum_probs=82.2
Q ss_pred CCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC-cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEE
Q 047739 413 LPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP-ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTL 491 (1099)
Q Consensus 413 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 491 (1099)
+++|++|+|++|.++ .+|..+.++++|++|++++|.+++..+ ..+..+++|+.|++++|.+.+..+..+.++++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 334444444444433 233333344444444444444433222 234444444444444444444444444444444444
Q ss_pred EeccCcCcc-cCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcC
Q 047739 492 DLSKQNFSG-ELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHI 570 (1099)
Q Consensus 492 ~L~~n~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l 570 (1099)
++++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|++|++++|++++..+..+..+++|+.|++++|++
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 444444443 2344444444444444444444444444444444555555555555444444444444455555555555
Q ss_pred CCCCCCCCCCCC-CCceEEecCCccc
Q 047739 571 SGSIPPELGNCS-DLEVLELRSNSLT 595 (1099)
Q Consensus 571 ~~~~p~~l~~l~-~L~~L~L~~N~l~ 595 (1099)
++..|..+..++ +|++|+|++|.++
T Consensus 236 ~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp CBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred cccCHHHHHhhhccCCEEEccCCCee
Confidence 544444555442 5555555555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=283.64 Aligned_cols=203 Identities=17% Similarity=0.164 Sum_probs=156.7
Q ss_pred CCCCCCCCCCCCCCCcccceE--ecCCcEeEEecCCCccccccccccccccccceEEccCCcc-CcccCcccc-------
Q 047739 42 GALNGWDSSTPAAPCDWRGVA--CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSF-NGTIPATLA------- 111 (1099)
Q Consensus 42 ~~l~~w~~~~~~~~c~w~gv~--c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~-~~~~p~~~~------- 111 (1099)
+...+|... ..|+.|..+. |...+++.+++.++.+ .+|+.+... |+.|+|++|.+ .+.+|..+.
T Consensus 19 ~~~~~~~~~--~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~ 92 (312)
T 1wwl_A 19 DPKPDWSSA--FNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVL 92 (312)
T ss_dssp SSSCCGGGG--GGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHH
T ss_pred ccccchHHH--hhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhc
Confidence 335678643 2355666654 4457789999999999 888777766 99999999999 567888887
Q ss_pred cCCcccEEEeccccCCCccCccc--ccCCCCceeecccccCCCcccCCcc-------cccceeeCCCCccCCCCCCCCcc
Q 047739 112 QCTLLRAVFLQYNSLSGNLPANI--GNLSNLEILNVAANRLSGEIANDLP-------RNLKYFDLSSNGFSGPIPTSISN 182 (1099)
Q Consensus 112 ~l~~L~~L~l~~n~l~g~~p~~~--~~l~~L~~L~ls~N~l~~~i~~~~~-------~~L~~L~ls~N~l~~~~p~~~~~ 182 (1099)
++++|++|+|++|+++|.+|..+ +.+++|++|+|++|++++. |..+. ++|++|+|++|++++..|..|++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 89999999999999999999987 9999999999999999987 55433 68888888888888877788888
Q ss_pred ccccccccccccccccccccccccccCccc--cccCceeEEEccCCcCCcc---ChhhhcCCCCccEEEcccccCCCccC
Q 047739 183 LSQLQLINFSFNKFSREVPATFEGTLPSAI--ANCSSLVHLSAQGNALGGV---IPPAIGALPKLQVVSLAQNNLSGVVP 257 (1099)
Q Consensus 183 l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l--~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p 257 (1099)
+++|++|+|++|++.+.. .+|..+ +.+++|++|++++|++++. ....+..+++|++|+|++|++++..|
T Consensus 172 l~~L~~L~Ls~N~l~~~~------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGER------GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CSSCCEEECCSCTTCHHH------HHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCCCCEEECCCCCcCcch------HHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 888888888888876321 123334 6677888888888888732 22345677788888888887775443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=264.31 Aligned_cols=236 Identities=23% Similarity=0.223 Sum_probs=119.8
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCc-CCCCCCccccCCCCCCeeec
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR-FSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L 397 (1099)
+|++|+|++|.|++..+..|.++++|++|+|++|.+++..+..+..+++|++|+|++|+ ++...|..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 44444444444444333444444444444444444444444444444444444444443 44333444444555555555
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
++|.+++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 55555544445555555555555555555544444455555555555555555544444455555555555555555555
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCccc
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFS 555 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 555 (1099)
.|..|.++++|+.|++++|++++..+..+..+++|+.|++++|.+....+.. .-...++.+..+.+.+....|..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 5555555556666666666665544445555666666666666655332211 1123344455555555555555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=262.37 Aligned_cols=268 Identities=21% Similarity=0.223 Sum_probs=177.5
Q ss_pred eEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccC
Q 047739 272 RVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351 (1099)
Q Consensus 272 ~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~ 351 (1099)
+.++.+.+.++.++.. ..+.|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~~ip~~----~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSSCCTT----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcccCCcC----CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 4566677777666542 245677777777777766666677777777777777777766667777777777777777
Q ss_pred Cc-cCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc
Q 047739 352 NS-FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430 (1099)
Q Consensus 352 n~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 430 (1099)
|. ++...+..+..+++|++|+|++|++++..|..+..+++|++|++++|++++..+..|.++++|++|+|++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 75 66555666777777777777777777666666777777777777777777666666777777777777777777555
Q ss_pred chhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCC
Q 047739 431 PEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLP 510 (1099)
Q Consensus 431 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 510 (1099)
+..+.++++|+.|+|++|.+++..|..+.++++|+.|++++|++++..+..+.++++|++|++++|.+....+.. .-..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 555677777777777777777666777777777777777777777655556677777777777777766332211 1123
Q ss_pred ccceeeeccccccCCCchhhhc--ccccceeccccc
Q 047739 511 NLQVIALQENKLSGNVPEGFSS--LMSLRYLNLSFN 544 (1099)
Q Consensus 511 ~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~Ls~N 544 (1099)
.++.+....+.+....|..+.+ +..++..++.+|
T Consensus 249 ~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp HHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred HHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence 3445555666666556655543 334444444433
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=292.80 Aligned_cols=234 Identities=22% Similarity=0.191 Sum_probs=120.0
Q ss_pred CCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEe
Q 047739 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDL 493 (1099)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 493 (1099)
++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|+.|+|++|.+++..+ .++|++|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 355555555555555445555555555555555555554333 5555555555555555543221 144455555
Q ss_pred ccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCC
Q 047739 494 SKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573 (1099)
Q Consensus 494 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~ 573 (1099)
++|.++ +..+. .+++|++|+|++|.+++..|..++.+++|+.|++++|++++.
T Consensus 107 ~~N~l~------------------------~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 107 ANNNIS------------------------RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp CSSCCC------------------------CEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred cCCcCC------------------------CCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCc
Confidence 555444 33322 234455555555555544455555555555555555555544
Q ss_pred CCCCCC-CCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhc
Q 047739 574 IPPELG-NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAK 652 (1099)
Q Consensus 574 ~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 652 (1099)
+|..+. .+++|+.|+|++|.+++. |. ...+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+|+ .+|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccchhhcc
Confidence 444443 455555555555555533 21 2235555555555555553 3334555555555566555555 24555555
Q ss_pred cCCCCeeecCCCcCC-CcCCCCcccccccccccc
Q 047739 653 LSNLAVLDLSANNLS-GEIPANLSSIFGLMNFNV 685 (1099)
Q Consensus 653 l~~L~~L~ls~N~l~-~~~p~~~~~~~~l~~l~l 685 (1099)
+++|+.|++++|+++ +.+|..+..+..+..+++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~ 269 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence 555666666666555 444444555555555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=273.82 Aligned_cols=246 Identities=23% Similarity=0.247 Sum_probs=132.5
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
...++.+++.++. +|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 3455666666653 333332 4566666666666665556666666666666666666655556666666666666666
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccC-cCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN-SLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
|++++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+++. +
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-I 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-C
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-c
Confidence 6666444455666666666666666666555556666666666666663 3332233345555556666666555552 2
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 534 (1099)
| .+..+++|+.|+|++|++++..|..|.++++|+.|++++|++++..+..|.++++|+.|+|++|++++..+..|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 2 244445555555555555544444455555555555555544444444444444444444444444433333333344
Q ss_pred ccceeccccccc
Q 047739 535 SLRYLNLSFNGF 546 (1099)
Q Consensus 535 ~L~~L~Ls~N~l 546 (1099)
+|+.|+|++|.+
T Consensus 280 ~L~~L~L~~Np~ 291 (440)
T 3zyj_A 280 HLERIHLHHNPW 291 (440)
T ss_dssp TCCEEECCSSCE
T ss_pred CCCEEEcCCCCc
Confidence 444444444433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-27 Score=275.36 Aligned_cols=247 Identities=23% Similarity=0.241 Sum_probs=140.6
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
...++.+++.++. +|..+. +++++|+|++|.|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 3456666666653 333332 4667777777777666666666666677777766666666666666666666666666
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccC-cCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHN-SLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
|++++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|.++++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 6666554555666666666666666665555555666666666666653 33322223344555555555555555422
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 534 (1099)
| . +..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..++
T Consensus 212 ~-~------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 266 (452)
T 3zyi_A 212 P-N------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266 (452)
T ss_dssp C-C------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred c-c------------------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC
Confidence 1 2 34444455555555555544455555555555555555555555555555555
Q ss_pred ccceecccccccCCCCCCcccccceeeEEEccCCcCC
Q 047739 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHIS 571 (1099)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~ 571 (1099)
+|++|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 267 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 5666666666665555555555666666666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=277.43 Aligned_cols=263 Identities=18% Similarity=0.183 Sum_probs=169.2
Q ss_pred eccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCC
Q 047739 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 396 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
+++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+ +..+++|++|+|++|+++
T Consensus 16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~ 93 (317)
T 3o53_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (317)
T ss_dssp SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE
T ss_pred eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc
Confidence 333344433333334444555555555555555555555555555555555555554333 555555666666665555
Q ss_pred CcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcc-
Q 047739 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATF- 554 (1099)
Q Consensus 476 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l- 554 (1099)
+.. ..++|++|++++|++++..+. .+++|+.|++++|++++..+..+..+++|++|++++|.+++..+..+
T Consensus 94 ~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 165 (317)
T 3o53_A 94 ELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165 (317)
T ss_dssp EEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred ccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh
Confidence 322 225666666666666644332 24556666677776666555566666777777777777766555554
Q ss_pred cccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCE
Q 047739 555 SFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634 (1099)
Q Consensus 555 ~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 634 (1099)
..+++|++|++++|++++. +. ...+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.
T Consensus 166 ~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~ 241 (317)
T 3o53_A 166 ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241 (317)
T ss_dssp GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE
T ss_pred hccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE
Confidence 3566777777777777643 32 234788888888888888 45666888888888888888888 57888888888888
Q ss_pred EECcCcccc-ccCChhhhccCCCCeeecCCC-cCCCcCCC
Q 047739 635 LLVNSNHLS-GGIPDSLAKLSNLAVLDLSAN-NLSGEIPA 672 (1099)
Q Consensus 635 L~Ls~N~l~-~~~p~~l~~l~~L~~L~ls~N-~l~~~~p~ 672 (1099)
|++++|+++ +.+|..+..+++|+.+++++| .++|..|.
T Consensus 242 L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp EECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred EEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 888888887 777888888888888888844 45655544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-27 Score=275.86 Aligned_cols=247 Identities=21% Similarity=0.183 Sum_probs=140.8
Q ss_pred CeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCC
Q 047739 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGN 472 (1099)
Q Consensus 393 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 472 (1099)
..++.+++.++. +|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 344444444442 233222 34555555555555444445555555555555555555444445555555555555555
Q ss_pred cCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceeccccc-ccCCCCC
Q 047739 473 AFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFN-GFVGQIP 551 (1099)
Q Consensus 473 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~ 551 (1099)
++++..+..|.++++|++|+|++|+++ ...+..|..+++|++|++++| .+....+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIE------------------------SIPSYAFNRVPSLMRLDLGELKKLEYISE 189 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCC------------------------EECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred cCCccChhhhcccCCCCEEECCCCCcc------------------------eeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence 554433344444444444444444444 333344445555555555552 2322223
Q ss_pred CcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCC
Q 047739 552 ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631 (1099)
Q Consensus 552 ~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 631 (1099)
..|..+++|+.|++++|++++ +| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++
T Consensus 190 ~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 267 (452)
T 3zyi_A 190 GAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267 (452)
T ss_dssp TTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence 345555566666666666653 23 3666677777777777777666677777777777777777777666667777777
Q ss_pred CCEEECcCccccccCChhhhccCCCCeeecCCCcCCC
Q 047739 632 LRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 632 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
|+.|+|++|+|++..+..+..+++|+.|+|++|++..
T Consensus 268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 7777777777776556666777777777777777653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=273.38 Aligned_cols=247 Identities=24% Similarity=0.261 Sum_probs=153.4
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccC
Q 047739 368 LSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 368 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1099)
...++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 456666666666 5555444 4566666666666666666666677777777777777666666666677777777777
Q ss_pred CcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCc-CcccCCcccCCCCccceeeeccccccCCC
Q 047739 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN-FSGELPIELAGLPNLQVIALQENKLSGNV 526 (1099)
Q Consensus 448 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 526 (1099)
|+++...+..|..+++|+.|+|++|+++...+..|.++++|++|++++|+ +....+..|.++++|+.|+|++|+++
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~--- 198 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--- 198 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS---
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc---
Confidence 77665555566666666666666666665555566666666666666632 33222233444444444444444444
Q ss_pred chhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccC
Q 047739 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS 606 (1099)
Q Consensus 527 p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 606 (1099)
.+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..++
T Consensus 199 ----------------------~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 199 ----------------------EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp ----------------------SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred ----------------------ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 122 244455556666666666655566666666777777777777666666667777
Q ss_pred cccEEeccCccccccCCcccCCCCCCCEEECcCcccc
Q 047739 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643 (1099)
Q Consensus 607 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 643 (1099)
+|+.|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 7777777777777555555666777777777777764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-26 Score=279.65 Aligned_cols=266 Identities=27% Similarity=0.340 Sum_probs=155.5
Q ss_pred CCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcc
Q 047739 343 RLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLR 422 (1099)
Q Consensus 343 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 422 (1099)
+++.|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+++ |. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEECc
Confidence 5777888888777 5565554 67777777777777 4554 356666666666666642 32 45666666666
Q ss_pred cCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccC
Q 047739 423 HNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGEL 502 (1099)
Q Consensus 423 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 502 (1099)
+|++++ +|. .+.+|+.|++++|++++ +|.. +++|+.|+|++|++++ +|. .+.+|+.|++++|
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N------ 171 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNN------ 171 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS------
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCC------
Confidence 666663 333 34556666666666553 3322 2455555555555552 222 1234444445444
Q ss_pred CcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCC
Q 047739 503 PIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582 (1099)
Q Consensus 503 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~ 582 (1099)
++++ +| ..+++|+.|++++|.+++ +|.. +++|+.|++++|+++ .+|.. ++
T Consensus 172 ------------------~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~ 221 (622)
T 3g06_A 172 ------------------QLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PS 221 (622)
T ss_dssp ------------------CCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CT
T ss_pred ------------------CCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CC
Confidence 4442 22 223455555555555553 2221 245566666666665 34432 35
Q ss_pred CCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecC
Q 047739 583 DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662 (1099)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls 662 (1099)
+|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 67777777777763 45 34466777777777776 4555 4566777777777777 667777777777777777
Q ss_pred CCcCCCcCCCCccc
Q 047739 663 ANNLSGEIPANLSS 676 (1099)
Q Consensus 663 ~N~l~~~~p~~~~~ 676 (1099)
+|++++.+|..+..
T Consensus 293 ~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 293 GNPLSERTLQALRE 306 (622)
T ss_dssp SCCCCHHHHHHHHH
T ss_pred CCCCCCcCHHHHHh
Confidence 77777766665444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=270.84 Aligned_cols=267 Identities=21% Similarity=0.235 Sum_probs=140.9
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
++.++++.+.+...++..+..+++|++|+|++|+|++..|..|+++++|++|+|++|.+++..+ +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4445555555554444444444555555555555555445555555555555555555543322 44444444444444
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|+++ +.. ..++|++|++++|++++..+. .+++|++|++++|++++..+
T Consensus 90 n~l~------------------------~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 90 NYVQ------------------------ELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp SEEE------------------------EEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGG
T ss_pred Cccc------------------------ccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccc
Confidence 4443 211 114455555555555433222 13445555555555554444
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCC-CCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 534 (1099)
..+..+++|+.|+|++|.+++..+..+ ..+++|++|++++|.+++. +. ...++
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-------------------------~~-~~~l~ 191 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-------------------------KG-QVVFA 191 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-------------------------EC-CCCCT
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-------------------------cc-ccccc
Confidence 444444455555555554444333333 2344444444444444422 11 11245
Q ss_pred ccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCccc-CcCCcchhccCcccEEec
Q 047739 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT-GHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L 613 (1099)
+|++|++++|++++. |..+..+++|+.|++++|+++ .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|++
T Consensus 192 ~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l 269 (317)
T 3o53_A 192 KLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269 (317)
T ss_dssp TCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHH
T ss_pred cCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEEC
Confidence 555555555555532 223555555666666666665 45667777888888888888887 667778888888888888
Q ss_pred cC-ccccccCCc
Q 047739 614 SI-NNLTGEIPD 624 (1099)
Q Consensus 614 s~-N~l~~~~p~ 624 (1099)
++ +.++|..|.
T Consensus 270 ~~~~~l~~~~~~ 281 (317)
T 3o53_A 270 QTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHHSSSSC
T ss_pred CCchhccCCchh
Confidence 84 456665444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-30 Score=315.76 Aligned_cols=186 Identities=16% Similarity=0.201 Sum_probs=116.8
Q ss_pred CCcccceEecCCcEeEEecCCCccccccc-cccccccccceEEccCCccCcc---cCc------------ccccCCcccE
Q 047739 55 PCDWRGVACTNNRVTELRLPRLQLSGRIS-DHLSNLRMLRKLSLRSNSFNGT---IPA------------TLAQCTLLRA 118 (1099)
Q Consensus 55 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~n~~~~~---~p~------------~~~~l~~L~~ 118 (1099)
|++|.++... ....+++.... +..+ ..+..++.|+.|+|+++..... .|. ....+++|++
T Consensus 34 ck~W~~~~~~--~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~ 109 (594)
T 2p1m_B 34 CKSWYEIERW--CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE 109 (594)
T ss_dssp CHHHHHHHHH--HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCE
T ss_pred HHHHHHhhhh--hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCe
Confidence 5589999322 23455554322 2222 3467889999999999864322 222 2346889999
Q ss_pred EEeccccCCCccCcccc-cCCCCceeecccc-cCCCc-ccCCc--ccccceeeCCCCccCCCCCCCC----ccccccccc
Q 047739 119 VFLQYNSLSGNLPANIG-NLSNLEILNVAAN-RLSGE-IANDL--PRNLKYFDLSSNGFSGPIPTSI----SNLSQLQLI 189 (1099)
Q Consensus 119 L~l~~n~l~g~~p~~~~-~l~~L~~L~ls~N-~l~~~-i~~~~--~~~L~~L~ls~N~l~~~~p~~~----~~l~~L~~L 189 (1099)
|+|++|.+++..+..+. .+++|++|+|++| .+++. ++... .++|++|+|++|.+++..+.++ ..+++|+.|
T Consensus 110 L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L 189 (594)
T 2p1m_B 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189 (594)
T ss_dssp EEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEE
T ss_pred EEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEE
Confidence 99999999888777775 7889999999888 55432 22222 2678888888887765443333 355677777
Q ss_pred cccccccccccccccccccCccccccCceeEEEccCC-cCCccChhhhcCCCCccEEEcccc
Q 047739 190 NFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGN-ALGGVIPPAIGALPKLQVVSLAQN 250 (1099)
Q Consensus 190 ~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~Ls~N 250 (1099)
++++|. ..... ..++.-+..+++|++|++++| .+++ ++..+..+++|++|+++.+
T Consensus 190 ~l~~~~-~~~~~----~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 190 NISCLA-SEVSF----SALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp ECTTCC-SCCCH----HHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBC
T ss_pred EecccC-CcCCH----HHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccc
Confidence 777775 11111 112222344677777777777 3433 6666777777777776544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=275.64 Aligned_cols=237 Identities=20% Similarity=0.193 Sum_probs=190.2
Q ss_pred CCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEE
Q 047739 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVF 467 (1099)
Q Consensus 388 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 467 (1099)
.+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34489999999999999999999999999999999999997666 8999999999999999985443 3899999
Q ss_pred EccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhh-cccccceeccccccc
Q 047739 468 NLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS-SLMSLRYLNLSFNGF 546 (1099)
Q Consensus 468 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l 546 (1099)
++++|.+++..+.. +++|+.|++++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 99999999766543 46677788877777766666666666666666666666655555554 455555555555555
Q ss_pred CCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCccc
Q 047739 547 VGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEI 626 (1099)
Q Consensus 547 ~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 626 (1099)
+ +. |. +..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++ +|..+
T Consensus 182 ~------------------------~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 182 Y------------------------DV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp C------------------------EE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred c------------------------cc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 4 22 21 2347889999999999985 56668999999999999999994 88889
Q ss_pred CCCCCCCEEECcCcccc-ccCChhhhccCCCCeeecC
Q 047739 627 SKCSSLRSLLVNSNHLS-GGIPDSLAKLSNLAVLDLS 662 (1099)
Q Consensus 627 ~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ls 662 (1099)
..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 99999999999999998 7788889999999888886
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-28 Score=302.30 Aligned_cols=87 Identities=23% Similarity=0.298 Sum_probs=41.0
Q ss_pred CCCCCceEEecCCcccCcCCcchhc-cCcccEEeccCccccccCCccc-CCCCCCCEEECcCccccccCCh-hhhccCCC
Q 047739 580 NCSDLEVLELRSNSLTGHIPTDISH-LSHLNVLDLSINNLTGEIPDEI-SKCSSLRSLLVNSNHLSGGIPD-SLAKLSNL 656 (1099)
Q Consensus 580 ~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L 656 (1099)
.+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|
T Consensus 430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L 508 (594)
T 2p1m_B 430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETM 508 (594)
T ss_dssp HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGS
T ss_pred hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCC
Confidence 344555555544 444333333333 4555555555555544333322 3355555555555555432222 22335555
Q ss_pred CeeecCCCcCC
Q 047739 657 AVLDLSANNLS 667 (1099)
Q Consensus 657 ~~L~ls~N~l~ 667 (1099)
+.|++++|+++
T Consensus 509 ~~L~l~~~~~~ 519 (594)
T 2p1m_B 509 RSLWMSSCSVS 519 (594)
T ss_dssp SEEEEESSCCB
T ss_pred CEEeeeCCCCC
Confidence 55555555553
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-27 Score=282.09 Aligned_cols=183 Identities=19% Similarity=0.099 Sum_probs=124.0
Q ss_pred ccccccceeEEEEE-ECCceEEEEEECCCCC-----------ccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEE
Q 047739 810 VLSRTRYGLVFKAC-YNDGMVLSIRRLPDGS-----------LDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 810 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~l 876 (1099)
..+.|++|.+..++ +--|+.+++|.+.... ...++|.+|+++|+++ .|+||+++++++.++ ...||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-QSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-SEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-CEEEE
Confidence 34555665555443 2236778888884321 1225699999999999 699999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||++||+|.+++.+.+ .++.. +|+.||++||+|+|+.|||||||||+|||++.++.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999998532 34443 5889999999999999999999999999999999999999999986522
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCC
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR 1005 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~ 1005 (1099)
........+||+.|||||++.+ .+..++|+||+|++.+++.++..
T Consensus 392 ---~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 ---DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ---CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2234456789999999999875 46778999999999887755543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-24 Score=236.23 Aligned_cols=208 Identities=24% Similarity=0.245 Sum_probs=148.3
Q ss_pred cccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceeccc
Q 047739 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542 (1099)
Q Consensus 463 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1099)
+|+.|++++|++++..+..|.++++|++|++++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555555555555566666666666666665555666666777777777
Q ss_pred ccccCCCCCCcccccceeeEEEccCCcCCCC-CCCCCCCCCCCceEEecCCcccCcCCcchhccCccc----EEeccCcc
Q 047739 543 FNGFVGQIPATFSFLRSVVVLSFSGNHISGS-IPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN----VLDLSINN 617 (1099)
Q Consensus 543 ~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~ 617 (1099)
+|.+.+..+..+..+++|++|++++|++++. +|..++++++|++|+|++|++++..+..+..+.+|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 7777666565677777777777777777753 577888888999999999999876667787777777 89999999
Q ss_pred ccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCC
Q 047739 618 LTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 618 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
+++ +|.......+|+.|+|++|++++..+..+.++++|+.|++++|++++..|
T Consensus 189 l~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 189 MNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCE-ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccc-cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 985 44444555689999999999987666678889999999999999987654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=231.32 Aligned_cols=221 Identities=21% Similarity=0.229 Sum_probs=130.2
Q ss_pred EEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcC
Q 047739 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450 (1099)
Q Consensus 371 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 450 (1099)
.+.++..++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444444444 4444433 3566666666666655555666666666666666666655555666666666666666666
Q ss_pred ccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCccc-CCcccCCCCccceeeeccccccCCCchh
Q 047739 451 SGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGE-LPIELAGLPNLQVIALQENKLSGNVPEG 529 (1099)
Q Consensus 451 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 529 (1099)
++..+..|.++++|+.|++++|++++..+..+.++++|++|++++|++++. +|..+..+++|+.|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 666666666666677777766666655555666677777777777776643 4666666777777777777776665666
Q ss_pred hhcccccc----eecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCccc
Q 047739 530 FSSLMSLR----YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595 (1099)
Q Consensus 530 ~~~l~~L~----~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 595 (1099)
|..+.+|+ .|++++|.+++..+..+.. .+|+.|++++|++++..+..+..+++|++|+|++|.++
T Consensus 169 ~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp GHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred hhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 66666665 5555666555433333322 24555555555554333333444444555555544444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-23 Score=224.27 Aligned_cols=202 Identities=19% Similarity=0.240 Sum_probs=127.4
Q ss_pred ceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEcc
Q 047739 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLE 374 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 374 (1099)
..+.+++++++++. +|..+. ++|++|+|++|+|++..+..|+++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 35667777777774 444333 467777777777776655667777777777777777775555556667777777777
Q ss_pred CCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 375 GNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
+|++++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 77776555555666666666666666666666666666666666666666666544444556666666666666666555
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 555555666666666666665444444555555555555555544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=231.20 Aligned_cols=225 Identities=22% Similarity=0.261 Sum_probs=127.8
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
+..+++..+.+.... .+..+++|+.|++++|.++. + ..+..+++|++|+|++|.+++. ..+..+++|++|+|++
T Consensus 21 l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 344455555554332 24455666666666666652 2 2456666666666666666542 3556666666666666
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|++++..+..+..+++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 66665555555666666666666666665555556666666666666666665444445556666666666666655555
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 533 (1099)
..++.+++|+.|++++|++++..+..+.++++|++|++++|.+.+. +++|+.|+++.|.++|.+|..++.+
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 5555555666666666665555555555555555555555554422 3344555555555555555444443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=229.20 Aligned_cols=228 Identities=20% Similarity=0.256 Sum_probs=187.4
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
.++..+++..+.+.+. ..+..+.+|+.|++++|.++. ...+..+++|++|+|++|++++ + ..+..+++|++|++
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 3566778888887644 345678899999999999874 3458889999999999999985 3 47888999999999
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
++|.+++..+..|.++++|++|+|++|++++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 99999988888889999999999999999877777788889999999999999877777788888899999999988877
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCccccc
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFL 557 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 557 (1099)
.+..+.++++|++|++++|++++..+..+..+++|+.|++++|.+.+. +++|++|+++.|.++|.+|..++.+
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 777788888888888888888877777788888888888888887643 4467788888888888877777655
Q ss_pred c
Q 047739 558 R 558 (1099)
Q Consensus 558 ~ 558 (1099)
.
T Consensus 246 ~ 246 (272)
T 3rfs_A 246 A 246 (272)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-22 Score=221.66 Aligned_cols=203 Identities=21% Similarity=0.290 Sum_probs=156.9
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
+.+.+++++|.++ .+|..+. .+|++|+|++|++++..+..|.++++|++|+|++|+++...+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 5778999999888 4665554 578888888888887777788888888888888888886555667778888888888
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcC
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 478 (1099)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88888777777788888888888888888766677777888888888888887666666777788888888888777666
Q ss_pred CCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccC
Q 047739 479 PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524 (1099)
Q Consensus 479 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 524 (1099)
+..|.++++|++|++++|++++..+..+..+++|+.|+|++|.+..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 6667777777777777777776555566777777777777777653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=248.21 Aligned_cols=255 Identities=19% Similarity=0.225 Sum_probs=186.9
Q ss_pred EEEcCCCccccCcchhccCCCCccEEeCCCCccccCch----hhhCCCC-CCCEEEccCCccCccCCccccCC-----CC
Q 047739 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIP----AQIGGLW-RLEELKMANNSFGGAVPVEIKQC-----SS 367 (1099)
Q Consensus 298 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l-----~~ 367 (1099)
.++|+.|.+++.+|..+...++|++|||++|.|++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788888888888877777779999999999887766 7778888 89999999999887777776664 88
Q ss_pred CCEEEccCCcCCCCCCcccc----CC-CCCCeeeccCccccccCCcc----CCC-CCCCCEEEcccCcCccccc----hh
Q 047739 368 LSLLDLEGNRFSGEIPEFLG----DI-RGLKSLTLAANLFSGSIPAS----FRN-LPGLENLNLRHNSLSGSLP----EE 433 (1099)
Q Consensus 368 L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~L~~n~l~~~~~~~----~~~-l~~L~~L~L~~N~l~~~~~----~~ 433 (1099)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+.. +.. .++|++|+|++|++++... ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999998876666443 34 78888888888888766544 334 3588889998888885443 34
Q ss_pred hhCCC-CCCEEEccCCcCccccCccc----CCC-CcccEEEccCCcCCCc----CCCCCCC-CCCCCEEEeccCcCcccC
Q 047739 434 VLGMN-NLSTLDLSENKFSGEVPASI----GNL-SQLMVFNLSGNAFSGR----IPASLGN-LLKLTTLDLSKQNFSGEL 502 (1099)
Q Consensus 434 ~~~l~-~L~~L~Ls~N~l~~~~~~~l----~~l-~~L~~L~L~~N~l~~~----~~~~l~~-l~~L~~L~L~~n~l~~~~ 502 (1099)
+..++ +|++|+|++|++++..+..+ ..+ ++|+.|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 88888888888876665443 344 5888888888888853 3334444 358888888888887654
Q ss_pred C----cccCCCCccceeeeccccccCCCch-------hhhcccccceecccccccCCCCCC
Q 047739 503 P----IELAGLPNLQVIALQENKLSGNVPE-------GFSSLMSLRYLNLSFNGFVGQIPA 552 (1099)
Q Consensus 503 ~----~~l~~l~~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~Ls~N~l~~~~~~ 552 (1099)
+ ..+..+++|+.|+|++|.+.+..+. .+..+++|++||+++|.+.+..+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 4 3356678888888888886544333 455667788888888887655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-24 Score=256.02 Aligned_cols=186 Identities=14% Similarity=0.195 Sum_probs=140.5
Q ss_pred ccccccccccceeEEEEEECCceEEEEEECCCCCcc---------HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 806 DEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 806 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
...++||+|+||.||+|.+. +..+++|+....... .+.+.+|++++++++||||+++..++..... .|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KRI 416 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cEE
Confidence 44678999999999999655 566777765332211 2458999999999999999955555554333 499
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.++++. +..++.|+++||+|||+.+|+||||||+||+++. .+||+|||+|+....
T Consensus 417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999974 4578999999999999999999999999999999 999999999987522
Q ss_pred CCCCC----ccccccccCccccCcccccc--CCCCCcCchhhHHHHHHHHHhCCCCCC
Q 047739 957 TPAEA----STSTTAVGTLGYVSPEAALT--GETTKESDVYSFGIVLLELLTGKRPVM 1008 (1099)
Q Consensus 957 ~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~G~il~elltg~~P~~ 1008 (1099)
..... .......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11000 01235689999999999976 567888999999999888888877763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-22 Score=222.39 Aligned_cols=177 Identities=21% Similarity=0.199 Sum_probs=105.7
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
++++|+|++|.|++..+..|.++++|++|+|++|.+++..+. ..+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 444445555544444444455555555555555555432221 44555555555555555 455555556666666666
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcC
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 478 (1099)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|+++ .+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~i 187 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-cc
Confidence 66666555566666666666666666666555555566666666666666666555555666677777777777776 55
Q ss_pred CCCCCCCCCCCEEEeccCcCc
Q 047739 479 PASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 479 ~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
|..+..+.+|+.|+|++|.+.
T Consensus 188 p~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 188 PKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CTTTTTTCCCSEEECCSCCBC
T ss_pred ChhhcccccCCeEEeCCCCcc
Confidence 666666667777777777665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-22 Score=221.67 Aligned_cols=203 Identities=19% Similarity=0.255 Sum_probs=151.3
Q ss_pred ccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCC
Q 047739 314 LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLK 393 (1099)
Q Consensus 314 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 393 (1099)
+..+++++++++++|.++ .+|..+. +++++|+|++|.+++..+..|..+++|++|+|++|+|++. +.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 456667777777777776 4554443 5678888888888777777777888888888888887743 322 6777788
Q ss_pred eeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCc
Q 047739 394 SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473 (1099)
Q Consensus 394 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 473 (1099)
+|+|++|+++ .+|..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888877 456677778888888888888876666777778888888888888877666677778888888888888
Q ss_pred CCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc
Q 047739 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523 (1099)
Q Consensus 474 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 523 (1099)
++...+..|.++++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 87655566777788888888888877 56667777777888888888775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=249.84 Aligned_cols=257 Identities=19% Similarity=0.220 Sum_probs=127.2
Q ss_pred EEccCCccCccCCccccCCCCCCEEEccCCcCCCCCC----ccccCCC-CCCeeeccCccccccCCccCCCC-----CCC
Q 047739 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIP----EFLGDIR-GLKSLTLAANLFSGSIPASFRNL-----PGL 416 (1099)
Q Consensus 347 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L 416 (1099)
++|++|.+++.+|..+...++|++|||++|++++..+ +.+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566666665555555555556666666666654444 4444554 55555555555554444444332 555
Q ss_pred CEEEcccCcCccccchhhhC----C-CCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCC-CCCCCE
Q 047739 417 ENLNLRHNSLSGSLPEEVLG----M-NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGN-LLKLTT 490 (1099)
Q Consensus 417 ~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~ 490 (1099)
++|+|++|++++..+..+.. + ++|++|+|++|.+++..+..+.. .+.. .++|++
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L~~ 142 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASITS 142 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTCCE
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCceeE
Confidence 55555555555444433222 2 44555555555554333322211 1112 134555
Q ss_pred EEeccCcCcccCC----cccCCCC-ccceeeeccccccCCCchhhhcc-----cccceecccccccCCC----CCCcccc
Q 047739 491 LDLSKQNFSGELP----IELAGLP-NLQVIALQENKLSGNVPEGFSSL-----MSLRYLNLSFNGFVGQ----IPATFSF 556 (1099)
Q Consensus 491 L~L~~n~l~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~l~~ 556 (1099)
|+|++|++++... ..+..++ +|++|+|++|++++..+..+... ++|++|+|++|.+++. ++..+..
T Consensus 143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 5555555543222 2223333 55555555555555444433322 3566666666665542 2222322
Q ss_pred -cceeeEEEccCCcCCCCCC----CCCCCCCCCceEEecCCcccCc-------CCcchhccCcccEEeccCccccccCC
Q 047739 557 -LRSVVVLSFSGNHISGSIP----PELGNCSDLEVLELRSNSLTGH-------IPTDISHLSHLNVLDLSINNLTGEIP 623 (1099)
Q Consensus 557 -l~~L~~L~ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p 623 (1099)
.++|+.|++++|++++..+ ..+..+++|++|+|++|.+.+. ++..+..+++|+.||+++|++.+..+
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 2355566666665554322 2345566677777777764422 22344556667777777777665433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=233.37 Aligned_cols=205 Identities=20% Similarity=0.230 Sum_probs=127.1
Q ss_pred cccceeeCCCCccCCCCCCCC--ccccccccccccccccccccccccccccC-ccccccCceeEEEccCCcCCccChhhh
Q 047739 160 RNLKYFDLSSNGFSGPIPTSI--SNLSQLQLINFSFNKFSREVPATFEGTLP-SAIANCSSLVHLSAQGNALGGVIPPAI 236 (1099)
Q Consensus 160 ~~L~~L~ls~N~l~~~~p~~~--~~l~~L~~L~ls~N~l~~~~~~~~~g~lp-~~l~~l~~L~~L~l~~N~l~~~~p~~~ 236 (1099)
++|++|++++|++++.+|..+ +++++|++|+|++|++++..+ .++ ..+..+++|++|+|++|++++..+..|
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~-----~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 165 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRS-----WLAELQQWLKPGLKVLSIAQAHSPAFSCEQV 165 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTS-----SHHHHHTTBCSCCCEEEEECCSSCCCCTTSC
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhh-----hhHHHHhhhccCCCEEEeeCCCcchhhHHHh
Confidence 346666667777777777777 888999999999999884322 011 234467889999999999988888888
Q ss_pred cCCCCccEEEcccccCCCc--cCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhc
Q 047739 237 GALPKLQVVSLAQNNLSGV--VPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWL 314 (1099)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~--~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 314 (1099)
+.+++|++|+|++|++.+. ++. +..+
T Consensus 166 ~~l~~L~~L~Ls~N~l~~~~~~~~----------------------------------------------------~~~~ 193 (310)
T 4glp_A 166 RAFPALTSLDLSDNPGLGERGLMA----------------------------------------------------ALCP 193 (310)
T ss_dssp CCCTTCCEEECCSCTTCHHHHHHT----------------------------------------------------TSCT
T ss_pred ccCCCCCEEECCCCCCccchhhhH----------------------------------------------------HHhh
Confidence 8899999999999987642 111 0112
Q ss_pred cCCCCccEEeCCCCccccCchh----hhCCCCCCCEEEccCCccCccCCccccCC---CCCCEEEccCCcCCCCCCcccc
Q 047739 315 TRASTLTRLDVSGNSISGKIPA----QIGGLWRLEELKMANNSFGGAVPVEIKQC---SSLSLLDLEGNRFSGEIPEFLG 387 (1099)
Q Consensus 315 ~~l~~L~~L~Ls~N~i~~~~p~----~~~~l~~L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~ 387 (1099)
..+++|++|+|++|+++. ++. .++++++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+.
T Consensus 194 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 194 HKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp TSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred hcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence 233445555555555541 221 13445555555555555555445444444 45666666666665 4454443
Q ss_pred CCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc
Q 047739 388 DIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 388 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
++|++|+|++|++++. |. +..+++|+.|+|++|.++
T Consensus 272 --~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 272 --AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp --SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred --CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 5666666666666643 22 456667777777777765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=219.59 Aligned_cols=189 Identities=22% Similarity=0.235 Sum_probs=166.2
Q ss_pred CCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCccc
Q 047739 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI 134 (1099)
Q Consensus 55 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~ 134 (1099)
||.|.|++|.. ..+.++++++++. .+|+.+. +.|+.|+|++|++.+..|..++++++|++|+|++|++++..|..+
T Consensus 4 Cp~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 79 (251)
T 3m19_A 4 CETVTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF 79 (251)
T ss_dssp CHHHHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred CCCCCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh
Confidence 78999999963 2346888888876 5666555 689999999999999888899999999999999999999888889
Q ss_pred ccCCCCceeecccccCCCcccCCcc--cccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccc
Q 047739 135 GNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI 212 (1099)
Q Consensus 135 ~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l 212 (1099)
+++++|++|+|++|.+++..+..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++. .|..+
T Consensus 80 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--------~~~~~ 151 (251)
T 3m19_A 80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI--------PAGAF 151 (251)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC--------CTTTT
T ss_pred ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc--------CHHHc
Confidence 9999999999999999977666554 8999999999999987778899999999999999999832 23357
Q ss_pred cccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCc
Q 047739 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255 (1099)
Q Consensus 213 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 255 (1099)
+.+++|++|+|++|++++..+..|..+++|++|+|++|.+++.
T Consensus 152 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 7889999999999999998888999999999999999999854
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-24 Score=253.20 Aligned_cols=216 Identities=25% Similarity=0.342 Sum_probs=135.1
Q ss_pred CCCCCCCCCCCCCC-----cccce-EecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcc
Q 047739 43 ALNGWDSSTPAAPC-----DWRGV-ACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLL 116 (1099)
Q Consensus 43 ~l~~w~~~~~~~~c-----~w~gv-~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 116 (1099)
.+.+|..+ ..|| .|.|+ .|..++++.|+|+++++.+ ||+.+. ++|++|+|++|.++ .+| +.+++|
T Consensus 32 ~l~~W~~~--~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQ--ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTT--CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhcc--CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 45678653 3478 79999 8987778888888888877 776653 67788888888777 566 446677
Q ss_pred cEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCcccccccccccccccc
Q 047739 117 RAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKF 196 (1099)
Q Consensus 117 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 196 (1099)
++|+|++|+|++ ||. +.+ +|++|+|++|.+++ +|. .+++|++|+|++|+|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-----------------------lp~---~l~~L~~L~Ls~N~l 152 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-----------------------LPE---LPALLEYINADNNQL 152 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-----------------------CCC---CCTTCCEEECCSSCC
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-----------------------CCC---cCccccEEeCCCCcc
Confidence 777777777776 665 443 55555555555554 333 345566666666655
Q ss_pred ccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEe
Q 047739 197 SREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276 (1099)
Q Consensus 197 ~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l 276 (1099)
+ .+|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+|. |.. ++
T Consensus 153 ~---------~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~--~~~------~L----- 202 (571)
T 3cvr_A 153 T---------MLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA--VPV------RN----- 202 (571)
T ss_dssp S---------CCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC--CC--------------
T ss_pred C---------cCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh--HHH------hh-----
Confidence 5 2333 34566666666666665 444 44 67777777777776 4443 110 00
Q ss_pred ccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCC
Q 047739 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGL 341 (1099)
Q Consensus 277 ~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 341 (1099)
......|+.|+|++|+|+. +|..+..+++|++|+|++|.+++.+|..|..+
T Consensus 203 -------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 203 -------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp ------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred -------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 0011234777777777764 55556667777777777777777777666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=251.17 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=157.6
Q ss_pred CCccCCCCCCCCEEEcccCcCccccchh----hhCCCCCCEEEccCCcC---ccccCcccCCCCcccEEEccCCcCCCcC
Q 047739 406 IPASFRNLPGLENLNLRHNSLSGSLPEE----VLGMNNLSTLDLSENKF---SGEVPASIGNLSQLMVFNLSGNAFSGRI 478 (1099)
Q Consensus 406 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l---~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 478 (1099)
++..+..+++|++|+|++|++++..+.. +..+++|++|+|++|.+ ++.+|..+. .+
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~-----------------~l 86 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------LL 86 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------HH
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHH-----------------HH
Confidence 4445555666666666666666443322 44556666666666432 233333220 00
Q ss_pred CCCCCCCCCCCEEEeccCcCcc----cCCcccCCCCccceeeeccccccCCCchhh----hcc---------cccceecc
Q 047739 479 PASLGNLLKLTTLDLSKQNFSG----ELPIELAGLPNLQVIALQENKLSGNVPEGF----SSL---------MSLRYLNL 541 (1099)
Q Consensus 479 ~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~L 541 (1099)
...+..+++|++|+|++|.+++ .++..+..+++|+.|+|++|.+++..+..+ ..+ ++|++|++
T Consensus 87 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L 166 (386)
T 2ca6_A 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166 (386)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEEC
Confidence 0112344555555555555543 244445555555555555555543322222 222 67777777
Q ss_pred cccccC-CCCC---CcccccceeeEEEccCCcCC--C---CCCCCCCCCCCCceEEecCCccc----CcCCcchhccCcc
Q 047739 542 SFNGFV-GQIP---ATFSFLRSVVVLSFSGNHIS--G---SIPPELGNCSDLEVLELRSNSLT----GHIPTDISHLSHL 608 (1099)
Q Consensus 542 s~N~l~-~~~~---~~l~~l~~L~~L~ls~N~l~--~---~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L 608 (1099)
++|+++ +.++ ..+..+++|+.|++++|+++ + ..|..+..+++|++|+|++|.++ +.+|..+..+++|
T Consensus 167 ~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L 246 (386)
T 2ca6_A 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246 (386)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred CCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCc
Confidence 777775 2333 34556677777777777776 2 34447788888999999999985 4677788888999
Q ss_pred cEEeccCcccccc----CCccc--CCCCCCCEEECcCccccc----cCChhh-hccCCCCeeecCCCcCCCcCC
Q 047739 609 NVLDLSINNLTGE----IPDEI--SKCSSLRSLLVNSNHLSG----GIPDSL-AKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 609 ~~L~Ls~N~l~~~----~p~~l--~~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~L~ls~N~l~~~~p 671 (1099)
+.|+|++|.+++. +|..+ +.+++|+.|+|++|++++ .+|..+ .++++|+.|++++|++++..|
T Consensus 247 ~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 9999999998865 56666 448899999999999986 478777 668999999999999986553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-23 Score=237.56 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=143.3
Q ss_pred eeEEEcCCCccccCcchhccCC--CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCcc-CCccccCCCCCCEEE
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRA--STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGA-VPVEIKQCSSLSLLD 372 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~ 372 (1099)
++.+++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 566777776665 3445555 6677777777777655443 44566777777777766654 555666666777777
Q ss_pred ccCCcCCCCCCccccCCCCCCeeeccCc-cccc-cCCccCCCCCCCCEEEcccC-cCccc-cchhhhCCC-CCCEEEccC
Q 047739 373 LEGNRFSGEIPEFLGDIRGLKSLTLAAN-LFSG-SIPASFRNLPGLENLNLRHN-SLSGS-LPEEVLGMN-NLSTLDLSE 447 (1099)
Q Consensus 373 Ls~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~ 447 (1099)
|++|.+++..+..++.+++|++|++++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 7777666666666666666666666666 4554 24445556666666666666 66543 455556666 666666666
Q ss_pred C--cCc-cccCcccCCCCcccEEEccCCc-CCCcCCCCCCCCCCCCEEEeccCc-CcccCCcccCCCCccceeeeccccc
Q 047739 448 N--KFS-GEVPASIGNLSQLMVFNLSGNA-FSGRIPASLGNLLKLTTLDLSKQN-FSGELPIELAGLPNLQVIALQENKL 522 (1099)
Q Consensus 448 N--~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~l 522 (1099)
| .++ +.++..+.++++|+.|++++|. +++..+..+.++++|++|++++|. +.......+..+++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 6 343 3344455556666666666665 454455555556666666666653 22111123445555555555555 2
Q ss_pred cCCCchhhhcc-cccceecccccccCCCCCCccc
Q 047739 523 SGNVPEGFSSL-MSLRYLNLSFNGFVGQIPATFS 555 (1099)
Q Consensus 523 ~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~l~ 555 (1099)
+.. .+..+ .+|+.|++++|++++..|..++
T Consensus 284 ~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 284 PDG---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CTT---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CHH---HHHHHHhhCcceEEecccCccccCCccc
Confidence 221 22222 2244444555555544444433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.9e-24 Score=246.07 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=159.4
Q ss_pred CcchhccCCCCccEEeCCCCccccCch----hhhCCCCCCCEEEccCCc---cCccCCccc-------cCCCCCCEEEcc
Q 047739 309 AFPLWLTRASTLTRLDVSGNSISGKIP----AQIGGLWRLEELKMANNS---FGGAVPVEI-------KQCSSLSLLDLE 374 (1099)
Q Consensus 309 ~~~~~~~~l~~L~~L~Ls~N~i~~~~p----~~~~~l~~L~~L~L~~n~---l~~~~~~~l-------~~l~~L~~L~Ls 374 (1099)
.++..+..+++|++|+|++|.|++..+ ..|..+++|++|+|++|. +++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455667778888888888888876543 346678888888888853 444455444 577888888888
Q ss_pred CCcCCC----CCCccccCCCCCCeeeccCccccccCCccC----CCC---------CCCCEEEcccCcCc-cccc---hh
Q 047739 375 GNRFSG----EIPEFLGDIRGLKSLTLAANLFSGSIPASF----RNL---------PGLENLNLRHNSLS-GSLP---EE 433 (1099)
Q Consensus 375 ~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l---------~~L~~L~L~~N~l~-~~~~---~~ 433 (1099)
+|++++ .+|..+..+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++ +.++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888876 356667777777777777777764333333 333 77778888887776 3333 35
Q ss_pred hhCCCCCCEEEccCCcCcc-----ccCcccCCCCcccEEEccCCcCC----CcCCCCCCCCCCCCEEEeccCcCccc---
Q 047739 434 VLGMNNLSTLDLSENKFSG-----EVPASIGNLSQLMVFNLSGNAFS----GRIPASLGNLLKLTTLDLSKQNFSGE--- 501 (1099)
Q Consensus 434 ~~~l~~L~~L~Ls~N~l~~-----~~~~~l~~l~~L~~L~L~~N~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~--- 501 (1099)
+..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|++|+|++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 5667777777777777762 33446667777777777777774 34555666677777777777776644
Q ss_pred -CCccc--CCCCccceeeeccccccC----CCchhh-hcccccceecccccccCCCC
Q 047739 502 -LPIEL--AGLPNLQVIALQENKLSG----NVPEGF-SSLMSLRYLNLSFNGFVGQI 550 (1099)
Q Consensus 502 -~~~~l--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 550 (1099)
++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|++++|.+++..
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 34444 236667777777776665 355555 44566666666666666544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=226.69 Aligned_cols=222 Identities=20% Similarity=0.256 Sum_probs=110.2
Q ss_pred CCCEEEcccCcCccccch---hhhCCCCCCEEEccCCcCccccCccc--CCCCcccEEEccCCcCCCcCC----CCCCCC
Q 047739 415 GLENLNLRHNSLSGSLPE---EVLGMNNLSTLDLSENKFSGEVPASI--GNLSQLMVFNLSGNAFSGRIP----ASLGNL 485 (1099)
Q Consensus 415 ~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~----~~l~~l 485 (1099)
.++.+.+.++.++...-. .+..+++|++|++++|.+++..|..+ ..+++|+.|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 355556655555421111 11223456666666666666666655 666666666666666664333 223345
Q ss_pred CCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCC--C--chhhhcccccceecccccccCCCCCC----ccccc
Q 047739 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN--V--PEGFSSLMSLRYLNLSFNGFVGQIPA----TFSFL 557 (1099)
Q Consensus 486 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~~~----~l~~l 557 (1099)
++|++|++++|++.+..+..+..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 6666666666666655555666666666666666655421 1 1112455566666666666541 111 12334
Q ss_pred ceeeEEEccCCcCCCCCCCCCCCC---CCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCE
Q 047739 558 RSVVVLSFSGNHISGSIPPELGNC---SDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634 (1099)
Q Consensus 558 ~~L~~L~ls~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 634 (1099)
++|++|++++|++++..|+.+..+ ++|++|+|++|+++ .+|..+. ++|+.|||++|+|++ +|. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccE
Confidence 444444444444444444444433 34555555555554 3444332 344444444444442 222 333444444
Q ss_pred EECcCccc
Q 047739 635 LLVNSNHL 642 (1099)
Q Consensus 635 L~Ls~N~l 642 (1099)
|+|++|++
T Consensus 299 L~L~~N~l 306 (310)
T 4glp_A 299 LTLDGNPF 306 (310)
T ss_dssp EECSSTTT
T ss_pred EECcCCCC
Confidence 44444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-23 Score=236.53 Aligned_cols=254 Identities=20% Similarity=0.248 Sum_probs=180.1
Q ss_pred CCccEEeCCCCccccCchhhhCCC--CCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCC-CCccccCCCCCCe
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGL--WRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGE-IPEFLGDIRGLKS 394 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~ 394 (1099)
..++.+|+++|.+. +..+..+ .+++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 35889999999886 5667777 8899999999999876655 55789999999999998765 7778888888999
Q ss_pred eeccCccccccCCccCCCCCCCCEEEcccC-cCccc-cchhhhCCCCCCEEEccCC-cCccc-cCcccCCCC-cccEEEc
Q 047739 395 LTLAANLFSGSIPASFRNLPGLENLNLRHN-SLSGS-LPEEVLGMNNLSTLDLSEN-KFSGE-VPASIGNLS-QLMVFNL 469 (1099)
Q Consensus 395 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~-~L~~L~L 469 (1099)
|+|++|.+++..+..+.++++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|+.|+|
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 999998888778888888888889998888 67753 5666778888888888888 88754 466677777 8888888
Q ss_pred cCC--cCC-CcCCCCCCCCCCCCEEEeccCc-CcccCCcccCCCCccceeeecccc-ccCCCchhhhcccccceeccccc
Q 047739 470 SGN--AFS-GRIPASLGNLLKLTTLDLSKQN-FSGELPIELAGLPNLQVIALQENK-LSGNVPEGFSSLMSLRYLNLSFN 544 (1099)
Q Consensus 470 ~~N--~l~-~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N 544 (1099)
++| .++ +.++..+.++++|++|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|++|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 888 444 3445556667777777777777 565666667777777777777774 22221224556666777777666
Q ss_pred ccCCCCCCccccc-ceeeEEEccCCcCCCCCCCCCC
Q 047739 545 GFVGQIPATFSFL-RSVVVLSFSGNHISGSIPPELG 579 (1099)
Q Consensus 545 ~l~~~~~~~l~~l-~~L~~L~ls~N~l~~~~p~~l~ 579 (1099)
++. ..+..+ .++..|++++|++++..|..++
T Consensus 283 -i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 283 -VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp -SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred -cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 221 122222 2244444555555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8e-22 Score=211.77 Aligned_cols=179 Identities=17% Similarity=0.228 Sum_probs=99.4
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCc-cccCchhhhCCCCCCCEEEccC-CccCccCCccccCCCCCCEE
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS-ISGKIPAQIGGLWRLEELKMAN-NSFGGAVPVEIKQCSSLSLL 371 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L 371 (1099)
+.|++|+|++|+++++.+..|..+++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 356666666666666555566666666666666665 6655555666666666666666 66665555566666666666
Q ss_pred EccCCcCCCCCCccccCCCCCC---eeeccCc-cccccCCccCCCCCCCC-EEEcccCcCccccchhhhCCCCCCEEEcc
Q 047739 372 DLEGNRFSGEIPEFLGDIRGLK---SLTLAAN-LFSGSIPASFRNLPGLE-NLNLRHNSLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 372 ~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
+|++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ +|++++|+++ .+|.......+|+.|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 666666663 444 55555555 5555555 55554444555555555 5555555554 233222222445555555
Q ss_pred CCc-CccccCcccCCC-CcccEEEccCCcCC
Q 047739 447 ENK-FSGEVPASIGNL-SQLMVFNLSGNAFS 475 (1099)
Q Consensus 447 ~N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~ 475 (1099)
+|+ +++..+..|.++ ++|+.|++++|+++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 552 443334444444 44444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-21 Score=211.01 Aligned_cols=181 Identities=20% Similarity=0.279 Sum_probs=126.3
Q ss_pred CCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccC
Q 047739 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG 567 (1099)
Q Consensus 488 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 567 (1099)
.++++++++.++ .+|..+. ++++.|+|++|.+++..+..|..+++|++|+|++|.+++..+..+..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 445555555555 3343333 4566666666666655555666666666677776666666666666677777777777
Q ss_pred CcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCC
Q 047739 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIP 647 (1099)
Q Consensus 568 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 647 (1099)
|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 77776666667777788888888888875555556778888888888888876555567788888888888888886666
Q ss_pred hhhhccCCCCeeecCCCcCCCcCC
Q 047739 648 DSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 648 ~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
..+..+++|+.|++++|++++..+
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTST
T ss_pred HHHhCCCCCCEEEeeCCceeCCcc
Confidence 778888888888888888876533
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=209.72 Aligned_cols=197 Identities=15% Similarity=0.195 Sum_probs=133.3
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCc-cCccCCccccCCCCCCEEEccC-CcCCCCCCccccCCCCCCee
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNS-FGGAVPVEIKQCSSLSLLDLEG-NRFSGEIPEFLGDIRGLKSL 395 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 395 (1099)
.+|++|+|++|+|++..+..|+++++|++|++++|+ ++...+..|..+++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 378888888888887666678888888888888886 7766666788888888888887 88876666677777777777
Q ss_pred eccCccccccCCccCCCCCCCC---EEEcccC-cCccccchhhhCCCCCC-EEEccCCcCccccCcccCCCCcccEEEcc
Q 047739 396 TLAANLFSGSIPASFRNLPGLE---NLNLRHN-SLSGSLPEEVLGMNNLS-TLDLSENKFSGEVPASIGNLSQLMVFNLS 470 (1099)
Q Consensus 396 ~L~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 470 (1099)
++++|++++ +|. |.++++|+ +|++++| ++++..+..|.++++|+ .|++++|+++...+..+.. ++|+.|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 777777775 444 66677776 7777777 67655555566677777 7777777776333333333 566666666
Q ss_pred CCc-CCCcCCCCCCCC-CCCCEEEeccCcCcccCCcccCCCCccceeeeccc
Q 047739 471 GNA-FSGRIPASLGNL-LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQEN 520 (1099)
Q Consensus 471 ~N~-l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 520 (1099)
+|+ +++..+..|.++ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 663 665445556666 6666666666666532 222 3445555555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=220.79 Aligned_cols=207 Identities=17% Similarity=0.137 Sum_probs=126.4
Q ss_pred CccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcc
Q 047739 180 ISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPAS 259 (1099)
Q Consensus 180 ~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 259 (1099)
++.++. +.++.++|+|+ +||..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|..
T Consensus 6 ~C~C~~-~~v~C~~~~Lt---------~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 6 ICHCSN-RVFLCQESKVT---------EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp SSEEET-TEEEEESTTCC---------SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred ccEeeC-CEEEecCCCCC---------ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 344433 56788888887 566555 357899999999999777788999999999999999987777766
Q ss_pred cccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhC
Q 047739 260 MFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIG 339 (1099)
Q Consensus 260 ~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~ 339 (1099)
.|.++. ..++.+.++.|+|+.+.|..|..+++|++|++++|+|++..+..+.
T Consensus 74 ~f~~L~----------------------------~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~ 125 (350)
T 4ay9_X 74 VFSNLP----------------------------KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125 (350)
T ss_dssp SBCSCT----------------------------TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC
T ss_pred Hhhcch----------------------------hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhc
Confidence 655421 1233455666777766666677777777777777777655555555
Q ss_pred CCCCCCEEEccC-CccCccCCccccCCC-CCCEEEccCCcCCCCCCccccCCCCCCeeeccC-ccccccCCccCCCCCCC
Q 047739 340 GLWRLEELKMAN-NSFGGAVPVEIKQCS-SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA-NLFSGSIPASFRNLPGL 416 (1099)
Q Consensus 340 ~l~~L~~L~L~~-n~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L 416 (1099)
...++..|++.+ +++....+..|..+. .+++|+|++|+|+ .+|.......+|++|++.+ |.++.+.++.|.++++|
T Consensus 126 ~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L 204 (350)
T 4ay9_X 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204 (350)
T ss_dssp CBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECC
T ss_pred ccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCccc
Confidence 555666666644 445544444444443 4555666666665 2333322334455555442 33443333444444444
Q ss_pred CEEEcccCcCc
Q 047739 417 ENLNLRHNSLS 427 (1099)
Q Consensus 417 ~~L~L~~N~l~ 427 (1099)
++|+|++|+|+
T Consensus 205 ~~LdLs~N~l~ 215 (350)
T 4ay9_X 205 VILDISRTRIH 215 (350)
T ss_dssp SEEECTTSCCC
T ss_pred chhhcCCCCcC
Confidence 44444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-21 Score=212.83 Aligned_cols=192 Identities=24% Similarity=0.406 Sum_probs=90.4
Q ss_pred CCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCee
Q 047739 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395 (1099)
Q Consensus 316 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 395 (1099)
.+++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++ ++ .+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE
Confidence 34455555555555542 23 35555555555555555553322 5555555555555555542 22 34445555555
Q ss_pred eccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCC
Q 047739 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 396 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
++++|++++.. .+.++++|++|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|+++
T Consensus 113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 55555544321 14455555555555555553222 4455555555555555543222 444445555555555444
Q ss_pred CcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc
Q 047739 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523 (1099)
Q Consensus 476 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 523 (1099)
+..+ +..+++|++|++++|++++.. .+..+++|+.|++++|+++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 3222 344444444444444444222 1333444444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.5e-21 Score=217.02 Aligned_cols=242 Identities=16% Similarity=0.152 Sum_probs=131.5
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccc-hhhhCCCCCCE-EEcc
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP-EEVLGMNNLST-LDLS 446 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~Ls 446 (1099)
++++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++++. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56777778777 6666552 567777777777776666677777777777777777655444 34566666554 4555
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEecc-CcCcccCCcccCCCCccceeeeccccccCC
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSK-QNFSGELPIELAGLPNLQVIALQENKLSGN 525 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 525 (1099)
.|+++...|..|.++++|+.|++++|+++...+..+....++..|++.+ +++....+..|..+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~--------------- 153 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------- 153 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB---------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc---------------
Confidence 6677666666667777777777777776655555555555566666644 344433333333332
Q ss_pred CchhhhcccccceecccccccCCCCCCcccccceeeEEEccC-CcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhc
Q 047739 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG-NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604 (1099)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1099)
..++.|++++|+++.. +.......+|+.|++++ |.++...+..|.++++|++|+|++|+|+ .+|.. .
T Consensus 154 --------~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~--~ 221 (350)
T 4ay9_X 154 --------FESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY--G 221 (350)
T ss_dssp --------SSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSS--S
T ss_pred --------hhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChh--h
Confidence 1244444444444422 22222233455555543 3333222234555555666666666555 33321 1
Q ss_pred cCcccEEeccCccccccCCcccCCCCCCCEEECcCcc
Q 047739 605 LSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641 (1099)
Q Consensus 605 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 641 (1099)
+.+|+.|.+.++.--..+|. +.++++|+.++++++.
T Consensus 222 ~~~L~~L~~l~~~~l~~lP~-l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 222 LENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257 (350)
T ss_dssp CTTCCEEECTTCTTCCCCCC-TTTCCSCCEEECSCHH
T ss_pred hccchHhhhccCCCcCcCCC-chhCcChhhCcCCCCc
Confidence 22333333332222224443 5556666666665543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-20 Score=209.85 Aligned_cols=192 Identities=22% Similarity=0.352 Sum_probs=164.1
Q ss_pred CCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEE
Q 047739 293 SSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLD 372 (1099)
Q Consensus 293 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 372 (1099)
+++|++|++++|+++.. + .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.+++. ..+..+++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence 45688999999998864 4 58889999999999999986544 89999999999999999853 4688899999999
Q ss_pred ccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcc
Q 047739 373 LEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSG 452 (1099)
Q Consensus 373 Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 452 (1099)
|++|++++ ++. +..+++|++|++++|.+++..+ +.++++|+.|+|++|++++. +. +..+++|+.|++++|.+++
T Consensus 114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCc
Confidence 99999985 443 8899999999999999987654 88899999999999999864 33 8899999999999999986
Q ss_pred ccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc
Q 047739 453 EVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 453 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 500 (1099)
..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 188 ~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 554 8889999999999999996553 8899999999999999974
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=213.50 Aligned_cols=149 Identities=15% Similarity=0.066 Sum_probs=118.8
Q ss_pred HHHHHhccccccccccccceeEEEEEECCceEEEEEECCCCCc-------------------cHHHHHHHHHHhhhccCC
Q 047739 798 TVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-------------------DENLFRKEAEFLGKVRHR 858 (1099)
Q Consensus 798 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~H~ 858 (1099)
.......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... ....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556677899999999999999997799999999864321 2456889999999999
Q ss_pred cceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC
Q 047739 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD 938 (1099)
Q Consensus 859 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~ 938 (1099)
| +++.+++.. ...++||||+++|+|.+ +.. .....++.|+++||+|||+.||+||||||+||+++
T Consensus 163 ~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred C-CCcCeEEec--cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE
Confidence 4 556565543 23499999999999988 431 12346899999999999999999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCCccccccccCccccCccccc
Q 047739 939 ADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980 (1099)
Q Consensus 939 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 980 (1099)
++.+||+|||+|+.. ..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~~----------------~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEV----------------GEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEET----------------TSTTHHHHHH
T ss_pred -CCcEEEEECCCCeEC----------------CCCCHHHHHH
Confidence 999999999998643 3478898764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=223.13 Aligned_cols=188 Identities=27% Similarity=0.432 Sum_probs=103.1
Q ss_pred CCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeec
Q 047739 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQ 518 (1099)
Q Consensus 439 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 518 (1099)
+|+.|+|++|.+++ +|..+. ++|+.|+|++|+|+ .+| ..+++|++|++++|+|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555554 333332 45555555555555 334 234555566666665554 343 333 55555555
Q ss_pred cccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcC
Q 047739 519 ENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHI 598 (1099)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 598 (1099)
+|++++ +|. .+++|++|++++|.+++ +|. .+++|+.|++++|++++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 555554 333 34556666666666654 333 34556666666666654 444 44 56666666666666 45
Q ss_pred CcchhccCcc-------cEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccC
Q 047739 599 PTDISHLSHL-------NVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLS 654 (1099)
Q Consensus 599 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 654 (1099)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 54 433 44 66666666666 4666666666666666666666666666665554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-21 Score=242.33 Aligned_cols=215 Identities=20% Similarity=0.198 Sum_probs=106.2
Q ss_pred hhhHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCcc
Q 047739 24 SPEIEALTSFKLNLH-DPLGALNGWDSSTPAAPCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSF 102 (1099)
Q Consensus 24 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~ 102 (1099)
..++.+|+++..+.. +....-.+|.... ...+.|.+++++..+|++|+|.++++.+. +. ..|+.++|+.|.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i 203 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDS-TPSGTATNSAVSTPLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSI 203 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCC-CccccCCCceecCCccceEEeeCCCCCcc-hh-----hHhhcCccCcccc
Confidence 368899999998873 2233445775432 23489999999999999999998887763 32 2345555666555
Q ss_pred Cc---------ccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--cccceeeCCCCc
Q 047739 103 NG---------TIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--RNLKYFDLSSNG 171 (1099)
Q Consensus 103 ~~---------~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~~L~~L~ls~N~ 171 (1099)
.+ ..|..+..++.|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..+. ++|++|+|++|+
T Consensus 204 ~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 204 DEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred cCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 43 23667888888888888888887 78888888888888888888887 6666554 567777777777
Q ss_pred cCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCC-CccEEEcccc
Q 047739 172 FSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP-KLQVVSLAQN 250 (1099)
Q Consensus 172 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N 250 (1099)
|+ .+|..|+++++|++|+|++|.|+ .||..++.+++|++|+|++|.|++.+|..+..+. .+..|+|++|
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~---------~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N 351 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT---------TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDN 351 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC---------CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC---------ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccC
Confidence 76 56666777777777777777664 4566666666777777777777666666654432 2223566666
Q ss_pred cCCCccC
Q 047739 251 NLSGVVP 257 (1099)
Q Consensus 251 ~l~~~~p 257 (1099)
.+++.+|
T Consensus 352 ~l~~~~p 358 (727)
T 4b8c_D 352 RPEIPLP 358 (727)
T ss_dssp CCCCCCC
T ss_pred cccCcCc
Confidence 6665443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=188.65 Aligned_cols=159 Identities=22% Similarity=0.230 Sum_probs=71.0
Q ss_pred CCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEcc
Q 047739 391 GLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLS 470 (1099)
Q Consensus 391 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 470 (1099)
+|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 33444444444443333334444444444444444443333333444444444444444443333334444444444444
Q ss_pred CCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCC
Q 047739 471 GNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI 550 (1099)
Q Consensus 471 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 550 (1099)
+|++++..+..|.++++|++|++++|++++..+..+..+++|+.|++++|.+.+ .+++|++|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 444443333344444444444444444443333334444445555555444432 1234555555555555555
Q ss_pred CCcccc
Q 047739 551 PATFSF 556 (1099)
Q Consensus 551 ~~~l~~ 556 (1099)
|..++.
T Consensus 182 p~~~~~ 187 (208)
T 2o6s_A 182 RNSAGS 187 (208)
T ss_dssp BCTTSS
T ss_pred eccCcc
Confidence 544443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.1e-19 Score=187.02 Aligned_cols=181 Identities=22% Similarity=0.237 Sum_probs=99.8
Q ss_pred cEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCc
Q 047739 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN 400 (1099)
Q Consensus 321 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n 400 (1099)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..+..+++|++|+|++|+++
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------- 65 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ--------------------- 65 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC---------------------
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC---------------------
Confidence 45666666665 233322 234555555555555444444455555555555555554
Q ss_pred cccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCC
Q 047739 401 LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480 (1099)
Q Consensus 401 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 480 (1099)
+..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++..+..+.++++|+.|+|++|++++..+.
T Consensus 66 ---~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 66 ---SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp ---CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ---ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 44444445555555555555555544444445555555555555555554444555566666666666666654444
Q ss_pred CCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccc
Q 047739 481 SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535 (1099)
Q Consensus 481 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 535 (1099)
.+.++++|++|++++|.+.+ .+++|+.|+++.|++++.+|+.++.++.
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 55666666666666665542 3456667777777777777766665543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-19 Score=189.53 Aligned_cols=158 Identities=22% Similarity=0.302 Sum_probs=119.9
Q ss_pred CCcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCccc
Q 047739 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI 134 (1099)
Q Consensus 55 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~ 134 (1099)
.|+|++|.|++.+++ .+|..+. +.|++|+|++|++++..|..++.+++|++|+|++|+|++..+..+
T Consensus 18 ~Cs~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 18 SCSGTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp EEETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred EEeCCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence 599999999865433 3333332 788888999988888778888888888888888888875555556
Q ss_pred ccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccc
Q 047739 135 GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIAN 214 (1099)
Q Consensus 135 ~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~ 214 (1099)
+++++|++|+|++|.++ +..+..|..+++|++|+|++|+|+ .+|..+..
T Consensus 85 ~~l~~L~~L~Ls~N~l~----------------------~l~~~~~~~l~~L~~L~Ls~N~l~---------~lp~~~~~ 133 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLT----------------------VLPSAVFDRLVHLKELFMCCNKLT---------ELPRGIER 133 (229)
T ss_dssp TTCTTCCEEECCSSCCC----------------------CCCTTTTTTCTTCCEEECCSSCCC---------SCCTTGGG
T ss_pred ccCCCcCEEECCCCcCC----------------------ccChhHhCcchhhCeEeccCCccc---------ccCccccc
Confidence 77777777776666665 344455677788888888888876 56667777
Q ss_pred cCceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCcc
Q 047739 215 CSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVV 256 (1099)
Q Consensus 215 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 256 (1099)
+++|++|+|++|+|++..+..|..+++|++|+|++|.+....
T Consensus 134 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 134 LTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 888888888888888777777888888888888888887544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-21 Score=236.09 Aligned_cols=35 Identities=17% Similarity=0.151 Sum_probs=22.5
Q ss_pred ceeEEEccCCcCCccChhhhcCCCCccEEEcccccCC
Q 047739 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLS 253 (1099)
Q Consensus 217 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 253 (1099)
.|+.|+|++|+|++ +|. |+.+++|++|+|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc
Confidence 36667777777765 344 666666666666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=191.98 Aligned_cols=171 Identities=27% Similarity=0.364 Sum_probs=84.5
Q ss_pred cCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCe
Q 047739 315 TRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKS 394 (1099)
Q Consensus 315 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 394 (1099)
..+++|++|++++|.+++. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3455566666666665532 2 35555556666666665554332 5555555555555555553 22 2444555555
Q ss_pred eeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcC
Q 047739 395 LTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474 (1099)
Q Consensus 395 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 474 (1099)
|++++|++++. ..+.++++|+.|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|+|++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 55555554432 2344455555555555555432 344455555555555555543332 44445555555555544
Q ss_pred CCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 475 SGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 475 ~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
++. + .+.++++|+.|++++|+++
T Consensus 191 ~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 191 SDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred CCC-h-hhccCCCCCEEECcCCccc
Confidence 421 2 2444444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=210.27 Aligned_cols=189 Identities=25% Similarity=0.351 Sum_probs=110.1
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
+..++++.+.+....+ +..+++|+.|+|++|.|+. ++ .|..+++|+.|+|++|.+++..+ +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3444555555554433 3456667777777777663 23 46666667777777776665433 66666667777766
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|++++ +| .+..+++|++|+|++|.+.+. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 66663 22 455566666666666666542 3455566666666666666543 445566666666666666654444
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 500 (1099)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55566666666666666532 235555566666666655553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-18 Score=208.79 Aligned_cols=189 Identities=20% Similarity=0.256 Sum_probs=107.3
Q ss_pred ccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCC
Q 047739 161 NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240 (1099)
Q Consensus 161 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 240 (1099)
++..+.++.+.+...++ +..+++|+.|++++|.++ .+| .++.+++|+.|+|++|++++..| +..++
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~---------~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~ 87 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---------SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLK 87 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC---------CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCT
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC---------CCh-HHccCCCCCEEEeeCCCCCCChh--hccCC
Confidence 44555566666654433 456777777777777776 333 36677777777777777776554 77777
Q ss_pred CccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCc
Q 047739 241 KLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTL 320 (1099)
Q Consensus 241 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 320 (1099)
+|++|+|++|+|++ +|. ...+++|++|+|++|+|+++ ..+..+++|
T Consensus 88 ~L~~L~Ls~N~l~~-l~~-------------------------------l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L 133 (605)
T 1m9s_A 88 NLGWLFLDENKIKD-LSS-------------------------------LKDLKKLKSLSLEHNGISDI--NGLVHLPQL 133 (605)
T ss_dssp TCCEEECCSSCCCC-CTT-------------------------------STTCTTCCEEECTTSCCCCC--GGGGGCTTC
T ss_pred CCCEEECcCCCCCC-Chh-------------------------------hccCCCCCEEEecCCCCCCC--ccccCCCcc
Confidence 77777777777752 110 11234455555555555542 235555566
Q ss_pred cEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCc
Q 047739 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN 400 (1099)
Q Consensus 321 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n 400 (1099)
+.|+|++|.|++. ..|..+++|++|+|++|.+++..| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|
T Consensus 134 ~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N 207 (605)
T 1m9s_A 134 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQ 207 (605)
T ss_dssp SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSE
T ss_pred CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCC
Confidence 6666666665543 345555555555555555554333 55555555555555555532 2 3444444444444444
Q ss_pred ccc
Q 047739 401 LFS 403 (1099)
Q Consensus 401 ~l~ 403 (1099)
.+.
T Consensus 208 ~l~ 210 (605)
T 1m9s_A 208 ECL 210 (605)
T ss_dssp EEE
T ss_pred cCc
Confidence 444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.7e-21 Score=229.39 Aligned_cols=203 Identities=20% Similarity=0.211 Sum_probs=104.9
Q ss_pred cccccccccccccccccccccccccccCccccccCceeEEEccCCc-------------CCccChhhhcCCCCccEEE-c
Q 047739 182 NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNA-------------LGGVIPPAIGALPKLQVVS-L 247 (1099)
Q Consensus 182 ~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~-------------l~~~~p~~~~~l~~L~~L~-L 247 (1099)
.+++|+.|+|++|+|+ .||++|+++++|++|++++|. +.+.+|..++.+++|+.|+ +
T Consensus 347 ~~~~L~~L~Ls~n~L~---------~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l 417 (567)
T 1dce_A 347 TDEQLFRCELSVEKST---------VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM 417 (567)
T ss_dssp TTTTSSSCCCCHHHHH---------HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGG
T ss_pred cCccceeccCChhhHH---------hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcch
Confidence 3445555555555554 445555555555555554443 5567788888888888888 7
Q ss_pred ccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCC
Q 047739 248 AQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327 (1099)
Q Consensus 248 s~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 327 (1099)
+.|.+. .+..+.++.|.+..++. ..|+.|+|++|+|++
T Consensus 418 ~~n~~~----------------~L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~------------------- 455 (567)
T 1dce_A 418 RAAYLD----------------DLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV------------------- 455 (567)
T ss_dssp GHHHHH----------------HHHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-------------------
T ss_pred hhcccc----------------hhhhhhhhcccccccCc-------cCceEEEecCCCCCC-------------------
Confidence 777653 12222333333333321 124444444444443
Q ss_pred CccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccC-
Q 047739 328 NSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSI- 406 (1099)
Q Consensus 328 N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~- 406 (1099)
+|. |+++++|++|+|++|.|+ .+|..+..+++|++|+|++|+|++ +| .++.+++|++|+|++|+|++..
T Consensus 456 ------lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~ 525 (567)
T 1dce_A 456 ------LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAA 525 (567)
T ss_dssp ------CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSST
T ss_pred ------CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCC
Confidence 333 444445555555555544 344455555555555555555553 34 4555555555555555555444
Q ss_pred CccCCCCCCCCEEEcccCcCccccch---hhhCCCCCCEEEc
Q 047739 407 PASFRNLPGLENLNLRHNSLSGSLPE---EVLGMNNLSTLDL 445 (1099)
Q Consensus 407 ~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L 445 (1099)
|..|.++++|+.|+|++|.+++..|. .+..+++|+.|++
T Consensus 526 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp TGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred cHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 55555556666666666666543321 1233566666653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=189.78 Aligned_cols=190 Identities=26% Similarity=0.391 Sum_probs=135.6
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
++..+.+..+.+++.. .+..+++|++|++++|.+... ..+..+++|++|+|++|++++..+ +..+++|++|+++
T Consensus 25 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 3555567777776433 345678899999999988754 347888899999999999885443 7888888888888
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcC
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 478 (1099)
+|.+++. ..+.++++|++|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..
T Consensus 99 ~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 99 ENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 8888753 3477888888888888888753 4577777888888888877754 46677777777777777777544
Q ss_pred CCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccC
Q 047739 479 PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524 (1099)
Q Consensus 479 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 524 (1099)
+ +..+++|+.|++++|.+++. + .+..+++|+.|++++|+++.
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred h--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 4 66677777777777776642 2 35666666666666666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=196.91 Aligned_cols=156 Identities=23% Similarity=0.221 Sum_probs=85.7
Q ss_pred ccEEeCCCCccccCchhhhC-CCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 320 LTRLDVSGNSISGKIPAQIG-GLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 320 L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 45555555555544444444 55555555555555554444455555555555555555554444455555555555555
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhh---hCCCCCCEEEccCCcCccccCcccCCCCc--ccEEEccCCc
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEV---LGMNNLSTLDLSENKFSGEVPASIGNLSQ--LMVFNLSGNA 473 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~--L~~L~L~~N~ 473 (1099)
+|+|++..+..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+...+..+..++. |+.|+|++|.
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 555555555556666666666666666664333333 34566666666666666544455555555 3667777776
Q ss_pred CC
Q 047739 474 FS 475 (1099)
Q Consensus 474 l~ 475 (1099)
+.
T Consensus 201 ~~ 202 (361)
T 2xot_A 201 LE 202 (361)
T ss_dssp EE
T ss_pred cc
Confidence 65
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-18 Score=193.21 Aligned_cols=176 Identities=24% Similarity=0.208 Sum_probs=101.3
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCC-CCCCCCEEEcccCcCccccchhhhCCCCCCEEEccC
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR-NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1099)
+++++++|+++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45555555555 3444333 2355555555555555555555 566666666666666655555566666666666666
Q ss_pred CcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCccc---CCCCccceeeeccccccC
Q 047739 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIEL---AGLPNLQVIALQENKLSG 524 (1099)
Q Consensus 448 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l---~~l~~L~~L~L~~N~l~~ 524 (1099)
|+|+...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..+ ..+++|+.|+|++|++++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555556666666666666666665555666666666666666666664333333 345666666666666665
Q ss_pred CCchhhhcccc--cceecccccccC
Q 047739 525 NVPEGFSSLMS--LRYLNLSFNGFV 547 (1099)
Q Consensus 525 ~~p~~~~~l~~--L~~L~Ls~N~l~ 547 (1099)
..+..|..++. |+.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 55455555554 355566655553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=176.70 Aligned_cols=128 Identities=23% Similarity=0.320 Sum_probs=57.5
Q ss_pred eEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCC
Q 047739 297 QVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 297 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 376 (1099)
+.+++++|+++. +|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 345556665553 233222 34555555555555444444555555555555555555444444554555555555555
Q ss_pred cCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc
Q 047739 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
+|+...+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 444322233333433333333333333333333333333333333333333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-17 Score=175.33 Aligned_cols=152 Identities=22% Similarity=0.311 Sum_probs=83.4
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCC
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSEN 448 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 448 (1099)
+.+++++|.++ .+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 34555555554 3444332 34555555555555555555555555555555555555555555555555555555555
Q ss_pred cCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc
Q 047739 449 KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523 (1099)
Q Consensus 449 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 523 (1099)
.|+...+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 555444444555555555555555555555555555555555555555555544445555555555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-17 Score=174.48 Aligned_cols=131 Identities=22% Similarity=0.321 Sum_probs=66.6
Q ss_pred CEEEccCCcCCCCCC-ccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccC
Q 047739 369 SLLDLEGNRFSGEIP-EFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1099)
++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 344444444443322 2234444444444444444444444455555555555555555544444455555555555555
Q ss_pred CcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 448 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
|++++..|..|..+++|+.|+|++|++++..|..|..+++|++|++++|.+.
T Consensus 115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 5555555555555555555555555555444555555555555555555554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=177.18 Aligned_cols=135 Identities=26% Similarity=0.287 Sum_probs=81.8
Q ss_pred cccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
++|++|+|++|.+++..|..|..+++|+.|+|++|+++...+..|.++++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 45555555555555555555555555555555555555444445566666666666666666444444566666666666
Q ss_pred cCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCc
Q 047739 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGE 669 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 669 (1099)
++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++++.
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 666666 5666666666666666666666654455566666667777777766654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-17 Score=174.90 Aligned_cols=155 Identities=20% Similarity=0.275 Sum_probs=128.8
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCC-ccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccC
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIP-ASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1099)
+++++++|.++ .+|..+. ..+++|+|++|++++..+ ..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 58899999988 5676654 456899999999987754 5578889999999999999877777888888999999999
Q ss_pred CcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCC
Q 047739 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526 (1099)
Q Consensus 448 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 526 (1099)
|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+....
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9988877778888888888888888888877888888888888888888888777888888888888888888887543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-18 Score=214.19 Aligned_cols=223 Identities=22% Similarity=0.228 Sum_probs=118.6
Q ss_pred CCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEe
Q 047739 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDL 493 (1099)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 493 (1099)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.|.+ +++..|.+. ..+..+..+..|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 345666666666653 222 234555555555542 234455555 55677777888888888
Q ss_pred ccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCC
Q 047739 494 SKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573 (1099)
Q Consensus 494 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~ 573 (1099)
++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 888887 66667778888899999999888 78888899999999999999998 77888999999999999999997 7
Q ss_pred CCCCCCCCCCCceEEecCCcccCcCCcchhccCc-ccEEeccCccccccCCcccCCCCCCCEEECcCc--------cccc
Q 047739 574 IPPELGNCSDLEVLELRSNSLTGHIPTDISHLSH-LNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN--------HLSG 644 (1099)
Q Consensus 574 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N--------~l~~ 644 (1099)
+|..|+++++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .|.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence 7888999999999999999999888888766532 335889999999888764 556677777 2333
Q ss_pred cCChhhhccCCCCeeecCCCcCC
Q 047739 645 GIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 645 ~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
..+..+.++..+....+++|-+.
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp --------------------CCC
T ss_pred cccchhhcccccceeeeeccccc
Confidence 33333444444555555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.4e-18 Score=183.62 Aligned_cols=166 Identities=20% Similarity=0.278 Sum_probs=85.9
Q ss_pred ceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEcc
Q 047739 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLE 374 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 374 (1099)
.+..+++++|.+++.. .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3455566666665433 35556666666666666653 33 45566666666666666664333 5566666666666
Q ss_pred CCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 375 GNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
+|++++ +|.... ++|++|+|++|++++. +.+.++++|+.|+|++|++++. + .+..+++|+.|+|++|++++.
T Consensus 94 ~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 666653 332221 4555555555555432 2344555555555555555432 2 344445555555555554433
Q ss_pred CcccCCCCcccEEEccCCcCC
Q 047739 455 PASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
..+..+++|+.|++++|.+.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEE
T ss_pred -HHhccCCCCCEEeCCCCccc
Confidence 33444444444444444444
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=180.05 Aligned_cols=135 Identities=19% Similarity=0.156 Sum_probs=105.1
Q ss_pred cccccccccccceeEEEEEE-CCceE--EEEEECCCCCcc-------------------------HHHHHHHHHHhhhcc
Q 047739 805 FDEENVLSRTRYGLVFKACY-NDGMV--LSIRRLPDGSLD-------------------------ENLFRKEAEFLGKVR 856 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 856 (1099)
|++.+.||+|+||.||+|.+ .+|+. ||+|.+...... ...+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998 67888 999986432111 136789999999998
Q ss_pred CCcc--eEEeeEEecCCCceEEEEeecCC-C----CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc-cCCceec
Q 047739 857 HRNL--TVLRGYYAGAPDLRLLVYDYMPN-G----NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH-TSNMVHG 928 (1099)
Q Consensus 857 H~ni--v~l~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~iiH~ 928 (1099)
|+++ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.|++||| +.||+||
T Consensus 129 ~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 8864 333332 124899999942 4 66665432 224456789999999999999 9999999
Q ss_pred CCCCCCEEECCCCcEEEecccccccc
Q 047739 929 DIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 929 Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=180.57 Aligned_cols=171 Identities=23% Similarity=0.330 Sum_probs=133.4
Q ss_pred CCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCee
Q 047739 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395 (1099)
Q Consensus 316 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 395 (1099)
.+.++..+++++|.+++. + .+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 456788889999999854 3 67888999999999999984 44 78889999999999999985444 8888899999
Q ss_pred eccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCC
Q 047739 396 TLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 396 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
+|++|++++..+ +.. ++|++|+|++|++++. +.+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 999998886433 222 7888888888888853 3577888888888888888754 3 5777788888888888887
Q ss_pred CcCCCCCCCCCCCCEEEeccCcCccc
Q 047739 476 GRIPASLGNLLKLTTLDLSKQNFSGE 501 (1099)
Q Consensus 476 ~~~~~~l~~l~~L~~L~L~~n~l~~~ 501 (1099)
+. ..+..+++|+.|++++|++.+.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 55 5677777777777777777644
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=172.10 Aligned_cols=154 Identities=20% Similarity=0.304 Sum_probs=96.6
Q ss_pred CCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCce
Q 047739 507 AGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEV 586 (1099)
Q Consensus 507 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~ 586 (1099)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34455555555555555 333 4555666666666666443 2235556666666666666666556666777777777
Q ss_pred EEecCCcccCcCCcchhccCcccEEeccCcc-ccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCc
Q 047739 587 LELRSNSLTGHIPTDISHLSHLNVLDLSINN-LTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANN 665 (1099)
Q Consensus 587 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~ 665 (1099)
|++++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777776666667777777777777776 44 455 46677777777777777764 33 66777777777777777
Q ss_pred CCC
Q 047739 666 LSG 668 (1099)
Q Consensus 666 l~~ 668 (1099)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=187.21 Aligned_cols=296 Identities=16% Similarity=0.135 Sum_probs=158.1
Q ss_pred cccCccccc--cCceeEEEccCCcCCccChhhhcC-CCCccEEEcccccCCCccCcccccccCCCCCcceEEEecccccc
Q 047739 206 GTLPSAIAN--CSSLVHLSAQGNALGGVIPPAIGA-LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFT 282 (1099)
Q Consensus 206 g~lp~~l~~--l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~ 282 (1099)
|+++..+.. +.++++|.++++ +....-..+.. +++|++|||++|+++. |.....
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~------~~~~~~---------------- 69 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKM------YSGKAG---------------- 69 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECC------EEESSS----------------
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEE------ecCccc----------------
Confidence 344444433 567777877764 22222234444 7889999999998861 111000
Q ss_pred ccCCCCCCCCCCceeEEEcCCCccccCcchhccC--------CCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCcc
Q 047739 283 NVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTR--------ASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354 (1099)
Q Consensus 283 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l 354 (1099)
..+.+..+.+..|.| .+..|.. +++|++|+|.+ .++.+.+.+|.++++|++|++.+|.+
T Consensus 70 ---------~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i 136 (329)
T 3sb4_A 70 ---------TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTA 136 (329)
T ss_dssp ---------SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSC
T ss_pred ---------ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCc
Confidence 011123333444422 2344555 77888888877 77666666777778888888887777
Q ss_pred CccCCccccCCCCCCEEEccCCc----CCCCCCccccCCCCCC-eeeccCcc-ccccCCccCCCCCCCCEEEcccCcCcc
Q 047739 355 GGAVPVEIKQCSSLSLLDLEGNR----FSGEIPEFLGDIRGLK-SLTLAANL-FSGSIPASFRNLPGLENLNLRHNSLSG 428 (1099)
Q Consensus 355 ~~~~~~~l~~l~~L~~L~Ls~N~----l~~~~p~~~~~l~~L~-~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~ 428 (1099)
....+..|..+.++..+.+..+. ........|.++.+|+ .+.+.... +.......-....++..+.+.++-..
T Consensus 137 ~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~- 215 (329)
T 3sb4_A 137 PNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN- 215 (329)
T ss_dssp CEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-
T ss_pred cccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-
Confidence 76667777777777666665532 1212223344444444 23322211 00000011112344555555544222
Q ss_pred ccchhh-hCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCC-EEEeccCcCcccCCccc
Q 047739 429 SLPEEV-LGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLT-TLDLSKQNFSGELPIEL 506 (1099)
Q Consensus 429 ~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~l 506 (1099)
.....+ ..+++|+.|+|++|+++.+.+.+|.++.+|+.|+|.+| ++...+.+|.++.+|+ .+++.+ .++.+.+..|
T Consensus 216 ~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF 293 (329)
T 3sb4_A 216 ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAF 293 (329)
T ss_dssp HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTT
T ss_pred HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhh
Confidence 111122 13566666666666666555556666666666666665 5545555666666666 666665 4554555555
Q ss_pred CCCCccceeeeccccccCCCchhhhcccccceec
Q 047739 507 AGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLN 540 (1099)
Q Consensus 507 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 540 (1099)
.++++|+.+++++|.++.+.+.+|.++++|+.++
T Consensus 294 ~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 294 MGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred hCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5566666666555555544455555555555553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=188.00 Aligned_cols=293 Identities=13% Similarity=0.101 Sum_probs=156.9
Q ss_pred ccccccccc--cccccceEEccCCccCcccCccccc-CCcccEEEeccccCC--CccCcccccCCCCceeecccccCCCc
Q 047739 79 SGRISDHLS--NLRMLRKLSLRSNSFNGTIPATLAQ-CTLLRAVFLQYNSLS--GNLPANIGNLSNLEILNVAANRLSGE 153 (1099)
Q Consensus 79 ~g~~~~~l~--~l~~L~~L~L~~n~~~~~~p~~~~~-l~~L~~L~l~~n~l~--g~~p~~~~~l~~L~~L~ls~N~l~~~ 153 (1099)
.|.++..+. .+..++.|.++++ +.+.--..+.. +++|++|||++|+++ ...+. .++.
T Consensus 12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~-------------- 73 (329)
T 3sb4_A 12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPN-------------- 73 (329)
T ss_dssp TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGG--------------
T ss_pred CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccc--------------
Confidence 345554444 3777888888754 22111112233 566777777777666 11111 1111
Q ss_pred ccCCcccccceeeCCCCccCCCCCCCCcc--------ccccccccccccccccccccccccccCccccccCceeEEEccC
Q 047739 154 IANDLPRNLKYFDLSSNGFSGPIPTSISN--------LSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG 225 (1099)
Q Consensus 154 i~~~~~~~L~~L~ls~N~l~~~~p~~~~~--------l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~ 225 (1099)
++.+.+..|.|. +.+|.+ +++|+.|+|.+ .++.+.+.+|. .+++|+.|++++
T Consensus 74 --------~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~--------~~~~L~~l~l~~ 133 (329)
T 3sb4_A 74 --------GKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFK--------GCDNLKICQIRK 133 (329)
T ss_dssp --------GCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTT--------TCTTCCEEEBCC
T ss_pred --------cccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHhh--------cCcccceEEcCC
Confidence 233333333221 234555 88888888888 77755554444 477888888888
Q ss_pred CcCCccChhhhcCCCCccEEEcccccCC---CccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCcee-EEEc
Q 047739 226 NALGGVIPPAIGALPKLQVVSLAQNNLS---GVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQ-VLDL 301 (1099)
Q Consensus 226 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~-~L~L 301 (1099)
|.+..+.+.+|..+.++..+.+..+... ..+....|.+. ..|+ .+++
T Consensus 134 n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~-----------------------------~~L~~~i~~ 184 (329)
T 3sb4_A 134 KTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG-----------------------------EPLETTIQV 184 (329)
T ss_dssp SSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES-----------------------------CCCEEEEEE
T ss_pred CCccccchhhhcCCCceEEecCcchhhhhccccccccccccc-----------------------------cccceeEEe
Confidence 8888777788888777777776653221 01222222221 1122 2222
Q ss_pred CCCccccCcchhc----cCCCCccEEeCCCCccccCchhhh-CCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCC
Q 047739 302 QQNQIRGAFPLWL----TRASTLTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 302 ~~n~l~~~~~~~~----~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 376 (1099)
.... .++..+ ....+++.+.+.++-.. .....+ ..+++|+.|+|++|+++......|.+|++|+.|+|.+|
T Consensus 185 ~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n 260 (329)
T 3sb4_A 185 GAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN 260 (329)
T ss_dssp CTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT
T ss_pred cCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc
Confidence 2211 111111 12334445554443221 111111 12556666666666666555556666666666666665
Q ss_pred cCCCCCCccccCCCCCC-eeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEE
Q 047739 377 RFSGEIPEFLGDIRGLK-SLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLD 444 (1099)
Q Consensus 377 ~l~~~~p~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 444 (1099)
++...+..|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|+++...+.+|.++++|+.|+
T Consensus 261 -i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 261 -LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp -CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred -cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5544455666666666 666666 55556666677777777777767776655556666777776665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.5e-17 Score=167.66 Aligned_cols=151 Identities=15% Similarity=0.233 Sum_probs=82.1
Q ss_pred CCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEE
Q 047739 341 LWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLN 420 (1099)
Q Consensus 341 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 420 (1099)
+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..+.++++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 344445555555444 222 3455555555555555443 122455555555555555555555555566666666666
Q ss_pred cccCcCccccchhhhCCCCCCEEEccCCc-CccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 421 LRHNSLSGSLPEEVLGMNNLSTLDLSENK-FSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 421 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
|++|++++..+..+..+++|++|++++|. ++ .++ .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66666665556666666666666666665 44 233 45556666666666666653 22 4555556666666666554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=162.83 Aligned_cols=132 Identities=21% Similarity=0.265 Sum_probs=84.0
Q ss_pred ceeeeccccccCCCchhhhcccccceecccccccCCCCCC-cccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecC
Q 047739 513 QVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPA-TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591 (1099)
Q Consensus 513 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~ 591 (1099)
+.+++++|.++ .+|..+. .+|++|++++|++++..+. .+..+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 34444444443 3343332 2556666666666544443 356666666666666666666666677777777777777
Q ss_pred CcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCC
Q 047739 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIP 647 (1099)
Q Consensus 592 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 647 (1099)
|++++..+..+..+++|+.|+|++|+|++.+|..+..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666667777777777777777776667777777777777777777765543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=8.4e-16 Score=158.37 Aligned_cols=133 Identities=23% Similarity=0.317 Sum_probs=120.5
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCC-CCCCCCCCceEEecCCcccCcCCcchhccCcccEEecc
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP-ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLS 614 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 614 (1099)
-+++++++|.++ .+|..+.. +|+.|++++|++++..+. .++.+++|++|+|++|++++..|..|..+++|+.|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 378999999996 66765543 899999999999976664 48999999999999999998889999999999999999
Q ss_pred CccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCC
Q 047739 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 615 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
+|+|++..|..+..+++|++|+|++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999998888889999999999999999999999999999999999999999998655
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.9e-16 Score=154.28 Aligned_cols=137 Identities=23% Similarity=0.222 Sum_probs=117.7
Q ss_pred ccccceecccccccC-CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEE
Q 047739 533 LMSLRYLNLSFNGFV-GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL 611 (1099)
Q Consensus 533 l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 611 (1099)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..++.+++|++|+|++|++++.+|..+..+++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367888888888887 67788888888999999999998865 788899999999999999997788888889999999
Q ss_pred eccCccccccCC--cccCCCCCCCEEECcCccccccCC---hhhhccCCCCeeecCCCcCCCcCCCC
Q 047739 612 DLSINNLTGEIP--DEISKCSSLRSLLVNSNHLSGGIP---DSLAKLSNLAVLDLSANNLSGEIPAN 673 (1099)
Q Consensus 612 ~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~ls~N~l~~~~p~~ 673 (1099)
+|++|++++ +| ..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+. ++|..
T Consensus 101 ~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 999999985 44 789999999999999999996555 48999999999999999987 45543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-14 Score=167.40 Aligned_cols=268 Identities=12% Similarity=0.117 Sum_probs=146.0
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
++.+.+.+ .++.+...+|.+. +|+.+++.+| ++.+...+|.+. +|+.+.+.+ .+.......|.+|++|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 34444432 3444445556653 5777777655 554555566663 577777664 45545556666677777777776
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccC
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVP 455 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 455 (1099)
|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .+.++.+..
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~ 264 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIAS 264 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECT
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEECh
Confidence 666643334444 456666666533 55555566666666666666553 33333444444 45555555 233443444
Q ss_pred cccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccc
Q 047739 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMS 535 (1099)
Q Consensus 456 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 535 (1099)
.+|.++++|+.+++.+|.+.. +.+....+..|.++++|+.+.|. +.++.+...+|.++++
T Consensus 265 ~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~ 324 (401)
T 4fdw_A 265 RAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRK 324 (401)
T ss_dssp TTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCS
T ss_pred hHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCC
Confidence 555555555555555544430 00002333445555555555555 2344344455555666
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCC-CCceEEecCCccc
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS-DLEVLELRSNSLT 595 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~ 595 (1099)
|+.++|..| ++......|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 325 L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 325 VTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 666666433 444455566666 666666666666555555666663 6777777776654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.2e-14 Score=163.66 Aligned_cols=265 Identities=8% Similarity=0.074 Sum_probs=166.5
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
..++.+.+.++ ++.+...+|.+. +|+.+.+.++ ++.....+|.++ +|+.++|.. .++
T Consensus 113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~------------------ 169 (401)
T 4fdw_A 113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE------------------ 169 (401)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC------------------
T ss_pred CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc------------------
Confidence 45666666543 333444555553 5666666544 443444445443 455555543 333
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCc
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 477 (1099)
.+...+|.++++|+.++|.+|+++.....+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++..
T Consensus 170 ------~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 170 ------QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp ------EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred ------EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 34444455555555555555555533233333 345555555532 44444455555555555555543 3333
Q ss_pred CCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc-----CCCchhhhcccccceecccccccCCCCCC
Q 047739 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS-----GNVPEGFSSLMSLRYLNLSFNGFVGQIPA 552 (1099)
Q Consensus 478 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 552 (1099)
...+|.+ .+|+.+.+. +.++......|.++++|+.+.+.+|.+. .+.+.+|.++++|+.+++. +.++.....
T Consensus 241 ~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 4445555 456666663 3455455566666666666666666553 3566789999999999999 558777788
Q ss_pred cccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccC-cccEEeccCcccc
Q 047739 553 TFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS-HLNVLDLSINNLT 619 (1099)
Q Consensus 553 ~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 619 (1099)
.|.++++|+.++|..| ++..-+.+|.++ +|+.+++++|.+....+..|..++ .++.|++..+.+.
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 9999999999999665 765667899999 999999999999866666777774 7899999988765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=149.35 Aligned_cols=129 Identities=19% Similarity=0.182 Sum_probs=108.0
Q ss_pred ccccceecccccccC-CCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEE
Q 047739 533 LMSLRYLNLSFNGFV-GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVL 611 (1099)
Q Consensus 533 l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 611 (1099)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..++.+++|++|++++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888887 67777788888888888888888865 778889999999999999987788888889999999
Q ss_pred eccCcccccc-CCcccCCCCCCCEEECcCccccccCC---hhhhccCCCCeeecCC
Q 047739 612 DLSINNLTGE-IPDEISKCSSLRSLLVNSNHLSGGIP---DSLAKLSNLAVLDLSA 663 (1099)
Q Consensus 612 ~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~ls~ 663 (1099)
++++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999862 34788899999999999999986655 5788899999998874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=152.10 Aligned_cols=132 Identities=19% Similarity=0.219 Sum_probs=61.7
Q ss_pred CCccEEeCCCCccc-cCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeee
Q 047739 318 STLTRLDVSGNSIS-GKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT 396 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 396 (1099)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34445555555444 33444444444455555555444433 3444445555555555555443444444444444444
Q ss_pred ccCccccccC-CccCCCCCCCCEEEcccCcCccccc---hhhhCCCCCCEEEccCCcCc
Q 047739 397 LAANLFSGSI-PASFRNLPGLENLNLRHNSLSGSLP---EEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 397 L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
|++|.+++.. +..+.++++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 4444444321 1344445555555555555553322 24444555555555555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=147.55 Aligned_cols=126 Identities=20% Similarity=0.237 Sum_probs=63.4
Q ss_pred CccEEeCCCCccc-cCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 319 TLTRLDVSGNSIS-GKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
+|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3444444444444 34444444444455555555544433 34445555555555555555444444444555555555
Q ss_pred cCcccccc-CCccCCCCCCCCEEEcccCcCccccc---hhhhCCCCCCEEEcc
Q 047739 398 AANLFSGS-IPASFRNLPGLENLNLRHNSLSGSLP---EEVLGMNNLSTLDLS 446 (1099)
Q Consensus 398 ~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls 446 (1099)
++|++++. .+..+.++++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55554432 22445555566666666666654433 345556666666554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=149.00 Aligned_cols=127 Identities=28% Similarity=0.375 Sum_probs=65.7
Q ss_pred ceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCc
Q 047739 537 RYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN 616 (1099)
Q Consensus 537 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 616 (1099)
+++++++|.++ .+|..+. ++|+.|++++|+++ .+|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45566666665 3333322 34555555555555 44455555555555555555555444444555555555555555
Q ss_pred cccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCC
Q 047739 617 NLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 617 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555444444555555555555555555333334555555555555555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=8e-14 Score=161.13 Aligned_cols=327 Identities=11% Similarity=0.064 Sum_probs=153.1
Q ss_pred hhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCC
Q 047739 312 LWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRG 391 (1099)
Q Consensus 312 ~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 391 (1099)
.+|.++.+|+.+.|..+ ++.+...+|.++++|+.+++.++ ++......|.++++|+.+.+..+ +.......|.++..
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 34555555555555432 44334445555555555555433 33333444555555555444433 22222333443322
Q ss_pred CCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccC
Q 047739 392 LKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471 (1099)
Q Consensus 392 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 471 (1099)
++..... .+......+|.++++|+.+.+.++..+ .....|.++.+|+.+++..| ++.+...+|.++..|+.+.+..
T Consensus 142 ~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPE--GVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCT--TCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCc--cccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 2221111 112233445666666666666544322 34445555666666666554 3334445556666666555554
Q ss_pred CcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCC
Q 047739 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP 551 (1099)
Q Consensus 472 N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 551 (1099)
+... +...+.....|+.+.+..+ ++......+.++..|+.+.+..+... .....|..+..++.+....+.+ ..
T Consensus 218 ~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~ 290 (394)
T 4fs7_A 218 SLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PE 290 (394)
T ss_dssp TCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CT
T ss_pred CceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cc
Confidence 4332 1222333445566555433 22233444555555666655554333 3344555555555555544332 12
Q ss_pred CcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCC
Q 047739 552 ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631 (1099)
Q Consensus 552 ~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 631 (1099)
..|..+.+|+.+.+..+ ++.+-..+|.++.+|+.++|..+ ++..-...|.++.+|+.+++..| ++..-...|..|++
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 33444555555555433 33233345555555555555432 43233345555555555555544 43233345555555
Q ss_pred CCEEECcCccccccCChhhhccCCCC
Q 047739 632 LRSLLVNSNHLSGGIPDSLAKLSNLA 657 (1099)
Q Consensus 632 L~~L~Ls~N~l~~~~p~~l~~l~~L~ 657 (1099)
|+.+++..+ ++ .+..+|.++++|+
T Consensus 368 L~~i~lp~~-~~-~~~~~F~~c~~L~ 391 (394)
T 4fs7_A 368 LKKVELPKR-LE-QYRYDFEDTTKFK 391 (394)
T ss_dssp CCEEEEEGG-GG-GGGGGBCTTCEEE
T ss_pred CCEEEECCC-CE-EhhheecCCCCCc
Confidence 555555433 22 2233444444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=146.55 Aligned_cols=133 Identities=19% Similarity=0.231 Sum_probs=98.7
Q ss_pred cceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccC
Q 047739 536 LRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSI 615 (1099)
Q Consensus 536 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 615 (1099)
.+.+++++|.++. +|..+ .++|+.|++++|++++..+..++++++|++|+|++|++++..+..+..+++|+.|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4566777777663 33332 25677777777777766666677888888888888888865555678888888888888
Q ss_pred ccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCC
Q 047739 616 NNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671 (1099)
Q Consensus 616 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 671 (1099)
|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88886655667788888888888888886555567788888888888888887554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-14 Score=147.89 Aligned_cols=127 Identities=21% Similarity=0.312 Sum_probs=75.6
Q ss_pred eEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCC
Q 047739 297 QVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 297 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 376 (1099)
+.+++++|+++. +|..+. ++|++|+|++|.|+ .+|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 356666666663 333222 45666666666665 45566666666666666666666555556666666666666666
Q ss_pred cCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCc
Q 047739 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666555555555655555555555555555555555556666666655554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-13 Score=160.29 Aligned_cols=219 Identities=16% Similarity=0.153 Sum_probs=109.7
Q ss_pred CccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCC
Q 047739 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMN 438 (1099)
Q Consensus 359 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 438 (1099)
..+|.+|++|+.+.+..+. .......|.++.+|+.+.+..| ++.+...+|.++..|+.+.+..+... +.+......
T Consensus 155 ~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 4456666666666665443 2233445666666666666554 44455566666666666666554432 223333445
Q ss_pred CCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeec
Q 047739 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQ 518 (1099)
Q Consensus 439 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 518 (1099)
+|+.+.+..+ ++.+....+.++..|+.+.+..+... .....|.++..++.+....+.+. ...+..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence 6666666543 23244455566666666666655433 44455666666666665544322 2345555556655554
Q ss_pred cccccCCCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEe
Q 047739 519 ENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLEL 589 (1099)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L 589 (1099)
++ ++.+...+|.++.+|+.+++..+ ++......|.++.+|+.+++..+ ++..-..+|.+|++|+.+++
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 43 33334445555555555555422 33233334444444444444333 22222333444444444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.7e-14 Score=143.27 Aligned_cols=132 Identities=19% Similarity=0.246 Sum_probs=87.4
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
.+.+++++|+++.+ |..+ .++|++|++++|++++..+..|+++++|++|+|++|++++..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 35666677776643 3222 25677777777777765556667777777777777777765555667777777777777
Q ss_pred CcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc
Q 047739 376 NRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430 (1099)
Q Consensus 376 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 430 (1099)
|++++..+..+..+++|++|++++|++++..+..|.++++|++|+|++|.+.+..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 7777555555666666777777766666655555666677777777777766543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=5.8e-15 Score=165.29 Aligned_cols=135 Identities=11% Similarity=0.106 Sum_probs=99.1
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCcc---------------HHH--------HHHHHHHhhhccCCcce
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---------------ENL--------FRKEAEFLGKVRHRNLT 861 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------~~~--------~~~E~~~l~~l~H~niv 861 (1099)
|++.+.||+|+||.||+|...+|+.||||.+...... ... ..+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 8899999999999999999999999999986432110 111 23567777777555442
Q ss_pred EEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC
Q 047739 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF 941 (1099)
Q Consensus 862 ~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~ 941 (1099)
...-+.. . . .++||||++++.|.++... .....++.|++.+|.|||+.|||||||||.|||+++++
T Consensus 177 vp~p~~~-~-~-~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ-S-R-HTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE-E-T-TEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec-c-C-ceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 2211111 1 1 2799999998887654321 12345789999999999999999999999999998776
Q ss_pred ----------cEEEeccccccc
Q 047739 942 ----------EAHLSDFGLDRL 953 (1099)
Q Consensus 942 ----------~~kl~DfGla~~ 953 (1099)
.+.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-16 Score=165.09 Aligned_cols=149 Identities=21% Similarity=0.301 Sum_probs=88.6
Q ss_pred ccccceEEccCCccCcccCc------ccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcc--c
Q 047739 89 LRMLRKLSLRSNSFNGTIPA------TLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLP--R 160 (1099)
Q Consensus 89 l~~L~~L~L~~n~~~~~~p~------~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~--~ 160 (1099)
...++.++|+.|.+.|.+|. .++.+++|++|+|++|++++ +| .++.+++|++|+|++|.++ .+|..+. +
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34444445555555544444 45555555555555555554 44 4555555555555555554 3333222 4
Q ss_pred ccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccC--ccccccCceeEEEccCCcCCccChh----
Q 047739 161 NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLP--SAIANCSSLVHLSAQGNALGGVIPP---- 234 (1099)
Q Consensus 161 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp--~~l~~l~~L~~L~l~~N~l~~~~p~---- 234 (1099)
+|++|+|++|++++ +| .++.+++|++|++++|+++. +| ..+..+++|++|++++|.+.+..|.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~---------~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 162 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN---------WGEIDKLAALDKLEDLLLAGNPLYNDYKENNAT 162 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC---------HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc---------hhHHHHHhcCCCCCEEEecCCccccccccccch
Confidence 55555555555554 34 46777888888888887762 22 2566777888888888888766554
Q ss_pred ------hhcCCCCccEEEcccccCC
Q 047739 235 ------AIGALPKLQVVSLAQNNLS 253 (1099)
Q Consensus 235 ------~~~~l~~L~~L~Ls~N~l~ 253 (1099)
.+..+++|++|| +|.++
T Consensus 163 ~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 163 SEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHHHHHhCCCcEEEC--CcccC
Confidence 377888888886 56554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.1e-16 Score=161.73 Aligned_cols=153 Identities=25% Similarity=0.314 Sum_probs=104.1
Q ss_pred CCccceeeeccccccCCCch------hhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCC
Q 047739 509 LPNLQVIALQENKLSGNVPE------GFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582 (1099)
Q Consensus 509 l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~ 582 (1099)
...++.++++.+.+++..|. .|..+++|++|++++|.+++ +| .+..+++|+.|++++|+++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34445555555555544443 67777777777777777765 44 6677777777777777776 5666666667
Q ss_pred CCceEEecCCcccCcCCcchhccCcccEEeccCccccccCC-cccCCCCCCCEEECcCccccccCChh----------hh
Q 047739 583 DLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIP-DEISKCSSLRSLLVNSNHLSGGIPDS----------LA 651 (1099)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~----------l~ 651 (1099)
+|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++++.+|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 77888888887774 44 57777888888888888774221 36777788888888888877655542 67
Q ss_pred ccCCCCeeecCCCcCCC
Q 047739 652 KLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 652 ~l~~L~~L~ls~N~l~~ 668 (1099)
.+++|+.|| +|.++.
T Consensus 172 ~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HCSSCSEEC--CGGGTT
T ss_pred hCCCcEEEC--CcccCH
Confidence 777888776 666653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.4e-14 Score=144.16 Aligned_cols=132 Identities=21% Similarity=0.193 Sum_probs=99.3
Q ss_pred hhcccccceecccccccCCCCCCccccc-ceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQIPATFSFL-RSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHL 608 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 608 (1099)
+..+.+|+.|++++|.++. ++. +..+ ++|+.|++++|++++. ..++.+++|++|+|++|++++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455667777777777763 343 3333 3777777777777754 567888888999999998885444445888899
Q ss_pred cEEeccCccccccCCc--ccCCCCCCCEEECcCccccccCChh----hhccCCCCeeecCCCcCC
Q 047739 609 NVLDLSINNLTGEIPD--EISKCSSLRSLLVNSNHLSGGIPDS----LAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 609 ~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~ls~N~l~ 667 (1099)
+.|+|++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999886 5666 7888889999999999987 55664 888899999999888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=9.1e-14 Score=140.94 Aligned_cols=132 Identities=17% Similarity=0.216 Sum_probs=67.3
Q ss_pred ccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCC
Q 047739 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLS 441 (1099)
Q Consensus 362 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 441 (1099)
+.++.+|++|+|++|+++ .+|......++|++|++++|.+++. ..|.++++|++|+|++|++++..+..+..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 334455555555555555 2333222222555555555555543 4555566666666666666643334445666666
Q ss_pred EEEccCCcCccccCc--ccCCCCcccEEEccCCcCCCcCCCC----CCCCCCCCEEEeccCcC
Q 047739 442 TLDLSENKFSGEVPA--SIGNLSQLMVFNLSGNAFSGRIPAS----LGNLLKLTTLDLSKQNF 498 (1099)
Q Consensus 442 ~L~Ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~----l~~l~~L~~L~L~~n~l 498 (1099)
+|+|++|.++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.||+++|.+
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 6666666664 2332 4555555555555555554 23332 44455555555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=7.5e-13 Score=133.14 Aligned_cols=107 Identities=18% Similarity=0.240 Sum_probs=91.1
Q ss_pred CceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCcee
Q 047739 140 LEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219 (1099)
Q Consensus 140 L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~ 219 (1099)
.+++++++|.++. +|..++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+ ..+..+++|+
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~--------~~f~~l~~L~ 81 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPA--------GVFDKLTQLT 81 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT--------TTTTTCTTCC
T ss_pred CCEEEeCCCCcCc-cCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccCh--------hhccCCCCCC
Confidence 4677777777764 777778889999999999998889999999999999999999984332 2346788999
Q ss_pred EEEccCCcCCccChhhhcCCCCccEEEcccccCCCc
Q 047739 220 HLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255 (1099)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 255 (1099)
+|+|++|+|+++.+.+|..+++|++|+|++|.++..
T Consensus 82 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 82 QLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred EEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999999999988888899999999999999999854
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=131.76 Aligned_cols=107 Identities=26% Similarity=0.293 Sum_probs=76.8
Q ss_pred eeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcC
Q 047739 560 VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNS 639 (1099)
Q Consensus 560 L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 639 (1099)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345666666666 3555443 6777777777777766677777777788888888887755555567778888888888
Q ss_pred ccccccCChhhhccCCCCeeecCCCcCCCc
Q 047739 640 NHLSGGIPDSLAKLSNLAVLDLSANNLSGE 669 (1099)
Q Consensus 640 N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 669 (1099)
|+|++..+..|.++++|+.|+|++|++++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 888765566677888888888888887754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=131.95 Aligned_cols=104 Identities=22% Similarity=0.335 Sum_probs=90.6
Q ss_pred ceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCcc-ccccCcee
Q 047739 141 EILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSA-IANCSSLV 219 (1099)
Q Consensus 141 ~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~-l~~l~~L~ 219 (1099)
+.+++++|+++ .+|..++++|++|+|++|+|++..|..|+++++|++|+|++|+|++ +|.. ++.+++|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------i~~~~~~~l~~L~ 84 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA---------IPTGVFDKLTQLT 84 (174)
T ss_dssp SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------CCTTTTTTCTTCC
T ss_pred cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc---------cChhHhCCcchhh
Confidence 67788888874 6777888899999999999998889999999999999999999983 4443 46789999
Q ss_pred EEEccCCcCCccChhhhcCCCCccEEEcccccCCC
Q 047739 220 HLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSG 254 (1099)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 254 (1099)
+|+|++|+|+++.+.+|..+++|++|+|++|.+..
T Consensus 85 ~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 85 QLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred EEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99999999998888889999999999999999974
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-12 Score=129.42 Aligned_cols=105 Identities=25% Similarity=0.295 Sum_probs=71.6
Q ss_pred eEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCc
Q 047739 561 VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640 (1099)
Q Consensus 561 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 640 (1099)
+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666665 4555443 56777777777777666667777777777777777777544444567777777777777
Q ss_pred cccccCChhhhccCCCCeeecCCCcCCC
Q 047739 641 HLSGGIPDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 641 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
+|++..+..|..+++|+.|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 7775545557777777777777777764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=6e-11 Score=136.89 Aligned_cols=156 Identities=8% Similarity=0.079 Sum_probs=70.4
Q ss_pred chhccCCC-CccEEeCCCCccccCchhhhCCCCCCCEEEccCCc---cCccCCccccCCCCCCEEEccCCcCCCCCCccc
Q 047739 311 PLWLTRAS-TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNS---FGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFL 386 (1099)
Q Consensus 311 ~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~---l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 386 (1099)
..+|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.+..|. ++..... +|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~------------------------aF 110 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQ------------------------AF 110 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTT------------------------TT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechh------------------------hc
Confidence 33444442 3555555433 443444455555555555554432 3322333 44
Q ss_pred cCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccE
Q 047739 387 GDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMV 466 (1099)
Q Consensus 387 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 466 (1099)
.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+- .......|.++.+|+.+.+..+ ++.+...+|.+ ..|+.
T Consensus 111 ~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~ 186 (394)
T 4gt6_A 111 MFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQ 186 (394)
T ss_dssp TTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSE
T ss_pred hhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeE
Confidence 44444444444332 333344445555555555554322 2233344555555555555443 22233334432 34555
Q ss_pred EEccCCcCCCcCCCCCCCCCCCCEEEeccC
Q 047739 467 FNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496 (1099)
Q Consensus 467 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n 496 (1099)
+.+..+-.. .....|.++..++......+
T Consensus 187 i~ip~~~~~-i~~~af~~c~~l~~~~~~~~ 215 (394)
T 4gt6_A 187 IHIPAKVTR-IGTNAFSECFALSTITSDSE 215 (394)
T ss_dssp EEECTTCCE-ECTTTTTTCTTCCEEEECCS
T ss_pred EEECCcccc-cccchhhhccccceeccccc
Confidence 555443322 33444555555555554443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=8.4e-11 Score=135.66 Aligned_cols=151 Identities=11% Similarity=0.134 Sum_probs=100.6
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCc---cccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCE
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS---ISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSL 370 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~---i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 370 (1099)
..|+.+.+-.+ ++.+-..+|.++.+|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++......|..+.+|+.
T Consensus 64 ~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~ 141 (394)
T 4gt6_A 64 YVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDT 141 (394)
T ss_dssp SCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCE
T ss_pred CcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccc
Confidence 45788888654 776777889999999999998774 66556778999999998887655 44456677888888888
Q ss_pred EEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcC
Q 047739 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF 450 (1099)
Q Consensus 371 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 450 (1099)
+.+..+. .......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. ....+|.++.+++......+..
T Consensus 142 i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~ 217 (394)
T 4gt6_A 142 VTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESY 217 (394)
T ss_dssp EECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSS
T ss_pred cccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccc
Confidence 8886543 3244556667777777777654 44344455544 45666666554332 3445555566666655544433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.5e-13 Score=156.43 Aligned_cols=158 Identities=18% Similarity=0.192 Sum_probs=82.1
Q ss_pred CceeEEEcCCCccccCcchhccC-----CCCccEEeCCCCccccCchhhhC-CCCCCCEEEccCCccCccCCccc-----
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTR-----ASTLTRLDVSGNSISGKIPAQIG-GLWRLEELKMANNSFGGAVPVEI----- 362 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~l----- 362 (1099)
+.|++|+|++|.|+......+.. .++|++|||++|.|+......+. .+.+|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45777777777776533333322 25777777777777643333332 34566777777776664433333
Q ss_pred cCCCCCCEEEccCCcCCCC----CCccccCCCCCCeeeccCcccccc----CCccCCCCCCCCEEEcccCcCccc----c
Q 047739 363 KQCSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAANLFSGS----IPASFRNLPGLENLNLRHNSLSGS----L 430 (1099)
Q Consensus 363 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~ 430 (1099)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2345666666666666531 223334455555555555555421 133344444555555555555432 1
Q ss_pred chhhhCCCCCCEEEccCCcCc
Q 047739 431 PEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 431 ~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
...+...++|++|+|++|.|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHhCCCCCEEeccCCCCC
Confidence 222233445555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.4e-13 Score=154.77 Aligned_cols=187 Identities=20% Similarity=0.197 Sum_probs=88.3
Q ss_pred CceeEEEccCCcCCccChhhhcC-----CCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCC
Q 047739 216 SSLVHLSAQGNALGGVIPPAIGA-----LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG 290 (1099)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~ 290 (1099)
+.|++|+|++|.++......+.. .++|++|+|++|.++..-...++.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~---------------------------- 123 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLP---------------------------- 123 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHH----------------------------
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHH----------------------------
Confidence 45666777777666443333322 256666666666665321111111
Q ss_pred CCCCceeEEEcCCCccccCcchhc-----cCCCCccEEeCCCCccccC----chhhhCCCCCCCEEEccCCccCcc----
Q 047739 291 SCSSVLQVLDLQQNQIRGAFPLWL-----TRASTLTRLDVSGNSISGK----IPAQIGGLWRLEELKMANNSFGGA---- 357 (1099)
Q Consensus 291 ~~~~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~---- 357 (1099)
.+.+|++|+|++|+|+......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.+++.
T Consensus 124 -~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~ 202 (372)
T 3un9_A 124 -VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLEL 202 (372)
T ss_dssp -HHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHH
T ss_pred -HHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHH
Confidence 12235556666665553322222 2345566666666666432 223334555556666655555432
Q ss_pred CCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCC
Q 047739 358 VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGM 437 (1099)
Q Consensus 358 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 437 (1099)
+...+..+++|++|+|++|.|++.... .+...+...++|++|+|++|.|++.....+..+
T Consensus 203 L~~~L~~~~~L~~L~Ls~N~i~~~g~~--------------------~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 203 LAAQLDRNRQLQELNVAYNGAGDTAAL--------------------ALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHGGGCSCCCEEECCSSCCCHHHHH--------------------HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHHHhcCCCcCeEECCCCCCCHHHHH--------------------HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 133344445555555555555421111 122233344566667777776665544444433
Q ss_pred C-----CCCEEE--ccCCcCc
Q 047739 438 N-----NLSTLD--LSENKFS 451 (1099)
Q Consensus 438 ~-----~L~~L~--Ls~N~l~ 451 (1099)
. .|+.+. +..|.++
T Consensus 263 ~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 263 GGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp C------CEEECCCC----CH
T ss_pred hcCCCccchhhHhhhcCCccC
Confidence 1 155555 5555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=139.39 Aligned_cols=107 Identities=20% Similarity=0.182 Sum_probs=86.2
Q ss_pred CcccceEecCCcEeEEecCCCccccccccccccccccceEEccC-CccCcccCcccccCCcccEEEeccccCCCccCccc
Q 047739 56 CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRS-NSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANI 134 (1099)
Q Consensus 56 c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~ 134 (1099)
|.|.+|.|++. ++|.+ ||+ +.+++.|+.|+|++ |.+++..|..|+.|++|++|+|++|+|++.+|..|
T Consensus 8 C~~~~v~~~~~---------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 76 (347)
T 2ifg_A 8 HGSSGLRCTRD---------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76 (347)
T ss_dssp SSSSCEECCSS---------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG
T ss_pred ccCCEEEcCCC---------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHh
Confidence 99999999752 13443 777 99999999999996 99998878899999999999999999999999999
Q ss_pred ccCCCCceeecccccCCCcccCCcc-cccceeeCCCCccC
Q 047739 135 GNLSNLEILNVAANRLSGEIANDLP-RNLKYFDLSSNGFS 173 (1099)
Q Consensus 135 ~~l~~L~~L~ls~N~l~~~i~~~~~-~~L~~L~ls~N~l~ 173 (1099)
+++++|++|+|++|+|++..+..+. ..|+.|+|++|.|.
T Consensus 77 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp GSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCcc
Confidence 9999999999999998854433322 23666666666655
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.15 E-value=4e-11 Score=135.89 Aligned_cols=101 Identities=24% Similarity=0.217 Sum_probs=51.9
Q ss_pred EccCC-cCCCCCCCCCCCCCCCceEEecC-CcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCcc
Q 047739 564 SFSGN-HISGSIPPELGNCSDLEVLELRS-NSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNH 641 (1099)
Q Consensus 564 ~ls~N-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 641 (1099)
+.+++ +++ .+|. +..+++|++|+|++ |+|++..+..|+.|++|+.|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 14 ~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 444 3444 55555555555553 55554444455555555555555555555444555555555555555555
Q ss_pred ccccCChhhhccCCCCeeecCCCcCC
Q 047739 642 LSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 642 l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
|++..+..+..++ |+.|+|++|++.
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCcc
Confidence 5543333343333 555555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.9e-10 Score=123.27 Aligned_cols=142 Identities=10% Similarity=0.028 Sum_probs=109.7
Q ss_pred HHHHhccccccccccccceeEEEEEECCceEEEEEECCCCC-ccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEE
Q 047739 799 VEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGS-LDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 799 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~l 876 (1099)
......|+.....+.|+.+.||++... +..+++|...... .....+.+|+++++.+. +..+.++++++.. ....|+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEE
Confidence 344567888888999999999999865 6788899875421 23356899999999985 6677788888774 445699
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc----------------------------------
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT---------------------------------- 922 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------- 922 (1099)
||||++|.++.+.+. +......++.+++++++.||+
T Consensus 88 v~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999988876532 111234678899999999998
Q ss_pred -------------------------CCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 923 -------------------------SNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 923 -------------------------~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++|+|+++.||+++++..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876667799999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.5e-08 Score=116.22 Aligned_cols=108 Identities=13% Similarity=0.160 Sum_probs=49.2
Q ss_pred hhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCccc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 609 (1099)
|.++..|+.+.+..+ ++......|..+.+|+.+.+..+ +.......|.++++|+.+.+.++.++..-...|.++.+|+
T Consensus 236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~ 313 (379)
T 4h09_A 236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS 313 (379)
T ss_dssp TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence 333444444444332 22233333444444444444322 2222233455555555555555555433344555555566
Q ss_pred EEeccCccccccCCcccCCCCCCCEEECcCc
Q 047739 610 VLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640 (1099)
Q Consensus 610 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 640 (1099)
.++|..+ ++..-...|.+|.+|+.+.+..+
T Consensus 314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 314 SVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred EEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 6555533 33222344555666666655443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.99 E-value=2.5e-08 Score=114.25 Aligned_cols=310 Identities=11% Similarity=0.057 Sum_probs=159.4
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 373 (1099)
.+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ +.......|..+ +|+.+++
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccC
Confidence 3455555542 345455566777777777777644 554555667665 5666666543 333344445443 6777777
Q ss_pred cCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccc
Q 047739 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453 (1099)
Q Consensus 374 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1099)
..+- +......|.+. +|+...+..+ ++.+....|.++.+++.+.+..+.........+.. +.. ..
T Consensus 121 p~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~-----------~~~-~~ 185 (379)
T 4h09_A 121 PGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLY-----------NKN-KT 185 (379)
T ss_dssp CTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEE-----------ETT-SS
T ss_pred CCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceec-----------ccc-cc
Confidence 6542 21223334333 4555555433 33455566666677777666554432111110000 000 01
Q ss_pred cCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc
Q 047739 454 VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533 (1099)
Q Consensus 454 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 533 (1099)
....+.....+..+.+..+... .....+..+.+|+.+.+..+ +.......+.++..|+.+.+..+ ++.+...+|.++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~ 262 (379)
T 4h09_A 186 ILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNC 262 (379)
T ss_dssp EEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTC
T ss_pred eeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcccccee
Confidence 1122333334444443333222 33344555555665555443 33344445555566666666544 333444556666
Q ss_pred cccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
.+|+.+.+..+ +.......|..+.+|+.+.+.++.++......|.+|.+|+.+.|..+ ++..-...|.++.+|+.+.+
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 66666666433 44344455666666666666666666445556777777777777543 44333456677777777777
Q ss_pred cCccccccCCcccCCC
Q 047739 614 SINNLTGEIPDEISKC 629 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l 629 (1099)
..+ ++..-...|.++
T Consensus 341 p~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 341 PKS-ITLIESGAFEGS 355 (379)
T ss_dssp CTT-CCEECTTTTTTS
T ss_pred CCc-cCEEchhHhhCC
Confidence 554 442233445444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-11 Score=132.15 Aligned_cols=160 Identities=19% Similarity=0.186 Sum_probs=96.4
Q ss_pred CCcccceEecC--CcEeEEecCC---Cccccccccc-cccccccceEEccCCccCcccCc-ccccCCcccE--EEecccc
Q 047739 55 PCDWRGVACTN--NRVTELRLPR---LQLSGRISDH-LSNLRMLRKLSLRSNSFNGTIPA-TLAQCTLLRA--VFLQYNS 125 (1099)
Q Consensus 55 ~c~w~gv~c~~--~~v~~l~l~~---~~l~g~~~~~-l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~l~~n~ 125 (1099)
.|.|.|+.|+. .||+.+..++ ..+.|.+.++ +..++. .|..+.|..++.++- .+...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 48999999985 4888877766 5667777643 455554 455555655555442 2555555555 5666663
Q ss_pred CC---CccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCcccccccccccccccccccccc
Q 047739 126 LS---GNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPA 202 (1099)
Q Consensus 126 l~---g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 202 (1099)
.. +.++..-.++++|++|+||+|.|++.. .+|..++.+++|+.|+|++|+|++.
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~--------------------~l~~~~~~l~~L~~L~Ls~N~i~~~--- 211 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLD--------------------DMSSIVQKAPNLKILNLSGNELKSE--- 211 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCG--------------------GGTTHHHHSTTCCEEECTTSCCCSG---
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCc--------------------cchhHHhhCCCCCEEECCCCccCCc---
Confidence 22 222222234455555555555444310 3455666777788888888877732
Q ss_pred ccccccCccccccC--ceeEEEccCCcCCccCh-------hhhcCCCCccEEE
Q 047739 203 TFEGTLPSAIANCS--SLVHLSAQGNALGGVIP-------PAIGALPKLQVVS 246 (1099)
Q Consensus 203 ~~~g~lp~~l~~l~--~L~~L~l~~N~l~~~~p-------~~~~~l~~L~~L~ 246 (1099)
..+..++ +|++|+|++|.+.+.+| ..+..+|+|+.||
T Consensus 212 -------~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 -------RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp -------GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred -------hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 1233333 78888888888876554 3467788888876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=1.4e-09 Score=117.54 Aligned_cols=133 Identities=19% Similarity=0.150 Sum_probs=97.2
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc--eEEeeEEecCCCceEEEEeec
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL--TVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~lV~e~~ 881 (1099)
++....+.+.|..+.||++...+|..+++|..... ....+.+|+++++.+++.++ .+++++.... +..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEec
Confidence 34444444566679999998877888999987543 33568899999999975554 4477776644 4469999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC-------------------------------------
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN------------------------------------- 924 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 924 (1099)
+|.++. ... .+ ...++.++++.++.||+..
T Consensus 98 ~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 998773 211 11 2246677777788887643
Q ss_pred ---------------------ceecCCCCCCEEECCCCcEEEecccccc
Q 047739 925 ---------------------MVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 925 ---------------------iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
++|+|++|.||+++++..+.|.|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999887667799999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.87 E-value=5.7e-10 Score=125.73 Aligned_cols=163 Identities=12% Similarity=0.101 Sum_probs=79.9
Q ss_pred CCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhc--CCCCccEEEccc--ccCCC
Q 047739 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIG--ALPKLQVVSLAQ--NNLSG 254 (1099)
Q Consensus 179 ~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~ 254 (1099)
.+..+++|+.|+|++|.-. .+|. + .+++|++|++..+.++......+. .+|+|++|+|+. |...+
T Consensus 167 ll~~~P~L~~L~L~g~~~l---------~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~ 235 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL---------SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGF 235 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC---------BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTC
T ss_pred HHhcCCCCcEEEEeCCCCc---------eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEecccccccc
Confidence 3444566666666655200 1222 2 256677777776666543333443 678888888753 22211
Q ss_pred ccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhcc---CCCCccEEeCCCCccc
Q 047739 255 VVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLT---RASTLTRLDVSGNSIS 331 (1099)
Q Consensus 255 ~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~N~i~ 331 (1099)
... +..+........+++|++|+|++|.+.+..+..+. .+++|++|||+.|.|+
T Consensus 236 ~~~-----------------------~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 236 DGD-----------------------MNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp CSC-----------------------GGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred chh-----------------------HHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 100 00000001112245667777776666543222222 3556777777777766
Q ss_pred cCchh----hhCCCCCCCEEEccCCccCccCCccccC-CCCCCEEEccCCc
Q 047739 332 GKIPA----QIGGLWRLEELKMANNSFGGAVPVEIKQ-CSSLSLLDLEGNR 377 (1099)
Q Consensus 332 ~~~p~----~~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~Ls~N~ 377 (1099)
+..+. .+..+++|+.|+|++|.++......+.. + ...++++.++
T Consensus 293 d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred hHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 43222 2234566666666666665433333332 1 2445666555
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.3e-10 Score=124.87 Aligned_cols=181 Identities=13% Similarity=0.156 Sum_probs=120.1
Q ss_pred CcEeEEecCCCcccc-c-------cccccccccccceEEccCCccC---------cccCcccccCCcccEEEeccccCCC
Q 047739 66 NRVTELRLPRLQLSG-R-------ISDHLSNLRMLRKLSLRSNSFN---------GTIPATLAQCTLLRAVFLQYNSLSG 128 (1099)
Q Consensus 66 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~L~~n~~~---------~~~p~~~~~l~~L~~L~l~~n~l~g 128 (1099)
.+|++|.+...+..| . +..++.++++|+.|.+..+.+. +.++..+..+++|+.|+|++|.- -
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~-l 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN-L 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT-C
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC-c
Confidence 579999999877764 2 2455778999999999776432 23555667889999999988731 1
Q ss_pred ccCcccccCCCCceeecccccCCCcccCCc----ccccceeeCCC--CccCCC-----CCCCC--ccccccccccccccc
Q 047739 129 NLPANIGNLSNLEILNVAANRLSGEIANDL----PRNLKYFDLSS--NGFSGP-----IPTSI--SNLSQLQLINFSFNK 195 (1099)
Q Consensus 129 ~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~----~~~L~~L~ls~--N~l~~~-----~p~~~--~~l~~L~~L~ls~N~ 195 (1099)
.+|. +. +++|++|+|+.+.++......+ .++|++|+|+. |...|. +...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 3444 43 8899999999888875433222 26888888853 322211 11122 347889999998888
Q ss_pred cccccccccccccCccccccCceeEEEccCCcCCccC----hhhhcCCCCccEEEcccccCCC
Q 047739 196 FSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVI----PPAIGALPKLQVVSLAQNNLSG 254 (1099)
Q Consensus 196 l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~ 254 (1099)
++...+..+. ....+++|++|+|+.|.++..- +..+..+++|+.|+|++|.++.
T Consensus 264 i~~~~~~~la-----~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 264 EQNVVVEMFL-----ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp THHHHHHHHH-----HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CchHHHHHHH-----hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 8643221111 0124678888899888887643 3334567888888888888763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=1e-08 Score=116.62 Aligned_cols=139 Identities=15% Similarity=0.207 Sum_probs=102.8
Q ss_pred cccccccccceeEEEEEECCceEEEEEECC--CCC--ccHHHHHHHHHHhhhcc--CCcceEEeeEEecCC--CceEEEE
Q 047739 807 EENVLSRTRYGLVFKACYNDGMVLSIRRLP--DGS--LDENLFRKEAEFLGKVR--HRNLTVLRGYYAGAP--DLRLLVY 878 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~--~~~~lV~ 878 (1099)
..+.++.|.++.||+....+ ..+++|+.. ... .....+.+|+++++.++ +..+.++++++.+.. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998765 467777765 332 23457889999999997 455778888876442 2358999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc------------------------------------
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT------------------------------------ 922 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~------------------------------------ 922 (1099)
||++|..+.+... ..++...+..++.++++.|+.||+
T Consensus 121 e~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999876643211 226778888899999999999996
Q ss_pred ----------------------CCceecCCCCCCEEECCCCc--EEEeccccccc
Q 047739 923 ----------------------SNMVHGDIKPQNVLFDADFE--AHLSDFGLDRL 953 (1099)
Q Consensus 923 ----------------------~~iiH~Dlk~~NIll~~~~~--~kl~DfGla~~ 953 (1099)
..++|+|+++.||+++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=6.4e-09 Score=115.24 Aligned_cols=186 Identities=15% Similarity=0.136 Sum_probs=114.3
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCc--ceEEeeEEecCC--CceEEEEeecC
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRN--LTVLRGYYAGAP--DLRLLVYDYMP 882 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~--~~~~lV~e~~~ 882 (1099)
.+.++.|....||+.. ..+++|.-.. ......+.+|+++++.+. +.. +.+++.+..... ...|+|||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568899999999864 3467776542 233567899999999884 333 233444432222 12378999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc----------------------------------------
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT---------------------------------------- 922 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------- 922 (1099)
|.++.+.... .++..++..++.++++.++.||+
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9877653321 15566667777777777777774
Q ss_pred ------------------CCceecCCCCCCEEECC--CCcEEEeccccccccCCCCCCCcccc-----------ccccCc
Q 047739 923 ------------------SNMVHGDIKPQNVLFDA--DFEAHLSDFGLDRLTIPTPAEASTST-----------TAVGTL 971 (1099)
Q Consensus 923 ------------------~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~-----------~~~gt~ 971 (1099)
..++|+|+++.||++++ ...+.|.||+.+....+...-..... .....+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 14799999999999998 45688999998865321100000000 000111
Q ss_pred cccC-ccccccCCCCCcCchhhHHHHHHHHHhCCCCC
Q 047739 972 GYVS-PEAALTGETTKESDVYSFGIVLLELLTGKRPV 1007 (1099)
Q Consensus 972 ~y~a-PE~~~~~~~~~~~DV~S~G~il~elltg~~P~ 1007 (1099)
++.. |+.... .....+.|+++.++|++.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1112 221111 112257899999999999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=6.2e-08 Score=98.38 Aligned_cols=122 Identities=11% Similarity=0.124 Sum_probs=67.0
Q ss_pred cchhccCCCCccEEeCCCC-ccccC----chhhhCCCCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCCcCCC
Q 047739 310 FPLWLTRASTLTRLDVSGN-SISGK----IPAQIGGLWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFSG 380 (1099)
Q Consensus 310 ~~~~~~~l~~L~~L~Ls~N-~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~ 380 (1099)
+...+...++|++|+|++| .|... +...+...++|++|+|++|.++.. +...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3344556677777777777 66532 334445556666666666666542 22334444566666666666653
Q ss_pred CCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEc--ccCcCccc----cchhhhCCCCCCEEEccCCcCc
Q 047739 381 EIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNL--RHNSLSGS----LPEEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 381 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
.... .+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 108 ~g~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGIL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2111 12233344455666666 55666543 2233444566777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.35 E-value=9.8e-08 Score=96.93 Aligned_cols=123 Identities=16% Similarity=0.199 Sum_probs=85.3
Q ss_pred CchhhhCCCCCCCEEEccCC-ccCcc----CCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCC
Q 047739 333 KIPAQIGGLWRLEELKMANN-SFGGA----VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIP 407 (1099)
Q Consensus 333 ~~p~~~~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~ 407 (1099)
.+...+...+.|++|+|++| .++.. +...+...++|++|+|++|+|....... +.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~--------------------l~ 86 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA--------------------LA 86 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH--------------------HH
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH--------------------HH
Confidence 34456667778888888887 77643 3344555667777777777765322111 22
Q ss_pred ccCCCCCCCCEEEcccCcCccc----cchhhhCCCCCCEEEc--cCCcCccc----cCcccCCCCcccEEEccCCcCC
Q 047739 408 ASFRNLPGLENLNLRHNSLSGS----LPEEVLGMNNLSTLDL--SENKFSGE----VPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 408 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
..+...++|++|+|++|.|... +...+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334457788899999988754 3556677889999999 88999754 3345566789999999999986
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=2.4e-08 Score=106.43 Aligned_cols=65 Identities=28% Similarity=0.403 Sum_probs=30.9
Q ss_pred CCCCceEEecCCcccC--cCCcchhccCcccEEeccCccccccCCcccCCCC--CCCEEECcCccccccCC
Q 047739 581 CSDLEVLELRSNSLTG--HIPTDISHLSHLNVLDLSINNLTGEIPDEISKCS--SLRSLLVNSNHLSGGIP 647 (1099)
Q Consensus 581 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p 647 (1099)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 4455555555555554 2334444555555555555555532 2222222 45555555555554333
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.4e-06 Score=91.48 Aligned_cols=134 Identities=18% Similarity=0.144 Sum_probs=85.7
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCC---cceEEeeEEecCCCceEEEEeecCCC
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHR---NLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
.+.++.|....||+. |..+++|.-. .......+.+|+++++.+.+. .+.+.+.+.....+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 345788888899988 4456667632 222346789999999999753 24455566543445568999999987
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH------------------------------------------- 921 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH------------------------------------------- 921 (1099)
.+.+..-. .++...+..++.++++.|+.||
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 77652110 0122223333333333333333
Q ss_pred -----------------cCCceecCCCCCCEEECC---CCc-EEEeccccccc
Q 047739 922 -----------------TSNMVHGDIKPQNVLFDA---DFE-AHLSDFGLDRL 953 (1099)
Q Consensus 922 -----------------~~~iiH~Dlk~~NIll~~---~~~-~kl~DfGla~~ 953 (1099)
...++|+|+++.||+++. ++. +.|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 225699999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5.1e-05 Score=82.02 Aligned_cols=131 Identities=18% Similarity=0.131 Sum_probs=88.2
Q ss_pred ccccccce-eEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCceEEEEeecCCCCH
Q 047739 810 VLSRTRYG-LVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 810 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
.+..|..| .||+.... ++..+++|+-... ....+.+|++.++.+. +--+-++++++.+. +..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccc
Confidence 34445544 69998765 4567888875432 3456889999999885 22355667777644 456999999998877
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-------------------------------------------
Q 047739 887 GTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS------------------------------------------- 923 (1099)
Q Consensus 887 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------- 923 (1099)
.+..... ......++.++++.++.||+.
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 6654321 112233444555555555521
Q ss_pred ---------------CceecCCCCCCEEECCCCcEEEecccccc
Q 047739 924 ---------------NMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 924 ---------------~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
.++|+|+++.||+++.++.+-|.||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 26899999999999988777899999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=2e-05 Score=89.13 Aligned_cols=80 Identities=13% Similarity=0.019 Sum_probs=55.2
Q ss_pred cccc-ccccceeEEEEEEC-------CceEEEEEECCCCC---c-cHHHHHHHHHHhhhcc-C--CcceEEeeEEecCC-
Q 047739 808 ENVL-SRTRYGLVFKACYN-------DGMVLSIRRLPDGS---L-DENLFRKEAEFLGKVR-H--RNLTVLRGYYAGAP- 871 (1099)
Q Consensus 808 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~- 871 (1099)
.+.| +.|....+|+.... ++..+++|.-.... . ....+.+|+++++.+. + -.+.++++++.+..
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26678888765432 1 2356889999999885 2 24566777765432
Q ss_pred -CceEEEEeecCCCCHH
Q 047739 872 -DLRLLVYDYMPNGNLG 887 (1099)
Q Consensus 872 -~~~~lV~e~~~~gsL~ 887 (1099)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 2348999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00018 Score=80.63 Aligned_cols=140 Identities=18% Similarity=0.234 Sum_probs=79.6
Q ss_pred cccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhcc-----CCcceEEe-e-EEecCCCceEEEEeec
Q 047739 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-----HRNLTVLR-G-YYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~-~~~~~~~~~~lV~e~~ 881 (1099)
+.++.|..+.||+....+|. +++|+... ....+..|+++++.+. .|.++... | ++....+..++||||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 44666788999999887665 77888764 2344556677776663 23333310 1 1111234458999999
Q ss_pred CCCCHH--------------HHHhhhccC---C-C-----CCCCHHHHH-------------------------------
Q 047739 882 PNGNLG--------------TLLQEASHQ---D-G-----HVLNWPMRH------------------------------- 907 (1099)
Q Consensus 882 ~~gsL~--------------~~l~~~~~~---~-~-----~~l~~~~~~------------------------------- 907 (1099)
+|..+. ..++..... . . ....|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 112221110 0 0 112232210
Q ss_pred HHHHHHHHHHHHHc-------------cCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 908 LIALGVARGLAFLH-------------TSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 908 ~i~~~ia~~L~~LH-------------~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
.+...+..++++++ ...++|+|+++.||+++.++.+.|.||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122334566665 3579999999999999888899999999765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.61 E-value=2e-05 Score=77.76 Aligned_cols=34 Identities=18% Similarity=0.169 Sum_probs=16.2
Q ss_pred CCCEEEeccCcCcccCCcccCCCCccceeeeccc
Q 047739 487 KLTTLDLSKQNFSGELPIELAGLPNLQVIALQEN 520 (1099)
Q Consensus 487 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 520 (1099)
.|+.||++++.++..--..+..+++|+.|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3455555554444433334444555555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=2.4e-05 Score=77.11 Aligned_cols=83 Identities=12% Similarity=0.101 Sum_probs=42.2
Q ss_pred cccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCc-CcccCCcccCCC----Cccceeeecccc-ccCCCchhhhccccc
Q 047739 463 QLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN-FSGELPIELAGL----PNLQVIALQENK-LSGNVPEGFSSLMSL 536 (1099)
Q Consensus 463 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 536 (1099)
+|+.||++++.+++.....+.++++|++|+|++|. +++.--..++.+ ++|+.|+|++|. +++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555554444445556666666666653 443333333332 245555555553 444333444555555
Q ss_pred ceecccccc
Q 047739 537 RYLNLSFNG 545 (1099)
Q Consensus 537 ~~L~Ls~N~ 545 (1099)
++|++++|.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 555555553
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00023 Score=81.56 Aligned_cols=74 Identities=14% Similarity=0.063 Sum_probs=48.4
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEECCCCC--------ccHHHHHHHHHHhhhccC--Ccce-EEeeEEecCCCceE
Q 047739 808 ENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS--------LDENLFRKEAEFLGKVRH--RNLT-VLRGYYAGAPDLRL 875 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~H--~niv-~l~~~~~~~~~~~~ 875 (1099)
.+.+|.|..+.||++... ++..+++|...... ...+++..|+++++.+.. +..+ +++.+ . .+ ..+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d-~~-~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-TE-MAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-TT-TTE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c-CC-ccE
Confidence 457899999999999754 46788888754221 123567889999998843 4444 45443 2 22 348
Q ss_pred EEEeecCCC
Q 047739 876 LVYDYMPNG 884 (1099)
Q Consensus 876 lV~e~~~~g 884 (1099)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.29 E-value=8.9e-05 Score=74.55 Aligned_cols=64 Identities=13% Similarity=0.186 Sum_probs=29.5
Q ss_pred CCCCCCEEEccCCcCCCC----CCccccCCCCCCeeeccCc---cccc----cCCccCCCCCCCCEEEcccCcCc
Q 047739 364 QCSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAAN---LFSG----SIPASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 364 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n---~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 427 (1099)
.-+.|++|+|++|.|... +-+.+..-+.|++|+|++| .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 96 ~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 96 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred cCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 334455555555544421 1223333344555555433 2221 12334444566777777766543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00012 Score=73.65 Aligned_cols=112 Identities=12% Similarity=0.135 Sum_probs=59.6
Q ss_pred CCCCCCCEEEccCC-ccCcc----CCccccCCCCCCEEEccCCcCCCC----CCccccCCCCCCeeeccCccccc----c
Q 047739 339 GGLWRLEELKMANN-SFGGA----VPVEIKQCSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAANLFSG----S 405 (1099)
Q Consensus 339 ~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~----~ 405 (1099)
.+-+.|++|+|++| +|... +.+.+..-+.|+.|+|++|+|... +.+.+..-+.|++|+|+.|.|.. .
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 33444555555543 44321 333455556677777777777532 23344455667777777777753 2
Q ss_pred CCccCCCCCCCCEEEcccC---cCccc----cchhhhCCCCCCEEEccCCcC
Q 047739 406 IPASFRNLPGLENLNLRHN---SLSGS----LPEEVLGMNNLSTLDLSENKF 450 (1099)
Q Consensus 406 ~~~~~~~l~~L~~L~L~~N---~l~~~----~~~~~~~l~~L~~L~Ls~N~l 450 (1099)
+..++..-+.|++|+|++| .+... +.+.+..-+.|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 3334555556777777654 22321 223344455666666665543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0039 Score=69.06 Aligned_cols=158 Identities=11% Similarity=0.126 Sum_probs=91.0
Q ss_pred cCCHHHHHHHHhcccc-----ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCc--ceEEe
Q 047739 792 KITLAETVEATRQFDE-----ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN--LTVLR 864 (1099)
Q Consensus 792 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 864 (1099)
..+..++....+.|.. ...++ |....||+....+|..+++|.........+.+..|+++++.+.... +.+++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 3455555555555543 23466 7788999988777777888988644445677888999988885322 33343
Q ss_pred eEEec-----CCCceEEEEeecCCCCHH-----------HH---HhhhccC----CCCCCCHHHH---------------
Q 047739 865 GYYAG-----APDLRLLVYDYMPNGNLG-----------TL---LQEASHQ----DGHVLNWPMR--------------- 906 (1099)
Q Consensus 865 ~~~~~-----~~~~~~lV~e~~~~gsL~-----------~~---l~~~~~~----~~~~l~~~~~--------------- 906 (1099)
.. .+ ..+..++||||++|..+. .. ++..... .....++...
T Consensus 89 ~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 89 AF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred ec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 32 11 123457899999874432 11 1211110 0111222111
Q ss_pred -------HHHHHHHHHHHHHH----ccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 907 -------HLIALGVARGLAFL----HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 907 -------~~i~~~ia~~L~~L----H~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
...+.+++..++-. ....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11112222222222 234689999999999999 4 899999987753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0023 Score=69.49 Aligned_cols=78 Identities=19% Similarity=0.264 Sum_probs=56.8
Q ss_pred ccccccccccccceeEEEEEECCceEEEEEECCCCCc-cHHHHHHHHHHhhhccCC---cceEEeeEEecCCCceEEEEe
Q 047739 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHR---NLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~~lV~e 879 (1099)
.+...+.+|.|..+.||+.+..||+.|.+|+-..... ....|.+|++.|+.+.-. -+.+++++. . .++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~--~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D--RTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T--TEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---C--ceEEEE
Confidence 4555678999999999999999999999998764432 245689999999988422 233444432 1 279999
Q ss_pred ecCCCCH
Q 047739 880 YMPNGNL 886 (1099)
Q Consensus 880 ~~~~gsL 886 (1099)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00059 Score=64.10 Aligned_cols=57 Identities=14% Similarity=0.308 Sum_probs=47.5
Q ss_pred ceeecccccCC-CcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccc
Q 047739 141 EILNVAANRLS-GEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFS 197 (1099)
Q Consensus 141 ~~L~ls~N~l~-~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 197 (1099)
..++-++++|+ ..+|..++.+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36778888886 5788888999999999999999666677888888888888888775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.003 Score=69.80 Aligned_cols=159 Identities=15% Similarity=0.128 Sum_probs=88.1
Q ss_pred cCCHHHHHHHHhcccc-----ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc--eEEe
Q 047739 792 KITLAETVEATRQFDE-----ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL--TVLR 864 (1099)
Q Consensus 792 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 864 (1099)
.++.+++.....+|.. .+.|+.|....+|+....+| .+++|..... ...+.+..|+++++.+....+ .+++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4566677777677765 23466788889999988766 4667776542 233456778888887753222 2222
Q ss_pred eEEe-----cCCCceEEEEeecCCCCHHH--------------HHhhhccC-CC------CCCCHHHHHH----------
Q 047739 865 GYYA-----GAPDLRLLVYDYMPNGNLGT--------------LLQEASHQ-DG------HVLNWPMRHL---------- 908 (1099)
Q Consensus 865 ~~~~-----~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~~-~~------~~l~~~~~~~---------- 908 (1099)
.... ...+..++||+|++|..+.. .++..... .. ....|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 2110 01234589999998754321 12221100 00 0012222110
Q ss_pred --HHHHHHHHHHHHcc-------CCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 909 --IALGVARGLAFLHT-------SNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 909 --i~~~ia~~L~~LH~-------~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
+...+.+.++++++ .+++|+|+++.||+++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01123344555542 369999999999999987666899998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0032 Score=72.47 Aligned_cols=78 Identities=13% Similarity=0.109 Sum_probs=47.0
Q ss_pred ccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCccccccc--cCccccCccccccCC---CCCcCchhhHHH
Q 047739 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV--GTLGYVSPEAALTGE---TTKESDVYSFGI 995 (1099)
Q Consensus 921 H~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DV~S~G~ 995 (1099)
+...++|+|+++.||+++.++ ++|.||+.+....+. .+ ..... -...|++|+...... .....++.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 567899999999999998876 999999988753110 00 00001 113466666543111 111234557777
Q ss_pred HHHHHHhC
Q 047739 996 VLLELLTG 1003 (1099)
Q Consensus 996 il~elltg 1003 (1099)
.+|+...+
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77777654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0019 Score=70.71 Aligned_cols=71 Identities=15% Similarity=0.052 Sum_probs=42.4
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcce-EEeeEEecCCCceEEEEeec-CCCC
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT-VLRGYYAGAPDLRLLVYDYM-PNGN 885 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~~lV~e~~-~~gs 885 (1099)
.+.|+.|....+|+. ..+++|.............+|+++++.+....+. +++++.. +.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~---~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP---ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT---TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC---CCCEEEEeecCCCcc
Confidence 567888999999998 3466776643321112245788888877533333 4444432 2237899999 5544
Q ss_pred H
Q 047739 886 L 886 (1099)
Q Consensus 886 L 886 (1099)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0044 Score=69.72 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=79.9
Q ss_pred cccccccceeEEEEEEC--------CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYN--------DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV~e 879 (1099)
+.+..|-...+|+.... ++..+++|+............+|.++++.+.-..+ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----ccEEE
Confidence 45777888899999874 24678888863322345667799999998853223 445555542 38999
Q ss_pred ecCCCCHHH--------------HH---hhhccCCCCCCC--HHHHHHHHHHHH-------------------HHHHHHc
Q 047739 880 YMPNGNLGT--------------LL---QEASHQDGHVLN--WPMRHLIALGVA-------------------RGLAFLH 921 (1099)
Q Consensus 880 ~~~~gsL~~--------------~l---~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~~LH 921 (1099)
|++|..+.. .+ +.....-+.... |....++..++. ..+.++.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999754431 11 111111111122 333333333321 1222322
Q ss_pred ----c----CCceecCCCCCCEEECCC----CcEEEeccccccc
Q 047739 922 ----T----SNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRL 953 (1099)
Q Consensus 922 ----~----~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~ 953 (1099)
. ..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 258999999999999876 7899999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0061 Score=67.70 Aligned_cols=141 Identities=12% Similarity=0.054 Sum_probs=72.9
Q ss_pred ccccccccee-EEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCc--ceEEeeEEecCCCceEEEEeecCCCC
Q 047739 809 NVLSRTRYGL-VFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN--LTVLRGYYAGAPDLRLLVYDYMPNGN 885 (1099)
Q Consensus 809 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~lV~e~~~~gs 885 (1099)
+.++.|.... +|+....+|..+++|...... .+.+..|+++++.+.... +.+++.+.. ... ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g-~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARG-LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTT-EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC--CCC-EEEEeeCCCcc
Confidence 3455454443 667765445666677654322 134567788877774222 344555533 223 78999997766
Q ss_pred HHHHHhhhc-----------------cC---C-CCCCCHHHHH--------------------HHHHHHHHHHHHH----
Q 047739 886 LGTLLQEAS-----------------HQ---D-GHVLNWPMRH--------------------LIALGVARGLAFL---- 920 (1099)
Q Consensus 886 L~~~l~~~~-----------------~~---~-~~~l~~~~~~--------------------~i~~~ia~~L~~L---- 920 (1099)
+.+++.... +. . -...+..... .....+...++.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443210 00 0 0111111000 0001112222222
Q ss_pred --ccCCceecCCCCCCEEECCC----CcEEEecccccccc
Q 047739 921 --HTSNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRLT 954 (1099)
Q Consensus 921 --H~~~iiH~Dlk~~NIll~~~----~~~kl~DfGla~~~ 954 (1099)
+...++|+|+++.||+++.+ +.+.|.||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23479999999999999874 67999999988643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.011 Score=64.59 Aligned_cols=137 Identities=13% Similarity=0.154 Sum_probs=87.2
Q ss_pred ccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhcc---CCcceEEeeEEecCCCceEEEEeecCCC
Q 047739 808 ENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR---HRNLTVLRGYYAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~lV~e~~~~g 884 (1099)
.+.|+.|....+|+.... +..+++|.-... ....+.+|++.++.+. ...+.+++++.... +..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEeccCC
Confidence 456899999999999864 556777876432 3567899999999884 25577777777643 4569999999987
Q ss_pred CHH--------H---HHhhhccCC-----------------CCCCCHHHHH---HHHH----------------HHHHH-
Q 047739 885 NLG--------T---LLQEASHQD-----------------GHVLNWPMRH---LIAL----------------GVARG- 916 (1099)
Q Consensus 885 sL~--------~---~l~~~~~~~-----------------~~~l~~~~~~---~i~~----------------~ia~~- 916 (1099)
.+. + .++...... ...-+|.... ++.. .+.+.
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 223221100 0012454321 1111 11111
Q ss_pred HHHHc----cCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 917 LAFLH----TSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 917 L~~LH----~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
...|. ...++|+|+.+.|++++.++ +.|.||+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22342 23699999999999999887 8899974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0054 Score=57.47 Aligned_cols=57 Identities=25% Similarity=0.353 Sum_probs=39.1
Q ss_pred cEEeccCcccc-ccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCC
Q 047739 609 NVLDLSINNLT-GEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 609 ~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 667 (1099)
..++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 24665433 46778888888887555566777778888888877775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0078 Score=67.93 Aligned_cols=73 Identities=7% Similarity=-0.013 Sum_probs=44.3
Q ss_pred ccccccccceeEEEEEECCc---------eEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEE
Q 047739 808 ENVLSRTRYGLVFKACYNDG---------MVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~g---------~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV 877 (1099)
.+.++.|....+|+....++ ..+++|..............|.++++.+...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N---GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C---CcEE
Confidence 45677888889999987642 678888865432211234678888888853343 3555443 1 2789
Q ss_pred EeecCCCC
Q 047739 878 YDYMPNGN 885 (1099)
Q Consensus 878 ~e~~~~gs 885 (1099)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.07 E-value=0.013 Score=67.30 Aligned_cols=72 Identities=14% Similarity=0.189 Sum_probs=48.7
Q ss_pred ccccccccceeEEEEEECC--------ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEEE
Q 047739 808 ENVLSRTRYGLVFKACYND--------GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV~ 878 (1099)
.+.|+.|-...||+....+ +..+++|+.... ...+.+.+|..+++.+...++ .++++.+. + .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~---~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS---G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--CEEE
Confidence 3567888889999998753 467888887432 122456689999998854344 45566543 1 4899
Q ss_pred eecCCCC
Q 047739 879 DYMPNGN 885 (1099)
Q Consensus 879 e~~~~gs 885 (1099)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.043 Score=63.39 Aligned_cols=73 Identities=10% Similarity=0.077 Sum_probs=46.9
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEEEeecCCCCH
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
+.|+.|-...+|+....+ +..+++|+........-...+|..+++.+...++ .++++++. . ..||||++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT---N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET---T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C--eEEEEeeCCccC
Confidence 567888899999998875 4778888764322111112689999999875555 34666552 2 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.31 E-value=0.11 Score=57.57 Aligned_cols=31 Identities=26% Similarity=0.313 Sum_probs=27.4
Q ss_pred CCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 923 ~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
..++|+|+.+.||+++.++.+.+.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.88 E-value=0.27 Score=55.89 Aligned_cols=73 Identities=7% Similarity=-0.007 Sum_probs=47.4
Q ss_pred cccccccceeEEEEEECC--------ceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYND--------GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV~e 879 (1099)
+.+..|-...+|+....+ +..+++|+........-...+|.++++.+.-.++ .++++.+. -+.|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP-----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-----CCEEEE
Confidence 457778888999998763 5778888864432221234678999988853333 34444332 178999
Q ss_pred ecCCCCH
Q 047739 880 YMPNGNL 886 (1099)
Q Consensus 880 ~~~~gsL 886 (1099)
|++|..+
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.60 E-value=0.62 Score=46.92 Aligned_cols=101 Identities=14% Similarity=0.087 Sum_probs=66.5
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCcc
Q 047739 885 NLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963 (1099)
Q Consensus 885 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 963 (1099)
+|.+.|+.. +.++++.+.|.++.|.+.+|.-.-. ..-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 789999864 3569999999999999999877621 1111333456889999999988763 1110
Q ss_pred ccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCC
Q 047739 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP 1006 (1099)
Q Consensus 964 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P 1006 (1099)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456787653 3456778899999999999886555
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.96 E-value=1.3 Score=50.06 Aligned_cols=30 Identities=23% Similarity=0.366 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEE------CCCCcEEEeccccccc
Q 047739 924 NMVHGDIKPQNVLF------DADFEAHLSDFGLDRL 953 (1099)
Q Consensus 924 ~iiH~Dlk~~NIll------~~~~~~kl~DfGla~~ 953 (1099)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1099 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-19 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-13 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-08 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 7e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-58
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 23/279 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDE-NLFRKEAEFLGKVRHRNLTV 862
Q + +G V+K ++ + + + + + + F+ E L K RH N+ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
GY +V + +L L H IA A+G+ +LH
Sbjct: 69 FMGYSTA--PQLAIVTQWCEGSSLYHHL----HIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+++H D+K N+ D + DFGL + + + G++ +++PE
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 983 ET---TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ + +SDVY+FGIVL EL+TG+ P + + + + +G L P L ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIFMVGRG----YLSPDLSKV 234
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ ++ C +RP I+ +E
Sbjct: 235 RSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 23/275 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
L ++G V+ YN ++++ L GS+ + F EA + +++H+ L L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS 923
P ++ +YM NG+L L+ G L +A +A G+AF+
Sbjct: 74 YAVVTQEP--IYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
N +H D++ N+L ++DFGL RL E + A + + +PEA G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
T +SDV+SFGI+L E++T R ++ + LE G + P++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------------EVIQNLERGYRMVRPDN 234
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E ++ LC P DRPT + +LE
Sbjct: 235 CPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-54
Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 31/295 (10%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
E L + +G V+ +N ++I+ L G++ F +EA+ + K+RH L L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS 923
+ P +V +YM G+L L + G L P +A +A G+A++
Sbjct: 78 YAVVSEEP--IYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
N VH D++ N+L + ++DFGL RL E + A + + +PEAAL G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 984 TTKESDVYSFGIVLLELLTGKRPV-MFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPE 1042
T +SDV+SFGI+L EL T R + +++ V++ + + PE
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------MPCPPE 238
Query: 1043 SSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQPS 1097
E + C +P +RPT + LE D +S +P QP
Sbjct: 239 CPES-----LHDLMCQCWRKEPEERPTFEYLQAFLE------DYFTSTEPQYQPG 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-52
Identities = 56/279 (20%), Positives = 107/279 (38%), Gaps = 31/279 (11%)
Query: 807 EENVLSRTRYGLVFKACYND---GMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNL 860
E+ L +G V K Y ++++ L + + D L EA + ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY- 69
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
++R + +LV + G L LQ+ H + + V+ G+ +L
Sbjct: 70 -IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYL 123
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
SN VH D+ +NVL A +SDFGL + T + + +PE
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 981 TGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ + +SDV+SFG+++ E + G++P + ++ ++K + +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------MGC 231
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E + LC D +RP + + L
Sbjct: 232 PAGCP--REM---YDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-52
Identities = 52/277 (18%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
+ L ++G+V + ++I+ + +GS+ E+ F +EA+ + + H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L G ++ +YM NG L L + H + V + +L +
Sbjct: 64 LYGVCT-KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+H D+ +N L + +SDFGL R E ++S + + + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 983 ETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
+ + +SD+++FG+++ E+ + GK P + + + + + L L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------------LRLYR 222
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
E+ + C +RPT ++ +
Sbjct: 223 PHLASEKV---YTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 7e-52
Identities = 56/275 (20%), Positives = 114/275 (41%), Gaps = 23/275 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
+ + ++GLV + + ++I+ + +G++ E F +EAE + K+ H L L
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 864 RGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS 923
G + LV+++M +G L + + + L V G+A+L +
Sbjct: 66 YGVCLEQAPI-CLVFEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 924 NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGE 983
++H D+ +N L + +SDFG+ R + + ++ST + + SPE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 178
Query: 984 TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPES 1043
+ +SDV+SFG+++ E+ + + + ++ E + G P
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------EVVEDISTGFRLYKPRL 226
Query: 1044 SEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ ++ C P DRP S ++ L
Sbjct: 227 ASTH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-51
Identities = 53/280 (18%), Positives = 107/280 (38%), Gaps = 29/280 (10%)
Query: 807 EENVLSRTRYGLVFKACY---NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLT 861
+ L +G V + Y + ++I+ L G+ + +EA+ + ++ + +
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L G +LV + G L L + + V+ G+ +L
Sbjct: 73 RLIGVCQAEA--LMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
N VH D+ +NVL A +SDFGL + + + + L + +PE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 982 GETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+ + SDV+S+G+ + E L+ G++P + +++ ++++ + +E
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------MECP 234
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
PE E + C DRP + + C
Sbjct: 235 PECP--PEL---YALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 65/297 (21%), Positives = 126/297 (42%), Gaps = 31/297 (10%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDG-----MVLSIRRLPDGSLDENL--FRKEAEFLGKVR 856
+ V+ +G V+K + ++I+ L G ++ F EA +G+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
H N+ L G + + +++ +YM NG L + + + + G+A G
Sbjct: 68 HHNIIRLEGVISKYKPM-MIITEYMENG----ALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+ +L N VH D+ +N+L +++ +SDFGL R+ P T++ + + +P
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMF-TQDEDIVKWVKKQLQKGQITELLEPG 1035
EA + T SDV+SFGIV+ E++T + + +++K + +
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------- 231
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD-IPSSAD 1091
L + ++ + C + RP +DIV +L+ PD + + AD
Sbjct: 232 -LPTPMDCPSA-----IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-51
Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 29/280 (10%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
++ + + +G V Y V +++ + + + + F EA + ++RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSNLVQ 64
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L G +V +YM G+L L+ + VL +L V + +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+N VH D+ +NVL D A +SDFGL + +ST T + + +PEA
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREK 175
Query: 983 ETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
+ + +SDV+SFGI+L E+ + G+ P +D+V V+K K + P + E+
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYEV-- 232
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
C D RP+ + LE +
Sbjct: 233 --------------MKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 2e-50
Identities = 68/314 (21%), Positives = 130/314 (41%), Gaps = 40/314 (12%)
Query: 794 TLAETVEATRQFDEE---------NVLSRTRYGLVFKACY----NDGMVLSIRRLPDGSL 840
T + EA R+F +E V+ +G V + ++I+ L G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 841 DENL--FRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDG 898
++ F EA +G+ H N+ L G +++ ++M NG+L + Q+
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSF----LRQND 122
Query: 899 HVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958
+ G+A G+ +L N VH D+ +N+L +++ +SDFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 959 AEASTSTTA--VGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDI 1015
++ + ++ + + +PEA + T SDV+S+GIV+ E+++ G+RP ++D+
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 1016 VKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075
+ +++ + L P ++ L C D RP IV
Sbjct: 243 INAIEQDYR--------------LPPPMDCPSAL---HQLMLDCWQKDRNHRPKFGQIVN 285
Query: 1076 MLEGCRVGPDIPSS 1089
L+ P+ +
Sbjct: 286 TLDKMIRNPNSLKA 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-50
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 29/285 (10%)
Query: 804 QFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLDENL--FRKEAEFLGKVRH 857
F+E V+ R +G V+ D + +++ L + + F E + H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 858 RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
N+ L G + L+V YM +G+L + H L VA+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKGM 143
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAV-GTLGYVSP 976
FL + VH D+ +N + D F ++DFGL R ++ + T + +++
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 977 EAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
E+ T + T +SDV+SFG++L EL+T P D + LQ ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRL-------- 253
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
L PE +V L C P RP+ S++V +
Sbjct: 254 --LQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 57/309 (18%), Positives = 100/309 (32%), Gaps = 35/309 (11%)
Query: 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
R + + + R+G V++ + V +++ E +RH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 863 LRGYY---AGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
G LV DY +G+L L + + +AL A GLA
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 115
Query: 920 LHTS--------NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTA-VGT 970
LH + H D+K +N+L + ++D GL + VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 971 LGYVSPEAALT------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDI-------VK 1017
Y++PE E+ K +D+Y+ G+V E+ +D +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 1018 WVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFML 1077
++++K + L P + K+ C + R T I L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTL 292
Query: 1078 EGCRVGPDI 1086
I
Sbjct: 293 SQLSQQEGI 301
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 2e-48
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 45/302 (14%)
Query: 804 QFDEENVLSRTRYGLVFKA------CYNDGMVLSIRRLPDGSLDENL--FRKEAEFLGKV 855
+ + +G VF+A Y +++++ L + + + F++EA + +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQ------------------- 896
+ N+ L G A L+++YM G+L L+ S
Sbjct: 74 DNPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 897 DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956
L+ + IA VA G+A+L VH D+ +N L + ++DFGL R I
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN-IY 191
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV 1016
+ + ++ PE+ T ESDV+++G+VL E+ + + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076
V ++ G I E LEL + LC + P DRP+ I +
Sbjct: 250 -EVIYYVRDGNILACPENCPLEL-------------YNLMRLCWSKLPADRPSFCSIHRI 295
Query: 1077 LE 1078
L+
Sbjct: 296 LQ 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 4e-48
Identities = 63/286 (22%), Positives = 124/286 (43%), Gaps = 25/286 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTV 862
++ L +YG V++ + + ++++ L + +++ F KEA + +++H NL
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L G P + + ++M GNL L+E + Q+ ++ + +A ++ + +L
Sbjct: 78 LLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK 133
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
N +H D+ +N L + ++DFGL RL T + A + + +PE+
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 983 ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL-LELDP 1041
+ + +SDV++FG++L E+ T D Q+ ELLE +E
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYELLEKDYRMERPE 239
Query: 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087
E ++ C +P DRP+ ++I E I
Sbjct: 240 GCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-46
Identities = 65/299 (21%), Positives = 112/299 (37%), Gaps = 39/299 (13%)
Query: 804 QFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKV 855
+ L +G V +A + M ++++ L + + E + L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 856 -RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE-------------ASHQDGHVL 901
H N+ L G L++ +Y G+L L+ D L
Sbjct: 84 GNHMNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ + VA+G+AFL + N +H D+ +N+L + DFGL R I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNY 201
Query: 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK 1021
A + +++PE+ T ESDV+S+GI L EL + D
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------- 254
Query: 1022 QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
+ ++++ G L PE + E + C DP+ RPT IV ++E
Sbjct: 255 ----SKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-46
Identities = 56/299 (18%), Positives = 118/299 (39%), Gaps = 41/299 (13%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDE--NLFRKEAEFLGKVRHRNLT 861
F++ + L G+VFK + G+V++ + + N +E + L + +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
G + ++ + ++M G+L +L++A + + +++ V +GL +L
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLR 121
Query: 922 TSN-MVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
+ ++H D+KP N+L ++ E L DFG+ I + + + VGT Y+SPE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ 176
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+ +SD++S G+ L+E+ G+ P+ +++ Q++ P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 1041 PESSEWEEFLLGVKVALL--------------------------CTAPDPIDRPTMSDI 1073
S + LL C +P +R + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-46
Identities = 59/282 (20%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 803 RQFDEENVLSRTRYGLVFKACYND-GMVLSIRRLPDGSLDEN---LFRKEAEFLGKVRHR 858
R + + R + V+K + + ++ L D L ++ F++EAE L ++H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 859 NLTVLRGYYAGA---PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
N+ + +LV + M +G L T L+ V+ + + +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILK 123
Query: 916 GLAFLHTSN--MVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
GL FLHT ++H D+K N+ + D GL L AS + +GT
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPE 178
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+++PE + + DVY+FG+ +LE+ T + P +++ ++ + ++ +T +
Sbjct: 179 FMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRR------VTSGV 229
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+P + E +E + G C + +R ++ D++
Sbjct: 230 KPASFD-KVAIPEVKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-46
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 804 QFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDGSLDENL--FRKEAEFLGKV 855
+ VL +G V A + ++++ L + + E + + ++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 856 -RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE------------------ASHQ 896
H N+ L G + + L+++Y G+L L+ +
Sbjct: 98 GSHENIVNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 897 DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956
D +VL + A VA+G+ FL + VH D+ +NVL + DFGL R I
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-IM 215
Query: 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIV 1016
+ + A + +++PE+ G T +SDV+S+GI+L E+ + +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIPVD 273
Query: 1017 KWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076
K +Q G ++D EE + C A D RP+ ++
Sbjct: 274 ANFYKLIQNG----------FKMDQPFYATEEI---YIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 1077 LEGC 1080
L GC
Sbjct: 321 L-GC 323
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-45
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 31/280 (11%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDEN---LFRKEAEFLGKVRHRNL 860
++ + YG K +DG +L + L GS+ E + E L +++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 861 TVLRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ L +V +Y G+L +++ + + + + L+ + + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKE 124
Query: 920 LH-----TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
H ++H D+KP NV D L DFGL R+ + S + VGT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTSFAKAFVGTPYYM 181
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
SPE ++SD++S G +L EL P +++ ++++G+ +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFRRIPY- 236
Query: 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
S E E + RP++ +I+
Sbjct: 237 ------RYSDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-45
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 38/295 (12%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDG---MVLSIRRLPDGSLDENL--FRKEAEFLGKV-RH 857
++V+ +G V KA M +I+R+ + + ++ F E E L K+ H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 858 RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQE-----------ASHQDGHVLNWPMR 906
N+ L G L +Y P+GNL L++ ++ L+
Sbjct: 71 PNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
A VARG+ +L +H D+ +N+L ++ A ++DFGL R T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----VKKTM 185
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
+ +++ E+ T SDV+S+G++L E+++ + +K
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEK----- 238
Query: 1027 QITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081
L + LE +E + C P +RP+ + I+ L
Sbjct: 239 ----LPQGYRLEKPLNCD--DEV---YDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 58/291 (19%), Positives = 121/291 (41%), Gaps = 33/291 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV 855
+ L + +G+V++ ++I+ + + + + F EA + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ-----EASHQDGHVLNWPMRHLIA 910
++ L G + L++ + M G+L + L+ A++ + +A
Sbjct: 81 NCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 911 LGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGT 970
+A G+A+L+ + VH D+ +N + DF + DFG+ R I +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLP 198
Query: 971 LGYVSPEAALTGETTKESDVYSFGIVLLELLTGKR-PVMFTQDEDIVKWVKKQLQKGQIT 1029
+ ++SPE+ G T SDV+SFG+VL E+ T P +E ++++V
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---------- 248
Query: 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
+E GLL+ + ++ +C +P RP+ +I+ ++
Sbjct: 249 --MEGGLLDKPDNCPDM-----LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 55/285 (19%), Positives = 103/285 (36%), Gaps = 31/285 (10%)
Query: 803 RQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGSLDE----NLFRKEAEFLGK 854
+ L +G+V + ++ + ++++ L L + + F +E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 855 VRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914
+ HRNL L G P +V + P G+L + + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPP--MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
G+ +L + +H D+ +N+L + DFGL R +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 975 SPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
+PE+ T + SD + FG+ L E+ T G+ P + I+ + K+ ++ E
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+ + + C A P DRPT + L
Sbjct: 242 QDIYNV----------------MVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACY----NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRH 857
+ + + ++G V + Y N + ++I+ + + D F +EA + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 858 RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGL 917
++ L G + ++ + G L + + L+ L A ++ L
Sbjct: 68 PHIVKLIGVIT--ENPVWIIMELCTLGELRSF----LQVRKYSLDLASLILYAYQLSTAL 121
Query: 918 AFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
A+L + VH DI +NVL ++ L DFGL R + ++ + +++PE
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPE 179
Query: 978 AALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036
+ T SDV+ FG+ + E+L G +P ++ D++ ++ +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------ 227
Query: 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
L + P + C A DP RP +++ L
Sbjct: 228 LPMPPNCPPT-----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 59/273 (21%), Positives = 95/273 (34%), Gaps = 26/273 (9%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENL--FRKEAEFLGKVRHRNLT 861
+D L YG V A ++++ + + +KE + H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
G+ +++ L +Y G L ++ + P + G+ +LH
Sbjct: 67 KFYGHRRE-GNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 120
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
+ H DIKP+N+L D +SDFGL + GTL YV+PE
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 982 GE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
E + DV+S GIVL +L G+ + Q D + +K
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLN-------PWK 230
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S L +P R T+ DI
Sbjct: 231 KIDSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 4e-44
Identities = 65/281 (23%), Positives = 104/281 (37%), Gaps = 37/281 (13%)
Query: 802 TRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDEN----LFRKEAEFLGKVR 856
+ F + + +G V+ A + V++I+++ N KE FL K+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
H N RG Y LV +Y + L + G +G
Sbjct: 74 HPNTIQYRGCYL-REHTAWLVMEYCLGSAS-----DLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
LA+LH+ NM+H D+K N+L L DFG + P + VGT +++P
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAP 180
Query: 977 EAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033
E L G+ + DV+S GI +EL K P+ + + + + L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPALQS 236
Query: 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
S + F+ C P DRPT ++
Sbjct: 237 GHW------SEYFRNFVDS------CLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-44
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRN 859
F+ L + ++G V+ A +L+++ L L+ E+ R+E E +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ L GY+ A + L+ +Y P G + LQ+ S + +A L++
Sbjct: 68 ILRLYGYFHDATRV-YLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSY 121
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
H+ ++H DIKP+N+L + E ++DFG A +S TT GTL Y+ PE
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTTLCGTLDYLPPEMI 176
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
++ D++S G++ E L GK P ++ K + + + + + G +L
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDL 234
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
+P RP + +++
Sbjct: 235 ----------------ISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 52/276 (18%), Positives = 110/276 (39%), Gaps = 30/276 (10%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDE-NLFRKEAEFLGKVRHRNLTV 862
++ L +G V+KA ++ + + + S +E + E + L H N+
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L + + ++ ++ G + ++ + L ++ L +LH
Sbjct: 74 LLDAFY-YENNLWILIEFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 923 SNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTG 982
+ ++H D+K N+LF D + L+DFG+ T + +GT +++PE +
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQRRDSFIGTPYWMAPEVVMCE 185
Query: 983 ET-----TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
+ ++DV+S GI L+E+ + P ++ ++ K + L +P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL----LKIAKSEPPTLAQP--- 238
Query: 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
SS +++FL C + R T S +
Sbjct: 239 --SRWSSNFKDFLKK------CLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 57/306 (18%), Positives = 115/306 (37%), Gaps = 35/306 (11%)
Query: 804 QFDEENVLSRTRYGLVFKACYND-----GMVLSIRRLPDGSLDENL--FRKEAEFLGKVR 856
+F + VL +G V+K + + ++I+ L + + + EA + V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
+ + V R L+ MP G L + + + + +A+G
Sbjct: 70 NPH--VCRLLGICLTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
+ +L +VH D+ +NVL ++DFGL +L + + + + +++
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMAL 182
Query: 977 EAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E+ L T +SDV+S+G+ + EL+T G +P +I ++K +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------- 231
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD---IPSSADP 1092
L P + + + + C D RP +++ P + +
Sbjct: 232 -LPQPPICT--IDV---YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 1093 TTQPSP 1098
PSP
Sbjct: 286 MHLPSP 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 60/297 (20%), Positives = 109/297 (36%), Gaps = 36/297 (12%)
Query: 804 QFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLDENL--FRKEAEFLGKV 855
+ L R +G V +A ++++ L +G+ E + L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 856 RHRNLTV-LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQD-----------GHVLNW 903
H V L G +++ ++ GNL T L+ ++ L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 904 PMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAST 963
+ VA+G+ FL + +H D+ +N+L + DFGL R I +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVR 192
Query: 964 STTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL 1023
A L +++PE T +SDV+SFG++L E+ + I + ++L
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRL 250
Query: 1024 QKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
++G + E+ + L C +P RPT S++V L
Sbjct: 251 KEGTRMRAPDYTTPEM-------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-41
Identities = 56/274 (20%), Positives = 110/274 (40%), Gaps = 27/274 (9%)
Query: 802 TRQFDEENVLSRTRYGLVFKACY-NDGMVLSIRRL-PDGSLDENLFRKEAEFLGKVRHRN 859
+++ + + G V+ A G ++IR++ + L E + + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ Y D +V +Y+ G+L ++ E + + + L F
Sbjct: 79 IVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEF 131
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
LH++ ++H DIK N+L D L+DFG P E S +T VGT +++PE
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVV 188
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ D++S GI+ +E++ G+ P +E+ ++ + G L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEKL--- 242
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S+ + +FL C D R + ++
Sbjct: 243 ---SAIFRDFLNR------CLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 42/300 (14%)
Query: 804 QFDEENVLSRTRYGLVFKA--------CYNDGMVLSIRRLPDGSLDENL--FRKEAEFLG 853
+ L +G V A N ++++ L + +++L E E +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 854 KV-RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQ-----------EASHQDGHVL 901
+ +H+N+ L G ++ +Y GNL LQ SH L
Sbjct: 74 MIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 902 NWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961
+ A VARG+ +L + +H D+ +NVL D ++DFGL R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYY 191
Query: 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVK 1020
+T + +++PEA T +SDV+SFG++L E+ T G P E++ K +K
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 1021 KQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080
+ + +D S+ E + C P RPT +V L+
Sbjct: 252 EGHR--------------MDKPSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 8e-40
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 27/274 (9%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLT 861
+D L +G+V + G + + + D+ RKE + + +RH L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L + ++ +++Y++M G L + + + ++ V +GL +H
Sbjct: 87 NLHDAFEDDNEM-VMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 922 TSNMVHGDIKPQNVLFDADFEAH--LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
+N VH D+KP+N++F L DFGL P + GT + +PE A
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVA 197
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+D++S G++ LL+G P D++ ++ VK + + G+
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWNMDDSAFSGI--- 252
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S + ++F+ DP R T+
Sbjct: 253 ---SEDGKDFIRK------LLLADPNTRMTIHQA 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-39
Identities = 48/261 (18%), Positives = 100/261 (38%), Gaps = 26/261 (9%)
Query: 816 YGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874
+G+V + + + + D+ L +KE L RHRN+ L + +L
Sbjct: 18 FGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEEL- 76
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
+++++++ ++ + + LN V L FLH+ N+ H DI+P+N
Sbjct: 77 VMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 935 VLFDADFEAH--LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYS 992
+++ + + +FG R P Y +PE + +D++S
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 993 FGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLG 1052
G ++ LL+G P + ++ I++ + + E + S E +F+
Sbjct: 189 LGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFDEEAFKEI------SIEAMDFVDR 240
Query: 1053 VKVALLCTAPDPIDRPTMSDI 1073
+ R T S+
Sbjct: 241 ------LLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 3e-39
Identities = 44/271 (16%), Positives = 94/271 (34%), Gaps = 24/271 (8%)
Query: 816 YGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874
+G ++ G ++I+ + L E++ ++ + D
Sbjct: 20 FGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQGGVGIPTIRWCGAEGDYN 78
Query: 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934
++V + + L++ + + L+A + + ++H+ N +H D+KP N
Sbjct: 79 VMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133
Query: 935 VLF---DADFEAHLSDFGLDRLTIPTPAEAST----STTAVGTLGYVSPEAALTGETTKE 987
L ++ DFGL + + GT Y S L E ++
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193
Query: 988 SDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDPESSEWE 1047
D+ S G VL+ G P + + ++ +K ++ P + SE+
Sbjct: 194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMSTPIEVLCKGYPSEFA 249
Query: 1048 EFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
+L C + D+P S + +
Sbjct: 250 TYL------NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (361), Expect = 9e-38
Identities = 50/273 (18%), Positives = 103/273 (37%), Gaps = 27/273 (9%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRL-PDGSLDENLFRKEAEFLGKVRHRNLTV 862
+D L +G+V + G V + + LD+ + E + ++ H L
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 863 LRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
L + ++ +L+ +++ G L + + + ++ GL +H
Sbjct: 91 LHDAFEDKYEM-VLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 923 SNMVHGDIKPQNVLFDADFEAH--LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
++VH DIKP+N++ + + + DFGL P T + +PE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD----EIVKVTTATAEFAAPEIVD 201
Query: 981 TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040
+D+++ G++ LL+G P D + ++ VK+ + E +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR--CDWEFDEDAFSSV---- 255
Query: 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S E ++F+ +P R T+ D
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 140 bits (354), Expect = 1e-37
Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 28/289 (9%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRL-PDGSLDENL---FRKEAEFLGKVRHR 858
+++ +L V A ++++ L D + D + FR+EA+ + H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 859 NLTVLRGYYA---GAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
+ + A L +V +Y+ L ++ + + +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQ 122
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
L F H + ++H D+KP N++ A + DFG+ R + + + +GT Y+S
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 976 PEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
PE A SDVYS G VL E+LTG+ P FT D + + + G
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLEGCRVG 1083
L S++ + +L A +P +R T +++ L G
Sbjct: 241 L------SADLDAVVLK------ALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 2e-37
Identities = 60/288 (20%), Positives = 99/288 (34%), Gaps = 42/288 (14%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDE----------NLFRKEAEFL 852
++ + +L R +V + +++ + KE + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 853 GKVR-HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIAL 911
KV H N+ L+ Y LV+D M G L L E L+ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMR 117
Query: 912 GVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTL 971
+ + LH N+VH D+KP+N+L D D L+DFG P GT
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----EKLREVCGTP 173
Query: 972 GYVSPEAALTGET------TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK 1025
Y++PE KE D++S G+++ LL G P + +++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--- 230
Query: 1026 GQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ G E D S ++ + P R T +
Sbjct: 231 -----NYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 7e-37
Identities = 64/275 (23%), Positives = 107/275 (38%), Gaps = 30/275 (10%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLT 861
+D +VL + V A +++I+ + +L+ E E L K++H N+
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L Y L L+ + G L + E + V + +LH
Sbjct: 71 ALDDIYESGGHL-YLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLH 124
Query: 922 TSNMVHGDIKPQNVLF---DADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+VH D+KP+N+L+ D D + +SDFGL ++ P S +TA GT GYV+PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEV 180
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038
+K D +S G++ LL G P D + + + K + + +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDI-- 236
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S ++F+ DP R T
Sbjct: 237 ----SDSAKDFIRH------LMEKDPEKRFTCEQA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-36
Identities = 47/275 (17%), Positives = 96/275 (34%), Gaps = 32/275 (11%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRN 859
F +L + V A +I+ L + +E + + ++ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
L + L Y NG L +++ + + L +
Sbjct: 70 FVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEY 123
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
LH ++H D+KP+N+L + D ++DFG ++ P ++ + + + VGT YVSPE
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP-ESKQARANSFVGTAQYVSPELL 182
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
K SD+++ G ++ +L+ G P + I + + K +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDF 229
Query: 1040 DPE-SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + + + D R ++
Sbjct: 230 PEKFFPKARDLVEK------LLVLDATKRLGCEEM 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (342), Expect = 7e-36
Identities = 47/281 (16%), Positives = 90/281 (32%), Gaps = 26/281 (9%)
Query: 808 ENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGY 866
+ +G++F+ + ++I+ P S R E + Y
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-LRDEYRTYKLLAGCTGIPNVYY 68
Query: 867 YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMV 926
+ +LV D + L G + + A + + +H ++V
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 927 HGDIKPQNVLFDADFEAH-----LSDFGLDRLTIPTPAEAST----STTAVGTLGYVSPE 977
+ DIKP N L + + DFG+ + + GT Y+S
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 978 AALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037
L E ++ D+ + G V + L G P + + ++ +K Q T L E L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE--LC 241
Query: 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078
PE E+ +++ P + +
Sbjct: 242 AGFPE--EFYKYM------HYARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 61/291 (20%), Positives = 114/291 (39%), Gaps = 33/291 (11%)
Query: 808 ENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRG 865
VL G V + +++ L D R+E E + + ++ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVD 72
Query: 866 YYAGAPDLR---LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT 922
Y R L+V + + G L + +Q+ Q I + + +LH+
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS 129
Query: 923 SNMVHGDIKPQNVLFDADFE---AHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
N+ H D+KP+N+L+ + L+DFG + T ++ TT T YV+PE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTPYYVAPEVL 185
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
+ K D++S G+++ LL G P I +K +++ GQ E E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY----EFPNPEW 241
Query: 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV---FMLEGCRVGPDIP 1087
S E + + +P R T+++ + ++++ +V P P
Sbjct: 242 SEVSEEVKMLIRN------LLKTEPTQRMTITEFMNHPWIMQSTKV-PQTP 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 57/294 (19%), Positives = 109/294 (37%), Gaps = 20/294 (6%)
Query: 797 ETVEATRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENL--FRKEAEFLG 853
+ + ++ + + YG+V A N + + ++I+++ +E + L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 854 KVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV 913
+ RH N+ + AP + + Y+ +G L + L+ +
Sbjct: 62 RFRHENIIGINDIIR-APTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQI 118
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
RGL ++H++N++H D+KP N+L + + + DFGL R+ P T V T Y
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 974 VSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+PE L + TK D++S G +L E+L+ + D + + L +L
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 1033 EPGLLEL--------DPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
L+ W L +P R +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 3e-33
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 24/285 (8%)
Query: 804 QFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNL 860
++ + YG+V+KA N G +++++ DE + +E L +++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
L L +LV++++ L L L + G+A+
Sbjct: 63 VKLYDVIHTKKRL-VLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYC 116
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H ++H D+KPQN+L + + E ++DFGL R T + TL Y +P+ +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 981 -TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG------QITELLE 1033
+ + + D++S G + E++ G + D + + + L +TEL +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 1034 PGLLELDPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
E WE FL G+ + + DP R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-33
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 40/294 (13%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVL 863
+ + V+ +G+V++A + G +++I+++ D+ +E + + K+ H N+ L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 864 RGYYAGAPDLR-----LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
R ++ + + + LV DY+P + L L + R LA
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAH-LSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPE 977
++H+ + H DIKPQN+L D D L DFG + + + + + + Y +PE
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPE 192
Query: 978 AALTGET-TKESDVYSFGIVLLELLTGKRP---------------VMFTQDEDIVKWVKK 1021
T DV+S G VL ELL G+ V+ T + ++ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 1022 QLQKGQITELLEPGLLELDPE--SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + ++ ++ E P R T +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR------LLEYTPTARLTPLEA 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 21/290 (7%)
Query: 801 ATRQFDEENVLSRTRYGLVFKACY--NDGMVLSIRRLPDGSLDENLFR------KEAEFL 852
A +Q++ + YG VFKA N G ++++R+ + +E + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 853 GKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG 912
H N+ L + R + L + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ RGL FLH+ +VH D+KPQN+L + + L+DFGL R+ T+ V TL
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLW 180
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED----IVKWVKKQLQKGQI 1028
Y +PE L D++S G + E+ K + D D I+ + ++
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 1029 TELLEPGLLELDPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
++ P + E+F+ + C +P R +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 58/276 (21%), Positives = 107/276 (38%), Gaps = 33/276 (11%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLD-----ENLFRKEAEFLGKVRHR 858
F +L + +G VF A + +I+ L + E ++ H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
LT + + +L V +Y+ G+L +Q H + A + GL
Sbjct: 64 FLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQ 117
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
FLH+ +V+ D+K N+L D D ++DFG+ + + + + T GT Y++PE
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEI 174
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038
L + D +SFG++L E+L G+ P +E++ ++ P L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------NPFYPRWL- 226
Query: 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIV 1074
E ++ L+ +P R + +
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (318), Expect = 5e-32
Identities = 57/276 (20%), Positives = 94/276 (34%), Gaps = 37/276 (13%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSL----DENLFRKE---AEFLGKVR 856
F ++ R +G V+ + G + +++ L + E L E +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
+ + + PD + D M G+L L + + A + G
Sbjct: 66 CPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILG 119
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSP 976
L +H +V+ D+KP N+L D +SD GL +VGT GY++P
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-----SKKKPHASVGTHGYMAP 174
Query: 977 EAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035
E G +D +S G +L +LL G P + +D + + L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TM 224
Query: 1036 LLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPTM 1070
+EL S E L G D R
Sbjct: 225 AVELPDSFSPELRSLLEG------LLQRDVNRRLGC 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 61/282 (21%), Positives = 99/282 (35%), Gaps = 46/282 (16%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDEN-------LFRKEAEFLGKV 855
Q+ +L +G V+ +D + ++I+ + + + E L KV
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 856 RHRNLTVLRGYYAGA-PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914
V+R PD +L+ + + L + V
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF----ITERGALQEELARSFFWQVL 120
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDAD-FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
+ H ++H DIK +N+L D + E L DFG L T T GT Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTRVY 175
Query: 974 VSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
PE + + V+S GI+L +++ G P F DE+I++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIR--------------- 218
Query: 1033 EPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
G + SSE + + C A P DRPT +I
Sbjct: 219 --GQVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-31
Identities = 49/281 (17%), Positives = 100/281 (35%), Gaps = 36/281 (12%)
Query: 805 FDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDEN-------LFRKEAEFLGKVR 856
+D L ++ +V K + G+ + + + + +E L +++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARG 916
H N+ L Y D+ +L+ + + G L + L + G
Sbjct: 72 HPNVITLHEVYENKTDV-ILILELVAGGELFD-----FLAEKESLTEEEATEFLKQILNG 125
Query: 917 LAFLHTSNMVHGDIKPQNVLFDAD----FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLG 972
+ +LH+ + H D+KP+N++ + DFGL + GT
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNIFGTPE 181
Query: 973 YVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+V+PE E+D++S G++ LL+G P + ++ + V + +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--VNYEFEDEY 239
Query: 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
S+ ++F+ DP R T+ D
Sbjct: 240 FSNT------SALAKDFIRR------LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 62/285 (21%), Positives = 104/285 (36%), Gaps = 31/285 (10%)
Query: 809 NVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDEN------LFRKEAEFLGKVRHRNLT 861
+ L ++ V+KA N +++I+++ G E +E + L ++ H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 862 VLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L + G LV+D+M + + VL L +GL +LH
Sbjct: 64 GLLDAF-GHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 922 TSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
++H D+KP N+L D + L+DFGL + + T V T Y +PE
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 982 GET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL- 1039
D+++ G +L ELL + D D + + + L G TE P + L
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL--GTPTEEQWPDMCSLP 232
Query: 1040 ------DPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
LL +P R T +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-31
Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 28/287 (9%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRNL 860
F + + YG+V+KA G V++++++ + E + +E L ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 861 TVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFL 920
L L LV++++ L + + P+ + +GLAF
Sbjct: 64 VKLLDVIHTENKL-YLVFEFLHQD----LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 921 HTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
H+ ++H D+KPQN+L + + L+DFGL R T T V TL Y +PE L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILL 175
Query: 981 -TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG---L 1036
+ D++S G + E++T + F D +I + + G E++ PG +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 1037 LELDPESSEWEEFLLGVKVALL----------CTAPDPIDRPTMSDI 1073
+ P +W V L DP R +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 1e-29
Identities = 53/271 (19%), Positives = 96/271 (35%), Gaps = 37/271 (13%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDE----NLFRKEAEFLGKVRHRN 859
F L +G V ++G +++ L + E L V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ + G + ++ DY+ G L +L + P+ A V L +
Sbjct: 66 IIRMWGTFQ-DAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
LH+ ++++ D+KP+N+L D + ++DFG + + T GT Y++PE
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEVV 173
Query: 980 LTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLEL 1039
T K D +SFGI++ E+L G P + + + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------------AELRF 220
Query: 1040 DPE-SSEWEEFLLGVKVALLCTAPDPIDRPT 1069
P + + ++ L D R
Sbjct: 221 PPFFNEDVKDLLSR------LITRDLSQRLG 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 52/297 (17%), Positives = 109/297 (36%), Gaps = 32/297 (10%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRN 859
++++ + + +G VFKA + G ++++++ + E +E + L ++H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 860 LTVLRGY-------YAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALG 912
+ L Y LV+D+ + G L +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQM 125
Query: 913 VARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR-LTIPTPAEASTSTTAVGTL 971
+ GL ++H + ++H D+K NVL D L+DFGL R ++ ++ + T V TL
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 972 GYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKK--------- 1021
Y PE L D++ G ++ E+ T + ++ + + +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 1022 -----QLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073
+ + EL++ ++ + + + DP R D
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-28
Identities = 55/287 (19%), Positives = 111/287 (38%), Gaps = 26/287 (9%)
Query: 804 QFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENL---FRKEAEFLGKVRHRN 859
++++ + YG VFKA +++++R+ DE + +E L +++H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 860 LTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAF 919
+ V + LV+++ L+ + + +GL F
Sbjct: 63 I-VRLHDVLHSDKKLTLVFEFCDQDLKKY-----FDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 920 LHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAA 979
H+ N++H D+KPQN+L + + E L++FGL R + V TL Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVTLWYRPPDVL 173
Query: 980 L-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDED-------IVKWVKKQLQKGQITEL 1031
+ D++S G + EL RP+ D D + + Q +T+L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 1032 LEPGLLELDPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
+ + P ++ + + +P+ R + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-28
Identities = 63/294 (21%), Positives = 106/294 (36%), Gaps = 26/294 (8%)
Query: 798 TVEATRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENL---FRKEAEFLG 853
E + + + YG V A G ++I++L E +E L
Sbjct: 13 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 72
Query: 854 KVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV 913
+RH N+ L + L Y+ +GT L + L + +
Sbjct: 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVYQM 130
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
+GL ++H + ++H D+KP N+ + D E + DFGL R S T V T Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA------DSEMTGYVVTRWY 184
Query: 974 VSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL--------Q 1024
+PE L T+ D++S G ++ E++TGK + D +K + K Q
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
+ Q E + E ++ L + D R T +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-27
Identities = 59/285 (20%), Positives = 102/285 (35%), Gaps = 41/285 (14%)
Query: 792 KITLAETVEATRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDEN----LFR 846
K+T+ + FD +L + +G V G +++ L +
Sbjct: 1 KVTMND-------FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 847 KEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMR 906
E+ L RH LT L+ + D V +Y G L L V
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSR-----ERVFTEERA 107
Query: 907 HLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTT 966
+ L +LH+ ++V+ DIK +N++ D D ++DFGL + I + +T T
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKT 164
Query: 967 AVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG 1026
GT Y++PE + + D + G+V+ E++ G+ P E + + +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----- 219
Query: 1027 QITELLEPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPTM 1070
+ S E + L G DP R
Sbjct: 220 --------EEIRFPRTLSPEAKSLLAG------LLKKDPKQRLGG 250
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (275), Expect = 2e-26
Identities = 75/388 (19%), Positives = 142/388 (36%), Gaps = 23/388 (5%)
Query: 87 SNLRMLRKLSLRSNSFNGTIP-ATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNV 145
+ L K L + T+ L Q T L+A L S+ G + L+NL +N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 146 AANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFE 205
+ N+L+ L +++N + P + + + +
Sbjct: 74 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 206 GTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVS 265
+N ++ +SA + L+ ++ + ++ ++S
Sbjct: 134 LNRLELSSN--TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 266 GYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDV 325
+ L ++ + L L L NQ++ L + LT LD+
Sbjct: 192 VLAKLTNLESLIAT-NNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 326 SGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEF 385
+ N IS P + GL +L ELK+ N P + ++L+ L+L N+ P
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS 304
Query: 386 LGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDL 445
+++ L LTL N S P +L L+ L +N +S + + N++ L
Sbjct: 305 --NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 446 SENKFSGEVPASIGNLSQLMVFNLSGNA 473
N+ S P + NL+++ L+ A
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 109 bits (272), Expect = 5e-26
Identities = 80/411 (19%), Positives = 133/411 (32%), Gaps = 39/411 (9%)
Query: 121 LQYNSLSGNLPANI----GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPI 176
L +++ + P N L+ + ++ ++ + G
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI- 59
Query: 177 PTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAI 236
+ L+ L INFS N+ + P + N + LV + N + + P A
Sbjct: 60 -DGVEYLNNLTQINFSNNQLTDITP----------LKNLTKLVDILMNNNQIADITPLAN 108
Query: 237 GALPKLQVVSLAQNNLSGVVPASMFCNVSGYPP-SIRVVQLGFNAFTNVAGPETGSCSSV 295
+ Q + N +I + + + +
Sbjct: 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL 168
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTR------LDVSGNSISGKIPAQIGGLWRLEELKM 349
+ +L + ++ S L + L + N IS P I L+EL +
Sbjct: 169 KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSL 226
Query: 350 ANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPAS 409
N + ++L+ LDL N+ S P L + L L L AN S P
Sbjct: 227 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 280
Query: 410 FRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNL 469
L L NL L N L P L L+ L L N S P + +L++L
Sbjct: 281 LAGLTALTNLELNENQLEDISPISNLKN--LTYLTLYFNNISDISP--VSSLTKLQRLFF 336
Query: 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQEN 520
+ N S +SL NL + L S P LA L + + L +
Sbjct: 337 ANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 1e-23
Identities = 78/388 (20%), Positives = 142/388 (36%), Gaps = 47/388 (12%)
Query: 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANN---SFGGAVPVEIKQCSSLSLLDLEGN 376
+ + +++ + L ++ L+ S G ++ ++L+ ++ N
Sbjct: 24 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNN 76
Query: 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG 436
+ + P L ++ L + + N + P + L + L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 437 M------NNLSTLDLSENKFSGEVPAS---------IGNLSQLMVFNLSGNAFSGRIPAS 481
N +S + S + + + NL+ L ++S N S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
L L +L + S P+ + NL ++L N+L +SL +L L+L
Sbjct: 195 --KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 542 SFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD 601
+ N P S L + L N IS P L + L LEL N +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISP 302
Query: 602 ISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661
IS+L +L L L NN++ P +S + L+ L +N +S SLA L+N+ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 662 SANNLSGEIP-ANLSSIFGLMNFNVSSN 688
N +S P ANL+ + ++
Sbjct: 359 GHNQISDLTPLANLTR---ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (252), Expect = 2e-23
Identities = 70/379 (18%), Positives = 124/379 (32%), Gaps = 35/379 (9%)
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
L + + T +T L I I + L L ++ +NN
Sbjct: 27 TVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDIT 82
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR------- 411
P +K + L + + N+ + P +L +
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 412 --NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKF----SGEVPASIGNLSQLM 465
+ + L+ + S +V + L+ L E + + L+ L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 466 VFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN 525
+ N S P + L L L+ LA L NL + L N++S
Sbjct: 201 SLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585
P S L L L L N P + L ++ L + N + P N +L
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLT 310
Query: 586 VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645
L L N+++ P +S L+ L L + N ++ ++ +++ L N +S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 646 IPDSLAKLSNLAVLDLSAN 664
P LA L+ + L L+
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 7e-18
Identities = 86/383 (22%), Positives = 142/383 (37%), Gaps = 43/383 (11%)
Query: 66 NRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNS 125
++VT L+ RL + D + L L +++ +N P L T L + N+
Sbjct: 44 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV--DILMNN 97
Query: 126 LSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQ 185
+ NL+NL L + N+++ NL +LSSN S
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS------------ 145
Query: 186 LQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVV 245
+ S +++ + T +AN ++L L N + L L+ +
Sbjct: 146 -DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDISVLAKLTNLESL 202
Query: 246 SLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQ 305
N +S + P + N + + L N T + + L LDL NQ
Sbjct: 203 IATNNQISDITPLGILTN-------LDELSLNGNQLK---DIGTLASLTNLTDLDLANNQ 252
Query: 306 IRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQC 365
I PL + LT L + N IS P + GL L L++ N I
Sbjct: 253 ISNLAPLS--GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISNL 306
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
+L+ L L N S P + + L+ L A N S +S NL + L+ HN
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 426 LSGSLPEEVLGMNNLSTLDLSEN 448
+S P + + ++ L L++
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 3e-15
Identities = 59/354 (16%), Positives = 125/354 (35%), Gaps = 49/354 (13%)
Query: 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430
L + + + D+ + +L SI L L +N +N L+
Sbjct: 27 TVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT 82
Query: 431 PEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA---------- 480
P + + L + ++ N+ + P + + + +
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 481 --SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS-GNVPEGFSSLMSLR 537
++ ++ L+ L +Q G +L L NL + + + + + L +L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 538 YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH 597
L + N P L ++ LS +GN + L + ++L L+L +N ++
Sbjct: 201 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 598 IPTDISHLSHLNVLDLSINNLTGEIP--------------------DEISKCSSLRSLLV 637
P +S L+ L L L N ++ P IS +L L +
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314
Query: 638 NSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
N++S P ++ L+ L L + N +S ++L+++ + + N +
Sbjct: 315 YFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 4e-14
Identities = 43/216 (19%), Positives = 71/216 (32%), Gaps = 43/216 (19%)
Query: 85 HLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILN 144
L+ L L L +N + P + T L + L N L + +L+NL L+
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 145 VAANRLSGEIANDLPRNLKYFDLSSNGFSGPIP--------------------TSISNLS 184
+A N++S L L +N S P + ISNL
Sbjct: 248 LANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 185 QLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQV 244
L + FN S P +++ + L L N + ++ L +
Sbjct: 308 NLTYLTLYFNNISDISP----------VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 245 VSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNA 280
+S N +S + P + I + L A
Sbjct: 356 LSAGHNQISDLTPLANL-------TRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 3e-12
Identities = 40/185 (21%), Positives = 65/185 (35%), Gaps = 36/185 (19%)
Query: 63 CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQ 122
+ EL L QL L++L L L L +N + P L+ T L + L
Sbjct: 216 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 123 YNSLSGNLP--------------------ANIGNLSNLEILNVAANRLSGEIANDLPRNL 162
N +S P + I NL NL L + N +S L
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL 331
Query: 163 KYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLS 222
+ ++N S +S++NL+ + ++ N+ S P +AN + + L
Sbjct: 332 QRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP----------LANLTRITQLG 379
Query: 223 AQGNA 227
A
Sbjct: 380 LNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 3e-09
Identities = 55/314 (17%), Positives = 106/314 (33%), Gaps = 53/314 (16%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L L +++ ++ + L + ++TL ++ G
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDL--DQVTTLQADRLGIK----------------SIDG 61
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
+ L LT ++ S + P L L L I + N+++ P
Sbjct: 62 ----------VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANL 109
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVL---------------SFSGNHISGSIPP 576
+ ++ L + + + + R + +
Sbjct: 110 TNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169
Query: 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLL 636
L N + LE L++ SN + ++ L++L L + N ++ P I ++L L
Sbjct: 170 PLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELS 225
Query: 637 VNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAFANN 696
+N N L +LA L+NL LDL+ N +S P LS + L + +N + +
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281
Query: 697 QDLCGKPLGRKCEN 710
L EN
Sbjct: 282 AGLTALTNLELNEN 295
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 19/99 (19%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 589 LRSNSLTGHIPTDI----SHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG 644
L S ++T P + + L+ L N+T + + + +L + +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS 58
Query: 645 GIPDSLAKLSNLAVLDLSANNLSGEIP-ANLSSIFGLMN 682
D + L+NL ++ S N L+ P NL+ + ++
Sbjct: 59 --IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILM 95
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 4e-26
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 24/250 (9%)
Query: 804 QFDEENVLSRTRYGLVFKACY-NDGMVLSIRRLPDGSLDEN----LFRKEAEFLGKVRHR 858
QFD L +G V + G +++ L + + E L V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 859 NLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLA 918
L L + +L + V +Y+ G + + L+ + P A +
Sbjct: 102 FLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFE 155
Query: 919 FLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEA 978
+LH+ ++++ D+KP+N+L D ++DFG + + T GT ++PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWTLCGTPEALAPEI 209
Query: 979 ALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQK------GQITELL 1032
L+ K D ++ G+++ E+ G P Q I + + + + +LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 1033 EPGLLELDPE 1042
LL++D
Sbjct: 270 R-NLLQVDLT 278
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 5e-26
Identities = 58/280 (20%), Positives = 108/280 (38%), Gaps = 34/280 (12%)
Query: 804 QFDEENVLSRTRYGLVFKA----CYNDGMVLSIRRLPDGSLDEN-----LFRKEAEFLGK 854
F+ VL YG VF ++ G + +++ L ++ + R E + L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 855 VRHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVA 914
+R V Y L+ DY+ G L T L + + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIV 139
Query: 915 RGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYV 974
L LH +++ DIK +N+L D++ L+DFGL + + E + GT+ Y+
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCGTIEYM 197
Query: 975 SPEAALTGET--TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032
+P+ G++ K D +S G+++ ELLTG P +++ + +++ K +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---- 253
Query: 1033 EPGLLELDPE-SSEWEEFLLGVKVALLCTAPDPIDRPTMS 1071
E S+ ++ + DP R
Sbjct: 254 -----PYPQEMSALAKDLIQR------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-25
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 39/294 (13%)
Query: 805 FDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTV 862
+ L R +Y VF+A + + ++ L + ++E + L +R N+
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGPNIIT 94
Query: 863 LRGYYAGAPDLRL-LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLH 921
L LV++++ N + L Q L + + L + H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCH 146
Query: 922 TSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAAL 980
+ ++H D+KP NV+ D + + L D+GL P V + + PE +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLV 202
Query: 981 TGET-TKESDVYSFGIVLLELLTGKRPVMFTQDE-DIVKWVKKQLQKGQITELLEPGLLE 1038
+ D++S G +L ++ K P D D + + K L + + ++ +E
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 1039 LDPESSE---------WEEFLLGVKVALL----------CTAPDPIDRPTMSDI 1073
LDP ++ WE F+ L+ D R T +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 5e-25
Identities = 64/289 (22%), Positives = 119/289 (41%), Gaps = 18/289 (6%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416
VP ++ +LLDL+ N+ + +++ L +L L N S P +F L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 417 ENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG--NAF 474
E L L N L LPE++ L L + EN+ + + L+Q++V L
Sbjct: 82 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
SG + + KL+ + ++ N + I P+L + L NK++ L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594
+L L LSFN + + + L + N + +P L + ++V+ L +N++
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254
Query: 595 TG------HIPTDISHLSHLNVLDLSINNLT-GEIPDEISKCSSLRSLL 636
+ P + + + + L N + EI +C +R+ +
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (254), Expect = 3e-24
Identities = 61/277 (22%), Positives = 102/277 (36%), Gaps = 13/277 (4%)
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
+LDLQ N+I L L + N IS P L +LE L ++ N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPG 415
K L + + E + + L + + L SG +F+ +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKK 151
Query: 416 LENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475
L + + +++ ++P+ + +L+ L L NK + AS+ L+ L LS N+ S
Sbjct: 152 LSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 476 GRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG------NVPEG 529
SL N L L L+ P LA +QV+ L N +S P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 530 FSSLMSLRYLNLSFN--GFVGQIPATFSFLRSVVVLS 564
+ S ++L N + P+TF + +
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (250), Expect = 1e-23
Identities = 63/314 (20%), Positives = 110/314 (35%), Gaps = 30/314 (9%)
Query: 355 GGAVPVEIKQCS-SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413
G P +C L ++ ++P+ L L L N + F+NL
Sbjct: 1 GPVCP---FRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNL 54
Query: 414 PGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNA 473
L L L +N +S P + L L LS+N+ L +L V
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 474 FSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533
+ L ++ + L + SG G+ L I + + ++ +P+G
Sbjct: 115 VRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP- 171
Query: 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNS 593
SL L+L N A+ L ++ L S N IS L N L L L +N
Sbjct: 172 -SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 594 LTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKL 653
L +P ++ ++ V+ L NN++ ++ P K
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC------------------PPGYNTKK 271
Query: 654 SNLAVLDLSANNLS 667
++ + + L +N +
Sbjct: 272 ASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 7e-23
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 36/284 (12%)
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNF 498
+L + S+ +VP + + +L N + NL L TL L
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 499 SGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG------------- 545
S P A L L+ + L +N+L + +L LR
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 546 ----------FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595
G F ++ + + + +I+ +IP G L L L N +T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 184
Query: 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSN 655
+ L++L L LS N+++ ++ LR L +N+N L +P LA
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 656 LAVLDLSANNLSG------EIPANLSSIFGLMNFNVSSNNLQAF 693
+ V+ L NN+S P + ++ SN +Q +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 7e-22
Identities = 62/273 (22%), Positives = 94/273 (34%), Gaps = 16/273 (5%)
Query: 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377
LD+ N I+ L L L + NN P L L L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 378 FSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH--NSLSGSLPEEVL 435
E+PE + + L + N + + F L + + L SG
Sbjct: 91 LK-ELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 436 GMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSK 495
GM LS + +++ + +P + L +L GN + ASL L L L LS
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 496 QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGF------VGQ 549
+ S LA P+L+ + L NKL VP G + ++ + L N
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 550 IPATFSFLRSVVVLSFSGNHIS-GSIPPELGNC 581
P + S +S N + I P C
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.0 bits (214), Expect = 5e-19
Identities = 52/301 (17%), Positives = 88/301 (29%), Gaps = 29/301 (9%)
Query: 153 EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI 212
++ DLP + DL +N + NL L + N P A
Sbjct: 24 KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN--------KISKISPGAF 75
Query: 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIR 272
A L L N L + L +L+V + V + + +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 135
Query: 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG 332
+ G L + + I +LT L + GN I+
Sbjct: 136 LKSSGIE-------NGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITK 185
Query: 333 KIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGL 392
A + GL L +L ++ NS + L L L N+ ++P L D + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENL-NLRHNSLSGSLPEEVLGMNNLSTLDLSENKFS 451
+ + L N S F + SL N + ++ + F
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS---------NPVQYWEIQPSTFR 295
Query: 452 G 452
Sbjct: 296 C 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 9e-18
Identities = 43/223 (19%), Positives = 79/223 (35%), Gaps = 7/223 (3%)
Query: 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFV 547
L + S ++P +L P+ ++ LQ NK++ F +L +L L L N
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 548 GQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSH 607
P F+ L + L S N + +L V E + + ++ +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 608 LNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
+ L + +G L + + +++ IP L +L L L N ++
Sbjct: 129 VE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 668 GEIPANLSSIFGLMNFNVSSNNLQAFANNQDLCGKPLGRKCEN 710
A+L + L +S N++ A N L N
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 6e-16
Identities = 37/228 (16%), Positives = 70/228 (30%), Gaps = 11/228 (4%)
Query: 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLE 585
VP+ L+L N F L+++ L N IS P LE
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 586 VLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGG 645
L L N L L L V + I + + + +++ + L N SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 646 IPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ-----AFANNQDLC 700
+ + L+ + ++ N++ S L ++ N + + +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNLA 198
Query: 701 GKPLGRKCENADDRDRRKKLILLIVIAASGACLLALCCCFYIFSLLRW 748
L +A D L + + L+ + ++
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 64/374 (17%), Positives = 113/374 (30%), Gaps = 86/374 (22%)
Query: 56 CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTL 115
C R V C++ + + + L L L++N
Sbjct: 10 CHLRVVQCSDLGLEK-----------VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 116 LRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGP 175
L + L N +S P L LE L ++ N+L E+ +P+ L+ + N +
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKV 115
Query: 176 IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
+ + L N +V L G+ A
Sbjct: 116 RKSVFNGL------------------------------NQMIVVELGTNPLKSSGIENGA 145
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295
+ KL + +A N++ +P + +
Sbjct: 146 FQGMKKLSYIRIADTNIT-TIPQGLPPS-------------------------------- 172
Query: 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFG 355
L L L N+I L + L +L +S NSIS + L EL + NN
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
Query: 356 GAVPVEIKQCSSLSLLDLEGNRFSG------EIPEFLGDIRGLKSLTLAAN--LFSGSIP 407
VP + + ++ L N S P + ++L +N + P
Sbjct: 233 K-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
Query: 408 ASFRNLPGLENLNL 421
++FR + + L
Sbjct: 292 STFRCVYVRAAVQL 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 1e-24
Identities = 58/304 (19%), Positives = 103/304 (33%), Gaps = 45/304 (14%)
Query: 803 RQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDEN---LFRKEAEFLGKVRHR 858
+++ + G+V A ++I++L ++ +E + V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 859 NLTVLRGYYAGAPDLR-----LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGV 913
N+ L + L LV + M + E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQM 128
Query: 914 ARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGY 973
G+ LH++ ++H D+KP N++ +D + DFGL R + T V T Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYY 184
Query: 974 VSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQL---------- 1023
+PE L + D++S G ++ E++ K D V +QL
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 1024 ----------QKGQITELLEPGLL--ELDPESSEWEEFLLGVKVALL--CTAPDPIDRPT 1069
+ + L P L L P SE + LL DP R +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 1070 MSDI 1073
+ D
Sbjct: 305 VDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-24
Identities = 59/294 (20%), Positives = 105/294 (35%), Gaps = 30/294 (10%)
Query: 800 EATRQFDEENVLSRTRYGLVFKA-CYNDGMVLSIRRLPDGSLDE---NLFRKEAEFLGKV 855
E ++ + + YG V A G+ +++++L +E L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 856 RHRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVAR 915
+H N+ L + A L Y+ +G L L + + R
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 916 GLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVS 975
GL ++H+++++H D+KP N+ + D E + DFGL R T T V T Y +
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRA 186
Query: 976 PEAAL-TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034
PE L + D++S G ++ ELLTG+ T D +K + + + G L
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV--GTPGAELLK 244
Query: 1035 GLLELDPE----------SSEWEEFLLGVKVALL-----CTAPDPIDRPTMSDI 1073
+ + +G + D R T +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (238), Expect = 2e-22
Identities = 64/265 (24%), Positives = 103/265 (38%), Gaps = 7/265 (2%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
++P + + L N +S NL+ L L N + A+ L+ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 465 MVFNLSGNAFSGRI-PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
+LS NA + PA+ L +L TL L + P GL LQ + LQ+N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSD 583
+ F L +L +L L N F L S+ L N ++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
L L L +N+L+ ++ L L L L+ N + + L+ +S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 644 GGIPDSLAKLSNLAVLDLSANNLSG 668
+P LA + L+AN+L G
Sbjct: 262 CSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 3e-21
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 8/274 (2%)
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
+ L ++P + + L N+ S AS L + L N +
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 479 PASLGNLLKLTTLDLSKQNFSGEL-PIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLR 537
A+ L L LDLS + P GL L + L L P F L +L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 538 YLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGH 597
YL L N TF L ++ L GN IS L+ L L N +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 598 IPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLA 657
P L L L L NNL+ + ++ +L+ L +N N + + L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQ 251
Query: 658 VLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
S++ + +P L+ G +++N+LQ
Sbjct: 252 KFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 8e-18
Identities = 47/276 (17%), Positives = 82/276 (29%), Gaps = 17/276 (6%)
Query: 153 EIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAI 212
+ +P + L N S S L ++ N +R A F
Sbjct: 25 AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF-------T 77
Query: 213 ANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIR 272
+ L V P L +L + +L + + +++
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL-----HLDRCGLQELGPGLFRGLAALQ 132
Query: 273 VVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISG 332
+ L NA + +T L L L N+I +L RL + N ++
Sbjct: 133 YLYLQDNALQALP-DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 333 KIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGL 392
P L RL L + N+ + +L L L N + + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL 250
Query: 393 KSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG 428
+ +++ S+P G + L N L G
Sbjct: 251 QKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 9e-18
Identities = 63/280 (22%), Positives = 96/280 (34%), Gaps = 29/280 (10%)
Query: 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377
+ R+ + GN IS A L L + +N + L LDL N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 378 FSGEI-PEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG 436
+ P + L +L L P FR L L+ L L+ N+L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 437 MNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
+ NL+ L L N+ S + L L L N + P + +L +L TL L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA- 210
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSF 556
N LS E + L +L+YL L+ N +V A
Sbjct: 211 -----------------------NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246
Query: 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG 596
+ S + + S+P L ++ L +N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 5e-17
Identities = 57/269 (21%), Positives = 96/269 (35%), Gaps = 11/269 (4%)
Query: 232 IPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGS 291
+P I Q + L N +S V PA+ F ++ ++ L N +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHV-PAASFRAC----RNLTILWLHSNVLARIDAAAFTG 78
Query: 292 CSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351
+ + Q+ Q+R P L L + + P GL L+ L + +
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 352 NSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFR 411
N+ + +L+ L L GNR S + L L L N + P +FR
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
+L L L L N+LS E + + L L L++N + + + + L F S
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSS 257
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSG 500
+ +P L L+ + G
Sbjct: 258 SEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 5e-17
Identities = 61/255 (23%), Positives = 88/255 (34%), Gaps = 5/255 (1%)
Query: 438 NNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQN 497
T + VP I SQ L GN S AS LT L L
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 498 FSGELPIELAGLPNLQVIALQENKLSGNV-PEGFSSLMSLRYLNLSFNGFVGQIPATFSF 556
+ GL L+ + L +N +V P F L L L+L G P F
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSIN 616
L ++ L N + + +L L L N ++ L L+ L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 617 NLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSS 676
+ P L +L + +N+LS ++LA L L L L+ N + A
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
Query: 677 IFGLMNFNVSSNNLQ 691
+ L F SS+ +
Sbjct: 248 AW-LQKFRGSSSEVP 261
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (161), Expect = 2e-12
Identities = 53/291 (18%), Positives = 90/291 (30%), Gaps = 24/291 (8%)
Query: 55 PCDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCT 114
PC C N P+ L + + +++ L N + A+ C
Sbjct: 1 PCP-GACVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACR 56
Query: 115 LLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN---DLPRNLKYFDLSSNG 171
L ++L N L+ A L+ LE L+++ N + L L G
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 172 FSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGV 231
P L+ LQ + N + + +L HL GN + V
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNA--------LQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 232 IPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGS 291
A L L + L QN ++ V P + + N + +
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF-----ANNLSALPTEALAP 223
Query: 292 CSSVLQVLDLQQNQIRGAFPL-WLTRASTLTRLDVSGNSISGKIPAQIGGL 341
+ LQ L L N L + L + S + + +P ++ G
Sbjct: 224 LRA-LQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAGR 271
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 94.4 bits (233), Expect = 2e-21
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 15/270 (5%)
Query: 439 NLSTLDLSENKFSG--EVPASIGNLSQLMVFNLSGNA-FSGRIPASLGNLLKLTTLDLSK 495
++ LDLS +P+S+ NL L + G G IP ++ L +L L ++
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 496 QNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFS 555
N SG +P L+ + L + N LSG +P SSL +L + N G IP ++
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 556 FLRS-VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLS 614
++ S N ++G IPP + S ++ + +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANL 674
N ++ +L L + +N + G +P L +L L L++S NNL GEIP
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP--- 285
Query: 675 SSIFGLMNFNVSSNNLQAFANNQDLCGKPL 704
L F+VS+ +ANN+ LCG PL
Sbjct: 286 -QGGNLQRFDVSA-----YANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 88.3 bits (217), Expect = 2e-19
Identities = 78/350 (22%), Positives = 119/350 (34%), Gaps = 52/350 (14%)
Query: 26 EIEALTSFKLNLHDPLGALNGWDSSTPAAPCDWRGVACTNN----RVTELRLPRLQLSGR 81
+ +AL K +L +P L+ W +T W GV C + RV L L L L
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 82 --ISDHLSNLRMLRKLSLRSN-SFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLS 138
I L+NL L L + + G IP +A+ T L +++ + ++SG +P + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 139 NLEILNVAANRLSGEIANDL--PRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKF 196
L L+ + N LSG + + NL N SG IP S + S+L
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 197 SREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVV 256
L A + S + G Q
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--------------QKIHLAKN 231
Query: 257 PASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTR 316
+ G ++ + L N G P LT+
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIY-------------------------GTLPQGLTQ 266
Query: 317 ASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCS 366
L L+VS N++ G+IP Q G L R + ANN P + C+
Sbjct: 267 LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.4 bits (207), Expect = 4e-18
Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 9/272 (3%)
Query: 315 TRASTLTRLDVSGNSISGK--IPAQIGGLWRLEELKMANN-SFGGAVPVEIKQCSSLSLL 371
T+ + LD+SG ++ IP+ + L L L + + G +P I + + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 372 DLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLP 431
+ SG IP+FL I+ L +L + N SG++P S +LP L + N +SG++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 432 EEVLGMNNLST-LDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTT 490
+ + L T + +S N+ +G++P + N + F + L K T
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 491 LDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQI 550
+N ++ NL + L+ N++ G +P+G + L L LN+SFN G+I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 551 PATFSFLRSVVVLSFSGNHISGSIPPELGNCS 582
P L+ V +++ N P L C+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.2 bits (183), Expect = 5e-15
Identities = 58/283 (20%), Positives = 95/283 (33%), Gaps = 13/283 (4%)
Query: 201 PATFEGTLPSAIANCSSLVHLSAQGNALGGV--IPPAIGALPKLQVVSLAQN-NLSGVVP 257
T+ G L + +L G L IP ++ LP L + + NL G +P
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 258 ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRA 317
++ + + + + S L LD N + G P ++
Sbjct: 95 PAIAKL-----TQLHYLYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 318 STLTRLDVSGNSISGKIPAQIGGLWRLEE-LKMANNSFGGAVPVEIKQCSSLSLLDLEGN 376
L + GN ISG IP G +L + ++ N G +P +
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF--VDLSR 206
Query: 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLG 436
L A L L+LR+N + G+LP+ +
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 437 MNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP 479
+ L +L++S N GE+P GNL + V + N P
Sbjct: 267 LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.6 bits (179), Expect = 1e-14
Identities = 56/268 (20%), Positives = 100/268 (37%), Gaps = 17/268 (6%)
Query: 166 DLSSNGFSG--PIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSA 223
DLS PIP+S++NL L + G +P AIA + L +L
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN-------LVGPIPPAIAKLTQLHYLYI 108
Query: 224 QGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTN 283
+ G IP + + L + + N LSG +P S+ P++ + N +
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL-----PNLVGITFDGNRISG 163
Query: 284 VAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWR 343
GS S + + + +N++ G P + ++ + + G +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDK 221
Query: 344 LEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFS 403
+ + ++ +L+ LDL NR G +P+ L ++ L SL ++ N
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 404 GSIPASFRNLPGLENLNLRHNSLSGSLP 431
G IP NL + +N P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 8e-14
Identities = 61/277 (22%), Positives = 100/277 (36%), Gaps = 9/277 (3%)
Query: 230 GVIPPAIGALPKLQVVSLAQNNLSGVVP-ASMFCNVSGYPPSIRVVQLGFNAFTNVAGPE 288
GV+ ++ + L+ NL P S N+ P + + +G P
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL----PYLNFLYIGGINNLVGPIPP 95
Query: 289 TGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELK 348
+ + L L + + GA P +L++ TL LD S N++SG +P I L L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 349 MANNSFGGAVPVEIKQCSSLSL-LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIP 407
N GA+P S L + + NR +G+IP ++ +
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDA 213
Query: 408 ASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVF 467
+ + +V NL+ LDL N+ G +P + L L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 468 NLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPI 504
N+S N G IP GNL + + P+
Sbjct: 274 NVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 0.001
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 603 SHLSHLNVLDLSINNLTG--EIPDEISKCSSLR-SLLVNSNHLSGGIPDSLAKLSNLAVL 659
+ +N LDLS NL IP ++ L + N+L G IP ++AKL+ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 660 DLSANNLSGEIPANLSSIFGLMNFNVSSNN 689
++ N+SG IP LS I L+ + S N
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.6 bits (218), Expect = 3e-19
Identities = 51/248 (20%), Positives = 91/248 (36%), Gaps = 19/248 (7%)
Query: 816 YGLVFKA-CYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLR 874
+ V+ A + ++++ + + E + L +V + T A L+
Sbjct: 26 FSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI-LK 84
Query: 875 LLVY--DYMPNGNLGTLLQEASHQDGHVL---------NWPMRHLIALGVARGLAFLHTS 923
LL + PNG ++ E ++ L I+ + GL ++H
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR 144
Query: 924 -NMVHGDIKPQNVLFDA-DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALT 981
++H DIKP+NVL + D +L + L T ++ T Y SPE L
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHYTNSIQTREYRSPEVLLG 203
Query: 982 GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041
+D++S ++ EL+TG + ++ + K QI ELL L
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLF---EPDEGHSYTKDDDHIAQIIELLGELPSYLLR 260
Query: 1042 ESSEWEEF 1049
F
Sbjct: 261 NGKYTRTF 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (169), Expect = 2e-13
Identities = 43/274 (15%), Positives = 91/274 (33%), Gaps = 16/274 (5%)
Query: 371 LDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL 430
LDL G ++ L +G+ + + + F +++++L ++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 431 PEEVLG-MNNLSTLDLSENKFSGEVPASIGNLSQL--------MVFNLSGNAFSGRIPAS 481
+L + L L L + S + ++ S L F+ +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNL 541
L L D ++++ + + L + ++N ++ +L +L+L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 542 SFN-GFVGQIPATFSFLRSVVVLSFSG-NHISGSIPPELGNCSDLEVLELRSNSLTGHIP 599
S + F L + LS S I ELG L+ L++ G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 600 TDISHLSHLNVLDLSINNLTGEIPDEISKCSSLR 633
L HL + + ++ T I +
Sbjct: 243 LLKEALPHLQI---NCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 3e-12
Identities = 42/285 (14%), Positives = 91/285 (31%), Gaps = 16/285 (5%)
Query: 143 LNVAANRLSGE-IANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVP 201
L++ L + L + + F + P+ S ++Q ++ S +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS-- 61
Query: 202 ATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLA--QNNLSGVVPAS 259
TL ++ CS L +LS +G L I + L ++L+ +
Sbjct: 62 -----TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116
Query: 260 MFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRAST 319
+ ++ VA + L + ++N + + R
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 320 LTRLDVSGN-SISGKIPAQIGGLWRLEELKMAN-NSFGGAVPVEIKQCSSLSLLDLEGNR 377
L LD+S + + + L L+ L ++ +E+ + +L L + G
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 378 FSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLR 422
G + L L + + F+ + N E ++
Sbjct: 237 PDGTLQLL---KEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.5 bits (158), Expect = 6e-12
Identities = 45/281 (16%), Positives = 91/281 (32%), Gaps = 16/281 (5%)
Query: 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSG 380
LD++G ++ + ++ + + + + E + +DL +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 381 E-IPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRH--NSLSGSLPEEVLGM 437
+ L L++L+L S I + L LNL +L +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 438 NNLSTLDL------SENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTL 491
+ L L+L +E V ++QL + N + + L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 492 DLSK-QNFSGELPIELAGLPNLQVIALQE-NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQ 549
DLS + E L LQ ++L + + +L+ L + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 550 IPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELR 590
+ L L + +H + P +GN + E+ ++
Sbjct: 241 LQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 563 LSFSGNHISGSIPPELGNCSDLEVLELR-SNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
L +G ++ P G V+ R S + + +DLS + +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 622 -IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLD 660
+ +S+CS L++L + LS I ++LAK SNL L+
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (164), Expect = 7e-13
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 7/210 (3%)
Query: 409 SFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFN 468
+ +N +L+ +LP ++ + + L LSEN A++ ++L N
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 469 LSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPE 528
L + L + N LP+ LP L V+ + N+L+
Sbjct: 62 LDRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 529 GFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLE 588
L L+ L L N P + + LS + N+++ L +L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 589 LRSNSLTGHIPTDISHLSHLNVLDLSINNL 618
L+ NSL IP L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 43/207 (20%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 481 SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLN 540
+ + ++ K+N + LP +L + ++ L EN L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 541 LS---------------------FNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579
L + + +P L ++ VL S N ++ L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 580 NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNS 639
+L+ L L+ N L P ++ L L L+ NNLT ++ +L +LL+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 640 NHLSGGIPDSLAKLSNLAVLDLSANNL 666
N L IP L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 7e-09
Identities = 37/206 (17%), Positives = 65/206 (31%), Gaps = 9/206 (4%)
Query: 291 SCSSV--LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELK 348
S V ++ + + A P L + T L +S N + A + RL +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 349 MANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA 408
+ +++ + + +P + L L ++ N +
Sbjct: 62 LDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 409 SFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFN 468
+ R L L+ L L+ N L P + L L L+ N + + L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 469 LSGNAFSGRIPASLGNLLKLTTLDLS 494
L N+ IP L L
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLH 203
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 34/221 (15%), Positives = 67/221 (30%), Gaps = 19/221 (8%)
Query: 134 IGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSF 193
+ +++ +N L+ + DLP++ LS N ++ ++L +N
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 194 NKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLS 253
+ ++ L + + + L L G L + + + A L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 254 GVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLW 313
+ + N P P + + L+ L L N +
Sbjct: 125 ELQELYLKGNELKTLP-----------------PGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 314 LTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSF 354
L L L + NS+ IP G L + N +
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 35/248 (14%), Positives = 64/248 (25%), Gaps = 45/248 (18%)
Query: 179 SISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA 238
+S ++ +N + LP + L N L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT---------ALPPDLP--KDTTILHLSENLLYTFSLATLMP 53
Query: 239 LPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQV 298
+L ++L + L+ + + S +Q +
Sbjct: 54 YTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV------ 107
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
N++ L L L + GN + P + +LE+L +ANN+
Sbjct: 108 ---SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
+ +L L L+ N +IP F L
Sbjct: 165 AGLLNGLENLDTLLLQENSLY-------------------------TIPKGFFGSHLLPF 199
Query: 419 LNLRHNSL 426
L N
Sbjct: 200 AFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 4e-04
Identities = 33/210 (15%), Positives = 60/210 (28%), Gaps = 24/210 (11%)
Query: 87 SNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVA 146
S + +++ + +P L + L N L A + + L LN+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 147 ANRLSGEIANDLPRNLKYFDLSSNGFSGPIPT---------------SISNLSQLQLINF 191
L+ + L DLS N +++L L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 192 SFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNN 251
+ + P + L LS N L + + L L + L +N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 252 LSGVVPASMFCNVSGYPPSIRVVQLGFNAF 281
L +P F + + L N +
Sbjct: 184 LY-TIPKGFFGS-----HLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 19/75 (25%), Positives = 30/75 (40%), Gaps = 3/75 (4%)
Query: 625 EISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFN 684
E+SK +S + + +L+ +P L K + +L LS N L A L L N
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 685 VSSNNLQAFANNQDL 699
+ L + L
Sbjct: 62 LDRAELTKLQVDGTL 76
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 29/216 (13%), Positives = 49/216 (22%), Gaps = 25/216 (11%)
Query: 52 PAAPCDWRG----VACTNNR-----------VTELRLPRLQLSGRISDHLSNLRMLRKLS 96
P V C T L L L L L +L+
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 97 LRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN 156
L + L + L+ L++ L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
L + + N P ++ +L+ ++ + N + +
Sbjct: 122 GLGELQELYL-KGNELKTLPPGLLTPTPKLEKLSLANNNLT--------ELPAGLLNGLE 172
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNL 252
+L L Q N+ IP L L N
Sbjct: 173 NLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 3e-12
Identities = 23/154 (14%), Positives = 41/154 (26%), Gaps = 23/154 (14%)
Query: 809 NVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-----------ENLFRKEAEFLGKVRH 857
++ + VF ++ G + F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 858 RNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHL-IALGVARG 916
R L L+G Y + N +L E + +
Sbjct: 66 RALQKLQGLAVPKV------YAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 917 LAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950
+A + +VHGD+ NVL + + DF
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 56.9 bits (136), Expect = 1e-09
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 22/215 (10%)
Query: 454 VPASIG------NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELA 507
VP I ++ + NL + + + + L + + + + I+
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQ-- 65
Query: 508 GLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG 567
LPN+ + L NKL+ P + +L+ + + + S
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS------LSL 119
Query: 568 NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEIS 627
H S L + LE L L +N +T L+ L+ L L N ++ +P ++
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LA 175
Query: 628 KCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662
+ L++L ++ NH+S +LA L NL VL+L
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 35/207 (16%), Positives = 64/207 (30%), Gaps = 28/207 (13%)
Query: 357 AVPVEIKQ------CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASF 410
VP IKQ + +L+ + + + ++ + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--I 64
Query: 411 RNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENK---------------FSGEVP 455
+ LP + L L N L+ P L LD ++ K
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 456 ASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVI 515
+ I L L + ++ + L + N ++ LAGL LQ +
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183
Query: 516 ALQENKLSGNVPEGFSSLMSLRYLNLS 542
L +N +S + L +L L L
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 37/199 (18%), Positives = 72/199 (36%), Gaps = 19/199 (9%)
Query: 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
+ +L K++ + + L ++ I + + +G L ++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDIS 603
N P + L+++ L N + + +S SL + +DI+
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKL-------KSLSLEHNGISDIN 128
Query: 604 HLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSA 663
L HL L+ + + L ++ I LA L+ L L LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187
Query: 664 NNLSGEIPANLSSIFGLMN 682
N++S +L ++ GL N
Sbjct: 188 NHIS-----DLRALAGLKN 201
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 16/197 (8%)
Query: 395 LTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454
L + ++ + L ++ + ++ + + L N++ L L+ NK +
Sbjct: 29 DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYL--PNVTKLFLNGNKLTDIK 84
Query: 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQV 514
P + NL L L N LS ++ L LP L+
Sbjct: 85 P--LANLKNLGWLFLDENKVKDLSSLKDLK----KLKSLSLEHNGISDINGLVHLPQLES 138
Query: 515 IALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSI 574
+ L NK++ L L L+L N +P + L + L S NHIS
Sbjct: 139 LYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 575 PPELGNCSDLEVLELRS 591
L +L+VLEL S
Sbjct: 193 LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 27/198 (13%), Positives = 60/198 (30%), Gaps = 16/198 (8%)
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
+L++ + + +++ ++ + + I I L + +L + N
Sbjct: 29 DNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
P+ + LD + + + +++ +L N
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
LS + L + + D+ + L++L LS N S
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP----------LAGLTKLQNLYLSKNHISD-- 192
Query: 479 PASLGNLLKLTTLDLSKQ 496
+L L L L+L Q
Sbjct: 193 LRALAGLKNLDVLELFSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 24/178 (13%), Positives = 55/178 (30%), Gaps = 14/178 (7%)
Query: 87 SNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVA 146
K +L+ S + T + + + + + I L N+ L +
Sbjct: 21 DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 147 ANRLSGEIANDLPRNLKYFDLSSNGF---------SGPIPTSISNLSQLQLINFSFNKFS 197
N+L+ +NL + L N S+ + +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 198 REVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255
+ + + + + + + I P + L KLQ + L++N++S +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 193
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 30/224 (13%), Positives = 72/224 (32%), Gaps = 18/224 (8%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L + ++++ ++ + L + ++TL + + L+ L+ L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
N + P +L+K L + + + + +
Sbjct: 73 NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
+ ++ + QI + S + S L N S L L+
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 592 NSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSL 635
N ++ P ++ L +L + L N ++ P ++ S+L +
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 39/212 (18%), Positives = 70/212 (33%), Gaps = 21/212 (9%)
Query: 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
L + K N + + A L + ++ ++ EG L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDIS 603
N P + + LS + +I + ++ +++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 604 HLSHLNVLDLSINNLTG--------------EIPDEISKCSSLRSLLVNSNHLSGGIPDS 649
L +I+ L G ++ S L +L + N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 650 LAKLSNLAVLDLSANNLSGEIP-ANLSSIFGL 680
LA L NL + L N +S P AN S++F +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIV 222
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 36/218 (16%), Positives = 76/218 (34%), Gaps = 24/218 (11%)
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIE-LAGLPNLQVIALQ 518
L+ + + + + + +L +TTL + IE + L NL + L+
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELK 71
Query: 519 ENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSG----------- 567
+N+++ P + ++ L+ + V I S + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 568 ---NHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPD 624
I + L + T +++LS L L N ++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 625 EISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLS 662
++ +L + + +N +S P LA SNL ++ L+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 34/212 (16%), Positives = 69/212 (32%), Gaps = 22/212 (10%)
Query: 299 LDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV 358
+ ++ + + +T L G ++ I + L L L++ +N
Sbjct: 24 IAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLA 79
Query: 359 PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLEN 418
P++ + L + I + T ++ + ++ + L N
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 419 LNLRHNSL--------------SGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
+ L S + ++ L+TL +NK S P + +L L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
+ +L N S P L N L + L+ Q
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 32/227 (14%), Positives = 72/227 (31%), Gaps = 19/227 (8%)
Query: 366 SSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNS 425
++ + + + + D+ G+ +L+ + +I + L L L L+ N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 426 LSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNL 485
++ P + L L + K + + + + ++L L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 486 LKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNG 545
+ +G ++ + ++L L L N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYL----------SIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 546 FVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592
P + L +++ + N IS P L N S+L ++ L +N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 28/216 (12%), Positives = 58/216 (26%), Gaps = 6/216 (2%)
Query: 136 NLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNK 195
L+N + + ++ + + G + + L+ L + N+
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 196 FSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGV 255
+ P + + + L ++SA +NL +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 256 VPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLT 315
+ +Q V+ + S L L N+I P L
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMAN 351
L + + N IS P + L + + N
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 41/253 (16%), Positives = 73/253 (28%), Gaps = 38/253 (15%)
Query: 177 PTSIS------NLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGG 230
PT+I+ L+ I + + V A+ + LSA G +
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVT----------QADLDGITTLSAFGTGVTT 55
Query: 231 VIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETG 290
+ + L L + L N ++ + P ++ S ++ +
Sbjct: 56 I--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTL- 112
Query: 291 SCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA 350
+ L S L L + N I+ P + + A
Sbjct: 113 -----------DLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA 161
Query: 351 NNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASF 410
S + S L+ L + N+ S P L + L + L N S P
Sbjct: 162 QVSD----LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--L 213
Query: 411 RNLPGLENLNLRH 423
N L + L +
Sbjct: 214 ANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 133 NIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFS 192
+ NLS L L N++S NL L +N S P ++N S L ++ +
Sbjct: 168 PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 31/208 (14%), Positives = 64/208 (30%), Gaps = 38/208 (18%)
Query: 88 NLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAA 147
L K++ ++ T+ T A + + ++ + + L+NL L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREV------- 200
N+++ + +LS N + + + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 201 -------------------------PATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPA 235
+ + + +AN S L L A N + + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 236 IGALPKLQVVSLAQNNLSGVVPASMFCN 263
+ +LP L V L N +S V P + N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 2e-09
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 420 NLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP 479
N+ S + +L L++S NK E+PA L +L S N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320
Query: 480 ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQV 514
N L L + E P + +L++
Sbjct: 321 ELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 6e-09
Identities = 28/88 (31%), Positives = 36/88 (40%), Gaps = 10/88 (11%)
Query: 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIG 459
N S I + P LE LN+ +N L LP L L S N + EVP
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQ 324
Query: 460 NLSQLMVFNLSGNAFSG--RIPASLGNL 485
NL QL ++ N IP S+ +L
Sbjct: 325 NLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 1e-08
Identities = 56/364 (15%), Positives = 102/364 (28%), Gaps = 35/364 (9%)
Query: 43 ALNGWDSSTPAAPCDWRGVA------CTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLS 96
A + W+ + P + R +A C + + EL L L LS + + +L L
Sbjct: 9 AWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLE---SLV 64
Query: 97 LRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN 156
NS +P L+ + N + +L L +N ++
Sbjct: 65 ASCNSLT-ELPELPQS--------LKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 115
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCS 216
+ N +P +L + N + F + + +
Sbjct: 116 LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175
Query: 217 SLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSI----- 271
L L ++ + L + ++
Sbjct: 176 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNY 235
Query: 272 --RVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNS 329
+ +L + S S L N +L L+VS N
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 330 ISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDI 389
+ ++PA RLE L + N VP +L L +E N E P+ +
Sbjct: 296 LI-ELPALPP---RLERLIASFNHL-AEVPELP---QNLKQLHVEYNPLR-EFPDIPESV 346
Query: 390 RGLK 393
L+
Sbjct: 347 EDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 1e-08
Identities = 22/91 (24%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 589 LRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPD 648
N+ + I + L L++S N L E+P L L+ + NHL+ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 649 SLAKLSNLAVLDLSANNLSG--EIPANLSSI 677
NL L + N L +IP ++ +
Sbjct: 322 L---PQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 23/94 (24%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 517 LQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPP 576
N S + SL LN+S N + ++PA L L S NH++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPE 321
Query: 577 ELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNV 610
N L+ L + N L P + L +
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 97 LRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIAN 156
N+ + I + L + + N L LPA L E L + N L+ E+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EV-P 320
Query: 157 DLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLIN 190
+LP+NLK + N P ++ L++ +
Sbjct: 321 ELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 25/96 (26%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 465 MVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSG 524
NA S I + L L++S ELP A P L+ + N L+
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA- 317
Query: 525 NVPEGFSSLMSLRYLNLSFNGF--VGQIPATFSFLR 558
VPE +L+ L++ +N IP + LR
Sbjct: 318 EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 8/64 (12%)
Query: 581 CSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
LEL + L+ +P HL L S N+LT E+P+ SL+SLLV++N
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELP---QSLKSLLVDNN 88
Query: 641 HLSG 644
+L
Sbjct: 89 NLKA 92
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 2e-09
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 562 VLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE 621
VL + ++ + L + L+L N L P ++ L L VL ++ E
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALE 56
Query: 622 IPDEISKCSSLRSLLVNSNHLSGG-IPDSLAKLSNLAVLDLSANNLSGE 669
D ++ L+ LL+ +N L L L +L+L N+L E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 4e-09
Identities = 25/128 (19%), Positives = 45/128 (35%), Gaps = 9/128 (7%)
Query: 513 QVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISG 572
+V+ L L+ V L+ + +L+LS N P + + + +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNAL 55
Query: 573 SIPPELGNCSDLEVLELRSNSLTG-HIPTDISHLSHLNVLDLSINNLTGE---IPDEISK 628
+ N L+ L L +N L + L +L+L N+L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 629 CSSLRSLL 636
S+ S+L
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 6e-08
Identities = 28/130 (21%), Positives = 44/130 (33%), Gaps = 9/130 (6%)
Query: 93 RKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSG 152
R L L T+ L Q L+ + L +N L P + L LE+L + N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 153 EIANDLPRNLKYFDLSSNGF-SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSA 211
L+ L +N + + +L L+N N +E EG
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-----EGIQERL 112
Query: 212 IANCSSLVHL 221
S+ +
Sbjct: 113 AEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 3e-07
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 9/125 (7%)
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
L+L H L+ + + ++ LDLS N+ P ++ L L V + +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 479 PASLGNLLKLTTLDLSKQNF-SGELPIELAGLPNLQVIALQENKLS---GNVPEGFSSLM 534
+ NL +L L L L P L ++ LQ N L G L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 535 SLRYL 539
S+ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 29/132 (21%), Positives = 44/132 (33%), Gaps = 28/132 (21%)
Query: 297 QVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGG 356
+VL L + L + +T LD+S N + PA + L LE L+ ++N+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE- 56
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416
+ L L L NR + + P L
Sbjct: 57 -NVDGVANLPRLQELLLCNNRLQ-----------------------QSAAIQPLVSCPRL 92
Query: 417 ENLNLRHNSLSG 428
LNL+ NSL
Sbjct: 93 VLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 9/121 (7%)
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL-TLAANLFSGS 405
L +A+ V ++Q ++ LDL NR P L+ L L A+ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNALE 56
Query: 406 IPASFRNLPGLENLNLRHNSL-SGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
NLP L+ L L +N L + + ++ L L+L N E L+++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQERLAEM 115
Query: 465 M 465
+
Sbjct: 116 L 116
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 5e-09
Identities = 15/103 (14%), Positives = 33/103 (32%), Gaps = 5/103 (4%)
Query: 161 NLKYFDLSSNGFS-GPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219
+++ D+ S + L Q Q++ + + SA+ +L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----ISSALRVNPALA 58
Query: 220 HLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFC 262
L+ + N LG V + + + + +L C
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 8e-09
Identities = 14/89 (15%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 608 LNVLDLSINNLTGE-IPDEISKCSSLRSLLVNSNHLSG----GIPDSLAKLSNLAVLDLS 662
+ LD+ L+ + + + + ++ L+ I +L LA L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 663 ANNLSGEIPANLSSIFGLMNFNVSSNNLQ 691
+N L + + + +LQ
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 1e-08
Identities = 19/90 (21%), Positives = 27/90 (30%), Gaps = 9/90 (10%)
Query: 407 PASFRNLPGLENLNLRHNSLSG----SLPEEVLGMNNLSTLDLSENKFSGEVPASIG--- 459
+ L L L +S SL +L ++L LDLS N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 460 --NLSQLMVFNLSGNAFSGRIPASLGNLLK 487
L L +S + L L K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 1e-08
Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 5/92 (5%)
Query: 439 NLSTLDLSENKFSGE-VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLK----LTTLDL 493
++ +LD+ + S + L Q V L + + + L+ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 494 SKQNFSGELPIELAGLPNLQVIALQENKLSGN 525
+ +Q+ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 1e-08
Identities = 18/90 (20%), Positives = 31/90 (34%), Gaps = 9/90 (10%)
Query: 597 HIPTDISHLSHLNVLDLSINNLTGE----IPDEISKCSSLRSLLVNSNHLSGGIPDSLAK 652
S L VL L+ +++ + + SLR L +++N L L +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 653 -----LSNLAVLDLSANNLSGEIPANLSSI 677
L L L S E+ L ++
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 4e-08
Identities = 19/109 (17%), Positives = 31/109 (28%), Gaps = 15/109 (13%)
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISG----SIPPELGNCSDLEVLELRSNSLTGHIP 599
G + VL + +S S+ L L L+L +N L
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 600 TDIS-----HLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
+ L L L + E+ D L++L + L
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 5e-08
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 583 DLEVLELRSNSLT-GHIPTDISHLSHLNVLDLSINNLTGE----IPDEISKCSSLRSLLV 637
D++ L+++ L+ + L V+ L LT I + +L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 638 NSNHLSGGIPDSLAKL-----SNLAVLDLSANN 665
SN L + + + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 8e-08
Identities = 18/83 (21%), Positives = 29/83 (34%), Gaps = 9/83 (10%)
Query: 580 NCSDLEVLELRSNSLTG----HIPTDISHLSHLNVLDLSINNLTGEIPDEISK-----CS 630
S L VL L ++ + + L LDLS N L ++ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 631 SLRSLLVNSNHLSGGIPDSLAKL 653
L L++ + S + D L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 20/104 (19%), Positives = 32/104 (30%), Gaps = 23/104 (22%)
Query: 291 SCSSVLQVLDLQQNQIRG----AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEE 346
SVL+VL L + + L +L LD+S N + Q+ R
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR--- 422
Query: 347 LKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIR 390
+ L L L +S E+ + L +
Sbjct: 423 ----------------QPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 16/75 (21%), Positives = 26/75 (34%), Gaps = 5/75 (6%)
Query: 486 LKLTTLDLSKQNFSGELPIELA-GLPNLQVIALQENKLSG----NVPEGFSSLMSLRYLN 540
L + +LD+ + S EL L QV+ L + L+ ++ +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 541 LSFNGFVGQIPATFS 555
L N
Sbjct: 62 LRSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 16/87 (18%), Positives = 26/87 (29%), Gaps = 5/87 (5%)
Query: 563 LSFSGNHISGSIPPEL-GNCSDLEVLELRSNSLTG----HIPTDISHLSHLNVLDLSINN 617
L +S + EL +V+ L LT I + + L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 618 LTGEIPDEISKCSSLRSLLVNSNHLSG 644
L + + S + L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 22/92 (23%), Positives = 33/92 (35%), Gaps = 12/92 (13%)
Query: 367 SLSL--LDLEGNRFSGE-IPEFLGDIRGLKSLTLAANLFSG----SIPASFRNLPGLENL 419
SL + LD++ S E L ++ + + L + I ++ R P L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 420 NLRHNSLSGSLPEEVLGM-----NNLSTLDLS 446
NLR N L VL + L L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 12/83 (14%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 320 LTRLDVSGNSISGKIPAQI-GGLWRLEELKMANNSFGGAVPVEI----KQCSSLSLLDLE 374
+ LD+ +S A++ L + + +++ + A +I + +L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 375 GNRFSGEIPEFLGDIRGLKSLTL 397
N + S +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 9/81 (11%)
Query: 392 LKSLTLAANLFSG----SIPASFRNLPGLENLNLRHNSLSGSLPEEVLG-----MNNLST 442
L+ L LA S S+ A+ L L+L +N L + +++ L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 443 LDLSENKFSGEVPASIGNLSQ 463
L L + +S E+ + L +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 11/91 (12%), Positives = 27/91 (29%), Gaps = 10/91 (10%)
Query: 392 LKSLTLAANLFSGS-IPASFRNLPGLENLNLRHNSLSG----SLPEEVLGMNNLSTLDLS 446
++SL + S + L + + L L+ + + L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 447 ENKFSGEVPASIG-----NLSQLMVFNLSGN 472
N+ + ++ +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 7e-06
Identities = 13/92 (14%), Positives = 26/92 (28%), Gaps = 5/92 (5%)
Query: 534 MSLRYLNLSFNGFV-GQIPATFSFLRSVVVLSFSGNHISG----SIPPELGNCSDLEVLE 588
+ ++ L++ + L+ V+ ++ I L L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 589 LRSNSLTGHIPTDISHLSHLNVLDLSINNLTG 620
LRSN L + + +L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 17/97 (17%), Positives = 29/97 (29%), Gaps = 10/97 (10%)
Query: 335 PAQIGGLWRLEELKMANNSFGG----AVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDI- 389
L L +A+ ++ + SL LDL N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 390 ----RGLKSLTLAANLFSGSIPASFRNLPGLENLNLR 422
L+ L L +S + + L + +LR
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE-KDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 11/89 (12%), Positives = 30/89 (33%), Gaps = 12/89 (13%)
Query: 116 LRAVFLQYNSLSGN-LPANIGNLSNLEILNVAANRLSGEIANDLP------RNLKYFDLS 168
++++ +Q LS + L +++ + L+ D+ L +L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 169 SNGFSGPIPTSI-----SNLSQLQLINFS 192
SN + + ++Q ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 11/90 (12%)
Query: 107 PATLAQCTLLRAVFLQYNSLSGN----LPANIGNLSNLEILNVAANRLSGEIANDLPR-- 160
++LR ++L +S + L A + +L L+++ N L L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 161 -----NLKYFDLSSNGFSGPIPTSISNLSQ 185
L+ L +S + + L +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 13/98 (13%)
Query: 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLK----LTTLDLSKQNFSGELPIELAG-- 508
S L V L+ S +SL L L LDLS ++L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 509 ---LPNLQVIALQENKLSGNVPEGFSSLM----SLRYL 539
L+ + L + S + + +L SLR +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 296 LQVLDLQQNQIRGA-FPLWLTRASTLTRLDVSGNSISGK----IPAQIGGLWRLEELKMA 350
+Q LD+Q ++ A + L + + ++ I + + L EL +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 351 NNSFGGAVPVEI-----KQCSSLSLLDLEGNRF 378
+N G + + L L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 11/82 (13%), Positives = 28/82 (34%), Gaps = 5/82 (6%)
Query: 92 LRKLSLRSNSFNGT-IPATLAQCTLLRAVFLQYNSLSG----NLPANIGNLSNLEILNVA 146
++ L ++ + L + V L L+ ++ + + L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 147 ANRLSGEIANDLPRNLKYFDLS 168
+N L + + + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 15/104 (14%), Positives = 28/104 (26%), Gaps = 9/104 (8%)
Query: 159 PRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL 218
+ L G S L+++ + S ++ L + + SL
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS----LAATLLANHSL 399
Query: 219 VHLSAQGNALGGVIPPAIGA-----LPKLQVVSLAQNNLSGVVP 257
L N LG + L+ + L S +
Sbjct: 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 17/99 (17%), Positives = 28/99 (28%), Gaps = 13/99 (13%)
Query: 479 PASLGNLLKLTTLDLSKQNFSGE----LPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534
L L L+ + S L L +L+ + L N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 535 -----SLRYLNLSFNGFVGQIPATFSFLR----SVVVLS 564
L L L + ++ L S+ V+S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 15/71 (21%), Positives = 21/71 (29%), Gaps = 9/71 (12%)
Query: 629 CSSLRSLLVNSNHLSG----GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIF-----G 679
S LR L + +S + +L +L LDLS N L L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 680 LMNFNVSSNNL 690
L +
Sbjct: 428 LEQLVLYDIYW 438
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 9/74 (12%), Positives = 20/74 (27%), Gaps = 4/74 (5%)
Query: 270 SIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRG----AFPLWLTRASTLTRLDV 325
I+ + + ++ E QV+ L + L L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 326 SGNSISGKIPAQIG 339
N + +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.5 bits (129), Expect = 3e-08
Identities = 49/333 (14%), Positives = 90/333 (27%), Gaps = 39/333 (11%)
Query: 160 RNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLV 219
++LK +++ + + ++ I S N E L IA+ L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARW----LSENIASKKDLE 62
Query: 220 HLSAQGN---ALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQL 276
+ IP A+ L + A + + N G ++
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQ------ALLKCPKLHTVRLSDNAFGPTAQEPLIDF 116
Query: 277 GFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKI-P 335
+ + + A A L + N +
Sbjct: 117 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176
Query: 336 AQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG------------NRFSGEIP 383
L G P I+ L + + S +
Sbjct: 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 384 EFLGDIRGLKSLTLAANLFSGSIPA------SFRNLPGLENLNLRHNSLSG----SLPEE 433
L L+ L L L S A S GL+ L L++N + +L
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 434 VLG-MNNLSTLDLSENKFSGEVPASIGNLSQLM 465
+ M +L L+L+ N+FS E + + ++
Sbjct: 297 IDEKMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.7 bits (127), Expect = 5e-08
Identities = 41/328 (12%), Positives = 95/328 (28%), Gaps = 34/328 (10%)
Query: 390 RGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSG----SLPEEVLGMNNLSTLDL 445
+ LK + S+ A ++ + L N++ L E + +L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 446 SEN---KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGEL 502
S+ + E+P ++ L Q ++ + A + LSK L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 503 PIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP----------- 551
+ GL + V + + LR + N
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 552 --ATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609
T +++ + + + + ++ + + + +L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 610 VLDLSINNLTGEIPDEISKC------SSLRSLLVNSNHLSGGIPDSLA-----KLSNLAV 658
L L+ L+ + L++L + N + +L K+ +L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 659 LDLSANNLS--GEIPANLSSIFGLMNFN 684
L+L+ N S ++ + +F
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 38/317 (11%), Positives = 83/317 (26%), Gaps = 37/317 (11%)
Query: 357 AVPVEIKQCSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAAN---LFSGSIPAS 409
+V + + S+ + L GN E + E + + L+ + IP +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 410 FRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNL 469
R L + +++ S LS++ + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 470 SGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG 529
+ + N L ++ +N ++ L K+ N
Sbjct: 142 ARALQELAVNKKAKNAPPLRSII-CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 530 -------FSSLMSLRYLNLSFNGFVGQIPATFSFLRS-------VVVLSFSGNHISGSIP 575
L + L + S L + L + +S
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 576 PELGNC------SDLEVLELRSNSLTGHIPTDI-----SHLSHLNVLDLSINNLTGEIPD 624
+ + L+ L L+ N + + + L L+L+ N + +
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS----E 316
Query: 625 EISKCSSLRSLLVNSNH 641
E +R +
Sbjct: 317 EDDVVDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 39/310 (12%), Positives = 87/310 (28%), Gaps = 35/310 (11%)
Query: 416 LENLNLRHNSLSG----SLPEEVLGMNNLSTLDLSENKFSGE----VPASIGNLSQLMVF 467
+E +L+ ++++ S+ +L +++ + LS N E + +I + L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 468 NLSGN----------AFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIAL 517
S + +L KL T+ LS F L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 518 QENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPE 577
+ + + ++ L+ N P S + L
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 578 LG------NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631
+ E + L + + + + + + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 632 LRSLLVNSNHLSGGIPDSLA------KLSNLAVLDLSANNLSGEIPANLSSIFG-----L 680
LR L +N LS ++ + L L L N + + L ++ L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 681 MNFNVSSNNL 690
+ ++ N
Sbjct: 305 LFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 41/334 (12%), Positives = 75/334 (22%), Gaps = 46/334 (13%)
Query: 82 ISDHLSNLRMLRKLSLRSNSFNG----TIPATLAQCTLLRAVFLQYNS---LSGNLPANI 134
+ L ++++ L N+ + +A L + +P +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 135 GNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFN 194
L A + L N + L
Sbjct: 83 RLLLQ------ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 136
Query: 195 KFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGA-------LPKLQVVSL 247
++ A E + N L + N L L +++V
Sbjct: 137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 196
Query: 248 AQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIR 307
+ + F + A L+ L L +
Sbjct: 197 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 308 G------AFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVE 361
L L + N I + V
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK-------------------TVI 297
Query: 362 IKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395
++ L L+L GNRFS E + + +IR + S
Sbjct: 298 DEKMPDLLFLELNGNRFSEE-DDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 6/96 (6%)
Query: 552 ATFSF-LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTG----HIPTDISHLS 606
A FS +S+ + + + S+ L ++ + L N++ + +I+
Sbjct: 1 ARFSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHL 642
L + + S + L L+ L
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 11/88 (12%), Positives = 28/88 (31%), Gaps = 8/88 (9%)
Query: 631 SLRSLLVNSNHLSG----GIPDSLAKLSNLAVLDLSANNLSGE----IPANLSSIFGLMN 682
S+ + + ++ + L + ++ + LS N + E + N++S L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 683 FNVSSNNLQAFANNQDLCGKPLGRKCEN 710
S + + L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLK 91
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (120), Expect = 8e-08
Identities = 26/150 (17%), Positives = 47/150 (31%), Gaps = 9/150 (6%)
Query: 397 LAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA 456
L A L + A + N L+LR + + ++ +D S+N+
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57
Query: 457 SIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG-ELPIELAGLPNLQVI 515
L +L ++ N L LT L L+ + LA L +L +
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 516 ALQENK---LSGNVPEGFSSLMSLRYLNLS 542
+ N + +R L+
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 3/92 (3%)
Query: 576 PELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSL 635
+ N L+LR + I + L + +D S N + D L++L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 636 LVNSNHLSGGIPDSLAKLSNLAVLDLSANNLS 667
LVN+N + L +L L L+ N+L
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 18/132 (13%), Positives = 37/132 (28%), Gaps = 5/132 (3%)
Query: 113 CTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172
R + L+ + + L + ++ + N + L R LK +++N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRI 75
Query: 173 SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVI 232
L L + + N +L S C
Sbjct: 76 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL----RNPVTNKKHYR 131
Query: 233 PPAIGALPKLQV 244
I +P+++V
Sbjct: 132 LYVIYKVPQVRV 143
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 2e-07
Identities = 29/152 (19%), Positives = 42/152 (27%), Gaps = 4/152 (2%)
Query: 364 QCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPA-SFRNLPGLENLNLR 422
S L + + L L L + + R L L NL +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 423 HNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS-GRIPAS 481
+ L P+ LS L+LS N + L LSGN
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
Query: 482 LGNLLKLTTLDLSKQNFSGELPIELAGLPNLQ 513
L + + +Q LA +PN
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 5e-05
Identities = 28/149 (18%), Positives = 51/149 (34%), Gaps = 11/149 (7%)
Query: 488 LTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEG-FSSLMSLRYLNLSFNGF 546
+ L ++ + L G NL + ++ + ++ L LR L + +G
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 547 VGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS 606
P F F + L+ S N + S+ + L+ L L N L H + L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL--HCSCALRWLQ 125
Query: 607 HLNVLDLSINNLTGEIPDEISKCSSLRSL 635
G +P++ +C L
Sbjct: 126 RW------EEEGLGGVPEQKLQCHGQGPL 148
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.6 bits (114), Expect = 7e-07
Identities = 39/186 (20%), Positives = 67/186 (36%), Gaps = 8/186 (4%)
Query: 441 STLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASL-GNLLKLTTLDLSKQNFS 499
+T+D + E+P I L+ N L G L L L+L + +
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 500 GELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRS 559
G P G ++Q + L ENK+ + F L L+ LNL N +P +F L S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 560 VVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLT 619
+ L+ + N + + + L + P S + + + DL +
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRK-KSLNGGAARCGAP---SKVRDVQIKDLPHSEFK 183
Query: 620 GEIPDE 625
+
Sbjct: 184 CSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 38/180 (21%), Positives = 64/180 (35%), Gaps = 10/180 (5%)
Query: 489 TTLDLSKQNFSGELPIELAGLP-NLQVIALQENKLSGNVPEGFSSLMS-LRYLNLSFNGF 546
TT+D + + E+P +P + + L +N+L +G + L L L N
Sbjct: 11 TTVDCTGRGLK-EIP---RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 547 VGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS 606
G P F + L N I L+ L L N ++ +P HL+
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNL 666
L L+ +N LR +N G P +K+ ++ + DL +
Sbjct: 127 SLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 8/179 (4%)
Query: 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQ-CSSLSLLDLEGNRFS 379
T +D +G + +IP I EL + +N G + L L+L+ N+ +
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 380 GEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNN 439
G P ++ L L N F L L+ LNL N +S +P +N+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 440 LSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNF 498
L++L+L+ N F+ L +L+G A P+ + + + DL F
Sbjct: 128 LTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 34/166 (20%), Positives = 56/166 (33%), Gaps = 7/166 (4%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLG-MNNLSTLDLSENKFSGEVPASIGNLSQ 463
IP L L N L + + G + +L L+L N+ +G P + S
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 464 LMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523
+ L N L +L TL+L S +P L +L + L N +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 524 GNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNH 569
N + LR +L+ P+ +R V + +
Sbjct: 140 CNCHLAW-FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSE 181
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 1e-06
Identities = 26/155 (16%), Positives = 52/155 (33%), Gaps = 6/155 (3%)
Query: 492 DLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIP 551
+L + +L + ++ + AL L + LN + +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLR 58
Query: 552 ATFSFLRSVVVLSFSGNHISG--SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609
+ ++ L+ S N + + + +L++L L N L D L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 610 VLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSG 644
L L N+L+ D+ + S++R L G
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 8e-06
Identities = 22/145 (15%), Positives = 43/145 (29%), Gaps = 12/145 (8%)
Query: 405 SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQL 464
+ L L +++ N L+ + + + N+ +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 465 MVFNLSGNAFSGR--IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKL 522
+ NLS N + + + L L+LS E ++ L+ + L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 523 SGNVPEG-------FSSLMSLRYLN 540
S + L L+
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 1e-05
Identities = 35/156 (22%), Positives = 56/156 (35%), Gaps = 20/156 (12%)
Query: 520 NKLSGNVPEGFSSLMSLRY------LNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGS 573
N+L E +MS RY L+L VVL+ + ++ +
Sbjct: 2 NELKPEQVEQLKLIMSKRYDGSQQALDLKGLRS----DPDLVAQNIDVVLN-RRSSMAAT 56
Query: 574 IPPELGNCSDLEVLELRSNSLTGH--IPTDISHLSHLNVLDLSINNLTGEIPDEISKCSS 631
+ N +L L L +N L + + + +L +L+LS N L E + K
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 632 LRSLLVNSNHLSGGIPDS-------LAKLSNLAVLD 660
L L ++ N LS D + L LD
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 24/127 (18%), Positives = 44/127 (34%), Gaps = 5/127 (3%)
Query: 573 SIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSL 632
+ + D L L D+ + VL+ +++ + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 633 RSLLVNSNHLSG--GIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNL 690
SL +++N L + + K NL +L+LS N L E + L + N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 691 QAFANNQ 697
+Q
Sbjct: 128 SDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 26/125 (20%), Positives = 44/125 (35%), Gaps = 5/125 (4%)
Query: 549 QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHL 608
Q+ S + + P+L + VL RS+ + ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 609 NVLDLSINNLTG--EIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNL 666
L+LS N L ++ + K +L+ L ++ N L K L L L N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 667 SGEIP 671
S
Sbjct: 128 SDTFR 132
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 35/194 (18%), Positives = 67/194 (34%), Gaps = 15/194 (7%)
Query: 484 NLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSF 543
L + L K N + + L + + + +G L +L +N S
Sbjct: 16 ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 544 NGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDIS 603
N P + L+ + + + I
Sbjct: 72 NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 604 HLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSA 663
+ N+ L +++ T +S +SL+ L +SN ++ P LA L+ L LD+S+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 664 NNLSG-EIPANLSS 676
N +S + A L++
Sbjct: 182 NKVSDISVLAKLTN 195
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 34/192 (17%), Positives = 69/192 (35%), Gaps = 24/192 (12%)
Query: 460 NLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQE 519
L++ M L + + S +L ++TTL + +E L NL I
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSN 71
Query: 520 NKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELG 579
N+L+ P + + +N + + + + + + + L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 580 ----------------NCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIP 623
+ L+ L SN +T P +++L+ L LD+S N ++
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--I 187
Query: 624 DEISKCSSLRSL 635
++K ++L SL
Sbjct: 188 SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 35/200 (17%), Positives = 69/200 (34%), Gaps = 16/200 (8%)
Query: 412 NLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSG 471
L L +++ ++ + L + ++TL + L+ L N S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDL--DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 472 NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFS 531
N + P LK T + + ++ + L +
Sbjct: 72 NQLTDITP------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 532 SLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRS 591
+L +L L LS N + + FS N ++ P L N + LE L++ S
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLN--FSSNQVTDLKP--LANLTTLERLDISS 181
Query: 592 NSLTGHIPTDISHLSHLNVL 611
N ++ + ++ L++L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 26/237 (10%), Positives = 58/237 (24%), Gaps = 10/237 (4%)
Query: 439 NLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNF 498
+ E+K + E+P+ + + + L +++S+ +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 499 SGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLR 558
+ ++ E + + L + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 559 SVVVLSFSGNHISGSIPPELGNCSDLEV----LELRSNSLTGHIPTDISHLSHLNVLDLS 614
S+ + E + L L L N + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIP 671
NNL D S L ++ + L L L NL ++P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 32/229 (13%), Positives = 61/229 (26%), Gaps = 9/229 (3%)
Query: 419 LNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478
+ + ++ +P ++ N L K + L +S N I
Sbjct: 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 479 --PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSL 536
N P LPNLQ + + + +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 537 RYLNLSFNGFVGQIPATFSFLRSVV--VLSFSGNHISGSIPPELGNCSDLEVLELRSNSL 594
L++ N + I S +L + N I E+ +N+L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 595 TGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLS 643
S +LD+S + + LR+ ++ +L
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 29/233 (12%), Positives = 59/233 (25%), Gaps = 33/233 (14%)
Query: 489 TTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG 548
+ + E+P +L N + KL FS L + +S N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 549 QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT------------- 595
I A + + + + L ++
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 596 ---------------GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640
+ + +L L+ N + + L ++N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 641 HLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNNLQAF 693
+L D S +LD+S + L ++ L + NL+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.001
Identities = 32/230 (13%), Positives = 60/230 (26%), Gaps = 11/230 (4%)
Query: 148 NRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGT 207
++++ EI +DLPRN + S L+ I S N + A
Sbjct: 18 SKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 76
Query: 208 LPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGY 267
LP + N P A LP LQ + ++ + + ++
Sbjct: 77 LPKLHEIRIEKANNLLYIN------PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130
Query: 268 PPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSG 327
I+ N + +L L +N I+
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFES----VILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 328 NSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377
N++ G L ++ ++ L +
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 9/45 (20%), Positives = 13/45 (28%), Gaps = 2/45 (4%)
Query: 406 IPASFRNLPGLENLNLRHNSLSGSLPEEVL-GMNNLSTLDLSENK 449
F G L++ + SLP L + L K
Sbjct: 193 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 16/96 (16%), Positives = 22/96 (22%), Gaps = 10/96 (10%)
Query: 418 NLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGR 477
L L N + G N S ++ ++S
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 478 IPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQ 513
L NL KL L LP L+
Sbjct: 217 PSYGLENLKKLRARSTYN----------LKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 12/67 (17%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 575 PPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRS 634
+ +CS+ L + + +T IP+D+ + L + L S L
Sbjct: 2 HHRICHCSNRVFL-CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 635 LLVNSNH 641
+ ++ N
Sbjct: 58 IEISQND 64
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 42.8 bits (99), Expect = 7e-05
Identities = 28/186 (15%), Positives = 55/186 (29%), Gaps = 32/186 (17%)
Query: 437 MNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496
++ + + + G +P I + A+L L L LS
Sbjct: 17 RKSVVATEAEKVELHGMIP-PIEKM-----------------DATLSTLKACKHLALSTN 58
Query: 497 NFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSF 556
N ++ L+G+ NL++ L + E ++ + +
Sbjct: 59 NIE-KIS-SLSGMENLRI--LSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKL 114
Query: 557 LRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTD----------ISHLS 606
+ V+ + + +L LE L L N L + + L
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174
Query: 607 HLNVLD 612
+L LD
Sbjct: 175 NLKKLD 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1099 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.2 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.12 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.05 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.59 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.89 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.77 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=419.82 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=204.0
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|+..+.||+|+||.||+|.+.++..||||++.......++|.+|++++++++|||||+++|++...+ ..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEEEecC
Confidence 468889999999999999999999999999999887778889999999999999999999999998554 4599999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++... ...+++..+..++.|||+||+|+|+.+|+||||||+||++|+++.+||+|||+|+.... ....
T Consensus 84 ~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~--~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYT 157 (263)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC--CCce
Confidence 99999998742 24589999999999999999999999999999999999999999999999999986532 2222
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhC-CCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTG-KRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++||......+....+..... ...+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------~~~p------- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKP------- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------CCCC-------
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------CCCc-------
Confidence 33456799999999999999999999999999999999995 556655555555554443211 0111
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
...+ ..+.+++.+||+.||++||||+||++.|+++++
T Consensus 225 ~~~~----~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLAS----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1111 134689999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-48 Score=423.59 Aligned_cols=259 Identities=21% Similarity=0.351 Sum_probs=212.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|++.+.||+|+||+||+|.++ +|+.||||++..+....++|.+|++++++++|||||++++++.+. +..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-CeeEEEeec
Confidence 467999999999999999999986 488999999988777788999999999999999999999999855 445999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.+. ....+++..+..++.|||+||+|||+.+|+||||||+|||+++++.+||+|||+|+.... ..
T Consensus 95 ~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~--~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DT 169 (287)
T ss_dssp CTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS--SS
T ss_pred ccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC--CC
Confidence 9999999999753 235689999999999999999999999999999999999999999999999999986522 22
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCC-CchhHHHHHHHHhhhccccccccCcccCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFT-QDEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........||+.|+|||++.+..++.++|||||||++|||++|..||... +.....+.+.. +...+.
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----~~~~~~-------- 237 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMER-------- 237 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----TCCCCC--------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc----CCCCCC--------
Confidence 23344556899999999999999999999999999999999977766543 33333332222 110000
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
+...+ ..+.+++.+||+.||++|||++||++.|+.+...
T Consensus 238 -~~~~~----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 -PEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -Cccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01111 1346899999999999999999999999877543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=415.26 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=201.6
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.+.||+|+||+||+|++++ .||||++.... ...+.|.+|++++++++|||||++++++.+ + ..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~-~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P-QLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-SCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c-EEEEEE
Confidence 4578899999999999999998764 48999986432 334779999999999999999999999864 3 359999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+++|+|.+++... +..+++..+..++.|||+||+|||+.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~- 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW- 157 (276)
T ss_dssp ECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc-
Confidence 999999999999742 235899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCccccccccCccccCccccccC---CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH-HHHhhhccccccccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTG---ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV-KKQLQKGQITELLEP 1034 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~d~ 1034 (1099)
..........||+.|||||++.+. .++.++|||||||++|||+||+.||............ ........
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~------- 230 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD------- 230 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-------
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-------
Confidence 222334567899999999998643 4789999999999999999999999876554333222 22211111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+.... .+ ..+.+++.+||+.||++||||+||++.|+.++.
T Consensus 231 -~~~~~~~-~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 -LSKVRSN-CP----KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGGSCTT-CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -chhcccc-ch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 11 134578999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=416.28 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=209.2
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|.++++..||||++.......+.|.+|++++++++|||||+++|++.++ ..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC--CeEEEEEeC
Confidence 467999999999999999999999899999999988777888999999999999999999999998643 358999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++.... ...+++..+..|+.|||+||+|||+.+|+||||||+|||+++++.+||+|||+|+.... ...
T Consensus 90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~--~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 164 (272)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS--SCE
T ss_pred CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC--Ccc
Confidence 9999999886432 23489999999999999999999999999999999999999999999999999987632 222
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCC-CCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRP-VMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......||+.|+|||++.++.++.++|||||||++|||+||..| +......+..+.+.. +.... .
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~----~~~~~---------~ 231 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMV---------R 231 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCC---------C
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCC---------C
Confidence 334456799999999999999999999999999999999996555 444444444443322 11000 0
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
+...+ ..+.+++.+||+.||++||||+||++.|+.
T Consensus 232 p~~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 232 PDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11111 124679999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=409.17 Aligned_cols=254 Identities=21% Similarity=0.366 Sum_probs=214.8
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++|+..++||+|+||+||+|+++++..||||.+..+....+.|.+|++++++++|||||+++|++.++ ...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEccC
Confidence 57899999999999999999999999999999988777888999999999999999999999999854 45699999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.+++.... ..+++..+.+++.|+|+||+|||+.||+||||||+||++++++.+||+|||+|+..... ...
T Consensus 83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYT 156 (258)
T ss_dssp TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--SCC
T ss_pred CCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC--Cce
Confidence 999999976432 34889999999999999999999999999999999999999999999999999865322 223
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......++...+..... ... +
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------~~~-------p 223 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------LYR-------P 223 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------CCC-------C
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------CCC-------c
Confidence 3445679999999999999999999999999999999998 8999988776665554433211 011 1
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+ ..+.+++.+||+.||++|||++||++.|.++
T Consensus 224 ~~~~----~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccc----HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111 1346899999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-47 Score=421.27 Aligned_cols=271 Identities=24% Similarity=0.409 Sum_probs=204.0
Q ss_pred cCCHHHHHHHHh---------ccccccccccccceeEEEEEECC----ceEEEEEECCCCCc--cHHHHHHHHHHhhhcc
Q 047739 792 KITLAETVEATR---------QFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSL--DENLFRKEAEFLGKVR 856 (1099)
Q Consensus 792 ~~~~~~~~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~ 856 (1099)
.+++++...+++ +|++.++||+|+||+||+|.++. ...||||.+..... ..+.|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 344555555544 44567899999999999999753 34799999865433 3467999999999999
Q ss_pred CCcceEEeeEEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEE
Q 047739 857 HRNLTVLRGYYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVL 936 (1099)
Q Consensus 857 H~niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIl 936 (1099)
|||||+++|++... +..++||||+++|+|.+++... ...++|.++..++.|||+||+|||+.+|+||||||+|||
T Consensus 86 HpnIv~l~g~~~~~-~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160 (299)
T ss_dssp CTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCCccEEEEEeeC-CEEEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence 99999999999854 4569999999999999988742 235899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeccccccccCCCCCCC--ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCch
Q 047739 937 FDADFEAHLSDFGLDRLTIPTPAEA--STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDE 1013 (1099)
Q Consensus 937 l~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~ 1013 (1099)
++.++.+||+|||+|+......... .......||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998753322211 12223568999999999999999999999999999999998 89999877766
Q ss_pred hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCC
Q 047739 1014 DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGP 1084 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 1084 (1099)
+....+....... .+...+ ..+.+++.+||+.||++||||.||++.|+++...|
T Consensus 241 ~~~~~i~~~~~~~-------------~~~~~~----~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 241 DVINAIEQDYRLP-------------PPMDCP----SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHTTCCCC-------------CCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHcCCCCC-------------CCccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 6555443321100 001111 12457999999999999999999999999875543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=409.93 Aligned_cols=265 Identities=28% Similarity=0.419 Sum_probs=209.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|.++++..||||++.......+.|.+|+.++++++|||||+++|++.+ + ..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~-~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-PIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-C-CeEEEEEec
Confidence 36799999999999999999999988899999998877788899999999999999999999999864 3 358999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|..++.... ...++|..+..++.|||.||+|||+.+|+||||||+|||+|.++.+||+|||+|+.... ...
T Consensus 94 ~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~--~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 168 (285)
T ss_dssp TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC--CCc
Confidence 9999999987532 23489999999999999999999999999999999999999999999999999986522 222
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCC-CCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV-MFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......||+.|+|||++..+.++.++|||||||++|||++|..|+ ......+....+..... .+ .+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----~~-~~------- 236 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----MP-CP------- 236 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CC-CC-------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----CC-CC-------
Confidence 3344567999999999999999999999999999999999976655 44444444444332211 00 11
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCCCCCCCCCCC
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIPSSADPTTQP 1096 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 1096 (1099)
...+ ..+.+++.+||+.||++||++.+|+++|+.. .++.+|.++|
T Consensus 237 -~~~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~------~~~~~p~~~p 281 (285)
T d1fmka3 237 -PECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY------FTSTEPQYQP 281 (285)
T ss_dssp -TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT------TSCSCCCCCC
T ss_pred -cccC----HHHHHHHHHHcccCHhHCcCHHHHHHHHhhh------hcCCCCCCCC
Confidence 1111 1245899999999999999999999999954 3444555554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=411.94 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=209.0
Q ss_pred Hhccccccc-cccccceeEEEEEEC---CceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENV-LSRTRYGLVFKACYN---DGMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|...+. ||+|+||+||+|.++ ++..||||.+.... ...+.|.+|++++++++|||||+++|++.++ ..|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEE
Confidence 356777774 999999999999874 35689999986543 2346799999999999999999999998743 369
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++..+..++.|||+||+|||+.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 lvmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999998642 2458999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.............||+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+.. +...+. +
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~----~~~~~~-p- 234 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----GKRMEC-P- 234 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----TCCCCC-C-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CCCCCC-C-
Confidence 43333344456679999999999999999999999999999999998 9999987766665554432 211111 0
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
...+ ..+.+++.+||+.||++||||.+|.+.|+.+
T Consensus 235 -------~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 -------PECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -------TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 1245899999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=404.84 Aligned_cols=244 Identities=24% Similarity=0.391 Sum_probs=204.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||+||+|+++ +|+.||+|.+... ....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence 57999999999999999999986 5889999998532 2235678999999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 85 mEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~-- 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 157 (263)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC--
T ss_pred EeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC--
Confidence 9999999999999864 248999999999999999999999999999999999999999999999999997642
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+ .... +++
T Consensus 158 ---~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~~~--~p~--- 225 (263)
T d2j4za1 158 ---SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFT--FPD--- 225 (263)
T ss_dssp ---CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCC--CCT---
T ss_pred ---CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCC--CCc---
Confidence 1233456899999999999999999999999999999999999999987666555444332 1110 011
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+ ..+.+++.+||+.||++|||++|+++
T Consensus 226 -----~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 -----FVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011 12457899999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=411.44 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=200.1
Q ss_pred hccccccccccccceeEEEEEECCc-----eEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDG-----MVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
..|+..++||+|+||.||+|.+++. ..||||++..... ..+.|.+|++++++++|||||+++|++.+. ...+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceE
Confidence 4688899999999999999987642 5799999865432 235689999999999999999999999854 4569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+.+|++.+++... ...+++..+..++.|||.||+|||+.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999988653 2458999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCC-CCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPV-MFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
.............||+.|+|||++.+..++.++|||||||++|||++|..|+ ......++...+.. +....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~----~~~~~---- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLP---- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----TCCCC----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc----cCCCC----
Confidence 3333333344567899999999999999999999999999999999965554 44444444433322 11000
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPD 1085 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 1085 (1099)
.+...+ ..+.+++.+||+.||++||||.||++.|+++...|+
T Consensus 234 -----~~~~~~----~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 234 -----TPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp -----CCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -----CchhhH----HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 011111 134689999999999999999999999998766554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=407.75 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=196.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecC-CCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-PDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~l 876 (1099)
.++|++.+.||+|+||+||+|+.+ +|+.||+|.+...... .+.+.+|++++++++|||||++++++.+. ....|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999985 5899999998665433 35688999999999999999999998643 445689
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC-----ceecCCCCCCEEECCCCcEEEeccccc
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN-----MVHGDIKPQNVLFDADFEAHLSDFGLD 951 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----iiH~Dlk~~NIll~~~~~~kl~DfGla 951 (1099)
||||+++|+|.+++.+... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999999975432 2346899999999999999999999865 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc
Q 047739 952 RLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL 1031 (1099)
Q Consensus 952 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1099)
+.... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||...+..++...+.. +.....
T Consensus 162 ~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~----~~~~~~ 234 (269)
T d2java1 162 RILNH---DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKFRRI 234 (269)
T ss_dssp HHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----TCCCCC
T ss_pred eeccc---CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc----CCCCCC
Confidence 87522 22234457899999999999999999999999999999999999999987766655544433 221111
Q ss_pred ccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 LEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 ~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
...+ . ..+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~--------s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -PYRY--------S----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CTTS--------C----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Cccc--------C----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 1 12457899999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=404.56 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=204.0
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
++|+..+.||+|+||+||+|... +|+.||+|++... ....+.+.+|++++++++|||||++++++.+. +..|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEe
Confidence 46999999999999999999874 6899999998543 23457799999999999999999999999854 456999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.... .
T Consensus 99 ~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~---~ 169 (293)
T d1yhwa1 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---E 169 (293)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS---T
T ss_pred cCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc---c
Confidence 999999998864 2489999999999999999999999999999999999999999999999999986532 2
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... +...-...+.+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~---- 242 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKL---- 242 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGS----
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccC----
Confidence 23345668999999999999999999999999999999999999999876654444333222 11000000100
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|||+.|+++
T Consensus 243 --s------~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 --S------AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --C------HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --C------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 12457899999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=405.41 Aligned_cols=251 Identities=23% Similarity=0.272 Sum_probs=199.2
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|++.+.||+|+||+||+|.++ +|+.||+|++..... ..+.+.+|++++++++|||||++++++.+ ++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEe
Confidence 57999999999999999999985 589999999854322 34678999999999999999999999985 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+++|+|.+++... ..+++.....++.||++||+|||+.||+||||||+|||+++++.+||+|||+|+..... .
T Consensus 84 y~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~-~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN-N 157 (271)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET-T
T ss_pred ccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC-C
Confidence 99999999999642 35899999999999999999999999999999999999999999999999999865322 1
Q ss_pred CCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 960 EASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
........+||+.|||||++.+..+ +.++||||+||++|||++|+.||....+......... ...... +....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~~~~~~----~~~~~ 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKTYL----NPWKK 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--TTCTTS----TTGGG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCC----Ccccc
Confidence 2233456789999999999988876 5789999999999999999999976544322211111 111000 00000
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. + ..+.+++.+||+.||++|||++|+++
T Consensus 232 ~-----s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 I-----D----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp S-----C----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----C----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 12357899999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=405.47 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=198.6
Q ss_pred cccccccceeEEEEEECC---ceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeecC
Q 047739 809 NVLSRTRYGLVFKACYND---GMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYMP 882 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~~ 882 (1099)
++||+|+||.||+|.+++ ++.||||++..... ..+.|.+|++++++++|||||+++|+|.. + ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCC
Confidence 579999999999998753 57899999864332 24679999999999999999999999864 3 3589999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCCc
Q 047739 883 NGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEAS 962 (1099)
Q Consensus 883 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 962 (1099)
+|+|.++++.. ..+++..+..++.|||+||+|||+.+|+||||||+||+++.++.+|++|||+|+..........
T Consensus 91 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999753 3489999999999999999999999999999999999999999999999999987643333333
Q ss_pred cccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCCC
Q 047739 963 TSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELDP 1041 (1099)
Q Consensus 963 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1041 (1099)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......++...+.+ +..... +
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~----~~~~~~---------p 232 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGC---------P 232 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCC---------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc----CCCCCC---------C
Confidence 3445679999999999999999999999999999999998 8999987766555444432 211110 0
Q ss_pred CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhc
Q 047739 1042 ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEG 1079 (1099)
Q Consensus 1042 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~ 1079 (1099)
...+ ..+.+++.+||+.||++|||++||.+.|+.
T Consensus 233 ~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 AGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1111 124578999999999999999999988864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=413.14 Aligned_cols=259 Identities=23% Similarity=0.321 Sum_probs=203.9
Q ss_pred HhccccccccccccceeEEEEEECC------ceEEEEEECCCC--CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND------GMVLSIRRLPDG--SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|++.++||+|+||+||+|++.. ...||+|.+... ......+.+|+++++++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 4689999999999999999998743 247999998543 23346789999999998 8999999999998554
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc------------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH------------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQN 934 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~N 934 (1099)
..++||||+++|+|.++++.... .....+++..++.++.||++||+|||+.+||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 46999999999999999975321 122458999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCch
Q 047739 935 VLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDE 1013 (1099)
Q Consensus 935 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~ 1013 (1099)
|+++.++.+||+|||+|+..... ..........||+.|||||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGC-TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCC-CceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865322 22223345678999999999999999999999999999999998 89999876554
Q ss_pred hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhh
Q 047739 1014 DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLE 1078 (1099)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~ 1078 (1099)
+....+......... +...+ ..+.+++.+||+.||++|||++||++.|.
T Consensus 274 ~~~~~~~~~~~~~~~------------p~~~~----~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQ------------PFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHTTCCCCC------------CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC------------CCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433332221111100 01111 13468999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=405.83 Aligned_cols=248 Identities=19% Similarity=0.295 Sum_probs=201.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||+||+|.+. +|+.||||.+... ....+.+.+|++++++++|||||++++++.++ +..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEE
Confidence 57999999999999999999985 6899999998532 22346789999999999999999999999854 556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||++++++.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999998864 34899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+ +... ++..+
T Consensus 162 -~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----~~~~--~p~~~- 233 (288)
T d1uu3a_ 162 -SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----LEYD--FPEKF- 233 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT----TCCC--CCTTC-
T ss_pred -CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc----CCCC--CCccC-
Confidence 222334556899999999999999999999999999999999999999987766555544432 2110 11111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|||++|+++
T Consensus 234 -------s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 -------F----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -------C----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -------C----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 12458999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=402.46 Aligned_cols=250 Identities=18% Similarity=0.274 Sum_probs=203.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC-CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG-SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
+.|++.+.||+|+||.||+|.+. +|+.||+|++... ....+.+.+|++++++++|||||++++++.+. +..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEec
Confidence 46899999999999999999985 5889999998543 33447899999999999999999999999854 556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE 960 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 960 (1099)
+++|+|.+++.+.. ..+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+|+.... .
T Consensus 91 ~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~---~ 163 (288)
T d2jfla1 91 CAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---T 163 (288)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH---H
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC---C
Confidence 99999999987532 3489999999999999999999999999999999999999999999999999975411 1
Q ss_pred CccccccccCccccCccccc-----cCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 961 ASTSTTAVGTLGYVSPEAAL-----TGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
.......+||+.|+|||++. ...|+.++||||+||++|||++|+.||......+....+... .......+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----~~~~~~~~- 238 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----EPPTLAQP- 238 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----CCCCCSSG-
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CCCCCCcc-
Confidence 12334578999999999984 455889999999999999999999999877766655544432 11111000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
...+ ..+.+++.+||+.||++|||++|+++
T Consensus 239 ------~~~s----~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 ------SRWS----SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 13457899999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=396.92 Aligned_cols=245 Identities=22% Similarity=0.360 Sum_probs=194.7
Q ss_pred cccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEec---CCCceEEE
Q 047739 805 FDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAG---APDLRLLV 877 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~~lV 877 (1099)
|+..++||+|+||+||+|.+. +++.||+|.+..... ..+.+.+|++++++++|||||++++++.+ +....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999986 578999999854332 34678999999999999999999999864 23446899
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCC--ceecCCCCCCEEEC-CCCcEEEecccccccc
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSN--MVHGDIKPQNVLFD-ADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--iiH~Dlk~~NIll~-~~~~~kl~DfGla~~~ 954 (1099)
|||+++|+|.+++.+. ..+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999764 34899999999999999999999998 99999999999996 5789999999999864
Q ss_pred CCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. .......+||+.|||||++.+ .++.++||||+||++|||++|+.||........ +.+.+..+.....++.
T Consensus 166 ~-----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 166 R-----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDK 236 (270)
T ss_dssp C-----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGG
T ss_pred c-----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---HHHHHHcCCCCcccCc
Confidence 2 223345689999999998865 699999999999999999999999975543322 1122222211111111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.. . ..+.+++.+||++||++|||++|+++
T Consensus 237 ~~--------~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 VA--------I----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CC--------C----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC--------C----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 0 12458999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=398.32 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=202.7
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++|++.+.||+|+||.||+|.++ |+.||||++... ...+.|.+|++++++++||||++++|++.++....|+||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 357889999999999999999996 778999999654 345779999999999999999999999976555569999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAEA 961 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 961 (1099)
++|+|.+++..... ..++|..+++++.|||+||+|||+.+|+||||||+||+++.++.+|++|||+++...
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~------ 154 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 154 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC------
Confidence 99999999975322 348999999999999999999999999999999999999999999999999998642
Q ss_pred ccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccCcccCCC
Q 047739 962 STSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLELD 1040 (1099)
Q Consensus 962 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1040 (1099)
.......+|..|+|||++.++.++.++|||||||++|||+| |+.||......++...+..... .+. ++
T Consensus 155 ~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~----~~~-~~------ 223 (262)
T d1byga_ 155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDA-PD------ 223 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----CCC-CT------
T ss_pred CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCC-Cc------
Confidence 12234568899999999999999999999999999999998 7888887777776665543211 111 11
Q ss_pred CCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1041 PESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1041 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
..+ ..+.+++.+||+.||++||||.|++++|++++
T Consensus 224 --~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 --GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp --TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111 13458899999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=409.35 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=175.5
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.++|++.+.||+|+||+||+|.+. +|+.||+|++... ....+.+.+|++++++++|||||++++++.+. ...|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence 468999999999999999999985 6899999998543 23356789999999999999999999999854 5569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC-CceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS-NMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
||+++|+|.+++.+. ..+++..+..++.|+++||+|||+. ||+||||||+|||++.++.+||+|||+|+...+
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999999864 2489999999999999999999975 999999999999999999999999999986521
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCch
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDE 1013 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~ 1013 (1099)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 2234568999999999999999999999999999999999999999765543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=398.89 Aligned_cols=257 Identities=22% Similarity=0.307 Sum_probs=199.8
Q ss_pred HhccccccccccccceeEEEEEECC----ceEEEEEECCCCC----ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGS----LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||.||+|+++. ...||||.+.... ...+.|.+|++++++++|||||+++|++.+ + .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~-~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-P 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c-c
Confidence 3679999999999999999998642 3578999885432 223679999999999999999999999974 3 3
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++||||+++|++.+++.... ..+++..+..++.|||+||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred hheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 589999999999999887532 3489999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
...............|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+...++.+..... + .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~---~-~ 236 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---P-R 236 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---C-C
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---C-C
Confidence 6444333344455678899999999999999999999999999999998 899998877766655544321110 0 0
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
. ...+ ..+.+++.+||+.||++||||.||.+.|++.
T Consensus 237 ~--------~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 P--------EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c--------cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 0001 1245899999999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-45 Score=401.48 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=199.1
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
.+.|+..+.||+|+||+||+|.+. +|+.||||++...... .+.+.+|++++++++|||||++++++.+ ++..|+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~i 92 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL 92 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEE
Confidence 356999999999999999999875 6899999998654322 2568899999999999999999999985 455799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|++..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987666532 3589999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCccccccccCccccCcccccc---CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT---GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||......+....+.. +......+
T Consensus 168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~ 236 (309)
T d1u5ra_ 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQS 236 (309)
T ss_dssp -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSC
T ss_pred -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCCC
Confidence 234679999999999864 4589999999999999999999999986655443333322 11111111
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+ + ..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~--------s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 GHW--------S----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTS--------C----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC--------C----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 1 13457899999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=399.58 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=190.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
.+.|++.+.||+|+||+||+|.++ +|+.||+|.+..... ..+.+.+|++++++++|||||++++++.+ ++..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 467999999999999999999986 589999999864332 34568899999999999999999999985 45679999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC---CCCcEEEeccccccccC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD---ADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~ 955 (1099)
||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+||++. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999742 3589999999999999999999999999999999999994 57899999999998652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCc
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPG 1035 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1035 (1099)
. .......+||+.|||||++.+..++.++||||+||++|||++|+.||......+....+... ... ...+.
T Consensus 162 ~----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----~~~-~~~~~ 232 (307)
T d1a06a_ 162 P----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA----EYE-FDSPY 232 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT----CCC-CCTTT
T ss_pred C----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CCC-CCCcc
Confidence 2 22334568999999999999999999999999999999999999999877665555444332 110 00000
Q ss_pred ccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1036 LLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... + ..+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~-----s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 233 WDDI-----S----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTS-----C----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCC-----C----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 0 124588999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=400.77 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=210.2
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 872 (1099)
..++|++.+.||+|+||+||+|+++ +++.||||++...... .++|.+|++++++++||||+++++++... .
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-K 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-S
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-C
Confidence 4568999999999999999999874 3678999999654332 46799999999999999999999999854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH-------------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQ 933 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~ 933 (1099)
..++||||+++|+|.++++.... .....+++..+..|+.|+|.||+|||+.+||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 56999999999999999975321 12235899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCC-CCCCCCCc
Q 047739 934 NVLFDADFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK-RPVMFTQD 1012 (1099)
Q Consensus 934 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~-~P~~~~~~ 1012 (1099)
|||+|.++.+||+|||+|+...+. ..........||+.|+|||++.+..++.++|||||||++|||++|. .||.....
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGG-GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCC-ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999865322 1223344567899999999999999999999999999999999985 57877766
Q ss_pred hhHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1013 EDIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
.+....+.. +..... + ...+ ..+.+++.+||+.||++||||.||+++|+++.
T Consensus 249 ~e~~~~v~~----~~~~~~-p--------~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYVRD----GNILAC-P--------ENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHT----TCCCCC-C--------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHc----CCCCCC-C--------ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 665554432 221111 1 1111 13468999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=400.09 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=199.8
Q ss_pred HHhccccccccccccceeEEEEEEC------CceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCC
Q 047739 801 ATRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAP 871 (1099)
Q Consensus 801 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 871 (1099)
..++|++.++||+|+||.||+|.+. +++.||||++..... ..+.+.+|.+++.++ +|+|||.+++++....
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3468999999999999999999864 357899999965332 346678888888887 6899999999988666
Q ss_pred CceEEEEeecCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCC
Q 047739 872 DLRLLVYDYMPNGNLGTLLQEASHQ-----------DGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDAD 940 (1099)
Q Consensus 872 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~ 940 (1099)
...++||||+++|+|.++++..... ....+++..+..++.|||+||+|||+.+|+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 6679999999999999999754321 13458999999999999999999999999999999999999999
Q ss_pred CcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCC-CCCCCCCchhHHHHH
Q 047739 941 FEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK-RPVMFTQDEDIVKWV 1019 (1099)
Q Consensus 941 ~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~-~P~~~~~~~~~~~~~ 1019 (1099)
+.+||+|||+|+..... ..........||+.|+|||++.+..++.++|||||||++|||+||. .||......+.....
T Consensus 171 ~~~Kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSC-TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhcccc-ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999865322 2223345568999999999999999999999999999999999974 577655443332222
Q ss_pred HHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1020 KKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1020 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
. ..+...... .... ..+.+++.+||+.||++|||++||++.|+++.
T Consensus 250 ~---~~~~~~~~~---------~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 250 L---KEGTRMRAP---------DYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H---HHTCCCCCC---------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---hcCCCCCCC---------ccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 222111111 0011 12468999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-44 Score=399.74 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=207.2
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... +.+.+.+|++++++++|||||++++++.+ ++..|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 458999999999999999999985 689999999865443 34678999999999999999999999985 455799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC--CCCcEEEeccccccccCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD--ADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~ 957 (1099)
||++|+|.+++... ...+++..+..++.||+.||+|||+.|||||||||+|||++ .++.+||+|||+|+....
T Consensus 104 ~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 104 FMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp CCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred cCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 99999999999642 23589999999999999999999999999999999999995 468899999999986522
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........||+.|||||++.+..++.++||||+||++|||++|+.||......+....+..... .......+.+
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~- 252 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGI- 252 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CSCCGGGGGC-
T ss_pred ---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCC-
Confidence 2334567899999999999999999999999999999999999999987776665555443211 1111000111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
+ ..+.+++.+||+.||++|||++|+++.
T Consensus 253 -----s------~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 -----S------EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----C------HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 124578999999999999999999884
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=392.12 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=199.0
Q ss_pred HhccccccccccccceeEEEEEECC----ceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND----GMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.....+ .+.|.+|++++++++|||||++++++.+ +..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence 4689999999999999999998753 467999998654333 4679999999999999999999999963 3469
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+||||+++|+|.+++... ...+++..+..++.||++||+|||+.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 84 iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999988652 2458999999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
. ..........||+.|+|||++.+..++.++|||||||++|||++ |..||......++...+... .... .++
T Consensus 160 ~--~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~----~~~~-~~~ 232 (273)
T d1mp8a_ 160 D--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG----ERLP-MPP 232 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----CCCC-CCT
T ss_pred C--CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCCC-CCC
Confidence 2 22233445678999999999999999999999999999999998 89999887777766655432 1111 111
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
..+ ..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 233 --------~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 233 --------NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp --------TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 13468999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=390.98 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=204.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-------ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-------LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|++.+.||+|+||+||+|.++ +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+ +..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence 467999999999999999999985 68999999984321 235779999999999999999999999985 456
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC----cEEEeccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF----EAHLSDFG 949 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~----~~kl~DfG 949 (1099)
.|+||||+++|+|.+++.+. ..+++.....++.|++.||+|||+.+|+||||||+||+++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence 69999999999999999763 2489999999999999999999999999999999999998776 59999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+|+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+..... ...
T Consensus 163 ~a~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~ 236 (293)
T d1jksa_ 163 LAHKIDF----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--EFE 236 (293)
T ss_dssp TCEECTT----SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--CCC
T ss_pred hhhhcCC----CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCC
Confidence 9986522 2334456899999999999999999999999999999999999999987766655544332110 111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....+.. + ..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~------s------~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 DEYFSNT------S------ALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTS------C------HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhcCCC------C------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111110 0 13457999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=398.86 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=204.5
Q ss_pred hccccccccccccceeEEEEEECC-c----eEEEEEECCCC--CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-G----MVLSIRRLPDG--SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRL 875 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 875 (1099)
.+|++.++||+|+||+||+|.+.. | .+||+|++... ....+.|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence 469999999999999999998753 3 36899988543 23457899999999999999999999999853 358
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
+|+||+.+|+|.+++... ...+++..+..++.|||+||+|||+.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 87 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 899999999999988753 3458999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHHHHHHhhhccccccccC
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKWVKKQLQKGQITELLEP 1034 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1034 (1099)
... .........||+.|+|||++.++.++.++|||||||++|||+| |+.||......++...+...... ..
T Consensus 163 ~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~------ 234 (317)
T d1xkka_ 163 AEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQ------ 234 (317)
T ss_dssp TTC-C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-CC------
T ss_pred ccc-ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC------
Confidence 222 2223344578999999999999999999999999999999998 89999877766665554432111 00
Q ss_pred cccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1035 GLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
+...+ ..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 235 ------p~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 235 ------PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CcccC----HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01111 124579999999999999999999999887653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-43 Score=398.95 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=206.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCC-ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS-LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .+.+.+.+|++++++++|||||++++++.+ +...|+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 357999999999999999999985 68999999986543 345678899999999999999999999985 456699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC--CCCcEEEeccccccccCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD--ADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~ 957 (1099)
|+++|+|.+++.. ....+++.....++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+|+....
T Consensus 107 ~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 107 FLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp CCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred cCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-
Confidence 9999999988764 234589999999999999999999999999999999999998 678999999999987632
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+..... .......+.+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~- 255 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSV- 255 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTS-
T ss_pred ---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCC-
Confidence 2334567899999999999999999999999999999999999999987776665554443211 1111111111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..+.+++.+||+.||++|||++|+++
T Consensus 256 -------s----~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 256 -------S----PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -------C----HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -------C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12458999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-43 Score=386.19 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=201.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHHHHHhhhccCCcceEEeeEEecCCC---c
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---L 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~ 873 (1099)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ..+.|.+|++++++++|||||++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999974 689999999865332 23568999999999999999999999875432 3
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||+++|+|.+++... ..+++.+...++.||++||+|||+.||+||||||+||+++.++..+++|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 68999999999999998754 2489999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc-cccc
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI-TELL 1032 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1032 (1099)
..............+||+.|+|||++.+..++.++||||+||++|||+||+.||......+....+.. .... ....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~ 237 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---EDPIPPSAR 237 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---CCCCCGGGT
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh---cCCCCCchh
Confidence 53333333455667899999999999999999999999999999999999999987665544333222 1111 1111
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHhhccc
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-TMSDIVFMLEGCR 1081 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~L~~~~ 1081 (1099)
.+.+ + ..+.+++.+||+.||++|| |++++.+.|.++.
T Consensus 238 ~~~~------s------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 238 HEGL------S------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSSC------C------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccCC------C------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111 0 1245789999999999999 8999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=390.35 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|+.+ +|+.||+|++... ....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccc
Confidence 57999999999999999999985 6899999998532 2234678899999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|.+++.+. ..+++.....++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 9999999999999864 3478899999999999999999999999999999999999999999999999986522
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..++.+.+... .+. ++..
T Consensus 158 --~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----~~~--~p~~-- 227 (337)
T d1o6la_ 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----EIR--FPRT-- 227 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCTT--
T ss_pred --CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC----CCC--CCcc--
Confidence 223445678999999999999999999999999999999999999999887766655544332 110 1111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
.. ..+.+++.+||+.||++||+ +.|+++
T Consensus 228 ------~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 ------LS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11 12457999999999999995 888876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=392.38 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=202.0
Q ss_pred ccccccccceeEEEEEECC----ceEEEEEECCCCC--ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 808 ENVLSRTRYGLVFKACYND----GMVLSIRRLPDGS--LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 808 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
.++||+|+||+||+|.+.+ ...||||++.... ...++|.+|++++++++|||||+++|++...+...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999999754 2468999986432 234679999999999999999999999886666779999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCCC-
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPAE- 960 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~- 960 (1099)
++|+|.+++... ....++..+.+++.|+|+||.|+|+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998742 334788899999999999999999999999999999999999999999999999876433222
Q ss_pred CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCC-chhHHHHHHHHhhhccccccccCcccCC
Q 047739 961 ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQ-DEDIVKWVKKQLQKGQITELLEPGLLEL 1039 (1099)
Q Consensus 961 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1039 (1099)
........||+.|+|||.+.+..++.++||||||+++|||+||+.||.... ..+....+. .+... ..+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~~~--~~p----- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRRL--LQP----- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTCCC--CCC-----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCCCC--CCc-----
Confidence 223345679999999999999999999999999999999999888875432 222222222 22111 011
Q ss_pred CCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1040 DPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1040 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
...+ ..+.+++.+||+.||++||+|.||++.|+++...
T Consensus 257 --~~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 --EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --ccCc----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111 1245889999999999999999999999988643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=391.56 Aligned_cols=268 Identities=21% Similarity=0.247 Sum_probs=201.5
Q ss_pred HhccccccccccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCC---ceEEEE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---LRLLVY 878 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~lV~ 878 (1099)
.++|...+.||+|+||.||+|+++ |+.||||++.........++.|+..+.+++|||||++++++.+... ..++||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 367888899999999999999975 8899999986543333334455666678899999999999975432 468999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc--------CCceecCCCCCCEEECCCCcEEEecccc
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT--------SNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
|||++|+|.+++++. .++|..+.+++.|+|.||+|+|+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999852 38999999999999999999996 5999999999999999999999999999
Q ss_pred ccccCCCCCC-CccccccccCccccCccccccCC------CCCcCchhhHHHHHHHHHhCCCCCCCCCch----------
Q 047739 951 DRLTIPTPAE-ASTSTTAVGTLGYVSPEAALTGE------TTKESDVYSFGIVLLELLTGKRPVMFTQDE---------- 1013 (1099)
Q Consensus 951 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~G~il~elltg~~P~~~~~~~---------- 1013 (1099)
++........ .......+||+.|+|||++.+.. ++.++|||||||++|||+||..||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9865332221 22345678999999999987542 577899999999999999999887542221
Q ss_pred -hHHHHHHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1014 -DIVKWVKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1014 -~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
.....+......... ++.+ .......+....+.+++.+||+.||++|||+.||++.|+++...
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 112222222222211 1111 11111223344567899999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-43 Score=389.50 Aligned_cols=243 Identities=22% Similarity=0.342 Sum_probs=202.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||+||+|+.+ +|+.||+|++... ....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence 57999999999999999999985 5899999998532 2234678999999999999999999999985 4567999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+++|+|..++... ..+++.....++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~-- 155 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-- 155 (316)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS--
T ss_pred eeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec--
Confidence 9999999999998753 337888888999999999999999999999999999999999999999999998652
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... .. ...+.+
T Consensus 156 ----~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~--~~p~~~- 224 (316)
T d1fota_ 156 ----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----EL--RFPPFF- 224 (316)
T ss_dssp ----SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC----CC--CCCTTS-
T ss_pred ----cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC----CC--CCCCCC-
Confidence 1234578999999999999999999999999999999999999999877666555544332 11 011111
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. ..+.+++.+||+.||.+|| |++|+++
T Consensus 225 -------s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 -------N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -------C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------C----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1 1245789999999999996 8999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=387.69 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=205.8
Q ss_pred HhccccccccccccceeEEEEEECC--------ceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYND--------GMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGA 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 870 (1099)
.++|++.+.||+|+||.||+|+... +..||||++..+.. ....+.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998632 35899999966443 336788999999998 899999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASH-----------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
...++||||+++|+|.+++..... .....+++.++..++.|||.||+|||+.+||||||||+|||++.
T Consensus 92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 456999999999999999975431 12356899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+||+|||+++..... ..........||+.|+|||.+.++.|+.++||||||+++|||++ |+.||......++...
T Consensus 171 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHI-DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGC-CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhcccccc-ccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999865332 22233455679999999999999999999999999999999998 7888877666555444
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhccc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCR 1081 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 1081 (1099)
+.. +..... ++ ... ..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 250 i~~----~~~~~~-p~--------~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 250 LKE----GHRMDK-PS--------NCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHT----TCCCCC-CS--------SCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHc----CCCCCC-Cc--------cch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 332 211111 11 111 13468999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=390.30 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=207.3
Q ss_pred HhccccccccccccceeEEEEEE------CCceEEEEEECCCCCc--cHHHHHHHHHHhhhc-cCCcceEEeeEEecCCC
Q 047739 802 TRQFDEENVLSRTRYGLVFKACY------NDGMVLSIRRLPDGSL--DENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 872 (1099)
.++|++.++||+|+||.||+|++ .+++.||||++..... ....|.+|+.+++++ +|||||++++++.+. .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-G 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-C
Confidence 46899999999999999999986 2467999999965433 345689999999999 699999999999855 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASH-------------QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA 939 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~ 939 (1099)
..++||||+++|+|.+++++... .....+++..+..++.|||+||+|||+++|+||||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 46999999999999999986432 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHh-CCCCCCCCCchhHHHH
Q 047739 940 DFEAHLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLT-GKRPVMFTQDEDIVKW 1018 (1099)
Q Consensus 940 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~ellt-g~~P~~~~~~~~~~~~ 1018 (1099)
++.+|++|||.++..... ..........||+.|+|||++.++.++.++|||||||++|||+| |.+||......+....
T Consensus 181 ~~~~ki~DfG~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSC-TTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCC-CcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999875322 22334456789999999999999999999999999999999999 5555555444333333
Q ss_pred HHHHhhhccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1019 VKKQLQKGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1019 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
+........ .+...+ ..+.+++.+||+.||++||||+||+++|++.
T Consensus 260 ~i~~~~~~~------------~~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 260 MIKEGFRML------------SPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHTCCCC------------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCC------------Cccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222111110 001111 1346899999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=388.37 Aligned_cols=251 Identities=18% Similarity=0.280 Sum_probs=208.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEee
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
.++|++.+.||+|+||+||+|.+. +|+.||+|.+.....+...+.+|++++++++|||||++++++.++ ...|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEec
Confidence 467999999999999999999986 589999999987777777899999999999999999999999854 557999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC--CCcEEEeccccccccCCCC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA--DFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~ 958 (1099)
+++|+|.+++.+. +..+++.+...++.||+.||+|||+.||+||||||+|||++. ...+|++|||+++...
T Consensus 83 ~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 83 ISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp CCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 9999999999742 235899999999999999999999999999999999999985 4589999999998652
Q ss_pred CCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcccC
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLLE 1038 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1038 (1099)
.........||+.|+|||...+..++.++||||+||++|||++|+.||......+....+..... .......+.+.
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s- 231 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY--TFDEEAFKEIS- 231 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CCCHHHHTTSC-
T ss_pred -cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCChhhccCCC-
Confidence 22334556899999999999999999999999999999999999999988776665555443211 11111111110
Q ss_pred CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1039 LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1039 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+.+++.+|++.||++|||+.|+++
T Consensus 232 -----------~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 232 -----------IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----------HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12468999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=387.00 Aligned_cols=258 Identities=20% Similarity=0.213 Sum_probs=197.7
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEECCCCCcc------HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 807 EENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD------ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 807 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
..++||+|+||+||+|.++ +|+.||||++...... .+.+.+|++++++++|||||++++++..+. ..|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehhh
Confidence 3578999999999999975 5899999998643322 246889999999999999999999998654 4699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|++++++..+.. ....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--- 152 (299)
T d1ua2a_ 81 FMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--- 152 (299)
T ss_dssp CCSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS---
T ss_pred hhcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC---
Confidence 998876665543 234588899999999999999999999999999999999999999999999999986522
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc-----
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE----- 1033 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 1033 (1099)
........+||+.|+|||++... .++.++||||+||++|||++|+.||....+.+....+.+...........+
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 22233456899999999998754 579999999999999999999999988777776666655433221111100
Q ss_pred --CcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1034 --PGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1034 --~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
....... ..+... -..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 011111 123568999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=391.55 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=203.5
Q ss_pred hccccccccccccceeEEEEEECC-c--eEEEEEECCCC--CccHHHHHHHHHHhhhc-cCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYND-G--MVLSIRRLPDG--SLDENLFRKEAEFLGKV-RHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~l 876 (1099)
++|+..++||+|+||+||+|.+++ | ..||||++... ....+.|.+|+++++++ +|||||+++|++.++ +..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence 678899999999999999998864 3 35788887432 22446799999999998 799999999999854 55699
Q ss_pred EEeecCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 877 VYDYMPNGNLGTLLQEAS-----------HQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
||||+++|+|.+++++.. ......+++..+..++.|||+||.|+|+.+|+||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 999999999999997531 233466999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCC-CCCCCCCchhHHHHHHHHhh
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK-RPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~-~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
+|||+|+... .........||..|+|||.+.+..++.++|||||||++|||++|. .||......++...+..
T Consensus 169 ~DfG~a~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~--- 241 (309)
T d1fvra_ 169 ADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 241 (309)
T ss_dssp CCTTCEESSC----EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG---
T ss_pred cccccccccc----ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh---
Confidence 9999997542 122233457899999999999999999999999999999999976 46766555554443322
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCC
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVG 1083 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 1083 (1099)
+...+. +...+ ..+.+++.+||+.||++||||+||++.|+++...
T Consensus 242 -~~~~~~---------~~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 -GYRLEK---------PLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -TCCCCC---------CTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCC---------CccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 211100 01111 1346899999999999999999999999887643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-42 Score=376.17 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=202.3
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc----------HHHHHHHHHHhhhcc-CCcceEEeeEEecC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD----------ENLFRKEAEFLGKVR-HRNLTVLRGYYAGA 870 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 870 (1099)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .+.+.+|++++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 57999999999999999999974 6899999998543221 245889999999997 9999999999984
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
++..|+||||+++|+|.++++.. ..+++.....++.||++||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 55679999999999999999753 2489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCccccCcccccc------CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhh
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALT------GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQ 1024 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~ 1024 (1099)
|+...+ .......+||..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+...
T Consensus 157 a~~~~~----~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDP----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCT----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccC----CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 987532 223345789999999998863 34788999999999999999999999877665555444332
Q ss_pred hccccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1025 KGQITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1025 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ...+..... . ..+.+++.+||+.||++|||++||++
T Consensus 231 --~~~-~~~~~~~~~-----s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 --NYQ-FGSPEWDDY-----S----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --CCC-CCTTTGGGS-----C----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --CCC-CCCcccccC-----C----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 110 001111000 0 13457899999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=386.65 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=210.7
Q ss_pred HhccccccccccccceeEEEEEEC------CceEEEEEECCCCCcc--HHHHHHHHHHhhhccCCcceEEeeEEecCCCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN------DGMVLSIRRLPDGSLD--ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 873 (1099)
.++|+..+.||+|+||+||+|.++ +++.||||++...... ...|.+|++++++++|||||+++|++..++ .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-P 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC-c
Confidence 468899999999999999999874 2578999999754332 356899999999999999999999998544 4
Q ss_pred eEEEEeecCCCCHHHHHhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASH-----QDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDF 948 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~Df 948 (1099)
.++||||+++|+|.+++..... .....+++..+.+++.|+|+||.|||+.+|+||||||+|||+|+++.+||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 6999999999999999875321 22234789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCC-CCCCCCCchhHHHHHHHHhhhcc
Q 047739 949 GLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGK-RPVMFTQDEDIVKWVKKQLQKGQ 1027 (1099)
Q Consensus 949 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~-~P~~~~~~~~~~~~~~~~~~~~~ 1027 (1099)
|+|+..... ..........||+.|+|||.+.+..++.++||||||+++|||+||. .||......+....+.. +.
T Consensus 178 Gla~~~~~~-~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~----~~ 252 (308)
T d1p4oa_ 178 GMTRDIYET-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----GG 252 (308)
T ss_dssp TCCCGGGGG-GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT----TC
T ss_pred ccceeccCC-cceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----CC
Confidence 999865322 1223334557999999999999999999999999999999999984 77776666555544432 21
Q ss_pred ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccC
Q 047739 1028 ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRV 1082 (1099)
Q Consensus 1028 ~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 1082 (1099)
..+.. ...+ ..+.+++.+||+.||++||||.||++.|++...
T Consensus 253 ~~~~p---------~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLDKP---------DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCC---------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCc---------ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11110 1111 135689999999999999999999999987754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=388.95 Aligned_cols=243 Identities=20% Similarity=0.259 Sum_probs=202.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLV 877 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV 877 (1099)
++|++.+.||+|+||.||+|+++ +|+.||+|++... ....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence 57999999999999999999985 6899999998532 2234678899999999999999999999985 4556999
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPT 957 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~ 957 (1099)
|||+.+|+|.+++.+.+ .+++.....++.||+.||+|||+.+||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999997642 489999999999999999999999999999999999999999999999999986521
Q ss_pred CCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCccc
Q 047739 958 PAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGLL 1037 (1099)
Q Consensus 958 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1037 (1099)
......||+.|||||++.+..++.++||||+||++|||+||+.||...........+... ... ....+
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~--~p~~~- 261 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVR--FPSHF- 261 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCC--CCTTC-
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC----CCC--CCccC-
Confidence 234568999999999999999999999999999999999999999876665555444332 110 00101
Q ss_pred CCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1038 ELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. ..+.+++.+||+.||.+|+ |++|+++
T Consensus 262 -------s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 -------S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------C----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 1245889999999999994 8999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-42 Score=387.88 Aligned_cols=199 Identities=33% Similarity=0.549 Sum_probs=148.9
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCCC--cccceEecC----CcEeEEecCCCcccc--ccccccccccccc
Q 047739 22 DRSPEIEALTSFKLNLHDPLGALNGWDSSTPAAPC--DWRGVACTN----NRVTELRLPRLQLSG--RISDHLSNLRMLR 93 (1099)
Q Consensus 22 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c--~w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 93 (1099)
|.++|++||++||++++||. .+++|+.++| || .|+||+|++ +|||+|+|+++++.| .||+++++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d--~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTD--CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSC--TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCCCC--CCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 56699999999999999885 6899987654 77 599999985 489999999999998 5789999999999
Q ss_pred eEEccC-CccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCCCcc
Q 047739 94 KLSLRS-NSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGF 172 (1099)
Q Consensus 94 ~L~L~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l 172 (1099)
+|+|++ |++.|.||+++++|++|++|+|++|++++.+|..+..+..|+++++++|.+.+.+|.
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~---------------- 143 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP---------------- 143 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCG----------------
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCch----------------
Confidence 999997 899999999999999999999999999998998888888888888877777655554
Q ss_pred CCCCCCCCccccccccccccccccccccccccccccCccccccCce-eEEEccCCcCCccChhhhcCCCCccEEEccccc
Q 047739 173 SGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSL-VHLSAQGNALGGVIPPAIGALPKLQVVSLAQNN 251 (1099)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L-~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 251 (1099)
+++++++|+++++++|+++ |.+|+.++.+..+ +.+++++|++++..|..+..+..+ .++++.|.
T Consensus 144 ------~l~~l~~L~~l~l~~n~l~--------~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 144 ------SISSLPNLVGITFDGNRIS--------GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp ------GGGGCTTCCEEECCSSCCE--------EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred ------hhccCcccceeeccccccc--------cccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 4555555555555555554 3444444444443 455555555555555555444333 35555544
Q ss_pred CCC
Q 047739 252 LSG 254 (1099)
Q Consensus 252 l~~ 254 (1099)
+.+
T Consensus 209 ~~~ 211 (313)
T d1ogqa_ 209 LEG 211 (313)
T ss_dssp EEE
T ss_pred ccc
Confidence 443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=385.15 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=197.7
Q ss_pred Hhccccc-cccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhc-cCCcceEEeeEEec---CCCceE
Q 047739 802 TRQFDEE-NVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKV-RHRNLTVLRGYYAG---APDLRL 875 (1099)
Q Consensus 802 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---~~~~~~ 875 (1099)
.++|.+. ++||+|+||+||+|.+. +++.||||++.. .+.+.+|++++.++ +|||||++++++.+ .....|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4578876 46999999999999974 689999999853 35678999987665 89999999999864 234569
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC---CCcEEEecccccc
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA---DFEAHLSDFGLDR 952 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~---~~~~kl~DfGla~ 952 (1099)
+|||||++|+|.+++.+. ....+++.....++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 999999999999999742 2346999999999999999999999999999999999999975 5679999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELL 1032 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1099)
.... .......+||+.|+|||++.+..|+.++||||+||++|||+||+.||...........+......+...
T Consensus 163 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~--- 235 (335)
T d2ozaa1 163 ETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--- 235 (335)
T ss_dssp ECCC----CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS---
T ss_pred eccC----CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC---
Confidence 6532 223455689999999999999999999999999999999999999998765554444333322222110
Q ss_pred cCcccCCCCCChhHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1033 EPGLLELDPESSEWEEF-LLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.....+..+ ..+.+++.+||+.||++|||+.|+++
T Consensus 236 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 --------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011111111 23568999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=384.40 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=200.9
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCC----CccHHHHHHHHHHhh-hccCCcceEEeeEEecCCCceEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDG----SLDENLFRKEAEFLG-KVRHRNLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~l 876 (1099)
++|++.+.||+|+||+||+|+.. +|+.||+|++... ....+.+.+|..++. .++|||||++++++.+. +..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeE
Confidence 57999999999999999999986 5899999998532 223355677777765 68999999999999854 55799
Q ss_pred EEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCC
Q 047739 877 VYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIP 956 (1099)
Q Consensus 877 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~ 956 (1099)
||||+++|+|.++++... .+++.....++.||+.||+|||+.+|+||||||+|||++.++.+|++|||+|+....
T Consensus 81 vmEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999998643 378899999999999999999999999999999999999999999999999986422
Q ss_pred CCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL 1036 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1036 (1099)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....++...+... .. ..++.
T Consensus 156 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~--~~p~~- 225 (320)
T d1xjda_ 156 ---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----NP--FYPRW- 225 (320)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CC--CCCTT-
T ss_pred ---ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CC--CCCcc-
Confidence 223345568999999999999999999999999999999999999999887766655544321 11 01110
Q ss_pred cCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 047739 1037 LELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMS-DIV 1074 (1099)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1074 (1099)
.+ ..+.+++.+||+.||++||++. |++
T Consensus 226 -------~s----~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 226 -------LE----KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -------SC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CC----HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 11 1246899999999999999995 675
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.9e-42 Score=386.65 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=194.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc----cHHHHHHH---HHHhhhccCCcceEEeeEEecCCCce
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL----DENLFRKE---AEFLGKVRHRNLTVLRGYYAGAPDLR 874 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~~ 874 (1099)
++|++.++||+|+||.||+|+.. +|+.||+|++..... ....+.+| +++++.++|||||++++++.+ ++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEE
Confidence 57999999999999999999986 589999999853211 22334444 667777789999999999985 4557
Q ss_pred EEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccccc
Q 047739 875 LLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLT 954 (1099)
Q Consensus 875 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~ 954 (1099)
|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999764 34788999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc
Q 047739 955 IPTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE 1033 (1099)
Q Consensus 955 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 1033 (1099)
.. ......+||+.|+|||++.. ..++.++||||+||++|||+||+.||......+....... ...... ..+
T Consensus 158 ~~-----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~--~~~ 229 (364)
T d1omwa3 158 SK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAV--ELP 229 (364)
T ss_dssp SS-----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCC--CCC
T ss_pred CC-----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCC--CCC
Confidence 22 23345689999999999875 4689999999999999999999999986554443332221 111110 011
Q ss_pred CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 047739 1034 PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPT-----MSDIVF 1075 (1099)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1075 (1099)
..+ . ..+.+++.+||+.||++||| ++|+++
T Consensus 230 ~~~--------s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSF--------S----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSS--------C----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC--------C----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111 1 12458999999999999999 688874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-41 Score=368.75 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=201.6
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|++.+.||+|+||+||+|.+. +|+.||+|++..... ..+.+.+|++++++++|||||++++++.+ +...|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence 57999999999999999999984 689999999865432 24678999999999999999999999985 45569999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
||+.+ ++.+++... ....+++..+..++.||+.||+|||+.|||||||||+|||++.++.+||+|||+|+....
T Consensus 81 e~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-- 154 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-- 154 (298)
T ss_dssp ECCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--
T ss_pred eecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--
Confidence 99975 555555432 234589999999999999999999999999999999999999999999999999986522
Q ss_pred CCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccccccCcc-
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLEPGL- 1036 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~- 1036 (1099)
.........||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+....+........ +...+..
T Consensus 155 -~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 231 (298)
T d1gz8a_ 155 -PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--EVVWPGVT 231 (298)
T ss_dssp -CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC--TTTSTTGG
T ss_pred -CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc--hhhccccc
Confidence 223445568999999999887665 47899999999999999999999987766555444443322111 1100000
Q ss_pred ------cCCC-CCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1037 ------LELD-PESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1037 ------~~~~-~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
.... ........ -..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00111111 0234689999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-41 Score=367.76 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=199.6
Q ss_pred hccccccccccccceeEEEEEECCceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e 879 (1099)
++|+..++||+|+||+||+|++++|+.||||++...... .+.+.+|+.++++++|||||++++++..+. ..++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEEE
Confidence 579999999999999999999999999999999654433 467999999999999999999999998554 5699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTPA 959 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 959 (1099)
|+.++.+..+... ...+++.....++.||++||+|||+.+||||||||+|||++.++.+|++|||.|.....
T Consensus 81 ~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--- 152 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--- 152 (286)
T ss_dssp CCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc---
Confidence 9987666555542 24599999999999999999999999999999999999999999999999999976522
Q ss_pred CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccc-------
Q 047739 960 EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITEL------- 1031 (1099)
Q Consensus 960 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 1031 (1099)
.........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+............
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 12233445789999999998765 4689999999999999999999999877666555554443222111000
Q ss_pred -ccCcccCCCCCChh--HH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1032 -LEPGLLELDPESSE--WE-EFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1032 -~d~~~~~~~~~~~~--~~-~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.........+.... .+ --..+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 00 0123468999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=371.72 Aligned_cols=261 Identities=22% Similarity=0.267 Sum_probs=201.0
Q ss_pred HhccccccccccccceeEEEEEEC-C-ceEEEEEECCCC---CccHHHHHHHHHHhhhc---cCCcceEEeeEEec----
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-D-GMVLSIRRLPDG---SLDENLFRKEAEFLGKV---RHRNLTVLRGYYAG---- 869 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 869 (1099)
.++|++.+.||+|+||+||+|.+. + ++.||||++... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 678999998432 22234577888887776 79999999999852
Q ss_pred CCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccc
Q 047739 870 APDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFG 949 (1099)
Q Consensus 870 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfG 949 (1099)
.....++||||+++|++...... ....+++.....++.|++.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 23456899999988766544332 33458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 950 LDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 950 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
+++.. .........+||+.|+|||++.+..|+.++||||+||++|||++|+.||....+.+....+..........
T Consensus 162 ~~~~~----~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIY----SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCC----CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhh----cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 98754 22344566789999999999999999999999999999999999999998877766666655443221110
Q ss_pred ccc--------------cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELL--------------EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~--------------d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
... ........... . ..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s----~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDI-D----ELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSC-C----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccC-C----HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000000 0 12457899999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=368.81 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=191.4
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCc-------cHHHHHHHHHHhhhcc--CCcceEEeeEEecCCC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL-------DENLFRKEAEFLGKVR--HRNLTVLRGYYAGAPD 872 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 872 (1099)
++|++.++||+|+||+||+|.+. +|+.||||++..... ...++.+|++++++++ |||||++++++.+ ++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PD 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-CC
Confidence 57999999999999999999985 689999999853221 1244778999999996 8999999999985 45
Q ss_pred ceEEEEeecCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-CCcEEEecccc
Q 047739 873 LRLLVYDYMPN-GNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-DFEAHLSDFGL 950 (1099)
Q Consensus 873 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-~~~~kl~DfGl 950 (1099)
..++||||+.+ +++.+++.+. ..+++..+..++.||++||+|||+.||+||||||+||+++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 56999999976 5788888753 34899999999999999999999999999999999999985 47999999999
Q ss_pred ccccCCCCCCCccccccccCccccCccccccCCC-CCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc
Q 047739 951 DRLTIPTPAEASTSTTAVGTLGYVSPEAALTGET-TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT 1029 (1099)
Q Consensus 951 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1099)
|+... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... + +. .+..
T Consensus 158 a~~~~-----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~----~~~~- 221 (273)
T d1xwsa_ 158 GALLK-----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----II----RGQV- 221 (273)
T ss_dssp CEECC-----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH----HCCC-
T ss_pred ceecc-----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----Hh----hccc-
Confidence 98642 223345789999999999987776 567899999999999999999996421 1 11 1111
Q ss_pred ccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1030 ELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1030 ~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
.+.+.+ + ..+.+++.+||+.||++|||++|+++
T Consensus 222 -~~~~~~--------s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFRQRV--------S----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCSSCC--------C----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCC--------C----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011111 1 12457899999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=367.91 Aligned_cols=275 Identities=20% Similarity=0.268 Sum_probs=203.3
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc--cHHHHHHHHHHhhhccCCcceEEeeEEecCCC---ceE
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL--DENLFRKEAEFLGKVRHRNLTVLRGYYAGAPD---LRL 875 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~ 875 (1099)
+.+|++.+.||+|+||+||+|... +|+.||||++..... ..+.+.+|++++++++||||+++++++..... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999874 789999999865332 24678899999999999999999999864321 224
Q ss_pred EEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccC
Q 047739 876 LVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 876 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~ 955 (1099)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+.|||||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55667779999999974 248999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccccccc-
Q 047739 956 PTPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITELLE- 1033 (1099)
Q Consensus 956 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d- 1033 (1099)
............+||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+...................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43333344566789999999999854 5578999999999999999999999987665544444333221111000000
Q ss_pred ------C-cccCCCCCChhHHHH-----HHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccC
Q 047739 1034 ------P-GLLELDPESSEWEEF-----LLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRV 1082 (1099)
Q Consensus 1034 ------~-~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~ 1082 (1099)
. ..........++... ..+.+++.+|++.||++|||+.|+++. ++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 000000001111111 235689999999999999999999974 554433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=364.83 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=197.8
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecCC-----C
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGAP-----D 872 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 872 (1099)
.++|++.+.||+|+||+||+|.+. +|+.||||++...... .+.+.+|++++++++|||||+++++|...+ .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457999999999999999999975 5899999999654333 356889999999999999999999997543 2
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..|+||||+ +++|..+.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccccee
Confidence 358999999 5678777753 248999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc----
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ---- 1027 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1027 (1099)
... ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+........
T Consensus 170 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QAD------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECC------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccC------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 642 223457899999999998764 468999999999999999999999987665554433333211100
Q ss_pred --------------ccccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--hhcccCCCCCC
Q 047739 1028 --------------ITELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFM--LEGCRVGPDIP 1087 (1099)
Q Consensus 1028 --------------~~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~~ 1087 (1099)
..+.....+....... . ..+.+++.+|+..||++|||+.|+++. ++.+....+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNA-S----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTC-C----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCC-C----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 0000001111111111 1 124579999999999999999999984 66665444443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=367.51 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=197.9
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecC-----CCceEEE
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PDLRLLV 877 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~~lV 877 (1099)
+|+..++||+|+||+||+|++. +|+.||||++.... ....+|++++++++|||||++++++... ....++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5888999999999999999986 58999999986543 2345799999999999999999998532 2345899
Q ss_pred EeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCC
Q 047739 878 YDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIP 956 (1099)
Q Consensus 878 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~ 956 (1099)
|||+++| +.+.+.... .....+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+|+....
T Consensus 98 ~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 98 LDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9999765 444443321 2335689999999999999999999999999999999999999775 899999999986532
Q ss_pred CCCCCccccccccCccccCcccccc-CCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcc-------c
Q 047739 957 TPAEASTSTTAVGTLGYVSPEAALT-GETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQ-------I 1028 (1099)
Q Consensus 957 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------~ 1028 (1099)
.......+||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.+...... .
T Consensus 176 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 ----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp ----TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ----CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 223345689999999998875 4689999999999999999999999987766555444433221110 0
Q ss_pred cccccCcccC--------CCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--Hhhccc
Q 047739 1029 TELLEPGLLE--------LDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCR 1081 (1099)
Q Consensus 1029 ~~~~d~~~~~--------~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 1081 (1099)
....+..+.. ....... ..+.+++.+||+.||++|||+.|+++ +++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000111100 0000011 12467899999999999999999996 355543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=360.87 Aligned_cols=268 Identities=19% Similarity=0.207 Sum_probs=200.4
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCc---cHHHHHHHHHHhhhccCCcceEEeeEEecC-------
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSL---DENLFRKEAEFLGKVRHRNLTVLRGYYAGA------- 870 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 870 (1099)
.++|++.++||+|+||+||+|.+. +|+.||||++..... ..+++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999985 689999999854322 346788999999999999999999988642
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccc
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 950 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGl 950 (1099)
....++||||++++.+..+.. ....+++.....++.|++.||+|||+.||+||||||+||+++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 234689999998766554433 234578899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-CCccccccccCccccCccccccC-CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc
Q 047739 951 DRLTIPTPA-EASTSTTAVGTLGYVSPEAALTG-ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI 1028 (1099)
Q Consensus 951 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1028 (1099)
++....... ........+||+.|+|||++.+. .+++++||||+||++|||++|+.||....+......+.+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~- 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT- 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC-
Confidence 976532221 12233456899999999998765 588999999999999999999999987776666555555432211
Q ss_pred cccccCc---------ccCCCCCCh-hHHH------HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 TELLEPG---------LLELDPESS-EWEE------FLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 ~~~~d~~---------~~~~~~~~~-~~~~------~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
...... ......... ..+. -..+.+++.+||+.||++|||++|+++.
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 -PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp -TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100000 000000111 1111 1234679999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-39 Score=359.28 Aligned_cols=260 Identities=17% Similarity=0.202 Sum_probs=198.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEEeec
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVYDYM 881 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~e~~ 881 (1099)
++|++.+.||+|+||+||+|.+. +|+.||||.+.... ..+.+.+|++++++++|+|++..++++....+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 47999999999999999999975 58999999875533 33568899999999998887777666665677779999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEEC---CCCcEEEeccccccccCCCC
Q 047739 882 PNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFD---ADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 882 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~~~ 958 (1099)
+|++.+.+... ...+++..+..++.|++.||+|||+.||+||||||+||+++ .+..+|++|||+|+......
T Consensus 86 -~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 56777766542 34589999999999999999999999999999999999986 35579999999998763322
Q ss_pred CC----CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhc--cccccc
Q 047739 959 AE----ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKG--QITELL 1032 (1099)
Q Consensus 959 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1032 (1099)
.. .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+....... ...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 11 123345689999999999999999999999999999999999999997655544333332221110 000001
Q ss_pred cCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcc
Q 047739 1033 EPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGC 1080 (1099)
Q Consensus 1033 d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~ 1080 (1099)
.+.+ + ..+.+++..||+.+|++||++.++.+.|+..
T Consensus 241 ~~~~--------p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 241 CKGY--------P----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TTTS--------C----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ccCC--------C----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 0 1245789999999999999999998888765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.3e-39 Score=351.31 Aligned_cols=265 Identities=17% Similarity=0.185 Sum_probs=205.1
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhccC-CcceEEeeEEecCCCceEEEEee
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVRH-RNLTVLRGYYAGAPDLRLLVYDY 880 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~lV~e~ 880 (1099)
++|.+.++||+|+||+||+|++. +|+.||+|.+... .+.+.+.+|+++++.++| +|++.+++++.. ....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEe
Confidence 57999999999999999999975 5899999987543 234568889999999975 899999998875 4556999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECC-----CCcEEEeccccccccC
Q 047739 881 MPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDA-----DFEAHLSDFGLDRLTI 955 (1099)
Q Consensus 881 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~-----~~~~kl~DfGla~~~~ 955 (1099)
+ +|+|.++++.. ...+++.++..++.|++.||+|||+.||+||||||+||+++. ++.+|++|||+|+...
T Consensus 83 ~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 68999998753 245899999999999999999999999999999999999974 5789999999998653
Q ss_pred CCCCC----CccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHH---HHHhhhccc
Q 047739 956 PTPAE----ASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWV---KKQLQKGQI 1028 (1099)
Q Consensus 956 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~---~~~~~~~~~ 1028 (1099)
..... .......+||+.|||||++.+..++.++||||+||++|||++|+.||............ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 22111 12344568999999999999999999999999999999999999999765444332222 221111111
Q ss_pred cccccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHhhcccCCCCCC
Q 047739 1029 TELLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVFMLEGCRVGPDIP 1087 (1099)
Q Consensus 1029 ~~~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1087 (1099)
.+. .+.+ + + .+.+++..|++.+|++||+++.+.+.|+++...-...
T Consensus 238 ~~l-~~~~--------p-~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 238 REL-CAGF--------P-E---EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHH-TTTS--------C-H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHh-cCCC--------C-H---HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111 1111 1 1 2457888999999999999999998887765433333
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-38 Score=356.67 Aligned_cols=259 Identities=19% Similarity=0.258 Sum_probs=195.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-CCcceEEeeEEecC-CCceEEEEe
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGA-PDLRLLVYD 879 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~-~~~~~lV~e 879 (1099)
++|++.++||+|+||+||+|+.. +|+.||+|++... ..+.+.+|++++++++ ||||+++++++... ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 57999999999999999999984 6899999998643 4577899999999995 99999999998743 345789999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCC-cEEEeccccccccCCCC
Q 047739 880 YMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADF-EAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 880 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~ 958 (1099)
|+++|+|..+.+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+|++|||+|+...+.
T Consensus 113 ~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 113 HVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp CCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred ecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 999999876643 389999999999999999999999999999999999998655 6999999999865322
Q ss_pred CCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchh-HHHHHHHHhhh---------cc
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDED-IVKWVKKQLQK---------GQ 1027 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~-~~~~~~~~~~~---------~~ 1027 (1099)
......+||..|+|||.+.+.. ++.++||||+||+++||++|+.||....+.. ....+...... ..
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2345568999999999987654 7999999999999999999999997654432 11111111110 00
Q ss_pred c------ccccc----CcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1028 I------TELLE----PGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1028 ~------~~~~d----~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
. ..... ...............-..+.+++.+|++.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 000000000000000123468999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=356.41 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=200.3
Q ss_pred hccccccccccccceeEEEEEEC----CceEEEEEECCCCC-----ccHHHHHHHHHHhhhccC-CcceEEeeEEecCCC
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN----DGMVLSIRRLPDGS-----LDENLFRKEAEFLGKVRH-RNLTVLRGYYAGAPD 872 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 872 (1099)
++|++.+.||+|+||+||+|... +|+.||+|.+.... ...+.+.+|++++++++| |||+++++++.+. .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-T 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-C
Confidence 57999999999999999999862 47899999985432 234678899999999977 8999999998854 4
Q ss_pred ceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 873 LRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 873 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
..++||||+.+|+|.+++...+ .+.+.....++.|++.|++|+|+.+|+||||||+||+++.++.+||+|||+|+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 5699999999999999998643 36778888899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCccccCccccccC--CCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccccc
Q 047739 953 LTIPTPAEASTSTTAVGTLGYVSPEAALTG--ETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQITE 1030 (1099)
Q Consensus 953 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1099)
.... ..........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+.+........
T Consensus 178 ~~~~--~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~- 254 (322)
T d1vzoa_ 178 EFVA--DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP- 254 (322)
T ss_dssp ECCG--GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-
T ss_pred hhcc--cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-
Confidence 6522 223334567899999999998765 46789999999999999999999998766655555554443322211
Q ss_pred cccCcccCCCCCChhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 047739 1031 LLEPGLLELDPESSEWEEFLLGVKVALLCTAPDPIDRP-----TMSDIVF 1075 (1099)
Q Consensus 1031 ~~d~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1075 (1099)
. . .... ..+.+++.+||++||++|| |++|+++
T Consensus 255 -----~---~-~~~s----~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 -----Y---P-QEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----C---C-TTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----C---c-ccCC----HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 0 0001 2345789999999999999 4888886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=349.22 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=198.8
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCC---ccHHHHHHHHHHhhhccCCcceEEeeEEecCCCceEEEE
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGS---LDENLFRKEAEFLGKVRHRNLTVLRGYYAGAPDLRLLVY 878 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~lV~ 878 (1099)
++|++.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+ +...++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence 57999999999999999999985 68899999984332 234778999999999999999999999985 45568999
Q ss_pred eecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccccCCCC
Q 047739 879 DYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRLTIPTP 958 (1099)
Q Consensus 879 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 958 (1099)
|++.++++..++... ..+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+|++|||.|+....
T Consensus 81 ~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~-- 153 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-- 153 (292)
T ss_dssp ECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred eeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--
Confidence 999998888877642 3478999999999999999999999999999999999999999999999999986522
Q ss_pred CCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCC-chhHHHHHHHHhhhcccc------c
Q 047739 959 AEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQ-DEDIVKWVKKQLQKGQIT------E 1030 (1099)
Q Consensus 959 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~------~ 1030 (1099)
.........++..|+|||.+.... ++.++||||+||++|||++|+.||.... ..+....+.......... .
T Consensus 154 -~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 222334456788999999887665 6899999999999999999999975433 333333333322211000 0
Q ss_pred cccC---cccCC-CCCChh-HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 047739 1031 LLEP---GLLEL-DPESSE-WEEFLLGVKVALLCTAPDPIDRPTMSDIVF 1075 (1099)
Q Consensus 1031 ~~d~---~~~~~-~~~~~~-~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1075 (1099)
..+. ..... ...... ...-..+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 000000 000123457899999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=356.51 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=191.7
Q ss_pred hccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecC-----CCc
Q 047739 803 RQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGA-----PDL 873 (1099)
Q Consensus 803 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 873 (1099)
++|++.++||+|+||+||+|.+. +|+.||||++.....+ .+.+.+|+.++++++|||||++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999986 5999999999654332 35688999999999999999999998633 356
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.|+||||+.+ ++.+.+. ..+++.....++.||+.||+|||+.||+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 7999999975 4545443 2378999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhccc-----
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQI----- 1028 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----- 1028 (1099)
.. ........+||+.|+|||++.+..+++++||||+||+++||++|+.||...+.......+.........
T Consensus 169 ~~----~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cc----cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 42 233445668999999999999999999999999999999999999999877665554444332221000
Q ss_pred --------------------cccccCcccCCCCCChhH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 047739 1029 --------------------TELLEPGLLELDPESSEW-EEFLLGVKVALLCTAPDPIDRPTMSDIVFM 1076 (1099)
Q Consensus 1029 --------------------~~~~d~~~~~~~~~~~~~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1076 (1099)
........ ........ ..-..+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCcccccccccccccccc--ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00011111 122345789999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-38 Score=355.51 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=204.7
Q ss_pred HhccccccccccccceeEEEEEEC-CceEEEEEECCCCCcc---HHHHHHHHHHhhhccCCcceEEeeEEecC----CCc
Q 047739 802 TRQFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLD---ENLFRKEAEFLGKVRHRNLTVLRGYYAGA----PDL 873 (1099)
Q Consensus 802 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~ 873 (1099)
.++|++.++||+|+||+||+|.+. +|+.||||++.....+ .+.+.+|++++++++|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999975 6999999999754333 35688999999999999999999998632 223
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEEeccccccc
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGLDRL 953 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl~DfGla~~ 953 (1099)
.++|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+|++|||+|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 3667788889999999863 2489999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCccccCccccccCC-CCCcCchhhHHHHHHHHHhCCCCCCCCCchhHHHHHHHHhhhcccc--c
Q 047739 954 TIPTPAEASTSTTAVGTLGYVSPEAALTGE-TTKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQKGQIT--E 1030 (1099)
Q Consensus 954 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~ 1030 (1099)
. ........||..|+|||...+.. ++.++||||+||++|||++|+.||.+.+.......+.......... .
T Consensus 171 ~------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 T------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp C------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred c------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4 23345568999999999877654 6889999999999999999999998877666655554443211100 0
Q ss_pred c--------ccCcccCCCCCChhHHH-----HHHHHHHHHhcCCCCCCCCCCHHHHHH--HhhcccCCCCCC
Q 047739 1031 L--------LEPGLLELDPESSEWEE-----FLLGVKVALLCTAPDPIDRPTMSDIVF--MLEGCRVGPDIP 1087 (1099)
Q Consensus 1031 ~--------~d~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~~~ 1087 (1099)
. ......... ...+.. -..+.+++.+|++.||++|||++|+++ .+.+.....+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMP--KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp TCCCHHHHHHHTTSCCCC--CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred hccchhhhhhhhhcccCC--CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 0 000000000 000100 023468999999999999999999998 566554444333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-34 Score=323.82 Aligned_cols=265 Identities=17% Similarity=0.189 Sum_probs=189.8
Q ss_pred ccccccccccccceeEEEEEEC-CceEEEEEECCCCCccHHHHHHHHHHhhhcc-----------CCcceEEeeEEec-C
Q 047739 804 QFDEENVLSRTRYGLVFKACYN-DGMVLSIRRLPDGSLDENLFRKEAEFLGKVR-----------HRNLTVLRGYYAG-A 870 (1099)
Q Consensus 804 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~-~ 870 (1099)
+|++.++||+|+||+||+|+.. +|+.||||++.......+.+.+|++++++++ |+||+++++++.. .
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 5899999999999999999985 6999999999876555677889999998885 5789999988763 3
Q ss_pred CCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCceecCCCCCCEEECCCC------cE
Q 047739 871 PDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHT-SNMVHGDIKPQNVLFDADF------EA 943 (1099)
Q Consensus 871 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~iiH~Dlk~~NIll~~~~------~~ 943 (1099)
....++||+++..+........ .......++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3455677777766543333332 2334568899999999999999999997 8999999999999998654 49
Q ss_pred EEeccccccccCCCCCCCccccccccCccccCccccccCCCCCcCchhhHHHHHHHHHhCCCCCCCCCchh------HHH
Q 047739 944 HLSDFGLDRLTIPTPAEASTSTTAVGTLGYVSPEAALTGETTKESDVYSFGIVLLELLTGKRPVMFTQDED------IVK 1017 (1099)
Q Consensus 944 kl~DfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G~il~elltg~~P~~~~~~~~------~~~ 1017 (1099)
+++|||.|+... ......+||+.|+|||++....++.++||||+||+++||++|+.||....... ...
T Consensus 172 kl~dfg~s~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 172 KIADLGNACWYD------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EECCCTTCEETT------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEeecccccccc------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999987542 22345689999999999999999999999999999999999999996533211 111
Q ss_pred HHHHHhhh--------ccc-ccccc-----CcccCCCC----------CChhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 047739 1018 WVKKQLQK--------GQI-TELLE-----PGLLELDP----------ESSEWEEFLLGVKVALLCTAPDPIDRPTMSDI 1073 (1099)
Q Consensus 1018 ~~~~~~~~--------~~~-~~~~d-----~~~~~~~~----------~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ev 1073 (1099)
........ +.. ....+ ........ ..........+.+++.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11111000 000 00000 00000000 00011223356789999999999999999999
Q ss_pred HHH
Q 047739 1074 VFM 1076 (1099)
Q Consensus 1074 l~~ 1076 (1099)
++.
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 873
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.9e-30 Score=287.27 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=165.4
Q ss_pred CCEEEccCCcCcc--ccCcccCCCCcccEEEccC-CcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceee
Q 047739 440 LSTLDLSENKFSG--EVPASIGNLSQLMVFNLSG-NAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIA 516 (1099)
Q Consensus 440 L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 516 (1099)
++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4444444444433 2444555555555555543 455555555555555555555555555555555555555566666
Q ss_pred eccccccCCCchhhhcccccceecccccccCCCCCCccccccee-eEEEccCCcCCCCCCCCCCCCCCCceEEecCCccc
Q 047739 517 LQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSV-VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLT 595 (1099)
Q Consensus 517 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 595 (1099)
+++|.+.+.+|..+.+++.|+++++++|.+.+.+|..+..+.++ +.+++++|++++..|..+.++.. ..+++++|...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc
Confidence 66665555566666666666666666666666666666555554 56666666666666666666543 36778888887
Q ss_pred CcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCcc
Q 047739 596 GHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLS 675 (1099)
Q Consensus 596 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 675 (1099)
+.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|+.|+++++|+.|||++|+|+|.+|+ +.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~ 288 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence 7777777888888888888888876544 577778888888888888888888888888888888888888888885 35
Q ss_pred ccccccccccCCCCcccCCCCccCCCCCCC
Q 047739 676 SIFGLMNFNVSSNNLQAFANNQDLCGKPLG 705 (1099)
Q Consensus 676 ~~~~l~~l~l~~n~~~~~~~n~~l~~~~~~ 705 (1099)
.+.+|..++++ +|..+||.|+.
T Consensus 289 ~L~~L~~l~l~--------~N~~l~g~plp 310 (313)
T d1ogqa_ 289 NLQRFDVSAYA--------NNKCLCGSPLP 310 (313)
T ss_dssp TGGGSCGGGTC--------SSSEEESTTSS
T ss_pred cCCCCCHHHhC--------CCccccCCCCC
Confidence 55666666644 44567887764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.2e-28 Score=276.66 Aligned_cols=340 Identities=23% Similarity=0.300 Sum_probs=208.2
Q ss_pred CceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEc
Q 047739 294 SVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDL 373 (1099)
Q Consensus 294 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 373 (1099)
.+|++|++++|+|+.+ +.+..+++|++|||++|+|++. | .|+++++|++|++++|++.+.. .+..+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--ccccccccccccc
Confidence 3577888888888753 3577788888888888888754 3 3888888888888888887533 3778888888888
Q ss_pred cCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccc
Q 047739 374 EGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGE 453 (1099)
Q Consensus 374 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 453 (1099)
++|.+++..+ ......+..+....|.+....+..................+ ..+.............|...
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-- 188 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS-- 188 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC--
T ss_pred cccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccccc--
Confidence 8888774333 33445666777777766544443333322222222222111 23344445555555555443
Q ss_pred cCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcc
Q 047739 454 VPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSL 533 (1099)
Q Consensus 454 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 533 (1099)
....+..+++++.+++++|.+++..| +..+++|++|++++|.++. + ..+..+++|+.|++++|.+++.. .+..+
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~ 262 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGL 262 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--ccccc
Confidence 23445566666677777776665433 3445666777777776653 2 24556666666677666666432 25566
Q ss_pred cccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEec
Q 047739 534 MSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDL 613 (1099)
Q Consensus 534 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 613 (1099)
++|++|++++|++++.. .+..++.++.+++++|++++. ..+..+++++.|++++|++++. + .+..+++|+.|++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEEC
Confidence 66677777666665432 255556666666666666532 2355666666677776666643 2 2666666777777
Q ss_pred cCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCC
Q 047739 614 SINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSAN 664 (1099)
Q Consensus 614 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 664 (1099)
++|+|++ ++ .+..+++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7776663 33 46666667777777776664433 666666777776666
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=8.9e-28 Score=275.34 Aligned_cols=80 Identities=21% Similarity=0.402 Sum_probs=49.3
Q ss_pred ccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCC
Q 047739 161 NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240 (1099)
Q Consensus 161 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 240 (1099)
+|++|++++|+|+. + +.++.+++|++|+|++|+|+ .+| .++++++|++|++++|++.+.. .++.++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~---------~l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~ 110 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT---------DIT-PLKNLTKLVDILMNNNQIADIT--PLANLT 110 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC---------CCG-GGTTCTTCCEEECCSSCCCCCG--GGTTCT
T ss_pred CCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC---------CCc-cccCCccccccccccccccccc--cccccc
Confidence 44555555555542 2 34566777777777777766 233 2666677777777777776543 266677
Q ss_pred CccEEEcccccCCC
Q 047739 241 KLQVVSLAQNNLSG 254 (1099)
Q Consensus 241 ~L~~L~Ls~N~l~~ 254 (1099)
+|+.|++++|.+++
T Consensus 111 ~L~~L~~~~~~~~~ 124 (384)
T d2omza2 111 NLTGLTLFNNQITD 124 (384)
T ss_dssp TCCEEECCSSCCCC
T ss_pred cccccccccccccc
Confidence 77777777777664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4.6e-26 Score=252.03 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=161.0
Q ss_pred CcccceEecCCcEeEEecCCCccccccccccccccccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccc
Q 047739 56 CDWRGVACTNNRVTELRLPRLQLSGRISDHLSNLRMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIG 135 (1099)
Q Consensus 56 c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~ 135 (1099)
|.|.+|.|++.+.+ ++|+.+. +.+++|+|++|+++...+..|.++++|++|++++|.++...|..+.
T Consensus 10 c~~~~~~C~~~~L~-----------~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~ 76 (305)
T d1xkua_ 10 CHLRVVQCSDLGLE-----------KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76 (305)
T ss_dssp EETTEEECTTSCCC-----------SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred ecCCEEEecCCCCC-----------ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhh
Confidence 88999999864433 3444443 5799999999999854455799999999999999999988888899
Q ss_pred cCCCCceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCcccccc
Q 047739 136 NLSNLEILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANC 215 (1099)
Q Consensus 136 ~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l 215 (1099)
++++|++|++++|+++ .+|......+..|++++|.+.+..+..+.....++.++...|...
T Consensus 77 ~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~------------------ 137 (305)
T d1xkua_ 77 PLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK------------------ 137 (305)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC------------------
T ss_pred CCCccCEecccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhcccccccccccccccc------------------
Confidence 9999999999999987 466666667777777777776544444444444444444444322
Q ss_pred CceeEEEccCCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCc
Q 047739 216 SSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSV 295 (1099)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~ 295 (1099)
.....+.+|..+++|+++++++|+++ .+|.. ..++
T Consensus 138 ------------~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~--------------------------------~~~~ 172 (305)
T d1xkua_ 138 ------------SSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--------------------------------LPPS 172 (305)
T ss_dssp ------------GGGBCTTGGGGCTTCCEEECCSSCCC-SCCSS--------------------------------CCTT
T ss_pred ------------ccCCCccccccccccCccccccCCcc-ccCcc--------------------------------cCCc
Confidence 11223345666666777777666665 22221 1234
Q ss_pred eeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccC
Q 047739 296 LQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEG 375 (1099)
Q Consensus 296 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 375 (1099)
|++|++++|.+++..+..|..++.+++|++++|.+++..+..|.++++|++|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 173 L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~ 251 (305)
T d1xkua_ 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251 (305)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred cCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCC
Confidence 555555555555555555666666666666666666555555666666666666666665 3455555566666666666
Q ss_pred CcCC
Q 047739 376 NRFS 379 (1099)
Q Consensus 376 N~l~ 379 (1099)
|+|+
T Consensus 252 N~i~ 255 (305)
T d1xkua_ 252 NNIS 255 (305)
T ss_dssp SCCC
T ss_pred CccC
Confidence 6655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=8.3e-25 Score=241.85 Aligned_cols=269 Identities=20% Similarity=0.292 Sum_probs=141.9
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEcc
Q 047739 367 SLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLS 446 (1099)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 446 (1099)
.++++|-++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3455666666666 4454443 345555555555554444455555555555555555554445555555555555555
Q ss_pred CCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCC
Q 047739 447 ENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNV 526 (1099)
Q Consensus 447 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 526 (1099)
+|+++. +|..+ ...++.|++.+|.+.+..+..+.....+..++...|... .....
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~----------------------~~~~~ 142 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK----------------------SSGIE 142 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC----------------------GGGBC
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccc----------------------ccCCC
Confidence 555542 22211 123444444444444333223333333444444333221 11122
Q ss_pred chhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccC
Q 047739 527 PEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLS 606 (1099)
Q Consensus 527 p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 606 (1099)
+..|..+++|+++++++|.+.. +|..+ +++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+..+.+++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 2334445555555555555542 22222 34555666666666555555666666666666666666655556666666
Q ss_pred cccEEeccCccccccCCcccCCCCCCCEEECcCccccccCCh------hhhccCCCCeeecCCCcCC
Q 047739 607 HLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPD------SLAKLSNLAVLDLSANNLS 667 (1099)
Q Consensus 607 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~------~l~~l~~L~~L~ls~N~l~ 667 (1099)
+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+..... ....+.+|+.|++++|++.
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 6666666666666 4566666666666666666666632122 2334566777777777774
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.6e-24 Score=235.03 Aligned_cols=223 Identities=24% Similarity=0.251 Sum_probs=134.0
Q ss_pred EEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEcc-CC
Q 047739 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLE-GN 376 (1099)
Q Consensus 298 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls-~N 376 (1099)
.++.++++++. +|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.++.+ .|
T Consensus 15 ~v~c~~~~L~~-iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCSS-CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCCc-cCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 45677777774 454443 467788888888876555667777777777777777777666666677777776654 34
Q ss_pred cCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCc
Q 047739 377 RFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPA 456 (1099)
Q Consensus 377 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 456 (1099)
.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|+++...+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 55544455666666666666666666555555555556666666666666544444555555555555555555555555
Q ss_pred ccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeecccccc
Q 047739 457 SIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLS 523 (1099)
Q Consensus 457 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 523 (1099)
.|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|..+++|+.|+|++|.+.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 5555555555555555555555555555555555555555555444444445555555555555444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.6e-24 Score=231.78 Aligned_cols=223 Identities=22% Similarity=0.250 Sum_probs=154.5
Q ss_pred EEeccccccccCCCCCCCCCCceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEcc-CC
Q 047739 274 VQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMA-NN 352 (1099)
Q Consensus 274 l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~-~n 352 (1099)
+..++.+++.+|.. ..+.+++|+|++|+|+.+.+.+|.++++|++||+++|+|....+..+.++..++.+... .|
T Consensus 16 v~c~~~~L~~iP~~----ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 16 TSCPQQGLQAVPVG----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EECCSSCCSSCCTT----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEcCCCCCCccCCC----CCCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 45566666666542 23456777777777776666667777777777777777776666666677777776654 45
Q ss_pred ccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccch
Q 047739 353 SFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPE 432 (1099)
Q Consensus 353 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 432 (1099)
.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|.++++.+..|..+++|++|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 56655566677777777777777777655566666677777777777777766667777777777777777777766666
Q ss_pred hhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcc
Q 047739 433 EVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSG 500 (1099)
Q Consensus 433 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 500 (1099)
.|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|.++++|++|++++|.+..
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 67777777777777777776667777777777777777777776666667777777777777776653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=7.1e-22 Score=213.01 Aligned_cols=198 Identities=24% Similarity=0.214 Sum_probs=99.0
Q ss_pred CCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceec
Q 047739 461 LSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLN 540 (1099)
Q Consensus 461 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 540 (1099)
...+.+.+.+++.++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .+..+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccc
Confidence 344445555665555 3444332 345555555555554444455555555555555555542 22 233444555555
Q ss_pred ccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccc
Q 047739 541 LSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTG 620 (1099)
Q Consensus 541 Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 620 (1099)
|++|++ + ..+..+.++++|++|++++|.+.+..+..+..+.+++.|++++|.+++
T Consensus 84 Ls~N~l------------------------~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 84 LSHNQL------------------------Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (266)
T ss_dssp CCSSCC------------------------S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred cccccc------------------------c-ccccccccccccccccccccccceeeccccccccccccccccccccce
Confidence 555554 4 233344445555555555555544444444455555555555555553
Q ss_pred cCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCccccccccccccCCCC
Q 047739 621 EIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLSSIFGLMNFNVSSNN 689 (1099)
Q Consensus 621 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~l~~n~ 689 (1099)
..+..+..+++|+.|++++|+|++..+..|..+++|+.|||++|+|+ .+|+.+..+..|+.+++++|+
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 33334444555555555555555444444555555555555555555 455554455555555544443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.2e-21 Score=209.05 Aligned_cols=198 Identities=20% Similarity=0.193 Sum_probs=137.9
Q ss_pred ceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEcc
Q 047739 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLE 374 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 374 (1099)
.+.+.+.++++|+. +|..+. +++++|||++|+|++..+.+|.++++|++|+|++|+|+.. + .+..+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence 34556777777775 454443 4688888888888766667788888888888888888743 2 34667788888888
Q ss_pred CCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 375 GNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
+|+++ ..+..+..+++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 88877 45666777777777777777777666777777777777777777777555555666677777777777776666
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 499 (1099)
+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 666666666666666666666 55655666666666666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.8e-19 Score=202.56 Aligned_cols=138 Identities=30% Similarity=0.454 Sum_probs=98.4
Q ss_pred cccceEEccCCccCcccCcccccCCcccEEEeccccCCCccCcccccCCCCceeecccccCCCcccCCcccccceeeCCC
Q 047739 90 RMLRKLSLRSNSFNGTIPATLAQCTLLRAVFLQYNSLSGNLPANIGNLSNLEILNVAANRLSGEIANDLPRNLKYFDLSS 169 (1099)
Q Consensus 90 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~N~l~~~i~~~~~~~L~~L~ls~ 169 (1099)
..|+.|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++ .+++.|++|++++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~-~lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LS-DLPPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CC-SCCTTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hh-hhccccccccccc
Confidence 35777888888776 57753 457788888888887 667654 467788888888763 33 3567789999999
Q ss_pred CccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCCCccEEEccc
Q 047739 170 NGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALPKLQVVSLAQ 249 (1099)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 249 (1099)
|.++ .+|. ++++++|++|++++|.++. .|.. ...+..+.+..+... ....++.++.++.|+++.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~---------~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKK---------LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN 171 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSC---------CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCS
T ss_pred cccc-cccc-hhhhccceeeccccccccc---------cccc---cccccchhhcccccc--ccccccccccceeccccc
Confidence 9988 5564 6789999999999988873 2222 235666777666554 344567788888888888
Q ss_pred ccCC
Q 047739 250 NNLS 253 (1099)
Q Consensus 250 N~l~ 253 (1099)
|.+.
T Consensus 172 n~~~ 175 (353)
T d1jl5a_ 172 NSLK 175 (353)
T ss_dssp SCCS
T ss_pred cccc
Confidence 8776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=4.6e-19 Score=199.23 Aligned_cols=306 Identities=26% Similarity=0.335 Sum_probs=150.9
Q ss_pred ceeEEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEcc
Q 047739 295 VLQVLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLE 374 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 374 (1099)
++++|||++|.++. +|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++. ++. + .++|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh-h--cccccccccc
Confidence 46677777777764 4442 356777777777776 44543 2456666666666652 221 1 1346666666
Q ss_pred CCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCcccc
Q 047739 375 GNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEV 454 (1099)
Q Consensus 375 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 454 (1099)
+|.+. .+|. ++.+++|++|++++|.+.... .....+..+.+.++.... ...+..+..++.|++++|.+
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~---- 174 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL---- 174 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCC----
T ss_pred ccccc-cccc-hhhhccceeeccccccccccc----cccccccchhhccccccc--cccccccccceecccccccc----
Confidence 66665 3443 345555555555555554221 112334444444443321 22333444444455444444
Q ss_pred CcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccc
Q 047739 455 PASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLM 534 (1099)
Q Consensus 455 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 534 (1099)
.. .+.. ....+.+...++.+. ..+ .+..++.|+.+++++|.... .+. ...
T Consensus 175 --------------------~~-~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~ 224 (353)
T d1jl5a_ 175 --------------------KK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPP 224 (353)
T ss_dssp --------------------SS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCT
T ss_pred --------------------cc-cccc---ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---ccc
Confidence 31 1111 112233333333332 111 23344555555555554442 222 123
Q ss_pred ccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEecc
Q 047739 535 SLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLS 614 (1099)
Q Consensus 535 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 614 (1099)
++..+.+.+|.+.. .+.. ..++...++..+.+.+. +.. .......++..|.+.+ ++ ..+++|++|+|+
T Consensus 225 ~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 225 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC---DLPPSLEELNVS 292 (353)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC---CCCTTCCEEECC
T ss_pred cccccccccccccc-cccc---ccccccccccccccccc-ccc---cchhcccccccCcccc-cc---ccCCCCCEEECC
Confidence 44455555555432 1111 22344444444443311 110 1233455666666652 22 234567777777
Q ss_pred CccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCCCcc
Q 047739 615 INNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPANLS 675 (1099)
Q Consensus 615 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 675 (1099)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|+. +++|+.|++++|+++ .+|....
T Consensus 293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~ 344 (353)
T d1jl5a_ 293 NNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE 344 (353)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT
T ss_pred CCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc
Confidence 77777 56643 466777777777776 56643 356777778887776 4665443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=7.7e-22 Score=201.09 Aligned_cols=164 Identities=13% Similarity=0.062 Sum_probs=119.5
Q ss_pred cccccccccccceeEEEEEECCceEEEEEECCCCCcc-------------------HHHHHHHHHHhhhccCCcceEEee
Q 047739 805 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGSLD-------------------ENLFRKEAEFLGKVRHRNLTVLRG 865 (1099)
Q Consensus 805 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~H~niv~l~~ 865 (1099)
+.+.++||+|+||.||+|...+|+.||||.+..+... .....+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999999999999999986432110 133457889999999999998876
Q ss_pred EEecCCCceEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccCCceecCCCCCCEEECCCCcEEE
Q 047739 866 YYAGAPDLRLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTSNMVHGDIKPQNVLFDADFEAHL 945 (1099)
Q Consensus 866 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iiH~Dlk~~NIll~~~~~~kl 945 (1099)
+.. .++||||++++.+.+ ++......++.|+++|++|||+.||+||||||+|||++++ .+++
T Consensus 82 ~~~-----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG-----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET-----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred ecC-----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence 632 279999998754322 3334456789999999999999999999999999999865 5899
Q ss_pred eccccccccCCCCCCCccccccccCccccCc--c---ccccCCCCCcCchhhHHHHH
Q 047739 946 SDFGLDRLTIPTPAEASTSTTAVGTLGYVSP--E---AALTGETTKESDVYSFGIVL 997 (1099)
Q Consensus 946 ~DfGla~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DV~S~G~il 997 (1099)
+|||.|+....... ..|... + ....+.|..++||||..--+
T Consensus 144 iDFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGW-----------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTH-----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCc-----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999975421110 011111 0 11245678999999975443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.7e-21 Score=224.98 Aligned_cols=384 Identities=17% Similarity=0.186 Sum_probs=216.0
Q ss_pred ccceEEccCCccCcc-cCcccccCCcccEEEeccccCC----CccCcccccCCCCceeecccccCCCc----ccCCcc--
Q 047739 91 MLRKLSLRSNSFNGT-IPATLAQCTLLRAVFLQYNSLS----GNLPANIGNLSNLEILNVAANRLSGE----IANDLP-- 159 (1099)
Q Consensus 91 ~L~~L~L~~n~~~~~-~p~~~~~l~~L~~L~l~~n~l~----g~~p~~~~~l~~L~~L~ls~N~l~~~----i~~~~~-- 159 (1099)
.|+.||++.|++++. +.+-+..+++++.|+|++|+++ ..|+..+..+++|++|||++|.++.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 466677777777643 2344556667777777777666 23455566677777777777776532 222221
Q ss_pred -cccceeeCCCCccCCC----CCCCCccccccccccccccccccccccccccccCcccc-ccCceeEEEccCCcCCccC-
Q 047739 160 -RNLKYFDLSSNGFSGP----IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIA-NCSSLVHLSAQGNALGGVI- 232 (1099)
Q Consensus 160 -~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~-~l~~L~~L~l~~N~l~~~~- 232 (1099)
.+|++|+|++|+++.. ++..+..+++|++|+|++|+++...... ++..+. ..............+....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~----l~~~l~~~~~~~~~~~~~~~~~~~~~~ 158 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL----LCEGLLDPQCRLEKLQLEYCSLSAASC 158 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH----HHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh----hhhcccccccccccccccccccchhhh
Confidence 3677788887777632 4556777888888888888876432211 111111 1223344444444443221
Q ss_pred ---hhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCCccccC
Q 047739 233 ---PPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQNQIRGA 309 (1099)
Q Consensus 233 ---p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 309 (1099)
...+.....++.++++.+.....--......+.. .......+++..+.+...
T Consensus 159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~-------------------------~~~~~~~l~~~~~~~~~~ 213 (460)
T d1z7xw1 159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD-------------------------SPCQLEALKLESCGVTSD 213 (460)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHH-------------------------SCCCCCEEECTTSCCBTT
T ss_pred ccccccccccccccccccccccccccccccccccccc-------------------------ccccccccccccccccch
Confidence 1234556778888888776542100000000000 012244555555555421
Q ss_pred ----cchhccCCCCccEEeCCCCcccc-----CchhhhCCCCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCC
Q 047739 310 ----FPLWLTRASTLTRLDVSGNSISG-----KIPAQIGGLWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 310 ----~~~~~~~l~~L~~L~Ls~N~i~~-----~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N 376 (1099)
....+.....++.+++++|.+.. ..+..+.....++.|++++|.+... ....+...+.++.+++++|
T Consensus 214 ~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n 293 (460)
T d1z7xw1 214 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 293 (460)
T ss_dssp HHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred hhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11233455667777777776532 1223344456677777777766532 2223445667777777777
Q ss_pred cCCCCCCcc----c-cCCCCCCeeeccCccccccCCc----cCCCCCCCCEEEcccCcCccc----cchhhh-CCCCCCE
Q 047739 377 RFSGEIPEF----L-GDIRGLKSLTLAANLFSGSIPA----SFRNLPGLENLNLRHNSLSGS----LPEEVL-GMNNLST 442 (1099)
Q Consensus 377 ~l~~~~p~~----~-~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~ 442 (1099)
.++...... + .....|+.+++++|.++..... .+...++|++|+|++|++++. +++.+. ..+.|++
T Consensus 294 ~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~ 373 (460)
T d1z7xw1 294 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 373 (460)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred cccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCE
Confidence 765322111 1 1234677777777776643322 334456788888888887643 233333 3566888
Q ss_pred EEccCCcCccc----cCcccCCCCcccEEEccCCcCCCcCCC----CCC-CCCCCCEEEeccCcCcccCC
Q 047739 443 LDLSENKFSGE----VPASIGNLSQLMVFNLSGNAFSGRIPA----SLG-NLLKLTTLDLSKQNFSGELP 503 (1099)
Q Consensus 443 L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~----~l~-~l~~L~~L~L~~n~l~~~~~ 503 (1099)
|+|++|.|+.. +...+..+++|++|+|++|+|++.... .+. +...|+.|++.+|.+.....
T Consensus 374 L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred EECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 88888888643 334456678888888888888753322 222 33478999999988875443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.8e-18 Score=183.35 Aligned_cols=219 Identities=17% Similarity=0.149 Sum_probs=144.9
Q ss_pred ceeecccccCCCcccCCcccccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeE
Q 047739 141 EILNVAANRLSGEIANDLPRNLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVH 220 (1099)
Q Consensus 141 ~~L~ls~N~l~~~i~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~ 220 (1099)
++++.++++++ .+|..+++++++|||++|+|+...+..|.++++|++|++++|.+...++ +..+..++++++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~-------~~~f~~l~~l~~ 82 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE-------ADVFSNLPKLHE 82 (242)
T ss_dssp SEEEEESCSCS-SCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEEC-------SSSEESCTTCCE
T ss_pred CEEEEeCCCCC-CcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceee-------cccccccccccc
Confidence 56677777777 7888888889999999999985555679999999999999999874222 224556888898
Q ss_pred EEcc-CCcCCccChhhhcCCCCccEEEcccccCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEE
Q 047739 221 LSAQ-GNALGGVIPPAIGALPKLQVVSLAQNNLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVL 299 (1099)
Q Consensus 221 L~l~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L 299 (1099)
+.+. .|++....+..|..+++|++|++++|++... +...+ ......+..+
T Consensus 83 l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~-~~~~~----------------------------~~~l~~l~~~ 133 (242)
T d1xwdc1 83 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHK----------------------------IHSLQKVLLD 133 (242)
T ss_dssp EEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSC-CCCTT----------------------------TCBSSCEEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccc-ccccc----------------------------cccccccccc
Confidence 8875 5788888889999999999999999998732 22111 1123445555
Q ss_pred EcCCCccccCcchhccCCC-CccEEeCCCCccccCchhhhCCCCCCCE-EEccCCccCccCCccccCCCCCCEEEccCCc
Q 047739 300 DLQQNQIRGAFPLWLTRAS-TLTRLDVSGNSISGKIPAQIGGLWRLEE-LKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377 (1099)
Q Consensus 300 ~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~-L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 377 (1099)
...++++....+..|..++ .++.|++++|+++...+..| ...+++. +.+++|+++...+..|.++++|++|+|++|+
T Consensus 134 ~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~ 212 (242)
T d1xwdc1 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 212 (242)
T ss_dssp EESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSC
T ss_pred cccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCc
Confidence 5566666655555555443 56667777777664333333 3334333 3456666664444556666777777777777
Q ss_pred CCCCCCccccCCCCCCeeec
Q 047739 378 FSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 378 l~~~~p~~~~~l~~L~~L~L 397 (1099)
|+...+..|.++++|+.|++
T Consensus 213 l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 213 IHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCCCSSSCTTCCEEESSSE
T ss_pred CCccCHHHHcCCcccccCcC
Confidence 66433444555555555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=4.8e-21 Score=223.98 Aligned_cols=375 Identities=19% Similarity=0.155 Sum_probs=194.2
Q ss_pred ceeEEEcCCCccccC-cchhccCCCCccEEeCCCCcccc----CchhhhCCCCCCCEEEccCCccCcc----CCcccc-C
Q 047739 295 VLQVLDLQQNQIRGA-FPLWLTRASTLTRLDVSGNSISG----KIPAQIGGLWRLEELKMANNSFGGA----VPVEIK-Q 364 (1099)
Q Consensus 295 ~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~-~ 364 (1099)
.|+.||+++|++++. +.+.+..++++++|+|++|.|+. .++..+..+++|++|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 477777777777652 23345566777788888887763 2344566777788888877777532 122222 2
Q ss_pred CCCCCEEEccCCcCCCC----CCccccCCCCCCeeeccCccccccCCcc-----CCCCCCCCEEEcccCcCcccc----c
Q 047739 365 CSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAANLFSGSIPAS-----FRNLPGLENLNLRHNSLSGSL----P 431 (1099)
Q Consensus 365 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~----~ 431 (1099)
..+|++|+|++|++++. ++..+..+++|++|+|++|.++...... ................+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 34677788887777643 3445666777777777777765321111 112233444444444433211 1
Q ss_pred hhhhCCCCCCEEEccCCcCccccC----ccc-CCCCcccEEEccCCcCCCcC----CCCCCCCCCCCEEEeccCcCcc--
Q 047739 432 EEVLGMNNLSTLDLSENKFSGEVP----ASI-GNLSQLMVFNLSGNAFSGRI----PASLGNLLKLTTLDLSKQNFSG-- 500 (1099)
Q Consensus 432 ~~~~~l~~L~~L~Ls~N~l~~~~~----~~l-~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~n~l~~-- 500 (1099)
..+.....++.++++++.+..... ..+ ..-.....+++.++.+.... ...+.....++.+++++|.+..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 223345667777777766542110 011 11234455666666554211 1123345667777777776542
Q ss_pred ---cCCcccCCCCccceeeeccccccCCC----chhhhcccccceecccccccCCCCCCcc-----cccceeeEEEccCC
Q 047739 501 ---ELPIELAGLPNLQVIALQENKLSGNV----PEGFSSLMSLRYLNLSFNGFVGQIPATF-----SFLRSVVVLSFSGN 568 (1099)
Q Consensus 501 ---~~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~~~l-----~~l~~L~~L~ls~N 568 (1099)
...........++.+++++|.+.... ...+...+.++.+++++|.+.+.....+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 12233344556777777777665321 2233455667777777776643221111 11234566666666
Q ss_pred cCCCCCCC----CCCCCCCCceEEecCCcccCc----CCcchh-ccCcccEEeccCccccc----cCCcccCCCCCCCEE
Q 047739 569 HISGSIPP----ELGNCSDLEVLELRSNSLTGH----IPTDIS-HLSHLNVLDLSINNLTG----EIPDEISKCSSLRSL 635 (1099)
Q Consensus 569 ~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L 635 (1099)
.++..... .+..+++|++|+|++|++++. ++..+. ..+.|+.|+|++|+|+. .++..+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 55432111 122334566666666665432 112222 23446666666666653 233344455666666
Q ss_pred ECcCccccccCChhhh-----ccCCCCeeecCCCcCCCc
Q 047739 636 LVNSNHLSGGIPDSLA-----KLSNLAVLDLSANNLSGE 669 (1099)
Q Consensus 636 ~Ls~N~l~~~~p~~l~-----~l~~L~~L~ls~N~l~~~ 669 (1099)
+|++|+|+......+. +...|+.|++++|.+..+
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 6666666533222221 122466666666665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.6e-17 Score=172.36 Aligned_cols=188 Identities=24% Similarity=0.382 Sum_probs=80.3
Q ss_pred cCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCe
Q 047739 315 TRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKS 394 (1099)
Q Consensus 315 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 394 (1099)
..+.+|++|++++|.|+. + ..+..+++|++|++++|++++.. .+..+++|+++++++|.++ .++ .+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-cccccccccc
Confidence 334445555555555542 2 23444555555555555444322 1444445555555554444 121 2334444444
Q ss_pred eeccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcC
Q 047739 395 LTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAF 474 (1099)
Q Consensus 395 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 474 (1099)
++++++...+. ..+...+.++.+.++++.+... ..+.++++|+.|++++|.+
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~------------------------ 163 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV------------------------ 163 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC------------------------
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccc------------------------
Confidence 44444433321 1123334444444444444321 1233344444444444444
Q ss_pred CCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceeccc
Q 047739 475 SGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLS 542 (1099)
Q Consensus 475 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1099)
.+.. .+.++++|+.|++++|++++. + .++.+++|++|+|++|++++. + .+.++++|++|+++
T Consensus 164 ~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 164 SDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred ccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 3211 134444444444444444422 1 244445555555555555432 2 24455555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.2e-17 Score=172.88 Aligned_cols=207 Identities=21% Similarity=0.327 Sum_probs=144.6
Q ss_pred CccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeecc
Q 047739 319 TLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLA 398 (1099)
Q Consensus 319 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 398 (1099)
++..++++.+++++.. .++++.+|++|++.+|.++. + ..+.++++|++|++++|++++..| +.
T Consensus 20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~----------- 82 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LK----------- 82 (227)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GT-----------
T ss_pred HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cc-----------
Confidence 3455667777776543 44556677777777777764 2 346677777777777777663222 44
Q ss_pred CccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcC
Q 047739 399 ANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRI 478 (1099)
Q Consensus 399 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 478 (1099)
++++|+.+++++|.++. + ..+.++++|+.++++++...+. ..+...+.++.+.++++.+....
T Consensus 83 -------------~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~ 145 (227)
T d1h6ua2 83 -------------NLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS 145 (227)
T ss_dssp -------------TCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG
T ss_pred -------------ccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh
Confidence 44555555555555542 2 2355666666666666665432 23556677777777777776432
Q ss_pred CCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhcccccceecccccccCCCCCCcccccc
Q 047739 479 PASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLR 558 (1099)
Q Consensus 479 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 558 (1099)
.+.++++|++|++++|.+.+. ..+.++++|+.|+|++|++++. + .+.++++|++|+|++|++++..| +..++
T Consensus 146 --~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~ 217 (227)
T d1h6ua2 146 --PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTS 217 (227)
T ss_dssp --GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCT
T ss_pred --hhccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCC
Confidence 367788999999999998744 3488999999999999999853 3 48899999999999999986543 88999
Q ss_pred eeeEEEccC
Q 047739 559 SVVVLSFSG 567 (1099)
Q Consensus 559 ~L~~L~ls~ 567 (1099)
+|+.|++++
T Consensus 218 ~L~~L~lsn 226 (227)
T d1h6ua2 218 NLFIVTLTN 226 (227)
T ss_dssp TCCEEEEEE
T ss_pred CCCEEEeeC
Confidence 999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.9e-17 Score=173.89 Aligned_cols=220 Identities=15% Similarity=0.139 Sum_probs=117.3
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCCCEEEcccCcCcccc-chhhhCCCCCCEEEccC
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGLENLNLRHNSLSGSL-PEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~ 447 (1099)
+.++.+++.++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56666666666 5554443 45666777777666655566777777777777777665433 33456666666666543
Q ss_pred -CcCccccCcccCCCCcccEEEccCCcCCCcCCC-CCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCC
Q 047739 448 -NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA-SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGN 525 (1099)
Q Consensus 448 -N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 525 (1099)
|.+....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+....+..+.+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~--------------- 152 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------- 152 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB---------------
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc---------------
Confidence 556555666666666666666666666532221 233344444445555555443333343332
Q ss_pred CchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhcc
Q 047739 526 VPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHL 605 (1099)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 605 (1099)
..++.|++++|+++...+..+.....++.+.+++|+++...+..|.++++|++|+|++|+++...+..+.++
T Consensus 153 --------~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 153 --------FESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp --------SSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred --------ccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 134444444444443222222222222223344555553333345666666666666666663333345555
Q ss_pred CcccEEecc
Q 047739 606 SHLNVLDLS 614 (1099)
Q Consensus 606 ~~L~~L~Ls 614 (1099)
++|+.+++.
T Consensus 225 ~~L~~l~~~ 233 (242)
T d1xwdc1 225 KKLRARSTY 233 (242)
T ss_dssp CEEESSSEE
T ss_pred cccccCcCC
Confidence 555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=2.5e-17 Score=167.35 Aligned_cols=176 Identities=18% Similarity=0.206 Sum_probs=123.1
Q ss_pred eeeeccccccCCCchhhhcccccceecccccccCC-CCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCC
Q 047739 514 VIALQENKLSGNVPEGFSSLMSLRYLNLSFNGFVG-QIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSN 592 (1099)
Q Consensus 514 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N 592 (1099)
+++.++++++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|++++|++.+..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4455555555 3444432 466777777777765 33556677777777888888877777778888888888888888
Q ss_pred cccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeecCCCcCCCcCCC
Q 047739 593 SLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDLSANNLSGEIPA 672 (1099)
Q Consensus 593 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 672 (1099)
+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..... ...-...++.+.+..|.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh
Confidence 8886666778888888888888888887667778888888888888888874332 222223466677888888877776
Q ss_pred CccccccccccccCCCCcccCCCC
Q 047739 673 NLSSIFGLMNFNVSSNNLQAFANN 696 (1099)
Q Consensus 673 ~~~~~~~l~~l~l~~n~~~~~~~n 696 (1099)
.+ .+++..+++.|++.|-..|
T Consensus 168 ~l---~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp TT---TTSBGGGSCTTTCCCCCC-
T ss_pred hh---cCCEeeecCHhhCcCCCCC
Confidence 54 4456677777776654433
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.4e-16 Score=164.13 Aligned_cols=146 Identities=26% Similarity=0.346 Sum_probs=59.6
Q ss_pred CCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 318 STLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 318 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
.+|++|++++|.|++. + .+..+++|++|+|++|++++.. .+..+++|++|++++|++++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 3455555555555422 1 2444445555555555444321 23444445555555554442 22 2334444444444
Q ss_pred cCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCC
Q 047739 398 AANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 398 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
++|.+.. ...+.++++|+.+++++|.+++ +..+..+++|+.+++++|++++.. .++++++|+.|+|++|+++
T Consensus 120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 120 EHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp TTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence 4443331 1223334444444444444432 122333444444444444443211 1333444444444444433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=5.1e-17 Score=165.01 Aligned_cols=172 Identities=26% Similarity=0.325 Sum_probs=100.3
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCeeeccCccccc-cCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccC
Q 047739 369 SLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSG-SIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSE 447 (1099)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 447 (1099)
++++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|++|+|++|++....+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45666666666 5555443 456666666666654 3345556666677777777766666666666666677777777
Q ss_pred CcCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCc
Q 047739 448 NKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVP 527 (1099)
Q Consensus 448 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 527 (1099)
|+|+...+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+...... ..-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCC
Confidence 776666666666666666666666666665566666666666666666666532111 0011224444455555544444
Q ss_pred hhhhcccccceecccccccC
Q 047739 528 EGFSSLMSLRYLNLSFNGFV 547 (1099)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~ 547 (1099)
..+ ..++.++|+.|.+.
T Consensus 167 ~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TTT---TTSBGGGSCTTTCC
T ss_pred hhh---cCCEeeecCHhhCc
Confidence 332 33445555555553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.9e-16 Score=163.16 Aligned_cols=183 Identities=27% Similarity=0.412 Sum_probs=113.1
Q ss_pred ccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccC
Q 047739 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAA 399 (1099)
Q Consensus 320 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 399 (1099)
....+++.+.+++.++. ..+.+|++|++++|.+++.. .+..+++|++|+|++|+|++ ++ .++.+++|++|++++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~ 99 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDE 99 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccc
Confidence 33446677777655443 34567888888888887532 47778888888888888874 33 356777777777777
Q ss_pred ccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCC
Q 047739 400 NLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIP 479 (1099)
Q Consensus 400 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 479 (1099)
|++++. + .+.++++|+.|++++|.+.. + ..+..++.++.+++++|.+++ +..+.++++|+.+++++|++++..
T Consensus 100 n~i~~l-~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~- 172 (210)
T d1h6ta2 100 NKVKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV- 172 (210)
T ss_dssp SCCCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG-
T ss_pred cccccc-c-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc-
Confidence 777643 2 46667777777777776652 2 345666667777777766653 223455566666666666655322
Q ss_pred CCCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeec
Q 047739 480 ASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQ 518 (1099)
Q Consensus 480 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 518 (1099)
.+.++++|++|++++|++++ ++ .+.++++|++|+|+
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 25555555555555555542 22 34455555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=4e-16 Score=159.24 Aligned_cols=160 Identities=27% Similarity=0.402 Sum_probs=70.0
Q ss_pred CCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeee
Q 047739 317 ASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLT 396 (1099)
Q Consensus 317 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 396 (1099)
+.++++|++++|.|+. + +.+..+++|++|++++|++++.. .+.++++|++|++++|.+. .++ .+.+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~-~~~-~l~~-------- 104 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA-DIT-PLAN-------- 104 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCG-GGTT--------
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCcc--cccCCcccccccccccccc-ccc-cccc--------
Confidence 4445555555555542 1 12444444555555555444321 1444444444554444443 122 2334
Q ss_pred ccCccccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCC
Q 047739 397 LAANLFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSG 476 (1099)
Q Consensus 397 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 476 (1099)
+++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++
T Consensus 105 ----------------l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 105 ----------------LTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp ----------------CTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC
T ss_pred ----------------ccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccC
Confidence 44444444444444321 223444444444444444432 1 134444444455555444443
Q ss_pred cCCCCCCCCCCCCEEEeccCcCcccCCcccCCCCccce
Q 047739 477 RIPASLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQV 514 (1099)
Q Consensus 477 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 514 (1099)
.. .++++++|++|++++|++++ ++ .++.+++|++
T Consensus 165 l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 165 LK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred Cc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 21 24445555555555555543 22 2444455444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=4.5e-16 Score=158.92 Aligned_cols=179 Identities=21% Similarity=0.354 Sum_probs=128.4
Q ss_pred cEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCc
Q 047739 321 TRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN 400 (1099)
Q Consensus 321 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n 400 (1099)
..++++.+.+++.++ ...+.++++|++++|.++.. +.+..+++|++|+|++|+
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~----------------------- 73 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ----------------------- 73 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSC-----------------------
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCcccccc-----------------------
Confidence 344555666554322 22345555666666555421 234444455555555554
Q ss_pred cccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEEEccCCcCccccCcccCCCCcccEEEccCCcCCCcCCC
Q 047739 401 LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTLDLSENKFSGEVPASIGNLSQLMVFNLSGNAFSGRIPA 480 (1099)
Q Consensus 401 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 480 (1099)
+++..+ ++++++|++|++++|.+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++.. + .
T Consensus 74 -l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~ 144 (199)
T d2omxa2 74 -LTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-S 144 (199)
T ss_dssp -CCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-G
T ss_pred -ccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-c
Confidence 443322 6667888888888888874 33 488999999999999998754 358899999999999999984 3 3
Q ss_pred CCCCCCCCCEEEeccCcCcccCCcccCCCCccceeeeccccccCCCchhhhccccccee
Q 047739 481 SLGNLLKLTTLDLSKQNFSGELPIELAGLPNLQVIALQENKLSGNVPEGFSSLMSLRYL 539 (1099)
Q Consensus 481 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 539 (1099)
.+..+++|++|++++|++++.. .++++++|+.|++++|++++ ++ .+.++++|+.|
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 5889999999999999998543 48899999999999999985 43 58889998876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.8e-15 Score=163.54 Aligned_cols=85 Identities=20% Similarity=0.250 Sum_probs=55.2
Q ss_pred ccceeeCCCCccCCCCCCCCccccccccccccccccccccccccccccCccccccCceeEEEccCCcCCccChhhhcCCC
Q 047739 161 NLKYFDLSSNGFSGPIPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQGNALGGVIPPAIGALP 240 (1099)
Q Consensus 161 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 240 (1099)
.+..+.++...+...+ .......+|++||++++.++.. .++.-+.++++|++|+++++.++...+.+++.++
T Consensus 24 ~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~-------~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~ 95 (284)
T d2astb2 24 GVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVS-------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95 (284)
T ss_dssp TCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHH-------HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCT
T ss_pred cceEeeccccccccch-hhhccCCCCCEEECCCCccCHH-------HHHHHHHhCCCcccccccccCCCcHHHHHHhcCC
Confidence 3445555555554332 2233456788888888777621 2334456677888888888888777777787888
Q ss_pred CccEEEcccc-cCC
Q 047739 241 KLQVVSLAQN-NLS 253 (1099)
Q Consensus 241 ~L~~L~Ls~N-~l~ 253 (1099)
+|++|+|+++ .++
T Consensus 96 ~L~~L~Ls~c~~it 109 (284)
T d2astb2 96 NLVRLNLSGCSGFS 109 (284)
T ss_dssp TCSEEECTTCBSCC
T ss_pred CCcCcccccccccc
Confidence 8888888774 443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=9.3e-16 Score=165.85 Aligned_cols=181 Identities=17% Similarity=0.231 Sum_probs=110.4
Q ss_pred cccceeeCCCCccCCC-CCCCCccccccccccccccccccccccccccccCccccccCceeEEEccC-CcCCcc-Chhhh
Q 047739 160 RNLKYFDLSSNGFSGP-IPTSISNLSQLQLINFSFNKFSREVPATFEGTLPSAIANCSSLVHLSAQG-NALGGV-IPPAI 236 (1099)
Q Consensus 160 ~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~g~lp~~l~~l~~L~~L~l~~-N~l~~~-~p~~~ 236 (1099)
.+|++|||+++.++.. ++..+.++++|++|+|++++++ +..+..++.+++|++|++++ +.++.. +...+
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~--------~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~ 117 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS--------DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCC--------HHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCC--------cHHHHHHhcCCCCcCccccccccccccccchhh
Confidence 3555666666655432 3344667778888888887776 34445666777888888887 355532 22234
Q ss_pred cCCCCccEEEcccc-cCCCccCcccccccCCCCCcceEEEeccccccccCCCCCCCCCCceeEEEcCCC--cccc-Ccch
Q 047739 237 GALPKLQVVSLAQN-NLSGVVPASMFCNVSGYPPSIRVVQLGFNAFTNVAGPETGSCSSVLQVLDLQQN--QIRG-AFPL 312 (1099)
Q Consensus 237 ~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n--~l~~-~~~~ 312 (1099)
..+++|++|+++++ .++.......+. ...+.|+.|+++++ .++. .+..
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~~~~~----------------------------~~~~~L~~L~l~~~~~~i~~~~l~~ 169 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQVAVA----------------------------HVSETITQLNLSGYRKNLQKSDLST 169 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHH----------------------------HSCTTCCEEECCSCGGGSCHHHHHH
T ss_pred HHHHhccccccccccccccccchhhhc----------------------------ccccccchhhhcccccccccccccc
Confidence 56788888888875 343211000000 11345677777654 2332 1233
Q ss_pred hccCCCCccEEeCCCC-ccccCchhhhCCCCCCCEEEccCC-ccCccCCccccCCCCCCEEEccCC
Q 047739 313 WLTRASTLTRLDVSGN-SISGKIPAQIGGLWRLEELKMANN-SFGGAVPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 313 ~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~Ls~N 376 (1099)
.+..+++|++|||++| .+++.....+.++++|++|+|++| .+++.....+.++++|++|+++++
T Consensus 170 l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3456777888888775 466666667777777888888774 566555566777777777777776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=2.8e-15 Score=167.37 Aligned_cols=237 Identities=21% Similarity=0.262 Sum_probs=133.6
Q ss_pred chhccCCCCccEEeCCCCccccC----chhhhCCCCCCCEEEccCCccCcc----------CCccccCCCCCCEEEccCC
Q 047739 311 PLWLTRASTLTRLDVSGNSISGK----IPAQIGGLWRLEELKMANNSFGGA----------VPVEIKQCSSLSLLDLEGN 376 (1099)
Q Consensus 311 ~~~~~~l~~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~----------~~~~l~~l~~L~~L~Ls~N 376 (1099)
...+.....|++|+|++|.|... +...+...++|+.|+++++..... +...+..+++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 34456667777777777777533 233455667777777776654321 1223455677777888877
Q ss_pred cCCCCC----CccccCCCCCCeeeccCccccccCCc-------------cCCCCCCCCEEEcccCcCccc----cchhhh
Q 047739 377 RFSGEI----PEFLGDIRGLKSLTLAANLFSGSIPA-------------SFRNLPGLENLNLRHNSLSGS----LPEEVL 435 (1099)
Q Consensus 377 ~l~~~~----p~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~N~l~~~----~~~~~~ 435 (1099)
.++... ...+...++|++|++++|.+...... .....+.|+.+++++|+++.. +...+.
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~ 183 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence 776532 23344556677777777765421110 113456777777777777533 223344
Q ss_pred CCCCCCEEEccCCcCccc-----cCcccCCCCcccEEEccCCcCCCc----CCCCCCCCCCCCEEEeccCcCcccCCccc
Q 047739 436 GMNNLSTLDLSENKFSGE-----VPASIGNLSQLMVFNLSGNAFSGR----IPASLGNLLKLTTLDLSKQNFSGELPIEL 506 (1099)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~l 506 (1099)
....|+.|+|++|.++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|++++|.+++.....+
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l 263 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence 567777777777777532 233455666777777777766532 22344556667777777776654322222
Q ss_pred ----C--CCCccceeeeccccccCCC----chhhh-cccccceecccccccC
Q 047739 507 ----A--GLPNLQVIALQENKLSGNV----PEGFS-SLMSLRYLNLSFNGFV 547 (1099)
Q Consensus 507 ----~--~l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~ 547 (1099)
. ..+.|++|++++|.++... ...+. ++++|++|+|++|.+.
T Consensus 264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 1 1244666666666654321 11221 3445666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=7.1e-15 Score=164.05 Aligned_cols=247 Identities=16% Similarity=0.184 Sum_probs=112.3
Q ss_pred cCccccccCceeEEEccCCcCCcc----ChhhhcCCCCccEEEcccccCCCcc---Ccc---cccccCCCCCcceEEEec
Q 047739 208 LPSAIANCSSLVHLSAQGNALGGV----IPPAIGALPKLQVVSLAQNNLSGVV---PAS---MFCNVSGYPPSIRVVQLG 277 (1099)
Q Consensus 208 lp~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~---p~~---~~~~~~~~~~~l~~l~l~ 277 (1099)
+...+...+.|++|+|++|.++.. +..++...++|+.|+++++.....- |.. ++..
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~-------------- 88 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA-------------- 88 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH--------------
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHH--------------
Confidence 334455566666666766666432 2234555667777777666543111 100 0000
Q ss_pred cccccccCCCCCCCCCCceeEEEcCCCccccC----cchhccCCCCccEEeCCCCccccCchhh-------------hCC
Q 047739 278 FNAFTNVAGPETGSCSSVLQVLDLQQNQIRGA----FPLWLTRASTLTRLDVSGNSISGKIPAQ-------------IGG 340 (1099)
Q Consensus 278 ~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~p~~-------------~~~ 340 (1099)
....++|++|+|++|.++.. +...+...++|++|++++|.++...... ...
T Consensus 89 ------------l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~ 156 (344)
T d2ca6a1 89 ------------LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKN 156 (344)
T ss_dssp ------------HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ------------HhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccccccccccccccccc
Confidence 00123455555555555432 2333445566666666666654211111 123
Q ss_pred CCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCCCCC
Q 047739 341 LWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNLPGL 416 (1099)
Q Consensus 341 l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 416 (1099)
...|+.|.+++|.++.. +...+..+++|++|+|++|+|+.... ...+...+..+++|
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~-------------------~~~l~~~l~~~~~L 217 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQEL 217 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTC
T ss_pred Ccccceeecccccccccccccccchhhhhhhhccccccccccccccc-------------------ccchhhhhcchhhh
Confidence 34555555555555422 12223344555555555555542100 00112233344455
Q ss_pred CEEEcccCcCccc----cchhhhCCCCCCEEEccCCcCccccCcc----cC--CCCcccEEEccCCcCCCcC----CCCC
Q 047739 417 ENLNLRHNSLSGS----LPEEVLGMNNLSTLDLSENKFSGEVPAS----IG--NLSQLMVFNLSGNAFSGRI----PASL 482 (1099)
Q Consensus 417 ~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----l~--~l~~L~~L~L~~N~l~~~~----~~~l 482 (1099)
+.|+|++|.++.. +...+...++|++|+|++|.|++..... +. ..+.|+.|++++|+|+... ...+
T Consensus 218 ~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l 297 (344)
T d2ca6a1 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297 (344)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHH
Confidence 5555555554322 2223344455555555555554321111 11 1244556666666554321 1122
Q ss_pred C-CCCCCCEEEeccCcCc
Q 047739 483 G-NLLKLTTLDLSKQNFS 499 (1099)
Q Consensus 483 ~-~l~~L~~L~L~~n~l~ 499 (1099)
. ++++|+.|++++|++.
T Consensus 298 ~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 298 DEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHCTTCCEEECTTSBSC
T ss_pred HccCCCCCEEECCCCcCC
Confidence 1 3456667777776665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.1e-13 Score=128.35 Aligned_cols=103 Identities=25% Similarity=0.366 Sum_probs=70.4
Q ss_pred eEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCcccEEeccCccccccCCcccCCCCCCCEEECcCc
Q 047739 561 VVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGEIPDEISKCSSLRSLLVNSN 640 (1099)
Q Consensus 561 ~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 640 (1099)
+.|++++|+++ .++ .++.+++|++|++++|+|+ .+|..++.+++|+.|++++|+|+ .+| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 35666666666 343 3667777777777777776 56666777777777777777777 344 3677777777777777
Q ss_pred cccccC-ChhhhccCCCCeeecCCCcCCC
Q 047739 641 HLSGGI-PDSLAKLSNLAVLDLSANNLSG 668 (1099)
Q Consensus 641 ~l~~~~-p~~l~~l~~L~~L~ls~N~l~~ 668 (1099)
+++... +..+..+++|+.|++++|++++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 776332 2456777777777777777763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=9.4e-14 Score=135.64 Aligned_cols=126 Identities=21% Similarity=0.196 Sum_probs=83.3
Q ss_pred hhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhccCccc
Q 047739 530 FSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISHLSHLN 609 (1099)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 609 (1099)
|.++.+|++|+|++|+++ .++..+..+++|+.|++++|+|+ .++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 344556666666666665 33455555666666666666666 332 467777888888888888744344456678888
Q ss_pred EEeccCccccccCC--cccCCCCCCCEEECcCccccccCCh----hhhccCCCCeee
Q 047739 610 VLDLSINNLTGEIP--DEISKCSSLRSLLVNSNHLSGGIPD----SLAKLSNLAVLD 660 (1099)
Q Consensus 610 ~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~ 660 (1099)
.|++++|+++. ++ ..+..+++|++|++++|+++ ..|. .+..+++|+.||
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 88888888763 33 35677788888888888776 3342 467777777776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=9.6e-14 Score=135.57 Aligned_cols=109 Identities=18% Similarity=0.155 Sum_probs=46.2
Q ss_pred CCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCee
Q 047739 316 RASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSL 395 (1099)
Q Consensus 316 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 395 (1099)
+..+|++|||++|+|+. ++..+..+++|+.|+|++|+|+.. +.+..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 33444444444444442 233334444444444444444422 124444444444444444443222333334444444
Q ss_pred eccCccccccCC-ccCCCCCCCCEEEcccCcCc
Q 047739 396 TLAANLFSGSIP-ASFRNLPGLENLNLRHNSLS 427 (1099)
Q Consensus 396 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 427 (1099)
++++|+|+.... ..+..+++|++|++++|.++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 444444432211 23444455555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=2.9e-13 Score=125.45 Aligned_cols=77 Identities=26% Similarity=0.350 Sum_probs=31.9
Q ss_pred EEEcCCCccccCcchhccCCCCccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCc
Q 047739 298 VLDLQQNQIRGAFPLWLTRASTLTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNR 377 (1099)
Q Consensus 298 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 377 (1099)
+|+|++|+|+.. + .+..+++|++||+++|+|+ .+|..|+.+++|++|++++|.+++. + .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 344444444422 2 1444444444444444444 2333344444444444444444321 1 23344444444444444
Q ss_pred CC
Q 047739 378 FS 379 (1099)
Q Consensus 378 l~ 379 (1099)
|+
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=1.3e-13 Score=139.67 Aligned_cols=130 Identities=28% Similarity=0.357 Sum_probs=77.6
Q ss_pred CCchhhhcccccceecccccccCCCCCCcccccceeeEEEccCCcCCCCCCCCCCCCCCCceEEecCCcccCcCCcchhc
Q 047739 525 NVPEGFSSLMSLRYLNLSFNGFVGQIPATFSFLRSVVVLSFSGNHISGSIPPELGNCSDLEVLELRSNSLTGHIPTDISH 604 (1099)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1099)
.++..+..+++|++|+|++|+++. ++ .+..+++|+.|++++|+|+ .+|.....+++|++|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 344556666666666666666653 22 3555666666666666665 344433444566777777777763 3 34666
Q ss_pred cCcccEEeccCccccccCC--cccCCCCCCCEEECcCccccccCChh----------hhccCCCCeee
Q 047739 605 LSHLNVLDLSINNLTGEIP--DEISKCSSLRSLLVNSNHLSGGIPDS----------LAKLSNLAVLD 660 (1099)
Q Consensus 605 l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~L~ 660 (1099)
+++|+.|++++|+++. ++ ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 7777777777777763 33 34666777777777777765333221 45566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=9.5e-14 Score=140.63 Aligned_cols=113 Identities=18% Similarity=0.258 Sum_probs=57.2
Q ss_pred chhhhCCCCCCCEEEccCCccCccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCccccccCCccCCCC
Q 047739 334 IPAQIGGLWRLEELKMANNSFGGAVPVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAANLFSGSIPASFRNL 413 (1099)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 413 (1099)
++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++.. +.+.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 44555555566666666665553 22 3555566666666666655 3443333334455555555555432 224444
Q ss_pred CCCCEEEcccCcCccccc-hhhhCCCCCCEEEccCCcCc
Q 047739 414 PGLENLNLRHNSLSGSLP-EEVLGMNNLSTLDLSENKFS 451 (1099)
Q Consensus 414 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 451 (1099)
++|+.|+|++|+|+.... ..+..+++|+.|+|++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555542211 23445555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=1.4e-11 Score=119.07 Aligned_cols=109 Identities=22% Similarity=0.170 Sum_probs=70.1
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCCCCCeeeccCc-cccccCCccCCCCCCCCEEEcccCcCccccchhhhCCCCCCEE
Q 047739 365 CSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTLAAN-LFSGSIPASFRNLPGLENLNLRHNSLSGSLPEEVLGMNNLSTL 443 (1099)
Q Consensus 365 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 443 (1099)
+...+.++++++.+. ..|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+...+.+|.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344556677776666 45666666667777777554 3666666667777777777777777776666667777777777
Q ss_pred EccCCcCccccCcccCCCCcccEEEccCCcCC
Q 047739 444 DLSENKFSGEVPASIGNLSQLMVFNLSGNAFS 475 (1099)
Q Consensus 444 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 475 (1099)
+|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCccc
Confidence 777777764444444333 5666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=1.4e-10 Score=111.92 Aligned_cols=103 Identities=17% Similarity=0.153 Sum_probs=45.3
Q ss_pred EEEcccCcCccccchhhhCCCCCCEEEccCC-cCccccCcccCCCCcccEEEccCCcCCCcCCCCCCCCCCCCEEEeccC
Q 047739 418 NLNLRHNSLSGSLPEEVLGMNNLSTLDLSEN-KFSGEVPASIGNLSQLMVFNLSGNAFSGRIPASLGNLLKLTTLDLSKQ 496 (1099)
Q Consensus 418 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~n 496 (1099)
.++.+++.+. ..|..+.++++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+...+..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444443 23334444444444444333 244333344444444444444444444444444444455555555555
Q ss_pred cCcccCCcccCCCCccceeeeccccc
Q 047739 497 NFSGELPIELAGLPNLQVIALQENKL 522 (1099)
Q Consensus 497 ~l~~~~~~~l~~l~~L~~L~L~~N~l 522 (1099)
+|+...+..+. ..+|+.|+|++|.+
T Consensus 91 ~l~~l~~~~~~-~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 91 ALESLSWKTVQ-GLSLQELVLSGNPL 115 (156)
T ss_dssp CCSCCCSTTTC-SCCCCEEECCSSCC
T ss_pred CCcccChhhhc-cccccccccCCCcc
Confidence 54422222222 22455555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=3.4e-08 Score=95.42 Aligned_cols=100 Identities=23% Similarity=0.182 Sum_probs=54.3
Q ss_pred CceEEecCCcccCcCCcchhccCcccEEeccCcccccc--CCcccCCCCCCCEEECcCccccccCChhhhccCCCCeeec
Q 047739 584 LEVLELRSNSLTGHIPTDISHLSHLNVLDLSINNLTGE--IPDEISKCSSLRSLLVNSNHLSGGIPDSLAKLSNLAVLDL 661 (1099)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 661 (1099)
+..++..+|... .++.....+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++...+-...+..+|+.|++
T Consensus 44 ~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L 122 (162)
T d1koha1 44 DVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122 (162)
T ss_dssp CCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCC
T ss_pred hhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeec
Confidence 333344344333 3333345567777777777777632 2233555677777777777776322223333446777777
Q ss_pred CCCcCCCcCCCC-------ccccccccccc
Q 047739 662 SANNLSGEIPAN-------LSSIFGLMNFN 684 (1099)
Q Consensus 662 s~N~l~~~~p~~-------~~~~~~l~~l~ 684 (1099)
++|+++...... +..+++|+.||
T Consensus 123 ~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 777776544322 33445555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=3.3e-08 Score=95.51 Aligned_cols=83 Identities=19% Similarity=0.137 Sum_probs=38.3
Q ss_pred ccEEeCCCCccccCchhhhCCCCCCCEEEccCCccCccC--CccccCCCCCCEEEccCCcCCCCCCccccCCCCCCeeec
Q 047739 320 LTRLDVSGNSISGKIPAQIGGLWRLEELKMANNSFGGAV--PVEIKQCSSLSLLDLEGNRFSGEIPEFLGDIRGLKSLTL 397 (1099)
Q Consensus 320 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 397 (1099)
+..++..++.+. .++..+.++++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|++
T Consensus 44 ~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L 122 (162)
T d1koha1 44 DVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122 (162)
T ss_dssp CCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCC
T ss_pred hhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeec
Confidence 333333333332 33334445566666666666665432 233445556666666666655322212222234455555
Q ss_pred cCcccc
Q 047739 398 AANLFS 403 (1099)
Q Consensus 398 ~~n~l~ 403 (1099)
++|.+.
T Consensus 123 ~~Npl~ 128 (162)
T d1koha1 123 DGNSLS 128 (162)
T ss_dssp TTSTTS
T ss_pred CCCCcC
Confidence 555444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.05 E-value=8.6e-06 Score=85.06 Aligned_cols=145 Identities=10% Similarity=0.057 Sum_probs=92.5
Q ss_pred HHHHHHHhccccccccccccceeEEEEEECCceEEEEEECCCC-CccHHHHHHHHHHhhhcc-CCcceEEeeEEecCCCc
Q 047739 796 AETVEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDG-SLDENLFRKEAEFLGKVR-HRNLTVLRGYYAGAPDL 873 (1099)
Q Consensus 796 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 873 (1099)
.++....+.|...+..+.++.+.||+...+++ .+++|+.... ......+.+|+.+++.+. +--+.+++.+... ++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCc
Confidence 45566667787777666666678999876544 4566665432 223445788999988774 3224455666653 455
Q ss_pred eEEEEeecCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHHccC------------------------------
Q 047739 874 RLLVYDYMPNGNLGTLLQEASHQDGHVLNWPMRHLIALGVARGLAFLHTS------------------------------ 923 (1099)
Q Consensus 874 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------ 923 (1099)
.++||+++++.++.+..... .....++.++++.++.||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 68999999987775433210 01122333344444444421
Q ss_pred -----------------------------CceecCCCCCCEEECCCCcEEEecccccc
Q 047739 924 -----------------------------NMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 924 -----------------------------~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
.++|+|+.|.||++++++.+.|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 26899999999999987777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.59 E-value=1e-05 Score=77.83 Aligned_cols=63 Identities=17% Similarity=0.302 Sum_probs=31.3
Q ss_pred CCCccEEeCCCC-ccccC----chhhhCCCCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCCcCC
Q 047739 317 ASTLTRLDVSGN-SISGK----IPAQIGGLWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFS 379 (1099)
Q Consensus 317 l~~L~~L~Ls~N-~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~ 379 (1099)
.++|++|+|+++ .++.. +...+...+.|++|+|++|.++.. +...+...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 355666666543 34321 223344555566666666655432 1223334455666666666655
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=2.8e-05 Score=74.73 Aligned_cols=110 Identities=12% Similarity=0.106 Sum_probs=60.9
Q ss_pred CCCCCCCEEEccCC-ccCcc----CCccccCCCCCCEEEccCCcCCCC----CCccccCCCCCCeeeccCcccccc----
Q 047739 339 GGLWRLEELKMANN-SFGGA----VPVEIKQCSSLSLLDLEGNRFSGE----IPEFLGDIRGLKSLTLAANLFSGS---- 405 (1099)
Q Consensus 339 ~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~---- 405 (1099)
.+.++|++|+|+++ .++.. +...+...++|++|+|++|.+... +.+.+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45577888888864 45432 333466677788888888877632 223344455666666666666521
Q ss_pred CCccCCCCCCCCEEEcccCcCccc-------cchhhhCCCCCCEEEccCC
Q 047739 406 IPASFRNLPGLENLNLRHNSLSGS-------LPEEVLGMNNLSTLDLSEN 448 (1099)
Q Consensus 406 ~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~Ls~N 448 (1099)
+...+...++|++|+|++|++... +...+...+.|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 223445555566666665544321 2223333455555555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=0.00011 Score=75.81 Aligned_cols=73 Identities=16% Similarity=0.133 Sum_probs=50.7
Q ss_pred ccccc-ceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCc--ceEEeeEEecCCCceEEEEeecCCCCH
Q 047739 811 LSRTR-YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRN--LTVLRGYYAGAPDLRLLVYDYMPNGNL 886 (1099)
Q Consensus 811 lg~G~-~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~lV~e~~~~gsL 886 (1099)
+..|. -+.||+...+++..+++|.-.... ...+.+|++.++.+.... +.+++++..+ +...++||+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeecccc
Confidence 34444 467999998888888888865443 345788999888875333 4456666554 4556899999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.94 E-value=0.0011 Score=72.80 Aligned_cols=74 Identities=14% Similarity=0.073 Sum_probs=46.3
Q ss_pred cccccccceeEEEEEECC-ceEEEEEECCC--------CCccHHHHHHHHHHhhhcc-C-C-cceEEeeEEecCCCceEE
Q 047739 809 NVLSRTRYGLVFKACYND-GMVLSIRRLPD--------GSLDENLFRKEAEFLGKVR-H-R-NLTVLRGYYAGAPDLRLL 876 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~-H-~-niv~l~~~~~~~~~~~~l 876 (1099)
+.||.|....||+....+ ++.|++|.-.. -.....+...|+++++.+. + | .+.+++.+. .+ ..++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~-~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE-MAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT-TTEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC-CCEE
Confidence 468999999999998754 56788885321 1122345667888888773 2 3 344455543 22 3489
Q ss_pred EEeecCCCC
Q 047739 877 VYDYMPNGN 885 (1099)
Q Consensus 877 V~e~~~~gs 885 (1099)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.89 E-value=6.5e-05 Score=72.01 Aligned_cols=65 Identities=12% Similarity=0.164 Sum_probs=33.7
Q ss_pred cCCCCccEEeCCC-CccccC----chhhhCCCCCCCEEEccCCccCcc----CCccccCCCCCCEEEccCCcCC
Q 047739 315 TRASTLTRLDVSG-NSISGK----IPAQIGGLWRLEELKMANNSFGGA----VPVEIKQCSSLSLLDLEGNRFS 379 (1099)
Q Consensus 315 ~~l~~L~~L~Ls~-N~i~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~ 379 (1099)
.+.+.|++|+|++ +.|+.. +...+...+.|++|+|++|.++.. +-..+...++++.|++++|.+.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3445666666665 334321 223344556666666666665432 1223344556666666666654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.88 E-value=8.6e-05 Score=71.13 Aligned_cols=70 Identities=21% Similarity=0.241 Sum_probs=41.7
Q ss_pred chhhhCCCCCCCEEEccC-CccCcc----CCccccCCCCCCEEEccCCcCCCCCC----ccccCCCCCCeeeccCcccc
Q 047739 334 IPAQIGGLWRLEELKMAN-NSFGGA----VPVEIKQCSSLSLLDLEGNRFSGEIP----EFLGDIRGLKSLTLAANLFS 403 (1099)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~-n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~n~l~ 403 (1099)
+.....+.++|++|+|++ +.++.. +...+...++|++|+|++|.++.... +.+...++++.+++.+|.+.
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 334445678888888887 456532 33345567788888888887764322 23334445555555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0018 Score=69.09 Aligned_cols=69 Identities=7% Similarity=0.085 Sum_probs=47.7
Q ss_pred ceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcc--eEEeeE----EecCCCceEEEEeecCCC
Q 047739 816 YGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL--TVLRGY----YAGAPDLRLLVYDYMPNG 884 (1099)
Q Consensus 816 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~----~~~~~~~~~lV~e~~~~g 884 (1099)
.-.||++...+|..+++|....+....+++..|.+.+..+....+ +..+.. ........+.|+++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 458999999999999999987666677889999999988853222 111110 111234457899999763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.81 E-value=0.011 Score=64.48 Aligned_cols=72 Identities=17% Similarity=0.243 Sum_probs=48.9
Q ss_pred cccccccceeEEEEEECCc--------eEEEEEECCCCCccHHHHHHHHHHhhhccCCcc-eEEeeEEecCCCceEEEEe
Q 047739 809 NVLSRTRYGLVFKACYNDG--------MVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNL-TVLRGYYAGAPDLRLLVYD 879 (1099)
Q Consensus 809 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~lV~e 879 (1099)
+.|+.|-.-.+|+....++ ..|.++... .....-...+|.++++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceEEE
Confidence 5688888899999987543 456666654 33334456789999998853344 356666542 68999
Q ss_pred ecCCCCH
Q 047739 880 YMPNGNL 886 (1099)
Q Consensus 880 ~~~~gsL 886 (1099)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.77 E-value=0.013 Score=61.86 Aligned_cols=159 Identities=14% Similarity=0.051 Sum_probs=85.2
Q ss_pred cCCHHHHHHHHhccccccc-----cccccceeEEEEEECCceEEEEEECCCCCccHHHHHHHHHHhhhccCCcce--EEe
Q 047739 792 KITLAETVEATRQFDEENV-----LSRTRYGLVFKACYNDGMVLSIRRLPDGSLDENLFRKEAEFLGKVRHRNLT--VLR 864 (1099)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~ 864 (1099)
+.+.+|+.....+|...+. |..|---+.|+.+..+|+ +++|+.... .+.+.+..|++++..+...++. ..+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccc
Confidence 3567788888889977554 345666788999887765 677777543 2345667788888887532221 111
Q ss_pred eEE-----ecCCCceEEEEeecCCCCHHH--------------HHhhhcc----CCC-CC-----------------CCH
Q 047739 865 GYY-----AGAPDLRLLVYDYMPNGNLGT--------------LLQEASH----QDG-HV-----------------LNW 903 (1099)
Q Consensus 865 ~~~-----~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~----~~~-~~-----------------l~~ 903 (1099)
... ..-....+.++.++.+..... .++.... ... .. ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 100 001222356667666532221 0110000 000 00 001
Q ss_pred HHHHHHHHHHHHHHHHHcc----CCceecCCCCCCEEECCCCcEEEecccccc
Q 047739 904 PMRHLIALGVARGLAFLHT----SNMVHGDIKPQNVLFDADFEAHLSDFGLDR 952 (1099)
Q Consensus 904 ~~~~~i~~~ia~~L~~LH~----~~iiH~Dlk~~NIll~~~~~~kl~DfGla~ 952 (1099)
......+..+...+.-.+. .|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222223333333332 279999999999999998777899999775
|